PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Hungerford, DW; Pollock, DA				Hungerford, DW; Pollock, DA			Alcohol interventions in emergency medicine: referral makes a difference	LANCET			English	Editorial Material							DRINKERS		Ctr Dis Control & Prevent, Natl Ctr Injury Prevent & Control, Atlanta, GA 30341 USA; Ctr Dis Control & Prevent, Informat Resources Management Off, Atlanta, GA USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Hungerford, DW (corresponding author), Ctr Dis Control & Prevent, Natl Ctr Injury Prevent & Control, Atlanta, GA 30341 USA.	DHungerford@cdc.gov						Campillo C., 1992, PROJECT IDENTIFICATI, P129; Fleming MF, 1997, JAMA-J AM MED ASSOC, V277, P1039, DOI 10.1001/jama.277.13.1039; Gentilello LM, 1999, ANN SURG, V230, P473, DOI 10.1097/00000658-199910000-00003; Glasgow RE, 2003, AM J PUBLIC HEALTH, V93, P1261, DOI 10.2105/AJPH.93.8.1261; Longabaugh R, 2001, J STUD ALCOHOL, V62, P806, DOI 10.15288/jsa.2001.62.806; Monti PM, 1999, J CONSULT CLIN PSYCH, V67, P989, DOI 10.1037/0022-006X.67.6.989; PERSSON J, 1989, ALCOHOL, V6, P403, DOI 10.1016/0741-8329(89)90011-6	7	3	3	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	OCT 9	2004	364	9442					1289	1290		10.1016/S0140-6736(04)17200-0	http://dx.doi.org/10.1016/S0140-6736(04)17200-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	860NG	15474116				2022-12-28	WOS:000224349700003
J	Petrylak, DP; Tangen, CM; Hussain, MHA; Lara, PN,J; Jones, JA; Taplin, ME; Burch, PA; Berry, D; Moinpour, C; Kohli, M; Benson, MC; Small, EJ; Raghavan, D; Crawford, ED				Petrylak, DP; Tangen, CM; Hussain, MHA; Lara, PN,J; Jones, JA; Taplin, ME; Burch, PA; Berry, D; Moinpour, C; Kohli, M; Benson, MC; Small, EJ; Raghavan, D; Crawford, ED			Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ORAL ESTRAMUSTINE; PHASE-II; CONTROLLED-TRIAL; MEN; HYDROCORTISONE; CHEMOTHERAPY; PHOSPHATE; CARCINOMA; FLUTAMIDE; TAXOTERE	BACKGROUND: Mitoxantrone-based chemotherapy palliates pain without extending survival in men with progressive androgen-independent prostate cancer. We compared docetaxel plus estramustine with mitoxantrone plus prednisone in men with metastatic, hormone-independent prostate cancer. METHODS: We randomly assigned 770 men to one of two treatments, each given in 21-day cycles: 280 mg of estramustine three times daily on days 1 through 5, 60 mg of docetaxel per square meter of body-surface area on day 2, and 60 mg of dexamethasone in three divided doses before docetaxel, or 12 mg of mitoxantrone per square meter on day 1 plus 5 mg of prednisone twice daily. The primary end point was overall survival; secondary end points were progression-free survival, objective response rates, and post-treatment declines of at least 50 percent in serum prostate-specific antigen (PSA) levels. RESULTS: Of 674 eligible patients, 338 were assigned to receive docetaxel and estramustine and 336 to receive mitoxantrone and prednisone. In an intention-to-treat analysis, the median overall survival was longer in the group given docetaxel and estramustine than in the group given mitoxantrone and prednisone (17.5 months vs. 15.6 months, P=0.02 by the log-rank test), and the corresponding hazard ratio for death was 0.80 (95 percent confidence interval, 0.67 to 0.97). The median time to progression was 6.3 months in the group given docetaxel and estramustine and 3.2 months in the group given mitoxantrone and prednisone (P<0.001 by the log-rank test). PSA declines of at least 50 percent occurred in 50 percent and 27 percent of patients, respectively (P<0.001), and objective tumor responses were observed in 17 percent and 11 percent of patients with bidimensionally measurable disease, respectively (P=0.30). Grade 3 or 4 neutropenic fevers (P=0.01), nausea and vomiting (P<0.001), and cardiovascular events (P=0.001) were more common among patients receiving docetaxel and estramustine than among those receiving mitoxantrone and prednisone. Pain relief was similar in both groups. CONCLUSIONS: The improvement in median survival of nearly two months with docetaxel and estramustine, as compared with mitoxantrone and prednisone, provides support for this approach in men with metastatic, androgen-independent prostate cancer.	Columbia Univ, Herbert Irving Comprehens Canc Ctr, New York, NY USA; SW Oncol Grp, Ctr Stat, Seattle, WA USA; Univ Michigan, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA; Univ Calif Davis, Sacramento, CA 95817 USA; Baylor Coll Med, Houston, TX 77030 USA; Univ Massachusetts, Med Ctr, Worcester, MA USA; Mayo Clin, Rochester, MN USA; Univ Washington, Seattle, WA 98195 USA; Univ Arkansas Med Sci, Little Rock, AR 72205 USA; Univ Calif San Francisco, Ctr Canc, San Francisco, CA 94143 USA; Cleveland Clin Fdn, Cleveland, OH 44195 USA; Univ Colorado, Hlth Sci Ctr, Denver, CO USA	Columbia University; Southwest Oncology Group; University of Michigan System; University of Michigan; University of California System; University of California Davis; Baylor College of Medicine; University of Massachusetts System; University of Massachusetts Worcester; Mayo Clinic; University of Washington; University of Washington Seattle; University of Arkansas System; University of Arkansas Medical Sciences; University of California System; University of California San Francisco; Cleveland Clinic Foundation; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Petrylak, DP (corresponding author), SW Oncol Grp S9916 Operat Off, 14980 Omicron Dr, San Antonio, TX 78245 USA.		Kohli, Manish/AAN-8862-2021		NATIONAL CANCER INSTITUTE [U10CA013612, U10CA046282, U10CA012213, U10CA063850, U10CA004919, U10CA058416, U10CA068183, U10CA058723, U10CA032102, U10CA027057, U10CA035128, U10CA063844, U10CA046441, U10CA067663, U10CA063845, U10CA003096, U10CA058882, U10CA086780, U10CA012644, U10CA045377, U10CA020319, U10CA011083, U10CA025224, U10CA035176, U10CA038926, U10CA074811, U10CA058861, U10CA014028, U10CA045461, U10CA035119, U10CA045808, U10CA046368, U10CA076447, U10CA037981, U10CA037135, U10CA046113, U10CA022433, U10CA035090, U10CA067575, U10CA046136, U10CA058686, U10CA063848, U10CA035192, U10CA074647, U10CA016385, U10CA035261, U10CA058658, U10CA042777, U10CA035431, U10CA045450, R01CA046462, U10CA035178, U10CA035281] Funding Source: NIH RePORTER; NCI NIH HHS [CA76132, CA76129, CA74811, CA74647, CA68183, CA11083, CA76447, CA86780, CA35090, CA32102, CA27057, CA25224, CA22433, CA04919, CA35178, CA20319, CA16385, CA35192, CA14028, CA13612, CA12644, CA12213, CA35261, CA35281, CA35431, CA35996, CA37135, CA37981, CA38926, CA42777, CA45377, CA45450, CA45461, CA45807, CA35176, CA45808, CA03096, CA46113, CA46136, CA46282, CA46368, CA46441, CA46462, CA35128, CA67663, CA67575, CA63850, CA63848, CA35119, CA63845, CA63844, CA58882, CA58861, CA58723, CA58686, CA58658, CA58416] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BENSON R, 1990, CANCER INVEST, V8, P375, DOI 10.3109/07357909009012056; Berry W, 2002, J UROLOGY, V168, P2439, DOI 10.1016/S0022-5347(05)64163-8; Bubley GJ, 1999, J CLIN ONCOL, V17, P3461, DOI 10.1200/JCO.1999.17.11.3461; BUBLEY GJ, 2000, J CLIN ONCOL, V18, P2644; CRAWFORD ED, 1989, NEW ENGL J MED, V321, P419, DOI 10.1056/NEJM198908173210702; CRAWFORD ED, 1989, NEW ENGL J MED, V321, P1420; Eisenberger MA, 1998, NEW ENGL J MED, V339, P1036, DOI 10.1056/NEJM199810083391504; Ernst DS, 2003, J CLIN ONCOL, V21, P3335, DOI 10.1200/JCO.2003.03.042; Fakih M, 2002, UROLOGY, V60, P553, DOI 10.1016/S0090-4295(02)01741-7; Haldar S, 1996, CANCER RES, V56, P1253; Hudes G, 1999, J CLIN ONCOL, V17, P3160, DOI 10.1200/JCO.1999.17.10.3160; Jemal A, 2004, CA-CANCER J CLIN, V54, P8, DOI 10.3322/canjclin.54.1.8; Kantoff PW, 1999, J CLIN ONCOL, V17, P2506, DOI 10.1200/JCO.1999.17.8.2506; Kreis W, 1999, SEMIN ONCOL, V26, P34; Kreis W, 1997, BRIT J UROL, V79, P196, DOI 10.1046/j.1464-410X.1997.06310.x; McDonnell TJ, 1997, J UROLOGY, V157, P569, DOI 10.1016/S0022-5347(01)65204-2; Petrylak DP, 1999, J CLIN ONCOL, V17, P958, DOI 10.1200/JCO.1999.17.3.958; Petrylak DP, 1999, SEMIN ONCOL, V26, P28; Savarese DM, 2001, J CLIN ONCOL, V19, P2509, DOI 10.1200/JCO.2001.19.9.2509; Sinibaldi VJ, 2002, CANCER-AM CANCER SOC, V94, P1457, DOI 10.1002/cncr.10350; Tannock IF, 1996, J CLIN ONCOL, V14, P1756, DOI 10.1200/JCO.1996.14.6.1756; Tannock IF, 2004, NEW ENGL J MED, V351, P1502, DOI 10.1056/NEJMoa040720; Weitzman AL, 2000, J UROLOGY, V163, P834, DOI 10.1016/S0022-5347(05)67815-9; YAGODA A, 1993, CANCER-AM CANCER SOC, V71, P1098, DOI 10.1002/1097-0142(19930201)71:3+<1098::AID-CNCR2820711432>3.0.CO;2-G	24	2902	3023	10	127	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 7	2004	351	15					1513	1520		10.1056/NEJMoa041318	http://dx.doi.org/10.1056/NEJMoa041318			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	859UP	15470214				2022-12-28	WOS:000224293700009
J	Glatzel, M				Glatzel, M			Testing for prions: a novel protocol for vCJD prevalence studies	LANCET			English	Editorial Material							CREUTZFELDT-JAKOB-DISEASE; TISSUE SAMPLES; PROTEIN; UK; ACCUMULATION; VARIANT		Univ Zurich Hosp, Inst Neuropathol, CH-8091 Zurich, Switzerland; Univ Zurich Hosp, Natl Reference Ctr Prion Dis, CH-8091 Zurich, Switzerland	University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital	Glatzel, M (corresponding author), Univ Zurich Hosp, Inst Neuropathol, CH-8091 Zurich, Switzerland.	markus.glatzel@usz.ch	Glatzel, Markus/G-3356-2011; Glatzel, Markus/V-8844-2019	Glatzel, Markus/0000-0002-7720-8817; Glatzel, Markus/0000-0002-7720-8817				Aguzzi A, 2001, NAT REV NEUROSCI, V2, P745, DOI 10.1038/35094590; Brown P, 2000, NEUROLOGY, V55, P1075, DOI 10.1212/WNL.55.8.1075; Ghani AC, 2003, BMC INFECT DIS, V3, DOI 10.1186/1471-2334-3-4; Glatzel M, 2004, TRENDS MICROBIOL, V12, P51, DOI 10.1016/j.tim.2003.12.001; Glatzel M, 2003, LANCET NEUROL, V2, P757, DOI 10.1016/S1474-4422(03)00588-X; Glatzel M, 2003, NEW ENGL J MED, V349, P1812, DOI 10.1056/NEJMoa030351; Hilton DA, 2002, BRIT MED J, V325, P633, DOI 10.1136/bmj.325.7365.633; Hilton DA, 2004, J PATHOL, V203, P733, DOI 10.1002/path.1580; MCKINLEY MP, 1983, CELL, V35, P57, DOI 10.1016/0092-8674(83)90207-6; *NAT CREUTZF JAK D, CJD STAT; Nathanson N, 1997, AM J EPIDEMIOL, V145, P959, DOI 10.1093/oxfordjournals.aje.a009064; Will RG, 1996, LANCET, V347, P921, DOI 10.1016/S0140-6736(96)91412-9	12	1	1	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	OCT 2	2004	364	9441					1196	1197		10.1016/S0140-6736(04)17155-9	http://dx.doi.org/10.1016/S0140-6736(04)17155-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	859HO	15464165				2022-12-28	WOS:000224254200005
J	Newell, ML; Coovadia, H; Cortina-Borja, M; Rollins, N; Gaillard, P; Dabis, F				Newell, ML; Coovadia, H; Cortina-Borja, M; Rollins, N; Gaillard, P; Dabis, F		IAS	Mortality of infected and uninfected infants born to HIV-infected mothers in Africa: a pooled analysis	LANCET			English	Article							TO-CHILD TRANSMISSION; HUMAN-IMMUNODEFICIENCY-VIRUS; DISEASE PROGRESSION; RANDOMIZED-TRIAL; NATURAL-HISTORY; ORAL ZIDOVUDINE; COTE-DIVOIRE; FOLLOW-UP; PREVENTION; REGIMEN	Background HIV contributes substantially to child mortality, but factors underlying these deaths are inadequately described. With individual data from seven randomised mother-to-child transmission (MTCT) intervention trials, we estimate mortality in African children born to HIV-infected mothers and analyse selected risk factors. Methods Early HIV infection was defined as a positive HIV-PCR test before 4 weeks of age; and late infection by a negative PCR test at or after 4 weeks of age, followed by a positive test. Mortality rate was expressed per 1000 child-years. We investigated the effect of maternal health, infant HIV infection, feeding practices, and age at acquisition of infection on mortality assessed with Cox proportional hazards models, and allowed for random effects for trials grouped geographically. Findings 378 (11%) of 3468 children died. By age 1 year, an estimated 35.2% infected and 4.9% unindected children will have died; by 2 years of age, 52.5% and 7.6% will have died, respectively. Mortality varied by geographical region, and was associated with maternal death (adjusted odds ratio 2.27, 95% CI 1.62-3.19), CD4+ cell counts <200 per mu L (1.91, 1.39-2.62), and infant HIV infection (8.16, 6.43-10.33). Mortality was not associated with either ever breastfeeding and never breastfeeding in either infected or uninfected children. In infected children, mortality was significantly lower for those with late infection than those with early infection (0.52, 0.39-0.70). This effect was also seen in analyses of survival from the age at infection (0.74, 0.55-0.99). Interpretation These findings highlight the necessity for timely antiretroviral care, for support for HIV-infected women and children in developing countries, and for assessment of prophylactic programmes to prevent MTCT, including child mortality and infection averted.	Inst Child Hlth, Ctr Paediat Epidemiol & Biostat, London WC1N 1EH, England; Ghent Int AIDS Soc, Working Grp HIV Infect Women & Children, Ghent, Belgium	University of London; University College London	Newell, ML (corresponding author), Inst Child Hlth, Ctr Paediat Epidemiol & Biostat, 30 Guilford St, London WC1N 1EH, England.	m.newell@ich.ucl.ac.uk	Gaillard, Philippe/E-7256-2019; Newell, Marie-Louise/AAE-8222-2019; Van de Perre, Philippe/B-9692-2008; Borja, Mario Cortina/A-3847-2009; Sharma, Sushma/AAA-4966-2022; DABIS, FRANCOIS/S-9298-2019	Newell, Marie-Louise/0000-0002-1074-7699; Van de Perre, Philippe/0000-0002-3912-0427; Borja, Mario Cortina/0000-0003-0627-2624; DABIS, FRANCOIS/0000-0002-1614-8857	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [N01HD033345] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Abrams EJ, 2003, AIDS, V17, P867, DOI 10.1097/00002030-200304110-00012; [Anonymous], 2004, 2004 REP GLOB AIDS E; BECQUET R, 2003, ANTIRETROVIRAL TH S1, V8, pS200; Bertolli J, 2003, AIDS, V17, P2089, DOI 10.1097/00002030-200309260-00010; Brahmbhatt H, 2002, SOC SCI MED, V55, P585, DOI 10.1016/S0277-9536(01)00189-7; Coutsoudis A, 1999, AIDS, V13, P1517, DOI 10.1097/00002030-199908200-00012; Coutsoudis A, 2004, J INFECT DIS, V189, P2154, DOI 10.1086/420834; Coutsoudis A, 2003, ACTA PAEDIATR, V92, P890, DOI 10.1080/08035250310004261; Dabis F, 2002, LANCET, V359, P2097, DOI 10.1016/S0140-6736(02)08909-2; Dabis F, 1999, LANCET, V353, P786, DOI 10.1016/S0140-6736(98)11046-2; De Cock KM, 2000, JAMA-J AM MED ASSOC, V283, P1175, DOI 10.1001/jama.283.9.1175; Fawzi WW, 2002, AIDS, V16, P1935, DOI 10.1097/00002030-200209270-00011; Gaillard P, 2001, AIDS, V15, P389, DOI 10.1097/00002030-200102160-00012; Gray L, 2001, PEDIATRICS, V108, P116, DOI 10.1542/peds.108.1.116; Ioannidis JPA, 2004, AIDS, V18, P99, DOI 10.1097/00002030-200401020-00012; Jackson JB, 2003, LANCET, V362, P859, DOI 10.1016/S0140-6736(03)14341-3; Lepage P, 1998, PEDIATR INFECT DIS J, V17, P581, DOI 10.1097/00006454-199807000-00002; Leroy V, 2003, AIDS, V17, P1493, DOI 10.1097/00002030-200307040-00010; Leroy V, 2002, AIDS, V16, P631, DOI 10.1097/00002030-200203080-00016; LEROY V, 1995, J ACQ IMMUN DEF SYND, V9, P415; Mandelbrot L, 2002, SEX TRANSM INFECT, V78, P267, DOI 10.1136/sti.78.4.267; Nduati R, 2000, JAMA-J AM MED ASSOC, V283, P1167, DOI 10.1001/jama.283.9.1167; Newell ML, 2004, AIDS, V18, pS27, DOI 10.1097/00002030-200406002-00004; Newell ML, 1998, AIDS, V12, P831, DOI 10.1097/00002030-199808000-00004; NEWELL ML, 2003, 2 IAS C HIV PATH TRE, P97; Rouet F, 2003, PEDIATRICS, V112, pE289, DOI 10.1542/peds.112.4.e289; Saba J, 2002, LANCET, V359, P1178; Spira R, 1999, PEDIATRICS, V104, DOI 10.1542/peds.104.5.e56; Therneau T. M., 2013, MODELING SURVIVAL DA, DOI 10.1007/978-1-4757-3294-8; Walker N, 2002, LANCET, V360, P284, DOI 10.1016/S0140-6736(02)09550-8; Wiktor SZ, 1999, LANCET, V353, P781, DOI 10.1016/S0140-6736(98)10412-9; Zijenah LS, 2004, AIDS, V18, P273, DOI 10.1097/00002030-200401230-00017	32	848	867	0	34	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 2	2004	364	9441					1236	1243		10.1016/S0140-6736(04)17140-7	http://dx.doi.org/10.1016/S0140-6736(04)17140-7			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	859HO	15464184				2022-12-28	WOS:000224254200030
J	Hall, A				Hall, A			Src launches vaccinia	SCIENCE			English	Editorial Material							ACTIN-BASED MOTILITY; VIRUS; RECEPTOR; KINESIN		UCL, MRC, Mol Cell Biol Lab, London WC1E 6BT, England; UCL, Cell Biol Unit, London WC1E 6BT, England	University of London; University College London; University of London; University College London	Hall, A (corresponding author), UCL, MRC, Mol Cell Biol Lab, Mortimer St, London WC1E 6BT, England.	alan.hall@ucl.ac.uk						Chen XY, 2003, J CELL BIOL, V163, P547, DOI 10.1083/jcb.200305137; Frischknecht F, 1999, NATURE, V401, P926, DOI 10.1038/44860; Newsome TP, 2004, SCIENCE, V306, P124, DOI 10.1126/science.1101509; Phillips N, 2004, NAT CELL BIOL, V6, P618, DOI 10.1038/ncb1148; Sanderson CM, 1998, J GEN VIROL, V79, P1415, DOI 10.1099/0022-1317-79-6-1415; Smith GL, 2003, ANNU REV MICROBIOL, V57, P323, DOI 10.1146/annurev.micro.57.030502.091037; Ward BM, 2004, J VIROL, V78, P2486, DOI 10.1128/JVI.78.5.2486-2493.2004	7	4	5	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 1	2004	306	5693					65	67		10.1126/science.1104481	http://dx.doi.org/10.1126/science.1104481			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	859YJ	15459376				2022-12-28	WOS:000224304000033
J	Saffarian, S; Collier, IE; Marmer, BL; Elson, EL; Goldberg, G				Saffarian, S; Collier, IE; Marmer, BL; Elson, EL; Goldberg, G			Interstitial collagenase is a Brownian ratchet driven by proteolysis of collagen	SCIENCE			English	Article							FLUORESCENCE CORRELATION SPECTROSCOPY; SKIN FIBROBLAST COLLAGENASE; MATRIX METALLOPROTEINASES; MOLECULAR MOTORS; ACTIVE-SITE; I COLLAGEN; KINETICS; PROTEIN	We show that activated collagenase (MMP-1) moves processively on the collagen fibril. The mechanism of movement is a biased diffusion with the bias component dependent on the proteolysis of its substrate, not adenosine triphosphate (ATP) hydrolysis. inactivation of the enzyme by a single amino acid residue substitution in the active center eliminates the bias without noticeable effect on rate of diffusion. Monte Carlo simulations using a model similar to a "burnt bridge" Brownian ratchet accurately describe our experimental results and previous observations on kinetics of collagen digestion. The biological implications of MMP-1 acting as a molecular ratchet tethered to the cell surface suggest new mechanisms for its role in tissue remodeling and cell-matrix interaction.	Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA; Washington Univ, Sch Med, Div Dermatol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL)	Goldberg, G (corresponding author), Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA.	goldberg@medicine.wustl.edu			NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR040618, R01AR039472] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038838] Funding Source: NIH RePORTER; NIAMS NIH HHS [AR39472, AR40618] Funding Source: Medline; NIGMS NIH HHS [GM-38838] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Astumian RD, 1997, SCIENCE, V276, P917, DOI 10.1126/science.276.5314.917; Collier IE, 2001, BIOPHYS J, V81, P2370, DOI 10.1016/S0006-3495(01)75883-3; Derenyi I, 1999, PHYS REV LETT, V83, P903, DOI 10.1103/PhysRevLett.83.903; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Feynman R. P., 1966, FEYNMAN LECT PHYS, VI; FIELDS GB, 1987, J BIOL CHEM, V262, P6221; Fox RF, 1998, PHYS REV E, V57, P2177, DOI 10.1103/PhysRevE.57.2177; GOLDBERG GI, 1986, J BIOL CHEM, V261, P6600; JEFFREY JJ, 1983, J BIOL CHEM, V258, P1123; Julicher F, 1997, REV MOD PHYS, V69, P1269, DOI 10.1103/RevModPhys.69.1269; Kadler KE, 1996, BIOCHEM J, V316, P1; Leikina E, 2002, P NATL ACAD SCI USA, V99, P1314, DOI 10.1073/pnas.032307099; MAGDE D, 1978, BIOPOLYMERS, V17, P361, DOI 10.1002/bip.1978.360170208; Mai J, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.011102; Ohuchi E, 1997, J BIOL CHEM, V272, P2446, DOI 10.1074/jbc.272.4.2446; PESKIN CS, 1993, BIOPHYS J, V65, P316, DOI 10.1016/S0006-3495(93)81035-X; Pilcher BK, 1997, J CELL BIOL, V137, P1445, DOI 10.1083/jcb.137.6.1445; PROST J, 1994, PHYS REV LETT, V72, P2652, DOI 10.1103/PhysRevLett.72.2652; Qian H, 2000, BIOPHYS CHEM, V83, P35, DOI 10.1016/S0301-4622(99)00121-0; Saffarian S, 2003, BIOPHYS J, V84, P2030, DOI 10.1016/S0006-3495(03)75011-5; SAFFARIAN S, UNPUB; Schliwa M, 2003, NATURE, V422, P759, DOI 10.1038/nature01601; Shimada T, 1999, EUR J BIOCHEM, V262, P907, DOI 10.1046/j.1432-1327.1999.00459.x; Steele DL, 2000, PROTEIN ENG, V13, P397, DOI 10.1093/protein/13.6.397; TORBET J, 1984, BIOCHEM J, V219, P1057, DOI 10.1042/bj2191057; Vale RD, 2000, SCIENCE, V288, P88, DOI 10.1126/science.288.5463.88; Visse R, 2003, CIRC RES, V92, P827, DOI 10.1161/01.RES.0000070112.80711.3D; Vu TH, 2000, GENE DEV, V14, P2123, DOI 10.1101/gad.815400; WELGUS HG, 1980, J BIOL CHEM, V255, P6806; WINDSOR LJ, 1994, J BIOL CHEM, V269, P26201	30	144	147	0	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 1	2004	306	5693					108	111		10.1126/science.1099179	http://dx.doi.org/10.1126/science.1099179			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	859YJ	15459390	Green Submitted			2022-12-28	WOS:000224304000047
J	Holzelova, E; Vonarbourg, C; Stolzenberg, MC; Arkwright, PD; Selz, F; Prieur, AM; Blanche, S; Bartunkova, J; Vilmer, E; Fischer, A; Le Deist, F; Rieux-Laucat, F				Holzelova, E; Vonarbourg, C; Stolzenberg, MC; Arkwright, PD; Selz, F; Prieur, AM; Blanche, S; Bartunkova, J; Vilmer, E; Fischer, A; Le Deist, F; Rieux-Laucat, F			Autoimmune lymphoproliferative syndrome with somatic Fas mutations	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SEVERE COMBINED IMMUNODEFICIENCY; IN-VIVO REVERSION; GENE-MUTATIONS; CELL APOPTOSIS; HUMAN-DISEASE; T-CELLS; EXPRESSION; DOMINANT; PATIENT; LYMPHOCYTE	BACKGROUND: Impaired Fas-induced apoptosis of lymphocytes in vitro is a principal feature of the autoimmune lymphoproliferative syndrome (ALPS). We studied six children with ALPS whose lymphocytes had normal sensitivity to Fas-induced apoptosis in vitro. METHODS: Susceptibility to Fas-mediated apoptosis and the Fas gene were analyzed in purified subgroups of T cells and other mononuclear cells from six patients with ALPS type III. RESULTS: Heterozygous dominant Fas mutations were detected in the polyclonal double-negative T cells from all six patients. In two patients, these mutations were found in a fraction of CD4+ and CD8+ T cells, monocytes, and CD34+ hematopoietic precursors, but not in hair or mucosal epithelial cells. CONCLUSIONS: Somatic heterozygous mutations of Fas can cause a sporadic form of ALPS by allowing lymphoid precursors to resist the normal process of cell death.	Hop Necker Enfants Malad, INSERM, U429, Paris, France; Hop Necker Enfants Malad, Unite Immunol Hematol Pediat, Paris, France; Univ Manchester, Booth Hall Childrens Hosp, Acad Unit Child Hlth, Manchester, Lancs, England; Charles Univ, Sch Med 2, Inst Immunol, Prague, Czech Republic; Hop Robert Debre, Unite Immunohematol, F-75019 Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Royal Manchester Children's Hospital; University of Manchester; Charles University Prague; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite	Holzelova, E (corresponding author), Hop Necker Enfants Malad, INSERM, U429, Paris, France.		Arkwright, Peter/C-5149-2012; Stolzenberg, Marie-Claude/I-6281-2017; Rieux-Laucat, Frédéric/A-7916-2017	Stolzenberg, Marie-Claude/0000-0001-8026-0360; Rieux-Laucat, Frédéric/0000-0001-7858-7866; Arkwright, Peter/0000-0002-7411-5375				Bensoussan D, 2002, BRIT J HAEMATOL, V117, P899, DOI 10.1046/j.1365-2141.2002.03496.x; Bettinardi A, 1997, BLOOD, V89, P902, DOI 10.1182/blood.V89.3.902; Bleesing JJH, 2001, CLIN IMMUNOL, V100, P314, DOI 10.1006/clim.2001.5069; CANALE VC, 1967, J PEDIATR-US, V70, P891, DOI 10.1016/S0022-3476(67)80262-2; Drappa J, 1996, NEW ENGL J MED, V335, P1643, DOI 10.1056/NEJM199611283352204; Erickson RP, 2003, MUTAT RES-REV MUTAT, V543, P125, DOI 10.1016/S1383-5742(03)00010-3; FISHER GH, 1995, CELL, V81, P935, DOI 10.1016/0092-8674(95)90013-6; Fuss IJ, 1997, J IMMUNOL, V158, P1912; Hacein-Bey-Abina S, 2002, NEW ENGL J MED, V346, P1185, DOI 10.1056/NEJMoa012616; Hezard N, 1998, THROMB HAEMOSTASIS, V79, P1054; Hirschhorn R, 1996, NAT GENET, V13, P290, DOI 10.1038/ng0796-290; ILLUM N, 1991, SCAND J IMMUNOL, V34, P635, DOI 10.1111/j.1365-3083.1991.tb01587.x; Jackson CE, 1999, AM J HUM GENET, V64, P1002, DOI 10.1086/302333; Kasahara Y, 1998, INT IMMUNOL, V10, P195, DOI 10.1093/intimm/10.2.195; Krueger A, 2003, IMMUNOL REV, V193, P58, DOI 10.1034/j.1600-065X.2003.00047.x; LeDeist F, 1996, LANCET, V348, P719, DOI 10.1016/S0140-6736(96)02293-3; Leuer M, 2001, AM J HUM GENET, V69, P75, DOI 10.1086/321285; Locksley RM, 2001, CELL, V104, P487, DOI 10.1016/S0092-8674(01)00237-9; NAGATA S, 1995, IMMUNOL TODAY, V16, P39, DOI 10.1016/0167-5699(95)80069-7; Ramenghi U, 2000, BLOOD, V95, P3176; Renno T, 1998, EUR J IMMUNOL, V28, P540, DOI 10.1002/(SICI)1521-4141(199802)28:02<540::AID-IMMU540>3.3.CO;2-P; Rieux-Laucat F, 1999, BLOOD, V94, P2575; Rieux-Laucat F, 2003, CURR OPIN IMMUNOL, V15, P325, DOI 10.1016/S0952-7915(03)00042-6; RIEUXLAUCAT F, 1995, SCIENCE, V268, P1347, DOI 10.1126/science.7539157; Schneider E, 1999, BLOOD, V94, P2613, DOI 10.1182/blood.V94.8.2613.420k33_2613_2621; Senju S, 1996, INT IMMUNOL, V8, P423, DOI 10.1093/intimm/8.3.423; Simon HU, 1996, J EXP MED, V183, P1071, DOI 10.1084/jem.183.3.1071; Sneller MC, 1997, BLOOD, V89, P1341, DOI 10.1182/blood.V89.4.1341; Stephan V, 1996, NEW ENGL J MED, V335, P1563, DOI 10.1056/NEJM199611213352104; Strain L, 1998, NEW ENGL J MED, V338, P166, DOI 10.1056/NEJM199801153380305; Vaishnaw AK, 1999, J CLIN INVEST, V103, P1099, DOI 10.1172/JCI5121C1; Vaishnaw AK, 1999, J CLIN INVEST, V103, P355, DOI 10.1172/JCI5121; van der Burg M, 2000, PEDIATR RES, V47, P336, DOI 10.1203/00006450-200003000-00009; vanDijk BA, 1996, AM J MED GENET, V61, P264, DOI 10.1002/(SICI)1096-8628(19960122)61:3<264::AID-AJMG11>3.0.CO;2-R; Wada T, 2001, P NATL ACAD SCI USA, V98, P8697, DOI 10.1073/pnas.151260498; Wang J, 1999, CELL, V98, P47, DOI 10.1016/S0092-8674(00)80605-4; Wu JG, 1996, J CLIN INVEST, V98, P1107, DOI 10.1172/JCI118892	37	212	237	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 30	2004	351	14					1409	1418		10.1056/NEJMoa040036	http://dx.doi.org/10.1056/NEJMoa040036			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	857XT	15459302				2022-12-28	WOS:000224153900009
J	Schwartz, RA				Schwartz, RA			Superficial fungal infections	LANCET			English	Review							TINEA NIGRA PALMARIS; PITYRIASIS-VERSICOLOR; WHITE PIEDRA; BLACK PIEDRA; DOUBLE-BLIND; MALASSEZIA YEASTS; EQUATORIAL AFRICA; GENUS MALASSEZIA; 400 MG; ITRACONAZOLE	Superficial fungal infections arise from a pathogen that is restricted to the stratum corneum, with little or no tissue reaction. In this Seminar, three types of infection will be covered: tinea versicolor, piedra, and tinea nigra. Tinea versicolor is common worldwide and is caused by Malassezia spp, which are human saprophytes that sometimes switch from yeast to pathogenic mycelial form. Malassezia furfur, Malassezia globosa, and Malassezia sympodialis are most closely linked to tinea versicolor. White and black piedra are both common in tropical regions of the world; white piedra is also endemic in temperate climates. Black piedra is caused by Piedraia hortae; white piedra is due to pathogenic species of the Trichosporon genus. Tinea nigra. is also common in tropical areas and has been confused with melanoma.	Univ Med & Dent New Jersey, New Jersey Med Sch, Newark, NJ 07103 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Schwartz, RA (corresponding author), Univ Med & Dent New Jersey, New Jersey Med Sch, 185 S Orange Ave, Newark, NJ 07103 USA.	roschwar@umdnj.edu						Abliz P, 2003, DIAGN MICR INFEC DIS, V46, P89, DOI 10.1016/S0732-8893(03)00035-X; ADAMSKI Z, 1995, POSTEPY DERMATOL POZ, V12, P349; Aljabre SHM, 2001, INT J DERMATOL, V40, P273, DOI 10.1046/j.1365-4362.2001.01201.x; ALLEN HB, 1976, ARCH DERMATOL, V112, P1110, DOI 10.1001/archderm.112.8.1110; ALTMAN R, 2004, EMEDICINE DERMATOLOG; Aly R, 1996, CLIN INFECT DIS, V22, pS128, DOI 10.1093/clinids/22.Supplement_2.S128; Amer MA, 1997, INT J DERMATOL, V36, P940, DOI 10.1046/j.1365-4362.1997.00213.x; Amichai B, 2000, CLIN EXP DERMATOL, V25, P660, DOI 10.1046/j.1365-2230.2000.00730-6.x; ARYA V, 2002, EMEDICINE DERMATOLOG; ASTE N, 1991, MYCOSES, V34, P353, DOI 10.1111/j.1439-0507.1991.tb00676.x; BABEL DE, 1986, J DERMATOL SURG ONC, V12, P502, DOI 10.1111/j.1524-4725.1986.tb01940.x; Baran E., 1993, PRZEGL DERMATOL, V80, P49; BECKER KA, 2004, EMEDICINE DERMATOLOG; Bhogal CS, 2001, J DERMATOL, V28, P535, DOI 10.1111/j.1346-8138.2001.tb00026.x; BIRNBAUM JE, 1990, J AM ACAD DERMATOL, V23, P782, DOI 10.1016/0190-9622(90)70288-S; BLANK H, 1979, J AM ACAD DERMATOL, V1, P49, DOI 10.1016/S0190-9622(79)80052-3; BORTON LK, 1981, ARIZ MED, V38, P598; BREATHNACH AS, 1975, GIORNALE ITALIANO DE, V110, P457; BRUSKO CS, 1991, DICP ANN PHARMAC, V25, P1321, DOI 10.1177/106002809102501206; Budimulja U, 2002, J DERMATOL TREAT, V13, P39, DOI 10.1080/09546630252775243; BURKE RC, 1961, J INVEST DERMATOL, V36, P389, DOI 10.1038/jid.1961.60; BURKE WA, 1993, CUTIS, V52, P209; CARR JF, 1975, ARCH DERMATOL, V111, P904, DOI 10.1001/archderm.111.7.904; Castellani A, 1965, An Inst Med Trop (Lisb), V22, P5; CASTRO RM, 1987, REV I MED TROP, V29, P251, DOI 10.1590/S0036-46651987000400011; CAUWENBERGH G, 1988, J AM ACAD DERMATOL, V18, P263, DOI 10.1016/S0190-9622(88)70037-7; Chu C. M., 2002, Hong Kong Medical Journal, V8, P212; COIMBRA CEA, 1989, MYCOPATHOLOGIA, V107, P57, DOI 10.1007/BF00437590; CONILL C, 1990, ACTA ONCOL, V29, P949, DOI 10.3109/02841869009096397; CORTE M, 1989, MYCOSES, V32, P200, DOI 10.1111/j.1439-0507.1989.tb02232.x; Crowson AN, 2003, INT J DERMATOL, V42, P928, DOI 10.1111/j.1365-4632.2003.02110.x; DAFONSECA O, 1928, MEM I O CRUZ, V4, P124; De Leon-Morales J, 2001, INT J ELEC POWER, V23, P1, DOI 10.1016/S0142-0615(00)00039-9; DEALMEIDA HL, 1991, MYCOSES, V34, P447, DOI 10.1111/j.1439-0507.1991.tb00859.x; DEALMEIDA HL, 1990, MYCOSES, V33, P491, DOI 10.1111/myc.1990.33.9-10.491; Desruelles F, 1999, INT J DERMATOL, V38, P948; Drake LA, 1996, J AM ACAD DERMATOL, V34, P287, DOI 10.1016/S0190-9622(96)80136-8; Drake LA, 1996, J AM ACAD DERMATOL, V34, P122; Dutta S, 2002, INT J DERMATOL, V41, P823, DOI 10.1046/j.1365-4362.2002.01645.x; Dworecka-Kaszak B, 1999, MIKOL LEK, V6, P133; ELEWSKI B, 1995, J AM ACAD DERMATOL, V33, P816, DOI 10.1016/0190-9622(95)91838-8; ELLNER KM, 1990, BRIT J DERMATOL, V123, P355, DOI 10.1111/j.1365-2133.1990.tb06296.x; Elmer KB, 2002, CUTIS, V70, P209; ELMETS CA, 1994, J AM ACAD DERMATOL, V31, pS60, DOI 10.1016/S0190-9622(08)81270-4; Erchiga VC, 2000, BRIT J DERMATOL, V143, P799, DOI 10.1046/j.1365-2133.2000.03779.x; Erchiga VC, 2002, CURR OPIN INFECT DIS, V15, P133, DOI 10.1097/00001432-200204000-00006; Fader R C, 1988, Infect Dis Clin North Am, V2, P925; FAERGEMANN J, 1993, CLIN EXP DERMATOL, V18, P102, DOI 10.1111/j.1365-2230.1993.tb00987.x; Faergemann J, 1997, DERMATOLOGY, V194, P19, DOI 10.1159/000246178; Faergemann J, 2002, ARCH DERMATOL, V138, P69, DOI 10.1001/archderm.138.1.69; FAERGEMANN J, 1988, MYCOSES, V31, P377, DOI 10.1111/j.1439-0507.1988.tb04435.x; FAERGEMANN J, 1980, CUTIS, V25, P667; FAERGEMANN J, 1981, J INVEST DERMATOL, V77, P314, DOI 10.1111/1523-1747.ep12482488; FAERGEMANN J, 1980, ACTA DERM-VENEREOL, V60, P92; FAERGEMANN J, 2004, MIKOL LEK, V11, P129; FALABELL.R, 1965, ARCH DERMATOL, V91, P637, DOI 10.1001/archderm.1965.01600120069018; Farshchian M, 2002, J DERMATOL TREAT, V13, P73, DOI 10.1080/095466302317584421; FernandezNava HD, 1997, INT J DERMATOL, V36, P64, DOI 10.1046/j.1365-4362.1997.00023.x; Fischman O., 1983, Boletin Micologico, V1, P68; Fischman O, 1973, Rev Inst Med Trop Sao Paulo, V15, P103; FISCHMAN O, 1965, MYCOPATH MYCOL APPL, V25, P201, DOI 10.1007/BF02049624; FISCHMAN O, 1989, PAHO SCI PUBL, V396, P70; FONSECA OJM, 1971, ACTA AMAZONICA, V1, P55; GAITANIS G, 2004, MIKOL LEK S1, V11, P29; GALADARI I, 1992, INT J DERMATOL, V31, P253, DOI 10.1111/j.1365-4362.1992.tb03565.x; Gorani A, 2001, MYCOSES, V44, P516, DOI 10.1046/j.1439-0507.2001.00647.x; GUEHO E, 1994, MYCOSES, V37, P3, DOI 10.1111/j.1439-0507.1994.tb00277.x; Gueho E, 1996, ANTON LEEUW INT J G, V69, P337, DOI 10.1007/BF00399623; GUPTA AK, 1994, J AM ACAD DERMATOL, V30, P911, DOI 10.1016/S0190-9622(94)70112-1; Gupta AK, 2002, J EUR ACAD DERMATOL, V16, P19, DOI 10.1046/j.1468-3083.2002.00378.x; GUPTA AK, 1994, J AM ACAD DERMATOL, V30, P677, DOI 10.1016/S0190-9622(08)81495-8; Gupta AK, 2001, MED MYCOL, V39, P199, DOI 10.1080/mmy.39.2.199.206; Gupta G, 1997, BRIT J DERMATOL, V137, P483, DOI 10.1111/j.1365-2133.1997.tb03775.x; Hall J, 1998, CUTIS, V62, P45; HASHIM FA, 1994, INT J DERMATOL, V33, P258, DOI 10.1111/j.1365-4362.1994.tb01038.x; HENANZ AD, 1987, REV INFECT DIS S1, V9, pS121; Hickman JG, 1996, J AM ACAD DERMATOL, V34, P785, DOI 10.1016/S0190-9622(96)90014-6; HORTA P, 1911, MEM I OSWALDO CRUZ, V3, P86; HORTA Parreiras, 1921, Revista Medico-Cirurgica do Brasil, V29, P269; HUGHES JR, 1993, CLIN EXP DERMATOL, V18, P481, DOI 10.1111/j.1365-2230.1993.tb02258.x; Imazu Lucia Emiko, 1995, Acta Dermatologica (Kyoto), V90, P479; JACOBS PH, 1990, J AM ACAD DERMATOL, V23, P549, DOI 10.1016/0190-9622(90)70251-C; JONES HE, 1989, J AM ACAD DERMATOL, V20, P704, DOI 10.1016/S0190-9622(89)80167-7; KALTER DC, 1986, J AM ACAD DERMATOL, V14, P982, DOI 10.1016/S0190-9622(86)70121-7; Khandpur S, 2002, J AM ACAD DERMATOL, V47, P415, DOI 10.1067/mjd.2002.124072; Kose O, 2002, J DERMATOL TREAT, V13, P77, DOI 10.1080/095466302317584430; Lange DS, 1998, J AM ACAD DERMATOL, V39, P944, DOI 10.1016/S0190-9622(98)70267-1; LEEMING JP, 1989, J APPL BACTERIOL, V67, P47, DOI 10.1111/j.1365-2672.1989.tb04953.x; LEWIS JH, 1984, GASTROENTEROLOGY, V86, P503; LIAO WQ, 1991, CHINESE MED J-PEKING, V104, P425; LONDERO A. T., 1966, SABOURAUDIA, V5, P132; MARKS JG, 1980, ARCH DERMATOL, V116, P321, DOI 10.1001/archderm.116.3.321; Mayser P, 2003, ANTON LEEUW INT J G, V84, P185, DOI 10.1023/A:1026042903354; Mayser P, 2001, BJU INT, V88, P554, DOI 10.1046/j.1464-410X.2001.02375.x; MCBRIDE ME, 1993, J MED MICROBIOL, V39, P255, DOI 10.1099/00222615-39-4-255; Midgley G, 2000, MED MYCOL, V38, P9, DOI 10.1080/mmy.38.s1.9.16; MITTAG H, 1993, MYCOSES, V36, P343, DOI 10.1111/j.1439-0507.1993.tb00721.x; Muellenhoff M, 2003, INT J DERMATOL, V42, P810, DOI 10.1046/j.1365-4362.2003.01686.x; Nakabayashi A, 2000, MED MYCOL, V38, P337, DOI 10.1080/mmy.38.5.337.341; NAZZAROPORRO M, 1978, J INVEST DERMATOL, V71, P205, DOI 10.1111/1523-1747.ep12547184; NOWICKI R, 1992, PRZEGL DERMATOL, V79, P239; Partap R, 2004, DERMATOLOGY, V208, P55, DOI 10.1159/000075047; PAYLE B, 1994, INT J DERMATOL, V33, P182, DOI 10.1111/j.1365-4362.1994.tb04945.x; Pecher S A, 1986, Med Cutan Ibero Lat Am, V14, P333; Pegas JR, 2003, PEDIATR DERMATOL, V20, P315, DOI 10.1046/j.1525-1470.2003.20408.x; PONTASCH MJ, 1989, CUTIS, V43, P81; Pontes ZBVD, 2002, MEM I OSWALDO CRUZ, V97, P747, DOI 10.1590/S0074-02762002000500028; QUEILLEROUSSEL C, 1991, THERAPIE, V46, P201; RAUSCH LJ, 1984, CUTIS, V34, P470; RITCHIE EB, 1964, ARCH DERMATOL, V89, P601, DOI 10.1001/archderm.1964.01590280101018; RITTER SE, 2002, CUTIS, V70, P121; Rogers CJ, 2000, PEDIATR DERMATOL, V17, P68, DOI 10.1046/j.1525-1470.2000.01715.x; Saadatzadeh MR, 2001, BRIT J DERMATOL, V144, P77, DOI 10.1046/j.1365-2133.2001.03955.x; Savin R, 1999, INT J DERMATOL, V38, P863, DOI 10.1046/j.1365-4362.1999.00730.x; SAYEGHCARRENO R, 1989, INT J DERMATOL, V28, P46, DOI 10.1111/j.1365-4362.1989.tb01312.x; SCHEYNIUS A, 1984, ACTA DERM-VENEREOL, V64, P473; SEVERO LC, 1994, MYCOPATHOLOGIA, V126, P157, DOI 10.1007/BF01103769; Shannon PL, 1999, CUTIS, V64, P199; Shapiro LE, 2002, J AM ACAD DERMATOL, V47, P467, DOI 10.1067/mjd.2002.126823; Silva V., 1996, Mycopathologia, V132, P143, DOI 10.1007/BF01103979; Silva V, 1997, J MED VET MYCOL, V35, P73; SILVALIZAMA E, 1995, INT J DERMATOL, V34, P611, DOI 10.1111/j.1365-4362.1995.tb01084.x; SIMMONS RB, 1990, MYCOL RES, V94, P1146, DOI 10.1016/S0953-7562(09)81349-X; Smith SB, 2001, CUTIS, V68, P377; Sugita T, 2000, MED MYCOL, V38, P27, DOI 10.1080/714030894; Sunenshine PJ, 1998, INT J DERMATOL, V37, P648, DOI 10.1046/j.1365-4362.1998.00441.x; SYKES NL, 1994, INT J DERMATOL, V33, P543, DOI 10.1111/j.1365-4362.1994.tb02889.x; SZEPIETOWSKI J, 1994, MIKOL LEK, V1, P33; Szepietowski JC, 2000, KOREAN J MED MYCOL, V5, P108; TERRAGNI L, 1991, MYCOSES, V34, P345, DOI 10.1111/j.1439-0507.1991.tb00674.x; TERRAGNI L, 1991, PEDIATR DERMATOL, V8, P9, DOI 10.1111/j.1525-1470.1991.tb00831.x; THERIZOLFERLY M, 1994, MYCOSES, V37, P255, DOI 10.1111/j.1439-0507.1994.tb00422.x; THERIZOLFERLY M, 1994, MYCOSES, V37, P249, DOI 10.1111/j.1439-0507.1994.tb00421.x; Tseng SS, 1999, CUTIS, V64, P265; TUREKURASINSKA K, 1993, POSTEPY DERMATOL POZ, V10, P68; URBANOWSKI S, 1993, ADV PATHOGENESIS DIA, P117; URBANOWSKI S, 1993, P 24 C POL DERM SOC, P191; VANVELSOR H, 1964, ARCH DERMATOL, V90, P59, DOI 10.1001/archderm.1964.01600010065013; WASIK F, 1993, PRZEGL DERMATOL, V80, P172; Weiss R, 2000, MYCOSES, V43, P69; Youker SR, 2003, J AM ACAD DERMATOL, V49, P746, DOI 10.1067/S0190-9622(03)00459-6	142	108	118	0	7	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 25	2004	364	9440					1173	1182		10.1016/S0140-6736(04)17107-9	http://dx.doi.org/10.1016/S0140-6736(04)17107-9			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	857FT	15451228				2022-12-28	WOS:000224102400034
J	Go, AS; Chertow, GM; Fan, DJ; McCulloch, CE; Hsu, CY				Go, AS; Chertow, GM; Fan, DJ; McCulloch, CE; Hsu, CY			Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization	NEW ENGLAND JOURNAL OF MEDICINE			English	Article; Proceedings Paper	36th Annual Meeting of the American-Society-of-Nephrology	NOV 12-17, 2003	SAN DIEGO, CA	Amer Soc Nephrol			CHRONIC RENAL-INSUFFICIENCY; 3RD NATIONAL-HEALTH; SERUM CREATININE; ALL-CAUSE; MORTALITY; OUTCOMES; CARE; HYPERTENSION; IMPACT; COHORT	Background: End-stage renal disease substantially increases the risks of death, cardiovascular disease, and use of specialized health care, but the effects of less severe kidney dysfunction on these outcomes are less well defined. Methods: We estimated the longitudinal glomerular filtration rate (GFR) among 1,120,295 adults within a large, integrated system of health care delivery in whom serum creatinine had been measured between 1996 and 2000 and who had not undergone dialysis or kidney transplantation. We examined the multivariable association between the estimated GFR and the risks of death, cardiovascular events, and hospitalization. Results: The median follow-up was 2.84 years, the mean age was 52 years, and 55 percent of the group were women. After adjustment, the risk of death increased as the GFR decreased below 60 ml per minute per 1.73 m(2) of body-surface area: the adjusted hazard ratio for death was 1.2 with an estimated GFR of 45 to 59 ml per minute per 1.73 m(2) (95 percent confidence interval, 1.1 to 1.2), 1.8 with an estimated GFR of 30 to 44 ml per minute per 1.73 m(2) (95 percent confidence interval, 1.7 to 1.9), 3.2 with an estimated GFR of 15 to 29 ml per minute per 1.73 m(2) (95 percent confidence interval, 3.1 to 3.4), and 5.9 with an estimated GFR of less than 15 ml per minute per 1.73 m(2) (95 percent confidence interval, 5.4 to 6.5). The adjusted hazard ratio for cardiovascular events also increased inversely with the estimated GFR: 1.4 (95 percent confidence interval, 1.4 to 1.5), 2.0 (95 percent confidence interval, 1.9 to 2.1), 2.8 (95 percent confidence interval, 2.6 to 2.9), and 3.4 (95 percent confidence interval, 3.1 to 3.8), respectively. The adjusted risk of hospitalization with a reduced estimated GFR followed a similar pattern. Conclusions: An independent, graded association was observed between a reduced estimated GFR and the risk of death, cardiovascular events, and hospitalization in a large, community-based population. These findings highlight the clinical and public health importance of chronic renal insufficiency.	Kaiser Permanente No Calif, Div Res, Oakland, CA 94612 USA; Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Med, San Francisco, CA USA	Kaiser Permanente; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Go, AS (corresponding author), Kaiser Permanente No Calif, Div Res, 2000 Broadway,3rd Fl, Oakland, CA 94612 USA.	alan.s.go@kp.org	Go, Alan S./AAE-7745-2019	Hsu, Chi-yuan/0000-0001-8182-1238; Chertow, Glenn/0000-0002-7599-0534	NIDDK NIH HHS [R01 DK58411] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058411] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Alexander M, 1999, ARCH INTERN MED, V159, P2673, DOI 10.1001/archinte.159.22.2673; [Anonymous], 2003, USRDS 2003 ANN DAT R; ARELLANO MG, 1984, AM J PUBLIC HEALTH, V74, P1324, DOI 10.2105/AJPH.74.12.1324; Blacher J, 2003, KIDNEY INT, V63, P1852, DOI 10.1046/j.1523-1755.2003.00932.x; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; Coresh J, 2003, AM J KIDNEY DIS, V41, P1, DOI 10.1053/ajkd.2003.50007; Culleton BF, 1999, KIDNEY INT, V56, P2214, DOI 10.1046/j.1523-1755.1999.00773.x; DAMSGAARD EM, 1990, BRIT MED J, V300, P297, DOI 10.1136/bmj.300.6720.297; Drey N, 2003, AM J KIDNEY DIS, V42, P677, DOI 10.1016/S0272-6386(03)00916-8; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Feldman HI, 2003, J AM SOC NEPHROL, V14, pS148, DOI 10.1097/01.ASN.0000070149.78399.CE; Fireman BH, 2000, J NATL CANCER I, V92, P136, DOI 10.1093/jnci/92.2.136; Garg AX, 2002, KIDNEY INT, V61, P1486, DOI 10.1046/j.1523-1755.2002.00270.x; Go AS, 1999, ANN INTERN MED, V131, P927, DOI 10.7326/0003-4819-131-12-199912210-00004; Hsu CY, 2002, J AM SOC NEPHROL, V13, P504, DOI 10.1681/ASN.V132504; Karter AJ, 2002, JAMA-J AM MED ASSOC, V287, P2519, DOI 10.1001/jama.287.19.2519; Karter AJ, 2002, JAMA-J AM MED ASSOC, V288, P46; Khan SS, 2002, KIDNEY INT, V62, P229, DOI 10.1046/j.1523-1755.2002.00432.x; Landis JR, 2003, J AM SOC NEPHROL, V14, p294A; LANGFORD HG, 1986, PROG CARDIOVASC DIS, V29, P29, DOI 10.1016/0033-0620(86)90033-2; Levey Andrew S., 2000, Journal of the American Society of Nephrology, V11, p155A; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Levin A, 1999, AM J KIDNEY DIS, V34, P125, DOI 10.1016/S0272-6386(99)70118-6; London GM, 2003, NEPHROL DIAL TRANSPL, V18, P1731, DOI 10.1093/ndt/gfg414; Manjunath G, 2003, KIDNEY INT, V63, P1121, DOI 10.1046/j.1523-1755.2003.00838.x; Manjunath G, 2003, J AM COLL CARDIOL, V41, P47, DOI 10.1016/S0735-1097(02)02663-3; Mann JFE, 2001, ANN INTERN MED, V134, P629, DOI 10.7326/0003-4819-134-8-200104170-00007; Muntner P, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133745; Muntner P, 2004, ANN INTERN MED, V140, P9, DOI 10.7326/0003-4819-140-1-200401060-00006; Raggi P, 2002, J AM COLL CARDIOL, V39, P695, DOI 10.1016/S0735-1097(01)01781-8; Ruilope LM, 2001, J AM SOC NEPHROL, V12, P218, DOI 10.1681/ASN.V122218; Selby JV, 1997, DIABETES CARE, V20, P1396, DOI 10.2337/diacare.20.9.1396; SHEMESH O, 1985, KIDNEY INT, V28, P830, DOI 10.1038/ki.1985.205; Shlipak MG, 2002, ANN INTERN MED, V137, P555, DOI 10.7326/0003-4819-137-7-200210010-00006; Shlipak MG, 2001, J AM COLL CARDIOL, V38, P705, DOI 10.1016/S0735-1097(01)01450-4; Shlipak MG, 2003, CIRCULATION, V107, P87, DOI 10.1161/01.CIR.0000042700.48769.59; SHULMAN N B, 1989, Hypertension (Dallas), V13, pI80; Therneau TM, 2000, MODELING SURVIVAL DA; *US BUR CENS, 2001, 2000 CENS POP HOUS S; Wang JG, 2001, HYPERTENSION, V37, P1069, DOI 10.1161/01.HYP.37.4.1069; Wannamethee SG, 1997, STROKE, V28, P557, DOI 10.1161/01.STR.28.3.557	42	8355	8669	13	600	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 23	2004	351	13					1296	1305		10.1056/NEJMoa041031	http://dx.doi.org/10.1056/NEJMoa041031			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	855TP	15385656	Bronze			2022-12-28	WOS:000223997700007
J	Lappe, JM; Muhlestein, JB; Lappe, DL; Badger, RS; Bair, TL; Brockman, R; French, TK; Hofmann, LC; Horne, BD; Kralick-Goldberg, S; Nicponski, N; Orton, JA; Pearson, RR; Renlund, DG; Rimmasch, H; Roberts, C; Anderson, JL				Lappe, JM; Muhlestein, JB; Lappe, DL; Badger, RS; Bair, TL; Brockman, R; French, TK; Hofmann, LC; Horne, BD; Kralick-Goldberg, S; Nicponski, N; Orton, JA; Pearson, RR; Renlund, DG; Rimmasch, H; Roberts, C; Anderson, JL			Improvements in 1-year cardiovascular clinical outcomes associated with a hospital-based discharge medication program	ANNALS OF INTERNAL MEDICINE			English	Article							ACUTE MYOCARDIAL-INFARCTION; CORONARY-ARTERY-DISEASE; STATIN THERAPY; UNITED-STATES; ASPIRIN; MORTALITY; PREVENTION; ANGINA; TRIAL	Background: Despite recent advances in the treatment and prevention of cardiovascular disease, a treatment gap for secondary prevention medications still exists. Objective: To develop and implement a program ensuring appropriate prescription of aspirin, statins, beta-blockers, angiotensin-converting enzyme inhibitors, and warfarin at hospital discharge. Design: A nonrandomized before-after study comparing patients hospitalized before (1996-1998) and after (1999-2002) implementation of a discharge medication program (DMP). Patients were followed for up to 1 year. Setting: The 10 largest hospitals in the Utah-based Intermountain Health Care system. Patients: In the pre-DMP and DMP time periods, 26 000 and 31465 patients, respectively, were admitted to cardiovascular services (n = 57 465). Measurements: Prescription of indicated medications at hospital discharge; postdischarge death or readmission. Results: By 1 year, the rate of prescription of each medication increased significantly to more than 90% (P < 0.001); this rate was sustained. At 1 year, unadjusted absolute event rates for readmission and death, respectively, were 210 per 1000 years and 96 per 1000 person-years before DMP implementation and 191 per 1000 person-years and 70 per 1000 person-years afterward. Relative risk for death and readmission at 30 days decreased after DMP implementation; hazard ratios (HRs) for death and readmission were 0.81 (95% Cl, 0.73 to 0.89) and 0.92 (Cl, 0.87 to 0.99) (P < 0.001 and P = 0.017, respectively). At 1 year, risk for death continued to decrease (hazard ratio, 0.79 [Cl, 0.75 to 0.84]; P < 0.001) while risk for readmission stabilized (hazard ratio, 0.94 [Cl, 0.90 to 0.98]; P = 0.002), probably because survivors had more opportunities to be readmitted. Limitations: The study design was observational and nonrandomized, and the authors could not control for potential confounders or determine the extent to which secular trends accounted for the observed improvements. Conclusions: A relatively simple quality improvement program aimed at enhancing the prescription of appropriate discharge medications among cardiovascular patients is feasible and can be sustained within an integrated multihospital system. Such a program may be associated with improvements in cardiovascular readmission rates and mortality.	LDS Hosp, Intermt Hlth Care, Salt Lake City, UT USA	Intermountain Healthcare	Muhlestein, JB (corresponding author), Hosp Cardiovasc Dept, 8th Ave & C St, Salt Lake City, UT 84143 USA.		Horne, Benjamin/GQP-7851-2022					*AM HEART ASS, 2001, HEART DIS STROK STAT; Collins R, 2002, LANCET, V360, P7, DOI 10.1016/S0140-6736(02)09327-3; ELLERBECK EF, 1995, JAMA-J AM MED ASSOC, V273, P1509, DOI 10.1001/jama.273.19.1509; Fonarow GC, 2001, AM J CARDIOL, V87, P819, DOI 10.1016/S0002-9149(00)01519-8; Frolkis JP, 1998, CIRCULATION, V98, P851, DOI 10.1161/01.CIR.98.9.851; Gottlieb SS, 1998, NEW ENGL J MED, V339, P489, DOI 10.1056/NEJM199808203390801; Horne BD, 2000, J AM COLL CARDIOL, V36, P1774, DOI 10.1016/S0735-1097(00)00950-5; JUULMOLLER S, 1992, LANCET, V340, P1421, DOI 10.1016/0140-6736(92)92619-Q; LEWIS HD, 1983, NEW ENGL J MED, V309, P396, DOI 10.1056/NEJM198308183090703; Maycock CAA, 2002, J AM COLL CARDIOL, V40, P1777, DOI 10.1016/S0735-1097(02)02477-4; Miller M, 2000, ARCH INTERN MED, V160, P343, DOI 10.1001/archinte.160.3.343; Muhlestein JB, 2001, AM J CARDIOL, V87, P257, DOI 10.1016/S0002-9149(00)01354-0; Packer M, 1996, NEW ENGL J MED, V334, P1349, DOI 10.1056/NEJM199605233342101; PEDERSEN TR, 1994, LANCET, V344, P1383; PETERSEN P, 1989, LANCET, V1, P175; Stafford RS, 2000, CIRCULATION, V101, P1097, DOI 10.1161/01.CIR.101.10.1097; Sueta CA, 1999, AM J CARDIOL, V83, P1303, DOI 10.1016/S0002-9149(99)00117-4; *UT DEP HLTH CTR H, 2001, UT VIT STAT 2001; *UT DEP HTLH CTR H, 1998, VIT STAT 1998; 1929, N ENGL J MED, V328, P293	20	104	103	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 21	2004	141	6					446	453		10.7326/0003-4819-141-6-200409210-00010	http://dx.doi.org/10.7326/0003-4819-141-6-200409210-00010			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	856TM	15381518				2022-12-28	WOS:000224067900005
J	Ball, JE; Osbourne, J; Jowett, S; Pellen, M; Welfare, MR				Ball, JE; Osbourne, J; Jowett, S; Pellen, M; Welfare, MR			Quality improvement programme to achieve acceptable colonoscopy completion rates: prospective before and after study	BMJ-BRITISH MEDICAL JOURNAL			English	Article								Problem A large audit of colonoscopy in the United Kingdom showed that the unadjusted completion rate was 57% when stringent criteria for identifying the caecum were applied. The caecum should be reached 90% of the time. Little information is available on what units or operators need to do to improve to acceptable levels. Design Quality improvement programme using two completed cycles of audit. Setting Endoscopy department in a university linked general hospital in northeast England. Key measures for improvement Colonoscopy completion rate. Strategy for change Two audit cycles were completed between 1999 and 2002. Changes to practice were based on results of audit and took into account the opinions of relevant staff. Lack of time for each colonoscopy, poor bowel preparation, especially in frail patients, and a mismatch between number of colonoscopies done and completion rate for individual operators were responsible for failed colonoscopies. Appropriate changes were made. Effects of change The initial crude colonoscopy completion rate was 60%, improving to 71% after the first round of audit and 88% after the second round, which approximates to the agreed audit standard of 90%. The final adjusted completion rate was 94%. Lessons learnt Achievement of the national targets in a UK general hospital is possible by lengthening appointments, admitting frail patients for bowel preparation to one ward, and allocating colonoscopies to the most successful operators.	N Tyneside Gen Hosp, Endoscopy Dept, N Shields NE29 8NH, England		Welfare, MR (corresponding author), N Tyneside Gen Hosp, Endoscopy Dept, N Shields NE29 8NH, England.	doctormarkw@aol.com	Wilkins, Thad/G-2541-2010; Jowett, Sue/AAO-4198-2021	Jowett, Sue/0000-0001-8936-3745				Balfour TW, 1999, J ROY SOC MED, V94, P160; Bowles CJA, 2004, GUT, V53, P277, DOI 10.1136/gut.2003.016436; Bowles CJA, 2001, GUT, V48, pA10; Dafnis G, 2001, ENDOSCOPY, V33, P511, DOI 10.1055/s-2001-14964; LINDSAY DC, 1988, BRIT MED J, V296, P167, DOI 10.1136/bmj.296.6616.167; Mitchell RMS, 2002, ULSTER MED J, V71, P34; Nelson DB, 1999, GASTROINTEST ENDOSC, V49, pAB65; Palmer KR, 2004, GUT, V53, P163, DOI 10.1136/gut.2003.022053; *ROYAL COLL PHYS, 2001, GUID TRAIN APPR ASS; Thomas-Gibson S, 2002, J ROY SOC MED, V95, P194, DOI 10.1258/jrsm.95.4.194	10	51	53	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 18	2004	329	7467					665	667		10.1136/bmj.329.7467.665	http://dx.doi.org/10.1136/bmj.329.7467.665			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	856JU	15374917	Green Published			2022-12-28	WOS:000224042300023
J	Sybert, VP; McCauley, E				Sybert, VP; McCauley, E			Turner's syndrome	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							GROWTH-HORMONE TREATMENT; MIDDLE-AGED WOMEN; FINAL HEIGHT; ADULT HEIGHT; CARDIOVASCULAR MALFORMATIONS; REPLACEMENT THERAPY; COGNITIVE DEFICITS; MOLECULAR ANALYSIS; AORTIC DILATION; CELIAC-DISEASE		Univ Washington, Sch Med, Dept Med, Div Med Genet, Seattle, WA 98195 USA; Univ Washington, Sch Med, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA; Grp Hlth Permanente Seattle, Seattle, WA USA; Childrens Hosp & Med Ctr, Seattle, WA 98105 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Seattle Children's Hospital	Sybert, VP (corresponding author), Univ Washington, Sch Med, Dept Med, Div Med Genet, Seattle, WA 98195 USA.							Albareda MM, 1999, EUR J GASTROEN HEPAT, V11, P1037, DOI 10.1097/00042737-199909000-00015; Alvarez-Nava F, 2003, J PEDIATR-US, V142, P336, DOI 10.1067/mpd.2003.95; ARULANANTHAM K, 1980, PEDIATRICS, V66, P63; Bakalov VK, 2003, AM J MED, V115, P259, DOI 10.1016/S0002-9343(03)00364-4; Betts PR, 1999, ARCH DIS CHILD, V80, P221, DOI 10.1136/adc.80.3.221; Bonamico M, 2002, J CLIN ENDOCR METAB, V87, P5495, DOI 10.1210/jc.2002-020855; Boucher CA, 2001, J MED GENET, V38, P591, DOI 10.1136/jmg.38.9.591; Bramswig JH, 1997, EUR J ENDOCRINOL, V137, P446, DOI 10.1530/eje.0.1370446; Buchanan L, 1998, DEV NEUROPSYCHOL, V14, P341, DOI 10.1080/87565649809540715; *CAN GROWTH HORM A, 1998, HORM RES S3, V50, P25; CAVE CB, 2003, COCHRANE DB SYST REV, V3; CHANG HJ, 1990, AM J HUM GENET, V46, P156; CHROUSOS GA, 1984, OPHTHALMOLOGY, V91, P926; Chu CE, 1997, ACTA PAEDIATR, V86, P160, DOI 10.1111/j.1651-2227.1997.tb08858.x; Davenport ML, 2002, HORM RES, V57, P157, DOI 10.1159/000058376; DELGADO JA, 1986, CLIN GENET, V29, P291; Donaldson MDC, 1997, HORM RES, V48, P35, DOI 10.1159/000191327; DOWNEY J, 1989, J NERV MENT DIS, V177, P191, DOI 10.1097/00005053-198904000-00002; Elliott TK, 1996, DEV NEUROPSYCHOL, V12, P365, DOI 10.1080/87565649609540658; Elsheikh M, 2002, ENDOCR REV, V23, P120, DOI 10.1210/er.23.1.120; Elsheikh M, 2001, CLIN ENDOCRINOL, V54, P69, DOI 10.1046/j.1365-2265.2001.01154.x; Elsheikh M, 2001, CLIN ENDOCRINOL, V55, P223, DOI 10.1046/j.1365-2265.2001.01296.x; Elsheikh M, 2001, CLIN ENDOCRINOL, V55, P227, DOI 10.1046/j.1365-2265.2001.01321.x; FORD CE, 1959, LANCET, V1, P711; GERMAIN EL, 1986, ACTA PAEDIATR SCAND, V75, P750, DOI 10.1111/j.1651-2227.1986.tb10285.x; GOTZSCHE CO, 1994, ARCH DIS CHILD, V71, P433, DOI 10.1136/adc.71.5.433; Gravholt CH, 1998, J CLIN EPIDEMIOL, V51, P147, DOI 10.1016/S0895-4356(97)00237-0; Gravholt CH, 2003, CLIN ENDOCRINOL, V59, P89, DOI 10.1046/j.1365-2265.2003.01807.x; Gravholt CH, 2000, J CLIN ENDOCR METAB, V85, P3199, DOI 10.1210/jc.85.9.3199; Guttmann H, 2001, CLIN ENDOCRINOL, V54, P159, DOI 10.1046/j.1365-2265.2001.01181.x; Haberecht MF, 2001, HUM BRAIN MAPP, V14, P96, DOI 10.1002/hbm.1044; HAEUSLER G, 1994, ACTA PAEDIATR, V83, P309, DOI 10.1111/j.1651-2227.1994.tb18100.x; Haeusler G, 1996, ACTA PAEDIATR, V85, P1408; Hasle H, 1996, BRIT J CANCER, V73, P1156, DOI 10.1038/bjc.1996.222; Haverkamp F, 1999, J CLIN ENDOCR METAB, V84, P4578, DOI 10.1210/jc.84.12.4578; Hochberg Z, 1999, EUR J ENDOCRINOL, V141, P218, DOI 10.1530/eje.0.1410218; Hogler W, 2004, J CLIN ENDOCR METAB, V89, P193, DOI 10.1210/jc.2003-030799; HULTCRANTZ M, 1994, HEARING RES, V76, P127, DOI 10.1016/0378-5955(94)90094-9; Ivarsson SA, 1999, ACTA PAEDIATR, V88, P933, DOI 10.1080/08035259950168397; Karnis MF, 2003, FERTIL STERIL, V80, P498, DOI 10.1016/S0015-0282(03)00974-9; KESSLER RC, 1994, ARCH GEN PSYCHIAT, V51, P8; KOEBERL DD, 1995, AM J HUM GENET, V57, P661; Landin-Wilhelmsen K, 1999, CLIN ENDOCRINOL, V51, P497, DOI 10.1046/j.1365-2265.1999.00841.x; Larralde M, 1998, PEDIATR DERMATOL, V15, P18, DOI 10.1046/j.1525-1470.1998.1998015018.x; Lawrence K, 2003, NEUROPSYCHOLOGY, V17, P39, DOI 10.1037/0894-4105.17.1.39; LIN AE, 1986, J PEDIATR-US, V109, P820, DOI 10.1016/S0022-3476(86)80700-4; Lin AE, 1998, PEDIATRICS, V102, DOI 10.1542/peds.102.1.e12; LIPPE B, 1988, PEDIATRICS, V82, P852; LYON AJ, 1985, ARCH DIS CHILD, V60, P932, DOI 10.1136/adc.60.10.932; MASSA G, 1995, HORM RES, V43, P144, DOI 10.1159/000184262; MATHISEN B, 1992, DEV MED CHILD NEUROL, V34, P141; Mazzocco MMM, 2001, J LEARN DISABIL-US, V34, P520, DOI 10.1177/002221940103400605; MCCAULEY E, 1987, CHILD DEV, V58, P464, DOI 10.2307/1130523; McCauley E, 2001, J DEV BEHAV PEDIATR, V22, P360, DOI 10.1097/00004703-200112000-00003; MCCAULEY E, 1995, J DEV BEHAV PEDIATR, V16, P210; MCCAULEY E, 1990, AAAS SELECT, V112, P78; MCCAULEY E, 1995, J DEV BEHAV PEDIATR, V16, P82; Modi DN, 2003, MOL HUM REPROD, V9, P219, DOI 10.1093/molehr/gag031; Nilsson KO, 1996, J CLIN ENDOCR METAB, V81, P635, DOI 10.1210/jc.81.2.635; Nishi MY, 2002, AM J MED GENET, V113, P116, DOI 10.1002/ajmg.10881; Nishi MY, 2002, AM J MED GENET, V107, P299, DOI 10.1002/ajmg.10168; O'Connor J, 2000, IRISH J PSYCHOL MED, V17, P82, DOI 10.1017/S0790966700005826; OGATA T, 1995, HUM GENET, V95, P607; Ogata T, 2001, J CLIN ENDOCR METAB, V86, P5498, DOI 10.1210/jc.86.11.5498; PAVLIDIS K, 1995, CLIN GENET, V47, P85; Plotnick L, 1998, PEDIATRICS, V102, P479; PRICE WH, 1986, J EPIDEMIOL COMMUN H, V40, P97, DOI 10.1136/jech.40.2.97; Prueitt RL, 2000, CYTOGENET CELL GENET, V89, P44, DOI 10.1159/000015560; Ranke MB, 2002, EUR J ENDOCRINOL, V147, P625, DOI 10.1530/eje.0.1470625; Rao E, 1997, NAT GENET, V16, P54, DOI 10.1038/ng0597-54; ROCHICCIOLI P, 1995, HORM RES, V44, P172, DOI 10.1159/000184620; Romans SM, 1997, DEV NEUROPSYCHOL, V13, P23, DOI 10.1080/87565649709540666; Rosenfeld RG, 1998, J PEDIATR-US, V132, P319, DOI 10.1016/S0022-3476(98)70452-4; Ross J, 2000, MENT RETARD DEV D R, V6, P135, DOI 10.1002/1098-2779(2000)6:2<135::AID-MRDD8>3.0.CO;2-K; ROSS JL, 1995, AM J MED GENET, V58, P74, DOI 10.1002/ajmg.1320580115; Ross JL, 2000, AM J HUM GENET, V67, P672, DOI 10.1086/303039; Ross JL, 2002, NEUROLOGY, V58, P218, DOI 10.1212/WNL.58.2.218; Ross JL, 1996, J CLIN ENDOCR METAB, V81, P2191; ROSS JL, 1991, J CLIN ENDOCR METAB, V73, P355, DOI 10.1210/jcem-73-2-355; Rourke B. P., 1995, SYNDROME NONVERBAL L; ROVET J, 1994, J PEDIATR PSYCHOL, V19, P779, DOI 10.1093/jpepsy/19.6.779; ROVET JF, 1990, AAAS SELECT, V112, P38; Sas TCJ, 1999, ARCH DIS CHILD, V80, P36, DOI 10.1136/adc.80.1.36; Silverman BL, 1997, J PEDIATR-US, V131, pS70, DOI 10.1016/S0022-3476(97)70016-7; Skuse DH, 1997, NATURE, V387, P705, DOI 10.1038/42706; Swerdlow AJ, 2001, ANN HUM GENET, V65, P177, DOI 10.1017/S0003480001008569; Sybert VP, 2002, J MED GENET, V39, P217, DOI 10.1136/jmg.39.3.217; SYBERT VP, 1984, J PEDIATR-US, V104, P365, DOI 10.1016/S0022-3476(84)81096-3; Sybert VP, 1998, PEDIATRICS, V101, DOI 10.1542/peds.101.1.e11; Sybert VP, 2001, MANAGEMENT GENETIC S, P459; SYLVEN L, 1993, ACTA ENDOCRINOL-COP, V129, P188, DOI 10.1530/acta.0.1290188; Taback SP, 1996, LANCET, V348, P25, DOI 10.1016/S0140-6736(96)01267-6; Takano K, 1997, EUR J ENDOCRINOL, V137, P138, DOI 10.1530/eje.0.1370138; Tarani L, 1998, GYNECOL ENDOCRINOL, V12, P83, DOI 10.3109/09513599809024955; Temple CM, 1998, DEV NEUROPSYCHOL, V14, P47, DOI 10.1080/87565649809540700; Temple CM, 1996, DEV NEUROPSYCHOL, V12, P343, DOI 10.1080/87565649609540657; Turner HH, 1938, ENDOCRINOLOGY, V23, P566, DOI 10.1210/endo-23-5-566; van Pareren YK, 2003, J CLIN ENDOCR METAB, V88, P1119, DOI 10.1210/jc.2002-021171; van Pareren YK, 2002, J CLIN ENDOCR METAB, V87, P5442, DOI 10.1210/jc.2002-020789; VANDENBROECK J, 1995, J PEDIATR-US, V127, P729, DOI 10.1016/S0022-3476(95)70161-3; Zinn AR, 1998, CURR OPIN GENET DEV, V8, P322, DOI 10.1016/S0959-437X(98)80089-0; Zinn AR, 2001, SEMIN REPROD MED, V19, P141, DOI 10.1055/s-2001-15394	102	507	546	0	68	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 16	2004	351	12					1227	1238		10.1056/NEJMra030360	http://dx.doi.org/10.1056/NEJMra030360			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	853WS	15371580				2022-12-28	WOS:000223861300011
J	Sauerland, S; Maegele, M				Sauerland, S; Maegele, M			A CRASH landing in severe head injury	LANCET			English	Editorial Material							TRAUMATIC BRAIN-INJURY; CARE MANAGEMENT; METHYLPREDNISOLONE		Univ Cologne, Fac Med, Biochem & Expt Div, D-5000 Cologne 41, Germany; Univ Witten Herdecke, Dept Trauma Surg, D-51109 Cologne, Germany	University of Cologne; Witten Herdecke University	Sauerland, S (corresponding author), Univ Cologne, Fac Med, Biochem & Expt Div, D-5000 Cologne 41, Germany.	S.Sauerland@uni-koeln.de		Sauerland, Stefan/0000-0003-1048-796X				ALDERSON P, 2001, COCHRANE LIB; Bouillon B, 1999, RESTOR NEUROL NEUROS, V14, P85; Bullock RM, 2000, J NEUROTRAUM, V17, P449; Coleman WP, 2000, J SPINAL DISORD, V13, P185, DOI 10.1097/00002517-200006000-00001; GHAJAR J, 1995, CRIT CARE MED, V23, P560, DOI 10.1097/00003246-199503000-00023; Marion DW, 2000, CRIT CARE MED, V28, P16, DOI 10.1097/00003246-200001000-00003; Masson F, 2001, J TRAUMA, V51, P481, DOI 10.1097/00005373-200109000-00010; PETO R, 1995, J CLIN EPIDEMIOL, V48, P23, DOI 10.1016/0895-4356(94)00150-O; Roberts I, 1998, J NEUROL NEUROSUR PS, V65, P729, DOI 10.1136/jnnp.65.5.729; Sauerland S, 2000, DRUG SAFETY, V23, P449, DOI 10.2165/00002018-200023050-00007; Sauerland S, 2003, J NEUROTRAUM, V20, P953, DOI 10.1089/089771503770195803; SCHONFELD SA, 1983, ANN INTERN MED, V99, P438, DOI 10.7326/0003-4819-99-4-438; United States Census Bureau, INT DAT BAS	13	36	41	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	OCT 9	2004	364	9442					1291	1292		10.1016/S0140-6736(04)17202-4	http://dx.doi.org/10.1016/S0140-6736(04)17202-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	860NG	15474118				2022-12-28	WOS:000224349700005
J	Campbell, CT				Campbell, CT			The active site in nanopaticle gold catalysis	SCIENCE			English	Editorial Material							CO OXIDATION; OXYGEN; NANOPARTICLES; ADSORPTION; CLUSTERS; TITANIA; AU		Univ Washington, Dept Chem, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Campbell, CT (corresponding author), Univ Washington, Dept Chem, Seattle, WA 98195 USA.	campbell@chem.washington.edu						Bondzie VA, 1999, CATAL LETT, V63, P143, DOI 10.1023/A:1019012903936; Chen MS, 2004, SCIENCE, V306, P252, DOI 10.1126/science.1102420; Fu Q, 2003, SCIENCE, V301, P935, DOI 10.1126/science.1085721; Grunwaldt JD, 1999, J PHYS CHEM B, V103, P1002, DOI 10.1021/jp983206j; Guzman J, 2002, J PHYS CHEM B, V106, P7659, DOI 10.1021/jp020584m; Haruta M, 1997, CATAL TODAY, V36, P153, DOI 10.1016/S0920-5861(96)00208-8; Hayashi T, 1998, J CATAL, V178, P566, DOI 10.1006/jcat.1998.2157; Lemire C, 2004, ANGEW CHEM INT EDIT, V43, P118, DOI 10.1002/anie.200352538; LIBUDA J, 1994, SURF SCI, V318, P61, DOI 10.1016/0039-6028(94)90341-7; Lopez N, 2004, J CATAL, V223, P232, DOI 10.1016/j.jcat.2004.01.001; Mills G, 2003, J CHEM PHYS, V118, P4198, DOI 10.1063/1.1542879; Molina LM, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.206102; Rodriguez JA, 2002, J AM CHEM SOC, V124, P5242, DOI 10.1021/ja020115y; Sanchez A, 1999, J PHYS CHEM A, V103, P9573, DOI 10.1021/jp9935992; Schroeder T, 2002, PHYS REV B, V66, DOI 10.1103/PhysRevB.66.165422; Schubert MM, 2001, J CATAL, V197, P113, DOI 10.1006/jcat.2000.3069; Valden M, 1998, SCIENCE, V281, P1647, DOI 10.1126/science.281.5383.1647; WU MC, 1991, CHEM PHYS LETT, V182, P472, DOI 10.1016/0009-2614(91)90110-U; Zanella R, 2004, J CATAL, V222, P357, DOI 10.1016/j.jcat.2003.11.005	19	297	302	2	171	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 8	2004	306	5694					234	235		10.1126/science.1104246	http://dx.doi.org/10.1126/science.1104246			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	861MC	15472065				2022-12-28	WOS:000224419700024
J	Yadav, JS; Wholey, MH; Kuntz, RE; Fayad, P; Katzen, BT; Mishkel, GJ; Bajwa, TK; Whitlow, P; Strickman, NE; Jaff, MR; Popma, JJ; Snead, DB; Cutlip, DE; Firth, BG; Ouriel, K				Yadav, JS; Wholey, MH; Kuntz, RE; Fayad, P; Katzen, BT; Mishkel, GJ; Bajwa, TK; Whitlow, P; Strickman, NE; Jaff, MR; Popma, JJ; Snead, DB; Cutlip, DE; Firth, BG; Ouriel, K		SAPPHIRE	Protected carotid-artery stenting versus endarterectomy in high-risk patients	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PERIOPERATIVE MYOCARDIAL-INFARCTION; HEALTH-CARE PROFESSIONALS; VASCULAR-SURGERY; MORTALITY; VOLUME; ANGIOPLASTY; OUTCOMES; EMBOLIZATION; POPULATION; PREVENTION	BACKGROUND: Carotid endarterectomy is more effective than medical management in the prevention of stroke in patients with severe symptomatic or asymptomatic atherosclerotic carotid-artery stenosis. Stenting with the use of an emboli-protection device is a less invasive revascularization strategy than endarterectomy in carotid-artery disease. METHODS: We conducted a randomized trial comparing carotid-artery stenting with the use of an emboli-protection device to endarterectomy in 334 patients with coexisting conditions that potentially increased the risk posed by endarterectomy and who had either a symptomatic carotid-artery stenosis of at least 50 percent of the luminal diameter or an asymptomatic stenosis of at least 80 percent. The primary end point of the study was the cumulative incidence of a major cardiovascular event at 1 year -- a composite of death, stroke, or myocardial infarction within 30 days after the intervention or death or ipsilateral stroke between 31 days and 1 year. The study was designed to test the hypothesis that the less invasive strategy, stenting, was not inferior to endarterectomy. RESULTS: The primary end point occurred in 20 patients randomly assigned to undergo carotid-artery stenting with an emboli-protection device (cumulative incidence, 12.2 percent) and in 32 patients randomly assigned to undergo endarterectomy (cumulative incidence, 20.1 percent; absolute difference, -7.9 percentage points; 95 percent confidence interval, -16.4 to 0.7 percentage points; P=0.004 for noninferiority, and P=0.053 for superiority). At one year, carotid revascularization was repeated in fewer patients who had received stents than in those who had undergone endarterectomy (cumulative incidence, 0.6 percent vs. 4.3 percent; P=0.04). CONCLUSIONS: Among patients with severe carotid-artery stenosis and coexisting conditions, carotid stenting with the use of an emboli-protection device is not inferior to carotid endarterectomy.	Cleveland Clin Fdn, Cleveland, OH 44195 USA; Pittsburgh Vasc Inst, Pittsburgh, PA USA; Brigham & Womens Hosp, Dept Cardiol, Boston, MA 02115 USA; Brigham & Womens Hosp, Angiog Core Lab, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA; Univ Nebraska, Omaha, NE 68182 USA; Miami Vasc Inst, Miami, FL USA; Prairie Cardiovasc Inst, Springfield, IL USA; St Lukes Hosp, Milwaukee, WI USA; Texas Heart Inst, Houston, TX 77025 USA; Vasc Ultrasound Core Lab, Morristown, NJ USA; Cordis, Warren, NJ USA; Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA	Cleveland Clinic Foundation; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of Nebraska System; Texas Heart Institute; Johnson & Johnson; Johnson & Johnson USA; Harvard University; Beth Israel Deaconess Medical Center	Yadav, JS (corresponding author), Cleveland Clin Fdn, Desk F25,9500 Euclid Ave, Cleveland, OH 44195 USA.	yadavj@ccf.org	Strickman, Neil/AFS-7515-2022					Badner NH, 1999, ANESTHESIOLOGY, V90, P644, DOI 10.1097/00000542-199902000-00057; Bettmann MA, 1998, CIRCULATION, V97, P121, DOI 10.1161/01.CIR.97.1.121; Biller J, 1998, CIRCULATION, V97, P501; Birkmeyer JD, 2003, NEW ENGL J MED, V349, P2117, DOI 10.1056/NEJMsa035205; BROTT T, 1989, STROKE, V20, P864, DOI 10.1161/01.STR.20.7.864; Cebul RD, 1998, JAMA-J AM MED ASSOC, V279, P1282, DOI 10.1001/jama.279.16.1282; CHAMBERS BR, 1986, NEW ENGL J MED, V315, P860, DOI 10.1056/NEJM198610023151404; Grube E, 2001, CIRCULATION, V104, P2436, DOI 10.1161/hc4501.099317; Hannan EL, 1998, STROKE, V29, P2292, DOI 10.1161/01.STR.29.11.2292; Hertzer N R, 2000, Semin Vasc Surg, V13, P95; Hosmer D. W., 1999, APPL SURVIVAL ANAL; Huston J, 2000, MAYO CLIN PROC, V75, P1133, DOI 10.4065/75.11.1133; Kim LJ, 2002, CIRCULATION, V106, P2366, DOI 10.1161/01.CIR.0000036016.52396.BB; LopezJimenez F, 1997, J AM COLL CARDIOL, V29, P1241, DOI 10.1016/S0735-1097(97)82754-4; MAHONEY F I, 1965, Md State Med J, V14, P61; McFalls EO, 1998, CHEST, V113, P681, DOI 10.1378/chest.113.3.681; Naylor AR, 1998, J VASC SURG, V28, P326, DOI 10.1016/S0741-5214(98)70182-X; Ohki T, 1998, J VASC SURG, V27, P463, DOI 10.1016/S0741-5214(98)70321-0; Ouriel K, 2001, J VASC SURG, V33, P728, DOI 10.1067/mva.2001.111981; RANKIN J, 1957, Scott Med J, V2, P200; Roubin GS, 2001, CIRCULATION, V103, P532, DOI 10.1161/01.CIR.103.4.532; Ruby ST, 1996, ANN VASC SURG, V10, P22, DOI 10.1007/BF02002337; Segal H E, 1993, QRB Qual Rev Bull, V19, P152; Stukenborg GJ, 1997, ARCH NEUROL-CHICAGO, V54, P826, DOI 10.1001/archneur.1997.00550190018009; TAYLOR DW, 1991, NEW ENGL J MED, V325, P445; Topol EJ, 2000, CIRCULATION, V101, P570, DOI 10.1161/01.CIR.101.5.570; WALKER MD, 1995, JAMA-J AM MED ASSOC, V273, P1421, DOI 10.1001/jama.1995.03520420037035; WARLOW C, 1991, LANCET, V337, P1235, DOI 10.1016/0140-6736(91)92916-P; Wennberg DE, 1998, JAMA-J AM MED ASSOC, V279, P1278, DOI 10.1001/jama.279.16.1278; Whitehead J, 1997, STAT PRACTICE; Yadav JS, 1997, CIRCULATION, V95, P376, DOI 10.1161/01.cir.95.2.376; YEAGER RA, 1994, J VASC SURG, V20, P598, DOI 10.1016/0741-5214(94)90284-4	32	1981	2178	0	56	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 7	2004	351	15					1493	1501		10.1056/NEJMoa040127	http://dx.doi.org/10.1056/NEJMoa040127			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	859UP	15470212	Bronze			2022-12-28	WOS:000224293700007
J	Howe, GR				Howe, GR			Studies of nuclear workers: the pros and cons	LANCET			English	Editorial Material							ATOMIC-ENERGY-AUTHORITY; MORTALITY; EMPLOYEES; CANCER		Columbia Univ, Mailman Sch Publ Hlth, New York, NY 10032 USA	Columbia University	Howe, GR (corresponding author), Columbia Univ, Mailman Sch Publ Hlth, New York, NY 10032 USA.	gh68@columbia.edu						Armitage P., 1987, STAT METHODS MED RES; Atkinson WD, 2004, OCCUP ENVIRON MED, V61, P577, DOI 10.1136/oem.2003.012443; BERAL V, 1985, BRIT MED J, V291, P440, DOI 10.1136/bmj.291.6493.440; CARDIS E, 1994, LANCET, V344, P1039; HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503; Muirhead C. R., 1999, Journal of Radiological Protection, V19, P3, DOI 10.1088/0952-4746/19/1/002; PERSTON DL, 2003, RADIAT RES, V160, P381; ROONEY C, 1993, BRIT MED J, V307, P1391, DOI 10.1136/bmj.307.6916.1391; *UNSCEAR, 2000, GEN ASS SCI ANN EFF, V2	9	0	0	0	8	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 2	2004	364	9441					1199	1200		10.1016/S0140-6736(04)17157-2	http://dx.doi.org/10.1016/S0140-6736(04)17157-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	859HO	15464167				2022-12-28	WOS:000224254200007
J	Bellows, DS; Tyers, M				Bellows, DS; Tyers, M			Chemical genetics hits "reality"	SCIENCE			English	Editorial Material							SMALL MOLECULES; PROTEOLYSIS; PROTEASOME; DISCOVERY; SYSTEM; TARGET		Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute	Bellows, DS (corresponding author), Mt Sinai Hosp, Samuel Lunenfeld Res Inst, 600 Univ Ave, Toronto, ON M5G 1X5, Canada.	tyers@mshri.on.ca	Tyers, Michael/ABE-3194-2021					Adams J, 2004, NAT REV CANCER, V4, P349, DOI 10.1038/nrc1361; Arkin MR, 2004, NAT REV DRUG DISCOV, V3, P301, DOI 10.1038/nrd1343; Bredel M, 2004, NAT REV GENET, V5, P262, DOI 10.1038/nrg1317; Hartwell LH, 1997, SCIENCE, V278, P1064, DOI 10.1126/science.278.5340.1064; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; King RW, 1996, SCIENCE, V274, P1652, DOI 10.1126/science.274.5293.1652; Mayer TU, 2003, TRENDS CELL BIOL, V13, P270, DOI 10.1016/S0962-8924(03)00077-1; Pawson T, 2003, SCIENCE, V300, P445, DOI 10.1126/science.1083653; Peters JM, 2002, MOL CELL, V9, P931, DOI 10.1016/S1097-2765(02)00540-3; Sharom JR, 2004, CURR OPIN CHEM BIOL, V8, P81, DOI 10.1016/j.cbpa.2003.12.007; Verma R, 2004, SCIENCE, V306, P117, DOI 10.1126/science.1100946; Verma R, 2004, CELL, V118, P99, DOI 10.1016/j.cell.2004.06.014; Zheng XFS, 2004, CHEM BIOL, V11, P609, DOI 10.1016/j.chembiol.2003.08.011	13	6	6	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 1	2004	306	5693					67	68		10.1126/science.1104611	http://dx.doi.org/10.1126/science.1104611			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	859YJ	15459377				2022-12-28	WOS:000224304000034
J	Strunk, C				Strunk, C			Boosting magnetoresistance in molecular devices	SCIENCE			English	Editorial Material							CARBON NANOTUBE; TRANSISTOR		Univ Regensburg, Dept Expt & Appl Phys, D-93040 Regensburg, Germany	University of Regensburg	Strunk, C (corresponding author), Univ Regensburg, Dept Expt & Appl Phys, Univ Str 31, D-93040 Regensburg, Germany.	christoph.strunk@physik.uni-r.de						Cronenwett SM, 1998, SCIENCE, V281, P540, DOI 10.1126/science.281.5376.540; Goldhaber-Gordon D, 1998, NATURE, V391, P156, DOI 10.1038/34373; JOACHIM C, 1995, PHYS REV LETT, V74, P2102, DOI 10.1103/PhysRevLett.74.2102; Keren K, 2003, SCIENCE, V302, P1380, DOI 10.1126/science.1091022; Liang WJ, 2002, NATURE, V417, P725, DOI 10.1038/nature00790; Park J, 2002, NATURE, V417, P722, DOI 10.1038/nature00791; Pasupathy AN, 2004, SCIENCE, V306, P86, DOI 10.1126/science.1102068; Reichert J, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.176804; Tans SJ, 1998, NATURE, V393, P49, DOI 10.1038/29954; Wolf SA, 2001, SCIENCE, V294, P1488, DOI 10.1126/science.1065389	10	4	5	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 1	2004	306	5693					63	64		10.1126/science.1104133	http://dx.doi.org/10.1126/science.1104133			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	859YJ	15459374				2022-12-28	WOS:000224304000031
J	Zhang, LX; Zhou, H; Su, Y; Sun, ZH; Zhang, HW; Zhang, L; Zhang, Y; Ning, YH; Chen, YG; Meng, AM				Zhang, LX; Zhou, H; Su, Y; Sun, ZH; Zhang, HW; Zhang, L; Zhang, Y; Ning, YH; Chen, YG; Meng, AM			Zebrafish Dpr2 inhibits mesoderm induction by promoting degradation of nodal receptors	SCIENCE			English	Article							TGF-BETA RECEPTOR; ONE-EYED-PINHEAD; WNT SIGNALS; GASTRULATION; INTERNALIZATION; ENDOCYTOSIS; ANTAGONIST; INTERACTS; ANTIVIN; SMAD2	Nodal proteins, members of the transforming growth factor-beta (TGFbeta) superfamily, have been identified as key endogenous mesoderm inducers in vertebrates. Precise control of Nodal signaling is essential for normal development of embryos. Here, we report that zebrafish dapper2 (dpr2) is expressed in mesoderm precursors during early embryogenesis and is positively regulated by Nodal signals. In vivo functional studies in zebrafish suggest that Dpr2 suppresses mesoderm induction activities of Nodal signaling. Dpr2 is localized in late endosomes, binds to the TGFbeta receptors ALK5 and ALK4, and accelerates lysosomal degradation of these receptors.	Tsing Hua Univ, Dept Biol Sci & Biotechnol, Minist Educ,Prot Sci Lab,Lab Dev Biol, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100084, Peoples R China; Tsing Hua Univ, Dept Biol Sci & Biotechnol, Minist Educ,Prot Sci Lab,Lab Mol Cell Biol, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100084, Peoples R China	Tsinghua University; Tsinghua University	Chen, YG (corresponding author), Tsing Hua Univ, Dept Biol Sci & Biotechnol, Minist Educ,Prot Sci Lab,Lab Dev Biol, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100084, Peoples R China.	ygchen@mail.tsinghua.edu.cn; mengam@mail.tsinghua.edu.cn	Zhang, Yu/F-6583-2016; Su, Ying/M-5825-2013; Meng, Anming/A-4785-2012; Chen, Ye-Guang/L-6998-2019; Su, Ying/ABA-8545-2021; Zhang, Long/AAT-6571-2021	Su, Ying/0000-0002-8466-0043; Su, Ying/0000-0002-8466-0043; Zhang, Long/0000-0001-8139-0474; Meng, Anming/0000-0001-7228-3431; Zhang, Yu/0000-0001-5512-9272				Agathon A, 2001, GENESIS, V30, P178, DOI 10.1002/gene.1059; Chen W, 2003, SCIENCE, V301, P1394, DOI 10.1126/science.1083195; Chen Y, 2002, CURR BIOL, V12, P2124, DOI 10.1016/S0960-9822(02)01362-3; Cheyette BNR, 2002, DEV CELL, V2, P449, DOI 10.1016/S1534-5807(02)00140-5; Di Guglielmo GM, 2003, NAT CELL BIOL, V5, P410, DOI 10.1038/ncb975; Feldman B, 1998, NATURE, V395, P181, DOI 10.1038/26013; Gloy J, 2002, NAT CELL BIOL, V4, P351, DOI 10.1038/ncb784; Gritsman K, 1999, CELL, V97, P121, DOI 10.1016/S0092-8674(00)80720-5; Harms PW, 2003, GENE DEV, V17, P2624, DOI 10.1101/gad.1127703; HATTA K, 1991, NATURE, V350, P339, DOI 10.1038/350339a0; Hayes S, 2002, J CELL BIOL, V158, P1239, DOI 10.1083/jcb.200204088; Iratni R, 2002, SCIENCE, V298, P1996, DOI 10.1126/science.1073405; Katoh M, 2003, INT J ONCOL, V22, P907; Lu ZX, 2002, J BIOL CHEM, V277, P29363, DOI 10.1074/jbc.M203495200; Meno C, 1999, MOL CELL, V4, P287, DOI 10.1016/S1097-2765(00)80331-7; Osada SI, 2000, DEVELOPMENT, V127, P2503; Penheiter SG, 2002, MOL CELL BIOL, V22, P4750, DOI 10.1128/MCB.22.13.4750-4759.2002; Piccolo S, 1999, NATURE, V397, P707, DOI 10.1038/17820; Sakuma R, 2002, GENES CELLS, V7, P401, DOI 10.1046/j.1365-2443.2002.00528.x; Schier AF, 2000, NATURE, V403, P385, DOI 10.1038/35000126; Schier AF, 1997, DEVELOPMENT, V124, P327; Thisse C, 1999, DEVELOPMENT, V126, P229; Zhang JJ, 1998, CELL, V92, P241, DOI 10.1016/S0092-8674(00)80918-6; Zhang L., UNPUB; ZHOU XL, 1993, NATURE, V361, P543, DOI 10.1038/361543a0	25	110	122	1	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 1	2004	306	5693					114	117		10.1126/science.1100569	http://dx.doi.org/10.1126/science.1100569			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	859YJ	15459392				2022-12-28	WOS:000224304000049
J	Frank, RG				Frank, RG			Election 2004: Prescription-drug prices	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Frank, RG (corresponding author), Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA.							BADGER D, 2004, ASK WHITE HOUSE; Baker C, 2004, WOULD PRESCRIPTION D; Levit K, 2004, HEALTH AFFAIR, V23, P147, DOI 10.1377/hlthaff.23.1.147; *REP NAT COMM, REP PART PLATF	4	16	16	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 30	2004	351	14					1375	1377		10.1056/NEJMp048158	http://dx.doi.org/10.1056/NEJMp048158			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	857XT	15459294				2022-12-28	WOS:000224153900001
J	Walsh, TJ; Teppler, H; Donowitz, GR; Maertens, JA; Baden, LR; Dmoszynska, A; Cornely, OA; Bourque, MR; Lupinacci, RJ; Sable, CA; dePauw, BE				Walsh, TJ; Teppler, H; Donowitz, GR; Maertens, JA; Baden, LR; Dmoszynska, A; Cornely, OA; Bourque, MR; Lupinacci, RJ; Sable, CA; dePauw, BE			Caspofungin versus liposomal amphotericin B for empirical antifungal therapy in patients with persistent fever and neutropenia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							DOUBLE-BLIND; IMMUNOCOMPROMISED PATIENTS; MK-0991; CANCER; ASPERGILLOSIS; FLUCONAZOLE; MULTICENTER; INFECTIONS; L-743,872; TRIAL	BACKGROUND: Patients with persistent fever and neutropenia often receive empirical therapy with conventional or liposomal amphotericin B for the prevention and early treatment of invasive fungal infections. Caspofungin, a member of the new echinocandin class of compounds, may be an effective alternative that is better tolerated than amphotericin B. METHODS: In this randomized, double-blind, multinational trial, we assessed the efficacy and safety of caspofungin as compared with liposomal amphotericin B as empirical antifungal therapy. At study entry, patients were stratified according to risk and according to whether they had previously received antifungal prophylaxis. A successful outcome was defined as the fulfillment of all components of a five-part composite end point. RESULTS: Efficacy was evaluated in 1095 patients (556 receiving caspofungin and 539 receiving liposomal amphotericin B). After adjustment for strata, the overall success rates were 33.9 percent for caspofungin and 33.7 percent for liposomal amphotericin B (95.2 percent confidence interval for the difference, -5.6 to 6.0 percent), fulfilling statistical criteria for the noninferiority of caspofungin. Among patients with baseline fungal infections, a higher proportion of those treated with caspofungin had a successful outcome (51.9 percent vs. 25.9 percent, P=0.04). The proportion of patients who survived at least seven days after therapy was greater in the caspofungin group (92.6 percent vs. 89.2 percent, P=0.05). Premature study discontinuation occurred less often in the caspofungin group than in the amphotericin B group (10.3 percent vs. 14.5 percent, P=0.03). The rates of breakthrough fungal infections and resolution of fever during neutropenia were similar in the two groups. Fewer patients who received caspofungin sustained a nephrotoxic effect (2.6 percent vs. 11.5 percent, P<0.001), an infusion-related event (35.1 percent vs. 51.6 percent, P<0.001), or a drug-related adverse event or discontinued therapy because of drug-related adverse events. CONCLUSIONS: Caspofungin is as effective as and generally better tolerated than liposomal amphotericin B when given as empirical antifungal therapy in patients with persistent fever and neutropenia.	NCI, NIH, Bethesda, MD 20892 USA; Merck Res Labs, West Point, PA USA; Univ Virginia Hlth Syst, Charlottesville, VA USA; Univ Ziekenhuis Leuven, Louvain, Belgium; Brigham & Womens Hosp, Boston, MA 02115 USA; Dana Farber Canc Inst, Boston, MA 02115 USA; Clin Hosp 4, Lublin, Poland; Univ Cologne Klinikum, Cologne, Germany; Univ Hosp St Radboud, Nijmegen, Netherlands	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Merck & Company; University of Virginia; KU Leuven; University Hospital Leuven; Harvard University; Brigham & Women's Hospital; Harvard University; Dana-Farber Cancer Institute; University of Cologne; Radboud University Nijmegen	Walsh, TJ (corresponding author), NCI, NIH, Bldg 10,Rm 13N-240,10 Ctr Dr, Bethesda, MD 20892 USA.		Cornely, Oliver A./J-5095-2013	Cornely, Oliver A./0000-0001-9599-3137	NATIONAL CANCER INSTITUTE [Z01SC006830, ZIASC006830] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Abruzzo GK, 1997, ANTIMICROB AGENTS CH, V41, P2333, DOI 10.1128/AAC.41.11.2333; ANDRIOLE VT, 1993, CLIN INFECT DIS, V17, pS481, DOI 10.1093/clinids/17.Supplement_2.S481; Arathoon EG, 2002, ANTIMICROB AGENTS CH, V46, P451, DOI 10.1128/AAC.46.2.451-457.2002; Ascioglu S, 2002, CLIN INFECT DIS, V34, P7, DOI 10.1086/323335; Bartizal K, 1997, ANTIMICROB AGENTS CH, V41, P2326, DOI 10.1128/AAC.41.11.2326; Boogaerts M, 2001, ANN INTERN MED, V135, P412, DOI 10.7326/0003-4819-135-6-200109180-00010; Bowman JC, 2002, ANTIMICROB AGENTS CH, V46, P3001, DOI 10.1128/AAC.46.9.3001-3012.2002; Deresinski SC, 2003, CLIN INFECT DIS, V36, P1445, DOI 10.1086/375080; Hughes WT, 2002, CLIN INFECT DIS, V34, P730, DOI 10.1086/339215; Koch GG, 1990, STAT METHODOLOGY PHA, P414; MAERTENS J, 2002, 42 INT C ANT AG CHEM; MEUNIER F, 1989, AM J MED, V86, P668; Mora-Duarte J, 2002, NEW ENGL J MED, V347, P2020, DOI 10.1056/NEJMoa021585; *NAT COMM CLIN LAB, 2001, M38A NAT COMM CLIN L; PANNUTI C, 1992, CANCER-AM CANCER SOC, V69, P2653, DOI 10.1002/1097-0142(19920601)69:11<2653::AID-CNCR2820691106>3.0.CO;2-8; Petraitiene R, 2002, ANTIMICROB AGENTS CH, V46, P12, DOI 10.1128/AAC.46.1.12-23.2002; PIZZO PA, 1982, AM J MED, V72, P101, DOI 10.1016/0002-9343(82)90594-0; Standards N., 1997, M27A NAT COMM CLIN L; VARTIVARIAN SE, 1993, CLIN INFECT DIS, V17, pS487, DOI 10.1093/clinids/17.Supplement_2.S487; Vazquez JA, 1997, ANTIMICROB AGENTS CH, V41, P1612, DOI 10.1128/AAC.41.7.1612; Villanueva A, 2002, AM J MED, V113, P294, DOI 10.1016/S0002-9343(02)01191-9; Villanueva A, 2001, CLIN INFECT DIS, V33, P1529, DOI 10.1086/323401; Walsh TJ, 2002, NEW ENGL J MED, V346, P225, DOI 10.1056/NEJM200201243460403; Walsh TJ, 1999, NEW ENGL J MED, V340, P764, DOI 10.1056/NEJM199903113401004; WALSH TJ, 2002, 42 INT C ANT AG CHEM; Wingard JR, 2000, CLIN INFECT DIS, V31, P1155, DOI 10.1086/317451; Winston DJ, 2000, AM J MED, V108, P282, DOI 10.1016/S0002-9343(99)00457-X	27	626	680	1	19	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 30	2004	351	14					1391	1402		10.1056/NEJMoa040446	http://dx.doi.org/10.1056/NEJMoa040446			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	857XT	15459300				2022-12-28	WOS:000224153900007
J	Chartier-Harlin, MC; Kachergus, J; Roumier, C; Mouroux, V; Douay, X; Lincoln, S; Levecque, C; Larvor, L; Andrieux, J; Hulihan, M; Waucquier, N; Defebvre, L; Amouyel, P; Farrer, M; Destee, A				Chartier-Harlin, MC; Kachergus, J; Roumier, C; Mouroux, V; Douay, X; Lincoln, S; Levecque, C; Larvor, L; Andrieux, J; Hulihan, M; Waucquier, N; Defebvre, L; Amouyel, P; Farrer, M; Destee, A			alpha-synuclein locus duplication as a cause of familial Parkinson's disease	LANCET			English	Article								Genomic triplication of the alpha-synuclein gene (SNCA) has been reported to cause hereditary early-onset parkinsonism with dementia. These findings prompted us to screen for multiplication of the SNCA locus in nine families in whom parkinsonism segregates as an autosomal dominant trait. One kindred was identified with SNCA duplication by semiquantitative PCR and confirmed by fluorescent in-situ hybridisation analysis in peripheral leucocytes. By contrast with SNCA triplication families, the clinical phenotype of SNCA duplication closely resembles idiopathic Parkinson's disease, which has a late age-of-onset, progresses slowly, and in which neither cognitive decline nor dementia are prominent. These findings suggest a direct relation between SNCA gene dosage and disease progression.	Mayo Clin, Dept Neurosci, Jacksonville, FL 32224 USA; INSERM, U508, F-59019 Lille, France; INSERM, U524, F-59045 Lille, France; CHU Lille, EA MENRT 2683, Dept Neurol, Movement Disorder Clin, Lille, France	Mayo Clinic; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; CHU Lille	Farrer, M (corresponding author), Mayo Clin, Dept Neurosci, Jacksonville, FL 32224 USA.	farrer.matthew@mayo.edu	Chartier-Harlin, Marie-Christine/L-4527-2018; LICEND, CEMND/F-1296-2015	Chartier-Harlin, Marie-Christine/0000-0001-6416-6526; Amouyel, Philippe/0000-0001-9088-234X; Farrer, Matthew/0000-0003-1159-5321; Levecque, Clotilde/0000-0002-0519-337X				Farrer M, 2000, MOVEMENT DISORD, V15, P1075, DOI 10.1002/1531-8257(200011)15:6<1075::AID-MDS1004>3.0.CO;2-2; Farrer M, 2004, ANN NEUROL, V55, P174, DOI 10.1002/ana.10846; Farrer M, 2001, HUM MOL GENET, V10, P1847, DOI 10.1093/hmg/10.17.1847; Golbe LI, 2004, ANN NEUROL, V55, P153, DOI 10.1002/ana.20036; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278	5	1462	1511	2	98	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 25	2004	364	9440					1167	1169		10.1016/S0140-6736(04)17103-1	http://dx.doi.org/10.1016/S0140-6736(04)17103-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	857FT	15451224				2022-12-28	WOS:000224102400030
J	Oransky, I				Oransky, I			Sir Godfrey N Hounsfield - Obituary	LANCET			English	Biographical-Item												ivan-oransky@erols.com						HOUNSFIELD GN, PUBLICATION LIST	1	9	9	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 18	2004	364	9439					1032	1032		10.1016/S0140-6736(04)17049-9	http://dx.doi.org/10.1016/S0140-6736(04)17049-9			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	855FT	15455486	Bronze			2022-12-28	WOS:000223959300013
J	Ruger, JP				Ruger, JP			Ethics of the social determinants of health	LANCET			English	Article							INEQUALITIES; POLICY; DEATH		Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, New Haven, CT 06520 USA	Yale University	Ruger, JP (corresponding author), Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, 333 Cedar St, New Haven, CT 06520 USA.	jennifer.ruger@yale.edu			NATIONAL INSTITUTE ON DRUG ABUSE [K01DA016358] Funding Source: NIH RePORTER; NIDA NIH HHS [1K01DA016358-01, K01 DA016358] Funding Source: Medline	NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))		Acheson D., 1998, INDEPENDENT INQUIRY; Amick B.C, 1995, SOC HLTH; ANAND S, 2000, BOSTON REV, P25; ANGELL M, 2000, BOSTON REV, P25; [Anonymous], 1999, DEV FREEDOM; Aristotle, 1987, NICOMACHEAN ETHICS; Black D, 1999, BMJ-BRIT MED J, V318, P724, DOI 10.1136/bmj.318.7185.724; Braveman P, 2003, J EPIDEMIOL COMMUN H, V57, P254, DOI 10.1136/jech.57.4.254; Brock DW, 2000, KENNEDY INST ETHIC J, V10, P21; DANIELS N, 2000, IS INEQUALITY BAD OU; DANIELS N, 2002, MED SOCIAL JUSTICE, P6; DANIELS N, 2000, BOSTON REV, P25; Deaton A, 2002, HEALTH AFFAIR, V21, P13, DOI 10.1377/hlthaff.21.2.13; EMANUEL EJ, 2000, BOSTON REV, P25; EVANS PG, 1994, WHY SOME PEOPLE HLTH; Evans T., 2001, CHALLENGING INEQUITI; GAKIDOU E, 2000, BOSTON REV, P25; Horton R, 2002, LANCET, V360, P186, DOI 10.1016/S0140-6736(02)09502-8; Kamm Frances M., 2001, American Journal of Bioethics, V1, P17, DOI 10.1162/152651601300168843; KREISLER H, 2002, COMMUNICATION   0318; Leon DA, 2001, BMJ-BRIT MED J, V322, P591, DOI 10.1136/bmj.322.7286.591; Lord C., 1984, POLITICS; Macinko James A, 2002, Int J Equity Health, V1, P1, DOI 10.1186/1475-9276-1-1; Macintyre S, 2000, BRIT MED J, V320, P1399, DOI 10.1136/bmj.320.7246.1399; Mackenbach JP, 2002, BRIT MED J, V325, P1029, DOI 10.1136/bmj.325.7371.1029; MARMOR T, 2000, BOSTON REV, P25; Marmot M, 2001, NEW ENGL J MED, V345, P134, DOI 10.1056/NEJM200107123450210; Marmot MG, 1998, LANCET, V351, P57, DOI 10.1016/S0140-6736(97)08084-7; MARMOT MG, 1991, LANCET, V337, P1387, DOI 10.1016/0140-6736(91)93068-K; MARMOT MG, 1984, LANCET, V1, P1003; MARMOT MG, 2000, BOSTON REV, P25; Martikainen P, 1999, BRIT MED J, V319, P319, DOI 10.1136/bmj.319.7205.319; Nussbaum M. C., 1990, ARISTOTELES POLITIK; Nussbaum Martha C., 1998, ETHICS CONSUMPTION G, P312; NUSSBAUM MC, 1992, POLIT THEORY, V20, P202, DOI 10.1177/0090591792020002002; Peter F., 2001, CHALLENGING INEQUITI, P24; Rawls J., 1971, THEORY JUSTICE; Ruger JP, 2004, BRIT MED J, V329, P121, DOI 10.1136/bmj.329.7458.121; Ruger JP, 2003, LANCET, V362, P678, DOI 10.1016/S0140-6736(03)14243-2; RUGER JP, 1998, THESIS HARVARD U CAM; RUGER JP, IN PRESS AM J PUBLIC; SEN A, 1993, SCI AM, V268, P40, DOI 10.1038/scientificamerican0593-40; Sen A, 1992, INEQUALITY RE EXAMIN; Sen A., 1999, COMMODITIES CAPABILI; SEN AK, 2000, IS INEQUALITY BAD OU; Smith GD, 1998, BMJ-BRIT MED J, V317, P1465, DOI 10.1136/bmj.317.7171.1465; STARFIED B, 2000, BOSTON REV, P25; *UN, PREV HIV AIDS; WOOLHANDLER S, 2000, BOSTON REV, P25; World Bank, 1999, CURB EP GOV EC TOB C; 1999, REDUCING HLTH INEQUA	51	69	71	0	7	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 18	2004	364	9439					1092	1097		10.1016/S0140-6736(04)17067-0	http://dx.doi.org/10.1016/S0140-6736(04)17067-0			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	855FT	15380971	Green Accepted			2022-12-28	WOS:000223959300031
J	Humbles, AA; Lloyd, CM; McMillan, SJ; Friend, DS; Xanthou, G; McKenna, EE; Ghiran, S; Gerard, NP; Yu, CN; Orkin, SH; Gerard, C				Humbles, AA; Lloyd, CM; McMillan, SJ; Friend, DS; Xanthou, G; McKenna, EE; Ghiran, S; Gerard, NP; Yu, CN; Orkin, SH; Gerard, C			A critical role for eosinophils in allergic airways remodeling	SCIENCE			English	Article							SUBEPITHELIAL FIBROSIS; BRONCHIAL-ASTHMA; INFLAMMATION; EXPRESSION; HYPERREACTIVITY; BIOPSIES; GATA-1; MOUSE; LEADS	Features of chronic asthma include airway hyperresponsiveness, inflammatory infiltrates, and structural changes in the airways, termed remodeling. The contribution of eosinophils, cells associated with asthma and allergy, remains to be established. We show that in mice with a total ablation of the eosinophil lineage, increases in airway hyperresponsiveness and mucus secretion were similar to those observed in wild-type mice, but eosinophil-deficient mice were significantly protected from peribronchiolar collagen deposition and increases in airway smooth muscle. These data suggest that eosinophils contribute substantially to airway remodeling but are not obligatory for allergen-induced lung dysfunction, and support an important role for eosinophil-targeted therapies in chronic asthma.	Harvard Univ, Childrens Hosp, Sch Med, Dept Pediat, Boston, MA 02115 USA; Univ London Imperial Coll Sci Technol & Med, Fac Med, Div Biomed Sci, London SW7 2AZ, England; Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Pathol, Boston, MA 02111 USA; Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Med, Boston, MA 02114 USA; Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; Howard Hughes Med Inst, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Imperial College London; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Dana-Farber Cancer Institute; Howard Hughes Medical Institute	Humbles, AA (corresponding author), Harvard Univ, Childrens Hosp, Sch Med, Dept Pediat, Boston, MA 02115 USA.	alison.humbles@childrens.harvard.edu; c.lloyd@imperial.ac.uk	Xanthou, Georgina/AAH-8682-2019	Lloyd, Clare/0000-0001-8977-6726; Yu, Channing/0000-0002-3231-2565	Wellcome Trust [087618] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F32HL010463] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI039759] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bandeira-Melo C, 2003, PROSTAG LEUKOTR ESS, V69, P135, DOI 10.1016/S0952-3278(03)00074-7; Beller TC, 2004, P NATL ACAD SCI USA, V101, P3047, DOI 10.1073/pnas.0400235101; Blyth DI, 2000, AM J RESP CELL MOL, V23, P241, DOI 10.1165/ajrcmb.23.2.3999; Bousquet J, 2000, AM J RESP CRIT CARE, V161, P1720, DOI 10.1164/ajrccm.161.5.9903102; BREWSTER CEP, 1990, AM J RESP CELL MOL, V3, P507, DOI 10.1165/ajrcmb/3.5.507; Busse W, 1999, AM J RESP CRIT CARE, V160, P1035, DOI 10.1164/ajrccm.160.3.9902064; Chapman HA, 2004, J CLIN INVEST, V113, P148, DOI 10.1172/JCI200420729; Cho JY, 2004, J CLIN INVEST, V113, P551, DOI 10.1172/JCI200419133; Elias JA, 1999, J CLIN INVEST, V104, P1001, DOI 10.1172/JCI8124; Flood-Page P, 2003, J CLIN INVEST, V112, P1029, DOI 10.1172/JCI200317974; GLEICH GJ, 1993, ANNU REV MED, V44, P85, DOI 10.1146/annurev.me.44.020193.000505; Hamelmann E, 1997, AM J RESP CRIT CARE, V156, P766, DOI 10.1164/ajrccm.156.3.9606031; HUMBLES AA, UNPUB; JEFFERY PK, 1989, AM REV RESPIR DIS, V140, P1745, DOI 10.1164/ajrccm/140.6.1745; Lee JJ, 1997, J EXP MED, V185, P2143, DOI 10.1084/jem.185.12.2143; LENDRUM AC, 1962, J CLIN PATHOL, V15, P401, DOI 10.1136/jcp.15.5.401; MARTIN TR, 1988, J APPL PHYSIOL, V64, P2318, DOI 10.1152/jappl.1988.64.6.2318; MCMILLAN S, 2004, CLIN EXP ALLERGY, V34, P1; Migliaccio AR, 2003, J EXP MED, V197, P281, DOI 10.1084/jem.20021149; Minshall EM, 1997, AM J RESP CELL MOL, V17, P326, DOI 10.1165/ajrcmb.17.3.2733; Moir LM, 2003, AM J PHYSIOL-LUNG C, V284, pL148, DOI 10.1152/ajplung.00105.2002; Ohno I, 1996, AM J RESP CELL MOL, V15, P404, DOI 10.1165/ajrcmb.15.3.8810646; Rankin JA, 1996, P NATL ACAD SCI USA, V93, P7821, DOI 10.1073/pnas.93.15.7821; Temann UA, 1998, J EXP MED, V188, P1307, DOI 10.1084/jem.188.7.1307; Vignola AM, 1997, AM J RESP CRIT CARE, V156, P591, DOI 10.1164/ajrccm.156.2.9609066; WANNER A, 1990, CHEST, V97, pS11; Wenzel SE, 1999, AM J RESP CRIT CARE, V160, P1001, DOI 10.1164/ajrccm.160.3.9812110; Yu CN, 2002, J EXP MED, V195, P1387, DOI 10.1084/jem.20020656; Zhou Z, 1999, J CLIN INVEST, V103, P779, DOI 10.1172/JCI5909	29	686	723	0	46	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 17	2004	305	5691					1776	1779		10.1126/science.1100283	http://dx.doi.org/10.1126/science.1100283			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	856IS	15375268				2022-12-28	WOS:000224039500042
J	Shevenell, AE; Kennett, JP; Lea, DW				Shevenell, AE; Kennett, JP; Lea, DW			Middle Miocene Southern Ocean cooling and Antarctic cryosphere expansion	SCIENCE			English	Article							ATMOSPHERIC CARBON-DIOXIDE; SEA-SURFACE TEMPERATURE; ICE-SHEET DEVELOPMENT; SOUTHWEST PACIFIC; CLIMATE; MG/CA; GLACIATION; AUSTRALIA; SECTION; RECORD	Magnesium/calcium data from Southern Ocean planktonic foraminifera demonstrate that high-latitude (similar to55degreesS) southwest Pacific sea surface temperatures (SSTs) cooled 6degrees to 7degreesC during the middle Miocene climate transition (14.2 to 13.8 million years,ago). Stepwise surface cooling is paced by eccentricity forcing and precedes Antarctic cryosphere expansion by similar to60 thousand years, suggesting the involvement of additional feedbacks during this interval of inferred low-atmospheric partial pressure of CO2 (pCO(2)). Comparing SSTs and global carbon cycling proxies challenges the notion that episodic PCO2 drawdown drove this major Cenozoic climate transition. SST, salinity, and ice-volume trends suggest instead that orbitally paced ocean circulation changes altered meridional heat/vapor transport, triggering ice growth and global cooling.	Univ Calif Santa Barbara, Dept Geol Sci, Santa Barbara, CA 93106 USA; Univ Calif Santa Barbara, Inst Marine Sci, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara	Shevenell, AE (corresponding author), Univ Calif Santa Barbara, Dept Geol Sci, Santa Barbara, CA 93106 USA.	ashevenell@umail.ucsb.edu	Shevenell, Amelia/C-2757-2015; shevenell, Amelia/A-4161-2009	Shevenell, Amelia/0000-0002-6457-6530; 				Billups K, 2002, PALEOCEANOGRAPHY, V17, DOI 10.1029/2000PA000567; DeConto RM, 2003, NATURE, V421, P245, DOI 10.1038/nature01290; EXON NF, 2001, P OCEAN DRILL PROG I, V189; FLOWER BP, 1994, PALAEOGEOGR PALAEOCL, V108, P537, DOI 10.1016/0031-0182(94)90251-8; FLOWER BP, 1995, PALEOCEANOGRAPHY, V10, P1095, DOI 10.1029/95PA02022; FLOWER BP, 1993, GEOLOGY, V21, P877, DOI 10.1130/0091-7613(1993)021<0877:RBMFDA>2.3.CO;2; Hall IR, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2002PA000817; HAQ BU, 1987, SCIENCE, V235, P1156, DOI 10.1126/science.235.4793.1156; HODELL DA, 1994, PALEOCEANOGRAPHY, V9, P405, DOI 10.1029/94PA00292; Hsu K.J, 1978, INITIAL REPORTS DEEP, V42, P943, DOI DOI 10.2973/DSDP.PR0C.42-1.149.1978; Kennett J.P., 1990, Proceedings of the Ocean Drilling Program Scientific Results, V113, P937; Lamy F, 2004, SCIENCE, V304, P1959, DOI 10.1126/science.1097863; LASKAR J, IN PRESS ASTRON ASTR; Lawver L.A., 1992, ANTARCTIC PALEOENVIR, P7; Lea DW, 2000, SCIENCE, V289, P1719, DOI 10.1126/science.289.5485.1719; Lear CH, 2000, SCIENCE, V287, P269, DOI 10.1126/science.287.5451.269; LOCKER S, 1989, GEOL RUNDSCH, V78, P1165, DOI 10.1007/BF01829338; Mashiotta TA, 1999, EARTH PLANET SC LETT, V170, P417, DOI 10.1016/S0012-821X(99)00116-8; Miller KG, 1987, PALEOCEANOGRAPHY, V2, P1, DOI 10.1029/PA002i001p00001; Pagani M, 1999, PALEOCEANOGRAPHY, V14, P273, DOI 10.1029/1999PA900006; Pahnke K, 2003, SCIENCE, V301, P948, DOI 10.1126/science.1084451; Pearson PN, 2000, NATURE, V406, P695, DOI 10.1038/35021000; RAYMO ME, 1994, PALEOCEANOGRAPHY, V9, P399, DOI 10.1029/94PA00289; Rintoul SR, 1999, DEEP-SEA RES PT I, V46, P1417, DOI 10.1016/S0967-0637(99)00013-8; Rosenthal Y, 2002, PALEOCEANOGRAPHY, V17, DOI 10.1029/2001PA000749; Royer DL, 2001, SCIENCE, V292, P2310, DOI 10.1126/science.292.5525.2310; SCHNITKER D, 1980, NATURE, V284, P615, DOI 10.1038/284615a0; Sclater J. G., 1985, MIOCENE OCEAN, P1; Shackleton N.J., 1975, INITIAL REPORTS DEEP, V29, P743, DOI [DOI 10.2973/DSDP.PROC.29.117.1975, 10.2973/DSDP.PROC.29.117.1975]; SHEVENELL AE, IN PRESS CENOZOIC SO; Sluiter IRK, 1995, INT J COAL GEOL, V28, P277, DOI 10.1016/0166-5162(95)00021-6; VINCENT E, 1985, CARBON CYCLE ATMOSPH, V32, P455; WILKINSON BH, 1989, AM J SCI, V289, P1158, DOI 10.2475/ajs.289.10.1158; Woodruff F, 1989, PALEOCEANOGRAPHY, V4, P87, DOI 10.1029/PA004i001p00087; Wright JD, 1992, PALEOCEANOGRAPHY, V7, P357, DOI 10.1029/92PA00760; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412; Zachos JC, 2001, SCIENCE, V292, P274, DOI 10.1126/science.1058288	37	402	422	4	112	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 17	2004	305	5691					1766	1770		10.1126/science.1100061	http://dx.doi.org/10.1126/science.1100061			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	856IS	15375266				2022-12-28	WOS:000224039500039
J	Xiong, ZG; Zhu, XM; Chu, XP; Minami, M; Hey, J; Wei, WL; MacDonald, JF; Wemmie, JA; Price, MP; Welsh, MJ; Simon, RP				Xiong, ZG; Zhu, XM; Chu, XP; Minami, M; Hey, J; Wei, WL; MacDonald, JF; Wemmie, JA; Price, MP; Welsh, MJ; Simon, RP			Neuroprotection in ischemia: Blocking calcium-permeable acid-sensing ion channels	CELL			English	Article							NMDA RECEPTOR ACTIVATION; D-ASPARTATE RECEPTORS; GATED NA+ CHANNEL; CATION CHANNEL; GLUTAMATE NEUROTOXICITY; GLUCOSE DEPRIVATION; CEREBRAL-ISCHEMIA; NEURONAL INJURY; SENSORY NEURONS; CELL-CULTURE	Ca2+ toxicity remains the central focus of ischemic brain injury. The mechanism by which toxic Ca2+ loading of cells occurs in the ischemic brain has become less clear as multiple human trials of glutamate antagonists have failed to show effective neuroprotection in stroke. Acidosis is a common feature of ischemia and is assumed to play a critical role in brain injury; however, the mechanism(s) remain ill defined. Here, we show that acidosis activates Ca2+-permeable acid-sensing ion channels (ASICs), inducing glutamate receptor-independent, Ca2+-dependent, neuronal injury inhibited by ASIC blockers. Cells lacking endogenous ASICs are resistant to acid injury, while transfection of Ca2+-permeable ASIC1a establishes sensitivity. In focal ischemia, intracerebroventricular injection of ASIC1 a blockers or knockout of the ASIC1 a gene protects the brain from ischemic injury and does so more potently than glutamate antagonism. Thus, acidosis injures the brain via membrane receptor-based mechanisms with resultant toxicity of [Ca2+](i), disclosing new potential therapeutic targets for stroke.	Robert S Dow Neurobiol Labs Legacy Res, Portland, OR 97232 USA; Univ Toronto, Dept Physiol, Toronto, ON M5S 1A8, Canada; Univ Iowa, Dept Psychiat, Iowa City, IA 52242 USA; Univ Iowa, Dept Vet Affairs Med Ctr, Iowa City, IA 52242 USA; Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA; Univ Iowa, Howard Hughes Med Inst, Iowa City, IA 52242 USA; Oregon Hlth & Sci Univ, Dept Neurol Physiol & Pharmacol, Portland, OR 97239 USA	University of Toronto; University of Iowa; University of Iowa; US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System; University of Iowa; Howard Hughes Medical Institute; University of Iowa; Oregon Health & Science University	Xiong, ZG (corresponding author), Robert S Dow Neurobiol Labs Legacy Res, Portland, OR 97232 USA.	zxiong@downeurobiology.org	Minami, Manabu/H-8540-2016	Wemmie, John/0000-0001-7531-9065; Chu, Xiang-Ping/0000-0002-6781-0468; Welsh, Michael/0000-0002-1646-6206				Aarts M, 2003, CELL, V115, P863, DOI 10.1016/S0092-8674(03)01017-1; Akopian AN, 2000, NEUROREPORT, V11, P2217, DOI 10.1097/00001756-200007140-00031; Allen NJ, 2002, J PHYSIOL-LONDON, V543, P521, DOI 10.1113/jphysiol.2002.020297; Bassilana F, 1997, J BIOL CHEM, V272, P28819, DOI 10.1074/jbc.272.46.28819; BEDERSON JB, 1986, STROKE, V17, P1304, DOI 10.1161/01.STR.17.6.1304; Benos DJ, 1999, J PHYSIOL-LONDON, V520, P631, DOI 10.1111/j.1469-7793.1999.00631.x; Benson CJ, 1999, CIRC RES, V84, P921; BEVAN S, 1991, J PHYSIOL-LONDON, V433, P145, DOI 10.1113/jphysiol.1991.sp018419; Bianchi L, 2002, NEURON, V34, P337, DOI 10.1016/S0896-6273(02)00687-6; Chen CC, 1998, P NATL ACAD SCI USA, V95, P10240, DOI 10.1073/pnas.95.17.10240; Chen CC, 2002, P NATL ACAD SCI USA, V99, P8992, DOI 10.1073/pnas.122245999; CHOI DW, 1988, NEURON, V1, P623, DOI 10.1016/0896-6273(88)90162-6; CHOI DW, 1988, TRENDS NEUROSCI, V11, P465, DOI 10.1016/0166-2236(88)90200-7; CHOI DW, 1995, TRENDS NEUROSCI, V18, P58; Chu XP, 2002, J NEUROPHYSIOL, V87, P2555, DOI 10.1152/jn.00741.2001; de la Rosa DA, 2003, J PHYSIOL-LONDON, V546, P77, DOI 10.1113/jphysiol.2002.030692; de la Rosa DA, 2002, P NATL ACAD SCI USA, V99, P2326, DOI 10.1073/pnas.042688199; Dingledine R, 1999, PHARMACOL REV, V51, P7; Escoubas P, 2000, J BIOL CHEM, V275, P25116, DOI 10.1074/jbc.M003643200; GIFFARD RG, 1990, BRAIN RES, V506, P339, DOI 10.1016/0006-8993(90)91276-M; GOLDBERG MP, 1993, J NEUROSCI, V13, P3510; Grunder S, 2000, NEUROREPORT, V11, P1607; Immke DC, 2001, NAT NEUROSCI, V4, P869, DOI 10.1038/nn0901-869; Jia ZP, 1996, NEURON, V17, P945, DOI 10.1016/S0896-6273(00)80225-1; Johnson MB, 2001, J CEREBR BLOOD F MET, V21, P734, DOI 10.1097/00004647-200106000-00011; KAKU DA, 1991, BRAIN RES, V554, P344, DOI 10.1016/0006-8993(91)90214-G; KAKU DA, 1993, SCIENCE, V260, P1516, DOI 10.1126/science.8389056; KOH JY, 1987, J NEUROSCI METH, V20, P83, DOI 10.1016/0165-0270(87)90041-0; Krishtal O, 2003, TRENDS NEUROSCI, V26, P477, DOI 10.1016/S0166-2236(03)00210-8; KRISHTAL OA, 1981, NEUROSCIENCE, V6, P2599, DOI 10.1016/0306-4522(81)90105-6; Lee JM, 1999, NATURE, V399, pA7, DOI 10.1038/399a007; Lingueglia E, 1997, J BIOL CHEM, V272, P29778, DOI 10.1074/jbc.272.47.29778; LITT L, 1985, J CEREBR BLOOD F MET, V5, P537, DOI 10.1038/jcbfm.1985.81; LONGA EZ, 1989, STROKE, V20, P84, DOI 10.1161/01.STR.20.1.84; MacGregor DG, 2003, J NEUROCHEM, V85, P1402, DOI 10.1046/j.1471-4159.2003.01772.x; McDonald JW, 1998, J NEUROSCI, V18, P6290; MCLENNAN H, 1983, PROG NEUROBIOL, V20, P251, DOI 10.1016/0301-0082(83)90004-7; MELDRUM BS, 1995, ANN NY ACAD SCI, V757, P492, DOI 10.1111/j.1749-6632.1995.tb17509.x; Miyamoto O, 2000, NEUROLOGY, V54, P362, DOI 10.1212/WNL.54.2.362; NEDERGAARD M, 1991, AM J PHYSIOL, V260, pR581, DOI 10.1152/ajpregu.1991.260.3.R581; Pearigen P, 1996, BRAIN RES, V725, P184; Price MP, 2000, NATURE, V407, P1007, DOI 10.1038/35039512; Price MP, 1996, J BIOL CHEM, V271, P7879, DOI 10.1074/jbc.271.14.7879; Price MP, 2001, NEURON, V32, P1071, DOI 10.1016/S0896-6273(01)00547-5; REHNCRONA S, 1985, ANN EMERG MED, V14, P770, DOI 10.1016/S0196-0644(85)80055-X; ROTHMAN SM, 1986, ANN NEUROL, V19, P105, DOI 10.1002/ana.410190202; Sattler R, 1999, SCIENCE, V284, P1845, DOI 10.1126/science.284.5421.1845; Siesjo BK, 1996, ADV NEUROL, V71, P209; SIMON RP, 1984, SCIENCE, V226, P850, DOI 10.1126/science.6093256; SIMON RP, 1985, J PHARMACOL EXP THER, V234, P830; Sluka KA, 2003, PAIN, V106, P229, DOI 10.1016/S0304-3959(03)00269-0; Stenzel-Poore MP, 2003, LANCET, V362, P1028, DOI 10.1016/S0140-6736(03)14412-1; SWANSON RA, 1995, J CEREBR BLOOD F MET, V15, P417, DOI 10.1038/jcbfm.1995.52; TANG CM, 1990, P NATL ACAD SCI USA, V87, P6445, DOI 10.1073/pnas.87.16.6445; Tariot PN, 2004, JAMA-J AM MED ASSOC, V291, P317, DOI 10.1001/jama.291.3.317; TOMBAUGH GC, 1993, J NEUROCHEM, V61, P793, DOI 10.1111/j.1471-4159.1993.tb03589.x; TRAYNELIS SF, 1990, NATURE, V345, P347, DOI 10.1038/345347a0; Ugawa S, 2002, J CLIN INVEST, V110, P1185, DOI 10.1172/JCI200215709; Varming T, 1999, NEUROPHARMACOLOGY, V38, P1875, DOI 10.1016/S0028-3908(99)00079-9; Wahlgren NG, 2004, CEREBROVASC DIS, V17, P153, DOI 10.1159/000074808; Waldmann R, 1997, J BIOL CHEM, V272, P20975, DOI 10.1074/jbc.272.34.20975; Waldmann R, 1999, ANN NY ACAD SCI, V868, P67, DOI 10.1111/j.1749-6632.1999.tb11274.x; Waldmann R, 1997, NATURE, V386, P173, DOI 10.1038/386173a0; Waldmann R, 1998, CURR OPIN NEUROBIOL, V8, P418, DOI 10.1016/S0959-4388(98)80070-6; Wemmie JA, 2002, NEURON, V34, P463, DOI 10.1016/S0896-6273(02)00661-X; Wemmie JA, 2003, J NEUROSCI, V23, P5496; WESTERGAARD E, 1969, ACTA ANAT, V74, P405; Xiong ZG, 1997, P NATL ACAD SCI USA, V94, P7012, DOI 10.1073/pnas.94.13.7012; Yermolaieva O, 2004, P NATL ACAD SCI USA, V101, P6752, DOI 10.1073/pnas.0308636100; Ying WH, 1999, J NEUROCHEM, V73, P1549, DOI 10.1046/j.1471-4159.1999.0731549.x	70	790	855	1	64	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 17	2004	118	6					687	698		10.1016/j.cell.2004.08.026	http://dx.doi.org/10.1016/j.cell.2004.08.026			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	855RW	15369669	Bronze			2022-12-28	WOS:000223992400006
J	Yamashita, F; Fukuyama, E; Omura, C				Yamashita, F; Fukuyama, E; Omura, C			Estimation of fault strength: Reconstruction of stress before the 1995 Kobe earthquake	SCIENCE			English	Article							HYOGO-KEN-NANBU; MECHANISM; INVERSION; SHEAR; ZONE	We have estimated the stress field before the 1995 Kobe, Japan, earthquake (moment magnitude 6.9) using in situ post-shock stress measurements obtained from hydraulic fracturing experiments near the fault. We reconstructed the pre-shock stress field using a kinematic source model inverted from seismic waveforms and geodetic deformations. We found that at the center of the fault, two sides of the fault surface coupled completely before the earthquake, with a coefficient of friction of 0.6, which is equivalent to strong crust. At the edge of the fault, a possible aseismic slip is expected to occur from the pre-shock stress orientation.	Natl Res Inst Earth Sci & Disaster Prevent, Tsukuba, Ibaraki 3050006, Japan	National Research Institute for Earth Science & Disaster Resilience	Yamashita, F (corresponding author), Natl Res Inst Earth Sci & Disaster Prevent, 3-1 Tennodai, Tsukuba, Ibaraki 3050006, Japan.	yamafuto@bosai.go.jp		Fukuyama, Eiichi/0000-0002-9405-9155; Yamashita, Futoshi/0000-0001-9938-3766				AMADEI B, 1997, ROCK STRESS ITS MEAS, P102; AWATA Y, 1996, J SEISM SOC JAPAN, V49, P113; BYERLEE J, 1978, PURE APPL GEOPHYS, V116, P615, DOI 10.1007/BF00876528; GEPHART JW, 1984, J GEOPHYS RES, V89, P9305, DOI 10.1029/JB089iB11p09305; Hashimoto M, 1996, J PHYS EARTH, V44, P255, DOI 10.4294/jpe1952.44.255; Ide S, 1997, J GEOPHYS RES-SOL EA, V102, P27379, DOI 10.1029/97JB02675; Ikeda R, 2001, ISL ARC, V10, P252, DOI 10.1046/j.1440-1738.2001.00323.x; Ito T, 1999, INT J ROCK MECH MIN, V36, P811, DOI 10.1016/S0148-9062(99)00053-4; Katao H, 1997, J PHYS EARTH, V45, P105, DOI 10.4294/jpe1952.45.105; Kitamura SY, 2002, IRONMAK STEELMAK, V29, P121, DOI 10.1179/030192302225004070; Matsuura M, 1997, TECTONOPHYSICS, V277, P189, DOI 10.1016/S0040-1951(97)00085-1; OKADA Y, 1992, B SEISMOL SOC AM, V82, P1018; Sekiguchi H, 1996, J PHYS EARTH, V44, P473, DOI 10.4294/jpe1952.44.473; Spudich P, 1998, B SEISMOL SOC AM, V88, P413; Townend J, 2000, GEOLOGY, V28, P399, DOI 10.1130/0091-7613(2000)28<399:HFKTCS>2.0.CO;2; Tsukahara H, 2001, ISL ARC, V10, P261, DOI 10.1046/j.1440-1738.2001.00324.x; WALD DJ, 1996, J PHYS EARTH, V44, P189; Yoshida S, 1996, J PHYS EARTH, V44, P437, DOI 10.4294/jpe1952.44.437; Zoback MD, 2003, INT J ROCK MECH MIN, V40, P1049, DOI 10.1016/j.ijrmms.2003.07.001	19	31	36	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 8	2004	306	5694					261	263		10.1126/science.1101771	http://dx.doi.org/10.1126/science.1101771			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	861MC	15472072				2022-12-28	WOS:000224419700035
J	Kobasa, D; Takada, A; Shinya, K; Hatta, M; Halfmann, P; Theriault, S; Suzuki, H; Nishimura, H; Mitamura, K; Sugaya, N; Usui, T; Murata, T; Maeda, Y; Watanabe, S; Suresh, M; Suzuki, T; Suzuki, Y; Feldmann, H; Kawaoka, Y				Kobasa, D; Takada, A; Shinya, K; Hatta, M; Halfmann, P; Theriault, S; Suzuki, H; Nishimura, H; Mitamura, K; Sugaya, N; Usui, T; Murata, T; Maeda, Y; Watanabe, S; Suresh, M; Suzuki, T; Suzuki, Y; Feldmann, H; Kawaoka, Y			Enhanced virulence of influenza A viruses with the haemagglutinin of the 1918 pandemic virus	NATURE			English	Article							INFECTION; CYTOKINE; PATHOGENICITY; RESPONSES; PROTEIN; GENES	The 'Spanish' influenza pandemic of 1918-19 was the most devastating outbreak of infectious disease in recorded history. At least 20 million people(1) died from their illness, which was characterized by an unusually severe and rapid clinical course. The complete sequencing of several genes of the 1918 influenza virus has made it possible to study the functions of the proteins encoded by these genes in viruses generated by reverse genetics, a technique that permits the generation of infectious viruses entirely from cloned complementary DNA. Thus, to identify properties of the 1918 pandemic influenza A strain that might be related to its extraordinary virulence, viruses were produced containing the viral haemagglutinin(2) (HA) and neuraminidase(3) (NA) genes of the 1918 strain. The HA of this strain supports the pathogenicity of a mouse-adapted virus in this animal(4,5). Here we demonstrate that the HA of the 1918 virus confers enhanced pathogenicity in mice to recent human viruses that are otherwise non-pathogenic in this host. Moreover, these highly virulent recombinant viruses expressing the 1918 viral HA could infect the entire lung and induce high levels of macrophage-derived chemokines and cytokines, which resulted in infiltration of inflammatory cells and severe haemorrhage, hallmarks of the illness produced during the original pandemic(6).	Univ Wisconsin, Dept Pathobiol Sci, Madison, WI 53706 USA; Univ Tokyo, Inst Med Sci, Dept Microbiol & Immunol, Div Virol, Tokyo 1088639, Japan; Japan Sci & Technol Agcy, CREST, Saitama 3320012, Japan; Hlth Canada, Natl Microbiol Lab, Special Pathogens Program, Winnipeg, MB R3E 3R2, Canada; Univ Manitoba, Dept Med Microbiol, Winnipeg, MB R3E 3R2, Canada; Niigata Univ, Sch Med, Dept Publ Hlth, Niigata 9518510, Japan; Sendai Natl Hosp, Div Clin Res, Viral Res Ctr, Sendai, Miyagi 9838520, Japan; Nippon Kokan Ltd Co Hosp, Dept Pediat, Kawasaki, Kanagawa 2100852, Japan; Univ Shizuoka, Dept Appl Biol Chem, Shizuoka 4228529, Japan; Univ Shizuoka, Sch Pharmaceut Sci, Dept Biochem, Shizuoka 4228526, Japan; COE Program 21st Century, Shizuoka 4228526, Japan	University of Wisconsin System; University of Wisconsin Madison; University of Tokyo; Japan Science & Technology Agency (JST); Health Canada; University of Manitoba; Niigata University; University of Shizuoka; University of Shizuoka	Kawaoka, Y (corresponding author), Univ Wisconsin, Dept Pathobiol Sci, Madison, WI 53706 USA.	kawaokay@svm.vetmed.wisc.edu	Halfmann, Peter/W-8084-2019; Takada, Ayato/A-6679-2012	Yasuo, Suzuki/0000-0003-3518-5642; Suresh, Marulasiddappa/0000-0003-1794-3358				Abraham E, 2003, CRIT CARE MED, V31, pS195, DOI 10.1097/01.CCM.0000057843.47705.E8; [Anonymous], FIELDS VIROLOGY; Basler CF, 2001, P NATL ACAD SCI USA, V98, P2746, DOI 10.1073/pnas.031575198; Chen WS, 2001, NAT MED, V7, P1306, DOI 10.1038/nm1201-1306; Cheung CY, 2002, LANCET, V360, P1831, DOI 10.1016/S0140-6736(02)11772-7; CONNOR JS, 1994, VIROLOGY, V15, P17; DESTGROTH SF, 1966, J EXP MED, V124, P331, DOI 10.1084/jem.124.3.331; FRANCIS T, 1953, ANN INTERN MED, V39, P203, DOI 10.7326/0003-4819-39-2-203; Fritz RS, 1999, J INFECT DIS, V180, P586, DOI 10.1086/314938; GAMBARYAN AS, 1992, J VIROL METHODS, V39, P111, DOI 10.1016/0166-0934(92)90130-6; Gamblin SJ, 2004, SCIENCE, V303, P1838, DOI 10.1126/science.1093155; Geiss GK, 2002, P NATL ACAD SCI USA, V99, P10736, DOI 10.1073/pnas.112338099; Goto H, 2001, J VIROL, V75, P9297, DOI 10.1128/JVI.75.19.9297-9301.2001; Guan Y, 2004, P NATL ACAD SCI USA, V101, P8156, DOI 10.1073/pnas.0402443101; Hayden FG, 1998, J CLIN INVEST, V101, P643, DOI 10.1172/JCI1355; Johnson NPAS, 2002, B HIST MED, V76, P105, DOI 10.1353/bhm.2002.0022; Lamb R.A., 2001, FIELDS VIROLOGY, P1487; Lee W L, 2001, Curr Opin Crit Care, V7, P1, DOI 10.1097/00075198-200102000-00001; Matrosovich MN, 2004, P NATL ACAD SCI USA, V101, P4620, DOI 10.1073/pnas.0308001101; Neumann G, 1999, P NATL ACAD SCI USA, V96, P9345, DOI 10.1073/pnas.96.16.9345; Oxford JS, 2002, LANCET INFECT DIS, V2, P111, DOI 10.1016/S1473-3099(02)00185-8; Oxford JS, 2000, REV MED VIROL, V10, P119, DOI 10.1002/(SICI)1099-1654(200003/04)10:2&lt;119::AID-RMV272&gt;3.0.CO;2-O; REED L. J., 1938, AMER JOUR HYG, V27, P493; Reid AH, 2000, P NATL ACAD SCI USA, V97, P6785, DOI 10.1073/pnas.100140097; Reid AH, 1999, P NATL ACAD SCI USA, V96, P1651, DOI 10.1073/pnas.96.4.1651; Stevens J, 2004, SCIENCE, V303, P1866, DOI 10.1126/science.1093373; Totani K, 2003, GLYCOBIOLOGY, V13, P315, DOI 10.1093/glycob/cwg032; Tumpey TM, 2004, P NATL ACAD SCI USA, V101, P3166, DOI 10.1073/pnas.0308391100; Tumpey TM, 2002, P NATL ACAD SCI USA, V99, P13849, DOI 10.1073/pnas.212519699	30	360	408	0	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 7	2004	431	7009					703	707		10.1038/nature02951	http://dx.doi.org/10.1038/nature02951			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	859WS	15470432	Bronze			2022-12-28	WOS:000224299300044
J	Cushman, M; Kuller, LH; Prentice, R; Rodabough, RJ; Psaty, BM; Stafford, RS; Sidney, S; Rosendaal, FR				Cushman, M; Kuller, LH; Prentice, R; Rodabough, RJ; Psaty, BM; Stafford, RS; Sidney, S; Rosendaal, FR		Women's Hlth Initiative Investigat	Estrogen plus progestin and risk of venous thrombosis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HORMONE REPLACEMENT THERAPY; HEALTHY POSTMENOPAUSAL WOMEN; FACTOR-V-LEIDEN; THROMBOEMBOLISM; HEART; OUTCOMES; DISEASE; CANCER; BREAST; USERS	Context Postmenopausal hormone therapy increases the risk of venous thrombosis. It is not known whether other factors influencing thrombosis add to this risk. Objective To report final data on incidence of venous thrombosis in the Women's Health Initiative Estrogen Plus Progestin clinical trial and the association of hormone therapy with venous thrombosis in the setting of other thrombosis risk factors. Design, Setting, and Participants Double-blind randomized controlled trial of 16608 postmenopausal women between the ages of 50 and 79 years, who were enrolled in 1993 through 1998 at 40 US clinical centers with 5.6 years of follow up; and a nested case-control study. Baseline gene variants related to thrombosis risk were measured in the first 147 women who developed thrombosis and in 513 controls. Intervention Random assignment to 0.625 mg/d of conjugated equine estrogen plus 2.5 mg/d of medroxyprogesterone acetate, or placebo. Main Outcome Measures Centrally validated deep vein thrombosis and pulmonary embolus. Results Venous thrombosis occurred in 167 women taking estrogen plus progestin (3.5 per 1000 person-years) and in 76 taking placebo (1.7 per 1000 person-years); hazard ratio (HR), 2.06 (95% confidence interval [CI], 1.57-2.70). Compared with women between the ages of 50 and 59 years who were taking placebo, the risk associated with hormone therapy was higher with age: HR of 4.28 (95% CI, 2.38-7.72) for women aged 60 to 69 years and 7.46 (95% CI, 4.32-14.38) for women aged 70 to 79 years. Compared with women who were of normal weight and taking placebo, the risk associated with taking estrogen plus progestin was increased among overweight and obese women: HR of 3.80 (95% CI, 2.08-6.94) and 5.61 (95% CI, 3.12-10.11), respectively. Factor V Leiden enhanced the hormone-associated risk of thrombosis with a 6.69-fold increased risk compared with women in the placebo group without the mutation (95% CI, 3.09-14.49). Other genetic variants (prothrombin 20210A, methylenetetrahydrofolate reductase C677T, factor XIII Val34Leu, PAI-14G/5G, and factor V HR2) did not modify the association of hormone therapy with venous thrombosis. Conclusions Estrogen plus progestin was associated with doubling the risk of venous thrombosis. Estrogen plus progestin therapy increased the risks associated with age, overweight or obesity, and factor V Leiden.	Univ Vermont, Dept Med, Burlington, VT USA; Univ Pittsburgh, Dept Epidemiol, Pittsburgh, PA 15261 USA; Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98104 USA; Univ Washington, Dept Med, Cardiovasc Hlth Res Unit, Seattle, WA USA; Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; Univ Washington, Dept Hlth Serv, Seattle, WA 98195 USA; Stanford Univ, Stanford Prevent Res Ctr, Program Prevent Outcomes & Practices, Stanford, CA 94305 USA; Kaiser Permanente, Div Res, Oakland, CA USA; Leiden Univ, Med Ctr, Dept Clin Epidemiol, Leiden, Netherlands	University of Vermont; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Stanford University; Kaiser Permanente; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Cushman, M (corresponding author), Univ Vermont, 208 S Pk Dr,Suite 2, Colchester, VT 05446 USA.	mary.cushman@uvm.edu	Rosendaal, Frits/Q-3842-2017; Stafford, Randall/F-3974-2017	Rosendaal, Frits/0000-0003-2558-7496; Stafford, Randall/0000-0003-1805-1271; Cushman, Mary/0000-0002-7871-6143				Abdollahi M, 2003, THROMB HAEMOSTASIS, V89, P493, DOI 10.1055/s-0037-1613379; Anderson G, 1998, CONTROL CLIN TRIALS, V19, P61; Anderson GL, 2004, JAMA-J AM MED ASSOC, V291, P1701, DOI 10.1001/jama.291.14.1701; Berkowitz DE, 2003, CIRCULATION, V108, P2000, DOI 10.1161/01.CIR.0000092948.04444.C7; Chlebowski RT, 2003, JAMA-J AM MED ASSOC, V289, P3243, DOI 10.1001/jama.289.24.3243; Collaboration AT, 1994, BMJ-BRIT MED J, V308, P235; Curb JD, 2003, ANN EPIDEMIOL, V13, pS122, DOI 10.1016/S1047-2797(03)00048-6; Cuzick J, 2002, LANCET, V360, P817; Daly E, 1996, LANCET, V348, P977, DOI 10.1016/S0140-6736(96)07113-9; Doggen CJM, 2004, J THROMB HAEMOST, V2, P700, DOI 10.1111/j.1538-7836.2004.00696.x; Ettinger B, 1999, JAMA-J AM MED ASSOC, V282, P637, DOI 10.1001/jama.282.7.637; Fisher B, 1998, J NATL CANCER I, V90, P1371, DOI 10.1093/jnci/90.18.1371; Grady D, 2000, ANN INTERN MED, V132, P689, DOI 10.7326/0003-4819-132-9-200005020-00002; Grodstein F, 1996, LANCET, V348, P983, DOI 10.1016/S0140-6736(96)07308-4; Gutthann SP, 1997, BMJ-BRIT MED J, V314, P796, DOI 10.1136/bmj.314.7083.796; Herrington DM, 2002, ARTERIOSCL THROM VAS, V22, P1012, DOI 10.1161/01.ATV.0000018301.91721.94; Hoibraaten E, 2000, THROMB HAEMOSTASIS, V84, P961; Holbraaten E, 1999, THROMB HAEMOSTASIS, V82, P1218; Hulley S, 2002, JAMA-J AM MED ASSOC, V288, P58, DOI 10.1001/jama.288.1.58; Jick H, 1996, LANCET, V348, P981, DOI 10.1016/S0140-6736(96)07114-0; Manson JE, 2003, NEW ENGL J MED, V349, P523, DOI 10.1056/NEJMoa030808; Middeldorp S, 2001, ANN INTERN MED, V135, P322, DOI 10.7326/0003-4819-135-5-200109040-00008; O'Brien J, 2000, LANCET, V355, P1295; Ray JG, 2001, ARCH INTERN MED, V161, P1405, DOI 10.1001/archinte.161.11.1405; Rosendaal FR, 2002, ARTERIOSCL THROM VAS, V22, P201, DOI 10.1161/hq0202.102318; Rosendaal FR, 2002, BRIT J HAEMATOL, V116, P851, DOI 10.1046/j.0007-1048.2002.03356.x; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Samama MM, 2000, ARCH INTERN MED, V160, P3415, DOI 10.1001/archinte.160.22.3415; Scarabin PY, 2003, LANCET, V362, P428, DOI 10.1016/S0140-6736(03)14066-4; Skrondal A, 2003, AM J EPIDEMIOL, V158, P251, DOI 10.1093/aje/kwg113; Tsai AW, 2002, ARCH INTERN MED, V162, P1182, DOI 10.1001/archinte.162.10.1182; Varas-Lorenzo C, 1998, AM J EPIDEMIOL, V147, P387; Wassertheil-Smoller S, 2003, JAMA-J AM MED ASSOC, V289, P2673, DOI 10.1001/jama.289.20.2673	33	438	449	0	12	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 6	2004	292	13					1573	1580		10.1001/jama.292.13.1573	http://dx.doi.org/10.1001/jama.292.13.1573			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	859HS	15467059	Green Published, Bronze			2022-12-28	WOS:000224254600024
J	Kerjaschki, D				Kerjaschki, D			Pathomechanisms and molecular basis of membranous glomerulopathy	LANCET			English	Editorial Material							PASSIVE HEYMANN NEPHRITIS; GLOMERULONEPHRITIS; ANTIBODIES; INDUCTION; ANTIGEN; KIDNEY; CELLS; RATS		Med Univ Vienna, Allgemeines Krankenhaus, Dept Pathol, A-1090 Vienna, Austria	Medical University of Vienna	Kerjaschki, D (corresponding author), Med Univ Vienna, Allgemeines Krankenhaus, Dept Pathol, A-1090 Vienna, Austria.	dontscho.kerjaschki@akh-wien.ac.at						ADLER S, 1984, KIDNEY INT, V26, P830, DOI 10.1038/ki.1984.225; ASSMANN KJM, 1992, J EXP MED, V175, P623, DOI 10.1084/jem.175.3.623; COUSER WG, 1978, J CLIN INVEST, V62, P1275, DOI 10.1172/JCI109248; Debiec H, 2002, NEW ENGL J MED, V346, P2053, DOI 10.1056/NEJMoa012895; Haas M, 1999, KIDNEY INT, V56, pS110, DOI 10.1046/j.1523-1755.1999.07127.x; HEYMANN W, 1952, J LAB CLIN MED, V39, P218; Horl WH, 2000, J NEPHROL, V13, P291; KERJASCHKI D, 1983, J EXP MED, V157, P667, DOI 10.1084/jem.157.2.667; Kerjaschki D, 1996, J EXP MED, V183, P2007, DOI 10.1084/jem.183.5.2007; KERJASCHKI D, 1982, P NATL ACAD SCI-BIOL, V79, P5557, DOI 10.1073/pnas.79.18.5557; NEALE TJ, 1993, P NATL ACAD SCI USA, V90, P3645, DOI 10.1073/pnas.90.8.3645; NEALE TJ, 1994, J CLIN INVEST, V94, P1577, DOI 10.1172/JCI117499; RONCO P, 1989, Applied Pathology, V7, P85; SAITO A, 1996, P NATL ACAD SCI USA, V93, P86010; SHAH SV, 1988, AM J PHYSIOL, V254, pF337, DOI 10.1152/ajprenal.1988.254.3.F337; Wasserstein AG, 1997, J AM SOC NEPHROL, V8, P664	16	58	61	1	3	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	OCT 2	2004	364	9441					1194	1196		10.1016/S0140-6736(04)17154-7	http://dx.doi.org/10.1016/S0140-6736(04)17154-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	859HO	15464164				2022-12-28	WOS:000224254200004
J	Li, ZB; Kesselman, E; Talmon, Y; Hillmyer, MA; Lodge, TP				Li, ZB; Kesselman, E; Talmon, Y; Hillmyer, MA; Lodge, TP			Multicompartment micelles from ABC miktoarm stars in water	SCIENCE			English	Article							FLUOROCARBON; HYDROCARBON; NANOTECHNOLOGY; POLYMERS; STRATEGY	By combining three mutually immiscible polymeric components in a mixed-arm star block terpolymer architecture, we have observed the formation of a previously unknown class of multicompartment micelles in dilute aqueous solution. Connection of water-soluble poly(ethylene oxide) and two hydrophobic but immiscible components (a polymeric hydrocarbon and a perfluorinated polyether) at a common junction leads to molecular frustration when dispersed in aqueous solution. The incompatible hydrophobic blocks form cores that are protected from the water by the poly(ethylene oxide) blocks, but both are forced to make contact with the poly(ethylene oxide) by virtue of the chain architecture. The structures that emerge depend on the relative lengths of the blocks and can be tuned from discrete multicompartment micelles to extended wormlike structures with segmented cores.	Univ Minnesota, Dept Chem, Minneapolis, MN 55455 USA; Univ Minnesota, Dept Chem Engn & Mat Sci, Minneapolis, MN 55455 USA; Technion Israel Inst Technol, Dept Chem Engn, IL-32000 Haifa, Israel	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Technion Israel Institute of Technology	Hillmyer, MA (corresponding author), Univ Minnesota, Dept Chem, 207 Pleasant St SE, Minneapolis, MN 55455 USA.	hillmyer@chem.umn.edu; lodge@chem.umn.edu	Li, Zhibo/K-1614-2013; Talmon, Yeshayahu/N-1076-2019	Li, Zhibo/0000-0001-9512-1507; Talmon, Yeshayahu/0000-0002-9854-3972; Hillmyer, Marc/0000-0001-8255-3853; Lodge, Timothy/0000-0001-5916-8834				Bailey TS, 2002, MACROMOLECULES, V35, P7007, DOI 10.1021/ma011716x; Balsamo V, 2003, MACROMOLECULES, V36, P4515, DOI 10.1021/ma020129o; BATES FS, 1991, SCIENCE, V251, P898, DOI 10.1126/science.251.4996.898; Collier JH, 2001, ANNU REV MATER RES, V31, P237, DOI 10.1146/annurev.matsci.31.1.237; Danino D, 2001, COLLOID SURFACE A, V183, P113, DOI 10.1016/S0927-7757(01)00543-X; Discher DE, 2002, SCIENCE, V297, P967, DOI 10.1126/science.1074972; Dormidontova EE, 1997, MACROMOLECULES, V30, P1980, DOI 10.1021/ma961076b; Gohy JF, 2001, ANGEW CHEM INT EDIT, V40, P3214, DOI 10.1002/1521-3773(20010903)40:17<3214::AID-ANIE3214>3.0.CO;2-F; Goldacker T, 1999, NATURE, V398, P137, DOI 10.1038/18191; Hadjichristidis N, 1999, J POLYM SCI POL CHEM, V37, P857, DOI 10.1002/(SICI)1099-0518(19990401)37:7<857::AID-POLA1>3.0.CO;2-P; HALPERIN A, 1992, ADV POLYM SCI, V100, P31; Hamley I. W., 1998, PHYS BLOCK COPOLYMER; Jain S, 2003, SCIENCE, V300, P460, DOI 10.1126/science.1082193; Kisak ET, 2004, CURR MED CHEM, V11, P199, DOI 10.2174/0929867043456197; Kotzev A, 2002, MACROMOLECULES, V35, P1091, DOI 10.1021/ma011047n; Laschewsky A, 2003, CURR OPIN COLLOID IN, V8, P274, DOI 10.1016/S1359-0294(03)00049-9; Li Z.B., UNPUB; Lodge TP, 2004, MACROMOLECULES, V37, P6680, DOI 10.1021/ma048708b; Lodge TP, 2003, MACROMOL CHEM PHYSIC, V204, P265, DOI 10.1002/macp.200290073; Park C, 2003, POLYMER, V44, P6725, DOI 10.1016/j.polymer.2003.08.011; Park M, 1997, SCIENCE, V276, P1401, DOI 10.1126/science.276.5317.1401; Riess G, 2003, PROG POLYM SCI, V28, P1107, DOI 10.1016/S0079-6700(03)00015-7; Savic R, 2003, SCIENCE, V300, P615, DOI 10.1126/science.1078192; SEMENOV AN, 1995, MACROMOLECULES, V28, P7491, DOI 10.1021/ma00126a029; Shimomura M, 2001, CURR OPIN COLLOID IN, V6, P11, DOI 10.1016/S1359-0294(00)00081-9; Sioula S, 1998, MACROMOLECULES, V31, P8429, DOI 10.1021/ma980622t; Stahler K, 1999, LANGMUIR, V15, P7565, DOI 10.1021/la990431z; Weberskirch R, 2000, MACROMOL CHEM PHYSIC, V201, P995, DOI 10.1002/1521-3935(20000601)201:10<995::AID-MACP995>3.0.CO;2-T; Zhou ZL, 2003, J AM CHEM SOC, V125, P10182, DOI 10.1021/ja036551h	29	892	911	7	431	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 1	2004	306	5693					98	101		10.1126/science.1103350	http://dx.doi.org/10.1126/science.1103350			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	859YJ	15459387				2022-12-28	WOS:000224304000044
J	Kassutto, S; Daily, JP				Kassutto, S; Daily, JP			Clinical problem-solving: Footprints	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							POLYMERASE-CHAIN-REACTION; MYCOBACTERIUM-TUBERCULOSIS; CUTANEOUS TUBERCULOSIS; ERYTHEMA-INDURATUM; NODOSUM; BAZIN		Beth Israel Deaconess Med Ctr, Div Infect Dis, Boston, MA 02215 USA; Harvard Univ, Sch Med, Boston, MA USA; Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA; Brigham & Womens Hosp, Div Infect Dis, Boston, MA 02115 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital	Kassutto, S (corresponding author), Beth Israel Deaconess Med Ctr, Div Infect Dis, Boston, MA 02215 USA.	skassutto@bidmc.harvard.edu						Boonchai W, 1998, INT J DERMATOL, V37, P361, DOI 10.1046/j.1365-4362.1998.00299.x; Cho KH, 1996, INT J DERMATOL, V35, P802, DOI 10.1111/j.1365-4362.1996.tb02979.x; Cribier B, 1998, INT J DERMATOL, V37, P667, DOI 10.1046/j.1365-4362.1998.00316.x; CRIBIER B, 1990, ANN DERMATOL VENER, V117, P937; Garcia-Porrua C, 2000, ARTHRITIS RHEUM, V43, P584, DOI 10.1002/1529-0131(200003)43:3<584::AID-ANR15>3.0.CO;2-6; Handa R, 2002, J Assoc Physicians India, V50, P1008; Tan SH, 2001, ANN ACAD MED SINGAP, V30, P3; Tan SH, 1999, INT J DERMATOL, V38, P122, DOI 10.1046/j.1365-4362.1999.00576.x; 2003, MMWR MORB MORTAL WKL, V52, P222; 2003, MMWR MORB MORTAL WKL, V52, P217	10	2	2	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 30	2004	351	14					1438	1443		10.1056/NEJMcps040422	http://dx.doi.org/10.1056/NEJMcps040422			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	857XT	15459306				2022-12-28	WOS:000224153900014
J	Mangles, SPD; Murphy, CD; Najmudin, Z; Thomas, AGR; Collier, JL; Dangor, AE; Divall, EJ; Foster, PS; Gallacher, JG; Hooker, CJ; Jaroszynski, DA; Langley, AJ; Mori, WB; Norreys, PA; Tsung, FS; Viskup, R; Walton, BR; Krushelnick, K				Mangles, SPD; Murphy, CD; Najmudin, Z; Thomas, AGR; Collier, JL; Dangor, AE; Divall, EJ; Foster, PS; Gallacher, JG; Hooker, CJ; Jaroszynski, DA; Langley, AJ; Mori, WB; Norreys, PA; Tsung, FS; Viskup, R; Walton, BR; Krushelnick, K			Monoenergetic beams of relativistic electrons from intense laser-plasma interactions	NATURE			English	Article							WAKEFIELD ACCELERATION; PULSE; GENERATION	High-power lasers that fit into a university-scale laboratory(1) can now reach focused intensities of more than 10(19) W cm(-2) at high repetition rates. Such lasers are capable of producing beams of energetic electrons(2-11), protons(12) and gamma-rays(13). Relativistic electrons are generated through the breaking(9,10,14) of large-amplitude relativistic plasma waves created in the wake of the laser pulse as it propagates through a plasma, or through a direct interaction between the laser field and the electrons in the plasma(15). However, the electron beams produced from previous laser - plasma experiments have a large energy spread(6,7,9,14), limiting their use for potential applications. Here we report high-resolution energy measurements of the electron beams produced from intense laser - plasma interactions, showing that - under particular plasma conditions - it is possible to generate beams of relativistic electrons with low divergence and a small energy spread ( less than three per cent). The monoenergetic features were observed in the electron energy spectrum for plasma densities just above a threshold required for breaking of the plasma wave. These features were observed consistently in the electron spectrum, although the energy of the beam was observed to vary from shot to shot. If the issue of energy reproducibility can be addressed, it should be possible to generate ultrashort monoenergetic electron bunches of tunable energy, holding great promise for the future development of 'table-top' particle accelerators.	Univ London Imperial Coll Sci Technol & Med, Blackett Lab, London SW7 2AZ, England; Rutherford Appleton Lab, Cent Laser Facil, Didcot OX11 0QX, Oxon, England; Univ Strathclyde, Dept Phys, Glasgow G4 0NG, Lanark, Scotland; Univ Calif Los Angeles, Dept Phys & Astron, Los Angeles, CA 90095 USA	Imperial College London; UK Research & Innovation (UKRI); Science & Technology Facilities Council (STFC); STFC Rutherford Appleton Laboratory; University of Strathclyde; University of California System; University of California Los Angeles	Mangles, SPD (corresponding author), Univ London Imperial Coll Sci Technol & Med, Blackett Lab, Prince Consort Rd, London SW7 2AZ, England.	stuart.mangles@imperial.ac.uk	Mangles, Stuart PD/F-9070-2014; Thomas, Alexander George Roy/D-8210-2011; 丛士宇, Frank/AAN-7776-2020; Najmudin, Zulfikar/ABH-5942-2020; Krushelnick, Karl/AAZ-3028-2020; Viskup, Richard/ABH-1590-2020; Mangles, Stuart/Q-5829-2019	Mangles, Stuart PD/0000-0003-2443-4201; Thomas, Alexander George Roy/0000-0003-3206-8512; 丛士宇, Frank/0000-0001-9257-7920; Najmudin, Zulfikar/0000-0001-6323-4005; Viskup, Richard/0000-0003-1774-0294; Mangles, Stuart/0000-0003-2443-4201	Engineering and Physical Sciences Research Council [GR/R88090/01] Funding Source: researchfish	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))		AKHIEZER AI, 1956, ZH EKSP TEOR FIZ, V3, P696; Amiranoff F, 1998, PHYS REV LETT, V81, P995, DOI 10.1103/PhysRevLett.81.995; BULANOV SV, 1989, JETP LETT+, V50, P198; Clark EL, 2000, PHYS REV LETT, V84, P670, DOI 10.1103/PhysRevLett.84.670; Edwards RD, 2002, APPL PHYS LETT, V80, P2129, DOI 10.1063/1.1464221; Esarey E, 1996, IEEE T PLASMA SCI, V24, P252, DOI 10.1109/27.509991; Faure J, 2002, PHYS PLASMAS, V9, P756, DOI 10.1063/1.1447556; Fonseca RA, 2002, LECT NOTES COMPUT SC, V2331, P342; Joshi C, 2003, PHYS TODAY, V56, P47, DOI 10.1063/1.1595054; Key MH, 1998, PHYS PLASMAS, V5, P1966, DOI 10.1063/1.872867; Malka V, 2002, SCIENCE, V298, P1596, DOI 10.1126/science.1076782; MANGLES SPD, UNPUB PHYS REV LETT; MODENA A, 1995, NATURE, V377, P606, DOI 10.1038/377606a0; PERRY MD, 1994, SCIENCE, V264, P917, DOI 10.1126/science.264.5161.917; Pukhov A, 1999, PHYS PLASMAS, V6, P2847, DOI 10.1063/1.873242; Pukhov A, 2002, APPL PHYS B-LASERS O, V74, P355, DOI 10.1007/s003400200795; Santala MIK, 2001, PHYS REV LETT, V86, P1227, DOI 10.1103/PhysRevLett.86.1227; SPRANGLE P, 1988, APPL PHYS LETT, V53, P2146, DOI 10.1063/1.100300; SPRANGLE P, 1990, PHYS REV A, V41, P4463, DOI 10.1103/PhysRevA.41.4463; TAJIMA T, 1979, PHYS REV LETT, V43, P267, DOI 10.1103/PhysRevLett.43.267; Ting A, 1997, PHYS PLASMAS, V4, P1889, DOI 10.1063/1.872332; Tzeng KC, 1998, PHYS REV LETT, V81, P104, DOI 10.1103/PhysRevLett.81.104; Umstadter D, 1996, PHYS REV LETT, V76, P2073, DOI 10.1103/PhysRevLett.76.2073; Umstadter D, 2001, PHYS PLASMAS, V8, P1774, DOI 10.1063/1.1364515; Wagner R, 1997, PHYS REV LETT, V78, P3125, DOI 10.1103/PhysRevLett.78.3125	26	1652	1698	4	236	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 30	2004	431	7008					535	538		10.1038/nature02939	http://dx.doi.org/10.1038/nature02939			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	857YP	15457251				2022-12-28	WOS:000224156700037
J	Blane, D				Blane, D			InWHO's interest: the debate surrounding the 2003 election of the Director-General of WHO	LANCET			English	Editorial Material									UCL, Int Hlth & Med Educ Ctr, London N19 5LW, England	University of London; University College London	Blane, D (corresponding author), UCL, Int Hlth & Med Educ Ctr, Archway Campus, London N19 5LW, England.	davidblane@hotmail.com	Blane, David N/AAW-8215-2021	Blane, David N/0000-0002-3872-3621				Bluestone K, 2003, LANCET, V361, P2, DOI 10.1016/S0140-6736(03)12172-1; Ford N, 2003, LANCET, V361, P3, DOI 10.1016/S0140-6736(03)12173-3; Germain A, 2003, LANCET, V361, P171, DOI 10.1016/S0140-6736(03)12197-6; Lee K., 1996, NEW POLIT ECON, V1, P355, DOI DOI 10.1080/13563469608406267; United Nations Committee on Economic Social and Cultural Rights, 2000, RIGHT HIGH ATT STAND; World Health Organisation, 1946, WHO CONST; World Health Organization, 2001, MACR HLTH INV HLTH E; Yamey G, 2002, BMJ-BRIT MED J, V325, P1251, DOI 10.1136/bmj.325.7375.1251	8	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	SEP 25	2004	364	9440					1188	1189		10.1016/S0140-6736(04)17110-9	http://dx.doi.org/10.1016/S0140-6736(04)17110-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	857FT	15451231				2022-12-28	WOS:000224102400037
J	Potts, M; Campbell, M				Potts, M; Campbell, M			Three meetings and fewer funerals - misoprostol in postpartum haemorrhage	LANCET			English	Editorial Material							MORTALITY		Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Potts, M (corresponding author), Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA.	potts@socrates.berkeley.edu						AbouZahr C, 2003, BRIT MED BULL, V67, P1, DOI 10.1093/bmb/ldg015; FORTNEY JA, 1986, AM J PUBLIC HEALTH, V76, P134, DOI 10.2105/AJPH.76.2.134; Goldberg AB, 2001, NEW ENGL J MED, V344, P38, DOI 10.1056/NEJM200101043440107; Tsu VD, 2004, LANCET, V363, P75, DOI 10.1016/S0140-6736(03)15180-X	4	16	16	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 25	2004	364	9440					1110	1111		10.1016/S0140-6736(04)17120-1	http://dx.doi.org/10.1016/S0140-6736(04)17120-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	857FT	15451208				2022-12-28	WOS:000224102400009
J	Shaffer, K				Shaffer, K			Becoming a physician - Teaching anatomy in the digital world.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Harvard Univ, Sch Med, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Shaffer, K (corresponding author), Harvard Univ, Sch Med, Boston, MA 02115 USA.			Shaffer, Kitt/0000-0001-6488-6988				Broder John M, 2004, N Y Times Web, pA16; ZUGER A, 2004, NY TIMES        0323, pF1	2	82	87	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 23	2004	351	13					1279	1281		10.1056/NEJMp048100	http://dx.doi.org/10.1056/NEJMp048100			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	855TP	15385652				2022-12-28	WOS:000223997700003
J	Stein, SH				Stein, SH			Update in oncology	ANNALS OF INTERNAL MEDICINE			English	Review							CELL LUNG-CANCER; RANDOMIZED-TRIAL; BREAST-CANCER; CHEMOTHERAPY		GlaxoSmithKline, Collegeville, PA 19426 USA; Univ Penn, Philadelphia, PA 19104 USA	GlaxoSmithKline; University of Pennsylvania	Stein, SH (corresponding author), GlaxoSmithKline, 1250 S Collegeville Rd,UP 4420,POB 5089, Collegeville, PA 19426 USA.							ALRDINOIS D, 2003, NEW ENGL J MED, V348, P2500; Attal M, 2003, NEW ENGL J MED, V349, P2495, DOI 10.1056/NEJMoa032290; Citron ML, 2003, J CLIN ONCOL, V21, P1431, DOI 10.1200/JCO.2003.09.081; Goss PE, 2003, NEW ENGL J MED, V349, P1793, DOI 10.1056/NEJMoa032312; Kris MG, 2003, JAMA-J AM MED ASSOC, V290, P2149, DOI 10.1001/jama.290.16.2149; Le Chevalier T, 2004, NEW ENGL J MED, V350, P351, DOI 10.1056/nejmoa031644; Pickhardt PJ, 2003, NEW ENGL J MED, V349, P2191, DOI 10.1056/NEJMoa031618; Thompson IM, 2003, NEW ENGL J MED, V349, P215, DOI 10.1056/NEJMoa030660; Zhang L, 2003, NEW ENGL J MED, V348, P203, DOI 10.1056/NEJMoa020177	9	1	1	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 21	2004	141	6					454	459		10.7326/0003-4819-141-6-200409210-00011	http://dx.doi.org/10.7326/0003-4819-141-6-200409210-00011			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	856TM	15381519				2022-12-28	WOS:000224067900006
J	Mundil, R; Ludwig, KR; Metcalfe, I; Renne, PR				Mundil, R; Ludwig, KR; Metcalfe, I; Renne, PR			Age and timing of the Permian mass extinctions: U/Pb dating of closed-system zircons	SCIENCE			English	Article							TRIASSIC BOUNDARY; END; IMPACT; PB; GEOCHRONOLOGY	The age and timing of the Permian-Triassic mass extinction have been difficult to determine because zircon populations from the type sections are typically affected by pervasive lead loss and contamination by indistinguishable older xenocrysts. Zircons from nine ash beds within the Shangsi and Meishan sections (China), pretreated by annealing followed by partial attack with hydrofluoric acid, result in suites of consistent and concordant uranium/lead (U/Pb) ages, eliminating the effects of lead loss. The U/Pb age of the main pulse of the extinction is 252.6 +/- 0.2 million years, synchronous with the Siberian flood volcanism, and it occurred within the quoted uncertainty.	Berkeley Geochronol Ctr, Berkeley, CA 94709 USA; Univ New England, Asia Ctr, Armidale, NSW 2351, Australia; Univ Calif Berkeley, Dept Earth & Planetary Sci, Berkeley, CA 94720 USA	Berkeley Geochronolgy Center; University of New England; University of California System; University of California Berkeley	Mundil, R (corresponding author), Berkeley Geochronol Ctr, 2455 Ridge Rd, Berkeley, CA 94709 USA.		Metcalfe, Ian/AAK-3429-2020; Mundil, Roland/E-5174-2011	Metcalfe, Ian/0000-0003-3538-1686; Renne, Paul/0000-0003-1769-5235				Basu AR, 2003, SCIENCE, V302, P1388, DOI 10.1126/science.1090852; BAUD A, 1989, GEOL RUNDSCH, V78, P649, DOI 10.1007/BF01776196; Becker L, 2004, SCIENCE, V304, P1469, DOI 10.1126/science.1093925; Becker L, 2001, SCIENCE, V291, P1530, DOI 10.1126/science.1057243; Bowring SA, 1998, SCIENCE, V280, P1039, DOI 10.1126/science.280.5366.1039; Brown SJA, 1999, GEOLOGY, V27, P1035, DOI 10.1130/0091-7613(1999)027<1035:SUPDOT>2.3.CO;2; Buck C.E., 1996, BAYESIAN APPROACH IN; Cherniak DJ, 2001, CHEM GEOL, V172, P5, DOI 10.1016/S0009-2541(00)00233-3; Courtillot VE, 2003, CR GEOSCI, V335, P113, DOI 10.1016/S1631-0713(03)00006-3; Farley KA, 2001, SCIENCE, V293, P2343; Jin YG, 2000, SCIENCE, V289, P432, DOI 10.1126/science.289.5478.432; Koeberl C, 2002, GEOLOGY, V30, P855, DOI 10.1130/0091-7613(2002)030<0855:EPCBBI>2.0.CO;2; KROGH TE, 1982, GEOCHIM COSMOCHIM AC, V46, P637, DOI 10.1016/0016-7037(82)90165-X; Krull ES, 2000, GEOL SOC AM BULL, V112, P1459, DOI 10.1130/0016-7606(2000)112<1459:CDPFPA>2.0.CO;2; Kwon JY, 2002, MATH GEOL, V34, P457, DOI 10.1023/A:1015035228810; Lee JKW, 1997, NATURE, V390, P159, DOI 10.1038/36554; LI ZS, 1986, ACTA GEOL SIN-ENGL, V60, P1; Litton C.D., 1995, ARCHAEOMETRY, V37, P1, DOI DOI 10.1111/J.1475-4754.1995.TB00723.X; Ludwig K.R, 2003, USERS MANUAL ISOPLOT; Ludwig KR, 1998, GEOCHIM COSMOCHIM AC, V62, P665, DOI 10.1016/S0016-7037(98)00059-3; MATTINSON JM, 1994, CONTRIB MINERAL PETR, V116, P117, DOI 10.1007/BF00310694; MATTINSON JM, UNPUB; MATTINSON JM, 2001, AM GEOPH UN M SAN FR; Min KW, 2000, GEOCHIM COSMOCHIM AC, V64, P73, DOI 10.1016/S0016-7037(99)00204-5; Mundil R, 2001, EARTH PLANET SC LETT, V187, P131, DOI 10.1016/S0012-821X(01)00274-6; NICHOLLS G, 1998, 407 U AUCKL; Nicoll RS, 2002, J ASIAN EARTH SCI, V20, P609, DOI 10.1016/S1367-9120(02)00021-4; Ramsey CB, 1998, RADIOCARBON, V40, P461; Reid MR, 1997, EARTH PLANET SC LETT, V150, P27, DOI 10.1016/S0012-821X(97)00077-0; RENNE PR, 1995, SCIENCE, V269, P1413, DOI 10.1126/science.269.5229.1413; Ryskin G, 2003, GEOLOGY, V31, P741, DOI 10.1130/G19518.1; STANLEY SM, 1994, SCIENCE, V266, P1340, DOI 10.1126/science.266.5189.1340; STEIN C, 1954, 3 BERK S MATH STAT P; *STEIN C, 1955, 3 BERK S MATH STAT P; Yin H.F., 1992, PERMOTRIASSIC EVENTS, P1; Yin HF, 2001, EPISODES, V24, P102; Zhou MF, 2002, EARTH PLANET SC LETT, V196, P113, DOI 10.1016/S0012-821X(01)00608-2	37	487	540	5	97	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 17	2004	305	5691					1760	1763		10.1126/science.1101012	http://dx.doi.org/10.1126/science.1101012			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	856IS	15375264				2022-12-28	WOS:000224039500037
J	Ponti, A; Machacek, M; Gupton, SL; Waterman-Storer, CM; Danuser, G				Ponti, A; Machacek, M; Gupton, SL; Waterman-Storer, CM; Danuser, G			Two distinct actin networks drive the protrusion of migrating cells	SCIENCE			English	Article							FLUORESCENT SPECKLE MICROSCOPY; FILAMENTS; MOTILITY; POLYMERIZATION; ELONGATION	Cell migration initiates by extension of the actin cytoskeleton at the leading edge. Computational analysis of fluorescent speckle microscopy movies of migrating epithelial cells revealed this process is mediated by two spatially colocalized but kinematically, kinetically, molecularly, and functionally distinct actin networks. A lamelhpodium network assembled at the leading edge but completely disassembled within 1 to 3 micrometers. It was weakly coupled to the rest of the cytoskeleton and promoted the random protrusion and retraction of the leading edge. Productive cell advance was a function of the second colocalized network, the lamella, where actomyosin contraction was integrated with substrate adhesion.	Scripps Res Inst TSRI, Dept Cell Biol, La Jolla, CA 92037 USA	Scripps Research Institute	Waterman-Storer, CM (corresponding author), Scripps Res Inst TSRI, Dept Cell Biol, La Jolla, CA 92037 USA.	waterman@scripps.edu; gdanuser@scripps.edu		Danuser, Gaudenz/0000-0001-8583-2014; Waterman, Clare/0000-0001-6142-6775	NIGMS NIH HHS [GM67230] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067230, U01GM067230] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abraham VC, 1999, BIOPHYS J, V77, P1721, DOI 10.1016/S0006-3495(99)77018-9; Cramer LP, 1999, CURR BIOL, V9, P1095, DOI 10.1016/S0960-9822(99)80478-3; Danuser G, 2003, J MICROSC-OXFORD, V211, P191, DOI 10.1046/j.1365-2818.2003.01222.x; Fischer RS, 2003, J CELL BIOL, V161, P371, DOI 10.1083/jcb.200209057; FORSCHER P, 1988, J CELL BIOL, V107, P1505, DOI 10.1083/jcb.107.4.1505; Ghosh M, 2004, SCIENCE, V304, P743, DOI 10.1126/science.1094561; Giannone G, 2004, CELL, V116, P431, DOI 10.1016/S0092-8674(04)00058-3; Higashida C, 2004, SCIENCE, V303, P2007, DOI 10.1126/science.1093923; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Mullins RD, 1998, P NATL ACAD SCI USA, V95, P6181, DOI 10.1073/pnas.95.11.6181; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Ponti A, 2003, BIOPHYS J, V84, P3336, DOI 10.1016/S0006-3495(03)70058-7; SAMPATH P, 1991, BIOCHEMISTRY-US, V30, P1973, DOI 10.1021/bi00221a034; Small JV, 1999, CURR OPIN CELL BIOL, V11, P54, DOI 10.1016/S0955-0674(99)80007-6; Straight AF, 2003, SCIENCE, V299, P1743, DOI 10.1126/science.1081412; THERIOT JA, 1991, NATURE, V352, P126, DOI 10.1038/352126a0; Vallotton P, 2003, BIOPHYS J, V85, P1289, DOI 10.1016/S0006-3495(03)74564-0; Zigmond SH, 2003, CURR BIOL, V13, P1820, DOI 10.1016/j.cub.2003.09.057	18	578	587	2	53	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 17	2004	305	5691					1782	1786		10.1126/science.1100533	http://dx.doi.org/10.1126/science.1100533			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	856IS	15375270				2022-12-28	WOS:000224039500044
J	Quigley, JG; Yang, ZT; Worthington, MT; Phillips, JD; Sabo, KM; Sabath, DE; Berg, CL; Sassa, S; Wood, BL; Abkowitz, JL				Quigley, JG; Yang, ZT; Worthington, MT; Phillips, JD; Sabo, KM; Sabath, DE; Berg, CL; Sassa, S; Wood, BL; Abkowitz, JL			Identification of a human heme exporter that is essential for erythropoiesis	CELL			English	Article							FELINE LEUKEMIA-VIRUS; RED-CELL APLASIA; SUBGROUP-C; BINDING PROTEIN; ERYTHROID-DIFFERENTIATION; ERYTHROLEUKEMIA-CELLS; ANEMIA RETROVIRUS; SURFACE RECEPTOR; IRON; TRANSPORTER	FLVCR, a member of the major facilitator superfamily of transporter proteins, is the cell surface receptor for feline leukemia virus, subgroup C. Retroviral interference with FLVCR display results in a loss of erythroid progenitors (colony-forming units-erythroid, CFU-E) and severe anemia in cats. In this report, we demonstrate that human FLVCR exports cytoplasmic heme and hypothesize that human FLVCR is required on developing erythroid cells to protect them from heme toxicity. Inhibition of FLVCR in K562 cells decreases heme export, impairs their erythroid maturation and leads to apoptosis. FLVCR is upregulated on CFU-E, indicating that heme export is important in primary cells at this stage. Studies of FLVCR expression in cell lines suggest this exporter also impacts heme trafficking in intestine and liver. To our knowledge, this is the first description of a mammalian heme transporter.	Univ Washington, Dept Med Hematol, Seattle, WA 98195 USA; Univ Washington, Dept Lab Med, Seattle, WA 98195 USA; Univ Virginia, Dept Med Gastroenterol, Charlottesville, VA 22908 USA; Univ Utah, Dept Med, Salt Lake City, UT 84132 USA; Rockefeller Univ, Lab Biochem Hematol, New York, NY 10021 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Virginia; Utah System of Higher Education; University of Utah; Rockefeller University	Abkowitz, JL (corresponding author), Univ Washington, Dept Med Hematol, Seattle, WA 98195 USA.	janabk@u.washington.edu	Quigley, John/X-4366-2019	quigley, john/0000-0003-3116-4545	NCRR NIH HHS [RR00037] Funding Source: Medline; NHLBI NIH HHS [HL31823] Funding Source: Medline; NIDDK NIH HHS [DK32890, R01 DK020503, DK20503] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL031823] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK020503, R37DK020503, R01DK032890] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Abbott BL, 2003, HEMATOL ONCOL, V21, P115, DOI 10.1002/hon.714; ABKOWITZ JL, 1987, J CLIN INVEST, V80, P1056, DOI 10.1172/JCI113160; BENZ EJ, 1980, P NATL ACAD SCI-BIOL, V77, P3509, DOI 10.1073/pnas.77.6.3509; Blackmon BJ, 2002, ARCH BIOCHEM BIOPHYS, V407, P196, DOI 10.1016/S0003-9861(02)00471-X; BORSOOK H, 1969, BLOOD-J HEMATOL, V34, P32, DOI 10.1182/blood.V34.1.32.32; Bryant NJ, 2002, NAT REV MOL CELL BIO, V3, P267, DOI 10.1038/nrm782; CARPENTER CE, 1992, CRIT REV FOOD SCI, V31, P333, DOI 10.1080/10408399209527576; Charles RJ, 1996, BLOOD, V87, P4831, DOI 10.1182/blood.V87.11.4831.bloodjournal87114831; DEAN GA, 1992, J VIROL, V66, P5561, DOI 10.1128/JVI.66.9.5561-5568.1992; Druker BJ, 1996, NAT MED, V2, P561, DOI 10.1038/nm0596-561; FUJITA H, 1989, BRIT J HAEMATOL, V73, P557, DOI 10.1111/j.1365-2141.1989.tb00297.x; GALBRAITH RA, 1990, J HEPATOL, V10, P305, DOI 10.1016/0168-8278(90)90137-G; Harlow E., 1988, ANTIBODIES LAB MANUA; HOLDEN SA, 1983, EXP HEMATOL, V11, P953; IBRAHIM NG, 1982, BRIT J HAEMATOL, V50, P17, DOI 10.1111/j.1365-2141.1982.tb01886.x; IWAHARA S, 1995, BIOCHEMISTRY-US, V34, P13398, DOI 10.1021/bi00041a017; Jonker JW, 2002, P NATL ACAD SCI USA, V99, P15649, DOI 10.1073/pnas.202607599; KINNESAFFRAN E, 1989, METHOD ENZYMOL, V172, P3; Krishnamurthy P, 2004, J BIOL CHEM, V279, P24218, DOI 10.1074/jbc.M313599200; Lipovich L, 2002, GENE, V286, P203, DOI 10.1016/S0378-1119(02)00457-2; LUBBEN M, 1994, J BIOL CHEM, V269, P21473; Mitchell BA, 1999, J BIOL CHEM, V274, P3541, DOI 10.1074/jbc.274.6.3541; Nakajima O, 1999, EMBO J, V18, P6282, DOI 10.1093/emboj/18.22.6282; NEYFAKH AA, 1991, P NATL ACAD SCI USA, V88, P4781, DOI 10.1073/pnas.88.11.4781; Ogawa K, 2001, EMBO J, V20, P2835, DOI 10.1093/emboj/20.11.2835; ONIONS D, 1982, NATURE, V296, P156, DOI 10.1038/296156a0; PAO SS, 1994, MICROBIOL MOL BIOL R, V62, P1; PAPAYANNOPOULOU T, 1987, BLOOD, V70, P1764; PONKA P, 1982, BIOCHIM BIOPHYS ACTA, V720, P96, DOI 10.1016/0167-4889(82)90043-X; Ponka P, 1997, BLOOD, V89, P1; Quigley JG, 2000, BLOOD, V95, P1093, DOI 10.1182/blood.V95.3.1093.003k01_1093_1099; Rafie-Kolpin M, 2000, J BIOL CHEM, V275, P5171, DOI 10.1074/jbc.275.7.5171; RIEDEL N, 1988, P NATL ACAD SCI USA, V85, P2758, DOI 10.1073/pnas.85.8.2758; RIEDEL N, 1986, J VIROL, V60, P242, DOI 10.1128/JVI.60.1.242-250.1986; RIGBY MA, 1992, J GEN VIROL, V73, P2839, DOI 10.1099/0022-1317-73-11-2839; Rudra-Ganguly N, 1998, BBA-GENE STRUCT EXPR, V1443, P407, DOI 10.1016/S0167-4781(98)00241-3; RUTHERFORD TR, 1979, NATURE, V280, P164, DOI 10.1038/280164a0; Ryter SW, 2000, FREE RADICAL BIO MED, V28, P289, DOI 10.1016/S0891-5849(99)00223-3; SASSA S, 1976, J EXP MED, V143, P305, DOI 10.1084/jem.143.2.305; Smith K. M., 1975, PORPHYRINS METALLOPO; Tailor CS, 1999, J VIROL, V73, P6500, DOI 10.1128/JVI.73.8.6500-6505.1999; Taketani S, 1998, J BIOL CHEM, V273, P31388, DOI 10.1074/jbc.273.47.31388; TAKEUCHI Y, 1992, J VIROL, V66, P1219, DOI 10.1128/JVI.66.2.1219-1222.1992; Uzel C, 1998, SEMIN HEMATOL, V35, P27; Wandersman C, 2000, CURR OPIN MICROBIOL, V3, P215, DOI 10.1016/S1369-5274(00)00078-3; WARDROP KJ, 1986, AM J VET RES, V47, P2274; WEISS RA, 1995, CELL, V82, P531, DOI 10.1016/0092-8674(95)90024-1; WICKREMA A, 1992, BLOOD, V80, P1940, DOI 10.1182/blood.V80.8.1940.1940; Worthington MT, 2001, AM J PHYSIOL-GASTR L, V280, pG1172, DOI 10.1152/ajpgi.2001.280.6.G1172	49	307	320	3	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 17	2004	118	6					757	766		10.1016/j.cell.2004.08.014	http://dx.doi.org/10.1016/j.cell.2004.08.014			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	855RW	15369674	Bronze			2022-12-28	WOS:000223992400011
J	Dornan, T; Bundy, C				Dornan, T; Bundy, C			What can experience add to early medical education? Consensus survey	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PROFESSIONAL-DEVELOPMENT; VERTICAL INTEGRATION; CLINICAL MEDICINE; BASIC SCIENCE; STUDENTS	Objective To provide a rationale for integrating experience into early medical education ("early experience"). Design Small group discussions to obtain stakeholders' views. Grounded theory analysis with respondent, internal, and external validation. Setting Problem based, undergraduate medical curriculum that is not vertically integrated. Participants A purposive sample of 64 students, staff, and curriculum leaders from three university medical schools in the United Kingdom. Results Without early experience, the curriculum was socially isolating and divorced from clinical practice. The abruptness of students' transition to the clinical environment in year 3 generated positive and negative emotions. The rationale for early experience would be to ease the transition; orientate the curriculum towards the social context of practice; make students more confident to approach patients; motivate them; increase their awareness of themselves and others; strengthen, deepen, and contextualise their theoretical knowledge; teach intellectual skills; strengthen learning of behavioural and social sciences; and teach them about the role of health professionals. Conclusion A rationale for early experience would be to strengthen and deepen cognitively, broaden affectively, contextualise, and integrate medical education. This is partly a process of professional socialisation that should start earlier to avoid an abrupt transition. "Experience" can be defined as "authentic human contact in a social or clinical context that enhances learning of health, illness or disease, and the role of the health professional."	Hope Hosp, Salford M6 8HD, Lancs, England; Univ Manchester, Sch Med, Manchester M13 9PL, Lancs, England	University of Manchester	Dornan, T (corresponding author), Hope Hosp, Salford M6 8HD, Lancs, England.	tim.dornan@man.ac.uk	Bundy, Chrstine/I-4286-2015	Bundy, Chrstine/0000-0002-5981-3984				Angelo TA., 1993, CLASSROOM ASSESSMENT, V2nd; Bandura A., 1986, SOCIAL FDN THOUGHT A; Barbour RS, 2001, BMJ-BRIT MED J, V322, P1115, DOI 10.1136/bmj.322.7294.1115; Brennan T, 2002, CLIN MED, V2, P116; Brynhildsen J, 2002, MED TEACH, V24, P286, DOI 10.1080/01421590220134105; Dahle LO, 2002, MED TEACH, V24, P280, DOI 10.1080/01421590220134097; DBR_Collective, 2003, ED RES, V32, P5, DOI [DOI 10.3102/0013189X032001005, 10.3102/0013189X032001005]; DORNAN T, 2004, CAN EALRY EXPERIENCE; General Medical Council, 2002, TOM DOCT; Gordon J, 2000, MED EDUC, V34, P841, DOI 10.1046/j.1365-2923.2000.00759.x; Gordon J, 2003, MED EDUC, V37, P341, DOI 10.1046/j.1365-2923.2003.01470.x; Hamilton JD, 1999, MED TEACH, V21, P125, DOI 10.1080/01421599979725; Howe A, 2002, MED EDUC, V36, P353, DOI 10.1046/j.1365-2923.2002.01168.x; Irvine D, 1999, LANCET, V353, P1174, DOI 10.1016/S0140-6736(99)91160-1; Kachur EK, 2003, MED EDUC, V37, P88, DOI 10.1046/j.1365-2923.2003.01421.x; LITTLEWOOD SL, 2002, WHAT ARE BENEFITS EA; ONEILL PA, 1998, ED HLTH, V11, P37; Pitkala KH, 2003, MED TEACH, V25, P155, DOI 10.1080/0142159031000092544; Radcliffe C, 2003, MED EDUC, V37, P32, DOI 10.1046/j.1365-2923.2003.01405.x; SCHMIDT HG, 1990, ACAD MED, V65, P611, DOI 10.1097/00001888-199010000-00001; SUAUSS A, 1998, BASICS QUALITATIVE R; ten Cate O, 2004, ACAD MED, V79, P219, DOI 10.1097/00001888-200403000-00005; Wenger Etienne., 1998, COMMUNITIES PRACTICE, V18th ed	23	128	138	2	11	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 9	2004	329	7470					834	837		10.1136/bmj.329.7470.834	http://dx.doi.org/10.1136/bmj.329.7470.834			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	862EK	15472265	Green Submitted, Green Published, Bronze			2022-12-28	WOS:000224472800020
J	Villier, L; Korn, D				Villier, L; Korn, D			Morphological disparity of ammonoids and the mark of Permian mass extinctions	SCIENCE			English	Article							END	The taxonomic diversity of ammonoids, in terms of the number of taxa preserved, provides an incomplete picture of the extinction pattern during the Permian because of a strongly biased fossil record. The analysis of morphological disparity (the variety of shell shapes) is a powerful complementary tool for testing hypotheses about the selectivity of extinction and permits the recognition of three distinct patterns. First, a trend of decreasing disparity, ranging for about 30 million years, led to a minimum disparity immediately before the Permian-Triassic boundary. Second, the strongly selective Capitanian crisis fits a model of background extinction driven by standard environmental changes. Third, the end-Permian mass extinction operated as a random, nonselective sorting of morphologies, which is consistent with a catastrophic cause.	Univ Aix Marseille 1, Ctr Sedimentol Paleontol, FRE 2761, CNRS, F-13331 Marseille 3, France; Humboldt Univ, Museum Naturkunde, D-10115 Berlin, Germany	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Humboldt University of Berlin; Leibniz Institut fur Evolutions und Biodiversitatsforschung	Villier, L (corresponding author), Univ Aix Marseille 1, Ctr Sedimentol Paleontol, FRE 2761, CNRS, 3 Pl Victor Hugo, F-13331 Marseille 3, France.	lvillier@up.univ-mrs.fr	Korn, Dieter/B-2963-2009	Korn, Dieter/0000-0003-1104-6939				Aberhan M, 2003, GEOLOGY, V31, P1077, DOI 10.1130/G19938.1; Benton M. J., 2003, LIFE NEARLY DIED GRE; Ciampaglio CN, 2001, PALEOBIOLOGY, V27, P695, DOI 10.1666/0094-8373(2001)027<0695:DCIMOP>2.0.CO;2; Erwin D. H, 1993, GREAT PALEOZOIC CRIS; Erwin DH, 2002, GEOL SOC AM SPEC PAP, V356, P363; FOOTE M, 1993, PALEOBIOLOGY, V19, P185, DOI 10.1017/S0094837300015864; GLENISTER BF, 1981, AMMONOIDEA, P49; JABLONSKI D, 1986, SCIENCE, V231, P129, DOI 10.1126/science.231.4734.129; Jablonski D, 2002, P NATL ACAD SCI USA, V99, P8139, DOI 10.1073/pnas.102163299; KULLMANN J, 2002, GONIAT VERSION 3 1 P; LEONOVA TB, 2002, PALEONTOL J S1, V36; Peters SE, 2002, NATURE, V416, P420, DOI 10.1038/416420a; Peters SE, 2001, PALEOBIOLOGY, V27, P583, DOI 10.1666/0094-8373(2001)027<0583:BITPAR>2.0.CO;2; Raup David M., 1996, P419; Roy K, 1997, TRENDS ECOL EVOL, V12, P277, DOI 10.1016/S0169-5347(97)81026-9; Saunders WB, 2004, PALEOBIOLOGY, V30, P19, DOI 10.1666/0094-8373(2004)030<0019:TEHOSG>2.0.CO;2; Saunders WB, 1999, SCIENCE, V286, P760, DOI 10.1126/science.286.5440.760; Smith AB, 1998, NATURE, V392, P69, DOI 10.1038/32155; STANLEY SM, 1994, SCIENCE, V266, P1340, DOI 10.1126/science.266.5189.1340; Wills M. A., 2001, FOSSILS PHYLOGENY FO, P55; ZHOU Z, 1996, PERMOPHILES, V29, P195	21	54	59	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 8	2004	306	5694					264	266		10.1126/science.1102127	http://dx.doi.org/10.1126/science.1102127			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	861MC	15472073				2022-12-28	WOS:000224419700036
J	Jeffery, WR; Strickler, AG; Yamamoto, Y				Jeffery, WR; Strickler, AG; Yamamoto, Y			Migratory neural crest-like cells form body pigmentation in a urochordate embryo	NATURE			English	Article							EVOLUTION; EXPRESSION; TUNICATE; PLACODES; PROTOCHORDATE; AMPHIOXUS; ORIGIN; PLATE; GENES	The neural crest, a source of many different cell types in vertebrate embryos, has not been identified in other chordates(1-3). Current opinion therefore holds that neural crest cells were a vertebrate innovation(4-7). Here we describe a migratory cell population resembling neural crest cells in the ascidian urochordate Ecteinascidia turbinata. Labelling of embryos and larvae with the vital lipophilic dye DiI enabled us to detect cells that emerge from the neural tube, migrate into the body wall and siphon primordia, and subsequently differentiate as pigment cells. These cells express HNK-1 antigen and Zic gene markers of vertebrate neural crest cells. The results suggest that migratory cells with some of the features of neural crest cells are present in the urochordates. Thus, we propose a hypothesis for neural crest evolution beginning with the release of migratory cells from the CNS to produce body pigmentation in the common ancestor of the urochordates and vertebrates. These cells may have gained additional functions or were joined by other cell types to generate the variety of derivatives typical of the vertebrate neural crest.	Univ Maryland, Dept Biol, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park	Jeffery, WR (corresponding author), Univ Maryland, Dept Biol, College Pk, MD 20742 USA.	jeffery@umd.edu		Yamamoto, Yoshiyuki/0000-0003-4830-5703				AKITAYA T, 1992, DEV DYNAM, V194, P12, DOI 10.1002/aja.1001940103; ATOU Y, 2002, DEV GENES EVOL, V212, P87; Baker CVH, 1997, MECH DEVELOP, V69, P13, DOI 10.1016/S0925-4773(97)00129-9; Berrill NJ, 1935, PHILOS T ROY SOC B, V225, P255, DOI 10.1098/rstb.1935.0013; Brewster R, 1998, NATURE, V393, P579, DOI 10.1038/31242; Burighel P, 1998, J COMP NEUROL, V394, P230, DOI 10.1002/(SICI)1096-9861(19980504)394:2<230::AID-CNE7>3.0.CO;2-3; Corbo JC, 1997, DEVELOPMENT, V124, P2335; Elms P, 2003, DEV BIOL, V264, P391, DOI 10.1016/j.ydbio.2003.09.005; ERICKSON CA, 1993, PIGM CELL RES, V6, P336, DOI 10.1111/j.1600-0749.1993.tb00611.x; GANS C, 1983, SCIENCE, V220, P268, DOI 10.1126/science.220.4594.268; Gostling NJ, 2003, EVOL DEV, V5, P136, DOI 10.1046/j.1525-142X.2003.03020.x; Hall BK, 1999, NEURAL CREST DEV EVO; Hirata M, 1997, ZOOL SCI, V14, P305, DOI 10.2108/zsj.14.305; Holland LZ, 2001, J ANAT, V199, P85, DOI 10.1046/j.1469-7580.2001.19910085.x; JEFFERY WR, 1992, BIOESSAYS, V14, P219, DOI 10.1002/bies.950140404; JUNGALWALA FB, 1992, J NEUROCHEM, V58, P1045, DOI 10.1111/j.1471-4159.1992.tb09360.x; KATZ MJ, 1983, BIOL BULL-US, V164, P1, DOI 10.2307/1541186; Langeland JA, 1998, DEV GENES EVOL, V208, P569, DOI 10.1007/s004270050216; Le Douarin NM, 1999, NEURAL CREST, V2; LYERLA TA, 1975, BIOL BULL, V149, P178, DOI 10.2307/1540488; Manni L, 2001, EVOL DEV, V3, P297, DOI 10.1046/j.1525-142X.2001.01040.x; Manni L, 1999, J COMP NEUROL, V412, P527, DOI 10.1002/(SICI)1096-9861(19990927)412:3<527::AID-CNE11>3.0.CO;2-U; Nakata K, 1998, MECH DEVELOP, V75, P43, DOI 10.1016/S0925-4773(98)00073-2; Olsen CL, 1997, DEVELOPMENT, V124, P3609; Shimeld SM, 2000, P NATL ACAD SCI USA, V97, P4449, DOI 10.1073/pnas.97.9.4449; Stone JR, 2004, EVOL DEV, V6, P123, DOI 10.1111/j.1525-142X.2004.04014.x; THIERY JP, 1982, DEV BIOL, V93, P324, DOI 10.1016/0012-1606(82)90121-X; THORNDYKE MC, 1979, CELL TISSUE RES, V203, P301; Wada H, 1998, DEVELOPMENT, V125, P1113; Wada H, 2001, DEV GROWTH DIFFER, V43, P509	30	188	196	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 7	2004	431	7009					696	699		10.1038/nature02975	http://dx.doi.org/10.1038/nature02975			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	859WS	15470430				2022-12-28	WOS:000224299300042
J	Krasilnikov, AS; Xiao, YH; Pan, T; Mondragon, A				Krasilnikov, AS; Xiao, YH; Pan, T; Mondragon, A			Basis for structural diversity in homologous RNAs	SCIENCE			English	Article							RIBONUCLEASE-P RNA; CRYSTAL-STRUCTURE; FOLDING MOTIF; RIBOZYME; DOMAIN	Large RNA molecules, such as ribozymes, fold with well-defined tertiary structures that are important for their activity. There are many instances of ribozymes with identical function but differences in their secondary structures, suggesting alternative tertiary folds. Here, we report a crystal structure of the 161-nucleotide specificity domain of an A-type ribonuclease P that differs in secondary and tertiary structure from the specificity domain of a B-type molecule. Despite the differences, the cores of the domains have similar three-dimensional structure. Remarkably, the similar geometry of the cores is stabilized by a different set of interactions involving distinct auxiliary elements.	Northwestern Univ, Dept Biochem Mol Biol & Cell Biol, Evanston, IL 60208 USA; Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60637 USA	Northwestern University; University of Chicago	Mondragon, A (corresponding author), Northwestern Univ, Dept Biochem Mol Biol & Cell Biol, Evanston, IL 60208 USA.	a-mondragon@northwestern.edu						Altman S., 1999, RNA WORLD, P351; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BROWN JW, 1994, NUCLEIC ACIDS RES, V22, P3660, DOI 10.1093/nar/22.17.3660; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cate JH, 1996, SCIENCE, V273, P1678, DOI 10.1126/science.273.5282.1678; Chen JL, 1997, RNA, V3, P557; Chen JL, 1998, EMBO J, V17, P1515, DOI 10.1093/emboj/17.5.1515; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; Frank DN, 1998, ANNU REV BIOCHEM, V67, P153, DOI 10.1146/annurev.biochem.67.1.153; Haas ES, 1996, NUCLEIC ACIDS RES, V24, P4775, DOI 10.1093/nar/24.23.4775; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Krasilnikov AS, 2003, RNA, V9, P640, DOI 10.1261/rna.2202703; Krasilnikov AS, 2003, NATURE, V421, P760, DOI 10.1038/nature01386; LAGRANDEUR TE, 1994, EMBO J, V13, P3945, DOI 10.1002/j.1460-2075.1994.tb06710.x; Loria A, 1996, RNA, V2, P551; Massire C, 1998, J MOL BIOL, V279, P773, DOI 10.1006/jmbi.1998.1797; Moore PB, 1999, ANNU REV BIOCHEM, V68, P287, DOI 10.1146/annurev.biochem.68.1.287; Nagaswamy U, 2002, RNA, V8, P1112, DOI 10.1017/S135583820202006X; Nissen P, 2001, P NATL ACAD SCI USA, V98, P4899, DOI 10.1073/pnas.081082398; Odell L, 1998, NUCLEIC ACIDS RES, V26, P3717, DOI 10.1093/nar/26.16.3717; PAN T, 1995, BIOCHEMISTRY-US, V34, P902, DOI 10.1021/bi00003a024	21	117	126	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 1	2004	306	5693					104	107		10.1126/science.1101489	http://dx.doi.org/10.1126/science.1101489			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	859YJ	15459389				2022-12-28	WOS:000224304000046
J	Rawlins, MD				Rawlins, MD			NICE work - Providing guidance to the British National Health Service	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Natl Inst Clin Excellence, London, England; Univ Newcastle Upon Tyne, Wolfson Unit Clin Pharmacol, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	National Institute for Health & Care Excellence; Newcastle University - UK	Rawlins, MD (corresponding author), Natl Inst Clin Excellence, London, England.							*NAT I CLIN EXC, GUID US HUM GROWTH H; *NAT I CLIN EXC, GUIDE NICE; National Institute for Clinical Excellence, HUM GROWTH HORM SOM; Rawlins MD, 2004, BRIT MED J, V329, P224, DOI 10.1136/bmj.329.7459.224	4	36	36	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 30	2004	351	14					1383	1385		10.1056/NEJMp048221	http://dx.doi.org/10.1056/NEJMp048221			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	857XT	15459297				2022-12-28	WOS:000224153900004
J	Sesma, A; Osbourn, AE				Sesma, A; Osbourn, AE			The rice leaf blast pathogen undergoes developmental processes typical of root-infecting fungi	NATURE			English	Article							MAGNAPORTHE-GRISEA; SP-NOV; PENETRATION; GENE; RESISTANCE; BIOLOGY; PROTEIN	Pathogens have evolved different strategies to overcome the various barriers that they encounter during infection of their hosts(1). The rice blast fungus Magnaporthe grisea causes one of the most damaging diseases of cultivated rice and has emerged as a paradigm system for investigation of foliar pathogenicity. This fungus undergoes a series of well-defined developmental steps during leaf infection, including the formation of elaborate penetration structures (appressoria). This process has been studied in great detail(2), and over thirty M. grisea genes that condition leaf infection have been identified(3). Here we show a new facet of the M. grisea life cycle: this fungus can undergo a different ( and previously uncharacterized) set of programmed developmental events that are typical of root-infecting pathogens. We also show that root colonization can lead to systemic invasion and the development of classical disease symptoms on the aerial parts of the plant. Gene-for-gene type specific disease resistance that is effective against rice blast in leaves also operates in roots. These findings have significant implications for fungal development, epidemiology, plant breeding and disease control.	John Innes Ctr Plant Sci Res, Sainsbury Lab, Norwich NR4 7UH, Norfolk, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center	Osbourn, AE (corresponding author), John Innes Ctr Plant Sci Res, Sainsbury Lab, Colney Lane, Norwich NR4 7UH, Norfolk, England.	annie.osbourn@sainsbury-laboratory.ac.uk	Sesma, Ane/A-8883-2010; Sesma, Ane/AAF-4796-2021	Sesma, Ane/0000-0003-3982-8932; 				Cannon P. F., 1994, Systema Ascomycetum, V13, P25; CHUMLEY FG, 1990, MOL PLANT MICROBE IN, V3, P135, DOI 10.1094/MPMI-3-135; deJong JC, 1997, NATURE, V389, P244, DOI 10.1038/38418; Dufresne M, 2001, MOL PLANT MICROBE IN, V14, P300, DOI 10.1094/MPMI.2001.14.3.300; Farman ML, 2002, MOL PLANT MICROBE IN, V15, P6, DOI 10.1094/MPMI.2002.15.1.6; GANGOPADHYAY S, 1986, International Journal of Tropical Plant Diseases, V4, P187; HORNBY D, 1981, BIOL CONTROL TAKE AL; Hornby D, 1998, TAKE ALL DIS CEREALS; Howard RJ, 1996, ANNU REV MICROBIOL, V50, P491, DOI 10.1146/annurev.micro.50.1.491; Inoue I, 2002, PLANT CELL, V14, P1869, DOI 10.1105/tpc.002576; LANDSCHOOT PJ, 1989, MYCOL RES, V93, P59, DOI 10.1016/S0953-7562(89)80137-6; Lorang JM, 2001, APPL ENVIRON MICROB, V67, P1987, DOI 10.1128/AEM.67.5.1987-1994.2001; Mendgen K, 1996, ANNU REV PHYTOPATHOL, V34, P367, DOI 10.1146/annurev.phyto.34.1.367; MITCHELL TK, 1995, PLANT CELL, V7, P1869, DOI 10.1105/tpc.7.11.1869; Ou SH, 1985, RICE DIS; Resendes CM, 2001, NEW PHYTOL, V150, P563, DOI 10.1046/j.1469-8137.2001.00131.x; Rho HS, 2001, MOL CELLS, V12, P407; Rodrigues FA, 2003, PHYTOPATHOLOGY, V93, P535, DOI 10.1094/PHYTO.2003.93.5.535; Sambrook J., 2002, MOL CLONING LAB MANU; SCOTT DB, 1983, T BRIT MYCOL SOC, V81, P77, DOI 10.1016/S0007-1536(83)80206-X; Sosnowski M, 2001, PLANT PATHOL, V50, P808, DOI 10.1046/j.1365-3059.2001.00631.x; Sweigard JA, 1997, FUNGAL GENET NEWSL, V44, P52, DOI DOI 10.4148/1941-4765.1287; Talbot NJ, 2003, ANNU REV MICROBIOL, V57, P177, DOI 10.1146/annurev.micro.57.030502.090957; TALBOT NJ, 1993, PLANT CELL, V5, P1575, DOI 10.1105/tpc.5.11.1575; Tian D, 2003, NATURE, V423, P74, DOI 10.1038/nature01588; Tucker SL, 2001, ANNU REV PHYTOPATHOL, V39, P385, DOI 10.1146/annurev.phyto.39.1.385; VALENT B, 1991, GENETICS, V127, P87; Vereijssen J, 2004, EUR J PLANT PATHOL, V110, P103, DOI 10.1023/B:EJPP.0000010130.38700.88; Xu JR, 1997, MOL PLANT MICROBE IN, V10, P187, DOI 10.1094/MPMI.1997.10.2.187	29	247	272	1	77	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 30	2004	431	7008					582	586		10.1038/nature02880	http://dx.doi.org/10.1038/nature02880			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	857YP	15457264				2022-12-28	WOS:000224156700050
J	Wallace, SC; Wang, XM				Wallace, SC; Wang, XM			Two new carnivores from an unusual late Tertiary forest biota in eastern North America	NATURE			English	Article							EARLY PLIOCENE; PLANTS	Late Cenozoic terrestrial fossil records of North America are biased by a predominance of mid-latitude deposits, mostly in the western half of the continent. Consequently, the biological history of eastern North America, including the eastern deciduous forest, remains largely hidden. Unfortunately, vertebrate fossil sites from this vast region are rare(1,2), and few pertain to the critically important late Tertiary period, during which intensified global climatic changes took place(3,4). Moreover, strong phylogenetic affinities between the flora of eastern North America and eastern Asia clearly demonstrate formerly contiguous connections, but disparity among shared genera ( eastern Asia - eastern North America disjunction) implies significant periods of separation since at least the Miocene epoch(1,2). Lacustrine sediments deposited within a former sinkhole in the southern Appalachian Mountains provide a rare example of a late Miocene to early Pliocene terrestrial biota from a forested ecosystem(5). Here we show that the vertebrate remains contained within this deposit represent a unique combination of North American and Eurasian taxa. A new genus and species of the red ( lesser) panda ( Pristinailurus bristoli), the earliest and most primitive so far known, was recovered. Also among the fauna are a new species of Eurasian badger (Arctomeles dimolodontus) and the largest concentration of fossil tapirs ever recorded. Cladistical analyses of the two new carnivores strongly suggest immigration events that were earlier than and distinct from previous records(6,7), and that the close faunal affinities between eastern North America and eastern Asia in the late Tertiary period are consistent with the contemporaneous botanical record(8,9).	Nat Hist Museum Los Angeles, Dept Vertebrate Paleontol, Los Angeles, CA 90007 USA; E Tennessee State Univ, Dept Phys Astron & Geol, Johnson City, TN 37614 USA	East Tennessee State University	Wang, XM (corresponding author), Nat Hist Museum Los Angeles, Dept Vertebrate Paleontol, 900 Exposit Blvd, Los Angeles, CA 90007 USA.	xwang@nhm.org	Wang, Xiaoming/I-9033-2019	Wang, Xiaoming/0000-0003-1610-3840				[Anonymous], [No title captured]; BOYDDAWKINS W, 1888, Q J GEOL SOC LOND, V44, P228; Cerling TE, 1997, NATURE, V389, P153, DOI 10.1038/38229; EMRY RJ, 1998, GEOLOGY PALEONTOLOGY, P153; Farlow JO, 2001, AM MIDL NAT, V145, P367, DOI 10.1674/0003-0031(2001)145[0367:TPCSBA]2.0.CO;2; Ginsburg Leonard, 2001, Geodiversitas, V23, P81; HULBERT RCJ, IN PRESS B FLA MUS N; HUNT RM, 1998, EVOLUTION TERTIARY M, V1, P174; Jacobs BF, 1999, ANN MO BOT GARD, V86, P590, DOI 10.2307/2666186; KORMOS TH, 1935, MITTEILUNGEN JB KONI, V30, P1; Kundrat M., 1997, Journal of Vertebrate Paleontology, V17, p58A; MACFADDEN BJ, 1988, NATURE, V336, P466, DOI 10.1038/336466a0; MacFadden BJ, 1998, PALEOBIOLOGY, V24, P274; Morlo Michael, 2001, Palaeontologische Zeitschrift, V75, P163; Pagani M, 1999, SCIENCE, V285, P876, DOI 10.1126/science.285.5429.876; Parmalee PW, 2002, ANN CARNEGIE MUS, V71, P233; Qian H, 2000, NATURE, V407, P180, DOI 10.1038/35025052; Schlosser M., 1899, MITTHEILUNGEN JB KON, V13, P66; SCHMIDTKITTLER N, 1995, VERTEBRATE LOCALITY, P75; Stach J., 1951, Acta Geologica Polonica, V2, P129; Tedford RH, 2003, NATURE, V425, P388, DOI 10.1038/nature01892; TEDFORD RH, 1977, NATURE, V265, P621, DOI 10.1038/265621a0; Tedford RH, 2001, J VERTEBR PALEONTOL, V21, P311, DOI 10.1671/0272-4634(2001)021[0311:PATBUC]2.0.CO;2; Tedford Richard H., 2004, P169; VOORHIES MR, 1979, SCIENCE, V206, P331, DOI 10.1126/science.206.4416.331; WALLACE SC, 2002, J VERT PALEONTOL, V22, P117; Wang XM, 1997, J VERTEBR PALEONTOL, V17, P184, DOI 10.1080/02724634.1997.10010963; Wen J, 1999, ANNU REV ECOL SYST, V30, P421, DOI 10.1146/annurev.ecolsys.30.1.421; Zdansky O., 1924, Palaeontologia Sinica Series C, V2, P1; [No title captured]	30	72	74	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 30	2004	431	7008					556	559		10.1038/nature02819	http://dx.doi.org/10.1038/nature02819			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	857YP	15457257				2022-12-28	WOS:000224156700043
J	Collin, J; Muggli, ME; Carlyle, J; Lee, K; Hurt, RD				Collin, J; Muggli, ME; Carlyle, J; Lee, K; Hurt, RD			A race to the death: British American Tobacco and the Chinese Grand Prix	LANCET			English	Editorial Material									Univ London London Sch Hyg & Trop Med, Ctr Global Change & Hlth, London WC1E 7HT, England; Mayo Clin, Nicotine Res Program, Rochester, MN USA; Mayo Clin, Nicotine Dependence Ctr, Rochester, MN USA	University of London; London School of Hygiene & Tropical Medicine; Mayo Clinic; Mayo Clinic	Collin, J (corresponding author), Univ London London Sch Hyg & Trop Med, Ctr Global Change & Hlth, Keppel St, London WC1E 7HT, England.	jeff.collin@lshtm.ac.uk			NATIONAL CANCER INSTITUTE [R01CA091021, R01CA090791] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA90791, R01 CA091021-03] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		*BRIT AM TOB, 2004, 2004 NEWS REL APPR M; Carlyle J, 2004, BRIT MED J, V329, P104, DOI 10.1136/bmj.329.7457.104; Cox H, 2000, GLOBAL CIGARETTE ORI, P48; LEE K, IN PRESS TOB CONTROL; Liu BQ, 1998, BMJ-BRIT MED J, V317, P1411, DOI 10.1136/bmj.317.7170.1411; Mackay J, 2002, TOBACCO ATLAS; O'Sullivan B, 2000, TOB CONTROL, V9, P292, DOI 10.1136/tc.9.3.292; Rawnsley Andrew., 2001, SERVANTS PEOPLE INSI; Shatenstein S, 2004, TOB CONTROL, V13, P213; World Health Organization, 2003, WHO FRAM CONV TOB CO; ZHANG F, 2004, CHINA DAILY     0902	11	7	7	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 25	2004	364	9440					1107	1108		10.1016/S0140-6736(04)17118-3	http://dx.doi.org/10.1016/S0140-6736(04)17118-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	857FT	15451206				2022-12-28	WOS:000224102400007
J	McVernon, J; Trotter, CL; Slack, MPE; Ramsay, ME				McVernon, J; Trotter, CL; Slack, MPE; Ramsay, ME			Trends in Haemophilus influenzae type b infections in adults in England and Wales: surveillance study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CONJUGATE VACCINE; IMMUNITY; DISEASE; IMPACT; HIB; COLONIZATION; EPIGLOTTITIS; CARRIAGE; CHILDREN	Objective To describe invasive Haemophilus influenzae type b (Hib) infections in individuals aged 15 years or older in England and Wales between 1991 and 2003. Design Prospective, laboratory based surveillance of invasive Hib infections and cross sectional seroprevalence study. Setting England and Wales. Participants Cases were confirmed by isolation of H influenzae from a normally sterile site, or from a non-sterile site in cases with a diagnosis of epiglottitis. Excess serum samples collected from English 30-39 year olds as part of a national serosurvey were identified for the years 1990, 1994, 1997, 2000, and 2002. Main outcome measures The number of invasive Hib infections from 1991 to 2003. Population immunity to H influenzae type b in English adults was also measured. Results After routine infant immunisation was introduced in October 1992, adult Hib infections decreased initially but then rose from a low in 1998 to reach prevaccine levels in 2003. An associated fall in median Hib antibody concentrations occurred, from 1.29 mug/ml (95% confidence interval 0.90 to 1.64) in 1991 to 0.70 mug/ml (0.57 to 0.89) in 1994 (P=0.006), with no significant change observed thereafter. Conclusions Although immunisation of infants resulted in an initial decline in Hib infections in adults, a resurgence in reported cases occurred in 2002-3. This rise was associated with an increase in cases in children and evidence of reduced immunity in older unimmunised cohorts. Childhood immunisation programmes may have unanticipated effects on the epidemiology of disease in older age groups, and surveillance strategies must be targeted at entire populations.	Hlth Protect Agcy, Ctr Communicable Dis Surveillance, Immunisat Dept, London NW9 5EQ, England; Hlth Protect Agcy, Ctr Communicable Dis Surveillance, Stat Modelling & Econ Dept, London NW9 5EQ, England; John Radcliffe Hosp, Hlth Protect Agcy Specialist & Reference Microbio, Haemophilus Reference Unit, Oxford OX3 9DU, England	Health Protection Agency; Health Protection Agency; University of Oxford	Ramsay, ME (corresponding author), Hlth Protect Agcy, Ctr Communicable Dis Surveillance, Immunisat Dept, London NW9 5EQ, England.	mary.ramsay@hpa.org.uk	Trotter, Caroline L/H-5077-2013; Ramsay, Mary Elizabeth/S-8281-2016	Ramsay, Mary Elizabeth/0000-0002-7156-7640; McVernon, Jodie/0000-0001-9774-1961; Trotter, Caroline/0000-0003-4000-2708				BARBOUR ML, 1995, J INFECT DIS, V171, P93, DOI 10.1093/infdis/171.1.93; BOISVERT PL, 1948, AM J DIS CHILD, V75, P427; *DEP HLTH, 2003, BOOST VACC OFF FOLL; European Union Invasive Bacterial Infections Surveillance Network, 2006, INV HAEM INFL EUR 20; GLODE MP, 1984, PEDIATR INFECT DIS J, V3, P548, DOI 10.1097/00006454-198411000-00013; *HLTH PROT AG, Q COMM DIS REP COVER; Kelly H, 2002, VACCINE, V20, P3130, DOI 10.1016/S0264-410X(02)00255-4; Leino T, 2000, EPIDEMIOL INFECT, V125, P583, DOI 10.1017/S0950268800004799; McVernon J, 2004, EPIDEMIOL INFECT, V132, P765, DOI 10.1017/S0950268804002122; McVernon J, 2003, LANCET, V361, P1521, DOI 10.1016/S0140-6736(03)13171-6; MICHAELS RH, 1977, J INFECT DIS, V136, P222, DOI 10.1093/infdis/136.2.222; *NAT STAT ONL, BIRTH STAT BIRTHS PA; Osborne K, 2000, INT J EPIDEMIOL, V29, P362, DOI 10.1093/ije/29.2.362; PHIPPS DC, 1990, J IMMUNOL METHODS, V135, P121, DOI 10.1016/0022-1759(90)90264-V; Ramsay ME, 2003, J INFECT DIS, V188, P481, DOI 10.1086/376997; Ramsay ME, 2003, BRIT MED J, V326, P365, DOI 10.1136/bmj.326.7385.365; Rijkers GT, 2003, LANCET, V361, P1563, DOI 10.1016/S0140-6736(03)13201-1; Sarangi J, 2000, EPIDEMIOL INFECT, V124, P441, DOI 10.1017/S0950268899003611; Slack MPE, 1998, PEDIATR INFECT DIS J, V17, pS204, DOI 10.1097/00006454-199809001-00026; Trotter C L, 2003, Commun Dis Public Health, V6, P55; Trotter CL, 2003, LANCET, V361, P1523, DOI 10.1016/S0140-6736(03)13172-8; Whitney CG, 2003, NEW ENGL J MED, V348, P1737, DOI 10.1056/NEJMoa022823	22	51	54	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 18	2004	329	7467					655	658		10.1136/bmj.329.7467.655	http://dx.doi.org/10.1136/bmj.329.7467.655			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	856JU	15374916	Green Published, Green Submitted, Bronze			2022-12-28	WOS:000224042300019
J	Coqueugniot, H; Hublin, JJ; Veillon, F; Houet, F; Jacob, T				Coqueugniot, H; Hublin, JJ; Veillon, F; Houet, F; Jacob, T			Early brain growth in Homo erectus and implications for cognitive ability	NATURE			English	Article							AGE; DMANISI; GEORGIA; JAVA	Humans differ from other primates in their significantly lengthened growth period. The persistence of a fetal pattern of brain growth after birth is another important feature of human development(1). Here we present the results of an analysis of the 1.8-million-year-old Mojokerto child (Perning 1, Java), the only well preserved skull of a Homo erectus infant, by computed tomography. Comparison with a large series of extant humans and chimpanzees indicates that this individual was about 1 yr (0-1.5 yr) old at death and had an endocranial capacity at 72-84% of an average adult H. erectus. This pattern of relative brain growth resembles that of living apes, but differs from that seen in extant humans. It implies that major differences in the development of cognitive capabilities existed between H. erectus and anatomically modern humans.	Max Planck Inst Evolutionary Anthropol, Dept Human Evolut, D-04130 Leipzig, Germany; Univ Bordeaux 1, Lab Anthropol Populat Passe, PACEA, UMR 5199, F-33405 Talence, France; Hop Hautepierre, Serv Radiol 1, F-67200 Strasbourg, France; Gadjah Mada Univ, Coll Med, Dept Phys Anthropol, Yogyakarta, Indonesia	Max Planck Society; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite de Bordeaux; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Gadjah Mada University	Hublin, JJ (corresponding author), Max Planck Inst Evolutionary Anthropol, Dept Human Evolut, Deutsch Pl 6, D-04130 Leipzig, Germany.	hublin@eva.mpg.de						Anton SC, 1997, AM J PHYS ANTHROPOL, V102, P497, DOI 10.1002/(SICI)1096-8644(199704)102:4<497::AID-AJPA6>3.0.CO;2-P; Begun David, 1993, P326; Dean C, 2001, NATURE, V414, P628, DOI 10.1038/414628a; DUBOIS E, 1936, KONINKLIJKE AKAD WET, V34, P1180; Gabunia L, 2000, SCIENCE, V288, P1019, DOI 10.1126/science.288.5468.1019; Gould S. J., 1977, ONTOGENY PHYLOGENY; HOHNE KH, 1995, NAT MED, V1, P506, DOI 10.1038/nm0695-506; Holloway R L, 1983, Hum Neurobiol, V2, P105; HOLLOWAY RL, 1981, AM J PHYS ANTHROPOL, V55, P503, DOI 10.1002/ajpa.1330550412; Huffman OF, 2001, J HUM EVOL, V40, P353, DOI 10.1006/jhev.2001.0464; HUTTENLOCHER PR, 1990, NEUROPSYCHOLOGIA, V28, P517, DOI 10.1016/0028-3932(90)90031-I; Jacob T., 1975, P311; Martin R.D., 1983, HUMAN BRAIN EVOLUTIO; RAGIR S, 1985, J MIND BEHAV, V6, P451; RAK Y, 1987, AM J PHYS ANTHROPOL, V73, P227, DOI 10.1002/ajpa.1330730209; Riscutia C., 1975, P373; Rosenberg K, 2002, BJOG-INT J OBSTET GY, V109, P1199, DOI 10.1046/j.1471-0528.2002.00010.x; Rosenzweig MR, 1996, BEHAV BRAIN RES, V78, P57, DOI 10.1016/0166-4328(95)00216-2; Sartono S., 1993, INT C HUM PAL JAK LI, P1; SCHULTZ AH, 1940, CONTRIB EMBRYOL, V170, P1; SMITH BH, 1995, ANNU REV ANTHROPOL, V24, P257, DOI 10.1146/annurev.an.24.100195.001353; SPOOR CF, 1993, AM J PHYS ANTHROPOL, V91, P469, DOI 10.1002/ajpa.1330910405; SWISHER CC, 1994, SCIENCE, V263, P118, DOI DOI 10.1126/SCIENCE.8108729; Vekua A, 2002, SCIENCE, V297, P85, DOI 10.1126/science.1072953; VONKOENIGSWALD GHR, 1936, INGENIEUR NED INDIE, V8, P149; Walker Alan, 1993, P221; Weidennreich F., 1940, WETENSCHAPPELIJKE ME, V28, P7; WEINERT H, 1938, ENTSTEHUNG MENSCHENR; Wood B, 1999, SCIENCE, V284, P65, DOI 10.1126/science.284.5411.65; ZUCKERMAN S, 1928, P ZOOL SOC LOND, V1, P1	30	119	125	1	39	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 16	2004	431	7006					299	302		10.1038/nature02852	http://dx.doi.org/10.1038/nature02852			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	853XJ	15372030				2022-12-28	WOS:000223864000038
J	Corma, A; Rey, F; Rius, J; Sabater, MJ; Valencia, S				Corma, A; Rey, F; Rius, J; Sabater, MJ; Valencia, S			Supramolecular self-assembled molecules as organic directing agent for synthesis of zeolites	NATURE			English	Article								Solid materials with uniform micropores, such as zeolites, can act as selective catalysts and adsorbents for molecular mixtures by separating those molecules small enough to enter their pores while leaving the larger molecules behind(1,2). Zeolite A is a microporous material with a high void volume. Despite its widespread industrial use in, for example, molecular separations and in detergency(3,4), its capability as a petroleum-refining material is limited owing to its poor acid-catalytic activity and hydrothermal stability, and its low hydrophobicity. These characteristics are ultimately a consequence of the low framework Si/Al ratio (normally around one) and the resulting high cationic fraction within the pores and cavities(1,2). Researchers have modified the properties of type-A zeolites by increasing the Si/Al compositions up to a ratio of three(5-9). Here we describe the synthesis of zeolite A structures exhibiting high Si/Al ratios up to infinity ( pure silica). We synthesize these materials, named ITQ-29, using a supramolecular organic structure-directing agent obtained by the self-assembly, through pi-pi type interactions, of two identical organic cationic moieties. The highly hydrophobic pure-silica zeolite A can be used for hydrocarbon separations that avoid oligomerization reactions, whereas materials with high Si/Al ratios give excellent shape-selective cracking additives for increasing propylene yield in fluid catalytic cracking operations. We have also extended the use of our supramolecular structure-directing agents to the synthesis of a range of other zeolites.	Univ Politecn Valencia, CSIC, Inst Tecnol Quim, Valencia 46022, Spain; CSIC, Inst Ciencia Mat Barcelona, Bellaterra 08193, Catalunya, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Universitat Politecnica de Valencia; CSIC-UPV - Instituto de Tecnologia Quimica (ITQ); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Ciencia de Materiales de Barcelona (ICMAB)	Corma, A (corresponding author), Univ Politecn Valencia, CSIC, Inst Tecnol Quim, Avda Naranjos S-N, Valencia 46022, Spain.	acorma@itq.upv.es	Rey, Fernando/C-6778-2011; CANOS, AVELINO CORMA/A-3040-2013; Valencia, Susana/I-4644-2015	Rey, Fernando/0000-0003-3227-5669; CANOS, AVELINO CORMA/0000-0002-2232-3527; Valencia, Susana/0000-0001-7160-2795; Sabater, Maria J./0000-0001-5089-7264; RIUS, JORDI/0000-0002-8376-8634				BARRER RM, 1978, ZEOLITES CLAY MINERA, pCH1; BARRER RM, 1967, Patent No. 3306922; Barrett PA, 2003, CHEM COMMUN, P2114, DOI 10.1039/b306440a; Blasco T, 2002, J PHYS CHEM B, V106, P2634, DOI 10.1021/jp013302b; Boucheffa Y, 1997, IND ENG CHEM RES, V36, P3198, DOI 10.1021/ie960646t; BRECK DW, 1974, ZEOLITE MOL SIEVES, pCH1; Castaneda R, 2003, J AM CHEM SOC, V125, P7820, DOI 10.1021/ja035534p; Corma A, 2004, CHEM COMMUN, P1356, DOI 10.1039/b406572g; Corma A, 2002, NATURE, V418, P514, DOI 10.1038/nature00924; Corma A, 2003, NAT MATER, V2, P493, DOI 10.1038/nmat921; GIES H, 1992, ZEOLITES, V12, P42, DOI 10.1016/0144-2449(92)90008-D; GRAMLICH V, 1971, Z KRISTALLOGR KRIST, V133, P134, DOI 10.1524/zkri.1971.133.133.134; Grande CA, 2002, IND ENG CHEM RES, V41, P85, DOI 10.1021/ie010494o; Kerr G. T., 1967, US Patent, Patent No. [3,314,752, 3314752]; KERR GT, 1966, INORG CHEM, V5, P1537, DOI 10.1021/ic50043a015; Kuehl G. H, 1981, US patent, Patent No. [4,299,686, 4299686]; Lee H, 2003, NATURE, V425, P385, DOI 10.1038/nature01980; LOBO RF, 1995, J INCLUS PHENOM MOL, V21, P47; MOSCOU L, 1991, INTRO ZEOLITE SCI TE, pCH1; Nakano T, 2003, J AM CHEM SOC, V125, P15474, DOI 10.1021/ja037836x; Olson DH, 2004, MICROPOR MESOPOR MAT, V67, P27, DOI 10.1016/j.micromeso.2003.09.025; RIUS J, 2002, LSP7 COMPUTER PROGRA; Sherman JD, 1999, P NATL ACAD SCI USA, V96, P3471, DOI 10.1073/pnas.96.7.3471; WADLINGER RL, 1968, Patent No. 3375205; Wang YX, 2003, SOLID STATE SCI, V5, P1421, DOI 10.1016/j.solidstatesciences.2003.09.003	25	429	441	12	321	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 16	2004	431	7006					287	290		10.1038/nature02909	http://dx.doi.org/10.1038/nature02909			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	853XJ	15372027				2022-12-28	WOS:000223864000035
J	Lippman, Z; Martienssen, R				Lippman, Z; Martienssen, R			The role of RNA interference in heterochromatic silencing	NATURE			English	Article							H3 LYSINE-9 METHYLATION; DIRECTED DNA METHYLATION; DOUBLE-STRANDED-RNA; NON-CG METHYLATION; ELEGANS GERM-LINE; HISTONE H3; DROSOPHILA-MELANOGASTER; FISSION YEAST; X-CHROMOSOME; PERICENTRIC HETEROCHROMATIN		Watson Sch Biol Sci, Cold Spring Harbor, NY 11724 USA; Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	Cold Spring Harbor Laboratory; Cold Spring Harbor Laboratory	Lippman, Z (corresponding author), Watson Sch Biol Sci, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.	martiens@cshl.edu		Lippman, Zachary/0000-0001-7668-9025				Akhtar A, 2000, NATURE, V407, P405, DOI 10.1038/35030169; Ananiev E V, 2000, Tsitol Genet, V34, P11; Aravin AA, 2003, DEV CELL, V5, P337, DOI 10.1016/S1534-5807(03)00228-4; Aravin AA, 2001, CURR BIOL, V11, P1017, DOI 10.1016/S0960-9822(01)00299-8; Avner P, 2001, NAT REV GENET, V2, P59, DOI 10.1038/35047580; Baroux C, 2002, ADV GENET, V46, P165; Bartee L, 2001, GENE DEV, V15, P1753, DOI 10.1101/gad.905701; BENDER J, 1995, CELL, V83, P725, DOI 10.1016/0092-8674(95)90185-X; Bernard P, 2001, SCIENCE, V294, P2539, DOI 10.1126/science.1064027; Bernstein E, 2003, NAT GENET, V35, P215, DOI 10.1038/ng1253; Brehm A, 2004, BIOESSAYS, V26, P133, DOI 10.1002/bies.10392; Cao XF, 2002, CURR BIOL, V12, P1138, DOI 10.1016/S0960-9822(02)00925-9; Cao XF, 2003, CURR BIOL, V13, P2212, DOI 10.1016/j.cub.2003.11.052; Chan SWL, 2004, SCIENCE, V303, P1336, DOI 10.1126/science.1095989; Choo KHA, 2001, DEV CELL, V1, P165, DOI 10.1016/S1534-5807(01)00028-4; Colot V, 1996, CELL, V86, P855, DOI 10.1016/S0092-8674(00)80161-0; Comfort NC, 2001, TRENDS GENET, V17, P475, DOI 10.1016/S0168-9525(01)02383-6; Deng W, 2002, DEV CELL, V2, P819, DOI 10.1016/S1534-5807(02)00165-X; Dernburg AF, 2000, GENE DEV, V14, P1578; Djikeng A, 2001, RNA, V7, P1522; Fagard M, 2000, P NATL ACAD SCI USA, V97, P11650, DOI 10.1073/pnas.200217597; Fransz P, 2003, CHROMOSOME RES, V11, P227, DOI 10.1023/A:1022835825899; Freitag M, 2004, SCIENCE, V304, P1939, DOI 10.1126/science.1099709; Fuks F, 2003, NUCLEIC ACIDS RES, V31, P2305, DOI 10.1093/nar/gkg332; Fuks F, 2003, J BIOL CHEM, V278, P4035, DOI 10.1074/jbc.M210256200; Gendrel AV, 2002, SCIENCE, V297, P1871, DOI 10.1126/science.1074950; Grewal SIS, 2000, J CELL PHYSIOL, V184, P311, DOI 10.1002/1097-4652(200009)184:3<311::AID-JCP4>3.0.CO;2-D; Hall IM, 2003, P NATL ACAD SCI USA, V100, P193, DOI 10.1073/pnas.232688099; Hall IM, 2002, SCIENCE, V297, P2232, DOI 10.1126/science.1076466; Heard E, 2001, CELL, V107, P727, DOI 10.1016/S0092-8674(01)00598-0; HEATH EM, 1991, GENET RES, V57, P213, DOI 10.1017/S0016672300029360; Heitz E., 1928, JAHRB WISS BOT, V69, P762; Hennig W, 1999, CHROMOSOMA, V108, P1, DOI 10.1007/s004120050346; Jackson JP, 2002, NATURE, V416, P556, DOI 10.1038/nature731; Jacobs SA, 2002, SCIENCE, V295, P2080, DOI 10.1126/science.1069473; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Jeddeloh JA, 1999, NAT GENET, V22, P94, DOI 10.1038/8803; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Jia ST, 2004, SCIENCE, V304, P1971, DOI 10.1126/science.1099035; Johnson LM, 2002, CURR BIOL, V12, P1360, DOI 10.1016/S0960-9822(02)00976-4; Jorgensen Richard A., 2003, P5; Kankel MW, 2003, GENETICS, V163, P1109; Kato M, 2003, CURR BIOL, V13, P421, DOI 10.1016/S0960-9822(03)00106-4; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; Kelley RL, 2000, CELL, V103, P9, DOI 10.1016/S0092-8674(00)00099-4; Kelly WG, 2002, DEVELOPMENT, V129, P479; Kinoshita T, 2004, SCIENCE, V303, P521, DOI 10.1126/science.1089835; Kiyosue T, 1999, P NATL ACAD SCI USA, V96, P4186, DOI 10.1073/pnas.96.7.4186; Kouzminova E, 2001, EMBO J, V20, P4309, DOI 10.1093/emboj/20.15.4309; Kuramochi-Miyagawa S, 2004, DEVELOPMENT, V131, P839, DOI 10.1242/dev.00973; Lachner M, 2002, CURR OPIN CELL BIOL, V14, P286, DOI 10.1016/S0955-0674(02)00335-6; Lee YS, 2004, CELL, V117, P69, DOI 10.1016/S0092-8674(04)00261-2; Lehnertz B, 2003, CURR BIOL, V13, P1192, DOI 10.1016/S0960-9822(03)00432-9; Lindroth AM, 2001, SCIENCE, V292, P2077, DOI 10.1126/science.1059745; Lippman Z, 2004, NATURE, V430, P471, DOI 10.1038/nature02651; Lippman Z, 2003, PLOS BIOL, V1, P420, DOI 10.1371/journal.pbio.0000067; Lynn K, 1999, DEVELOPMENT, V126, P469; Maison C, 2002, NAT GENET, V30, P329, DOI 10.1038/ng843; Malagnac F, 2002, EMBO J, V21, P6842, DOI 10.1093/emboj/cdf687; Martienssen RA, 2003, NAT GENET, V35, P213, DOI 10.1038/ng1252; Martienssen RA, 2001, SCIENCE, V293, P1070, DOI 10.1126/science.293.5532.1070; Matzke M, 2004, BBA-GENE STRUCT EXPR, V1677, P129, DOI 10.1016/j.bbaexp.2003.10.015; MCCLINTOCK B, 1951, COLD SPRING HARB SYM, V16, P13, DOI 10.1101/SQB.1951.016.01.004; MCCLINTOCK B, 1981, MONOGRAPH COLEGIO PO; Melquist S, 2003, GENE DEV, V17, P2036, DOI 10.1101/gad.1081603; Merok JR, 2002, CANCER RES, V62, P6791; Mette MF, 2000, EMBO J, V19, P5194, DOI 10.1093/emboj/19.19.5194; Mochizuki K, 2002, CELL, V110, P689, DOI 10.1016/S0092-8674(02)00909-1; Muller HJ, 1930, J GENET, V22, P299, DOI 10.1007/BF02984195; Nagaki K, 2004, NAT GENET, V36, P138, DOI 10.1038/ng1289; Nguyen CT, 2002, CANCER RES, V62, P6456; Osborn TC, 2003, TRENDS GENET, V19, P141, DOI 10.1016/S0168-9525(03)00015-5; Pal-Bhadra M, 2004, SCIENCE, V303, P669, DOI 10.1126/science.1092653; Pal-Bhadra M, 2002, MOL CELL, V9, P315, DOI 10.1016/S1097-2765(02)00440-9; Reik W, 2001, NAT REV GENET, V2, P21, DOI 10.1038/35047554; Reinhart BJ, 2002, SCIENCE, V297, P1831, DOI 10.1126/science.1077183; RUDERT F, 1995, MAMM GENOME, V6, P76, DOI 10.1007/BF00303248; Sarot E, 2004, GENETICS, V166, P1313, DOI 10.1534/genetics.166.3.1313; Schramke V, 2003, SCIENCE, V301, P1069, DOI 10.1126/science.1086870; Seitz H, 2003, NAT GENET, V34, P261, DOI 10.1038/ng1171; Selker EU, 2003, NATURE, V422, P893, DOI 10.1038/nature01564; Shiu PKT, 2002, GENETICS, V161, P1483; Sijen T, 2003, NATURE, V426, P310, DOI 10.1038/nature02107; Sleutels F, 2002, ADV GENET, V46, P119; Soppe WJJ, 2000, MOL CELL, V6, P791, DOI 10.1016/S1097-2765(05)00090-0; Stam M, 2002, GENE DEV, V16, P1906, DOI 10.1101/gad.1006702; Sun XP, 2003, GENOME RES, V13, P182, DOI 10.1101/gr.681703; Tamaru H, 2001, NATURE, V414, P277, DOI 10.1038/35104508; Tariq M, 2003, P NATL ACAD SCI USA, V100, P8823, DOI 10.1073/pnas.1432939100; Taverna SD, 2002, CELL, V110, P701, DOI 10.1016/S0092-8674(02)00941-8; Verdel A, 2004, SCIENCE, V303, P672, DOI 10.1126/science.1093686; Volpe T, 2003, CHROMOSOME RES, V11, P137, DOI 10.1023/A:1022815931524; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973; VONGS A, 1993, SCIENCE, V260, P1926, DOI 10.1126/science.8316832; WASSENEGGER M, 1994, CELL, V76, P567, DOI 10.1016/0092-8674(94)90119-8; Wu-Scharf D, 2000, SCIENCE, V290, P1159, DOI 10.1126/science.290.5494.1159; Xiao WY, 2003, DEV CELL, V5, P891, DOI 10.1016/S1534-5807(03)00361-7; Xie ZX, 2004, PLOS BIOL, V2, P642, DOI 10.1371/journal.pbio.0020104; Zilberman D, 2003, SCIENCE, V299, P716, DOI 10.1126/science.1079695; Zilberman D, 2004, CURR BIOL, V14, P1214, DOI 10.1016/j.cub.2004.06.055	100	425	464	2	50	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 16	2004	431	7006					364	370		10.1038/nature02875	http://dx.doi.org/10.1038/nature02875			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	853XJ	15372044				2022-12-28	WOS:000223864000053
J	Nishida, K; Yamato, M; Hayashida, Y; Watanabe, K; Yamamoto, K; Adachi, E; Nagai, S; Kikuchi, A; Maeda, N; Watanabe, H; Okano, T; Tano, Y				Nishida, K; Yamato, M; Hayashida, Y; Watanabe, K; Yamamoto, K; Adachi, E; Nagai, S; Kikuchi, A; Maeda, N; Watanabe, H; Okano, T; Tano, Y			Corneal reconstruction with tissue-engineered cell sheets composed of autologous oral mucosal epithelium	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							STEM-CELLS; CONJUNCTIVAL INFLAMMATION; TRANSPLANTATION; SURFACE; CULTURE; DIFFERENTIATION; EXPRESSION; ALLOGRAFT; SURVIVAL	Background: Ocular trauma or disease may lead to severe corneal opacification and, consequently, severe loss of vision as a result of complete loss of corneal epithelial stem cells. Transplantation of autologous corneal stem-cell sources is an alternative to allograft transplantation and does not require immunosuppression, but it is not possible in many cases in which bilateral disease produces total corneal stem-cell deficiency in both eyes. We studied the use of autologous oral mucosal epithelial cells as a source of cells for the reconstruction of the corneal surface. Methods: We harvested 3-by-3-mm specimens of oral mucosal tissue from four patients with bilateral total corneal stem-cell deficiencies. Tissue-engineered epithelial-cell sheets were fabricated ex vivo by culturing harvested cells for two weeks on temperature-responsive cell-culture surfaces with 3T3 feeder cells that had been treated with mitomycin C. After conjunctival fibrovascular tissue had been surgically removed from the ocular surface, sheets of cultured autologous cells that had been harvested with a simple reduced-temperature treatment were transplanted directly to the denuded corneal surfaces (one eye of each patient) without sutures. Results: Complete reepithelialization of the corneal surfaces occurred within one week in all four treated eyes. Corneal transparency was restored and postoperative visual acuity improved remarkably in all four eyes. During a mean follow-up period of 14 months, all corneal surfaces remained transparent. There were no complications. Conclusions: Sutureless transplantation of carrier-free cell sheets composed of autologous oral mucosal epithelial cells may be used to reconstruct corneal surfaces and can restore vision in patients with bilateral severe disorders of the ocular surface.	Osaka Univ, Sch Med, Dept Ophthalmol, Suita, Osaka 5650871, Japan; Tokyo Womens Med Univ, Inst Adv Biomed Engn & Sci, Tokyo, Japan; Kitasato Univ, Grad Sch Med, Dept Mol Morphol, Kanagawa, Japan	Osaka University; Tokyo Women's Medical University; Kitasato University	Nishida, K (corresponding author), Osaka Univ, Sch Med, Dept Ophthalmol, Room E7,Yamadaoka 2-2, Suita, Osaka 5650871, Japan.	knishida@ophthal.med.osaka-u.ac.jp	Okano, Teruo/J-4028-2012	Nishida, Kohji/0000-0001-9069-3610				BUCK RC, 1985, INVEST OPHTH VIS SCI, V26, P1296; CHEN JJY, 1990, INVEST OPHTH VIS SCI, V31, P1301; COTSARELIS G, 1989, CELL, V57, P201, DOI 10.1016/0092-8674(89)90958-6; Dua HS, 2003, EYE, V17, P877, DOI 10.1038/sj.eye.6700573; Dua HS, 2000, BRIT J OPHTHALMOL, V84, P273, DOI 10.1136/bjo.84.3.273; FANTES FE, 1990, ARCH OPHTHALMOL-CHIC, V108, P665, DOI 10.1001/archopht.1990.01070070051034; FOSTER CS, 1988, OPHTHALMOLOGY, V95, P453; Hirose M, 2000, BIOMACROMOLECULES, V1, P377, DOI 10.1021/bm0002961; Hiscott P, 1996, EXP CELL RES, V226, P140, DOI 10.1006/excr.1996.0212; Holland EJ, 1999, NEW ENGL J MED, V340, P1752, DOI 10.1056/NEJM199906033402208; Ilari L, 2002, OPHTHALMOLOGY, V109, P1278, DOI 10.1016/S0161-6420(02)01081-3; JONES PH, 1993, CELL, V73, P713, DOI 10.1016/0092-8674(93)90251-K; Kawasaki S, 2000, BRIT J OPHTHALMOL, V84, P1191, DOI 10.1136/bjo.84.10.1191; KENYON KR, 1989, OPHTHALMOLOGY, V96, P709; KINOSHITA S, 1981, INVEST OPHTH VIS SCI, V21, P434; Kinoshita S, 2004, ARTIF ORGANS, V28, P22, DOI 10.1111/j.1525-1594.2004.07319.x; MOLL R, 1982, CELL, V31, P11, DOI 10.1016/0092-8674(82)90400-7; Nakamura T, 2003, INVEST OPHTH VIS SCI, V44, P106, DOI 10.1167/iovs.02-0195; Nishida K, 2003, CORNEA, V22, pS28, DOI 10.1097/00003226-200310001-00005; Nishida K, 2004, TRANSPLANTATION, V77, P379, DOI 10.1097/01.TP.0000110320.45678.30; Pellegrini G, 2001, P NATL ACAD SCI USA, V98, P3156, DOI 10.1073/pnas.061032098; Rama P, 2001, TRANSPLANTATION, V72, P1478, DOI 10.1097/00007890-200111150-00002; RHEINWALD JG, 1975, CELL, V6, P331, DOI 10.1016/S0092-8674(75)80001-8; Samson CM, 2002, OPHTHALMOLOGY, V109, P862, DOI 10.1016/S0161-6420(02)00994-6; SCHERMER A, 1986, J CELL BIOL, V103, P49, DOI 10.1083/jcb.103.1.49; Schwab IR, 2000, CORNEA, V19, P421, DOI 10.1097/00003226-200007000-00003; Shimazaki J, 1999, INVEST OPHTH VIS SCI, V40, P1664; Shimazaki J, 2000, OPHTHALMOLOGY, V107, P1518, DOI 10.1016/S0161-6420(00)00214-1; SHORE JW, 1992, OPHTHALMOLOGY, V99, P383; THOFT RA, 1983, INVEST OPHTH VIS SCI, V24, P1442; Tsai RJ, 2000, NEW ENGL J MED, V343, P86, DOI 10.1056/NEJM200007133430202; TSENG SCG, 1989, EYE, V3, P141, DOI 10.1038/eye.1989.22; Tsubota K, 1999, NEW ENGL J MED, V340, P1697, DOI 10.1056/NEJM199906033402201; WILLIAMS KA, 1995, AM J OPHTHALMOL, V120, P342, DOI 10.1016/S0002-9394(14)72164-6; Yamato M, 2004, MATER TODAY, V7, P42, DOI 10.1016/S1369-7021(04)00234-2	35	1108	1189	5	193	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 16	2004	351	12					1187	1196		10.1056/NEJMoa040455	http://dx.doi.org/10.1056/NEJMoa040455			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	853WS	15371576				2022-12-28	WOS:000223861300007
J	Suh, GSB; Wong, AM; Hergarden, AC; Wang, JW; Simon, AF; Benzer, S; Axel, R; Anderson, DJ				Suh, GSB; Wong, AM; Hergarden, AC; Wang, JW; Simon, AF; Benzer, S; Axel, R; Anderson, DJ			A single population of olfactory sensory neurons mediates an innate avoidance behaviour in Drosophila	NATURE			English	Article							ANTENNAL LOBE; MUSHROOM BODIES; MANDUCA-SEXTA; CENTRAL PROJECTIONS; SPHINX MOTH; MELANOGASTER; LEPIDOPTERA; ATTRACTION; RESPONSES; MOSQUITOS	All animals exhibit innate behaviours in response to specific sensory stimuli that are likely to result from the activation of developmentally programmed neural circuits. Here we observe that Drosophila exhibit robust avoidance to odours released by stressed flies. Gas chromatography and mass spectrometry identifies one component of this 'Drosophila stress odorant (dSO)' as CO2. CO2 elicits avoidance behaviour, at levels as low as 0.1%. We used two-photon imaging with the Ca2+-sensitive fluorescent protein G-CaMP to map the primary sensory neurons governing avoidance to CO2. CO2 activates only a single glomerulus in the antennal lobe, the V glomerulus; moreover, this glomerulus is not activated by any of 26 other odorants tested. Inhibition of synaptic transmission in sensory neurons that innervate the V glomerulus, using a temperature-sensitive Shibire gene (Shi(ts))(1), blocks the avoidance response to CO2. Inhibition of synaptic release in the vast majority of other olfactory receptor neurons has no effect on this behaviour. These data demonstrate that the activation of a single population of sensory neurons innervating one glomerulus is responsible for an innate avoidance behaviour in Drosophila.	CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA; CALTECH, Div Biol 216 76 & 156 29, Pasadena, CA 91125 USA; Columbia Univ Coll Phys & Surg, New York, NY 10032 USA	California Institute of Technology; Howard Hughes Medical Institute; California Institute of Technology; Columbia University	Anderson, DJ (corresponding author), CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA.	wuwei@caltech.edu	Simon, Anne/J-9199-2015; Wang, Jing W/C-3885-2008	Simon, Anne/0000-0002-6509-4541; Wang, Jing W/0000-0001-6291-5802; Axel, Richard/0000-0002-3141-4076; Suh, Greg/0000-0003-4381-658X				Anton S, 1996, CIBA F SYMP, V200, P184; ANTON S, 1996, CIBA F SYMP, V200, P226; ANTON S, 1996, CIBA F SYMP, V200, P192; Beck CDO, 2000, J NEUROSCI, V20, P2944; BOGNER F, 1986, J COMP PHYSIOL A, V158, P741, DOI 10.1007/BF01324818; CHRISTENSEN TA, 1995, CHEM SENSES, V20, P313, DOI 10.1093/chemse/20.3.313; Connolly JB, 1996, SCIENCE, V274, P2104, DOI 10.1126/science.274.5295.2104; de Bruyne M, 2001, NEURON, V30, P537, DOI 10.1016/S0896-6273(01)00289-6; DEBELLE JS, 1994, SCIENCE, V263, P692, DOI 10.1126/science.8303280; Distler PG, 1997, J EXP BIOL, V200, P1873; DUDAI Y, 1976, P NATL ACAD SCI USA, V73, P1684, DOI 10.1073/pnas.73.5.1684; Enserink M, 2002, SCIENCE, V298, P90, DOI 10.1126/science.298.5591.90; Galizia CG, 1999, NAT NEUROSCI, V2, P473, DOI 10.1038/8144; Hansson BS, 2003, J COMP PHYSIOL A, V189, P301, DOI 10.1007/s00359-003-0403-5; Heimbeck G, 2001, P NATL ACAD SCI USA, V98, P15336, DOI 10.1073/pnas.011314898; Heisenberg M, 2003, NAT REV NEUROSCI, V4, P266, DOI 10.1038/nrn1074; KENT KS, 1986, CELL TISSUE RES, V245, P237; Kitamoto T, 2001, J NEUROBIOL, V47, P81, DOI 10.1002/neu.1018; Laurent G, 2002, NAT REV NEUROSCI, V3, P884, DOI 10.1038/nrn964; Ng M, 2002, NEURON, V36, P463, DOI 10.1016/S0896-6273(02)00975-3; Scott K, 2001, CELL, V104, P661, DOI 10.1016/S0092-8674(01)00263-X; SHOREY HH, 1973, ANNU REV ENTOMOL, V18, P349, DOI 10.1146/annurev.en.18.010173.002025; Stange G., 1996, Advances in Bioclimatology, V4, P223; Stange G, 1999, MICROSC RES TECHNIQ, V47, P416, DOI 10.1002/(SICI)1097-0029(19991215)47:6<416::AID-JEMT5>3.0.CO;2-X; Stensmyr MC, 2003, J EXP BIOL, V206, P715, DOI 10.1242/jeb.00143; Stocker RF, 1997, J NEUROBIOL, V32, P443, DOI 10.1002/(SICI)1097-4695(199705)32:5<443::AID-NEU1>3.0.CO;2-5; STOCKER RF, 1994, CELL TISSUE RES, V275, P3, DOI 10.1007/BF00305372; Troemel ER, 1997, CELL, V91, P161, DOI 10.1016/S0092-8674(00)80399-2; Wang JW, 2003, CELL, V112, P271, DOI 10.1016/S0092-8674(03)00004-7; Wang YL, 2003, CURR BIOL, V13, P1900, DOI 10.1016/j.cub.2003.10.003; Wang YL, 2001, NEURON, V29, P267, DOI 10.1016/S0896-6273(01)00196-9; Wilson RI, 2004, SCIENCE, V303, P366, DOI 10.1126/science.1090782	32	390	394	3	82	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 14	2004	431	7010					854	859		10.1038/nature02980	http://dx.doi.org/10.1038/nature02980			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	861RE	15372051				2022-12-28	WOS:000224435500049
J	Molassiotis, A				Molassiotis, A			The prince and the professor - With respect, Professor Baum, you've got it wrong	BRITISH MEDICAL JOURNAL			English	Letter									Univ Manchester, Sch Nursing Midwifery & Hlth Visiting, Manchester M13 9PL, Lancs, England	University of Manchester	Molassiotis, A (corresponding author), Univ Manchester, Sch Nursing Midwifery & Hlth Visiting, Manchester M13 9PL, Lancs, England.	alex.molassiotis@man.ac.uk		Molassiotis, Alex/0000-0001-6351-9991				Baum M, 2004, BRIT MED J, V329, P118, DOI 10.1136/bmj.329.7457.118; BRIGHTHOPE I, DO YOU TRUST ORTHODO	2	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 9	2004	329	7470					858	858		10.1136/bmj.329.7470.858-a	http://dx.doi.org/10.1136/bmj.329.7470.858-a			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	862EK	15472282	Green Published			2022-12-28	WOS:000224472800040
J	Walswortrh, RL				Walswortrh, RL			The maser of 50	SCIENCE			English	Editorial Material									Harvard Smithsonian Ctr Astrophys, Cambridge, MA 02138 USA	Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution	Walswortrh, RL (corresponding author), Harvard Smithsonian Ctr Astrophys, 60 Garden St, Cambridge, MA 02138 USA.	rwalsworth@cfa.harvard.edu						Bear D, 2000, PHYS REV LETT, V85, P5038, DOI 10.1103/PhysRevLett.85.5038; Chu KR, 2004, REV MOD PHYS, V76, P489, DOI 10.1103/RevModPhys.76.489; GOLDENBERG HM, 1960, PHYS REV LETT, V5, P361, DOI 10.1103/PhysRevLett.5.361; GORDON JP, 1954, PHYS REV, V95, P282, DOI 10.1103/PhysRev.95.282; MAKHOV G, 1958, PHYS REV, V109, P1399, DOI 10.1103/PhysRev.109.1399; Raimond JM, 2001, REV MOD PHYS, V73, P565, DOI 10.1103/RevModPhys.73.565; Varcoe BTH, 2000, NATURE, V403, P743, DOI 10.1038/35001526	7	4	4	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 8	2004	306	5694					236	237		10.1126/science.1101354	http://dx.doi.org/10.1126/science.1101354			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	861MC	15472067				2022-12-28	WOS:000224419700026
J	Kaplan, AE				Kaplan, AE			The long and the short of it...	NATURE			English	Editorial Material									Johns Hopkins Univ, Dept Elect & Comp Engn, Baltimore, MD 21218 USA	Johns Hopkins University	Kaplan, AE (corresponding author), Johns Hopkins Univ, Dept Elect & Comp Engn, Baltimore, MD 21218 USA.		Kaplan, Alexander E/A-8132-2009	Kaplan, Alexander E/0000-0002-8094-5332				Greene Brian, 2003, ELEGANT UNIVERSE; Hentschel M, 2001, NATURE, V414, P509, DOI 10.1038/35107000; Kaplan AE, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.074801; Paul PM, 2001, SCIENCE, V292, P1689, DOI 10.1126/science.1059413; Zewail AH, 2001, NATURE, V412, P279, DOI 10.1038/35085661	5	4	4	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 7	2004	431	7009					633	633		10.1038/431633a	http://dx.doi.org/10.1038/431633a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	859WS	15470407	Bronze			2022-12-28	WOS:000224299300021
J	Tsai, CJ; Leitzmann, MF; Willett, WC; Giovannucci, EL				Tsai, CJ; Leitzmann, MF; Willett, WC; Giovannucci, EL			The effect of long-term intake of cis unsaturated fats on the risk for gallstone disease in men - A prospective cohort study	ANNALS OF INTERNAL MEDICINE			English	Article							DIETARY-FAT; CHOLESTEROL CHOLELITHIASIS; GALLBLADDER-DISEASE; INSULIN-RESISTANCE; LIPIDS; ACIDS; PREVALENCE; HAMSTERS; QUESTIONNAIRE; POPULATION	Background: Monounsaturated and polyunsaturated fats act as inhibitors of cholesterol cholelithiasis in animal experiments. Objective: To examine the association between long-term intake of cis unsaturated fats and the incidence of gallstone disease in humans. Design: Prospective population-based cohort study. Setting: The Health Professional Follow-up Study. Participants: 45 756 men, age 40 to 75 years in 1986, who were free of gallstone disease. Measurements: Consumption of cis unsaturated fats was assessed starting in 1986 as part of the 131-item semi-quantitative food-frequency questionnaires. Questionnaires were mailed to participants every 2 years. The main outcome measure was self-reported newly diagnosed symptomatic gallstone disease. Results: During 14 years of follow-up, 2323 new cases of gallstone disease were documented. After adjustment for age and other potential risk factors, the relative risk for gallstone disease among men in the highest quintile of dietary intake of cis unsaturated fats compared with men in the lowest quintile was 0.82 (95% Cl, 0.69 to 0.96; P for trend = 0.006). The relative risk among men in the highest quintile of polyunsaturated fat consumption compared with men in the lowest quintile was 0.84 (Cl, 0.73 to 0.96; P for trend = 0.01), and the relative risk among men in the highest quintile of monounsaturated fat consumption compared with men in the lowest quintile was 0.83 (Cl, 0.70 to 1.00; P for trend = 0.01). Limitations: Outcomes were restricted to men with cholecystectomy or diagnostically confirmed but unremoved symptomatic gallstones. Conclusions: A high intake of polyunsaturated and monounsaturated fats in the context of an energy-balanced diet is associated with a reduced risk for gallstone disease in men.	Harvard Univ, Sch Med, Channing Lab, Brigham & Womens Hosp, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health	Tsai, CJ (corresponding author), Univ Kentucky, Med Ctr, Div Digest Dis & Nutr, 800 Rose St,MN649, Lexington, KY 40536 USA.	hpcjt@channing.harvard.edu			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK046200] Funding Source: NIH RePORTER; NCI NIH HHS [CA55075] Funding Source: Medline; NIDDK NIH HHS [DK46200] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Ayyad N, 1996, LIPIDS, V31, P721, DOI 10.1007/BF02522888; CHAIT A, 1979, J CLIN INVEST, V64, P1309, DOI 10.1172/JCI109587; CLANDININ MT, 1993, ANN NY ACAD SCI, V683, P151, DOI 10.1111/j.1749-6632.1993.tb35701.x; COHEN BI, 1992, LIPIDS, V27, P526, DOI 10.1007/BF02536135; Cox D. R., 1984, ANAL SURVIVAL DATA; DIEHL AK, 1991, GASTROENTEROL CLIN N, V20, P1; Diehl AK, 2000, HEPATOLOGY, V31, P528, DOI 10.1002/hep.510310238; DIEHL AK, 1989, GASTROENTEROLOGY, V97, P1527, DOI 10.1016/0016-5085(89)90399-5; Dowling RH, 2000, ALIMENT PHARM THER, V14, P39, DOI 10.1046/j.1365-2036.2000.014s2039.x; Dubrac S, 2001, J HEPATOL, V35, P550, DOI 10.1016/S0168-8278(01)00180-5; Eritsland J, 2000, AM J CLIN NUTR, V71, p197S, DOI 10.1093/ajcn/71.1.197S; Everhart JE, 1999, GASTROENTEROLOGY, V117, P632, DOI 10.1016/S0016-5085(99)70456-7; Flanders W D, 1990, Epidemiology, V1, P239, DOI 10.1097/00001648-199005000-00010; GILAT T, 1985, AM J CLIN NUTR, V41, P336, DOI 10.1093/ajcn/41.2.336; HAY DW, 1990, HEPATOLOGY, V12, pS6; HAYES KC, 1992, ANNU REV NUTR, V12, P299, DOI 10.1146/annurev.nu.12.070192.001503; Hu FB, 1999, AM J EPIDEMIOL, V149, P531, DOI 10.1093/oxfordjournals.aje.a009849; Hu FB, 2003, AM J CLIN NUTR, V78, p544S, DOI 10.1093/ajcn/78.3.544S; JONNALAGADDA SS, 1995, LIPIDS, V30, P415, DOI 10.1007/BF02536299; JORGENSEN T, 1989, SCAND J GASTROENTERO, V24, P821, DOI 10.3109/00365528909089221; JORGENSEN T, 1989, HEPATOLOGY, V9, P856, DOI 10.1002/hep.1840090611; LINOS AD, 1989, HPB SURG, V18, P221; Lovejoy J C, 1999, Curr Atheroscler Rep, V1, P215, DOI 10.1007/s11883-999-0035-5; MENSINK RP, 1992, ARTERIOSCLER THROMB, V12, P911, DOI 10.1161/01.ATV.12.8.911; MIETTINEN M, 1976, ANN CLIN RES, V8, P111; Misciagna G, 1999, AM J CLIN NUTR, V69, P120; Moerman Clara J., 1994, Annals of Epidemiology, V4, P248, DOI 10.1016/1047-2797(94)90104-X; *NAT HOSP DISCH SU, 2000, ADV DAT VIT HLTH STA; NEPOKROEFF CM, 1974, ARCH BIOCHEM BIOPHYS, V160, P387, DOI 10.1016/0003-9861(74)90412-3; Oliver MF, 1997, AM J CLIN NUTR, V66, P980; Ortega RM, 1997, J AM COLL NUTR, V16, P88, DOI 10.1080/07315724.1997.10718655; PARILLO M, 1992, METABOLISM, V41, P1373, DOI 10.1016/0026-0495(92)90111-M; RIMM EB, 1992, AM J EPIDEMIOL, V135, P1114, DOI 10.1093/oxfordjournals.aje.a116211; Rivellese AA, 2002, ANN NY ACAD SCI, V967, P329; Rose DP, 1997, AM J CLIN NUTR, V66, P998; Rothman K., 1998, MODERN EPIDEMIOLOGY; SCOBEY MW, 1991, HEPATOLOGY, V14, P679, DOI 10.1002/hep.1840140417; SHIFFMAN ML, 1993, GASTROENTEROLOGY, V105, P1200, DOI 10.1016/0016-5085(93)90968-I; *USDA, 1998, AGR HDB USDA, V8; Willett W, 2001, AM J EPIDEMIOL, V154, P1107, DOI 10.1093/aje/154.12.1107; Willett W., 2012, NUTR EPIDEMIOLOGY	41	47	49	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 5	2004	141	7					514	522		10.7326/0003-4819-141-7-200410050-00007	http://dx.doi.org/10.7326/0003-4819-141-7-200410050-00007			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	862CR	15466768				2022-12-28	WOS:000224467800003
J	Barnosky, AD; Koch, PL; Feranec, RS; Wing, SL; Shabel, AB				Barnosky, AD; Koch, PL; Feranec, RS; Wing, SL; Shabel, AB			Assessing the causes of Late Pleistocene extinctions on the continents	SCIENCE			English	Review							HEMISPHERE ICE SHEETS; LATE QUATERNARY; MEGAFAUNAL EXTINCTIONS; IRISH ELK; MAMMALIAN EXTINCTIONS; WRANGEL-ISLAND; CLIMATE-CHANGE; OVERKILL; MAMMOTHS; RECORD	One of the great debates about extinction is whether humans or climatic change caused the demise of the Pleistocene megafauna. Evidence from paleontology, climatology, archaeology, and ecology now supports the idea that humans contributed to extinction on some continents, but human hunting was not solely responsible for the pattern of extinction everywhere. instead, evidence suggests that the intersection of human impacts with pronounced climatic change drove the precise timing and geography of extinction in the Northern Hemisphere. The story from the Southern Hemisphere is still unfolding. New evidence from Australia supports the view that humans helped cause extinctions there, but the correlation with climate is weak or contested. Firmer chronologies, more realistic ecological models, and regional paleoecological insights still are needed to understand details of the worldwide extinction pattern and the population dynamics of the species involved.	Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; Univ Calif Berkeley, Museum Paleontol, Berkeley, CA 94720 USA; Univ Calif Berkeley, Museum Vertebrate Zool, Berkeley, CA 94720 USA; Univ Calif Santa Cruz, Dept Earth Sci, Santa Cruz, CA 95064 USA; Smithsonian Inst, Natl Museum Nat Hist, Washington, DC 20560 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Santa Cruz; Smithsonian Institution; Smithsonian National Museum of Natural History	Barnosky, AD (corresponding author), Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA.	barnosky@socrates.berkeley.edu		Wing, Scott/0000-0002-2954-8905				Alberdi MT, 2001, J ARCHAEOL SCI, V28, P411, DOI 10.1006/jasc.2000.0647; Alroy J, 2001, SCIENCE, V292, P1893, DOI 10.1126/science.1059342; Alroy J, 2001, SCIENCE, V294, P1461; ALROY J, EXTINCTIONS NEAR TIM, P105; ANDERSON A, 1989, J ARCHAEOL SCI, V16, P137, DOI 10.1016/0305-4403(89)90062-9; ANDERSON DG, N AM PALEOINDIAN DAT; [Anonymous], 2004, BIODIVERSITY RESPONS; Bar-Yosef O, 2002, ANNU REV ANTHROPOL, V31, P363, DOI 10.1146/annurev.anthro.31.040402.085416; Bard E, 2004, SCIENCE, V303, P178, DOI 10.1126/science.1091964; Bard E, 1997, NATURE, V385, P707, DOI 10.1038/385707a0; Barnes I, 2002, SCIENCE, V295, P2267, DOI 10.1126/science.1067814; Barnosky A.D., 1989, P235; Barnosky AD, 2003, J MAMMAL, V84, P354, DOI 10.1644/1545-1542(2003)084<0354:MRTGWO>2.0.CO;2; Barnosky AD, 2004, P NATL ACAD SCI USA, V101, P9297, DOI 10.1073/pnas.0402592101; BARNOSKY AD, 1986, QUATERNARY RES, V25, P128, DOI 10.1016/0033-5894(86)90049-9; BARNOSKY AD, 1985, SCIENCE, V228, P340, DOI 10.1126/science.228.4697.340; Beck JW, 2001, SCIENCE, V292, P2453, DOI 10.1126/science.1056649; BELOVSKY GE, 1988, J ANTHROPOL ARCHAEOL, V7, P329, DOI 10.1016/0278-4165(88)90002-5; Brook BW, 2002, P NATL ACAD SCI USA, V99, P14624, DOI 10.1073/pnas.232126899; BUDYKO MI, 1967, SOV GEOGR, V8, P783, DOI 10.1080/00385417.1967.10770945; Burney DA, 2003, P NATL ACAD SCI USA, V100, P10800, DOI 10.1073/pnas.1534700100; Callicott JB, 2002, J BIOSCIENCES, V27, P409, DOI 10.1007/BF02704969; Choquenot D, 1998, GLOBAL ECOL BIOGEOGR, V7, P167, DOI 10.2307/2997372; DIAMOND JM, 1989, J ARCHAEOL SCI, V16, P167, DOI 10.1016/0305-4403(89)90064-2; Dillehay T., 2000, SETTLEMENT AM NEW PR; Dodson John, 1993, Archaeology in Oceania, V28, P94; FAUNMAP Working Group, 1994, ILLINOIS STATE MUSEU, V25, P1; Fiedel S, 2004, J ARCHAEOL SCI, V31, P121, DOI 10.1016/j.jas.2003.06.004; Field J, 2001, ANTIQUITY, V75, P696, DOI 10.1017/S0003598X00089195; Forster MA, 2003, OIKOS, V103, P235, DOI 10.1034/j.1600-0706.2003.12557.x; Gonzalez S, 2000, NATURE, V405, P753, DOI 10.1038/35015668; GRAHAM R, 2002, 67 ANN M SOC AM ARCH; Graham R.W., 1984, P223; Grayson DK, 2004, J ARCHAEOL SCI, V31, P133, DOI 10.1016/j.jas.2003.09.001; Grayson DK, 2002, J WORLD PREHIST, V16, P313, DOI 10.1023/A:1022912030020; Grayson DK, 2003, J ARCHAEOL SCI, V30, P585, DOI 10.1016/S0305-4403(02)00205-4; Grayson DK, 2001, J WORLD PREHIST, V15, P1, DOI 10.1023/A:1011165119141; Grayson DK, 2001, SCIENCE, V294, P1459; GRAYSON DK, 1991, J WORLD PREHIST, V5, P193, DOI 10.1007/BF00974990; GRAYSON DK, IN PRESS HDB N AM IN, V3; Guthrie R.D., 1984, P259; Guthrie RD, 2004, NATURE, V429, P746, DOI 10.1038/nature02612; Guthrie RD, 2003, NATURE, V426, P169, DOI 10.1038/nature02098; Guthrie RD, 1984, CARNEGIE MUS NAT HIS, V8, P482; Hadly EA, 2004, PLOS BIOL, V2, P1600, DOI 10.1371/journal.pbio.0020290; Hadly EA, 1998, P NATL ACAD SCI USA, V95, P6893, DOI 10.1073/pnas.95.12.6893; Hadly EA, 2003, J MAMMAL, V84, P403, DOI 10.1644/1545-1542(2003)084<0403:ADEOPP>2.0.CO;2; Haynes G., 2002, EARLY SETTLEMENT N A; Herbert TD, 2001, SCIENCE, V293, P71, DOI 10.1126/science.1059209; Holdaway RN, 2000, SCIENCE, V287, P2250, DOI 10.1126/science.287.5461.2250; Imbrie J, 1992, PALEOCEANOGRAPHY, V7, P701, DOI 10.1029/92PA02253; Jablonski NG, 2000, J HUM EVOL, V39, P131, DOI 10.1006/jhev.2000.0405; Johnson CN, 2002, P ROY SOC B-BIOL SCI, V269, P2221, DOI 10.1098/rspb.2002.2130; Koch PL, 1998, ANNU REV EARTH PL SC, V26, P573, DOI 10.1146/annurev.earth.26.1.573; Kohn MJ, 2002, REV MINERAL GEOCHEM, V48, P455, DOI 10.2138/rmg.2002.48.12; *KOV COMP SERV, MULT STAT PACK; Kuhn SL, 2001, BIOSOCIAL S, V13, P99; Kutzbach J, 1998, QUATERNARY SCI REV, V17, P473, DOI 10.1016/S0277-3791(98)00009-2; Lea DW, 2000, SCIENCE, V289, P1719, DOI 10.1126/science.289.5485.1719; LYNCH TF, 1990, AM ANTIQUITY, V55, P12, DOI 10.2307/281490; Lyons SK, 2004, EVOL ECOL RES, V6, P339; MacPhee R.D.E., 1999, EXTINCTIONS NEAR TIM; MacPhee RDE, 2002, J ARCHAEOL SCI, V29, P1017, DOI 10.1006/jasc.2001.0802; Martin PS, 1999, CONSERV BIOL, V13, P36, DOI 10.1046/j.1523-1739.1999.97417.x; MARTIN PS, 1978, QUATERNARY EXTINCTIO; MARTIN PS, 1967, PLEISTOCENE EXTINCTI, V6; Meltzer DJ, 1997, AM ANTIQUITY, V62, P659, DOI 10.2307/281884; Moriarty KC, 2000, PALAEOGEOGR PALAEOCL, V159, P113, DOI 10.1016/S0031-0182(00)00036-5; MOSIMANN JE, 1975, AM SCI, V63, P304; Nurnberg D, 2000, PALEOCEANOGRAPHY, V15, P124, DOI 10.1029/1999PA000370; OWENSMITH N, 1987, PALEOBIOLOGY, V13, P351; Pahnke K, 2003, SCIENCE, V301, P948, DOI 10.1126/science.1084451; Raymo ME, 1989, PALEOCEANOGRAPHY, V4, P413, DOI 10.1029/PA004i004p00413; Regan HM, 2001, AM NAT, V157, P1, DOI 10.1086/317005; Roberts RG, 2001, SCIENCE, V292, P1888, DOI 10.1126/science.1060264; Ruddiman WF, 1989, PALEOCEANOGRAPHY, V4, P353, DOI 10.1029/PA004i004p00353; Scheffer M, 2001, NATURE, V413, P591, DOI 10.1038/35098000; SCHNEIDER RR, 1995, PALEOCEANOGRAPHY, V10, P197, DOI 10.1029/94PA03308; Sole RV, 2001, P ROY SOC B-BIOL SCI, V268, P2039, DOI 10.1098/rspb.2001.1767; Stafford TW, 1999, GEOLOGY, V27, P903, DOI 10.1130/0091-7613(1999)027<0903:FAMSCD>2.3.CO;2; STUART AJ, 1991, BIOL REV, V66, P453, DOI 10.1111/j.1469-185X.1991.tb01149.x; Stuart AJ, 2002, QUATERNARY SCI REV, V21, P1559, DOI 10.1016/S0277-3791(02)00026-4; Stuart Anthony John, 1999, P257; Stuiver M, 1998, RADIOCARBON, V40, P1041, DOI 10.1017/S0033822200019123; Thieme H, 1997, NATURE, V385, P807, DOI 10.1038/385807a0; VARTANYAN SL, 1995, RADIOCARBON, V37, P1; VARTANYAN SL, 1993, NATURE, V362, P337, DOI 10.1038/362337a0; Whittington S.L., 1984, P451; Winterhalder B, 1997, CONSERV BIOL, V11, P1354, DOI 10.1046/j.1523-1739.1997.95184.x; Wroe S, 2004, ALCHERINGA, V28, P291, DOI 10.1080/03115510408619286	90	635	663	35	909	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 1	2004	306	5693					70	75		10.1126/science.1101476	http://dx.doi.org/10.1126/science.1101476			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	859YJ	15459379	Green Submitted			2022-12-28	WOS:000224304000036
J	Sibum, HO				Sibum, HO			Beyond the ivory tower - What kind of science is experimental physics?	SCIENCE			English	Article									Max Planck Inst Hist Sci, D-10117 Berlin, Germany	Max Planck Society	Sibum, HO (corresponding author), Max Planck Inst Hist Sci, Wilhelmstr 44, D-10117 Berlin, Germany.	sibum@mpiwg-bertin.mpg.de						AUERBACH F, 1923, ENTWICKLUNGSGESCHICH; AUERBACH F, 1925, METHODEN THEORETISCH; DEBELIDOR BF, 1764, ARCH HYD; DIETZGEN J, 1969, WESEN MENSCHLICHEN K; Einstein Albert, 1954, IDEAS OPINIONS, P270; HELMHOLTZ H, 1871, ZIELE FORTSCHRITTE N; Sibum Heinz Otto, 1995, CAMBRIDGE REV, P25; Sibum HO, 2003, SCI CONTEXT, V16, P89, DOI 10.1017/S0269889703000747; WISE MN, UNPUB BOURGEOIS BERL	9	8	8	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 1	2004	306	5693					60	61		10.1126/science.1093598	http://dx.doi.org/10.1126/science.1093598			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	859YJ	15459372				2022-12-28	WOS:000224304000029
J	Zhu, RX; Potts, R; Xie, F; Hoffman, KA; Deng, CL; Shi, CD; Pan, YX; Wang, HQ; Shi, RP; Wang, YC; Shi, GH; Wu, NQ				Zhu, RX; Potts, R; Xie, F; Hoffman, KA; Deng, CL; Shi, CD; Pan, YX; Wang, HQ; Shi, RP; Wang, YC; Shi, GH; Wu, NQ			New evidence on the earliest human presence at high northern latitudes in northeast Asia	NATURE			English	Article							INDONESIA; HOMINIDS; DMANISI; GEORGIA; CHINA; HOMO; JAVA; AGE	The timing of early human dispersal to Asia is a central issue in the study of human evolution. Excavations in predominantly lacustrine sediments at Majuangou, Nihewan basin, north China, uncovered four layers of indisputable hominin stone tools. Here we report magnetostratigraphic results that constrain the age of the four artefact layers to an interval of nearly 340,000 yr between the Olduvai subchron and the Cobb Mountain event. The lowest layer, about 1.66 million years old (Myr), provides the oldest record of stone-tool processing of animal tissues in east Asia. The highest layer, at about 1.32 Myr, correlates with the stone tool layer at Xiaochangliang(1), previously considered the oldest archaeological site in this region. The findings at Majuangou indicate that the oldest known human presence in northeast Asia at 40degreesN is only slightly younger than that in western Asia(2,3). This result implies that a long yet rapid migration from Africa, possibly initiated during a phase of warm climate, enabled early human populations to inhabit northern latitudes of east Asia over a prolonged period.	Chinese Acad Sci, Inst Geol & Geophys, Paleomagnetism Lab, Beijing 100029, Peoples R China; Natl Museum Nat Hist, Human Origins Program, Washington, DC 20560 USA; Hebei Prov Inst Cultural Rel, Shijiazhuang 050000, Peoples R China; Calif Polytech State Univ San Luis Obispo, Dept Phys, San Luis Obispo, CA 93410 USA	Chinese Academy of Sciences; Institute of Geology & Geophysics, CAS; Smithsonian Institution; Smithsonian National Museum of Natural History; California State University System; California Polytechnic State University San Luis Obispo	Zhu, RX (corresponding author), Chinese Acad Sci, Inst Geol & Geophys, Paleomagnetism Lab, Beijing 100029, Peoples R China.	rxzhucn@yahoo.com; potts.rick@nmnh.si.edu	Pan, Yongxin/B-4302-2008; Deng, Chenglong/B-8881-2009; Zhu, Rixiang/F-2126-2018; Deng, Chenglong/B-8871-2009	Pan, Yongxin/0000-0002-4227-3061; Zhu, Rixiang/0000-0002-4985-925X; Deng, Chenglong/0000-0003-1848-3170				AN ZH, 1989, QUATERNARY RES, V32, P213, DOI 10.1016/0033-5894(89)90077-X; Berggren W. A., 1995, GEOCHRONOLOGY TIME S, P129, DOI DOI 10.2110/PEC.95.04.0129; Clark PU, 1999, SCIENCE, V286, P1104, DOI 10.1126/science.286.5442.1104; de Heinzelin J, 1999, SCIENCE, V284, P625; Gabunia L, 2000, SCIENCE, V288, P1019, DOI 10.1126/science.288.5468.1019; HPICR, 1998, PAP ARCH HEB PROV, P30; HUANG WP, 1991, WUSHAN HOMINID SITE, P105; Larick R, 2001, P NATL ACAD SCI USA, V98, P4866, DOI 10.1073/pnas.081077298; Li H.M., 1982, QUATERNARY GEOLOGY E, P33; Potts R, 1999, J HUM EVOL, V37, P747, DOI 10.1006/jhev.1999.0344; Potts R., 1988, EARLY HOMINID ACTIVI; POTTS R, 2001, HUMAN ROOTS AFRICA A, P5; Qiu Z.X., 2000, QUATERNARY SCI, V20, P142; Semaw S, 1997, NATURE, V385, P333, DOI 10.1038/385333a0; Singer BS, 1999, J GEOPHYS RES-SOL EA, V104, P679, DOI 10.1029/1998JB900016; SWISHER CC, 1994, SCIENCE, V263, P1118, DOI 10.1126/science.8108729; Tang Yingjun, 1995, Vertebrata Palasiatica, V33, P74; Tian J, 2002, EARTH PLANET SC LETT, V203, P1015, DOI 10.1016/S0012-821X(02)00923-8; Vekua A, 2002, SCIENCE, V297, P85, DOI 10.1126/science.1072953; Wei Q., 1994, ACTA ANTHR SIN, V13, P223; Wei Q., 1997, EVIDENCE EVOLUTION E, P193; Zhu RX, 2003, EARTH-SCI REV, V61, P341, DOI 10.1016/S0012-8252(02)00132-0; Zhu RX, 2001, NATURE, V413, P413, DOI 10.1038/35096551	23	235	307	4	76	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 30	2004	431	7008					559	562		10.1038/nature02829	http://dx.doi.org/10.1038/nature02829			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	857YP	15457258				2022-12-28	WOS:000224156700044
J	Lee, JJ; Dimina, D; Macias, MP; Ochkur, SI; McGarry, MP; O'Neill, KR; Protheroe, C; Pero, R; Nguyen, T; Cormier, SA; Lenkiewicz, E; Colbert, D; Rinaldi, L; Ackerman, SJ; Irvin, CG; Lee, NA				Lee, JJ; Dimina, D; Macias, MP; Ochkur, SI; McGarry, MP; O'Neill, KR; Protheroe, C; Pero, R; Nguyen, T; Cormier, SA; Lenkiewicz, E; Colbert, D; Rinaldi, L; Ackerman, SJ; Irvin, CG; Lee, NA			Defining a link with asthma in mice congenitally deficient in eosinophils	SCIENCE			English	Article							AIRWAYS HYPERREACTIVITY; TRANSGENIC MICE; MOUSE; GENE; EXPRESSION; CLONING; IL-5; HYPERRESPONSIVENESS; IDENTIFICATION; INFLAMMATION	Eosinophils are often dominant inflammatory cells present in the lungs of asthma patients. Nonetheless, the role of these leukocytes remains poorly understood. We have created a transgenic line of mice (PHIL) that are specifically devoid of eosinophils, but otherwise have a full complement of hematopoietically derived cells. Allergen challenge of PHIL mice demonstrated that eosinophils were required for pulmonary mucus accumulation and the airway hyperresponsiveness associated with asthma. The development of an eosinophil-less mouse now permits an unambiguous assessment of a number of human diseases that have been linked to this granulocyte, including allergic diseases, parasite infections, and tumorigenesis.	Mayo Clin Arizona, Div Pulm Med, Scottsdale, AZ 85259 USA; Mayo Clin Arizona, Dept Biochem & Mol Biol, Scottsdale, AZ 85259 USA; Mayo Clin Arizona, Div Hematol Oncol, Scottsdale, AZ 85259 USA; Univ Vermont, Dept Med, Vermont Lung Ctr, Burlington, VT 05405 USA; Univ Illinois, Coll Med, Dept Biochem & Mol Biol, Chicago, IL 60612 USA	Mayo Clinic; Mayo Clinic Phoenix; Mayo Clinic; Mayo Clinic Phoenix; Mayo Clinic; Mayo Clinic Phoenix; University of Vermont; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Lee, JJ (corresponding author), Mayo Clin Arizona, Div Pulm Med, Scottsdale, AZ 85259 USA.	jjlee@mayo.edu; nlee@mayo.edu	Cormier, Stephania A/I-7382-2017	Cormier, Stephania A/0000-0002-6050-6172	NATIONAL CENTER FOR RESEARCH RESOURCES [P40RR001555] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F32HL010105, P01HL067004, R01HL067273, R56HL058723, R01HL065228, R01HL058723] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI033043, R01AI025230] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [F32AR008545] Funding Source: NIH RePORTER; NCRR NIH HHS [NCRR-COBRE P20RR1555] Funding Source: Medline; NHLBI NIH HHS [HL065228, HL10105, HLEB67273, P01-HL67004, HL058723] Funding Source: Medline; NIAID NIH HHS [AI025230, AI033043] Funding Source: Medline; NIAMS NIH HHS [F32 AR008545-02, AR08545, F32 AR008545, F32 AR008545-01, F32 AR008545-03] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		BOUSQUET J, 1990, NEW ENGL J MED, V323, P1033, DOI 10.1056/NEJM199010113231505; Busse WW, 2001, NEW ENGL J MED, V344, P350, DOI 10.1056/NEJM200102013440507; BUSSE WW, 1993, AM REV RESPIR DIS, V147, P20; Cho JY, 2004, J CLIN INVEST, V113, P551, DOI 10.1172/JCI200419133; Collier RJ, 2001, TOXICON, V39, P1793, DOI 10.1016/S0041-0101(01)00165-9; Cormier SA, 2001, MAMM GENOME, V12, P352, DOI 10.1007/s003350020007; Denzler KL, 2000, J IMMUNOL, V165, P5509, DOI 10.4049/jimmunol.165.10.5509; Denzler KL, 2001, J IMMUNOL, V167, P1672, DOI 10.4049/jimmunol.167.3.1672; Flood-Page P, 2003, J CLIN INVEST, V112, P1029, DOI 10.1172/JCI200317974; Henderson WR, 1997, J CLIN INVEST, V100, P3083, DOI 10.1172/JCI119863; Hogan SP, 1998, J IMMUNOL, V161, P1501; Horton MA, 1996, J LEUKOCYTE BIOL, V60, P285, DOI 10.1002/jlb.60.2.285; Huber HL, 1922, ARCH INTERN MED, V30, P689, DOI 10.1001/archinte.1922.00110120002001; Irvin CG, 1997, AM J PHYSIOL-LUNG C, V272, pL1053, DOI 10.1152/ajplung.1997.272.6.L1053; Justice JP, 2002, AM J PHYSIOL-LUNG C, V282, pL302, DOI 10.1152/ajplung.00158.2001; Justice JP, 2003, AM J PHYSIOL-LUNG C, V284, pL169, DOI 10.1152/ajplung.00260.2002; LARSON KA, 1995, J IMMUNOL, V155, P3002; Larson KA, 1996, P NATL ACAD SCI USA, V93, P12370, DOI 10.1073/pnas.93.22.12370; Leckie MJ, 2000, LANCET, V356, P2144, DOI 10.1016/S0140-6736(00)03496-6; Lee JJ, 1997, J EXP MED, V185, P2143, DOI 10.1084/jem.185.12.2143; Macias MP, 2000, J LEUKOCYTE BIOL, V67, P567, DOI 10.1002/jlb.67.4.567; Mattes J, 2002, J EXP MED, V195, P1433, DOI 10.1084/jem.20020009; O'Byrne P, 1998, J ALLERGY CLIN IMMUN, V102, pS85, DOI 10.1016/S0091-6749(98)70036-3; OCHKUR SI, UNPUB; PALMITER RD, 1987, CELL, V50, P435, DOI 10.1016/0092-8674(87)90497-1; PAUL CC, 1994, J LEUKOCYTE BIOL, V56, P74, DOI 10.1002/jlb.56.1.74; Shen HHH, 2003, J IMMUNOL, V170, P3296, DOI 10.4049/jimmunol.170.6.3296; Shi HZ, 2000, J CLIN INVEST, V105, P945, DOI 10.1172/JCI8945	28	560	583	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 17	2004	305	5691					1773	1776		10.1126/science.1099472	http://dx.doi.org/10.1126/science.1099472			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	856IS	15375267	Green Submitted			2022-12-28	WOS:000224039500041
J	Sorensen, EJ; Sammis, GM				Sorensen, EJ; Sammis, GM			A dash of proline makes things sweet	SCIENCE			English	Editorial Material							ALDOL REACTIONS; MECHANISM; ENZYME		Princeton Univ, Dept Chem, Princeton, NJ 08544 USA	Princeton University	Sorensen, EJ (corresponding author), Princeton Univ, Dept Chem, Princeton, NJ 08544 USA.	ejs@princeton.edu						EDER U, 1971, ANGEW CHEM INT EDIT, V10, P496, DOI 10.1002/anie.197104961; HAJOS ZG, 1974, J ORG CHEM, V39, P1615, DOI 10.1021/jo00925a003; Heine A, 2001, SCIENCE, V294, P369, DOI 10.1126/science.1063601; Lin CH, 1997, P NATL ACAD SCI USA, V94, P11773, DOI 10.1073/pnas.94.22.11773; List B, 2002, TETRAHEDRON, V58, P5573, DOI 10.1016/S0040-4020(02)00516-1; List B, 2000, J AM CHEM SOC, V122, P2395, DOI 10.1021/ja994280y; Movassaghi M, 2002, SCIENCE, V298, P1904, DOI 10.1126/science.1076547; MUKAIYAMA T, 1974, J AM CHEM SOC, V96, P7503, DOI 10.1021/ja00831a019; Northrup AB, 2004, SCIENCE, V305, P1752, DOI 10.1126/science.1101710; Northrup AB, 2004, ANGEW CHEM INT EDIT, V43, P2152, DOI 10.1002/anie.200453716; STORK G, 1954, J AM CHEM SOC, V76, P2029, DOI 10.1021/ja01636a103; Wang P. G., 2001, GLYCOCHEMISTRY PRINC	12	20	20	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 17	2004	305	5691					1725	1726		10.1126/science.1103026	http://dx.doi.org/10.1126/science.1103026			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	856IS	15375255				2022-12-28	WOS:000224039500026
J	Stelling, J; Sauer, U; Szallasi, Z; Doyle, FJ; Doyle, J				Stelling, J; Sauer, U; Szallasi, Z; Doyle, FJ; Doyle, J			Robustness of cellular functions	CELL			English	Review							HIGHLY OPTIMIZED TOLERANCE; NETWORK MOTIFS; GENETIC NETWORKS; HIGH-THROUGHPUT; ORGANIZATION; EVOLUTION; FEEDBACK; COMPLEX; EXPRESSION; METABOLISM	Robustness, the ability to maintain performance in the face of perturbations and uncertainty, is a long-recognized key property of living systems. Owing to intimate links to cellular complexity, however, its molecular and cellular basis has only recently begun to be understood. Theoretical approaches to complex engineered systems can provide guidelines for investigating cellular robustness because biology and engineering employ a common set of basic mechanisms in different combinations. Robustness may be a key to understanding cellular complexity, elucidating design principles, and fostering closer interactions between experimentation and theory.	Max Planck Inst Dynam Complex Tech Syst, D-39106 Magdeburg, Germany; Swiss Fed Inst Technol, Inst Biotechnol, CH-8093 Zurich, Switzerland; Harvard Univ, Sch Med, Childrens Hosp, Informat Program, Boston, MA 02115 USA; Univ Calif Santa Barbara, Dept Chem Engn, Santa Barbara, CA 93106 USA; Univ Calif Santa Barbara, Inst Collaborat Biotechnol, Santa Barbara, CA 93106 USA; CALTECH, Control & Dynam Syst, Pasadena, CA 91125 USA	Max Planck Society; Swiss Federal Institutes of Technology Domain; ETH Zurich; Harvard University; Boston Children's Hospital; Harvard Medical School; University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; California Institute of Technology	Stelling, J (corresponding author), Max Planck Inst Dynam Complex Tech Syst, D-39106 Magdeburg, Germany.	stelling@mpi-magdeburg.mpg.de	Sauer, Uwe/Y-3556-2019; Stelling, Joerg/F-7499-2010	Stelling, Joerg/0000-0002-1145-891X; Szallasi, Zoltan/0000-0001-5395-7509	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065507] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM65507-01] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; Albert R, 2003, J THEOR BIOL, V223, P1, DOI 10.1016/S0022-5193(03)00035-3; Allada R, 2003, CELL, V112, P284, DOI 10.1016/S0092-8674(03)00076-X; Almogy G, 2001, BIOPHYS J, V81, P3016, DOI 10.1016/S0006-3495(01)75942-5; Alon U, 1999, NATURE, V397, P168, DOI 10.1038/16483; Angeli D, 2004, P NATL ACAD SCI USA, V101, P1822, DOI 10.1073/pnas.0308265100; Bailey JE, 1999, NAT BIOTECHNOL, V17, P616, DOI 10.1038/10794; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Barkai N, 1997, NATURE, V387, P913, DOI 10.1038/43199; Becskei A, 2000, NATURE, V405, P590, DOI 10.1038/35014651; Becskei A, 2001, EMBO J, V20, P2528, DOI 10.1093/emboj/20.10.2528; Blake WJ, 2003, NATURE, V422, P633, DOI 10.1038/nature01546; Borisuk MT, 1998, J THEOR BIOL, V195, P69, DOI 10.1006/jtbi.1998.0781; Bornholdt S, 2001, BIOL CHEM, V382, P1289, DOI 10.1515/BC.2001.161; Carlson JM, 1999, PHYS REV E, V60, P1412, DOI 10.1103/PhysRevE.60.1412; Carlson JM, 2000, PHYS REV LETT, V84, P2529, DOI 10.1103/PhysRevLett.84.2529; Christopher R, 2004, ANN NY ACAD SCI, V1020, P132, DOI 10.1196/annals.1310.014; Cluzel P, 2000, SCIENCE, V287, P1652, DOI 10.1126/science.287.5458.1652; Cooper TF, 2003, P NATL ACAD SCI USA, V100, P1072, DOI 10.1073/pnas.0334340100; COVE TM, 1991, ELEMENTS INFORMATION; Covert MW, 2004, NATURE, V429, P92, DOI 10.1038/nature02456; Csete M, 2004, TRENDS BIOTECHNOL, V22, P446, DOI 10.1016/j.tibtech.2004.07.007; Cyran SA, 2003, CELL, V112, P329, DOI 10.1016/S0092-8674(03)00074-6; de Visser JAGM, 2003, EVOLUTION, V57, P1959, DOI 10.1554/02-750R; DINARDO S, 1994, CURR OPIN GENET DEV, V4, P529, DOI 10.1016/0959-437X(94)90068-E; Edelman GM, 2001, P NATL ACAD SCI USA, V98, P13763, DOI 10.1073/pnas.231499798; Eldar A, 2003, DEV CELL, V5, P635, DOI 10.1016/S1534-5807(03)00292-2; Eldar A, 2002, NATURE, V419, P304, DOI 10.1038/nature01061; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; Emmerling M, 2002, J BACTERIOL, V184, P152, DOI 10.1128/JB.184.1.152-164.2002; Endy D, 2001, NATURE, V409, P391, DOI 10.1038/35053181; Fischer E, 2003, EUR J BIOCHEM, V270, P880, DOI 10.1046/j.1432-1033.2003.03448.x; Fraser HB, 2004, PLOS BIOL, V2, P834, DOI 10.1371/journal.pbio.0020137; Freeman M, 2000, NATURE, V408, P313, DOI 10.1038/35042500; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Gerdes SY, 2003, J BACTERIOL, V185, P5673, DOI 10.1128/JB.185.19.5673-5684.2003; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Gu X, 2003, TRENDS GENET, V19, P354, DOI 10.1016/S0168-9525(03)00139-2; Guimera R, 2001, PHYSICA A, V299, P247, DOI 10.1016/S0378-4371(01)00302-8; Hahn MW, 2004, J MOL EVOL, V58, P203, DOI 10.1007/s00239-003-2544-0; Han JDJ, 2004, NATURE, V430, P88, DOI 10.1038/nature02555; Hartman JL, 2001, SCIENCE, V291, P1001, DOI 10.1126/science.291.5506.1001; Hartwell LH, 1999, NATURE, V402, pC47, DOI 10.1038/35011540; Hasty J, 2002, NATURE, V420, P224, DOI 10.1038/nature01257; HAZELBAUER GL, 1993, CELL, V73, P15, DOI 10.1016/0092-8674(93)90156-K; Holstege FCP, 1998, CELL, V95, P717, DOI 10.1016/S0092-8674(00)81641-4; Huang CYF, 1996, P NATL ACAD SCI USA, V93, P10078, DOI 10.1073/pnas.93.19.10078; Ihmels J, 2004, NAT BIOTECHNOL, V22, P86, DOI 10.1038/nbt918; IHMELS S, 2004, NAT GENET, V31, P370; Ingolia NT, 2004, PLOS BIOL, V2, P805, DOI 10.1371/journal.pbio.0020123; Jeong H, 2000, NATURE, V407, P651, DOI 10.1038/35036627; Kacser H, 1973, Symp Soc Exp Biol, V27, P65; KANAL AR, 2004, DIABETES TECHNOL THE, V6, P39; KIANO H, 2004, NAT REV CANCER, V4, P227; Kirschner M, 1998, P NATL ACAD SCI USA, V95, P8420, DOI 10.1073/pnas.95.15.8420; Kitano H, 2002, SCIENCE, V295, P1662, DOI 10.1126/science.1069492; Korobkova E, 2004, NATURE, V428, P574, DOI 10.1038/nature02404; Krakauer DC, 2002, P NATL ACAD SCI USA, V99, P1405, DOI 10.1073/pnas.032668599; Lai K, 2004, BIOPHYS J, V86, P2748, DOI 10.1016/S0006-3495(04)74328-3; Laub MT, 2000, SCIENCE, V290, P2144, DOI 10.1126/science.290.5499.2144; Lauffenburger DA, 2000, P NATL ACAD SCI USA, V97, P5031, DOI 10.1073/pnas.97.10.5031; Lee E, 2003, PLOS BIOL, V1, P116, DOI 10.1371/journal.pbio.0000010; Lee TI, 2002, SCIENCE, V298, P799, DOI 10.1126/science.1075090; Leloup JC, 1998, J BIOL RHYTHM, V13, P70, DOI 10.1177/074873098128999934; Ma L, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-38; May RM, 2004, SCIENCE, V303, P790, DOI 10.1126/science.1094442; McAdams HH, 1997, P NATL ACAD SCI USA, V94, P814, DOI 10.1073/pnas.94.3.814; Meir E, 2002, CURR BIOL, V12, P778, DOI 10.1016/S0960-9822(02)00839-4; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Morohashi M, 2002, J THEOR BIOL, V216, P19, DOI 10.1006/jtbi.2002.2537; Nurse P, 2003, NATURE, V424, P883, DOI 10.1038/424883a; Ozcan S, 1999, MICROBIOL MOL BIOL R, V63, P554; Papin JA, 2004, TRENDS BIOTECHNOL, V22, P400, DOI 10.1016/j.tibtech.2004.06.010; Papp B, 2004, NATURE, V429, P661, DOI 10.1038/nature02636; Paulsson J, 2000, P NATL ACAD SCI USA, V97, P7148, DOI 10.1073/pnas.110057697; Pomerening JR, 2003, NAT CELL BIOL, V5, P346, DOI 10.1038/ncb954; Ptashne M, 1997, NATURE, V386, P569, DOI 10.1038/386569a0; Rao CV, 2004, PLOS BIOL, V2, P239, DOI 10.1371/journal.pbio.0020049; Raser JM, 2004, SCIENCE, V304, P1811, DOI 10.1126/science.1098641; Ravasz E, 2002, SCIENCE, V297, P1551, DOI 10.1126/science.1073374; Rives AW, 2003, P NATL ACAD SCI USA, V100, P1128, DOI 10.1073/pnas.0237338100; Sauer U, 2004, CURR OPIN BIOTECH, V15, P58, DOI 10.1016/j.copbio.2003.11.001; Sauer U, 2004, J BIOL CHEM, V279, P6613, DOI 10.1074/jbc.M311657200; SAVAGEAU MA, 1974, NATURE, V252, P546, DOI 10.1038/252546a0; SAVAGEAU MA, 1971, NATURE, V229, P542, DOI 10.1038/229542a0; Schoeberl B, 2002, NAT BIOTECHNOL, V20, P370, DOI 10.1038/nbt0402-370; Segal E, 2003, NAT GENET, V34, P166, DOI 10.1038/ng1165; Sha W, 2003, P NATL ACAD SCI USA, V100, P975, DOI 10.1073/pnas.0235349100; Shen-Orr SS, 2002, NAT GENET, V31, P64, DOI 10.1038/ng881; Sourjik V, 2004, NATURE, V428, P437, DOI 10.1038/nature02406; Stelling J, 2002, NATURE, V420, P190, DOI 10.1038/nature01166; Stelling J, 2004, P NATL ACAD SCI USA, V101, P13210, DOI 10.1073/pnas.0401463101; Tanay A, 2004, P NATL ACAD SCI USA, V101, P2981, DOI 10.1073/pnas.0308661100; Thattai M, 2001, P NATL ACAD SCI USA, V98, P8614, DOI 10.1073/pnas.151588598; von Dassow G, 2000, NATURE, V406, P188, DOI 10.1038/35018085; Waddington CH, 1942, NATURE, V150, P563, DOI 10.1038/150563a0; Warner JB, 2003, MICROBIOL MOL BIOL R, V67, P475, DOI 10.1128/MMBR.67.4.475-490.2003; Yeger-Lotem E, 2004, P NATL ACAD SCI USA, V101, P5934, DOI 10.1073/pnas.0306752101; Yi TM, 2000, P NATL ACAD SCI USA, V97, P4649, DOI 10.1073/pnas.97.9.4649; Zhou K., 1995, ROBUST OPTIMAL CONTR	104	746	763	2	96	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 17	2004	118	6					675	685		10.1016/j.cell.2004.09.008	http://dx.doi.org/10.1016/j.cell.2004.09.008			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	855RW	15369668	Bronze			2022-12-28	WOS:000223992400005
J	Yurimoto, H; Kuramoto, K				Yurimoto, H; Kuramoto, K			Molecular cloud origin for the oxygen isotope heterogeneity in the solar system	SCIENCE			English	Article							ROTATIONAL-EXCITATION; INTERSTELLAR CLOUDS; CARBON-MONOXIDE; CHEMISTRY; CO; PHOTODISSOCIATION; METEORITES; EXTINCTION; NEBULA; GRAIN	Meteorites and their components have anomalous oxygen isotopic compositions characterized by large variations in O-18/O-16 and O-17/O-16 ratios. On the basis of recent observations of star-forming regions and models of accreting protoplanetary disks, we suggest that these variations may originate in a parent molecular cloud by ultraviolet photodissociation processes. Materials with anomalous isotopic compositions were then transported into the solar nebula by icy dust grains during the collapse of the cloud. The icy dust grains drifted toward the Sun in the disk, and their subsequent evaporation resulted in the O-17- and O-18-enrichment of the inner disk gas.	Tokyo Inst Technol, Dept Earth & Planetary Sci, Meguro Ku, Tokyo 1528551, Japan; Hokkaido Univ, Div Earth & Planetary Sci, Sapporo, Hokkaido 0600810, Japan	Tokyo Institute of Technology; Hokkaido University	Yurimoto, H (corresponding author), Tokyo Inst Technol, Dept Earth & Planetary Sci, Meguro Ku, Tokyo 1528551, Japan.	yuri@geo.titech.ac.jp	Yurimoto, Hisayoshi/S-9938-2018	Yurimoto, Hisayoshi/0000-0003-0702-0533; Kuramoto, Kiyoshi/0000-0002-6757-8064				Ando M, 2002, ASTROPHYS J, V574, P187, DOI 10.1086/340922; BALLY J, 1982, ASTROPHYS J, V255, P143, DOI 10.1086/159812; Beckwith S. V. W., 2000, Protostars and planets 4, P533; Bergin EA, 2000, ASTROPHYS J, V539, pL129, DOI 10.1086/312843; Calvet N., 2000, Protostars and planets 4, P377; Choi BG, 1998, NATURE, V392, P577, DOI 10.1038/33356; CHU YH, 1983, ASTROPHYS J, V267, P151, DOI 10.1086/160852; CLAYTON RN, 1993, ANNU REV EARTH PL SC, V21, P115, DOI 10.1146/annurev.earth.21.1.115; Clayton RN, 2002, NATURE, V415, P860, DOI 10.1038/415860b; CLAYTON RN, 1988, PHILOS T R SOC A, V325, P483, DOI 10.1098/rsta.1988.0062; Connolly HC, 1998, SCIENCE, V280, P62, DOI 10.1126/science.280.5360.62; CUZZI JN, IN PRESS ASTROPHYS J; GLASSGOLD AE, 1985, ASTROPHYS J, V290, P615, DOI 10.1086/163019; Greenberg JM, 1998, ASTRON ASTROPHYS, V330, P375; Hayashi C., 1985, PROTOSTARS PLANETS, VII, P1100; KITAMURA Y, 1983, MOON PLANETS, V29, P199, DOI 10.1007/BF00928327; Kobayashi S, 2003, GEOCHEM J, V37, P663, DOI 10.2343/geochemj.37.663; Kurtz S., 2000, Protostars and planets 4, P299; LADA CJ, 1994, ASTROPHYS J, V429, P694, DOI 10.1086/174354; LANGER WD, 2000, PROTOSTARS PLANETS, V4, P29; LYONS JR, 2004, LUNAR PLANET SCI, V35, P1970; Marechal P, 1997, ASTRON ASTROPHYS, V324, P221; Marechal P, 1997, ASTRON ASTROPHYS, V328, P617; Nittler LR, 1998, NATURE, V393, P222, DOI 10.1038/30377; Ruffle DP, 2001, MON NOT R ASTRON SOC, V324, P1054, DOI 10.1046/j.1365-8711.2001.04394.x; Sheffer Y, 2002, ASTROPHYS J, V574, pL171, DOI 10.1086/342501; STEVENSON DJ, 1988, ICARUS, V75, P146, DOI 10.1016/0019-1035(88)90133-9; THIEMENS MH, 1983, SCIENCE, V219, P1073, DOI 10.1126/science.219.4588.1073; Thiemens MH, 1999, SCIENCE, V283, P341, DOI 10.1126/science.283.5400.341; van Dishoeck E. F., 1993, PROTOSTARS PLANETS, P163; VANDISHOECK EF, 1988, ASTROPHYS J, V334, P771, DOI 10.1086/166877; Warin S, 1996, ASTRON ASTROPHYS, V308, P535; Weidenschilling S.J., 1993, PROTOSTARS PLANETS, P1031; Whittet DCB, 2001, ASTROPHYS J, V547, P872, DOI 10.1086/318421; Yurimoto H, 2002, METEORIT PLANET SCI, V37, pA153	35	321	322	0	43	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 17	2004	305	5691					1763	1766		10.1126/science.1100989	http://dx.doi.org/10.1126/science.1100989			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	856IS	15375265				2022-12-28	WOS:000224039500038
J	Campo, R				Campo, R			Doctors and patients - Just the facts	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Campo, R (corresponding author), Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA.							Williams William Carlos, 1967, AUTOBIOGRAPHY WC WIL	1	0	0	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 16	2004	351	12					1167	1169		10.1056/NEJMp048105	http://dx.doi.org/10.1056/NEJMp048105			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	853WS	15371572				2022-12-28	WOS:000223861300003
J	Ludmerer, KM				Ludmerer, KM			Becoming a physician - Learning-centered medical education	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Washington Univ, Sch Med, Dept Med, St Louis, MO 63130 USA	Washington University (WUSTL)	Ludmerer, KM (corresponding author), Washington Univ, Sch Med, Dept Med, St Louis, MO 63130 USA.							CHRISTAKIS NA, 1995, JAMA-J AM MED ASSOC, V274, P706, DOI 10.1001/jama.274.9.706; Ludmerer K., 1999, TIME HEAL AM MED ED; Ludmerer Kenneth M., 1985, LEARNING HEAL DEV AM	3	49	50	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 16	2004	351	12					1163	1164		10.1056/NEJMp048112	http://dx.doi.org/10.1056/NEJMp048112			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	853WS	15371570				2022-12-28	WOS:000223861300001
J	Xiao, T; Takagi, J; Coller, BS; Wang, JH; Springer, TA				Xiao, T; Takagi, J; Coller, BS; Wang, JH; Springer, TA			Structural basis for allostery in integrins and binding to fibrinogen-mimetic therapeutics	NATURE			English	Article							GLYCOPROTEIN-IIB-IIIA; INSIDE-OUT ACTIVATION; LIGAND-BINDING; CRYSTAL-STRUCTURE; A-DOMAIN; EXTRACELLULAR SEGMENT; SIGNAL-TRANSDUCTION; BETA(3) SUBUNIT; HYBRID DOMAIN; GPIIB-IIIA	Integrins are important adhesion receptors in all Metazoa that transmit conformational change bidirectionally across the membrane. Integrin alpha and beta subunits form a head and two long legs in the ectodomain and span the membrane. Here, we define with crystal structures the atomic basis for allosteric regulation of the conformation and affinity for ligand of the integrin ectodomain, and how fibrinogen- mimetic therapeutics bind to platelet integrin alpha(IIb)beta(3). Allostery in the beta(3)I domain alters three metal binding sites, associated loops and alpha1- and alpha7-helices. Piston-like displacement of the alpha7-helix causes a 62degrees reorientation between the beta(3)I and hybrid domains. Transmission through the rigidly connected plexin/semaphorin/integrin ( PSI) domain in the upper beta(3) leg causes a 70 Angstrom separation between the knees of the alpha and beta legs. Allostery in the head thus disrupts interaction between the legs in a previously described low-affinity bent integrin conformation, and leg extension positions the high-affinity head far above the cell surface.	Harvard Univ, Sch Med, CBR Inst Biomed Res, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; Rockefeller Univ, Lab Blood & Vasc Biol, New York, NY 10021 USA; Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Harvard Medical School; Rockefeller University; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Springer, TA (corresponding author), Harvard Univ, Sch Med, CBR Inst Biomed Res, 200 Longwood Ave, Boston, MA 02115 USA.	springer@cbr.med.harvard.edu	Xiao, Tsan Sam/A-8590-2010; Xiao, Tsan/I-7616-2013	Xiao, Tsan Sam/0000-0001-9688-475X; Xiao, Tsan/0000-0001-9688-475X	NHLBI NIH HHS [P01 HL048675] Funding Source: Medline	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Adair BD, 2002, P NATL ACAD SCI USA, V99, P14059, DOI 10.1073/pnas.212498199; ARTONI A, 2004, IN PRESS P NATL ACAD; Beglova N, 2002, NAT STRUCT BIOL, V9, P282, DOI 10.1038/nsb779; Bork P, 1999, TRENDS BIOCHEM SCI, V24, P261, DOI 10.1016/S0968-0004(99)01416-4; CALVETE JJ, 1991, BIOCHEM J, V274, P63, DOI 10.1042/bj2740063; Carson M, 1997, METHOD ENZYMOL, V277, P493, DOI 10.1016/S0076-6879(97)77027-7; Chen JF, 2003, NAT STRUCT BIOL, V10, P995, DOI 10.1038/nsb1011; CHEN JF, IN PRESS J BIOL CHEM; Coller BS, 1997, J CLIN INVEST, V99, P1467, DOI 10.1172/JCI119307; COLLER BS, 1983, J CLIN INVEST, V72, P325, DOI 10.1172/JCI110973; DU XP, 1991, CELL, V65, P409, DOI 10.1016/0092-8674(91)90458-B; Egbertson MS, 1999, J MED CHEM, V42, P2409, DOI 10.1021/jm980722p; Esnouf RM, 1997, J MOL GRAPH MODEL, V15, P132, DOI 10.1016/S1093-3263(97)00021-1; Gottschalk KE, 2002, ANGEW CHEM INT EDIT, V41, P3767, DOI 10.1002/1521-3773(20021018)41:20<3767::AID-ANIE3767>3.0.CO;2-T; Hughes PE, 1998, TRENDS CELL BIOL, V8, P359, DOI 10.1016/S0962-8924(98)01339-7; Kamata T, 2001, J BIOL CHEM, V276, P44275, DOI 10.1074/jbc.M107021200; Kim M, 2003, SCIENCE, V301, P1720, DOI 10.1126/science.1084174; KUNICKI TJ, 1995, BLOOD CELL MOL DIS, V21, P131, DOI 10.1006/bcmd.1995.0015; LEE JO, 1995, CELL, V80, P631, DOI 10.1016/0092-8674(95)90517-0; Lee JO, 1995, STRUCTURE, V3, P1333, DOI 10.1016/S0969-2126(01)00271-4; Love CA, 2003, NAT STRUCT BIOL, V10, P843, DOI 10.1038/nsb977; Luo BH, 2004, PLOS BIOL, V2, P776, DOI 10.1371/journal.pbio.0020153; Luo BH, 2004, J BIOL CHEM, V279, P27466, DOI 10.1074/jbc.M404354200; Luo BH, 2004, J BIOL CHEM, V279, P10215, DOI 10.1074/jbc.M312732200; Luo BH, 2003, J BIOL CHEM, V278, P17185, DOI 10.1074/jbc.M301516200; Luo BH, 2003, P NATL ACAD SCI USA, V100, P2403, DOI 10.1073/pnas.0438060100; MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869, DOI 10.1107/S0907444994006396; Mould AP, 2003, J BIOL CHEM, V278, P39993, DOI 10.1074/jbc.M304627200; Mould AP, 2003, J BIOL CHEM, V278, P17028, DOI 10.1074/jbc.M213139200; Mould AP, 2002, J BIOL CHEM, V277, P19800, DOI 10.1074/jbc.M201571200; NEWMAN PJ, 1989, J CLIN INVEST, V83, P1778, DOI 10.1172/JCI114082; PERUTZ MF, 1989, Q REV BIOPHYS, V22, P139, DOI 10.1017/S0033583500003826; Puzon-McLaughlin W, 2000, J BIOL CHEM, V275, P7795, DOI 10.1074/jbc.275.11.7795; SCARBOROUGH RM, 1993, J BIOL CHEM, V268, P1066; Scarborough RM, 2000, J MED CHEM, V43, P3453, DOI 10.1021/jm000022w; Shimaoka M, 2003, CELL, V112, P99, DOI 10.1016/S0092-8674(02)01257-6; Springer TA, 2002, CURR OPIN STRUC BIOL, V12, P802, DOI 10.1016/S0959-440X(02)00384-6; SPRINGER TA, 2004, CELL SURFACE RECEPTO; Takagi J, 2002, CELL, V110, P599, DOI 10.1016/S0092-8674(02)00935-2; Takagi J, 2003, EMBO J, V22, P4607, DOI 10.1093/emboj/cdg445; Takagi J, 2002, IMMUNOL REV, V186, P141, DOI 10.1034/j.1600-065X.2002.18613.x; Takagi J, 2001, NAT STRUCT BIOL, V8, P412, DOI 10.1038/87569; Tozer EC, 1996, J BIOL CHEM, V271, P21978, DOI 10.1074/jbc.271.36.21978; Vinogradova O, 2002, CELL, V110, P587, DOI 10.1016/S0092-8674(02)00906-6; von der Mark H, 2002, J BIOL CHEM, V277, P6012, DOI 10.1074/jbc.M102188200; Watkins NA, 2002, BLOOD, V99, P1833, DOI 10.1182/blood.V99.5.1833; Xiong JP, 2001, SCIENCE, V294, P339, DOI 10.1126/science.1064535; Xiong JP, 2002, SCIENCE, V296, P151, DOI 10.1126/science.1069040; Yang W, 2004, P NATL ACAD SCI USA, V101, P2333, DOI 10.1073/pnas.0307291101; ZAVORTINK M, 1993, CELL ADHES COMMUN, V1, P251, DOI 10.3109/15419069309097258	50	629	651	0	65	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 4	2004	432	7013					59	67		10.1038/nature02976	http://dx.doi.org/10.1038/nature02976			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	867PQ	15378069	Green Accepted			2022-12-28	WOS:000224854900038
J	von Storch, H; Zorita, E; Jones, JM; Dimitriev, Y; Gonzalez-Rouco, F; Tett, SFB				von Storch, H; Zorita, E; Jones, JM; Dimitriev, Y; Gonzalez-Rouco, F; Tett, SFB			Reconstructing past climate from noisy data	SCIENCE			English	Article							LAST MILLENNIUM; TEMPERATURE; EVOLUTION; TRENDS; MODEL	Empirical reconstructions of the Northern Hemisphere (NH) temperature in the past millennium based on multiproxy records depict small-amplitude variations followed by a clear warming trend in the past two centuries. We use a coupled atmosphere-ocean model simulation of the past 1000 years as a surrogate climate to test the skill of these methods, particularly at multi-decadal and centennial time scales. Idealized proxy records are represented by simulated grid-point temperature, degraded with statistical noise. The centennial variability of the NH temperature is underestimated by the regression-based methods applied here, suggesting that past variations may have been at least a factor of 2 larger than indicated by empirical reconstructions.	GKSS Forschungszentrum Geesthacht GmbH, Inst Coastal Res, D-21502 Geesthacht, Germany; Univ Complutense, Dept Astrophys & Atmospher Phys, E-28040 Madrid, Spain; Univ Reading, UK Meteorol Off, Hadley Ctr, Reading Unit, Reading RG6 6BB, Berks, England	Helmholtz Association; Helmholtz-Zentrum Geesthacht - Zentrum fur Material- und Kustenforschung; Complutense University of Madrid; Met Office - UK; Hadley Centre; University of Reading	von Storch, H (corresponding author), GKSS Forschungszentrum Geesthacht GmbH, Inst Coastal Res, D-21502 Geesthacht, Germany.	storch@gkss.de	González-Rouco, Jesús Fidel/B-1761-2012; von Storch, Hans/J-4165-2012; Tett, Simon F. B./B-1504-2013	González-Rouco, Jesús Fidel/0000-0001-7090-6797; von Storch, Hans/0000-0002-5825-8069; Tett, Simon F. B./0000-0001-7526-560X; Jones, Julie/0000-0003-2892-8647				Bauer E, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2002GL016639; Crowley TJ, 2000, SCIENCE, V289, P270, DOI 10.1126/science.289.5477.270; Esper J, 2002, SCIENCE, V295, P2250, DOI 10.1126/science.1066208; Gerber S, 2003, CLIM DYNAM, V20, P281, DOI 10.1007/s00382-002-0270-8; Goosse H, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2003GL019140; Houghton J. T., 2001, CLIMATE CHANGE 2001; Huang SP, 2000, NATURE, V403, P756, DOI 10.1038/35001556; Jones JM, 2003, J CLIMATE, V16, P3511, DOI [10.1175/1520-0442(2003)016<3511:IATEOT>2.0.CO;2, 10.1175/1520-0442(2003)016&lt;3511:IATEOT&gt;2.0.CO;2]; Jones PD, 2001, SCIENCE, V292, P662, DOI 10.1126/science.1059126; Jones PD, 1998, HOLOCENE, V8, P455, DOI 10.1191/095968398667194956; Jones PD, 2004, REV GEOPHYS, V42, DOI 10.1029/2003RG000143; Jones PD, 1999, REV GEOPHYS, V37, P173, DOI 10.1029/1999RG900002; Luterbacher J, 2004, SCIENCE, V303, P1499, DOI 10.1126/science.1093877; Luterbacher J, 1999, GEOPHYS RES LETT, V26, P2745, DOI 10.1029/1999GL900576; Mann ME, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL014554; Mann ME, 1998, NATURE, V392, P779, DOI 10.1038/33859; Mann ME, 1999, GEOPHYS RES LETT, V26, P759, DOI 10.1029/1999GL900070; Osborn T. J., 2000, Dendrochronologia, V18, P9; Rind D, 2004, J CLIMATE, V17, P906, DOI 10.1175/1520-0442(2004)017<0906:TRIOSA>2.0.CO;2; Rutherford S, 2003, J CLIMATE, V16, P462, DOI [10.1175/1520-0442(2003)016<0462:CFRUSA>2.0.CO;2, 10.1175/1520-0442(2003)016&lt;0462:CFRUSA&gt;2.0.CO;2]; von Storch H, 1999, J CLIMATE, V12, P3505, DOI 10.1175/1520-0442(1999)012<3505:OTUOII>2.0.CO;2; Zorita E, 2004, METEOROL Z, V13, P271, DOI 10.1127/0941-2948/2004/0013-0271; Zorita E, 2003, J CLIMATE, V16, P1378, DOI 10.1175/1520-0442(2003)16&lt;1378:TTMEAA&gt;2.0.CO;2	23	317	323	1	41	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 22	2004	306	5696					679	682		10.1126/science.1096109	http://dx.doi.org/10.1126/science.1096109			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866EN	15459344				2022-12-28	WOS:000224756700049
J	Strippoli, GFM; Craig, M; Deeks, JJ; Schena, FP; Craig, JC				Strippoli, GFM; Craig, M; Deeks, JJ; Schena, FP; Craig, JC			Effects of angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists on mortality and renal outcomes in diabetic nephropathy: systematic review	BMJ-BRITISH MEDICAL JOURNAL			English	Article							RANDOMIZED CONTROLLED-TRIAL; AMBULATORY BLOOD-PRESSURE; PLACEBO-CONTROLLED TRIAL; TERM ENALAPRIL TREATMENT; LOW-DOSE RAMIPRIL; KIDNEY-FUNCTION; ANTIHYPERTENSIVE THERAPY; NORMOTENSIVE PATIENTS; ACE-INHIBITION; IDDM PATIENTS	Objective To evaluate the effects of angiotensin converting enzyme (ACE) inhibitors and angiotensin H receptor antagonists (AIIRAs) on renal outcomes and all cause mortality in patients with diabetic nephropathy. Data sources, Medline, Embase, the Cochrane controlled trials register, conference proceedings, and contact with investigators. Study selection Trials comparing ACE inhibitors or AIIRAs with placebo or with each other in patients with diabetic nephropathy. Data extraction Mortality, renal outcomes (end stage renal disease, doubling of serum creatinine concentration, prevention of progression of microalbuminuria to macroalbuminuria, remission of microalbuminuria), and quality of trials. Data synthesis 36 of 43 identified trials compared ACE inhibitors with placebo (4008 patients), four compared AIIRAs with placebo (3331 patients), and three compared ACE inhibitors with AIIRAs (206 patients). We obtained unpublished data for 11 trials. ACE inhibitors significantly reduced all cause mortality (relative risk 0.79, 95% confidence interval 0.63 to 0.99) compared with placebo but AIIRAs did not (0.99, 0.85 to 1.17), although baseline mortality was similar in the trials. Both agents had similar effects on renal outcomes. Reliable estimates of the unconfounded relative effects of ACE inhibitors compared with AIIRAs could not be obtained owing to small sample sizes. Conclusion Although the survival benefits of ACE inhibitors for patients with diabetic nephropathy are known, the relative effects of ACE inhibitors and AIIRAs on survival are unknown owing to the lack of adequate head to head trials.	Childrens Hosp Westmead, NHMRC, Ctr Clin Res Excellence Renal Med, Cochrane Renal Grp, Westmead, NSW 2145, Australia; Univ Bari, Dept Emergency & Organ Transplantat, Nephrol Sect, I-70121 Bari, Italy	University of Sydney; Universita degli Studi di Bari Aldo Moro	Strippoli, GFM (corresponding author), Childrens Hosp Westmead, NHMRC, Ctr Clin Res Excellence Renal Med, Cochrane Renal Grp, Westmead, NSW 2145, Australia.	gfmstrippoli@katamail.com	Deeks, Jon/AAV-5745-2020; Schena, Francesco P/K-6982-2016; Craig, Jonathan/E-2813-2013	Deeks, Jon/0000-0002-8850-1971; Schena, Francesco P/0000-0001-7927-5207; Craig, Jonathan/0000-0002-2548-4035; Craig, Maria E/0000-0001-6004-576X; Strippoli, Giovanni/0000-0002-6936-0616				Ahmad J, 1997, DIABETES CARE, V20, P1576, DOI 10.2337/diacare.20.10.1576; Ahmad J, 2003, DIABETES RES CLIN PR, V60, P131, DOI 10.1016/S0168-8227(03)00016-0; [Anonymous], 2000, LANCET, V355, P253, DOI DOI 10.1016/S0140-6736(99)12323-7; Arauz-Pacheco Carlos, 2003, Diabetes Care, V26 Suppl 1, pS80; Baines LA, 2001, DIABETES, V50, P843; BAKRIS GL, 1994, J DIABETES COMPLICAT, V8, P2, DOI 10.1016/1056-8727(94)90003-5; BAUER JH, 1992, AM J KIDNEY DIS, V20, P443, DOI 10.1016/S0272-6386(12)70256-1; Bojestig M, 2001, DIABETES CARE, V24, P919, DOI 10.2337/diacare.24.5.919; Brenner BM, 2001, NEW ENGL J MED, V345, P861, DOI 10.1056/NEJMoa011161; CAPEK M, 1994, CLIN INVESTIGATOR, V72, P961, DOI 10.1007/BF00577736; Carella Michael J., 1999, Journal of Medicine (Westbury), V30, P305; CHASE HP, 1993, ANN OPHTHALMOL, V25, P284; Chaturvedi N, 1997, LANCET, V349, P1787, DOI 10.1016/S0140-6736(96)10244-0; Chaturvedi N, 2001, ANN INTERN MED, V134, P370, DOI 10.7326/0003-4819-134-5-200103060-00009; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Cohn JN, 2001, NEW ENGL J MED, V345, P1667, DOI 10.1056/NEJMoa010713; Cordonnier DJ, 1999, J AM SOC NEPHROL, V10, P1253; Crepaldi G, 1998, DIABETES CARE, V21, P104, DOI 10.2337/diacare.21.1.104; DICKERSIN K, 1994, BMJ-BRIT MED J, V309, P1286, DOI 10.1136/bmj.309.6964.1286; Dinneen SF, 1997, ARCH INTERN MED, V157, P1413, DOI 10.1001/archinte.157.13.1413; Estacio RO, 1998, AM J CARDIOL, V82, p9R; GARG R, 1995, JAMA-J AM MED ASSOC, V273, P1450, DOI 10.1001/jama.273.18.1450; Garg SK, 1998, ANN OPHTHALMOL GLAUC, V30, P33; Gerstein HC, 2000, LANCET, V355, P253; GROSSMAN E, 2001, EVIDENCE BASED MED, V6, P44; HANSEN KW, 1994, DIABETES METAB, V20, P485; Hansen PM, 1995, J DIABETES COMPLICAT, V9, P158, DOI 10.1016/1056-8727(94)00026-K; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Jerums G, 2001, AM J KIDNEY DIS, V37, P890, DOI 10.1016/S0272-6386(05)80003-4; KASISKE BL, 1993, ANN INTERN MED, V118, P129, DOI 10.7326/0003-4819-118-2-199301150-00009; Katayama S, 2002, DIABETES RES CLIN PR, V55, P113, DOI 10.1016/S0168-8227(01)00289-3; Klahr S, 2002, KIDNEY INT, V62, pS23, DOI 10.1046/j.1523-1755.62.s82.5.x; Lacourciere Y, 2000, KIDNEY INT, V58, P762, DOI 10.1046/j.1523-1755.2000.00224.x; LAFFEL LMB, 1995, AM J MED, V99, P497, DOI 10.1016/S0002-9343(99)80226-5; LEBOWITZ HE, 1994, KIDNEY INT S45, V45, P150; Lewis EJ, 2001, NEW ENGL J MED, V345, P851, DOI 10.1056/NEJMoa011303; LEWIS EJ, 1993, NEW ENGL J MED, V329, P1456, DOI 10.1056/NEJM199311113292004; Mann JFE, 2001, ANN INTERN MED, V134, P629, DOI 10.7326/0003-4819-134-8-200104170-00007; MARRE M, 1988, BMJ-BRIT MED J, V297, P1092, DOI 10.1136/bmj.297.6656.1092; MARRE M, 1990, Journal of Diabetic Complications, V4, P84, DOI 10.1016/0891-6632(90)90042-4; MARRE M, 1987, BMJ-BRIT MED J, V294, P1448, DOI 10.1136/bmj.294.6585.1448; Maschio G, 1996, NEW ENGL J MED, V334, P939, DOI 10.1056/NEJM199604113341502; Mathiesen ER, 1999, BRIT MED J, V319, P24, DOI 10.1136/bmj.319.7201.24; MATHIESEN ER, 1991, BMJ-BRIT MED J, V303, P81, DOI 10.1136/bmj.303.6794.81; Mogensen CE, 1995, J DIABETES COMPLICAT, V9, P337, DOI 10.1016/1056-8727(95)80036-E; Mogensen CE, 1999, CLIN EXP HYPERTENS, V21, P895, DOI 10.3109/10641969909061018; Muirhead N, 1999, CURR THER RES CLIN E, V60, P650, DOI 10.1016/S0011-393X(99)90003-6; Nakao N, 2003, LANCET, V361, P117, DOI 10.1016/S0140-6736(03)12229-5; Nankervis A, 1998, METABOLISM, V47, P12, DOI 10.1016/S0026-0495(98)90364-X; O'Hare JP, 2000, DIABETES CARE, V23, P1823, DOI 10.2337/diacare.23.12.1823; ODONNELL MJ, 1993, J HUM HYPERTENS, V7, P327; Ozer MK, 2002, PHARMACOL RES, V45, P257, DOI 10.1006/phrs.2002.0965; Parving H H, 2001, Ugeskr Laeger, V163, P5514; PARVING HH, 1989, BMJ-BRIT MED J, V299, P533, DOI 10.1136/bmj.299.6698.533; Parving HH, 2001, KIDNEY INT, V60, P228, DOI 10.1046/j.1523-1755.2001.00790.x; Parving HH, 2001, NEW ENGL J MED, V345, P870, DOI 10.1056/NEJMoa011489; Penno G, 1998, DIABETES, V47, P1507, DOI 10.2337/diabetes.47.9.1507; PHILLIPS PJ, 1993, AM J MED, V94, pS58; Poulsen PL, 2001, DIABETES METAB, V27, P123; Poulsen PL, 2001, J INTERN MED, V249, P433, DOI 10.1046/j.1365-2796.2001.00821.x; RAVID M, 1995, KIDNEY INT, V47, P907, DOI 10.1038/ki.1995.135; Ravid M, 1996, ARCH INTERN MED, V156, P286, DOI 10.1001/archinte.156.3.286; RAVID M, 1993, ANN INTERN MED, V118, P577, DOI 10.7326/0003-4819-118-8-199304150-00001; RAVID M, 1993, ANN INTERN MED, V119, P6; Ritz E, 1999, NEW ENGL J MED, V341, P1127, DOI 10.1056/NEJM199910073411506; ROMERO R, 1993, DIABETES CARE, V16, P597, DOI 10.2337/diacare.16.4.597; Sano T, 1996, DIABETIC MED, V13, P120, DOI 10.1002/(SICI)1096-9136(199602)13:2<120::AID-DIA6>3.0.CO;2-F; SANO T, 1994, DIABETES CARE, V17, P420, DOI 10.2337/diacare.17.5.420; Schrier RW, 2002, KIDNEY INT, V61, P1086, DOI 10.1046/j.1523-1755.2002.00213.x; Song F, 2003, BMJ-BRIT MED J, V326, P472, DOI 10.1136/bmj.326.7387.472; STORNELLO M, 1989, J CARDIOVASC PHARM, V14, P851, DOI 10.1097/00005344-198912000-00009; STORNELLO M, 1992, CLIN SCI, V82, P19, DOI 10.1042/cs0820019; Tan KCB, 2002, DIABETES-METAB RES, V18, P71, DOI 10.1002/dmrr.255; TREVISAN R, 1995, AM J HYPERTENS, V8, P876, DOI 10.1016/0895-7061(95)00162-I; Tutuncu NB, 2001, ACTA DIABETOL, V38, P157, DOI 10.1007/s592-001-8073-2; VIBERTI G, 1994, JAMA-J AM MED ASSOC, V271, P275, DOI 10.1001/jama.271.4.275; Wachtell K, 2003, ANN INTERN MED, V139, P901, DOI 10.7326/0003-4819-139-11-200312020-00008; Watanabe K, 2003, J CARDIOVASC PHARM, V41, pS93; Zuanetti G, 1996, J DIABETES COMPLICAT, V10, P139, DOI 10.1016/1056-8727(96)00027-X	79	261	268	0	12	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 9	2004	329	7470					828	831		10.1136/bmj.38237.585000.7C	http://dx.doi.org/10.1136/bmj.38237.585000.7C			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	862EK	15459003	Green Published, Bronze, Green Submitted			2022-12-28	WOS:000224472800018
J	Famulok, M				Famulok, M			RNAs turn on in tandem	SCIENCE			English	Editorial Material							GENE-EXPRESSION; MOLECULES; RIBOZYME; LIGANDS; BINDING		Univ Bonn, Inst Organ Chem & Biochem, D-53121 Bonn, Germany	University of Bonn	Famulok, M (corresponding author), Univ Bonn, Inst Organ Chem & Biochem, D-53121 Bonn, Germany.	m.famulok@uni-bonn.de						Carothers JM, 2004, J AM CHEM SOC, V126, P5130, DOI 10.1021/ja031504a; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; Famulok M, 1999, CURR OPIN STRUC BIOL, V9, P324, DOI 10.1016/S0959-440X(99)80043-8; Jose AM, 2001, NUCLEIC ACIDS RES, V29, P1631, DOI 10.1093/nar/29.7.1631; Mandal M, 2004, SCIENCE, V306, P275, DOI 10.1126/science.1100829; Nudler E, 2004, TRENDS BIOCHEM SCI, V29, P11, DOI 10.1016/j.tibs.2003.11.004; Sudarsan N, 2003, RNA, V9, P644, DOI 10.1261/rna.5090103; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Werstuck G, 1998, SCIENCE, V282, P296, DOI 10.1126/science.282.5387.296; Winkler WC, 2004, NATURE, V428, P281, DOI 10.1038/nature02362	10	5	8	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 8	2004	306	5694					233	234		10.1126/science.1104975	http://dx.doi.org/10.1126/science.1104975			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	861MC	15472064				2022-12-28	WOS:000224419700023
J	Katz, SL				Katz, SL			Conquering polio - From culture to vaccine - Salk and Sabin	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Duke Univ, Med Ctr, Durham, NC 27710 USA	Duke University	Katz, SL (corresponding author), Duke Univ, Med Ctr, Durham, NC 27710 USA.								0	13	13	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 7	2004	351	15					1485	1487		10.1056/NEJMp048217	http://dx.doi.org/10.1056/NEJMp048217			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	859UP	15470209				2022-12-28	WOS:000224293700004
J	Daviglus, ML; Stamler, J; Pirzada, A; Yan, LJL; Garside, DB; Liu, K; Wang, RW; Dyer, AR; Lloyd-Jones, DM; Greenland, P				Daviglus, ML; Stamler, J; Pirzada, A; Yan, LJL; Garside, DB; Liu, K; Wang, RW; Dyer, AR; Lloyd-Jones, DM; Greenland, P			Favorable cardiovascular risk profile in young women and long-term risk of cardiovascular and all-cause mortality	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CORONARY-HEART-DISEASE; MIDDLE-AGE; OLDER AGE; PREVALENCE; OBESITY; TRENDS; LIFE; COHORTS	Content For women, impact of cardiovascular risk factors measured in young adulthood, particularly favorable (low-risk) profile, on mortality has been difficult to assess due to low short-term death rates. Objective To assess the relationship of baseline coronary risk factor status to mortality from coronary heart disease (CHD), cardiovascular diseases (CVDs), and all causes in young women. Design Prospective cohort study. Setting and Participants A total of 7302 women aged 18 to 39 years without prior CHID or major electrocardiographic abnormalities screened between 1967 and 1973 for the Chicago Heart Association Detection Project in Industry. Risk groups were defined using national guidelines for values of systolic and diastolic blood pressure, serum cholesterol level, body mass index, presence of diabetes, and smoking status. Participants were divided into 4 groups: low risk, 0 risk factors high but 1 or more unfavorable, 1 only risk factor high, and 2 or more risk factors high. Main Outcome Measures All-cause mortality, CHD mortality, and CVD mortality; hazard ratio of outcome measures comparing low-risk group with other groups. Results Only 20% met low-risk criteria; 59% had high levels of 1 or more risk factors. During an average follow-up of 31 years, there were 47 CHID deaths, 94 CVD deaths, and 469 deaths from all causes. The age-adjusted CVD death rate per 10000 person-years was lowest for low-risk women and increased with the number of risk factors, ie, 1.5, 1.7, 5.0, and 9.1 for low-risk; 0, 1, and 2 or more risk factors high, respectively. Multivariate-adjusted CVD mortality hazard ratio for low-risk women was 0.19 (95% confidence interval, 0.08-0.45) compared with women with 2 or more risk factors high. Similar patterns were observed for CHD and all-cause mortality and for both blacks and whites. Conclusion For women with favorable levels for all 5 major risk factors at younger ages, CHID and CVD are rare; long-term and all-cause mortality are much lower compared with others.	Northwestern Univ, Feinberg Sch Med, Dept Prevent Med, Chicago, IL 60611 USA; Northwestern Univ, Feinberg Sch Med, Dept Med, Div Geriatr, Chicago, IL 60611 USA; Northwestern Univ, Feinberg Sch Med, Dept Med, Div Cardiol, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine	Daviglus, ML (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Prevent Med, 680 N Lake Shore Dr,Suite 1102, Chicago, IL 60611 USA.	daviglus@northwestern.edu	Pirzada, Amber/ABG-6028-2021; Greenland, Philip/ABD-5528-2021; Lloyd-Jones, Donald M/C-5899-2009	Pirzada, Amber/0000-0003-0526-3611; Lloyd-Jones, Donald/0000-0003-0847-6110	NHLBI NIH HHS [R01 HL21010] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL021010] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Daviglus ML, 1998, NEW ENGL J MED, V339, P1122, DOI 10.1056/NEJM199810153391606; Daviglus ML, 2003, ARCH INTERN MED, V163, P2460, DOI 10.1001/archinte.163.20.2460; Daviglus ML, 2004, AM J CARDIOL, V94, P367, DOI 10.1016/j.amjcard.2004.04.038; Eckel RH, 1998, CIRCULATION, V97, P2099, DOI 10.1161/01.CIR.97.21.2099; Flegal KM, 1998, INT J OBESITY, V22, P39, DOI 10.1038/sj.ijo.0800541; Flegal KM, 2002, JAMA-J AM MED ASSOC, V288, P1723, DOI 10.1001/jama.288.14.1723; Lloyd-Jones DM, 1998, ANN INTERN MED, V129, P1020, DOI 10.7326/0003-4819-129-12-199812150-00005; Rosengren A, 2001, EUR HEART J, V22, P136, DOI 10.1053/euhj.2000.2179; STAMLER J, 1975, J CHRON DIS, V28, P527, DOI 10.1016/0021-9681(75)90060-0; STAMLER J, 1993, CARDIOLOGY, V82, P191, DOI 10.1159/000175868; Stamler J, 1999, JAMA-J AM MED ASSOC, V282, P2012, DOI 10.1001/jama.282.21.2012; Stampfer MJ, 2000, NEW ENGL J MED, V343, P16, DOI 10.1056/NEJM200007063430103; *US DEP HHS, 1980, DHHS PUBL PHS, V1; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; World Health Organization, 2004, ICD 10 INT STAT CLAS, V2nd; World Health Organization, 1967, INT CLASS DIS 8 REV; Yan LJL, 2003, CIRCULATION, V107, pE7037	17	175	181	1	6	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 6	2004	292	13					1588	1592		10.1001/jama.292.13.1588	http://dx.doi.org/10.1001/jama.292.13.1588			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	859HS	15467061	Bronze			2022-12-28	WOS:000224254600026
J	Fiser, J; Chiu, CY; Weliky, M				Fiser, J; Chiu, CY; Weliky, M			Small modulation of ongoing cortical dynamics by sensory input during natural vision	NATURE			English	Article							RESPONSE VARIABILITY; VISUAL-CORTEX; NEURONS; INFORMATION; MECHANISMS; DISCHARGE; SCENES; CELLS	During vision, it is believed that neural activity in the primary visual cortex is predominantly driven by sensory input from the environment. However, visual cortical neurons respond to repeated presentations of the same stimulus with a high degree of variability(1-4). Although this variability has been considered to be noise owing to random spontaneous activity within the cortex(5-7), recent studies show that spontaneous activity has a highly coherent spatio-temporal structure(8-13). This raises the possibility that the pattern of this spontaneous activity may shape neural responses during natural viewing conditions to a larger extent than previously thought. Here, we examine the relationship between spontaneous activity and the response of primary visual cortical neurons to dynamic natural-scene and random-noise film images in awake, freely viewing ferrets from the time of eye opening to maturity. The correspondence between evoked neural activity and the structure of the input signal was weak in young animals, but systematically improved with age. This improvement was linked to a shift in the dynamics of spontaneous activity. At all ages including the mature animal, correlations in spontaneous neural firing were only slightly modified by visual stimulation, irrespective of the sensory input. These results suggest that in both the developing and mature visual cortex, sensory evoked neural activity represents the modulation and triggering of ongoing circuit dynamics by input signals, rather than directly reflecting the structure of the input signal itself.	Univ Rochester, Ctr Visual Sci, Rochester, NY 14627 USA; Univ Rochester, Interdepartmental Program Neruosci, Rochester, NY 14627 USA; Univ Rochester, Dept Brain & Cognit Sci, Rochester, NY 14627 USA	University of Rochester; University of Rochester; University of Rochester	Weliky, M (corresponding author), Univ Rochester, Ctr Visual Sci, Rochester, NY 14627 USA.	weliky@cvs.rochester.edu	Fiser, József/A-2877-2009	Fiser, Jozsef/0000-0002-7064-0690; Chiu, Chiayu/0000-0001-5809-6306				Anderson J, 2000, NAT NEUROSCI, V3, P617, DOI 10.1038/75797; ARIELI A, 1995, J NEUROPHYSIOL, V73, P2072, DOI 10.1152/jn.1995.73.5.2072; Attwell D, 2001, J CEREBR BLOOD F MET, V21, P1133, DOI 10.1097/00004647-200110000-00001; Azouz R, 1999, J NEUROSCI, V19, P2209; Chiu CY, 2001, J NEUROSCI, V21, P8906, DOI 10.1523/JNEUROSCI.21-22-08906.2001; Cossart R, 2003, NATURE, V423, P283, DOI 10.1038/nature01614; Gallant JL, 1998, NEUROREPORT, V9, P1673, DOI 10.1097/00001756-199805110-00075; Gao WJ, 1999, J COMP NEUROL, V409, P261, DOI 10.1002/(SICI)1096-9861(19990628)409:2<261::AID-CNE7>3.0.CO;2-R; GAWNE TJ, 1993, J NEUROSCI, V13, P2758; HENRY GH, 1973, VISION RES, V13, P1771, DOI 10.1016/0042-6989(73)90094-1; Hirsch JA, 2002, J PHYSIOL-LONDON, V540, P335, DOI 10.1113/jphysiol.2001.012777; Kara P, 2000, NEURON, V27, P635, DOI 10.1016/S0896-6273(00)00072-6; Kenet T, 2003, NATURE, V425, P954, DOI 10.1038/nature02078; Lennie P, 2003, CURR BIOL, V13, P493, DOI 10.1016/S0960-9822(03)00135-0; MEISTER M, 1991, SCIENCE, V252, P939, DOI 10.1126/science.2035024; Nirenberg S, 2003, P NATL ACAD SCI USA, V100, P7348, DOI 10.1073/pnas.1131895100; Pola G, 2003, NETWORK-COMP NEURAL, V14, P35, DOI 10.1088/0954-898X/14/1/303; Pouget A, 2003, ANNU REV NEUROSCI, V26, P381, DOI 10.1146/annurev.neuro.26.041002.131112; SCHILLER PH, 1976, BRAIN RES, V105, P347, DOI 10.1016/0006-8993(76)90432-7; Shadlen MN, 1998, J NEUROSCI, V18, P3870; Shu YS, 2003, J NEUROSCI, V23, P10388; Tsodyks M, 1999, SCIENCE, V286, P1943, DOI 10.1126/science.286.5446.1943; Vinje WE, 2000, SCIENCE, V287, P1273, DOI 10.1126/science.287.5456.1273; VOGELS R, 1989, EXP BRAIN RES, V77, P432, DOI 10.1007/BF00275002; Weliky M, 1999, SCIENCE, V285, P599, DOI 10.1126/science.285.5427.599; Weliky M, 2003, NEURON, V37, P703, DOI 10.1016/S0896-6273(03)00022-9; ZOHARY E, 1994, NATURE, V370, P140, DOI 10.1038/370140a0	27	302	303	1	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 30	2004	431	7008					573	578		10.1038/nature02907	http://dx.doi.org/10.1038/nature02907			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	857YP	15457262				2022-12-28	WOS:000224156700048
J	Roland, M				Roland, M			Linking physicians' pay to the quality of care - A major experiment in the United Kingdom	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							FINANCIAL INCENTIVES; IMPROVE QUALITY; GENERAL-PRACTICE; HEALTH-CARE; ENGLAND; WILL; UK		Univ Manchester, Natl Primary Care Res & Dev Ctr, Manchester, Lancs, England	University of Manchester	Roland, M (corresponding author), Univ Manchester, Natl Primary Care Res & Dev Ctr, Manchester, Lancs, England.							Baker D, 2003, J EPIDEMIOL COMMUN H, V57, P417, DOI 10.1136/jech.57.6.417; Brook RH, 1996, NEW ENGL J MED, V335, P966, DOI 10.1056/NEJM199609263351311; Chaix-Couturier C, 2000, INT J QUAL HEALTH C, V12, P133, DOI 10.1093/intqhc/12.2.133; Charles-Jones H, 2003, SOCIOL HEALTH ILL, V25, P71, DOI 10.1111/1467-9566.t01-1-00325; Epstein AM, 2004, NEW ENGL J MED, V350, P406, DOI 10.1056/NEJMsb035374; Heath I, 2002, BRIT J GEN PRACT, V52, P602; Institute of Medicine, 2001, CROSSING QUALITY CHA; Marshall M, 2003, QUAL SAF HEALTH CARE, V12, P397, DOI 10.1136/qhc.12.6.397; McElduff P, 2004, QUAL SAF HEALTH CARE, V13, P191, DOI 10.1136/qshc.2003.007401; Middleton E, 2003, BMJ-BRIT MED J, V326, P854, DOI 10.1136/bmj.326.7394.854; Robinson JC, 2001, MILBANK Q, V79, P149, DOI 10.1111/1468-0009.00202; *ROYAL COLL PRACT, FELL ASS; *ROYAL COLL PRACT, QUAL PRACT AW QPA; Schuster MA, 1998, MILBANK Q, V76, P517, DOI 10.1111/1468-0009.00105; Seddon ME, 2001, QUAL HEALTH CARE, V10, P152, DOI 10.1136/qhc.0100152..; Shekelle P, 2003, BRIT MED J, V326, P457, DOI 10.1136/bmj.326.7387.457; Shield T, 2003, QUAL SAF HEALTH CARE, V12, P100, DOI 10.1136/qhc.12.2.100; Spooner A, 2001, J Health Serv Res Policy, V6, P145, DOI 10.1258/1355819011927396; Starfield Barbara, 2003, Ann Fam Med, V1, P8, DOI 10.1370/afm.1; 1986, BMJ, V293, P1384	20	477	480	1	27	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 30	2004	351	14					1448	1454		10.1056/NEJMhpr041294	http://dx.doi.org/10.1056/NEJMhpr041294			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	857XT	15459308				2022-12-28	WOS:000224153900016
J	Fenton, L				Fenton, L			Preventing HIV/AIDS through poverty reduction: the only sustainable solution?	LANCET			English	Editorial Material									UCL, Int Hlth & Med Educ Ctr, London N19 5LW, England	University of London; University College London	Fenton, L (corresponding author), UCL, Int Hlth & Med Educ Ctr, Archway Campus, London N19 5LW, England.	lynda.fenton@doctors.org.uk						Ainsworth M., 1998, CONFRONTING AIDS EVI; Bloom D. E., 2002, HLTH WEALTH AIDS POV; COHEN D, 2000, SEPED C PAPER SERIES, V2; Collins J., 2000, 4 UNRISDUNAIDS; Horton R, 2000, LANCET, V356, P225; Stillwaggon E, 2002, J DEV STUD, V38, P1, DOI 10.1080/00220380412331322561; 2003, LANCET, V362, P9383	7	86	87	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	SEP 25	2004	364	9440					1186	1187		10.1016/S0140-6736(04)17109-2	http://dx.doi.org/10.1016/S0140-6736(04)17109-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	857FT	15451230				2022-12-28	WOS:000224102400036
J	Aide, TM; Grau, HR				Aide, TM; Grau, HR			Ecology - Globalization, migration, and Latin American ecosystems	SCIENCE			English	Editorial Material									Univ Puerto Rico, Dept Biol, San Juan, PR 00931 USA; Univ Nacl Tucuman, Lab Invest Ecol Yungas, RA-4107 San Miguel De Tucuman, Argentina	University of Puerto Rico; University of Puerto Rico Medical Sciences Campus; Universidad Nacional de Tucuman	Aide, TM (corresponding author), Univ Puerto Rico, Dept Biol, San Juan, PR 00931 USA.	tmaide@yahoo.com; chilograu@yahoo.com.ar						Dirzo R, 2003, ANNU REV ENV RESOUR, V28, P137, DOI 10.1146/annurev.energy.28.050302.105532; Fearnside PM, 2001, ENVIRON CONSERV, V28, P23, DOI 10.1017/S0376892901000030; Geist HJ, 2002, BIOSCIENCE, V52, P143, DOI 10.1641/0006-3568(2002)052[0143:PCAUDF]2.0.CO;2; Grau HR, 2003, BIOSCIENCE, V53, P1159, DOI 10.1641/0006-3568(2003)053[1159:TECOSA]2.0.CO;2; GRAU HR, UNPUB ENV CONSERV; Houghton RA, 1999, TELLUS B, V51, P298, DOI 10.1034/j.1600-0889.1999.00013.x; Janzen DH, 2002, HANDBOOK OF ECOLOGICAL RESTORATION, VOL 2, P559; JANZEN DH, COMMUNICATION; Laurance WF, 2002, CONSERV BIOL, V16, P605, DOI 10.1046/j.1523-1739.2002.01025.x; Lugo AE, 2002, LANDSCAPE ECOL, V17, P601, DOI 10.1023/A:1021419815480; Mather AS, 1998, AREA, V30, P117, DOI 10.1111/j.1475-4762.1998.tb00055.x; PRESTON D, 1996, LATIN AM DEV GEOGRAP, P165; Waggoner PE, 2001, POPUL DEV REV, V27, P239, DOI 10.1111/j.1728-4457.2001.00239.x	13	353	379	2	86	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 24	2004	305	5692					1915	1916		10.1126/science.1103179	http://dx.doi.org/10.1126/science.1103179			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	857RM	15448256				2022-12-28	WOS:000224136000031
J	Anderson, DG; Burdick, JA; Langer, R				Anderson, DG; Burdick, JA; Langer, R			Materials science - Smart biomaterials	SCIENCE			English	Editorial Material							EXTRACELLULAR MATRICES; DRUG-DELIVERY; MICROCHIP; RELEASE; CELLS		MIT, Dept Chem Engn, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Anderson, DG (corresponding author), MIT, Dept Chem Engn, Cambridge, MA 02139 USA.	rlanger@mit.edu						Anderson DG, 2004, NAT BIOTECHNOL, V22, P863, DOI 10.1038/nbt981; Anseth KS, 2002, MRS BULL, V27, P130, DOI 10.1557/mrs2002.49; Drury JL, 2003, BIOMATERIALS, V24, P4337, DOI 10.1016/S0142-9612(03)00340-5; Grayson ACR, 2003, NAT MATER, V2, P767, DOI 10.1038/nmat998; Lahann J, 2003, SCIENCE, V299, P371, DOI 10.1126/science.1078933; Langer R, 2004, NATURE, V428, P487, DOI 10.1038/nature02388; Lee KY, 2000, NATURE, V408, P998, DOI 10.1038/35050141; Lendlein A, 2002, SCIENCE, V296, P1673, DOI 10.1126/science.1066102; Lutolf MR, 2003, NAT BIOTECHNOL, V21, P513, DOI 10.1038/nbt818; McFadden P, 2002, SCIENCE, V297, P2075, DOI 10.1126/science.297.5589.2075; PEPPAS NA, 1994, SCIENCE, V263, P1715, DOI 10.1126/science.8134835; Saltzman WM, 2002, NAT REV DRUG DISCOV, V1, P177, DOI 10.1038/nrd744; Santini JT, 1999, NATURE, V397, P335, DOI 10.1038/16898; Shea LD, 1999, NAT BIOTECHNOL, V17, P551, DOI 10.1038/9853; Silva GA, 2004, SCIENCE, V303, P1352, DOI 10.1126/science.1093783; Zhang SG, 2003, NAT BIOTECHNOL, V21, P1171, DOI 10.1038/nbt874	16	239	251	2	141	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 24	2004	305	5692					1923	1924		10.1126/science.1099987	http://dx.doi.org/10.1126/science.1099987			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	857RM	15448260				2022-12-28	WOS:000224136000036
J	Sekiguchi, A; Kinjo, R; Ichinohe, M				Sekiguchi, A; Kinjo, R; Ichinohe, M			A stable compound containing a silicon-silicon triple bond	SCIENCE			English	Article							ORGANOSILICON COMPOUNDS; CHEMISTRY	The reaction of 2,2,3,3-tetrabromo-1,1,4,4-tetrakis [bis(trimethylsilyl)methyl]1,4-diisopropyltetrasilane with four equivalents of potassium graphite (KC8) in tetrahydrofuran produces 1,1,4,4-tetrakis[bis(trimethylsilyl)methyl]-1,4-diisopropyl-2-tetrasilyne, a stable compound with a silicon-silicon triple bond, which can be isolated as emerald green crystals stable up to 100 C in the absence of air. The Si=Si triple-bond length (and its estimated standard deviation) is 2.0622(9) angstroms, which shows half the magnitude of the bond shortening of alkynes compared with that of alkenes. Unlike alkynes, the substituents at the Si=Si group are not arranged in a linear fashion, but, are trans-bent with a bond angle of 137.44(4)degrees.	Univ Tsukuba, Grad Sch Pure & Appl Sci, Dept Chem, Tsukuba, Ibaraki 3058571, Japan	University of Tsukuba	Sekiguchi, A (corresponding author), Univ Tsukuba, Grad Sch Pure & Appl Sci, Dept Chem, Tsukuba, Ibaraki 3058571, Japan.	sekiguch@staff.chem.tsukuba.ac.jp	Kinjo, Rei/AAA-7212-2020; Kinjo, Rei/E-4504-2014	Kinjo, Rei/0000-0002-4425-3937; Kinjo, Rei/0000-0002-4425-3937				BOOK AG, 1981, J CHEM SOC CHEM COMM, P191; DAVIDSON PJ, 1973, J CHEM SOC CHEM COMM, P317; GOUBEAU J, 1957, ANGEW CHEM INT EDIT, V69, P77, DOI 10.1002/ange.19570690302; Ichinohe M, 2003, J AM CHEM SOC, V125, P13328, DOI 10.1021/ja0305050; JUTZI P, 1975, ANGEW CHEM INT EDIT, V14, P232, DOI 10.1002/anie.197502321; KIRA M, 1994, ANGEW CHEM INT EDIT, V33, P1489, DOI 10.1002/anie.199414891; Kobayashi K, 1997, ORGANOMETALLICS, V16, P2489, DOI 10.1021/om970232f; Nagase S, 2000, J ORGANOMET CHEM, V611, P264, DOI 10.1016/S0022-328X(00)00489-7; Pietschnig R, 2000, ORGANOMETALLICS, V19, P2724, DOI 10.1021/om990924z; Power PP, 1999, CHEM REV, V99, P3463, DOI 10.1021/cr9408989; Power PP, 2003, CHEM COMMUN, P2091, DOI 10.1039/b212224c; Raabe G., 1989, CHEM ORGANIC SILICON; Robinson GH, 1999, ACCOUNTS CHEM RES, V32, P773, DOI 10.1021/ar980135y; SAKURAI H, 1982, CHEM LETT, P1251, DOI 10.1246/cl.1982.1251; SEKIGUCHI A, 1986, J AM CHEM SOC, V108, P4241, DOI 10.1021/ja00274a075; Stender M, 2002, ANGEW CHEM INT EDIT, V41, P1785, DOI 10.1002/1521-3773(20020517)41:10<1785::AID-ANIE1785>3.0.CO;2-6; Takagi N, 2002, EUR J INORG CHEM, P2775; Weidenbruch M., 2001, CHEM ORGANIC SILICON, V3; WEST R, 1987, ANGEW CHEM INT EDIT, V26, P1201, DOI 10.1002/anie.198712013; WEST R, 1981, SCIENCE, V214, P1343, DOI 10.1126/science.214.4527.1343; WIBERG E, 1943, LEHRBUCH ANORGANISCH; Wiberg N, 2002, EUR J INORG CHEM, P1066	22	407	411	2	116	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 17	2004	305	5691					1755	1757		10.1126/science.1102209	http://dx.doi.org/10.1126/science.1102209			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC)	Science & Technology - Other Topics	856IS	15375262				2022-12-28	WOS:000224039500035
J	Hannon, GJ; Rossi, JJ				Hannon, GJ; Rossi, JJ			Unlocking the potential of the human genome with RNA interference	NATURE			English	Review							CHRONIC MYELOGENOUS LEUKEMIA; ABL GENE-EXPRESSION; DOUBLE-STRANDED-RNA; HIV-1 INFECTION; IN-VIVO; IMATINIB MESYLATE; LENTIVIRAL VECTOR; SYNTHETIC SIRNAS; TRANSGENIC MICE; MOLECULAR-BASIS		Cold Spring Harbor Lab, Watson Sch Biol Sci, Cold Spring Harbor, NY 11724 USA; Grad Sch Biol Sci, Beckman Res Inst City Hope, Div Mol Biol, Duarte, CA 91010 USA	Cold Spring Harbor Laboratory; City of Hope; Beckman Research Institute of City of Hope	Hannon, GJ (corresponding author), Cold Spring Harbor Lab, Watson Sch Biol Sci, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.	haiinon@cshl.edu; JRossi@coh.org	Hannon, Gregory/AAB-3568-2019					Amado RG, 2004, HUM GENE THER, V15, P251, DOI 10.1089/104303404322886101; Aza-Blanc P, 2003, MOL CELL, V12, P627, DOI 10.1016/S1097-2765(03)00348-4; Banerjea A, 2003, MOL THER, V8, P62, DOI 10.1016/S1525-0016(03)00140-0; Berns K, 2004, NATURE, V428, P431, DOI 10.1038/nature02371; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Blight KJ, 2000, SCIENCE, V290, P1972, DOI 10.1126/science.290.5498.1972; Boden D, 2003, J VIROL, V77, P11531, DOI 10.1128/JVI.77.21.11531-11535.2003; Brummelkamp TR, 2002, CANCER CELL, V2, P243, DOI 10.1016/S1535-6108(02)00122-8; Brummelkamp TR, 2003, NATURE, V424, P797, DOI 10.1038/nature01811; Buchele T, 2003, ONKOLOGIE, V26, P60, DOI 10.1159/000076177; Capodici J, 2002, J IMMUNOL, V169, P5196, DOI 10.4049/jimmunol.169.9.5196; Carmell MA, 2003, NAT STRUCT BIOL, V10, P91, DOI 10.1038/nsb896; Chiu YL, 2003, RNA, V9, P1034, DOI 10.1261/rna.5103703; Coburn GA, 2002, J VIROL, V76, P9225, DOI 10.1128/JVI.76.18.9225-9231.2002; Cowan-Jacob SW, 2004, MINI-REV MED CHEM, V4, P285, DOI 10.2174/1389557043487321; Czauderna F, 2003, NUCLEIC ACIDS RES, V31, P2705, DOI 10.1093/nar/gkg393; Davidson BL, 2004, LANCET NEUROL, V3, P145, DOI 10.1016/S1474-4422(04)00678-7; Davis BM, 2004, MOL THER, V9, P160, DOI 10.1016/j.ymthe.2003.11.003; Dell'Agnola C, 2002, EXP HEMATOL, V30, P905, DOI 10.1016/S0301-472X(02)00866-4; Ding HL, 2003, AGING CELL, V2, P209, DOI 10.1046/j.1474-9728.2003.00054.x; Doench JG, 2004, GENE DEV, V18, P504, DOI 10.1101/gad.1184404; Dropulic B, 2001, MOL THER, V4, P511; Eastman SJ, 2002, HUM GENE THER, V13, P2065, DOI 10.1089/10430340260395910; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Enright AJ, 2004, GENOME BIOL, V5; EugenOlsen J, 1997, AIDS, V11, P305, DOI 10.1097/00002030-199703110-00007; FIRE A, 1991, DEVELOPMENT, V113, P503; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Grishok A, 2001, CELL, V106, P23, DOI 10.1016/S0092-8674(01)00431-7; GUO S, 1995, CELL, V81, P611, DOI 10.1016/0092-8674(95)90082-9; Hammond SM, 2001, SCIENCE, V293, P1146, DOI 10.1126/science.1064023; Hannon GJ, 2002, NATURE, V418, P244, DOI 10.1038/418244a; Hasuwa H, 2002, FEBS LETT, V532, P227, DOI 10.1016/S0014-5793(02)03680-3; Hemann MT, 2003, NAT GENET, V33, P396, DOI 10.1038/ng1091; Holtz MS, 2004, LEUKEMIA LYMPHOMA, V45, P237, DOI 10.1080/1042819031000151905; Hsieh AC, 2004, NUCLEIC ACIDS RES, V32, P893, DOI 10.1093/nar/gkh238; Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961; Hutvagner G, 2004, PLOS BIOL, V2, P465, DOI 10.1371/journal.pbio.0020098; Ikeda M, 2002, J VIROL, V76, P2997, DOI 10.1128/JVI.76.6.2997-3006.2002; Jackson AL, 2003, NAT BIOTECHNOL, V21, P635, DOI 10.1038/nbt831; Jacque JM, 2002, NATURE, V418, P435, DOI 10.1038/nature00896; Kapadia SB, 2003, P NATL ACAD SCI USA, V100, P2014, DOI 10.1073/pnas.252783999; Ketting RF, 2001, GENE DEV, V15, P2654, DOI 10.1101/gad.927801; Khvorova A, 2003, CELL, V115, P209, DOI 10.1016/S0092-8674(03)00801-8; Kim DH, 2004, NAT BIOTECHNOL, V22, P321, DOI 10.1038/nbt940; Kittler R, 2003, SEMIN CANCER BIOL, V13, P259, DOI 10.1016/S1044-579X(03)00039-7; Kunath T, 2003, NAT BIOTECHNOL, V21, P559, DOI 10.1038/nbt813; Lai EC, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-7-r42; Layzer JM, 2004, RNA, V10, P766, DOI 10.1261/rna.5239604; Lee NS, 2002, NAT BIOTECHNOL, V20, P500, DOI 10.1038/nbt0502-500; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lewis DL, 2002, NAT GENET, V32, P107, DOI 10.1038/ng944; Li MJ, 2003, OLIGONUCLEOTIDES, V13, P401, DOI 10.1089/154545703322617087; Li MJ, 2003, MOL THER, V8, P196, DOI 10.1016/S1525-0016(03)00165-5; Lohmann V, 1999, SCIENCE, V285, P110, DOI 10.1126/science.285.5424.110; Lu PY, 2003, CURR OPIN MOL THER, V5, P225; Luo B, 2004, P NATL ACAD SCI USA, V101, P5494, DOI 10.1073/pnas.0400551101; Marcucci G, 2003, CLIN CANCER RES, V9, P1248; Marcucci G., 2003, CLIN CANCER RES, V9, P1333; Martinez MA, 2002, AIDS, V16, P2385, DOI 10.1097/00002030-200212060-00002; Matsuda T, 2004, P NATL ACAD SCI USA, V101, P16, DOI 10.1073/pnas.2235688100; McCaffrey AP, 2002, NATURE, V418, P38, DOI 10.1038/418038a; McCaffrey AP, 2003, NAT BIOTECHNOL, V21, P639, DOI 10.1038/nbt824; Michienzi A, 2003, ANN NY ACAD SCI, V1002, P63, DOI 10.1196/annals.1281.008; Miller VM, 2004, NUCLEIC ACIDS RES, V32, P661, DOI 10.1093/nar/gkh208; Miller VM, 2003, P NATL ACAD SCI USA, V100, P7195, DOI 10.1073/pnas.1231012100; Moss EG, 2002, CURR BIOL, V12, pR138, DOI 10.1016/S0960-9822(02)00708-X; Novina CD, 2002, NAT MED, V8, P681, DOI 10.1038/nm725; Paddison Patrick J, 2004, Methods Mol Biol, V265, P85; Paddison PJ, 2004, NATURE, V428, P427, DOI 10.1038/nature02370; Park WS, 2002, NUCLEIC ACIDS RES, V30, P4830, DOI 10.1093/nar/gkf627; Pasquinelli AE, 2002, TRENDS GENET, V18, P171, DOI 10.1016/S0168-9525(01)02624-5; Pebernard S, 2004, DIFFERENTIATION, V72, P103, DOI 10.1111/j.1432-0436.2004.07202001.x; Persengiev SP, 2004, RNA, V10, P12, DOI 10.1261/rna5160904; Pietschmann T, 2001, J VIROL, V75, P1252, DOI 10.1128/JVI.75.3.1252-1264.2001; Qin XF, 2003, P NATL ACAD SCI USA, V100, P183, DOI 10.1073/pnas.232688199; Randall G, 2003, P NATL ACAD SCI USA, V100, P235, DOI 10.1073/pnas.0235524100; Reynolds A, 2004, NAT BIOTECHNOL, V22, P326, DOI 10.1038/nbt936; Rubinson DA, 2003, NAT GENET, V33, P401, DOI 10.1038/ng1117; Samson M, 1996, NATURE, V382, P722, DOI 10.1038/382722a0; Saxena S, 2003, J BIOL CHEM, V278, P44312, DOI 10.1074/jbc.M307089200; Scacheri PC, 2004, P NATL ACAD SCI USA, V101, P1892, DOI 10.1073/pnas.0308698100; Scherr M, 2003, BLOOD, V101, P1566, DOI 10.1182/blood-2002-06-1685; Schwarz DS, 2003, CELL, V115, P199, DOI 10.1016/S0092-8674(03)00759-1; Sen G, 2004, NAT GENET, V36, P183, DOI 10.1038/ng1288; Shirane D, 2004, NAT GENET, V36, P190, DOI 10.1038/ng1290; Silva JM, 2004, P NATL ACAD SCI USA, V101, P6548, DOI 10.1073/pnas.0400165101; Silva JM, 2003, NAT GENET, V35, P303, DOI 10.1038/ng1203-303; Sledz CA, 2003, NAT CELL BIOL, V5, P834, DOI 10.1038/ncb1038; Song EW, 2003, NAT MED, V9, P347, DOI 10.1038/nm828; Sorensen DR, 2003, J MOL BIOL, V327, P761, DOI 10.1016/S0022-2836(03)00181-5; Surabhi RM, 2002, J VIROL, V76, P12963, DOI 10.1128/JVI.76.24.12963-12973.2002; Tauchi T, 2004, LEUK RES S1, V28, P39; Tiscornia G, 2003, P NATL ACAD SCI USA, V100, P1844, DOI 10.1073/pnas.0437912100; Wall NR, 2003, LANCET, V362, P1401, DOI 10.1016/S0140-6736(03)14637-5; Wang LX, 2003, ANTISENSE NUCLEIC A, V13, P169, DOI 10.1089/108729003768247637; Williams BRG, 1997, BIOCHEM SOC T, V25, P509, DOI 10.1042/bst0250509; Wilson JA, 2003, P NATL ACAD SCI USA, V100, P2783, DOI 10.1073/pnas.252758799; Wohlbold L, 2003, BLOOD, V102, P2236, DOI 10.1182/blood-2002-12-3899; Zheng LX, 2004, P NATL ACAD SCI USA, V101, P135, DOI 10.1073/pnas.2136685100; Ziauddin J, 2001, NATURE, V411, P107, DOI 10.1038/35075114	101	874	1033	0	87	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 16	2004	431	7006					371	378		10.1038/nature02870	http://dx.doi.org/10.1038/nature02870			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	853XJ	15372045				2022-12-28	WOS:000223864000054
J	Wright, AA; Katz, IT				Wright, AA; Katz, IT			Becoming a physician - Match point?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Brigham & Womens Hosp, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital	Wright, AA (corresponding author), Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA.		Wright, Alexi/T-5793-2019	Katz, Ingrid/0000-0002-3014-238X					0	3	3	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 16	2004	351	12					1165	1167		10.1056/NEJMp048122	http://dx.doi.org/10.1056/NEJMp048122			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	853WS	15371571				2022-12-28	WOS:000223861300002
J	Gebelein, B; McKay, DJ; Mann, RS				Gebelein, B; McKay, DJ; Mann, RS			Direct integration of Hox and segmentation gene inputs during Drosophila development	NATURE			English	Article							BITHORAX COMPLEX; HOMEODOMAIN PROTEIN; LIMB DEVELOPMENT; ULTRABITHORAX PROTEINS; TARGET GENES; DISTAL-LESS; REPRESSION; EXPRESSION; EXTRADENTICLE; EMBRYO	During Drosophila embryogenesis, segments, each with an anterior and posterior compartment, are generated by the segmentation genes while the Hox genes provide each segment with a unique identity. These two processes have been thought to occur independently. Here we show that abdominal Hox proteins work directly with two different segmentation proteins, Sloppy paired and Engrailed, to repress the Hox target gene Distalless in anterior and posterior compartments, respectively. These results suggest that segmentation proteins can function as Hox cofactors and reveal a previously unanticipated use of compartments for gene regulation by Hox proteins. Our results suggest that these two classes of proteins may collaborate to directly control gene expression at many downstream target genes.	Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10032 USA; Columbia Univ, Ctr Neurobiol & Behav, New York, NY 10032 USA; Columbia Univ, Integrated Program Cellular Mol & Biophys Studies, New York, NY 10032 USA	Columbia University; Columbia University; Columbia University	Mann, RS (corresponding author), Columbia Univ, Dept Biochem & Mol Biophys, 701 W 168th St,HHSC 1104, New York, NY 10032 USA.	rsm10@columbia.edu	Nakafuku, Masato/J-3068-2013		NIGMS NIH HHS [R01 GM054510] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054510] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alexandre C, 2003, DEVELOPMENT, V130, P729, DOI 10.1242/dev.00286; Andrioli LPM, 2002, DEVELOPMENT, V129, P4931; Aspland SE, 1997, DEVELOPMENT, V124, P741; CADIGAN KM, 1994, P NATL ACAD SCI USA, V91, P6324, DOI 10.1073/pnas.91.14.6324; CADIGAN KM, 1994, GENE DEV, V8, P899, DOI 10.1101/gad.8.8.899; CARROLL SB, 1988, GENE DEV, V2, P350, DOI 10.1101/gad.2.3.350; CASANOVA J, 1987, EMBO J, V6, P3103, DOI 10.1002/j.1460-2075.1987.tb02619.x; COHEN SM, 1990, NATURE, V343, P173, DOI 10.1038/343173a0; COHEN SM, 1989, NATURE, V338, P432, DOI 10.1038/338432a0; Dahmann C, 1999, TRENDS GENET, V15, P320, DOI 10.1016/S0168-9525(99)01774-6; DINARDO S, 1994, CURR OPIN GENET DEV, V4, P529, DOI 10.1016/0959-437X(94)90068-E; Ferretti E, 2000, DEVELOPMENT, V127, P155; FJOSE A, 1985, NATURE, V313, P284, DOI 10.1038/313284a0; FRASER S, 1990, NATURE, V344, P431, DOI 10.1038/344431a0; Galant R, 2002, DEVELOPMENT, V129, P3115; GARCIABELLIDO A, 1973, NATURE-NEW BIOL, V245, P251, DOI 10.1038/newbio245251a0; Gebelein B, 2002, DEV CELL, V3, P487, DOI 10.1016/S1534-5807(02)00257-5; GIBSON G, 1988, DEVELOPMENT, V102, P657; GONZALEZREYES A, 1990, CELL, V61, P515, DOI 10.1016/0092-8674(90)90533-K; Grieder NC, 1997, EMBO J, V16, P7402, DOI 10.1093/emboj/16.24.7402; GROSSNIKLAUS U, 1992, GENE DEV, V6, P1030, DOI 10.1101/gad.6.6.1030; Irvine KD, 2001, ANNU REV CELL DEV BI, V17, P189, DOI 10.1146/annurev.cellbio.17.1.189; Jimenez G, 1997, GENE DEV, V11, P3072, DOI 10.1101/gad.11.22.3072; KARCH F, 1990, GENE DEV, V4, P1573, DOI 10.1101/gad.4.9.1573; Kobayashi M, 2001, DEVELOPMENT, V128, P1805; KORNBERG T, 1985, CELL, V40, P45, DOI 10.1016/0092-8674(85)90307-1; Kosman D, 1998, DEV GENES EVOL, V208, P290, DOI 10.1007/s004270050184; Lawrence PA, 1996, CELL, V85, P951, DOI 10.1016/S0092-8674(00)81297-0; LEWIS EB, 1978, NATURE, V276, P565, DOI 10.1038/276565a0; Lohmann I, 2002, CELL, V110, P457, DOI 10.1016/S0092-8674(02)00871-1; Mann RS, 2000, ANNU REV CELL DEV BI, V16, P243, DOI 10.1146/annurev.cellbio.16.1.243; Mann RS, 2002, CURR OPIN GENET DEV, V12, P592, DOI 10.1016/S0959-437X(02)00344-1; MANN RS, 1994, DEVELOPMENT, V120, P3205; MANN RS, 1990, CELL, V60, P597, DOI 10.1016/0092-8674(90)90663-Y; Mann RS, 1996, NATURE, V383, P630, DOI 10.1038/383630a0; MARTINEZARIAS A, 1985, NATURE, V313, P639, DOI 10.1038/313639a0; MCGINNIS W, 1992, CELL, V68, P283, DOI 10.1016/0092-8674(92)90471-N; MORATA G, 1975, NATURE, V255, P614, DOI 10.1038/255614a0; Nasiadka A., 2002, AD DEV BIOL, V12, P155; POPPERL H, 1995, CELL, V81, P1031, DOI 10.1016/S0092-8674(05)80008-X; Rieckhof GE, 1997, CELL, V91, P171, DOI 10.1016/S0092-8674(00)80400-6; Ryoo HD, 1999, GENE DEV, V13, P1704, DOI 10.1101/gad.13.13.1704; SANCHEZHERRERO E, 1985, NATURE, V313, P108, DOI 10.1038/313108a0; Shen WF, 1997, MOL CELL BIOL, V17, P6448, DOI 10.1128/MCB.17.11.6448; STRUHL G, 1984, NATURE, V308, P454, DOI 10.1038/308454a0; Tolkunova EN, 1998, MOL CELL BIOL, V18, P2804, DOI 10.1128/MCB.18.5.2804; VACHON G, 1992, CELL, V71, P437, DOI 10.1016/0092-8674(92)90513-C	47	117	117	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 7	2004	431	7009					653	659		10.1038/nature02946	http://dx.doi.org/10.1038/nature02946			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	859WS	15470419				2022-12-28	WOS:000224299300031
J	Kratz, A; Ferraro, M; Sluss, PM; Lewandrowski, KB				Kratz, A; Ferraro, M; Sluss, PM; Lewandrowski, KB			Laboratory reference value	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Massachusetts Gen Hosp, Dept Pathol, Clin Hematol Lab, Boston, MA 02114 USA; Massachusetts Gen Hosp, Microbiol Lab, Boston, MA 02114 USA; Massachusetts Gen Hosp, Immunodiagnost Lab, Boston, MA 02114 USA; Harvard Univ, Sch Med, Cambridge, MA 02138 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University	Kratz, A (corresponding author), Massachusetts Gen Hosp, Dept Pathol, Clin Hematol Lab, Boston, MA 02114 USA.							Kratz A, 1998, NEW ENGL J MED, V339, P1063, DOI 10.1056/NEJM199810083391508	1	410	420	0	17	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 7	2004	351	15					1548	1563		10.1056/NEJMcpc049016	http://dx.doi.org/10.1056/NEJMcpc049016			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	859UP	15470219				2022-12-28	WOS:000224293700014
J	Benamouzig, R; Chaussade, S				Benamouzig, R; Chaussade, S			Calcium supplementation for preventing colorectal cancer: where do we stand?	LANCET			English	Editorial Material							VITAMIN-D; ADENOMAS; RISK; RECURRENCE; TRIAL		Univ Paris 13, AP HP, Avicenne Hosp, Dept Gastroenterol, F-93009 Bobigny, France; Cochin Hosp, Dept Gastroenterol, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Avicenne - APHP; Universite Paris 13; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite	Benamouzig, R (corresponding author), Univ Paris 13, AP HP, Avicenne Hosp, Dept Gastroenterol, F-93009 Bobigny, France.	apacc@club-internet.fr	Coriat, Romain/O-7902-2017; BENAMOUZIG, Robert/W-8067-2019	BENAMOUZIG, ROBERT/0000-0003-1952-6830				Baron JA, 1999, NEW ENGL J MED, V340, P101, DOI 10.1056/NEJM199901143400204; Benamouzig R, 2003, GASTROENTEROLOGY, V125, P328, DOI 10.1016/S0016-5085(03)00887-4; BergsmaKadijk JA, 1996, EPIDEMIOLOGY, V7, P590, DOI 10.1097/00001648-199611000-00005; Boyapati SM, 2003, CANCER EPIDEM BIOMAR, V12, P631; CURHAN GC, 1993, NEW ENGL J MED, V328, P833, DOI 10.1056/NEJM199303253281203; Grau MV, 2003, J NATL CANCER I, V95, P1765, DOI 10.1093/jnci/djg110; Martinez ME, 2001, GASTROENTEROLOGY, V120, P1077, DOI 10.1053/gast.2001.23247; Martinez ME, 1998, CANCER EPIDEM BIOMAR, V7, P163; WALLACE K, 2004, J NATL CANCER I, V96, P21; WEINGARTEN MA, 2004, COCHRANE LIB	10	3	3	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 2	2004	364	9441					1197	1199		10.1016/S0140-6736(04)17156-0	http://dx.doi.org/10.1016/S0140-6736(04)17156-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	859HO	15464166				2022-12-28	WOS:000224254200006
J	Bonsall, MB; Jansen, VAA; Hassell, MP				Bonsall, MB; Jansen, VAA; Hassell, MP			Life history trade-offs assemble ecological guilds	SCIENCE			English	Article							LIMITING SIMILARITY; COMPETITION; DYNAMICS; HOST; COEXISTENCE	Ecological theory predicts that competition for a limiting resource will lead to the exclusion of species unless the within-species effects outweigh the between-species effects. Understanding how multiple competitors might coexist on a single resource has focused on the prescriptive formalism of a necessary niche width and limiting similarity. Here, we show how continuously varying life histories and trade-offs in these characteristics can allow multiple competitors to coexist, and we reveal how limiting similarity emerges and is shaped by the ecological and evolutionary characteristics of competitors. In this way, we illustrate how the interplay of ecological and evolutionary processes acts to shape ecological communities in a unique way. This leads us to argue that evolutionary processes (life-history trait trade-offs) are fundamental to the understanding of the structure of ecological communities.	Univ London Imperial Coll Sci Technol & Med, Dept Biol Sci, Silwood Pk Campus, Ascot SL5 7PY, Berks, England; Royal Holloway Univ London, Sch Biol Sci, Egham TW20 0EX, Surrey, England	Imperial College London; University of London; Royal Holloway University London	Bonsall, MB (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Biol Sci, Silwood Pk Campus, Ascot SL5 7PY, Berks, England.	m.bonsall@imperial.ac.uk	Jansen, Vincent A A/C-8353-2009	Bonsall, Michael/0000-0003-0250-0423; Jansen, Vincent A.A./0000-0002-6518-2090				ABRAMS P, 1975, THEOR POPUL BIOL, V8, P356, DOI 10.1016/0040-5809(75)90052-0; ARMSTRONG RA, 1980, AM NAT, V115, P151, DOI 10.1086/283553; Bell G, 2000, AM NAT, V155, P606, DOI 10.1086/303345; Bonsall MB, 2004, P ROY SOC B-BIOL SCI, V271, P1143, DOI 10.1098/rspb.2004.2722; Bonsall MB, 2002, ECOLOGY, V83, P925, DOI 10.1890/0012-9658(2002)083[0925:ETORPA]2.0.CO;2; BRIGGS CJ, 1993, AM NAT, V141, P372, DOI 10.1086/285479; Dieckmann U, 1999, NATURE, V400, P354, DOI 10.1038/22521; Dieckmann U, 1997, TRENDS ECOL EVOL, V12, P128, DOI 10.1016/S0169-5347(97)01004-5; Doebeli M, 2003, NATURE, V421, P259, DOI 10.1038/nature01274; Geritz SAH, 1998, EVOL ECOL, V12, P35, DOI 10.1023/A:1006554906681; HAIGH J, 1972, THEOR POPUL BIOL, V3, P290, DOI 10.1016/0040-5809(72)90005-6; Hassell MP., 1978, DYNAMICS ARTHROPOD P; HASSELL MP, 2000, TEMPORAL SPATIAL DYN; Hubbell Stephen P., 2001, V32, pi; HUTCHINSON GE, 1959, AM NAT, V93, P145, DOI 10.1086/282070; Jansen VAA, 1999, ECOL LETT, V2, P379; Lack D., 1947, DARWINS FINCHES; LEVIN BR, 1971, EVOLUTION, V25, P249, DOI 10.1111/j.1558-5646.1971.tb01878.x; LEVINS R, 1971, P NATL ACAD SCI USA, V68, P1246, DOI 10.1073/pnas.68.6.1246; MACARTHUR R, 1967, AM NAT, V101, P377, DOI 10.1086/282505; May R.M., 1974, STABILITY COMPLEXITY; MAY RM, 1981, AM NAT, V117, P234, DOI 10.1086/283704; METZ JAJ, 1992, TRENDS ECOL EVOL, V7, P198, DOI 10.1016/0169-5347(92)90073-K; Morin P., 1999, COMMUNITY ECOL; Nicholson A. J., 1935, P ZOOL SOC LOND, V105, P551, DOI DOI 10.1111/J.1096-3642.1935.TB01680.X; Roff Derek A., 1992; ROOT RB, 1967, ECOL MONOGR, V37, P317, DOI 10.2307/1942327; Stearns S.C., 1992, pi; STEWART FM, 1973, AM NAT, V107, P171, DOI 10.1086/282825; TILMAN D, 1994, ECOLOGY, V75, P2, DOI 10.2307/1939377; Tilman D, 2004, P NATL ACAD SCI USA, V101, P10854, DOI 10.1073/pnas.0403458101; Tilman D., 1982, Monographs in Population Biology, pi	32	106	112	1	46	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 1	2004	306	5693					111	114		10.1126/science.1100680	http://dx.doi.org/10.1126/science.1100680			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	859YJ	15459391				2022-12-28	WOS:000224304000048
J	Stecyk, JAW; Stenslokken, KO; Farrell, AP; Nilsson, GE				Stecyk, JAW; Stenslokken, KO; Farrell, AP; Nilsson, GE			Maintained cardiac pumping in anoxic crucian carp	SCIENCE			English	Article							CARDIOVASCULAR-RESPONSES; 5-DEGREES-C; 22-DEGREES; HYPOXIA; TURTLE; OXYGEN		Simon Fraser Univ, Dept Biol Sci, Burnaby, BC V5A 1S6, Canada; Univ Oslo, Dept Mol Biosci, Physiol Programme, N-0316 Oslo, Norway	Simon Fraser University; University of Oslo	Stecyk, JAW (corresponding author), Simon Fraser Univ, Dept Biol Sci, 8888 Univ Dr, Burnaby, BC V5A 1S6, Canada.	jstecyk@interchange.ubc.ca	Nilsson, Goran E/K-7668-2012; Stecyk, Jonathan/B-4530-2013; Nilsson, Göran Erik/Q-6129-2019	Nilsson, Goran E/0000-0002-3195-3053; Stecyk, Jonathan/0000-0002-0973-9472; Stenslokken, Kare-Olav/0000-0003-2962-4143				AXELSSON M, 1990, J EXP BIOL, V151, P297; Hicks JMT, 2000, J EXP BIOL, V203, P3775; Hicks JMT, 2000, J EXP BIOL, V203, P3765; Jackson DC, 2002, J PHYSIOL-LONDON, V543, P731, DOI 10.1113/jphysiol.2002.024729; JACKSON DC, 1968, J APPL PHYSIOL, V24, P503, DOI 10.1152/jappl.1968.24.4.503; Nilsson GE, 2001, NEWS PHYSIOL SCI, V16, P217; Stecyk JAW, 2002, J EXP BIOL, V205, P759	7	94	97	1	40	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 1	2004	306	5693					77	77		10.1126/science.1100763	http://dx.doi.org/10.1126/science.1100763			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	859YJ	15459381				2022-12-28	WOS:000224304000038
J	Verweij, J; Casali, PG; Zalcberg, J; LeCesne, A; Reichardt, P; Blay, JY; Issels, R; van Oosterom, A; Hogendoorn, PCW; Van Glabbeke, M; Bertulli, R; Judson, I				Verweij, J; Casali, PG; Zalcberg, J; LeCesne, A; Reichardt, P; Blay, JY; Issels, R; van Oosterom, A; Hogendoorn, PCW; Van Glabbeke, M; Bertulli, R; Judson, I		EORTC Soft Tissue Bone Sarcoma Grp; Italian Sarcoma Grp; Australasian Gastrointestinal Tria	Progression-free survival in gastrointestinal stromal tumours with high-dose imatinib: randomised trial	LANCET			English	Article							DIAGNOSIS; MESYLATE; EFFICACY; SAFETY	Background Imatinib is approved worldwide for use in gastrointestinal stromal tumours (GIST). We aimed to assess dose dependency of response and progression-free survival with imatinib for metastatic GIST. Methods 946 patients were randomly allocated imatinib 400 mg either once or twice a day. Those assigned the once a day regimen who had progression were offered the option of crossover. The primary endpoint was progression-free survival. Analysis was by intention to treat. Findings At median follow-up of 760 days (IQR 644-859), 263 (56%) of 473 patients allocated imatinib once a day had progressed compared with 235 (50%) of 473 who were assigned treatment twice a day (estimated hazard ratio 0-82 [95% Cl 0-69-0-98]; p = 0.026). Side-effects arose in 465/470 (99%) patients allocated the once daily regimen compared with 468/472 (99%) assigned treatment twice a day. By comparison with the group treated once a day, more dose reductions (77 [16%] vs 282 [60%]) and treatment interruptions (189 [40%] vs 302 [64%]) were recorded in patients allocated the twice daily regimen, but treatment in both arms was fairly well tolerated. 52 (5%) patients achieved a complete response, 442 (47%) a partial response, and 300 (32%) stable disease, with no difference between groups. Median time to best response was 107 days (IQR 58-172). Interpretation If response induction is the only aim of treatment, a daily dose of 400 mg of imatinib is sufficient; however, a dose of 400 mg twice a day achieves significantly longer progression-free survival.	Erasmus Univ, Med Ctr, Dept Med Oncol, NL-3075 EA Rotterdam, Netherlands; Inst Tumori, Dept Med Oncol, Milan, Italy; Peter MacCallum Canc Ctr, Dept Med Oncol, Melbourne, Vic, Australia; Inst Gustave Roussy, Dept Med Oncol, Villejuif, France; HELIOS Klinikum, Dept Haematol Oncol & Tumorimmunol, Berlin, Germany; Ctr Leon Berard, INSERM, U590, Dept Med Oncol, F-69373 Lyon, France; Hosp Civils Lyon, Lyon, France; Univ Munich, Klinikum Grosshadern, Dept Med Oncol, D-8000 Munich, Germany; GSF Natl Res Ctr Environm & Hlth, Neuherberg, Germany; Univ Hosp Gasthuisberg, Dept Oncol, B-3000 Louvain, Belgium; Leiden Univ, Med Ctr, Dept Pathol, Leiden, Netherlands; EORTC Data Ctr, Brussels, Belgium; Royal Marsden Hosp, Dept Med Oncol, London SW3 6JJ, England	Erasmus University Rotterdam; Erasmus MC; Fondazione IRCCS Istituto Nazionale Tumori Milan; Peter Maccallum Cancer Center; UNICANCER; Gustave Roussy; Helios Kliniken; Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Centre Leon Berard; CHU Lyon; University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; KU Leuven; University Hospital Leuven; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; European Organisation for Research & Treatment of Cancer; Royal Marsden NHS Foundation Trust	Verweij, J (corresponding author), Erasmus Univ, Med Ctr, Dept Med Oncol, Groene Hilledijk 301, NL-3075 EA Rotterdam, Netherlands.	j.verweij@erasmusmc.nl	Hogendoorn, Pancras C.W./H-5859-2015; casali, Paolo Giovanni/D-1524-2017; ravegnini, gloria/K-1330-2016; Bertulli, Rossella/G-8916-2017; Hogendoorn, Pancras/O-6494-2019; Blay, Jean-Yves/N-3966-2016	Hogendoorn, Pancras C.W./0000-0002-1513-8104; casali, Paolo Giovanni/0000-0003-4056-8023; ravegnini, gloria/0000-0002-7774-402X; Bertulli, Rossella/0000-0002-7237-7515; Hogendoorn, Pancras/0000-0002-1513-8104; Blay, Jean-Yves/0000-0001-7190-120X; Issels, Rolf/0000-0002-3494-6561				Blay JY., 2004, P AM SOC CLIN ONCOL, V23, P815; Demetri GD, 2002, NEW ENGL J MED, V347, P472, DOI 10.1056/NEJMoa020461; Fletcher CDM, 2002, HUM PATHOL, V33, P459, DOI 10.1053/hupa.2002.123545; GRAY RJ, 1988, ANN STAT, V16, P1141, DOI 10.1214/aos/1176350951; Hirota S, 1998, SCIENCE, V279, P577, DOI 10.1126/science.279.5350.577; HOMMEL G, 1988, BIOMETRIKA, V75, P383, DOI 10.2307/2336190; Joensuu H, 2002, LANCET ONCOL, V3, P655, DOI 10.1016/S1470-2045(02)00899-9; Joensuu H, 2004, ACTA ORTHOP SCAND, V75, P62, DOI 10.1080/00016470410001708340; JUDSON IR, IN PRESS CANC CHEMOT; Kalbfleisch JD, 1980, STAT ANAL FAILURE TI, P163; Miettinen M, 2002, HUM PATHOL, V33, P478, DOI 10.1053/hupa.2002.124123; RANKIN C, 2004, P AN M AM SOC CLIN, V23, P815; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; van Oosterom AT, 2001, LANCET, V358, P1421, DOI 10.1016/S0140-6736(01)06535-7; van Roggen JFG, 2001, J CLIN PATHOL, V54, P96, DOI 10.1136/jcp.54.2.96; Verweij J, 2003, EUR J CANCER, V39, P2006, DOI 10.1016/S0959-8049(02)00836-5; ZALCBERG JR, 2004, P AN M AM SOC CLIN, V23, P815	17	1242	1335	1	59	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 25	2004	364	9440					1127	1134		10.1016/S0140-6736(04)17098-0	http://dx.doi.org/10.1016/S0140-6736(04)17098-0			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	857FT	15451219				2022-12-28	WOS:000224102400025
J	Klass, P				Klass, P			Croup - The bark is worse than the bite	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Boston Univ, Sch Med, Boston, MA 02118 USA; Boston Med Ctr, Boston, MA USA	Boston University; Boston Medical Center	Klass, P (corresponding author), Boston Univ, Sch Med, Boston, MA 02118 USA.								0	1	1	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 23	2004	351	13					1283	1284		10.1056/NEJMp048231	http://dx.doi.org/10.1056/NEJMp048231			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	855TP	15385654				2022-12-28	WOS:000223997700005
J	Selvin, E; Marinopoulos, S; Berkenblit, G; Rami, T; Brancati, FL; Powe, NR; Golden, SH				Selvin, E; Marinopoulos, S; Berkenblit, G; Rami, T; Brancati, FL; Powe, NR; Golden, SH			Meta-analysis: Glycosylated hemoglobin and cardiovascular disease in diabetes mellitus	ANNALS OF INTERNAL MEDICINE			English	Article							CORONARY-HEART-DISEASE; LOWER-EXTREMITY AMPUTATIONS; CAUSE-SPECIFIC MORTALITY; GLYCATION END-PRODUCTS; MIDDLE-AGED PATIENTS; 10-YEAR FOLLOW-UP; GLYCEMIC CONTROL; RISK-FACTORS; ARTERY-DISEASE; MICROVASCULAR COMPLICATIONS	Background: in persons with diabetes, chronic hyperglycemia (assessed by glycosylated hemoglobin level) is related to the development of microvascular disease; however, the relation of glycosylated hemoglobin to macrovascular disease is less clear. Purpose: To conduct a meta-analysis of observational studies of the association between glycosylated hemoglobin and cardiovascular disease in diabetic persons. Data Sources: search of the MEDLINE database by using Medical Subject Heading search terms and key words related to glycosylated hemoglobin, diabetes, and cardiovascular disease. Study Selection: Prospective cohort studies with data on glycosylated hemoglobin levels and incident cardiovascular disease. Data Extraction: Relative risk estimates were derived or abstracted from each cohort study that met the inclusion criteria. Data Synthesis: Adjusted relative risk estimates for glycosylated hemoglobin (total glycosylated hemoglobin, hemoglobin A, or hemoglobin A,c levels) and cardiovascular disease events (coronary heart disease and stroke) were pooled by using random-effects models. Three studies involved persons with type 1 diabetes (n = 1688), and 10 studies involved persons with type 2 diabetes (n = 7435). The pooled relative risk for cardiovascular disease was 1.18; this represented a 1-percentage point increase in glycosylated hemoglobin level (95% Cl, 1.10 to 1.26) in persons with type 2 diabetes. Results in persons with type I diabetes were similar but had a wider Cl (pooled relative risk, 1.15 [Cl, 0.92 to 1.43]). Limitations: This review largely reflects the limitations of the literature. Important concerns were residual confounding, the possibility of publication bias, the small number of studies, and the heterogeneity of study results. Conclusions: Pending confirmation from large, ongoing clinical trials, this analysis shows that observational studies are consistent with limited clinical trial data and suggests that chronic hyperglycemia is associated with an increased risk for cardiovascular disease in persons with diabetes.	Johns Hopkins Univ, Sch Med, Div Endocrinol & Metab, Baltimore, MD 21205 USA; Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Golden, SH (corresponding author), Johns Hopkins Univ, Sch Med, Div Endocrinol & Metab, 2024 E Monument St,Suite 2-616, Baltimore, MD 21205 USA.	sgolden1@jhem.jhmi.edu	Marinopoulos, Spyridon/C-4541-2008		NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007024] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K24DK002643] Funding Source: NIH RePORTER; NHLBI NIH HHS [T32HL07024] Funding Source: Medline; NIDDK NIH HHS [K24-DK6222-O1, K24DK02643] Funding Source: Medline; PHS HHS [290-97-0006] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Abraira C, 1997, ARCH INTERN MED, V157, P181, DOI 10.1001/archinte.157.2.181; Adler AI, 2002, DIABETES CARE, V25, P894, DOI 10.2337/diacare.25.5.894; Adler AI, 1999, AM HEART J, V138, pS353; Agewall S, 1997, AM J CARDIOL, V80, P164, DOI 10.1016/S0002-9149(97)00312-3; American Diabetes Association, 2004, Diabetes Care, V27 Suppl 1, pS15; [Anonymous], 1982, Diabetes, V31 Suppl 5, P1; Balkau B, 1998, DIABETES CARE, V21, P360, DOI 10.2337/diacare.21.3.360; Beckman JA, 2002, JAMA-J AM MED ASSOC, V287, P2570, DOI 10.1001/jama.287.19.2570; Coutinho M, 1999, DIABETES CARE, V22, P233, DOI 10.2337/diacare.22.2.233; de Vegt F, 1999, DIABETOLOGIA, V42, P926, DOI 10.1007/s001250051249; della Rovere GR, 2003, NUTR METAB CARDIOVAS, V13, P46, DOI 10.1016/S0939-4753(03)80167-9; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; DONAHUE RP, 1992, DIABETES CARE, V15, P1141, DOI 10.2337/diacare.15.9.1141; FEENER EP, 1997, LANCET S1, V350, P9; Florkowski CM, 1998, DIABETIC MED, V15, P386, DOI 10.1002/(SICI)1096-9136(199805)15:5<386::AID-DIA587>3.0.CO;2-D; Forrest KYZ, 2000, ATHEROSCLEROSIS, V148, P159, DOI 10.1016/S0021-9150(99)00217-8; FU CC, 1993, DIABETES CARE, V16, P137, DOI 10.2337/diacare.16.1.137; FULLER JH, 1983, BMJ-BRIT MED J, V287, P867, DOI 10.1136/bmj.287.6396.867; GALL MA, 1995, DIABETES, V44, P1303, DOI 10.2337/diabetes.44.11.1303; Gaster B, 1998, ARCH INTERN MED, V158, P134, DOI 10.1001/archinte.158.2.134; Genuth Saul, 2003, Diabetes Care, V26 Suppl 1, pS28; Gerich JE, 2003, ARCH INTERN MED, V163, P1306, DOI 10.1001/archinte.163.11.1306; GOLDEN S, 2003, 84 US DEP HLTH HUM S; Goldstein DE, 2004, DIABETES CARE, V27, P1761, DOI 10.2337/diacare.27.7.1761; GREENLAND S, 1987, EPIDEMIOL REV, V9, P1; Haffner SM, 1998, NEW ENGL J MED, V339, P229, DOI 10.1056/NEJM199807233390404; HARRELL F, SOME PROBLEMS STEPWI; Harrell F.E., 2015, REGRESSION MODELING, DOI [10.1007/978-3-319-19425-7, DOI 10.1007/978-3-319-19425-7, 10.1007/978-1-4757-3462-1]; Huang ES, 2001, AM J MED, V111, P633, DOI 10.1016/S0002-9343(01)00978-0; Khaw KT, 2001, BMJ-BRIT MED J, V322, P15, DOI 10.1136/bmj.322.7277.15; KILPATRICK ES, 1994, BMJ-BRIT MED J, V309, P983, DOI 10.1136/bmj.309.6960.983; Klein R, 1996, ANN INTERN MED, V124, P90, DOI 10.7326/0003-4819-124-1_Part_2-199601011-00003; KLEIN R, 1994, ARCH INTERN MED, V154, P2169, DOI 10.1001/archinte.154.19.2169; KLEIN R, 1988, JAMA-J AM MED ASSOC, V260, P2864, DOI 10.1001/jama.260.19.2864; Kothari V, 2002, STROKE, V33, P1776, DOI 10.1161/01.STR.0000020091.07144.C7; KUUSISTO J, 1994, STROKE, V25, P1157, DOI 10.1161/01.STR.25.6.1157; Laakso M, 1999, DIABETES, V48, P937, DOI 10.2337/diabetes.48.5.937; Laakso M, 1996, ANN MED, V28, P415, DOI 10.3109/07853899608999101; Lehto S, 1997, DIABETES, V46, P1354, DOI 10.2337/diabetes.46.8.1354; Lehto S, 1999, ARTERIOSCL THROM VAS, V19, P1014, DOI 10.1161/01.ATV.19.4.1014; Lehto S, 1996, STROKE, V27, P63, DOI 10.1161/01.STR.27.1.63; Lehto S, 1996, DIABETES CARE, V19, P607, DOI 10.2337/diacare.19.6.607; Libby P, 2002, CIRCULATION, V106, P2760, DOI 10.1161/01.CIR.0000037282.92395.AE; Lloyd CE, 1996, ARTERIOSCL THROM VAS, V16, P720, DOI 10.1161/01.ATV.16.6.720; MALMBERG K, 1995, J AM COLL CARDIOL, V26, P57, DOI 10.1016/0735-1097(95)00126-K; Mattock MB, 1998, DIABETES, V47, P1786, DOI 10.2337/diabetes.47.11.1786; Meigs JB, 1996, J CLIN EPIDEMIOL, V49, P411, DOI 10.1016/0895-4356(95)00513-7; Meigs JB, 2002, DIABETES CARE, V25, P1845, DOI 10.2337/diacare.25.10.1845; Moss SE, 1999, DIABETES CARE, V22, P951, DOI 10.2337/diacare.22.6.951; MOSS SE, 1992, ARCH INTERN MED, V152, P610, DOI 10.1001/archinte.152.3.610; MOSS SE, 1994, ARCH INTERN MED, V154, P2473; Moss SE, 1996, ARCH FAM MED, V5, P391, DOI 10.1001/archfami.5.7.391; MOSS SE, 1991, AM J PUBLIC HEALTH, V81, P1158, DOI 10.2105/AJPH.81.9.1158; *NAT DIAB DAT GROU, 1995, DIAB AM; Nathan DM, 2003, NEW ENGL J MED, V348, P761; Niskanen L, 1998, DIABETES CARE, V21, P1861, DOI 10.2337/diacare.21.11.1861; Olson JC, 2002, METABOLISM, V51, P248, DOI 10.1053/meta.2002.30021; Orchard TJ, 2003, DIABETES CARE, V26, P1374, DOI 10.2337/diacare.26.5.1374; Park S, 1996, DIABETES CARE, V19, P450, DOI 10.2337/diacare.19.5.450; Rohlfing C, 2002, CLIN CHEM, V48, P1116; Rohlfing CL, 2002, DIABETES CARE, V25, P275, DOI 10.2337/diacare.25.2.275; Sacks DB, 2002, CLIN CHEM, V48, P436; Saydah SH, 2001, DIABETES CARE, V24, P1397, DOI 10.2337/diacare.24.8.1397; Schmidt AM, 1999, CIRC RES, V84, P489, DOI 10.1161/01.RES.84.5.489; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Sheetz MJ, 2002, JAMA-J AM MED ASSOC, V288, P2579, DOI 10.1001/jama.288.20.2579; Shichiri M, 2000, DIABETES CARE, V23, pB21; Standl E, 1996, DIABETOLOGIA, V39, P1540, DOI 10.1007/s001250050612; *STAT CORP, 2003, STAT STAT SOFTW REL; Stratton IM, 2000, BMJ-BRIT MED J, V321, P405, DOI 10.1136/bmj.321.7258.405; Toyry JP, 1996, DIABETES, V45, P308, DOI 10.2337/diabetes.45.3.308; Turner RC, 1998, BMJ-BRIT MED J, V316, P823, DOI 10.1136/bmj.316.7134.823; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; UUSITUPA MIJ, 1993, DIABETOLOGIA, V36, P1175, DOI 10.1007/BF00401063; Vlassara H, 1997, DIABETES, V46, pS19, DOI 10.2337/diab.46.2.S19; Wild SH, 1999, DIABETES-METAB RES, V15, P197, DOI 10.1002/(SICI)1520-7560(199905/06)15:3<197::AID-DMRR28>3.0.CO;2-F; WITZTUM JL, 1982, DIABETES, V31, P283, DOI 10.2337/diabetes.31.4.283	77	1056	1141	4	72	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 21	2004	141	6					421	431		10.7326/0003-4819-141-6-200409210-00007	http://dx.doi.org/10.7326/0003-4819-141-6-200409210-00007			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	856TM	15381515				2022-12-28	WOS:000224067900002
J	Kreicbergs, U; Valdimarsdottir, U; Onelov, E; Henter, JI; Steineck, G				Kreicbergs, U; Valdimarsdottir, U; Onelov, E; Henter, JI; Steineck, G			Talking about death with children who have severe malignant disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							TERMINALLY-ILL CHILDREN; SIOP WORKING COMMITTEE; PSYCHOSOCIAL ISSUES; OF-LIFE; CANCER; ASSISTANCE; GUIDELINES; CARE	Background: One of the questions faced by the parents of a child who is terminally ill with a malignant disease is whether or not they should talk about death with their child. Methods: In 2001, we attempted to contact all parents in Sweden who had lost a child to cancer between 1992 and 1997. Among 561 eligible parents, 449 answered a questionnaire, and 429 stated whether or not they had talked about death with their child. Results: None of the 147 parents who talked with their child about death regretted it. In contrast, 69 of 258 parents (27 percent) who did not talk with their child about death regretted not having done so. Parents who sensed that their child was aware of his or her imminent death were more likely to regret not having talked about it (47 percent, as compared with 13 percent of parents who did not sense this awareness in their child; relative risk, 3.7; 95 percent confidence interval, 2.3 to 6.0). The same variable was related to having talked about death (50 percent vs. 13 percent; relative risk, 3.8; 95 percent confidence interval, 2.6 to 5.6), as was being religious (42 percent vs. 25 percent; relative risk, 1.7; 95 percent confidence interval, 1.2 to 2.3). The child's age was related to both having talked about death and the parents' regretting not having talked about it. Conclusions: Parents who sense that their child is aware of his or her imminent death more often later regret not having talked with their child than do parents who do not sense this awareness in their child; overall, no parent in this cohort later regretted having talked with his or her child about death.	Karolinska Inst, Karolinska Hosp Z6 01, Dept Pathol & Oncol, Div Clin Canc Epidemiol, SE-17176 Stockholm, Sweden; Karolinska Inst, Childhood Canc Res Unit, SE-17176 Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet	Steineck, G (corresponding author), Karolinska Inst, Karolinska Hosp Z6 01, Dept Pathol & Oncol, Div Clin Canc Epidemiol, SE-17176 Stockholm, Sweden.	gunnar.steineck@onkpat.ki.se	Steineck, Gunnar/W-1515-2019	Steineck, Gunnar/0000-0002-0787-3969; Valdimarsdottir, Unnur/0000-0001-5382-946X; Henter, Jan-Inge/0000-0002-0629-2126				Bergmark K, 1999, NEW ENGL J MED, V340, P1383, DOI 10.1056/NEJM199905063401802; Bluebond-Langner M, 1978, TERMINALLY ILL CHILD, P166; GOLDMAN A, 1993, PEDIATR HEMAT ONCOL, V10, P223, DOI 10.3109/08880019309029488; Henningsohn L, 2001, EUR UROL, V40, P151, DOI 10.1159/000049766; Hilden JM, 2001, J CLIN ONCOL, V19, P205, DOI 10.1200/JCO.2001.19.1.205; Hilden JM, 2000, J CLIN ONCOL, V18, P3193, DOI 10.1200/JCO.2000.18.17.3193; Himelstein BP, 2004, NEW ENGL J MED, V350, P1752, DOI 10.1056/NEJMra030334; KREICHBERGS U, 2004, PSYCHOL MED, V34, P1; Masera G, 1999, MED PEDIATR ONCOL, V32, P44, DOI 10.1002/(SICI)1096-911X(199901)32:1<44::AID-MPO9>3.0.CO;2-P; Nitschke R, 2000, MED PEDIATR ONCOL, V34, P268; Nitschke R, 2000, MED PEDIATR ONCOL, V34, P271, DOI 10.1002/(SICI)1096-911X(200004)34:4<271::AID-MPO10>3.0.CO;2-0; Radestad I, 1996, BRIT MED J, V312, P1505, DOI 10.1136/bmj.312.7045.1505; RAIMBAULT G, 1981, ACTA PAEDIATR SCAND, V70, P179, DOI 10.1111/j.1651-2227.1981.tb05538.x; ROTHMAN KJ, 1998, MODERN EPIDEMIOLOGY, P271; *SAS I INC, 1999, SAS STAT US GUID VER, P1365; SPINETTA J J, 1981, Journal of Pediatric Psychology, V6, P251, DOI 10.1093/jpepsy/6.3.251; SPINETTA JJ, 1973, PEDIATRICS, V52, P841; SPINETTA JJ, 1974, PSYCHOL BULL, V81, P256, DOI 10.1037/h0036229; Steineck G, 1998, ACTA ONCOL, V37, P15, DOI 10.1080/028418698423131; Steineck G, 2002, ACTA ONCOL, V41, P244, DOI 10.1080/02841860260088782; Steineck G, 2002, NEW ENGL J MED, V347, P790, DOI 10.1056/NEJMoa021483; Valdimarsdottir U, 2002, BRIT J CANCER, V86, P1540, DOI 10.1038/sj.bjc.6600271; VALDIMARSDOTTIR U, 2003, THESIS KAROLINSKA I	23	292	293	1	26	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 16	2004	351	12					1175	1186		10.1056/NEJMoa040366	http://dx.doi.org/10.1056/NEJMoa040366			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	853WS	15371575				2022-12-28	WOS:000223861300006
J	Wellens, HJJ				Wellens, HJJ			Catheter ablation for cardiac arrhythmias	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Limburg, Cardiovasc Res Inst, NL-6200 MD Maastricht, Netherlands	Hasselt University; Maastricht University	Wellens, HJJ (corresponding author), Univ Limburg, Cardiovasc Res Inst, NL-6200 MD Maastricht, Netherlands.								0	17	18	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 16	2004	351	12					1172	1174		10.1056/NEJMp048197	http://dx.doi.org/10.1056/NEJMp048197			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	853WS	15371574				2022-12-28	WOS:000223861300005
J	Toyoshima, C; Nomura, H; Tsuda, T				Toyoshima, C; Nomura, H; Tsuda, T			Lumenal gating mechanism revealed in calcium pump crystal structures with phosphate analogues	NATURE			English	Article							SARCOPLASMIC-RETICULUM CA2+-ATPASE; P-TYPE ATPASES; INSENSITIVE PHOSPHOENZYME INTERMEDIATE; RESPONSE REGULATOR PROTEIN; HIGH-AFFINITY; A-DOMAIN; ADENOSINE-TRIPHOSPHATASE; FUNCTIONAL CONSEQUENCES; PHOSPHORYL TRANSFER; TRANSPORT SITES	P-type ion transporting ATPases are ATP-powered ion pumps that establish ion concentration gradients across biological membranes. Transfer of bound cations to the lumenal or extracellular side occurs while the ATPase is phosphorylated. Here we report at 2.3 Angstrom resolution the structure of the calcium-ATPase of skeletal muscle sarcoplasmic reticulum, a representative P-type ATPase that is crystallized in the absence of Ca2+ but in the presence of magnesium fluoride, a stable phosphate analogue. This and other crystal structures determined previously provide atomic models for all four principal states in the reaction cycle. These structures show that the three cytoplasmic domains rearrange to move six out of ten transmembrane helices, thereby changing the affinity of the Ca2+-binding sites and the gating of the ion pathway. Release of ADP triggers the opening of the lumenal gate and release of phosphate its closure, effected mainly through movement of the A-domain, the actuator of transmembrane gates.	Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo 1130032, Japan	University of Tokyo	Toyoshima, C (corresponding author), Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo 1130032, Japan.	ct@iam.u-tokyo.ac.jp	Toyoshima, Chikashi/R-4153-2019	Toyoshima, Chikashi/0000-0001-9640-0778				ALBERS RW, 1967, ANNU REV BIOCHEM, V36, P727, DOI 10.1146/annurev.bi.36.070167.003455; BRANDL CJ, 1987, J BIOL CHEM, V262, P3768; BRUNGER AT, 1990, ACTA CRYSTALLOGR A, V46, P46, DOI 10.1107/S0108767389009633; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CHAMPEIL P, 1988, J BIOL CHEM, V263, P12288; CLARKE DM, 1990, J BIOL CHEM, V265, P14088; Clausen JD, 2004, P NATL ACAD SCI USA, V101, P2776, DOI 10.1073/pnas.0400122101; Clausen JD, 2001, J BIOL CHEM, V276, P35741, DOI 10.1074/jbc.M105434200; COLL RJ, 1984, J BIOL CHEM, V259, P4249; COLL RJ, 1992, J BIOL CHEM, V267, P21584; DAIHO T, 1993, BIOCHEMISTRY-US, V32, P10021, DOI 10.1021/bi00089a018; Danko S, 2004, J BIOL CHEM, V279, P14991, DOI 10.1074/jbc.M313363200; Danko S, 2001, FEBS LETT, V505, P129, DOI 10.1016/S0014-5793(01)02801-0; Danko S, 2001, FEBS LETT, V489, P277, DOI 10.1016/S0014-5793(01)02111-1; DEMEIS L, 1979, ANNU REV BIOCHEM, V48, P275; Graham DL, 2002, CHEM BIOL, V9, P375, DOI 10.1016/S1074-5521(02)00112-6; Inesi G, 2004, J BIOL CHEM, V279, P31629, DOI 10.1074/jbc.M403211200; JUUL B, 1995, J BIOL CHEM, V270, P20123, DOI 10.1074/jbc.270.34.20123; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kato S, 2003, J BIOL CHEM, V278, P9624, DOI 10.1074/jbc.M208861200; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Kuhlbrandt W, 2004, NAT REV MOL CELL BIO, V5, P282, DOI 10.1038/nrm1354; Lenoir G, 2004, J BIOL CHEM, V279, P9156, DOI 10.1074/jbc.M311411200; Lewis RJ, 1999, J MOL BIOL, V294, P9, DOI 10.1006/jmbi.1999.3261; MACLENNAN DH, 1985, NATURE, V316, P696, DOI 10.1038/316696a0; MARUYAMA K, 1989, J BIOL CHEM, V264, P13038; MCINTOSH DB, 1983, BIOCHEMISTRY-US, V22, P2867, DOI 10.1021/bi00281a015; Moller JV, 2002, J BIOL CHEM, V277, P38647, DOI 10.1074/jbc.M204603200; Moller JV, 1996, BBA-REV BIOMEMBRANES, V1286, P1, DOI 10.1016/0304-4157(95)00017-8; MURPHY AJ, 1992, J BIOL CHEM, V267, P5229; OGURUSU T, 1991, J BIOCHEM-TOKYO, V109, P472, DOI 10.1093/oxfordjournals.jbchem.a123406; ORLOWSKI S, 1991, BIOCHEMISTRY-US, V30, P352, DOI 10.1021/bi00216a007; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Palmgren MG, 1998, BBA-BIOENERGETICS, V1365, P37, DOI 10.1016/S0005-2728(98)00041-3; POST RL, 1972, J BIOL CHEM, V247, P6530; Ridder IS, 1999, BIOCHEM J, V339, P223, DOI 10.1042/0264-6021:3390223; Sorensen TLM, 2004, SCIENCE, V304, P1672, DOI 10.1126/science.1099366; STOKES DL, 1990, BIOPHYS J, V57, P1, DOI 10.1016/S0006-3495(90)82501-7; Toyoshima C, 2004, NATURE, V430, P529, DOI 10.1038/nature02680; Toyoshima C, 2004, ANNU REV BIOCHEM, V73, P269, DOI 10.1146/annurev.biochem.73.011303.073700; Toyoshima C, 2000, NATURE, V405, P647, DOI 10.1038/35015017; Toyoshima C, 2002, NATURE, V418, P605, DOI 10.1038/nature00944; TROULLIER A, 1992, J BIOL CHEM, V267, P22821; Wang WR, 2002, J MOL BIOL, V319, P421, DOI 10.1016/S0022-2836(02)00324-8; Yamasaki K, 2004, J BIOL CHEM, V279, P2202, DOI 10.1074/jbc.M309398200; Yamasaki K, 2002, J BIOL CHEM, V277, P13615, DOI 10.1074/jbc.M200625200; Zhang PJ, 1998, NATURE, V392, P835, DOI 10.1038/33959	47	364	376	0	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 18	2004	432	7015					361	368		10.1038/nature02981	http://dx.doi.org/10.1038/nature02981			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	871UX	15448704				2022-12-28	WOS:000225161400047
J	Thomas, R; Rignot, E; Casassa, G; Kanagaratnam, P; Acuna, C; Akins, T; Brecher, H; Frederick, E; Gogineni, P; Krabill, W; Manizade, S; Ramamoorthy, H; Rivera, A; Russell, R; Sonntag, J; Swift, R; Yungel, J; Zwally, J				Thomas, R; Rignot, E; Casassa, G; Kanagaratnam, P; Acuna, C; Akins, T; Brecher, H; Frederick, E; Gogineni, P; Krabill, W; Manizade, S; Ramamoorthy, H; Rivera, A; Russell, R; Sonntag, J; Swift, R; Yungel, J; Zwally, J			Accelerated sea-level rise from West Antarctica	SCIENCE			English	Article							PINE ISLAND GLACIER; GREENLAND ICE-SHEET; AMUNDSEN SEA; POLAR ICE; THICKNESS; BALANCE; RETREAT; MODEL	Recent aircraft and satellite laser altimeter surveys of the Amundsen Sea sector of West Antarctica show that local glaciers are discharging about 250 cubic kilometers of ice per year to the ocean, almost 60% more than is accumulated within their catchment basins. This discharge is sufficient to raise sea level by more than 0.2 millimeters per year. Glacier thinning rates near the coast during 2002-2003 are much larger than those observed during the 1990s. Most of these glaciers flow into floating ice shelves over bedrock up to hundreds of meters deeper than previous estimates, providing exit routes for ice from further inland if ice-sheet collapse is under way.	NASA, Goddard Space Flight Ctr, EG&G Inc, Wallops Flight Facil, Wallops Isl, VA 23337 USA; Ctr Estudios Cient, Valdivia, Chile; CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; Univ Kansas, Radar Syst & Remote Sensing Lab, Lawrence, KS 66045 USA; Ohio State Univ, Byrd Polar Res Ctr, Columbus, OH 43210 USA; Univ Chile, Dept Geog, Santiago, Chile	National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); University of Kansas; University System of Ohio; Ohio State University; Universidad de Chile	Thomas, R (corresponding author), NASA, Goddard Space Flight Ctr, EG&G Inc, Wallops Flight Facil, Bldg N-159, Wallops Isl, VA 23337 USA.	thomas@osb.wff.nasa.gov	Rignot, Eric/A-4560-2014; Casassa, Gino/AAX-6142-2020	Rignot, Eric/0000-0002-3366-0481; Rivera, Andres/0000-0002-2779-4192				Corr HFJ, 2001, J GLACIOL, V47, P51, DOI 10.3189/172756501781832395; De Angelis H, 2003, SCIENCE, V299, P1560, DOI 10.1126/science.1077987; Dyurgerov M. B., 2001, POLAR GEOGRAPHY, V25, P241, DOI DOI 10.1080/10889370109377717; Gogineni S, 2001, J GEOPHYS RES-ATMOS, V106, P33761, DOI 10.1029/2001JD900183; HINDMARSH R, 1993, ANN GLACIOL, V23, P105; Hughes T, 1972, ISCAP B, V1; Huybrechts P., 1990, ANN GLACIOL, V14, P115; Intergovernmental Panel on Climate Change, 2001, IPCC 3 ASS REP CLIM; Joughin I, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017609; KELLOGG TB, 1987, J GEOPHYS RES-SOLID, V92, P8859, DOI 10.1029/JB092iB09p08859; Krabill W, 2000, SCIENCE, V289, P428, DOI 10.1126/science.289.5478.428; Krabill WB, 2002, J GEODYN, V34, P357, DOI 10.1016/S0264-3707(02)00040-6; Liu HX, 1999, J GEOPHYS RES-SOL EA, V104, P23199, DOI 10.1029/1999JB900224; Lythe MB, 2001, J GEOPHYS RES-SOL EA, V106, P11335, DOI 10.1029/2000JB900449; MERCER J, 1978, NATURE, V27, P321; Rignot E, 2002, SCIENCE, V297, P1502, DOI 10.1126/science.1073888; Rignot E, 2002, ANN GLACIOL, V34, P189, DOI 10.3189/172756402781817950; Rignot E, 2001, J GLACIOL, V47, P213, DOI 10.3189/172756501781832340; RIGNOT E, IN PRESS ANN GLACIOL; Rignot EJ, 1998, SCIENCE, V281, P549, DOI 10.1126/science.281.5376.549; Shepherd A, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL014183; Shepherd A, 2001, SCIENCE, V291, P862, DOI 10.1126/science.291.5505.862; THOMAS R, IN PRESS ANN GLACIOL; Thomas RH, 2003, J GLACIOL, V49, P231, DOI 10.3189/172756503781830764; Thomas RH, 1977, GEOGR PHYS QUATERN, V31, P347; THOMAS RH, IN PRESS J GLACIOL; Zwally HJ, 2002, J GEODYN, V34, P405, DOI 10.1016/S0264-3707(02)00042-X	27	252	263	1	41	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 8	2004	306	5694					255	258		10.1126/science.1099650	http://dx.doi.org/10.1126/science.1099650			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	861MC	15388895	Green Submitted, Green Published			2022-12-28	WOS:000224419700033
J	Wright, JG; Wedge, JH				Wright, JG; Wedge, JH			Clinicians and patients' welfare: where does academic freedom fit in?	BRITISH MEDICAL JOURNAL			English	Article							SCIENTIFIC FREEDOM	Academic freedom has accompanying responsibilities, and boundaries; but are there additional constraints specific to clinicians, such that research and teaching would conflict with caring for patients?	Univ Toronto, Hosp Sick Children, Dept Surg, Toronto, ON M5G 1X8, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Wright, JG (corresponding author), Univ Toronto, Hosp Sick Children, Dept Surg, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	jim.wright@sickkids.ca						BENATAR SR, 1990, LANCET, V335, P1576, DOI 10.1016/0140-6736(90)91390-V; BIRGENEAU RJ, 2001, TORONTO STAR    1001; Brennan T, 2002, LANCET, V359, P520, DOI 10.1016/s0140-6736(02)07684-5; *CAN ASS U TEACH, AC FREED; Dyer O, 2001, BRIT MED J, V323, P591, DOI 10.1136/bmj.323.7313.591a; EDSALL JT, 1975, SCIENCE, V188, P687, DOI 10.1126/science.11643270; *GEN MED COUNC, 2002, RES ROL RESP DOCT; *HARV U LIB, 1970, U WID STAT RIGHTS RE; METZGER WP, 1978, DAEDALUS, V107, P93; *NHS RES DEV, FORUM; Pellegrino ED, 1999, ACAD MED, V74, pS21, DOI 10.1097/00001888-199908000-00025; Shuchman M, 2002, CAN MED ASSOC J, V166, P487; The American Association of University Professors, 2001, AAUP POL DOC REP; *U TOR HUM RES DEP, 1998, MEM AGR GOV COUNC U; *YAL U FAC HDB, 1993, YAL U POL FREED EXPR	15	6	6	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 2	2004	329	7469					795	796		10.1136/bmj.329.7469.795	http://dx.doi.org/10.1136/bmj.329.7469.795			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	859TW	15459057	Green Published			2022-12-28	WOS:000224291800027
J	Maldonado, RA; Irvine, DJ; Schreiber, R; Glimcher, LH				Maldonado, RA; Irvine, DJ; Schreiber, R; Glimcher, LH			A role for the immunological synapse in lineage commitment of CD4 lymphocytes	NATURE			English	Article							HELPER T-CELLS; LIPID RAFTS; LEISHMANIA-MAJOR; INTERFERON-GAMMA; IL-2 PRODUCTION; DIFFERENTIATION; PHOSPHORYLATION; MICRODOMAINS; INHIBITION; ACTIVATION	Activation of the naive T-helper lymphocyte (Thp) directs it down one of two major developmental pathways called Th1 and Th2. Signals transmitted by T cell, co-stimulatory and cytokine receptors control Thp lineage commitment but the mechanism by which these signals are integrated remains a mystery. The interferon-gamma ( IFNGR) and interleukin 4 (IL-4R) cytokine receptors, in particular, direct the earliest stages of T-helper commitment. Here we report that on engagement of the T-cell receptor (TCR) on Thp cells, rapid co-polarization of IFNGR with the TCR occurs within the developing immunological synapse. Thp cells from the intrinsically Th1-like C57BL/6 mouse strain have significantly more receptor co-polarization than Th2-prone BALB/c Thp cells. Remarkably, in the presence of IL-4, a cytokine required for Th2 differentiation, IFNGR co-polarization with TCR is prevented. This inhibition depends on Stat6, the transcription factor downstream of IL-4R that is required for Th2 differentiation. This cytokine receptor crossregulation provides an explanation for the effect of IL-4 in inhibiting Th1 differentiation. These observations suggest a scenario in which physical co-polarization of critical receptors directs the fate of the naive Thp, and offer a novel function for the immunological synapse in directing cell differentiation. They further suggest a new mechanism of membrane-bound signalling control by the physical disruption of large receptor-rich domains on signalling through a functionally antagonistic receptor.	Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA; MIT, Dept Mat Sci & Engn, Biol Engn Div, Cambridge, MA 02139 USA; Washington Univ, Sch Med, Ctr Immunol, Dept Pathol & Immunol, St Louis, MO 63110 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health; Massachusetts Institute of Technology (MIT); Washington University (WUSTL); Harvard University; Harvard Medical School	Glimcher, LH (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, 665 Huntington Ave, Boston, MA 02115 USA.	lglimche@hsph.harvard.edu		Schreiber, Robert/0000-0003-1590-2341				Balamuth F, 2001, IMMUNITY, V15, P729, DOI 10.1016/S1074-7613(01)00223-0; Bromley SK, 2001, ANNU REV IMMUNOL, V19, P375, DOI 10.1146/annurev.immunol.19.1.375; Chen CH, 2003, J EXP MED, V197, P1689, DOI 10.1084/jem.20021170; Fowell DJ, 1999, BIOESSAYS, V21, P510, DOI 10.1002/(SICI)1521-1878(199906)21:6&lt;510::AID-BIES7&gt;3.0.CO;2-5; Gamero AM, 2000, J BIOL CHEM, V275, P16574, DOI 10.1074/jbc.M910149199; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Granucci F, 2001, NAT IMMUNOL, V2, P882, DOI 10.1038/ni0901-882; Huppa JB, 2003, NAT REV IMMUNOL, V3, P973, DOI 10.1038/nri1245; Huppa JB, 2003, NAT IMMUNOL, V4, P749, DOI 10.1038/ni951; Launois P, 1997, IMMUNITY, V6, P541, DOI 10.1016/S1074-7613(00)80342-8; Lee KH, 2003, SCIENCE, V302, P1218, DOI 10.1126/science.1086507; Lee KH, 2002, SCIENCE, V295, P1539, DOI 10.1126/science.1067710; Madrenas J, 2003, IMMUNITY, V18, P459, DOI 10.1016/S1074-7613(03)00089-X; Manes S, 2001, SEMIN IMMUNOL, V13, P147, DOI 10.1006/smim.2000.0306; Miller MJ, 2002, SCIENCE, V296, P1869, DOI 10.1126/science.1070051; Murphy KM, 2002, NAT REV IMMUNOL, V2, P933, DOI 10.1038/nri954; O'Garra A, 1998, IMMUNITY, V8, P275, DOI 10.1016/S1074-7613(00)80533-6; POO WJ, 1988, NATURE, V332, P378, DOI 10.1038/332378a0; Reichert P, 2001, J IMMUNOL, V166, P4278, DOI 10.4049/jimmunol.166.7.4278; Szabo SJ, 2003, ANNU REV IMMUNOL, V21, P713, DOI 10.1146/annurev.immunol.21.120601.140942; Takaoka A, 2000, SCIENCE, V288, P2357, DOI 10.1126/science.288.5475.2357; Trambas CM, 2003, NAT IMMUNOL, V4, P399, DOI 10.1038/ni0503-399; Tsui-Pierchala BA, 2002, TRENDS NEUROSCI, V25, P412, DOI 10.1016/S0166-2236(02)02215-4; Vereb G, 2000, P NATL ACAD SCI USA, V97, P6013, DOI 10.1073/pnas.97.11.6013; Viola A, 1999, SCIENCE, V283, P680, DOI 10.1126/science.283.5402.680; Watzl C, 2003, J EXP MED, V197, P77, DOI 10.1084/jem.20020427; Welte T, 1999, SCIENCE, V283, P222, DOI 10.1126/science.283.5399.222; Zhang YK, 2001, J EXP MED, V194, P165, DOI 10.1084/jem.194.2.165; Zhu JF, 2000, J EXP MED, V192, P1125, DOI 10.1084/jem.192.8.1125; Zhu JF, 2003, IMMUNITY, V19, P739, DOI 10.1016/S1074-7613(03)00292-9	30	152	155	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 30	2004	431	7008					527	532		10.1038/nature02916	http://dx.doi.org/10.1038/nature02916			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	857YP	15386021				2022-12-28	WOS:000224156700035
J	Yaffe, MJ				Yaffe, MJ			What should the burden of proof be for acceptance of a new breast-cancer screening technique?	LANCET			English	Editorial Material							FOLLOW-UP; MAMMOGRAPHY; PROGRESSION; MORTALITY		Univ Toronto, Dept Med Imaging, Toronto, ON M4N 3M5, Canada; Univ Toronto, Dept Med Biophys, Toronto, ON M4N 3M5, Canada	University of Toronto; University of Toronto	Yaffe, MJ (corresponding author), Univ Toronto, Dept Med Imaging, Toronto, ON M4N 3M5, Canada.	martin.yaffe@swri.ca						*AM COLL RAD IM NE, CURR PROT; GUSTERSON BA, 1995, DRUG HORMONAL RESIST, P39; Hayes DF, 1996, JNCI-J NATL CANCER I, V88, P1456, DOI 10.1093/jnci/88.20.1456; Heimann R, 1998, J CLIN ONCOL, V16, P2686, DOI 10.1200/JCO.1998.16.8.2686; Heimann R, 2000, EUR J CANCER, V36, P1631, DOI 10.1016/S0959-8049(00)00151-9; Hellman S, 2000, CANCER J, V6, pS131; Hendrick R E, 1997, J Natl Cancer Inst Monogr, P87; Irwig L, 2004, BRIT J CANCER, V90, P2118, DOI 10.1038/sj.bjc.6601836; Kriege M, 2004, NEW ENGL J MED, V351, P427, DOI 10.1056/NEJMoa031759; NYSTROM L, 1993, LANCET, V341, P973, DOI 10.1016/0140-6736(93)91067-V; Tabar L, 2000, RADIOL CLIN N AM, V38, P625, DOI 10.1016/S0033-8389(05)70191-3; Tabar L, 2003, LANCET, V361, P1405, DOI 10.1016/S0140-6736(03)13143-1; TRUDEAU ME, IN PRESS BREAST CANC; WARNER E, IN PRESS JAMA	14	9	9	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 25	2004	364	9440					1111	1112		10.1016/S0140-6736(04)17121-3	http://dx.doi.org/10.1016/S0140-6736(04)17121-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	857FT	15451209				2022-12-28	WOS:000224102400010
J	Murff, HJ; Spigel, DR; Syngal, S				Murff, HJ; Spigel, DR; Syngal, S			Does this patient have a family history of cancer? An evidence-based analysis of the accuracy of family cancer history	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							SERVICE-CENTRAL-REGISTER; FOLLOW-UP CARE; BREAST-CANCER; ENDOMETRIAL CANCER; INHERITED PREDISPOSITION; GENETICS SERVICES; RISK-ASSESSMENT; OVARIAN-CANCER; VALIDATION; PROSTATE	Context A family history of certain cancers is associated with an increased risk of developing cancer. Both cancer screening and genetic services referral decisions are often based on self-reported pedigree information. Objective To determine the accuracy of self-reported family cancer history information. Data Sources English-language articles were retrieved by searching MEDLINE (1966-June 2004) using Medical Subject Headings family, genetic predisposition to disease, medical history taking, neoplasm, and reproducibility of results. Additional articles were identified through bibliography searches. Study Selection Original studies in which investigators validated self-reported family history by reviewing the identified relatives' medical records, death certificate, or cancer registry information were included, as well as studies that evaluated breast, colon, ovarian, endometrial, and prostate cancers. Data Extraction Two of the 3 investigators independently reviewed and abstracted data for estimating the likelihood ratios (LRs) of self-reported family cancer history information. only data from studies that evaluated both positive and negative family cancer histories were included within the analyses. A total of 14 studies met the search criteria and were included in the review. Data Synthesis For patients without a personal history of cancer, the positive and negative LRs of a family history of the following cancers in a first-degree relative were 23.0 (95% confidence interval [CI], 6.4-81.0) and 0.25 (95 % CI, 0.10-0.63) for colon cancer; 8.9 (95% Cl, 5.4-15.0) and 0.20 (95% Cl, 0.08-0.49) for breast cancer; 14.0 (95% Cl, 2.2-83.4) and 0.68 (95% Cl, 0.31-1.52) for endometrial cancer; 34.0 (95% Cl, 5.7-202.0) and 0.51 (95% Cl, 0.13-2.10) for ovarian cancer; and 12.3 (95% Cl, 6.5-24.0) and 0.32 (95 % Cl, 0.18-0.55) for prostate cancer, respectively. Positive predictive values tended to be better in articles concerning first-degree relatives compared with second-degree relatives. Conclusions Patient-reported family cancer histories for first-degree relatives are accurate and valuable for breast and colon cancer risk assessments. Negative family history reports for ovarian and endometrial cancers are less useful, although the prevalence of these malignancies within families is low.	Vanderbilt Univ, Med Ctr, Div Gen Internal Med, Nashville, TN 37212 USA; Dept Vet Affairs, Tennessee Valley Healthcare Syst, Ctr Geriatr Res Educ & Clin, Nashville, TN 37212 USA; Sarah Cannon Canc Ctr, Nashville, TN USA; Brigham & Womens Hosp, Div Gastroenterol, Boston, MA 02115 USA; Dana Farber Canc Inst, Div Populat Sci, Boston, MA 02115 USA	Vanderbilt University; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System; Sarah Cannon Research Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Dana-Farber Cancer Institute	Murff, HJ (corresponding author), Vanderbilt Univ, Med Ctr, Div Gen Internal Med, 1310 24th Ave S, Nashville, TN 37212 USA.	harvey.murff@med.va.gov			NCI NIH HHS [K07CA08453] Funding Source: Medline	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Airewele G, 1998, J NATL CANCER I, V90, P543, DOI 10.1093/jnci/90.7.543; AITKEN J, 1995, AM J EPIDEMIOL, V141, P863, DOI 10.1093/oxfordjournals.aje.a117522; *AM AC FAM PHYS, PER HLTH EX SUMM POL; [Anonymous], 1994, Gynecol Oncol, V55, pS4; AntonCulver H, 1996, GENET EPIDEMIOL, V13, P193, DOI 10.1002/(SICI)1098-2272(1996)13:2<193::AID-GEPI5>3.0.CO;2-9; BENNETT RL, 1995, AM J HUM GENET, V56, P745, DOI 10.1007/BF01408073; Bennett RL, 1999, PRACTICAL GUIDE GENE; Berg AO, 2002, ANN INTERN MED, V137, P129, DOI 10.7326/0003-4819-137-2-200207160-00014; Berg AO, 2002, ANN INTERN MED, V137, P915, DOI 10.7326/0003-4819-137-11-200212030-00013; Berg AO, 2002, ANN INTERN MED, V137, P344, DOI 10.7326/0003-4819-137-5_Part_1-200209030-00011; Bergmann MM, 1998, AM J EPIDEMIOL, V147, P556; Bickell NA, 2000, ANN INTERN MED, V132, P705, DOI 10.7326/0003-4819-132-9-200005020-00004; Blumenthal D, 1999, J FAM PRACTICE, V48, P264; BONDY ML, 1994, J CLIN EPIDEMIOL, V47, P89, DOI 10.1016/0895-4356(94)90037-X; BREUER B, 1993, GENET EPIDEMIOL, V10, P245, DOI 10.1002/gepi.1370100405; Bruinooge SS, 2003, J CLIN ONCOL, V21, P2397, DOI 10.1200/JCO.2003.03.189; Burke W, 1997, JAMA-J AM MED ASSOC, V277, P997, DOI 10.1001/jama.277.12.997; Burke W, 1997, JAMA-J AM MED ASSOC, V277, P915, DOI 10.1001/jama.277.11.915; BURT RW, 1990, B WORLD HEALTH ORGAN, V68, P655; Cauley JA, 2001, BREAST CANCER RES TR, V65, P125, DOI 10.1023/A:1006478317173; Cerhan JR, 1999, CANCER EPIDEM BIOMAR, V8, P53; COLE J, 1978, J MED GENET, V15, P10, DOI 10.1136/jmg.15.1.10; Desai MM, 2001, AM J EPIDEMIOL, V153, P299, DOI 10.1093/aje/153.3.299; Dickinson HO, 2001, J EPIDEMIOL COMMUN H, V55, P414, DOI 10.1136/jech.55.6.414; Douglas FS, 1999, J MED GENET, V36, P309; EBELL MH, 1988, J FAM PRACTICE, V27, P536; Eerola H, 2000, EUR J CANCER, V36, P1143, DOI 10.1016/S0959-8049(00)00093-9; Emery J, 1999, BRIT J GEN PRACT, V49, P260; Emery J, 1999, FAM PRACT, V16, P426, DOI 10.1093/fampra/16.4.426; Emery J, 1999, BRIT J GEN PRACT, V49, P572; Ferrini R, 1996, AM J PREV MED, V12, P340, DOI 10.1016/S0749-3797(18)30289-7; Fisher B, 1998, J NATL CANCER I, V90, P1371, DOI 10.1093/jnci/90.18.1371; Fletcher SW, 2003, NEW ENGL J MED, V348, P1672, DOI 10.1056/NEJMcp021804; Fry A, 1999, FAM PRACT, V16, P468, DOI 10.1093/fampra/16.5.468; FUCHS CS, 1994, NEW ENGL J MED, V331, P1669, DOI 10.1056/NEJM199412223312501; Garbers V, 2001, EUR J EPIDEMIOL, V17, P517, DOI 10.1023/A:1014500204757; GERSON R, 1985, PRIMARY CARE, V12, P535; GIERLOWSKI TC, 1995, AM J PUBLIC HEALTH, V85, P408, DOI 10.2105/AJPH.85.3.408; Gilpin CA, 2000, CLIN GENET, V58, P299, DOI 10.1034/j.1399-0004.2000.580408.x; Gollust SE, 2002, JAMA-J AM MED ASSOC, V288, P1762, DOI 10.1001/jama.288.14.1762; Gordis L, 1997, J NATL CANCER I, V89, P1015, DOI 10.1093/jnci/89.14.1015; Green M J, 1997, J Cancer Educ, V12, P204; Green MJ, 1997, GENET TEST, V1, P131, DOI 10.1089/gte.1997.1.131; Gruber SB, 1996, CANCER EPIDEM BIOMAR, V5, P411; Harris R, 1996, J MED GENET, V33, P346, DOI 10.1136/jmg.33.4.346; Hartmann LC, 1999, NEW ENGL J MED, V340, P77, DOI 10.1056/NEJM199901143400201; HAWKINS MM, 1992, BRIT J CANCER, V66, P408, DOI 10.1038/bjc.1992.279; Hughes Kevin S, 2003, Breast J, V9, P19, DOI 10.1046/j.1524-4741.2003.09105.x; Hunter A, 1998, CLIN GENET, V53, P447; Ivanovich J, 2002, CLIN CANCER RES, V8, P1849; Izquierdo JN, 2000, AM J PUBLIC HEALTH, V90, P695, DOI 10.2105/AJPH.90.5.695; James DS, 1996, J CLIN PATHOL, V49, P213, DOI 10.1136/jcp.49.3.213; JOHNSON N, 1995, FAM PRACT, V12, P287, DOI 10.1093/fampra/12.3.287; Kalish LA, 2000, UROLOGY, V56, P803, DOI 10.1016/S0090-4295(00)00780-9; Katballe N, 2001, BRIT J SURG, V88, P1228, DOI 10.1046/j.0007-1323.2001.01868.x; Kerber RA, 1997, AM J EPIDEMIOL, V146, P244; Kerr B, 1998, EUR J SURG ONCOL, V24, P275, DOI 10.1016/S0748-7983(98)80005-X; King TM, 2002, UROLOGY, V59, P546, DOI 10.1016/S0090-4295(01)01598-9; KIRCHER T, 1985, NEW ENGL J MED, V313, P1263, DOI 10.1056/NEJM198511143132005; KOCH M, 1987, CANCER DETECT PREV, V10, P279; Korhonen P, 2002, ACTA ONCOL, V41, P381, DOI 10.1080/028418602760169442; Kuijten R. R, 1992, American Journal of Epidemiology, V136, P1019; Lesko SM, 1996, AM J EPIDEMIOL, V144, P1041, DOI 10.1093/oxfordjournals.aje.a008876; LEVIN B, 1992, CA-CANCER J CLIN, V42, P296, DOI 10.3322/canjclin.42.5.296; Loescher LJ, 1999, CANCER NURS, V22, P96, DOI 10.1097/00002820-199902000-00017; LOVE RR, 1985, J CHRON DIS, V38, P289, DOI 10.1016/0021-9681(85)90074-8; Lynch HT, 2003, NEW ENGL J MED, V348, P919, DOI 10.1056/NEJMra012242; LYNCH HT, 1985, CANCER, V56, P934, DOI 10.1002/1097-0142(19850815)56:4<934::AID-CNCR2820560439>3.0.CO;2-I; LYNCH HT, 1976, JAMA-J AM MED ASSOC, V236, P582, DOI 10.1001/jama.236.6.582; Makinen T, 2002, J CLIN ONCOL, V20, P2658, DOI 10.1200/JCO.2002.05.006; Mitchell RJ, 2004, GUT, V53, P291, DOI 10.1136/gut.2003.027896; MUKHERJEE AK, 1991, PUBLIC HEALTH, V105, P69, DOI 10.1016/S0033-3506(05)80319-1; Mussio P, 1998, ANTICANCER RES, V18, P2811; NELSON CL, 1993, GENET EPIDEMIOL, V10, P235, DOI 10.1002/gepi.1370100404; Novakovic B, 1996, JNCI-J NATL CANCER I, V88, P1492, DOI 10.1093/jnci/88.20.1492; PARAZZINI F, 1993, INT J EPIDEMIOL, V22, P614, DOI 10.1093/ije/22.4.614; PARENT ME, 1995, EPIDEMIOLOGY, V6, P184, DOI 10.1097/00001648-199503000-00018; Parslov M, 2000, AM J OBSTET GYNECOL, V182, P23, DOI 10.1016/S0002-9378(00)70486-8; Penberthy L, 2003, AM J EPIDEMIOL, V158, P27, DOI 10.1093/aje/kwg108; Pharoah PDP, 1997, INT J CANCER, V71, P800, DOI 10.1002/(SICI)1097-0215(19970529)71:5<800::AID-IJC18>3.3.CO;2-R; Rose P, 1999, FAM PRACT, V16, P78, DOI 10.1093/fampra/16.1.78; Salkind AR, 2001, JAMA-J AM MED ASSOC, V285, P2498, DOI 10.1001/jama.285.19.2498; Scheuner MT, 1997, AM J MED GENET, V71, P315, DOI 10.1002/(SICI)1096-8628(19970822)71:3<315::AID-AJMG12>3.0.CO;2-N; Schmidt S, 1998, HUM GENET, V102, P348, DOI 10.1007/s004390050704; Severin M J, 1996, Oncology (Williston Park), V10, P211; SEVERIN MJ, 1996, ONCOLOGY HUNTINGT, V10, P217; ShattuckEidens D, 1997, JAMA-J AM MED ASSOC, V278, P1242, DOI 10.1001/jama.278.15.1242; Sijmons RH, 2000, EUR J HUM GENET, V8, P181, DOI 10.1038/sj.ejhg.5200441; SIMEL DL, 1991, J CLIN EPIDEMIOL, V44, P763, DOI 10.1016/0895-4356(91)90128-V; SLATTERY ML, 1993, JAMA-J AM MED ASSOC, V270, P1563, DOI 10.1001/jama.270.13.1563; Smith RA, 2001, CA-CANCER J CLIN, V51, P38, DOI 10.3322/canjclin.51.1.38; STJOHN DJB, 1993, ANN INTERN MED, V118, P785, DOI 10.7326/0003-4819-118-10-199305150-00005; Stratton JF, 1998, BRIT J OBSTET GYNAEC, V105, P493, DOI 10.1111/j.1471-0528.1998.tb10148.x; Sweet KM, 2002, J CLIN ONCOL, V20, P528, DOI 10.1200/JCO.20.2.528; Theis B, 1994, Eur J Cancer Prev, V3, P321, DOI 10.1097/00008469-199407000-00004; THOMPSON WD, 1991, INT J EPIDEMIOL, V20, P595, DOI 10.1093/ije/20.3.595; Vasen HFA, 1999, GASTROENTEROLOGY, V116, P1453, DOI 10.1016/S0016-5085(99)70510-X; Verkooijen HM, 2004, ANN ONCOL, V15, P350, DOI 10.1093/annonc/mdh072; WEBER W, 1986, CANCER DETECT PREV, V9, P455; WEBER W, 1993, ANTICANCER RES, V13, P1197; Weinstock MA, 1998, J CLIN EPIDEMIOL, V51, P1299, DOI 10.1016/S0895-4356(98)00070-5; Westman J, 2000, J MED GENET, V37, P354, DOI 10.1136/jmg.37.5.354; Winawer S, 2003, GASTROENTEROLOGY, V124, P544, DOI 10.1053/gast.2003.50044; Ziogas A, 2003, AM J PREV MED, V24, P190, DOI 10.1016/S0749-3797(02)00593-7; ZIPPIN C, 1995, CANCER, V76, P2343, DOI 10.1002/1097-0142(19951201)76:11<2343::AID-CNCR2820761124>3.0.CO;2-#	105	251	255	0	16	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 22	2004	292	12					1480	1489		10.1001/jama.292.12.1480	http://dx.doi.org/10.1001/jama.292.12.1480			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	856FT	15383520				2022-12-28	WOS:000224031800031
J	Livingstone, MS; Conway, BR				Livingstone, MS; Conway, BR			Was Rembrandt stereoblind?	NEW ENGLAND JOURNAL OF MEDICINE			English	Letter									Harvard Univ, Sch Med, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Livingstone, MS (corresponding author), Harvard Univ, Sch Med, Boston, MA 02115 USA.		Conway, Bevil/AAG-2412-2020	Conway, Bevil/0000-0001-7715-9253; Livingstone, Margaret/0000-0002-1950-0123	NEI NIH HHS [R01 EY016187, R01 EY016187-01A2] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY016187] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		REMBRANDT HR, 1634, SELF PORTRAIT; White Christopher, 1999, REMBRANDT HIMSELF	2	25	27	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 16	2004	351	12					1264	1265		10.1056/NEJM200409163511224	http://dx.doi.org/10.1056/NEJM200409163511224			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	853WS	15371590	Bronze, Green Accepted			2022-12-28	WOS:000223861300033
J	Vogeley, L; Sineshchekov, OA; Trivedi, VD; Sasaki, J; Spudich, JL; Luecke, H				Vogeley, L; Sineshchekov, OA; Trivedi, VD; Sasaki, J; Spudich, JL; Luecke, H			Anabaena sensory rhodopsin: A photochromic color 0 sensor at 2.0 angstrom	SCIENCE			English	Article							LIGHT; BACTERIORHODOPSIN	Microbial sensory rhodopsins are a family of membrane-embedded photoreceptors in prokaryotic and eukaryotic organisms. Structures of archaeal rhodopsins, which function as light-driven ion pumps or photosensors, have been reported. We present the structure of a eubacterial rhodopsin, which differs from those of previously characterized archaeal rhodopsins in its chromophore and cytoplasmic-side portions. Anabaena sensory rhodopsin exhibits light-induced interconversion between stable 13-cis and all-trans states of the retinylidene protein. The ratio of its cis and trans chromophore forms depends on the wavelength of illumination, thus providing a mechanism for a single protein to signal the color of light, for example, to regulate color-sensitive processes such as chromatic adaptation in photosynthesis. Its cytoplasmic half channel, highly hydrophobic in the archaeal rhodopsins, contains numerous hydrophilic residues networked by water molecules, providing a connection from the photoactive site to the cytoplasmic surface believed to interact with the receptor's soluble 14-kilodalton transducer.	Univ Texas, Sch Med, Dept Biochem & Mol Biol, Ctr Membrane Biol, Houston, TX 77030 USA; Univ Texas, Sch Med, Dept Microbiol & Mol Genet, Houston, TX 77030 USA; Moscow MV Lomonosov State Univ, Dept Biol, Moscow, Russia; Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92697 USA; Univ Calif Irvine, Dept Physiol & Biophys, Irvine, CA 92697 USA; Univ Calif Irvine, Dept Informat & Comp Sci, Irvine, CA 92697 USA	University of Texas System; University of Texas System; Lomonosov Moscow State University; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine	Spudich, JL (corresponding author), Univ Texas, Sch Med, Dept Biochem & Mol Biol, Ctr Membrane Biol, Houston, TX 77030 USA.	john.l.spudich@uth.tmc.edu; hudel@uci.edu	Luecke, Hartmut/F-4712-2012	Luecke, Hartmut/0000-0002-4938-0775	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM027750, R01GM059970, R01GM067808] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Beja O, 2000, SCIENCE, V289, P1902, DOI 10.1126/science.289.5486.1902; Cartailler JP, 2004, STRUCTURE, V12, P133, DOI 10.1016/j.str.2003.12.001; Gartner W., 2000, HDB BIOL PHYS, V3, P297; Gordeliy VI, 2002, NATURE, V419, P484, DOI 10.1038/nature01109; Grossman AR, 2001, J BIOL CHEM, V276, P11449, DOI 10.1074/jbc.R100003200; Gyula N, 2003, CURR OPIN PLANT BIOL, V6, P446, DOI 10.1016/S1369-5266(03)00082-7; Jung KH, 2003, MOL MICROBIOL, V47, P1513, DOI 10.1046/j.1365-2958.2003.03395.x; Kolbe M, 2000, SCIENCE, V288, P1390, DOI 10.1126/science.288.5470.1390; Luecke H, 2001, SCIENCE, V293, P1499, DOI 10.1126/science.1062977; Luecke H, 1998, SCIENCE, V280, P1934, DOI 10.1126/science.280.5371.1934; Luecke H, 1999, J MOL BIOL, V291, P899, DOI 10.1006/jmbi.1999.3027; MacColl R, 1998, J STRUCT BIOL, V124, P311, DOI 10.1006/jsbi.1998.4062; Royant A, 2001, P NATL ACAD SCI USA, V98, P10131, DOI 10.1073/pnas.181203898; Sineshchekov OA, 2004, PHOTOCH PHOTOBIO SCI, V3, P548, DOI 10.1039/b316207a; Sineshchekov OA, 2002, P NATL ACAD SCI USA, V99, P8689, DOI 10.1073/pnas.122243399; SINESHCHEKOV OA, UNPUB; Singh B, 2001, CURR MICROBIOL, V43, P265, DOI 10.1007/s002840010299; SPUDICH JL, 1984, NATURE, V312, P509, DOI 10.1038/312509a0; Spudich JL, 2000, ANNU REV CELL DEV BI, V16, P365, DOI 10.1146/annurev.cellbio.16.1.365; SPUDICH JL, IN PRESS HDB PHOTOSE; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; WAGNER G, 2001, ESP REV SERIES PHOTO, P421; Wang H.S.., 2002, ARABIDOPSIS BOOK, P1	23	184	189	1	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 19	2004	306	5700					1390	1393		10.1126/science.1103943	http://dx.doi.org/10.1126/science.1103943			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	873SP	15459346	Green Accepted			2022-12-28	WOS:000225301600057
J	Woodruff, BA; Kaiser, R				Woodruff, BA; Kaiser, R			Violence and mortality in West Darfur	LANCET			English	Editorial Material							REFUGEE; WAR		Ctr Dis Control & Prevent, Maternal & Child Nutr Branch, Atlanta, GA 30341 USA; Ctr Dis Control & Prevent, Int Emergency & Refugee Hlth Branch, Atlanta, GA USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Woodruff, BA (corresponding author), Ctr Dis Control & Prevent, Maternal & Child Nutr Branch, Atlanta, GA 30341 USA.	baw4@cdc.gov						[Anonymous], 1995, Lancet, V345, P339; Brown V, 2002, LANCET, V359, P161, DOI 10.1016/S0140-6736(02)07378-6; Leaning J, 2004, NEW ENGL J MED, V351, P735, DOI 10.1056/NEJMp048206; Spiegel PB, 2000, LANCET, V355, P2204, DOI 10.1016/S0140-6736(00)02404-1; Spiegel PB, 2001, DISASTERS, V25, P172, DOI 10.1111/1467-7717.00169; Spiegel PB, 2001, LANCET, V357, P714, DOI 10.1016/S0140-6736(00)04143-X; The Sphere Project, 2004, HUM CHART MIN STAND; TOOLE MJ, 1990, JAMA-J AM MED ASSOC, V263, P3296, DOI 10.1001/jama.263.24.3296; TOOLE MJ, 1993, LANCET, V341, P1193, DOI 10.1016/0140-6736(93)91013-C; [No title captured]	10	2	2	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 9	2004	364	9442					1290	1291		10.1016/S0140-6736(04)17201-2	http://dx.doi.org/10.1016/S0140-6736(04)17201-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	860NG	15474117				2022-12-28	WOS:000224349700004
J	Rosen, FS				Rosen, FS			Conquering polio - Isolation of poliovirus - John Enders and the nobel prize.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Childrens Hosp, Ctr Blood Res, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard University; Harvard Medical School	Rosen, FS (corresponding author), Childrens Hosp, Ctr Blood Res, 300 Longwood Ave, Boston, MA 02115 USA.							ENDERS JF, 1949, SCIENCE, V109, P85, DOI 10.1126/science.109.2822.85; Enders JF, 1944, J CLIN INVEST, V23, P510, DOI 10.1172/JCI101517; Feller AE, 1940, J EXP MED, V72, P367, DOI 10.1084/jem.72.4.367; Hammon WD, 1939, J EXP MED, V69, P327, DOI 10.1084/jem.69.3.327; Ward HK, 1933, J EXP MED, V57, P527, DOI 10.1084/jem.57.4.527	5	9	9	0	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 7	2004	351	15					1481	1483		10.1056/NEJMp048202	http://dx.doi.org/10.1056/NEJMp048202			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	859UP	15470207				2022-12-28	WOS:000224293700002
J	Gally, C; Eimer, S; Richmond, JE; Bessereau, JL				Gally, C; Eimer, S; Richmond, JE; Bessereau, JL			A transmembrane protein required for acetylcholine receptor clustering in Caenorhabditis elegans	NATURE			English	Article							LEVAMISOLE RESISTANCE; AMPA RECEPTORS; CUB-DOMAIN; GENE; GABA; MUTANTS; SYNAPSE; MODULE	Clustering neurotransmitter receptors at the synapse is crucial for efficient neurotransmission. Here we identify a Caenorhabditis elegans locus, lev-10, required for postsynaptic aggregation of ionotropic acetylcholine receptors (AChRs). lev-10 mutants were identified on the basis of weak resistance to the anthelminthic drug levamisole, a nematode-specific cholinergic agonist that activates AChRs present at neuromuscular junctions (NMJs) resulting in muscle hypercontraction and death at high concentrations(1-3). In lev-10 mutants, the density of levamisole-sensitive AChRs at NMJs is markedly reduced, yet the number of functional AChRs present at the muscle cell surface remains unchanged. LEV-10 is a transmembrane protein localized to cholinergic NMJs and required in body-wall muscles for AChR clustering. We also show that the LEV-10 extracellular region, containing five predicted CUB domains and one LDLa domain, is sufficient to rescue AChR aggregation in lev-10 mutants. This suggests a mechanism for AChR clustering that relies on extracellular protein - protein interactions. Such a mechanism is likely to be evolutionarily conserved because CUB/LDL transmembrane proteins similar to LEV-10, but lacking any assigned function, are expressed in the mammalian nervous system and might be used to cluster ionotropic receptors in vertebrates.	Ecole Normale Super, INSERM, U497, F-75005 Paris, France; Univ Illinois, Chicago, IL 60607 USA	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Bessereau, JL (corresponding author), Ecole Normale Super, INSERM, U497, 46 Rue Ulm, F-75005 Paris, France.	jlbesse@wotan.ens.fr	Eimer, Stefan/B-1865-2013; Bessereau, Jean-Louis/M-2988-2017	Bessereau, Jean-Louis/0000-0002-3088-7621	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041477] Funding Source: NIH RePORTER; NINDS NIH HHS [R01NS41477-03, R01 NS041477-02, R01 NS041477, R01 NS041477-01A1, R01 NS041477-03] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALFONSO A, 1993, SCIENCE, V261, P617, DOI 10.1126/science.8342028; Bamber BA, 1999, J NEUROSCI, V19, P5348; Bessereau JL, 2001, NATURE, V413, P70, DOI 10.1038/35092567; BORK P, 1993, J MOL BIOL, V231, P539, DOI 10.1006/jmbi.1993.1305; Bredt DS, 2003, NEURON, V40, P361, DOI 10.1016/S0896-6273(03)00640-8; Choquet D, 2003, NAT REV NEUROSCI, V4, P251, DOI 10.1038/nrn1077; Christensen EI, 2002, NAT REV MOL CELL BIO, V3, P258, DOI 10.1038/nrm778; Dalva MB, 2000, CELL, V103, P945, DOI 10.1016/S0092-8674(00)00197-5; Duerr JS, 2001, AM J PHYSIOL-CELL PH, V280, pC1616, DOI 10.1152/ajpcell.2001.280.6.C1616; Fleming JT, 1997, J NEUROSCI, V17, P5843; Gally C, 2003, J NEUROSCI, V23, P2591; Herz J, 2002, ANNU REV BIOCHEM, V71, P405, DOI 10.1146/annurev.biochem.71.110601.135342; LEWIS JA, 1980, GENETICS, V95, P905; LEWIS JA, 1980, NEUROSCIENCE, V5, P967, DOI 10.1016/0306-4522(80)90180-3; LEWIS JA, 1987, J NEUROSCI, V7, P3059; McKay JP, 2004, GENETICS, V166, P161, DOI 10.1534/genetics.166.1.161; Michishita M, 2003, BIOCHEM BIOPH RES CO, V306, P680, DOI 10.1016/S0006-291X(03)01035-0; Miller T, 2000, J AGING PHYS ACTIV, V8, P289; O'Brien RJ, 1999, NEURON, V23, P309, DOI 10.1016/S0896-6273(00)80782-5; OKKEMA PG, 1993, GENETICS, V135, P385; Ono F, 2004, J NEUROSCI, V24, P5475, DOI 10.1523/JNEUROSCI.0851-04.2004; Passafaro M, 2003, NATURE, V424, P677, DOI 10.1038/nature01781; RAIZEN DM, 1995, GENETICS, V141, P1365; Richmond JE, 1999, NAT NEUROSCI, V2, P791, DOI 10.1038/12160; Stohr H, 2002, GENE, V286, P223, DOI 10.1016/S0378-1119(02)00438-9; Tomita S, 2004, SCIENCE, V303, P1508, DOI 10.1126/science.1090262; Yochem J, 1998, GENETICS, V149, P1323; Zheng Y, 2004, NATURE, V427, P451, DOI 10.1038/nature02244	28	110	115	0	9	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 30	2004	431	7008					578	582		10.1038/nature02893	http://dx.doi.org/10.1038/nature02893			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	857YP	15457263	Green Accepted			2022-12-28	WOS:000224156700049
J	Newman, JP; Segal, R				Newman, JP; Segal, R			Images in clinical medicine: Communicating hydrocephalus	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Hadassah Hebrew Univ Med Ctr, IL-91120 Jerusalem, Israel	Hebrew University of Jerusalem	Newman, JP (corresponding author), Hadassah Hebrew Univ Med Ctr, IL-91120 Jerusalem, Israel.								0	2	2	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 30	2004	351	14					E13	E13		10.1056/NEJMicm030726	http://dx.doi.org/10.1056/NEJMicm030726			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	857XT	15459316				2022-12-28	WOS:000224153900013
J	Zeman, A; Britton, T; Douglas, N; Hansen, A; Hicks, J; Howard, R; Meredith, A; Smith, I; Stores, G; Wilson, S; Zaiwalla, Z				Zeman, A; Britton, T; Douglas, N; Hansen, A; Hicks, J; Howard, R; Meredith, A; Smith, I; Stores, G; Wilson, S; Zaiwalla, Z			Narcolepsy and excessive daytime sleepiness	BMJ-BRITISH MEDICAL JOURNAL			English	Review							DEPENDENT DIABETES-MELLITUS; RENAL-FUNCTION; NEPHROTIC SYNDROME; FOLLOW-UP; PREGNANCY; NEPHROPATHY; WOMEN; PROGRESSION; RETINOPATHY; MUTATION		Western Gen Hosp, Edinburgh EH4 1PU, Midlothian, Scotland; Kings Coll Hosp London, London, England; Royal Infirm, Edinburgh, Midlothian, Scotland; Ridge Med Ctr, Bradford, W Yorkshire, England; Frenchay Hosp, Burden Ctr, Bristol BS16 1LE, Avon, England; Natl Hosp Neurol & Neurosurg, London WC1N 3BG, England; Conquest Hosp, St Leonards On Sea, E Sussex, England; Papworth Hosp, Resp Support & Sleep Ctr, Cambridge CB3 8RE, England; Univ Oxford, Oxford, England; Univ Bristol, Bristol, Avon, England; Radcliffe Infirm, Oxford OX2 6HE, England; Pk Hosp, Oxford, England	University of Edinburgh; King's College Hospital NHS Foundation Trust; King's College Hospital; Royal Infirmary of Edinburgh; University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust; Papworth Hospital; University of Oxford; University of Bristol; Radcliffe Infirmary	Zeman, A (corresponding author), Western Gen Hosp, Edinburgh EH4 1PU, Midlothian, Scotland.	az@skull.dcn.ed.ac.uk	Douglas, Neil/B-1491-2013	Zeman, Adam/0000-0003-4875-658X				Bar J, 1999, J PEDIATR ENDOCR MET, V12, P659; Becker PM, 2000, NEUROLOGY, V54, P1166; BIESENBACH G, 1987, KLIN WOCHENSCHR, V65, P1048, DOI 10.1007/BF01726324; BIESENBACH G, 1992, NEPHROL DIAL TRANSPL, V7, P105, DOI 10.1093/oxfordjournals.ndt.a092077; Biesenbach G, 1999, J NEPHROL, V12, P41; Biesenbach G, 2000, RENAL FAILURE, V22, P573, DOI 10.1081/JDI-100100898; Chan PTK, 2001, CANCER, V92, P1632, DOI 10.1002/1097-0142(20010915)92:6<1632::AID-CNCR1489>3.0.CO;2-I; CONTI FG, 1995, GROWTH REGULAT, V5, P101; Czajkowski K, 1999, Ginekol Pol, V70, P753; Daniels O, 2000, CARDIOL YOUNG, V10, P75; De Lecea L, 1998, P NATL ACAD SCI USA, V95, P322, DOI 10.1073/pnas.95.1.322; Dunne FP, 1999, QJM-MON J ASSOC PHYS, V92, P451, DOI 10.1093/qjmed/92.8.451; Ekbom P, 2001, DIABETES CARE, V24, P1739, DOI 10.2337/diacare.24.10.1739; Gelineau J, 1880, GAZ HOPITAUX, V53, P735; Gordon M, 1996, OBSTET GYNECOL, V87, P401, DOI 10.1016/0029-7844(95)00420-3; Guilleminault C, 2001, BRAIN, V124, P1482, DOI 10.1093/brain/124.8.1482; HEMACHANDRA A, 1995, DIABETES CARE, V18, P950, DOI 10.2337/diacare.18.7.950; HIRONAKA K, 1992, DIABETIC MED, V9, P307, DOI 10.1111/j.1464-5491.1992.tb01785.x; Hobson JA, 2002, NAT REV NEUROSCI, V3, P679, DOI 10.1038/nrn915; HOPP H, 1995, GEBURTSH FRAUENHEILK, V55, P275, DOI 10.1055/s-2007-1023317; HOPP H, 1995, ARCH GYNECOL OBSTET, V257, P573, DOI 10.1007/BF02264893; HUBLIN C, 1994, ANN NEUROL, V35, P709, DOI 10.1002/ana.410350612; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; JUJI T, 1984, TISSUE ANTIGENS, V24, P316, DOI 10.1111/j.1399-0039.1984.tb02144.x; Khoury J C, 2002, J Matern Fetal Neonatal Med, V11, P238, DOI 10.1080/713605516; KIMMERLE R, 1995, DIABETOLOGIA, V38, P227, DOI 10.1007/s001250050275; Kitzmiller JL, 1998, GYNAKOLOGE, V31, P165, DOI 10.1007/s001290050240; KITZMILLER JL, 1981, AM J OBSTET GYNECOL, V141, P741, DOI 10.1016/0002-9378(81)90698-0; Lenz O, 1998, NEPHROL DIAL TRANSPL, V13, P3074, DOI 10.1093/ndt/13.12.3074; Lin L, 1999, CELL, V98, P365, DOI 10.1016/S0092-8674(00)81965-0; Littner M, 2001, SLEEP, V24, P451; Mackie ADR, 1996, DIABETIC MED, V13, P90; Mellors R C, 1966, Int Rev Exp Pathol, V5, P217; MENDES P, 2003, ARQUIVOS MED, V17, P113; Menjivar M, 1997, LIFE SCI, V61, P1159, DOI 10.1016/S0024-3205(97)00657-7; Meredith A., 2002, GUIDELINES DIAGNOSIS; Mignot E, 1997, SLEEP, V20, P1012; Mignot E, 2002, ARCH NEUROL-CHICAGO, V59, P1553, DOI 10.1001/archneur.59.10.1553; Mignot E, 1998, NEUROLOGY, V50, pS16, DOI 10.1212/WNL.50.2_Suppl_1.S16; Miodovnik M, 1996, AM J OBSTET GYNECOL, V174, P1180, DOI 10.1016/S0002-9378(96)70660-9; Nishino S, 2000, LANCET, V355, P39, DOI 10.1016/S0140-6736(99)05582-8; Ohayon MM, 1996, BRIT J PSYCHIAT, V169, P459, DOI 10.1192/bjp.169.4.459; Overeem S, 2001, J CLIN NEUROPHYSIOL, V18, P78, DOI 10.1097/00004691-200103000-00002; Pace-Schott EF, 2002, NAT REV NEUROSCI, V3, P591, DOI 10.1038/nrn895; Peyron C, 2000, NAT MED, V6, P991, DOI 10.1038/79690; Purdy LP, 1996, DIABETES CARE, V19, P1067, DOI 10.2337/diacare.19.10.1067; RECHTSCHAFFEN A, 1963, ELECTROEN CLIN NEURO, V15, P599, DOI 10.1016/0013-4694(63)90032-4; Reece E A, 1998, J Matern Fetal Med, V7, P213, DOI 10.1002/(SICI)1520-6661(199807/08)7:4<213::AID-MFM11>3.0.CO;2-E; REECE EA, 1988, AM J OBSTET GYNECOL, V159, P56, DOI 10.1016/0002-9378(88)90494-2; Reusch C, 1991, Tierarztl Prax, V19, P181; Rogers AE, 2001, SLEEP, V24, P385, DOI 10.1093/sleep/24.4.385; Rossing K, 2002, DIABETOLOGIA, V45, P36, DOI 10.1007/s125-002-8242-4; Sakurai T, 1998, CELL, V92, P573, DOI 10.1016/S0092-8674(00)80949-6; Scammell TE, 2003, ANN NEUROL, V53, P154, DOI 10.1002/ana.10444; SHULTZ LD, 1991, LAB INVEST, V65, P588; Silber MH, 2002, SLEEP, V25, P197, DOI 10.1093/sleep/25.2.197; Sobczak M, 2000, Ginekol Pol, V71, P893; SOBCZAK M, 1999, DIABETOLOGIA POLSKA, V6, P175; Star J, 1998, CLIN PERINATOL, V25, P887, DOI 10.1016/S0095-5108(18)30089-7; Stores G, 1998, J ROY COLL PHYS LOND, V32, P149; Thannickal TC, 2000, NEURON, V27, P469, DOI 10.1016/S0896-6273(00)00058-1; Tofovic SP, 2000, RENAL FAILURE, V22, P387, DOI 10.1081/JDI-100100882; TROMPETER RS, 1981, LANCET, V1, P1177, DOI 10.1016/S0140-6736(81)92348-5	63	37	38	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 25	2004	329	7468					724	728C		10.1136/bmj.329.7468.724	http://dx.doi.org/10.1136/bmj.329.7468.724			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	858RV	15388615	Green Published, Green Submitted			2022-12-28	WOS:000224210300021
J	Bloche, MG				Bloche, MG			Back to the 90's - The Supreme Court immunizes managed care	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Georgetown Univ, Ctr Law, Washington, DC 20057 USA; Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD USA	Georgetown University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Bloche, MG (corresponding author), Georgetown Univ, Ctr Law, Washington, DC 20057 USA.							Bloche MG, 2003, CALIF LAW REV, V91, P247, DOI 10.2307/3481333; BLOCHE MG, 2003, PRIVATIZATION HLTH C, P22	2	1	1	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 23	2004	351	13					1277	1279		10.1056/NEJMp048196	http://dx.doi.org/10.1056/NEJMp048196			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	855TP	15385651				2022-12-28	WOS:000223997700002
J	Siegal, M				Siegal, M			Signposts to the essence of language	SCIENCE			English	Editorial Material									Univ Sheffield, Dept Psychol, Sheffield S10 2TP, S Yorkshire, England	University of Sheffield	Siegal, M (corresponding author), Univ Sheffield, Dept Psychol, Sheffield S10 2TP, S Yorkshire, England.	m.siegal@sheffield.ac.uk						Chomsky N, 1980, RULES REPRESENTATION; EPSTEIN R, 1980, SCIENCE, V207, P543, DOI 10.1126/science.207.4430.543; GELMAN R, IN PRESS TRENDS COGN; Goldin-Meadow S., 2003, RESILIENCE LANGUAGE; LANE H, 1977, WILD BOY AVEYRON, P83; Mayberry RI, 2002, NATURE, V417, P38, DOI 10.1038/417038a; PETITTO LA, 1991, SCIENCE, V251, P1493, DOI 10.1126/science.2006424; Sacks O., 1989, SEEING VOICES; Senghas A, 2004, SCIENCE, V305, P1779, DOI 10.1126/science.1100199; STROMSWOLD K, 2000, NEW COGNITIVE NEUROS, P909; Vouloumanos A, 2004, DEVELOPMENTAL SCI, V7, P270, DOI 10.1111/j.1467-7687.2004.00345.x; Woolfe T, 2002, CHILD DEV, V73, P768, DOI 10.1111/1467-8624.00437	12	2	2	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 17	2004	305	5691					1720	1721		10.1126/science.1102894	http://dx.doi.org/10.1126/science.1102894			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	856IS	15375252				2022-12-28	WOS:000224039500023
J	Chae, CU; Afridi, NA; Karchmer, AW; Torchiana, DF; Houser, SL				Chae, CU; Afridi, NA; Karchmer, AW; Torchiana, DF; Houser, SL			Case 29-2004: A 75-year-old woman with acute onset of chest pain followed by fever - Acute bacterial endocarditis with aortic-root abscess, due to infection by S-anginosus (S-milleri group)	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							CARDIAC CONDUCTION ABNORMALITIES; STREPTOCOCCUS-MILLERI; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; VALVE ENDOCARDITIS; DUKE CRITERIA; DIAGNOSIS; REPLACEMENT; DETERMINANTS; MANAGEMENT		Massachusetts Gen Hosp, Beth Israel Deaconess Med Ctr, Div Infect Dis, Boston, MA 02114 USA; Massachusetts Gen Hosp, Div Cardiac Surg, Boston, MA 02114 USA; Massachusetts Gen Hosp, Div Cardiol, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; Harvard Univ, Sch Med, Dept Surg, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA USA; Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Beth Israel Deaconess Medical Center; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Chae, CU (corresponding author), Massachusetts Gen Hosp, Beth Israel Deaconess Med Ctr, Div Infect Dis, Boston, MA 02114 USA.							Alexiou C, 2000, ANN THORAC SURG, V69, P1448, DOI 10.1016/S0003-4975(00)01139-5; ARNETT EN, 1976, CIRCULATION, V54, P140, DOI 10.1161/01.CIR.54.1.140; Baumgartner FJ, 2000, ANN THORAC SURG, V70, P442, DOI 10.1016/S0003-4975(00)01363-1; Bayer AS, 1998, CIRCULATION, V98, P2936, DOI 10.1161/01.CIR.98.25.2936; BLUMBERG EA, 1992, CLIN INFECT DIS, V15, P983, DOI 10.1093/clind/15.6.983; BLUMBERG EA, 1995, CHEST, V107, P898, DOI 10.1378/chest.107.4.898; Clarke NRA, 2002, POSTGRAD MED J, V78, P168, DOI 10.1136/pmj.78.917.168; Clarridge JE, 2001, CLIN INFECT DIS, V32, P1511, DOI 10.1086/320163; DANIEL WG, 1991, NEW ENGL J MED, V324, P795, DOI 10.1056/NEJM199103213241203; DINUBILE MJ, 1986, AM J CARDIOL, V58, P1213, DOI 10.1016/0002-9149(86)90384-X; Doern GV, 1996, ANTIMICROB AGENTS CH, V40, P891, DOI 10.1128/AAC.40.4.891; Dossche KM, 1997, ANN THORAC SURG, V63, P1644, DOI 10.1016/S0003-4975(97)00107-0; DOUGLAS A, 1986, LANCET, V1, P1341; dUdekem Y, 1996, ANN THORAC SURG, V62, P48, DOI 10.1016/0003-4975(96)00274-3; GROVER FL, 1994, J THORAC CARDIOV SUR, V108, P207; HASBUN R, 2003, JAMA-J AM MED ASSOC, V15, P1933; HAYDOCK D, 1992, J THORAC CARDIOV SUR, V103, P130; HERZOG CA, 1991, AM J MED, V90, P392, DOI 10.1016/0002-9343(91)90583-J; HORSTKOTTE D, 1988, EUR HEART J, V9, P57, DOI 10.1093/eurheartj/9.suppl_E.57; LEDERMAN MM, 1992, MEDICINE, V71, P52, DOI 10.1097/00005792-199201000-00005; Lefort A, 2002, ARCH INTERN MED, V162, P2450, DOI 10.1001/archinte.162.21.2450; LEUNG DYC, 1994, BRIT HEART J, V72, P175; Li JS, 2000, CLIN INFECT DIS, V30, P633, DOI 10.1086/313753; Meine TJ, 2001, AM HEART J, V142, P280, DOI 10.1067/mhj.2001.116964; Mylonakis E, 2001, NEW ENGL J MED, V345, P1318, DOI 10.1056/NEJMra010082; ROBERTS RB, 1979, REV INFECT DIS, V1, P955; STECKELBERG JM, 1991, ANN INTERN MED, V114, P635, DOI 10.7326/0003-4819-114-8-635; SWEENEY MS, 1985, J THORAC CARDIOV SUR, V90, P676; Tracy M, 2001, ANTIMICROB AGENTS CH, V45, P1511, DOI 10.1128/AAC.45.5.1511-1514.2001; TUAZON CU, 1986, REV INFECT DIS, V8, P54; WALLACE AG, 1965, CIRCULATION, V31, P450, DOI 10.1161/01.CIR.31.3.450; Wanahita A, 2002, J INFECT DIS, V185, P85, DOI 10.1086/338145	32	3	3	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 16	2004	351	12					1240	1248		10.1056/NEJMcpc049020	http://dx.doi.org/10.1056/NEJMcpc049020			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	853WS	15371582				2022-12-28	WOS:000223861300014
J	McCook, A				McCook, A			Sune K Bergstrom - Obituary	LANCET			English	Biographical-Item												abmccook@yahoo.com							0	2	2	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 11	2004	364	9438					930	930		10.1016/S0140-6736(04)17009-8	http://dx.doi.org/10.1016/S0140-6736(04)17009-8			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	853MF	15384207				2022-12-28	WOS:000223831000015
J	FitzGerald, GA				FitzGerald, GA			Coxibs and cardiovascular disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							THERAPEUTIC ARTHRITIS RESEARCH; RANDOMIZED CONTROLLED-TRIAL; LUMIRACOXIB; IBUPROFEN; NAPROXEN; TARGET; COX-2		Univ Penn, Inst Translat Med & Therapeut, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine	FitzGerald, GA (corresponding author), Univ Penn, Inst Translat Med & Therapeut, Philadelphia, PA 19104 USA.		FitzGerald, Garret A/A-4222-2010					Farkouh ME, 2004, LANCET, V364, P675, DOI 10.1016/S0140-6736(04)16894-3; FitzGerald G, 2003, NAT REV DRUG DISCOV, V2, P879, DOI 10.1038/nrd1225; FitzGerald GA, 2001, NEW ENGL J MED, V345, P433, DOI 10.1056/NEJM200108093450607; Ray WA, 2002, LANCET, V360, P1071, DOI 10.1016/S0140-6736(02)11131-7; Schnitzer TJ, 2004, LANCET, V364, P665, DOI 10.1016/S0140-6736(04)16893-1	5	676	719	1	22	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 21	2004	351	17					1709	1711		10.1056/NEJMp048288	http://dx.doi.org/10.1056/NEJMp048288			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	863TH	15470192				2022-12-28	WOS:000224585200002
J	Claussen, M				Claussen, M			Astronomical masers	SCIENCE			English	Editorial Material							LINE		Natl Radio Astron Observ, Socorro, NM 87801 USA	National Radio Astronomy Observatory (NRAO)	Claussen, M (corresponding author), Natl Radio Astron Observ, POB O, Socorro, NM 87801 USA.	mclausse@aoc.nrao.edu						Claussen MJ, 1998, ASTROPHYS J, V507, pL79, DOI 10.1086/311669; Diamond PJ, 2003, ASTROPHYS J, V599, P1372, DOI 10.1086/379347; Fish VL, 2003, ASTROPHYS J, V596, P328, DOI 10.1086/377081; GENZEL R, 1981, ASTROPHYS J, V244, P884, DOI 10.1086/158764; Hoffman IM, 2003, ASTROPHYS J, V583, P272, DOI 10.1086/345355; MIYOSHI M, 1995, NATURE, V373, P127, DOI 10.1038/373127a0; Shepherd DS, 2001, SCIENCE, V292, P1513, DOI 10.1126/science.1059475; Walswortrh RL, 2004, SCIENCE, V306, P236, DOI 10.1126/science.1101354; WEAVER H, 1965, NATURE, V208, P29, DOI 10.1038/208029a0	9	1	1	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 8	2004	306	5694					235	236		10.1126/science.1101353	http://dx.doi.org/10.1126/science.1101353			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	861MC	15472066				2022-12-28	WOS:000224419700025
J	Flory, J; Emanuel, E				Flory, J; Emanuel, E			Interventions to improve research participants' understanding in informed consent for research - A systematic review	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							VACCINE EFFICACY TRIALS; CANCER CLINICAL-TRIALS; INFORMATION; COMPREHENSION; QUALITY; HIV; VIDEO; CAPACITY; STANDARD; LEVEL	Context Available data suggest that prospective research participants may frequently not understand information disclosed to them in the informed consent process. Little is known about how understanding can be improved. Objective To review research on interventions to improve research participants' understanding of information disclosed in the informed consent process. Data Sources and Study Selection A search of MEDLINE was performed using the terms informed consent and clinical research and informed consent and (comprehension or understanding) from 1966 to March 2004, which included randomized controlled trials, longitudinal trials, and controlled trials with nonrandom allocation that compared the understanding of research participants who had undergone only a standard informed consent process to that of participants who had received an intervention to improve their understanding. A comprehensive bibliography of empirical research on informed consent published in January 1999 was also reviewed, as were personal files and all issues of the journals IRB and Controlled Clinical Trials. Data Extraction Study design, quality criteria, population characteristics, interventions, and outcomes for each trial were extracted. The statistical significance of the interventions' effects on understanding were noted, as were mean scores for understanding for each group of each trial. For those trials that measured the secondary outcomes of satisfaction and willingness to enroll, results were also summarized. Data Synthesis Thirty studies described 42 trials that met inclusion criteria. Of 12 trials of multimedia interventions, 3 showed significant improvement in understanding. Of 15 trials of enhanced consent forms, 6 showed significant improvement in understanding (all P<.05), but 5 of 6 trials were of limited quality, casting doubt on their practical relevance. Of 5 trials of extended discussion, 3 showed significant improvement in understanding (all P<.001) and 2 showed trends toward improvement (P=.054 and P=.08). Of 5 trials of test/feedback, all showed significant improvement in understanding (all P<.05) but were flawed in that they may have mistaken rote memorization for improvement in understanding. Another 5 trials were put into a miscellaneous category and had varying impact on understanding. Some demographic factors, particularly lower education, were associated with less understanding. Satisfaction and willingness to enroll were never significantly diminished by an intervention. Conclusions Efforts to improve understanding through the use of multimedia and enhanced consent forms have had only limited success. Having a study team member or a neutral educator spend more time talking one-on-one to study participants appears to be the most effective available way of improving research participants' understanding; however, further research is needed.	NIH, Dept Clin Bioeth, Warren G Magnuson Clin Ctr, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA	Emanuel, E (corresponding author), NIH, Dept Clin Bioeth, Warren G Magnuson Clin Ctr, 10 Ctr Dr,Bldg 10,Room 1C118, Bethesda, MD 20892 USA.	eemanuel@cc.nih.gov						Aaronson NK, 1996, J CLIN ONCOL, V14, P984, DOI 10.1200/JCO.1996.14.3.984; AGRE P, 1994, GASTROINTEST ENDOSC, V40, P271, DOI 10.1016/S0016-5107(94)70054-0; Agre Patricia, 2003, IRB, V25, P1, DOI 10.2307/3564285; Agre Patricia, 2003, IRB, VSuppl 25, pS11, DOI 10.2307/3564117; BENSON PR, 1988, LAW HUMAN BEHAV, V12, P455, DOI 10.1007/BF01044628; BERGLER JH, 1980, CLIN PHARMACOL THER, V27, P435, DOI 10.1038/clpt.1980.60; Bjorn E, 1999, J MED ETHICS, V25, P263, DOI 10.1136/jme.25.3.263; Carpenter WT, 2000, ARCH GEN PSYCHIAT, V57, P533, DOI 10.1001/archpsyc.57.6.533; Coletti AS, 2003, JAIDS-J ACQ IMM DEF, V32, P161, DOI 10.1097/00126334-200302010-00008; Coyne CA, 2003, J CLIN ONCOL, V21, P836, DOI 10.1200/JCO.2003.07.022; Daugherty C K, 2000, IRB, V22, P6, DOI 10.2307/3564113; Davis TC, 1998, JNCI-J NATL CANCER I, V90, P668, DOI 10.1093/jnci/90.9.668; Dresden GM, 2001, ACAD EMERG MED, V8, P246, DOI 10.1111/j.1553-2712.2001.tb01300.x; Dunn LB, 2002, AM J GERIAT PSYCHIAT, V10, P142, DOI 10.1176/appi.ajgp.10.2.142; Dunn LB, 2001, AM J PSYCHIAT, V158, P1911, DOI 10.1176/appi.ajp.158.11.1911; EPSTEIN LC, 1969, ARCH INTERN MED, V123, P682, DOI 10.1001/archinte.123.6.682; Fitzgerald DW, 2002, LANCET, V360, P1301, DOI 10.1016/S0140-6736(02)11338-9; Fureman I, 1997, AIDS EDUC PREV, V9, P330; HOWARD JM, 1981, CONTROL CLIN TRIALS, V2, P287, DOI 10.1016/0197-2456(81)90019-2; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Joffe S, 2001, LANCET, V358, P1772, DOI 10.1016/S0140-6736(01)06805-2; Juni P, 1999, JAMA-J AM MED ASSOC, V282, P1054, DOI 10.1001/jama.282.11.1054; Kucia AM, 2000, AM HEART J, V140, P94, DOI 10.1067/mhj.2000.106625; Lavori PW, 1999, CONTROL CLIN TRIALS, V20, P187, DOI 10.1016/S0197-2456(98)00064-6; Linde K, 1999, J CLIN EPIDEMIOL, V52, P631, DOI 10.1016/S0895-4356(99)00048-7; LLEWELLYNTHOMAS HA, 1995, PATIENT EDUC COUNS, V25, P97, DOI 10.1016/0738-3991(94)00705-Q; Mason V, 2003, BJOG-INT J OBSTET GY, V110, P1062, DOI 10.1111/j.1471-0528.2003.03041.x; MILLER C, 1994, J CLIN RES DRUG DEV, V8, P237; Murphy DA, 1999, AIDS EDUC PREV, V11, P389; OCONNOR AM, 2004, COCHRANE LIB; Preziosi MP, 1997, NEW ENGL J MED, V336, P370, DOI 10.1056/NEJM199701303360511; Rikkert MGMO, 1997, J MED ETHICS, V23, P271, DOI 10.1136/jme.23.5.271; Rogers CG, 1998, J PEDIATR-US, V132, P606, DOI 10.1016/S0022-3476(98)70347-6; Siminoff Laura A, 2003, IRB, VSuppl 25, pS1, DOI 10.2307/3564115; Stiles PG, 2001, PSYCHIAT SERV, V52, P780, DOI 10.1176/appi.ps.52.6.780; Sugarman J, 1999, Hastings Cent Rep, V29, pS1, DOI 10.2307/3528546; TAUB HA, 1981, EXP AGING RES, V7, P137, DOI 10.1080/03610738108259796; TAUB HA, 1986, J AM GERIATR SOC, V34, P601, DOI 10.1111/j.1532-5415.1986.tb05766.x; TAUB HA, 1980, GERONTOLOGIST, V20, P686, DOI 10.1093/geront/20.6.686; TAUB HA, 1987, EXP AGING RES, V13, P173; TINDALL B, 1994, PATIENT EDUC COUNS, V24, P261, DOI 10.1016/0738-3991(94)90069-8; van Stuijvenberg M, 1998, ARCH DIS CHILD, V79, P120, DOI 10.1136/adc.79.2.120; Weston J, 1997, PATIENT EDUC COUNS, V30, P239, DOI 10.1016/S0738-3991(96)00968-8; Wirshing DA, 1998, AM J PSYCHIAT, V155, P1508, DOI 10.1176/ajp.155.11.1508; Young Daniel R, 1990, IRB, V12, P1, DOI 10.2307/3564107	45	674	685	3	58	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 6	2004	292	13					1593	1601		10.1001/jama.292.13.1593	http://dx.doi.org/10.1001/jama.292.13.1593			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	859HS	15467062				2022-12-28	WOS:000224254600027
J	Forman, D; Altman, D				Forman, D; Altman, D			Vitamins to prevent cancer: supplementary problems	LANCET			English	Editorial Material							BETA-CAROTENE; LUNG-CANCER; TRIAL		Univ Leeds, Ctr Biostat & Epidemiol, Leeds, W Yorkshire, England; Ctr Stat Med, Canc Res UK Med Stat Grp, Oxford, England	University of Leeds; Cancer Research UK; University of Oxford	Forman, D (corresponding author), Univ Leeds, Ctr Biostat & Epidemiol, Leeds, W Yorkshire, England.	d.forman@leeds.ac.uk						BJELAKOVIC G, 2004, COCHRANE LIB; BLOCK G, 1991, AM J CLIN NUTR, V54, pS1310, DOI 10.1093/ajcn/54.6.1310s; Collins R, 2002, LANCET, V360, P23, DOI 10.1016/S0140-6736(02)09328-5; DARLOW BA, 2004, COCHRANE LIB; DOUGLAS RM, 2004, COCHRANE LIB; HEINONEN OP, 1994, NEW ENGL J MED, V330, P1029; Klaunig JE, 2004, ANNU REV PHARMACOL, V44, P239, DOI 10.1146/annurev.pharmtox.44.101802.121851; Lawlor DA, 2004, LANCET, V363, P1724, DOI 10.1016/S0140-6736(04)16260-0; Omenn GS, 1996, NEW ENGL J MED, V334, P1150, DOI 10.1056/NEJM199605023341802	9	23	23	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	OCT 2	2004	364	9441					1193	1194		10.1016/S0140-6736(04)17153-5	http://dx.doi.org/10.1016/S0140-6736(04)17153-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	859HO	15464163				2022-12-28	WOS:000224254200003
J	Sheridan, EA; Cepeda, J; De Palma, R; Brett, MM; Nagendran, K				Sheridan, EA; Cepeda, J; De Palma, R; Brett, MM; Nagendran, K			A drug user with a sore throat	LANCET			English	Editorial Material							WOUND BOTULISM		St Bartholomews Hosp, Dept Med Microbiol, London E1 1BB, England; St Bartholomews Hosp, Dept Neurol, London E1 1BB, England; St Bartholomews Hosp, Dept Clin Neurophysiol, London E1 1BB, England; Royal London Hosp, Dept Clin Neurophysiol, London E1 1BB, England; Royal London Hosp, Dept Neurol, London E1 1BB, England; Royal London Hosp, Dept Med Microbiol, London E1 1BB, England; HPA Cent Publ Hlth Lab, Food Safety Microbiol Lab, London NW9 5HT, England	University of London; Queen Mary University London; University of London; Queen Mary University London; University of London; Queen Mary University London; Barts Health NHS Trust; Royal London Hospital; Barts Health NHS Trust; Royal London Hospital; Barts Health NHS Trust; Royal London Hospital	Sheridan, EA (corresponding author), St Bartholomews Hosp, Dept Med Microbiol, London E1 1BB, England.	elizabeth.sheridan@doctors.org.uk		De Palma, Rodney/0000-0002-3004-9089				Brett MM, 2004, J MED MICROBIOL, V53, P555, DOI 10.1099/jmm.0.05379-0; Mulleague L, 2001, ANAESTHESIA, V56, P120, DOI 10.1046/j.1365-2044.2001.01833.x; TACKET CO, 1984, AM J MED, V76, P794, DOI 10.1016/0002-9343(84)90988-4; Werner SB, 2000, CLIN INFECT DIS, V31, P1018, DOI 10.1086/318134; Witcome M, 1998, J APPL MICROBIOL S S, V84, p87S	5	2	2	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	OCT 2	2004	364	9441					1286	1286		10.1016/S0140-6736(04)17150-X	http://dx.doi.org/10.1016/S0140-6736(04)17150-X			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	859HO	15464191				2022-12-28	WOS:000224254200040
J	Gai', DH; Zhao, R; Li, DW; Finkielstein, CV; Chen, XS				Gai', DH; Zhao, R; Li, DW; Finkielstein, CV; Chen, XS			Mechanisms of conformational change for a replicative hexameric helicase of SV40 large tumor antigen	CELL			English	Article							LARGE T-ANTIGEN; MINICHROMOSOME MAINTENANCE PROTEIN; BOVINE MITOCHONDRIAL F-1-ATPASE; SIMIAN VIRUS-40 DNA; IN-VITRO; CRYSTAL-STRUCTURE; SIMIAN-VIRUS-40 ORIGIN; SEQUENTIAL HYDROLYSIS; ESCHERICHIA-COLI; ATP SYNTHASE	The large tumor antigen (LTag) of simian virus 40, an AAA(+) protein, is a hexameric helicase essential for viral DNA replication in eukaryotic cells. LTag functions as an efficient molecular machine powered by ATP binding and hydrolysis for origin DNA melting and replication fork unwinding. To understand how ATP binding and hydrolysis are coupled to conformational changes, we have determined high-resolution structures (similar to1.9 Angstrom) of LTag hexamers in distinct nucleotide binding states. The structural differences of LTag in various nucleotide states detail the molecular mechanisms of conformational changes triggered by ATP binding/hydrolysis and reveal a potential mechanism of concerted nucleotide binding and hydrolysis. During these conformational changes, the angles and orientations between domains of a monomer alter, creating an "iris"-like motion in the hexamer. Additionally, six unique P hairpins on the channel surface move longitudinally along the central channel, possibly serving as a motor for pulling DNA into the LTag double hexamer for unwinding.	Univ Colorado, Hlth Sci Ctr, Dept Biochem & Mol Genet, Denver, CO 80262 USA; Univ So Calif, Dept Mol & Computat Biol, Los Angeles, CA 90089 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Southern California	Chen, XS (corresponding author), Univ Colorado, Hlth Sci Ctr, Dept Biochem & Mol Genet, 4200 E 9th Ave, Denver, CO 80262 USA.	xiaojiang.chen@usc.edu	Li, Dawei/I-8751-2016	Li, Dawei/0000-0003-4133-1263; finkielstein, carla/0000-0002-8417-4643	PHS HHS [NIH-R01] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; ARTHUR AK, 1988, J VIROL, V62, P1999, DOI 10.1128/JVI.62.6.1999-2006.1988; BOROWIEC JA, 1990, CELL, V60, P181, DOI 10.1016/0092-8674(90)90730-3; BOROWIEC JA, 1991, J VIROL, V65, P1228, DOI 10.1128/JVI.65.3.1228-1235.1991; BRUNGER AT, 1998, CRYSTALLOGRAPHY NMR; Brush GS, 1995, METHOD ENZYMOL, V262, P522; Bullock PA, 1997, CRIT REV BIOCHEM MOL, V32, P503, DOI 10.3109/10409239709082001; BULLOCK PA, 1991, MOL CELL BIOL, V11, P2350, DOI 10.1128/MCB.11.5.2350; Campbell KS, 1997, GENE DEV, V11, P1098, DOI 10.1101/gad.11.9.1098; Chong JPJ, 2000, P NATL ACAD SCI USA, V97, P1530, DOI 10.1073/pnas.030539597; Crampton DJ, 2004, P NATL ACAD SCI USA, V101, P4373, DOI 10.1073/pnas.0400968101; DEAN FB, 1987, P NATL ACAD SCI USA, V84, P16, DOI 10.1073/pnas.84.1.16; FANNING E, 1992, ANNU REV BIOCHEM, V61, P55; FISHER AJ, 1995, BIOCHEMISTRY-US, V34, P8960, DOI 10.1021/bi00028a004; Fletcher RJ, 2003, NAT STRUCT BIOL, V10, P160, DOI 10.1038/nsb893; Gomez-Lorenzo MG, 2003, EMBO J, V22, P6205, DOI 10.1093/emboj/cdg612; Hingorani MM, 1997, P NATL ACAD SCI USA, V94, P5012, DOI 10.1073/pnas.94.10.5012; Huang SG, 1998, BIOCHEMISTRY-US, V37, P15336, DOI 10.1021/bi981094g; Kelman Z, 1999, P NATL ACAD SCI USA, V96, P14783, DOI 10.1073/pnas.96.26.14783; Kim DE, 1999, J BIOL CHEM, V274, P11623, DOI 10.1074/jbc.274.17.11623; Leslie AGW, 1999, BIOCHEM SOC T, V27, P37, DOI 10.1042/bst0270037; Levin MK, 2003, J BIOL CHEM, V278, P23311, DOI 10.1074/jbc.M301283200; Li DW, 2003, NATURE, V423, P512, DOI 10.1038/nature01691; Maegley KA, 1996, P NATL ACAD SCI USA, V93, P8160, DOI 10.1073/pnas.93.16.8160; Menz RI, 2001, FEBS LETT, V494, P11, DOI 10.1016/S0014-5793(01)02302-X; Neuwald AF, 1999, GENOME RES, V9, P27; Ogura T, 2001, GENES CELLS, V6, P575, DOI 10.1046/j.1365-2443.2001.00447.x; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Petsko CA, 2000, P NATL ACAD SCI USA, V97, P538, DOI 10.1073/pnas.97.2.538; Rittinger K, 1998, NATURE, V392, P448, DOI 10.1038/33043; Sawaya MR, 1999, CELL, V99, P167, DOI 10.1016/S0092-8674(00)81648-7; Scheffzek K, 1997, SCIENCE, V277, P333, DOI 10.1126/science.277.5324.333; Simmons DT, 2000, ADV VIRUS RES, V55, P75, DOI 10.1016/S0065-3527(00)55002-7; Singleton MR, 2000, CELL, V101, P589, DOI 10.1016/S0092-8674(00)80871-5; Smelkova NV, 1998, J VIROL, V72, P8676, DOI 10.1128/JVI.72.11.8676-8681.1998; STILLMAN B, 1985, EMBO J, V4, P2933, DOI 10.1002/j.1460-2075.1985.tb04026.x; STILLMAN B, 1994, CELL, V78, P725, DOI 10.1016/S0092-8674(94)90362-X; STILLMAN BW, 1985, MOL CELL BIOL, V5, P2051, DOI 10.1128/MCB.5.8.2051; Stitt BL, 1998, J BIOL CHEM, V273, P26477, DOI 10.1074/jbc.273.41.26477; Stock D, 1999, SCIENCE, V286, P1700, DOI 10.1126/science.286.5445.1700; Sullivan CS, 2002, MICROBIOL MOL BIOL R, V66, P179, DOI 10.1128/MMBR.66.2.179-202.2002; Tesmer JJG, 1997, SCIENCE, V278, P1907, DOI 10.1126/science.278.5345.1907; TSURIMOTO T, 1991, J BIOL CHEM, V266, P1950; WAGA S, 1994, NATURE, V369, P207, DOI 10.1038/369207a0; WALKER JE, 1994, CURR OPIN STRUC BIOL, V4, P912, DOI 10.1016/0959-440X(94)90274-7; WESSEL R, 1992, J VIROL, V66, P804, DOI 10.1128/JVI.66.2.804-815.1992; Wittinghofer A, 1998, BIOL CHEM, V379, P933; WOBBE CR, 1987, P NATL ACAD SCI USA, V84, P1834, DOI 10.1073/pnas.84.7.1834	48	254	261	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 1	2004	119	1					47	60		10.1016/j.cell.2004.09.017	http://dx.doi.org/10.1016/j.cell.2004.09.017			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	859UE	15454080	Bronze			2022-12-28	WOS:000224292600008
J	Hommes, OR; Sorensen, PS; Fazekas, F; Enriquez, MM; Koelmel, HW; Fernandez, O; Pozzilli, C; O'Connor, P				Hommes, OR; Sorensen, PS; Fazekas, F; Enriquez, MM; Koelmel, HW; Fernandez, O; Pozzilli, C; O'Connor, P		European Study Immunoglobulin Mult	Intravenous immunoglobulin in secondary progressive multiple sclerosis: randomised placebo-controlled trial	LANCET			English	Article							INTERFERON BETA-1B; DOUBLE-BLIND; MS; MULTICENTER; METAANALYSIS; OUTCOMES	Background Several double-blind placebo-controlled trials of relapsing-remitting multiple sclerosis have shown beneficial effects of intravenous immunoglobulin (IVIG) on relapse rate and disability. The European Study on Intravenous Immunoglobulin in Multiple Sclerosis set out to test IVIG in the secondary progressive phase of the disease. Methods 318 patients with clinically definite secondary progressive multiple sclerosis (mean age 44 years [SD 7]) were randomly assigned IVIG 1 g/kg per month (n = 159) or an equivalent volume of placebo (albumin 0.1%; n = 159) for 27 months. After baseline investigation, clinical assessments were made every 3 months and MRI was repeated after 12 months and 24 months. The primary outcome was confirmed worsening of disability as defined by the time to first confirmed progression on the expanded disability status scale (EDSS). Analyses were by intention to treat. Findings 19 patients in the IVIG group and 39 in the placebo group terminated study treatment prematurely but were included in the analyses. IVIG treatment had no beneficial effect on time to confirmed EDSS progression (hazard ratio 1.11 [95% CI 0.80-1.53] for IVIG versus placebo). The annual relapse rate was 0.46 in both groups. No significant differences between the treatment groups were found in any of the other clinical outcome measures or in the change of T2-lesion load over time. The treatment was generally well tolerated, although deep venous thrombosis, pulmonary embolism, or both occurred in seven patients with risk factors for thromboembolism (IVIG six, placebo one). Interpretation Treatment with IVIG in this study did not show any clinical benefit and therefore cannot be recommended for patients with secondary progressive multiple sclerosis.	European Charcot Fdn, NL-6533 PA Nijmegen, Netherlands; Univ Copenhagen Hosp, Rigshosp, Dept Neurol, DK-2100 Copenhagen, Denmark; Karl Franzens Univ Graz, Dept Neurol, Graz, Austria; Karl Franzens Univ Graz, MR Ctr, Graz, Austria; Bayer Vital, Leverkusen, Germany; Klinikum Erfurt, Dept Neurol, Erfurt, Germany; Hosp Reg Carlos Haya, Dept Neurol, Malaga, Spain; Univ Roma La Sapienza, Clin Neurol 1, Rome, Italy; St Michaels Hosp, Toronto, ON M5B 1W8, Canada	Rigshospitalet; University of Copenhagen; University of Graz; University of Graz; Bayer AG; Hospital Carlos Haya; Sapienza University Rome; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto	Hommes, OR (corresponding author), European Charcot Fdn, Heiweg 97, NL-6533 PA Nijmegen, Netherlands.	info@charcot-ms.org	Pozzilli, Carlo/AAC-3270-2022; Macedo, Ana/L-9912-2018	Pozzilli, Carlo/0000-0002-6360-4798; Macedo, Ana/0000-0002-6978-8989; Sorensen, Per Soelberg/0000-0002-2818-3780				ACHIRON A, 1992, ARCH NEUROL-CHICAGO, V49, P1233, DOI 10.1001/archneur.1992.00530360031013; Achiron A, 1998, NEUROLOGY, V50, P398, DOI 10.1212/WNL.50.2.398; Cohen JA, 2002, NEUROLOGY, V59, P679, DOI 10.1212/WNL.59.5.679; Comi G, 2001, LANCET, V357, P1576, DOI 10.1016/S0140-6736(00)04725-5; Fazekas F, 1999, NEUROLOGY, V53, P448, DOI 10.1212/WNL.53.3.448; Fazekas F, 1997, LANCET, V349, P589, DOI 10.1016/S0140-6736(96)09377-4; GOODKIN DE, 1995, ANN NEUROL, V37, P30, DOI 10.1002/ana.410370108; Goodkin DE, 2000, NEUROLOGY, V54, P2352; Hartung HP, 2002, LANCET, V360, P2018, DOI 10.1016/S0140-6736(02)12023-X; Hommes O R, 2000, Mult Scler, V6 Suppl 2, pS27; Kappos L, 1998, LANCET, V352, P1491, DOI 10.1016/S0140-6736(98)10039-9; King J, 2001, NEUROLOGY, V56, P1496; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Lewanska M, 2002, EUR J NEUROL, V9, P565, DOI 10.1046/j.1468-1331.2002.00500.x; Li DKB, 2001, NEUROLOGY, V56, P1505, DOI 10.1212/WNL.56.11.1505; Miller DH, 1999, ANN NEUROL, V46, P850, DOI 10.1002/1531-8249(199912)46:6<850::AID-ANA7>3.0.CO;2-Q; Molyneux PD, 1998, J NEUROL NEUROSUR PS, V65, P42, DOI 10.1136/jnnp.65.1.42; RIDKER PM, 1995, NEW ENGL J MED, V332, P912, DOI 10.1056/NEJM199504063321403; Rudick R, 1997, ANN NEUROL, V42, P379, DOI 10.1002/ana.410420318; SCHULLER E, 1983, EUR NEUROL, V22, P205, DOI 10.1159/000115560; Sorensen P S, 1996, Mult Scler, V1, P349; Sorensen PS, 2002, EUR J NEUROL, V9, P557, DOI 10.1046/j.1468-1331.2002.00501.x; Sorensen PS, 1998, NEUROLOGY, V50, P1273, DOI 10.1212/WNL.50.5.1273; SORENSEN PS, 2001, MULT SCLER S, V7, pS94; Strasser-Fuchs S, 2000, Mult Scler, V6 Suppl 2, pS9; Weinshenker BG, 1996, NEUROLOGY, V46, P1613, DOI 10.1212/WNL.46.6.1613	26	131	134	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 25	2004	364	9440					1149	1156		10.1016/S0140-6736(04)17101-8	http://dx.doi.org/10.1016/S0140-6736(04)17101-8			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	857FT	15451222				2022-12-28	WOS:000224102400028
J	Klugman, KP; Madhi, SA				Klugman, KP; Madhi, SA			Oral antibiotics for the treatment of severe pneumonia in children	LANCET			English	Editorial Material							STREPTOCOCCUS-PNEUMONIAE; HAEMOPHILUS-INFLUENZAE; MANAGEMENT; RESISTANCE; HYPOXEMIA; MORTALITY; FAILURE		Univ Witwatersrand, MRC, Resp & Meningeal Pathogens Res Unit, Natl Hlth Lab Serv, Johannesburg, South Africa; Emory Univ, Sch Med, Dept Int Hlth,Rollins Sch Publ Hlth, Div Infect Dis, Atlanta, GA 30322 USA	National Health Laboratory Service; University of Witwatersrand; Emory University; Rollins School Public Health	Klugman, KP (corresponding author), Univ Witwatersrand, MRC, Resp & Meningeal Pathogens Res Unit, Natl Hlth Lab Serv, Johannesburg, South Africa.	keith.klugman@emory.edu						Djelantik IGG, 2003, J TROP PEDIATRICS, V49, P327, DOI 10.1093/tropej/49.6.327; Duke T, 2001, INT J TUBERC LUNG D, V5, P511; FRIEDLAND IR, 1992, LANCET, V339, P405, DOI 10.1016/0140-6736(92)90087-J; Gonzalez BE, 2004, PEDIATR INFECT DIS J, V23, P399, DOI 10.1097/01.inf.0000122605.34902.49; Graham SM, 2000, LANCET, V355, P369, DOI 10.1016/S0140-6736(98)11074-7; Kellner JD, 1998, PEDIATR INFECT DIS J, V17, P279, DOI 10.1097/00006454-199804000-00004; Klugman KP, 2002, EUR RESPIR J, V20, p3S, DOI 10.1183/09031936.02.00400402; KOORNHOF HJ, 1992, CLIN INFECT DIS, V15, P84, DOI 10.1093/clinids/15.1.84; Lehmann D, 1997, PEDIATR INFECT DIS J, V16, P297, DOI 10.1097/00006454-199703000-00009; Lozano JM, 2001, INT J TUBERC LUNG D, V5, P496; MASTRO TD, 1993, PEDIATR INFECT DIS J, V12, P824, DOI 10.1097/00006454-199310000-00006; Ostroff SM, 1996, CLIN INFECT DIS, V23, P1069, DOI 10.1093/clinids/23.5.1069; Shann F, 2001, LANCET, V357, P2070, DOI 10.1016/S0140-6736(00)05226-0; Simoes EAF, 2003, B WORLD HEALTH ORGAN, V81, P522; Smyth A, 1998, ANN TROP PAEDIATR, V18, P155, DOI 10.1080/02724936.1998.11747942; West TE, 1999, B WORLD HEALTH ORGAN, V77, P144	16	1	1	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 25	2004	364	9440					1104	1105		10.1016/S0140-6736(04)17116-X	http://dx.doi.org/10.1016/S0140-6736(04)17116-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	857FT	15451204				2022-12-28	WOS:000224102400005
J	Fernandes, CC; Podos, J; Lundberg, JG				Fernandes, CC; Podos, J; Lundberg, JG			Amazonian ecology: Tributaries enhance the diversity of electric fishes	SCIENCE			English	Article							RIVER-BASIN; GYMNOTIFORMES; ORGANIZATION; CHANNEL	Neotropical rivers support a diverse array of endemic taxa, including electric fishes of the order Gymnotiformes. A comprehensive survey of the main channels of the Amazon River and its major tributaries (>2000-kilometer transect) yielded 43 electric fish species. Biogeographical analyses suggest that local mainstem electric fish diversity is enhanced by tributaries. Mainstem species richness tends to increase downstream of tributary confluences, and species composition is most similar between tributaries and adjacent downstream mainstem locations. These findings support a "nodal" or heterogeneous model of riverine community organization across a particularly extensive and diverse geographical region.	Univ Massachusetts, Dept Biol, Amherst, MA 01003 USA; Univ Massachusetts, Grad Program Organism & Evolutionary Biol, Amherst, MA 01003 USA; Inst Nacl de Pesquisas da Amazonia, BR-69083 Manaus, Amazonas, Brazil; Acad Nat Sci Philadelphia, Dept Ichthyol, Philadelphia, PA 19103 USA	University of Massachusetts System; University of Massachusetts Amherst; University of Massachusetts System; University of Massachusetts Amherst; Institute Nacional de Pesquisas da Amazonia; Drexel University	Fernandes, CC (corresponding author), Univ Massachusetts, Dept Biol, Amherst, MA 01003 USA.	cristina@bio.umass.edu	Podos, Jeff/I-3843-2019; Fernandes, Cristina/B-4343-2019	Fernandes, Cristina/0000-0002-9670-8198; Podos, Jeffrey/0000-0002-2546-7999				AYRES JM, 1992, AM NAT, V140, P531, DOI 10.1086/285427; Benda L, 2004, BIOSCIENCE, V54, P413, DOI 10.1641/0006-3568(2004)054[0413:TNDHHC]2.0.CO;2; CAPPARELLA AP, 1991, ACTA C INT ORNITHOL, V20, P307; Fernandes CC, 1997, ECOL FRESHW FISH, V6, P36, DOI 10.1111/j.1600-0633.1997.tb00140.x; Fernandes CC, 2002, COPEIA, P52, DOI 10.1643/0045-8511(2002)002[0052:LOAEFS]2.0.CO;2; Fernandes CC, 1998, COPEIA, P730; GORMAN OT, 1986, AM NAT, V128, P611, DOI 10.1086/284592; Goulding M., 1988, RIO NEGRO RICH LIFE; HOPKINS CD, 1988, ANNU REV NEUROSCI, V11, P497, DOI 10.1146/annurev.ne.11.030188.002433; IBARRA M, 1989, COPEIA, P364; KULLANDER S, 2003, CHECK LIST FRESH WAT; Lowe-McConnell R. H., 1987, ECOLOGICAL STUDIES T; LUNDBERG JG, 1987, SCIENCE, V237, P81, DOI 10.1126/science.237.4810.81; Lundberg JG, 1996, COPEIA, P657; Lundberg JG, 2000, ANN MO BOT GARD, V87, P26, DOI 10.2307/2666207; Lundberg John G., 1998, P13; Mago-Leccia F., 1994, ELECT FISHES CONTINE; Matthews W. J., 1998, PATTERNS FRESHWATER; MEADE RH, 1991, ENVIRON GEOL WATER S, V18, P105, DOI 10.1007/BF01704664; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; OSBORNE LL, 1992, CAN J FISH AQUAT SCI, V49, P671, DOI 10.1139/f92-076; Patton JL, 2000, B AM MUS NAT HIST, P1, DOI 10.1206/0003-0090(2000)244<0001:MOTRJA>2.0.CO;2; PYDANIEL LR, UNPUB; Rice SP, 2001, CAN J FISH AQUAT SCI, V58, P824, DOI 10.1139/cjfas-58-4-824; RICHEY JE, 1991, BIOGEOCHEMISTRY MAJO, P51; SIOLI H, 1975, COUPLING LAND WATER, P199; STEWART DJ, 1987, POLITECNICA B, V1, P9; WALLACE AR, 1876, P ZOOL SOC LOND, V20, P107	28	137	150	3	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 24	2004	305	5692					1960	1962		10.1126/science.1101240	http://dx.doi.org/10.1126/science.1101240			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	857RM	15448270				2022-12-28	WOS:000224136000048
J	Di Paolo, G; Moskowitz, HS; Gipson, K; Wenk, MR; Voronov, S; Obayashi, M; Flavell, R; Fitzsimonds, RM; Ryan, TA; De Camilli, P				Di Paolo, G; Moskowitz, HS; Gipson, K; Wenk, MR; Voronov, S; Obayashi, M; Flavell, R; Fitzsimonds, RM; Ryan, TA; De Camilli, P			Impaired PtdIns(4,5)P-2 synthesis in nerve terminals produces defects in synaptic vesicle trafficking	NATURE			English	Article							TRANSMITTER RELEASE; MEMBRANE; POOL; ENDOCYTOSIS; CLATHRIN; TRANSMISSION; DOMAIN; ARF6; PHOSPHOINOSITIDES; SYNAPTOJANIN	Phosphatidylinositol-4,5-bisphosphate (PtdIns(4,5) P-2) has an important function in cell regulation both as a precursor of second messenger molecules and by means of its direct interactions with cytosolic and membrane proteins. Biochemical studies have suggested a role for PtdIns(4,5) P-2 in clathrin coat dynamics, and defects in its dephosphorylation at the synapse produce an accumulation of coated endocytic intermediates. However, the involvement of PtdIns(4,5) P-2 in synaptic vesicle exocytosis remains unclear. Here, we show that decreased levels of PtdIns(4,5) P-2 in the brain and an impairment of its depolarization-dependent synthesis in nerve terminals lead to early postnatal lethality and synaptic defects in mice. These include decreased frequency of miniature currents, enhanced synaptic depression, a smaller readily releasable pool of vesicles, delayed endocytosis and slower recycling kinetics. Our results demonstrate a critical role for PtdIns(4,5) P-2 synthesis in the regulation of multiple steps of the synaptic vesicle cycle.	Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06510 USA; Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06510 USA; Yale Univ, Sch Med, Dept Physiol, New Haven, CT 06510 USA; Yale Univ, Sch Med, Immunobiol Sect, New Haven, CT 06510 USA; Cornell Univ, Weill Med Coll, Dept Biochem, New York, NY 10021 USA	Howard Hughes Medical Institute; Yale University; Yale University; Yale University; Yale University; Cornell University	De Camilli, P (corresponding author), Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06510 USA.	pietro.decamilli@yale.edu	Ryan, Timothy/AAO-8286-2020; Wenk, Markus Rene/D-1441-2014	Ryan, Timothy/0000-0003-2533-9548; Fitzsimonds, Reiko/0000-0002-0576-9885	NINDS NIH HHS [R01 NS036942] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036942] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Aikawa Y, 2003, J CELL BIOL, V162, P647, DOI 10.1083/jcb.200212142; Aravanis AM, 2003, NATURE, V423, P643, DOI 10.1038/nature01686; AUDIGIER SMP, 1988, P NATL ACAD SCI USA, V85, P2859, DOI 10.1073/pnas.85.8.2859; Bai JH, 2004, NAT STRUCT MOL BIOL, V11, P36, DOI 10.1038/nsmb709; Cremona O, 1999, CELL, V99, P179, DOI 10.1016/S0092-8674(00)81649-9; Czech MP, 2003, ANNU REV PHYSIOL, V65, P791, DOI 10.1146/annurev.physiol.65.092101.142522; DeCamilli P, 1996, SCIENCE, V271, P1533, DOI 10.1126/science.271.5255.1533; Di Paolo G, 2002, NATURE, V420, P85, DOI 10.1038/nature01147; Doughman RL, 2003, J MEMBRANE BIOL, V194, P77, DOI 10.1007/s00232-003-2027-7; Evans PR, 2002, CURR OPIN STRUC BIOL, V12, P814, DOI 10.1016/S0959-440X(02)00395-0; Fesce R, 1999, NAT CELL BIOL, V1, pE3, DOI 10.1038/8950; Fitzsimonds RM, 1997, NATURE, V388, P439, DOI 10.1038/41267; Ford MGJ, 2002, NATURE, V419, P361, DOI 10.1038/nature01020; Gad H, 2000, NEURON, V27, P301, DOI 10.1016/S0896-6273(00)00038-6; Gandhi SP, 2003, NATURE, V423, P607, DOI 10.1038/nature01677; Harris TW, 2000, J CELL BIOL, V150, P589, DOI 10.1083/jcb.150.3.589; HAY JC, 1995, NATURE, V374, P173, DOI 10.1038/374173a0; HEUSER JE, 1973, J CELL BIOL, V57, P315, DOI 10.1083/jcb.57.2.315; Hilgemann D W, 2001, Sci STKE, V2001, pre19, DOI 10.1126/stke.2001.111.re19; Holz RW, 2000, J BIOL CHEM, V275, P17878, DOI 10.1074/jbc.M000925200; Honda A, 1999, CELL, V99, P521, DOI 10.1016/S0092-8674(00)81540-8; Kashani AH, 2001, J PHYSIOL-LONDON, V530, P243, DOI 10.1111/j.1469-7793.2001.0243l.x; Khvotchev M, 1998, J BIOL CHEM, V273, P21451, DOI 10.1074/jbc.273.34.21451; Kim WT, 2002, P NATL ACAD SCI USA, V99, P17143, DOI 10.1073/pnas.222657399; Krauss M, 2003, J CELL BIOL, V162, P113, DOI 10.1083/jcb.200301006; Lackner MR, 1999, NEURON, V24, P335, DOI 10.1016/S0896-6273(00)80848-X; Ling K, 2002, NATURE, V420, P89, DOI 10.1038/nature01082; Luthi A, 2001, J NEUROSCI, V21, P9101, DOI 10.1523/JNEUROSCI.21-23-09101.2001; Martin TFJ, 2001, CURR OPIN CELL BIOL, V13, P493, DOI 10.1016/S0955-0674(00)00241-6; McPherson PS, 1996, NATURE, V379, P353, DOI 10.1038/379353a0; Micheva KD, 2003, NAT NEUROSCI, V6, P925, DOI 10.1038/nn1114; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Murthy VN, 2003, ANNU REV NEUROSCI, V26, P701, DOI 10.1146/annurev.neuro.26.041002.131445; Neeb A, 1999, EUR J CELL BIOL, V78, P533, DOI 10.1016/S0171-9335(99)80018-1; Rhee JS, 2002, CELL, V108, P121, DOI 10.1016/S0092-8674(01)00635-3; Rosenmund C, 1996, NEURON, V16, P1197, DOI 10.1016/S0896-6273(00)80146-4; Ryan TA, 1999, J NEUROSCI, V19, P1317; Sankaranarayanan S, 2001, NAT NEUROSCI, V4, P129, DOI 10.1038/83949; Sankaranarayanan S, 2000, NAT CELL BIOL, V2, P197, DOI 10.1038/35008615; STEVENS CF, 1995, P NATL ACAD SCI USA, V92, P846, DOI 10.1073/pnas.92.3.846; Takei K, 1998, CELL, V94, P131, DOI 10.1016/S0092-8674(00)81228-3; Takei K, 1996, J CELL BIOL, V133, P1237, DOI 10.1083/jcb.133.6.1237; Valtorta Flavia, 1994, Seminars in Cell Biology, V5, P211, DOI 10.1006/scel.1994.1027; Verstreken P, 2003, NEURON, V40, P733, DOI 10.1016/S0896-6273(03)00644-5; WANG SSH, 1995, NEURON, V15, P755, DOI 10.1016/0896-6273(95)90167-1; Wenk MR, 2003, NAT BIOTECHNOL, V21, P813, DOI 10.1038/nbt837; Wenk MR, 2001, NEURON, V32, P79, DOI 10.1016/S0896-6273(01)00456-1; Wiedemann C, 1998, J NEUROSCI, V18, P5594	48	280	290	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 23	2004	431	7007					415	422		10.1038/nature02896	http://dx.doi.org/10.1038/nature02896			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855UN	15386003				2022-12-28	WOS:000224000500031
J	Doulatov, S; Hodes, A; Dai, LX; Mandhana, N; Liu, M; Deora, R; Simons, RW; Zimmerly, S; Miller, JF				Doulatov, S; Hodes, A; Dai, LX; Mandhana, N; Liu, M; Deora, R; Simons, RW; Zimmerly, S; Miller, JF			Tropism switching in Bordetella bacteriophage defines a family of diversity-generating retroelements	NATURE			English	Article							SITE-SPECIFIC RECOMBINATION; PERTUSSIS; DNA; RETROTRANSPOSITION; RETROVIRUSES; INTEGRATION; EXPRESSION; MECHANISMS; EVOLUTION; PEPTIDES	Bordetella bacteriophages generate diversity in a gene that specifies host tropism(1). This microevolutionary adaptation is produced by a genetic element that combines the basic retroelement life cycle of transcription, reverse transcription and integration with site-directed, adenine-specific mutagenesis. Central to this process is a reverse transcriptase-mediated exchange between two repeats; one serving as a donor template (TR) and the other as a recipient of variable sequence information (VR)(1). Here we describe the genetic basis for diversity generation. The directionality of information transfer is determined by a 21-base-pair sequence present at the 3' end of VR. On the basis of patterns of marker transfer in response to variant selective pressures, we propose that a TR reverse transcript is mutagenized, integrated into VR as a single non-coding strand, and then partially converted to the parental VR sequence. This allows the diversity-generating system to minimize variability to the subset of bases under selection. Using the Bordetella phage cassette as a signature, we have identified numerous related elements in diverse bacteria. These elements constitute a new family of retroelements with the potential to confer selective advantages to their host genomes.	Univ Calif Los Angeles, David Geffen Sch Med, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA; Univ Calgary, Dept Biol Sci, Calgary, AB T2N 1N4, Canada	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of Calgary	Miller, JF (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA.	jfmiller@ucla.edu						Adams MH, 1959, BACTERIOPHAGES; AKERLEY BJ, 1995, CELL, V80, P611, DOI 10.1016/0092-8674(95)90515-4; Bonen L, 2001, TRENDS GENET, V17, P322, DOI 10.1016/S0168-9525(01)02324-1; Bushman FD, 2003, CELL, V115, P135, DOI 10.1016/S0092-8674(03)00760-8; COTTER PA, 2000, PRINCIPLES BACTERIAL, P619; Edwards RA, 1998, GENE, V207, P149, DOI 10.1016/S0378-1119(97)00619-7; Emsley P, 1996, NATURE, V381, P90, DOI 10.1038/381090a0; Fairbrother WJ, 1998, BIOCHEMISTRY-US, V37, P17754, DOI 10.1021/bi981931e; FIGURSKI DH, 1979, P NATL ACAD SCI USA, V76, P1648, DOI 10.1073/pnas.76.4.1648; Gifford R, 2003, VIRUS GENES, V26, P291, DOI 10.1023/A:1024455415443; Hallet B, 1997, FEMS MICROBIOL REV, V21, P157, DOI 10.1016/S0168-6445(97)00055-7; Kazazian HH, 2002, CELL, V110, P277, DOI 10.1016/S0092-8674(02)00868-1; Kidwell MG, 2001, EVOLUTION, V55, P1, DOI 10.1111/j.0014-3820.2001.tb01268.x; KING JC, 1985, PRECISION FREQUENCY, V1, P147; Kurtz S, 2001, NUCLEIC ACIDS RES, V29, P4633, DOI 10.1093/nar/29.22.4633; Liu MS, 2004, J BACTERIOL, V186, P1503, DOI 10.1128/JB.186.5.1503-1517.2004; Liu MS, 2002, SCIENCE, V295, P2091, DOI 10.1126/science.1067467; Mattoo S, 2001, FRONT BIOSCI-LANDMRK, V6, pE168, DOI 10.2741/Mattoo; Morrish TA, 2002, NAT GENET, V31, P159, DOI 10.1038/ng898; ORGEL LE, 1980, NATURE, V284, P604, DOI 10.1038/284604a0; Parkhill J, 2003, NAT GENET, V35, P32, DOI 10.1038/ng1227; Pena CEA, 2000, P NATL ACAD SCI USA, V97, P7760, DOI 10.1073/pnas.140014297; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Uhl MA, 1996, EMBO J, V15, P1028, DOI 10.1002/j.1460-2075.1996.tb00440.x; van den Berg BM, 1999, INFECT IMMUN, V67, P1056, DOI 10.1128/IAI.67.3.1056-1062.1999; Wank H, 1999, MOL CELL, V4, P239, DOI 10.1016/S1097-2765(00)80371-8; Wrighton NC, 1996, SCIENCE, V273, P458, DOI 10.1126/science.273.5274.458	27	127	135	0	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 23	2004	431	7007					476	481		10.1038/nature02833	http://dx.doi.org/10.1038/nature02833			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855UN	15386016				2022-12-28	WOS:000224000500046
J	Yonezawa, H; Aoki, T; Furusawa, A				Yonezawa, H; Aoki, T; Furusawa, A			Demonstration of a quantum teleportation network for continuous variables	NATURE			English	Article							PODOLSKY-ROSEN CHANNELS; STATE	Quantum teleportation(1-8) involves the transportation of an unknown quantum state from one location to another, without physical transfer of the information carrier. Although quantum teleportation is a naturally bipartite process, it can be extended to a multipartite protocol known as a quantum teleportation network(9). In such a network, entanglement is shared between three or more parties. For the case of three parties ( a tripartite network), teleportation of a quantum state can occur between any pair, but only with the assistance of the third party. Multipartite quantum protocols are expected to form fundamental components for larger-scale quantum communication and computation(10,11). Here we report the experimental realization of a tripartite quantum teleportation network for quantum states of continuous variables ( electromagnetic field modes). We demonstrate teleportation of a coherent state between three different pairs in the network, unambiguously demonstrating its tripartite character.	Univ Tokyo, Sch Engn, Dept Appl Phys, Bunkyo Ku, Tokyo 1138656, Japan; Japan Sci & Technol Agcy, CREST, Chuo Ku, Tokyo 1030028, Japan	University of Tokyo; Japan Science & Technology Agency (JST)	Furusawa, A (corresponding author), Univ Tokyo, Sch Engn, Dept Appl Phys, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138656, Japan.	akiraf@ap.t.u-tokyo.ac.jp	Yonezawa, Hidehiro/C-4260-2015; Furusawa, Akira/P-5787-2014	Yonezawa, Hidehiro/0000-0002-5522-1439; Furusawa, Akira/0000-0002-6176-6742				Aoki T, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.080404; BENNETT CH, 1993, PHYS REV LETT, V70, P1895, DOI 10.1103/PhysRevLett.70.1895; Boschi D, 1998, PHYS REV LETT, V80, P1121, DOI 10.1103/PhysRevLett.80.1121; Bouwmeester D, 1997, NATURE, V390, P575, DOI 10.1038/37539; Bowen WP, 2003, PHYS REV A, V67, DOI 10.1103/PhysRevA.67.032302; Braunstein SL, 2000, J MOD OPTIC, V47, P267, DOI 10.1080/095003400148196; Braunstein SL, 2001, PHYS REV A, V64, DOI 10.1103/PhysRevA.64.022321; Braunstein SL, 1998, PHYS REV LETT, V80, P869, DOI 10.1103/PhysRevLett.80.869; Dur W, 2000, PHYS REV A, V62, DOI 10.1103/PhysRevA.62.062314; Furusawa A, 1998, SCIENCE, V282, P706, DOI 10.1126/science.282.5389.706; Jing JT, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.167903; Nielsen MA, 1998, NATURE, V396, P52, DOI 10.1038/23891; Nielsen Michael A., 2002, QUANTUM COMPUTATION; van Loock P, 2000, PHYS REV LETT, V84, P3482, DOI 10.1103/PhysRevLett.84.3482; van Loock P, 2003, PHYS REV A, V67, DOI 10.1103/PhysRevA.67.052315; van Loock P, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.247901; Zhang TC, 2003, PHYS REV A, V67, DOI 10.1103/PhysRevA.67.033802; [No title captured]	20	259	272	3	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 23	2004	431	7007					430	433		10.1038/nature02858	http://dx.doi.org/10.1038/nature02858			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855UN	15386006				2022-12-28	WOS:000224000500034
J	Esposito, K; Marfella, R; Ciotola, M; Di Palo, C; Giugliano, F; Giugliano, G; D'Armiento, M; D'Andrea, F; Giugliano, D				Esposito, K; Marfella, R; Ciotola, M; Di Palo, C; Giugliano, F; Giugliano, G; D'Armiento, M; D'Andrea, F; Giugliano, D			Effect of a Mediterranean-style diet on endothelial dysfunction and markers of vascular inflammation in the metabolic syndrome - A randomized trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							C-REACTIVE PROTEIN; INSULIN-RESISTANCE; HEALTHY-SUBJECTS; OBESE WOMEN; RISK; NUTRITION; FAT; INTERLEUKIN-18; ASSOCIATIONS; PREVALENCE	Context The metabolic syndrome has been identified as a target for dietary therapies to reduce risk of cardiovascular disease; however, the role of diet in the etiology of the metabolic syndrome is poorly understood. Objective To assess the effect of a Mediterranean-style diet on endothelial function and vascular inflammatory markers in patients with the metabolic syndrome. Design, Setting, and Patients Randomized, single-blind trial conducted from June 2001 to January 2004 at a university hospital in Italy among 180 patients (99 men and 81 women) with the metabolic syndrome, as defined by the Adult Treatment Panel III. Interventions Patients in the intervention group (n=90) were instructed to follow a Mediterranean-style diet and received detailed advice about how to increase daily consumption of whole grains, fruits, vegetables, nuts, and olive oil; patients in the control group (n=90) followed a prudent diet (carbohydrates, 50%-60%; proteins, 15%-20%; total fat, <30%). Main Outcome Measures Nutrient intake; endothelial function score as a measure of blood pressure and platelet aggregation response to L-arginine; lipid and glucose parameters; insulin sensitivity; and circulating levels of high-sensitivity C-reactive protein (hs-CRP) and interleukinsr 6 (IL-6), 7 (IL-7), and 18 (IL-18). Results After 2 years, patients following the Mediterranean-style diet consumed more foods rich in monounsaturated fat, polyunsaturated fat, and fiber and had a lower ratio of omega-6 to omega-3 fatty acids. Total fruit, vegetable, and nuts intake (274 g/d), whole grain intake (103 g/d), and olive oil consumption (8 g/d) were also significantly higher in the intervention group (P<.001). The level of physical activity increased in both groups by approximately 60%, without difference between groups (P=.22). Mean (SD) body weight decreased more in patients in the intervention group (-4.0 [1.1] kg) than in those in the control group (-1.2 [0.6) kg) (P<.001). Compared with patients consuming the control diet, patients consuming the intervention diet had significantly reduced serum concentrations of hs-CRP (P=.01), IL-6 (P=.04), IL-7 (P=0.4), and IL-18 (P=0.3), as well as decreased insulin resistance (P<.001). Endothelial function score improved in the intervention group (mean [SD] change, +1.9 [0.6]; P<.001) but remained stable in the control group (+0.2 [0.2]; P=33). At 2 years of follow-up, 40 patients in the intervention group still had features of the metabolic syndrome, compared with 78 patients in the control group (P<.001). Conclusion A Mediterranean-style diet might be effective in reducing the prevalence of the metabolic syndrome and its associated cardiovascular risk.	Univ Naples 2, Chair & Div Metab Dis, Naples, Italy; Univ Naples 2, Chair Urol, Naples, Italy; Univ Naples 2, Chair Plast & Reconstruct Surg, Naples, Italy	Universita della Campania Vanvitelli; Universita della Campania Vanvitelli; Universita della Campania Vanvitelli	Giugliano, D (corresponding author), Policlin Seconda Univ Napoli, Dept Geriatr & Metab Dis, Div Metab Dis, Piazza L Miraglia, I-80031 Naples, Italy.	dario.giugliano@unina2.it	Marfella, Raffaele/C-6899-2012; Esposito, Katherine/AHE-2564-2022; Maiorino, Maria Ida/AHE-9986-2022	Marfella, Raffaele/0000-0003-3960-9270; Esposito, Katherine/0000-0002-3652-5154; Maiorino, Maria Ida/0000-0003-4659-7546; Giugliano, Dario/0000-0002-9377-873X; D'andrea, Francesco/0000-0002-3518-0406				Andoh A, 1999, JPEN-PARENTER ENTER, V23, pS70, DOI 10.1177/014860719902300518; Bastard JP, 2000, J CLIN ENDOCR METAB, V85, P3338, DOI 10.1210/jc.85.9.3338; Blankenberg S, 2002, CIRCULATION, V106, P24, DOI 10.1161/01.CIR.0000020546.30940.92; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Damas JK, 2003, CIRCULATION, V107, P2670, DOI 10.1161/01.CIR.0000070542.18001.87; Dandona P, 2002, DIABETOLOGIA, V45, P924, DOI 10.1007/s00125-001-0766-5; de Lorgeril M, 1999, CIRCULATION, V99, P779, DOI 10.1161/01.CIR.99.6.779; Esposito K, 2003, AM J CLIN NUTR, V78, P1135, DOI 10.1093/ajcn/78.6.1135; Esposito K, 2003, AM J CLIN NUTR, V77, P139, DOI 10.1093/ajcn/77.1.139; Esposito K, 2003, J CLIN ENDOCR METAB, V88, P1055, DOI 10.1210/jc.2002-021437; Fernandez-Real JM, 2003, ENDOCR REV, V24, P278, DOI 10.1210/er.2002-0010; Ford ES, 2002, JAMA-J AM MED ASSOC, V287, P356, DOI 10.1001/jama.287.3.356; Giugliano D, 1997, AM J PHYSIOL-ENDOC M, V273, pE606, DOI 10.1152/ajpendo.1997.273.3.E606; Groop L, 2000, BRIT J NUTR, V83, pS39; Grundy SM, 2004, CIRCULATION, V109, P433, DOI 10.1161/01.CIR.0000111245.75752.C6; Han TS, 2002, DIABETES CARE, V25, P2016, DOI 10.2337/diacare.25.11.2016; Harris TB, 1999, AM J MED, V106, P506, DOI 10.1016/S0002-9343(99)00066-2; Hu FB, 2002, JAMA-J AM MED ASSOC, V288, P2569, DOI 10.1001/jama.288.20.2569; Krauss RM, 2000, CIRCULATION, V102, P2284; Kris-Etherton PM, 2002, CIRCULATION, V106, P2747, DOI 10.1161/01.CIR.0000038493.65177.94; Lidfeldt J, 2003, DIABETES OBES METAB, V5, P106, DOI 10.1046/j.1463-1326.2003.00250.x; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; McKeown NM, 2004, DIABETES CARE, V27, P538, DOI 10.2337/diacare.27.2.538; Mennen LI, 2000, NUTR RES, V20, P335, DOI 10.1016/S0271-5317(00)00127-5; Nappo F, 2002, J AM COLL CARDIOL, V39, P1145, DOI 10.1016/S0735-1097(02)01741-2; Pasceri V, 2000, CIRCULATION, V102, P2165; Plotnick GD, 1997, JAMA-J AM MED ASSOC, V278, P1682, DOI 10.1001/jama.278.20.1682; Ridker PM, 2003, CIRCULATION, V107, P391, DOI 10.1161/01.CIR.0000055014.62083.05; Robertson RM, 2001, CIRCULATION, V103, P1821, DOI 10.1161/01.CIR.103.13.1821; Singh RB, 2002, LANCET, V360, P1455, DOI 10.1016/S0140-6736(02)11472-3; Tamakoshi K, 2003, INT J OBESITY, V27, P443, DOI 10.1038/sj.ijo.0802260; Trichopoulou A, 2003, NEW ENGL J MED, V348, P2599, DOI 10.1056/NEJMoa025039; Wirfalt E, 2001, AM J EPIDEMIOL, V154, P1150, DOI 10.1093/aje/154.12.1150; Yeh ETH, 2001, CIRCULATION, V104, P974, DOI 10.1161/01.CIR.104.9.974; Yudkin JS, 1999, ARTERIOSCL THROM VAS, V19, P972, DOI 10.1161/01.ATV.19.4.972; Ziccardi P, 2002, CIRCULATION, V105, P804, DOI 10.1161/hc0702.104279	36	1463	1549	4	278	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 22	2004	292	12					1440	1446		10.1001/jama.292.12.1440	http://dx.doi.org/10.1001/jama.292.12.1440			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	856FT	15383514				2022-12-28	WOS:000224031800025
J	Castro-Rodriguez, I; Nakai, H; Zakharov, LN; Rheingold, AL; Meyer, K				Castro-Rodriguez, I; Nakai, H; Zakharov, LN; Rheingold, AL; Meyer, K			A linear, O-coordinated eta(1)-CO2 bound to uranium	SCIENCE			English	Article							CARBON-DIOXIDE; TRIVALENT URANIUM; COMPLEXES; CO2; REACTIVITY; TRIAZACYCLONONANE; DINITROGEN; CHEMISTRY; MONOXIDE	The electron-rich, six-coordinate tris-aryloxide uranium(III) complex [(((ArO)-Ar-Ad)(3)tacn)U-III] [where ((ArOH)-Ar-Ad)(3)tacn = 1,4,7-tris(3-adamantyl-5-tert-butyl-2-hydroxybenzyl)-1,4,7-triazacyclononane] reacts rapidly with CO, to yield [(((ArO)-Ar-Ad)(3)tacn)U-IV(CO2)], a complex in which the CO2 ligand is linearly coordinated to the metal through its oxygen atom (eta(1)-OCO). The latter complex has been crystallographically and spectroscopically characterized. The inequivalent O-C-O bond lengths [1.122 angstroms (Angstrom) for the O-C bond adjacent to uranium and 1.277 Angstrom for the other], considered together with magnetization data and electronic and vibrational-spectra, support the following bonding model: U-IV=O=C-.-O- H <----> U-IV-O=C-O-. In these charge-separated resonance structures, the uranium center is oxidized to uranium(IV) and the CO2 ligand reduced by one electron.	Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Meyer, K (corresponding author), Univ Calif San Diego, Dept Chem & Biochem, 9500 Gilman Dr,MC 0358, La Jolla, CA 92093 USA.	kmeyer@ucsd.edu	Rheingold, Arnold/U-4735-2019; Meyer, Karsten/G-2570-2012	Rheingold, Arnold/0000-0003-4472-8127; Meyer, Karsten/0000-0002-7844-2998; Nakai, Hidetaka/0000-0002-8548-1987	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007233] Funding Source: NIH RePORTER; NIDDK NIH HHS [3 T32 DK07233-2651] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Andrews L, 2000, J AM CHEM SOC, V122, P11440, DOI 10.1021/ja0016699; ARESTA M, 1975, J CHEM SOC CHEM COMM, P636, DOI 10.1039/c39750000636; ARESTA M, 1977, J CHEM SOC DALTON, P708, DOI 10.1039/dt9770000708; BRENNAN JG, 1986, J AM CHEM SOC, V108, P335, DOI 10.1021/ja00262a046; Castro-Rodriguez I, 2003, J AM CHEM SOC, V125, P15734, DOI 10.1021/ja0379316; Castro-Rodriguez I, 2003, J AM CHEM SOC, V125, P4565, DOI 10.1021/ja028342n; Castro-Rodriguez I, 2002, CHEM COMMUN, P2764, DOI 10.1039/b208473b; Clark D. L., 1997, INORG SYNTH, V31, P307; Conejo MD, 1999, CHEM-EUR J, V5, P3000; Diaconescu PL, 2000, J AM CHEM SOC, V122, P6108, DOI 10.1021/ja994484e; Falkowski P, 2000, SCIENCE, V290, P291, DOI 10.1126/science.290.5490.291; FREUND HJ, 1986, SURF SCI, V172, P1, DOI 10.1016/0039-6028(86)90580-7; Gibson DH, 1999, COORDIN CHEM REV, V185-6, P335, DOI 10.1016/S0010-8545(99)00021-1; Gibson DH, 1996, CHEM REV, V96, P2063, DOI 10.1021/cr940212c; HERSKOVITZ T, 1977, J AM CHEM SOC, V99, P2391, DOI 10.1021/ja00449a087; Katz J., 1980, CHEM ACTINIDE ELEMEN; Lee HJ, 2001, J MOL BIOL, V308, P937, DOI 10.1006/jmbi.2001.4649; Mauser H, 2001, J AM CHEM SOC, V123, P10821, DOI 10.1021/ja011362p; Nakai H, 2004, INORG CHEM, V43, P855, DOI 10.1021/ic035142j; Odom AL, 1998, J AM CHEM SOC, V120, P5836, DOI 10.1021/ja980095t; Roussel P, 1998, J AM CHEM SOC, V120, P1070, DOI 10.1021/ja972933+; Souter PF, 1997, J AM CHEM SOC, V119, P7350, DOI 10.1021/ja971038n	22	285	290	1	91	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 17	2004	305	5691					1757	1759		10.1126/science.1102602	http://dx.doi.org/10.1126/science.1102602			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC)	Science & Technology - Other Topics	856IS	15375263				2022-12-28	WOS:000224039500036
J	Jourdie, V; Moureau, B; Bennett, ATD; Heeb, P				Jourdie, V; Moureau, B; Bennett, ATD; Heeb, P			Ultraviolet reflectance by the skin of nestlings	NATURE			English	Editorial Material							COLOR; VISION		Univ Lausanne, Dept Ecol & Evolut, CH-1015 Lausanne, Switzerland; Univ Neuchatel, Dept Zool, CH-2007 Neuchatel, Switzerland; Univ Bristol, Sch Biol Sci, Bristol BS8 1UG, Avon, England	University of Lausanne; University of Neuchatel; University of Bristol	Jourdie, V (corresponding author), Univ Lausanne, Dept Ecol & Evolut, CH-1015 Lausanne, Switzerland.	philipp.heeb@ie-zea.unil.ch	Bennett, Andrew T.D. T.D./P-2670-2016; Vazquez-Dominguez, Guillermo GVD/L-7818-2014	Bennett, Andrew T.D. T.D./0000-0001-8512-2805; 				Andersson S, 1997, P ROY SOC B-BIOL SCI, V264, P1587, DOI 10.1098/rspb.1997.0221; Bennett ATD, 1996, NATURE, V380, P433, DOI 10.1038/380433a0; BENNETT ATD, 1994, AM NAT, V144, P848, DOI 10.1086/285711; Cuthill IC, 2000, ADV STUD BEHAV, V29, P159, DOI 10.1016/S0065-3454(08)60105-9; Heeb P, 2003, ANIM BEHAV, V66, P637, DOI 10.1006/anbe.2003.2238; Hunt S, 2003, P R SOC LOND S, V270, P25; Kilner R, 1997, P ROY SOC B-BIOL SCI, V264, P963, DOI 10.1098/rspb.1997.0133; Prum RO, 2003, J EXP BIOL, V206, P2409, DOI 10.1242/jeb.00431; Sheldon BC, 1999, NATURE, V402, P874, DOI 10.1038/47239; VIITALA J, 1995, NATURE, V373, P425, DOI 10.1038/373425a0	10	78	78	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 16	2004	431	7006					262	262		10.1038/431262a	http://dx.doi.org/10.1038/431262a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	853XJ	15372020	Bronze			2022-12-28	WOS:000223864000028
J	Chien, KR; Moretti, A; Laugwitz, KL				Chien, KR; Moretti, A; Laugwitz, KL			ES cells to the rescue	SCIENCE			English	Editorial Material							HEMATOPOIETIC STEM-CELLS; BONE-MARROW; INFARCTED MYOCARDIUM; TRANSPLANTATION; MORPHOGENESIS; FAILURE; GP130; MICE		Univ Calif San Diego, Inst Mol Med, La Jolla, CA 92037 USA	University of California System; University of California San Diego	Chien, KR (corresponding author), Univ Calif San Diego, Inst Mol Med, La Jolla, CA 92037 USA.	kchien@ucsd.edu	Moretti, Alessandra/O-9271-2015	Moretti, Alessandra/0000-0001-5782-7832				Assmus B, 2002, CIRCULATION, V106, P3009, DOI 10.1161/01.CIR.0000043246.74879.CD; Balsam LB, 2004, NATURE, V428, P668, DOI 10.1038/nature02460; Bel A, 2003, CIRCULATION, V108, P247, DOI 10.1161/01.cir.0000089040.11131.d4; Chen J, 1998, DEVELOPMENT, V125, P1943; Chien KR, 2002, CELL, V110, P153, DOI 10.1016/S0092-8674(02)00834-6; Chien KR, 2004, NATURE, V428, P607, DOI 10.1038/nature02500; DYSON E, 1995, P NATL ACAD SCI USA, V92, P7386, DOI 10.1073/pnas.92.16.7386; Fraidenraich D, 2004, SCIENCE, V306, P247, DOI 10.1126/science.1102612; Hirota H, 1999, CELL, V97, P189, DOI 10.1016/S0092-8674(00)80729-1; KASTNER P, 1995, CELL, V83, P859, DOI 10.1016/0092-8674(95)90202-3; Kovalchin JP, 2004, PEDIATR CARDIOL, V25, P299, DOI 10.1007/s00246-003-0593-1; Murry CE, 2004, NATURE, V428, P664, DOI 10.1038/nature02446; Nygren JM, 2004, NAT MED, V10, P494, DOI 10.1038/nm1040; Orlic D, 2001, NATURE, V410, P701, DOI 10.1038/35070587; Rideout WM, 2002, CELL, V109, P17, DOI 10.1016/S0092-8674(02)00681-5; SUCOV HM, 1994, GENE DEV, V8, P1007, DOI 10.1101/gad.8.9.1007; Tran CM, 1998, DEVELOPMENT, V125, P1951; Yoshida K, 1996, P NATL ACAD SCI USA, V93, P407, DOI 10.1073/pnas.93.1.407	18	32	38	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 8	2004	306	5694					239	240		10.1126/science.1104769	http://dx.doi.org/10.1126/science.1104769			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	861MC	15472069				2022-12-28	WOS:000224419700028
J	Benz, EJ				Benz, EJ			Genotypes and phenotypes - Another lesson from the hemoglobinopathies	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Dana Farber Canc Inst, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute	Benz, EJ (corresponding author), Dana Farber Canc Inst, Boston, MA 02115 USA.								0	2	4	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 7	2004	351	15					1490	1492		10.1056/NEJMp048198	http://dx.doi.org/10.1056/NEJMp048198			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	859UP	15470211				2022-12-28	WOS:000224293700006
J	Geva, A; Clark, JJ; Zhang, YX; Popowicz, A; Manning, JM; Neufeld, EJ				Geva, A; Clark, JJ; Zhang, YX; Popowicz, A; Manning, JM; Neufeld, EJ			Brief report: Hemoglobin Jamaica Plain - A sickling hemoglobin with reduced oxygen affinity	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							S ANTILLES; DISEASE	A baby girl presented with symptomatic sickle cell disease exacerbated by mild hypoxemia, despite a newborn-screening diagnosis of sickle cell trait. DNA sequencing of the (beta) globin gene revealed that her maternal (beta) globin allele was normal. Her paternal allele had not only the expected sickle-trait mutation, (beta)(sup Glu6Val), but also a second, charge-neutral mutation, (beta)(sup Leu68Phe). Analysis of the patient's hemoglobin revealed that the double-mutant protein, which we called ``hemoglobin Jamaica Plain,'' had severely reduced oxygen affinity. Structural modeling suggested destabilization of the oxy conformation as a molecular mechanism for sickling in a heterozygote at an ambient partial pressure of oxygen.	Childrens Hosp Boston, Div Hematol Oncol, Boston, MA 02115 USA; Dana Farber Canc Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA; Northeastern Univ, Dept Biol, Boston, MA 02115 USA; Rockefeller Univ, New York, NY 10021 USA	Harvard University; Boston Children's Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Northeastern University; Rockefeller University	Neufeld, EJ (corresponding author), Childrens Hosp Boston, Div Hematol Oncol, Karp 8210,300 Longwood Ave, Boston, MA 02115 USA.	ellis.neufeld@childrens.harvard.edu	Neufeld, Ellis J./F-9331-2011; Geva, Alon/AAM-6793-2021	Neufeld, Ellis J./0000-0001-8092-6281; Geva, Alon/0000-0002-8574-0133	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL018819, R01HL018819] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL18819, HL04184] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BONAVENTURA J, 1968, J BIOL CHEM, V243, P980; BUNN HF, 1986, HEMOGLOBIN MOL GENET, P13; BUNN HF, 1986, HEMOGLOBIN MOL GENET, P453; Dumoulin A, 1997, J BIOL CHEM, V272, P31326, DOI 10.1074/jbc.272.50.31326; Gendreau MA, 2002, NEW ENGL J MED, V346, P1067, DOI 10.1056/NEJMra012774; HARDISON RC, HUMAN HEMOGLOBIN VAR; Lee AP, 2002, PEDIATR EMERG CARE, V18, P78, DOI 10.1097/00006565-200204000-00004; LITTLE S, 2000, CURRENT PROTOCOLS HU; Manning LR, 1996, PROTEIN SCI, V5, P775; MONPLAISIR N, 1986, P NATL ACAD SCI USA, V83, P9363, DOI 10.1073/pnas.83.24.9363; PERRY D, 1990, CHEM ENG PROG, V86, P30; PERUTZ MF, 1989, Q REV BIOPHYS, V22, P139, DOI 10.1017/S0033583500003826; Popp RA, 1997, BLOOD, V89, P4204, DOI 10.1182/blood.V89.11.4204; STEINBERG MH, 2000, HEMATOLOGY BASIC PRI, P356	14	24	25	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 7	2004	351	15					1532	1538		10.1056/NEJMoa040771	http://dx.doi.org/10.1056/NEJMoa040771			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	859UP	15470216				2022-12-28	WOS:000224293700011
J	Xu, X; Norell, MA; Kuang, XW; Wang, XL; Zhao, Q; Jia, CK				Xu, X; Norell, MA; Kuang, XW; Wang, XL; Zhao, Q; Jia, CK			Basal tyrannosauroids from China and evidence for protofeathers in tyrannosauroids	NATURE			English	Article							NORTH-AMERICA; DINOSAURIA; EVOLUTION; THEROPOD; INFORMATION; ANATOMY	Tyrannosauroids are one of the last and the most successful large-bodied predatory dinosaur groups(1-5), but their early history remains poorly understood. Here we report a new basal tyrannosauroid from the Early Cretaceous Yixian Formation of western Liaoning, China, which is small and gracile and has relatively long arms with three-fingered hands. The new taxon is the earliest known unquestionable tyrannosauroid found so far(6-9). It shows a mosaic of characters, including a derived cranial structure resembling that of derived tyrannosauroids(1-5) and a primitive postcranial skeleton similar to basal coelurosaurians. One of the specimens also preserves a filamentous integumentary covering similar to that of other coelurosaurian theropods from western Liaoning. This provides the first direct fossil evidence that tyrannosauroids had protofeathers.	Amer Museum Nat Hist, New York, NY 10024 USA; Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Beijing 100044, Peoples R China; Tianjin Museum Nat Hist, Tianjin 300074, Peoples R China	American Museum of Natural History (AMNH); Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS	Xu, X (corresponding author), Amer Museum Nat Hist, Cent Pk W & 79th St, New York, NY 10024 USA.	xu@amnh.org; norell@amnh.org						Brochu CA, 2003, J VERTEBR PALEONTOL, V22, P1, DOI [10.1080/02724634.2003.10010947, DOI 10.1080/02724634.2003.10010947, 10.2307/3889334, DOI 10.2307/3889334]; Buffetaut E, 1996, NATURE, V381, P689, DOI 10.1038/381689a0; Carr TD, 1999, J VERTEBR PALEONTOL, V19, P497, DOI 10.1080/02724634.1999.10011161; Chen PJ, 1998, NATURE, V391, P147, DOI 10.1038/34356; Currie PJ, 1995, J VERTEBR PALEONTOL, V15, P576, DOI 10.1080/02724634.1995.10011250; Currie PJ, 2003, ACTA PALAEONTOL POL, V48, P191; Currie PJ, 2003, ACTA PALAEONTOL POL, V48, P227; Currie PJ, 2003, CAN J EARTH SCI, V40, P651, DOI 10.1139/E02-083; Currie PJ, 2001, CAN J EARTH SCI, V38, P1729, DOI 10.1139/e01-042; Erickson GM, 2004, NATURE, V430, P772, DOI 10.1038/nature02699; Gauthier J.A., 1986, ORIGIN BIRDS EVOLUTI, V8, P1; Holtz Jr T. R., 2000, GAIA, V15, P5; Holtz Thomas R. Jr, 2001, P64; HOLTZ TR, 1994, J PALEONTOL, V68, P1100, DOI 10.1017/S0022336000026706; HOLTZ TR, 1994, J VERTEBR PALEONTOL, V14, P480, DOI 10.1080/02724634.1995.10011574; Hurum JH, 2003, ACTA PALAEONTOL POL, V48, P161; Hutt S, 2001, CRETACEOUS RES, V22, P227, DOI 10.1006/cres.2001.0252; Hwang SH, 2002, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2002)381<0001:NSOMZT>2.0.CO;2; MADSEN JH, 1976, B UTAH GEOLOGICAL MI, V109, P1; Manabe M, 1999, J PALEONTOL, V73, P1176, DOI 10.1017/S002233600003105X; Martin LD, 2000, AM ZOOL, V40, P687, DOI 10.1668/0003-1569(2000)040[0687:TFROFE]2.0.CO;2; MOLNAR R E, 1991, Palaeontographica Abteilung A Palaeozoologie-Stratigraphie, V217, P137; Rauhut OWM, 2003, PALAEONTOLOGY, V46, P903, DOI 10.1111/1475-4983.00325; Sampson SD, 1998, SCIENCE, V280, P1048, DOI 10.1126/science.280.5366.1048; Sereno PC, 1999, SCIENCE, V284, P2137, DOI 10.1126/science.284.5423.2137; Spinage C.A., 1994, ELEPHANTS; Swisher C.C., 2001, CHINESE SCI BULL, V46, P2009; Xu X, 2002, NATURE, V415, P780, DOI 10.1038/415780a; Xu X, 2001, NATURE, V410, P200, DOI 10.1038/35065589; Xu X., 2002, THESIS CHINESE ACAD	30	178	201	2	47	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 7	2004	431	7009					680	684		10.1038/nature02855	http://dx.doi.org/10.1038/nature02855			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	859WS	15470426	Green Published			2022-12-28	WOS:000224299300038
J	Dhar, G; Sanders, ER; Johnson, RC				Dhar, G; Sanders, ER; Johnson, RC			Architecture of the Hin synaptic complex during recombination: The recombinase subunits translocate with the DNA strands	CELL			English	Article							GAMMA-DELTA-RESOLVASE; SITE-SPECIFIC RECOMBINATION; CRYSTAL-STRUCTURE; CATALYTIC DOMAIN; INVERSION; ENHANCER; EXCHANGE; MECHANISM; INVERTASOME; ACTIVATION	Most site-specific recombinases can be grouped into two mechanistically distinct families. Whereas tyrosine recombinases exchange DNA strands through a Holliday intermediate, serine recombinases such as Hin generate double-strand breaks in each recombining partner. Here, site-directed protein crosslinking is used to elucidate the configuration of protein subunits and DNA within the Hin synaptic complex and to follow the movement of protein subunits during DNA strand exchange. Our results show that the protein interface mediating synapsis is localized to a region within the catalytic domains, thereby positioning the DNA strands on the outside of the Hin tetrameric complex. Unexpected crosslinks between residues within the dimerization helices provide evidence for a conformational change that accompanies DNA cleavage. We demonstrate that the Hin subunits, which are linked to the cleaved DNA ends by serine-phosphodiester bonds translocate between synapsed dimers to exchange the DNA strands.	Univ Calif Los Angeles, David Geffen Sch Med, Dept Biol Chem, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles	Johnson, RC (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Biol Chem, Los Angeles, CA 90095 USA.	rcjohnson@mednet.ucla.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038509, R37GM038509] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM38509] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Burke ME, 2004, MOL MICROBIOL, V51, P837, DOI 10.1046/j.1365-2958.2003.03831.x; Chen Y, 2000, MOL CELL, V6, P885, DOI 10.1016/S1097-2765(05)00088-2; Chiu TK, 2002, EMBO J, V21, P801, DOI 10.1093/emboj/21.4.801; Craig NL, 2002, MOBILE DNA 2; Gopaul DN, 1998, EMBO J, V17, P4175, DOI 10.1093/emboj/17.14.4175; Grindley NDF, 2002, MOBILE DNA, P272; Guo F, 1997, NATURE, V389, P40, DOI 10.1038/37925; HAFFTER P, 1988, EMBO J, V7, P3991, DOI 10.1002/j.1460-2075.1988.tb03287.x; Haykinson MJ, 1996, CURR BIOL, V6, P163, DOI 10.1016/S0960-9822(02)00449-9; HEICHMAN KA, 1991, GENE DEV, V5, P1622, DOI 10.1101/gad.5.9.1622; HEICHMAN KA, 1990, SCIENCE, V249, P511, DOI 10.1126/science.2166334; HUGHES RE, 1993, EMBO J, V12, P1447, DOI 10.1002/j.1460-2075.1993.tb05788.x; Jayaram M., 2002, MOBILE DNA, P192; JOHNSON RC, 1985, CELL, V41, P781, DOI 10.1016/S0092-8674(85)80059-3; JOHNSON RC, 1987, NATURE, V329, P462, DOI 10.1038/329462a0; JOHNSON RC, 1986, CELL, V46, P531, DOI 10.1016/0092-8674(86)90878-0; Johnson RC, 2002, MOBILE DNA, P230; KANAAR R, 1990, CELL, V62, P353, DOI 10.1016/0092-8674(90)90372-L; KANAAR R, 1988, P NATL ACAD SCI USA, V85, P752, DOI 10.1073/pnas.85.3.752; KLIPPEL A, 1988, EMBO J, V7, P3983, DOI 10.1002/j.1460-2075.1988.tb03286.x; Lee HJ, 2003, MOL CELLS, V16, P377; Leschziner AE, 2003, MOL CELL, V12, P775, DOI 10.1016/S1097-2765(03)00351-4; LIM HM, 1994, J BIOL CHEM, V269, P31134; Merickel SK, 2004, MOL MICROBIOL, V51, P1143, DOI 10.1046/j.1365-2958.2003.03890.x; Merickel SK, 1998, GENE DEV, V12, P2803, DOI 10.1101/gad.12.17.2803; NUNESDUBY SE, 1995, CURR BIOL, V5, P139, DOI 10.1016/S0960-9822(95)00035-2; Pan B, 2001, J MOL BIOL, V310, P1089, DOI 10.1006/jmbi.2001.4821; Pan B, 1997, PROTEIN SCI, V6, P1237, DOI 10.1002/pro.5560060612; Rice P. A., 2002, MOBILE DNA, P219; RICE PA, 1994, STRUCTURE, V2, P371, DOI 10.1016/S0969-2126(00)00039-3; RICE PA, 1994, EMBO J, V13, P1514, DOI 10.1002/j.1460-2075.1994.tb06413.x; Sanders ER, 2004, J MOL BIOL, V340, P753, DOI 10.1016/j.jmb.2004.05.027; SANDERSON MR, 1990, CELL, V63, P1323, DOI 10.1016/0092-8674(90)90427-G; Sarkis GJ, 2001, MOL CELL, V8, P623, DOI 10.1016/S1097-2765(01)00334-3; SILVERMAN M, 1980, COLD SPRING HARB SYM, V45, P17, DOI 10.1101/SQB.1981.045.01.005; STARK WM, 1989, CELL, V58, P779, DOI 10.1016/0092-8674(89)90111-6; STARK WM, 1991, EMBO J, V10, P3541, DOI 10.1002/j.1460-2075.1991.tb04918.x; Van Duyne G.D., 2002, MOBILE DNA, VII, P93; YANG W, 1995, CELL, V82, P193, DOI 10.1016/0092-8674(95)90307-0; ZIEG J, 1977, SCIENCE, V196, P170, DOI 10.1126/science.322276	40	33	35	1	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 1	2004	119	1					33	45		10.1016/j.cell.2004.09.010	http://dx.doi.org/10.1016/j.cell.2004.09.010			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	859UE	15454079	Bronze			2022-12-28	WOS:000224292600007
J	Cole, TJ				Cole, TJ			Commentary: Teaching dogs new tricks	BRITISH MEDICAL JOURNAL			English	Editorial Material									Inst Child Hlth, Ctr Paediat Epidemiol & Biostat, London WC1N 1EH, England	University of London; University College London	Cole, TJ (corresponding author), Inst Child Hlth, Ctr Paediat Epidemiol & Biostat, 30 Guilford St, London WC1N 1EH, England.	tim.cole@ich.ucl.ac.uk	Cole, Tim J/B-7883-2008	Cole, Tim J/0000-0001-5711-8200				Willis CM, 2004, BMJ-BRIT MED J, V329, P712, DOI 10.1136/bmj.329.7468.712	1	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	SEP 25	2004	329	7468					715	715		10.1136/bmj.329.7468.715	http://dx.doi.org/10.1136/bmj.329.7468.715			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	858RV	15388613	Green Published, Bronze, Green Submitted			2022-12-28	WOS:000224210300017
J	Furness, C; Sharma, R; Harnden, A				Furness, C; Sharma, R; Harnden, A			10-minute consultation - Morbilliform rash	BMJ-BRITISH MEDICAL JOURNAL			English	Article									Univ Oxford Green Coll, Oxford OX2 6HG, England; Univ Oxford, Dept Primary Hlth Care, Oxford OX3 7LF, England	University of Oxford; University of Oxford	Harnden, A (corresponding author), Univ Oxford Green Coll, Oxford OX2 6HG, England.	anthony.harnden@dphpc.ox.ac.uk							0	2	2	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 25	2004	329	7468					719	719		10.1136/bmj.329.7468.719	http://dx.doi.org/10.1136/bmj.329.7468.719			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	858RV	15388614	Green Submitted, Bronze, Green Published			2022-12-28	WOS:000224210300019
J	Schall, P; Cohen, I; Weitz, DA; Spaepen, F				Schall, P; Cohen, I; Weitz, DA; Spaepen, F			Visualization of dislocation dynamics in colloidal crystals	SCIENCE			English	Article							HARD-SPHERE CRYSTALS; MISFIT; MOTION	The dominant mechanism for creating large irreversible strain in atomic crystals is the motion of dislocations, a class of line defects in the crystalline lattice. Here we show that the motion of dislocations can also be observed in strained colloidal crystals, allowing detailed investigation of their topology and propagation. We describe a laser diffraction microscopy setup used to study the growth and structure of misfit dislocations in colloidal crystalline films. Complementary microscopic information at the single-particle level is obtained with a laser scanning confocal microscope. The combination of these two techniques enables us to study dislocations over a range of length scales, allowing us to determine important parameters of misfit dislocations such as critical film thickness, dislocation density, Burgers vector, and lattice resistance to dislocation motion. We identify the observed dislocations as Shockley partials that bound stacking faults of vanishing energy. Remarkably, we find that even on the scale of a few lattice vectors, the dislocation behavior is well described by the continuum approach commonly used to describe dislocations in atomic crystals.	Harvard Univ, Div Engn & Appl Sci, Cambridge, MA 02138 USA; Harvard Univ, Dept Phys, Cambridge, MA 02138 USA	Harvard University; Harvard University	Schall, P (corresponding author), Harvard Univ, Div Engn & Appl Sci, 9 Oxford St, Cambridge, MA 02138 USA.	pschall@deas.harvard.edu		Cohen, Itai/0000-0001-9218-043X				[Anonymous], 1934, P R SOC LOND A, DOI [10.1098/rspa.1934.0107, DOI 10.1098/RSPA.1934.0107, DOI 10.1098/RSPA.1934.0106]; Dinsmore AD, 2001, APPL OPTICS, V40, P4152, DOI 10.1364/AO.40.004152; FRANK FC, 1949, PROC R SOC LON SER-A, V198, P216, DOI 10.1098/rspa.1949.0096; FRENKEL D, 1987, PHYS REV LETT, V59, P1169, DOI 10.1103/PhysRevLett.59.1169; HIGASHIGAKI Y, 1981, J PHYS CHEM-US, V85, P2531, DOI 10.1021/j150617a024; Hirth J. P., 1972, THEORY DISLOCATIONS; Hull D., 2011, INTRO TC DISLOCATION, V5th, DOI DOI 10.1016/B978-0-08-096672-4.00001-3; HULL R, 1988, APPL PHYS LETT, V52, P1605, DOI 10.1063/1.99055; JORAND M, 1985, J PHYS-PARIS, V46, P245, DOI 10.1051/jphyscol:1985319; LEPINOUX J, 2000, NATO SCI SERIES E, V367; MATTHEWS JW, 1970, J APPL PHYS, V41, P3800, DOI 10.1063/1.1659510; MATTHEWS JW, 1974, J CRYST GROWTH, V27, P118, DOI 10.1016/S0022-0248(74)80055-2; Orowan E, 1934, Z PHYS, V89, P605, DOI 10.1007/BF01341478; Polanyi M., 1934, Z PHYS, V89, P660, DOI [10.1007/BF01341481, DOI 10.1007/BF01341481]; Pronk S, 1999, J CHEM PHYS, V110, P4589, DOI 10.1063/1.478339; vanBlaaderen A, 1997, NATURE, V385, P321, DOI 10.1038/385321a0; Williams and Carter, 2010, TRANSMISSION ELECT M	17	173	180	7	103	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 24	2004	305	5692					1944	1948		10.1126/science.1102186	http://dx.doi.org/10.1126/science.1102186			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	857RM	15448265				2022-12-28	WOS:000224136000042
J	Offit, K; Groeger, E; Turner, S; Wadsworth, EA; Weiser, MA				Offit, K; Groeger, E; Turner, S; Wadsworth, EA; Weiser, MA			The "duty to warn" a patient's family members about hereditary disease risks	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							NEOPLASIA TYPE 2A; ADENOMATOUS POLYPOSIS; GENETIC-DISEASE; CANCER; INFORMATION; MUTATIONS; RELATIVES; CARRIERS; BREAST; BRCA1	Genetic tests for adult-onset disorders, including common forms of cancer, are now commercially available, and tests for genetic polymorphisms that predict drug effects or toxicity after treatment are under development. For each of these circumstances, testing of 1 individual may imply an increased risk to his/her relative. The obligation, if any, to warn family members of the identification of a genetic mutation has generated concerns regarding the conflict between the physician's ethical obligations to respect the privacy of genetic information vs the potential liabilities resulting from the physician's failure to notify at-risk relatives. A duty to warn relatives about risks due to some infectious agents has been assumed by state and local health agencies, and the duty to breach confidentiality to warn of imminent harm has been the subject of case law. In general, the special nature of genetic tests has been viewed as a barrier to physicians' breaching the confidentiality of personal genetic information. However, the failure to warn family members about hereditary disease risks has already resulted in 3 lawsuits against physicians in the United States. While the findings of case law and the state and federal statutes that bear on the issue of "duty to warn" of inherited health risk are still being defined, we believe that health care professionals have a responsibility to encourage but not to coerce the sharing of genetic information in families, while respecting the boundaries imposed by the law and by the ethical practice of medicine.	Mem Sloan Kettering Canc Ctr, Dept Med, Clin Genet Serv, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Off Legal Affairs, New York, NY 10021 USA; Ropes & Gray LLP, Washington, DC 20037 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Offit, K (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Med, Clin Genet Serv, 1275 York Ave, New York, NY 10021 USA.	offitk@mskcc.org						Beauchamp TL, 2009, PRINCIPLES BIOMEDICA; Bruinooge SS, 2003, J CLIN ONCOL, V21, P2397, DOI 10.1200/JCO.2003.03.189; Burke W, 2002, AM J EPIDEMIOL, V156, P311, DOI 10.1093/aje/kwf055; Burnett J W, 1999, Houst Law Rev, V36, P559; Chasman DI, 2004, JAMA-J AM MED ASSOC, V291, P2821, DOI 10.1001/jama.291.23.2821; Clayton EW, 2003, NEW ENGL J MED, V349, P562, DOI 10.1056/NEJMra012577; *COUNC ETH JUD AFF, 2A02 CEJA; Dugan RB, 2003, AM J MED GENET C, V119C, P27, DOI 10.1002/ajmg.c.10005; Falk MJ, 2003, AM J MED GENET A, V120A, P374, DOI 10.1002/ajmg.a.20227; Giardiello FM, 2002, NEW ENGL J MED, V346, P1054, DOI 10.1056/NEJMoa012015; *I MED COMM ASS GE, 1994, ASS GEN RISKS IMPL H; JARVINEN HJ, 1995, GASTROENTEROLOGY, V108, P1405, DOI 10.1016/0016-5085(95)90688-6; Kauff ND, 2002, NEW ENGL J MED, V346, P1609, DOI 10.1056/NEJMoa020119; Keeton WP, 1984, PROSSER KEETONS HORN; Knoppers BM, 1998, AM J HUM GENET, V62, P474; LI FP, 1992, J NATL CANCER I, V84, P1156, DOI 10.1093/jnci/84.15.1156; LINDEN AM, 1993, CANADIAN TORT LAW; LIPS CJM, 1994, NEW ENGL J MED, V331, P828, DOI 10.1056/NEJM199409293311302; MACKLIN R, 1992, GENE MAPPING USING L, P157; Offit K, 1998, CLIN CANC GENETICS R; OFFIT K, 2004, AM SOC CLIN ONCOLOGY; President's Commission for the Study of Ethical Problems in Medicine and Biomedical and Behavioral Research, 1998, SCREEN COUNS GEN CON; Sankar P, 2003, ANNU REV MED, V54, P393, DOI 10.1146/annurev.med.54.101601.152131; Satagopan JM, 2001, CANCER EPIDEM BIOMAR, V10, P467; Scheuer L, 2002, J CLIN ONCOL, V20, P1260, DOI 10.1200/JCO.2002.20.5.1260; Steinbach G, 2000, NEW ENGL J MED, V342, P1946, DOI 10.1056/NEJM200006293422603; Sudell A, 2001, J Contemp Health Law Policy, V18, P273; *US DEP HHS, OCR PRIV BRIEF SUMM; WELLS SA, 1994, ANN SURG, V220, P237, DOI 10.1097/00000658-199409000-00002	29	183	184	0	22	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 22	2004	292	12					1469	1473		10.1001/jama.292.12.1469	http://dx.doi.org/10.1001/jama.292.12.1469			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	856FT	15383518				2022-12-28	WOS:000224031800029
J	Esteban, A; Fernandez-Segoviano, P; Frutos-Vivar, F; Aramburu, JA; Najera, L; Ferguson, ND; Alia, I; Gordo, F; Rios, F				Esteban, A; Fernandez-Segoviano, P; Frutos-Vivar, F; Aramburu, JA; Najera, L; Ferguson, ND; Alia, I; Gordo, F; Rios, F			Comparison of clinical criteria for the acute respiratory distress syndrome with autopsy findings	ANNALS OF INTERNAL MEDICINE			English	Article							VENTILATOR-ASSOCIATED PNEUMONIA; INTENSIVE-CARE-UNIT; ACUTE LUNG INJURY; PULMONARY; TRIAL; ARDS; VALIDATION; MORTALITY; DIAGNOSIS; STRATEGY	Background: The American-European Consensus Conference definition for the acute respiratory distress syndrome (ARDS) has never been validated. Objective: To compare clinical criteria for ARDS with autopsy findings. Design: independent comparison of autopsy findings with clinical characteristics retrospectively abstracted from medical records. Setting: Tertiary medical-surgical intensive care unit. Participants: 382 patients who underwent clinical autopsy. Measurements: Sensitivity, specificity, and likelihood ratios for clinical criteria were calculated in 3 cohorts by using diffuse alveolar damage at autopsy as the reference standard. The 3 cohorts were 1) all patients, 2) patients with any risk factor for ARDS, and 3) patients who were separated according to their pulmonary or extrapulmonary risk factors. Results: 127 patients (33%) met the clinical criteria, and 112 (29%) had diffuse alveolar damage. In all patients, the sensitivity of the clinical definition was 75% (95% Cl, 66% to 82%) and the specificity was 84% (Cl, 79% to 88%). In 284 patients with risk factors, the sensitivity was 76% (Cl, 67% to 83%) and the specificity was 75% (Cl, 68% to 81%). Compared with patients with pulmonary risk factors, patients with extrapulmonary risk factors had significantly higher sensitivity (61 % vs. 85%; P = 0.009) and the specificity did not statistically significantly differ (69% vs. 78%; P > 0.2). Limitations: Only patients who died and underwent autopsy could be included in this study, so these results may not apply to less severe cases of ARDS. Conclusions: In a series of autopsy patients, the accuracy of the American-European Consensus Conference definition of ARDS was only moderate. The definition was more accurate for patients with extrapulmonary risk factors than for patients with pulmonary risk factors.	Hosp Univ Getafe, Unidad Cuidados Intens, Madrid 28905, Spain; Univ Toronto, Univ Hlth Network, Toronto, ON, Canada	Hospital Universitario de Getafe; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Esteban, A (corresponding author), Hosp Univ Getafe, Unidad Cuidados Intens, Carretera Toledo Km 12,500, Madrid 28905, Spain.	aesteban@ucigetafe.com	Ferguson, Niall/D-7619-2019; Gordo, Federico/T-6680-2019	Ferguson, Niall/0000-0002-6213-5264; Gordo, Federico/0000-0001-9605-1918; Frutos-Vivar, Fernando/0000-0002-4648-9636				Agresti A., 1984, ANAL ORDINAL CATEGOR; Amato MBP, 1998, NEW ENGL J MED, V338, P347, DOI 10.1056/NEJM199802053380602; Anzueto A, 1996, NEW ENGL J MED, V334, P1417, DOI 10.1056/NEJM199605303342201; ASHBAUGH DG, 1967, LANCET, V2, P319; BERNARD GR, 1994, AM J RESP CRIT CARE, V149, P818, DOI 10.1164/ajrccm.149.3.7509706; Brochard L, 1998, AM J RESP CRIT CARE, V158, P1831, DOI 10.1164/ajrccm.158.6.9801044; Brower RG, 2000, NEW ENGL J MED, V342, P1301, DOI 10.1056/nejm200005043421801; Deeks JJ., 2001, SYSTEMATIC REV HLTH, P248, DOI DOI 10.1002/9780470693926.CH14; Esteban A, 2000, CHEST, V117, P1690, DOI 10.1378/chest.117.6.1690; Esteban A, 2003, INTENS CARE MED, V29, P522, DOI 10.1007/s00134-002-1631-9; Esteban A, 1999, INTENS CARE MED, V25, P343, DOI 10.1007/s001340050853; Estenssoro E, 2002, CRIT CARE MED, V30, P2450, DOI 10.1097/00003246-200211000-00008; Fabregas N, 1999, THORAX, V54, P867, DOI 10.1136/thx.54.10.867; FERGUSON ND, 2003, YB INTENSIVE CARE EM, P231; FERNANDEZSEGOVIANO P, 1988, CRIT CARE MED, V16, P683, DOI 10.1097/00003246-198807000-00007; Garber BG, 1996, CRIT CARE MED, V24, P687, DOI 10.1097/00003246-199604000-00023; Gattinoni L, 1998, AM J RESP CRIT CARE, V158, P3, DOI 10.1164/ajrccm.158.1.9708031; GOLDMAN L, 1983, NEW ENGL J MED, V308, P1000, DOI 10.1056/NEJM198304283081704; Goodman LR, 1999, RADIOLOGY, V213, P545, DOI 10.1148/radiology.213.2.r99nv42545; Hudson LD, 1999, CHEST, V116, p74S, DOI 10.1378/chest.116.suppl_1.74S-a; JAESCHKE R, 1994, JAMA-J AM MED ASSOC, V271, P389, DOI 10.1001/jama.271.5.389; KATZENSTEIN ALA, 1976, AM J PATHOL, V85, P210; LEWANDOWSKI K, 1995, AM J RESP CRIT CARE, V151, P1121; Lim CM, 2001, INTENS CARE MED, V27, P477, DOI 10.1007/s001340000848; Meduri GU, 1998, JAMA-J AM MED ASSOC, V280, P159, DOI 10.1001/jama.280.2.159; PALAZON C, 1999, MED INTENSIVA, V23, P6; Roupie E, 1999, INTENS CARE MED, V25, P920, DOI 10.1007/s001340050983; Silfvast T, 2003, INTENS CARE MED, V29, P321, DOI 10.1007/s00134-002-1576-z; Stewart TE, 1998, NEW ENGL J MED, V338, P355, DOI 10.1056/NEJM199802053380603; THOMSEN GE, 1995, AM J RESP CRIT CARE, V152, P965, DOI 10.1164/ajrccm.152.3.7663811; Tomashefski JF, 2000, CLIN CHEST MED, V21, P435, DOI 10.1016/S0272-5231(05)70158-1; TORRES A, 1994, AM J RESP CRIT CARE, V149, P324, DOI 10.1164/ajrccm.149.2.8306025; Zaitoun AM, 1998, PATHOLOGY, V30, P100, DOI 10.1080/00313029800169036; ZAMORA J, 2004, 11 COCHR C BARC SPAI	34	188	213	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 21	2004	141	6					440	445		10.7326/0003-4819-141-6-200409210-00009	http://dx.doi.org/10.7326/0003-4819-141-6-200409210-00009			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	856TM	15381517				2022-12-28	WOS:000224067900004
J	Piantadosi, CA; Schwartz, DA				Piantadosi, CA; Schwartz, DA			The acute respiratory distress syndrome	ANNALS OF INTERNAL MEDICINE			English	Review							KERATINOCYTE GROWTH-FACTOR; ACUTE LUNG INJURY; QUALITY-OF-LIFE; PULMONARY-EDEMA; EPITHELIAL-CELLS; INNATE IMMUNITY; II PNEUMOCYTES; ALVEOLAR; PERMEABILITY; EXPRESSION	This review describes the clinical, etiologic, and physiologic basis of the acute respiratory distress syndrome and summarizes how its molecular pathogenesis leads to respiratory failure. The authors describe a physiologic basis for the respiratory management of patients with this syndrome.	Duke Univ, Med Ctr, Div Pulm & Crit Care Med, Durham, NC 27710 USA	Duke University	Piantadosi, CA (corresponding author), Duke Univ, Med Ctr, Div Pulm & Crit Care Med, Box 3315, Durham, NC 27710 USA.				NHLBI NIH HHS [P01 HL 31992-18] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL031992] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ABERLE DR, 1988, RADIOLOGY, V168, P73, DOI 10.1148/radiology.168.1.3380985; ADAMSON IYR, 1990, AM J PATHOL, V137, P385; ALBERTINE KH, 1998, HISTOPATHOLOGY PULMO, P37; ANDERSON WR, 1992, ULTRASTRUCT PATHOL, V16, P615, DOI 10.3109/01913129209023751; Arbour NC, 2000, NAT GENET, V25, P187, DOI 10.1038/76048; ASHBAUGH DG, 1967, LANCET, V2, P319; BACHOFEN M, 1982, CLIN CHEST MED, V3, P35; BACHOFEN M, 1977, AM REV RESPIR DIS, V116, P589, DOI 10.1164/arrd.1977.116.4.589; BERNARD GR, 1994, AM J RESP CRIT CARE, V149, P818, DOI 10.1164/ajrccm.149.3.7509706; Berthiaume Y, 1999, THORAX, V54, P150, DOI 10.1136/thx.54.2.150; Borok Z, 1998, AM J RESP CELL MOL, V18, P554, DOI 10.1165/ajrcmb.18.4.2838; Brower RG, 2001, CHEST, V120, P1347, DOI 10.1378/chest.120.4.1347; Brower RG, 2000, NEW ENGL J MED, V342, P1301, DOI 10.1056/nejm200005043421801; Brower RG, 2002, AM J RESP CRIT CARE, V166, P1515, DOI 10.1164/ajrccm.166.11.340; Chesnutt AN, 1997, CHEST, V111, P652, DOI 10.1378/chest.111.3.652; Cines DB, 1998, BLOOD, V91, P3527; Cordingley JJ, 2002, THORAX, V57, P729, DOI 10.1136/thorax.57.8.729; Davidson TA, 1999, JAMA-J AM MED ASSOC, V281, P354, DOI 10.1001/jama.281.4.354; Dobbs LG, 1998, P NATL ACAD SCI USA, V95, P2991, DOI 10.1073/pnas.95.6.2991; DONNELLY SC, 1994, LANCET, V344, P215, DOI 10.1016/S0140-6736(94)92995-5; DOYLE RL, 1995, AM J RESP CRIT CARE, V152, P1818, DOI 10.1164/ajrccm.152.6.8520742; Dreyfuss D, 1998, AM J RESP CRIT CARE, V157, P294, DOI 10.1164/ajrccm.157.1.9604014; Eichacker PQ, 2002, AM J RESP CRIT CARE, V166, P1510, DOI 10.1164/rccm.200208-956OC; ELLIOTT CG, 1987, AM REV RESPIR DIS, V135, P634; GATTINONI L, 1994, JAMA-J AM MED ASSOC, V271, P1772, DOI 10.1001/jama.271.22.1772; GHIO AJ, 1989, AM REV RESPIR DIS, V139, P1158, DOI 10.1164/ajrccm/139.5.1158; Goodman LR, 1996, RADIOL CLIN N AM, V34, P33; Grissom CK, 1997, CHEST, V112, P1572, DOI 10.1378/chest.112.6.1572; GUYTON AC, 1975, CIRCULATORY PHYSL, V2, P149; HEFFNER JE, 1995, AM J RESP CRIT CARE, V152, P1518, DOI 10.1164/ajrccm.152.5.7582287; Herridge MS, 2003, NEW ENGL J MED, V348, P683, DOI 10.1056/NEJMoa022450; HOGG JC, 1995, ANNU REV PHYSIOL, V57, P97, DOI 10.1146/annurev.ph.57.030195.000525; Hudson L. D., 1999, CHEST S1, V116, p74S; HUDSON LD, 1995, AM J RESP CRIT CARE, V151, P293, DOI 10.1164/ajrccm.151.2.7842182; Idell S, 2002, CRIT CARE MED, V30, pS274, DOI 10.1097/00003246-200205001-00017; Johnson MD, 2002, P NATL ACAD SCI USA, V99, P1966, DOI 10.1073/pnas.042689399; LESUR O, 1992, EXP LUNG RES, V18, P633, DOI 10.3109/01902149209031699; Lorenz E, 2002, ARCH INTERN MED, V162, P1028, DOI 10.1001/archinte.162.9.1028; Luhr OR, 1999, AM J RESP CRIT CARE, V159, P1849, DOI 10.1164/ajrccm.159.6.9808136; Luscinskas FW, 1996, ANNU REV MED, V47, P413, DOI 10.1146/annurev.med.47.1.413; MARON MB, 1994, J APPL PHYSIOL, V77, P1155, DOI 10.1152/jappl.1994.77.3.1155; MARTIN MA, 1991, PROG CLIN BIOL RES, V367, P111; Martin TR, 2002, J CLIN INVEST, V110, P1603, DOI 10.1172/JCI200217302; Matthay MA, 1996, AM J PHYSIOL-LUNG C, V270, pL487, DOI 10.1152/ajplung.1996.270.4.L487; MATTHAY MA, 1990, AM REV RESPIR DIS, V142, P1250, DOI 10.1164/ajrccm/142.6_Pt_1.1250; MCHUGH LG, 1994, AM J RESP CRIT CARE, V150, P90, DOI 10.1164/ajrccm.150.1.8025779; Medzhitov R, 1997, CURR OPIN IMMUNOL, V9, P4, DOI 10.1016/S0952-7915(97)80152-5; Medzhitov R, 1997, CELL, V91, P295, DOI 10.1016/S0092-8674(00)80412-2; Monchi M, 1998, AM J RESP CRIT CARE, V158, P1076, DOI 10.1164/ajrccm.158.4.9802009; Newman V, 2000, AM J RESP CRIT CARE, V161, P990, DOI 10.1164/ajrccm.161.3.9901042; PANOS RJ, 1995, J CLIN INVEST, V96, P2026, DOI 10.1172/JCI118250; PANOS RJ, 1993, J CLIN INVEST, V92, P969, DOI 10.1172/JCI116673; PANOS RJ, 1993, CYTOKINES LUNG, P417; Piani A, 2000, EUR J IMMUNOL, V30, P3140, DOI 10.1002/1521-4141(200011)30:11<3140::AID-IMMU3140>3.0.CO;2-O; Pittet JF, 1997, AM J RESP CRIT CARE, V155, P1187, DOI 10.1164/ajrccm.155.4.9105054; Post M, 1996, DEVELOPMENT, V122, P3107; RINALDO JE, 1982, NEW ENGL J MED, V306, P900, DOI 10.1056/NEJM198204153061504; SAKAMAKI F, 1995, AM J RESP CRIT CARE, V151, P1821, DOI 10.1164/ajrccm.151.6.7539327; Sakuma T, 1997, AM J RESP CRIT CARE, V155, P506, DOI 10.1164/ajrccm.155.2.9032186; Schromm AB, 2001, J EXP MED, V194, P79, DOI 10.1084/jem.194.1.79; Siflinger-Birnboim A, 2003, AM J PHYSIOL-LUNG C, V284, pL435, DOI 10.1152/ajplung.00106.2002; Slutsky AS, 1998, AM J RESP CRIT CARE, V157, P1721, DOI 10.1164/ajrccm.157.6.9709092; Staub N.C., 1984, EDEMA, P719; Steinbrook R, 2003, NEW ENGL J MED, V349, P629, DOI 10.1056/NEJMp038133; SUCHYTA MR, 1993, RESPIRATION, V60, P103; Takeuchi O, 2000, INT IMMUNOL, V12, P113, DOI 10.1093/intimm/12.1.113; TANSWELL AK, 1991, AM J PHYSIOL, V260, pL395, DOI 10.1152/ajplung.1991.260.6.L395; TAYLOR AE, 1991, LUNG SCI FDN, P1147; ULICH TR, 1994, J CLIN INVEST, V93, P1298, DOI 10.1172/JCI117086; Verkman AS, 1998, LUNG BIOL HEALTH DIS, V116, P525; VREIM CE, 1976, AM J PHYSIOL, V231, P1466, DOI 10.1152/ajplegacy.1976.231.5.1466; Ware LB, 2000, NEW ENGL J MED, V342, P1334, DOI 10.1056/NEJM200005043421806; Weinert CR, 1997, AM J RESP CRIT CARE, V156, P1120, DOI 10.1164/ajrccm.156.4.9611047; WEST JB, 1977, AM REV RESPIR DIS, V116, P919; Wright SD, 1999, J EXP MED, V189, P605, DOI 10.1084/jem.189.4.605; YANAGITA K, 1993, J BIOL CHEM, V268, P21212; Yi ES, 1998, INFLAMMATION, V22, P315, DOI 10.1023/A:1022304317111; Zilberberg MD, 1998, AM J RESP CRIT CARE, V157, P1159, DOI 10.1164/ajrccm.157.4.9704088; ZIMMERMAN G, 1996, LUNG SCI FDN, P289; ZIMMERMAN GA, 1984, AM REV RESPIR DIS, V129, P798, DOI 10.1164/arrd.1984.129.5.798	80	218	233	0	13	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 21	2004	141	6					460	470		10.7326/0003-4819-141-6-200409210-00012	http://dx.doi.org/10.7326/0003-4819-141-6-200409210-00012			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	856TM	15381520				2022-12-28	WOS:000224067900007
J	Ruger, JP				Ruger, JP			Health and social justice	LANCET			English	Article									Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, New Haven, CT 06520 USA	Yale University	Ruger, JP (corresponding author), Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, 333 Cedar St, New Haven, CT 06520 USA.	jennifer.ruger@yale.edu			NATIONAL INSTITUTE ON DRUG ABUSE [K01DA016358] Funding Source: NIH RePORTER; NIDA NIH HHS [1K01DA016358-01, K01 DA016358] Funding Source: Medline	NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))		ANAND S, 2001, CHALLENGES INEQUITIE; [Anonymous], 1999, DEV FREEDOM; Aristotle, 1987, NICOMACHEAN ETHICS; Beauchamp TL, 2009, PRINCIPLES BIOMEDICA; CHEN LC, 2001, CHALLENGES INEQUITIE; DANIELS N, 1985, JUST HLTH CARE; EMANUEL EJ, 1991, ENDS HUMAN LIFE; Gold MR, 1996, COST EFFECTIVENESS H; Horton R, 2000, LANCET, V355, P2231, DOI 10.1016/S0140-6736(00)02414-4; MARMOT M, 1995, SOC HLTH; Nussbaum M. C., 1990, ARISTOTELES POLITIK; Nussbaum Martha C., 1998, ETHICS CONSUMPTION G, P312; NUSSBAUM MC, 1992, POLIT THEORY, V20, P202, DOI 10.1177/0090591792020002002; RACKHAM H, 1994, POLITICS; Rawls J., 1971, THEORY JUSTICE; *ROCK FDN, PROGR HLTH EQ; Rodrik D., 1999, MAKING OPENNESS WORK; Ruger Jennifer Prah, 1995, HLTH HLTH CARE INCOM; Ruger JP, 2004, BRIT MED J, V329, P121, DOI 10.1136/bmj.329.7458.121; Ruger JP, 2003, LANCET, V362, P996, DOI 10.1016/S0140-6736(03)14376-0; Ruger JP, 2003, LANCET, V362, P678, DOI 10.1016/S0140-6736(03)14243-2; RUGER JP, 1998, THESIS HARVARD U; RUGER JP, 1997, SOCIAL JUSTICE HLTH; RUGER JP, IN PRESS AM J PUBLIC; Sen A, 1992, INEQUALITY RE EXAMIN; Sen A., 1999, COMMODITIES CAPABILI; STIGLITZ J, 1998, ANN WORLD BANK C DEV; SUNSTEIN CR, 1995, HARVARD LAW REV, V108, P1733, DOI 10.2307/1341816; *UN DEV PROGR, 2003, HUM DEV REP; VANDOORSLAER E, 1993, EQUITY FINANCE DELIV; Wolfensohn James, 1999, PROPOSAL COMPREHENSI	31	99	101	1	6	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 18	2004	364	9439					1075	1080		10.1016/S0140-6736(04)17064-5	http://dx.doi.org/10.1016/S0140-6736(04)17064-5			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	855FT	15380968	Green Published, Green Accepted, Bronze			2022-12-28	WOS:000223959300028
J	Takhar, AS; Palaniappan, P; Dhingsa, R; Lobo, DN				Takhar, AS; Palaniappan, P; Dhingsa, R; Lobo, DN			Recent developments in diagnosis of pancreatic cancer	BMJ-BRITISH MEDICAL JOURNAL			English	Review							OF-THE-ART; DUCTAL ADENOCARCINOMA; COMPUTED-TOMOGRAPHY; TUMORS; NEOPLASMS; CT; ULTRASONOGRAPHY; RESECTABILITY; EXPRESSION; CARCINOMA		Univ Nottingham Hosp, Queens Med Ctr, Sect Surg, Nottingham NG7 2UH, England; Univ Nottingham Hosp, Queens Med Ctr, Dept Radiol, Nottingham NG7 2UH, England	University of Nottingham; University of Nottingham	Lobo, DN (corresponding author), Univ Nottingham Hosp, Queens Med Ctr, Sect Surg, Nottingham NG7 2UH, England.	dileep.lobo@nottingham.ac.uk	Lobo, Dileep/AAC-6207-2020	Lobo, Dileep/0000-0003-1187-5796				Adamek HE, 2000, LANCET, V356, P190, DOI 10.1016/S0140-6736(00)02479-X; Berberat P, 1999, WORLD J SURG, V23, P882, DOI 10.1007/s002689900593; Beyer T, 2000, J NUCL MED, V41, P1369; Brand R, 2001, CANCER J, V7, P287; Clarke DL, 2003, J AM COLL SURGEONS, V196, P119, DOI 10.1016/S1072-7515(02)01609-5; Conio M, 2001, CRIT REV ONCOL HEMAT, V37, P127, DOI 10.1016/S1040-8428(00)00108-6; Cooperman AM, 2000, J CLIN GASTROENTEROL, V31, P107, DOI 10.1097/00004836-200009000-00004; DiMagno EP, 1999, ANN ONCOL, V10, P140, DOI 10.1023/A:1008382029375; FUHRMAN GM, 1994, AM J SURG, V167, P104, DOI 10.1016/0002-9610(94)90060-4; GRAHAM RA, 1994, J SURG ONCOL, V55, P92, DOI 10.1002/jso.2930550206; Grutzmann R, 2004, BRIT J CANCER, V90, P1053, DOI 10.1038/sj.bjc.6601645; Gullo L, 1999, ANN ONCOL, V10, P79, DOI 10.1023/A:1008349122106; Hanbidge AE, 2002, CAN J GASTROENTEROL, V16, P101, DOI 10.1155/2002/184370; Haycox A, 1998, ALIMENT PHARM THER, V12, P937; Hosten N, 2000, LANCET, V356, P909, DOI 10.1016/S0140-6736(00)02683-0; Jemal A, 2003, CA-CANCER J CLIN, V53, P5, DOI 10.3322/canjclin.53.1.5; Kalra MK, 2003, BRIT J RADIOL, V76, P857, DOI 10.1259/bjr/16642775; Kitano M, 2004, GUT, V53, P854, DOI 10.1136/gut.2003.029934; Li DH, 2004, LANCET, V363, P1049, DOI 10.1016/S0140-6736(04)15841-8; Mertz HR, 2000, GASTROINTEST ENDOSC, V52, P367, DOI 10.1067/mge.2000.107727; Midwinter MJ, 1999, BRIT J SURG, V86, P189, DOI 10.1046/j.1365-2168.1999.01042.x; *NAT CANC GUID GRO, 2001, GUID COMM CANC SERV; Neoptolemos JP, 2004, NEW ENGL J MED, V350, P1200, DOI 10.1056/NEJMoa032295; Ozkan H, 2003, HEPATO-GASTROENTEROL, V50, P1669; Pisters PWT, 2001, BRIT J SURG, V88, P325, DOI 10.1046/j.1365-2168.2001.01695.x; Plebani M, 1995, INT J BIOL MARKER, V10, P189, DOI 10.1177/172460089501000401; Potter MW, 2000, SURG ONCOL, V9, P103, DOI 10.1016/S0960-7404(01)00005-6; Quinn M, 2001, CANC TRENDS ENGLAND; RICHTER JM, 1989, ARCH INTERN MED, V149, P2292, DOI 10.1001/archinte.149.10.2292; Rickes S, 2002, SCAND J GASTROENTERO, V37, P1313, DOI 10.1080/003655202761020605; Saruc M, 2003, PANCREAS, V26, P381, DOI 10.1097/00006676-200305000-00012; Sewnath ME, 2002, ANN SURG, V236, P17, DOI 10.1097/00000658-200207000-00005; STEINER E, 1989, AM J ROENTGENOL, V152, P487, DOI 10.2214/ajr.152.3.487; Takamura M, 2003, CANCER SCI, V94, P425, DOI 10.1111/j.1349-7006.2003.tb01459.x; Tamm EP, 2003, AM J ROENTGENOL, V180, P1311, DOI 10.2214/ajr.180.5.1801311; Vargas R, 2004, AM J ROENTGENOL, V182, P419, DOI 10.2214/ajr.182.2.1820419; Yeo Theresa Pluth, 2002, Curr Probl Cancer, V26, P176, DOI 10.1067/mcn.2002.129579	37	57	68	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 18	2004	329	7467					668	673		10.1136/bmj.329.7467.668	http://dx.doi.org/10.1136/bmj.329.7467.668			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	856JU	15374918	Green Published			2022-12-28	WOS:000224042300024
J	Wills-Karp, M; Karp, CL				Wills-Karp, M; Karp, CL			Eosinophils in asthma: Remodeling a tangled tale	SCIENCE			English	Editorial Material							AIRWAY HYPERRESPONSIVENESS; MURINE MODEL; HYPERREACTIVITY; INTERLEUKIN-5; ANTIBODY; MEDIATOR; IL-5		Childrens Hosp, Med Ctr, Div Immunobiol, Cincinnati, OH 45229 USA; Childrens Hosp, Med Ctr, Div Mol Immunol, Cincinnati, OH 45229 USA	Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati	Wills-Karp, M (corresponding author), Childrens Hosp, Med Ctr, Div Immunobiol, Cincinnati, OH 45229 USA.	wildc7@cchmc.org		Karp, Christopher/0000-0002-0832-2659				Corry DB, 1996, J EXP MED, V183, P109, DOI 10.1084/jem.183.1.109; Flood-Page P, 2003, J CLIN INVEST, V112, P1029, DOI 10.1172/JCI200317974; Foster PS, 1996, J EXP MED, V183, P195, DOI 10.1084/jem.183.1.195; GLEICH GJ, 1993, ANNU REV MED, V44, P85, DOI 10.1146/annurev.me.44.020193.000505; Hogan SP, 1998, J IMMUNOL, V161, P1501; Huber HL, 1922, ARCH INTERN MED, V30, P689, DOI 10.1001/archinte.1922.00110120002001; Humbles AA, 2004, SCIENCE, V305, P1776, DOI 10.1126/science.1100283; KUNG TT, 1995, AM J RESP CELL MOL, V13, P360, DOI 10.1165/ajrcmb.13.3.7654390; Leckie MJ, 2000, LANCET, V356, P2144, DOI 10.1016/S0140-6736(00)03496-6; Lee JJ, 2004, SCIENCE, V305, P1773, DOI 10.1126/science.1099472; McDonald PP, 1999, J IMMUNOL, V163, P6164; Shi HZ, 2000, J CLIN INVEST, V105, P945, DOI 10.1172/JCI8945; Wills-Karp M, 1999, ANNU REV IMMUNOL, V17, P255, DOI 10.1146/annurev.immunol.17.1.255; Wills-Karp M, 1998, SCIENCE, V282, P2258, DOI 10.1126/science.282.5397.2258; Yu CN, 2002, J EXP MED, V195, P1387, DOI 10.1084/jem.20020656	15	83	86	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 17	2004	305	5691					1726	+		10.1126/science.1104134	http://dx.doi.org/10.1126/science.1104134			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	856IS	15375256				2022-12-28	WOS:000224039500027
J	Kim, SK; Rulifson, EJ				Kim, SK; Rulifson, EJ			Conserved mechanisms of glucose sensing and regulation by Drosophila corpora cardiaca cells	NATURE			English	Article							ADIPOKINETIC HORMONE-RELEASE; SENSITIVE K+ CHANNELS; INSULIN-LIKE PEPTIDES; PANCREATIC A-CELLS; SULFONYLUREA RECEPTOR; CORPUS CARDIACUM; GLUCAGON; GROWTH; NEURONS; LOCUST	Antagonistic activities of glucagon and insulin control metabolism in mammals, and disruption of this balance underlies diabetes pathogenesis. Insulin-producing cells (IPCs) in the brain of insects such as Drosophila also regulate serum glucose(1,2), but it remains unclear whether insulin is the sole hormonal regulator of glucose homeostasis and whether mechanisms of glucose-sensing and response in IPCs resemble those in pancreatic islets. Here we show, by targeted cell ablation, that Drosophila corpora cardiaca (CC) cells(3-5) of the ring gland are also essential for larval glucose homeostasis. Unlike IPCs, CC cells express Drosophila cognates of sulphonylurea receptor (Sur) and potassium channel (Ir), proteins that comprise ATP-sensitive potassium channels regulating hormone secretion by islets and other mammalian glucose-sensing cells(6-8). They also produce adipokinetic hormone, a polypeptide with glucagon-like functions. Glucose regulation by CC cells is impaired by exposure to sulphonylureas, drugs that target the Sur subunit. Furthermore, ubiquitous expression of an akh transgene reverses the effect of CC ablation on serum glucose. Thus, Drosophila CC cells are crucial regulators of glucose homeostasis and they use glucose-sensing and response mechanisms similar to islet cells.	Stanford Univ, Sch Med, Beckman Ctr B300, Dept Dev Biol,Oncol Div, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Beckman Ctr B300, Dept Med,Oncol Div, Stanford, CA 94305 USA; Univ Penn, Sch Med, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA	Stanford University; Stanford University; University of Pennsylvania	Kim, SK (corresponding author), Stanford Univ, Sch Med, Beckman Ctr B300, Dept Dev Biol,Oncol Div, Stanford, CA 94305 USA.	seungkim@cmgm.stanford.edu		Kim, Seung/0000-0001-6135-7810				AGUILARBRYAN L, 1995, SCIENCE, V268, P423, DOI 10.1126/science.7716547; Bokvist K, 1999, PFLUG ARCH EUR J PHY, V438, P428, DOI 10.1007/s004240051058; Brogiolo W, 2001, CURR BIOL, V11, P213, DOI 10.1016/S0960-9822(01)00068-9; COPENHAVER PF, 1991, DEVELOPMENT, V113, P111; DEVELASCO B, IN PRESS DEV BIOL; Doring F, 2002, J BIOL CHEM, V277, P25554, DOI 10.1074/jbc.M202385200; Gelling RW, 2003, P NATL ACAD SCI USA, V100, P1438, DOI 10.1073/pnas.0237106100; Gopel SO, 2000, J PHYSIOL-LONDON, V528, P509, DOI 10.1111/j.1469-7793.2000.00509.x; Hoy M, 2000, J PHYSIOL-LONDON, V527, P109, DOI 10.1111/j.1469-7793.2000.00109.x; Ikeya T, 2002, CURR BIOL, V12, P1293, DOI 10.1016/S0960-9822(02)01043-6; Lee GH, 2004, GENETICS, V167, P311, DOI 10.1534/genetics.167.1.311; McNabb SL, 1997, NEURON, V19, P813, DOI 10.1016/S0896-6273(00)80963-0; Miki T, 2001, NAT NEUROSCI, V4, P507, DOI 10.1038/87455; Nasonkin I, 1999, J BIOL CHEM, V274, P29420, DOI 10.1074/jbc.274.41.29420; NOYES BE, 1995, MOL CELL ENDOCRINOL, V109, P133, DOI 10.1016/0303-7207(95)03492-P; ORCHARD I, 1981, J NEUROBIOL, V12, P143, DOI 10.1002/neu.480120204; Ostergard T, 2004, J CLIN ENDOCR METAB, V89, P297, DOI 10.1210/jc.2003-031011; PANNABECKER T, 1987, BRAIN RES, V423, P13, DOI 10.1016/0006-8993(87)90819-5; PANNABECKER T, 1989, BRAIN RES, V477, P38, DOI 10.1016/0006-8993(89)91392-9; Paradis S, 2001, NEURON, V30, P737, DOI 10.1016/S0896-6273(01)00326-9; Passier PCCM, 1997, J ENDOCRINOL, V153, P299, DOI 10.1677/joe.0.1530299; Rulifson EJ, 2002, SCIENCE, V296, P1118, DOI 10.1126/science.1070058; Seino S, 2003, PROG BIOPHYS MOL BIO, V81, P133, DOI 10.1016/S0079-6107(02)00053-6; Staubli F, 2002, P NATL ACAD SCI USA, V99, P3446, DOI 10.1073/pnas.052556499; STURGESS NC, 1985, LANCET, V2, P474; TOMANCAK P, BERKELEY DROSOPHILA; TRUBE G, 1986, PFLUG ARCH EUR J PHY, V407, P493, DOI 10.1007/BF00657506; Van der Horst DJ, 2003, COMP BIOCHEM PHYS B, V136, P217, DOI 10.1016/S1096-4959(03)00151-9; Veelaert D, 1998, INT REV CYTOL, V182, P249, DOI 10.1016/S0074-7696(08)62171-3; Yu DH, 2003, J NEUROSCI, V23, P64	30	320	328	1	58	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 16	2004	431	7006					316	320		10.1038/nature02897	http://dx.doi.org/10.1038/nature02897			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	853XJ	15372035				2022-12-28	WOS:000223864000043
J	Lawrence, JS; Ashley, MCB; Tokovinin, A; Travouillon, T				Lawrence, JS; Ashley, MCB; Tokovinin, A; Travouillon, T			Exceptional astronomical seeing conditions above Dome C in Antarctica	NATURE			English	Article							TURBULENCE PROFILE; ADAPTIVE OPTICS	One of the most important considerations when planning the next generation of ground-based optical astronomical telescopes is to choose a site that has excellent 'seeing'-the jitter in the apparent position of a star that is caused by light bending as it passes through regions of differing refractive index in the Earth's atmosphere. The best mid-latitude sites have a median seeing ranging from 0.5 to 1.0 arcsec (refs 1-5). Sites on the Antarctic plateau have unique atmospheric properties that make them worth investigating as potential observatory locations. Previous testing at the US Amundsen-Scott South Pole Station has, however, demonstrated poor seeing, averaging 1.8 arcsec (refs 6, 7). Here we report observations of the wintertime seeing from Dome C (ref. 8), a high point on the Antarctic plateau at a latitude of 75 degrees S. The results are remarkable: the median seeing is 0.27 arcsec, and below 0.15 arcsec 25 per cent of the time. A telescope placed at Dome C would compete with one that is 2 to 3 times larger at the best mid-latitude observatories, and an interferometer based at this site could work on projects that would otherwise require a space mission.	Univ New S Wales, Sch Phys, Sydney, NSW 2052, Australia; Cerro Tololo Interamer Observ, La Serena, Chile	University of New South Wales Sydney; National Optical Astronomy Observatory	Ashley, MCB (corresponding author), Univ New S Wales, Sch Phys, Sydney, NSW 2052, Australia.	m.ashley@unsw.edu.au	Tokovinin, Andrei/AAG-3702-2020	Tokovinin, Andrei/0000-0002-2084-0782; Lawrence, Jon/0000-0002-6998-6993; Travouillon, Tony/0000-0001-9304-6718; Ashley, Michael/0000-0003-1412-2028				Aristidi E, 2003, ASTRON ASTROPHYS, V406, pL19, DOI 10.1051/0004-6361:20030836; ARISTIDI E, UNPUB ASTRON ASTROPH; Ashley MCB, 1996, PUBL ASTRON SOC PAC, V108, P721, DOI 10.1086/133792; ASHLEY MCB, ASP C SER, V13; Avila R, 2003, REV MEX AST ASTR, V19, P11; BECKERS JM, 1993, ANNU REV ASTRON ASTR, V31, P13, DOI 10.1146/annurev.aa.31.090193.000305; Candidi M., 2003, MEM SOC ASTRON ITAL, V74, P29; CHAININ M, 2003, MEM SOC ASTRON IT S, V2, P19; Chamberlain MA, 2000, ASTROPHYS J, V535, P501, DOI 10.1086/308843; CHAMBERLIN RA, 1994, APPL OPTICS, V33, P1095, DOI 10.1364/AO.33.001095; Ellerbroek BL, 1998, PUBL ASTRON SOC PAC, V110, P165, DOI 10.1086/316120; Gillingham P.R., 1993, ANARE RES NOTES, V88, P290; Kornilov V, 2003, PROC SPIE, V4839, P837, DOI 10.1117/12.457982; Lawrence JS, 2004, PUBL ASTRON SOC PAC, V116, P482, DOI 10.1086/420757; LAWRENCE JS, IN PRESS J ELECT ELE; Marks RD, 2002, ASTRON ASTROPHYS, V385, P328, DOI 10.1051/0004-6361:20020132; Marks RD, 1999, ASTRON ASTROPHYS SUP, V134, P161, DOI 10.1051/aas:1999100; Michel R, 2003, REV MEX AST ASTR, V19, P37; MunozTunon C, 1997, ASTRON ASTROPHYS SUP, V125, P183, DOI 10.1051/aas:1997216; *NAT ASTR OBS JAP, 2003, SUB TEL SEEING; *NAT OPT ASTR OBS, 2004, MASS DAT ACC; RACINE R, 1995, P SOC PHOTO-OPT INS, V2534, P248, DOI 10.1117/12.217743; Sarazin M. S., 1999, ASTROCLIMATOLOGY PAR; Tokovinin A, 2002, APPL OPTICS, V41, P957, DOI 10.1364/AO.41.000957; Tokovinin A, 2003, MON NOT R ASTRON SOC, V343, P891, DOI 10.1046/j.1365-8711.2003.06731.x; Tokovinin A, 2003, MON NOT R ASTRON SOC, V340, P52, DOI 10.1046/j.1365-8711.2003.06231.x; Travouillon T, 2003, ASTRON ASTROPHYS, V409, P1169, DOI 10.1051/0004-6361:20031170; Travouillon T, 2003, ASTRON ASTROPHYS, V400, P1163, DOI 10.1051/0004-6361:20021814; TRAVOUILLON T, UNPUB GEOPHYS RES LE; VERNIN J, 1994, ASTRON ASTROPHYS, V284, P311	30	247	261	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 16	2004	431	7006					278	281		10.1038/nature02929	http://dx.doi.org/10.1038/nature02929			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	853XJ	15372024				2022-12-28	WOS:000223864000032
J	Daly, MJ; Gaidamakova, EK; Matrosova, VY; Vasilenko, A; Zhai, M; Venkateswaran, A; Hess, M; Omelchenko, MV; Kostandarithes, HM; Makarova, KS; Wackett, LP; Fredrickson, JK; Ghosal, D				Daly, MJ; Gaidamakova, EK; Matrosova, VY; Vasilenko, A; Zhai, M; Venkateswaran, A; Hess, M; Omelchenko, MV; Kostandarithes, HM; Makarova, KS; Wackett, LP; Fredrickson, JK; Ghosal, D			Accumulation of Mn(II) in, Deinococcus radiodurans facilitates gamma-radiation resistance	SCIENCE			English	Article							IONIZING-RADIATION; MICROCOCCUS-RADIODURANS; SUPEROXIDE-DISMUTASE; TARGETED MUTAGENESIS; HYDROGEN-PEROXIDE; GENOME SEQUENCE; BACTERIUM; IRON; DNA; RADIORESISTANCE	Deinococcus radiodurans is extremely resistant to ionizing radiation. How this bacterium can grow under chronic gamma radiation [50 grays (Gy) per hour] or recover from acute doses greater than 10 kGy is unknown. We show that D. radiodurans accumulates very high intracellular manganese and low iron levels compared with radiation-sensitive bacteria and that resistance exhibits a concentration-dependent response to manganous chloride [Mn(II)]. Among the most radiation-resistant bacterial groups reported, Deinococcus, Enterococcus, Lactobacillus, and cyanobacteria accumulate Mn(II). in contrast, Shewanella oneidensis and Pseudomonas putida have high iron but low intracellular manganese concentrations and are very sensitive. We propose that Mn(II) accumulation facilitates recovery from radiation injury.	Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA; NIH, Bethesda, MD 20894 USA; Pacific NW Natl Lab, Richland, WA 99352 USA; Univ Minnesota, St Paul, MN 55108 USA	Uniformed Services University of the Health Sciences - USA; National Institutes of Health (NIH) - USA; United States Department of Energy (DOE); Pacific Northwest National Laboratory; University of Minnesota System; University of Minnesota Twin Cities	Daly, MJ (corresponding author), Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA.	mdaly@usuhs.mil	Matrosova, Vera/AAX-4125-2020; Hess, Matthias/R-3006-2017; Hess, Matthias/B-1783-2012	Hess, Matthias/0000-0003-0321-0380; 				ARCHIBALD FS, 1986, INFECT IMMUN, V51, P631, DOI 10.1128/IAI.51.2.631-641.1986; Billi D, 2000, APPL ENVIRON MICROB, V66, P1489, DOI 10.1128/AEM.66.4.1489-1492.2000; DALY MJ, 1994, J BACTERIOL, V176, P3508, DOI 10.1128/JB.176.12.3508-3517.1994; Daly MJ, 1996, J BACTERIOL, V178, P4461, DOI 10.1128/jb.178.15.4461-4471.1996; GUTMAN PD, 1993, J BACTERIOL, V175, P3581, DOI 10.1128/jb.175.11.3581-3590.1993; HANSEN MT, 1978, J BACTERIOL, V134, P71, DOI 10.1128/JB.134.1.71-75.1978; HASTINGS JW, 1986, APPL ENVIRON MICROB, V52, P898, DOI 10.1128/AEM.52.4.898-901.1986; Heidelberg JF, 2002, NAT BIOTECHNOL, V20, P1118, DOI 10.1038/nbt749; Imlay JA, 2003, ANNU REV MICROBIOL, V57, P395, DOI 10.1146/annurev.micro.57.030502.090938; Jakubovics NS, 2001, MICROBIOL-SGM, V147, P1709, DOI 10.1099/00221287-147-7-1709; Keren N, 2002, BIOCHEMISTRY-US, V41, P15085, DOI 10.1021/bi026892s; LEIBOWITZ PJ, 1976, PHOTOCHEM PHOTOBIOL, V23, P45; Levin-Zaidman S, 2003, SCIENCE, V299, P254, DOI 10.1126/science.1077865; Liu YQ, 2003, P NATL ACAD SCI USA, V100, P4191, DOI 10.1073/pnas.0630387100; Makarova KS, 2001, MICROBIOL MOL BIOL R, V65, P44, DOI 10.1128/MMBR.65.1.44-79.2001; Markillie LM, 1999, J BACTERIOL, V181, P666, DOI 10.1128/JB.181.2.666-669.1999; Mattimore V, 1996, J BACTERIOL, V178, P633, DOI 10.1128/jb.178.3.633-637.1996; Mehr IJ, 1998, MOL MICROBIOL, V30, P697, DOI 10.1046/j.1365-2958.1998.01089.x; OYAIZU H, 1987, INT J SYST BACTERIOL, V37, P62, DOI 10.1099/00207713-37-1-62; Posey JE, 2000, SCIENCE, V288, P1651, DOI 10.1126/science.288.5471.1651; Reelfs O, 2004, J INVEST DERMATOL, V122, P1440, DOI 10.1111/j.0022-202X.2004.22620.x; REPINE JE, 1981, P NATL ACAD SCI-BIOL, V78, P1001, DOI 10.1073/pnas.78.2.1001; THORNLEY MJ, 1965, ARCH MIKROBIOL, V51, P267, DOI 10.1007/BF00408143; van Gerwen SJC, 1999, J FOOD PROTECT, V62, P1024, DOI 10.4315/0362-028X-62.9.1024; Venkateswaran A, 2000, APPL ENVIRON MICROB, V66, P2620, DOI 10.1128/AEM.66.6.2620-2626.2000; WANG P, 1995, CAN J MICROBIOL, V41, P170, DOI 10.1139/m95-023; White O, 1999, SCIENCE, V286, P1571, DOI 10.1126/science.286.5444.1571	27	458	481	5	123	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 5	2004	306	5698					1025	1028		10.1126/science.1103185	http://dx.doi.org/10.1126/science.1103185			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	869RG	15459345				2022-12-28	WOS:000225001100041
J	Liaw, YF; Sung, JJY; Chow, WC; Farrell, G; Lee, CZ; Yuen, H; Tanwandee, T; Tao, QM; Shue, K; Keene, ON; Dixon, JS; Gray, DF; Sabbat, J				Liaw, YF; Sung, JJY; Chow, WC; Farrell, G; Lee, CZ; Yuen, H; Tanwandee, T; Tao, QM; Shue, K; Keene, ON; Dixon, JS; Gray, DF; Sabbat, J		Cirrhosis Asian Lamivudine Multice	Lamivudine for patients with chronic hepatitis B and advanced liver disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							E-ANTIGEN SEROCONVERSION; TERM FOLLOW-UP; HEPATOCELLULAR-CARCINOMA; INTERFERON THERAPY; PROGNOSTIC FACTORS; NATURAL COURSE; UNITED-STATES; CIRRHOSIS; VIRUS; SURVIVAL	BACKGROUND: The effectiveness of antiviral therapy in preventing disease progression in patients with chronic hepatitis B and advanced fibrosis or cirrhosis is unknown. METHODS: Patients with chronic hepatitis B who had histologically confirmed cirrhosis or advanced fibrosis were randomly assigned in a 2:1 ratio to receive lamivudine (100 mg per day) or placebo for a maximum of five years. Of 651 patients, 436 were assigned to receive lamivudine and 215 to receive placebo. The primary end point was time to disease progression, defined by hepatic decompensation, hepatocellular carcinoma, spontaneous bacterial peritonitis, bleeding gastroesophageal varices, or death related to liver disease. An independent data and safety monitoring board monitored the progress of the study and performed interim analyses of the data. RESULTS: We randomly assigned 651 patients (98 percent Asian and 85 percent male) to receive lamivudine or placebo. The study was terminated after a median duration of treatment of 32.4 months (range, 0 to 42) owing to a significant difference between treatment groups in the number of end points reached. End points were reached by 7.8 percent of the patients receiving lamivudine and 17.7 percent of those receiving placebo (hazard ratio for disease progression, 0.45; P=0.001). The Child-Pugh score increased in 3.4 percent of the patients receiving lamivudine and 8.8 percent of those receiving placebo (hazard ratio, 0.45; P=0.02), whereas hepatocellular carcinoma occurred in 3.9 percent of those in the lamivudine group and 7.4 percent of those in the placebo group (hazard ratio, 0.49; P=0.047). Genotypic resistance YMDD mutations developed in 49 percent of the patients treated with lamivudine, and the Child-Pugh score was more likely to increase in patients with these mutations than in the other patients treated with lamivudine (7 percent vs. <1 percent). Overall, 12 percent of the patients in the lamivudine group and 18 percent of the patients in the placebo group reported serious adverse events. CONCLUSIONS: Continuous treatment with lamivudine delays clinical progression in patients with chronic hepatitis B and advanced fibrosis or cirrhosis by significantly reducing the incidence of hepatic decompensation and the risk of hepatocellular carcinoma.	Chang Gung Mem Hosp & Univ, Liver Res Unit, Taipei 105, Taiwan; Prince Wales Hosp, Hong Kong, Hong Kong, Peoples R China; Singapore Gen Hosp, Singapore 0316, Singapore; Westmead Millennium Inst, Storr Liver Unit, Sydney, NSW, Australia; Univ Sydney, Sydney, NSW 2006, Australia; Natl Taiwan Univ, Coll Med, Taipei, Taiwan; Univ Hosp, Taipei, Taiwan; Princess Margaret Hosp, Hong Kong, Hong Kong, Peoples R China; Siriraj Hosp, Bangkok, Thailand; Peoples Hosp, Beijing, Peoples R China; GlaxosmithKline, Singapore, Singapore; GlaxosmithKline, Greenford, Middx, England	Chang Gung Memorial Hospital; Chinese University of Hong Kong; Prince of Wales Hospital; Singapore General Hospital; University of Sydney; Westmead Institute for Medical Research; University of Sydney; National Taiwan University; Mahidol University; GlaxoSmithKline; GlaxoSmithKline	Liaw, YF (corresponding author), Chang Gung Mem Hosp & Univ, Liver Res Unit, 199 Tung Hwa N Rd, Taipei 105, Taiwan.	liveryfl@so-net.net.tw	Liaw, Yun-Fan/B-4305-2009; Sung, Joseph J. Y./R-3203-2018; Tanwandee, Tawesak/AAR-6459-2020	Sung, Joseph J. Y./0000-0003-3125-5199; Tanwandee, Tawesak/0000-0001-7634-0843; Sullivan, Mark/0000-0003-3049-1034; Keene, Oliver/0000-0003-0016-9773				BEASLEY RP, 1988, CANCER, V61, P1942, DOI 10.1002/1097-0142(19880515)61:10<1942::AID-CNCR2820611003>3.0.CO;2-J; BEASLEY RP, 1981, LANCET, V2, P1129; COX DR, 1972, J R STAT SOC B, V34, P187; DEJONGH FE, 1992, GASTROENTEROLOGY, V103, P1630, DOI 10.1016/0016-5085(92)91188-A; Dienstag JL, 1999, NEW ENGL J MED, V341, P1256, DOI 10.1056/NEJM199910213411702; Dienstag JL, 2003, GASTROENTEROLOGY, V124, P105, DOI 10.1053/gast.2003.50013; EVERHART JE, 1992, GASTROENTEROLOGY, V103, P1692, DOI 10.1016/0016-5085(92)91198-D; FATTOVICH G, 1991, GUT, V32, P294, DOI 10.1136/gut.32.3.294; Fontana RJ, 2003, SEMIN LIVER DIS, V23, P89, DOI 10.1055/s-2003-37591; Freedman L S, 1982, Stat Med, V1, P121, DOI 10.1002/sim.4780010204; Goodman Z., 1999, Journal of Hepatology, V30, P59; Hsu YS, 2002, HEPATOLOGY, V35, P1522, DOI 10.1053/jhep.2002.33638; Hui JM, 2002, AM J GASTROENTEROL, V97, P1003, DOI 10.1111/j.1572-0241.2002.05621.x; Lai CL, 1998, NEW ENGL J MED, V339, P61, DOI 10.1056/NEJM199807093390201; Lai CL, 2003, CLIN INFECT DIS, V36, P687, DOI 10.1086/368083; Lampertico P, 2003, HEPATOLOGY, V37, P756, DOI 10.1053/jhep.2003.50148; Leung NWY, 2001, HEPATOLOGY, V33, P1527, DOI 10.1053/jhep.2001.25084; Liaw YF, 1999, HEPATOLOGY, V30, P567, DOI 10.1002/hep.510300221; LIAW YF, 1989, LIVER, V9, P235; LIAW YF, 1988, HEPATOLOGY, V8, P493, DOI 10.1002/hep.1840080310; Liaw YF, 2003, J GASTROEN HEPATOL, V18, P239, DOI 10.1046/j.1440-1746.2003.03037.x; Lin SM, 1999, HEPATOLOGY, V29, P971, DOI 10.1002/hep.510290312; LO KJ, 1982, J INFECT DIS, V146, P205, DOI 10.1093/infdis/146.2.205; Lok ASF, 2001, HEPATOLOGY, V34, P1225, DOI 10.1053/jhep.2001.29401; Manigold Tobias, 2003, Hepatology, V37, P707; Niederau C, 1996, NEW ENGL J MED, V334, P1422, DOI 10.1056/NEJM199605303342202; Perrillo R, 2004, GASTROENTEROLOGY, V126, P81, DOI 10.1053/j.gastro.2003.10.050; Perrillo RP, 2001, HEPATOLOGY, V33, P424, DOI 10.1053/jhep.2001.21554; REALDI G, 1994, J HEPATOL, V21, P656, DOI 10.1016/S0168-8278(94)80115-0; Velazquez RF, 2003, HEPATOLOGY, V37, P520, DOI 10.1053/jhep.2003.50093; WEISSBERG JI, 1984, ANN INTERN MED, V101, P613, DOI 10.7326/0003-4819-101-5-613; Whitehead J, 1997, DESIGN ANAL SEQUENTI; *WHO, 2000, HEP B FACT SHEET WHO; Yang HI, 2002, NEW ENGL J MED, V347, P168, DOI 10.1056/NEJMoa013215; Yuen MF, 2001, HEPATOLOGY, V34, P139, DOI 10.1053/jhep.2001.25273	35	1765	1898	2	104	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 7	2004	351	15					1521	1531		10.1056/NEJMoa033364	http://dx.doi.org/10.1056/NEJMoa033364			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	859UP	15470215				2022-12-28	WOS:000224293700010
J	Tu, DC; Batten, ML; Palczewski, K; Van Gelder, RN				Tu, DC; Batten, ML; Palczewski, K; Van Gelder, RN			Nonvisual photoreception in the chick iris	SCIENCE			English	Article							BLUE-LIGHT PHOTORECEPTORS; PROTEIN-KINASES; SMOOTH-MUSCLE; MICE; CRYPTOCHROMES; PHOTOSENSITIVITY; STAUROSPORINE; CONTRACTION; MELANOPSIN; RESPONSES	The embryonic chicken iris constricts to light ex vivo, but with characteristics atypical of visual phototransduction. The chick iris was most sensitive to short-wavelength light, demonstrating an action spectrum consistent with cryptochrome rather than with opsin pigments. Pupillary responses did not attenuate after saturating light exposure, but showed paradoxical potentiation. Iris photosensitivity was not affected by retinoid depletion or inhibitors of visual phototransduction. Knockdown of cryptochrome expression, but not of melanopsin expression, decreased iris photosensitivity. These data characterize a non-opsin photoreception mechanism in a vertebrate eye and suggest a conserved photoreceptive role for cryptochromes in vertebrates.	Washington Univ, Sch Med, Dept Ophthalmol & Visual Sci, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Mol Biol & Pharmacol, St Louis, MO 63110 USA; Univ Washington, Dept Ophthalmol, Seattle, WA 98195 USA; Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA; Univ Washington, Dept Chem, Seattle, WA 98195 USA	Washington University (WUSTL); Washington University (WUSTL); University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Van Gelder, RN (corresponding author), Washington Univ, Sch Med, Dept Ophthalmol & Visual Sci, St Louis, MO 63110 USA.	Vangelder@vision.wustl.edu	Van Gelder, Russell/ABB-4225-2021	Van Gelder, Russell/0000-0001-5368-3659				Abdel-Latif AA, 2001, EXP BIOL MED, V226, P153, DOI 10.1177/153537020122600302; BARR L, 1963, J GEN PHYSIOL, V46, P1249, DOI 10.1085/jgp.46.6.1249; Berson DM, 2002, SCIENCE, V295, P1070, DOI 10.1126/science.1067262; Brown-Sequard E., 1847, CR HEBD ACAD SCI, V25, P482; Cashmore AR, 2003, CELL, V114, P537, DOI 10.1016/j.cell.2003.08.004; DEGUCHI T, 1981, NATURE, V290, P706, DOI 10.1038/290706a0; Hattar S, 2003, NATURE, V424, P76, DOI 10.1038/nature01761; Hsu DS, 1996, BIOCHEMISTRY-US, V35, P13871, DOI 10.1021/bi962209o; Koyanagi M, 2004, P NATL ACAD SCI USA, V101, P6687, DOI 10.1073/pnas.0400819101; Kureishi Y, 1999, EUR J PHARMACOL, V376, P315, DOI 10.1016/S0014-2999(99)00367-2; McBee JK, 2001, J BIOL CHEM, V276, P48483, DOI 10.1074/jbc.M105840200; Moriya T, 1996, J EXP ZOOL, V276, P11, DOI 10.1002/(SICI)1097-010X(19960901)276:1<11::AID-JEZ2>3.3.CO;2-N; Panda S, 2003, SCIENCE, V301, P525, DOI 10.1126/science.1086179; Pasqualetti M, 2003, EUR J NEUROSCI, V18, P364, DOI 10.1046/j.1460-9568.2003.02770.x; PILAR G, 1987, J NEUROSCI, V7, P3813, DOI 10.1523/jneurosci.07-12-03813.1987; RUEGG UT, 1989, TRENDS PHARMACOL SCI, V10, P218, DOI 10.1016/0165-6147(89)90263-0; Sancar A, 2003, CHEM REV, V103, P2203, DOI 10.1021/cr0204348; Selby CP, 2000, P NATL ACAD SCI USA, V97, P14697, DOI 10.1073/pnas.260498597; SOLESSIO E, 1993, NATURE, V364, P442, DOI 10.1038/364442a0; THASTRUP O, 1989, AGENTS ACTIONS, V27, P17, DOI 10.1007/BF02222186; TU DC, UNPUB; Van Gelder RN, 2003, SCIENCE, V299, P222, DOI 10.1126/science.1079536; Worthington EN, 2003, J BIOL CHEM, V278, P39143, DOI 10.1074/jbc.M305792200	23	48	49	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 1	2004	306	5693					129	131		10.1126/science.1101484	http://dx.doi.org/10.1126/science.1101484			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	859YJ	15459395				2022-12-28	WOS:000224304000053
J	Westhof, E; Massire, C				Westhof, E; Massire, C			Evolution of RNA architecture	SCIENCE			English	Editorial Material							LARGE RIBOSOMAL-SUBUNIT; RIBONUCLEASE-P; CRYSTAL-STRUCTURE; SEQUENCE; GENOMICS; RIBOZYME; DOMAIN		Univ Strasbourg, CNRS, Inst Biol Mol & Cellulaire, F-67084 Strasbourg, France; Ibis Therapeut, Carlsbad, CA 92008 USA	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Westhof, E (corresponding author), Univ Strasbourg, CNRS, Inst Biol Mol & Cellulaire, F-67084 Strasbourg, France.	e.westhof@ibmc.u-strasbg.fr; cmassire@isisph.com						Adams PL, 2004, NATURE, V430, P45, DOI 10.1038/nature02642; Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Chen JL, 1998, EMBO J, V17, P1515, DOI 10.1093/emboj/17.5.1515; Dorsett Y, 2004, NAT REV DRUG DISCOV, V3, P318, DOI 10.1038/nrd1345; GUERRIERTAKADA C, 1983, CELL, V35, P849, DOI 10.1016/0092-8674(83)90117-4; GUO F, IN PRESS MOL CELL; JAMES BD, 1988, CELL, V52, P19, DOI 10.1016/0092-8674(88)90527-2; Khvorova A, 2003, NAT STRUCT BIOL, V10, P708, DOI 10.1038/nsb959; Krasilnikov AS, 2004, SCIENCE, V306, P104, DOI 10.1126/science.1101489; Krasilnikov AS, 2003, NATURE, V421, P760, DOI 10.1038/nature01386; KRUGER K, 1982, CELL, V31, P147, DOI 10.1016/0092-8674(82)90414-7; Loria A, 1996, RNA, V2, P551; Massire C, 1998, J MOL BIOL, V279, P773, DOI 10.1006/jmbi.1998.1797; Nissen P, 2001, P NATL ACAD SCI USA, V98, P4899, DOI 10.1073/pnas.081082398; Wimberly BT, 2000, NATURE, V407, P327, DOI 10.1038/35030006	16	16	16	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 1	2004	306	5693					62	63		10.1126/science.1104482	http://dx.doi.org/10.1126/science.1104482			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	859YJ	15459373				2022-12-28	WOS:000224304000030
J	Puck, JM; Straus, SE				Puck, JM; Straus, SE			Somatic mutations - Not just for cancer anymore	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME; APOPTOSIS		NHGRI, Genet & Mol Biol Branch, NIH, Bethesda, MD 20892 USA; NIAID, Lab Clin Infect Dis, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Puck, JM (corresponding author), NHGRI, Genet & Mol Biol Branch, NIH, Bethesda, MD 20892 USA.				NATIONAL HUMAN GENOME RESEARCH INSTITUTE [Z01HG000116] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000732, Z01AI000732] Funding Source: NIH RePORTER	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		FISHER GH, 1995, CELL, V81, P935, DOI 10.1016/0092-8674(95)90013-6; RIEUXLAUCAT F, 1995, SCIENCE, V268, P1347, DOI 10.1126/science.7539157; Schwartz RS, 2004, NEW ENGL J MED, V350, P537, DOI 10.1056/NEJMp038223; SNELLER MC, 1992, J CLIN INVEST, V90, P334, DOI 10.1172/JCI115867; Straus SE, 2001, BLOOD, V98, P194, DOI 10.1182/blood.V98.1.194	5	19	19	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 30	2004	351	14					1388	1390		10.1056/NEJMp048116	http://dx.doi.org/10.1056/NEJMp048116			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	857XT	15459299				2022-12-28	WOS:000224153900006
J	Tata, J				Tata, J			The domino effect	NATURE			English	Editorial Material									Natl Inst Med Res, London NW7 1AA, England	MRC National Institute for Medical Research	Tata, J (corresponding author), Natl Inst Med Res, Mill Hill, London NW7 1AA, England.								0	0	0	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 30	2004	431	7008					513	513		10.1038/431513a	http://dx.doi.org/10.1038/431513a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	857YP	15457238				2022-12-28	WOS:000224156700020
J	Mittendorfer-Rutz, E; Rasmussen, F; Wasserman, D				Mittendorfer-Rutz, E; Rasmussen, F; Wasserman, D			Restricted fetal growth and adverse maternal psychosocial and socioeconomic conditions as risk factors for suicidal behaviour of offspring: a cohort study	LANCET			English	Article							28-YEAR FOLLOW-UP; BODY-MASS INDEX; BIRTH COHORT; PERINATAL COMPLICATIONS; PSYCHIATRIC-DISORDERS; ADOLESCENT SUICIDE; PRENATAL EXPOSURE; EARLY ADULTHOOD; SCHIZOPHRENIA; ASSOCIATION	Background Until now, sparse and contradictory results about an association between adverse neonatal, obstetric, and maternal conditions and heightened suicide risk in adolescents have been reported. The aims of this study were to investigate the relations between fetal growth, obstetric complications, and the mother's psychosocial and socioeconomic situation and the risk in early adulthood of suicide and attempted suicide in the offspring. Methods Obstetric, neonatal, and maternal risk factors for suicide and attempted suicide in 713 370 young adults, born in Sweden between 1973 and 1980, who were followed-up until Dec 31, 1999, were examined by data linkage between Swedish registers. Univariate and multivariate hazard ratios, derived from proportional-hazard models, were estimated. Findings Significantly raised risk of attempted suicide was reported for individuals of short birth length, adjusted for gestational age (hazard ratio 1.29, 95% Cl 1.18-1.41, p < 0.0001); born fourth or more in birth order (1.79, 1.62-1.97, p < 0.0001); born to mothers with a low educational level (1.36, 1.27-1.46, p < 0.0001) (attributable proportion 10.3%); and those who, at time of delivery, had mothers aged 19 years or younger (2.09, 1.89-2.32, p < 0.0001). Significant predictors of suicide were low birthweight, adjusted for gestational age (2.23, 1.43-3.46, p < 0.0001), and teenage motherhood (2.30, 1.64-3.22, p < 0.0001). Interpretation Multiparity and low maternal education predicted suicide attempt, whereas restricted fetal growth and teenage motherhood were associated with both suicide completion and attempt in offspring.	Natl Inst Psychosocial Med, Ctr Suicide Res & Prevent Mental Ill Hlth, Swedish Natl & Stockholm Cty Council, Stockholm, Sweden; Karolinska Inst, Dept Publ Hlth Sci, Stockholm, Sweden	Karolinska Institutet	Wasserman, D (corresponding author), Natl Ctr Suicide Res & Prevent Mental Ill Hlth, Box 230, SE-17177 Stockholm, Sweden.	Danuta.Wasserman@ipm.ki.se		Rasmussen, Finn/0000-0001-7915-7809				Aberg A, 1992, Int J Technol Assess Health Care, V8 Suppl 1, P20; ALLEBECK P, 1991, SCAND J SOC MED, V19, P242, DOI 10.1177/140349489101900405; ALLEBECK P, 1992, PUBLIC HEALTH, V106, P375, DOI 10.1016/S0033-3506(05)80186-6; ANDREWS JA, 1992, J AM ACAD CHILD PSY, V31, P655, DOI 10.1097/00004583-199207000-00012; BARKER DJP, 1995, BRIT MED J, V311, P1203, DOI 10.1136/bmj.311.7014.1203; Bennedsen BE, 1999, BRIT J PSYCHIAT, V175, P239, DOI 10.1192/bjp.175.3.239; BROWN AS, 1995, BRIT J PSYCHIAT, V166, P601, DOI 10.1192/bjp.166.5.601; CNATTINGIUS S, 1990, SCAND J SOC MED, V18, P143, DOI 10.1177/140349489001800209; Fergusson DM, 1999, J CHILD PSYCHOL PSYC, V40, P479, DOI 10.1111/1469-7610.00464; Gale CR, 2004, BRIT J PSYCHIAT, V184, P28, DOI 10.1192/bjp.184.1.28; Godfrey KM, 2000, AM J CLIN NUTR, V71, p1344S, DOI 10.1093/ajcn/71.5.1344s; Gunther N, 2003, SOC PSYCH PSYCH EPID, V38, P101, DOI 10.1007/s00127-003-0607-6; Hosmer D. W., 1999, APPL SURVIVAL ANAL; Jiang GX, 1999, ACTA PSYCHIAT SCAND, V100, P433, DOI 10.1111/j.1600-0447.1999.tb10893.x; Jones PB, 1998, AM J PSYCHIAT, V155, P355, DOI 10.1176/ajp.155.3.355; Kemppainen L, 2000, SOC PSYCH PSYCH EPID, V35, P104, DOI 10.1007/s001270050191; Kessler RC, 1997, AM J PSYCHIAT, V154, P1405; Lawrence C, 1989, Acta Paediatr Scand Suppl, V350, P55; LEWINSOHN PM, 1994, J CONSULT CLIN PSYCH, V62, P297, DOI 10.1037/0022-006X.62.2.297; Li CI, 2003, PAEDIATR PERINAT EP, V17, P164, DOI 10.1046/j.1365-3016.2003.00487.x; Madge N, 1999, EUR CHILD ADOLES PSY, V8, P283, DOI 10.1007/s007870050103; Neugebauer R, 1999, JAMA-J AM MED ASSOC, V282, P455, DOI 10.1001/jama.282.5.455; Neugebauer R, 1998, ACTA PSYCHIAT SCAND, V97, P412, DOI 10.1111/j.1600-0447.1998.tb10024.x; Nilsson PM, 2001, INT J EPIDEMIOL, V30, P75, DOI 10.1093/ije/30.1.75; Olausson PO, 2001, FAM PLANN PERSPECT, V33, P70, DOI 10.2307/2673752; SALK L, 1985, LANCET, V1, P624; Wahlbeck K, 2001, ARCH GEN PSYCHIAT, V58, P48, DOI 10.1001/archpsyc.58.1.48; Walker A, 1999, CHILD ADOL PSYCH CL, V8, P845	28	127	128	0	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 25	2004	364	9440					1135	1140		10.1016/S0140-6736(04)17099-2	http://dx.doi.org/10.1016/S0140-6736(04)17099-2			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	857FT	15451220				2022-12-28	WOS:000224102400026
J	Blackburn, TM; Cassey, P; Duncan, RP; Evans, KL; Gaston, KJ				Blackburn, TM; Cassey, P; Duncan, RP; Evans, KL; Gaston, KJ			Avian extinction and mammalian introductions on oceanic islands	SCIENCE			English	Article							PREHISTORIC EXTINCTIONS; PATTERNS; BIRDS	The arrival of humans on oceanic islands has precipitated a wave of extinctions among the islands' native birds. Nevertheless, the magnitude of this extinction event varies markedly between avifaunas. We show that the probability that a bird species has been extirpated from each of 220 oceanic islands is positively correlated with the number of exotic predatory mamma[ species established on those islands after European colonization and that the effect of these predators is greater on island endemic species. In contrast, the proportions of currently threatened species are independent of the numbers of exotic mammalian predator species, suggesting that the principal threat to island birds has changed through time as species susceptible to exotic predators have been driven extinct.	Univ Birmingham, Sch Biosci, Birmingham B15 2TT, W Midlands, England; Lincoln Univ, Bioprotect & Ecol Div, Lincoln, New Zealand; Landcare Res, Lincoln, New Zealand; Univ Sheffield, Dept Anim & Plant Sci, Biodivers & Macroecol Grp, Sheffield S10 2TN, S Yorkshire, England	University of Birmingham; Lincoln University - New Zealand; Landcare Research - New Zealand; University of Sheffield	Blackburn, TM (corresponding author), Univ Birmingham, Sch Biosci, Birmingham B15 2TT, W Midlands, England.	t.blackburn@bham.ac.uk	Bond, Alexander L/A-3786-2010; Blackburn, Tim/AAC-3144-2019; Blackburn, Tim M/A-7685-2011; Duncan, Richard/ABD-4099-2020; Duncan, Richard P/E-7899-2013	Blackburn, Tim/0000-0003-0152-2663; Duncan, Richard/0000-0003-2295-449X; Duncan, Richard P/0000-0003-2295-449X; Cassey, Phillip/0000-0002-2626-0172				Ashmole NP, 1994, SEABIRDS ISLANDS THR, P94; Atkinson I., 2000, INVASIVE SPECIES PAC, P19; ATKINSON IAE, 1985, CONSERVATION ISLAND, P35; Balmford A, 1996, TRENDS ECOL EVOL, V11, P193, DOI 10.1016/0169-5347(96)10026-4; Biber E, 2002, ECOGRAPHY, V25, P661, DOI 10.1034/j.1600-0587.2002.t01-1-250603.x; Blackburn TM, 2004, ECOGRAPHY, V27, P124, DOI 10.1111/j.0906-7590.2004.03775.x; Burnham KP, 2001, WILDLIFE RES, V28, P111, DOI 10.1071/WR99107; Case TJ, 1996, BIOL CONSERV, V78, P69, DOI 10.1016/0006-3207(96)00019-5; Cassels R., 1984, P741; Curnutt J, 2001, STUD AVIAN BIOL-SER, P15; Diamond J.M., 1984, P824; Diamond J.M., 1984, P191; DIAMOND JM, 1989, PHILOS T ROY SOC B, V325, P469, DOI 10.1098/rstb.1989.0100; FLANNERTY TF, 1994, FUTURE EATERS; GASTON KJ, 2002, ENCY EVOLUTION, V1, P344; Grayson DK, 2001, J WORLD PREHIST, V15, P1, DOI 10.1023/A:1011165119141; Holdaway Richard N., 1999, P189; Holdaway RN, 2000, SCIENCE, V287, P2250, DOI 10.1126/science.287.5461.2250; Littell R. C., 2006, SAS SYSTEMS MIXED MO, V2nd; *LYNX ED BIRDLIFE, 2000, THREAT BIRDS WORLD; MAC ARTHUR ROBERT H., 1967; MacPhee R.D.E., 1999, EXTINCTIONS NEAR TIM; Martin P.S., 1984, P354; Martin P.S., 1999, EXTINCTIONS NEAR TIM, P17, DOI DOI 10.1007/978-1-4757-5202-1_2; MARTIN PS, 2001, ENCY BIODIVERSITY, V3, P825; Martin PS, 1984, QUATERNARY EXTINCTIO; MILBERG P, 1993, ECOGRAPHY, V16, P229, DOI 10.1111/j.1600-0587.1993.tb00213.x; Pimm Stuart L., 1995, P75; Roberts RG, 2001, SCIENCE, V292, P1888, DOI 10.1126/science.1060264; Roff DA, 2003, EVOL ECOL RES, V5, P759; STEADMAN DW, 1995, SCIENCE, V267, P1123, DOI 10.1126/science.267.5201.1123; Tilman D, 1997, P NATL ACAD SCI USA, V94, P1857, DOI 10.1073/pnas.94.5.1857	32	560	590	5	228	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 24	2004	305	5692					1955	1958		10.1126/science.1101617	http://dx.doi.org/10.1126/science.1101617			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	857RM	15448269				2022-12-28	WOS:000224136000046
J	Marks, PW; Harris, NL; Zarghamee-Gavami, M; Zukerberg, LR; Wexler, DJ; Axelrod, L				Marks, PW; Harris, NL; Zarghamee-Gavami, M; Zukerberg, LR; Wexler, DJ; Axelrod, L			A 37-year-old woman with paresthesias of the arms and legs - Anatomical diagnosis - Pernicious anemia with autoimmune gastritis and vitamin B12 deficiency.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							COBALAMIN		Brigham & Womens Hosp, Dept Med, Div Hematol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA USA; Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital	Marks, PW (corresponding author), Brigham & Womens Hosp, Dept Med, Div Hematol, Boston, MA 02115 USA.							Carmel R, 1996, ARCH INTERN MED, V156, P1097, DOI 10.1001/archinte.156.10.1097; Carmel R, 2003, BLOOD, V101, P3302, DOI 10.1182/blood-2002-09-2746; Chanarin I, 2000, BRIT J HAEMATOL, V111, P407, DOI 10.1046/j.1365-2141.2000.02238.x; JORGE AD, 1973, GUT, V14, P104, DOI 10.1136/gut.14.2.104; Kaptan K, 2000, ARCH INTERN MED, V160, P1349, DOI 10.1001/archinte.160.9.1349; Kuzminski AM, 1998, BLOOD, V92, P1191, DOI 10.1182/blood.V92.4.1191.416k15_1191_1198; MUIR A, 1991, ENDOCRIN METAB CLIN, V20, P619, DOI 10.1016/S0889-8529(18)30261-5; Pal B, 2002, BRIT MED J, V324, P1501, DOI 10.1136/bmj.324.7352.1501; PRUTHI RK, 1994, MAYO CLIN PROC, V69, P144, DOI 10.1016/S0025-6196(12)61041-6; Snow CF, 1999, ARCH INTERN MED, V159, P1289, DOI 10.1001/archinte.159.12.1289; Toh BH, 1997, NEW ENGL J MED, V337, P1441, DOI 10.1056/NEJM199711133372007; WALL A. J., 1968, CLIN EXP IMMUNOL, V3, P359	12	17	17	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 23	2004	351	13					1333	1341		10.1056/NEJMcpc040921	http://dx.doi.org/10.1056/NEJMcpc040921			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	855TP	15385661				2022-12-28	WOS:000223997700013
J	Weuve, J; Kang, JH; Manson, JE; Breteler, MMB; Ware, JH; Grodstein, F				Weuve, J; Kang, JH; Manson, JE; Breteler, MMB; Ware, JH; Grodstein, F			Physical activity, including walking, and cognitive function in older women	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ALZHEIMERS-DISEASE; IMPAIRMENT; EXERCISE; COMMUNITY; DEMENTIA; HEALTH; AGE; MACARTHUR; DECLINE; POPULATION	Context Physical activity may help maintain cognitive function in older adults. Objective To examine the relation of long-term regular physical activity, including walking, to cognitive function, Design Women reported participation in leisure-time physical activities on biennial mailed questionnaires beginning in 1986. We assessed long-term activity by averaging energy expenditures from questionnaires in 1986 through participants' baseline cognitive assessments (1995 to 2001). We used linear regression to estimate adjusted mean differences in baseline cognitive performance and cognitive decline over 2 years, across levels of physical activity and walking. Setting and Participants Nurses' Health Study, including 18766 US women aged 70 to 81 years. Main Outcome Measure Validated telephone assessments of cognition administered twice approximately 2 years apart (1995 to 2001 and 1997 to 2003), including tests of general cognition, verbal memory, category fluency, and attention. Results Higher levels of activity were associated with better cognitive performance. On a global score combining results of all 6 tests, women in the second through fifth quintiles of energy expenditure scored an average of 0.06, 0.06, 0.09, and 0.10 Standard units higher than women in the lowest quintile (P for trend <.001). Compared with women in the lowest physical activity quintile, we found a 20% lower risk of cognitive impairment for women in the highest quintile of activity. Among women performing the equivalent of walking at an easy pace for at least 1.5 h/wk, mean global scores were 0.06 to 0.07 units higher compared with walking less than 40 min/wk (P <=.003). We also observed less cognitive decline among women who were more active, especially those in the 2 highest quintiles of energy expenditure. Women in the fourth and fifth quintiles had mean changes in global scores that were 0.04 (95% confidence interval, 0.02-0.10) and 0.06 (95% confidence interval, 0.02-0.11) standard units better than those in the lowest quintile. Conclusion Long-term regular physical activity, including walking, is associated with significantly better cognitive function and less cognitive decline in older women.	Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med,Channing Lab, Boston, MA USA; Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med,Div Prevent Med, Boston, MA USA; Erasmus MC, Dept Epidemiol & Biostat, Rotterdam, Netherlands	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Erasmus University Rotterdam; Erasmus MC	Weuve, J (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Landmark Ctr,East Wing,3rd Floor,401 Pk Dr, Boston, MA 02215 USA.	jweuve@hsph.harvard.edu	Breteler, Monique M.B./J-5058-2014	Breteler, Monique M.B./0000-0002-0626-9305	NATIONAL CANCER INSTITUTE [P01CA087969] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG015424] Funding Source: NIH RePORTER; NCI NIH HHS [CA87969] Funding Source: Medline; NIA NIH HHS [AG15424, AG000158] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		AINSWORTH BE, 1993, MED SCI SPORT EXER, V25, P71, DOI 10.1249/00005768-199301000-00011; ALBERT M, 1991, INT J NEUROSCI, V57, P167, DOI 10.3109/00207459109150691; Albert MS, 1995, PSYCHOL AGING, V10, P578, DOI 10.1037/0882-7974.10.4.578; [Anonymous], 1996, PHYS ACT HLTH REP SU, P175; Bennett DA, 2002, NEUROLOGY, V59, P198, DOI 10.1212/WNL.59.2.198; BERKMAN LF, 1993, J CLIN EPIDEMIOL, V46, P1129, DOI 10.1016/0895-4356(93)90112-E; BLACK JE, 1990, P NATL ACAD SCI USA, V87, P5568, DOI 10.1073/pnas.87.14.5568; Brandt J., 1988, NEUROPSY NEUROPSY BE, V1, P111; Bretsky P, 2003, NEUROLOGY, V60, P1077, DOI 10.1212/01.WNL.0000055875.26908.24; Carmelli D, 1997, NEUROEPIDEMIOLOGY, V16, P285, DOI 10.1159/000109699; Chandra V, 1998, J GERIATR PSYCH NEUR, V11, P11, DOI 10.1177/089198879801100104; Chodzko-Zajko W J, 1994, Exerc Sport Sci Rev, V22, P195; Churchill JD, 2002, NEUROBIOL AGING, V23, P941, DOI 10.1016/S0197-4580(02)00028-3; CLARKSONSMITH L, 1990, PSYCHOL AGING, V5, P437; Colcombe S, 2003, PSYCHOL SCI, V14, P125, DOI 10.1111/1467-9280.t01-1-01430; Colditz GA, 1997, J WOMENS HEALTH, V6, P49, DOI 10.1089/jwh.1997.6.49; EMERY CF, 1995, GERONTOLOGIST, V35, P378, DOI 10.1093/geront/35.3.378; Farris W, 2003, P NATL ACAD SCI USA, V100, P4162, DOI 10.1073/pnas.0230450100; GANGULI M, 1993, J GERONTOL, V48, pM152, DOI 10.1093/geronj/48.4.M152; GomezPinilla F, 1997, BRAIN RES, V764, P1, DOI 10.1016/S0006-8993(97)00375-2; Goodglass H, 1983, ASSESSMENT APHASIA; Ho SC, 2001, INT J EPIDEMIOL, V30, P1389, DOI 10.1093/ije/30.6.1389; HULTSCH DF, 1993, J GERONTOL, V48, pP1, DOI 10.1093/geronj/48.1.P1; KAWAS C, 1994, ARCH NEUROL-CHICAGO, V51, P901, DOI 10.1001/archneur.1994.00540210073015; Kawas CH, 2003, NEUROLOGY, V60, P1089, DOI 10.1212/01.WNL.0000055813.36504.BF; Kramer AF, 1999, NATURE, V400, P418, DOI 10.1038/22682; Laurin D, 2001, ARCH NEUROL-CHICAGO, V58, P498, DOI 10.1001/archneur.58.3.498; Lezak M., 1995, NEUROPSYCHOLOGICAL A, P335; LINN RT, 1995, ARCH NEUROL-CHICAGO, V52, P485, DOI 10.1001/archneur.1995.00540290075020; Mulsant BH, 2003, ARCH GEN PSYCHIAT, V60, P198, DOI 10.1001/archpsyc.60.2.198; NEEPER SA, 1995, NATURE, V373, P109, DOI 10.1038/373109a0; ROGERS RL, 1990, J AM GERIATR SOC, V38, P123, DOI 10.1111/j.1532-5415.1990.tb03472.x; SCHERR PA, 1988, AM J EPIDEMIOL, V128, P1084; Schuit AJ, 2001, MED SCI SPORT EXER, V33, P772; Small BJ, 2003, ACTA NEUROL SCAND, V107, P29, DOI 10.1034/j.1600-0404.107.s179.6.x; Small BJ, 2000, ARCH NEUROL-CHICAGO, V57, P839, DOI 10.1001/archneur.57.6.839; Taddei S, 2000, CIRCULATION, V101, P2896, DOI 10.1161/01.CIR.101.25.2896; Thompson PD, 2001, MED SCI SPORT EXER, V33, pS438, DOI 10.1097/00005768-200106001-00012; U.S. Bureau of the Census, 1996, CURR POP REP SPEC ST, P23; van Dam RM, 2002, MED SCI SPORT EXER, V34, P1132, DOI 10.1097/00005768-200207000-00013; van Praag H, 1999, P NATL ACAD SCI USA, V96, P13427, DOI 10.1073/pnas.96.23.13427; Wareham NJ, 2000, AM J EPIDEMIOL, V152, P132, DOI 10.1093/aje/152.2.132; Watson GS, 2003, NEUROLOGY, V60, P1899, DOI 10.1212/01.WNL.0000065916.25128.25; Williams P, 1997, AUST NZ J PUBL HEAL, V21, P45, DOI 10.1111/j.1467-842X.1997.tb01653.x; WOLF AM, 1994, INT J EPIDEMIOL, V23, P991, DOI 10.1093/ije/23.5.991; Yaffe K, 2001, ARCH INTERN MED, V161, P1703, DOI 10.1001/archinte.161.14.1703; Yaffe K, 2001, NEW ENGL J MED, V344, P1207, DOI 10.1056/NEJM200104193441604	47	765	791	0	95	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 22	2004	292	12					1454	1461		10.1001/jama.292.12.1454	http://dx.doi.org/10.1001/jama.292.12.1454			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	856FT	15383516	Bronze			2022-12-28	WOS:000224031800027
J	Levinson, W; Lurie, N				Levinson, W; Lurie, N			When most doctors are women: What lies ahead?	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							PARENTAL LEAVE POLICIES; ACADEMIC MEDICINE; PHYSICIAN GENDER; UNITED-STATES; PRIMARY-CARE; PATIENT; COMMUNICATION; METAANALYSIS; OUTCOMES; VIEWS	The profession of medicine is becoming feminized: The number of women enrolled in medical school and residency programs has increased dramatically over the past several decades. Some researchers have examined how women are faring in the profession, but few have considered how feminization of the profession will affect patient care and health care systems, as well as the profession itself. We predict that notable changes may emerge in 4 domains: the patient-physician relationship, the local delivery of care, the societal delivery of care, and the medical profession itself. We also consider the potential positive and negative consequences of a predominantly female physician workforce on these domains.	Univ Toronto, St Michaels Hosp, Toronto, ON M5B 1W8, Canada; RAND Corp, Arlington, VA USA	University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; RAND Corporation	Levinson, W (corresponding author), Univ Toronto, St Michaels Hosp, 30 Bond St, Toronto, ON M5B 1W8, Canada.	wendy.levinson@utoronto.ca						*ACGME, GEN COMP; *ASS AM MED COLL, 2003, WOM US AC MED STAT; Barr DA, 2001, GENDER SOC, V15, P29, DOI 10.1177/089124301015001003; BATCHELOR AJ, 1990, NEW YORK STATE J MED, V90, P292; Bickel J, 2002, ACAD MED, V77, P1044, DOI 10.1097/00001888-200210000-00023; Cooper LA, 2003, ANN INTERN MED, V139, P907, DOI 10.7326/0003-4819-139-11-200312020-00009; Crandall SJS, 1997, TEACH LEARN MED, V9, P254, DOI 10.1207/s15328015tlm0904_2; CURRAN BA, 1994, LAWYER STAT REPORT U; Curran Barbara A, 1995, WOMEN LAW LOOK NUMBE; Daily CM, 1999, STRATEGIC MANAGE J, V20, P93, DOI 10.1002/(SICI)1097-0266(199901)20:1<93::AID-SMJ18>3.0.CO;2-7; Derose KP, 2001, J GEN INTERN MED, V16, P218, DOI 10.1046/j.1525-1497.2001.016004218.x; Doescher MP, 2000, J RURAL HEALTH, V16, P111, DOI 10.1111/j.1748-0361.2000.tb00444.x; EAGLY AH, 1990, PSYCHOL BULL, V108, P233, DOI 10.1037/0033-2909.108.2.233; Eagly AH, 2003, PSYCHOL BULL, V129, P569, DOI 10.1037/0033-2909.129.4.569; Franks P, 2003, J WOMEN HEALTH GEN-B, V12, P73, DOI 10.1089/154099903321154167; GINZBERG E, 1994, WOMAN PHYS, P135; GREENFIELD S, 1985, ANN INTERN MED, V102, P520, DOI 10.7326/0003-4819-102-4-520; GRISSO JA, 1991, ANN INTERN MED, V114, P43, DOI 10.7326/0003-4819-114-1-43; Hall J A, 1998, J Gend Specif Med, V1, P39; Harden J, 2001, EUR J WOMENS STUD, V8, P181, DOI 10.1177/135050680100800204; Hull KE, 2000, SOC FORCES, V79, P229, DOI 10.2307/2675570; Institute of Medicine, 2001, CROSS QUAL CHASM NEW, P39; KAPLAN RM, 1989, MED CARE, V27, pS27, DOI 10.1097/00005650-198903001-00003; McCormick D, 2004, ARCH INTERN MED, V164, P300, DOI 10.1001/archinte.164.3.300; Nonnemaker L, 2000, NEW ENGL J MED, V342, P399, DOI 10.1056/NEJM200002103420606; PASKO T, 2003, PHYS CHARACTERISTICS; PHILIBERT I, 1995, ACAD MED, V70, P1056, DOI 10.1097/00001888-199511000-00029; Robinson D, 1998, INT LABOUR REV, V137, P3; Roter DL, 2002, JAMA-J AM MED ASSOC, V288, P756, DOI 10.1001/jama.288.6.756; Samuels M E, 2001, J Ambul Care Manage, V24, P84; Sommers LS, 2000, ARCH INTERN MED, V160, P1825, DOI 10.1001/archinte.160.12.1825; Sox HC, 2002, ANN INTERN MED, V136, P243, DOI 10.7326/0003-4819-136-3-200202050-00012; Spenny M L, 2000, J Am Board Fam Pract, V13, P183; STEWART MA, 1995, CAN MED ASSOC J, V152, P1423; TESCH BJ, 1995, JAMA-J AM MED ASSOC, V273, P1022, DOI 10.1001/jama.273.13.1022; UHLENBERG P, 1990, SOC SCI MED, V30, P373, DOI 10.1016/0277-9536(90)90192-U; Wagner EH, 2000, BMJ-BRIT MED J, V320, P569, DOI 10.1136/bmj.320.7234.569; Wallace Amy E, 2002, J Am Med Womens Assoc (1972), V57, P180; Yedidia MJ, 2001, ACAD MED, V76, P453, DOI 10.1097/00001888-200105000-00017	39	127	130	1	10	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 21	2004	141	6					471	474		10.7326/0003-4819-141-6-200409210-00013	http://dx.doi.org/10.7326/0003-4819-141-6-200409210-00013			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	856TM	15381521				2022-12-28	WOS:000224067900008
J	Horton, R				Horton, R			Rediscovering human dignity	LANCET			English	Article							LIFE		Lancet, London NW1 7BY, England		Horton, R (corresponding author), Lancet, 32 Jamestown Rd, London NW1 7BY, England.	richard.horton@lancet.com						[Anonymous], 1999, DEV FREEDOM; Berlin I., 2002, DERS LIBERTY HG HARD, P336; BERLIN I, 1988, NEW YORK REV BO 0317; Chochinov HM, 2002, JAMA-J AM MED ASSOC, V287, P2253, DOI 10.1001/jama.287.17.2253; Hill T.E., 2000, RESPECT PLURALISM JU; Horton R, 2003, INT J HEALTH SERV, V33, P543, DOI 10.2190/N8MB-DV5B-TBAW-P1WB; HORTON R, 2003, NEW YORK REV BOOKS, P491; JUNOD T, 2003, OBSERVER        0907, pR1; Kendler KS, 2003, ARCH GEN PSYCHIAT, V60, P789, DOI 10.1001/archpsyc.60.8.789; Lunney JR, 2003, JAMA-J AM MED ASSOC, V289, P2387, DOI 10.1001/jama.289.18.2387; Macklin R, 2003, BRIT MED J, V327, P1419, DOI 10.1136/bmj.327.7429.1419; Marmot MG, 1997, LANCET, V350, P235, DOI 10.1016/S0140-6736(97)04244-X; Rantisi AAA, 2002, MIDDLE EAST POLICY, V9, P102, DOI 10.1111/1475-4967.00085; Sacks Jonathan., 2002, DIGNITY DIFFERENCE; TEMKIN O, 2002, 2 THOUGHT OTHER ESSA, P29; 2003, TIMES           0709, P21; [No title captured]	17	45	45	1	9	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 18	2004	364	9439					1081	1085		10.1016/S0140-6736(04)17065-7	http://dx.doi.org/10.1016/S0140-6736(04)17065-7			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	855FT	15380969				2022-12-28	WOS:000223959300029
J	Fridman, E; Carrari, F; Liu, YS; Fernie, AR; Zamir, D				Fridman, E; Carrari, F; Liu, YS; Fernie, AR; Zamir, D			Zooming in on a quantitative trait for tomato yield using interspecific introgressions	SCIENCE			English	Article							BACKCROSS QTL ANALYSIS; GENETIC ARCHITECTURE; SUGAR CONTENT; INVERTASE; IDENTIFICATION; DISSECTION; PENNELLII; GENOMICS; LEVEL; CROSS	To explore natural biodiversity we developed and examined introgression lines (ILs) containing chromosome segments of wild species (Solanum pennellii) in the background of the cultivated tomato (S. lycopersicum). We identified Brix9-2-5, which is a S. pennellii quantitative trait locus (QTL) that increases sugar yield of tomatoes and was mapped within a flower- and fruit-specific invertase (LIN5). QTL analysis representing five different tomato species delimited the functional polymorphism of Brix-9-2-5 to an amino acid near the catalytic site of the invertase crystal, affecting enzyme kinetics and fruit sink strength. These results underline the power of diverse ILs for high-resolution perspectives on complex phenotypes.	Hebrew Univ Jerusalem, Fac Agr, Robert H Smith Inst Plant Sci & Genet Agr, IL-76100 Rehovot, Israel; Max Planck Inst Mol Pflanzenphysiol, D-14476 Golm, Germany	Hebrew University of Jerusalem; Max Planck Society	Zamir, D (corresponding author), Hebrew Univ Jerusalem, Fac Agr, Robert H Smith Inst Plant Sci & Genet Agr, POB 12, IL-76100 Rehovot, Israel.	zamir@agri.huji.ac.il		Fridman, Eyal/0000-0003-1275-7791				Alberto F, 2004, J BIOL CHEM, V279, P18903, DOI 10.1074/jbc.M313911200; Bernacchi D, 1998, THEOR APPL GENET, V97, P170, DOI 10.1007/s001220050882; El-Assal SED, 2001, NAT GENET, V29, P435, DOI 10.1038/ng767; ESHED Y, 1995, GENETICS, V141, P1147; Frary A, 2004, THEOR APPL GENET, V108, P485, DOI 10.1007/s00122-003-1422-x; Freimer N, 2003, NAT GENET, V34, P15, DOI 10.1038/ng0503-15; Fridman E, 2003, PLANT PHYSIOL, V131, P603, DOI 10.1104/pp.014431; Fridman E, 2000, P NATL ACAD SCI USA, V97, P4718, DOI 10.1073/pnas.97.9.4718; Fridman E, 2002, MOL GENET GENOMICS, V266, P821, DOI 10.1007/s00438-001-0599-4; Fulton TM, 2000, THEOR APPL GENET, V100, P1025, DOI 10.1007/s001220051384; Ge H, 2003, TRENDS GENET, V19, P551, DOI 10.1016/j.tig.2003.08.009; GOZALBO D, 1990, CURR GENET, V17, P77, DOI 10.1007/BF00313252; Gur A, 2004, PLOS BIOL, V2, P1610, DOI 10.1371/journal.pbio.0020245; Gur A, 2004, TRENDS PLANT SCI, V9, P107, DOI 10.1016/j.tplants.2004.01.003; Knapp S, 2004, COMP FUNCT GENOM, V5, P285, DOI 10.1002/cfg.393; Koch K, 2004, CURR OPIN PLANT BIOL, V7, P235, DOI 10.1016/j.pbi.2004.03.014; Koornneef M, 2004, ANNU REV PLANT BIOL, V55, P141, DOI 10.1146/annurev.arplant.55.031903.141605; Liu YS, 2003, PLANT BIOTECHNOL J, V1, P195, DOI 10.1046/j.1467-7652.2003.00018.x; Mackay TFC, 2001, ANNU REV GENET, V35, P303, DOI 10.1146/annurev.genet.35.102401.090633; Mackay TFC, 2004, CURR OPIN GENET DEV, V14, P253, DOI 10.1016/j.gde.2004.04.003; Maloof JN, 2001, NAT GENET, V29, P441, DOI 10.1038/ng777; Paran I, 2003, TRENDS GENET, V19, P303, DOI 10.1016/S0168-9525(03)00117-3; Singer JB, 2004, SCIENCE, V304, P445, DOI 10.1126/science.1093139; Stam LF, 1996, GENETICS, V144, P1559; Tang GQ, 1999, PLANT CELL, V11, P177, DOI 10.1105/tpc.11.2.177; Tanksley SD, 1996, THEOR APPL GENET, V92, P213, DOI 10.1007/BF00223378; Zamir D, 2001, NAT REV GENET, V2, P983, DOI 10.1038/35103590	27	360	397	9	121	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 17	2004	305	5691					1786	1789		10.1126/science.1101666	http://dx.doi.org/10.1126/science.1101666			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	856IS	15375271				2022-12-28	WOS:000224039500045
J	Meister, G; Tuschl, T				Meister, G; Tuschl, T			Mechanisms of gene silencing by double-stranded RNA	NATURE			English	Article							DSRNA-BINDING-PROTEIN; SMALL INTERFERING RNA; C-ELEGANS; CAENORHABDITIS-ELEGANS; ARGONAUTE FAMILY; NUCLEAR EXPORT; VIRUS-RESISTANCE; DISTINCT ROLES; ENZYME COMPLEX; IMMUNE-SYSTEM		Rockefeller Univ, Lab RNA Mol Biol, New York, NY 10021 USA	Rockefeller University	Meister, G (corresponding author), Rockefeller Univ, Lab RNA Mol Biol, 1230 York Ave,Box 186, New York, NY 10021 USA.	ttuschl@rockefeller.edu						Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Basyuk E, 2003, NUCLEIC ACIDS RES, V31, P6593, DOI 10.1093/nar/gkg855; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Bohmert K, 1998, EMBO J, V17, P170, DOI 10.1093/emboj/17.1.170; Bohnsack MT, 2004, RNA, V10, P185, DOI 10.1261/rna.5167604; Boutet S, 2003, CURR BIOL, V13, P843, DOI 10.1016/S0960-9822(03)00293-8; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; Carmell MA, 2002, GENE DEV, V16, P2733, DOI 10.1101/gad.1026102; Caudy AA, 2003, NATURE, V425, P411, DOI 10.1038/nature01956; Caudy AA, 2002, GENE DEV, V16, P2491, DOI 10.1101/gad.1025202; Chan SWL, 2004, SCIENCE, V303, P1336, DOI 10.1126/science.1095989; Cogoni C, 1999, SCIENCE, V286, P2342, DOI 10.1126/science.286.5448.2342; Cogoni C, 1999, NATURE, V399, P166, DOI 10.1038/20215; Cook HA, 2004, CELL, V116, P817, DOI 10.1016/S0092-8674(04)00250-8; Dalmay T, 2001, EMBO J, V20, P2069, DOI 10.1093/emboj/20.8.2069; Doench JG, 2003, GENE DEV, V17, P438, DOI 10.1101/gad.1064703; Domeier ME, 2000, SCIENCE, V289, P1928, DOI 10.1126/science.289.5486.1928; Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301; Elbashir SM, 2001, EMBO J, V20, P6877, DOI 10.1093/emboj/20.23.6877; Fagard M, 2000, P NATL ACAD SCI USA, V97, P11650, DOI 10.1073/pnas.200217597; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; GAUWERKY CE, 1989, P NATL ACAD SCI USA, V86, P8867, DOI 10.1073/pnas.86.22.8867; Gitlin L, 2003, J VIROL, V77, P7159, DOI 10.1128/JVI.77.13.7159-7165.2003; Glazov E, 2003, PLANT J, V35, P342, DOI 10.1046/j.1365-313X.2003.01810.x; Grishok A, 2001, CELL, V106, P23, DOI 10.1016/S0092-8674(01)00431-7; Hammond SM, 2001, SCIENCE, V293, P1146, DOI 10.1126/science.1064023; Hammond SM, 2000, NATURE, V404, P293, DOI 10.1038/35005107; Han MH, 2004, P NATL ACAD SCI USA, V101, P1093, DOI 10.1073/pnas.0307969100; Hunter C, 2003, CURR BIOL, V13, P1734, DOI 10.1016/j.cub.2003.09.004; Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961; Hutvagner G, 2002, SCIENCE, V297, P2056, DOI 10.1126/science.1073827; Ishizuka A, 2002, GENE DEV, V16, P2497, DOI 10.1101/gad.1022002; Jin P, 2004, NAT NEUROSCI, V7, P113, DOI 10.1038/nn1174; Kennedy S, 2004, NATURE, V427, P645, DOI 10.1038/nature02302; Kennerdell JR, 2002, GENE DEV, V16, P1884, DOI 10.1101/gad.990802; Ketting RF, 1999, CELL, V99, P133, DOI 10.1016/S0092-8674(00)81645-1; Khvorova A, 2003, CELL, V115, P209, DOI 10.1016/S0092-8674(03)00801-8; Kidner CA, 2004, NATURE, V428, P81, DOI 10.1038/nature02366; Kim J, 2004, P NATL ACAD SCI USA, V101, P360, DOI 10.1073/pnas.2333854100; Knight SW, 2002, MOL CELL, V10, P809, DOI 10.1016/S1097-2765(02)00649-4; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lee Y, 2002, EMBO J, V21, P4663, DOI 10.1093/emboj/cdf476; Lee YS, 2004, CELL, V117, P69, DOI 10.1016/S0092-8674(04)00261-2; Li HW, 2002, SCIENCE, V296, P1319, DOI 10.1126/science.1070948; Li WX, 2001, CURR OPIN BIOTECH, V12, P150, DOI 10.1016/S0958-1669(00)00190-7; Lingel A, 2004, NAT STRUCT MOL BIOL, V11, P576, DOI 10.1038/nsmb777; LIU J, 2004, SCIENCE         0729; Liu QH, 2003, SCIENCE, V301, P1921, DOI 10.1126/science.1088710; Lund E, 2004, SCIENCE, V303, P95, DOI 10.1126/science.1090599; Ma JB, 2004, NATURE, V429, P318, DOI 10.1038/nature02519; Martinez J, 2004, GENE DEV, V18, P975, DOI 10.1101/gad.1187904; Martinez J, 2002, CELL, V110, P563, DOI 10.1016/S0092-8674(02)00908-X; Meister G, 2004, MOL CELL, V15, P185, DOI 10.1016/j.molcel.2004.07.007; Michael MZ, 2003, MOL CANCER RES, V1, P882; MOROY T, 1989, ONCOGENE, V4, P59; Mourelatos Z, 2002, GENE DEV, V16, P720, DOI 10.1101/gad.974702; Mourrain P, 2000, CELL, V101, P533, DOI 10.1016/S0092-8674(00)80863-6; Nykanen A, 2001, CELL, V107, P309, DOI 10.1016/S0092-8674(01)00547-5; Okamura K, 2004, GENE DEV, V18, P1655, DOI 10.1101/gad.1210204; Olsen PH, 1999, DEV BIOL, V216, P671, DOI 10.1006/dbio.1999.9523; Pal-Bhadra M, 2002, MOL CELL, V9, P315, DOI 10.1016/S1097-2765(02)00440-9; Pfeffer S, 2004, SCIENCE, V304, P734, DOI 10.1126/science.1096781; Pham JW, 2004, CELL, V117, P83, DOI 10.1016/S0092-8674(04)00258-2; Provost P, 2002, EMBO J, V21, P5864, DOI 10.1093/emboj/cdf578; Roignant JY, 2003, RNA, V9, P299, DOI 10.1261/rna.2154103; Sasaki T, 2003, GENOMICS, V82, P323, DOI 10.1016/S0888-7543(03)00129-0; Saxena S, 2003, J BIOL CHEM, V278, P44312, DOI 10.1074/jbc.M307089200; Schwarz DS, 2004, CURR BIOL, V14, P787, DOI 10.1016/j.cub.2004.03.008; Schwarz DS, 2003, CELL, V115, P199, DOI 10.1016/S0092-8674(03)00759-1; Schwarz DS, 2002, MOL CELL, V10, P537, DOI 10.1016/S1097-2765(02)00651-2; Seggerson K, 2002, DEV BIOL, V243, P215, DOI 10.1006/dbio.2001.0563; Sijen T, 2001, CELL, V107, P465, DOI 10.1016/S0092-8674(01)00576-1; Simmer F, 2002, CURR BIOL, V12, P1317, DOI 10.1016/S0960-9822(02)01041-2; Smardon A, 2000, CURR BIOL, V10, P169, DOI 10.1016/S0960-9822(00)00323-7; SONG JJ, 2004, SCIENCE         0729; STEINBRECH RW, 1992, FRACT MECH, V9, P187; Tabara H, 2002, CELL, V109, P861, DOI 10.1016/S0092-8674(02)00793-6; Tahbaz N, 2004, EMBO REP, V5, P189, DOI 10.1038/sj.embor.7400070; Tijsterman M, 2002, ANNU REV GENET, V36, P489, DOI 10.1146/annurev.genet.36.043002.091619; Tijsterman M, 2002, CURR BIOL, V12, P1535, DOI 10.1016/S0960-9822(02)01110-7; Tijsterman M, 2002, SCIENCE, V295, P694, DOI 10.1126/science.1067534; Tomari Y, 2004, CELL, V116, P831, DOI 10.1016/S0092-8674(04)00218-1; Tonkin LA, 2003, SCIENCE, V302, P1725, DOI 10.1126/science.1091340; Ullu E, 2004, CELL MICROBIOL, V6, P509, DOI 10.1111/j.1462-5822.2004.00399.x; Vargason JM, 2003, CELL, V115, P799, DOI 10.1016/S0092-8674(03)00984-X; Vazquez F, 2004, CURR BIOL, V14, P346, DOI 10.1016/j.cub.2004.01.035; Verdel A, 2004, SCIENCE, V303, P672, DOI 10.1126/science.1093686; Voinnet O, 2001, TRENDS GENET, V17, P449, DOI 10.1016/S0168-9525(01)02367-8; Wassenegger M, 1998, PLANT MOL BIOL, V37, P349, DOI 10.1023/A:1005946720438; Waterhouse PM, 2001, NATURE, V411, P834, DOI 10.1038/35081168; Waterhouse PM, 2001, TRENDS PLANT SCI, V6, P297, DOI 10.1016/S1360-1385(01)01989-6; Williams RW, 2002, P NATL ACAD SCI USA, V99, P6889, DOI 10.1073/pnas.072190799; Winston WM, 2002, SCIENCE, V295, P2456, DOI 10.1126/science.1068836; Xie ZX, 2004, PLOS BIOL, V2, P642, DOI 10.1371/journal.pbio.0020104; Ye KQ, 2003, NATURE, V426, P874, DOI 10.1038/nature02213; Yi R, 2003, GENE DEV, V17, P3011, DOI 10.1101/gad.1158803; Zhang HD, 2002, EMBO J, V21, P5875, DOI 10.1093/emboj/cdf582; Zilberman D, 2003, SCIENCE, V299, P716, DOI 10.1126/science.1079695	98	1810	2041	14	387	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 16	2004	431	7006					343	349		10.1038/nature02873	http://dx.doi.org/10.1038/nature02873			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	853XJ	15372041				2022-12-28	WOS:000223864000050
J	Knight, JR				Knight, JR			A 35-year-old physician with opioid dependence	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							SUBSTANCE USE DISORDERS; TREATMENT OUTCOMES; DRUG PROBLEMS; ALCOHOL; DEPRESSION; PREVALENCE; EXPERIENCE		Harvard Univ, Sch Med, Div Addict, Boston, MA USA; Massachusetts Med Soc, Phys Hlth Serv, Waltham, MA USA	Harvard University; Harvard Medical School	Knight, JR (corresponding author), Childrens Hosp, Ctr Adolescent Subst Abuse Res, 300 Longwood Ave, Boston, MA 02115 USA.	john.knight@childrens.harvard.edu						*ALC AN WORLD SERV, 1995, 12 STEPS 12 TRAD; Allen JP, 1997, J STUD ALCOHOL, V58, P7; *AM MED ASS, FED STAT PHYS HLTH P; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th ed., DOI DOI 10.1001/JAMA.1994.03520100096; Angres DH, 2003, J ADDICT DIS, V22, P79, DOI 10.1300/J069v22n03_07; [Anonymous], 1992, ANN INTERN MED, V117, P947; Bissell L, 1984, ALCOHOLISM PROFESSIO; BLONDELL RD, 1993, PRIMARY CARE, V20, P209; Bovasso G, 2001, J BEHAV HEALTH SER R, V28, P42, DOI 10.1007/BF02287233; BREWSTER JM, 1986, JAMA-J AM MED ASSOC, V255, P1913, DOI 10.1001/jama.255.14.1913; BROOKE D, 1991, BRIT J ADDICT, V86, P1011; CARLSON HB, 1994, J SUBST ABUSE TREAT, V11, P113, DOI 10.1016/0740-5472(94)90027-2; Charney DA, 2001, J CLIN PSYCHIAT, V62, P672, DOI 10.4088/JCP.v62n0902; CLARE AW, 1990, ALCOHOL ALCOHOLISM, V25, P277, DOI 10.1093/oxfordjournals.alcalc.a045001; CROWLEY T J, 1986, Alcohol and Drug Research, V6, P299; Eickelberg S. J., 1998, PRINCIPLES ADDICTION, P441; Federation of State Medical Boards of the United States Inc., REP AD HOC COMM PHYS; FLEMING M, 2002, STRATEGIC PLAN INTER; GALANTER M, 1990, AM J PSYCHIAT, V147, P64; Gallegos K V, 1992, Md Med J, V41, P315; Geyser M R, 1988, Fed Bull, V75, P77; GUALTIERI AC, 1983, JAMA-J AM MED ASSOC, V249, P226, DOI 10.1001/jama.249.2.226; Havassy BE, 2004, AM J PSYCHIAT, V161, P139, DOI 10.1176/appi.ajp.161.1.139; Hughes PH, 1999, J ADDICT DIS, V18, P23, DOI 10.1300/J069v18n02_03; HUGHES PH, 1992, JAMA-J AM MED ASSOC, V267, P2333, DOI 10.1001/jama.267.17.2333; Knight JR, 2002, J ADDICT DIS, V21, P27, DOI 10.1300/J069v21n04_03; Mansky PA, 1996, PSYCHIATR SERV, V47, P465; Markou A, 1998, NEUROPSYCHOPHARMACOL, V18, P135, DOI 10.1016/S0893-133X(97)00113-9; *MASS MED SOC, 2003, PHYS HLTH SERV 2003; McAuliffe W E, 1984, Adv Alcohol Subst Abuse, V4, P67; Mertens JR, 2003, ARCH INTERN MED, V163, P2511, DOI 10.1001/archinte.163.20.2511; MORSE RM, 1984, JAMA-J AM MED ASSOC, V251, P743, DOI 10.1001/jama.251.6.743; Pfifferling J H, 1997, Fam Pract Manag, V4, P76; Pfifferling JH, 1997, FAM PRACT MANAG, V4, P83; Pfifferling JH, 1997, FAM PRACT MANAG, V4, P87; *PHYS HLTH SERV, MAK REF; Reading E G, 1992, Md Med J, V41, P325; Rosenblum A, 2003, JAMA-J AM MED ASSOC, V289, P2370, DOI 10.1001/jama.289.18.2370; Schorling JB, 1997, MED CLIN N AM, V81, P845, DOI 10.1016/S0025-7125(05)70552-6; SHORE JH, 1987, JAMA-J AM MED ASSOC, V257, P2931; Skipper GE, 1997, J ADDICT DIS, V16, P67, DOI 10.1300/J069v16n03_07; Smith P C, 1991, J Okla State Med Assoc, V84, P599; STOUDEMIRE A, 1983, ANN INTERN MED, V98, P654, DOI 10.7326/0003-4819-98-5-654; TALBOTT GD, 1998, PRINCIPLES ADDICTION, P1263; VOGL W, 1996, DHHS PUBLICATION; VOGL WF, 1997, DHHS PUBLICATION; VOGTSBERGER KN, 1984, AM J DRUG ALCOHOL AB, V10, P23, DOI 10.3109/00952998409002653; Wijesinghe CP, 2001, PSYCHIAT QUART, V72, P181, DOI 10.1023/A:1010323710929	48	9	9	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 15	2004	292	11					1351	1357		10.1001/jama.292.11.1351	http://dx.doi.org/10.1001/jama.292.11.1351			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	853YL	15367558				2022-12-28	WOS:000223866800028
J	Thorpe, KE				Thorpe, KE			Election 2004 - Protecting the uninsured	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Emory Univ, Rollins Sch Publ Hlth, Dept Hlth Policy & Management, Atlanta, GA 30322 USA	Emory University; Rollins School Public Health	Thorpe, KE (corresponding author), Emory Univ, Rollins Sch Publ Hlth, Dept Hlth Policy & Management, Atlanta, GA 30322 USA.							Committee on the Consequences of Uninsurance, 2004, INS AM HLTH PRINC RE; THORPE KE, 2004, FEDERAL COSTS SAVING; *US BUR CENS, 2004, HIST HLTH INS TABL	3	12	12	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 7	2004	351	15					1479	1481		10.1056/NEJMp048160	http://dx.doi.org/10.1056/NEJMp048160			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	859UP	15470206	Bronze			2022-12-28	WOS:000224293700001
J	Loy, CT; Irwig, L				Loy, CT; Irwig, L			Accuracy a diagnostic tests read with and without clinical information - A systematic review	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							CHEST RADIOGRAPH; INTEROBSERVER AGREEMENT; COMPUTED-TOMOGRAPHY; LACUNAR INFARCTION; ECG INTERPRETATION; HISTORY; IMPACT; BIAS; KNOWLEDGE; LESIONS	Content Although it is common practice to read tests with clinical information, whether this improves or decreases the accuracy of test reading is uncertain. Objective To determine whether diagnostic tests are more accurate when read with clinical information or without it. DataSources MEDLINE search (1966-December 2003) extended by search of reference lists and articles citing the articles retrieved (Web of Science, 1985-December 2003). Study Selection All articles comparing the accuracy of tests read twice by the same readers, once without and once with clinical information, but otherwise under identical conditions. Only articles that reported sensitivity and specificity or receiver operating characteristic (ROC) curves were included. Data Extraction Data were extracted by one author and reviewed independently by the other. When the data were difficult to interpret, differences were resolved by discussion. Data Synthesis Sixteen articles met the inclusion criteria. Eleven articles compared areas under ROC curves for tests read with and without clinical information, and 5 compared only sensitivity and specificity. Ten articles used actual clinical information; 6 used constructed clinical information that was plausible. Overall, clinical information improved test reading accuracy although the effect was smaller in the articles using actual clinical information when compared with those using constructed clinical information. There were no instances in which clinical information resulted in significant reduction in test reading accuracy. In some instances, improved test reading accuracy came from improved sensitivity without loss of specificity. Conclusions At least for the tests examined, the common practice of reading diagnostic tests with clinical information seems justified. Future studies should be designed to investigate the best way of providing clinical information. These studies should also give an estimate of the accuracy of clinical information used, display ROC curves with identified data points, and include a wider range of diagnostic tests.	Univ Sydney, Sch Publ Hlth, Screening & Test Evaluat Program, Sydney, NSW 2006, Australia	University of Sydney	Irwig, L (corresponding author), Univ Sydney, Sch Publ Hlth, Screening & Test Evaluat Program, Room 301,A27,Edward Ford Bldg, Sydney, NSW 2006, Australia.	lesi@health.usyd.edu.au						Abbey LM, 1998, ORAL SURG ORAL MED O, V85, P74, DOI 10.1016/S1079-2104(98)90401-2; ASHWORTH CS, 1995, CHILD ABUSE NEGLECT, V19, P943, DOI 10.1016/0145-2134(95)00056-E; BABCOOK CJ, 1993, INVEST RADIOL, V28, P214, DOI 10.1097/00004424-199303000-00005; Berbaum K S, 1994, Acad Radiol, V1, P217, DOI 10.1016/S1076-6332(05)80717-2; BERBAUM KS, 1988, INVEST RADIOL, V23, P48, DOI 10.1097/00004424-198801000-00011; BERBAUM KS, 1986, INVEST RADIOL, V21, P532, DOI 10.1097/00004424-198607000-00004; BERBAUM KS, 1988, RADIOLOGY, V168, P507, DOI 10.1148/radiology.168.2.3393672; BERBAUM KS, 1989, AM J ROENTGENOL, V153, P1221, DOI 10.2214/ajr.153.6.1221; Berst MJ, 2001, AM J ROENTGENOL, V176, P507, DOI 10.2214/ajr.176.2.1760507; BONKE B, 1992, CEREBROVASC DIS, V2, P107, DOI 10.1159/000108997; BONKE B, 1989, NEURORADIOLOGY, V31, P170, DOI 10.1007/BF00698848; Bossuyt PM, 2003, BRIT MED J, V326, P41, DOI 10.1136/bmj.326.7379.41; COOPERSTEIN LA, 1990, INVEST RADIOL, V25, P670, DOI 10.1097/00004424-199006000-00009; DOUBILET P, 1981, AM J ROENTGENOL, V137, P1055, DOI 10.2214/ajr.137.5.1055; DUNN PM, 1990, ARCH INTERN MED, V150, P1917, DOI 10.1001/archinte.150.9.1917; Ehara S, 1999, TOHOKU J EXP MED, V189, P147, DOI 10.1620/tjem.189.147; ELDEVIK OP, 1982, RADIOLOGY, V145, P85, DOI 10.1148/radiology.145.1.7122902; Elmore JG, 1997, JAMA-J AM MED ASSOC, V277, P49, DOI 10.1001/jama.277.1.49; Flach SD, 2002, MED DECIS MAKING, V22, P318, DOI 10.1177/027298902400448885; GJORUP T, 1984, METHOD INFORM MED, V23, P96; GOOD BC, 1990, AM J ROENTGENOL, V154, P709, DOI 10.2214/ajr.154.4.2107662; Griscom NT, 2002, RADIOLOGY, V223, P9, DOI 10.1148/radiol.2231011274; GRUM CM, 1993, ACAD MED, V68, pS61, DOI 10.1097/00001888-199310000-00047; Hatala R, 1999, J GEN INTERN MED, V14, P126, DOI 10.1046/j.1525-1497.1999.00298.x; Hatala RA, 1996, ACAD MED, V71, pS68, DOI 10.1097/00001888-199610000-00047; KINNUNEN J, 1987, FORTSCHR RONTG NEUEN, V147, P143, DOI 10.1055/s-2008-1048609; Leslie A, 2000, BRIT J RADIOL, V73, P1052, DOI 10.1259/bjr.73.874.11271897; MCNEIL BJ, 1983, RADIOLOGY, V149, P75, DOI 10.1148/radiology.149.1.6611955; Paradise JE, 1999, PEDIATRICS, V103, P980, DOI 10.1542/peds.103.5.980; POTCHEN EJ, 1979, INVEST RADIOL, V14, P404; Quekel LGBA, 2001, J CLIN EPIDEMIOL, V54, P1146, DOI 10.1016/S0895-4356(01)00382-1; Raab SS, 2000, AM J CLIN PATHOL, V114, P78, DOI 10.1309/4099-QALD-NVGF-TM4G; RICKETT AB, 1992, INJURY, V23, P458, DOI 10.1016/0020-1383(92)90063-X; SACKETT DL, 2000, EVIDENCE BASED MED P, P74; SCHREIBER MH, 1963, JAMA-J AM MED ASSOC, V185, P399, DOI 10.1001/jama.1963.03060050077027; SIMONS M, 1994, J NUCL CARDIOL, V1, P365, DOI 10.1007/BF02939957; SONG K S, 1992, Yonsei Medical Journal, V33, P168; Tudor GR, 1997, CLIN RADIOL, V52, P235, DOI 10.1016/S0009-9260(97)80280-2; VANGIJN J, 1977, J NEUROL NEUROSUR PS, V40, P787, DOI 10.1136/jnnp.40.8.787; VOGEL HP, 1992, NEUROLOGY, V42, P2076, DOI 10.1212/WNL.42.11.2076; WHITED JD, 1995, J AM ACAD DERMATOL, V33, P603, DOI 10.1016/0190-9622(95)91278-9; Whiting Penny, 2003, BMC Med Res Methodol, V3, P25, DOI 10.1186/1471-2288-3-25; WILLIAMS GW, 1990, CLEV CLIN J MED, V57, P437, DOI 10.3949/ccjm.57.5.437	43	147	153	1	12	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 6	2004	292	13					1602	1609		10.1001/jama.292.13.1602	http://dx.doi.org/10.1001/jama.292.13.1602			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	859HS	15467063				2022-12-28	WOS:000224254600028
J	Bjelakovic, G; Nikolova, D; Simonetti, RG; Gluud, C				Bjelakovic, G; Nikolova, D; Simonetti, RG; Gluud, C			Antioxidant supplements for prevention of gastrointestinal cancers: a systematic review and meta-analysis	LANCET			English	Review							BETA-CAROTENE SUPPLEMENTATION; NUTRITION INTERVENTION TRIALS; DISEASE-SPECIFIC MORTALITY; PRIMARY LIVER-CANCER; CARDIOVASCULAR-DISEASE; RANDOMIZED-TRIALS; OXIDATIVE STRESS; LUNG-CANCER; VITAMIN-A; CHEMOPREVENTION	Background Oxidative stress can cause cancer. Our aim was to establish whether antioxidant supplements reduce the incidence of gastrointestinal cancer and mortality. Methods With the Cochrane Collaboration methodology, we reviewed all randomised trials comparing antioxidant supplements with placebo for prevention of gastrointestinal cancers. We searched electronic databases and reference lists (February, 2003). Outcome measures were incidence of gastrointestinal cancers, overall mortality, and adverse effects. Outcomes were analysed with fixed-effect and random-effects model meta-analyses and were reported as relative risk with 95% CIs. Findings We identified 14 randomised trials (n=170525). Trial quality was generally high. Heterogeneity of results was low to moderate. Neither the fixed-effect (relative risk 0.96, 95% CI 0.88-1.04) nor random-effects meta-analyses (0.90, 0.77-1.05) showed significant effects of supplementation with beta-carotene, vitamins A, C, E, and selenium (alone or in combination) versus placebo on oesophageal, gastric, colorectal, pancreatic, and liver cancer incidences. In seven high-quality trials (n=131727), the fixed-effect model showed that antioxidant significantly increased mortality (1.06, 1.02-1.10), unlike the random-effects meta-analysis (1.06, 0.98-1.15). Low-quality trials showed no significant effect of antioxidant supplementation on mortality. The difference between the mortality estimates in high-quality and low-quality trials was significant (Z=2.10, p=0.04 by test of interaction). beta-carotene and vitamin A (1.29, 1.14-1.45) and beta-carotene and vitamin E (1.10, 1.01-1.20) significantly increased mortality, whereas beta-carotene alone only tended to increase mortality (1.05, 0.99-1.11). In four trials (three with unclear or inadequate methodology), selenium showed significant beneficial effect on the incidence of gastrointestinal cancer. Interpretation We could not find evidence that antioxidant supplements can prevent gastrointestinal cancers; on the contrary, they seem to increase overall mortality. The potential preventive effect of selenium should be studied in adequate randomised trials.	Univ Nish, Fac Med, Dept Internal Med Gastroenterol & Hepatol, YU-18000 Nish, Serbia And Mont, Serbia; Univ Copenhagen Hosp, Rigshosp, Ctr Clin Intervent Res, Copenhagen Trial Unit,Cochrane Hepatobiliary Grp, DK-2100 Copenhagen, Denmark; Osped V Cervello, Div Med, Palermo, Italy	Rigshospitalet; University of Copenhagen	Bjelakovic, G (corresponding author), Univ Nish, Fac Med, Dept Internal Med Gastroenterol & Hepatol, YU-18000 Nish, Serbia And Mont, Serbia.	goranb@junis.ni.ac.yu	Gluud, Christian/HGB-3191-2022; Gluud, Christian/AAY-1027-2021	Gluud, Christian/0000-0002-8861-0799; Bjelakovic, Goran/0000-0002-3796-9945; Nikolova, Dimitrinka/0000-0001-5976-6762				Alderson P, 2004, COCHRANE LIB; Alpha-Tocopherol Beta Carotene Cancer Prevention Study Group, 1994, N Engl J Med, V330, P1029, DOI 10.1056/NEJM199404143301501; Altman DG, 2003, BMJ-BRIT MED J, V326, P219, DOI 10.1136/bmj.326.7382.219; AMES BN, 1995, P NATL ACAD SCI USA, V92, P5258, DOI 10.1073/pnas.92.12.5258; BJELAKOVIC G, 2003, COCHRANE LIB; BLOT WJ, 1993, JNCI-J NATL CANCER I, V85, P1483, DOI 10.1093/jnci/85.18.1483; Botterweck AAM, 1998, AM J EPIDEMIOL, V148, P842, DOI 10.1093/oxfordjournals.aje.a009709; BOYLE P, 1985, INT J CANCER, V36, P9, DOI 10.1002/ijc.2910360103; Camire M. E., 1999, Food Technology (Chicago), V53, P87; CARABALLOSO M, 2004, COCHRANE LIB; Clark LC, 1996, JAMA-J AM MED ASSOC, V276, P1957, DOI 10.1001/jama.276.24.1957; Collins R, 2002, LANCET, V360, P23, DOI 10.1016/S0140-6736(02)09328-5; Correa P, 2000, JNCI-J NATL CANCER I, V92, P1881, DOI 10.1093/jnci/92.23.1881; DARLOW BA, 2003, COCHRANE LIB; DeLeon MP, 1997, SCAND J GASTROENTERO, V32, P72, DOI 10.1080/00365521.1997.11720724; DEMETS DL, 1987, STAT MED, V6, P341, DOI 10.1002/sim.4780060325; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; DIPLOCK AT, 1994, MOL ASPECTS MED, V15, P293, DOI 10.1016/0098-2997(94)90005-1; GLASZIOU PP, 1993, BMJ-BRIT MED J, V306, P366, DOI 10.1136/bmj.306.6874.366; GREENBERG ER, 1994, NEW ENGL J MED, V331, P141, DOI 10.1056/NEJM199407213310301; Greenwald P, 2001, EUR J CANCER, V37, P948, DOI 10.1016/S0959-8049(01)00070-3; Halliwell B, 2000, FREE RADICAL RES, V33, P819, DOI 10.1080/10715760000301341; Halliwell B, 1997, NUTR REV, V55, pS44, DOI 10.1111/j.1753-4887.1997.tb06100.x; Hennekens CH, 1996, NEW ENGL J MED, V334, P1145, DOI 10.1056/NEJM199605023341801; Hercberg S, 1999, FOOD CHEM TOXICOL, V37, P925, DOI 10.1016/S0278-6915(99)00078-2; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hofstad B, 1998, DIGESTION, V59, P148, DOI 10.1159/000007480; *I MED FOOD NUTR B, 2000, PAN DIET ANT REL COM, P1; Janne PA, 2000, NEW ENGL J MED, V342, P1960, DOI 10.1056/NEJM200006293422606; Juni P, 2001, BMJ-BRIT MED J, V323, P42, DOI 10.1136/bmj.323.7303.42; Karakaya S, 1999, J SCI FOOD AGR, V79, P237, DOI [10.1002/(SICI)1097-0010(199902)79:2<237::AID-JSFA178>3.0.CO;2-K, 10.1002/(SICI)1097-0010(199902)79:2&lt;237::AID-JSFA178&gt;3.0.CO;2-K]; Kaur C, 2001, INT J FOOD SCI TECH, V36, P703, DOI 10.1046/j.1365-2621.2001.00513.x; Kjaergard LL, 2001, ANN INTERN MED, V135, P982, DOI 10.7326/0003-4819-135-11-200112040-00010; Klein EA, 2003, UROL ONCOL-SEMIN ORI, V21, P59, DOI 10.1016/S1078-1439(02)00301-0; Lee BM, 2003, MUTAT RES-FUND MOL M, V523, P265, DOI 10.1016/S0027-5107(02)00342-1; Lee IM, 1999, J NATL CANCER I, V91, P2102, DOI 10.1093/jnci/91.24.2102; LI JY, 1993, J NATL CANCER I, V85, P1492, DOI 10.1093/jnci/85.18.1492; Li Wenguang, 2000, Zhonghua Yufang Yixue Zazhi, V34, P336; MACLENNAN R, 1995, J NATL CANCER I, V87, P1760, DOI 10.1093/jnci/87.23.1760; Malila N, 1999, CANCER EPIDEM BIOMAR, V8, P489; MCKEOWNEYSSEN G, 1988, CANCER RES, V48, P4701; Michels KB, 2000, JNCI-J NATL CANCER I, V92, P1740, DOI 10.1093/jnci/92.21.1740; Moher D, 1998, LANCET, V352, P609, DOI 10.1016/S0140-6736(98)01085-X; MUNOZ N, 1985, LANCET, V2, P111; Omenn GS, 1998, ANNU REV PUBL HEALTH, V19, P73, DOI 10.1146/annurev.publhealth.19.1.73; Omenn GS, 1996, NEW ENGL J MED, V334, P1150, DOI 10.1056/NEJM199605023341802; Paolini M, 2003, MUTAT RES-REV MUTAT, V543, P195, DOI 10.1016/S1383-5742(03)00002-4; Podmore ID, 1998, NATURE, V392, P559, DOI 10.1038/33308; POPPEL G, 1996, EUR J CLIN NUTR, V50, pS57; Pritchard DM, 1996, PHARMACOL THERAPEUT, V72, P149, DOI 10.1016/S0163-7258(96)00102-7; Ritenbaugh C, ROUTINE VITAMIN SUPP; RONCUCCI L, 1993, DIS COLON RECTUM, V36, P227, DOI 10.1007/BF02053502; Salganik RI, 2001, J AM COLL NUTR, V20, p464S, DOI 10.1080/07315724.2001.10719185; Schatzkin A, 2000, NEW ENGL J MED, V342, P1149, DOI 10.1056/NEJM200004203421601; SCHULZ KF, 1995, JAMA-J AM MED ASSOC, V273, P408, DOI 10.1001/jama.273.5.408; SHETTY P, 1999, UPDATE EVIDENCE RAND; Shikany JM, 2003, PREV MED, V36, P379, DOI 10.1016/S0091-7435(02)00050-6; Sies H., 1985, OXIDATIVE STRESS, V501, P1, DOI DOI 10.1016/B978-0-12-642760-8.50005-3; Sihvo EIT, 2002, INT J CANCER, V102, P551, DOI 10.1002/ijc.10755; Sporn MB, 2000, CARCINOGENESIS, V21, P525, DOI 10.1093/carcin/21.3.525; Steinmetz KA, 1996, J AM DIET ASSOC, V96, P1027, DOI 10.1016/S0002-8223(96)00273-8; Tamimi RM, 2002, J INTERN MED, V251, P286, DOI 10.1046/j.1365-2796.2002.00969.x; Thomson A, 1998, DIGEST DIS, V16, P152, DOI 10.1159/000016859; van den Broek NR, 2003, COCHRANE LIB; vanPoppel G, 1997, CANCER LETT, V114, P195, DOI 10.1016/S0304-3835(97)04662-4; Vivekananthan DP, 2003, LANCET, V361, P2017, DOI 10.1016/S0140-6736(03)13637-9; WEISBURGER JH, 1991, AM J CLIN NUTR, V53, pS226, DOI 10.1093/ajcn/53.1.226S; YU SY, 1991, BIOL TRACE ELEM RES, V29, P289, DOI 10.1007/BF03032685; Yu SY, 1997, BIOL TRACE ELEM RES, V56, P117, DOI 10.1007/BF02778987; Zhu S., 2002, GASTROENTEROLOGY, V7, P73	70	437	463	2	73	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 2	2004	364	9441					1219	1228		10.1016/S0140-6736(04)17138-9	http://dx.doi.org/10.1016/S0140-6736(04)17138-9			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	859HO	15464182				2022-12-28	WOS:000224254200028
J	Partridge, EA; Le Roy, C; Di Guglielmo, GM; Pawling, J; Cheung, P; Granovsky, M; Nabi, IR; Wrana, JL; Dennis, JW				Partridge, EA; Le Roy, C; Di Guglielmo, GM; Pawling, J; Cheung, P; Granovsky, M; Nabi, IR; Wrana, JL; Dennis, JW			Regulation of cytokine receptors by Golgi N-glycan processing and endocytosis	SCIENCE			English	Article							GROWTH; COMPLEX; METASTASIS; EXPRESSION; PATHWAYS; MOUSE; CELLS	The Golgi enzyme beta1,6 N-acetylglucosaminyltransferase V (Mgat5) is upregulated in carcinomas and promotes the substitution of N-glycan with poly N-acetyllactosamine, the preferred ligand for galectin-3 (Gal-3). Here, we report that expression of Mgat5 sensitized mouse cells to multiple cytokines. Gal-3 cross-linked Mgat5-modified N-glycans on epidermal growth factor and transforming growth factor-beta receptors at the cell surface and delayed their removal by constitutive endocytosis. Mgat5 expression in mammary carcinoma was rate limiting for cytokine signaling and consequently for epithelial-mesenchymal transition, cell motility, and tumor metastasis. Mgat5 also promoted cytokine-mediated leukocyte signaling, phagocytosis, and extravasation in vivo. Thus, conditional regulation of N-glycan processing drives synchronous modification of cytokine receptors, which balances their surface retention against loss via endocytosis.	Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; Univ Toronto, Dept Med Genet & Microbiol, Toronto, ON M5S 1A8, Canada; Univ British Columbia, Dept Lab Med & Pathol, Vancouver, BC V6T 1Z3, Canada; Univ British Columbia, Dept Anat Cell Biol & Physiol, Vancouver, BC V6T 1Z3, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University of British Columbia; University of British Columbia	Dennis, JW (corresponding author), Mt Sinai Hosp, Samuel Lunenfeld Res Inst, 600 Univ Ave, Toronto, ON M5G 1X5, Canada.	Dennis@mshri.on.ca	Nabi, Ivan R/C-5493-2009; Wrana, Jeffrey/F-8857-2013; Nabi, Ivan/GWZ-5144-2022; Le Roy, Christine/N-3718-2017; Dennis, James/E-7268-2013	Nabi, Ivan/0000-0002-0670-0513; Le Roy, Christine/0000-0003-3538-6487; 				Ahmad N, 2004, J BIOL CHEM, V279, P10841, DOI 10.1074/jbc.M312834200; Chen L, 1998, ONCOGENE, V17, P2087, DOI 10.1038/sj.onc.1202124; Crowe MJ, 2000, J INVEST DERMATOL, V115, P3, DOI 10.1046/j.1523-1747.2000.00010.x; Demetriou M, 2001, NATURE, V409, P733, DOI 10.1038/35055582; DEMETRIOU M, 1995, J CELL BIOL, V130, P383, DOI 10.1083/jcb.130.2.383; Di Guglielmo GM, 2003, NAT CELL BIOL, V5, P410, DOI 10.1038/ncb975; Elleman TC, 2000, BIOCHEM J, V347, P771, DOI 10.1042/0264-6021:3470771; Gong HC, 1999, CANCER RES, V59, P6239; Granovsky M, 2000, NAT MED, V6, P306; Hirabayashi J, 2002, BBA-GEN SUBJECTS, V1572, P232, DOI 10.1016/S0304-4165(02)00311-2; Hughes RC, 1999, BBA-GEN SUBJECTS, V1473, P172, DOI 10.1016/S0304-4165(99)00177-4; IOFFE E, 1994, P NATL ACAD SCI USA, V91, P728, DOI 10.1073/pnas.91.2.728; Lanzetti L, 2004, NATURE, V429, P309, DOI 10.1038/nature02542; Levy Y, 2003, J BIOL CHEM, V278, P14533, DOI 10.1074/jbc.M207380200; METZLER M, 1994, EMBO J, V13, P2056, DOI 10.1002/j.1460-2075.1994.tb06480.x; MIYOSHI E, 1995, J BIOL CHEM, V270, P6216, DOI 10.1074/jbc.270.11.6216; Nangia-Makker P, 2000, AM J PATHOL, V156, P899, DOI 10.1016/S0002-9440(10)64959-0; Oft M, 2002, NAT CELL BIOL, V4, P487, DOI 10.1038/ncb807; Palacios F, 2002, NAT CELL BIOL, V4, P929, DOI 10.1038/ncb881; Park SC, 2002, MECH AGEING DEV, V123, P917, DOI 10.1016/S0047-6374(02)00029-5; Shiraha H, 2000, J BIOL CHEM, V275, P19343, DOI 10.1074/jbc.M000008200; Soubeyran P, 2002, NATURE, V416, P183, DOI 10.1038/416183a; Stroop CJM, 2000, GLYCOBIOLOGY, V10, P901, DOI 10.1093/glycob/10.9.901; Wang Y, 2001, GLYCOBIOLOGY, V11, P1051, DOI 10.1093/glycob/11.12.1051; Webster MA, 1998, MOL CELL BIOL, V18, P2344, DOI 10.1128/MCB.18.4.2344; Wiley HS, 2003, TRENDS CELL BIOL, V13, P43; YOUSEFI S, 1991, J BIOL CHEM, V266, P1772	27	564	595	2	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 1	2004	306	5693					120	124		10.1126/science.1102109	http://dx.doi.org/10.1126/science.1102109			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	859YJ	15459394				2022-12-28	WOS:000224304000051
J	Sauer, RT; Bolon, DN; Burton, BM; Burton, RE; Flynn, JM; Grant, RA; Hersch, GL; Joshi, SA; Kenniston, JA; Levchenko, I; Neher, SB; Oakes, ESC; Siddiqui, SM; Wah, DA; Baker, TA				Sauer, RT; Bolon, DN; Burton, BM; Burton, RE; Flynn, JM; Grant, RA; Hersch, GL; Joshi, SA; Kenniston, JA; Levchenko, I; Neher, SB; Oakes, ESC; Siddiqui, SM; Wah, DA; Baker, TA			Sculpting the proteome with AAA+ proteases and disassembly machines	CELL			English	Review							SPECIFICITY-ENHANCING FACTOR; DEPENDENT HSLVU PROTEASE; ESCHERICHIA-COLI; SUBSTRATE-BINDING; CRYSTAL-STRUCTURE; DEGRADE PROTEINS; MOLECULAR SWITCH; STRUCTURAL BASIS; ADAPTER PROTEIN; 20S PROTEASOME	Machines of protein destruction-including energy-dependent proteases and disassembly chaperones of the AAA+ ATPase family-function in all kingdoms of life to sculpt the cellular proteome, ensuring that unnecessary and dangerous proteins are eliminated and biological responses to environmental change are rapidly and properly regulated. Exciting progress has been made in understanding how AAA+ machines recognize specific proteins as targets and then carry out ATP-dependent dismantling of the tertiary and/or quaternary structure of these molecules during the processes of protein degradation and the disassembly of macromolecular complexes.	MIT, Dept Biol, Cambridge, MA 02139 USA; MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Baker, TA (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	tabaker@mit.edu		Bolon, Daniel/0000-0001-5857-6676; Sauer, Robert/0000-0002-1719-5399; Neher, Saskia/0000-0003-4165-6674	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI015706, R37AI015706, R01AI015067, R01AI016892] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049224, R01GM101988] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NIAID NIH HHS [R01 AI015706, R01 AI016892-27, R37 AI015706-27, R37 AI015706, AI-15067, AI-16892, R01 AI016892] Funding Source: Medline; NIGMS NIH HHS [R01 GM101988, R01 GM049224-12, R01 GM049224, GM-499224] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Beuron F, 1998, J STRUCT BIOL, V123, P248, DOI 10.1006/jsbi.1998.4039; Bochtler M, 2000, NATURE, V403, P800, DOI 10.1038/35001629; Bochtler M, 1997, P NATL ACAD SCI USA, V94, P6070, DOI 10.1073/pnas.94.12.6070; Bolon DN, 2004, MOL CELL, V13, P443, DOI 10.1016/S1097-2765(04)00027-9; BOLON DN, 2004, IN PRESS MOL CELL; BOWIE JU, 1989, J BIOL CHEM, V264, P7596; Burton BM, 2003, CHEM BIOL, V10, P463, DOI 10.1016/S1074-5521(03)00102-9; Burton BM, 2001, MOL CELL, V8, P449, DOI 10.1016/S1097-2765(01)00307-0; Burton RE, 2003, PROTEIN SCI, V12, P893, DOI 10.1110/ps.0237603; Burton RE, 2001, EMBO J, V20, P3092, DOI 10.1093/emboj/20.12.3092; Davey MJ, 2002, NAT REV MOL CELL BIO, V3, P826, DOI 10.1038/nrm949; Dougan DA, 2003, MOL CELL, V12, P373, DOI 10.1016/j.molcel.2003.08.012; Dougan DA, 2002, MOL CELL, V9, P673, DOI 10.1016/S1097-2765(02)00485-9; Flynn JM, 2003, MOL CELL, V11, P671, DOI 10.1016/S1097-2765(03)00060-1; Flynn JM, 2001, P NATL ACAD SCI USA, V98, P10584, DOI 10.1073/pnas.191375298; Glover JR, 2001, BIOCHEM CELL BIOL, V79, P557, DOI 10.1139/bcb-79-5-557; Gonciarz-Swiatek M, 1999, J BIOL CHEM, V274, P13999, DOI 10.1074/jbc.274.20.13999; Gonzalez M, 2000, EMBO J, V19, P5251, DOI 10.1093/emboj/19.19.5251; Gottesman S, 2003, ANNU REV CELL DEV BI, V19, P565, DOI 10.1146/annurev.cellbio.19.110701.153228; Gottesman S, 1998, GENE DEV, V12, P1338, DOI 10.1101/gad.12.9.1338; Groll M, 1997, NATURE, V386, P463, DOI 10.1038/386463a0; Herman C, 1998, GENE DEV, V12, P1348, DOI 10.1101/gad.12.9.1348; Herman C, 2003, MOL CELL, V11, P659, DOI 10.1016/S1097-2765(03)00068-6; Hersch GL, 2004, P NATL ACAD SCI USA, V101, P12136, DOI 10.1073/pnas.0404733101; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hoskins JR, 2002, P NATL ACAD SCI USA, V99, P11037, DOI 10.1073/pnas.172378899; Hoskins JR, 2002, ADV PROTEIN CHEM, V59, P413; Hoskins JR, 2000, J BIOL CHEM, V275, P35361, DOI 10.1074/jbc.M006288200; Joshi SA, 2003, MOL MICROBIOL, V48, P67, DOI 10.1046/j.1365-2958.2003.03424.x; Joshi SA, 2004, NAT STRUCT MOL BIOL, V11, P404, DOI 10.1038/nsmb752; Keiler KC, 1996, SCIENCE, V271, P990, DOI 10.1126/science.271.5251.990; Kenniston JA, 2003, CELL, V114, P511, DOI 10.1016/S0092-8674(03)00612-3; Kenniston JA, 2004, J STRUCT BIOL, V146, P130, DOI 10.1016/j.jsb.2003.10.023; Kim YI, 2000, MOL CELL, V5, P639, DOI 10.1016/S1097-2765(00)80243-9; Kim YI, 2001, NAT STRUCT BIOL, V8, P230, DOI 10.1038/84967; Laachouch JE, 1996, EMBO J, V15, P437, DOI 10.1002/j.1460-2075.1996.tb00374.x; Lee C, 2001, MOL CELL, V7, P627, DOI 10.1016/S1097-2765(01)00209-X; Levchenko I, 2000, SCIENCE, V289, P2354, DOI 10.1126/science.289.5488.2354; Levchenko I, 2003, MOL CELL, V12, P365, DOI 10.1016/j.molcel.2003.08.014; Levchenko I, 1997, GENE DEV, V11, P1561, DOI 10.1101/gad.11.12.1561; LOWE J, 1995, SCIENCE, V268, P533, DOI 10.1126/science.7725097; Neher SB, 2003, P NATL ACAD SCI USA, V100, P13219, DOI 10.1073/pnas.2235804100; Neher SB, 2003, GENE DEV, V17, P1084, DOI 10.1101/gad.1078003; Neuwald AF, 1999, GENOME RES, V9, P27; Nishii W, 2003, FEBS LETT, V553, P351, DOI 10.1016/S0014-5793(03)01044-5; Ortega J, 2002, EMBO J, V21, P4938, DOI 10.1093/emboj/cdf483; Ortega J, 2000, MOL CELL, V6, P1515, DOI 10.1016/S1097-2765(00)00148-9; PARSELL DA, 1990, GENE DEV, V4, P277, DOI 10.1101/gad.4.2.277; Persuh M, 2002, J BACTERIOL, V184, P2310, DOI 10.1128/JB.184.8.2310-2313.2002; PRAKASH S, 2004, IN PRESS NAT STRUCT; Ramachandran R, 2002, P NATL ACAD SCI USA, V99, P7396, DOI 10.1073/pnas.102188799; Reid BG, 2001, P NATL ACAD SCI USA, V98, P3768, DOI 10.1073/pnas.071043698; Schirmer EC, 1996, TRENDS BIOCHEM SCI, V21, P289, DOI 10.1016/0968-0004(96)10038-4; Schlieker C, 2004, NAT STRUCT MOL BIOL, V11, P607, DOI 10.1038/nsmb787; Schlothauer T, 2003, P NATL ACAD SCI USA, V100, P2306, DOI 10.1073/pnas.0535717100; Seol JH, 1997, EUR J BIOCHEM, V247, P1143, DOI 10.1111/j.1432-1033.1997.01143.x; Seong IS, 2002, J BIOL CHEM, V277, P25976, DOI 10.1074/jbc.M202793200; Siddiqui SM, 2004, GENE DEV, V18, P369, DOI 10.1101/gad.1170304; SIDDIQUI SM, 2004, THESIS MIT CAMBRIDGE; Singh SK, 2000, P NATL ACAD SCI USA, V97, P8898, DOI 10.1073/pnas.97.16.8898; Song HK, 2000, P NATL ACAD SCI USA, V97, P14103, DOI 10.1073/pnas.250491797; Song HK, 2003, MOL CELL, V12, P75, DOI 10.1016/S1097-2765(03)00271-5; Sousa MC, 2000, CELL, V103, P633, DOI 10.1016/S0092-8674(00)00166-5; Sousa MC, 2002, J MOL BIOL, V318, P779, DOI 10.1016/S0022-2836(02)00145-6; THOMPSON MW, 1994, J BIOL CHEM, V269, P18201; THOMPSON MW, 1994, J BIOL CHEM, V269, P18209; Turgay K, 1997, GENE DEV, V11, P119, DOI 10.1101/gad.11.1.119; Turgay K, 1998, EMBO J, V17, P6730; Wah DA, 2003, MOL CELL, V12, P355, DOI 10.1016/S1097-2765(03)00272-7; Wah DA, 2002, CHEM BIOL, V9, P1237, DOI 10.1016/S1074-5521(02)00268-5; Wang J, 2001, STRUCTURE, V9, P177, DOI 10.1016/S0969-2126(01)00570-6; Wang LY, 1999, J BACTERIOL, V181, P1211, DOI 10.1128/JB.181.4.1211-1219.1999; Weber-Ban EU, 1999, NATURE, V401, P90, DOI 10.1038/43481; Whitby FG, 2000, NATURE, V408, P115, DOI 10.1038/35040607; Yoo SJ, 1996, BIOCHEM BIOPH RES CO, V229, P531, DOI 10.1006/bbrc.1996.1838; Zhou YN, 2001, GENE DEV, V15, P627, DOI 10.1101/gad.864401	77	348	356	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 1	2004	119	1					9	18		10.1016/j.cell.2004.09.020	http://dx.doi.org/10.1016/j.cell.2004.09.020			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	859UE	15454077	Green Accepted, Bronze			2022-12-28	WOS:000224292600005
J	Swinburn, B; Egger, G				Swinburn, B; Egger, G			The runaway weight gain train: too many accelerators, not enough brakes	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ENERGY-EXPENDITURE; PHYSICAL-ACTIVITY; OBESITY; OVERWEIGHT; ADULTS		Deakin Univ, Sch Exercise & Nutr Sci, Melbourne, Vic 3125, Australia; So Cross Univ, E Lismore, NSW 2480, Australia	Deakin University; Southern Cross University	Swinburn, B (corresponding author), Deakin Univ, Sch Exercise & Nutr Sci, 221 Burwood Highway, Melbourne, Vic 3125, Australia.	swinbum@deakin.edu.au						Bjorntorp P, 2000, INT J OBESITY, V24, pS80, DOI 10.1038/sj.ijo.0801285; Blundell JE, 2001, OBES RES, V9, p263S, DOI 10.1038/oby.2001.129; Dulloo AG, 1997, AM J CLIN NUTR, V65, P717, DOI 10.1093/ajcn/65.3.717; FERRARO R, 1991, AM J CLIN NUTR, V53, P1368, DOI 10.1093/ajcn/53.6.1368; French SA, 2001, ANNU REV PUBL HEALTH, V22, P309, DOI 10.1146/annurev.publhealth.22.1.309; Han TS, 1998, AM J PUBLIC HEALTH, V88, P1814, DOI 10.2105/AJPH.88.12.1814; Hill JO, 2003, SCIENCE, V299, P853, DOI 10.1126/science.1079857; Jeffery RW, 1999, AM J PUBLIC HEALTH, V89, P747, DOI 10.2105/AJPH.89.5.747; LEIBEL RL, 1995, NEW ENGL J MED, V332, P621, DOI 10.1056/NEJM199503093321001; MOMMSEN S, 1994, WORLD J UROL, V12, P319; Peters J C, 2002, Obes Rev, V3, P69, DOI 10.1046/j.1467-789X.2002.00059.x; Prentice AM, 1996, EUR J CLIN NUTR, V50, P93; Puhl R, 2001, OBES RES, V9, P788, DOI 10.1038/oby.2001.108; RAVUSSIN E, 1993, INT J OBESITY, V17, pS28; Ravussin E., 1993, INT J OBES RELAT S3, V17, pS41; Reid S, 2002, PRIMARY CARE PSYCHIA, V8, P1, DOI 10.1185/135525702125000408; Rogers PJ, 2000, PHARMACOL BIOCHEM BE, V66, P3, DOI 10.1016/S0091-3057(00)00197-0; Stunkard AJ, 1996, CIBA F SYMP, V201, P174; Swinburn B, 2002, Obes Rev, V3, P289; Visscher TLS, 2001, ANNU REV PUBL HEALTH, V22, P355, DOI 10.1146/annurev.publhealth.22.1.355; Wardle J., 1999, Obesity: The report of the British Nutrition Foundation Task Force., P83; World Health Organization, 2000, WHO TECHN REP SER, V894	22	119	122	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 25	2004	329	7468					736	739		10.1136/bmj.329.7468.736	http://dx.doi.org/10.1136/bmj.329.7468.736			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	858RV	15388619	Green Published			2022-12-28	WOS:000224210300025
J	Kapadia, SR; Schlumpf, M				Kapadia, SR; Schlumpf, M			Tribute to a master's work - A 24-year follow-up	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Cleveland Clin Fdn, Cleveland, OH 44195 USA; Univ Zurich Hosp, CH-8006 Zurich, Switzerland	Cleveland Clinic Foundation; University of Zurich; University Zurich Hospital	Kapadia, SR (corresponding author), Cleveland Clin Fdn, 9500 Euclid Ave, Cleveland, OH 44195 USA.								0	2	2	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 23	2004	351	13					1332	1332		10.1056/NEJMicm020765	http://dx.doi.org/10.1056/NEJMicm020765			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	855TP	15385660				2022-12-28	WOS:000223997700011
J	Knoops, KTB; de Groot, LCPGM; Kromhout, D; Perrin, AE; Moreiras-Varela, O; Menotti, A; van Staveren, WA				Knoops, KTB; de Groot, LCPGM; Kromhout, D; Perrin, AE; Moreiras-Varela, O; Menotti, A; van Staveren, WA			Mediterranean diet, lifestyle factors, and 10-year mortality in elderly European men and women - The HALE project	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CORONARY-HEART-DISEASE; PHYSICAL-ACTIVITY; SMOKING-CESSATION; HEALTH BEHAVIORS; RISK-FACTORS; OLDER MEN; COHORT; SURVIVAL; QUESTIONNAIRE; PREVENTION	Context Dietary patterns and lifestyle factors are associated with mortality from all causes, coronary heart disease, cardiovascular diseases, and cancer, but few studies have investigated these factors in combination. Objective To investigate the single and combined effect of Mediterranean diet, being physically active, moderate alcohol use, and nonsmoking on all-cause and cause-specific mortality in European elderly individuals. Design, Setting, and Participants The Healthy Ageing: a Longitudinal study in Europe (HALE) population, comprising individuals enrolled in the Survey in Europe on Nutrition and the Elderly: a Concerned Action (SENECA) and the Finland, Italy, the Netherlands, Elderly (FINE) studies, includes 1507 apparently healthy men and 832 women, aged 70 to 90 years in 11 European countries. This cohort study was conducted between 1988 and 2000. Main Outcome Measures Ten-year mortality from all causes, coronary heart disease, cardiovascular diseases, and cancer. Results During follow-up, 935 participants died: 371 from cardiovascular diseases, 233 from cancer, and 145 from other causes; for 186, the cause of death was unknown. Adhering to a Mediterranean diet (hazard ratio [HR], 0.77; 95% confidence interval [CI], 0.68-0.88), moderate alcohol use (HR, 0.78; 95% Cl, 0.67-0.91), physical activity (HR, 0.63; 95% Cl, 0.55-0.72), and nonsmoking (HR, 0.65; 95% Cl, 0.57-0.75) were associated with a lower risk of all-cause mortality (HRs controlled for age, sex, years of education, body mass index, study, and other factors). Similar results were observed for mortality from coronary heart disease, cardiovascular diseases, and cancer. The combination of 4 low risk factors lowered the all-cause mortality rate to 0.35 (95% Cl, 0.28-0.44). In total, lack of adherence to this low-risk pattern was associated with a population attributable risk of 60% of all deaths, 64% of deaths from coronary heart disease, 61% from cardiovascular diseases, and 60% from cancer. Conclusion Among individuals aged 70 to 90 years, adherence to a Mediterranean diet and healthful lifestyle is associated with a more than 50% lower rate of all-causes and cause-specific mortality.	Univ Wageningen & Res Ctr, Div Human Nutr, NL-6700 EV Wageningen, Netherlands; Natl Inst Publ Hlth & Environm, Bilthoven, Netherlands; Univ Strasbourg, F-67070 Strasbourg, France; Univ Complutense Madrid, E-28040 Madrid, Spain; Assoc Ric Cardiol, Rome, Italy	Wageningen University & Research; Netherlands National Institute for Public Health & the Environment; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Complutense University of Madrid	Knoops, KTB (corresponding author), Univ Wageningen & Res Ctr, Div Human Nutr, POB 8129, NL-6700 EV Wageningen, Netherlands.	Kim.Knoops@wur.nl	Kromhout, Daan/A-8566-2014	de Groot, Lisette/0000-0003-2778-2789				ARAB JS, 1987, EUROPEAN FOOD COMPOS; Beard J, 2003, ENVIRON HEALTH PERSP, V111, P724, DOI 10.1289/ehp.5885; BIJNEN FCH, 1994, B WORLD HEALTH ORGAN, V72, P1; CASPERSEN CJ, 1991, AM J EPIDEMIOL, V133, P1078, DOI 10.1093/oxfordjournals.aje.a115821; DAVIS MA, 1994, PREV MED, V23, P369, DOI 10.1006/pmed.1994.1051; deGroot CPGM, 1996, EUR J CLIN NUTR, V50, pS123; DELORGERIL M, 1994, LANCET, V343, P1454, DOI 10.1016/S0140-6736(94)92580-1; GNARDELLIS C, 1995, EPIDEMIOLOGY, V6, P74, DOI 10.1097/00001648-199501000-00015; Haveman-Nies A, 2002, AM J EPIDEMIOL, V156, P962, DOI 10.1093/aje/kwf144; Huijbregts P, 1997, BRIT MED J, V315, P13, DOI 10.1136/bmj.315.7099.13; KAWACHI I, 1993, ANN INTERN MED, V119, P992, DOI 10.7326/0003-4819-119-10-199311150-00005; Kleinbaum DG, 1996, SURVIVAL ANAL SELF L; KROMHOUT D, 2001, PREVENTION CORONARY; Liao YL, 2000, AM J EPIDEMIOL, V151, P651, DOI 10.1093/oxfordjournals.aje.a010259; Menotti A, 2001, EUR HEART J, V22, P573, DOI 10.1053/euhj.2000.2402; Mukamal KJ, 2003, NEW ENGL J MED, V348, P109, DOI 10.1056/NEJMoa022095; PAFFENBARGER RS, 1993, NEW ENGL J MED, V328, P538, DOI 10.1056/NEJM199302253280804; Peto R, 2000, BRIT MED J, V321, P323, DOI 10.1136/bmj.321.7257.323; RUIGOMEZ A, 1995, AGE AGEING, V24, P113, DOI 10.1093/ageing/24.2.113; Singh RB, 2002, LANCET, V360, P1455, DOI 10.1016/S0140-6736(02)11472-3; Stampfer MJ, 2000, NEW ENGL J MED, V343, P16, DOI 10.1056/NEJM200007063430103; TRICHOPOULOU A, 1995, BMJ-BRIT MED J, V311, P1457, DOI 10.1136/bmj.311.7018.1457; Trichopoulou A, 2000, CANCER EPIDEM BIOMAR, V9, P869; Trichopoulou A, 2003, NEW ENGL J MED, V348, P2599, DOI 10.1056/NEJMoa025039; VANTHOF MA, 1991, EUR J CLIN NUTR, V45, P5; VOORRIPS LE, 1991, MED SCI SPORT EXER, V23, P974, DOI 10.1249/00005768-199108000-00015; WACHOLDER S, 1994, AM J EPIDEMIOL, V140, P303, DOI 10.1093/oxfordjournals.aje.a117252; Wannamethee SG, 1998, LANCET, V351, P1603, DOI 10.1016/S0140-6736(97)12355-8; White IR, 2002, BRIT MED J, V325, P191, DOI 10.1136/bmj.325.7357.191; Willett W., 2012, NUTR EPIDEMIOLOGY; World Health Organisation, 1977, INT CLASS DIS 9 REV; World Health Organisation, 2002, KEEP FIT LIF M NUTR; 1998, 135 N WHO	33	1082	1121	2	114	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 22	2004	292	12					1433	1439		10.1001/jama.292.12.1433	http://dx.doi.org/10.1001/jama.292.12.1433			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	856FT	15383513				2022-12-28	WOS:000224031800024
J	Berlinguer, G				Berlinguer, G			Bioethics, health, and inequality	LANCET			English	Article																		BERLINGER G, 2003, REPORT IBC POSSIBILI; Berlinguer G., 2003, EVERYDAY BIOETHICS R; BERLINGUER G., 1996, MERCE FINALE SAGGIO; BUCCINI G, 2003, CORRIERE SERA   1006, P1; Council of Europa, 1997, CONV PROT HUM RIGHTS; Emson HE, 2003, J MED ETHICS, V29, P125, DOI 10.1136/jme.29.3.125; Evans T., 2001, CHALLENGING INEQUITI; Flanagin A, 2003, JAMA-J AM MED ASSOC, V290, P1382, DOI 10.1001/jama.290.10.1382; GRAMSCI A, 1975, LETT PRISON, P447; Ogata S., 2003, HUMAN SECURITY NOW P; PORTER R, 1997, GREATEST BENEFIT MAN, P123; Ramsay S, 2002, LANCET, V360, P1118, DOI 10.1016/S0140-6736(02)11242-6; ROTHSCHILD E, 1995, DAEDALUS, V124, P53; SANDERS D, 2003, REPORT COMMISSION MA; Saracci Rodolfo, 2003, Epidemiol Prev, V27, P258; SEN A, 1992, BRIT MED J, V304, P587, DOI 10.1136/bmj.304.6827.587; SEN A, 2002, BRIT MED J, V327, P1297; The World Bank, 1993, INV HLTH WORLD DEV I; *UNESCO, 2003, SHSEST02CIB92 UNESCO; WATSON R, 2003, TIMES           1023; WINES M, 2003, NY TIMES        1211, P24; World Health Organization (WHO), 2013, WORLD HLTH REPORT 20	22	22	24	1	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 18	2004	364	9439					1086	1091		10.1016/S0140-6736(04)17066-9	http://dx.doi.org/10.1016/S0140-6736(04)17066-9			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	855FT	15380970	Green Published, Bronze			2022-12-28	WOS:000223959300030
J	Testa, G; Harris, J				Testa, G; Harris, J			Ethical aspects of ES cell-derived gametes	SCIENCE			English	Editorial Material							GERM-CELLS; DERIVATION		Tech Univ Dresden, BIOTEC, Dept Genom, D-8027 Dresden, Germany; Univ Manchester, Manchester Sch Law, Manchester M13 9PL, Lancs, England	Technische Universitat Dresden; University of Manchester	Testa, G (corresponding author), Tech Univ Dresden, BIOTEC, Dept Genom, D-8027 Dresden, Germany.	testa@mpi-cbg.de		Testa, Giuseppe/0000-0002-9104-0918				Dennis C, 2003, NATURE, V424, P364, DOI 10.1038/424364a; Geijsen N, 2004, NATURE, V427, P148, DOI 10.1038/nature02247; Golombok S., 1999, WHAT IS PARENT SOCIO, P161; HARRIS J, 2004, CLONING, P52; Hubner K, 2003, SCIENCE, V300, P1251, DOI 10.1126/science.1083452; Kass L R, 1998, Valparaiso Univ Law Rev, V32, P679; Kono T, 2004, NATURE, V428, P860, DOI 10.1038/nature02402; *NCHS, 1996, FERT FAM PLANN WOM H; Surani MA, 2004, NATURE, V427, P106, DOI 10.1038/427106a; Toyooka Y, 2003, P NATL ACAD SCI USA, V100, P11457, DOI 10.1073/pnas.1932826100	10	25	26	1	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 17	2004	305	5691					1719	1719		10.1126/science.1103083	http://dx.doi.org/10.1126/science.1103083			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	856IS	15375251	Green Submitted			2022-12-28	WOS:000224039500022
J	Hayashi, T; Carthew, RW				Hayashi, T; Carthew, RW			Surface mechanics mediate pattern formation in the developing retina	NATURE			English	Article							CELL-ADHESION; DROSOPHILA; CADHERIN; EYE; GENE; SPECIFICATION; EXPRESSION; ARMADILLO; TENSIONS; TISSUES	Pattern formation of biological structures involves organizing different types of cells into a spatial configuration. In this study, we investigate the physical basis of biological patterning of the Drosophila retina in vivo. We demonstrate that E- and N-cadherins mediate apical adhesion between retina epithelial cells. Differential expression of N-cadherin within a sub-group of retinal cells (cone cells) causes them to form an overall shape that minimizes their surface contact with surrounding cells. The cells within this group, in both normal and experimentally manipulated conditions, pack together in the same way as soap bubbles do. The shaping of the cone cell group and packing of its components precisely imitate the physical tendency for surfaces to be minimized. Thus, simple patterned expression of N-cadherin results in a complex spatial pattern of cells owing to cellular surface mechanics.	Northwestern Univ, Dept Biochem Mol Biol & Cell Biol, Evanston, IL 60208 USA; Univ Tokyo, Grad Sch Sci, Dept Biophys & Biochem, Tokyo 1130033, Japan	Northwestern University; University of Tokyo	Hayashi, T (corresponding author), Northwestern Univ, Dept Biochem Mol Biol & Cell Biol, 2153 Sheridan Rd, Evanston, IL 60208 USA.	t-hayashi@northwestern.edu; r-carthew@northwestern.edu	Hayashi, Takashi/D-5466-2016					BASLER K, 1994, NATURE, V368, P208, DOI 10.1038/368208a0; BLOCHLINGER K, 1993, DEVELOPMENT, V117, P441; Bloor JW, 2002, DEVELOPMENT, V129, P3173; CAGAN RL, 1989, DEV BIOL, V136, P346, DOI 10.1016/0012-1606(89)90261-3; Chanut F, 2002, GENETICS, V160, P623; CHICHILNISKY EJ, 1986, J THEOR BIOL, V123, P81, DOI 10.1016/S0022-5193(86)80237-5; Davis GS, 1997, DEV BIOL, V192, P630, DOI 10.1006/dbio.1997.8741; Duguay D, 2003, DEV BIOL, V253, P309, DOI 10.1016/S0012-1606(02)00016-7; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Foty RA, 1996, DEVELOPMENT, V122, P1611; Godt D, 1998, NATURE, V395, P387, DOI 10.1038/26493; GOLIC KG, 1989, CELL, V59, P499, DOI 10.1016/0092-8674(89)90033-0; Hayashi T, 1998, DEV BIOL, V200, P131, DOI 10.1006/dbio.1998.8959; HIGASHIJIMA SI, 1992, GENE DEV, V6, P50, DOI 10.1101/gad.6.1.50; Hynes RO, 2000, J CELL BIOL, V150, pF89, DOI 10.1083/jcb.150.2.F89; Ito K, 1997, DEVELOPMENT, V124, P761; Iwai Y, 1997, NEURON, V19, P77, DOI 10.1016/S0896-6273(00)80349-9; Jamora C, 2002, NAT CELL BIOL, V4, pE101, DOI 10.1038/ncb0402-e101; Knox AL, 2002, SCIENCE, V295, P1285, DOI 10.1126/science.1067549; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Morgan T.H., 1927, EXPT EMBRYOLOGY; Newsome TP, 2000, DEVELOPMENT, V127, P851; Oda H, 1999, DEV BIOL, V216, P406, DOI 10.1006/dbio.1999.9494; ODA H, 1994, DEV BIOL, V165, P716, DOI 10.1006/dbio.1994.1287; PEIFER M, 1994, DEV BIOL, V166, P543, DOI 10.1006/dbio.1994.1336; Pignoni F, 1997, DEVELOPMENT, V124, P271; Plateau J., 1873, STATIQUE EXPT THEORI; READY DF, 1976, DEV BIOL, V53, P217, DOI 10.1016/0012-1606(76)90225-6; RENFRANZ PJ, 1989, DEV BIOL, V136, P411, DOI 10.1016/0012-1606(89)90267-4; Sanson B, 1996, NATURE, V383, P627, DOI 10.1038/383627a0; STEINBERG MS, 1963, SCIENCE, V141, P401, DOI 10.1126/science.141.3579.401; STEINBERG MS, 1994, P NATL ACAD SCI USA, V91, P206, DOI 10.1073/pnas.91.1.206; Strausfeld N. J., 1981, HDB SENSORY PHYSL, VVII, P1; TAYLOR JE, 1976, ANN MATH, V103, P489, DOI 10.2307/1970949; Tepass U, 2001, ANNU REV GENET, V35, P747, DOI 10.1146/annurev.genet.35.102401.091415; Thomas GH, 1998, DEVELOPMENT, V125, P2125; Thompson D.W, 1917, GROWTH FORM; VINCENT JP, 1994, CELL, V77, P909, DOI 10.1016/0092-8674(94)90139-2; Wolff Tanya, 1993, P1277; Zhu B, 2003, BIOPHYS J, V84, P4033, DOI 10.1016/S0006-3495(03)75129-7	40	243	248	1	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 7	2004	431	7009					647	652		10.1038/nature02952	http://dx.doi.org/10.1038/nature02952			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	859WS	15470418				2022-12-28	WOS:000224299300030
J	Rao, SV; Jollis, JG; Harrington, RA; Granger, CB; Newby, LK; Armstrong, PW; Moliterno, DJ; Lindblad, L; Pieper, K; Topol, EJ; Stamler, JS; Califf, RM				Rao, SV; Jollis, JG; Harrington, RA; Granger, CB; Newby, LK; Armstrong, PW; Moliterno, DJ; Lindblad, L; Pieper, K; Topol, EJ; Stamler, JS; Califf, RM			Relationship of blood transfusion and clinical outcomes in patients with acute coronary syndromes	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CELL TRANSFUSION; TRIAL; STRATEGIES; SURVIVAL; IMPACT	Context It is unclear if blood transfusion in anemic patients with acute coronary syndromes is associated with improved survival. Objective To determine the association between blood transfusion and mortality among patients with acute coronary syndromes who develop bleeding, anemia, or both during their hospital course. Design, Setting, and Patients We analyzed 24112 enrollees in 3 large international trials of patients with acute coronary syndromes (the GUSTO IIb, PURSUIT, and PARAGON B trials). Patients were grouped according to whether they received a blood transfusion during the hospitalization. The association between transfusion and outcome was assessed using Cox proportional hazards modeling that incorporated transfusion as a time-dependent covariate and the propensity to receive blood, and a landmark analysis. Main Outcome Measure Thirty-day mortality. Results Of the patients included, 2401 (10.0%) underwent at least 1 blood transfusion during their hospitalization. Patients who underwent transfusion were older and had more comorbid illness at presentation and also had a significantly higher unadjusted rate of 30-day death (8.00% vs 3.08%; P<.001), myocardial infarction (MI) (25.16% vs 8.16%; P<.001), and death/Ml (29.24% vs 10.02%; P<.001) compared with patients who did not undergo transfusion. Using Cox proportional hazards modeling that incorporated transfusion as a time-dependent covariate, transfusion was associated with an increased hazard for 30-day death (adjusted hazard ratio [HR], 3.94; 95% confidence interval [CI], 3.26-4.75) and 30-day death/Ml (HR, 2.92; 95% Cl, 2.55-3.35). In the landmark analysis that included procedures and bleeding events, transfusion was associated with a trend toward increased mortality. The predicted probability of 30-day death was higher with transfusion at nadir hematocrit values above 25%. Conclusions Blood transfusion in the setting of acute coronary syndromes is associated with higher mortality, and this relationship persists after adjustment for other predictive factors and timing of events. Given the limitations of post hoc analysis of clinical trials data, a randomized trial of transfusion strategies is warranted to resolve the disparity in results between our study and other observational studies. We suggest caution regarding the routine use of blood transfusion to maintain arbitrary hematocrit levels in stable patients with ischemic heart disease.	Duke Clin Res Inst, Durham, NC 27715 USA; Duke Univ, Med Ctr, Howard Hughes Med Inst, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; Univ Alberta, Dept Cardiol, Edmonton, AB, Canada; Univ Kentucky, Div Cardiol, Lexington, KY USA; Cleveland Clin Fdn, Cleveland, OH 44195 USA	Duke University; Duke University; Howard Hughes Medical Institute; Duke University; University of Alberta; University of Kentucky; Cleveland Clinic Foundation	Rao, SV (corresponding author), Duke Clin Res Inst, POB 17969,2400 Pratt St, Durham, NC 27715 USA.	sunil.rao@duke.edu	Granger, Christopher B/D-3458-2014	Granger, Christopher B/0000-0002-0045-3291; Topol, Eric/0000-0002-1478-4729; Armstrong, Paul/0000-0002-0460-3445; Stamler, Jonathan/0000-0002-6866-1572				ANDERSON JR, 1983, J CLIN ONCOL, V1, P710, DOI 10.1200/JCO.1983.1.11.710; ANDERSON JR, 1985, CANCER TREAT REP, V69, P1139; Boersma E, 2000, CIRCULATION, V101, P2557, DOI 10.1161/01.CIR.101.22.2557; Bush RL, 1997, AM J SURG, V174, P143, DOI 10.1016/S0002-9610(97)00073-1; Carson JL, 1996, LANCET, V348, P1055, DOI 10.1016/S0140-6736(96)04330-9; Casutt M, 1999, CRIT CARE MED, V27, P2194, DOI 10.1097/00003246-199910000-00021; CHESEBRO JH, 1987, CIRCULATION, V76, P142, DOI 10.1161/01.CIR.76.1.142; DIETRICH KA, 1990, CRIT CARE MED, V18, P940, DOI 10.1097/00003246-199009000-00007; FORTUNE JB, 1987, J TRAUMA, V27, P243, DOI 10.1097/00005373-198703000-00003; Fransen E, 1999, CHEST, V116, P1233, DOI 10.1378/chest.116.5.1233; GOODNOUGH LT, 1993, AM J MED, V94, P509, DOI 10.1016/0002-9343(93)90086-5; Greenburg AG, 1995, AM J SURG, V170, pS44, DOI 10.1016/S0002-9610(99)80058-0; Hebert PC, 2001, CRIT CARE MED, V29, P227, DOI 10.1097/00003246-200102000-00001; Hebert PC, 1999, NEW ENGL J MED, V340, P409, DOI 10.1056/NEJM199902113400601; HEBERT PC, 2001, CMAJ S11, V156, pS27; JOHNSON RG, 1992, J THORAC CARDIOV SUR, V104, P307; McMahon TJ, 2002, NAT MED, V8, P711, DOI 10.1038/nm718; PARAGON B, 2002, CIRCULATION, V105, P316; TOPOL E, 1993, NEW ENGL J MED, V329, P673, DOI 10.1056/nejm199309023291001; Topol E, 1998, NEW ENGL J MED, V339, P436; Topol EJ, 1996, NEW ENGL J MED, V335, P775; WELCH HG, 1992, ANN INTERN MED, V116, P393, DOI 10.7326/0003-4819-116-5-393; Wu WC, 2001, NEW ENGL J MED, V345, P1230, DOI 10.1056/NEJMoa010615	23	788	818	0	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 6	2004	292	13					1555	1562		10.1001/jama.292.13.1555	http://dx.doi.org/10.1001/jama.292.13.1555			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	859HS	15467057	Bronze			2022-12-28	WOS:000224254600022
J	Humayun, M; Qin, LP; Norman, MD				Humayun, M; Qin, LP; Norman, MD			Geochemical evidence for excess iron in the mantle beneath Hawaii	SCIENCE			English	Article							PARTIAL MELTING EXPERIMENTS; EARTHS CORE; OS-186-OS-187 SYSTEMATICS; BOUNDARY-LAYER; DEEP-MANTLE; BASALTS; ELEMENTS; HETEROGENEITY; KOMATIITES; PYROXENITE	Chemical interaction of Earth's mantle with the liquid outer core should influence the mantle's iron content. Osmium isotope ratios in Hawaiian lavas indicate a mass flux of less than or equal to1% core to the mantle, which is the immediate source of these lavas. We present precise measurements of the Fe/Mn ratio for Hawaiian lavas, revealing an increase of 1 to 2% in the mote fraction of iron in the mantle beneath Hawaii. This corresponds to a density anomaly of about 0.5%, about the same magnitude observed in seismic tomography models of the Pacific superswell region. These data also rule out a role for Mn-rich sediments as the source of the Hawaiian Os isotope signal.	Univ Chicago, Dept Geophys Sci, Chicago, IL 60637 USA; Florida State Univ, Natl High Magnet Field Lab, Tallahassee, FL 32310 USA; Florida State Univ, Dept Geol Sci, Tallahassee, FL 32310 USA; Australian Natl Univ, Res Sch Earth Sci, Canberra, ACT 0200, Australia	University of Chicago; State University System of Florida; Florida State University; State University System of Florida; Florida State University; Australian National University	Humayun, M (corresponding author), Univ Chicago, Dept Geophys Sci, 5734 S Ellis Ave, Chicago, IL 60637 USA.	humayun@magnet.fsu.edu	Qin, Liping/AAW-1448-2021; Humayun, Munir/A-1247-2007	Norman, Marc/0000-0002-1357-5415; Humayun, Munir/0000-0001-8516-9435				Brandon AD, 1999, EARTH PLANET SC LETT, V174, P25, DOI 10.1016/S0012-821X(99)00251-4; Brandon AD, 2003, EARTH PLANET SC LETT, V206, P411, DOI 10.1016/S0012-821X(02)01101-9; Buffett BA, 2000, SCIENCE, V290, P1338, DOI 10.1126/science.290.5495.1338; Chabot NL, 2003, METEORIT PLANET SCI, V38, P181, DOI 10.1111/j.1945-5100.2003.tb00259.x; Forte AM, 2001, NATURE, V410, P1049, DOI 10.1038/35074000; Garnero EJ, 2000, ANNU REV EARTH PL SC, V28, P509, DOI 10.1146/annurev.earth.28.1.509; Jellinek AM, 2004, REV GEOPHYS, V42, DOI 10.1029/2003RG000144; Jellinek AM, 2002, NATURE, V418, P760, DOI 10.1038/nature00979; Kellogg LH, 1999, SCIENCE, V283, P1881, DOI 10.1126/science.283.5409.1881; KNITTLE E, 1991, SCIENCE, V251, P1438, DOI 10.1126/science.251.5000.1438; Kogiso T, 2003, EARTH PLANET SC LETT, V216, P603, DOI 10.1016/S0012-821X(03)00538-7; LANGMUIR CH, 1980, PHILOS T R SOC A, V297, P383, DOI 10.1098/rsta.1980.0223; Lay T, 1998, NATURE, V392, P461, DOI 10.1038/33083; MCDONOUGH WF, 1995, CHEM GEOL, V120, P223, DOI 10.1016/0009-2541(94)00140-4; Norman MD, 1999, EARTH PLANET SC LETT, V168, P27, DOI 10.1016/S0012-821X(99)00043-6; Pertermann M, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2000JB000118; Pertermann M, 2003, J PETROL, V44, P2173, DOI 10.1093/petrology/egg074; POIRIER JP, 1994, PHYS EARTH PLANET IN, V85, P319, DOI 10.1016/0031-9201(94)90120-1; Puchtel I, 2000, GEOCHIM COSMOCHIM AC, V64, P4227, DOI 10.1016/S0016-7037(00)00492-0; Ravizza G, 2001, EARTH PLANET SC LETT, V188, P369, DOI 10.1016/S0012-821X(01)00337-5; Rost S, 2001, SCIENCE, V294, P1911, DOI 10.1126/science.1065617; Rubie DC, 2004, NATURE, V429, P58, DOI 10.1038/nature02473; Ruzicka A, 2001, GEOCHIM COSMOCHIM AC, V65, P979, DOI 10.1016/S0016-7037(00)00599-8; Schersten A, 2004, NATURE, V427, P234, DOI 10.1038/nature02221; Walker D, 2000, GEOCHIM COSMOCHIM AC, V64, P2897, DOI 10.1016/S0016-7037(00)00429-4; Walter MJ, 1998, J PETROL, V39, P29, DOI 10.1093/petrology/39.1.29; Williams Q, 1998, SCIENCE, V281, P546, DOI 10.1126/science.281.5376.546	27	181	196	4	53	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 1	2004	306	5693					91	94		10.1126/science.1101050	http://dx.doi.org/10.1126/science.1101050			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	859YJ	15459385				2022-12-28	WOS:000224304000042
J	Khaw, KT; Wareham, N; Bingham, S; Luben, R; Welch, A; Day, N				Khaw, KT; Wareham, N; Bingham, S; Luben, R; Welch, A; Day, N			Association of hemoglobin A(1c) with cardiovascular disease and mortality in adults: The European prospective investigation into cancer in Norfolk	ANNALS OF INTERNAL MEDICINE			English	Article							CORONARY-HEART-DISEASE; RISK-FACTOR; GLYCATED HEMOGLOBIN; GLUCOSE-TOLERANCE; DIABETES-MELLITUS; FASTING GLYCEMIA; PLASMA-GLUCOSE; LIFE-STYLE; PREVENTION; CLASSIFICATION	Background: increasing evidence suggests a continuous relationship between blood glucose concentrations and cardiovascular risk, even below diagnostic threshold levels for diabetes. Objective: To examine the relationship between hemoglobin A(1c), cardiovascular disease, and total mortality. Design: Prospective population study. Setting: Norfolk, United Kingdom. Participants: 4662 men and 5570 women who were 45 to 79 years of age and were residents of Norfolk. Measurements: Hemoglobin A(1c) and cardiovascular disease risk factors were assessed from 1995 to 1997, and cardiovascular disease events and mortality were assessed during the follow-up period to 2003. Results: In men and women, the relationship between hemoglobin A(1c) and cardiovascular disease (806 events) and between hemoglobin A(1c) and all-cause mortality (521 deaths) was continuous and significant throughout the whole distribution. The relationship was apparent in persons without known diabetes. Persons with hemoglobin A(1c) concentrations less than 5% had the lowest rates of cardiovascular disease and mortality. An increase in hemoglobin A(1c) of 1 percentage point was associated with a relative risk for death from any cause of 1.24 (95% Cl, 1.14 to 1.34; P < 0.001) in men and with a relative risk of 1.28 (Cl, 1.06 to 1.32; P < 0.001) in women. These relative risks were independent of age, body mass index, waist-to-hip ratio, systolic blood pressure, serum cholesterol concentration, cigarette smoking, and history of cardiovascular disease. When persons with known diabetes, hemoglobin Ale concentrations of 7% or greater, or a history of cardiovascular disease were excluded, the result was similar (adjusted relative risk, 1.26 [Cl, 1.04 to 1.52]; P = 0.02). Fifteen percent (68 of 521) of the deaths in the sample occurred in persons with diabetes (4% of the sample), but 72% (375 of 521) occurred in persons with HbA(1c) concentrations between 5% and 6.9%. Limitations: Whether HbA(1c) concentrations and cardiovascular disease are causally related cannot be concluded from an observational study; intervention studies are needed to determine whether decreasing HbA(1c) concentrations would reduce cardiovascular disease. Conclusions: The risk for cardiovascular disease and total mortality associated with hemoglobin A(1c) concentrations increased continuously through the sample distribution. Most of the events in the sample occurred in persons with moderately elevated HbA(1c) concentrations. These findings support the need for randomized trials of interventions to reduce hemoglobin A(1c) concentrations in persons without diabetes.	Univ Cambridge, Epidemiol Unit, MRC, Cambridge CB2 2AH, England; MRC, Dunn Nutr Unit, Cambridge CB4 1XJ, England	University of Cambridge	Khaw, KT (corresponding author), Univ Cambridge, Addenbrookes Hosp, Sch Clin Med, Clin Gerontol Unit, Box 251, Cambridge CB2 2QQ, England.	kk101@medschl.cam.ac.uk	Luben, Robert N/H-5519-2015; Khaw, Kay-Tee/AAZ-3209-2021; Welch, Ailsa Ann/A-4850-2008	Luben, Robert N/0000-0002-5088-6343; Welch, Ailsa Ann/0000-0002-6702-3704				Alberti KGMM, 1998, DIABETIC MED, V15, P535, DOI 10.1002/(SICI)1096-9136(199807)15:7<535::AID-DIA670>3.3.CO;2-H; Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Balkau B, 1998, DIABETES CARE, V21, P360, DOI 10.2337/diacare.21.3.360; Coutinho M, 1999, DIABETES CARE, V22, P233, DOI 10.2337/diacare.22.2.233; Day N, 1999, BRIT J CANCER, V80, P95; de Vegt F, 1999, DIABETOLOGIA, V42, P926, DOI 10.1007/s001250051249; FULLER JH, 1979, J CHRON DIS, V32, P721, DOI 10.1016/0021-9681(79)90051-1; Gaede P, 2003, NEW ENGL J MED, V348, P383, DOI 10.1056/NEJMoa021778; Gavin JR, 1999, DIABETES CARE, V22, pS5; Gerstein HC, 1997, DIABETIC MED, V14, pS25, DOI 10.1002/(SICI)1096-9136(199708)14:3+<S25::AID-DIA441>3.3.CO;2-T; Haffner SM, 1998, NEW ENGL J MED, V339, P229, DOI 10.1056/NEJM199807233390404; Harding AH, 2001, DIABETES CARE, V24, P1911, DOI 10.2337/diacare.24.11.1911; Khaw KT, 2001, BMJ-BRIT MED J, V322, P15, DOI 10.1136/bmj.322.7277.15; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Lloyd-Jones DM, 1998, ANN INTERN MED, V129, P1020, DOI 10.7326/0003-4819-129-12-199812150-00005; Marshall SM, 2000, DIABETIC MED, V17, P5, DOI 10.1046/j.1464-5491.2000.00228.x; MCCANCE DR, 1994, BRIT MED J, V308, P1323, DOI 10.1136/bmj.308.6940.1323; Meigs JB, 2002, DIABETES CARE, V25, P1845, DOI 10.2337/diacare.25.10.1845; Park S, 1996, DIABETES CARE, V19, P450, DOI 10.2337/diacare.19.5.450; Pearson TA, 2002, CIRCULATION, V106, P388, DOI 10.1161/01.CIR.0000020190.45892.75; PYORALA K, 1979, J CHRON DIS, V32, P729, DOI 10.1016/0021-9681(79)90052-3; PYORALA K, 1994, EUR HEART J, V15, P1300; ROSE G, 1981, BMJ-BRIT MED J, V282, P1847, DOI 10.1136/bmj.282.6279.1847; Sargeant LA, 2001, EUR J CLIN NUTR, V55, P342, DOI 10.1038/sj.ejcn.1601162; SCHEIDTNAVE C, 1991, AM J EPIDEMIOL, V133, P565, DOI 10.1093/oxfordjournals.aje.a115928; Stearne MR, 1998, BMJ-BRIT MED J, V317, P703; Tuomilehto Jaakko, 2001, New England Journal of Medicine, V344, P1343, DOI 10.1056/NEJM200105033441801; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Unwin N, 2002, DIABETIC MED, V19, P708, DOI 10.1046/j.1464-5491.2002.00835.x; Vinicor F, 2003, LANCET, V361, P544, DOI 10.1016/S0140-6736(03)12561-5; Wood D, 1998, HEART, V80, pS1; Zimmet P, 2001, NATURE, V414, P782, DOI 10.1038/414782a	32	740	788	0	25	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 21	2004	141	6					413	420		10.7326/0003-4819-141-6-200409210-00006	http://dx.doi.org/10.7326/0003-4819-141-6-200409210-00006			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	856TM	15381514				2022-12-28	WOS:000224067900001
J	Gerald, D; Berra, E; Frapart, YM; Chan, DA; Giaccia, AJ; Mansuy, D; Pouyssegur, J; Yaniv, M; Mechta-Grigoriou, F				Gerald, D; Berra, E; Frapart, YM; Chan, DA; Giaccia, AJ; Mansuy, D; Pouyssegur, J; Yaniv, M; Mechta-Grigoriou, F			JunD reduces tumor angiogenesis by protecting cells from oxidative stress	CELL			English	Article							HYPOXIA-INDUCIBLE FACTOR; ENDOTHELIAL GROWTH-FACTOR; MITOCHONDRIAL RESPIRATORY-CHAIN; GENE-EXPRESSION; FACTOR-I; TRANSCRIPTIONAL RESPONSE; PARAMAGNETIC-RESONANCE; PROLYL HYDROXYLATION; CYCLE PROGRESSION; MESSENGER-RNA	Reactive oxygen species (ROS) are implicated in the pathophysiology of various diseases, including cancer. In this study, we show that JunD, a member of the AP-1 family of transcription factors, reduces tumor angiogenesis by limiting Ras-mediated production of ROS. Using junD-deficient cells, we demonstrate that JunD regulates genes involved in antioxidant defense, H2O2 production, and angiogenesis. The accumulation of H2O2 in junD(-/-) cells decreases the availability of Fell and reduces the activity of HIF prolyl hydroxylases (PHDs) that target hypoxia-inducible factors-alpha (HIF(alpha) for degradation. Subsequently, HIF-alpha proteins accumulate and enhance the transcription of VEGF-A, a potent proangiogenic factor. Our study uncovers the mechanism by which JunD protects cells from oxidative stress and exerts an antiangiogenic effect. Furthermore, we provide new insights into the regulation of PHD activity, allowing immediate reactive adaptation to changes in O-2 or iron levels in the cell.	Inst Pasteur, Unit Gene Express & Dis, CNRS, URA 1644, F-75724 Paris 15, France; CNRS, Inst Signaling Dev Biol & Canc Res, UMR 6543, Ctr Antoine Lacassagne, F-06189 Nice, France; Univ Paris 05, Lab Chim Biochim Pharmacol & Toxicol, CNRS, UMR 8601, F-75270 Paris 06, France; Stanford Univ, Dept Radiat Oncol, Sch Med, Stanford, CA 94305 USA	Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; UNICANCER; Centre Antoine Lacassagne; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite Paris Cite; Stanford University	Mechta-Grigoriou, F (corresponding author), Inst Pasteur, Unit Gene Express & Dis, CNRS, URA 1644, 25 Rue Docteur Roux, F-75724 Paris 15, France.	fmechta@pasteur.fr	MECHTA-GRIGORIOU, Fatima/C-5253-2017; Berra, Edurne/F-9692-2011; Chan, Doris/O-1227-2014	MECHTA-GRIGORIOU, Fatima/0000-0002-3751-6989; Berra, Edurne/0000-0002-3820-5744; Chan, Doris/0000-0002-4990-986X; Yves-Michel, FRAPART/0000-0003-3854-3580				Agani FH, 2000, J BIOL CHEM, V275, P35863, DOI 10.1074/jbc.M005643200; Arbiser JL, 2002, P NATL ACAD SCI USA, V99, P715, DOI 10.1073/pnas.022630199; BARBACID M, 1987, ANNU REV BIOCHEM, V56, P779, DOI 10.1146/annurev.bi.56.070187.004023; Benjamin LE, 1997, P NATL ACAD SCI USA, V94, P8761, DOI 10.1073/pnas.94.16.8761; Bergers G, 2003, NAT REV CANCER, V3, P401, DOI 10.1038/nrc1093; Berra E, 2003, EMBO J, V22, P4082, DOI 10.1093/emboj/cdg392; BOS JL, 1989, CANCER RES, V49, P4682; Bruick RK, 2001, SCIENCE, V294, P1337, DOI 10.1126/science.1066373; CAMMACK R, 1993, METHOD ENZYMOL, V227, P353, DOI 10.1016/0076-6879(93)27014-8; Chan DA, 2002, J BIOL CHEM, V277, P40112, DOI 10.1074/jbc.M206922200; Chandel NS, 1998, P NATL ACAD SCI USA, V95, P11715, DOI 10.1073/pnas.95.20.11715; Chen CH, 2001, J BIOL CHEM, V276, P9519, DOI 10.1074/jbc.M010144200; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Fandrey J, 2000, ADV EXP MED BIOL, V475, P153; Feger F, 2001, CANCER RES, V61, P5289; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; FOLKMAN J, 1990, JNCI-J NATL CANCER I, V82, P4, DOI 10.1093/jnci/82.1.4; Giaccia A, 2003, NAT REV DRUG DISCOV, V2, P803, DOI 10.1038/nrd1199; Guichet A, 1997, NATURE, V385, P548, DOI 10.1038/385548a0; IKEDA E, 1995, J BIOL CHEM, V270, P19761, DOI 10.1074/jbc.270.34.19761; Irani K, 1997, SCIENCE, V275, P1649, DOI 10.1126/science.275.5306.1649; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Kim W, 2003, CURR OPIN GENET DEV, V13, P55, DOI 10.1016/S0959-437X(02)00010-2; Knowles HJ, 2003, CANCER RES, V63, P1764; KOVARY K, 1991, MOL CELL BIOL, V11, P4466, DOI 10.1128/MCB.11.9.4466; Lallemand D, 1997, ONCOGENE, V14, P819, DOI 10.1038/sj.onc.1200901; Lando D, 2002, SCIENCE, V295, P858, DOI 10.1126/science.1068592; Leppa S, 1999, ONCOGENE, V18, P6158, DOI 10.1038/sj.onc.1203173; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Liu Q, 2004, P NATL ACAD SCI USA, V101, P4302, DOI 10.1073/pnas.0400265101; Mahon PC, 2001, GENE DEV, V15, P2675, DOI 10.1101/gad.924501; Mechta F, 1997, ONCOGENE, V14, P837, DOI 10.1038/sj.onc.1200900; Mechta-Grigoriou F, 2001, ONCOGENE, V20, P2378, DOI 10.1038/sj.onc.1204381; Mitsushita J, 2004, CANCER RES, V64, P3580, DOI 10.1158/0008-5472.CAN-03-3909; Peeper DS, 1997, NATURE, V386, P177, DOI 10.1038/386177a0; PFARR CM, 1994, CELL, V76, P747, DOI 10.1016/0092-8674(94)90513-4; Pugh CW, 2003, SEMIN CANCER BIOL, V13, P83, DOI 10.1016/S1044-579X(02)00103-7; Pugh CW, 2003, NAT MED, V9, P677, DOI 10.1038/nm0603-677; Quinn J, 2002, MOL BIOL CELL, V13, P805, DOI 10.1091/mbc.01-06-0288; Richard DE, 2000, J BIOL CHEM, V275, P26765; ROSCHE B, 1995, BIOCHIM BIOPHYS ACTA, V1252, P117; Semenza GL, 1999, ANNU REV CELL DEV BI, V15, P551, DOI 10.1146/annurev.cellbio.15.1.551; Shaulian E, 2002, NAT CELL BIOL, V4, pE131, DOI 10.1038/ncb0502-e131; Srinivas V, 2001, J BIOL CHEM, V276, P21995, DOI 10.1074/jbc.C100177200; Suzuki YJ, 1997, FREE RADICAL BIO MED, V22, P269, DOI 10.1016/S0891-5849(96)00275-4; TISCHER E, 1991, J BIOL CHEM, V266, P11947; TODARO GJ, 1963, J CELL BIOL, V17, P299, DOI 10.1083/jcb.17.2.299; Townsend DM, 2003, ONCOGENE, V22, P7369, DOI 10.1038/sj.onc.1206940; Ubbink M, 2002, ANNU REV BIOPH BIOM, V31, P393, DOI 10.1146/annurev.biophys.31.091701.171000; Vaux EC, 2001, BLOOD, V98, P296, DOI 10.1182/blood.V98.2.296; Venugopal R, 1998, ONCOGENE, V17, P3145, DOI 10.1038/sj.onc.1202237; Wagner EF, 2001, ONCOGENE, V20, P2334, DOI 10.1038/sj.onc.1204416; WANG GL, 1993, P NATL ACAD SCI USA, V90, P4304, DOI 10.1073/pnas.90.9.4304; Wang MC, 2003, DEV CELL, V5, P811, DOI 10.1016/S1534-5807(03)00323-X; Weitzman JB, 2000, MOL CELL, V6, P1109, DOI 10.1016/S1097-2765(00)00109-X; Wenger RH, 2002, FASEB J, V16, DOI 10.1096/fj.01-0944rev; Wisdom R, 1999, EMBO J, V18, P188, DOI 10.1093/emboj/18.1.188	58	451	468	1	42	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 17	2004	118	6					781	794		10.1016/j.cell.2004.08.025	http://dx.doi.org/10.1016/j.cell.2004.08.025			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	855RW	15369676	Bronze			2022-12-28	WOS:000223992400013
J	Nellist, PD; Chisholm, MF; Dellby, N; Krivanek, OL; Murfitt, MF; Szilagyi, ZS; Lupini, AR; Borisevich, A; Sides, WH; Pennycook, SJ				Nellist, PD; Chisholm, MF; Dellby, N; Krivanek, OL; Murfitt, MF; Szilagyi, ZS; Lupini, AR; Borisevich, A; Sides, WH; Pennycook, SJ			Direct sub-angstrom imaging of a crystal lattice	SCIENCE			English	Article							TRANSMISSION ELECTRON-MICROSCOPY; RESOLUTION		Oak Ridge Natl Lab, Condensed Matter Sci Div, Oak Ridge, TN 37831 USA; Nion Co, Kirkland, WA 98033 USA	United States Department of Energy (DOE); Oak Ridge National Laboratory	Pennycook, SJ (corresponding author), Oak Ridge Natl Lab, Condensed Matter Sci Div, Oak Ridge, TN 37831 USA.	pennycooksj@ornl.gov	Chisholm, Matthew F./F-7198-2017; Pennycook, Stephen/AAA-1112-2019; Borisevich, Albina Y/B-1624-2009	Chisholm, Matthew F./0000-0003-0546-5109; Pennycook, Stephen/0000-0002-3210-6323; Borisevich, Albina Y/0000-0002-3953-8460; Lupini, Andrew/0000-0002-1874-7925				Batson PE, 2002, NATURE, V418, P617, DOI 10.1038/nature00972; Kawasaki T, 2000, APPL PHYS LETT, V76, P1342, DOI 10.1063/1.126028; Nellist PD, 1998, PHYS REV LETT, V81, P4156, DOI 10.1103/PhysRevLett.81.4156; O'Keefe MA, 2001, PHILOS MAG B, V81, P1861, DOI 10.1080/13642810110079692; O'Keefe MA, 2001, ULTRAMICROSCOPY, V89, P215, DOI 10.1016/S0304-3991(01)00094-8	5	393	410	0	183	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 17	2004	305	5691					1741	1741		10.1126/science.1100965	http://dx.doi.org/10.1126/science.1100965			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	856IS	15375260				2022-12-28	WOS:000224039500031
J	Pelkmans, L; Burli, T; Zerial, M; Helenius, A				Pelkmans, L; Burli, T; Zerial, M; Helenius, A			Caveolin-stabilized membrane domains as multifunctional transport and sorting devices in endocytic membrane traffic	CELL			English	Article							CHOLERA-TOXIN; IN-VIVO; GOLGI; INTERNALIZATION; SIMIAN-VIRUS-40; ENDOSOME; PATHWAY; RAB5; INHIBITION; CELLS	Endocytosis comprises several routes of internalization. An outstanding question is whether the caveolar and endosomal pathways intersect. Following transport of the caveolar protein Caveolin-1 and two cargo complexes, Simian Virus 40 and Cholera toxin, in live cells, we uncovered a Rab5-dependent pathway in which caveolar vesicles are targeted to early endosomes and form distinct and stable membrane domains. In endosomes, the low pH selectively allowed the toxin to diffuse out of the caveolar domains into the surrounding membrane, while the virus remained trapped. Thus, we conclude that, unlike cyclic assembly and disassembly of coat proteins in vesicular transport, oligomeric complexes of caveolin-1 confer permanent structural stability to caveolar vesicles that transiently interact with endosomes to form subdomains and release cargo selectively by compartment-specific cues.	Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany; Swiss Fed Inst Technol, Inst Biochem, CH-8093 Zurich, Switzerland	Max Planck Society; Swiss Federal Institutes of Technology Domain; ETH Zurich	Pelkmans, L (corresponding author), Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany.	pelkmans@mpi-cbg.de		Pelkmans, Lucas/0000-0002-6754-9730				Anderson HA, 1996, MOL BIOL CELL, V7, P1825, DOI 10.1091/mbc.7.11.1825; Anderson RGW, 1998, ANNU REV BIOCHEM, V67, P199, DOI 10.1146/annurev.biochem.67.1.199; Bacia K, 2002, BIOPHYS J, V83, P1184, DOI 10.1016/S0006-3495(02)75242-9; Barbero P, 2002, J CELL BIOL, V156, P511, DOI 10.1083/jcb.200109030; Benmerah A, 1999, J CELL SCI, V112, P1303; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; Conner SD, 2003, NATURE, V422, P37, DOI 10.1038/nature01451; Di Guglielmo GM, 2003, NAT CELL BIOL, V5, P410, DOI 10.1038/ncb975; Drab M, 2001, SCIENCE, V293, P2449, DOI 10.1126/science.1062688; DUPREE P, 1993, EMBO J, V12, P1597, DOI 10.1002/j.1460-2075.1993.tb05804.x; Fernandez I, 2002, P NATL ACAD SCI USA, V99, P11193, DOI 10.1073/pnas.172196599; FRA AM, 1995, P NATL ACAD SCI USA, V92, P8655, DOI 10.1073/pnas.92.19.8655; Gagescu R, 2000, MOL BIOL CELL, V11, P2775, DOI 10.1091/mbc.11.8.2775; Gaidarov I, 1999, NAT CELL BIOL, V1, P1, DOI 10.1038/8971; Gillooly DJ, 2000, EMBO J, V19, P4577, DOI 10.1093/emboj/19.17.4577; Gruenberg J, 2001, NAT REV MOL CELL BIO, V2, P721, DOI 10.1038/35096054; HEYNINGEN SV, 1974, SCIENCE, V183, P656, DOI DOI 10.1126/SCIENCE.183.4125.656; JANICOT M, 1991, J BIOL CHEM, V266, P12858; Kaiser RD, 1998, BBA-BIOMEMBRANES, V1375, P13, DOI 10.1016/S0005-2736(98)00127-8; KARTENBECK J, 1989, J CELL BIOL, V109, P2721, DOI 10.1083/jcb.109.6.2721; Keller P, 2001, NAT CELL BIOL, V3, P140, DOI 10.1038/35055042; Lanzetti L, 2000, NATURE, V408, P374, DOI 10.1038/35042605; Lebrand C, 2002, EMBO J, V21, P1289, DOI 10.1093/emboj/21.6.1289; McBride HM, 1999, CELL, V98, P377, DOI 10.1016/S0092-8674(00)81966-2; McCann JA, 1997, BIOCHEMISTRY-US, V36, P9169, DOI 10.1021/bi962996p; McNally JG, 1999, METHODS, V19, P373, DOI 10.1006/meth.1999.0873; Mellman I, 1996, ANNU REV CELL DEV BI, V12, P575, DOI 10.1146/annurev.cellbio.12.1.575; MONIER S, 1995, MOL BIOL CELL, V6, P911, DOI 10.1091/mbc.6.7.911; MURATA M, 1995, P NATL ACAD SCI USA, V92, P10339, DOI 10.1073/pnas.92.22.10339; Nichols BJ, 2002, NAT CELL BIOL, V4, P374, DOI 10.1038/ncb787; Orlandi PA, 1998, J CELL BIOL, V141, P905, DOI 10.1083/jcb.141.4.905; Panopoulou E, 2002, J BIOL CHEM, V277, P18046, DOI 10.1074/jbc.M107983200; Parton RG, 2003, TRAFFIC, V4, P724, DOI 10.1034/j.1600-0854.2003.00128.x; PARTON RG, 1994, J CELL BIOL, V127, P1199, DOI 10.1083/jcb.127.5.1199; Pelkmans L, 2002, SCIENCE, V296, P535, DOI 10.1126/science.1069784; Pelkmans L, 2001, NAT CELL BIOL, V3, P473, DOI 10.1038/35074539; Peters PJ, 2003, J CELL BIOL, V162, P703, DOI 10.1083/jcb.200304140; Pfeffer S, 2003, CELL, V112, P507, DOI 10.1016/S0092-8674(03)00118-1; Presley JF, 2002, NATURE, V417, P187, DOI 10.1038/417187a; Puri V, 2001, J CELL BIOL, V154, P535, DOI 10.1083/jcb.200102084; Razani B, 2001, J BIOL CHEM, V276, P6727, DOI 10.1074/jbc.M008340200; Richards AA, 2002, MOL BIOL CELL, V13, P1750, DOI 10.1091/mbc.01-12-0592; ROTHBERG KG, 1992, CELL, V68, P673, DOI 10.1016/0092-8674(92)90143-Z; Sandvig K, 2002, FEBS LETT, V529, P49, DOI 10.1016/S0014-5793(02)03182-4; Sonnichsen B, 2000, J CELL BIOL, V149, P901, DOI 10.1083/jcb.149.4.901; Stang E, 1997, MOL BIOL CELL, V8, P47, DOI 10.1091/mbc.8.1.47; STENMARK H, 1994, EMBO J, V13, P1287, DOI 10.1002/j.1460-2075.1994.tb06381.x; Tall GG, 2001, DEV CELL, V1, P73, DOI 10.1016/S1534-5807(01)00008-9; Thomsen P, 2002, MOL BIOL CELL, V13, P238, DOI 10.1091/mbc.01-06-0317; TRAN D, 1987, P NATL ACAD SCI USA, V84, P7957, DOI 10.1073/pnas.84.22.7957; Tsai B, 2003, EMBO J, V22, P4346, DOI 10.1093/emboj/cdg439; UPCROFT P, 1987, J GEN VIROL, V68, P2477, DOI 10.1099/0022-1317-68-9-2477; Waguri S, 2003, MOL BIOL CELL, V14, P142, DOI 10.1091/mbc.E02-06-0338; White J, 1999, J CELL BIOL, V147, P743, DOI 10.1083/jcb.147.4.743; YGUERABIDE J, 1982, BIOPHYS J, V40, P69, DOI 10.1016/S0006-3495(82)84459-7; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055	56	400	413	3	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 17	2004	118	6					767	780		10.1016/j.cell.2004.09.003	http://dx.doi.org/10.1016/j.cell.2004.09.003			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	855RW	15369675	Bronze			2022-12-28	WOS:000223992400012
J	Pfanner, N; Wiedemann, N; Meisinger, C				Pfanner, N; Wiedemann, N; Meisinger, C			Double membrane fusion	SCIENCE			English	Editorial Material							MITOCHONDRIAL FUSION; INHERITANCE; MGM1P		Univ Freiburg, Inst Biochem & Mol Biol, D-79104 Freiburg, Germany	University of Freiburg	Pfanner, N (corresponding author), Univ Freiburg, Inst Biochem & Mol Biol, D-79104 Freiburg, Germany.	nikolaus.pfanner@biochemie.uni-freiburg.de	Pfanner, Nikolaus/AAV-7878-2021; Meisinger, Chris/J-1110-2014	Meisinger, Chris/0000-0002-8326-3548; Wiedemann, Nils/0000-0001-8305-6728				Boldogh IR, 2001, TRAFFIC, V2, P368, DOI 10.1034/j.1600-0854.2001.002006368.x; Bonifacino JS, 2004, CELL, V116, P153, DOI 10.1016/S0092-8674(03)01079-1; Herlan M, 2004, J CELL BIOL, V165, P167, DOI 10.1083/jcb.200403022; Koshiba T, 2004, SCIENCE, V305, P858, DOI 10.1126/science.1099793; Meeusen S, 2004, SCIENCE, V305, P1747, DOI 10.1126/science.1100612; Meisinger C, 2004, DEV CELL, V7, P61, DOI 10.1016/j.devcel.2004.06.003; Mozdy AD, 2003, NAT REV MOL CELL BIO, V4, P468, DOI 10.1038/nrm1125; Sesaki H, 2004, J BIOL CHEM, V279, P28298, DOI 10.1074/jbc.M401363200; Sickmann A, 2003, P NATL ACAD SCI USA, V100, P13207, DOI 10.1073/pnas.2135385100; van der Bliek AM, 2003, DEV CELL, V4, P769, DOI 10.1016/S1534-5807(03)00167-9; Westermann B, 2003, BBA-MOL CELL RES, V1641, P195, DOI 10.1016/S0167-4889(03)00091-0; Wong ED, 2003, J CELL BIOL, V160, P303, DOI 10.1083/jcb.200209015; Yaffe MP, 1999, SCIENCE, V283, P1493, DOI 10.1126/science.283.5407.1493	13	11	15	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 17	2004	305	5691					1723	1724		10.1126/science.1104244	http://dx.doi.org/10.1126/science.1104244			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	856IS	15375253				2022-12-28	WOS:000224039500024
J	Hancox, CI; Doret, SC; Hummon, MT; Luo, LJ; Doyle, JM				Hancox, CI; Doret, SC; Hummon, MT; Luo, LJ; Doyle, JM			Magnetic trapping of rare-earth atoms at millikelvin temperatures	NATURE			English	Article								The ability to create quantum degenerate gases has led to the realization of Bose-Einstein condensation of molecules(1-4), atom atom entanglement(5) and the accurate measurement of the Casimir force in atom-surface interactions(6). With a few exceptions(7-9), the achievement of quantum degeneracy relies on evaporative cooling of magnetically trapped atoms to ultracold temperatures. Magnetic traps confine atoms whose electronic magnetic moments are aligned anti-parallel to the magnetic field. This alignment must be preserved during the collisional thermalization of the atomic cloud. Quantum degeneracy has been reached in spherically symmetric, S-state atoms (atoms with zero internal orbital angular momentum). However, collisional relaxation of the atomic magnetic moments of non-S-state atoms (non-spherical atoms with non-zero internal orbital angular momentum) is thought to proceed rapidly. Here we demonstrate magnetic trapping of non-S-state rare-earth atoms, observing a suppression of the interaction anisotropy in collisions. The atoms behave effectively like S-state atoms because their unpaired electrons are shielded by two outer filled electronic shells that are spherically symmetric. Our results are promising for the creation of quantum degenerate gases with non-S-state atoms, and may facilitate the search for time variation of fundamental constants(10-12) and the development of a quantum computer with highly magnetic atoms(13).	Harvard Univ, Dept Phys, Cambridge, MA 02138 USA	Harvard University	Doyle, JM (corresponding author), Harvard Univ, Dept Phys, Cambridge, MA 02138 USA.	doyle@physics.harvard.edu	Hummon, Matthew Taylor/S-1139-2019	Hummon, Matthew Taylor/0000-0002-3020-0500; Doret, S. Charles/0000-0002-6349-7064				Barrett MD, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.010404; deCarvalho R, 1999, EUR PHYS J D, V7, P289, DOI 10.1007/s100530050572; DEREVIANKO A, QUANTUM COMPUTING MA; Donley EA, 2002, NATURE, V417, P529, DOI 10.1038/417529a; Dzuba VA, 1999, PHYS REV LETT, V82, P888, DOI 10.1103/PhysRevLett.82.888; Dzuba VA, 2003, PHYS REV A, V68, DOI 10.1103/PhysRevA.68.022506; Granade SR, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.120405; Greiner M, 2003, NATURE, V426, P537, DOI 10.1038/nature02199; Hansen DP, 2003, PHYS REV A, V67, DOI 10.1103/PhysRevA.67.021401; HARRIS JGE, IN PRESS EUROPHYS LE; HASTED JB, 1972, PHYS ATOMIC COLLISIO, P19; Jochim S, 2003, SCIENCE, V302, P2101, DOI 10.1126/science.1093280; Katori H, 2001, AIP CONF PROC, V551, P382, DOI 10.1063/1.1354362; Kim JH, 1997, PHYS REV LETT, V78, P3665, DOI 10.1103/PhysRevLett.78.3665; Kokoouline V, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.133201; Krems RV, 2003, PHYS REV A, V68, DOI 10.1103/PhysRevA.68.013406; KREMS RV, IN PRESS J PHYS CH A; Lin YJ, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.050404; Nagel SB, 2003, PHYS REV A, V67, DOI 10.1103/PhysRevA.67.011401; Nguyen AT, 2004, PHYS REV A, V69, DOI 10.1103/PhysRevA.69.022105; Schmidt PO, 2003, J OPT B-QUANTUM S O, V5, pS170, DOI 10.1088/1464-4266/5/2/376; Takasu Y, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.040404; Widera A, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.160406; Wynar R, 2000, SCIENCE, V287, P1016, DOI 10.1126/science.287.5455.1016; Xu XY, 2003, J OPT SOC AM B, V20, P968, DOI 10.1364/JOSAB.20.000968	25	106	108	0	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 16	2004	431	7006					281	284		10.1038/nature02938	http://dx.doi.org/10.1038/nature02938			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	853XJ	15372025				2022-12-28	WOS:000223864000033
J	Marcellin, P; Lau, GKK; Bonino, F; Farci, P; Hadziyannis, S; Jin, R; Lu, ZM; Piratvisuth, T; Germanidis, G; Yurdaydin, C; Diago, M; Gurel, S; Lai, MY; Button, P; Pluck, N				Marcellin, P; Lau, GKK; Bonino, F; Farci, P; Hadziyannis, S; Jin, R; Lu, ZM; Piratvisuth, T; Germanidis, G; Yurdaydin, C; Diago, M; Gurel, S; Lai, MY; Button, P; Pluck, N		Peginterferon Alfa-2a HBeAg-Negati	Peginterferon alfa-2a alone, lamivudine alone, and the two in combination in patients with HBeAg-negative chronic hepatitis B	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							INTERFERON TREATMENT; UNTREATED PATIENTS; DRUG-RESISTANCE; VIRAL-HEPATITIS; HBV-DNA; 40 KDA; ALPHA-2A; THERAPY; MONOTHERAPY; MANAGEMENT	Background: Available treatments for hepatitis B e antigen (HBeAg)-negative chronic hepatitis B are associated with poor sustained responses. As a result, nucleoside and nucleotide analogues are typically continued indefinitely, a strategy associated with the risk of resistance and unknown long-term safety implications. Methods: We compared the efficacy and safety of peginterferon alfa-2a (180 microg once weekly) plus placebo, peginterferon alfa-2a plus lamivudine (100 mg daily), and lamivudine alone in 177, 179, and 181 patients with HBeAg-negative chronic hepatitis B, respectively. Patients were treated for 48 weeks and followed for an additional 24 weeks. Results: After 24 weeks of follow-up, the percentage of patients with normalization of alanine aminotransferase levels or hepatitis B virus (HBV) DNA levels below 20,000 copies per milliliter was significantly higher with peginterferon alfa-2a monotherapy (59 percent and 43 percent, respectively) and peginterferon alfa-2a plus lamivudine (60 percent and 44 percent) than with lamivudine monotherapy (44 percent, P=0.004 and P=0.003, respectively; and 29 percent, P=0.007 and P=0.003, respectively). Rates of sustained suppression of HBV DNA to below 400 copies per milliliter were 19 percent with peginterferon alfa-2a monotherapy, 20 percent with combination therapy, and 7 percent with lamivudine alone (P<0.001 for both comparisons with lamivudine alone). Loss of hepatitis B surface antigen occurred in 12 patients in the peginterferon groups, as compared with 0 patients in the group given lamivudine alone. Adverse events, including pyrexia, fatigue, myalgia, and headache, were less frequent with lamivudine monotherapy than with peginterferon alfa-2a monotherapy or combination therapy. Conclusions: Patients with HBeAg-negative chronic hepatitis B had significantly higher rates of response, sustained for 24 weeks after the cessation of therapy, with peginterferon alfa-2a than with lamivudine. The addition of lamivudine to peginterferon alfa-2a did not improve post-therapy response rates.	Hop Beaujon, Serv Hepatol, INSERM, U481, F-92110 Clichy, France; Hop Beaujon, Ctr Rech Claude Bernard Hepatites Virales, F-92110 Clichy, France; Univ Hong Kong, Queen Mary Hosp, Hong Kong, Hong Kong, Peoples R China; Milano Policlin, Osped Maggiore, Ist Ricovero & Cura Carratere Sci, Milan, Italy; Univ Cagliari, Div Clin Med 1, Cagliari, Italy; Henry Dunant Hosp, Dept Med & Hepatol, Athens, Greece; Beijing You An Hosp, Digest Dis Dept, Beijing, Peoples R China; Ruijin Hosp, Dept Infect Dis, Shanghai, Peoples R China; Songklanakarin Hosp, Songkhla, Thailand; Papageorgiou Gen Hosp, Pathol Clin, Thessaloniki, Greece; Ankara Univ, Fac Med, TR-06100 Ankara, Turkey; Hosp Gen Univ Valencia, Valencia, Spain; Uludag Univ, Fac Med, Bursa, Turkey; Natl Taiwan Univ Hosp, Taipei, Taiwan; Roche, Dee Why, Australia; Roche, Welwyn Garden City, Herts, England	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Beaujon - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Beaujon - APHP; UDICE-French Research Universities; Universite Paris Cite; University of Hong Kong; University of Cagliari; Henry Dunant Hospital; Capital Medical University; Shanghai Jiao Tong University; Prince of Songkla University; Papageorgiou Hospital; Ankara University; Hospital Clinic Universitari de Valencia; Uludag University; National Taiwan University; National Taiwan University Hospital; Roche Holding; Roche Holding	Marcellin, P (corresponding author), Hop Beaujon, Serv Hepatol, INSERM, U481, F-92110 Clichy, France.	patrick.marcellin@bjn.ap-hop-paris.fr	DIAGO, MOISES/AAH-5364-2019; Lau, George/AAQ-2085-2021; Bonino, Ferruccio/C-6036-2018; GERMANIDIS, GEORGIOS/ABI-3764-2020; Bonino, Ferruccio/B-7522-2013	Bonino, Ferruccio/0000-0001-9942-0328; 				Bailon P, 2001, BIOCONJUGATE CHEM, V12, P195, DOI 10.1021/bc000082g; Barbaro G, 2001, J HEPATOL, V35, P406, DOI 10.1016/S0168-8278(01)00145-3; BONINO F, 1986, GASTROENTEROLOGY, V90, P1268, DOI 10.1016/0016-5085(86)90395-1; Brunetto MR, 2002, J HEPATOL, V36, P263, DOI 10.1016/S0168-8278(01)00266-5; Chu CJ, 2003, HEPATOLOGY, V38, P619, DOI 10.1053/jhep.2003.50352; Cooksley WGE, 2003, J VIRAL HEPATITIS, V10, P298, DOI 10.1046/j.1365-2893.2003.00450.x; de Franchis R, 2003, J HEPATOL, V39, pS3, DOI 10.1016/S0168-8278(03)00378-7; Forton DM, 2003, J VIRAL HEPATITIS, V10, P81, DOI 10.1046/j.1365-2893.2003.00416.x; Fried MW, 2002, NEW ENGL J MED, V347, P975, DOI 10.1056/NEJMoa020047; Funk ML, 2002, J VIRAL HEPATITIS, V9, P52, DOI 10.1046/j.1365-2893.2002.00304.x; Hadziyannis S, 2000, J VIRAL HEPATITIS, V7, P235; Hadziyannis SJ, 2000, HEPATOLOGY, V32, P847, DOI 10.1053/jhep.2000.17915; Hadziyannis SJ, 2003, NEW ENGL J MED, V348, P800, DOI 10.1056/NEJMoa021812; Hadziyannis SJ, 2001, HEPATOLOGY, V34, P617, DOI 10.1053/jhep.2001.27834; ISHAK K, 1995, J HEPATOL, V22, P696, DOI 10.1016/0168-8278(95)80226-6; JANSSEN HLA, 2003, HEPATOLOGY S1, V38, pA246; Koskinas J, 2002, DIGEST DIS, V20, P284, DOI 10.1159/000067682; Lai CL, 2003, LANCET, V362, P2089, DOI 10.1016/S0140-6736(03)15108-2; Lampertico P, 2003, HEPATOLOGY, V37, P756, DOI 10.1053/jhep.2003.50148; Liaw YF, 1999, HEPATOLOGY, V30, P567, DOI 10.1002/hep.510300221; Liaw YF, 2003, J GASTROEN HEPATOL, V18, P239, DOI 10.1046/j.1440-1746.2003.03037.x; LOK AS, 2003, AASLD PRACTICE GUIDE; Lok ASF, 2004, HEPATOLOGY, V39, P857, DOI 10.1002/hep.20110; Lok ASF, 2002, J CLIN MICROBIOL, V40, P3729, DOI 10.1128/JCM.40.10.3729-3734.2002; Manesis EK, 2001, GASTROENTEROLOGY, V121, P101, DOI 10.1053/gast.2001.25524; Martinot-Peignoux M, 2002, J HEPATOL, V36, P543, DOI 10.1016/S0168-8278(02)00004-1; Nair S, 2001, HEPATOLOGY, V34, P1021, DOI 10.1053/jhep.2001.28459; Oliveri F, 1999, AM J GASTROENTEROL, V94, P1366, DOI 10.1111/j.1572-0241.1999.01088.x; Papatheodoridis GV, 2001, J HEPATOL, V34, P306, DOI 10.1016/S0168-8278(00)00094-5; Perry CM, 2001, DRUGS, V61, P2263, DOI 10.2165/00003495-200161150-00013; Richman DD, 2000, HEPATOLOGY, V32, P866, DOI 10.1053/jhep.2000.18194; Santantonio T, 2000, J HEPATOL, V32, P300, DOI 10.1016/S0168-8278(00)80076-8; Santantonio T, 2002, J HEPATOL, V36, P799, DOI 10.1016/S0168-8278(02)00056-9; Schalm SW, 2000, GUT, V46, P562, DOI 10.1136/gut.46.4.562; Tassopoulos N. C., 1999, Journal of Hepatology, V30, P117; Zeuzem S, 2000, NEW ENGL J MED, V343, P1666, DOI 10.1056/NEJM200012073432301	36	852	959	0	52	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 16	2004	351	12					1206	1217		10.1056/NEJMoa040431	http://dx.doi.org/10.1056/NEJMoa040431			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	853WS	15371578	Bronze			2022-12-28	WOS:000223861300009
J	Silverman, WA				Silverman, WA			The power of labels	LANCET			English	Editorial Material												Fumer@aol.com							0	0	0	3	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 11	2004	364	9438					929	929		10.1016/S0140-6736(04)17007-4	http://dx.doi.org/10.1016/S0140-6736(04)17007-4			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	853MF	15384206				2022-12-28	WOS:000223831000013
J	Hock, H; Hamblen, MJ; Rooke, HM; Schindler, JW; Saleque, S; Fujiwara, Y; Orkin, SH				Hock, H; Hamblen, MJ; Rooke, HM; Schindler, JW; Saleque, S; Fujiwara, Y; Orkin, SH			Gfi-1 restricts proliferation and preserves functional integrity of haematopoietic stem cells	NATURE			English	Article							IN-VIVO; TRANSGENIC MICE; DIFFERENTIATION; EXPANSION; CAPACITY; BMI-1; MYC	Haematopoietic stem cells (HSCs) sustain blood production throughout life. HSCs are capable of extensive proliferative expansion, as a single HSC may reconstitute lethally irradiated hosts(1). In steady-state, HSCs remain largely quiescent and self-renew at a constant low rate, forestalling their exhaustion during adult life(2,3). Whereas nuclear regulatory factors promoting proliferative programmes of HSCs in vivo and ex vivo have been identified(4-6), transcription factors restricting their cycling have remained elusive. Here we report that the zinc-finger repressor Gfi-1 (growth factor independent 1), a cooperating oncogene in lymphoid cells(7,8), unexpectedly restricts proliferation of HSCs. After loss of Gfi-1, HSCs display elevated proliferation rates as assessed by 5-bromodeoxyuridine incorporation and cell-cycle analysis. Gfi-1(-/-) HSCs are functionally compromised in competitive repopulation and serial transplantation assays, and are rapidly out-competed in the bone marrow of mouse chimaeras generated with Gfi-1(-/-) embryonic stem cells. Thus, Gfi-1 is essential to restrict HSC proliferation and to preserve HSC functional integrity.	Harvard Univ, Childrens Hosp, Sch Med, Div Hematol Oncol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; Howard Hughes Med Inst, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Howard Hughes Medical Institute	Orkin, SH (corresponding author), Harvard Univ, Childrens Hosp, Sch Med, Div Hematol Oncol, Boston, MA 02115 USA.	stuart_orkin@dfci.harvard.edu						Adolfsson J, 2001, IMMUNITY, V15, P659, DOI 10.1016/S1074-7613(01)00220-5; Akagi K, 2004, NUCLEIC ACIDS RES, V32, pD523, DOI 10.1093/nar/gkh013; Allsopp RC, 2001, J EXP MED, V193, P917, DOI 10.1084/jem.193.8.917; CHAN WY, 1998, TOP ENDOCRINOL, V8, P9; Cheng T, 2000, SCIENCE, V287, P1804, DOI 10.1126/science.287.5459.1804; Cheshier SP, 1999, P NATL ACAD SCI USA, V96, P3120, DOI 10.1073/pnas.96.6.3120; Christensen JL, 2001, P NATL ACAD SCI USA, V98, P14541, DOI 10.1073/pnas.261562798; GILKS CB, 1993, MOL CELL BIOL, V13, P1759, DOI 10.1128/MCB.13.3.1759; Hock H, 2003, IMMUNITY, V18, P109, DOI 10.1016/S1074-7613(02)00501-0; JORDAN CT, 1990, GENE DEV, V4, P220, DOI 10.1101/gad.4.2.220; Lessard J, 2003, NATURE, V423, P255, DOI 10.1038/nature01572; Osawa M, 1996, SCIENCE, V273, P242, DOI 10.1126/science.273.5272.242; Park IK, 2003, NATURE, V423, P302, DOI 10.1038/nature01587; Phillips RL, 2000, SCIENCE, V288, P1635, DOI 10.1126/science.288.5471.1635; ROSS EAM, 1982, J EXP MED, V155, P432, DOI 10.1084/jem.155.2.432; Saleque S, 2002, GENE DEV, V16, P301, DOI 10.1101/gad.959102; SAUVAGEAU G, 1995, GENE DEV, V9, P1753, DOI 10.1101/gad.9.14.1753; Scheijen B, 1997, J VIROL, V71, P9, DOI 10.1128/JVI.71.1.9-16.1997; SPANGRUDE GJ, 1995, BLOOD, V85, P1006, DOI 10.1182/blood.V85.4.1006.bloodjournal8541006; TSAI FY, 1994, NATURE, V371, P221, DOI 10.1038/371221a0; VANLOHUIZEN M, 1991, CELL, V65, P737, DOI 10.1016/0092-8674(91)90382-9; Yucel R, 2003, J EXP MED, V197, P831, DOI 10.1084/jem.20021417; Zhu JF, 2002, IMMUNITY, V16, P733, DOI 10.1016/S1074-7613(02)00317-5	23	419	430	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 21	2004	431	7011					1002	1007		10.1038/nature02994	http://dx.doi.org/10.1038/nature02994			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863TI	15457180				2022-12-28	WOS:000224585600048
J	Wang, HB; Wang, LJ; Erdjument-Bromage, H; Vidal, M; Tempst, P; Jones, RS; Zhang, Y				Wang, HB; Wang, LJ; Erdjument-Bromage, H; Vidal, M; Tempst, P; Jones, RS; Zhang, Y			Role of histone H2A ubiquitination in polycomb silencing	NATURE			English	Article							H3 LYSINE-27 METHYLATION; RING FINGER PROTEINS; TRANSCRIPTIONAL ACTIVATION; LIGASE ACTIVITY; RAD6; COMPLEX; CORE; UBIQUITYLATION; RECRUITMENT; DROSOPHILA	Covalent modification of histones is important in regulating chromatin dynamics and transcription(1,2). One example of such modification is ubiquitination, which mainly occurs on histones H2A and H2B(3). Although recent studies have uncovered the enzymes involved in histone H2B ubiquitination(4-6) and a 'cross-talk' between H2B ubiquitination and histone methylation(7,8), the responsible enzymes and the functions of H2A ubiquitination are unknown. Here we report the purification and functional characterization of an E3 ubiquitin ligase complex that is specific for histone H2A. The complex, termed hPRC1L ( human Polycomb repressive complex 1-like), is composed of several Polycomb-group proteins including Ring1, Ring2, Bmi1 and HPH2. hPRC1L monoubiquitinates nucleosomal histone H2A at lysine 119. Reducing the expression of Ring2 results in a dramatic decrease in the level of ubiquitinated H2A in HeLa cells. Chromatin immunoprecipitation analysis demonstrated colocalization of dRing with ubiquitinated H2A at the PRE and promoter regions of the Drosophila Ubx gene in wing imaginal discs. Removal of dRing in SL2 tissue culture cells by RNA interference resulted in loss of H2A ubiquitination concomitant with derepression of Ubx. Thus, our studies identify the H2A ubiquitin ligase, and link H2A ubiquitination to Polycomb silencing.	Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; So Methodist Univ, Dept Biol Sci, Dallas, TX 75275 USA; Mem Sloan Kettering Canc Ctr, Program Mol Biol, New York, NY 10021 USA; Ctr Invest Biol, Dept Desarrollo & Biol Celular, E-28040 Madrid, Spain	University of North Carolina; University of North Carolina Chapel Hill; Southern Methodist University; Memorial Sloan Kettering Cancer Center; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB)	Zhang, Y (corresponding author), Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA.	yi_zhang@med.unc.edu	Vidal, Miguel/M-8861-2016	Vidal, Miguel/0000-0003-4374-6761; Zhang, Yi/0000-0002-2789-0811; Erdjument-Bromage, Hediye/0000-0003-0224-3594; Tempst, Paul/0000-0002-6680-3987; Wang, Hengbin/0000-0003-2414-0609				Briggs SD, 2002, NATURE, V418, P498, DOI 10.1038/nature00970; Cao R, 2004, MOL CELL, V15, P57, DOI 10.1016/j.molcel.2004.06.020; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Devroe E, 2004, J BIOL CHEM, V279, P24444, DOI 10.1074/jbc.M401999200; Dover J, 2002, J BIOL CHEM, V277, P28368, DOI 10.1074/jbc.C200348200; Francis NJ, 2001, MOL CELL, V8, P545, DOI 10.1016/S1097-2765(01)00316-1; Fritsch C, 2003, MECH DEVELOP, V120, P949, DOI 10.1016/S0925-4773(03)00083-2; Gorfinkiel N, 2004, MECH DEVELOP, V121, P449, DOI 10.1016/j.mod.2004.03.019; Henry KW, 2003, GENE DEV, V17, P2648, DOI 10.1101/gad.1144003; Hwang WW, 2003, MOL CELL, V11, P261, DOI 10.1016/S1097-2765(02)00826-2; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Joazeiro CAP, 2000, CELL, V102, P549, DOI 10.1016/S0092-8674(00)00077-5; Kao CF, 2004, GENE DEV, V18, P184, DOI 10.1101/gad.1149604; Lee SJ, 2001, FEBS LETT, V503, P61, DOI 10.1016/S0014-5793(01)02689-8; Levine SS, 2002, MOL CELL BIOL, V22, P6070, DOI 10.1128/MCB.22.17.6070-6078.2002; Ng HH, 2002, J BIOL CHEM, V277, P34655, DOI 10.1074/jbc.C200433200; NICKEL BE, 1989, BIOCHEMISTRY-US, V28, P964, DOI 10.1021/bi00429a007; Plath K, 2003, SCIENCE, V300, P131, DOI 10.1126/science.1084274; Robzyk K, 2000, SCIENCE, V287, P501, DOI 10.1126/science.287.5452.501; Satijn DPE, 1997, MOL CELL BIOL, V17, P4105, DOI 10.1128/MCB.17.7.4105; Schoorlemmer J, 1997, EMBO J, V16, P5930, DOI 10.1093/emboj/16.19.5930; Sun ZW, 2002, NATURE, V418, P104, DOI 10.1038/nature00883; VASSILEV AP, 1995, J CELL SCI, V108, P1205; Voncken JW, 2003, P NATL ACAD SCI USA, V100, P2468, DOI 10.1073/pnas.0434312100; Wang HB, 2003, MOL CELL, V12, P475, DOI 10.1016/j.molcel.2003.08.007; Wang L, 2004, MOL CELL, V14, P637, DOI 10.1016/j.molcel.2004.05.009; Wood A, 2003, MOL CELL, V11, P267, DOI 10.1016/S1097-2765(02)00802-X; Zhang Y, 2003, GENE DEV, V17, P2733, DOI 10.1101/gad.1156403; Zhang Y, 2001, GENE DEV, V15, P2343, DOI 10.1101/gad.927301	29	1236	1295	3	116	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 14	2004	431	7010					873	878		10.1038/nature02985	http://dx.doi.org/10.1038/nature02985			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	861RE	15386022				2022-12-28	WOS:000224435500053
J	Devey, L				Devey, L			The prince and the professor - Science is worth the effort	BRITISH MEDICAL JOURNAL			English	Letter									Univ Edinburgh, Sch Med, MRC, Ctr Inflammat Res,Tissue Injury & Repair Grp, Edinburgh EH8 9AG, Midlothian, Scotland	University of Edinburgh	Devey, L (corresponding author), Univ Edinburgh, Sch Med, MRC, Ctr Inflammat Res,Tissue Injury & Repair Grp, 6th Floor, Edinburgh EH8 9AG, Midlothian, Scotland.	devey@doctors.org.uk		Devey, Luke/0000-0002-1289-7332				Baum M, 2004, BRIT MED J, V329, P118, DOI 10.1136/bmj.329.7457.118	1	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 9	2004	329	7470					859	859		10.1136/bmj.329.7470.859-a	http://dx.doi.org/10.1136/bmj.329.7470.859-a			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	862EK	15472286	Green Submitted, Green Published			2022-12-28	WOS:000224472800043
J	Weng, AP; Ferrando, AA; Lee, W; Morris, JP; Silverman, LB; Sanchez-Irizarry, C; Blacklow, SC; Look, AT; Aster, JC				Weng, AP; Ferrando, AA; Lee, W; Morris, JP; Silverman, LB; Sanchez-Irizarry, C; Blacklow, SC; Look, AT; Aster, JC			Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia	SCIENCE			English	Article							GAMMA-SECRETASE; TRANSCRIPTIONAL ACTIVATION; TRANSGENIC MICE; PROTEIN; COMPLEX; INACTIVATION; PRESENILIN; INDUCTION; RECEPTORS; DOMAINS	Very rare cases of human T cell acute lymphoblastic leukemia (T-ALL) harbor chromosomal translocations that involve NOTCH1, a gene encoding a transmembrane receptor that regulates normal T cell development. Here, we report that more than 50% of human T-ALLs, including tumors from all major molecular oncogenic subtypes, have activating mutations that involve the extracellular heterodimerization domain and/or the C-terminal PEST domain of NOTCH1. These findings greatly expand the role of activated NOTCH1 in the molecular pathogenesis of human T-ALL and provide a strong rationale for targeted therapies that interfere with NOTCH signaling.	Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Pathol, Boston, MA 02115 USA; Harvard Univ, Dana Farber Canc Inst, Sch Med, Dept Pediat Oncol, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	Aster, JC (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Pathol, Boston, MA 02115 USA.	jaster@rics.bwh.harvard.edu	Ferrando, Adolfo A/Q-7026-2016; Weng, Andrew P/I-5015-2014	Weng, Andrew/0000-0001-7394-5425	NCI NIH HHS [CA68484, CA94233, CA98093, CA109901, CA21765, CA82308, P01 CA109901] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R56CA094233, P30CA021765, R01CA082308, R01CA094233, P01CA068484, K08CA098093, P01CA109901] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Allman D, 2001, J EXP MED, V194, P99, DOI 10.1084/jem.194.1.99; ASTER J, UNPUB; Aster JC, 2000, MOL CELL BIOL, V20, P7505, DOI 10.1128/MCB.20.20.7505-7515.2000; Berry LW, 1997, DEVELOPMENT, V124, P925; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; ELLISEN LW, 1991, CELL, V66, P649, DOI 10.1016/0092-8674(91)90111-B; Feldman BJ, 2000, BLOOD, V96, P1906, DOI 10.1182/blood.V96.5.1906.h8001906_1906_1913; Ferrando AA, 2002, CANCER CELL, V1, P75, DOI 10.1016/S1535-6108(02)00018-1; Francis R, 2002, DEV CELL, V3, P85, DOI 10.1016/S1534-5807(02)00189-2; Fryer CJ, 2002, GENE DEV, V16, P1397, DOI 10.1101/gad.991602; Gupta-Rossi N, 2001, J BIOL CHEM, V276, P34371, DOI 10.1074/jbc.M101343200; Hoemann CD, 2000, MOL CELL BIOL, V20, P3831, DOI 10.1128/MCB.20.11.3831-3842.2000; Kimberly WT, 2003, P NATL ACAD SCI USA, V100, P6382, DOI 10.1073/pnas.1037392100; KRAMER H, 2000, SCI STKE, pPE1; Logeat F, 1998, P NATL ACAD SCI USA, V95, P8108, DOI 10.1073/pnas.95.14.8108; Nam Y, 2003, J BIOL CHEM, V278, P21232, DOI 10.1074/jbc.M301567200; Pui C, 2004, NEW ENGL J MED, V350, P1535, DOI 10.1056/NEJMra023001; Radtke F, 1999, IMMUNITY, V10, P547, DOI 10.1016/S1074-7613(00)80054-0; Rand MD, 2000, MOL CELL BIOL, V20, P1825, DOI 10.1128/MCB.20.5.1825-1835.2000; SANCHEZIRIZARRY C, IN PRESS MOL CELL BI; Wallberg AE, 2002, MOL CELL BIOL, V22, P7812, DOI 10.1128/MCB.22.22.7812-7819.2002; Weng AP, 2003, MOL CELL BIOL, V23, P655, DOI 10.1128/MCB.23.2.655-664.2003; Wolfe MS, 2002, NAT REV DRUG DISCOV, V1, P859, DOI 10.1038/nrd938; Wolfer A, 2002, IMMUNITY, V16, P869, DOI 10.1016/S1074-7613(02)00330-8; Wong GT, 2004, J BIOL CHEM, V279, P12876, DOI 10.1074/jbc.M311652200	25	2082	2230	4	139	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 8	2004	306	5694					269	271		10.1126/science.1102160	http://dx.doi.org/10.1126/science.1102160			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	861MC	15472075				2022-12-28	WOS:000224419700038
J	Leopold, P				Leopold, P			Neuronal differentiation: TOR and insulin receptor pathways set the tempo	CELL			English	Editorial Material								Target of rapamycin (TOR) and insulin receptor pathways regulate growth in metazoans. A recent study (Bateman and McNeill [2004], this issue of Cell] reveals a novel role for these pathways in controlling the timing of neuronal differentiation during Drosophila development, thus allowing a tight coordination between growth and differentiation programs.	CNRS, Inst Signaling Dev Biol & Canc, F-06108 Nice 2, France	Centre National de la Recherche Scientifique (CNRS)	Leopold, P (corresponding author), CNRS, Inst Signaling Dev Biol & Canc, Parc Valrose, F-06108 Nice 2, France.							Bateman JM, 2004, CELL, V119, P87, DOI 10.1016/j.cell.2004.08.028; Britton JS, 2002, DEV CELL, V2, P239, DOI 10.1016/S1534-5807(02)00117-X; Colombani J, 2003, CELL, V114, P739, DOI 10.1016/S0092-8674(03)00713-X; Leevers Sally J., 2004, VVolume 42, P167; Neumann CJ, 2000, SCIENCE, V289, P2137, DOI 10.1126/science.289.5487.2137; Song JB, 2003, SCIENCE, V300, P502, DOI 10.1126/science.1081203; Voas MG, 2004, DEV DYNAM, V229, P162, DOI 10.1002/dvdy.10449	7	5	5	0	0	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	OCT 1	2004	119	1					4	5		10.1016/j.cell.2004.09.024	http://dx.doi.org/10.1016/j.cell.2004.09.024			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	859UE	15454075	Bronze			2022-12-28	WOS:000224292600003
J	Geddes, CGR; Toth, C; van Tilborg, J; Esarey, E; Schroeder, CB; Bruhwiler, D; Nieter, C; Cary, J; Leemans, WP				Geddes, CGR; Toth, C; van Tilborg, J; Esarey, E; Schroeder, CB; Bruhwiler, D; Nieter, C; Cary, J; Leemans, WP			High-quality electron beams from a laser wakefield accelerator using plasma-channel guiding	NATURE			English	Article							THOMSON SCATTERING; PULSES; GENERATION; INJECTION	Laser-driven accelerators, in which particles are accelerated by the electric field of a plasma wave ( the wakefield) driven by an intense laser, have demonstrated accelerating electric fields of hundreds of GV m(-1) ( refs 1 - 3). These fields are thousands of times greater than those achievable in conventional radiofrequency accelerators, spurring interest in laser accelerators(4,5) as compact next-generation sources of energetic electrons and radiation. To date, however, acceleration distances have been severely limited by the lack of a controllable method for extending the propagation distance of the focused laser pulse. The ensuing short acceleration distance results in low-energy beams with 100 per cent electron energy spread(1-3), which limits potential applications. Here we demonstrate a laser accelerator that produces electron beams with an energy spread of a few per cent, low emittance and increased energy ( more than 10(9) electrons above 80 MeV). Our technique involves the use of a preformed plasma density channel to guide a relativistically intense laser, resulting in a longer propagation distance. The results open the way for compact and tunable high-brightness sources of electrons and radiation.	Lawrence Berkeley Lab, Berkeley, CA 94720 USA; Univ Calif Berkeley, Berkeley, CA 94720 USA; Tech Univ Eindhoven, NL-5600 MB Eindhoven, Netherlands; Tech X Corp, Boulder, CO 80303 USA; Univ Colorado, Boulder, CO 80309 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Eindhoven University of Technology; Tech-X Corporation; University of Colorado System; University of Colorado Boulder	Leemans, WP (corresponding author), Lawrence Berkeley Lab, 1 Cyclotron Rd, Berkeley, CA 94720 USA.	wpleemans@lbl.gov	Cary, John/AAJ-3778-2021	Cary, John/0000-0002-5888-5193; Schroeder, Carl/0000-0002-9610-0166; Toth, Csaba/0000-0002-4599-4550				Catravas P, 2001, MEAS SCI TECHNOL, V12, P1828, DOI 10.1088/0957-0233/12/11/310; DURFEE CG, 1993, PHYS REV LETT, V71, P2409, DOI 10.1103/PhysRevLett.71.2409; Esarey E, 1997, PHYS REV LETT, V79, P2682, DOI 10.1103/PhysRevLett.79.2682; ESAREY E, 1994, PHYS REV LETT, V72, P2887, DOI 10.1103/PhysRevLett.72.2887; Esarey E, 1996, IEEE T PLASMA SCI, V24, P252, DOI 10.1109/27.509991; Esarey E, 1997, IEEE J QUANTUM ELECT, V33, P1879, DOI 10.1109/3.641305; Gaul EW, 2000, APPL PHYS LETT, V77, P4112, DOI 10.1063/1.1329323; Katsouleas T., 1987, Particle Accelerators, V22, P81; Kim KY, 2002, AIP CONF PROC, V647, P646, DOI 10.1063/1.1524919; Leemans WP, 2004, PHYS PLASMAS, V11, P2899, DOI 10.1063/1.1652834; Leemans WP, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.074802; Leemans WP, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.174802; Leemans WP, 2001, PHYS PLASMAS, V8, P2510, DOI 10.1063/1.1352617; Leemans WP, 1998, PHYS PLASMAS, V5, P1615, DOI 10.1063/1.872820; Leemans WP, 1996, IEEE T PLASMA SCI, V24, P331, DOI 10.1109/27.509997; Malka V, 2002, SCIENCE, V298, P1596, DOI 10.1126/science.1076782; MODENA A, 1995, NATURE, V377, P606, DOI 10.1038/377606a0; Najmudin Z, 2003, PHYS PLASMAS, V10, P2071, DOI 10.1063/1.1564083; Nieter C, 2004, J COMPUT PHYS, V196, P448, DOI 10.1016/j.jcp.2003.11.004; Reitsma AJW, 2002, PHYS REV SPEC TOP-AC, V5, DOI 10.1103/PhysRevSTAB.5.051301; Saes M, 2004, REV SCI INSTRUM, V75, P24, DOI 10.1063/1.1633003; Schoenlein RW, 1996, SCIENCE, V274, P236, DOI 10.1126/science.274.5285.236; SPRANGLE P, 1992, PHYS REV LETT, V69, P2200, DOI 10.1103/PhysRevLett.69.2200; STRICKLAND D, 1985, OPT COMMUN, V56, P219, DOI 10.1016/0030-4018(85)90120-8; TAJIMA T, 1979, PHYS REV LETT, V43, P267, DOI 10.1103/PhysRevLett.43.267; Toth C, 2004, PROC SPIE, V5448, P491, DOI 10.1117/12.548945; TSUNG FS, UNPUB PHYS REV LETT; Umstadter D, 1996, PHYS REV LETT, V76, P2073, DOI 10.1103/PhysRevLett.76.2073; Volfbeyn P, 1999, PHYS PLASMAS, V6, P2269, DOI 10.1063/1.873503; Wang XJ, 1996, PHYS REV E, V54, pR3121, DOI 10.1103/PhysRevE.54.R3121	30	1688	1735	3	242	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 30	2004	431	7008					538	541		10.1038/nature02900	http://dx.doi.org/10.1038/nature02900			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	857YP	15457252	Green Submitted			2022-12-28	WOS:000224156700038
J	Stephens, P; Hunter, C; Bignell, G; Edkins, S; Davies, H; Teague, J; Stevens, C; O'Meara, S; Smith, R; Parker, A; Barthorpe, A; Blow, M; Brackenbury, L; Butler, A; Clarke, O; Cole, J; Dicks, E; Dike, A; Drozd, A; Edwards, K; Forbes, S; Foster, R; Gray, K; Greenman, C; Halliday, K; Hills, K; Kosmidou, V; Lugg, R; Menzies, A; Perry, J; Petty, R; Raine, K; Ratford, L; Shepherd, R; Small, A; Stephens, Y; Tofts, C; Varian, J; West, S; Widaa, S; Yates, A; Brasseur, F; Cooper, CS; Flanagan, AM; Knowles, M; Leung, SY; Louis, DN; Looijenga, LHJ; Malkowicz, B; Pierotti, MA; Teh, B; Chenevix-Trench, G; Weber, BL; Yuen, ST; Harris, G; Goldstraw, P; Nicholson, AG; Futreal, PA; Wooster, R; Stratton, MR				Stephens, P; Hunter, C; Bignell, G; Edkins, S; Davies, H; Teague, J; Stevens, C; O'Meara, S; Smith, R; Parker, A; Barthorpe, A; Blow, M; Brackenbury, L; Butler, A; Clarke, O; Cole, J; Dicks, E; Dike, A; Drozd, A; Edwards, K; Forbes, S; Foster, R; Gray, K; Greenman, C; Halliday, K; Hills, K; Kosmidou, V; Lugg, R; Menzies, A; Perry, J; Petty, R; Raine, K; Ratford, L; Shepherd, R; Small, A; Stephens, Y; Tofts, C; Varian, J; West, S; Widaa, S; Yates, A; Brasseur, F; Cooper, CS; Flanagan, AM; Knowles, M; Leung, SY; Louis, DN; Looijenga, LHJ; Malkowicz, B; Pierotti, MA; Teh, B; Chenevix-Trench, G; Weber, BL; Yuen, ST; Harris, G; Goldstraw, P; Nicholson, AG; Futreal, PA; Wooster, R; Stratton, MR		Canc Genome Project Collaborat Grp	Intragenic ERBB2 kinase mutations in tumours	NATURE			English	Article							LUNG-CANCER		Wellcome Trust Sanger Inst, Canc Genome Project, Hinxton CB10 1SA, England; Ludwig Inst Canc Res, B-1200 Brussels, Belgium; Inst Canc Res, Sutton SM2 5NG, Surrey, England; UCL, Inst Orthopaed, Stanmore HA7 4LP, Middx, England; St James Univ Hosp, Canc Res UK Clin Ctr, Leeds LS9 7TF, W Yorkshire, England; Univ Hong Kong, Queen Mary Hosp, Dept Pathol, Hong Kong, Hong Kong, Peoples R China; Massachusetts Gen Hosp E, Mol Pathol Unit, Charlestown, MA 02129 USA; Erasmus MC Univ Med Ctr Rotterdam, Dr Daniel Den Hoed Canc Ctr, Josephine Nefkens Inst, Lab Pathol Expt Pathooncol, NL-3000 DR Rotterdam, Netherlands; Univ Penn, Div Urol, Philadelphia, PA 19104 USA; Inst Nazl Tumori, Milan, Italy; Inst Mol Oncol, FIRC, Milan, Italy; Van Andel Res Inst, Canc Genet Lab, Grand Rapids, MI 49503 USA; Royal Brisbane Hosp, Queensland Inst Med Res, Herston, Qld 4029, Australia; Univ Penn, Ctr Canc, Philadelphia, PA 19104 USA; Royal Brompton Hosp, London SW3 6NP, England	Wellcome Trust Sanger Institute; Ludwig Institute for Cancer Research; University of London; Institute of Cancer Research - UK; University of London; University College London; Cancer Research UK; Saint James's University Hospital; University of Leeds; University of Hong Kong; Erasmus University Rotterdam; Erasmus MC; Erasmus MC Cancer Institute; University of Pennsylvania; Fondazione IRCCS Istituto Nazionale Tumori Milan; IFOM - FIRC Institute of Molecular Oncology; Van Andel Institute; QIMR Berghofer Medical Research Institute; Royal Brisbane & Women's Hospital; University of Pennsylvania; Royal Brompton Hospital	Stephens, P (corresponding author), Wellcome Trust Sanger Inst, Canc Genome Project, Hinxton CB10 1SA, England.		Looijenga, Leendert/B-8145-2019; Blow, Matthew/G-6369-2012; Pierotti, Marco Alessandro/AAC-4728-2022; Chenevix-Trench, Georgia/AAV-2014-2020; Yuen, Siu/K-6311-2014; Leung, Suet Yi/C-4340-2009; Leung, Suet Yi/T-9620-2019	Looijenga, Leendert/0000-0002-8146-1911; Blow, Matthew/0000-0002-8844-9149; Pierotti, Marco Alessandro/0000-0002-7431-8332; Chenevix-Trench, Georgia/0000-0002-1878-2587; Hunter, Christopher/0000-0002-1335-0881; Flanagan, Adrienne/0000-0002-2832-1303; Leung, Suet Yi/0000-0001-8614-4619; Raine, Keiran/0000-0002-5634-1539; Edkins, Sarah/0000-0003-0717-1972; Knowles, Margaret/0000-0002-9363-8657; Yates, Andrew/0000-0002-8886-4772; Gray, Kristian/0000-0002-7035-7107				Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Hirsch FR, 2004, SEMIN ONCOL, V31, P75, DOI 10.1053/j.seminoncol.2003.12.018; Klapper LN, 2000, ADV CANCER RES, V77, P25; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Rosell R, 2004, J CLIN ONCOL, V22, P1171, DOI 10.1200/JCO.2004.01.904; Sawyers CL, 2003, GENE DEV, V17, P2998, DOI 10.1101/gad.1152403; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106	8	602	631	3	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 30	2004	431	7008					525	526		10.1038/431525b	http://dx.doi.org/10.1038/431525b			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	857YP	15457249				2022-12-28	WOS:000224156700034
J	Salomon, JA; Weinstein, MC; Goldie, SJ				Salomon, JA; Weinstein, MC; Goldie, SJ			Taking account of future technology in cost effectiveness analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CHRONIC HEPATITIS-C; ALPHA-2B PLUS RIBAVIRIN; COMBINATION THERAPY; INITIAL TREATMENT; INTERFERON-ALPHA; VIRUS-INFECTION; NAIVE PATIENTS; PERSPECTIVE		Harvard Univ, Sch Publ Hlth, Harvard Ctr Populat & Dev Studies, Dept Populat & Int Hlth, Cambridge, MA 02138 USA; Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health	Salomon, JA (corresponding author), Harvard Univ, Sch Publ Hlth, Harvard Ctr Populat & Dev Studies, Dept Populat & Int Hlth, 9 Bow St, Cambridge, MA 02138 USA.	jsalomon@hsph.harvard.edu	Salomon, Joshua A/D-3898-2009; Salomon, Joshua/S-1929-2019	Salomon, Joshua A/0000-0003-3929-5515; Salomon, Joshua/0000-0003-3929-5515				Alter HJ, 2000, SEMIN LIVER DIS, V20, P17, DOI 10.1055/s-2000-9505; Alter MJ, 1999, NEW ENGL J MED, V341, P556, DOI 10.1056/NEJM199908193410802; BEDOSSA P, 1994, HEPATOLOGY, V20, P15; Bennett WG, 1997, ANN INTERN MED, V127, P855, DOI 10.7326/0003-4819-127-10-199711150-00001; Birch Stephen, 2004, Health Care Manag Sci, V7, P35, DOI 10.1023/B:HCMS.0000005396.69890.48; Briggs A, 1998, PHARMACOECONOMICS, V13, P397, DOI 10.2165/00019053-199813040-00003; Buti M, 2000, J HEPATOL, V33, P651, DOI 10.1034/j.1600-0641.2000.033004651.x; Buti M, 2003, ALIMENT PHARM THER, V17, P687, DOI 10.1046/j.1365-2036.2003.01453.x; Dusheiko GM, 1995, HEPATOLOGY, V22, P1863, DOI 10.1016/0270-9139(95)90216-3; Evans Christopher, 2004, Health Care Manag Sci, V7, P43, DOI 10.1023/B:HCMS.0000005397.93173.bb; Gold MR, 1996, COST EFFECTIVENESS H; Hammer SM, 2002, NEW ENGL J MED, V346, P2022, DOI 10.1056/NEJM2p020052; Kim WR, 1997, ANN INTERN MED, V127, P866, DOI 10.7326/0003-4819-127-10-199711150-00002; Kim WR, 2002, MICROBES INFECT, V4, P1219, DOI 10.1016/S1286-4579(02)01649-0; Sagmeister M, 2001, EUR J GASTROEN HEPAT, V13, P483, DOI 10.1097/00042737-200105000-00004; Salomon JA, 2003, JAMA-J AM MED ASSOC, V290, P228, DOI 10.1001/jama.290.2.228; Sculpher M, 2001, BRIT MED J, V322, P943, DOI 10.1136/bmj.322.7292.943; SEEFF LB, 1999, AM J MED, V107, pS5; Sennfalt K, 2001, SCAND J GASTROENTERO, V36, P870, DOI 10.1080/003655201750313414; Shiell A, 1999, MED J AUSTRALIA, V171, P189, DOI 10.5694/j.1326-5377.1999.tb123595.x; Siebert U, 2003, GUT, V52, P425, DOI 10.1136/gut.52.3.425; Stein K, 2002, GUT, V50, P253, DOI 10.1136/gut.50.2.253; TONG MJ, 1995, NEW ENGL J MED, V332, P1463, DOI 10.1056/NEJM199506013322202; Tsuchiya A, 2001, EC EVALUATION HLTH C, P22; WEINSTEIN MC, 1977, NEW ENGL J MED, V296, P716, DOI 10.1056/NEJM197703312961304; Wong JB, 2000, ANN INTERN MED, V133, P665, DOI 10.7326/0003-4819-133-9-200011070-00008; Wong JB, 2000, AM J GASTROENTEROL, V95, P1524; Wong JB, 2002, ACTA GASTRO-ENT BELG, V65, P110; Younossi ZM, 1999, HEPATOLOGY, V30, P1318, DOI 10.1002/hep.510300518	29	23	23	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 25	2004	329	7468					733	736		10.1136/bmj.329.7468.733	http://dx.doi.org/10.1136/bmj.329.7468.733			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	858RV	15388618	Green Published, Green Submitted			2022-12-28	WOS:000224210300024
J	Gilden, DH				Gilden, DH			Bell's palsy	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							IDIOPATHIC FACIAL PARALYSIS; HERPES-SIMPLEX VIRUS; DOUBLE-BLIND; NATURAL-HISTORY; NERVE PARALYSIS; PREDNISONE; PROGNOSIS; SURGERY; ACYCLOVIR; STEROIDS		Univ Colorado, Hlth Sci Ctr, Dept Neurol, Denver, CO 80262 USA; Univ Colorado, Hlth Sci Ctr, Dept Microbiol, Denver, CO 80262 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Gilden, DH (corresponding author), Univ Colorado, Hlth Sci Ctr, Dept Neurol, 4200 E 9th Ave,Mail Stop B182, Denver, CO 80262 USA.	don.gilden@uchsc.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS032623] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R37AG006127, R01AG006127] Funding Source: NIH RePORTER; NIA NIH HHS [AG06127] Funding Source: Medline; NINDS NIH HHS [NS32623] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ADOUR KK, 1974, NEUROLOGY, V24, P1112, DOI 10.1212/WNL.24.12.1112; Adour KK, 1996, ANN OTO RHINOL LARYN, V105, P371, DOI 10.1177/000348949610500508; ADOUR KK, 1978, LARYNGOSCOPE, V88, P787; ADOUR KK, 1972, NEW ENGL J MED, V287, P1268, DOI 10.1056/NEJM197212212872503; AUSTIN JR, 1993, LARYNGOSCOPE, V103, P1326; BROWN JS, 1982, LARYNGOSCOPE, V92, P1369; CAMPBELL ED, 1962, BRIT MED J, V2, P7, DOI 10.1136/bmj.2.5296.7; CAWTHORNE T, 1963, ARCHIV OTOLARYNGOL, V78, P429, DOI 10.1001/archotol.78.3.40; CAWTHORNE T, 1950, P ROY SOC MED, V4, P565; De Diego JI, 1998, LARYNGOSCOPE, V108, P573, DOI 10.1097/00005537-199804000-00020; DIAMANT H, 1972, ARCHIV OTOLARYNGOL, V95, P431; FISCH U, 1984, AM J OTOL, V5, P494; FISCH U, 1972, ARCHIV OTOLARYNGOL, V95, P335; FISCH U, 1981, ARCH OTOLARYNGOL, V107, P1; Fisch U., 1977, NEUROLOGICAL SURG EA, P31; FURUTA Y, 1992, ACTA NEUROPATHOL, V84, P39, DOI 10.1007/BF00427213; GANTZ BJ, 1984, ANN OTO RHINOL LARYN, V93, P394, DOI 10.1177/000348948409300422; Gantz BJ, 1999, LARYNGOSCOPE, V109, P1177, DOI 10.1097/00005537-199908000-00001; Grogan PM, 2001, NEUROLOGY, V56, P830, DOI 10.1212/WNL.56.7.830; HAUSER WA, 1971, MAYO CLIN PROC, V46, P258; KATUSIC SK, 1986, ANN NEUROL, V20, P622, DOI 10.1002/ana.410200511; KEANE JR, 1994, NEUROLOGY, V44, P1198, DOI 10.1212/WNL.44.7.1198; MAY M, 1976, LARYNGOSCOPE, V86, P1111, DOI 10.1288/00005537-197608000-00003; MAY M, 1985, LARYNGOSCOPE, V95, P406; MAY M, 1981, LARYNGOSCOPE, V91, P2092; Merwarth HR, 1942, ANN INTERN MED, V17, P298, DOI 10.7326/0003-4819-17-2-298; Murakami S, 1996, ANN INTERN MED, V124, P27, DOI 10.7326/0003-4819-124-1_Part_1-199601010-00005; Mutsch M, 2004, NEW ENGL J MED, V350, P896, DOI 10.1056/NEJMoa030595; PEITERSEN E, 1982, AM J OTOL, V4, P107; RAFF MC, 1968, NEW ENGL J MED, V279, P17, DOI 10.1056/NEJM196807042790104; Ramsey MJ, 2000, LARYNGOSCOPE, V110, P335, DOI 10.1097/00005537-200003000-00001; RICHARDSON AT, 1963, ANN OTO RHINOL LARYN, V72, P569, DOI 10.1177/000348946307200223; SAITO O, 1994, ACTA OTO-LARYNGOL, P153; SARTORETTISCHEFER S, 1994, AM J NEURORADIOL, V15, P479; SNYDER MC, FACIAL NERVE PARALYS; Strupp M, 2004, NEW ENGL J MED, V351, P354, DOI 10.1056/NEJMoa033280; WENTWORTH BB, 1971, AM J EPIDEMIOL, V94, P496, DOI 10.1093/oxfordjournals.aje.a121347; Williamson IG, 1996, BRIT J GEN PRACT, V46, P743; WOLF SM, 1978, NEUROLOGY, V28, P158, DOI 10.1212/WNL.28.2.158	39	262	284	1	35	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 23	2004	351	13					1323	1331		10.1056/NEJMcp041120	http://dx.doi.org/10.1056/NEJMcp041120			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	855TP	15385659				2022-12-28	WOS:000223997700010
J	Ao, W; Gaudet, J; Kent, WJ; Muttumu, S; Mango, SE				Ao, W; Gaudet, J; Kent, WJ; Muttumu, S; Mango, SE			Environmentally induced foregut remodeling by PHA-4/FoxA and DAF-12/NHR	SCIENCE			English	Article							CAENORHABDITIS-ELEGANS; GENE-EXPRESSION; DNA-BINDING; DEVELOPMENTAL AGE; ENCODES; ISOFORMS; RECEPTOR; CEH-22	Growth and development of the Caenorhabditis elegans foregut (pharynx) depends on coordinated gene expression, mediated by pharynx defective (PHA)-4/FoxA in combination with additional, largely unidentified transcription factors. Here, we used whole genome analysis to establish clusters of genes expressed in different pharyngeal cell types. We created an expectation maximization algorithm to identify cis-regulatory elements that activate expression within the pharyngeal gene clusters. One of these elements mediates the response to environmental conditions within pharyngeal muscles and is recognized by the nuclear hormone receptor (NHR) DAF-12. Our data suggest that PHA-4 and DAF-12 endow the pharynx with transcriptional plasticity to respond to diverse developmental and physiological cues. Our combination of bioinformatics and in vivo analysis has provided a powerful means for genome-wide investigation of transcriptional control.	Univ Utah, Huntsman Canc Inst, Salt Lake City, UT 84112 USA; Univ Calif Santa Cruz, Genome Bioinformat Grp, Santa Cruz, CA 95064 USA	Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; University of California System; University of California Santa Cruz	Mango, SE (corresponding author), Univ Utah, Huntsman Canc Inst, 2000 Circle Hope, Salt Lake City, UT 84112 USA.	susan.mango@hci.utah.edu		Mango, Susan/0000-0002-2146-3237	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056264] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM056264-08S1, R01 GM056264, R01-GM56264, R01 GM056264-08, R01 GM056264-07] Funding Source: Medline; PHS HHS [2P303A42014] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		ALBERT PS, 1988, DEV BIOL, V126, P270, DOI 10.1016/0012-1606(88)90138-8; Antebi A, 2000, GENE DEV, V14, P1512; Antebi A, 1998, DEVELOPMENT, V125, P1191; AO W, UNPUB; Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Beaster-Jones L, 2004, J MOL BIOL, V339, P695, DOI 10.1016/j.jmb.2004.04.030; Finch CE, 2001, ANNU REV GENOM HUM G, V2, P435, DOI 10.1146/annurev.genom.2.1.435; Fire A, 1998, GREEN FLUORESCENT PROTEIN: PROPERTIES, APPLICATIONS, AND PROTOCOLS, P153; Gaudet J, 2002, SCIENCE, V295, P821, DOI 10.1126/science.1065175; GAUDET J, IN PRESS PLOS BIOL; Gerisch B, 2001, DEV CELL, V1, P841, DOI 10.1016/S1534-5807(01)00085-5; Horner MA, 1998, GENE DEV, V12, P1947, DOI 10.1101/gad.12.13.1947; Jia KL, 2002, DEVELOPMENT, V129, P221; Kim SK, 2001, SCIENCE, V293, P2087, DOI 10.1126/science.1061603; KISPERT A, 1993, EMBO J, V12, P3211, DOI 10.1002/j.1460-2075.1993.tb05990.x; LARSEN PL, 1995, GENETICS, V139, P1567; Li SL, 2003, MOL BIOL CELL, V14, P2630, DOI 10.1091/mbc.E02-11-0716; MANGO SE, 1994, DEVELOPMENT, V120, P3019; Mann RS, 2002, CURR OPIN GENET DEV, V12, P592, DOI 10.1016/S0959-437X(02)00344-1; MILLER DM, 1986, P NATL ACAD SCI USA, V83, P2305, DOI 10.1073/pnas.83.8.2305; Okkema PG, 1997, DEVELOPMENT, V124, P3965; OKKEMA PG, 1994, DEVELOPMENT, V120, P2175; RIDDLE DL, 1981, NATURE, V290, P668, DOI 10.1038/290668a0; Snow MI, 2000, BBA-GENE STRUCT EXPR, V1494, P104, DOI 10.1016/S0167-4781(00)00224-4; Stein LD, 2003, PLOS BIOL, V1, P166, DOI 10.1371/journal.pbio.0000045; SULSTON JE, 1983, DEV BIOL, V100, P64, DOI 10.1016/0012-1606(83)90201-4; Tatar M, 2003, SCIENCE, V299, P1346, DOI 10.1126/science.1081447; Thatcher JD, 1999, DEVELOPMENT, V126, P97; Thatcher JD, 2001, DEV BIOL, V229, P480, DOI 10.1006/dbio.2000.9978; Vilimas T, 2004, DEV BIOL, V266, P388, DOI 10.1016/j.ydbio.2003.10.015; Wang J, 2003, DEVELOPMENT, V130, P1621, DOI 10.1242/dev.00363; WANG MM, 1993, NATURE, V364, P121, DOI 10.1038/364121a0	32	135	145	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 17	2004	305	5691					1743	1746		10.1126/science.1102216	http://dx.doi.org/10.1126/science.1102216			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	856IS	15375261				2022-12-28	WOS:000224039500032
J	Rogers, FB				Rogers, FB			Traumatic laceration of the aorta	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Vermont, Burlington, VT 05401 USA	University of Vermont	Rogers, FB (corresponding author), Univ Vermont, Burlington, VT 05401 USA.								0	1	1	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 16	2004	351	12					1239	1239		10.1056/NEJMicm980914	http://dx.doi.org/10.1056/NEJMicm980914			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	853WS	15371581				2022-12-28	WOS:000223861300012
J	Cumberland, P; Rahi, JS; Peckham, CS				Cumberland, P; Rahi, JS; Peckham, CS			Impact of congenital colour vision deficiency on education and unintentional injuries: findings from the 1958 British birth cohort	BMJ-BRITISH MEDICAL JOURNAL			English	Article									Inst Child Hlth, Ctr Paediat Epidemiol & Biostat, London WC1N 1EH, England	University of London; University College London	Rahi, JS (corresponding author), Inst Child Hlth, Ctr Paediat Epidemiol & Biostat, 30 Guilford St, London WC1N 1EH, England.	j.rahi@ich.ucl.ac.uk	peckham, catherine s/I-6300-2013	Rahi, Jugnoo/0000-0002-5718-9209				ESSEN J, 1978, ED RES, V20, P300; *HLTH SAF EX, 1987, COL VIS, P1; Holroyd E, 1997, CHILD CARE HLTH DEV, V23, P391, DOI 10.1111/j.1365-2214.1997.tb00906.x; Jefferis BJMH, 2002, BRIT MED J, V325, P305, DOI 10.1136/bmj.325.7359.305; LAMPE JM, 1973, J SCHOOL HEALTH, V43, P309, DOI 10.1111/j.1746-1561.1973.tb03718.x	5	20	23	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 6	2004	329	7474					1074	1075		10.1136/bmj.38176.685208.F7	http://dx.doi.org/10.1136/bmj.38176.685208.F7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	870PN	15465847	Green Published, Bronze, Green Submitted			2022-12-28	WOS:000225070300020
J	Garnero, EJ; Maupin, V; Lay, T; Fouch, MJ				Garnero, EJ; Maupin, V; Lay, T; Fouch, MJ			Variable azimuthal anisotropy in Earth's lowermost mantle	SCIENCE			English	Article							SEISMIC ANISOTROPY; BOUNDARY-LAYER; BENEATH; BASE; HETEROGENEITY; TRANSITION	A persistent reversal in the expected polarity of the initiation of vertically polarized shear waves that graze the D" layer (the layer at the boundary between the outer core and the lower mantle of Earth) in some regions starts at the arrival time of horizontally polarized shear waves. Full waveform modeling of the split shear waves for paths beneath the Caribbean requires azimuthal anisotropy at the base of the mantle. Models with laterally coherent patterns of transverse isotropy with the hexagonal symmetry axis of the mineral phases tilted from the vertical by as much as 20degrees are consistent with the data. Small-scale convection cells within the mantle above the D" layer may cause the observed variations by inducing laterally variable crystallographic or shape-preferred orientation in minerals in the D" layer.	Arizona State Univ, Dept Geol Sci, Tempe, AZ 85287 USA; Univ Oslo, Dept Geosci, N-0316 Oslo, Norway; Univ Calif Santa Cruz, Inst Geophys & Planetary Phys, Santa Cruz, CA 95064 USA; Univ Calif Santa Cruz, Dept Earth Sci, Santa Cruz, CA 95064 USA	Arizona State University; Arizona State University-Tempe; University of Oslo; University of California System; University of California Santa Cruz; University of California System; University of California Santa Cruz	Garnero, EJ (corresponding author), Arizona State Univ, Dept Geol Sci, Tempe, AZ 85287 USA.	garnero@asu.edu	Lay, Thorne/ABE-6272-2021; Fouch, Matthew/F-6507-2010	Maupin, Valerie/0000-0001-8050-3596				Badro J, 2003, SCIENCE, V300, P789, DOI 10.1126/science.1081311; BOSTOCK MG, 1995, GEOPHYS RES LETT, V22, P5, DOI 10.1029/94GL02789; Bostock MG, 1996, J GEOPHYS RES-SOL EA, V101, P8393, DOI 10.1029/95JB03741; Cormier VF, 1999, GEOPHYS J INT, V136, P373, DOI 10.1046/j.1365-246X.1999.00736.x; Currie CA, 2004, GEOPHYS J INT, V157, P341, DOI 10.1111/j.1365-246X.2004.02175.x; Emery V, 1999, GEOPHYS J INT, V139, P325, DOI 10.1046/j.1365-246x.1999.00941.x; Garnero EJ, 2004, J GEOPHYS RES-SOL EA, V109, DOI 10.1029/2004JB003004; Garnero EJ, 2003, PHYS EARTH PLANET IN, V140, P219, DOI 10.1016/j.pepi.2003.07.014; Garnero EJ, 2004, SCIENCE, V304, P834, DOI 10.1126/science.1097849; Karki BB, 1999, SCIENCE, V286, P1705, DOI 10.1126/science.286.5445.1705; Kendall J.M., 2000, EARTHS DEEP INTERIOR, V117, P133, DOI [10.1029/GM117p0133, DOI 10.1029/GM117P0133]; Kendall JM, 1996, NATURE, V381, P409, DOI 10.1038/381409a0; Kendall JM, 1996, GEOPHYS RES LETT, V23, P399, DOI 10.1029/95GL02659; Lay T, 2004, PHYS EARTH PLANET IN, V146, P441, DOI 10.1016/j.pepi.2004.04.004; Lay T, 1998, NATURE, V392, P461, DOI 10.1038/33083; LAY T, 1983, J GEOPHYS RES, V88, P8160, DOI 10.1029/JB088iB10p08160; Mainprice D., 2000, EARTHS DEEP INTERIOR, P237, DOI [10.1029/GM117p0237, DOI 10.1029/GM117P0237]; Matzel E, 1996, GEOPHYS RES LETT, V23, P2417, DOI 10.1029/96GL02186; MAUPIN V, 1994, PHYS EARTH PLANET IN, V87, P1, DOI 10.1016/0031-9201(94)90019-1; McNamara AK, 2002, NATURE, V416, P310, DOI 10.1038/416310a; Moore MM, 2004, J GEOPHYS RES-SOL EA, V109, DOI 10.1029/2003JB002546; Murakami M, 2004, SCIENCE, V304, P855, DOI 10.1126/science.1095932; Panning M, 2004, SCIENCE, V303, P351, DOI 10.1126/science.1091524; Pulliam J, 1998, GEOPHYS J INT, V135, P113, DOI 10.1046/j.1365-246X.1998.00612.x; Ritsema J, 2000, GEOPHYS RES LETT, V27, P1041, DOI 10.1029/1999GL011037; Russell SA, 1998, NATURE, V396, P255, DOI 10.1038/24364; Shim SH, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL019639; Stixrude L, 1998, GEODYNAMICS, V28, P83; Thomas C, 2002, GEOPHYS J INT, V151, P296, DOI 10.1046/j.1365-246X.2002.01760.x; Yamazaki D, 2002, PHYS EARTH PLANET IN, V131, P251, DOI 10.1016/S0031-9201(02)00037-7	30	83	87	1	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 8	2004	306	5694					259	261		10.1126/science.1103411	http://dx.doi.org/10.1126/science.1103411			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	861MC	15472071				2022-12-28	WOS:000224419700034
J	O'Dowd, CD; Facchini, MC; Cavalli, F; Ceburnis, D; Mircea, M; Decesari, S; Fuzzi, S; Yoon, YJ; Putaud, JP				O'Dowd, CD; Facchini, MC; Cavalli, F; Ceburnis, D; Mircea, M; Decesari, S; Fuzzi, S; Yoon, YJ; Putaud, JP			Biogenically driven organic contribution to marine aerosol	NATURE			English	Article							SUBMICRON AEROSOL; CLOUD ALBEDO; SULFUR; FRACTIONATION; TRANSPORT; MATTER; MASS	Marine aerosol contributes significantly to the global aerosol load and consequently has an important impact on both the Earth's albedo and climate. So far, much of the focus on marine aerosol has centred on the production of aerosol from sea-salt(1) and non-sea-salt sulphates(2,3). Recent field experiments, however, have shown that known aerosol production processes for inorganic species cannot account for the entire aerosol mass that occurs in submicrometre sizes(4-6). Several experimental studies have pointed to the presence of significant concentrations of organic matter in marine aerosol(7-11). There is some information available about the composition of organic matter(12-14), but the contribution of organic matter to marine aerosol, as a function of aerosol size, as well as its characterization as hydrophilic or hydrophobic, has been lacking. Here we measure the physical and chemical characteristics of submicrometre marine aerosol over the North Atlantic Ocean during plankton blooms progressing from spring through to autumn. We find that during bloom periods, the organic fraction dominates and contributes 63% to the submicrometre aerosol mass (about 45% is water-insoluble and about 18% water-soluble). In winter, when biological activity is at its lowest, the organic fraction decreases to 15%. Our model simulations indicate that organic matter can enhance the cloud droplet concentration by 15% to more than 100% and is therefore an important component of the aerosol-cloud-climate feedback system involving marine biota.	CNR, Ist Sci Atmosfera & Clima, I-40129 Bologna, Italy; Natl Univ Ireland, Dept Expt Phys, Galway, Ireland; Natl Univ Ireland, Environm Change Inst, Galway, Ireland; Inst Phys, Environm Phys & Chem Div, LT-2053 Vilnius, Lithuania; Commiss European Communities, Inst Environm & Sustainabil, Joint Res Ctr, I-21021 Ispra, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze dell'Atmosfera e del Clima (ISAC-CNR); Ollscoil na Gaillimhe-University of Galway; Ollscoil na Gaillimhe-University of Galway; European Commission Joint Research Centre; EC JRC ISPRA Site	Facchini, MC (corresponding author), CNR, Ist Sci Atmosfera & Clima, I-40129 Bologna, Italy.	mc.facchini@isac.cnr.it	Facchini, Maria Cristina/AAA-1592-2019; Facchini, Maria Cristina/B-3369-2014; FACCHINI, MARIA CRISTINA/O-1230-2015; Decesari, Stefano/B-9588-2015; O'Dowd, Colin D/K-8904-2012; Ceburnis, Darius/C-1293-2012; Fuzzi, Sandro/F-2675-2010	Facchini, Maria Cristina/0000-0003-4833-9305; Facchini, Maria Cristina/0000-0003-4833-9305; FACCHINI, MARIA CRISTINA/0000-0003-4833-9305; Decesari, Stefano/0000-0001-6486-3786; O'Dowd, Colin D/0000-0002-3068-2212; Ceburnis, Darius/0000-0003-0231-5324; Fuzzi, Sandro/0000-0002-5275-2381				Beardall J, 2004, PHYCOLOGIA, V43, P26, DOI 10.2216/i0031-8884-43-1-26.1; BLANCHARD DC, 1976, ADV CHEM SER, V145, P360; Cavalli F, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2004JD005137; CHARLSON RJ, 1987, NATURE, V326, P655, DOI 10.1038/326655a0; Facchini MC, 1999, NATURE, V401, P257, DOI 10.1038/45758; GAGOSIAN RB, 1981, NATURE, V291, P312, DOI 10.1038/291312a0; GEEVER M, 2003, J AER SCI, V1, pS637; GERSHEY RM, 1983, LIMNOL OCEANOGR, V28, P309, DOI 10.4319/lo.1983.28.2.0309; Gogou AI, 1998, J CHROMATOGR A, V799, P215, DOI 10.1016/S0021-9673(97)01106-0; HOFFMAN EJ, 1974, J GEOPHYS RES, V79, P4474, DOI 10.1029/JC079i030p04474; Huebert BJ, 1998, J GEOPHYS RES-ATMOS, V103, P16493, DOI 10.1029/98JD00770; KAWAMURA K, 1990, J ATMOS CHEM, V11, P107, DOI 10.1007/BF00053670; Kleefeld S, 2002, ATMOS ENVIRON, V36, P4479, DOI 10.1016/S1352-2310(02)00346-1; Martensson EM, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002263; McInnes LM, 1996, ATMOS ENVIRON, V30, P869, DOI 10.1016/1352-2310(95)00354-1; Middlebrook AM, 1998, J GEOPHYS RES-ATMOS, V103, P16475, DOI 10.1029/97JD03719; Mochida M, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2001JD001278; Nenes A, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL015295; Novakov T, 1997, J GEOPHYS RES-ATMOS, V102, P21307, DOI 10.1029/97JD01487; ODowd CD, 1997, ATMOS ENVIRON, V31, P73, DOI 10.1016/S1352-2310(96)00106-9; Oppo C, 1999, MAR CHEM, V63, P235, DOI 10.1016/S0304-4203(98)00065-6; Putaud JP, 2000, TELLUS B, V52, P141, DOI 10.1034/j.1600-0889.2000.00056.x; Quinn PK, 2000, J GEOPHYS RES-ATMOS, V105, P6785, DOI 10.1029/1999JD901034; SHAW GE, 1983, CLIMATIC CHANGE, V5, P297, DOI 10.1007/BF02423524	24	682	692	13	306	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 7	2004	431	7009					676	680		10.1038/nature02959	http://dx.doi.org/10.1038/nature02959			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	859WS	15470425				2022-12-28	WOS:000224299300037
J	Snow, V; Barry, P; Fihn, SD; Gibbons, RJ; Owens, DK; Williams, SV; Mottur-Pilson, C; Weiss, KB				Snow, V; Barry, P; Fihn, SD; Gibbons, RJ; Owens, DK; Williams, SV; Mottur-Pilson, C; Weiss, KB		Amer Coll of Physicians	Primary care management of chronic stable angina and asymptomatic suspected or known coronary artery disease: A clinical practice guideline from the American College of Physicians	ANNALS OF INTERNAL MEDICINE			English	Article							ASSOCIATION TASK-FORCE; MYOCARDIAL-INFARCTION; CARDIOVASCULAR EVENTS; DOUBLE-BLIND; ISCHEMIA; EXERCISE; ATENOLOL; REDUCTION; COMMITTEE; ASPIRIN	In 1999, the American College of Physicians (ACP), then the American College of Physicians-American Society of Internal Medicine, and the American College of Cardiology/American Heart Association (ACC/AHA) developed joint guidelines on the management of patients with chronic stable angina. The ACC/AHA then published an updated guideline in 2002, which ACP recognized as a scientifically valid review of the evidence and background paper. This ACP guideline summarizes the recommendations of the 2002 ACC/AHA updated guideline and underscores the recommendations most likely to be important to physicians seeing patients in the primary care setting. This guideline is the second of 2 that provide guidance on the management of patients with chronic stable angina. This document covers treatment and follow-up of symptomatic patients who have not had an acute myocardial infarction or revascularization procedure in the previous 6 months. Sections addressing asymptomatic patients are also included. Asymptomatic refers to patients with known or suspected coronary disease based on a history or electrocardiographic evidence of previous myocardial infarction, coronary angiography, or abnormal results on noninvasive tests. A previous guideline covered diagnosis and risk stratification for symptomatic patients who have not had an acute myocardial infarction or revascularization procedure in the previous 6 months and asymptomatic patients with known or suspected coronary disease based on a history or electrocardiographic evidence of previous myocardial infarction, coronary angiography, or abnormal results on noninvasive tests.	Amer Coll Physicians, Philadelphia, PA 19106 USA; Univ Penn, Philadelphia, PA 19104 USA; Merck Inst Aging & Hlth, Washington, DC USA; Vet Affairs Puget Sound Hlth Care Syst, Seattle, WA USA; Mayo Clin, Rochester, MN USA; Vet Affairs Hlth Care Syst, Palo Alto, CA USA; Edward Hines Jr VA Hosp, Chicago, IL USA; Northwestern Univ, Chicago, IL 60611 USA	American College of Physicians; University of Pennsylvania; US Department of Veterans Affairs; Veterans Health Administration (VHA); Vet Affairs Puget Sound Health Care System; Mayo Clinic; US Department of Veterans Affairs; Veterans Health Administration (VHA); US Department of Veterans Affairs; Veterans Health Administration (VHA); Edward Hines Jr. VA Hospital; Northwestern University	Snow, V (corresponding author), Amer Coll Physicians, 192 N Independence Mall W, Philadelphia, PA 19106 USA.	vincenza@mail.acponline.org	Fihn, Stephan/ABA-1040-2020	Gibbons, Raymond/0000-0003-0704-1350				ALTMAN R, 1994, BMJ-BRIT MED J, V308, P81, DOI 10.1136/bmj.308.6921.81; Baigent C, 2002, BMJ-BRIT MED J, V324, P71, DOI 10.1136/bmj.324.7329.71; Braunwald E, 2002, J AM COLL CARDIOL, V40, P1366, DOI 10.1016/S0735-1097(02)02336-7; CHAITMAN BR, 1995, J AM COLL CARDIOL, V26, P585, DOI 10.1016/0735-1097(95)00013-T; Collins R, 2002, LANCET, V360, P7, DOI 10.1016/S0140-6736(02)09327-3; DAVIES RF, 1995, J AM COLL CARDIOL, V25, P619, DOI 10.1016/0735-1097(94)00436-T; DEEDWANIA PC, 1991, J AM COLL CARDIOL, V17, P963; Fox KM, 2003, LANCET, V362, P782; Gent M, 1996, LANCET, V348, P1329, DOI 10.1016/s0140-6736(96)09457-3; Gibbons RJ, 1999, J AM COLL CARDIOL, V33, P2092, DOI 10.1016/S0735-1097(99)00150-3; GIBBONS RJ, 2002, ACC AHA 2002 GUID UP; Gould AL, 1998, CIRCULATION, V97, P946; HENNEKENS CH, 1989, NEW ENGL J MED, V321, P129, DOI 10.1056/nejm198907203210301; JUULMOLLER S, 1992, LANCET, V340, P1421, DOI 10.1016/0140-6736(92)92619-Q; NICKLAS JM, 1992, NEW ENGL J MED, V327, P685; PEDERSEN TR, 1994, LANCET, V344, P1383; PEPINE CJ, 1994, CIRCULATION, V90, P762, DOI 10.1161/01.CIR.90.2.762; PFEFFER MA, 1992, NEW ENGL J MED, V327, P669, DOI 10.1056/NEJM199209033271001; RIDKER PM, 1991, ANN INTERN MED, V114, P835, DOI 10.7326/0003-4819-114-10-835; Ryan TJ, 1999, CIRCULATION, V100, P1016, DOI 10.1161/01.CIR.100.9.1016; Sacks FM, 1996, NEW ENGL J MED, V335, P1001, DOI 10.1056/NEJM199610033351401; Snow V, 2004, ANN INTERN MED, V141, P57, DOI 10.7326/0003-4819-141-1-200407060-00015; SWEDBERG K, 1987, NEW ENGL J MED, V316, P1429; TSUYA T, 1990, AM J CARDIOL, V66, P275, DOI 10.1016/0002-9149(90)90835-O; Wang TJ, 1998, ARCH INTERN MED, V158, P1901, DOI 10.1001/archinte.158.17.1901; Yusuf S, 2000, NEW ENGL J MED, V342, P145; 1998, N ENGL J MED, V339, P1349	27	42	54	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 5	2004	141	7					562	567		10.7326/0003-4819-141-7-200410050-00014	http://dx.doi.org/10.7326/0003-4819-141-7-200410050-00014			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	862CR	15466774				2022-12-28	WOS:000224467800009
J	Armbrust, EV; Berges, JA; Bowler, C; Green, BR; Martinez, D; Putnam, NH; Zhou, SG; Allen, AE; Apt, KE; Bechner, M; Brzezinski, MA; Chaal, BK; Chiovitti, A; Davis, AK; Demarest, MS; Detter, JC; Glavina, T; Goodstein, D; Hadi, MZ; Hellsten, U; Hildebrand, M; Jenkins, BD; Jurka, J; Kapitonov, VV; Kroger, N; Lau, WWY; Lane, TW; Larimer, FW; Lippmeier, JC; Lucas, S; Medina, M; Montsant, A; Obornik, M; Parker, MS; Palenik, B; Pazour, GJ; Richardson, PM; Rynearson, TA; Saito, MA; Schwartz, DC; Thamatrakoln, K; Valentin, K; Vardi, A; Wilkerson, FP; Rokhsar, DS				Armbrust, EV; Berges, JA; Bowler, C; Green, BR; Martinez, D; Putnam, NH; Zhou, SG; Allen, AE; Apt, KE; Bechner, M; Brzezinski, MA; Chaal, BK; Chiovitti, A; Davis, AK; Demarest, MS; Detter, JC; Glavina, T; Goodstein, D; Hadi, MZ; Hellsten, U; Hildebrand, M; Jenkins, BD; Jurka, J; Kapitonov, VV; Kroger, N; Lau, WWY; Lane, TW; Larimer, FW; Lippmeier, JC; Lucas, S; Medina, M; Montsant, A; Obornik, M; Parker, MS; Palenik, B; Pazour, GJ; Richardson, PM; Rynearson, TA; Saito, MA; Schwartz, DC; Thamatrakoln, K; Valentin, K; Vardi, A; Wilkerson, FP; Rokhsar, DS			The genome of the diatom Thalassiosira pseudonana: Ecology, evolution, and metabolism	SCIENCE			English	Article							GENE-TRANSFER; OCEAN; SILICA; POLYAMINES; PROTEINS; NUCLEUS; FAMILY; LIGHT	Diatoms are unicellular algae with plastids acquired by secondary endosymbiosis. They are responsible for similar to20% of global carbon fixation. We report the 34 million-base pair draft nuclear genome of the marine diatom Thalassiosira pseudonana and its 129 thousand-base pair ptastid and 44 thousand-base pair mitochondrial genomes. Sequence and optical restriction mapping revealed 24 diploid nuclear chromosomes. We identified novel genes for silicic acid transport and formation of silica-based cell walls, high-affinity iron uptake, biosynthetic enzymes for several types of polyunsaturated fatty acids, use of a range of nitrogenous compounds, and a complete urea cycle, all attributes that allow diatoms to prosper in aquatic environments.	Univ Washington, Sch Oceanog, Seattle, WA 98195 USA; Univ Wisconsin, Dept Biol Sci, Milwaukee, WI 53201 USA; Stn Zool, Plant Mol Biol Lab, I-80121 Naples, Italy; Ecole Normale Super, Dept Biol, F-75230 Paris, France; Univ British Columbia, Dept Bot, Vancouver, BC V6T 1Z4, Canada; Joint Genome Inst, Dept Energy, Walnut Creek, CA 94598 USA; Univ Wisconsin, Dept Genet, Madison, WI 53706 USA; Univ Wisconsin, Dept Chem, Madison, WI 53706 USA; Princeton Univ, Dept Geosci, Princeton, NJ 08540 USA; Martek Biosci Corp, Columbia, MD 21045 USA; Univ Calif Santa Barbara, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA 93106 USA; Univ Calif Santa Barbara, Inst Marine Sci, Santa Barbara, CA 93106 USA; Univ Melbourne, Sch Bot, Melbourne, Vic 3010, Australia; Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA; Sandia Natl Labs, Lockheed Martin Corp, Livermore, CA 94551 USA; Univ Calif Santa Cruz, Ocean Sci Dept, Santa Cruz, CA 95064 USA; Genet Informat Res Inst, Mountain View, CA 94043 USA; Univ Regensburg, Lehrstuhl Biochem 1, D-93053 Regensburg, Germany; Sandia Natl Labs, Biosyst Res Dept, Livermore, CA 94551 USA; Oak Ridge Natl Lab, Genome Anal Grp, Oak Ridge, TN 37831 USA; Univ Hull, Dept Biol Sci, Kingston Upon Hull HU6 7RX, N Humberside, England; Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA; Woods Hole Oceanog Inst, Dept Marine Chem & Geochem, Woods Hole, MA 02543 USA; Alfred Wegener Inst Polar & Marine Res, D-27570 Bremerhaven, Germany; San Francisco State Univ, Romberg Tiburon Ctr, Tiburon, CA 94920 USA; Univ Calif Berkeley, Ctr Integrat Genom, Berkeley, CA 94720 USA	University of Washington; University of Washington Seattle; University of Wisconsin System; University of Wisconsin Milwaukee; UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); University of British Columbia; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Princeton University; University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; University of Melbourne; University of California System; University of California San Diego; Scripps Institution of Oceanography; Lockheed Martin; United States Department of Energy (DOE); Sandia National Laboratories; University of California System; University of California Santa Cruz; University of Regensburg; United States Department of Energy (DOE); Sandia National Laboratories; United States Department of Energy (DOE); Oak Ridge National Laboratory; University of Hull; University of Massachusetts System; University of Massachusetts Worcester; Woods Hole Oceanographic Institution; Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; California State University System; San Francisco State University; University of California System; University of California Berkeley	Armbrust, EV (corresponding author), Univ Washington, Sch Oceanog, Seattle, WA 98195 USA.	armbrust@ocean.washington.edu; dsrokhsar@lbl.gov	Obornik, Miroslav/G-9350-2014; Zhou, Shiguo/B-3832-2011; Palenik, Brian/AAA-1822-2020; Green, Beverley R./AAJ-5199-2021; Bowler, Chris/AAC-6256-2019; Allen, Andrew E/C-4896-2012; Berges, John A/D-9520-2012; Valentin, Klaus/G-5862-2014; Putnam, Nicholas/B-9968-2008; Saito, Mak/ADT-4986-2022	Zhou, Shiguo/0000-0001-7421-2506; Palenik, Brian/0000-0002-3717-9046; Green, Beverley R./0000-0002-4021-9387; Allen, Andrew E/0000-0001-5911-6081; Berges, John A/0000-0002-3124-4783; Valentin, Klaus/0000-0001-7401-9423; Putnam, Nicholas/0000-0002-1315-782X; Rokhsar, Daniel/0000-0002-8704-2224; Goodstein, David/0000-0001-6287-2697; Bowler, Chris/0000-0003-3835-6187; Lippmeier, J./0000-0002-8157-1491; Thamatrakoln, Kimberlee/0000-0002-8029-5026; Lane, Todd/0000-0002-5816-2649; Parker, Micaela/0000-0003-1007-4612; Pazour, Gregory/0000-0002-6285-8796; Vardi, Assaf/0000-0002-7079-0234				Aparicio S, 2002, SCIENCE, V297, P1301, DOI 10.1126/science.1072104; Archibald JM, 2003, P NATL ACAD SCI USA, V100, P7678, DOI 10.1073/pnas.1230951100; Boyd PW, 2000, NATURE, V407, P695, DOI 10.1038/35037500; Brzezinski MA, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL014349; Cha JN, 1999, P NATL ACAD SCI USA, V96, P361, DOI 10.1073/pnas.96.2.361; CLINE K, 2003, LIGHT HARVESTING ANT, V13, P353; Coale KH, 2004, SCIENCE, V304, P408, DOI 10.1126/science.1089778; Coffino P, 2000, P NATL ACAD SCI USA, V97, P4421, DOI 10.1073/pnas.97.9.4421; Damste JSS, 2004, SCIENCE, V304, P584, DOI 10.1126/science.1096806; Dehal P, 2002, SCIENCE, V298, P2157, DOI 10.1126/science.1080049; Douglas S, 2001, NATURE, V410, P1091, DOI 10.1038/35074092; DUNSTAN GA, 1993, J APPL PHYCOL, V5, P71, DOI 10.1007/BF02182424; DUNSTAN GA, 1994, PHYTOCHEMISTRY, V35, P155, DOI 10.1016/S0031-9422(00)90525-9; Falciatore A, 2002, ANNU REV PLANT BIOL, V53, P109, DOI 10.1146/annurev.arplant.53.091701.153921; Falkowski PG, 2004, SCIENCE, V305, P354, DOI 10.1126/science.1095964; Field CB, 1998, SCIENCE, V281, P237, DOI 10.1126/science.281.5374.237; Foth BJ, 2003, SCIENCE, V299, P705, DOI 10.1126/science.1078599; Fulda M, 2002, PLANT J, V32, P93, DOI 10.1046/j.1365-313X.2002.01405.x; Hackett JD, 2004, CURR BIOL, V14, P213, DOI 10.1016/j.cub.2004.01.032; Hamm CE, 2003, NATURE, V421, P841, DOI 10.1038/nature01416; Hildebrand M, 1997, NATURE, V385, P688, DOI 10.1038/385688b0; Klein ATJ, 2002, J BIOL CHEM, V277, P25011, DOI 10.1074/jbc.M203254200; Kroger N, 2000, PROTIST, V151, P263, DOI 10.1078/1434-4610-00024; KROGER N, 1994, EMBO J, V13, P4676, DOI 10.1002/j.1460-2075.1994.tb06791.x; Kroth PG, 2002, INT REV CYTOL, V221, P191; Leblanc C, 1999, PLANT MOL BIOL, V40, P1031, DOI 10.1023/A:1006256300969; Li JB, 2004, CELL, V117, P541, DOI 10.1016/S0092-8674(04)00450-7; Li XP, 2000, NATURE, V403, P391, DOI 10.1038/35000131; Mann DG, 1999, PHYCOLOGIA, V38, P437, DOI 10.2216/i0031-8884-38-6-437.1; Martin W, 2003, P NATL ACAD SCI USA, V100, P8612, DOI 10.1073/pnas.1633606100; MCLACHLA.J, 1965, CAN J BOTANY, V43, P707, DOI 10.1139/b65-079; Moore JK, 2001, DEEP-SEA RES PT II, V49, P463; NELSON DM, 1995, GLOBAL BIOGEOCHEM CY, V9, P359, DOI 10.1029/95GB01070; Palenik B, 2003, NATURE, V424, P1037, DOI 10.1038/nature01943; Parkinson J, 1999, TRENDS BIOTECHNOL, V17, P190, DOI 10.1016/S0167-7799(99)01321-9; POULSEN N, IN PRESS J BIOL CHEM; Ragni M, 2004, J PLANKTON RES, V26, P433, DOI 10.1093/plankt/fbh044; Reinfelder JR, 2000, NATURE, V407, P996, DOI 10.1038/35039612; Robinson NJ, 1999, NATURE, V397, P694, DOI 10.1038/17800; Round F. E., 1990, DIATOMS BIOL MORPHOL; Stewart V, 2003, J BACTERIOL, V185, P2104, DOI 10.1128/JB.185.7.2104-2111.2003; Sumper M, 2004, J MATER CHEM, V14, P2059, DOI 10.1039/b401028k; TREGUER P, 1995, SCIENCE, V268, P375, DOI 10.1126/science.268.5209.375; Volcani B., 1981, SILICON SILICEOUS ST, P157; Walbot V, 2000, CURR OPIN PLANT BIOL, V3, P103, DOI 10.1016/S1369-5266(99)00051-5; Waller RF, 1998, P NATL ACAD SCI USA, V95, P12352, DOI 10.1073/pnas.95.21.12352; Yanovsky MJ, 2003, NAT REV MOL CELL BIO, V4, P265, DOI 10.1038/nrm1077; Zhang XP, 2002, TRENDS PLANT SCI, V7, P14, DOI 10.1016/S1360-1385(01)02180-X	48	1457	1567	20	683	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 1	2004	306	5693					79	86		10.1126/science.1101156	http://dx.doi.org/10.1126/science.1101156			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	859YJ	15459382	Green Submitted			2022-12-28	WOS:000224304000039
J	Turner, G; Harrison, TM; Holland, G; Mojzsis, SJ; Gilmour, J				Turner, G; Harrison, TM; Holland, G; Mojzsis, SJ; Gilmour, J			Extinct Pu-244 in ancient zircons	SCIENCE			English	Article							XENON; AGES	We have found evidence, in the form of fissiogenic xenon isotopes, for in situ decay of Pu-244 in individual 4.1- to 4.2-billion-year-old zircons from the Jack Hills region of Western Australia. Because of its short half-life, 82 million years, Pu-244 was extinct within 600 million years of Earth's formation. Detrital zircons are the only known relics to have survived from this period, and a study of their Pu geochemistry will allow us to date ancient metamorphic events and determine the terrestrial Pu/U ratio for comparison with the solar ratio.	Univ Manchester, Dept Earth Sci, Manchester M13 9PL, Lancs, England; Australian Natl Univ, Res Sch Earth Sci, Canberra, ACT 0200, Australia; Univ Calif Los Angeles, Dept Earth & Space Sci, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Inst Geophys & Planetary Phys, Los Angeles, CA 90095 USA; Univ Colorado, Dept Geol Sci, Ctr Astrobiol, Boulder, CO 80309 USA	University of Manchester; Australian National University; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of Colorado System; University of Colorado Boulder	Turner, G (corresponding author), Univ Manchester, Dept Earth Sci, Manchester M13 9PL, Lancs, England.	grenville.turner@man.ac.uk	Harrison, Timothy M/E-7443-2012; MOJZSIS, STEPHEN/AAU-9527-2020; Gilmour, Jamie/G-7515-2011	MOJZSIS, STEPHEN/0000-0003-0000-125X; Gilmour, Jamie/0000-0003-1990-8636				ALLEGRE CJ, 1987, EARTH PLANET SC LETT, V81, P127, DOI 10.1016/0012-821X(87)90151-8; ALLEGRE CJ, 1983, NATURE, V303, P762, DOI 10.1038/303762a0; CAMERON AGW, 1993, PHYS REP, V227, P283, DOI 10.1016/0370-1573(93)90073-M; CLAYTON DD, 1983, ASTROPHYS J, V268, P381, DOI 10.1086/160962; FROUDE DO, 1983, NATURE, V304, P616, DOI 10.1038/304616a0; GILMOUR JD, 1994, REV SCI INSTRUM, V65, P617, DOI 10.1063/1.1145127; Goriely S, 2001, ASTRON ASTROPHYS, V379, P1113, DOI 10.1051/0004-6361:20011368; Harrison TM, 2003, GEOCHIM COSMOCHIM AC, V67, pA135; Honda M, 2003, EARTH PLANET SC LETT, V207, P69, DOI 10.1016/S0012-821X(02)01147-0; Hudson G.B., 1989, LUNAR PLANETARY SCI, V19, P547; KROGH TE, 1982, GEOCHIM COSMOCHIM AC, V46, P637, DOI 10.1016/0016-7037(82)90165-X; Kunz J, 1998, SCIENCE, V280, P877, DOI 10.1126/science.280.5365.877; LUGMAIR GW, 1977, EARTH PLANET SC LETT, V35, P273, DOI 10.1016/0012-821X(77)90131-5; Miura YN, 1998, GEOCHIM COSMOCHIM AC, V62, P2369, DOI 10.1016/S0016-7037(98)00118-5; Mojzsis SJ, 2001, NATURE, V409, P178, DOI 10.1038/35051557; ONIONS RK, 1994, EARTH PLANET SC LETT, V124, P131, DOI 10.1016/0012-821X(94)00070-0; Pellas P, 1997, GEOCHIM COSMOCHIM AC, V61, P3477, DOI 10.1016/S0016-7037(97)00167-1; PORCELLI D, 1995, GEOCHIM COSMOCHIM AC, V59, P4921, DOI 10.1016/0016-7037(95)00336-3; Shukolyukov A, 1996, GEOCHIM COSMOCHIM AC, V60, P2453, DOI 10.1016/0016-7037(96)00085-3; SHUKOLYUKOV YA, 1994, NOBLE GAS GEOCHEMIST, P125; STAUDACHER T, 1986, EARTH PLANET SC LETT, V60, P389; WASSERBURG GJ, 1996, APJ, V466, P109; Wilde SA, 2001, NATURE, V409, P175, DOI 10.1038/35051550	24	53	53	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 1	2004	306	5693					89	91		10.1126/science.1101014	http://dx.doi.org/10.1126/science.1101014			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	859YJ	15459384				2022-12-28	WOS:000224304000041
J	Faure, J; Glinec, Y; Pukhov, A; Kiselev, S; Gordienko, S; Lefebvre, E; Rousseau, JP; Burgy, F; Malka, V				Faure, J; Glinec, Y; Pukhov, A; Kiselev, S; Gordienko, S; Lefebvre, E; Rousseau, JP; Burgy, F; Malka, V			A laser-plasma accelerator producing monoenergetic electron beams	NATURE			English	Article							WAKE-FIELD ACCELERATION; WAVE EXCITATION; PULSES; WAKEFIELDS; CHANNELS	Particle accelerators are used in a wide variety of fields, ranging from medicine and biology to high-energy physics. The accelerating fields in conventional accelerators are limited to a few tens of MeV m(-1), owing to material breakdown at the walls of the structure. Thus, the production of energetic particle beams currently requires large-scale accelerators and expensive infrastructures. Laser - plasma accelerators(1) have been proposed as a next generation of compact accelerators because of the huge electric fields they can sustain(2-5) (> 100 GeV m(-1)). However, it has been difficult to use them efficiently for applications because they have produced poor-quality particle beams with large energy spreads(2-10), owing to a randomization of electrons in phase space. Here we demonstrate that this randomization can be suppressed and that the quality of the electron beams can be dramatically enhanced. Within a length of 3 mm, the laser drives a plasma bubble(11) that traps and accelerates plasma electrons. The resulting electron beam is extremely collimated and quasi-monoenergetic, with a high charge of 0.5 nC at 170 MeV.	Ecole Polytech, ENSTA, CNRS,UMR 7639, Lab Opt Appl, F-91761 Palaiseau, France; Univ Dusseldorf, Inst Theoret Phys 1, D-40225 Dusseldorf, Germany; CEA DAM Ile France, Dept Phys Theor & Appl, F-91680 Bruyeres Le Chatel, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); Institut Polytechnique de Paris; Heinrich Heine University Dusseldorf; CEA	Malka, V (corresponding author), Ecole Polytech, ENSTA, CNRS,UMR 7639, Lab Opt Appl, F-91761 Palaiseau, France.	victor.malka@ensta.fr	Malka, Victor/AAU-2963-2020; Faure, Jerome/N-5873-2017; Lefebvre, Erik/B-9835-2009; pukhov, alexander/C-8082-2016; Malka, Victor/F-5260-2010	Malka, Victor/0000-0002-0488-2587; Faure, Jerome/0000-0003-0538-5774; pukhov, alexander/0000-0001-5043-960X; Malka, Victor/0000-0002-0488-2587				Amiranoff F, 1998, PHYS REV LETT, V81, P995, DOI 10.1103/PhysRevLett.81.995; AMIRANOFF F, 1992, PHYS REV LETT, V68, P3710, DOI 10.1103/PhysRevLett.68.3710; ANDREEV NE, 1992, JETP LETT+, V55, P571; ANTONSEN TM, 1992, PHYS REV LETT, V69, P2204, DOI 10.1103/PhysRevLett.69.2204; CLAYTON CE, 1985, PHYS REV LETT, V54, P2343, DOI 10.1103/PhysRevLett.54.2343; EVERETT M, 1994, NATURE, V368, P527, DOI 10.1038/368527a0; Gahn C, 1999, PHYS REV LETT, V83, P4772, DOI 10.1103/PhysRevLett.83.4772; KITAGAWA Y, 1992, PHYS REV LETT, V68, P48, DOI 10.1103/PhysRevLett.68.48; Leemans WP, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.174802; Malka V, 2002, SCIENCE, V298, P1596, DOI 10.1126/science.1076782; Malka V, 2001, PHYS PLASMAS, V8, P2605, DOI 10.1063/1.1374584; MODENA A, 1995, NATURE, V377, P606, DOI 10.1038/377606a0; Moore CI, 1997, PHYS REV LETT, V79, P3909, DOI 10.1103/PhysRevLett.79.3909; Pittman M, 2002, APPL PHYS B-LASERS O, V74, P529, DOI 10.1007/s003400200838; Pukhov A, 1999, PHYS PLASMAS, V6, P2847, DOI 10.1063/1.873242; Pukhov A, 1999, J PLASMA PHYS, V61, P425, DOI 10.1017/S0022377899007515; Pukhov A, 2002, APPL PHYS B-LASERS O, V74, P355, DOI 10.1007/s003400200795; SPRANGLE P, 1992, PHYS REV LETT, V69, P2200, DOI 10.1103/PhysRevLett.69.2200; STRICKLAND D, 1985, OPT COMMUN, V56, P219, DOI 10.1016/0030-4018(85)90120-8; TAJIMA T, 1979, PHYS REV LETT, V43, P267, DOI 10.1103/PhysRevLett.43.267; Umstadter D, 1996, SCIENCE, V273, P472, DOI 10.1126/science.273.5274.472	21	1740	1785	3	311	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 30	2004	431	7008					541	544		10.1038/nature02963	http://dx.doi.org/10.1038/nature02963			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	857YP	15457253				2022-12-28	WOS:000224156700039
J	Li, C; Rieppel, O; LaBarbera, MC				Li, C; Rieppel, O; LaBarbera, MC			A Triassic aquatic protorosaur with an extremely long neck	SCIENCE			English	Article									Chinese Acad Sci, IVPP, Beijing 100044, Peoples R China; Field Museum Nat Hist, Dept Geol, Chicago, IL 60605 USA; Univ Chicago, Dept Organismal Biol & Anat, Chicago, IL 60637 USA	Chinese Academy of Sciences; Field Museum of Natural History (Chicago); University of Chicago	Li, C (corresponding author), Chinese Acad Sci, IVPP, POB 643, Beijing 100044, Peoples R China.	lichun@pa.lvpp.ac.cn						Chun L, 2003, ACTA GEOL SIN-ENGL, V77, P419; Parra-Olea G, 2001, P NATL ACAD SCI USA, V98, P7888, DOI 10.1073/pnas.131203598; Rieppel Olivier, 2003, Atti della Societa Italiana di Scienze Naturali e del Museo Civico di Storia Naturale in Milano, V144, P359; TAYLOR MA, 1989, NATURE, V341, P688, DOI 10.1038/341688a0; TSCHANZ K, 1988, PALAEONTOLOGY, V31, P997; Tschanz K., 1986, THESIS U ZURICH	6	44	56	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 24	2004	305	5692					1931	1931		10.1126/science.1100498	http://dx.doi.org/10.1126/science.1100498			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	857RM	15448262				2022-12-28	WOS:000224136000038
J	Weber, T; Czasch, AO; Jagutzki, O; Muller, AK; Mergel, V; Kheifets, A; Rotenberg, E; Meigs, G; Prior, MH; Daveau, S; Landers, A; Cocke, CL; Osipov, T; Muino, RD; Schmidt-Bocking, H; Dorner, R				Weber, T; Czasch, AO; Jagutzki, O; Muller, AK; Mergel, V; Kheifets, A; Rotenberg, E; Meigs, G; Prior, MH; Daveau, S; Landers, A; Cocke, CL; Osipov, T; Muino, RD; Schmidt-Bocking, H; Dorner, R			Complete photo-fragmentation of the deuterium molecule	NATURE			English	Article							DIFFERENTIAL CROSS-SECTIONS; DOUBLE-PHOTOIONIZATION; DOUBLE-IONIZATION; HYDROGEN MOLECULE; D-2; H-2; HE; GAMMA,2E	All properties of molecules - from binding and excitation energies to their geometry - are determined by the highly correlated initial-state wavefunction of the electrons and nuclei. Details of these correlations can be revealed by studying the break-up of these systems into their constituents. The fragmentation might be initiated by the absorption of a single photon(1-6), by collision with a charged particle(7,8) or by exposure to a strong laser pulse(9,10): if the interaction causing the excitation is sufficiently understood, the fragmentation process can then be used as a tool to investigate the bound initial state(11,12). The interaction and resulting fragment motions therefore pose formidable challenges to quantum theory(13-15). Here we report the coincident measurement of the momenta of both nuclei and both electrons from the single-photon-induced fragmentation of the deuterium molecule. The results reveal that the correlated motion of the electrons is strongly dependent on the inter-nuclear separation in the molecular ground state at the instant of photon absorption.	Univ Frankfurt, Inst Kernphys, D-60486 Frankfurt, Germany; Univ Calif Berkeley, Lawrence Berkeley Lab, Berkeley, CA 94720 USA; Kansas State Univ, Dept Phys, Manhattan, KS 66506 USA; Australian Natl Univ, Res Sch Phys Sci & Engn, Canberra, ACT 0200, Australia; Auburn Univ, Allison Lab 206, Auburn, AL 36849 USA; Donostia Int Phys Ctr, Donostia San Sebastian 20018, Spain; Unidad Fis Mat, Donostia San Sebastian 20018, Spain	Goethe University Frankfurt; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Kansas State University; Australian National University; Auburn University System; Auburn University	Dorner, R (corresponding author), Univ Frankfurt, Inst Kernphys, D-60486 Frankfurt, Germany.	doerner@hsb.uni-frankfurt.de	Kheifets, Anatoli/C-9131-2009; Landers, Allen/C-1213-2013; Muino, Ricardo Diez/C-9203-2009; Rotenberg, Eli/B-3700-2009; Weber, Thorsten/K-2586-2013; Doerner, Reinhard/A-5340-2008	Kheifets, Anatoli/0000-0001-8318-9408; Muino, Ricardo Diez/0000-0001-8593-0327; Rotenberg, Eli/0000-0002-3979-8844; Weber, Thorsten/0000-0003-3756-2704; Doerner, Reinhard/0000-0002-3728-4268				Afaneh F, 2002, J PHYS B-AT MOL OPT, V35, pL229, DOI 10.1088/0953-4075/35/11/102; Briggs JS, 2000, J PHYS B-AT MOL OPT, V33, pR1, DOI 10.1088/0953-4075/33/1/201; Dorner R, 1998, PHYS REV A, V57, P1074, DOI 10.1103/PhysRevA.57.1074; Dorner R, 1998, PHYS REV LETT, V81, P5776, DOI 10.1103/PhysRevLett.81.5776; Dorner R, 2000, PHYS REP, V330, P95, DOI 10.1016/S0370-1573(99)00109-X; DUJARDIN G, 1987, PHYS REV A, V35, P5012, DOI 10.1103/PhysRevA.35.5012; Feagin JM, 1998, J PHYS B-AT MOL OPT, V31, pL729, DOI 10.1088/0953-4075/31/18/004; HAYES EF, 1967, J CHEM PHYS, V46, P4004, DOI 10.1063/1.1840477; JOY HW, 1958, J CHEM PHYS, V28, P448, DOI 10.1063/1.1744156; Kheifets AS, 1998, J PHYS B-AT MOL OPT, V31, pL447, DOI 10.1088/0953-4075/31/10/002; KOSSMANN H, 1989, PHYS REV LETT, V63, P2040, DOI 10.1103/PhysRevLett.63.2040; LEROUZO H, 1988, PHYS REV A, V37, P1512, DOI 10.1103/PhysRevA.37.1512; LEVIN VG, 1984, J PHYS B-AT MOL OPT, V17, P1525, DOI 10.1088/0022-3700/17/8/014; Moshammer R, 1996, NUCL INSTRUM METH B, V107, P62, DOI 10.1016/0168-583X(95)00844-6; MUNIO RD, 2002, J PHYS B ATOM MOL PH, V35, pL359; Reddish TJ, 1997, PHYS REV LETT, V79, P2438, DOI 10.1103/PhysRevLett.79.2438; Reddish TJ, 1999, J PHYS B-AT MOL OPT, V32, P2473, DOI 10.1088/0953-4075/32/11/301; Rescigno TN, 1999, SCIENCE, V286, P2474, DOI 10.1126/science.286.5449.2474; Rottke H, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.013001; Schulz M, 2003, NATURE, V422, P48, DOI 10.1038/nature01415; Seccombe DP, 2002, J PHYS B-AT MOL OPT, V35, P3767, DOI 10.1088/0953-4075/35/17/312; Staudte A, 2002, PHYS REV A, V65, DOI 10.1103/PhysRevA.65.020703; Ullrich J, 2003, REP PROG PHYS, V66, P1463, DOI 10.1088/0034-4885/66/9/203; Walter M, 2000, PHYS REV LETT, V85, P1630, DOI 10.1103/PhysRevLett.85.1630; Walter M, 1999, J PHYS B-AT MOL OPT, V32, P2487, DOI 10.1088/0953-4075/32/11/302; Weber T, 2000, NATURE, V405, P658, DOI 10.1038/35015033; Weber T, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.163001; Weber T, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.153003; Wightman JP, 1998, J PHYS B-AT MOL OPT, V31, P1753, DOI 10.1088/0953-4075/31/8/024; WOOD RM, 1977, PHYS REV A, V15, P1433, DOI 10.1103/PhysRevA.15.1433	30	140	142	2	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 23	2004	431	7007					437	440		10.1038/nature02839	http://dx.doi.org/10.1038/nature02839			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855UN	15386008	Green Submitted			2022-12-28	WOS:000224000500036
J	Pappone, C; Manguso, F; Santinelli, R; Vicedomini, G; Sala, S; Paglino, G; Mazzone, P; Lang, CC; Gulletta, S; Augello, G; Santinelli, O; Santinelli, V				Pappone, C; Manguso, F; Santinelli, R; Vicedomini, G; Sala, S; Paglino, G; Mazzone, P; Lang, CC; Gulletta, S; Augello, G; Santinelli, O; Santinelli, V			Radiofrequency ablation in children with asymptomatic Wolff-Parkinson-White syndrome	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							TERM-FOLLOW-UP; CATHETER ABLATION; SUPRAVENTRICULAR TACHYCARDIA; NATURAL-HISTORY; ARRHYTHMIAS; ADOLESCENTS; MANAGEMENT; EVENTS	Background: Ventricular fibrillation can be the presenting arrhythmia in children with asymptomatic Wolff-Parkinson-White syndrome. Deaths due to this arrhythmia are potentially preventable. Methods: We performed a randomized study in which prophylactic radiofrequency catheter ablation of accessory pathways was compared with no ablation in asymptomatic children (age range, 5 to 12 years) with the Wolff-Parkinson-White syndrome who were at high risk for arrhythmias. The primary end point was the occurrence of arrhythmic events during follow-up. Results: Of the 165 eligible children, 60 were determined to be at high risk for arrhythmias. After randomization, but before any ablation had been performed, the parents withdrew 13 children from the study. Of the remaining children, 20 underwent prophylactic ablation and 27 had no treatment. The characteristics of the two groups were similar. There were three ablation-related complications, one of which led to hospitalization. During follow-up, 1 child in the ablation group (5 percent) and 12 in the control group (44 percent) had arrhythmic events. Two children in the control group had ventricular fibrillation, and one died suddenly. The cumulative rate of arrhythmic events was lower among children at high risk who underwent ablation than among those at high risk who did not. The reduction in risk associated with ablation remained significant after adjustment in a Cox regression analysis. In both the ablation and the control groups, the independent predictors of arrhythmic events were the absence of prophylactic ablation and the presence of multiple accessory pathways. Conclusions: In asymptomatic, high-risk children with the Wolff-Parkinson-White syndrome, prophylactic catheter ablation performed by an experienced operator reduces the risk of life-threatening arrhythmias.	San Raffaele Univ Hosp, Dept Cardiol, Electrophysiol & Cardiac Pacing Unit, I-20132 Milan, Italy; Univ Naples Federico II, Dept Pediat, Naples, Italy	Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; University of Naples Federico II	Pappone, C (corresponding author), San Raffaele Univ Hosp, Dept Cardiol, Electrophysiol & Cardiac Pacing Unit, Via Olgettina 60, I-20132 Milan, Italy.	carlo.pappone@hsr.it	Sala, Simone/AAP-2524-2020; Vicedomini, Gabriele/K-5182-2018; Gulletta, Simone/AGQ-5866-2022; Augello, Giuseppe/AAM-2338-2021; Mazzone, Patrizio/HHC-7625-2022; Pappone, Carlo/J-9853-2016; Santinelli, Vincenzo/J-9927-2016	Sala, Simone/0000-0003-3303-8892; Vicedomini, Gabriele/0000-0002-2300-3621; Pappone, Carlo/0000-0002-0901-6135; Santinelli, Vincenzo/0000-0003-4169-3619				Blomstrom-Lundqvist C, 2003, CIRCULATION, V108, P1871, DOI 10.1161/01.CIR.0000091380.04100.84; Bromberg BI, 1996, J AM COLL CARDIOL, V27, P690, DOI 10.1016/0735-1097(95)00519-6; Campbell RM, 2003, PEDIATRICS, V111, DOI 10.1542/peds.111.3.e245; Campbell RM, 2002, J PEDIATR-US, V140, P150, DOI 10.1067/mpd.2002.121823; Deal BJ, 1995, PACE, V18, P815; DICK M, 1991, CIRCULATION, V84, P2318, DOI 10.1161/01.CIR.84.6.2318; FLENSTED.E, 1969, ACTA MED SCAND, V186, P65; GIARDINA AC, 1972, BRIT HEART J, V34, P839; Inoue K, 2000, ACTA PAEDIATR, V89, P542, DOI 10.1080/080352500750027817; KLEIN GJ, 1979, NEW ENGL J MED, V301, P1080, DOI 10.1056/NEJM197911153012003; KUGLER J, 2000, CARDIAC ELECTROPHYSI, P1056; Kugler JD, 1997, AM J CARDIOL, V80, P1438, DOI 10.1016/S0002-9149(97)00736-4; Kugler JD, 2002, J CARDIOVASC ELECTR, V13, P336, DOI 10.1046/j.1540-8167.2002.00336.x; KUGLER JD, 1994, NEW ENGL J MED, V330, P1481, DOI 10.1056/NEJM199405263302103; MANTAKAS ME, 1978, AM J CARDIOL, V41, P1097, DOI 10.1016/0002-9149(78)90863-9; MUNGER TM, 1993, CIRCULATION, V87, P866, DOI 10.1161/01.CIR.87.3.866; Orinius E, 1966, Acta Med Scand Suppl, V465, P1; Pappone C, 2003, NEW ENGL J MED, V349, P1803, DOI 10.1056/NEJMoa035345; Pappone C, 2003, J AM COLL CARDIOL, V41, P239, DOI 10.1016/S0735-1097(02)02706-7; PERRY JC, 1990, J AM COLL CARDIOL, V16, P1215, DOI 10.1016/0735-1097(90)90555-4; RUSSELL MW, 1993, CIRCULATION, V88, P484; Sano S, 1998, HEART, V79, P374, DOI 10.1136/hrt.79.4.374; VANHARE GF, 1991, J AM COLL CARDIOL, V17, P1613, DOI 10.1016/0735-1097(91)90656-T	23	135	149	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 16	2004	351	12					1197	1205		10.1056/NEJMoa040625	http://dx.doi.org/10.1056/NEJMoa040625			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	853WS	15371577	Bronze			2022-12-28	WOS:000223861300008
J	Fraidenraich, D; Stillwell, E; Romero, E; Wilkes, D; Manova, K; Basson, CT; Benezra, R				Fraidenraich, D; Stillwell, E; Romero, E; Wilkes, D; Manova, K; Basson, CT; Benezra, R			Rescue of cardiac defects in Id knockout embryos by injection of embryonic stem cells	SCIENCE			English	Article							GROWTH-FACTOR-I; TRANSGENIC MICE; GENE; EXPRESSION; PROLIFERATION; MORPHOGENESIS; DIFFERENTIATION; OVEREXPRESSION; NEUROGENESIS; INDUCTION	We report that Id knockout mouse embryos display multiple cardiac defects, but mid-gestation lethality is rescued by the injection of 15 wild-type embryonic stem (ES) cells into mutant blastocysts. Myocardial markers altered in Id mutant cells are restored to normal throughout the chimeric myocardium. Intraperitoneal injection of ES cells into female mice before conception also partially rescues the cardiac phenotype with no incorporation of ES cells. Insulin-like growth factor 1, a long-range secreted factor, in combination with WNT5a, a locally secreted factor, likely account for complete reversion of the cardiac phenotype. Thus, ES cells have the potential to reverse congenital defects through Id-dependent local and long-range effects in a mammalian embryo.	Cornell Univ, Canc Biol & Genet Program, Weill Med Coll, New York, NY 10021 USA; Cornell Univ, Mol Cytol Core Facil, Weill Med Coll, Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA; Cornell Univ, Mol Cardiol Lab, Weill Med Coll, Greenberg Cardiol Div,Dept Med, New York, NY 10021 USA	Cornell University; Cornell University; Memorial Sloan Kettering Cancer Center; Cornell University	Benezra, R (corresponding author), Cornell Univ, Canc Biol & Genet Program, Weill Med Coll, New York, NY 10021 USA.	r-benezra@ski.mskcc.org			NATIONAL CANCER INSTITUTE [R01CA107429] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K01HL076568] Funding Source: NIH RePORTER; NCI NIH HHS [R01CA107429, R01 CA107429] Funding Source: Medline; NHLBI NIH HHS [KO1HL076568, K01 HL076568] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ADAMO M, 1989, ENDOCRINOLOGY, V124, P2737, DOI 10.1210/endo-124-6-2737; Azmi S, 2003, J BIOL CHEM, V278, P20098, DOI 10.1074/jbc.M210427200; Boudjelal M, 1997, GENE DEV, V11, P2052, DOI 10.1101/gad.11.16.2052; BOUILLET P, 1995, DEV BIOL, V170, P420, DOI 10.1006/dbio.1995.1226; Cadigan KM, 1997, GENE DEV, V11, P3286, DOI 10.1101/gad.11.24.3286; Chen J, 1998, DEVELOPMENT, V125, P1943; Chen THP, 2002, DEV BIOL, V250, P198, DOI 10.1006/dbio.2002.0796; Clouthier DE, 2003, DEV BIOL, V261, P506, DOI 10.1016/S0012-1606(03)00128-3; Hatcher CJ, 2001, DEV BIOL, V230, P177, DOI 10.1006/dbio.2000.0134; Jen Y, 1996, DEV DYNAM, V207, P235; Jen Y, 1997, DEV DYNAM, V208, P92, DOI 10.1002/(SICI)1097-0177(199701)208:1<92::AID-AJA9>3.0.CO;2-X; KELLY R, 1995, J CELL BIOL, V129, P383, DOI 10.1083/jcb.129.2.383; Kelly RG, 1997, DEV BIOL, V187, P183, DOI 10.1006/dbio.1997.8577; LIU JP, 1993, CELL, V75, P59, DOI 10.1016/0092-8674(93)90679-K; Lyden D, 1999, NATURE, V401, P670, DOI 10.1038/44334; POWELLBRAXTON L, 1993, GENE DEV, V7, P2609, DOI 10.1101/gad.7.12b.2609; Reiss K, 1996, P NATL ACAD SCI USA, V93, P8630, DOI 10.1073/pnas.93.16.8630; Ruzinova MB, 2003, TRENDS CELL BIOL, V13, P410, DOI 10.1016/S0962-8924(03)00147-8; Tran CM, 1998, DEVELOPMENT, V125, P1951; Wu H, 1999, DEVELOPMENT, V126, P3597; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X	21	154	173	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 8	2004	306	5694					247	252		10.1126/science.1102612	http://dx.doi.org/10.1126/science.1102612			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	861MC	15472070	Green Accepted			2022-12-28	WOS:000224419700031
J	Foster, KR; Shaulsky, G; Strassmann, JE; Queller, DC; Thompson, CRL				Foster, KR; Shaulsky, G; Strassmann, JE; Queller, DC; Thompson, CRL			Pleiotropy as a mechanism to stabilize cooperation	NATURE			English	Article							AMEBA DICTYOSTELIUM-DISCOIDEUM; SOCIAL AMEBA; EVOLUTION; EXPRESSION; DIF-1	Most genes affect many traits(1-4). This phenomenon, known as pleiotropy, is a major constraint on evolution because adaptive change in one trait may be prevented because it would compromise other traits affected by the same genes(2,4). Here we show that pleiotropy can have an unexpected effect and benefit one of the most enigmatic of adaptations-cooperation. A spectacular act of cooperation occurs in the social amoeba Dictyostelium discoideum, in which some cells die to form a stalk that holds the other cells aloft as reproductive spores(5,6). We have identified a gene, dimA(7), in D. discoideum that has two contrasting effects. It is required to receive the signalling molecule DIF-1 that causes differentiation into prestalk cells. Ignoring DIF-1 and not becoming prestalk should allow cells to cheat by avoiding the stalk. However, we find that in aggregations containing the wildtype cells, lack of the dimA gene results in exclusion from spores. This pleiotropic linkage of stalk and spore formation limits the potential for cheating in D. discoideum because defecting on prestalk cell production results in an even greater reduction in spores. We propose that the evolution of pleiotropic links between cheating and personal costs can stabilize cooperative adaptations.	Rice Univ, Houston, TX 77005 USA; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Univ Manchester, Sch Biol Sci, Manchester M13 9PT, Lancs, England	Rice University; Baylor College of Medicine; University of Manchester	Foster, KR (corresponding author), Rice Univ, Houston, TX 77005 USA.	krfoster@rice.edu; christopher.thompson@man.ac.uk		Strassmann, Joan/0000-0003-0638-8440; Foster, Kevin/0000-0003-4687-6633; Shaulsky, Gad/0000-0002-0532-0551				Atzmony D, 1997, CURR SCI INDIA, V72, P142; BARTON NH, 1990, GENETICS, V124, P773; Featherstone DE, 2002, BIOESSAYS, V24, P267, DOI 10.1002/bies.10054; Fortunato A, 2003, MOL ECOL, V12, P1031, DOI 10.1046/j.1365-294X.2003.01792.x; Frank SA, 2003, EVOLUTION, V57, P693; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI [10.1016/0022-5193(64)90038-4, 10.1016/0022-5193(64)90039-6]; Hurst LD, 1996, Q REV BIOL, V71, P317, DOI 10.1086/419442; INSALL R, 1994, J CELL BIOL, V126, P1537, DOI 10.1083/jcb.126.6.1537; JERMYN KA, 1991, DEVELOPMENT, V111, P779; Kay RR, 2001, DEVELOPMENT, V128, P4959; KELLER L, 1993, ANIM BEHAV, V45, P787, DOI 10.1006/anbe.1993.1092; Keller L, 1999, LEVELS SELECTION EVO; Kessin R.H., 2001, DICTYOSTELIUM EVOLUT; Nunney L, 1999, MG BEH ECOL, P238; Otto SP, 2004, P ROY SOC B-BIOL SCI, V271, P705, DOI 10.1098/rspb.2003.2635; Ponte E, 1998, P NATL ACAD SCI USA, V95, P9360, DOI 10.1073/pnas.95.16.9360; Queller DC, 2003, SCIENCE, V299, P105, DOI 10.1126/science.1077742; Riley MA, 2002, ANNU REV MICROBIOL, V56, P117, DOI 10.1146/annurev.micro.56.012302.161024; SHAULSKY G, 1993, DEV BIOL, V160, P85, DOI 10.1006/dbio.1993.1288; Strassmann JE, 2000, NATURE, V408, P965, DOI 10.1038/35050087; Szathmary E, 1995, MAJOR TRANSITIONS EV; Thompson CRL, 2000, DEV BIOL, V227, P56, DOI 10.1006/dbio.2000.9877; Thompson CRL, 2004, DEVELOPMENT, V131, P513, DOI 10.1242/dev.00939; Thompson CRL, 2000, MOL CELL, V6, P1509, DOI 10.1016/S1097-2765(00)00147-7; Velicer GJ, 2003, TRENDS MICROBIOL, V11, P330, DOI 10.1016/S0966-842X(03)00152-5; Visick KL, 2000, J BACTERIOL, V182, P4578, DOI 10.1128/JB.182.16.4578-4586.2000; Vulic M, 2001, GENETICS, V158, P519; Wright S., 1968, EVOLUTION GENETICS P, P373	30	193	198	0	54	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 7	2004	431	7009					693	696		10.1038/nature02894	http://dx.doi.org/10.1038/nature02894			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	859WS	15470429				2022-12-28	WOS:000224299300041
J	Gunnarsson, TG; Gill, JA; Sigurbjornsson, T; Sutherland, WJ				Gunnarsson, TG; Gill, JA; Sigurbjornsson, T; Sutherland, WJ			Pair bonds - Arrival synchrony in migratory birds	NATURE			English	Editorial Material									Univ E Anglia, Sch Biol Sci, Ctr Ecol Evolut & Conservat, Norwich NR4 7TJ, Norfolk, England; Tyndall Ctr Climate Change Res, Norwich NR4 7TJ, Norfolk, England; Langhus, IS-570 Fljot, Iceland	University of East Anglia; University of East Anglia	Gunnarsson, TG (corresponding author), Univ E Anglia, Sch Biol Sci, Ctr Ecol Evolut & Conservat, Norwich NR4 7TJ, Norfolk, England.	t.gunnarsson@uea.ac.uk	Gunnarsson, Tomas G/L-9783-2015; Sutherland, William/B-1291-2013; Gill, Jennifer A/A-7759-2008	Gunnarsson, Tomas Gretar/0000-0001-7692-0637; Sutherland, William/0000-0002-6498-0437				COULSON JC, 1980, P INT ORN C, V17, P823; Ens B.J., 1996, PARTNERSHIPS BIRDS S, P344; Gill JA, 2001, NATURE, V412, P436, DOI 10.1038/35086568; GUNNARSSON TG, IN PRESS BIRD STUDY; Handel CM, 2000, ANIM BEHAV, V60, P471, DOI 10.1006/anbe.2000.1505; Reynolds JD, 1997, BEHAV ECOL, V8, P126, DOI 10.1093/beheco/8.2.126	6	71	75	2	44	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 7	2004	431	7009					646	646		10.1038/431646a	http://dx.doi.org/10.1038/431646a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	859WS	15470417				2022-12-28	WOS:000224299300029
J	Frosh, A; Smith, LC; Jackson, CJ; Linehan, JM; Brandner, S; Wadsworth, JDF; Collinge, J				Frosh, A; Smith, LC; Jackson, CJ; Linehan, JM; Brandner, S; Wadsworth, JDF; Collinge, J			Analysis of 2000 consecutive UK tonsillectomy specimens for disease-related prion protein	LANCET			English	Article							CREUTZFELDT-JAKOB-DISEASE; ACCUMULATION; APPENDIX; SAMPLES	Variant Creutzfeldt-Jakob disease (CJD) is thought to be caused by dietary or other exposure to bovine spongiform encephalopathy (BSE) prions. The prevalence of preclinical or subclinical prion infection in the UK is currently unknown. Since clinical variant CJD is uniformly associated with tonsillar prion infection, we screened 2000 anonymous surgical tonsillectomy specimens for disease-associated prion protein. Analysis by both high sensitivity immunoblotting and immunohistochemistry detected no positive cases. However, this negative result cannot provide reassurance that relevant community infection is unlikely because of the fairly small sample size, demographic and age-related factors, and unknown test sensitivity during the prolonged incubation period. Nevertheless, our findings establish a protocol for prevalence screening on a national scale.	Natl Hosp Neurol & Neurosurg, Inst Neurol, Univ Coll, MRC Prion Unit, London WC1N 3BG, England; Natl Hosp Neurol & Neurosurg, Inst Neurol, Univ Coll, Dept Neurodegenerat Dis, London WC1N 3BG, England	University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust; University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust	Collinge, J (corresponding author), Natl Hosp Neurol & Neurosurg, Inst Neurol, Univ Coll, MRC Prion Unit, Queen Sq, London WC1N 3BG, England.	j.collinge@prion.ucl.ac.uk	Brandner, Sebastian/J-4562-2014	Brandner, Sebastian/0000-0002-9821-0342; Wadsworth, Jonathan/0000-0002-4797-2259	Medical Research Council [MC_U123160655] Funding Source: Medline; MRC [MC_U123160655] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Collinge J, 1999, LANCET, V354, P317, DOI 10.1016/S0140-6736(99)05128-4; Flechsig E, 2001, MOL MED, V7, P679, DOI 10.1007/BF03401958; FRASER H, 1992, PRION DIS HUMANS ANI; Glatzel M, 2003, NEW ENGL J MED, V349, P1812, DOI 10.1056/NEJMoa030351; Hill AF, 1999, LANCET, V353, P183, DOI 10.1016/S0140-6736(98)12075-5; Hilton DA, 2004, J CLIN PATHOL, V57, P300, DOI 10.1136/jcp.2003.012278; Hilton DA, 1998, LANCET, V352, P703, DOI 10.1016/S0140-6736(98)24035-9; Hilton DA, 2004, J PATHOL, V203, P733, DOI 10.1002/path.1580; Joiner S, 2002, J NEUROL NEUROSUR PS, V73, P597, DOI 10.1136/jnnp.73.5.597; Wadsworth JDF, 2001, LANCET, V358, P171, DOI 10.1016/S0140-6736(01)05403-4	10	48	52	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 2	2004	364	9441					1260	1262		10.1016/S0140-6736(04)17143-2	http://dx.doi.org/10.1016/S0140-6736(04)17143-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	859HO	15464187				2022-12-28	WOS:000224254200033
J	Wilkinson, D				Wilkinson, D		Int Working Party Promote Revitali	ICRAM (the International Campaign to Revitalise Academic Medicine): agenda setting	BMJ-BRITISH MEDICAL JOURNAL			English	Article								Following die launch by the BMJ and others of the campaign to promote academic medicine, a working party of 20 medical academics from all over the world was convened : to develop a plan of action.	Univ Queensland, Sch Med, Brisbane, Qld 4006, Australia	University of Queensland	Wilkinson, D (corresponding author), Univ Queensland, Sch Med, Brisbane, Qld 4006, Australia.	david.wilkinson@LKI.edu.au	Wilkinson, David/A-6207-2008; Ward, Robyn L/I-2313-2013	Wilkinson, David/0000-0002-7265-9846; Ward, Robyn L/0000-0002-6877-8906				Clark J, 2003, BMJ-BRIT MED J, V327, P1001, DOI 10.1136/bmj.327.7422.1001; Ioannidis JPA, 2004, BMJ-BRIT MED J, V329, P789; Tugwell P, 2004, BRIT MED J, V328, P597, DOI 10.1136/bmj.328.7440.597	3	51	52	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 2	2004	329	7469					787	789						3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	859TW	15459054				2022-12-28	WOS:000224291800024
J	Houten, SM; Auwerx, J				Houten, SM; Auwerx, J			PGC-1 alpha: Turbocharging mitochondria	CELL			English	Editorial Material							ACTIVATION; PGC-1	PGC-1alpha plays essential and diverse functions in the control of metabolism ranging from mitochondrial biogenesis and respiration to hepatic gluconeogenesis and muscle fiber-type switching. In a paper by Lin et al. (2004, this issue of Cell), the characterization of PGC-1alpha(-/-) mice illustrates these plelotropic functions and reveals an unexpected role for PGC-1alpha in the brain.	ULP, INSERM, CNRS, IGBMC, F-67404 Illkirch Graffenstaden, France; Inst Clin Souris, F-67404 Illkirch Graffenstaden, France; Hop Univ Strasbourg, Lab Biochim Gen & Specialisee, F-67000 Strasbourg, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Houten, SM (corresponding author), ULP, INSERM, CNRS, IGBMC, 1 Rue Laurent Fries, F-67404 Illkirch Graffenstaden, France.		Houten, Sander/Y-3599-2019	Houten, Sander/0000-0002-6167-9147; Auwerx, Johan/0000-0002-5065-5393				Araki T, 2004, SCIENCE, V305, P1010, DOI 10.1126/science.1098014; Kelly DP, 2004, GENE DEV, V18, P357, DOI 10.1101/gad.1177604; Koo SH, 2004, NAT MED, V10, P530, DOI 10.1038/nm1044; Lin JD, 2004, CELL, V119, P121, DOI 10.1016/j.cell.2004.09.013; Petersen KF, 2004, NEW ENGL J MED, V350, P664, DOI 10.1056/NEJMoa031314; Picard F, 2002, CELL, V111, P931, DOI 10.1016/S0092-8674(02)01169-8; Puigserver P, 1999, SCIENCE, V286, P1368, DOI 10.1126/science.286.5443.1368; Puigserver P, 2003, ENDOCR REV, V24, P78, DOI 10.1210/er.2002-0012; Sano M, 2004, EMBO J, V23, P3559, DOI 10.1038/sj.emboj.7600351; Um SH, 2004, NATURE, V431, P200, DOI 10.1038/nature02866	10	85	88	2	11	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	OCT 1	2004	119	1					5	7		10.1016/j.cell.2004.09.016	http://dx.doi.org/10.1016/j.cell.2004.09.016			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	859UE	15454076	Bronze			2022-12-28	WOS:000224292600004
J	Bennett, CL; Luminari, S; Nissenson, AR; Tallman, MS; Klinge, SA; McWilliams, N; McKoy, JM; Kim, B; Lyons, EA; Trifilio, SM; Raisch, DW; Evens, AM; Kuzel, TM; Schumock, GT; Belknap, SM; Locatelli, F; Rossert, J; Casadevall, N				Bennett, CL; Luminari, S; Nissenson, AR; Tallman, MS; Klinge, SA; McWilliams, N; McKoy, JM; Kim, B; Lyons, EA; Trifilio, SM; Raisch, DW; Evens, AM; Kuzel, TM; Schumock, GT; Belknap, SM; Locatelli, F; Rossert, J; Casadevall, N			Pure red-cell aplasia and epoetin therapy	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RECOMBINANT-HUMAN-ERYTHROPOIETIN; ANTIERYTHROPOIETIN ANTIBODIES	BACKGROUND: Between 1988 and 1998, antibody-associated pure red-cell aplasia was reported in three patients who had undergone treatment with recombinant human erythropoietin (epoetin). Between 1998 and 2000, 13 such cases were reported from France -- 12 in patients who had received the Eprex formulation of epoetin alfa and 1 in a patient who had received Neorecormon (a formulation of epoetin beta); both are products that are marketed outside the United States. METHODS: We obtained reports of epoetin-associated pure red-cell aplasia from the Food and Drug Administration and from the manufacturers of Eprex, Epogen (another formulation of epoetin alfa), and Neorecormon. The numbers of case reports and estimates of exposure-adjusted incidence were analyzed according to the product, the cause of anemia, the route of administration, the country in which pure red-cell aplasia was identified, and the date on which pure red-cell aplasia was reported. RESULTS: Between January 1998 and April 2004, 175 cases of epoetin-associated pure red-cell aplasia were reported for Eprex, 11 cases for Neorecormon, and 5 cases for Epogen. Over half these cases had occurred in France, Canada, the United Kingdom, and Spain. Between 2001 and 2003, the estimated exposure-adjusted incidence was 18 cases per 100,000 patient-years for the Eprex formulation without human serum albumin, 6 per 100,000 patient-years for the Eprex formulation with human serum albumin, 1 case per 100,000 patient-years for Neorecormon, and 0.2 case per 100,000 patient-years for Epogen. After procedures were adopted to ensure appropriate storage, handling, and administration of Eprex to patients with chronic kidney disease, the exposure-adjusted incidence decreased by 83 percent worldwide. CONCLUSIONS: After the peak incidence of Eprex-associated pure red-cell aplasia was reached in 2001, interventions designed in response to drug-monitoring programs worldwide resulted in a reduction of more than 80 percent in the incidence of pure red-cell aplasia due to Eprex.	Northwestern Univ, Feinberg Sch Med, Jesse Brown Vet Affairs Med Ctr, Midw Ctr Hlth Serv Res & Policy Studies, Chicago, IL 60611 USA; Northwestern Univ, Feinberg Sch Med, Dept Med, Div Hematol & Oncol, Chicago, IL 60611 USA; Northwestern Univ, Feinberg Sch Med, Dept Med, Div Geriatr, Chicago, IL 60611 USA; Northwestern Univ, Feinberg Sch Med, Dept Med, Div Gen Internal Med, Chicago, IL 60611 USA; Northwestern Univ, Feinberg Sch Med, Inst Hlth Serv Res & Policy Studies, Chicago, IL 60611 USA; Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA; NW Mem Hosp, Dept Pharm, Chicago, IL 60611 USA; Univ Illinois, Coll Pharm, Ctr Pharmacoecon Res, Chicago, IL USA; Univ Modena & Reggio Emilia, Dipartimento Oncol & Ematol, Modena, Italy; Univ Calif Los Angeles, David Geffen Sch Med, Div Nephrol, Los Angeles, CA USA; Univ New Mexico, Vet Affairs Cooperat Study Program Clin Res Pharm, Albuquerque, NM 87131 USA; A Manzoni Hosp, Dept Nephrol & Dialysis, Lecce, Italy; Univ Paris 06, Tenon Hosp, Dept Nephrol, Paris, France; Hop Hotel Dieu, Dept Hematol, Paris, France; INSERM, U352, Paris, France	Northwestern University; Feinberg School of Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); Jesse Brown VA Medical Center; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Robert H. Lurie Comprehensive Cancer Center; Northwestern Memorial Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Universita di Modena e Reggio Emilia; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of New Mexico; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Hotel-Dieu - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm)	Bennett, CL (corresponding author), Jesse Brown Vet Affairs Med Ctr, Midw Ctr Hlth Serv & Policy Res, 333 E Huron St,Suite 277, Chicago, IL 60611 USA.	cbenne@northwestern.edu	Luminari, Stefano/J-5916-2014; Bennett, Charles L/C-2050-2008; MCKOY, JUNE/GRJ-5660-2022	Luminari, Stefano/0000-0001-8446-2285; Belknap, Steven/0000-0002-3670-7409; Evens, Andrew/0000-0002-6900-1824	NATIONAL CANCER INSTITUTE [P30CA060553, R01CA102713] Funding Source: NIH RePORTER; NCI NIH HHS [P 30 CA60553, 1R01CA 102713-01] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		*AG ESP MED, 2002, NOT INF EP ALF CONTR; *AG FRANC SEC SAN, 2002, LETT PRESCR EPR INF; *ARZN DTSCH ARZT, 2002, ART ANW NUR INTR APP; BERGREM H, 1993, ERYTHROPOIETIN, P265; Casadevall N, 2002, NEW ENGL J MED, V346, P469, DOI 10.1056/NEJMoa011931; Gershon SK, 2002, NEW ENGL J MED, V346, P1584; Hynes DM, 2002, AM J MED, V112, P169, DOI 10.1016/S0002-9343(01)01103-2; Kaufman J S, 1998, Am J Kidney Dis, V32, pS147, DOI 10.1016/S0272-6386(98)70178-7; Kaufman JS, 1998, NEW ENGL J MED, V339, P578, DOI 10.1056/NEJM199808273390902; Knauss MD, 2002, AM J HEALTH-SYST PH, V59, P1783, DOI 10.1093/ajhp/59.18.1783; Ladewski, 2004, J CLIN ONCOL, V22, P1169, DOI 10.1200/JCO.2004.01.914; Ladewski LA, 2003, J CLIN ONCOL, V21, P3859, DOI 10.1200/JCO.2003.04.537; Li JZ, 2001, BLOOD, V98, P3241, DOI 10.1182/blood.V98.12.3241; Locatelli F, 2004, NEPHROL DIAL TRANSPL, V19, P121, DOI 10.1093/ndt/gfg458; Locatelli F, 2003, ARTIF ORGANS, V27, P755, DOI 10.1046/j.1525-1594.2003.00991.x; Locatelli F, 2004, NEPHROL DIAL TRANSPL, V19, P288, DOI 10.1093/ndt/gfg489; *MED CONTR AG, EPR EP ALF PUR RED C; *MIN SAL, 2002, NOT INF IMP EP ALF G; Peces R, 1996, NEW ENGL J MED, V335, P523, DOI 10.1056/NEJM199608153350717; Porter S, 2001, J PHARM SCI-US, V90, P1; Prabhakar SS, 1997, CLIN NEPHROL, V47, P331; Rossert J, 2004, J AM SOC NEPHROL, V15, P398, DOI 10.1097/01.ASN.0000107561.59698.42; *SWISSM, 2003, PUR RED CELL APL; *THER GOODS ADM, 2002, AUSTR ADV DRUG REACT, V21; *THER PROD DIR, IMP SAF INF EPR EP A; Verhelst D, 2004, LANCET, V363, P1768, DOI 10.1016/S0140-6736(04)16302-2; 2004, JOHNSON JOHNSON 0120; 2003, NEORECORMON EPOETIN; 2003, WHO PHARMACEUT NEWSL; 2002, JOHNSON JOHNSON 1202; 2004, INFORMATION HEALTHCA; 2003, PROCRIT EPOETIN ALFA	32	283	308	0	18	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 30	2004	351	14					1403	1408		10.1056/NEJMoa040528	http://dx.doi.org/10.1056/NEJMoa040528			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	857XT	15459301				2022-12-28	WOS:000224153900008
J	Trontell, A				Trontell, A			Expecting the unexpected - Drug safety, pharmacovigilance, and the prepared mind	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									US FDA, Off Drug Safety, Ctr Drug Evaluat & Res, Rockville, MD 20857 USA	US Food & Drug Administration (FDA)	Trontell, A (corresponding author), US FDA, Off Drug Safety, Ctr Drug Evaluat & Res, Rockville, MD 20857 USA.							Bennett CL, 2000, NEW ENGL J MED, V342, P1773, DOI 10.1056/NEJM200006153422402	1	60	65	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 30	2004	351	14					1385	1387		10.1056/NEJMp048187	http://dx.doi.org/10.1056/NEJMp048187			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	857XT	15459298				2022-12-28	WOS:000224153900005
J	Treasure, T; Sedrakyan, A				Treasure, T; Sedrakyan, A			Pleural mesothelioma: little evidence, still time to do trials	LANCET			English	Review							RANDOMIZED-TRIAL; MALIGNANT MESOTHELIOMA; PHOTODYNAMIC THERAPY; RESPONSE EVALUATION; PHASE-III; CHEMOTHERAPY; MANAGEMENT; RADIOTHERAPY; SURGERY; PREVENTION	Context The incidence of malignant pleural mesothelioma is increasing throughout most of the world. This cancer is uniformly fatal, and characterised. by progressive breathlessness and unremitting pain in the chest wall. From the onset of symptoms, survival is from a few weeks to a few years. Desperation by patients and doctors has driven a search for effective treatments. Clinical benefits are marginal and evidence of a good quality is lamentably lacking. Starting point David Sugarbaker is the world's leading proponent of extrapleural pneumonectomy (EPP), an operation in which all the pleura is removed with the lung, pericardium, and diaphragm. He has recently reported the complications of this radical surgery in a series of 496 operations (J Thorac Cardiovasc Surg 2004; 128: 138-46). Although EPP as part of trimodality therapy (preoperative chemotherapy and postoperative radiation) is thought to be the best that can be offered and is regarded as the standard of care for selected patients given the morbidity associated with it, evidence for benefit is needed to justify its wider use. Where next? With the increase in the number of cases there is increasing awareness of the disease, leading to earlier diagnosis, and an expectation that something must be done. Survival is short and the treatments on offer are onerous. The only responsible approach from,a scientific, compassionate, or economic view (and why not combine all three?) is to find evidence of effectiveness to avoid futile and distressing treatment when possible.	Guys Hosp, Cardiothorac Unit, London SE1 9RT, England; Johns Hopkins Univ, Sch Publ Hlth, Baltimore, MD USA	Guy's & St Thomas' NHS Foundation Trust; Johns Hopkins University	Treasure, T (corresponding author), Guys Hosp, Cardiothorac Unit, London SE1 9RT, England.	Tom.Treasure@ukgateway.net						Abratt RP, 2004, LUNG CANCER-J IASLC, V45, pS3, DOI 10.1016/j.lungcan.2004.04.007; Ahamad A, 2003, CANCER J, V9, P476, DOI 10.1097/00130404-200311000-00008; Ahamad A, 2003, INT J RADIAT ONCOL, V55, P768, DOI 10.1016/S0360-3016(02)04151-2; Aziz T, 2002, EUR J CARDIO-THORAC, V22, P298, DOI 10.1016/S1010-7940(02)00273-7; Berghmans T, 2002, LUNG CANCER, V38, P111, DOI 10.1016/S0169-5002(02)00180-0; BOUTIN C, 1995, CHEST, V108, P754, DOI 10.1378/chest.108.3.754; Bydder S, 2004, BRIT J CANCER, V91, P9, DOI 10.1038/sj.bjc.6601957; Ceresoli GL, 2001, LUNG CANCER, V34, P279, DOI 10.1016/S0169-5002(01)00257-4; Friedberg JS, 2003, ANN THORAC SURG, V75, P952, DOI 10.1016/S0003-4975(02)04474-0; GRAAFSTRUKOWSKA L, 1999, INT J RADIAT ONCOL, V43, P511; Grossebner MW, 1999, EUR J CARDIO-THORAC, V16, P619, DOI 10.1016/S1010-7940(99)00323-1; Hodgson JT, 2000, ANN OCCUP HYG, V44, P565, DOI 10.1093/annhyg/44.8.565; Lee TT, 2002, J THORAC CARDIOV SUR, V124, P1183, DOI 10.1067/mtc.2002.125817; Maggi G, 2001, EUR J CARDIO-THORAC, V19, P346, DOI 10.1016/S1010-7940(01)00594-2; Monetti F, 2004, LUNG CANCER-J IASLC, V43, P71, DOI 10.1016/j.lungcan.2003.07.005; Montanaro F, 2003, CANCER CAUSE CONTROL, V14, P791, DOI 10.1023/A:1026300619747; Muers MF, 2004, THORAX, V59, P144, DOI 10.1136/thorax.2003.009290; Musk AW, 2004, LUNG CANCER, V45, pS21, DOI 10.1016/j.lungcan.2004.04.010; *NCRN, 2003, TRIALS PORTF MES TRI; Pass HI, 1997, ANN SURG ONCOL, V4, P628, DOI 10.1007/BF02303746; Peto J, 1999, BRIT J CANCER, V79, P666, DOI 10.1038/sj.bjc.6690105; Rusch VW, 1999, ANN THORAC SURG, V68, P1799, DOI 10.1016/S0003-4975(99)01038-3; Rusch VW, 2001, J THORAC CARDIOV SUR, V122, P788, DOI 10.1067/mtc.2001.116560; Shaw P, 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD002916.PUB2; Stewart DJ, 2004, ANN THORAC SURG, V78, P245, DOI 10.1016/j.athoracsur.2004.01.034; Sugarbaker DJ, 2004, J THORAC CARDIOV SUR, V128, P138, DOI 10.1016/j.jtcvs.2004.02.021; Sugarbaker DJ, 1999, J THORAC CARDIOV SUR, V117, P54, DOI 10.1016/S0022-5223(99)70469-1; Tan C, 2002, THORAX, V57; van Klaveren RJ, 2004, LUNG CANCER, V43, P63, DOI 10.1016/S0169-5002(03)00292-7; van Ruth S, 2003, ANN SURG ONCOL, V10, P176, DOI 10.1245/ASO.2003.03.022; van Ruth S, 2003, CHEST, V123, P551, DOI 10.1378/chest.123.2.551; Vogelzang NJ, 2003, J CLIN ONCOL, V21, P2636, DOI 10.1200/JCO.2003.11.136; Weill H, 2004, OCCUP ENVIRON MED, V61, P438, DOI 10.1136/oem.2003.010165; 2004, HLTH SAFETY EXECUTIV	34	81	83	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 25	2004	364	9440					1183	1185		10.1016/S0140-6736(04)17108-0	http://dx.doi.org/10.1016/S0140-6736(04)17108-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	857FT	15451229				2022-12-28	WOS:000224102400035
J	Chesebro, B				Chesebro, B			Biomedicine - A fresh look at BSE	SCIENCE			English	Editorial Material							BOVINE SPONGIFORM ENCEPHALOPATHY; CREUTZFELDT-JAKOB-DISEASE; PRION PROTEIN		NIAID, Rocky Mt Labs, Persistent Viral Dis Lab, Hamilton, MT 59840 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Chesebro, B (corresponding author), NIAID, Rocky Mt Labs, Persistent Viral Dis Lab, Hamilton, MT 59840 USA.	bschesebro@nih.gov						Biacabe AG, 2004, EMBO REP, V5, P110, DOI 10.1038/sj.embor.7400054; Casalone C, 2004, P NATL ACAD SCI USA, V101, P3065, DOI 10.1073/pnas.0305777101; Chesebro B, 1998, SCIENCE, V279, P42, DOI 10.1126/science.279.5347.42; Chiesa R, 2003, J VIROL, V77, P7611, DOI 10.1128/JVI.77.13.7611-7622.2003; Hill AF, 1999, J GEN VIROL, V80, P11, DOI 10.1099/0022-1317-80-1-11; Houston EF, 2002, J GEN VIROL, V83, P1247, DOI 10.1099/0022-1317-83-5-1247; Legname G, 2004, SCIENCE, V305, P673, DOI 10.1126/science.1100195; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Smith PG, 2003, BRIT MED BULL, V66, P185, DOI 10.1093/bmb/66.1.185; Weissmann C, 1997, CURR OPIN NEUROBIOL, V7, P695, DOI 10.1016/S0959-4388(97)80091-8; WESTAWAY D, 1994, CELL, V76, P117, DOI 10.1016/0092-8674(94)90177-5; Yamakawa Y, 2003, JPN J INFECT DIS, V56, P221	12	16	17	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 24	2004	305	5692					1918	+		10.1126/science.1103581	http://dx.doi.org/10.1126/science.1103581			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	857RM	15448258				2022-12-28	WOS:000224136000033
J	Chien, MC; Morozova, I; Shi, SD; Sheng, HT; Chen, J; Gomez, SM; Asamani, G; Hill, K; Nuara, J; Feder, M; Rineer, J; Greenberg, JJ; Steshenko, V; Park, SH; Zhao, BH; Teplitskaya, E; Edwards, JR; Pampou, S; Georghiou, A; Chou, IC; Iannuccilli, W; Ulz, ME; Kim, DH; Geringer-Sameth, A; Goldsberry, C; Morozov, P; Fischer, SG; Segal, G; Qu, XY; Rzhetsky, A; Zhang, PS; Cayanis, E; De Jong, PJ; Ju, JY; Kalachikov, S; Shuman, HA; Russo, JJ				Chien, MC; Morozova, I; Shi, SD; Sheng, HT; Chen, J; Gomez, SM; Asamani, G; Hill, K; Nuara, J; Feder, M; Rineer, J; Greenberg, JJ; Steshenko, V; Park, SH; Zhao, BH; Teplitskaya, E; Edwards, JR; Pampou, S; Georghiou, A; Chou, IC; Iannuccilli, W; Ulz, ME; Kim, DH; Geringer-Sameth, A; Goldsberry, C; Morozov, P; Fischer, SG; Segal, G; Qu, XY; Rzhetsky, A; Zhang, PS; Cayanis, E; De Jong, PJ; Ju, JY; Kalachikov, S; Shuman, HA; Russo, JJ			The genomic sequence of the accidental pathogen Legionella pneumophila	SCIENCE			English	Article							IV SECRETION SYSTEM; COXIELLA-BURNETII; LEGIONNAIRES-DISEASE; VIRULENCE SYSTEM; DOT/ICM SYSTEM	We present the genomic sequence of Legionella pneumophila, the bacteria[ agent of Legionnaires' disease, a potentially fatal pneumonia acquired from aerosolized contaminated fresh water. The genome includes a 45-kilobase pair element that can exist in chromosomal and episomal forms, selective expansions of important gene families, genes for unexpected metabolic pathways, and previously unknown candidate virulence determinants. We highlight the genes that may account for Legionella's ability to survive in protozoa, mammalian macrophages, and inhospitable environmental niches and that may define new therapeutic targets.	Columbia Univ Coll Phys & Surg, Columbia Genome Ctr, New York, NY 10032 USA; Inst Pasteur, Unite Biochim & Biol Mol Insectes, F-75015 Paris, France; Roswell Pk Canc Inst, BACPAC Resources Lab, Buffalo, NY 14263 USA; Columbia Univ, Fu Fdn Sch Engn & Appl Sci, Dept Chem Engn, New York, NY 10027 USA; Tel Aviv Univ, Dept Mol Microbiol & Biotechnol, IL-69978 Tel Aviv, Israel; Columbia Univ Coll Phys & Surg, Dept Microbiol, New York, NY 10032 USA	Columbia University; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Roswell Park Cancer Institute; Columbia University; Tel Aviv University; Columbia University	Russo, JJ (corresponding author), Columbia Univ Coll Phys & Surg, Columbia Genome Ctr, 630 W 168th St, New York, NY 10032 USA.	jjr4@columbia.edu	Segal, Gil/H-7987-2019; rzhetsky, andrey/B-6118-2012; Morozov, Pavel/GQP-7206-2022	Segal, Gil/0000-0003-0392-253X; rzhetsky, andrey/0000-0001-6959-7405; Geringer-Sameth, Alex/0000-0002-1269-6047; Gomez, Shawn/0000-0002-8251-4552	NIAID NIH HHS [U01 1 AI 4437, AI 23549] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI023549] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Brassinga AKC, 2003, J BACTERIOL, V185, P4630, DOI 10.1128/JB.185.15.4630-4637.2003; Chen J, 2004, SCIENCE, V303, P1358, DOI 10.1126/science.1094226; Cirillo SLG, 2000, MICROBIOL-SGM, V146, P1345, DOI 10.1099/00221287-146-6-1345; De Biase D, 1999, MOL MICROBIOL, V32, P1198, DOI 10.1046/j.1365-2958.1999.01430.x; DEFELIPE KS, UNPUB; Fernandez-Leborans G, 2000, ECOTOX ENVIRON SAFE, V47, P266, DOI 10.1006/eesa.2000.1944; Fields BS, 2002, CLIN MICROBIOL REV, V15, P506, DOI 10.1128/CMR.15.3.506-526.2002; FRASER DW, 1977, NEW ENGL J MED, V297, P1189, DOI 10.1056/NEJM197712012972201; Gao LY, 2000, ENVIRON MICROBIOL, V2, P79, DOI 10.1046/j.1462-2920.2000.00076.x; GEORGE JR, 1980, J CLIN MICROBIOL, V11, P286, DOI 10.1128/JCM.11.3.286-291.1980; Luo ZQ, 2004, P NATL ACAD SCI USA, V101, P841, DOI 10.1073/pnas.0304916101; Nagai H, 2003, CELL MICROBIOL, V5, P373, DOI 10.1046/j.1462-5822.2003.00285.x; Nagai H, 2002, SCIENCE, V295, P679, DOI 10.1126/science.1067025; Rendulic S, 2004, SCIENCE, V303, P689, DOI 10.1126/science.1093027; Segal G, 1999, MOL MICROBIOL, V34, P799, DOI 10.1046/j.1365-2958.1999.01642.x; Segal G, 1998, P NATL ACAD SCI USA, V95, P1669, DOI 10.1073/pnas.95.4.1669; Seshadri R, 2003, P NATL ACAD SCI USA, V100, P5455, DOI 10.1073/pnas.0931379100; Sturgill-Koszycki S, 2000, J EXP MED, V192, P1261, DOI 10.1084/jem.192.9.1261; Vogel JP, 1998, SCIENCE, V279, P873, DOI 10.1126/science.279.5352.873; Zamboni DS, 2003, MOL MICROBIOL, V49, P965, DOI 10.1046/j.1365-2958.2003.03626.x; Zusman T, 2003, INFECT IMMUN, V71, P3714, DOI 10.1128/IAI.71.7.3714-3723.2003	21	385	816	1	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 24	2004	305	5692					1966	1968		10.1126/science.1099776	http://dx.doi.org/10.1126/science.1099776			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	857RM	15448271				2022-12-28	WOS:000224136000050
J	Kelly, JA; Somlai, AM; Benotsch, EG; McAuliffe, TL; Amirkhanian, YA; Brown, KD; Stevenson, LY; Fernandez, MI; Sitzler, C; Gore-Fetton, C; Pinkerton, SD; Weinhardt, LS; Opgenorth, KM				Kelly, JA; Somlai, AM; Benotsch, EG; McAuliffe, TL; Amirkhanian, YA; Brown, KD; Stevenson, LY; Fernandez, MI; Sitzler, C; Gore-Fetton, C; Pinkerton, SD; Weinhardt, LS; Opgenorth, KM			Distance communication transfer of HIV prevention interventions to service providers	SCIENCE			English	Article							CONTINUING-EDUCATION; BEHAVIOR	Most acquired immunodeficiency syndrome (AIDS) service providers are in countries with little access to scientific developments relevant to their programs. It is critical to transfer advances from the scientific arena to service providers on a global scale. Human immunodeficiency virus (HIV) prevention organizations in 78 countries were randomized to receive either a control condition or a technology transfer condition with an interactive distance learning computer training curriculum and individualized distance consultation. Of 42 nongovernmental organizations in the technology transfer condition, 29 adopted the science-based program in their communities or trained other agencies to also use it. Advanced communication technologies can create a cost-effective infrastructure to disseminate new intervention models to service providers worldwide.	Med Coll Wisconsin, Dept Psychiat & Behav Med, CAIR, Milwaukee, WI 53226 USA; Univ Miami, Dept Publ Hlth, Miami, FL 33101 USA	Medical College of Wisconsin; University of Miami	Kelly, JA (corresponding author), Med Coll Wisconsin, Dept Psychiat & Behav Med, CAIR, Milwaukee, WI 53226 USA.	kdemming@mcw.edu	Benotsch, Eric/AAG-7466-2020; Weinhardt, Lance/AAC-1427-2019; Amirkhanian, Yuri/AAH-9924-2021	Weinhardt, Lance/0000-0002-5535-9809; Amirkhanian, Yuri/0000-0002-4983-2954	NIMH NIH HHS [P30-MH52776, R01-MH62982] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH062982, P30MH052776] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Centers for Disease Control (CDC), 1999, COMP HIV PREV INT EV; *CTR SUBST AB PREV, 2001, NAT REG EFF PREV PRO; Davis D, 1999, JAMA-J AM MED ASSOC, V282, P867, DOI 10.1001/jama.282.9.867; GRIMSHAW JM, 1993, LANCET, V342, P1317, DOI 10.1016/0140-6736(93)92244-N; Kelly JA, 2000, AM J PUBLIC HEALTH, V90, P1082, DOI 10.2105/AJPH.90.7.1082; Kelly JA, 1997, LANCET, V350, P1500, DOI 10.1016/S0140-6736(97)07439-4; *NIH, 1997, INT PREV HIV RISK BE, V15, P1; Rogers EM., 1983, DIFFUSION INNOVATION; Umble KE, 2000, AM J PUBLIC HEALTH, V90, P1218, DOI 10.2105/AJPH.90.8.1218	9	24	25	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 24	2004	305	5692					1953	1955		10.1126/science.1100733	http://dx.doi.org/10.1126/science.1100733			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	857RM	15448268				2022-12-28	WOS:000224136000045
J	Rietkerk, M; Dekker, SC; de Ruiter, PC; van de Koppel, J				Rietkerk, M; Dekker, SC; de Ruiter, PC; van de Koppel, J			Self-organized patchiness and catastrophic shifts in ecosystems	SCIENCE			English	Review							SEMIARID GRAZING SYSTEMS; VEGETATION PATTERNS; TURING PATTERNS; BISTABILITY; NUTRIENTS; PEATLANDS; MODEL; LAKES; SOIL	Unexpected sudden catastrophic shifts may occur in ecosystems, with concomitant losses or gains of ecological and economic resources. Such shifts have been theoretically attributed to positive feedback and bistability of ecosystem states. However, verifications and predictive power with respect to catastrophic responses to a changing environment are lacking for spatially extensive ecosystems. This situation impedes management and recovery strategies for such ecosystems. Here, we review recent studies on various ecosystems that link self-organized patchiness to catastrophic shifts between ecosystem states.	Univ Utrecht, Copernicus Inst, Dept Environm Sci, NL-3508 TC Utrecht, Netherlands; Netherlands Inst Ecol, Spatial Ecol Dept, NL-4400 AC Yerseke, Netherlands	Utrecht University; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW)	Rietkerk, M (corresponding author), Univ Utrecht, Copernicus Inst, Dept Environm Sci, POB 80115, NL-3508 TC Utrecht, Netherlands.	m.rietkerk@geog.uu.nl	Dekker, Stefan/F-5581-2013; Van de Koppel, Johan/E-7266-2010; Rietkerk, Max/H-6235-2011	Dekker, Stefan/0000-0001-7764-2464; Rietkerk, Max/0000-0002-2698-3848				BELSKY AJ, 1994, ECOLOGY, V75, P922, DOI 10.2307/1939416; Belyea LR, 2002, J ECOL, V90, P223, DOI 10.1046/j.1365-2745.2001.00647.x; Belyea LR, 2001, P ROY SOC B-BIOL SCI, V268, P1315, DOI 10.1098/rspb.2001.1665; Bruno JF, 2003, TRENDS ECOL EVOL, V18, P119, DOI 10.1016/S0169-5347(02)00045-9; Callaway RM, 2002, NATURE, V417, P844, DOI 10.1038/nature00812; Carpenter SR, 1999, ECOL APPL, V9, P751, DOI 10.1890/1051-0761(1999)009[0751:MOEFLS]2.0.CO;2; CASTETS V, 1990, PHYS REV LETT, V64, P2953, DOI 10.1103/PhysRevLett.64.2953; Couteron P, 2001, J ECOL, V89, P616, DOI 10.1046/j.0022-0477.2001.00588.x; FOSTER DR, 1983, NATURE, V306, P256, DOI 10.1038/306256a0; Hilbert DW, 2000, J ECOL, V88, P230, DOI 10.1046/j.1365-2745.2000.00438.x; HilleRisLambers R, 2001, ECOLOGY, V82, P50, DOI 10.1890/0012-9658(2001)082[0050:VPFISA]2.0.CO;2; JONES CG, 1994, OIKOS, V69, P373, DOI 10.2307/3545850; Judd SL, 2000, PHYSICA D, V136, P45, DOI 10.1016/S0167-2789(99)00154-2; Klausmeier CA, 1999, SCIENCE, V284, P1826, DOI 10.1126/science.284.5421.1826; Lejeune O, 2004, INT J QUANTUM CHEM, V98, P261, DOI 10.1002/qua.10878; Lejeune O, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.010901; LINDBLAD JT, 1985, B INDONES ECON STUD, V21, P69, DOI 10.1080/00074918512331335083; Ludwig J., 1997, LANDSCAPE ECOLOGY FU; Meinhardt H., 1995, ALGORITHMIC BEAUTY S; MURRAY JD, 1989, BIOMATHEMATICS TEXTS, V19; OUYANG Q, 1992, J PHYS CHEM-US, V96, P6773, DOI 10.1021/j100195a045; Rietkerk M, 1997, OIKOS, V79, P69, DOI 10.2307/3546091; Rietkerk M, 2004, AM NAT, V163, P699, DOI 10.1086/383065; Rietkerk M, 2002, AM NAT, V160, P524, DOI 10.1086/342078; Rietkerk M, 2000, PLANT ECOL, V148, P207, DOI 10.1023/A:1009828432690; Rietkerk M, 1997, OIKOS, V80, P241, DOI 10.2307/3546592; Rohani P, 1997, TRENDS ECOL EVOL, V12, P70, DOI 10.1016/S0169-5347(96)20103-X; Sakaguchi Y., 1980, B DEP GEOGR U TOKYO, V12, P35; Scheffer M, 2001, NATURE, V413, P591, DOI 10.1038/35098000; Scheffer M, 2003, TRENDS ECOL EVOL, V18, P648, DOI 10.1016/j.tree.2003.09.002; SCHEFFER M, 1993, TRENDS ECOL EVOL, V8, P275, DOI 10.1016/0169-5347(93)90254-M; Schlesinger WH, 1996, ECOLOGY, V77, P364, DOI 10.2307/2265615; Shnerb NM, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.038101; SWANSON DK, 1988, OIKOS, V53, P509; THIERY JM, 1995, J ECOL, V83, P497, DOI 10.2307/2261602; Turing A., 1952, PHILOS T R SOC B, V237, P37; von Hardenberg J, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.198101	37	941	981	19	384	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 24	2004	305	5692					1926	1929		10.1126/science.1101867	http://dx.doi.org/10.1126/science.1101867			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	857RM	15448261	Green Submitted			2022-12-28	WOS:000224136000037
J	Heymann, DL; Aylward, RB				Heymann, DL; Aylward, RB			Global health - Eradicating polio	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									WHO, Polio Eradicat Initiat, CH-1211 Geneva, Switzerland	World Health Organization	Heymann, DL (corresponding author), WHO, Polio Eradicat Initiat, CH-1211 Geneva, Switzerland.							[Anonymous], 2003, Wkly Epidemiol Rec, V78, P241; [Anonymous], 1995, WHOEPIGEN956; Plotkin SA, 2001, CLIN INFECT DIS, V32, P1068, DOI 10.1086/319612; *WHO, IN PRESS REP WHO CON; World Health Organization, 2004, GEN DECL ER POL	5	37	40	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 23	2004	351	13					1275	1277		10.1056/NEJMp048204	http://dx.doi.org/10.1056/NEJMp048204			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	855TP	15385650	Green Accepted			2022-12-28	WOS:000223997700001
J	Yen, L; Svendsen, J; Lee, JS; Gray, JT; Magnier, M; Baba, T; D'Amato, RJ; Mulligan, RC				Yen, L; Svendsen, J; Lee, JS; Gray, JT; Magnier, M; Baba, T; D'Amato, RJ; Mulligan, RC			Exogenous control of mammalian gene expression through modulation of RNA self-cleavage	NATURE			English	Article							HAMMERHEAD-RIBOZYME; IN-VITRO; SYSTEM; IDENTIFICATION; INHIBITION; CELLS	Recent studies on the control of specific metabolic pathways in bacteria have documented the existence of entirely RNA-based mechanisms for controlling gene expression. These mechanisms involve the modulation of translation, transcription termination or RNA self-cleavage through the direct interaction of specific intracellular metabolites and RNA sequences(1-4). Here we show that an analogous RNA-based gene regulation system can effectively be designed for mammalian cells via the incorporation of sequences encoding self-cleaving RNA motifs(5) into the transcriptional unit of a gene or vector. When correctly positioned, the sequences lead to potent inhibition of gene or vector expression, owing to the spontaneous cleavage of the RNA transcript. Administration of either oligonucleotides complementary to regions of the self-cleaving motif or a specific small molecule results in the efficient induction of gene expression, owing to inhibition of self-cleavage of the messenger RNA. Efficient regulation of transgene expression is shown in a variety of mammalian cell lines and live animals. In conjunction with other emerging technologies(6), this methodology may be particularly applicable to the development of gene regulation systems tailored to any small inducer molecule, and provide a novel means of biological sensing in vivo that may have an important application in the regulated delivery of protein therapeutics.	Harvard Univ, Sch Med, Harvard Inst Human Genet, Dept Genet, Boston, MA 02115 USA; Childrens Hosp, Div Mol Med, Boston, MA 02115 USA; Childrens Hosp, Dept Surg, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital	Mulligan, RC (corresponding author), Harvard Univ, Sch Med, Harvard Inst Human Genet, Dept Genet, Boston, MA 02115 USA.	mulligan@receptor.med.harvard.edu	Wilson, Matthew H/K-3193-2013; Gray, John T/D-2916-2016	Gray, John T/0000-0002-1888-4612				ASZALOS A, 1966, J ANTIBIOT, V19, P285; Braasch DA, 2002, BIOCHEMISTRY-US, V41, P4503, DOI 10.1021/bi0122112; Breaker RR, 2002, CURR OPIN BIOTECH, V13, P31, DOI 10.1016/S0958-1669(02)00281-1; Cech TR, 2004, NATURE, V428, P263, DOI 10.1038/428263a; CECH TR, 1990, BIOSCIENCE REP, V10, P239, DOI 10.1007/BF01117241; CHOWRIRA BM, 1994, J BIOL CHEM, V269, P25856; Conaty J, 1999, NUCLEIC ACIDS RES, V27, P2400, DOI 10.1093/nar/27.11.2400; Contag PR, 1998, NAT MED, V4, P245, DOI 10.1038/nm0298-245; Ferbeyre G, 1998, MOL CELL BIOL, V18, P3880, DOI 10.1128/MCB.18.7.3880; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; Hermann T, 1998, J MOL BIOL, V276, P903, DOI 10.1006/jmbi.1997.1590; HERTEL KJ, 1992, NUCLEIC ACIDS RES, V20, P3252, DOI 10.1093/nar/20.12.3252; Jenne A, 2001, NAT BIOTECHNOL, V19, P56, DOI 10.1038/83513; Mandal M, 2004, NAT STRUCT MOL BIOL, V11, P29, DOI 10.1038/nsmb710; Morcos PA, 2001, GENESIS, V30, P94, DOI 10.1002/gene.1039; Murray JB, 1996, BIOCHEM J, V317, P855, DOI 10.1042/bj3170855; Ory DS, 1996, P NATL ACAD SCI USA, V93, P11400, DOI 10.1073/pnas.93.21.11400; Rivera VM, 1996, NAT MED, V2, P1028, DOI 10.1038/nm0996-1028; Rojas AA, 2000, NUCLEIC ACIDS RES, V28, P4037, DOI 10.1093/nar/28.20.4037; RUFFNER DE, 1990, BIOCHEMISTRY-US, V29, P10695, DOI 10.1021/bi00499a018; Silverman SK, 2003, RNA, V9, P377, DOI 10.1261/rna.2200903; STAGE TK, 1995, RNA, V1, P95; Suhr ST, 1998, P NATL ACAD SCI USA, V95, P7999, DOI 10.1073/pnas.95.14.7999; Tor Y, 1998, CHEM BIOL, V5, pR277, DOI 10.1016/S1074-5521(98)90286-1; VONAHSEN U, 1991, NATURE, V353, P368, DOI 10.1038/353368a0; WANG YL, 1994, P NATL ACAD SCI USA, V91, P8180, DOI 10.1073/pnas.91.17.8180; Wilson DS, 1999, ANNU REV BIOCHEM, V68, P611, DOI 10.1146/annurev.biochem.68.1.611; Winkler W, 2002, NATURE, V419, P952, DOI 10.1038/nature01145; Winkler WC, 2004, NATURE, V428, P281, DOI 10.1038/nature02362; Zillmann M, 1997, RNA, V3, P734	30	200	226	1	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 23	2004	431	7007					471	476		10.1038/nature02844	http://dx.doi.org/10.1038/nature02844			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855UN	15386015				2022-12-28	WOS:000224000500045
J	Abbott, RD; White, LR; Ross, GW; Masaki, KH; Curb, JD; Petrovitch, H				Abbott, RD; White, LR; Ross, GW; Masaki, KH; Curb, JD; Petrovitch, H			Walking and dementia in physically capable elderly men	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HONOLULU-HEART-PROGRAM; JAPANESE-AMERICAN MEN; ALZHEIMERS-DISEASE; LEISURE ACTIVITIES; COGNITIVE DECLINE; APOLIPOPROTEIN-E; OLDER PERSONS; RISK-FACTORS; INCIDENT AD; HEALTH	Context Evidence suggests that physical activity may be related to the clinical expression of dementia. Whether the association includes low-intensity activity such as walking is not known. Objective To examine the association between walking and future risk of dementia in older men. Design Prospective cohort study. Setting and Participants Distance walked per day was assessed from 1991 to 1993 in 2257 physically capable men aged 71 to 93 years in the Honolulu-Asia Aging Study. Follow-up for incident dementia was based on neurological assessment at 2 repeat examinations (1994-1996 and 1997-1999). Main Outcome Measures Overall dementia, Alzheimer disease, and vascular dementia. Results During the course of follow-up, 158 cases of dementia were identified (15.6/ 1000 person-years). After adjusting for age, men who walked the least (<0.25 mile/d) experienced a 1.8-fold excess risk of dementia compared with those who walked more than 2 mile/d (17.8 vs 10.3/1000 person-years; relative hazard [RH], 1.77; 95% confidence interval [CI], 1.04-3.01). Compared with men who walked the most (>2 mile/d), an excess risk of dementia was also observed in those who walked 0.25 to 1 mile/d (17.6 vs 10.3/1000 person-years; RH, 1.71; 95% Cl, 1.02-2.86). These associations persisted after accounting for other factors, including the possibility that limited amounts of walking could be the result of a decline in physical function due to preclinical dementia. Conclusions Findings suggest that walking is associated with a reduced risk of dementia. Promoting active lifestyles in physically capable men could help late-life cognitive function.	Univ Virginia, Sch Med, Div Biostat & Epidemiol, Charlottesville, VA 22908 USA; Pacific Hlth Res Inst, Honolulu, HI USA; Dept Vet Affairs, Honolulu, HI USA; Kuakini Med Ctr, Honolulu Asia Aging Study, Honolulu, HI USA; Univ Hawaii, John A Burns Sch Med, Dept Geriatr Med, Honolulu, HI 96822 USA; Univ Hawaii, John A Burns Sch Med, Dept Med, Honolulu, HI 96822 USA	University of Virginia; Pacific Health Research & Education Institute; University of Hawaii System; University of Hawaii System	Abbott, RD (corresponding author), Univ Virginia Hlth Syst, Dept Hlth Evaluat Sci, POB 800717, Charlottesville, VA 22908 USA.	rda3e@virginia.edu			DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC005102] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041265] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [N01AG042149, R01AG017155] Funding Source: NIH RePORTER; NHLBI NIH HHS [N01-HC-05102] Funding Source: Medline; NIA NIH HHS [N01-AG-4-2149, 1-R01-AG17155-01A1] Funding Source: Medline; NINDS NIH HHS [1-R01-NS41265-01] Funding Source: Medline	DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ABBOTT RD, 1985, AM J EPIDEMIOL, V121, P465, DOI 10.1093/oxfordjournals.aje.a114019; ABBOTT RD, 1994, AM J EPIDEMIOL, V139, P881, DOI 10.1093/oxfordjournals.aje.a117094; American Psychiatric Association, 1987, DIAGN STAT MAN MENT; CHIU HC, 1992, NEUROLOGY, V42, P473; Cotman CW, 2002, TRENDS NEUROSCI, V25, P295, DOI 10.1016/S0166-2236(02)02143-4; COX DR, 1972, J R STAT SOC B, V34, P187; FABRIGOULE C, 1995, J AM GERIATR SOC, V43, P485, DOI 10.1111/j.1532-5415.1995.tb06093.x; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Hakim AA, 1998, NEW ENGL J MED, V338, P94, DOI 10.1056/NEJM199801083380204; Hakim AA, 1999, CIRCULATION, V100, P9, DOI 10.1161/01.CIR.100.1.9; HARRIS T, 1988, JAMA-J AM MED ASSOC, V259, P1520; Havlik RJ, 2000, NEUROLOGY, V54, P1526, DOI 10.1212/WNL.54.7.1526; JORM AF, 1989, PSYCHOL MED, V19, P1015, DOI 10.1017/S0033291700005742; Kalmijn S, 2000, ARTERIOSCL THROM VAS, V20, P2255, DOI 10.1161/01.ATV.20.10.2255; KANNEL WB, 1979, ARCH INTERN MED, V139, P857, DOI 10.1001/archinte.139.8.857; Kramer AF, 1999, NATURE, V400, P418, DOI 10.1038/22682; LANE PW, 1982, BIOMETRICS, V38, P613, DOI 10.2307/2530043; Laurin D, 2001, ARCH NEUROL-CHICAGO, V58, P498, DOI 10.1001/archneur.58.3.498; Lindsay J, 2002, AM J EPIDEMIOL, V156, P445, DOI 10.1093/aje/kwf074; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Ross GW, 1997, JAMA-J AM MED ASSOC, V277, P800, DOI 10.1001/jama.277.10.800; SAUNDERS AM, 1993, NEUROLOGY, V43, P1467, DOI 10.1212/WNL.43.8.1467; Scarmeas N, 2003, ARCH NEUROL-CHICAGO, V60, P359, DOI 10.1001/archneur.60.3.359; Scarmeas N, 2001, NEUROLOGY, V57, P2236, DOI 10.1212/WNL.57.12.2236; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P1977, DOI 10.1073/pnas.90.5.1977; Teng E L, 1994, Int Psychogeriatr, V6, P45, DOI 10.1017/S1041610294001602; Tyas SL, 2003, NEUROBIOL AGING, V24, P589, DOI 10.1016/S0197-4580(02)00156-2; Verghese J, 2003, NEW ENGL J MED, V348, P2508, DOI 10.1056/NEJMoa022252; White L, 1996, JAMA-J AM MED ASSOC, V276, P955, DOI 10.1001/jama.276.12.955; Wilson RS, 2002, NEUROLOGY, V59, P1910, DOI 10.1212/01.WNL.0000036905.59156.A1; Wilson RS, 2002, JAMA-J AM MED ASSOC, V287, P742, DOI 10.1001/jama.287.6.742; Yaffe K, 2001, ARCH INTERN MED, V161, P1703, DOI 10.1001/archinte.161.14.1703; YANO K, 1984, AM J EPIDEMIOL, V119, P653, DOI 10.1093/oxfordjournals.aje.a113787; YOSHITAKE T, 1995, NEUROLOGY, V45, P1161, DOI 10.1212/WNL.45.6.1161; YOUNG DR, 1995, J AM GERIATR SOC, V43, P845, DOI 10.1111/j.1532-5415.1995.tb05525.x	35	470	491	4	58	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 22	2004	292	12					1447	1453		10.1001/jama.292.12.1447	http://dx.doi.org/10.1001/jama.292.12.1447			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	856FT	15383515	Bronze			2022-12-28	WOS:000224031800026
J	Ran, MS; Chen, EYH				Ran, MS; Chen, EYH			Suicide and schizophrenia in China	LANCET			English	Editorial Material							FOLLOW-UP; COMMUNITY		Univ Hong Kong, Hong Kong Jockey Club Ctr Suicide Res & Prevent, Pokfulam, Hong Kong, Peoples R China	University of Hong Kong	Ran, MS (corresponding author), Univ Hong Kong, Hong Kong Jockey Club Ctr Suicide Res & Prevent, Pokfulam, Hong Kong, Peoples R China.	ranmaosh@yahoo.com	Ran, Maosheng/B-9847-2017	Ran, Maosheng/0000-0001-7343-3729; Chen, Eric/0000-0002-5247-3593				American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th ed., DOI DOI 10.1001/JAMA.1994.03520100096; Babidge NC, 2001, ACTA PSYCHIAT SCAND, V103, P105, DOI 10.1034/j.1600-0447.2001.00192.x; Chen C. H., 1998, CHINESE J PSYCHIAT, V31, P72; Cooper JE, 1996, MENTAL DISORDERS CHI; Fenton WS, 1997, AM J PSYCHIAT, V154, P199; Meltzer HY, 2003, ARCH GEN PSYCHIAT, V60, P82, DOI 10.1001/archpsyc.60.1.82; Phillips MR, 2002, LANCET, V360, P1728, DOI 10.1016/S0140-6736(02)11681-3; Phillips MR, 2002, LANCET, V359, P835, DOI 10.1016/S0140-6736(02)07954-0; Ran MS, 2003, AUST NZ J PSYCHIAT, V37, P452, DOI 10.1046/j.1440-1614.2003.01203.x; Ran MS, 2003, ACTA PSYCHIAT SCAND, V107, P430, DOI 10.1034/j.1600-0447.2003.02014.x; Ran MS, 2001, BRIT J PSYCHIAT, V178, P154, DOI 10.1192/bjp.178.2.154; Sartorius N, 1996, SOC PSYCH PSYCH EPID, V31, P249; *STAT COUNC, 1992, WORK PROGR DIS PERS, P52; [No title captured]	14	8	9	0	8	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 18	2004	364	9439					1016	1017		10.1016/S0140-6736(04)17073-6	http://dx.doi.org/10.1016/S0140-6736(04)17073-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	855FT	15380949				2022-12-28	WOS:000223959300005
J	Weber, KL; Sokac, AM; Berg, JS; Cheney, RE; Bement, WM				Weber, KL; Sokac, AM; Berg, JS; Cheney, RE; Bement, WM			A microtubule-binding myosin required for nuclear anchoring and spindle assembly	NATURE			English	Article							UNCONVENTIONAL MYOSIN; OOCYTE MATURATION; XENOPUS-OOCYTES; EGG CORTEX; IN-VITRO; F-ACTIN; MICROFILAMENTS; FERTILIZATION; MOVEMENT; PROTEIN	Proper spindle positioning and orientation are essential for asymmetric cell division and require microtubule-actin filament (F-actin) interactions in many systems(1,2). Such interactions are particularly important in meiosis(3), where they mediate nuclear anchoring(4-6), as well as meiotic spindle assembly and rotation(7,8), two processes required for asymmetric cell division. Myosin-10 proteins are phosphoinositide-binding(9), actin-based motors that contain carboxy-terminal MyTH4 and FERM domains of unknown function(10). Here we show that Xenopus laevis myosin-10 (Myo10) associates with microtubules in vitro and in vivo, and is concentrated at the point where the meiotic spindle contacts the F-actin-rich cortex. Microtubule association is mediated by the MyTH4-FERM domains, which bind directly to purified microtubules. Disruption of Myo10 function disrupts nuclear anchoring, spindle assembly and spindle-F-actin association. Thus, this myosin has a novel and critically important role during meiosis in integrating the F- actin and microtubule cytoskeletons.	Univ Wisconsin, Dept Zool, Madison, WI 53706 USA; Univ Wisconsin, Mol & Cellular Biol Program, Madison, WI 53706 USA; Univ N Carolina, Dept Cell & Mol Physiol, Chapel Hill, NC 27599 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of North Carolina; University of North Carolina Chapel Hill	Bement, WM (corresponding author), Univ Wisconsin, Dept Zool, Madison, WI 53706 USA.	wmbement@wisc.edu	Bement, William/AAA-5444-2021	Cheney, Richard/0000-0001-6565-7888; Berg, Jonathan/0000-0003-2360-2664	NIDCD NIH HHS [R01 DC003299] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC003299] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		ALEXANDRE H, 1989, DEV BIOL, V136, P311, DOI 10.1016/0012-1606(89)90258-3; BEMENT WM, 1994, P NATL ACAD SCI USA, V91, P6549, DOI 10.1073/pnas.91.14.6549; Berg JS, 2000, J CELL SCI, V113, P3439; Cao TT, 2004, MOL BIOL CELL, V15, P151, DOI 10.1091/mbc.E03-07-0504; Cox D, 2002, NAT CELL BIOL, V4, P469, DOI 10.1038/ncb805; GARD DL, 1993, DEV BIOL, V159, P298, DOI 10.1006/dbio.1993.1242; GARD DL, 1995, ZYGOTE, V3, P17, DOI 10.1017/S0967199400002331; GARD DL, 1991, DEV BIOL, V143, P346, DOI 10.1016/0012-1606(91)90085-H; Gundersen GG, 2003, SCIENCE, V300, P2040, DOI 10.1126/science.1084938; Homma K, 2001, J BIOL CHEM, V276, P34348, DOI 10.1074/jbc.M104785200; Huang JD, 1999, NATURE, V397, P267, DOI 10.1038/16722; Isakoff SJ, 1998, EMBO J, V17, P5374, DOI 10.1093/emboj/17.18.5374; Kim NH, 2000, ZYGOTE, V8, P25, DOI 10.1017/S0967199400000794; Lantz VA, 1998, J CELL BIOL, V140, P897, DOI 10.1083/jcb.140.4.897; LESSMAN CA, 1987, CELL DIFFER DEV, V20, P239, DOI 10.1016/0045-6039(87)90469-6; Mandato CA, 2003, CURR BIOL, V13, P1096, DOI 10.1016/S0960-9822(03)00420-2; Narasimhulu SB, 1998, PLANT CELL, V10, P957, DOI 10.1105/tpc.10.6.957; Rodriguez OC, 2003, NAT CELL BIOL, V5, P599, DOI 10.1038/ncb0703-599; Rogers SL, 1999, J CELL BIOL, V146, P1265, DOI 10.1083/jcb.146.6.1265; SARDET C, 1992, DEVELOPMENT, V115, P221; Sardet C, 2002, DEV BIOL, V241, P1, DOI 10.1006/dbio.2001.0474; SHIMIZU T, 1990, ANN NY ACAD SCI, V582, P260; Sokac AM, 2000, INT REV CYTOL, V200, P197, DOI 10.1016/S0074-7696(00)00005-X; Sokac AM, 2003, NAT CELL BIOL, V5, P727, DOI 10.1038/ncb1025; Sun QY, 2001, BIOL REPROD, V64, P879, DOI 10.1095/biolreprod64.3.879; Tokuo H, 2004, BIOCHEM BIOPH RES CO, V319, P214, DOI 10.1016/j.bbrc.2004.04.167; Weber KL, 2002, J CELL SCI, V115, P1373; WELL D, 1995, NATURE, V374, P60, DOI 10.1038/374060a0; Wolfrum U, 1998, CELL MOTIL CYTOSKEL, V40, P261, DOI 10.1002/(SICI)1097-0169(1998)40:3<261::AID-CM5>3.3.CO;2-#; Yonezawa S, 2003, DEV GROWTH DIFFER, V45, P175	30	192	198	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 16	2004	431	7006					325	329		10.1038/nature02834	http://dx.doi.org/10.1038/nature02834			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	853XJ	15372037				2022-12-28	WOS:000223864000045
J	Topol, EJ				Topol, EJ			Failing the public health - Rofecoxib, Merck, and the FDA	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Cleveland Clin Fdn, Cleveland, OH 44195 USA	Cleveland Clinic Foundation	Topol, EJ (corresponding author), Cleveland Clin Fdn, 9500 Euclid Ave, Cleveland, OH 44195 USA.			Topol, Eric/0000-0002-1478-4729				Bombardier C, 2000, NEW ENGL J MED, V343, P1520, DOI 10.1056/NEJM200011233432103; Mukherjee D, 2001, JAMA-J AM MED ASSOC, V286, P954, DOI 10.1001/jama.286.8.954; Topol EJ, 2004, LANCET, V364, P639, DOI 10.1016/S0140-6736(04)16906-7	3	424	442	2	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 21	2004	351	17					1707	1709		10.1056/NEJMp048286	http://dx.doi.org/10.1056/NEJMp048286			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	863TH	15470193	Bronze			2022-12-28	WOS:000224585200001
J	Hansmann, G				Hansmann, G			Neonatal resuscitation on air: it is time to turn down the oxygen tanks?	LANCET			English	Editorial Material							ROOM AIR; 100-PERCENT OXYGEN; NEWBORN-INFANTS; OXIDATIVE STRESS; TERM INFANTS; VENTILATION		Stanford Univ, Sch Med, Dept Pediat, Stanford, CA 94305 USA	Stanford University	Hansmann, G (corresponding author), Stanford Univ, Sch Med, Dept Pediat, Stanford, CA 94305 USA.	georg.hansmann@stanford.edu	Hansmann, Georg/AAW-5843-2020	Hansmann, Georg/0000-0003-0709-3935				Askie LM, 2003, NEW ENGL J MED, V349, P959, DOI 10.1056/NEJMoa023080; CARTER BS, 1993, CLIN PERINATOL, V20, P287, DOI 10.1016/S0095-5108(18)30394-4; Casey BM, 2001, NEW ENGL J MED, V344, P467, DOI 10.1056/NEJM200102153440701; Collins MP, 2001, PEDIATR RES, V50, P712, DOI 10.1203/00006450-200112000-00014; Finer NN, 2004, CURR OPIN PEDIATR, V16, P157, DOI 10.1097/00008480-200404000-00007; Kattwinkel J, 2003, J PEDIATR-US, V142, P221, DOI 10.1067/mpd.2003.147; LUNDSTROM KE, 1995, ARCH DIS CHILD-FETAL, V73, pF81, DOI 10.1136/fn.73.2.F81; Niermeyer S, 2004, J Matern Fetal Neonatal Med, V15, P75, DOI 10.1080/14767050310001650761; Niermeyer S, 2000, PEDIATRICS, V106; O'Donnell CPF, 2004, ACTA PAEDIATR, V93, P583, DOI 10.1111/j.1651-2227.2004.tb02981.x; Ramji S, 2003, Indian Pediatr, V40, P510; RAMJI S, 1993, PEDIATR RES, V34, P809, DOI 10.1203/00006450-199312000-00023; Saugstad AD, 2004, CLIN PERINATOL, V31, P431, DOI 10.1016/j.clp.2004.04.021; Saugstad OD, 1998, PEDIATRICS, V102, DOI 10.1542/peds.102.1.e1; Saugstad OD, 2005, BIOL NEONATE, V87, P27, DOI 10.1159/000080950; Tin W, 2001, ARCH DIS CHILD-FETAL, V84, pF106, DOI 10.1136/fn.84.2.F106; Tin Win, 2003, Paediatr Respir Rev, V4, P9, DOI 10.1016/S1526-0542(02)00307-X; Vento M, 2003, J PEDIATR-US, V142, P240, DOI 10.1067/mpd.2003.91; Vento M, 2001, PEDIATRICS, V107, P642, DOI 10.1542/peds.107.4.642; Vento M, 2001, BIOL NEONATE, V79, P261	20	19	21	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 9	2004	364	9442					1293	1294		10.1016/S0140-6736(04)17203-6	http://dx.doi.org/10.1016/S0140-6736(04)17203-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	860NG	15474119				2022-12-28	WOS:000224349700006
J	Buskirk, S				Buskirk, S			Keeping an eye on the neighbors	SCIENCE			English	Editorial Material							HOME RANGE; BODY-SIZE; MAMMALS		Univ Wyoming, Dept Zool & Physiol, Laramie, WY 82071 USA	University of Wyoming	Buskirk, S (corresponding author), Univ Wyoming, Dept Zool & Physiol, Laramie, WY 82071 USA.	marten@uwyo.edu	Buskirk, Steven W/K-2871-2016	Buskirk, Steven W/0000-0003-0611-6648				Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; DAMUTH J, 1987, BIOL J LINN SOC, V31, P193, DOI 10.1111/j.1095-8312.1987.tb01990.x; HARESTAD AS, 1979, ECOLOGY, V60, P389, DOI 10.2307/1937667; Jetz W, 2004, SCIENCE, V306, P266, DOI 10.1126/science.1102138; Kiltie RA, 2000, FUNCT ECOL, V14, P226, DOI 10.1046/j.1365-2435.2000.00404.x; Kleiber M., 1961, FIRE LIFE, DOI DOI 10.1002/JPS.2600510525; LINDSTEDT SL, 1986, ECOLOGY, V67, P413, DOI 10.2307/1938584; MCNAB BK, 1963, AM NAT, V97, P133, DOI 10.1086/282264; West GB, 1997, SCIENCE, V276, P122, DOI 10.1126/science.276.5309.122	9	8	9	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 8	2004	306	5694					238	239		10.1126/science.1104480	http://dx.doi.org/10.1126/science.1104480			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	861MC	15472068				2022-12-28	WOS:000224419700027
J	Mandal, M; Lee, M; Barrick, JE; Weinberg, Z; Emilsson, GM; Ruzzo, WL; Breaker, RR				Mandal, M; Lee, M; Barrick, JE; Weinberg, Z; Emilsson, GM; Ruzzo, WL; Breaker, RR			A glycine-dependent riboswitch that uses cooperative binding to control gene expression	SCIENCE			English	Article							MESSENGER-RNA STRUCTURE; MECHANISM; TRANSCRIPTION	We identified a previously unknown riboswitch class in bacteria that is selectively triggered by glycine. A representative of these glycine-sensing RNAs from Bacillus subtilis operates as a rare genetic on switch for the gcvT operon, which codes for proteins that form the glycine cleavage system. Most glycine riboswitches integrate two ligand-binding domains that function cooperatively to more closely approximate a two-state genetic switch. This advanced form of riboswitch may have evolved to ensure that excess glycine is efficiently used to provide carbon flux through the citric acid cycle and maintain adequate amounts of the amino acid for protein synthesis. Thus, riboswitches perform key regulatory roles and exhibit complex performance characteristics that previously had been observed only with protein factors.	Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA	Yale University; Yale University; University of Washington; University of Washington Seattle	Breaker, RR (corresponding author), Yale Univ, Dept Mol Cellular & Dev Biol, POB 208103, New Haven, CT 06520 USA.	ronald.breaker@yale.edu	Breaker, Ronald/E-9679-2010; Barrick, Jeffrey/A-3046-2012	Barrick, Jeffrey/0000-0003-0888-7358; Breaker, Ronald/0000-0002-2165-536X; Weinberg, Zasha/0000-0002-6681-3624; Ruzzo, Walter L./0000-0002-6260-2926; Lee, Mark/0000-0002-9576-9589				ANTSON AA, 1995, NATURE, V374, P693, DOI 10.1038/374693a0; Barrick JE, 2004, P NATL ACAD SCI USA, V101, P6421, DOI 10.1073/pnas.0308014101; Douce R, 2001, TRENDS PLANT SCI, V6, P167, DOI 10.1016/S1360-1385(01)01892-1; EDELSTEIN SJ, 1975, ANNU REV BIOCHEM, V44, P209, DOI 10.1146/annurev.bi.44.070175.001233; Gusarov I, 1999, MOL CELL, V3, P495, DOI 10.1016/S1097-2765(00)80477-3; Hill A.V, 1910, J PHYSL, V40, piv, DOI DOI 10.1113/JPHYSIOL.1910.SP001386; Jose AM, 2001, NUCLEIC ACIDS RES, V29, P1631, DOI 10.1093/nar/29.7.1631; KIKUCHI G, 1973, MOL CELL BIOCHEM, V1, P169, DOI 10.1007/BF01659328; KURGANOV BI, 1978, ALLOSTERIC ENZYMES; Mandal M, 2004, NAT STRUCT MOL BIOL, V11, P29, DOI 10.1038/nsmb710; Mandal M, 2003, CELL, V113, P577, DOI 10.1016/S0092-8674(03)00391-X; Mandal M., UNPUB; Mironov AS, 2002, CELL, V111, P747, DOI 10.1016/S0092-8674(02)01134-0; Nahvi A, 2002, CHEM BIOL, V9, P1043, DOI 10.1016/S1074-5521(02)00224-7; Nahvi A, 2004, NUCLEIC ACIDS RES, V32, P143, DOI 10.1093/nar/gkh167; Nudler E, 2004, TRENDS BIOCHEM SCI, V29, P11, DOI 10.1016/j.tibs.2003.11.004; PTASHNE M, 2002, GENES SIGNALS; Soukup GA, 1999, RNA, V5, P1308, DOI 10.1017/S1355838299990891; Sudarsan N, 2003, RNA, V9, P644, DOI 10.1261/rna.5090103; SUDARSAN N, 1932, GENE DEV, V17, P2688; Vitreschak AG, 2004, TRENDS GENET, V20, P44, DOI 10.1016/j.tig.2003.11.008; WEISSBLUTH M, 1974, MOL BIOL BIOCH BIOPH, V15, P27; Winkler W, 2002, NATURE, V419, P952, DOI 10.1038/nature01145; Winkler WC, 2003, CHEMBIOCHEM, V4, P1024, DOI 10.1002/cbic.200300685; Winkler WC, 2004, NATURE, V428, P281, DOI 10.1038/nature02362; Winkler WC, 2002, P NATL ACAD SCI USA, V99, P15908, DOI 10.1073/pnas.212628899; Winkler WC, 2003, NAT STRUCT BIOL, V10, P701, DOI 10.1038/nsb967; Yarnell WS, 1999, SCIENCE, V284, P611, DOI 10.1126/science.284.5414.611	28	392	433	1	84	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 8	2004	306	5694					275	279		10.1126/science.1100829	http://dx.doi.org/10.1126/science.1100829			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	861MC	15472076				2022-12-28	WOS:000224419700040
J	Alcolado, JC				Alcolado, JC			Clinicians and patients' welfare: where does academic freedom fit in? Commentary: Funding will make you free	BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ Wales Coll Med, Dept Med, Cardiff CF14 4XN, S Glam, Wales	Cardiff University	Alcolado, JC (corresponding author), Univ Wales Coll Med, Dept Med, Cardiff CF14 4XN, S Glam, Wales.	alcolado@btinternet.com		Alcolado, John/0000-0003-0666-0352				*GEN MED COUNC, 2002, RES ROL RESP DOCT; Wright JG, 2004, BRIT MED J, V329, P795, DOI 10.1136/bmj.329.7469.795	2	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 2	2004	329	7469					797	797		10.1136/bmj.329.7469.797	http://dx.doi.org/10.1136/bmj.329.7469.797			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	859TW	15459058	Green Published			2022-12-28	WOS:000224291800028
J	Zhang, SF; Ma, C; Chalfie, M				Zhang, SF; Ma, C; Chalfie, M			Combinatorial marking of cells and organelles with reconstituted fluorescent proteins	CELL			English	Article							CAENORHABDITIS-ELEGANS; C-ELEGANS; MOTOR-NEURONS; SYNAPTIC-TRANSMISSION; GENE-EXPRESSION; COMPLEMENTATION; IDENTIFICATION; VISUALIZATION; HOMEOPROTEIN; SENSITIVITY	Expression of GFP and other fluorescent proteins depends on cis-regulatory elements. Because these elements rarely direct expression to specific cell types, GFP production cannot always be sufficiently limited. Here we show that reconstitution of GFP, YFP, and CFP previously split into two polypeptides yields fluorescent products when coexpressed in C. elegans. Because this reconstitution involves two components, it can confirm cellular coexpression and identify cells expressing a previously uncharacterized promoter. By choosing promoters whose expression patterns overlap for a single cell type, we can produce animals with fluorescence only in those cells. Furthermore, when one partial GFP polypeptide is fused with a subcellularly localized protein or peptide, this restricted expression leads to the fluorescent marking of cellular components in a subset of cells.	Columbia Univ, Dept Biol Sci, New York, NY 10027 USA	Columbia University	Chalfie, M (corresponding author), Columbia Univ, Dept Biol Sci, New York, NY 10027 USA.	mc21@columbia.edu			NIGMS NIH HHS [GM30997, R37 GM030997] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM030997, R01GM030997] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abedi MR, 1998, NUCLEIC ACIDS RES, V26, P623, DOI 10.1093/nar/26.2.623; Baird GS, 1999, P NATL ACAD SCI USA, V96, P11241, DOI 10.1073/pnas.96.20.11241; BRENNER S, 1974, GENETICS, V77, P71; Brons-Poulsen J, 1998, MOL CELL PROBE, V12, P345, DOI 10.1006/mcpr.1998.0187; CHALFIE M, 1994, SCIENCE, V263, P802, DOI 10.1126/science.8303295; CHALFIE M, 2004, GREEN FLUORESCENT PR; DESAI C, 1988, NATURE, V336, P638, DOI 10.1038/336638a0; Doi N, 1999, FEBS LETT, V453, P305, DOI 10.1016/S0014-5793(99)00732-2; Du HP, 2001, GENETICS, V158, P197; Ghosh I, 2000, J AM CHEM SOC, V122, P5658, DOI 10.1021/ja994421w; Goodman MB, 1998, NEURON, V20, P763, DOI 10.1016/S0896-6273(00)81014-4; Hein R, 1996, CURR BIOL, V6, P178, DOI 10.1016/S0960-9822(02)00450-5; Hu CD, 2003, NAT BIOTECHNOL, V21, P539, DOI 10.1038/nbt816; Hu CD, 2002, MOL CELL, V9, P789, DOI 10.1016/S1097-2765(02)00496-3; Lickteig KM, 2001, J NEUROSCI, V21, P2001, DOI 10.1523/JNEUROSCI.21-06-02001.2001; McIntire SL, 1997, NATURE, V389, P870, DOI 10.1038/39908; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; MILLER DM, 1995, DEVELOPMENT, V121, P2877; Miller DM, 1999, BIOTECHNIQUES, V26, P914, DOI 10.2144/99265rr01; Nagai T, 2001, P NATL ACAD SCI USA, V98, P3197, DOI 10.1073/pnas.051636098; Nonet ML, 1998, J NEUROSCI, V18, P70; OKKEMA PG, 1994, DEVELOPMENT, V120, P2175; Ormo M, 1996, SCIENCE, V273, P1392, DOI 10.1126/science.273.5280.1392; Ozawa T, 2000, ANAL CHEM, V72, P5151, DOI 10.1021/ac000617z; Ozawa T, 2001, ANAL CHEM, V73, P5866, DOI 10.1021/ac010717k; Patterson GH, 2002, SCIENCE, V297, P1873, DOI 10.1126/science.1074952; Poyurovsky MV, 2003, MOL CELL, V12, P875, DOI 10.1016/S1097-2765(03)00400-3; Umezawa Y, 2003, CHEM REC, V3, P22, DOI 10.1002/tcr.10049; WAY JC, 1989, GENE DEV, V3, P1823, DOI 10.1101/gad.3.12a.1823; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Winnier AR, 1999, GENE DEV, V13, P2774, DOI 10.1101/gad.13.21.2774; Wu J, 2001, GENE DEV, V15, P789, DOI 10.1101/gad.857401; Zhang Y, 2002, NATURE, V418, P331, DOI 10.1038/nature00891	34	109	169	0	28	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 1	2004	119	1					137	+		10.1016/j.cell.2004.09.012	http://dx.doi.org/10.1016/j.cell.2004.09.012			9	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	859UE	15454087	Bronze			2022-12-28	WOS:000224292600015
J	Clementi, R; Dagna, L; Dianzani, U; Dupre, L; Dianzani, I; Ponzoni, M; Cometa, A; Chiocchetti, A; Sabbadini, MG; Rugarli, C; Ciceri, F; Maccario, R; Locatelli, F; Danesino, C; Ferrarini, M; Bregni, M				Clementi, R; Dagna, L; Dianzani, U; Dupre, L; Dianzani, I; Ponzoni, M; Cometa, A; Chiocchetti, A; Sabbadini, MG; Rugarli, C; Ciceri, F; Maccario, R; Locatelli, F; Danesino, C; Ferrarini, M; Bregni, M			Brief report: Inherited perforin and Fas mutations in a patient with autoimmune lymphoproliferative syndrome and lymphoma	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							GENE-MUTATIONS; HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS; DEFECTIVE LYMPHOCYTE; APOPTOSIS; LIGAND; SURVEILLANCE; DISEASES; FAMILIES; CHILDREN; PATHWAY	27-year-old man with the autoimmune lymphoproliferative syndrome and a large-B-cell lymphoma had heterozygous mutations in the Fas and perforin (Prf1) genes. The Fas mutation was inherited from his healthy father and was also carried by his healthy brother, whereas the Prf1 mutation was inherited from his healthy mother. The combined effect of the two mutant genes may have contributed to the development of the autoimmune lymphoproliferative syndrome and lymphoma in this patient.	Univ Pavia, Dept Biol & Med Genet, I-27100 Pavia, Italy; Policlin San Matteo, Ist Ricovero & Cura Carattere Sci, Dept Pediat Hematol Oncol, I-27100 Pavia, Italy; Univ Milan, Osped San Raffaele, Ist Ricovero & Cura Carattere Sci, Dept Oncol,Lab Tumor Immunol, I-20127 Milan, Italy; Univ Milan, Osped San Raffaele, Ist Ricovero & Cura Carattere Sci, Unit Hematol Bone Marrow Transplantat, I-20127 Milan, Italy; Univ Milan, Osped San Raffaele, Ist Ricovero & Cura Carattere Sci, Dept Pathol, I-20127 Milan, Italy; Univ Milan, Osped San Raffaele, Ist Ricovero & Cura Carattere Sci, Clin Immunol & Rheumatol Unit, I-20127 Milan, Italy; Univ Milan, Osped San Raffaele, Ist Ricovero & Cura Carattere Sci, Telethon Inst Gene Therapy, I-20127 Milan, Italy; Vita Salute San Raffaele Univ Sch Med, Milan, Italy; A Avogadro Univ Eastern Piedmont, Interdisciplinary Res Ctr Autoimmune Dis, Novara, Italy; A Avogadro Univ Eastern Piedmont, Dept Med Sci, Novara, Italy	University of Pavia; IRCCS Fondazione San Matteo; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Fondazione Telethon; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; University of Eastern Piedmont Amedeo Avogadro; University of Eastern Piedmont Amedeo Avogadro	Bregni, M (corresponding author), Ist Sci H San Raffaele, Unit Hematol Bone Marrow Transplantat, I-20132 Milan, Italy.	marco.bregni@hsr.it	Ferrarini, Marina/AAO-1548-2020; Dagna, Lorenzo/AAB-2790-2019; dupre, loic/L-8174-2014; Dianzani, Umberto/K-1952-2016	dupre, loic/0000-0002-7278-6503; DIANZANI, Umberto/0000-0001-6723-3931; bregni, marco/0000-0002-3789-1199; Dagna, Lorenzo/0000-0002-7428-315X; Ferrarini, Marina/0000-0003-1015-9632; Chiocchetti, Annalisa/0000-0002-4349-1087	Telethon [TGT03A03, GGP04071, E.1170, TGT06S01] Funding Source: Medline	Telethon(Fondazione Telethon)		Bettinardi A, 1997, BLOOD, V89, P902, DOI 10.1182/blood.V89.3.902; Bleesing JJH, 2001, BLOOD, V98, P2466, DOI 10.1182/blood.V98.8.2466; CASCINO I, 1995, J IMMUNOL, V154, P2706; Clementi R, 2001, J MED GENET, V38, P643, DOI 10.1136/jmg.38.9.643; Davidson WF, 1998, J EXP MED, V187, P1825, DOI 10.1084/jem.187.11.1825; Feldmann J, 2002, BRIT J HAEMATOL, V117, P965, DOI 10.1046/j.1365-2141.2002.03534.x; FISHER GH, 1995, CELL, V81, P935, DOI 10.1016/0092-8674(95)90013-6; Krammer PH, 2000, NATURE, V407, P789, DOI 10.1038/35037728; LICHTENHELD MG, 1989, J IMMUNOL, V143, P4267; Muschen M, 2002, TRENDS IMMUNOL, V23, P75, DOI 10.1016/S1471-4906(01)02115-9; NAGATA S, 1995, SCIENCE, V267, P1449, DOI 10.1126/science.7533326; NAGATA S, 1995, IMMUNOL TODAY, V16, P39, DOI 10.1016/0167-5699(95)80069-7; Pignata C, 2000, CLIN EXP IMMUNOL, V121, P53, DOI 10.1046/j.1365-2249.2000.01275.x; Ramenghi U, 2000, BLOOD, V95, P3176; Rieux-Laucat F, 2003, CURR OPIN IMMUNOL, V15, P325, DOI 10.1016/S0952-7915(03)00042-6; RIEUXLAUCAT F, 1995, SCIENCE, V268, P1347, DOI 10.1126/science.7539157; Smyth MJ, 2000, J EXP MED, V192, P755, DOI 10.1084/jem.192.5.755; Sneller MC, 2003, CURR OPIN RHEUMATOL, V15, P417, DOI 10.1097/00002281-200307000-00008; Stepp SE, 1999, SCIENCE, V286, P1957, DOI 10.1126/science.286.5446.1957; Straus SE, 2001, BLOOD, V98, P194, DOI 10.1182/blood.V98.1.194; Trapani JA, 2002, NAT REV IMMUNOL, V2, P735, DOI 10.1038/nri911; Ueda I, 2003, BRIT J HAEMATOL, V121, P503, DOI 10.1046/j.1365-2141.2003.04298.x; Vasudevan S, 2003, CURR OPIN CELL BIOL, V15, P332, DOI 10.1016/S0955-0674(03)00051-6; Wang J, 1999, CELL, V98, P47, DOI 10.1016/S0092-8674(00)80605-4; Wu JG, 1996, J CLIN INVEST, V98, P1107, DOI 10.1172/JCI118892	25	49	52	1	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 30	2004	351	14					1419	1424		10.1056/NEJMoa041432	http://dx.doi.org/10.1056/NEJMoa041432			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	857XT	15459303				2022-12-28	WOS:000224153900010
J	Morgan, R				Morgan, R			Doxazosin in the sigmoid	LANCET			English	Editorial Material									Arrowe Pk Hosp, Wirral Hosp NHS Trust, Wirral CH49 5PE, Merseyside, England		Morgan, R (corresponding author), Arrowe Pk Hosp, Wirral Hosp NHS Trust, Wirral CH49 5PE, Merseyside, England.	rosemary.morgan@whnt.nhs.uk							0	0	0	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 25	2004	364	9440					1172	1172		10.1016/S0140-6736(04)17106-7	http://dx.doi.org/10.1016/S0140-6736(04)17106-7			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	857FT	15451227	Bronze			2022-12-28	WOS:000224102400033
J	Alkire, S; Chen, L				Alkire, S; Chen, L			Global health and moral values	LANCET			English	Article									Harvard Univ, Global Equit Initiat, Cambridge, MA 02138 USA	Harvard University	Alkire, S (corresponding author), Harvard Univ, Global Equit Initiat, 1033 Massachusetts Ave, Cambridge, MA 02138 USA.	alkire@fas.harvard.edu						*A CONF, 1993, ACONF15723; Amrith S., 2002, PLAGUE POVERTY WHO T; ANAND S, 2004, IN PRESS PUBLIC HLTH; ANAND S, 2000, HUMAN DEV HUMAN RIGH; Bentham J., 1996, INTRO PRINCIPLES MOR; BRAVEMAN P, 2003, B WORLD HEALTH ORGAN, V80, P539; Brown RE, 1979, ROCKEFELLER MED MEN; BRUNDTLAND GH, 2002, 24 WORLD AIDS C BARC; De Cock KM, 2002, LANCET, V360, P67, DOI 10.1016/S0140-6736(02)09337-6; Evans T., 2001, CHALLENGING INEQUITI; Farmer P.E, 2001, INFECT INEQUALITIES; Lee JW, 2003, B WORLD HEALTH ORGAN, V81, P473; LEE JW, 2003, COMMUNICATION    MAY; Maritain Jacques., 1944, RIGHTS MAN NATURAL L; MARMOT M, 2000, IS INEQUALITY BAD OU, P37; ROTHSCHILD E, 2001, PHILANTHROPY HLTH; RUGER JP, 1998, THESIS HARVARD U CAM; Sen A, 2002, HEALTH ECON, V11, P659, DOI 10.1002/hec.762; Sen A, 1992, INEQUALITY RE EXAMIN; Sen A., 1979, RATIONAL ACTION, P115; SEN AK, 2002, BRIT MED J, V7342, P860; SUNSTEIN CR, 1998, THESIS HARVARD U CAM; *WHO COMM MACR HLT, 2001, MACR HLTH INV HLTH D; 1989, CONV RIGHTS CHILD NO	24	29	30	3	6	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 18	2004	364	9439					1069	1074		10.1016/S0140-6736(04)17063-3	http://dx.doi.org/10.1016/S0140-6736(04)17063-3			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	855FT	15380967	Bronze, Green Published			2022-12-28	WOS:000223959300027
J	Edwards, N				Edwards, N			Commentary: Model could work	BRITISH MEDICAL JOURNAL			English	Editorial Material									NHS Confederat, London SW1E 5ER, England		Edwards, N (corresponding author), NHS Confederat, London SW1E 5ER, England.	nigel.edwards@nhsconfed.org						Degeling PJ, 2004, BMJ-BRIT MED J, V329, P679, DOI 10.1136/bmj.329.7467.679	1	1	1	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	SEP 18	2004	329	7467					681	682		10.1136/bmj.329.7467.681	http://dx.doi.org/10.1136/bmj.329.7467.681			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	856JU	15374922	Green Published			2022-12-28	WOS:000224042300029
J	He, X				He, X			Wnt signaling went derailed again: a new track vie the LIN-18 receptor?	CELL			English	Editorial Material							PATHWAY	In this issue of Cell, Inoue et al. (2004) reports that LIN-18, an atypical receptor tyrosine kinase related to mammalian Ryk and Drosophila Derailed, mediates Wnt signaling in parallel to LIN-17/Frizzled (Fz) during worm vulval development. LIN-18/Ryk and LIN-17/Fz appear to exhibit distinct Wnt specificity, and surprisingly, the LIN-18 intracellular domain may be dispensable.	Harvard Univ, Childrens Hosp, Sch Med, Div Neurosci, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard Medical School	He, X (corresponding author), Harvard Univ, Childrens Hosp, Sch Med, Div Neurosci, 300 Longwood Ave, Boston, MA 02115 USA.							FERGUSON EL, 1987, NATURE, V326, P259, DOI 10.1038/326259a0; Halford MM, 2000, NAT GENET, V25, P414, DOI 10.1038/78099; He X, 2004, DEVELOPMENT, V131, P1663, DOI 10.1242/dev.01117; Hikasa H, 2002, DEVELOPMENT, V129, P5227; Oishi I, 2003, GENES CELLS, V8, P645, DOI 10.1046/j.1365-2443.2003.00662.x; Patthy L, 2000, TRENDS BIOCHEM SCI, V25, P12, DOI 10.1016/S0968-0004(99)01504-2; SAWA H, 1996, GENE DEV, V10, P2187; Tanaka M, 2003, EMBO J, V22, P847, DOI 10.1093/emboj/cdg088; Yoshikawa S, 2003, NATURE, V422, P583, DOI 10.1038/nature01522	9	12	17	0	1	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	SEP 17	2004	118	6					668	670		10.1016/j.cell.2004.09.009	http://dx.doi.org/10.1016/j.cell.2004.09.009			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	855RW	15369666	Bronze			2022-12-28	WOS:000223992400003
J	Mello, CC; Conte, D				Mello, CC; Conte, D			Revealing the world of RNA interference	NATURE			English	Article							DOUBLE-STRANDED-RNA; C-ELEGANS; MESSENGER-RNA; GENETIC INTERFERENCE; GERM-LINE; NEUROSPORA-CRASSA; EXPRESSION; SUPPRESSION; POLYMERASE; DROSOPHILA		Univ Massachusetts, Sch Med, Howard Hughes Med Inst, Worcester, MA 01605 USA; Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA	Howard Hughes Medical Institute; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Mello, CC (corresponding author), Univ Massachusetts, Sch Med, Howard Hughes Med Inst, Worcester, MA 01605 USA.	craig.mello@umassmed.edu						Aravin AA, 2001, CURR BIOL, V11, P1017, DOI 10.1016/S0960-9822(01)00299-8; Baulcombe DC, 1996, PLANT MOL BIOL, V32, P79, DOI 10.1007/BF00039378; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Bosher JM, 2000, NAT CELL BIOL, V2, pE31, DOI 10.1038/35000102; Catalanotto C, 2000, NATURE, V404, P245, DOI 10.1038/35005169; Cogoni C, 1999, NATURE, V399, P166, DOI 10.1038/20215; Dalmay T, 2000, CELL, V101, P543, DOI 10.1016/S0092-8674(00)80864-8; DECARVALHO F, 1992, EMBO J, V11, P2595, DOI 10.1002/j.1460-2075.1992.tb05324.x; Dernburg AF, 2000, GENE DEV, V14, P1578; DOUGHERTY WG, 1995, CURR OPIN CELL BIOL, V7, P399, DOI 10.1016/0955-0674(95)80096-4; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Fagard M, 2000, P NATL ACAD SCI USA, V97, P11650, DOI 10.1073/pnas.200217597; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; GILBERT W, 1986, NATURE, V319, P618, DOI 10.1038/319618a0; Grishok A, 2001, CELL, V106, P23, DOI 10.1016/S0092-8674(01)00431-7; Grishok A, 2000, SCIENCE, V287, P2494, DOI 10.1126/science.287.5462.2494; GUO S, 1995, CELL, V81, P611, DOI 10.1016/0092-8674(95)90082-9; Hamilton AJ, 1999, SCIENCE, V286, P950, DOI 10.1126/science.286.5441.950; Hammond SM, 2000, NATURE, V404, P293, DOI 10.1038/35005107; Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961; IZANT JG, 1984, CELL, V36, P1007, DOI 10.1016/0092-8674(84)90050-3; Joyce G. F., 1993, COLD SPRING HARB SYM, V24, P49; Kennerdell JR, 1998, CELL, V95, P1017, DOI 10.1016/S0092-8674(00)81725-0; Ketting RF, 2001, GENE DEV, V15, P2654, DOI 10.1101/gad.927801; Ketting RF, 2000, NATURE, V404, P296, DOI 10.1038/35005113; Ketting RF, 1999, CELL, V99, P133, DOI 10.1016/S0092-8674(00)81645-1; Kiss T, 2002, CELL, V109, P145, DOI 10.1016/S0092-8674(02)00718-3; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Llave C, 2002, SCIENCE, V297, P2053, DOI 10.1126/science.1076311; Makeyev EV, 2002, MOL CELL, V10, P1417, DOI 10.1016/S1097-2765(02)00780-3; Mette MF, 1999, EMBO J, V18, P241, DOI 10.1093/emboj/18.1.241; Mochizuki K, 2002, CELL, V110, P689, DOI 10.1016/S0092-8674(02)00909-1; Morey C, 2004, FEBS LETT, V567, P27, DOI 10.1016/j.febslet.2004.03.117; Mourrain P, 2000, CELL, V101, P533, DOI 10.1016/S0092-8674(00)80863-6; NAPOLI C, 1990, PLANT CELL, V2, P279, DOI 10.1105/tpc.2.4.279; NELLEN W, 1993, TRENDS BIOCHEM SCI, V18, P419, DOI 10.1016/0968-0004(93)90137-C; NEWPORT J, 1987, CELL, V48, P205, DOI 10.1016/0092-8674(87)90424-7; Ngo H, 1998, P NATL ACAD SCI USA, V95, P14687, DOI 10.1073/pnas.95.25.14687; Pal-Bhadra M, 2004, SCIENCE, V303, P669, DOI 10.1126/science.1092653; Palauqui JC, 1997, EMBO J, V16, P4738, DOI 10.1093/emboj/16.15.4738; Parrish S, 2001, RNA, V7, P1397; PROUD CG, 1995, TRENDS BIOCHEM SCI, V20, P241, DOI 10.1016/S0968-0004(00)89025-8; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Reinhart BJ, 2002, SCIENCE, V297, P1831, DOI 10.1126/science.1077183; Rocheleau CE, 1997, CELL, V90, P707, DOI 10.1016/S0092-8674(00)80531-0; ROMANO N, 1992, MOL MICROBIOL, V6, P3343, DOI 10.1111/j.1365-2958.1992.tb02202.x; SCHIEBEL W, 1993, J BIOL CHEM, V268, P11858; Schmidt A, 1999, GENETICS, V151, P749; Sijen T, 2003, NATURE, V426, P310, DOI 10.1038/nature02107; Sijen T, 2001, CELL, V107, P465, DOI 10.1016/S0092-8674(01)00576-1; Sleutels F, 2002, NATURE, V415, P810, DOI 10.1038/415810a; Smardon A, 2000, CURR BIOL, V10, P169, DOI 10.1016/S0960-9822(00)00323-7; Storz G, 2002, SCIENCE, V296, P1260, DOI 10.1126/science.1072249; Tabara H, 1999, CELL, V99, P123, DOI 10.1016/S0092-8674(00)81644-X; Tabara H, 1998, SCIENCE, V282, P430, DOI 10.1126/science.282.5388.430; Tabara H, 2002, CELL, V109, P861, DOI 10.1016/S0092-8674(02)00793-6; Tang GL, 2003, GENE DEV, V17, P49, DOI 10.1101/gad.1048103; Timmons L, 1998, NATURE, V395, P854, DOI 10.1038/27579; Timmons L, 2001, GENE, V263, P103, DOI 10.1016/S0378-1119(00)00579-5; Voinnet O, 1997, NATURE, V389, P553, DOI 10.1038/39215; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973; WASSENEGGER M, 1994, CELL, V76, P567, DOI 10.1016/0092-8674(94)90119-8; Waterhouse PM, 1998, P NATL ACAD SCI USA, V95, P13959, DOI 10.1073/pnas.95.23.13959; Williams BRG, 1997, BIOCHEM SOC T, V25, P509, DOI 10.1042/bst0250509; Wutz A, 2000, MOL CELL, V5, P695, DOI 10.1016/S1097-2765(00)80248-8; Yekta S, 2004, SCIENCE, V304, P594, DOI 10.1126/science.1097434; Zamore PD, 2000, CELL, V101, P25, DOI 10.1016/S0092-8674(00)80620-0	67	697	806	4	149	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 16	2004	431	7006					338	342		10.1038/nature02872	http://dx.doi.org/10.1038/nature02872			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	853XJ	15372040	Bronze			2022-12-28	WOS:000223864000049
J	Kassar-Duchossoy, L; Gayraud-Morel, B; Gomes, D; Rocancourt, D; Buckingham, M; Shinin, V; Tajbakhsh, S				Kassar-Duchossoy, L; Gayraud-Morel, B; Gomes, D; Rocancourt, D; Buckingham, M; Shinin, V; Tajbakhsh, S			Mrf4 determines skeletal muscle identity in Myf5 : Myod double-mutant mice	NATURE			English	Article							PROGENITOR CELLS; GENE-EXPRESSION; MYF-5; MYOD; MOUSE; SPECIFICATION; ACTIVATION; DISRUPTION; MYOGENESIS; MARKER	In vertebrates, skeletal muscle is a model for the acquisition of cell fate from stem cells(1). Two determination factors of the basic helix - loop - helixmyogenic regulatory factor (MRF) family, Myf5 and Myod, are thought to direct this transition because double-mutant mice totally lack skeletal muscle fibres and myoblasts(2-4). In the absence of these factors, progenitor cells remain multipotent and can change their fate(5,6). Gene targeting studies have revealed hierarchical relationships between these and the other MRF genes, Mrf4 and myogenin, where the latter are regarded as differentiation genes(7). Here we show, using an allelic series of three Myf5 mutants that differentially affect the expression of the genetically linked Mrf4 gene, that skeletal muscle is present in the new Myf5: Myod double- null mice only when Mrf4 expression is not compromised. This finding contradicts the widely held view thatmyogenic identity is conferred solely byMyf5 and Myod, and identifies Mrf4 as a determination gene. We revise the epistatic relationship of the MRFs, in which both Myf5 and Mrf4 act upstream of Myod to direct embryonic multipotent cells into the myogenic lineage.	CNRS, URA 2578, Dept Dev Biol, F-75724 Paris 15, France	Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Tajbakhsh, S (corresponding author), CNRS, URA 2578, Dept Dev Biol, 25 Rue Dr Roux, F-75724 Paris 15, France.	shaht@pasteur.fr		Gayraud-Morel, Barbara/0000-0002-1168-8504; Shinin, Vasily/0000-0002-4285-6515				Bergstrom DA, 2001, MOL CELL BIOL, V21, P2404, DOI 10.1128/MCB.21.7.2404-2412.2001; BOBER E, 1991, J CELL BIOL, V113, P1255, DOI 10.1083/jcb.113.6.1255; BRAUN T, 1992, CELL, V71, P369, DOI 10.1016/0092-8674(92)90507-9; Carvajal JJ, 2001, DEVELOPMENT, V128, P1857; Daubas P, 2000, DEVELOPMENT, V127, P319; Hadchouel J, 2000, DEVELOPMENT, V127, P4455; Kablar B, 2003, DEV BIOL, V258, P307, DOI 10.1016/S0012-1606(03)00139-8; Kablar B, 1997, DEVELOPMENT, V124, P4729; Kablar B, 1999, DEV BIOL, V206, P219, DOI 10.1006/dbio.1998.9126; Kaul A, 2000, CELL, V102, P17, DOI 10.1016/S0092-8674(00)00006-4; Kress C, 1998, MAMM GENOME, V9, P998, DOI 10.1007/s003359900914; Lallemand Y, 1998, TRANSGENIC RES, V7, P105, DOI 10.1023/A:1008868325009; Lu JR, 2002, SCIENCE, V298, P2378, DOI 10.1126/science.1078273; Maroto M, 1997, CELL, V89, P139, DOI 10.1016/S0092-8674(00)80190-7; Moran JL, 1999, NATURE, V399, P742, DOI 10.1038/21560; NABESHIMA Y, 1993, NATURE, V364, P532, DOI 10.1038/364532a0; Olson EN, 1996, CELL, V85, P1, DOI 10.1016/S0092-8674(00)81073-9; Pham CTN, 1996, P NATL ACAD SCI USA, V93, P13090, DOI 10.1073/pnas.93.23.13090; Rawls A, 1998, DEVELOPMENT, V125, P2349; RUDNICKI MA, 1993, CELL, V75, P1351, DOI 10.1016/0092-8674(93)90621-V; Summerbell D, 2002, MECH DEVELOP, V117, P331, DOI 10.1016/S0925-4773(02)00208-3; Tajbakhsh S, 2000, CURR TOP DEV BIOL, V48, P225; Tajbakhsh S, 1995, DEVELOPMENT, V121, P4077; Tajbakhsh S, 2003, CURR OPIN GENET DEV, V13, P413, DOI 10.1016/S0959-437X(03)00090-X; Tajbakhsh S, 1996, NATURE, V384, P266, DOI 10.1038/384266a0; Tajbakhsh S, 1997, CELL, V89, P127, DOI 10.1016/S0092-8674(00)80189-0; Tallquist MD, 2000, DEVELOPMENT, V127, P5059; Wang YK, 1997, DEVELOPMENT, V124, P2507; WEINTRAUB H, 1991, SCIENCE, V251, P761, DOI 10.1126/science.1846704	29	456	484	1	40	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 23	2004	431	7007					466	471		10.1038/nature02876	http://dx.doi.org/10.1038/nature02876			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855UN	15386014				2022-12-28	WOS:000224000500044
J	Mori, M; Abegg, MH; Gahwiler, BH; Gerber, U				Mori, M; Abegg, MH; Gahwiler, BH; Gerber, U			A frequency-dependent switch from inhibition to excitation in a hippocampal unitary circuit	NATURE			English	Article							MOSSY FIBER SYNAPSES; RAT HIPPOCAMPUS; SLICE CULTURES; SYNAPTIC CONNECTIONS; PYRAMIDAL CELLS; CA3 NEURONS; ORGANIZATION; CONDUCTANCE; DEPRESSION; INVITRO	The hippocampus, a brain structure essential for memory and cognition, is classically represented as a trisynaptic excitatory circuit. Recent findings challenge this view, particularly with regard to the mossy fibre input to CA3, the second synapse in the trisynaptic pathway(1). Thus, the powerful mossy fibre input to CA3 pyramidal cells might mediate both synaptic excitation and inhibition(2,3). Here we show, by recording from connected cell pairs in rat entorhinal - hippocampal slice cultures, that single action potentials in a dentate granule cell evoke a net inhibitory signal in a pyramidal cell. The hyperpolarization is due to disynaptic feedforward inhibition, which overwhelms monosynaptic excitation. Interestingly, this net inhibitory synaptic response changes to an excitatory signal when the frequency of presynaptic action potentials increases. The process responsible for this switch involves the facilitation of monosynaptic excitatory transmission coupled with rapid depression of inhibitory circuits. This ability to immediately switch the polarity of synaptic responses constitutes a novel synaptic mechanism, which might be crucial to the state-dependent processing of information in associative hippocampal networks.	Univ Zurich, Brain Res Inst, CH-8057 Zurich, Switzerland	University of Zurich	Mori, M (corresponding author), Univ Zurich, Brain Res Inst, Winterthurerstr 190, CH-8057 Zurich, Switzerland.	mori@hifo.unizh.ch						Acsady L, 1998, J NEUROSCI, V18, P3386; Bischofberger J, 2002, TRENDS NEUROSCI, V25, P600, DOI 10.1016/S0166-2236(02)02259-2; BROWN TH, 1983, J NEUROPHYSIOL, V50, P487, DOI 10.1152/jn.1983.50.2.487; CHICUREL ME, 1992, J COMP NEUROL, V325, P169, DOI 10.1002/cne.903250204; DEBANNE D, 1995, J NEUROPHYSIOL, V73, P1282, DOI 10.1152/jn.1995.73.3.1282; Debanne D, 1997, NATURE, V389, P286, DOI 10.1038/38502; Feldmeyer D, 1999, J PHYSIOL-LONDON, V521, P169, DOI 10.1111/j.1469-7793.1999.00169.x; FROTSCHER M, 1988, NEUROSCIENCE, V24, P541, DOI 10.1016/0306-4522(88)90348-X; FROTSCHER M, 1989, EXP BRAIN RES, V75, P441; Gahwiler BH, 1998, CULTURING NERVE CELL, P461; Galarreta M, 1998, NAT NEUROSCI, V1, P587, DOI 10.1038/2822; Geiger JRP, 2000, NEURON, V28, P927, DOI 10.1016/S0896-6273(00)00164-1; Hallermann S, 2003, P NATL ACAD SCI USA, V100, P8975, DOI 10.1073/pnas.1432836100; Henze DA, 2002, NAT NEUROSCI, V5, P790, DOI 10.1038/nn887; JONAS P, 1993, J PHYSIOL-LONDON, V472, P615, DOI 10.1113/jphysiol.1993.sp019965; JUNG MW, 1993, HIPPOCAMPUS, V3, P165, DOI 10.1002/hipo.450030209; Kobayashi K, 2004, NEURON, V41, P445, DOI 10.1016/S0896-6273(03)00873-0; Liang Y, 2002, J NEUROPHYSIOL, V87, P1132, DOI 10.1152/jn.00661.2001; Llano I, 2000, NAT NEUROSCI, V3, P1256, DOI 10.1038/81781; MILES R, 1990, J PHYSIOL-LONDON, V428, P61, DOI 10.1113/jphysiol.1990.sp018200; MILES R, 1986, J PHYSIOL-LONDON, V373, P397, DOI 10.1113/jphysiol.1986.sp016055; Nakazawa K, 2002, SCIENCE, V297, P211, DOI 10.1126/science.1071795; SCHWARTZKROIN PA, 1990, PROG BRAIN RES, V83, P269; SIEGEL SJ, 1994, P NATL ACAD SCI USA, V91, P564, DOI 10.1073/pnas.91.2.564; Spruston N, 1997, J COMP NEUROL, V385, P427; THOMPSON SM, 1989, J NEUROPHYSIOL, V61, P501, DOI 10.1152/jn.1989.61.3.501; Varela JA, 1999, J NEUROSCI, V19, P4293; Walker MC, 2001, NEURON, V29, P703, DOI 10.1016/S0896-6273(01)00245-8; Yeckel MF, 1999, NAT NEUROSCI, V2, P625, DOI 10.1038/10180; ZIMMER J, 1984, J COMP NEUROL, V228, P432, DOI 10.1002/cne.902280310	30	138	139	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 23	2004	431	7007					453	456		10.1038/nature02854	http://dx.doi.org/10.1038/nature02854			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855UN	15386013				2022-12-28	WOS:000224000500041
J	Rauch, EM; Bar-Yam, Y				Rauch, EM; Bar-Yam, Y			Theory predicts the uneven distribution of genetic diversity within species	NATURE			English	Article							GEOGRAPHIC BARRIERS; BIODIVERSITY; POPULATIONS; GENEALOGIES; COALESCENT; DISPERSAL; HOTSPOTS; SIZE	Global efforts to conserve species have been strongly influenced by the heterogeneous distribution of species diversity across the Earth. This is manifest in conservation efforts focused on diversity hotspots(1-3). The conservation of genetic diversity within an individual species(4,5) is an important factor in its survival in the face of environmental changes and disease(6,7). Here we show that diversity within species is also distributed unevenly. Using simple genealogical models, we show that genetic distinctiveness has a scale-free power law distribution. This property implies that a disproportionate fraction of the diversity is concentrated in small sub-populations, even when the population is well-mixed. Small groups are of such importance to overall population diversity that even without extrinsic perturbations, there are large fluctuations in diversity owing to extinctions of these small groups. We also show that diversity can be geographically non-uniform potentially including sharp boundaries between distantly related organisms - without extrinsic causes such as barriers to gene flow or past migration events. We obtained these results by studying the fundamental scaling properties of genealogical trees. Our theoretical results agree with field data from global samples of Pseudomonas bacteria. Contrary to previous studies(8), our results imply that diversity loss owing to severe extinction events is high, and focusing conservation efforts on highly distinctive groups can save much of the diversity.	MIT, Comp Sci & Artificial Intelligence Lab, Cambridge, MA 02139 USA; New England Complex Syst Inst, Cambridge, MA 02138 USA	Massachusetts Institute of Technology (MIT)	Rauch, EM (corresponding author), MIT, Comp Sci & Artificial Intelligence Lab, 32 Vassar St, Cambridge, MA 02139 USA.	rauch@necsi.org						Amos W, 2001, HEREDITY, V87, P257, DOI 10.1046/j.1365-2540.2001.00940.x; Bar-Yam Y, 2004, COMPLEXITY, V9, P15, DOI 10.1002/cplx.20029; BARTON NH, 1995, PHILOS T ROY SOC B, V349, P49, DOI 10.1098/rstb.1995.0090; Cann RL, 2001, SCIENCE, V291, P1742, DOI 10.1126/science.1058948; Cho JC, 2000, APPL ENVIRON MICROB, V66, P5448, DOI 10.1128/AEM.66.12.5448-5456.2000; Crozier RH, 1997, ANNU REV ECOL SYST, V28, P243, DOI 10.1146/annurev.ecolsys.28.1.243; EHRLICH PR, 1991, SCIENCE, V253, P758, DOI 10.1126/science.253.5021.758; FAITH DP, 1994, BIOL CONSERV, V68, P69, DOI 10.1016/0006-3207(94)90548-7; Finlay BJ, 2002, SCIENCE, V296, P1061, DOI 10.1126/science.1070710; Fisher R., 1930, P ROY SOC EDINB, V50, P205; Frankham R, 1999, ANIM CONSERV, V2, P255, DOI 10.1111/j.1469-1795.1999.tb00071.x; Gaston KJ, 2000, NATURE, V405, P220, DOI 10.1038/35012228; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hudson R.R., 1990, Oxford Surveys in Evolutionary Biology, V7, P1; Irwin DE, 2002, EVOLUTION, V56, P2383; MORITZ C, 1994, TRENDS ECOL EVOL, V9, P373, DOI 10.1016/0169-5347(94)90057-4; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Nee S, 1997, SCIENCE, V278, P692, DOI 10.1126/science.278.5338.692; Nei M., 1987, MOL EVOLUTIONARY GEN; Notohara M, 2001, J APPL PROBAB, V38, P1; PRENDERGAST JR, 1993, NATURE, V365, P335, DOI 10.1038/365335a0; Wakeley J, 2003, MOL BIOL EVOL, V20, P208, DOI 10.1093/molbev/msg024; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; WATTERSON GA, 1982, ADV APPL PROBAB, V14, P206, DOI 10.2307/1426517; Whitaker RJ, 2003, SCIENCE, V301, P976, DOI 10.1126/science.1086909; Wilkins JF, 2002, GENETICS, V161, P873; Willis KJ, 2000, SCIENCE, V287, P1406, DOI 10.1126/science.287.5457.1406; Wright S, 1943, GENETICS, V28, P114	28	44	45	0	37	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 23	2004	431	7007					449	452		10.1038/nature02745	http://dx.doi.org/10.1038/nature02745			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855UN	15386012				2022-12-28	WOS:000224000500040
J	Rolett, B; Diamond, J				Rolett, B; Diamond, J			Environmental predictors of pre-European deforestation on Pacific islands	NATURE			English	Article								Some Pacific island societies, such as those of Easter Island and Mangareva, inadvertently contributed to their own collapse by causing massive deforestation(1-7). Others retained forest cover and survived(3,8,9). How can those fateful differences be explained? Although the answers undoubtedly involve both different cultural responses of peoples and different susceptibilities of environments, how can one determine which environmental factors predispose towards deforestation and which towards replacement of native trees with useful introduced tree species? Here we code European-contact conditions and nine environmental variables for 81 sites on 69 Pacific islands from Yap in the west to Easter in the east, and from Hawaii in the north to New Zealand in the south. We thereby detect statistical decreases in deforestation and/or forest replacement with island rainfall, elevation, area, volcanic ash fallout, Asian dust transport and makatea terrain ( uplifted reef), and increases with latitude, age and isolation. Comparative analyses of deforestation therefore lend themselves to much more detailed interpretations than previously possible. These results might be relevant to similar deforestation-associated collapses ( for example, Fertile Crescent, Maya and Anasazi) or the lack thereof ( Japan and highland New Guinea) elsewhere in the world.	Univ Hawaii, Dept Anthropol, Honolulu, HI 96822 USA; Univ Calif Los Angeles, Dept Geog, Los Angeles, CA 90095 USA	University of Hawaii System; University of California System; University of California Los Angeles	Rolett, B (corresponding author), Univ Hawaii, Dept Anthropol, Honolulu, HI 96822 USA.	rolett@hawaii.edu						Austin AT, 1998, OECOLOGIA, V113, P519, DOI 10.1007/s004420050405; BARRAU J, 1958, BISHOP MUS B, V219; Bellwood P.S., 1987, POLYNESIANS PREHISTO; BETANCOURT JL, 1981, SCIENCE, V214, P656, DOI 10.1126/science.214.4521.656; Brieman L, 1984, CLASSIFICATION REGRE; Chadwick OA, 1999, NATURE, V397, P491, DOI 10.1038/17276; Flenley John, 2002, ENIGMAS EASTER ISLAN; Ginoux P, 2001, J GEOPHYS RES-ATMOS, V106, P20255, DOI 10.1029/2000JD000053; Haberle S.G., 1998, AUST ARCHAEOL, V47, P1, DOI DOI 10.1080/03122417.1998.11681610; JENNRICH R, 1995, INTRO COMPUTATIONAL, pCH9; Kirch PV, 1997, AM ANTHROPOL, V99, P30, DOI 10.1525/aa.1997.99.1.30; Mieth A, 2003, RAPA NUI J, V17, P34; Redman C.L., 1999, HUMAN IMPACT ANCIENT; Spriggs M., 1997, ISLAND MELANESIANS; Totman Conrad., 1989, GREEN ARCHIPELAGO FO; Vinton Kirch P., 2017, ROAD WINDS; Webster David, 2002, FALL ANCIENT MAYA	17	107	110	0	62	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 23	2004	431	7007					443	446		10.1038/nature02801	http://dx.doi.org/10.1038/nature02801			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855UN	15386010				2022-12-28	WOS:000224000500038
J	Yoda, K; Tomonaga, T				Yoda, K; Tomonaga, T			Centromere identity originates in the structure of CENP-A/H4 tetramer itself: a mechanism for aneuploidy	LANCET			English	Editorial Material							CENP-A; HISTONE H3; CHROMATIN		Nagoya Univ, Biosci & Biotechnol Ctr, Chikusa Ku, Nagoya, Aichi 4648601, Japan; Chiba Univ, Grad Sch Med, Dept Mol Diag, Chiba, Japan	Nagoya University; Chiba University	Yoda, K (corresponding author), Nagoya Univ, Biosci & Biotechnol Ctr, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648601, Japan.	i45156a@nucc.cc.nagoya-u.ac.jp						Black BE, 2004, NATURE, V430, P578, DOI 10.1038/nature02766; Cleveland DW, 2003, CELL, V112, P407, DOI 10.1016/S0092-8674(03)00115-6; EARNSHAW WC, 1985, CHROMOSOMA, V91, P313, DOI 10.1007/BF00328227; Lengauer C, 1998, NATURE, V396, P643, DOI 10.1038/25292; PALMER DK, 1985, MOL CELL BIOL, V5, P173, DOI 10.1128/MCB.5.1.173; RAJAGOPALAN H, 2003, NAT REV CANCER, V3, P3511; SART D, 1997, NAT GENET, V16, P144; Shelby RD, 1997, J CELL BIOL, V136, P501, DOI 10.1083/jcb.136.3.501; SULLIVAN KF, 1994, J CELL BIOL, V127, P581, DOI 10.1083/jcb.127.3.581; Tomonaga T, 2003, CANCER RES, V63, P3511; WILLARD HF, 1990, TRENDS GENET, V6, P410, DOI 10.1016/0168-9525(90)90302-M; Yoda K, 2000, P NATL ACAD SCI USA, V97, P7266, DOI 10.1073/pnas.130189697	12	3	3	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 18	2004	364	9439					1022	1024		10.1016/S0140-6736(04)17077-3	http://dx.doi.org/10.1016/S0140-6736(04)17077-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	855FT	15380953				2022-12-28	WOS:000223959300009
J	Vieites, DR; Nieto-Roman, S; Barluenga, M; Palanca, A; Vences, M; Meyer, A				Vieites, DR; Nieto-Roman, S; Barluenga, M; Palanca, A; Vences, M; Meyer, A			Post-mating clutch piracy in an amphibian	NATURE			English	Article							MULTIPLE PATERNITY; RANA-TEMPORARIA; BOREAL POPULATION; COMMON FROGS; BODY-SIZE; SELECTION; SUCCESS; SYSTEMS	Female multiple mating and alternative mating systems can decrease the opportunity for sexual selection(1-3). Sperm competition is often the outcome of females mating with multiple males and has been observed in many animals(1,4-7), and alternative reproductive systems are widespread among species with external fertilization and parental care(3,8-10). Multiple paternity without associated complex behaviour related to mating or parental care is also seen in simultaneously spawning amphibians(11-15) and fishes(16) that release gametes into water. Here we report 'clutch piracy' in a montane population of the common frog Rana temporaria, a reproductive behaviour previously unknown in vertebrates with external fertilization. Males of this species clasp the females and the pair deposits one spherical clutch of eggs. No parental care is provided. 'Pirate' males search for freshly laid clutches, clasp them as they would do a female and fertilize the eggs that were left unfertilized by the 'parental' male. This behaviour does not seem to be size-dependent, and some males mate with a female and perform clutch piracy in the same season. Piracy affected 84% of the clutches and in some cases increased the proportion of eggs fertilized, providing direct fitness benefits both for the pirate males and the females(17). Sexual selection probably caused by a strong male-biased sex ratio-occurs in this population, as indicated by size-assortative mating; however, clutch piracy may reduce its impact. This provides a good model to explore how alternative mating strategies can affect the intensity of sexual selection.	Univ Vigo, Fac Ciencias Biol, Dept Ecol & Biol Anim, Lab Anat Anim, Vigo 36201, Spain; Univ Konstanz, Dept Biol, Lehrstuhl Zool & Evolut Biol, D-78457 Constance, Germany; Univ Amsterdam, Inst Biodivers & Ecosyst Dynam, NL-1092 AD Amsterdam, Netherlands; Univ Amsterdam, Museum Zool, NL-1092 AD Amsterdam, Netherlands	Universidade de Vigo; University of Konstanz; University of Amsterdam; University of Amsterdam	Vieites, DR (corresponding author), Univ Calif Berkeley, Museum Vertebrate Zool, 3101 Valley Life Sci Bldg, Berkeley, CA 94720 USA.	vieites@berkeley.edu	Barluenga, Marta/ABA-4194-2020; Meyer, Axel/C-9826-2009; Vences, Miguel/E-5573-2010; Soler, Antonio Palanca/B-4206-2010; Vieites, David/B-4481-2009	Barluenga, Marta/0000-0003-1514-0586; Meyer, Axel/0000-0002-0888-8193; Vieites, David/0000-0001-5551-7419; Vences, Miguel/0000-0003-0747-0817				Avise JC, 2002, ANNU REV GENET, V36, P19, DOI 10.1146/annurev.genet.36.030602.090831; Bekkevold D, 2002, MOL ECOL, V11, P91, DOI 10.1046/j.0962-1083.2001.01424.x; Birkhead Timothy R., 1997, P121; Byrne PG, 2002, J EVOLUTION BIOL, V15, P347, DOI 10.1046/j.1420-9101.2002.00409.x; Byrne PG, 1999, P ROY SOC B-BIOL SCI, V266, P717, DOI 10.1098/rspb.1999.0695; Clutton-Brock T. H., 1991, MONOGRAPHS BEHAV ECO; DORGEIX CA, 1995, MOL ECOL, V4, P505, DOI 10.1111/j.1365-294X.1995.tb00245.x; Duellman WE, 1986, BIOL AMPHIBIANS, P1; ELMBERG J, 1987, HOLARCTIC ECOL, V10, P193; ELMBERG J, 1990, CAN J ZOOL, V68, P121, DOI 10.1139/z90-017; ELMBERG J, 1991, BEHAV ECOL SOCIOBIOL, V28, P125; Foerster K, 2003, NATURE, V425, P714, DOI 10.1038/nature01969; Garner TWJ, 2003, P ROY SOC B-BIOL SCI, V270, P619, DOI 10.1098/rspb.2002.2284; GIBBONS MM, 1986, J ZOOL, V209, P579, DOI 10.1111/j.1469-7998.1986.tb03613.x; Grossenbacher K., 1997, ATLAS AMPHIBIANS REP, P158; Jennions MD, 2000, BIOL REV, V75, P21, DOI 10.1017/S0006323199005423; Jones AG, 1998, EVOLUTION, V52, P848, DOI [10.2307/2411279, 10.1111/j.1558-5646.1998.tb03709.x]; Jones AG, 2001, P NATL ACAD SCI USA, V98, P9151, DOI 10.1073/pnas.171310198; Laurila A, 1998, BIOL J LINN SOC, V63, P221; Lode T, 2004, NATURWISSENSCHAFTEN, V91, P44, DOI 10.1007/s00114-003-0491-7; Marshall TC, 1998, MOL ECOL, V7, P639, DOI 10.1046/j.1365-294x.1998.00374.x; Neff BD, 2004, P NATL ACAD SCI USA, V101, P2381, DOI 10.1073/pnas.0307522100; Neff BD, 2002, J FISH BIOL, V61, P739, DOI 10.1111/j.1095-8649.2002.tb00908.x; Olsson M, 2001, J HERED, V92, P190, DOI 10.1093/jhered/92.2.190; Pearse DE, 2001, J HERED, V92, P206, DOI 10.1093/jhered/92.2.206; Rico C, 1992, MOL ECOL, V1, P79, DOI 10.1111/j.1365-294X.1992.tb00159.x; Roberts JD, 1999, ANIM BEHAV, V57, P721, DOI 10.1006/anbe.1998.1019; Shuster S. M., 2003, MONOGRAPHS BEHAV ECO; Taborsky M, 2001, J HERED, V92, P100, DOI 10.1093/jhered/92.2.100; Vos CC, 2001, HEREDITY, V86, P598, DOI 10.1046/j.1365-2540.2001.00865.x	30	94	103	0	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 16	2004	431	7006					305	308		10.1038/nature02879	http://dx.doi.org/10.1038/nature02879			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	853XJ	15372032	Green Submitted			2022-12-28	WOS:000223864000040
J	Jetz, W; Carbone, C; Fulford, J; Brown, JH				Jetz, W; Carbone, C; Fulford, J; Brown, JH			The scaling of animal space use	SCIENCE			English	Article							HOME-RANGE SIZE; POPULATION ENERGY-USE; BODY-SIZE; MAMMALS; DENSITY; MASS; AREA; ABUNDANCE; ECOLOGY; BIRDS	Space used by animals increases with increasing body size. Energy requirements alone can explain how population density decreases, but not the steep rate at which home range area increases. We present a general mechanistic model that predicts the frequency of interaction, spatial overlap, and loss of resources to neighbors. Extensive empirical evidence supports the model, demonstrating that spatial constraints on defense cause exclusivity of home range use to decrease with increasing body size. In large mammals, over 90% of available resources may be lost to neighbors. Our model offers a general framework to understand animal space use and sociality.	Princeton Univ, Dept Ecol & Evolut Biol, Princeton, NJ 08544 USA; Univ New Mexico, Dept Biol, Albuquerque, NM 87131 USA; Zool Soc London, Inst Zool, London NW1 4RY, England	Princeton University; University of New Mexico; Zoological Society of London	Jetz, W (corresponding author), Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA.	wjetz@princeton.edu	Jetz, Walter/ABF-1517-2020	Jetz, Walter/0000-0002-1971-7277				Barrett L, 1998, FUNCT ECOL, V12, P857, DOI 10.1046/j.1365-2435.1998.00261.x; Blackburn TM, 1997, J ANIM ECOL, V66, P233, DOI 10.2307/6025; Blackburn TM, 1996, OIKOS, V75, P303, DOI 10.2307/3546254; Calder WA., 1984, SIZE FUNCTION LIFE H; Carbone C, 2002, SCIENCE, V295, P2273, DOI 10.1126/science.1067994; CARBONE C, IN PRESS AM NAT; DAMUTH J, 1981, BIOL J LINN SOC, V15, P185, DOI 10.1111/j.1095-8312.1981.tb00758.x; DAMUTH J, 1981, NATURE, V290, P699, DOI 10.1038/290699a0; DAMUTH J, 1987, BIOL J LINN SOC, V31, P193, DOI 10.1111/j.1095-8312.1987.tb01990.x; Ernest SKM, 2003, ECOL LETT, V6, P990, DOI 10.1046/j.1461-0248.2003.00526.x; GARLAND T, 1983, AM NAT, V121, P571, DOI 10.1086/284084; GRANT JWA, 1992, BEHAV ECOL SOCIOBIOL, V31, P149; HARESTAD AS, 1979, ECOLOGY, V60, P389, DOI 10.2307/1937667; Haskell JP, 2002, NATURE, V418, P527, DOI 10.1038/nature00840; Johnson CN, 1999, OIKOS, V85, P565, DOI 10.2307/3546706; Kelt DA, 2001, AM NAT, V157, P637, DOI 10.1086/320621; Kiltie RA, 2000, FUNCT ECOL, V14, P226, DOI 10.1046/j.1365-2435.2000.00404.x; Kirschfeld K., 1976, P354; LINDSTEDT SL, 1986, ECOLOGY, V67, P413, DOI 10.2307/1938584; MACE GM, 1983, AM NAT, V121, P120, DOI 10.1086/284043; Marquet PA, 2002, SCIENCE, V295, P2229, DOI 10.1126/science.1070587; MCNAB BK, 1963, AM NAT, V97, P133, DOI 10.1086/282264; Okubo A., 1980, DIFFUSION ECOLOGICAL; PETERS RH, 1983, OECOLOGIA, V60, P89, DOI 10.1007/BF00379325; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; Savage VM, 2004, FUNCT ECOL, V18, P257, DOI 10.1111/j.0269-8463.2004.00856.x; SCHOENER TW, 1968, ECOLOGY, V49, P123, DOI 10.2307/1933567; Silva M, 2001, GLOBAL ECOL BIOGEOGR, V10, P469, DOI 10.1046/j.1466-822x.2001.00261.x; SWIHART RK, 1988, ECOLOGY, V69, P393, DOI 10.2307/1940437; WASER PM, 1976, AM NAT, V110, P911, DOI 10.1086/283117; WITTING L, 1995, J THEOR BIOL, V177, P129, DOI 10.1006/jtbi.1995.0231	31	382	392	7	165	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 8	2004	306	5694					266	268		10.1126/science.1102138	http://dx.doi.org/10.1126/science.1102138			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	861MC	15472074				2022-12-28	WOS:000224419700037
J	Okamoto, YK; Kataza, H; Honda, M; Yamashita, T; Onaka, T; Watanabe, J; Miyata, T; Sako, S; Fujiyoshi, T; Sakon, I				Okamoto, YK; Kataza, H; Honda, M; Yamashita, T; Onaka, T; Watanabe, J; Miyata, T; Sako, S; Fujiyoshi, T; Sakon, I			An early extrasolar planetary system revealed by planetesimal belts in beta Pictoris	NATURE			English	Article							INTERSTELLAR SILICATE MINERALOGY; COOLED MIDINFRARED CAMERA; SUBARU-TELESCOPE; DUST DISK; SPECTROMETER; SPECTRUM; FORCES; GRAINS; MODELS; COMICS	beta Pictoris (beta Pic) is a main-sequence star with an edge-on dust disk(1-3) that might represent a state of the early Solar System. The dust does not seem to be a remnant from the original protoplanetary disk, but rather is thought to have been generated from large bodies like planetesimals and/or comets(4,5). The history and composition of the parent bodies can therefore be revealed by determining the spatial distribution, grain size, composition and crystallinity of the dust through high-resolution mid-infrared observations. Here we report that the sub-micrometre amorphous silicate grains around beta Pic have peaks in their distribution around 6, 16 and 30 AU (1 AU is the Sun-Earth distance), whereas the crystalline and micrometre-sized amorphous silicate grains are concentrated in the disk centre. As sub-micrometre grains are blown quickly out from the system by radiation pressure from the central star, the peaks indicate the locations of ongoing dust replenishment, which originates from ring-like distributions of planetesimals or 'planetesimal belts'.	Kitasato Univ, Coll Liberal Arts & Sci, Ctr Nat Sci, Kanagawa 2288555, Japan; Japan Aerosp Explorat Agcy, Inst Space & Astronaut Sci, Dept Infrared Astrophys, Kanagawa 2298510, Japan; Univ Tokyo, Grad Sch Sci, Dept Astron, Bunkyo Ku, Tokyo 1130033, Japan; Natl Astron Observ Japan, Subaru Telescope, Hilo, HI 96720 USA; Natl Astron Observ Japan, Tokyo 1818588, Japan; Univ Tokyo, Sch Sci, Inst Astron, Tokyo 1810015, Japan	Kitasato University; Japan Aerospace Exploration Agency (JAXA); Institute of Space & Astronautical Science (ISAS); University of Tokyo; National Institutes of Natural Sciences (NINS) - Japan; National Astronomical Observatory of Japan (NAOJ); National Institutes of Natural Sciences (NINS) - Japan; National Astronomical Observatory of Japan (NAOJ); University of Tokyo	Okamoto, YK (corresponding author), Ibaraki Univ, Inst Astrophys & Planetary Sci, Bunkyo 2-1-1, Mito, Ibaraki 3108512, Japan.	okamtoys@cc.nao.ac.jp						ARTYMOWICZ P, 1988, ASTROPHYS J, V335, pL79, DOI 10.1086/185344; Backman D. E., 1993, PROTOSTARS PLANETS, P1253; BACKMAN DE, 1992, ASTROPHYS J, V385, P670, DOI 10.1086/170973; CAMPINS H, 1989, ASTROPHYS J, V341, P1059, DOI 10.1086/167563; Crifo F, 1997, ASTRON ASTROPHYS, V320, pL29; desEtangs AL, 1996, ASTRON ASTROPHYS, V307, P542; DORSCHNER J, 1995, ASTRON ASTROPHYS, V300, P503; Fabian D, 2000, ASTRON ASTROPHYS, V364, P282; Fixsen DJ, 2002, ASTROPHYS J, V578, P1009, DOI 10.1086/342658; Gillett F., 1986, LIGHT DARK MATTER, P61; Hallenbeck SL, 2000, ASTROPHYS J, V535, P247, DOI 10.1086/308810; Honda M, 2003, ASTROPHYS J, V585, pL59, DOI 10.1086/374034; Kataza H, 2000, P SOC PHOTO-OPT INS, V4008, P1144, DOI 10.1117/12.395433; KNACKE RF, 1993, ASTROPHYS J, V418, P440, DOI 10.1086/173405; Koike C, 2003, ASTRON ASTROPHYS, V399, P1101, DOI 10.1051/0004-6361:20021831; Malfait K, 1998, ASTRON ASTROPHYS, V332, pL25; MUKAI T, 1984, ASTRON ASTROPHYS, V131, P355; Navascues DBY, 1999, ASTROPHYS J, V520, pL123, DOI 10.1086/312162; Okamoto YK, 2003, P SOC PHOTO-OPT INS, V4841, P169, DOI 10.1117/12.458957; Pantin E, 1997, ASTRON ASTROPHYS, V327, P1123; Pantin E, 1999, ESA SPEC PUBL, V427, P385; Sako S, 2003, PUBL ASTRON SOC PAC, V115, P1407, DOI 10.1086/379748; SMITH BA, 1984, SCIENCE, V226, P1421, DOI 10.1126/science.226.4681.1421; Wahhaj Z, 2003, ASTROPHYS J, V584, pL27, DOI 10.1086/346123; Weinberger AJ, 2003, ASTROPHYS J, V584, pL33, DOI 10.1086/368065	25	103	104	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 7	2004	431	7009					660	663		10.1038/nature02948	http://dx.doi.org/10.1038/nature02948			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	859WS	15470420				2022-12-28	WOS:000224299300032
J	Stuart, AJ; Kosintsev, PA; Higham, TFG; Lister, AM				Stuart, AJ; Kosintsev, PA; Higham, TFG; Lister, AM			Pleistocene to Holocene extinction dynamics in giant deer and woolly mammoth	NATURE			English	Article							MEGALOCEROS-GIGANTEUS BLUMENBACH; IRISH ELK; EUROPE; ISLAND	The extinction of the many well-known large mammals (megafauna) of the Late Pleistocene epoch has usually been attributed to 'overkill' by human hunters, climatic/vegetational changes or to a combination of both(1,2). An accurate knowledge of the geography and chronology of these extinctions is crucial for testing these hypotheses. Previous assumptions that the megafauna of northern Eurasia had disappeared by the Pleistocene/Holocene transition(2) were first challenged a decade ago by the discovery that the latest woolly mammoths on Wrangel Island, northeastern Siberia, were contemporaneous with ancient Egyptian civilization(3,4). Here we show that another spectacular megafaunal species, the giant deer or 'Irish elk', survived to around 6,900 radiocarbon yr BP (about 7,700 yr ago) in western Siberia-more than three millennia later than its previously accepted terminal date(2,5)-and therefore, that the reasons for its ultimate demise are to be sought in Holocene not Pleistocene events. Before their extinction, both giant deer and woolly mammoth underwent dramatic shifts in distribution, driven largely by climatic/vegetational changes. Their differing responses reflect major differences in ecology.	UCL, Dept Biol, London WC1E 6BT, England; Inst Plant & Anim Ecol, Ekaterinburg 620144, Russia; Univ Oxford, Oxford Radiocarbon Accelerator Unit, Oxford OX1 3JQ, England	University of London; University College London; Russian Academy of Sciences; Institute of Plant & Animal Ecology of the Russian Academy of Sciences; University of Oxford	Stuart, AJ (corresponding author), UCL, Dept Biol, Mortimer St, London WC1E 6BT, England.	Tony@megafauna.freeserve.co.uk	Higham, Tom/Y-2707-2019	Higham, Tom/0000-0002-5949-598X; Lister, Adrian/0000-0002-7985-138X				Aaris-Sorensen K, 2004, BOREAS, V33, P61, DOI 10.1080/03009480310006970; BARNOSKY AD, 1986, QUATERNARY RES, V25, P128, DOI 10.1016/0033-5894(86)90049-9; BARNOSKY AD, 1985, SCIENCE, V228, P340, DOI 10.1126/science.228.4697.340; FORONOVA IV, 2001, UNITED I GEOLOGY T, V848, P243; Gamble C, 2004, PHILOS T R SOC B, V359, P243, DOI 10.1098/rstb.2003.1396; Gonzalez S, 2000, NATURE, V405, P753, DOI 10.1038/35015668; GOULD SJ, 1974, EVOLUTION, V28, P191, DOI 10.1111/j.1558-5646.1974.tb00740.x; Guenther E., 1960, SCHRIFT NATURWISS VE, V30, P79; Guthrie RD, 2004, NATURE, V429, P746, DOI 10.1038/nature02612; Hoekstra R, 2001, PSYCHIAT RES, V103, P115, DOI 10.1016/S0165-1781(01)00282-7; Kahlke Ralf-Dietrich, 1994, Abhandlungen der Senckenbergischen Naturforschenden Gesellschaft, V546, P1; Kaiser K., 1999, EISZEITALTER GEGENWA, V49, P102; LISTER AM, 1994, ZOOL J LINN SOC-LOND, V112, P65, DOI 10.1111/j.1096-3642.1994.tb00312.x; Litt T, 2003, QUATERNARY SCI REV, V22, P7, DOI 10.1016/S0277-3791(02)00180-4; Markova Anastasia K., 1997, Paleontologia i Evolucio, V28-29, P5; Martin P. S., 1984, QUATERNARY EXTINCTIO, P364; MITCHELL G. F., 1949, PROC ROY IRISH ACAD SECT B, V52, P291; Moen RA, 1999, EVOL ECOL RES, V1, P235; Panova N, 1996, FOREST DEV PROCESS U, P26; PAVLOW M, 1906, MEM ACAD SCI ST PETE, V20, P1; SERIKOV YB, 2000, PALEOLITHIC MESOLITH, P351; STUART AJ, 1991, BIOL REV, V66, P453, DOI 10.1111/j.1469-185X.1991.tb01149.x; Stuart AJ, 2002, QUATERNARY SCI REV, V21, P1559, DOI 10.1016/S0277-3791(02)00026-4; STUART AJ, IN PRESS QUAT INT; Tzedakis PC, 1995, QUATERNARY SCI REV, V14, P967, DOI 10.1016/0277-3791(95)00042-9; VARTANYAN SL, 1993, NATURE, V362, P337, DOI 10.1038/362337a0; Vereshchagin N.K., 1984, P483; Woodman P, 1997, QUATERNARY SCI REV, V16, P129, DOI 10.1016/S0277-3791(96)00037-6; Woodman P. C, 1985, QUATERNARY HIST IREL, P251	29	222	245	1	160	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 7	2004	431	7009					684	689		10.1038/nature02890	http://dx.doi.org/10.1038/nature02890			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	859WS	15470427				2022-12-28	WOS:000224299300039
J	Tannock, IF; de Wit, R; Berry, WR; Horti, J; Pluzanska, A; Chi, KN; Oudard, S; Theodore, C; James, ND; Turesson, I; Rosenthal, MA; Eisenberger, MA				Tannock, IF; de Wit, R; Berry, WR; Horti, J; Pluzanska, A; Chi, KN; Oudard, S; Theodore, C; James, ND; Turesson, I; Rosenthal, MA; Eisenberger, MA		TAX 327 Investigators	Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							QUALITY-OF-LIFE; LOW-DOSE HYDROCORTISONE; PHASE-II TRIAL; RANDOMIZED-TRIAL; DOUBLE-BLIND; MEN; PLACEBO; ESTRAMUSTINE; THERAPY; PAIN	BACKGROUND: Mitoxantrone plus prednisone reduces pain and improves the quality of life in men with advanced, hormone-refractory prostate cancer, but it does not improve survival. We compared such treatment with docetaxel plus prednisone in men with this disease. METHODS: From March 2000 through June 2002, 1006 men with metastatic hormone-refractory prostate cancer received 5 mg of prednisone twice daily and were randomly assigned to receive 12 mg of mitoxantrone per square meter of body-surface area every three weeks, 75 mg of docetaxel per square meter every three weeks, or 30 mg of docetaxel per square meter weekly for five of every six weeks. The primary end point was overall survival. Secondary end points were pain, prostate-specific antigen (PSA) levels, and the quality of life. All statistical comparisons were against mitoxantrone. RESULTS: As compared with the men in the mitoxantrone group, men in the group given docetaxel every three weeks had a hazard ratio for death of 0.76 (95 percent confidence interval, 0.62 to 0.94; P=0.009 by the stratified log-rank test) and those given weekly docetaxel had a hazard ratio for death of 0.91 (95 percent confidence interval, 0.75 to 1.11; P=0.36). The median survival was 16.5 months in the mitoxantrone group, 18.9 months in the group given docetaxel every 3 weeks, and 17.4 months in the group given weekly docetaxel. Among these three groups, 32 percent, 45 percent, and 48 percent of men, respectively, had at least a 50 percent decrease in the serum PSA level (P<0.001 for both comparisons with mitoxantrone); 22 percent, 35 percent (P=0.01), and 31 percent (P=0.08) had predefined reductions in pain; and 13 percent, 22 percent (P=0.009), and 23 percent (P=0.005) had improvements in the quality of life. Adverse events were also more common in the groups that received docetaxel. CONCLUSIONS: When given with prednisone, treatment with docetaxel every three weeks led to superior survival and improved rates of response in terms of pain, serum PSA level, and quality of life, as compared with mitoxantrone plus prednisone.	Princess Margaret Hosp, Dept Med Oncol & Hematol, Toronto, ON M5G 2M9, Canada; Univ Toronto, Toronto, ON, Canada; Erasmus Univ, Med Ctr, Dept Med Oncol, Rotterdam, Netherlands; Raleigh Hematol Oncol Associates, Cary, NC USA; Natl Inst Oncol, Dept Chemotherapy & Clin Pharmacol, Budapest, Hungary; Med Univ Lodz, Dept Chemotherapy, Lodz, Poland; British Columbia Canc Agcy, Vancouver, BC V5Z 4E6, Canada; Hop Europeen Georges Pompidou, Paris, France; Inst Gustave Roussy, Villejuif, France; Canc Res UK Inst Canc Studies, Birmingham, W Midlands, England; Univ Uppsala Hosp, Sect Oncol, Uppsala, Sweden; Johns Hopkins Univ, Sydney Kimmel Comprehens Canc Ctr, Baltimore, MD USA	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; Erasmus University Rotterdam; Erasmus MC; National Institute of Oncology Hungary; Medical University Lodz; British Columbia Cancer Agency; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; UNICANCER; Gustave Roussy; Cancer Research UK; University of Birmingham; Uppsala University; Uppsala University Hospital; Johns Hopkins University; Johns Hopkins Medicine	Tannock, IF (corresponding author), Princess Margaret Hosp, Dept Med Oncol & Hematol, 610 Univ Ave, Toronto, ON M5G 2M9, Canada.	ian.tannock@uhn.on.ca	James, Nick/AAL-6802-2020	OUDARD, Stephane/0000-0003-0893-285X				*ACS, 2003, CANC FACTS FIG; Beer TM, 2001, ANN ONCOL, V12, P1273, DOI 10.1023/A:1012258723075; Beer TM, 2003, J CLIN ONCOL, V21, P123, DOI 10.1200/jco.2003.05.117; Berry W, 2001, SEMIN ONCOL, V28, P8, DOI 10.1053/sonc.2001.26893; Berry W, 2002, J UROLOGY, V168, P2439, DOI 10.1016/S0022-5347(05)64163-8; Chen TT, 2000, JNCI-J NATL CANCER I, V92, P1601, DOI 10.1093/jnci/92.19.1601; Dearnaley DP, 2003, J NATL CANCER I, V95, P1300, DOI 10.1093/jnci/djg038; Ernst DS, 2003, J CLIN ONCOL, V21, P3335, DOI 10.1200/JCO.2003.03.042; Esper P, 1997, UROLOGY, V50, P920, DOI 10.1016/S0090-4295(97)00459-7; Fossa SD, 2001, J CLIN ONCOL, V19, P62, DOI 10.1200/JCO.2001.19.1.62; Friedland D, 1999, SEMIN ONCOL, V26, P19; Kantoff PW, 1999, J CLIN ONCOL, V17, P2506, DOI 10.1200/JCO.1999.17.8.2506; Kelly WK, 1997, UROL CLIN N AM, V24, P421, DOI 10.1016/S0094-0143(05)70389-X; Kornblith AB, 2001, ANN ONCOL, V12, P633, DOI 10.1023/A:1011102619058; Martel CL, 2003, CANCER TREAT REV, V29, P171, DOI 10.1016/S0305-7372(02)00090-7; MELZACK R, 1975, PAIN, V1, P277, DOI 10.1016/0304-3959(75)90044-5; Oades GM, 2002, PROSTATE CANCER P D, V5, P264, DOI 10.1038/sj.pcan.4500607; Osoba D, 1999, J CLIN ONCOL, V17, P1654, DOI 10.1200/JCO.1999.17.6.1654; Petrylak Daniel P, 2002, Semin Urol Oncol, V20, P31, DOI 10.1053/suro.2002.35052; Petrylak DP, 2004, NEW ENGL J MED, V351, P1513, DOI 10.1056/NEJMoa041318; Picus J, 1999, SEMIN ONCOL, V26, P14; Saad F, 2002, JNCI-J NATL CANCER I, V94, P1458, DOI 10.1093/jnci/94.19.1458; Savarese DM, 2001, J CLIN ONCOL, V19, P2509, DOI 10.1200/JCO.2001.19.9.2509; Small EJ, 2000, J CLIN ONCOL, V18, P1440, DOI 10.1200/JCO.2000.18.7.1440; TANNOCK I, 1989, J CLIN ONCOL, V7, P590, DOI 10.1200/JCO.1989.7.5.590; Tannock IF, 1996, J CLIN ONCOL, V14, P1756, DOI 10.1200/JCO.1996.14.6.1756; Weitzman AL, 2000, J UROLOGY, V163, P834, DOI 10.1016/S0022-5347(05)67815-9; Wirth MP, 1997, UROL RES, V25, pS67, DOI 10.1007/BF00941991; World Health Organization, 1979, WHO HDB REP RES CANC, V48	29	4394	4600	8	183	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 7	2004	351	15					1502	1512		10.1056/NEJMoa040720	http://dx.doi.org/10.1056/NEJMoa040720			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	859UP	15470213				2022-12-28	WOS:000224293700008
J	Ornstein, S; Jenkins, RG; Nietert, PJ; Feifer, C; Roylance, LF; Nemeth, L; Corley, S; Dickerson, L; Bradford, WD; Litvin, C				Ornstein, S; Jenkins, RG; Nietert, PJ; Feifer, C; Roylance, LF; Nemeth, L; Corley, S; Dickerson, L; Bradford, WD; Litvin, C			A multimethod quality improvement intervention to improve preventive cardiovascular care - A cluster randomized trial	ANNALS OF INTERNAL MEDICINE			English	Article							PRACTICE GUIDELINES; CLINICAL-PRACTICE; SHATTUCK LECTURE; CHRONIC ILLNESS; MANAGEMENT; CORONARY; COMMITTEE; DISEASE; DESIGN; ADULT	Background: Research is needed to validate effective and practical strategies for improving the provision of evidence-based medicine in primary care. Objective: To determine whether a multimethod quality improvement intervention was more effective than a less intensive intervention for improving adherence to 21 quality indicators for primary and secondary prevention of cardiovascular disease and stroke. Design: 2-year randomized, controlled clinical trial with the practice as the unit of randomization. Setting: 20 community-based family or general internal medicine practices in 14 states. All used the same electronic medical record. Participants: 44 physicians, 17 midlevel providers, and approximately 200 staff members; data from the electronic medical records of 87 291 patients. Interventions: All practices received copies of practice guidelines and quarterly performance reports. intervention practices also hosted quarterly site visits to help them adopt quality improvement approaches and participated in 2 network meetings to share "best practice" approaches. Measurements: The percentage of indicators at or above pre-defined targets and the percentage of patients who had achieved each clinical indicator. Results: Intervention practices improved 22.4 percentage points (from 11.3% to 33.7%) in the percentage of indicators at or above the target; control practices improved 16.4 percentage points (from 6.3% to 22.7%). The 6.0-percentage point absolute difference between the intervention and control group was not statistically significant (P > 0.2). Patients in intervention practices had greater improvements than those in control practices for diagnoses of hypertension (improvement difference, 15.7 percentage points [95% Cl, 5.2 to 26.3 percentage points]) and blood pressure control in patients with hypertension (improvement difference, 8.0 percentage points [Cl, 0.0 to 16.0 percentage points]). Limitations: The study involved a small number of practices and lacked a pure control group. Conclusions: Primary care practices that use electronic medical records and receive regular performance reports can improve their adherence to clinical practice guidelines for cardiovascular disease and stroke prevention.	Med Univ S Carolina, Dept Family Med, Charleston, SC 29425 USA; Univ So Calif, Los Angeles, CA USA	Medical University of South Carolina; University of Southern California	Ornstein, S (corresponding author), Med Univ S Carolina, Dept Family Med, 295 Calhoun St, Charleston, SC 29425 USA.	ornstesm@musc.edu	Nemeth, Lynne Sheri/A-8082-2009	Nemeth, Lynne Sheri/0000-0001-8691-1400; Nietert, Paul/0000-0002-3933-4986	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [U18HS011132] Funding Source: NIH RePORTER	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)		*AM DIAB ASS, DIAB QUAL IMPR PROJ; American Diabetes Association, 2003, DIABETES CARE, V26, ps33, DOI DOI 10.2337/DIACARE.26.2007.S33; Bodenheimer T, 2002, JAMA-J AM MED ASSOC, V288, P1775, DOI 10.1001/jama.288.14.1775; Braunwald E, 1997, NEW ENGL J MED, V337, P1360, DOI 10.1056/NEJM199711063371906; Cabana MD, 1999, JAMA-J AM MED ASSOC, V282, P1458, DOI 10.1001/jama.282.15.1458; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; DONNER A, 1994, AM J EPIDEMIOL, V140, P279, DOI 10.1093/oxfordjournals.aje.a117247; Gail MH, 1996, STAT MED, V15, P1069, DOI 10.1002/(SICI)1097-0258(19960615)15:11<1069::AID-SIM220>3.3.CO;2-H; GRUNDY SM, 1993, JAMA-J AM MED ASSOC, V269, P3015, DOI 10.1001/jama.269.23.3015; Hajjar I, 2003, JAMA-J AM MED ASSOC, V290, P199, DOI 10.1001/jama.290.2.199; Hunt SA, 2001, CIRCULATION, V104, P2996, DOI 10.1161/hc4901.102568; Institute of Medicine, 2001, CROSSING QUALITY CHA; Lenfant C, 2003, NEW ENGL J MED, V349, P868, DOI 10.1056/NEJMsa035507; McGlynn EA, 2003, NEW ENGL J MED, V348, P2635, DOI 10.1056/NEJMsa022615; MCNAMARA RL, 2001, AHRQ PUBLICATION; Meinert CL., 1986, CLIN TRIALS DESIGN C; Murray DM, 1997, ANN EPIDEMIOL, V7, pS69, DOI 10.1016/S1047-2797(97)80009-9; National Asthma Education and Prevention Program, 1997, NIH PUBL; National cholesterol education program National heart lung and blood institute National institutes of health, 2002, 3 REP NAT CHOL ED PR; OBRIEN T, 2003, COCHRANE LIB; Ogden LG, 2000, HYPERTENSION, V35, P539, DOI 10.1161/01.HYP.35.2.539; Ornstein S M, 1997, Jt Comm J Qual Improv, V23, P347; Pearson TA, 2002, CIRCULATION, V106, P388, DOI 10.1161/01.CIR.0000020190.45892.75; Prystowsky EN, 1996, CIRCULATION, V93, P1262, DOI 10.1161/01.CIR.93.6.1262; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Rothman AA, 2003, ANN INTERN MED, V138, P256, DOI 10.7326/0003-4819-138-3-200302040-00034; SMITH SC, 1995, CIRCULATION, V92, P2; SOUMERAI SB, 1990, JAMA-J AM MED ASSOC, V263, P549, DOI 10.1001/jama.263.4.549; Stafford RS, 1997, J AM COLL CARDIOL, V29, P139, DOI 10.1016/S0735-1097(96)00441-X; Tunis SR, 2003, JAMA-J AM MED ASSOC, V290, P1624, DOI 10.1001/jama.290.12.1624; Wang TJ, 1998, ARCH INTERN MED, V158, P1901, DOI 10.1001/archinte.158.17.1901; Weingarten SR, 2002, BRIT MED J, V325, P925, DOI 10.1136/bmj.325.7370.925; WILLIAMS JF, 1995, CIRCULATION, V92, P2764; Woolf SH, 2000, J FAM PRACTICE, V49, P126	34	100	99	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 5	2004	141	7					523	532		10.7326/0003-4819-141-7-200410050-00008	http://dx.doi.org/10.7326/0003-4819-141-7-200410050-00008			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	862CR	15466769				2022-12-28	WOS:000224467800004
J	Shin, K; Xiang, HQ; Moon, SI; Kim, T; McCarthy, TJ; Russell, TP				Shin, K; Xiang, HQ; Moon, SI; Kim, T; McCarthy, TJ; Russell, TP			Curving and frustrating flatland	SCIENCE			English	Article							DIBLOCK COPOLYMER; BLOCK-COPOLYMERS; MORPHOLOGY; ARRAYS		Univ Massachusetts, Dept Polymer Sci & Engn, Silvio O Conte Natl Ctr Polymer Res, Amherst, MA 01003 USA	University of Massachusetts System; University of Massachusetts Amherst	Russell, TP (corresponding author), Univ Massachusetts, Dept Polymer Sci & Engn, Silvio O Conte Natl Ctr Polymer Res, Amherst, MA 01003 USA.	russell@mail.pse.umass.edu	Russell, Thomas Paul/ADL-3689-2022	Russell, Thomas Paul/0000-0001-6384-5826				GIDO SP, 1994, MACROMOLECULES, V27, P849, DOI 10.1021/ma00081a034; He XH, 2001, J CHEM PHYS, V114, P10510, DOI 10.1063/1.1372189; LAMBOOY P, 1994, PHYS REV LETT, V72, P2899, DOI 10.1103/PhysRevLett.72.2899; Moon SI, 2003, MACROMOLECULES, V36, P4253, DOI 10.1021/ma0300239; Park M, 1997, SCIENCE, V276, P1401, DOI 10.1126/science.276.5317.1401; Sevink GJA, 2001, J CHEM PHYS, V115, P8226, DOI 10.1063/1.1403437; Thompson RB, 2001, SCIENCE, V292, P2469, DOI 10.1126/science.1060585; Thurn-Albrecht T, 2000, SCIENCE, V290, P2126, DOI 10.1126/science.290.5499.2126; Xiang HQ, 2004, MACROMOLECULES, V37, P5660, DOI 10.1021/ma049299m	9	322	325	0	134	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 1	2004	306	5693					76	76		10.1126/science.1100090	http://dx.doi.org/10.1126/science.1100090			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	859YJ	15459380				2022-12-28	WOS:000224304000037
J	Tung, R; DeSanctis, R				Tung, R; DeSanctis, R			Images in clinical medicine: Giant left atrium	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Massachusetts Gen Hosp, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital	Tung, R (corresponding author), Massachusetts Gen Hosp, Boston, MA 02114 USA.								0	3	3	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 30	2004	351	14					1437	1437		10.1056/NEJMicm030599	http://dx.doi.org/10.1056/NEJMicm030599			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	857XT	15459305				2022-12-28	WOS:000224153900012
J	Wills-Karp, M; Karp, CL				Wills-Karp, M; Karp, CL			Chitin checking - Novel insights into asthma	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ACIDIC MAMMALIAN CHITINASE		Univ Cincinnati, Coll Med, Cincinnati Childrens Hosp Med Ctr, Div Immunobiol, Cincinnati, OH 45221 USA; Univ Cincinnati, Coll Med, Cincinnati Childrens Hosp Med Ctr, Div Mol Immunol, Cincinnati, OH USA	Cincinnati Children's Hospital Medical Center; University of Cincinnati; Cincinnati Children's Hospital Medical Center; University of Cincinnati	Wills-Karp, M (corresponding author), Univ Cincinnati, Coll Med, Cincinnati Childrens Hosp Med Ctr, Div Immunobiol, Cincinnati, OH 45221 USA.			Karp, Christopher/0000-0002-0832-2659				Boot RG, 2001, J BIOL CHEM, V276, P6770, DOI 10.1074/jbc.M009886200; Herrera-Estrella A, 1999, EXS, V87, P171; Shibata Y, 2000, J IMMUNOL, V164, P1314, DOI 10.4049/jimmunol.164.3.1314; Wills-Karp M, 1998, SCIENCE, V282, P2258, DOI 10.1126/science.282.5397.2258; Zhu Z, 2004, SCIENCE, V304, P1678, DOI 10.1126/science.1095336	5	24	26	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 30	2004	351	14					1455	1457		10.1056/NEJMcibr041294	http://dx.doi.org/10.1056/NEJMcibr041294			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	857XT	15459309				2022-12-28	WOS:000224153900017
J	Bjornson, CL; Klassen, TP; Williamson, J; Brant, R; Mitton, C; Plint, A; Bulloch, B; Evered, L; Johnson, DW				Bjornson, CL; Klassen, TP; Williamson, J; Brant, R; Mitton, C; Plint, A; Bulloch, B; Evered, L; Johnson, DW		Pediat Emergency Res Canada Netw	A randomized trial of a single dose of oral dexamethasone for mild croup	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							NEBULIZED BUDESONIDE; CHILDREN; PLACEBO; GLUCOCORTICOIDS; VARICELLA	Background: The benefits of dexamethasone treatment for moderate-to-severe croup are well established. However, most children with croup have mild symptoms, and it is unknown whether they would derive the same degree of benefit from dexamethasone treatment as children with more severe disease. Methods: We conducted a double-blind trial at four pediatric emergency departments in which 720 children with mild croup were randomly assigned to receive one oral dose of either dexamethasone (0.6 mg per kilogram of body weight) or placebo. The children had mild croup, as defined by a score of less than or equal to2 on the croup scoring system of Westley et al. The primary outcome was a return to a medical care provider for croup within seven days after treatment. The secondary outcome was the presence of ongoing symptoms of croup on days 1, 2, and 3 after treatment. Other outcomes included economic costs, hours of sleep lost by the child, and stress on the part of the parent in relation to the child's illness. Results: Baseline clinical characteristics were similar in the two groups. Return to medical care was significantly lower in the dexamethasone group (7.3 percent vs. 15.3 percent, P<0.001). In the dexamethasone group, there was quicker resolution of croup symptoms (P=0.003), less lost sleep (P<0.001), and less stress on the part of the parent (P<0.001). Conclusions: For children with mild croup, dexamethasone is an effective treatment that results in consistent and small but important clinical and economic benefits. Although the long-term effects of this treatment are not known, our data support the use of dexamethasone in most, if not all, children with croup.	Univ Calgary, Dept Pediat, Calgary, AB T2N 1N4, Canada; Univ Calgary, Dept Community Hlth Sci, Calgary, AB, Canada; Univ Calgary, Dept Pharmacol & Therapeut, Calgary, AB, Canada; Univ Alberta, Dept Pediat, Edmonton, AB, Canada; Univ British Columbia, Ctr Healthcare Innovat & Improvement, Vancouver, BC V5Z 1M9, Canada; Univ Ottawa, Dept Pediat, Ottawa, ON K1N 6N5, Canada; Univ Manitoba, Dept Pediat, Winnipeg, MB R3T 2N2, Canada	University of Calgary; University of Calgary; University of Calgary; University of Alberta; University of British Columbia; University of Ottawa; University of Manitoba	Johnson, DW (corresponding author), Alberta Childrens Prov Gen Hosp, Child Hlth Res Grp, 1820 Richmond Rd SW, Calgary, AB T2T 5C7, Canada.		Plint, Amy/AAE-2250-2020	Brant, Rollin/0000-0002-8026-2451; Klassen, Terry/0000-0002-5309-7091				*ALB HLTH CAR INS, 2001, SCHED MED BEN PROC P; Ausejo M, 1999, BRIT MED J, V319, P595, DOI 10.1136/bmj.319.7210.595; CHERRY JD, 1979, J PEDIATR-US, V94, P352, DOI 10.1016/S0022-3476(79)80883-5; Croup Osmond M., 2002, CLIN EVIDENCE, V8, P319; DANGELO A, 2001, PEDIATR RES, V49, pA83; DENNY FW, 1983, PEDIATRICS, V71, P871; DOWELL SF, 1993, PEDIATRICS, V92, P223; Drummond MF, 2015, METHODS EC EVALUATIO; Ducharme FM, 2003, PEDIATRICS, V111, P376, DOI 10.1542/peds.111.2.376; Geelhoed GC, 1996, BRIT MED J, V313, P140, DOI 10.1136/bmj.313.7050.140; Geelhoed GC, 1995, PEDIATR PULM, V20, P362, DOI 10.1002/ppul.1950200605; GELLER NL, 1987, BIOMETRICS, V43, P213, DOI 10.2307/2531962; Heagerty PJ, 1996, J AM STAT ASSOC, V91, P1024, DOI 10.2307/2291722; Ihaka R., 1996, J COMPUTATIONAL GRAP, V5, P299, DOI [10.2307/1390807, DOI 10.1080/10618600.1996.10474713]; Johnson David W., 2001, Pediatric Research, V49, p83A; Johnson DW, 1998, NEW ENGL J MED, V339, P498, DOI 10.1056/NEJM199808203390802; Johnson DW, 1996, ARCH PEDIAT ADOL MED, V150, P349, DOI 10.1001/archpedi.1996.02170290015002; Johnson DW, 2003, PEDIATR RES, V53, p185A; Johnson DW, 2003, PEDIATR RES, V53, p110A; KAIRYS SW, 1989, PEDIATRICS, V83, P683; Klassen T, 1995, ARCH PEDIAT ADOLESC, V149, P60; KLASSEN TP, 1994, NEW ENGL J MED, V331, P285, DOI 10.1056/NEJM199408043310501; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; Luria JW, 2001, ARCH PEDIAT ADOL MED, V155, P1340, DOI 10.1001/archpedi.155.12.1340; Patel H, 1996, ARCH PEDIAT ADOL MED, V150, P409, DOI 10.1001/archpedi.1996.02170290075012; *STAT CAN, 2004, COMM PROF; TIBBALLS J, 1992, LANCET, V340, P745, DOI 10.1016/0140-6736(92)92293-O; WESTLEY CR, 1978, AM J DIS CHILD, V132, P484, DOI 10.1001/archpedi.1978.02120300044008; Yeh TF, 2004, NEW ENGL J MED, V350, P1304, DOI 10.1056/NEJMoa032089	29	87	89	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 23	2004	351	13					1306	1313		10.1056/NEJMoa033534	http://dx.doi.org/10.1056/NEJMoa033534			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	855TP	15385657				2022-12-28	WOS:000223997700008
J	Fernandez-Aviles, F; Alonso, JJ; Castro-Beiras, A; Vazquez, N; Blanco, J; Alonso-Briales, J; Lopez-Mesa, J; Fernandez-Vazquez, F; Calvo, I; Martinez-Elbal, L; San Roman, JA; Ramos, B				Fernandez-Aviles, F; Alonso, JJ; Castro-Beiras, A; Vazquez, N; Blanco, J; Alonso-Briales, J; Lopez-Mesa, J; Fernandez-Vazquez, F; Calvo, I; Martinez-Elbal, L; San Roman, JA; Ramos, B		GRACIA Grp	Routine invasive strategy within 24 hours of thrombolysis versus ischaemia-guided conservative approach for acute myocardial infarction with ST-segment elevation (GRACIA-1): a randomised controlled trial	LANCET			English	Article							PERCUTANEOUS CORONARY INTERVENTION; PRACTICE GUIDELINES COMMITTEE; ASSOCIATION TASK-FORCE; PRIMARY ANGIOPLASTY; ACC/AHA GUIDELINES; AMERICAN-COLLEGE; REOCCLUSION; OUTCOMES; THERAPY; CARDIOLOGY	Background In patients with ST-segment elevated myocardial infarction (STEMI), early post-thrombolysis routine angioplasty has been discouraged because of its association with high incidence of events. The GRACIA-1 trial was designed to reassess the benefits of an early post-thrombolysis interventional approach in the era of stents and new antiplatelet agents. Methods 500 patients with thrombolysed STEMI (with recombinant tissue plasminogen activator) were randomly assigned to angiography and intervention if indicated within 24 h of thrombolysis, or to an ischaemia-guided conservative approach. The primary endpoint was the combined rate of death, reinfarction, or revascularisation at 12 months. Analysis was by intention to treat. Findings Invasive treatment included stenting of the culprit artery in 80% (199 of 248) patients, bypass surgery in six (2%), non-culprit artery stenting in three, and no intervention in 40 (16%). Predischarge revascularisation was needed in 51 of 252 patients in the conservative group. By comparison with patients receiving conservative treatment, by 1 year, patients in the invasive group had lower frequency of primary endpoint (23 [9%] vs 51 [21%], risk ratio 0.44 [95% CI 0.28-0.70], p=0.0008), and they tended to have reduced rate of death or reinfarction (7% vs 12%, 0.59 [0.33-1.05], p=0.07). Index time in hospital was shorter in the invasive group, with no differences in major bleeding or vascular complications. At 30 days both groups had a similar incidence of cardiac events. Inhospital incidence of revascularisation induced by spontaneous recurrence of ischaemia was higher in patients in the conservative group than in those in the invasive group. Interpretation In patients with STEMI, early post-thrombolysis catheterisation and appropriate intervention is safe and might be preferable to a conservative strategy since it reduces the need for unplanned in-hospital revascularisation, and improves 1-year clinical outcome.	Hosp Univ Valladolid, Inst Ciencias Corazon, ICICOR, Valladolid 47005, Spain; Hosp Juan Canalejo, La Coruna, Spain; Hosp Rio Hortega, Valladolid, Spain; Hosp Univ Virgen Victoria, Malaga, Spain; Hosp Rio Carrion, Palencia, Spain; Hosp Leon, Leon, Spain; Hosp Miguel Servet, Zaragoza, Spain; Hosp Univ Princesa, Madrid, Spain	Universidad de Valladolid; Complejo Hospitalario Universitario A Coruna; Hospital del Rio Hortega; Hospital Virgen de la Victoria; Universidad de Leon; Hospital de Leon; Miguel Servet University Hospital; Hospital de La Princesa	Fernandez-Aviles, F (corresponding author), Hosp Univ Valladolid, Inst Ciencias Corazon, ICICOR, Ramon & Cajal 3, Valladolid 47005, Spain.	faviles@secardiologia.es	FERNANDEZ-VAZQUEZ, FELIPE FFV/R-8969-2018; San Roman, Jose A/A-9963-2012; Velasco, Berta/D-4325-2014	FERNANDEZ-VAZQUEZ, FELIPE FFV/0000-0001-7187-1290; Velasco, Berta/0000-0002-8390-3867; Alonso, Joaquin J/0000-0003-4360-5897; San Roman Calvar, Jose Alberto/0000-0003-0764-0839				Alfonso F, 1997, J AM COLL CARDIOL, V29, P725, DOI 10.1016/S0735-1097(96)00566-9; [Anonymous], 1989, NEW ENGL J MED, V320, P618; APPLEBY P, 1994, LANCET, V343, P311, DOI 10.1016/S0140-6736(94)91161-4; Aros F, 1999, REV ESP CARDIOL, V52, P919, DOI 10.1016/S0300-8932(99)75024-4; BROUWER MA, 1995, J AM COLL CARDIOL, V26, P1440, DOI 10.1016/0735-1097(95)00355-X; DEBONO DP, 1991, BMJ-BRIT MED J, V302, P555; Fernandez-Aviles F, 2002, CATHETER CARDIO INTE, V55, P467, DOI 10.1002/ccd.10107; GASH AK, 1986, AM J CARDIOL, V57, P175, DOI 10.1016/0002-9149(86)90975-6; Gibson CM, 2002, CIRCULATION, V105, P1909, DOI 10.1161/01.CIR.0000014683.52177.B5; Gibson CM, 2003, J AM COLL CARDIOL, V42, P7, DOI 10.1016/S0735-1097(03)00506-0; Grines CL, 1998, J AM COLL CARDIOL, V31, P967, DOI 10.1016/S0735-1097(98)00031-X; Hasdai D, 2002, EUR HEART J, V23, P1190, DOI 10.1053/euhj.2002.3193; Herrmann HC, 2000, J AM COLL CARDIOL, V36, P1489, DOI 10.1016/S0735-1097(00)00923-2; Jadad AR, 1998, RANDOMISED CONTROLLE; Keeley EC, 2003, LANCET, V361, P13, DOI 10.1016/S0140-6736(03)12113-7; MICHELS KB, 1995, CIRCULATION, V91, P476, DOI 10.1161/01.CIR.91.2.476; Montalescot G, 2001, NEW ENGL J MED, V344, P1895, DOI 10.1056/NEJM200106213442503; Morrow DA, 2001, JAMA-J AM MED ASSOC, V286, P1356, DOI 10.1001/jama.286.11.1356; O'Neill WW, 2003, J AM COLL CARDIOL, V42, P17, DOI 10.1016/S0735-1097(03)00507-2; PASSAMANI E, 1985, NEW ENGL J MED, V312, P932; Ross AM, 1999, J AM COLL CARDIOL, V34, P1954, DOI 10.1016/S0735-1097(99)00444-1; ROSS AM, 1993, NEW ENGL J MED, V329, P1615; Ryan TJ, 1999, CIRCULATION, V100, P1016, DOI 10.1161/01.CIR.100.9.1016; SIMOONS ML, 1988, LANCET, V1, P199; Smith SC, 2001, J AM COLL CARDIOL, V37, P2215, DOI 10.1016/S0735-1097(01)01344-4; Steinhubl SR, 2002, JAMA-J AM MED ASSOC, V288, P2411, DOI 10.1001/jama.288.19.2411; Stenestrand U, 2002, LANCET, V359, P1805, DOI 10.1016/S0140-6736(02)08710-X; Stone GW, 2002, NEW ENGL J MED, V347, P367; Van Belle E, 1998, CIRCULATION, V97, P26, DOI 10.1161/01.CIR.97.1.26; Van de Werf F, 2003, EUR HEART J, V24, P28, DOI 10.1016/S0195-668X(02)00618-8; VEEN G, 1993, J AM COLL CARDIOL, V22, P1755, DOI 10.1016/0735-1097(93)90754-O; Verheugt FWA, 1996, J AM COLL CARDIOL, V27, P766, DOI 10.1016/0735-1097(95)00492-0; Zeymer U, 2003, CIRCULATION, V108, P1324, DOI 10.1161/01.CIR.0000087605.09362.0E	33	275	296	0	14	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 18	2004	364	9439					1045	1053		10.1016/S0140-6736(04)17059-1	http://dx.doi.org/10.1016/S0140-6736(04)17059-1			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	855FT	15380963				2022-12-28	WOS:000223959300023
J	Hayashi, T; Fujita, Y; Iwasaki, O; Adachi, Y; Takahashi, K; Yanagida, M				Hayashi, T; Fujita, Y; Iwasaki, O; Adachi, Y; Takahashi, K; Yanagida, M			Mis16 and Mis18 are required for CENP-A loading and histone deacetylation at centromeres	CELL			English	Article							BUDDING YEAST KINETOCHORE; CULTURED-MAMMALIAN-CELLS; FISSION YEAST; CHROMOSOME SEGREGATION; SACCHAROMYCES-CEREVISIAE; NEGATIVE REGULATOR; OUTER KINETOCHORE; EQUAL SEGREGATION; PROTEIN; GENE	Centromeres contain specialized chromatin that includes the centromere-specific histone H3 variant, spCENP-A/Cnp1. Here we report identification of five fission yeast centromere proteins, Mis14-18. Mis14 is recruited to kinetochores independently of CENP-A, and, conversely, CENP-A does not require Mis14 to associate with centromeres. In contrast, Mis15, Mis16 (strong similarity with human RbAp48 and RbAp46), Mis17, and Mis18 are all part of the CENP-A recruitment pathway. Mis15 and Mis17form an evolutionarily conserved complex that also includes Mis6. Mis16 and Mis18 form a complex and maintain the deacetylated state of histones specifically in the central core of centromeres. Mis16 and Mis18 are the most upstream factors in kinetochore assembly as they can associate with kinetochores in all kinetochore mutants except for mis18 and mis16, respectively. RNAi knockdown in human cells shows that Mis16 function is conserved as RbAp48 and RbAp46 are both required for localization of human CENP-A.	Kyoto Univ, Dept Gene Mechanisms, Grad Sch Biostudies, Sakyo Ku, Kyoto 6068502, Japan	Kyoto University	Yanagida, M (corresponding author), Kyoto Univ, Dept Gene Mechanisms, Grad Sch Biostudies, Sakyo Ku, Kyoto 6068502, Japan.	yanagida@kozo.lif.kyoto-u.ac.jp						ADACHI Y, 1989, J CELL BIOL, V108, P1195, DOI 10.1083/jcb.108.4.1195; Cheeseman LM, 2002, CELL, V111, P163, DOI 10.1016/S0092-8674(02)00973-X; Chen ES, 2003, MOL CELL, V11, P175, DOI 10.1016/S1097-2765(03)00011-X; CHIKASHIGE Y, 1989, CELL, V57, P739, DOI 10.1016/0092-8674(89)90789-7; De Wulf P, 2003, GENE DEV, V17, P2902, DOI 10.1101/gad.1144403; EARNSHAW WC, 1985, CHROMOSOMA, V92, P290, DOI 10.1007/BF00329812; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Euskirchen GM, 2002, EUKARYOT CELL, V1, P229, DOI 10.1128/EC.1.2.229-240.2002; Furuyama T, 2003, GENESIS, V35, P114, DOI 10.1002/gene.10173; Goshima G, 1999, GENE DEV, V13, P1664, DOI 10.1101/gad.13.13.1664; Goshima G, 2000, CELL, V100, P619, DOI 10.1016/S0092-8674(00)80699-6; Goshima G, 2003, J CELL BIOL, V160, P25, DOI 10.1083/jcb.200210005; Harborth J, 2001, J CELL SCI, V114, P4557; HEIM R, 1995, NATURE, V373, P663, DOI 10.1038/373663b0; Henikoff S, 2003, NATURE, V423, P814, DOI 10.1038/423814a; Henikoff S, 2000, P NATL ACAD SCI USA, V97, P716, DOI 10.1073/pnas.97.2.716; Hennig L, 2003, DEVELOPMENT, V130, P2555, DOI 10.1242/dev.00470; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; Jin QW, 2002, MOL CELL BIOL, V22, P7168, DOI 10.1128/MCB.22.20.7168-7183.2002; Krude T, 1999, EUR J BIOCHEM, V263, P1, DOI 10.1046/j.1432-1327.1999.00508.x; Martinez-Balbas MA, 1998, P NATL ACAD SCI USA, V95, P132, DOI 10.1073/pnas.95.1.132; MAUNDRELL K, 1990, J BIOL CHEM, V265, P10857; Measday V, 2002, GENE DEV, V16, P101, DOI 10.1101/gad.949302; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Nabeshima K, 1997, METHOD ENZYMOL, V283, P459; Nakayama J, 2003, EMBO J, V22, P2776, DOI 10.1093/emboj/cdg248; Nekrasov VS, 2003, MOL BIOL CELL, V14, P4931, DOI 10.1091/mbc.E03-06-0419; PALMER DK, 1987, J CELL BIOL, V104, P805, DOI 10.1083/jcb.104.4.805; Pidoux AL, 2003, J CELL BIOL, V161, P295, DOI 10.1083/jcb.200212110; Pinsky BA, 2003, DEV CELL, V5, P735, DOI 10.1016/S1534-5807(03)00322-8; Pot I, 2003, MOL BIOL CELL, V14, P460, DOI 10.1091/mbc.E02-08-0517; QIAN YW, 1993, NATURE, V364, P648, DOI 10.1038/364648a0; QIAN YW, 1995, J BIOL CHEM, V270, P25507, DOI 10.1074/jbc.270.43.25507; Saitoh S, 1997, CELL, V90, P131, DOI 10.1016/S0092-8674(00)80320-7; Scharfenberger M, 2003, EMBO J, V22, P6584, DOI 10.1093/emboj/cdg636; STOLER S, 1995, GENE DEV, V9, P573, DOI 10.1101/gad.9.5.573; Straight AF, 1996, CURR BIOL, V6, P1599, DOI 10.1016/S0960-9822(02)70783-5; TAKAHASHI K, 1994, MOL BIOL CELL, V5, P1145, DOI 10.1091/mbc.5.10.1145; TAKAHASHI K, 1992, MOL BIOL CELL, V3, P819, DOI 10.1091/mbc.3.7.819; Takahashi K, 2000, SCIENCE, V288, P2215, DOI 10.1126/science.288.5474.2215; Verreault A, 1996, CELL, V87, P95, DOI 10.1016/S0092-8674(00)81326-4; Westermann S, 2003, J CELL BIOL, V163, P215, DOI 10.1083/jcb.200305100	42	323	340	0	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 17	2004	118	6					715	729		10.1016/j.cell.2004.09.002	http://dx.doi.org/10.1016/j.cell.2004.09.002			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	855RW	15369671	Bronze			2022-12-28	WOS:000223992400008
J	Reynolds, EE				Reynolds, EE			A 62-year-old woman with chronic obstructive pulmonary disease, 2 years later	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																		Celli BR, 2003, JAMA-J AM MED ASSOC, V290, P2721, DOI 10.1001/jama.290.20.2721	1	0	0	1	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 15	2004	292	11					1358	1358		10.1001/jama.292.11.1358	http://dx.doi.org/10.1001/jama.292.11.1358			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	853YL	15367559				2022-12-28	WOS:000223866800029
J	Picano, E				Picano, E			Informed consent and communication of risk from radiological and nuclear medicine examinations: how to escape from a communication inferno	BMJ-BRITISH MEDICAL JOURNAL			English	Article									CNR, Inst Clin Physiol, I-56100 Pisa, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Fisiologia Clinica (IFC-CNR)	Picano, E (corresponding author), CNR, Inst Clin Physiol, Via Moruzzi 1, I-56100 Pisa, Italy.	picano@ifc.cnr.it	Picano, E/G-2261-2014					Berrington de Gonzalez A, 2004, LANCET, V363, P345, DOI 10.1016/S0140-6736(04)15433-0; CRICHTON M, 1975, NEW ENGL J MED, V293, P1257, DOI 10.1056/NEJM197512112932413; *EUR PARL, CHART FUND RIGHTS EU; European Commission, 2001, RAD PROT 118 REF GUI; Gofman John, 1990, RAD INDUCED CANC LOW; Hall EJ, 2002, PEDIATR RADIOL, V32, P700, DOI 10.1007/S00247-002-0774-8; *INT COMM RAD PROT, 2001, RAD YOUR PAT GUID ME; LAWTON J, 1983, J ROY SOC MED, V76, P289; Lewars M, 2004, BRIT MED J, V328, P1201, DOI 10.1136/bmj.328.7449.1201-a; Meara Jill, 2002, Journal of Radiological Protection, V22, P79, DOI 10.1088/0952-4746/22/1/308; Overbeek FJ, 1999, APPL RADIAT ISOTOPES, V50, P63, DOI 10.1016/S0969-8043(98)00032-3; Picano E, 2004, LANCET, V363, P1909, DOI 10.1016/S0140-6736(04)16373-3; Picano E, 2004, BMJ-BRIT MED J, V328, P578, DOI 10.1136/bmj.328.7439.578; *SFBMN, INF PUBL; Shiralkar S, 2003, BRIT MED J, V327, P371, DOI 10.1136/bmj.327.7411.371; Sox HC, 2002, ANN INTERN MED, V136, P243, DOI 10.7326/0003-4819-136-3-200202050-00012; *UN SCI COMM SOURC, 2001, REP EFF AT RAD GEN A; World Medical Association, DECL HELS; ZAMENHOF R, 1997, JPNM PHYS	19	117	121	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 9	2004	329	7470					849	851		10.1136/bmj.329.7470.849	http://dx.doi.org/10.1136/bmj.329.7470.849			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	862EK	15472270	Green Published			2022-12-28	WOS:000224472800026
J	Relph, K; Harrington, K; Pandha, H				Relph, K; Harrington, K; Pandha, H			Recent developments and current status of gene therapy using viral vectors in the United Kingdom	BRITISH MEDICAL JOURNAL			English	Review							FACTOR-IX		St George Hosp, Sch Med, Dept Oncol, London SW17 0RE, England; Inst Canc Res, London SW7 3RP, England	St Georges University London; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK	Pandha, H (corresponding author), St George Hosp, Sch Med, Dept Oncol, London SW17 0RE, England.	hpandha@sghms.ac.uk	Relph, Kate/AAK-3131-2021	Harrington, Kevin/0000-0002-6014-348X; Relph, Kate/0000-0003-3648-7394				Aiuti A, 2002, SCIENCE, V296, P2410, DOI 10.1126/science.1070104; BBC News, 2002, BBC NEWS        0403; BUSHMAN F, 2000, MOL THER, P6; Cavazzana-Calvo M, 2000, SCIENCE, V288, P669, DOI 10.1126/science.288.5466.669; Cavazzana-Calvo M, 2004, NATURE, V427, P779, DOI 10.1038/427779a; Hacein-Bey-Abina S, 2003, SCIENCE, V302, P415, DOI 10.1126/science.1088547; Kay MA, 2003, NATURE, V424, P251, DOI 10.1038/424251b; Kay MA, 2000, NAT GENET, V24, P257, DOI 10.1038/73464; LEHRMAN S, 1999, NATURE; Olivares EC, 2002, NAT BIOTECHNOL, V20, P1124, DOI 10.1038/nbt753; Ries S, 2002, BRIT J CANCER, V86, P5, DOI 10.1038/sj.bjc.6600006	11	20	26	1	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 9	2004	329	7470					839	842		10.1136/bmj.329.7470.839	http://dx.doi.org/10.1136/bmj.329.7470.839			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	862EK	15472267	Green Published			2022-12-28	WOS:000224472800023
J	Leman, L; Orgel, L; Ghadiri, MR				Leman, L; Orgel, L; Ghadiri, MR			Carbonyl sulfide-mediated prebiotic formation of peptides	SCIENCE			English	Article							AQUEOUS MEDIUM; AMINO-ACIDS; POLYPHOSPHATES; POLYMERIZATION; ROCKS	Almost all discussions of prebiotic chemistry assume that amino acids, nucleotides, and possibly other monomers were first formed on the Earth or brought to it in comets and meteorites, and then condensed nonenzymatically to form oligomeric products. However, attempts to demonstrate plausibly prebiotic polymerization reactions have met with limited success. We show that carbonyl sulfide (COS), a simple volcanic gas, brings about the formation of peptides from amino acids under mild conditions in aqueous solution. Depending on the reaction conditions and additives used, exposure of alpha-amino acids to COS generates peptides in yields of up to 80% in minutes to hours at room temperature.	Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA; Scripps Res Inst, Skaggs Inst Biol Chem, La Jolla, CA 92037 USA; Salk Inst Biol Studies, San Diego, CA 92186 USA	Scripps Research Institute; Scripps Research Institute; Salk Institute	Ghadiri, MR (corresponding author), Scripps Res Inst, Dept Chem, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	ghadiri@scripps.edu		Leman, Luke/0000-0002-1879-5900				Biron JP, 2004, J AM CHEM SOC, V126, P9198, DOI 10.1021/ja048189s; BUNINGH WC, 1970, Patent No. 3507613; DEWEY RS, 1971, J ORG CHEM, V36, P49; FERM RJ, 1957, CHEM REV, V57, P621, DOI 10.1021/cr50016a002; Heinen W, 1996, ORIGINS LIFE EVOL B, V26, P131, DOI 10.1007/BF01809852; HERRINGTON DR, 1986, Patent No. 4618723; Hill AR, 1998, ORIGINS LIFE EVOL B, V28, P235; HIRSCHMA.R, 1967, J ORG CHEM, V32, P3415, DOI 10.1021/jo01286a030; Huber C, 2003, SCIENCE, V301, P938, DOI 10.1126/science.1086501; Huber C, 1998, SCIENCE, V281, P670, DOI 10.1126/science.281.5377.670; Kasting James F., 1998, P35; Keefe AD, 1996, ORIGINS LIFE EVOL B, V26, P111, DOI 10.1007/BF01809851; Liu RH, 1997, NATURE, V389, P52, DOI 10.1038/37944; Orgel LE, 1998, ORIGINS LIFE EVOL B, V28, P227, DOI 10.1023/A:1006595411403; RABINOWI.J, 1969, NATURE, V224, P795, DOI 10.1038/224795a0; SYMONDS RB, 1994, REV MINERAL, V30, P1; *US EPA, PUBL EPA; YAMAGATA Y, 1991, NATURE, V352, P516, DOI 10.1038/352516a0	18	257	267	4	95	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 8	2004	306	5694					283	286		10.1126/science.1102722	http://dx.doi.org/10.1126/science.1102722			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Current Chemical Reactions (CCR-EXPANDED)	Science & Technology - Other Topics	861MC	15472077				2022-12-28	WOS:000224419700042
J	Roth, J				Roth, J			Spectre of Noah - "Tell me a story!"	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												jesserothmd@hotmail.com							0	1	1	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 6	2004	292	13					1530	1530		10.1001/jama.292.13.1530	http://dx.doi.org/10.1001/jama.292.13.1530			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	859HS	15467040				2022-12-28	WOS:000224254600001
J	Aadil, N; Houti, IE; Moussamih, S				Aadil, N; Houti, IE; Moussamih, S			Drug intake during ramadan	BMJ-BRITISH MEDICAL JOURNAL			English	Review							GRAPEFRUIT JUICE; BLOOD-PRESSURE; PHARMACOKINETICS; BIOAVAILABILITY; PROPRANOLOL; FORMULATION; THEOPHYLLINE; DIGOXIN; FIBER; DIET		Fac Med & Pharm, Lab Pharmacol & Toxicol, Casablanca 20000, Morocco	Mohammed First University of Oujda	Aadil, N (corresponding author), Fac Med & Pharm, Lab Pharmacol & Toxicol, 19 Rue Tarik Bnou Ziad, Casablanca 20000, Morocco.	aadil-nadia@yahoo.fr						Aadil N, 2000, METHOD FIND EXP CLIN, V22, P109, DOI 10.1358/mf.2000.22.2.796073; [Anonymous], 1997, 9 FIQH MED SEM ISL V; ASLAM M, 1992, J ROY SOC HEALTH, V112, P135, DOI 10.1177/146642409211200308; ASLAM M, 1986, PUBLIC HEALTH, V100, P49, DOI 10.1016/S0033-3506(86)80086-5; ASLAM M, 1986, J CLIN HOSP PHARM, V11, P321, DOI 10.1111/j.1365-2710.1986.tb00859.x; Bailey DG, 1998, BRIT J CLIN PHARMACO, V46, P101, DOI 10.1046/j.1365-2125.1998.00764.x; BEAM WR, 1992, AM REV RESPIR DIS, V146, P1524, DOI 10.1164/ajrccm/146.6.1524; BENVENGA S, 1995, THYROID, V5, P249, DOI 10.1089/thy.1995.5.249; DAGHFOUS J, 1994, ANN SAUDI MED, V14, P523, DOI 10.5144/0256-4947.1994.523; Dresser GK, 2002, CLIN PHARMACOL THER, V71, P11, DOI 10.1067/mcp.2002.121152; Erol K, 2001, CHRONOBIOL INT, V18, P841, DOI 10.1081/CBI-100107519; ETERNADYFAR M, 2001, C HLTH RAM OCT 2001, P32; *FACTS COMP, 1991, FACTS COMP DRUG INF, pA178; *FACTS COMP, 1991, FACTS COMP DRUG INF, pS132; Garg SK, 1998, CLIN PHARMACOL THER, V64, P286, DOI 10.1016/S0009-9236(98)90177-1; GAY J P, 1990, Journal of Interdisciplinary Cycle Research, V21, P190; GERTZ BJ, 1995, CLIN PHARMACOL THER, V58, P288, DOI 10.1016/0009-9236(95)90245-7; Glasser SP, 2003, AM J HYPERTENS, V16, P51, DOI 10.1016/S0895-7061(02)03153-9; Habbal R, 1998, ARCH MAL COEUR VAISS, V91, P995; Halsas M, 1999, INT J PHARM, V189, P179, DOI 10.1016/S0378-5173(99)00250-1; HAMAGUCHI T, 1993, INT J CLIN PHARM TH, V31, P326; HOLT GA, 1998, FOOD DRUG INTERACTIO, P93; Horiguchi Takahiko, 2004, Nihon Kokyuki Gakkai Zasshi, V42, P132; Iraki L, 1997, J CLIN ENDOCR METAB, V82, P1261, DOI 10.1210/jc.82.4.1261; JOHNSON BF, 1987, J CLIN PHARMACOL, V27, P487, DOI 10.1002/j.1552-4604.1987.tb03054.x; KHASAWNEH SM, 1992, AM J GASTROENTEROL, V87, P1180; LANGNER B, 1988, EUR J CLIN PHARMACOL, V33, P619, DOI 10.1007/BF00542498; LEMMER B, 1991, CHRONOBIOL INT, V8, P485, DOI 10.3109/07420529109059184; Liel Y, 1996, J CLIN ENDOCR METAB, V81, P857, DOI 10.1210/jc.81.2.857; Perk G, 2001, J HUM HYPERTENS, V15, P723, DOI 10.1038/sj.jhh.1001262; Pincus DJ, 1997, J ALLERGY CLIN IMMUN, V100, P771, DOI 10.1016/S0091-6749(97)70272-0; Porras AG, 1999, CLIN PHARMACOKINET, V36, P315, DOI 10.2165/00003088-199936050-00002; SAOUR JN, 1989, ANN SAUDI MED, V9, P538, DOI 10.5144/0256-4947.1989.538; SHIGA T, 1993, J CLIN PHARMACOL, V33, P756, DOI 10.1002/j.1552-4604.1993.tb05620.x; Sica Domenic, 2003, Heart Dis, V5, P176, DOI 10.1097/01.HDX.0000074436.09658.3b; Sista S, 2003, J CLIN PHARMACOL, V43, P1149, DOI 10.1177/0091270003257214; Smith David H. G., 2001, American Journal of Hypertension, V14, p296S, DOI 10.1016/S0895-7061(01)02176-8; SMOLENSKY MH, 1987, CHRONOBIOL INT, V4, P435, DOI 10.3109/07420528709083532; WALLE T, 1981, CLIN PHARMACOL THER, V30, P790, DOI 10.1038/clpt.1981.239; Wang P, 2003, BIOMED CHROMATOGR, V17, P58, DOI 10.1002/bmc.214; WHCATLY RS, 1993, BRIT MED J, V307, P801; Wilder BJ, 2001, NEUROLOGY, V57, P582, DOI 10.1212/WNL.57.4.582; WITTE K, 1993, CLIN PHARMACOL THER, V54, P177, DOI 10.1038/clpt.1993.129	44	62	64	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 2	2004	329	7469					778	782B		10.1136/bmj.329.7469.778	http://dx.doi.org/10.1136/bmj.329.7469.778			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	859TW	15459052	Green Published			2022-12-28	WOS:000224291800022
J	Rowland, D; Price, D; Pollock, AM				Rowland, D; Price, D; Pollock, AM			Implications of the draft European Union services directive for health care	LANCET			English	Editorial Material									UCL, Sch Publ Policy, Publ Hlth Policy Unit, London WC1H 9QU, England	University of London; University College London	Pollock, AM (corresponding author), UCL, Sch Publ Policy, Publ Hlth Policy Unit, London WC1H 9QU, England.	allyson.pollock@ucl.ac.uk		pollock, allyson/0000-0002-7388-3110				*EUR COMM, 2002, REP COMM COUNC EUR P; *EUR SERV FOR, 2004, GLOB IND GROUPS LIB; European Commission, 2004, PROP DIR EUR PARL CO; Pollock AM, 2000, LANCET, V356, P1995, DOI 10.1016/S0140-6736(00)03317-1	4	4	4	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	OCT 2	2004	364	9441					1200	1202		10.1016/S0140-6736(04)17158-4	http://dx.doi.org/10.1016/S0140-6736(04)17158-4			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	859HO	15464168				2022-12-28	WOS:000224254200008
J	Van Valkenburgh, B; Wang, XM; Damuth, J				Van Valkenburgh, B; Wang, XM; Damuth, J			Cope's rule, hypercarnivory, and extinction in North American canids	SCIENCE			English	Article							POPULATION-DENSITY; BODY-MASS; EVOLUTION; SIZE	Over the past 50 million years, successive clades of large carnivorous mammals diversified and then declined to extinction. In most instances, the cause of the decline remains a puzzle. Here we argue that energetic constraints and pervasive selection for larger size (Cope's rule) in carnivores lead to dietary specialization (hypercarnivory) and increased vulnerability to extinction. In two major clades of extinct North American canids, the evolution of large size was associated with a dietary shift to hypercarnivory and a decline in species durations. Thus, selection for attributes that promoted individual success resulted in progressive evolutionary failure of their clades.	Univ Calif Los Angeles, Dept Ecol & Evolutionary Biol, Los Angeles, CA 90095 USA; Natl Hist Museum Los Angeles Cty, Dept Vertebrate Paleontol, Los Angeles, CA 90007 USA; Univ Calif Santa Barbara, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA 93106 USA	University of California System; University of California Los Angeles; University of California System; University of California Santa Barbara	Van Valkenburgh, B (corresponding author), Univ Calif Los Angeles, Dept Ecol & Evolutionary Biol, Los Angeles, CA 90095 USA.	bvanval@ucla.edu	Self, Casey J/B-6871-2011; Wang, Xiaoming/I-9033-2019	Damuth, John/0000-0002-1635-9726; Wang, Xiaoming/0000-0003-1610-3840				Alroy J, 1998, SCIENCE, V280, P731, DOI 10.1126/science.280.5364.731; Barry JC, 2002, PALEOBIOLOGY, V28, P1, DOI 10.1666/0094-8373(2002)28[1:FAECIT]2.0.CO;2; Baskin J.A., 1998, EVOLUTION TERTIARY M, V1, P144; BEHRENSMEYER AK, 1979, PALEOBIOLOGY, V5, P12, DOI 10.1017/S0094837300006254; Carbone C, 1999, NATURE, V402, P286, DOI 10.1038/46266; DAMUTH J, 1993, NATURE, V365, P748, DOI 10.1038/365748a0; DAMUTH J, 1982, PALEOBIOLOGY, V8, P434, DOI 10.1017/S009483730000717X; DAMUTH J, 1981, NATURE, V290, P699, DOI 10.1038/290699a0; DAMUTH J, 1987, BIOL J LINN SOC, V31, P193, DOI 10.1111/j.1095-8312.1987.tb01990.x; Jablonski D, 1997, NATURE, V385, P250, DOI 10.1038/385250a0; Jacobs L.L., 1998, EVOLUTION TERTIARY M; McKinney M.L., 1990, P75; Palomares F, 1999, AM NAT, V153, P492, DOI 10.1086/303189; Purvis A, 2000, P ROY SOC B-BIOL SCI, V267, P1947, DOI 10.1098/rspb.2000.1234; SKINNER MF, 1984, B AM MUS NAT HIST, V178, P217; Stanley S. M., 1979, MACROEVOLUTION PATTE; STANLEY SM, 1973, EVOLUTION, V27, P1, DOI 10.1111/j.1558-5646.1973.tb05912.x; TEDFORD RH, 1978, NUTR MANAGEMENT DOGS, pM23; Van Valkenburgh B, 1999, ANNU REV EARTH PL SC, V27, P463, DOI 10.1146/annurev.earth.27.1.463; van Valkenburgh B., 1990, P181; Van Valkenburgh B, 2003, B AM MUS NAT HIST, P147, DOI 10.1206/0003-0090(2003)279<0147:C>2.0.CO;2; Van Valkenburgh Blaire, 2001, P101; VANVALKENBURGH B, 1993, SYM ZOOL S, P15; VANVALKENBURGH B, 1991, PALEOBIOLOGY, V17, P340, DOI 10.1017/S0094837300010691; VANVALKENBURGH B, 2002, FOSSIL RECORD PREDA, V8, P267; VOORHIES MR, 1990, 8209 U NEBR; Wang XM, 1999, B AM MUS NAT HIST, P1; WANG XM, 1994, B AM MUS NAT HIST, P1	28	185	186	1	58	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 1	2004	306	5693					101	104		10.1126/science.1102417	http://dx.doi.org/10.1126/science.1102417			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	859YJ	15459388				2022-12-28	WOS:000224304000045
J	Humbert, M; Sitbon, O; Simonneau, G				Humbert, M; Sitbon, O; Simonneau, G			Drug therapy: Treatment of pulmonary arterial hypertension	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							LONG-TERM TREATMENT; CONTINUOUS INTRAVENOUS EPOPROSTENOL; RECEPTOR ANTAGONIST BOSENTAN; CALCIUM-CHANNEL BLOCKERS; INHALED NITRIC-OXIDE; ORAL SILDENAFIL; PROSTACYCLIN ANALOG; DOUBLE-BLIND; GERMLINE MUTATIONS; PROGNOSTIC-FACTORS		Univ Paris 11, Assistance Publ Hop Paris, Hop Antoine Beclere,Ctr Malad Vasc Pulm, Serv Pneumol & Reanimat Resp,Unite Propre Rech En, Clamart, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Antoine-Beclere - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Saclay	Humbert, M (corresponding author), Hop Antoine Beclere, Serv Pneumol, 157 Rue Porte Trivaux, F-92140 Clamart, France.	marc.humbert@abc.aphp.fr	Simonneau, Gerald/ABE-6614-2020; Sitbon, Olivier/I-3623-2019	Sitbon, Olivier/0000-0002-1942-1951; Humbert, Marc/0000-0003-0703-2892				Aguilar RV, 2000, AM J RESP CRIT CARE, V162, P1846, DOI 10.1164/ajrccm.162.5.2004042; Aldashev AA, 2002, AM J RESP CRIT CARE, V166, P1396, DOI 10.1164/rccm.200204-345OC; Badesch DB, 2000, ANN INTERN MED, V132, P425, DOI 10.7326/0003-4819-132-6-200003210-00002; Barst RJ, 2004, AM J RESP CRIT CARE, V169, P441, DOI 10.1164/rccm.200307-957OC; Barst RJ, 2002, CHEST, V121, P1860, DOI 10.1378/chest.121.6.1860; Barst RJ, 1996, NEW ENGL J MED, V334, P296, DOI 10.1056/NEJM199602013340504; Barst RJ, 2003, J AM COLL CARDIOL, V41, P2119, DOI 10.1016/S0735-1097(03)00463-7; Benigni A, 1999, LANCET, V353, P133, DOI 10.1016/S0140-6736(98)09423-9; Bhatia S, 2003, MAYO CLIN PROC, V78, P1207, DOI 10.4065/78.10.1207; BJORNSSON J, 1985, MAYO CLIN PROC, V60, P16, DOI 10.1016/S0025-6196(12)65277-X; Castelain V, 2002, AM J RESP CRIT CARE, V165, P338, DOI 10.1164/ajrccm.165.3.2106033; Channick RN, 2001, LANCET, V358, P1119, DOI 10.1016/S0140-6736(01)06250-X; CHRISTMAN BW, 1992, NEW ENGL J MED, V327, P70, DOI 10.1056/NEJM199207093270202; Clapp LH, 2002, AM J RESP CELL MOL, V26, P194, DOI 10.1165/ajrcmb.26.2.4695; Cowan KN, 2000, NAT MED, V6, P698, DOI 10.1038/76282; DALONZO GE, 1991, ANN INTERN MED, V115, P343, DOI 10.7326/0003-4819-115-5-343; Deng ZM, 2000, AM J HUM GENET, V67, P737, DOI 10.1086/303059; DICARLO VS, 1995, AM J PHYSIOL-LUNG C, V269, pL690, DOI 10.1152/ajplung.1995.269.5.L690; Dorfmuller P, 2003, EUR RESPIR J, V22, P358, DOI 10.1183/09031936.03.00038903; Du Lingling, 2003, New England Journal of Medicine, V348, P500, DOI 10.1056/NEJMoa021650; Eddahibi S, 2001, J CLIN INVEST, V108, P1141, DOI 10.1172/JCI12805; Fagan KA, 2001, RESP RES, V2, P90, DOI 10.1186/rr44; FUSTER V, 1984, CIRCULATION, V70, P580, DOI 10.1161/01.CIR.70.4.580; Galie N, 2002, J AM COLL CARDIOL, V39, P1496, DOI 10.1016/S0735-1097(02)01786-2; Galie N, 2003, J AM COLL CARDIOL, V41, P1380, DOI 10.1016/S0735-1097(03)00121-9; Galie N, 2002, EUR RESPIR J, V20, P1037, DOI 10.1183/09031936.02.05542002; Geraci MW, 1999, J CLIN INVEST, V103, P1509, DOI 10.1172/JCI5911; Gessler T, 2001, EUR RESPIR J, V17, P14, DOI 10.1183/09031936.01.17100140; Ghofrani HA, 2002, ANN INTERN MED, V136, P515, DOI 10.7326/0003-4819-136-7-200204020-00008; Ghofrani HA, 2002, LANCET, V360, P895, DOI 10.1016/S0140-6736(02)11024-5; Ghofrani HA, 2003, J AM COLL CARDIOL, V42, P158, DOI 10.1016/S0735-1097(03)00555-2; GIAID A, 1993, NEW ENGL J MED, V328, P1732, DOI 10.1056/NEJM199306173282402; GIAID A, 1995, NEW ENGL J MED, V333, P214, DOI 10.1056/NEJM199507273330403; Gibbs JSR, 2001, HEART, V86, pI1; Hasuda T, 2000, CIRCULATION, V101, P2066, DOI 10.1161/01.CIR.101.17.2066; HIGENBOTTAM T, 1984, LANCET, V1, P1046; HIRATA Y, 1989, ATHEROSCLEROSIS, V78, P225, DOI 10.1016/0021-9150(89)90227-X; Hoeper MM, 2000, NEW ENGL J MED, V342, P1866, DOI 10.1056/NEJM200006223422503; Hoeper MM, 2003, EUR RESPIR J, V22, P330, DOI 10.1183/09031936.03.00008003; HUBER K, 1994, AM J RESP CRIT CARE, V150, P929, DOI 10.1164/ajrccm.150.4.7921465; Humbert M, 2004, EUR RESPIR J, V24, P353, DOI 10.1183/09031936.04.00028404; Humbert M, 2001, CLIN CHEST MED, V22, P459, DOI 10.1016/S0272-5231(05)70284-7; Humbert M, 2004, J AM COLL CARDIOL, V43, p13S, DOI 10.1016/j.jacc.2004.02.029; Humbert M, 1999, EUR RESPIR J, V13, P1351, DOI 10.1034/j.1399-3003.1999.13f20.x; Humbert M, 2003, EUR RESPIR J, V22, P193, DOI 10.1183/09031936.03.00054103; Humbert M, 2004, AM J RESP CRIT CARE, V169, P6, DOI 10.1164/rccm.2310007; Humbert M, 1998, AM J RESP CRIT CARE, V157, P1681, DOI 10.1164/ajrccm.157.5.9708065; Kuhn KP, 2003, AM J RESP CRIT CARE, V167, P580, DOI 10.1164/rccm.200204-333OC; Kuo PC, 1997, TRANSPLANTATION, V63, P604, DOI 10.1097/00007890-199702270-00020; Lane KB, 2000, NAT GENET, V26, P81, DOI 10.1038/79226; Marcos E, 2003, AM J RESP CRIT CARE, V168, P487, DOI 10.1164/rccm.200210-1212OC; MCGOON MD, 1997, PRIMARY PULMONARY HY, P305; McLaughlin VV, 2002, CIRCULATION, V106, P1477, DOI 10.1161/01.CIR.0000029100.82385.58; Mehta S, 2003, CHEST, V123, P989, DOI 10.1378/chest.123.4.989; Michelakis ED, 2003, CIRCULATION, V108, P2066, DOI 10.1161/01.CIR.0000099502.17776.C2; Miyamoto S, 2000, AM J RESP CRIT CARE, V161, P487, DOI 10.1164/ajrccm.161.2.9906015; MONCADA S, 1976, NATURE, V263, P663, DOI 10.1038/263663a0; Nagaya N, 2001, AM J RESP CRIT CARE, V163, P887, DOI 10.1164/ajrccm.163.4.2007116; Nunes H, 2003, AM J RESP CRIT CARE, V167, P1433, DOI 10.1164/rccm.200204-330OC; Okano Y, 1997, LANCET, V350, P1406; Okano Y, 1997, LANCET, V349, P1365, DOI 10.1016/S0140-6736(97)24019-5; Olschewski H, 2002, NEW ENGL J MED, V347, P322, DOI 10.1056/NEJMoa020204; Palmer SM, 1998, CHEST, V113, P237, DOI 10.1378/chest.113.1.237; Pearson DL, 2001, NEW ENGL J MED, V344, P1832, DOI 10.1056/NEJM200106143442404; PEPKEZABA J, 1991, LANCET, V338, P1173, DOI 10.1016/0140-6736(91)92033-X; Petkov V, 2003, J CLIN INVEST, V111, P1339, DOI 10.1172/JCI200317500; Pielsticker EJ, 2001, J HEART LUNG TRANSPL, V20, P1297, DOI 10.1016/S1053-2498(01)00348-5; Prasad S, 2000, NEW ENGL J MED, V343, P1342, DOI 10.1056/NEJM200011023431814; Rich S, 1998, CHEST, V114, P787, DOI 10.1378/chest.114.3.787; RICH S, 1992, NEW ENGL J MED, V327, P76, DOI 10.1056/NEJM199207093270203; Robbins IM, 1998, CHEST, V114, P1269, DOI 10.1378/chest.114.5.1269; Rosenzweig EB, 1999, CIRCULATION, V99, P1858, DOI 10.1161/01.CIR.99.14.1858; Rubin LJ, 2002, AM J RESP CRIT CARE, V166, P1308, DOI 10.1164/rccm.2208008; Rubin LJ, 2002, NEW ENGL J MED, V346, P896, DOI 10.1056/NEJMoa012212; RUBIN LJ, 1990, ANN INTERN MED, V112, P485, DOI 10.7326/0003-4819-112-7-485; Rubin LJ, 1997, NEW ENGL J MED, V336, P111, DOI 10.1056/NEJM199701093360207; RUBIN LJ, 1997, PRIMARY PULMONARY HY, P271; Runo JR, 2003, LANCET, V361, P1533, DOI 10.1016/S0140-6736(03)13167-4; Sandoval J, 1998, J AM COLL CARDIOL, V32, P297, DOI 10.1016/S0735-1097(98)00238-1; Sastry BKS, 2004, J AM COLL CARDIOL, V43, P1149, DOI 10.1016/j.jacc.2003.10.056; Sayin T, 2002, CAN J CARDIOL, V18, P676; Schumacher YO, 2001, AIDS, V15, P1747, DOI 10.1097/00002030-200109070-00026; Simonneau G, 2004, J AM COLL CARDIOL, V43, p5S, DOI 10.1016/j.jacc.2004.02.037; Simonneau G, 2002, AM J RESP CRIT CARE, V165, P800, DOI 10.1164/ajrccm.165.6.2106079; Sitbon O, 1998, EUR RESPIR J, V12, P265, DOI 10.1183/09031936.98.12020265; Sitbon O, 2002, PROG CARDIOVASC DIS, V45, P115, DOI 10.1053/pcad.2002.128449; Sitbon O, 2002, J AM COLL CARDIOL, V40, P780, DOI 10.1016/S0735-1097(02)02012-0; Sitbon O, 2003, CHEST, V124, P247, DOI 10.1378/chest.124.1.247; Stiebellehner L, 2003, CHEST, V123, P1293, DOI 10.1378/chest.123.4.1293; Thomson JR, 2000, J MED GENET, V37, P741, DOI 10.1136/jmg.37.10.741; Tuder RM, 1999, AM J RESP CRIT CARE, V159, P1925, DOI 10.1164/ajrccm.159.6.9804054; Tuder RM, 2001, J PATHOL, V195, P367, DOI 10.1002/path.953; Vachiery JL, 2002, CHEST, V121, P1561, DOI 10.1378/chest.121.5.1561; VOELKEL NF, 1997, PRIMARY PULMONARY HY, P83; Wilkens H, 2001, CIRCULATION, V104, P1218, DOI 10.1161/hc3601.096826; YANAGISAWA M, 1988, NATURE, V332, P411, DOI 10.1038/332411a0; Yuan XJ, 1998, LANCET, V351, P726, DOI 10.1016/S0140-6736(05)78495-6	97	1274	1337	0	108	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 30	2004	351	14					1425	1436		10.1056/NEJMra040291	http://dx.doi.org/10.1056/NEJMra040291			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	857XT	15459304				2022-12-28	WOS:000224153900011
J	Tatem, AJ; Guerra, CA; Atkinson, PM; Hay, SI				Tatem, AJ; Guerra, CA; Atkinson, PM; Hay, SI			Momentous sprint at the 2156 Olympics?	NATURE			English	Article									Univ Oxford, Dept Zool, TALA Res Grp, Oxford OX1 3PS, England; Univ Southampton, Sch Geog, Southampton SO17 1BJ, Hants, England; KEMRI Wellcome Trust Res Labs, Publ Hlth Grp, Nairobi, Kenya	University of Oxford; University of Southampton	Tatem, AJ (corresponding author), Univ Oxford, Dept Zool, TALA Res Grp, S Parks Rd, Oxford OX1 3PS, England.	andy.tatem@zoology.oxford.ac.uk	Hay, Simon Iain/F-8967-2015; Atkinson, Peter M/L-9508-2013	Hay, Simon Iain/0000-0002-0611-7272; Atkinson, Peter/0000-0002-5489-6880	Wellcome Trust [069045] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		GILKS WR, 1994, STATISTICIAN, V43, P169, DOI 10.2307/2348941; Holden C, 2004, SCIENCE, V305, P639, DOI 10.1126/science.305.5684.639; RENDELL M, 2003, OLYMPICS ATHENS ATHE, P338; Vogel G, 2004, SCIENCE, V305, P632, DOI 10.1126/science.305.5684.632; WHIPP BJ, 1992, NATURE, V355, P25, DOI 10.1038/355025a0	5	53	54	1	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 30	2004	431	7008					525	525		10.1038/431525a	http://dx.doi.org/10.1038/431525a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	857YP	15457248	Bronze, Green Accepted			2022-12-28	WOS:000224156700033
J	Tice, MM; Lowe, DR				Tice, MM; Lowe, DR			Photosynthetic microbial mats in the 3,416-Myr-old ocean	NATURE			English	Article							BARBERTON GREENSTONE-BELT; SOUTH-AFRICA; SWAZILAND SUPERGROUP; CHERTS; SEDIMENTOLOGY; GEOCHEMISTRY; MICROFOSSILS; AUSTRALIA	Recent re-evaluations of the geological record of the earliest life on Earth have led to the suggestion that some of the oldest putative microfossils(1) and carbonaceous matter were formed through abiotic hydrothermal processes(2,3). Similarly, many early Archaean ( more than 3,400-Myr-old) cherts have been reinterpreted as hydrothermal deposits rather than products of normal marine sedimentary processes(2,4,5). Here we present the results of a field, petrographic and geochemical study testing these hypotheses for the 3,416-Myr-old Buck Reef Chert, South Africa. From sedimentary structures and distributions of sand and mud, we infer that deposition occurred in normal open shallow to deep marine environments. The siderite enrichment that we observe in deep-water sediments is consistent with a stratified early ocean(6,7). We show that most carbonaceous matter was formed by photosynthetic mats within the euphotic zone and distributed as detrital matter by waves and currents to surrounding environments. We find no evidence that hydrothermal processes had any direct role in the deposition of either the carbonaceous matter or the enclosing sediments. Instead, we conclude that photosynthetic organisms had evolved and were living in a stratified ocean supersaturated in dissolved silica(8,9) 3,416 Myr ago.	Stanford Univ, Dept Geog & Environm Sci, Stanford, CA 94305 USA	Stanford University	Tice, MM (corresponding author), Stanford Univ, Dept Geog & Environm Sci, Stanford, CA 94305 USA.	mtice@pangea.stanford.edu						BOGGS S., 1995, PRINCIPLES SEDIMENTO; Brasier MD, 2002, NATURE, V416, P76, DOI 10.1038/416076a; DEWIT MJ, 1982, ECON GEOL, V77, P1783, DOI 10.2113/gsecongeo.77.8.1783; Garcia-Ruiz JM, 2003, SCIENCE, V302, P1194, DOI 10.1126/science.1090163; Horita J, 1999, SCIENCE, V285, P1055, DOI 10.1126/science.285.5430.1055; KLEIN C, 1989, ECON GEOL, V84, P1733, DOI 10.2113/gsecongeo.84.7.1733; Knauth LP, 2003, GEOL SOC AM BULL, V115, P566, DOI 10.1130/0016-7606(2003)115<0566:HACTIF>2.0.CO;2; LALLI CM, 1997, BIOL OCEANOGRAPHY IN; LILJESTRAND FL, 1999, GEOL S AM S, P83, DOI 10.1130/0-8137-2329-9.83; Lowe DR, 2003, GEOLOGY, V31, P909, DOI 10.1130/G19664.1; LOWE DR, 1994, NOBEL S, V84, P24; Madigan MT, 1997, BROCK BIOL MICROORGA; PARIS I, 1985, J GEOL, V93, P111, DOI 10.1086/628935; Schidlowski M, 2000, MICROBIAL SEDIMENTS, P84; SCHOPF JW, 1987, SCIENCE, V237, P70, DOI 10.1126/science.11539686; SIEVER R, 1992, GEOCHIM COSMOCHIM AC, V56, P3265, DOI 10.1016/0016-7037(92)90303-Z; SIMONSON BM, 1993, PRECAMBRIAN RES, V60, P287, DOI 10.1016/0301-9268(93)90052-4; Sumner DY, 1997, PALAIOS, V12, P302, DOI 10.2307/3515333; Tice MM, 2004, GEOLOGY, V32, P37, DOI 10.1130/G19915.1; Walsh M.M., 1999, GEOL S AM S, P329; Westall F, 2001, PRECAMBRIAN RES, V106, P93, DOI 10.1016/S0301-9268(00)00127-3	21	322	348	2	83	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 30	2004	431	7008					549	552		10.1038/nature02888	http://dx.doi.org/10.1038/nature02888			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	857YP	15457255				2022-12-28	WOS:000224156700041
J	Mudge, DW; Johnson, DW				Mudge, DW; Johnson, DW			Coca-Cola and kangaroos	LANCET			English	Editorial Material							CONSUMPTION		Princess Alexandra Hosp, Dept Nephrol, Brisbane, Qld 4102, Australia		Mudge, DW (corresponding author), Princess Alexandra Hosp, Dept Nephrol, Brisbane, Qld 4102, Australia.	dmudge@mail.rah.sa.gov.au	Mudge, David W./C-1438-2011; Johnson, David/F-2897-2011	Mudge, David W./0000-0002-4112-5550; Johnson, David/0000-0001-5491-3460				Appel CC, 2001, OBSTET GYNECOL, V97, P805, DOI 10.1016/S0029-7844(00)01210-2; Mandel HG, 2002, FOOD CHEM TOXICOL, V40, P1231, DOI 10.1016/S0278-6915(02)00093-5; Rice JE, 2001, INTERN MED J, V31, P317, DOI 10.1046/j.1445-5994.2001.00063.x; YOUR HLTH OUR BEVERA	4	17	18	0	3	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 25	2004	364	9440					1190	1190		10.1016/S0140-6736(04)17111-0	http://dx.doi.org/10.1016/S0140-6736(04)17111-0			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	857FT	15451232				2022-12-28	WOS:000224102400038
J	Cockell, CS; Stokes, MD				Cockell, CS; Stokes, MD			Ecology - Widespread colonization by polar hypoliths	NATURE			English	Editorial Material									British Antarctic Survey, NERC, Cambridge CB3 0ET, England; Scripps Inst Oceanog, Marine Phys Lab, La Jolla, CA 92037 USA	UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey; University of California System; University of California San Diego; Scripps Institution of Oceanography	Cockell, CS (corresponding author), British Antarctic Survey, NERC, High Cross, Cambridge CB3 0ET, England.	csco@bas.ac.uk						BLISS LC, 1984, HOLARCTIC ECOL, V7, P305; BROADY PA, 1981, BRIT PHYCOL J, V16, P231, DOI 10.1080/00071618100650241; Cockell CS, 2003, POLAR BIOL, V26, P62, DOI 10.1007/s00300-002-0438-z; Cockell CS, 2002, METEORIT PLANET SCI, V37, P1287, DOI 10.1111/j.1945-5100.2002.tb01029.x; GOLUBIC S, 1981, J SEDIMENT PETROL, V51, P475; Kessler MA, 2003, SCIENCE, V299, P380, DOI 10.1126/science.1077309; Schlesinger WH, 2003, ECOLOGY, V84, P3222, DOI 10.1890/02-0549; Smith MC, 2000, ANTARCT SCI, V12, P177, DOI 10.1017/S0954102000000237	8	78	84	1	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 23	2004	431	7007					414	414		10.1038/431414a	http://dx.doi.org/10.1038/431414a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855UN	15386002	Bronze			2022-12-28	WOS:000224000500030
J	Beliveau, R; Gingras, D				Beliveau, R; Gingras, D			Green tea: prevention and treatment of cancer by nutraceuticals	LANCET			English	Editorial Material									Hop Ste Justine UQAM, Ctr Canc Charles Bruneau, Mol Med Lab, Montreal, PQ H3T 1C, Canada	University of Quebec; University of Quebec Montreal	Beliveau, R (corresponding author), Hop Ste Justine UQAM, Ctr Canc Charles Bruneau, Mol Med Lab, Montreal, PQ H3T 1C, Canada.	beliveau.richard@uqam.ca						Bergers G, 2003, J CLIN INVEST, V111, P1287, DOI 10.1172/JCI200317929; Cao YH, 1999, NATURE, V398, P381, DOI 10.1038/18793; de Botton S, 2004, J CLIN ONCOL, V22, P1404, DOI 10.1200/JCO.2004.09.008; Demeule Michel, 2002, Current Medicinal Chemistry - Anti-Cancer Agents, V2, P441, DOI 10.2174/1568011023353930; Folkman J, 2003, CURR MOL MED, V3, P643, DOI 10.2174/1566524033479465; GAO YT, 1994, JNCI-J NATL CANCER I, V86, P855, DOI 10.1093/jnci/86.11.855; Gescher AJ, 2001, LANCET ONCOL, V2, P371, DOI 10.1016/S1470-2045(00)00392-2; Lamy S, 2002, CANCER RES, V62, P381; Lee YK, 2004, BLOOD, V104, P788, DOI 10.1182/blood-2003-08-2763; Pisters KMW, 2001, J CLIN ONCOL, V19, P1830, DOI 10.1200/JCO.2001.19.6.1830	10	33	35	3	11	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 18	2004	364	9439					1021	1022		10.1016/S0140-6736(04)17076-1	http://dx.doi.org/10.1016/S0140-6736(04)17076-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	855FT	15380952				2022-12-28	WOS:000223959300008
J	Marmot, M				Marmot, M			Dignity and inequality	LANCET			English	Editorial Material							HEALTH		UCL, Dept Epidemiol & Publ Hlth, Int Ctr Hlth & Soc, London WC1E 6BT, England	University of London; University College London	Marmot, M (corresponding author), UCL, Dept Epidemiol & Publ Hlth, Int Ctr Hlth & Soc, Mortimer St, London WC1E 6BT, England.	m.marmot@ucl.ac.uk	Marmot, M G/Y-3920-2019	Marmot, M G/0000-0002-2431-6419	Medical Research Council [G19/35, G8802774, G0100222] Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Doyal L., 1991, THEORY HUMAN NEED, DOI DOI 10.1007/978-1-349-21500-3; Huxley A., 2004, BRAVE NEW WORLD; Klein R, 2000, HEALTH ECON, V9, P569, DOI 10.1002/1099-1050(200010)9:7<569::AID-HEC556>3.3.CO;2-A; Kuper Hannah, 2002, Semin Vasc Med, V2, P267, DOI 10.1055/s-2002-35401; LAYARD R, 2003, HAPPINESS SOCIAL SCI; Marmot M, 2002, HEALTH AFFAIR, V21, P31, DOI 10.1377/hlthaff.21.2.31; Marmot M, 2004, STATUS SYNDROME; Marmot MG, 1997, LANCET, V350, P235, DOI 10.1016/S0140-6736(97)04244-X; Sacks Jonathan., 2002, DIGNITY DIFFERENCE; Sen A, 1992, INEQUALITY RE EXAMIN	11	24	24	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	SEP 18	2004	364	9439					1019	1021		10.1016/S0140-6736(04)17075-X	http://dx.doi.org/10.1016/S0140-6736(04)17075-X			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	855FT	15380951				2022-12-28	WOS:000223959300007
J	Baldwin, SL; Monteleone, BD; Webb, LE; Fitzgerald, PG; Grove, M; Hill, EJ				Baldwin, SL; Monteleone, BD; Webb, LE; Fitzgerald, PG; Grove, M; Hill, EJ			Pliocene eclogite exhumation at plate tectonic rates in eastern Papua New Guinea	NATURE			English	Article							METAMORPHIC CORE COMPLEXES; DENTRECASTEAUX ISLANDS; ROCKS; GARNET; CONSTRAINTS; EVOLUTION; EXTENSION; INVERSION; BEARING; SYSTEM	As lithospheric plates are subducted, rocks are metamorphosed under high-pressure and ultrahigh-pressure conditions to produce eclogites and eclogite facies metamorphic rocks. Because chemical equilibrium is rarely fully achieved, eclogites may preserve in their distinctive mineral assemblages and textures a record of the pressures, temperatures and deformation the rock was subjected to during subduction and subsequent exhumation. Radioactive parent-daughter isotopic variations within minerals reveal the timing of these events. Here we present in situ zircon U/Pb ion microprobe data that dates the timing of eclogite facies metamorphism in eastern Papua New Guinea at 4.3 +/- 0.4 Myr ago, making this the youngest documented eclogite exposed at the Earth's surface. Eclogite exhumation from depths of similar to75 km was extremely rapid and occurred at plate tectonic rates (cm yr(-1)). The eclogite was exhumed within a portion of the obliquely convergent Australian-Pacific plate boundary zone, in an extending region located west of the Woodlark basin sea floor spreading centre. Such rapid exhumation (>1 cm yr(-1)) of high-pressure and, we infer, ultrahigh-pressure rocks is facilitated by extension within transient plate boundary zones associated with rapid oblique plate convergence.	Syracuse Univ, Dept Earth Sci, Syracuse, NY 13244 USA; Univ Calif Los Angeles, Dept Earth & Space Sci, Los Angeles, CA 90095 USA; Commonwealth Sci & Ind Res Org, Petr Resources, Kensington, WA 6151, Australia	Syracuse University; University of California System; University of California Los Angeles; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Baldwin, SL (corresponding author), Syracuse Univ, Dept Earth Sci, Syracuse, NY 13244 USA.	sbaldwin@syr.edu	Hill, Evelyn J/C-3679-2008; Webb, Laura E/F-8226-2011	Hill, Evelyn J/0000-0003-2784-0686; Webb, Laura E/0000-0002-0597-5793				Abers GA, 2001, GEOL SOC SPEC PUBL, V187, P305, DOI 10.1144/GSL.SP.2001.187.01.15; Abers GA, 2002, NATURE, V418, P862, DOI 10.1038/nature00990; ABERS GA, 1991, J GEOPHYS RES-SOLID, V96, P6379, DOI 10.1029/91JB00145; BALDWIN SL, 1993, TECTONICS, V12, P611, DOI 10.1029/93TC00235; BALDWIN SL, 2003, GEOL SOC AM ABSTR, V35, P556; BENES V, 1994, J GEOPHYS RES-SOL EA, V99, P4439, DOI 10.1029/93JB02878; Cherniak DJ, 2000, CONTRIB MINERAL PETR, V139, P198, DOI 10.1007/PL00007671; COOPER P, 1987, TECTONICS, V6, P53, DOI 10.1029/TC006i001p00053; Davies H. L., 1980, C INT CNRS, V272, P17; DAVIES HL, 1988, TECTONICS, V7, P1, DOI 10.1029/TC007i001p00001; DAVIES HL, 1971, GEOL SOC AM BULL, V82, P3299, DOI 10.1130/0016-7606(1971)82[3299:GOEP]2.0.CO;2; DAVIES HL, 1992, CONTRIB MINERAL PETR, V112, P463, DOI 10.1007/BF00310778; DAVIES HL, 1965, AUST BUR MINER RESOU, V82, P1; ELLIS DJ, 1979, CONTRIB MINERAL PETR, V71, P13, DOI 10.1007/BF00371878; Ernst WG, 2001, PHYS EARTH PLANET IN, V127, P253, DOI 10.1016/S0031-9201(01)00231-X; GASPARIK T, 1980, REV MINERAL, V7, P309; Hacker BR, 2003, LITHOS, V70, P61, DOI 10.1016/S0024-4937(03)00092-6; HALL R, 2003, MANTLE STRUCTURE TEC, P361; HILL EJ, 1993, J METAMORPH GEOL, V11, P261, DOI 10.1111/j.1525-1314.1993.tb00146.x; HILL EJ, 1992, GEOLOGY, V20, P907, DOI 10.1130/0091-7613(1992)020<0907:UOAMCC>2.3.CO;2; HILL EJ, 1994, J STRUCT GEOL, V16, P1093, DOI 10.1016/0191-8141(94)90054-X; Hill K.C, 2003, MESOZOIC CENOZOIC EV; HOLLAND TJB, 1980, AM MINERAL, V65, P129; Hoskin PWO, 2003, REV MINERAL GEOCHEM, V53, P27, DOI 10.2113/0530027; LITTLE TA, IN PRESS GEOL SOC AM; Martinez F, 2001, NATURE, V411, P930, DOI 10.1038/35082042; Maruyama S., 1996, INT GEOL REV, V38, P485, DOI DOI 10.1080/00206819709465347; MCDONOUGH WF, 1995, CHEM GEOL, V120, P223, DOI 10.1016/0009-2541(94)00140-4; PEGLER G, 1995, GEOPHYS J INT, V122, P961, DOI 10.1111/j.1365-246X.1995.tb06849.x; PLATT JP, 1993, TERRA NOVA, V5, P119, DOI 10.1111/j.1365-3121.1993.tb00237.x; POWELL R, 1985, J METAMORPH GEOL, V3, P231, DOI 10.1111/j.1525-1314.1985.tb00319.x; Rubatto D, 2001, GEOLOGY, V29, P3, DOI 10.1130/0091-7613(2001)029<0003:EAFAS>2.0.CO;2; Rubatto D, 2003, GEOCHIM COSMOCHIM AC, V67, P2173, DOI 10.1016/S0016-7037(02)01321-2; Rubatto D, 2002, CHEM GEOL, V184, P123, DOI 10.1016/S0009-2541(01)00355-2; Schmitt AK, 2003, GEOCHIM COSMOCHIM AC, V67, P3423, DOI 10.1016/S0016-7037(03)00140-6; Stein S., 2002, GEODYNAMICS, V30, P1, DOI 10.1029/GD030p0001; TAYLOR B, 1995, NATURE, V374, P534, DOI 10.1038/374534a0; Taylor B, 1999, J GEOPHYS RES-SOL EA, V104, P7497, DOI 10.1029/1998JB900115; Taylor B, 1999, P ODP INIT REPTS, V180, P1; Tregoning P, 1998, J GEOPHYS RES-SOL EA, V103, P12181, DOI 10.1029/97JB03676; Weiler PD, 2000, TECTONOPHYSICS, V316, P297, DOI 10.1016/S0040-1951(99)00259-0; WORTHING MA, 1988, AUST J EARTH SCI, V35, P159, DOI 10.1080/14400958808527937; ZHANG RY, 2000, GEOL SOC AM INT BOOK, V4, P216	43	199	209	0	39	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 16	2004	431	7006					263	267		10.1038/nature02846	http://dx.doi.org/10.1038/nature02846			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	853XJ	15372021				2022-12-28	WOS:000223864000029
J	Readhead, ACS; Myers, ST; Pearson, TJ; Sievers, JL; Mason, BS; Contaldi, CR; Bond, JR; Bustos, R; Altamirano, P; Achermann, C; Bronfrnan, L; Carlstrom, JE; Cartwright, JK; Casassus, S; Dickinson, C; Holzapfel, WL; Kovac, JM; Leitch, EM; May, J; Padin, S; Pogosyan, D; Pospieszalski, M; Pryke, C; Reeves, R; Shepherd, MC; Torres, S				Readhead, ACS; Myers, ST; Pearson, TJ; Sievers, JL; Mason, BS; Contaldi, CR; Bond, JR; Bustos, R; Altamirano, P; Achermann, C; Bronfrnan, L; Carlstrom, JE; Cartwright, JK; Casassus, S; Dickinson, C; Holzapfel, WL; Kovac, JM; Leitch, EM; May, J; Padin, S; Pogosyan, D; Pospieszalski, M; Pryke, C; Reeves, R; Shepherd, MC; Torres, S			Polarization observations with the cosmic background imager	SCIENCE			English	Article							PROBE WMAP OBSERVATIONS; ANGULAR POWER SPECTRUM; MOSAIC OBSERVATIONS; ANISOTROPY; RADIATION; TEMPERATURE; FLUCTUATIONS; STATISTICS; L=3500; LIMIT	Polarization observations of the cosmic microwave background with the Cosmic Background Imager from September 2002 to May 2004 provide a significant detection of the E-mode polarization and reveal an angular power spectrum of polarized emission showing peaks and valleys that are shifted in phase by half a cycle relative to those of the total intensity spectrum. This key agreement between the phase of the observed polarization spectrum and that predicted on the basis of the total intensity spectrum provides support for the standard model of cosmology, in which dark matter and dark energy are the dominant constituents, the geometry is close to flat, and primordial density fluctuations are predominantly adiabatic with a matter power spectrum commensurate with inflationary cosmological models.	CALTECH, Owens Valley Radio Observ, Pasadena, CA 91125 USA; Natl Radio Astron Observ, Socorro, NM 87801 USA; Univ Toronto, Canadian Inst Theoret Astrophys, Toronto, ON M5S 3H8, Canada; NRAO, Green Bank, WV 24944 USA; Univ Concepcion, Dept Ingn Elect, Concepcion, Chile; Univ Chile, Dept Astron, Santiago, Chile; Univ Chicago, Dept Astron & Astrophys, Kavli Inst Cosmol Phys, Chicago, IL 60637 USA; Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA; Univ Alberta, Dept Phys, Edmonton, AB T6G 2J1, Canada; Natl Radio Astron Observ, Charlottesville, VA 22903 USA	California Institute of Technology; National Radio Astronomy Observatory (NRAO); University of Toronto; National Radio Astronomy Observatory (NRAO); Universidad de Concepcion; Universidad de Chile; University of Chicago; University of California System; University of California Berkeley; University of Alberta; National Radio Astronomy Observatory (NRAO)	Readhead, ACS (corresponding author), CALTECH, Owens Valley Radio Observ, Pasadena, CA 91125 USA.	acr@astro.caltech.edu	Reeves, Rodrigo/AAC-9905-2020; Bronfman, Leonardo/H-9544-2013; Holzapfel, William L/I-4836-2015; Pearson, Timothy J/N-2376-2015; Casassus, Simon/I-8609-2016; Pospieszalski, Marian/FJR-7419-2022; Bustos, Ricardo A/H-3286-2014; Reeves, Rodrigo/H-2812-2014	Reeves, Rodrigo/0000-0001-5704-271X; Bronfman, Leonardo/0000-0002-9574-8454; Pearson, Timothy J/0000-0001-5213-6231; Bustos, Ricardo A/0000-0001-8468-9391; Reeves, Rodrigo/0000-0001-5704-271X; Sievers, Jonathan/0000-0001-6903-5074; casassus, simon/0000-0002-0433-9840; Dickinson, Clive/0000-0002-0045-442X; Mason, Brian/0000-0002-8472-836X; Contaldi, Carlo/0000-0001-7285-0707				BARKATS D, UNPUB; BENNETT CL, 1994, ASTROPHYS J, V436, P423, DOI 10.1086/174918; Bennett CL, 2003, ASTROPHYS J SUPPL S, V148, P97, DOI 10.1086/377252; Bennett CL, 2003, ASTROPHYS J SUPPL S, V148, P1, DOI 10.1086/377253; Benoit A, 2003, ASTRON ASTROPHYS, V399, pL19, DOI 10.1051/0004-6361:20021850; Bond JR, 2004, INT J THEOR PHYS, V43, P599, DOI 10.1023/B:IJTP.0000048167.24074.ef; Bond JR, 2003, PHILOS T R SOC A, V361, P2435, DOI [10.1098/rsta.2003.1289, 10.1098/rsta.2003.1295]; Bond JR, 1998, PHYS REV D, V57, P2117, DOI 10.1103/PhysRevD.57.2117; BOND JR, 1987, MON NOT R ASTRON SOC, V226, P655, DOI 10.1093/mnras/226.3.655; BOND JR, 1984, ASTROPHYS J, V285, pL45, DOI 10.1086/184362; BOND JR, UNPUB, P23507; Chandrasekhar S., 1950, Q J R METEOROLOG SOC; Church SE, 1997, ASTROPHYS J, V484, P523, DOI 10.1086/304362; Condon JJ, 1998, ASTRON J, V115, P1693, DOI 10.1086/300337; Cotton WD, 1999, ASTR SOC P, V180, P111; de Bernardis P, 2000, NATURE, V404, P955, DOI 10.1038/35010035; Dickinson C, 2004, MON NOT R ASTRON SOC, V353, P732, DOI 10.1111/j.1365-2966.2004.08206.x; Doroshkevich A. G., 1978, Soviet Astronomy, V22, P523; Halverson NW, 2002, ASTROPHYS J, V568, P38, DOI 10.1086/338879; Hanany S, 2000, ASTROPHYS J, V545, pL5, DOI 10.1086/317322; Hinshaw G, 2003, ASTROPHYS J SUPPL S, V148, P135, DOI 10.1086/377225; Hu W, 1997, NEW ASTRON, V2, P323, DOI 10.1016/S1384-1076(97)00022-5; Hu W, 2002, ANNU REV ASTRON ASTR, V40, P171, DOI 10.1146/annurev.astro.40.060401.093926; KAISER N, 1983, MON NOT R ASTRON SOC, V202, P1169, DOI 10.1093/mnras/202.4.1169; Kamionkowski M, 1997, PHYS REV D, V55, P7368, DOI 10.1103/PhysRevD.55.7368; Kogut A, 2003, ASTROPHYS J SUPPL S, V148, P161, DOI 10.1086/377219; Kovac JM, 2002, NATURE, V420, P772, DOI 10.1038/nature01269; Kuo CL, 2004, ASTROPHYS J, V600, P32, DOI 10.1086/379783; Leitch EM, 2000, ASTROPHYS J, V532, P37, DOI 10.1086/308529; Leitch EM, 2002, NATURE, V420, P763, DOI 10.1038/nature01271; LEITCH EM, UNPUB; Mason BS, 2003, ASTROPHYS J, V591, P540, DOI 10.1086/375507; Miller AD, 1999, ASTROPHYS J, V524, pL1, DOI 10.1086/312293; Myers S. L., UNPUB; Myers ST, 2003, ASTROPHYS J, V591, P575, DOI 10.1086/375509; Netterfield CB, 1997, ASTROPHYS J, V474, P47, DOI 10.1086/303438; Padin S, 2002, PUBL ASTRON SOC PAC, V114, P83, DOI 10.1086/324786; Padin S, 2001, ASTROPHYS J, V549, pL1, DOI 10.1086/319142; Park CG, 2003, ASTROPHYS J, V589, P67, DOI 10.1086/374638; Pearson TJ, 2003, ASTROPHYS J, V591, P556, DOI 10.1086/375508; PEEBLES PJE, 1970, ASTROPHYS J, V162, P815, DOI 10.1086/150713; Readhead ACS, 2004, ASTROPHYS J, V609, P498, DOI 10.1086/421105; READHEAD ACS, 1992, ANNU REV ASTRON ASTR, V30, P653, DOI 10.1146/annurev.astro.30.1.653; READHEAD ACS, 1989, ASTROPHYS J, V346, P566, DOI 10.1086/168039; REES MJ, 1968, ASTROPHYS J, V153, pL1, DOI 10.1086/180208; Riess AG, 2004, ASTROPHYS J, V607, P665, DOI 10.1086/383612; Seljak U, 1997, ASTROPHYS J, V482, P6, DOI 10.1086/304123; Sievers JL, 2003, ASTROPHYS J, V591, P599, DOI 10.1086/375510; Spergel DN, 2003, ASTROPHYS J SUPPL S, V148, P175, DOI 10.1086/377226; STOKES G G, 1851, CAMBRIDGE PHILOS SOC, V9, P399; SUNYAEV RA, 1970, ASTROPHYS SPACE SCI, V7, P3; Tegmark M, 2004, PHYS REV D, V69, DOI 10.1103/PhysRevD.69.103501; Verde L, 2003, ASTROPHYS J SUPPL S, V148, P195, DOI 10.1086/377335; VITTORIO N, 1984, ASTROPHYS J, V285, pL39, DOI 10.1086/184361; White M, 1999, ASTROPHYS J, V514, P12, DOI 10.1086/306911; WILSON ML, 1981, ASTROPHYS J, V243, P14, DOI 10.1086/158561; Zaldarriaga M, 1997, PHYS REV D, V55, P1830, DOI 10.1103/PhysRevD.55.1830	58	176	176	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 29	2004	306	5697					836	844		10.1126/science.1105598	http://dx.doi.org/10.1126/science.1105598			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	869FS	15472038	Green Submitted, Green Accepted			2022-12-28	WOS:000224969400037
J	Pocock, SJ; Collier, TJ; Dandreo, KJ; de Stavola, BL; Goldman, MB; Kalish, LA; Kasten, LE; McCormack, VA				Pocock, SJ; Collier, TJ; Dandreo, KJ; de Stavola, BL; Goldman, MB; Kalish, LA; Kasten, LE; McCormack, VA			Issues in the reporting of epidemiological studies: a survey of recent practice	BMJ-BRITISH MEDICAL JOURNAL			English	Article							METHODOLOGICAL QUALITY; CLINICAL RESEARCH; COLON-CANCER; RISK; ASSOCIATIONS; EXPOSURES; TIME	Objectives To review current practice in the analysis and reporting of epidemiological research and to identify limitations. Design Examination of articles published in January 2001 that investigated associations between risk factors/exposure variables and disease events/measures in individuals. Setting Eligible English language journals including all major epidemiological journals, all major general medical journals, and the two leading journals in cardiovascular disease and cancer. Main outcome measure Each article was evaluated with a standard proforma. Results We found 73 articles in observational epidemiology; most were either cohort or case-control studies. Most studies looked at cancer and cardiovascular disease, even after we excluded specialty journals. Quantitative exposure variables predominated, which were mostly analysed as ordered categories but with little consistency or explanation regarding choice of categories. Sample selection, participant refusal, and data quality received insufficient attention in many articles. Statistical analyses commonly used odds ratios (38 articles) and hazard/rate ratios (23), with some inconsistent use of terminology. Confidence intervals were reported in most studies (68), though use of P values was less common (38). Few articles explained their choice of confounding variables; many performed subgroup analyses claiming an effect modifier, though interaction tests were rare. Several investigated multiple associations between exposure and outcome, increasing the likelihood of false positive claims. There was evidence of publication bias. Conclusions This survey raises concerns regarding inadequacies in the analysis and reporting of epidemiological publications in mainstream journals.	Univ London London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, London WC1E 7HT, England; New England Res Inst, Watertown, MA 02472 USA; Harvard Univ, Sch Med, Dept Obstet & Gynaecol, Boston, MA 02215 USA; Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; Childrens Hosp, Clin Res Program, Boston, MA 02115 USA; Prometrika LLC, Cambridge, MA 02138 USA	University of London; London School of Hygiene & Tropical Medicine; HealthCore, Inc; Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Boston Children's Hospital	Pocock, SJ (corresponding author), Univ London London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, Keppel St, London WC1E 7HT, England.	stuart.pocock@lshtm.ac.uk		De Stavola, Bianca Lucia/0000-0001-7853-0528; McCormack, Valerie/0000-0001-7397-3442				ALTMAN DG, 1994, J NATL CANCER I, V86, P1798; ALUNAN DG, 2001, ANN INTERN MED, V134, P663; [Anonymous], J CITATION REPORTS; Assmann SF, 2000, LANCET, V355, P1064, DOI 10.1016/S0140-6736(00)02039-0; Blettner M, 2001, EUR J PUBLIC HEALTH, V11, P97, DOI 10.1093/eurpub/11.1.97; Breslow NE, 1980, STAT METHODS CANC RE, V2; Colhoun HM, 2003, LANCET, V361, P865, DOI 10.1016/S0140-6736(03)12715-8; Concato J, 2000, NEW ENGL J MED, V342, P1887, DOI 10.1056/NEJM200006223422507; DAGOSTINO RB, 1990, STAT MED, V9, P1501, DOI 10.1002/sim.4780091214; Deeks J J, 2003, Health Technol Assess, V7, piii; Downs SH, 1998, J EPIDEMIOL COMMUN H, V52, P377, DOI 10.1136/jech.52.6.377; *EP WORK GROUP INT, 1981, AM J EPIDEMIOL, V114, P609; Figueiras A, 2001, AM J EPIDEMIOL, V154, P264, DOI 10.1093/aje/154.3.264; Goodman SN, 2001, EPIDEMIOLOGY, V12, P295, DOI 10.1097/00001648-200105000-00006; GREENLAND S, 1998, MODERN EPIDEMIOLOGY, P301; GREENLAND S, 1998, AM J PUBLIC HEALTH, P253; Grimes DA, 2002, LANCET, V359, P248, DOI 10.1016/S0140-6736(02)07451-2; Grimes DA, 2002, LANCET, V359, P57, DOI 10.1016/S0140-6736(02)07283-5; Grimes DA, 2002, LANCET, V359, P145, DOI 10.1016/S0140-6736(02)07373-7; Grimes DA, 2002, LANCET, V359, P341, DOI 10.1016/S0140-6736(02)07500-1; Hennekens C.H., 1987, EPIDEMIOLOGY MED; HIGGINSON J, 1987, J CHRON DIS, V40, P371, DOI 10.1016/0021-9681(87)90170-6; Hills, 1993, STAT MODELS EPIDEMIO; HORWITZ RI, 1979, AM J MED, V66, P556, DOI 10.1016/0002-9343(79)91164-1; Kaijser M, 2001, J NATL CANCER I, V93, P60, DOI 10.1093/jnci/93.1.60; Kataria, 2016, SAUDI J SPORTS MED, V16, P139; Kuller LH, 1999, AM J EPIDEMIOL, V150, P897; Lang JM, 1998, EPIDEMIOLOGY, V9, P7, DOI 10.1097/00001648-199805000-00019; LANGHOLZ B, 2000, ENCY EPIDEMIOLOGIC M, P139; Lee KP, 2002, JAMA-J AM MED ASSOC, V287, P2805, DOI 10.1001/jama.287.21.2805; Moher D, 2001, LANCET, V357, P1191, DOI 10.1016/S0140-6736(00)04337-3; Olson SH, 2002, EPIDEMIOLOGY, V13, P123, DOI 10.1097/00001648-200203000-00004; Ottenbacher KJ, 1998, AM J EPIDEMIOL, V147, P615; PHILLIPS AN, 1989, J CLIN EPIDEMIOL, V42, P639, DOI 10.1016/0895-4356(89)90007-3; Rothman K., 1998, MODERN EPIDEMIOLOGY, P253; Rothman KJ., 2008, MODERN EPIDEMIOLOGY; Rushton L, 2000, OCCUP ENVIRON MED, V57, P1, DOI 10.1136/oem.57.1.1; SCHELSSELMAN JJ, 1932, CASE CONTROL STUDIES; Schlesselman JJ, 1982, CASE CONTROL STUDIES, P144; Schulz KF, 2002, LANCET, V359, P431, DOI 10.1016/S0140-6736(02)07605-5; SILVA LD, 1999, CANC EPIDEMIOLOGY PR; Smith GD, 2002, BMJ-BRIT MED J, V325, P1437; Sterne JAC, 2001, BMJ-BRIT MED J, V322, P226, DOI 10.1136/bmj.322.7280.226; Su LJ, 2001, ANN EPIDEMIOL, V11, P65, DOI 10.1016/S1047-2797(00)00188-5; Wacholder S, 1991, Epidemiology, V2, P155, DOI 10.1097/00001648-199103000-00013; Weinberg CR, 2001, EPIDEMIOLOGY, V12, P288, DOI 10.1097/00001648-200105000-00004; YUSUF S, 1991, JAMA-J AM MED ASSOC, V266, P93, DOI 10.1001/jama.266.1.93; Zeegers MPA, 2001, AM J EPIDEMIOL, V153, P38, DOI 10.1093/aje/153.1.38; Zhang YQ, 2001, AM J EPIDEMIOL, V153, P31, DOI 10.1093/aje/153.1.31; ZHAO LP, 1992, AM J EPIDEMIOL, V136, P464, DOI 10.1093/oxfordjournals.aje.a116520	51	202	207	0	18	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 16	2004	329	7471					883	887		10.1136/bmj.38250.571088.55	http://dx.doi.org/10.1136/bmj.38250.571088.55			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	863MU	15469946	Bronze, Green Published, Green Accepted, Green Submitted			2022-12-28	WOS:000224566800015
J	Ahluwalia, S; Lawn, SD; Kanagalingam, J; Grant, H; Lockwood, DNJ				Ahluwalia, S; Lawn, SD; Kanagalingam, J; Grant, H; Lockwood, DNJ			Lesson of the week; Mucocutaneous leishmaniasis: an imported infection among travellers to central and South America	BMJ-BRITISH MEDICAL JOURNAL			English	Article							DIAGNOSIS		Royal Natl Throat Nose & Ear Hosp, London WC1X 8DA, England; Hosp Trop Dis, London NW1 0PE, England	University College London Hospitals NHS Foundation Trust; University of London; University College London; University College London Hospitals NHS Foundation Trust; University of London; London School of Hygiene & Tropical Medicine	Lawn, SD (corresponding author), Univ London London Sch Hyg & Trop Med, Clin Res Unit, Dept Infect & Trop Dis, Keppel St, London WC1E 7HT, England.	stevelawn@yahoo.co.uk						Costa JW, 2003, ORAL SURG ORAL MED O, V96, P573, DOI 10.1016/S1079-2104(03)00299-3; DAVID C, 1993, T ROY SOC TROP MED H, V87, P7, DOI 10.1016/0035-9203(93)90398-A; DEBRUIJN MHL, 1992, ACTA TROP, V52, P45, DOI 10.1016/0001-706X(92)90006-J; DEDET JP, 2003, MANSONS TROPICAL DIS, P1339; Galioto Pietro, 2002, Ear Nose Throat J, V81, P46; Herwaldt BL, 1999, LANCET, V354, P1191, DOI 10.1016/S0140-6736(98)10178-2; Lohuis PJFM, 1997, J LARYNGOL OTOL, V111, P973, DOI 10.1017/S0022215100139106; Pirmez C, 1999, J CLIN MICROBIOL, V37, P1819, DOI 10.1128/JCM.37.6.1819-1823.1999; Rosbotham JL, 1996, CLIN EXP DERMATOL, V21, P288, DOI 10.1111/j.1365-2230.1996.tb00097.x; Scope A, 2003, CLIN INFECT DIS, V37, pE83, DOI 10.1086/377045; SINGER C, 1975, AM J MED, V59, P444, DOI 10.1016/0002-9343(75)90405-2	11	37	38	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 9	2004	329	7470					842	844		10.1136/bmj.329.7470.842	http://dx.doi.org/10.1136/bmj.329.7470.842			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	862EK	15472268	Green Accepted, Green Published			2022-12-28	WOS:000224472800024
J	Keeling, L; Anderson, L; Schutz, KE; Kerje, S; Fredriksson, R; Carlborg, O; Cornwallis, CK; Pizzari, T; Jensen, P				Keeling, L; Anderson, L; Schutz, KE; Kerje, S; Fredriksson, R; Carlborg, O; Cornwallis, CK; Pizzari, T; Jensen, P			Chicken genomics: Feather-pecking and victim pigmentation	NATURE			English	Editorial Material							QUANTITATIVE TRAIT LOCI; LAYING HENS; BEHAVIOR		Swedish Univ Agr Sci, Dept Anim Environm & Hlth, S-53223 Skara, Sweden; Uppsala Univ, Dept Med Biochem & Microbiol, S-75124 Uppsala, Sweden; Swedish Univ Agr Sci, Dept Anim Breeding & Genet, S-75124 Uppsala, Sweden; AgRes Anim Behav & Welf, Hamilton, New Zealand; Linkoping Univ, IFM, Dept Biol, S-58183 Linkoping, Sweden; Roslin Inst, Roslin EH25 9PS, Midlothian, Scotland; Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England; Univ Leeds, Sch Biol, Evolut & Ecol Grp, Leeds LS2 9JT, W Yorkshire, England	Swedish University of Agricultural Sciences; Uppsala University; Swedish University of Agricultural Sciences; AgResearch - New Zealand; Linkoping University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Sheffield; University of Leeds	Keeling, L (corresponding author), Swedish Univ Agr Sci, Dept Anim Environm & Hlth, POB 234, S-53223 Skara, Sweden.	per.jensen@ifm.liu.se	Cornwallis, Charlie/A-6276-2012; Keeling, Linda J/K-6542-2012; Fredriksson, Robert/AAH-3921-2019	Keeling, Linda J/0000-0003-2629-0117; Fredriksson, Robert/0000-0002-2810-3226; Schutz, Karin/0000-0002-2893-3465; Carlborg, Orjan/0000-0002-2722-5264				Blokhuis HJ, 1998, VET QUART, V20, P6, DOI 10.1080/01652176.1998.9694825; Buitenhuis AJ, 2003, POULTRY SCI, V82, P1661, DOI 10.1093/ps/82.11.1661; Buitenhuis AJ, 2003, POULTRY SCI, V82, P1215, DOI 10.1093/ps/82.8.1215; JENSEN P, 2003, ISAE 2003 M JUN 24 2, P68; Johnstone RA, 2004, P ROY SOC B-BIOL SCI, V271, P1917, DOI 10.1098/rspb.2003.2581; KERJE S, IN PRESS GENETICS; Kjaer JB, 1997, BRIT POULTRY SCI, V38, P333, DOI 10.1080/00071669708417999; McAdie TM, 2002, APPL ANIM BEHAV SCI, V75, P147, DOI 10.1016/S0168-1591(01)00182-4; Savory CJ, 1999, BRIT POULTRY SCI, V40, P565, DOI 10.1080/00071669986918; Smyth J.R., 1996, POULTRY BREEDING GEN, P109	10	84	88	1	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 7	2004	431	7009					645	646		10.1038/431645a	http://dx.doi.org/10.1038/431645a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	859WS	15470416				2022-12-28	WOS:000224299300028
J	Caporali, R; Cimmino, MA; Ferraccioli, G; Gerli, R; Klersy, C; Salvarani, C; Montecucco, C				Caporali, R; Cimmino, MA; Ferraccioli, G; Gerli, R; Klersy, C; Salvarani, C; Montecucco, C		Systematic Vasculitis Study Grp	Prednisone plus methotrexate for polymyalgia rheumatica - A randomized, double-blind, placebo-controlled trial	ANNALS OF INTERNAL MEDICINE			English	Article							GIANT-CELL ARTERITIS; 1ST 2 MONTHS; THERAPY; MULTICENTER; ARTHRITIS; REGIMENS	Background: Steroids are the standard treatment for polymyalgia rheumatica. The efficacy of the candidate drug methotrexate has not yet been demonstrated in controlled studies. Objective: To compare the efficacy and safety of prednisone plus methotrexate and prednisone alone in patients with polymyalgia rheumatica. Design: Multicenter randomized, double-blind, placebo-controlled trial. Setting: 5 Italian rheumatology clinics. Patients: 72 patients with newly diagnosed polymyalgia rheumatica. Measurements: The proportion of patients no longer taking prednisone, the number of flare-ups, and the cumulative prednisone dose after 76 weeks. Intervention: Prednisone dosage (25 mg/d) was tapered to 0 mg/d within 24 weeks and was adjusted if flare-ups occurred. Oral methotrexate (10 mg) or placebo, with folinic acid supplementation (7.5 mg), was given weekly for 48 weeks. Results: Twenty-eight of 32 patients in the methotrexate group and 16 of 30 patients in the placebo group were no longer taking prednisone at 76 weeks (P = 0.003). The risk difference was 34 percentage points (95% Cl, 11 to 53 percentage points). Similar results were obtained after adjustment for C-reactive protein level and duration of symptoms in a multivariate model. Fifteen of 32 patients in the methotrexate group and 22 of 30 patients in the placebo group had at least 1 flare-up by the end of follow-up (P = 0.04). The median prednisone dose was 2.1 g In the methotrexate group and 2.97 g in the placebo group (P = 0.03). The rate and severity of adverse events were similar. Limitations: Follow-up was short, and a high dose of folinic acid and a relatively high starting dosage of prednisone were used. Ten of 72 patients (14%) discontinued treatment or were lost to follow-up. Conclusions: Prednisone plus methotrexate is associated with shorter prednisone treatment and steroid sparing. It may be useful in patients at high risk for steroid-related toxicity.	Univ Pavia, I-27100 Pavia, Italy; Univ Genoa, Genoa, Italy; Univ Udine, I-33100 Udine, Italy; Univ Perugia, I-06100 Perugia, Italy; Arcispedale Santa Maria Nuova, Reggio Emilia, Italy	University of Pavia; University of Genoa; University of Udine; University of Perugia; IRCCS Arcispedale S. Maria Nuova	Caporali, R (corresponding author), Policlin San Matteo, Div Reumatol, Piazzale Golgi 2, I-27100 Pavia, Italy.	caporali@smatteo.pv.it	klersy, catherine/AAA-3003-2019; Salvarani, Carlo/K-2431-2018; caporali, roberto/AAB-1873-2019; Montecucco, Carlomaurizio/K-5236-2018	klersy, catherine/0000-0003-0314-8548; caporali, roberto/0000-0001-9300-6169; Montecucco, Carlomaurizio/0000-0001-8263-3925; Ferraccioli, Gianfranco/0000-0002-6884-4301; Salvarani, Carlo/0000-0001-5426-5133				AYOUB WT, 1985, AM J MED, V79, P309, DOI 10.1016/0002-9343(85)90309-2; Caporali R, 2001, ANN RHEUM DIS, V60, P1021, DOI 10.1136/ard.60.11.1021; CHUANG TY, 1982, ANN INTERN MED, V97, P672, DOI 10.7326/0003-4819-97-5-672; CIMMINO MA, 1994, ANN RHEUM DIS, V53, P331, DOI 10.1136/ard.53.5.331; Feinberg HL, 1996, J RHEUMATOL, V23, P1550; Ferraccioli G, 1996, J RHEUMATOL, V23, P624; Ferraccioli GF, 2000, CLIN EXP RHEUMATOL, V18, pS58; Gabriel SE, 1997, ARTHRITIS RHEUM, V40, P1873, DOI 10.1002/art.1780401022; Gran JT, 1999, SCAND J RHEUMATOL, V28, P269, DOI 10.1080/03009749950155445; Hoffman GS, 2002, ARTHRITIS RHEUM, V46, P1309, DOI 10.1002/art.10262; HUNDER GG, 1975, ANN INTERN MED, V82, P613, DOI 10.7326/0003-4819-82-5-613; Jover JA, 2001, ANN INTERN MED, V134, P106, DOI 10.7326/0003-4819-134-2-200101160-00010; KRALL PL, 1989, CLEV CLIN J MED, V56, P253, DOI 10.3949/ccjm.56.3.253; KYLE V, 1989, ANN RHEUM DIS, V48, P658, DOI 10.1136/ard.48.8.658; KYLE V, 1993, ANN RHEUM DIS, V52, P847, DOI 10.1136/ard.52.12.847; Langford CA, 1997, RHEUM DIS CLIN N AM, V23, P841, DOI 10.1016/S0889-857X(05)70363-X; Newcombe RG, 1998, STAT MED, V17, P873, DOI 10.1002/(SICI)1097-0258(19980430)17:8<873::AID-SIM779>3.0.CO;2-I; Salvarani C, 1998, ARTHRITIS RHEUM, V41, P1221, DOI 10.1002/1529-0131(199807)41:7<1221::AID-ART12>3.0.CO;2-W; Salvarani C, 2002, NEW ENGL J MED, V347, P261, DOI 10.1056/NEJMra011913; Salvarani C, 1999, ANN RHEUM DIS, V58, P303, DOI 10.1136/ard.58.5.303; Spiera RF, 2001, CLIN EXP RHEUMATOL, V19, P495; van Ede AE, 2001, ARTHRITIS RHEUM-US, V44, P1515, DOI 10.1002/1529-0131(200107)44:7&lt;1515::AID-ART273&gt;3.0.CO;2-7; vanderVeen MJ, 1996, ANN RHEUM DIS, V55, P218, DOI 10.1136/ard.55.4.218; Wagener P, 1995, Z RHEUMATOL, V54, P413	24	152	159	1	12	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 5	2004	141	7					493	500		10.7326/0003-4819-141-7-200410050-00005	http://dx.doi.org/10.7326/0003-4819-141-7-200410050-00005			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	862CR	15466766				2022-12-28	WOS:000224467800001
J	Newman, RD; Parise, ME; Barber, AM; Steketee, RW				Newman, RD; Parise, ME; Barber, AM; Steketee, RW			Malaria-related deaths among US travelers, 1963-2001	ANNALS OF INTERNAL MEDICINE			English	Review							PLASMODIUM-FALCIPARUM MALARIA; IMPORTED MALARIA; UNITED-STATES; AMERICAN TRAVELERS; AFRICA; PREVENTION; PROPHYLAXIS; DIAGNOSIS; MORTALITY; TRENDS	Nearly 1500 malaria cases occur each year in the United States; approximately 60% are among U.S. travelers. Despite the availability of sophisticated medical care, malaria-related deaths continue to occur. The authors reviewed all 185 fatal cases between 1963 and 2001 that were reported to the National Malaria Surveillance System: 123 (66.5%) occurred among U.S. travelers, and of these, 114 (92.7%) were attributed to Plasmodium falciparum. Failure to take or adhere to recommended chemoprophylaxis, to promptly seek medical care for post-travel illness, and to promptly diagnose and treat suspected malaria all contributed to fatal outcomes. Health care providers need to take a travel history, obtain a blood film for suspected malaria, and use the 24-hour malaria management advice available through the Centers for Disease Control and Prevention (CDC) Malaria Hotline (770-488-7788) or the CDC Malaria Web site (www.cdc.gov/Malaria). Hospitals must maintain intravenous quinidine gluconate on formulary because it is the only drug available to treat severe malaria in the United States.	Ctr Dis Control & Prevent, Malaria Branch, Atlanta, GA 30341 USA	Centers for Disease Control & Prevention - USA	Newman, RD (corresponding author), Ctr Dis Control & Prevent, Malaria Branch, 4770 Buford Highway NE,Mailstop F-22, Atlanta, GA 30341 USA.	ren5@cdc.gov						ADERA T, 1995, AM J TROP MED HYG, V52, P207, DOI 10.4269/ajtmh.1995.52.207; Behrens R H, 1998, J Travel Med, V5, P92, DOI 10.1111/j.1708-8305.1998.tb00471.x; Bloland, 1995, J Travel Med, V2, P16, DOI 10.1111/j.1708-8305.1995.tb00614.x; Breman JG, 2001, AM J TROP MED HYG, V64, P1; Causer Louise M., 2002, Morbidity and Mortality Weekly Report, V51, P9; *CDCP, 2003, HLTH INF INT TRAV 20; Dan, 1996, J Travel Med, V3, P182, DOI 10.1111/j.1708-8305.1996.tb00738.x; Dorsey G, 2000, ARCH INTERN MED, V160, P2505, DOI 10.1001/archinte.160.16.2505; FRAME JD, 1992, AM J TROP MED HYG, V46, P686, DOI 10.4269/ajtmh.1992.46.686; GREENBERG AE, 1990, ANN INTERN MED, V113, P326, DOI 10.7326/0003-4819-113-4-326; Humar A, 1997, CAN MED ASSOC J, V156, P1165; Jelinek T, 2002, CLIN INFECT DIS, V34, P572, DOI 10.1086/338235; Kain KC, 1998, CLIN INFECT DIS, V27, P142, DOI 10.1086/514616; Klement E, 2001, CLIN INFECT DIS, V33, pE1, DOI 10.1086/320872; Kyriacou DN, 1996, ANN EMERG MED, V27, P696, DOI 10.1016/S0196-0644(96)70186-5; LACKRITZ EM, 1991, JAMA-J AM MED ASSOC, V265, P383, DOI 10.1001/jama.265.3.383; LOBEL HO, 1987, JAMA-J AM MED ASSOC, V257, P2626, DOI 10.1001/jama.257.19.2626; Lobel HO, 2001, J TRAVEL MED, V8, P167, DOI 10.2310/7060.2001.22206; LOBEL HO, 1985, J INFECT DIS, V152, P613, DOI 10.1093/infdis/152.3.613; LOBEL HO, 1985, LANCET, V1, P873; Moody A, 2002, CLIN MICROBIOL REV, V15, P66, DOI 10.1128/CMR.15.1.66-78.2002; O'Brien D, 2001, CLIN INFECT DIS, V33, P603, DOI 10.1086/322602; *PAN AM HLTH ORG, 1969, REP CERT REG MAL ER; REILLY PC, 1980, NEW ENGL J MED, V303, P587; SVENSON JE, 1995, ARCH INTERN MED, V155, P861, DOI 10.1001/archinte.155.8.861; *US DEP COMM INT T, 2001, US RES TRAV ABR HIST; Weber G, 1998, J TRAVEL MED, V5, P147, DOI 10.1111/j.1708-8305.1998.tb00489.x; WINTERS RA, 1992, AM J MED, V93, P243, DOI 10.1016/0002-9343(92)90228-4; 1996, MMWR MORB MORTAL WKL, V45, P494; 2001, MMWR MORB MORTAL WKL, V50, P597; 2000, MMWR MORB MORTAL WKL, V49, P1138; 2001, MMWR MORB MORTAL WKL, V50, P169	32	123	129	0	10	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 5	2004	141	7					547	555		10.7326/0003-4819-141-7-200410050-00012	http://dx.doi.org/10.7326/0003-4819-141-7-200410050-00012			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	862CR	15466772				2022-12-28	WOS:000224467800007
J	Ioannidis, JPA				Ioannidis, JPA		Int Working Party Promote Revitali	Academic medicine: the evidence base	BMJ-BRITISH MEDICAL JOURNAL			English	Article							OUTCOMES; HEALTH; EDUCATION; WOMEN	The International Campaign to Revitalise Academic Medicine recognises that an evidence based approach is important in discussing the problems of academic medicine. A preliminary exploration of the evidence on academic medicine has led to a research agenda for examining and proposing realistic solutions.	Univ Ioannina, Sch Med, Dept Hyg & Epidemiol, GR-45110 Ioannina, Greece	University of Ioannina	Ioannidis, JPA (corresponding author), Univ Ioannina, Sch Med, Dept Hyg & Epidemiol, GR-45110 Ioannina, Greece.	jioannid@cc.uoi.gr	Ioannidis, John P. A./G-9836-2011	Underwood, Tim/0000-0001-9455-2188				*AC MED SCI, 2002, IMPL CLIN SCI SCHEM; Ash AS, 2004, ANN INTERN MED, V141, P205, DOI 10.7326/0003-4819-141-3-200408030-00009; Bach PB, 1998, AM J RESP CRIT CARE, V158, P1410, DOI 10.1164/ajrccm.158.5.9804042; BARER ML, 1989, ACAD MED, V64, P524, DOI 10.1097/00001888-198909000-00010; Boote J, 2002, HEALTH POLICY, V61, P213, DOI 10.1016/S0168-8510(01)00214-7; Cooper GS, 1996, GASTROENTEROLOGY, V111, P385, DOI 10.1053/gast.1996.v111.pm8690203; *COUNC HEADS MED S, SURV CLIN AC STAFF L; Danic A, 2003, CROAT MED J, V44, P32; DEANGELIS C, 2001, JAMA-J AM MED ASSOC, V292, P1060; Department of Health, 2001, INV PAT PUBL HEALTHC; Dimick JB, 2004, ARCH SURG-CHICAGO, V139, P137, DOI 10.1001/archsurg.139.2.137; Gamulin S, 2004, CROAT MED J, V45, P245; GARBER AM, 1984, NEW ENGL J MED, V310, P1231, DOI 10.1056/NEJM198405103101906; Garcia FAR, 2001, OBSTET GYNECOL, V97, P567, DOI 10.1016/S0029-7844(00)01219-9; Gray J, 2003, CLIN INVEST MED, V26, P315; Gross CP, 1999, NEW ENGL J MED, V340, P1881, DOI 10.1056/NEJM199906173402406; Howe A, 2003, BRIT J GEN PRACT, V53, P438; *I SCI INF, WEB KNOWL ESS SCI IN; Ioannidis JP, 2004, J TRANSL MED, V2, P5, DOI DOI 10.1186/1479-5876-2-5; PHILLIPSON EA, 2001, MEDINEWS, V13, P1; Simpson DE, 2001, ACAD MED, V76, P259, DOI 10.1097/00001888-200103000-00016; Spencer J, 2000, MED EDUC, V34, P851, DOI 10.1046/j.1365-2923.2000.00779.x; Wilkinson D, 2004, BMJ-BRIT MED J, V329, P787; 2001, LANCET, V357, P1543	24	35	37	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 2	2004	329	7469					789	792						4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	859TW	15459055				2022-12-28	WOS:000224291800025
J	Pasupathy, AN; Bialczak, RC; Martinek, J; Grose, JE; Donev, LAK; McEuen, PL; Ralph, DC				Pasupathy, AN; Bialczak, RC; Martinek, J; Grose, JE; Donev, LAK; McEuen, PL; Ralph, DC			The Kondo effect in the presence of ferromagnetism	SCIENCE			English	Article								We measured Kondo-assisted tunneling via C-60 molecules in contact with ferromagnetic nickel electrodes. Kondo correlations persisted despite the presence of ferromagnetism, but the Kondo peak in the differential conductance was split by an amount that decreased (even to zero) as the moments in the two electrodes were turned from parallel to antiparallel alignment. The splitting is too large to be explained by a local magnetic field. However, the voltage, temperature, and magnetic field dependence of the signals agree with predictions for an exchange splitting of the Kondo resonance. The Kondo effect leads to negative values of magnetoresistance, with magnitudes much larger than the Julliere estimate.	Cornell Univ, Atom & Solid State Phys Lab, Ithaca, NY 14853 USA; Univ Karlsruhe, Inst Theoret Festkorperphys, D-76128 Karlsruhe, Germany; Tohoku Univ, Inst Mat Res, Sendai, Miyagi 9808577, Japan; Polish Acad Sci, Inst Mol Phys, PL-60179 Poznan, Poland	Cornell University; Helmholtz Association; Karlsruhe Institute of Technology; Tohoku University; Polish Academy of Sciences; Institute of Molecular Physics of the Polish Academy of Sciences	Ralph, DC (corresponding author), Cornell Univ, Atom & Solid State Phys Lab, Ithaca, NY 14853 USA.	ralph@ccmr.cornell.edu	Ralph, Daniel C/G-3251-2010	Martinek, Jan/0000-0002-8125-025X				Bonet E, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.045317; Buitelaar MR, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.256801; Choi MS, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.056601; Cowburn RP, 2000, J PHYS D APPL PHYS, V33, pR1, DOI 10.1088/0022-3727/33/1/201; Cronenwett SM, 1998, SCIENCE, V281, P540, DOI 10.1126/science.281.5376.540; DONIACH S, 1977, PHYSICA B & C, V91, P231, DOI 10.1016/0378-4363(77)90190-5; Goldhaber-Gordon D, 1998, NATURE, V391, P156, DOI 10.1038/34373; Hewson A C, 1993, KONDO PROBLEM HEAVY; JULLIERE M, 1975, PHYS LETT A, V54, P225, DOI 10.1016/0375-9601(75)90174-7; Liang WJ, 2002, NATURE, V417, P725, DOI 10.1038/nature00790; Martinek J, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.247202; Martinek J, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.127203; Monsma DJ, 2000, APPL PHYS LETT, V77, P720, DOI 10.1063/1.127097; Nygard J, 2000, NATURE, V408, P342, DOI 10.1038/35042545; Park H, 1999, APPL PHYS LETT, V75, P301, DOI 10.1063/1.124354; Park H, 2000, NATURE, V407, P57, DOI 10.1038/35024031; Park J, 2002, NATURE, V417, P722, DOI 10.1038/nature00791; Rosch A, 2003, PHYS REV B, V68, DOI 10.1103/PhysRevB.68.014430; Sergueev N, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.165303; Tsymbal EY, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.186602; Tsymbal EY, 2003, J PHYS-CONDENS MAT, V15, pR109, DOI 10.1088/0953-8984/15/4/201; Yu LH, 2004, NANO LETT, V4, P79, DOI 10.1021/nl034893f; Zhang P, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.286803	23	478	486	5	130	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 1	2004	306	5693					86	89		10.1126/science.1102068	http://dx.doi.org/10.1126/science.1102068			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	859YJ	15459383				2022-12-28	WOS:000224304000040
J	D'Souza, V; Summers, MF				D'Souza, V; Summers, MF			Structural basis for packaging the dimeric genome of Moloney murine leukaemia virus	NATURE			English	Article							NUCLEOCAPSID PROTEIN; RETROVIRAL RNA; NMR STRUCTURE; ENCAPSIDATION SIGNAL; ZINC-FINGER; DIMERIZATION; RECOGNITION; ELEMENT; COMPLEX; VIRIONS	All retroviruses specifically package two copies of their genomes during virus assembly, a requirement for strand-transfer-mediated recombination during reverse transcription(1,2). Genomic RNA exists in virions as dimers, and the overlap of RNA elements that promote dimerization and encapsidation suggests that these processes may be coupled(3-5). Both processes are mediated by the nucleocapsid domain (NC) of the retroviral Gag polyprotein(3). Here we show that dimerization-induced register shifts in base pairing within the Psi-RNA packaging signal of Moloney murine leukaemia virus (MoMuLV) expose conserved UCUG elements that bind NC with high affinity ( dissociation constant = 75 +/- 12 nM). These elements are base-paired and do not bind NC in the monomeric RNA. The structure of the NC complex with a 101-nucleotide 'core encapsidation' segment of the MoMuLV Psi site(6) reveals a network of interactions that promote sequence- and structure-specific binding by NC's single CCHC zinc knuckle. Our findings support a structural RNA switch mechanism for genome encapsidation, in which protein binding sites are sequestered by base pairing in the monomeric RNA and become exposed upon dimerization to promote packaging of a diploid genome.	Univ Maryland Baltimore Cty, Howard Hughes Med Inst, Baltimore, MD 21250 USA; Univ Maryland Baltimore Cty, Dept Chem & Biochem, Baltimore, MD 21250 USA	Howard Hughes Medical Institute; University System of Maryland; University of Maryland Baltimore County; University System of Maryland; University of Maryland Baltimore County	Summers, MF (corresponding author), Univ Maryland Baltimore Cty, Howard Hughes Med Inst, 1000 Hilltop Circle, Baltimore, MD 21250 USA.	summers@hhmi.umbc.edu						Amarasinghe GK, 2000, J MOL BIOL, V301, P491, DOI 10.1006/jmbi.2000.3979; ANTAO VP, 1991, NUCLEIC ACIDS RES, V19, P5901, DOI 10.1093/nar/19.21.5901; BENDER MA, 1987, J VIROL, V61, P1639, DOI 10.1128/JVI.61.5.1639-1646.1987; Berkowitz R, 1996, CURR TOP MICROBIOL, V214, P177; BERKOWITZ RD, 1995, J VIROL, V69, P6445, DOI 10.1128/JVI.69.10.6445-6456.1995; D'Souza V, 2004, J MOL BIOL, V337, P427, DOI 10.1016/j.jmb.2004.01.037; D'Souza V, 2001, J MOL BIOL, V314, P217, DOI 10.1006/jmbi.2001.5139; De Guzman RN, 1998, SCIENCE, V279, P384, DOI 10.1126/science.279.5349.384; HIBBERT CS, IN PRESS J VIROL; HOUSSET V, 1993, J VIROL, V67, P2537, DOI 10.1128/JVI.67.5.2537-2545.1993; HU WS, 1990, SCIENCE, V250, P1227, DOI 10.1126/science.1700865; Huthoff H, 2001, RNA, V7, P143, DOI 10.1017/S1355838201001881; KAY LE, 1990, SCIENCE, V249, P411, DOI 10.1126/science.2377896; Kim CH, 2000, P NATL ACAD SCI USA, V97, P9396, DOI 10.1073/pnas.170283697; LEVIN JG, 1974, J VIROL, V14, P152, DOI 10.1128/JVI.14.1.152-161.1974; Ly H, 2002, J VIROL, V76, P3135, DOI 10.1128/JVI.76.7.3135-3144.2002; MANN R, 1983, CELL, V33, P153, DOI 10.1016/0092-8674(83)90344-6; MERIC C, 1989, J VIROL, V63, P1558; Mougel M, 1997, J VIROL, V71, P8061, DOI 10.1128/JVI.71.10.8061-8065.1997; Oroudjev EM, 1999, J MOL BIOL, V291, P603, DOI 10.1006/jmbi.1999.2984; Paillart JC, 2004, NAT REV MICROBIOL, V2, P461, DOI 10.1038/nrmicro903; PRATS AC, 1990, J VIROL, V64, P774, DOI 10.1128/JVI.64.2.774-783.1990; REIN A, 1994, J VIROL, V68, P6124, DOI 10.1128/JVI.68.9.6124-6129.1994; Sakuragi J, 2001, J VIROL, V75, P2557, DOI 10.1128/JVI.75.6.2557-2565.2001; Schuler W, 1999, BIOCHEMISTRY-US, V38, P12984, DOI 10.1021/bi990378d; TORRENT C, 1994, J MOL BIOL, V240, P434, DOI 10.1006/jmbi.1994.1459; TOUNEKTI N, 1992, J MOL BIOL, V223, P205, DOI 10.1016/0022-2836(92)90726-Z; VARMUS HE, 1982, SCIENCE, V216, P812, DOI 10.1126/science.6177038; Wuthrich K, 1986, NMR PROTEINS NUCL AC; YANG SL, 1994, EMBO J, V13, P713, DOI 10.1002/j.1460-2075.1994.tb06311.x	30	169	171	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 30	2004	431	7008					586	590		10.1038/nature02944	http://dx.doi.org/10.1038/nature02944			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	857YP	15457265				2022-12-28	WOS:000224156700051
J	Kanan, MW; Rozenman, MM; Sakurai, K; Snyder, TM; Liu, DR				Kanan, MW; Rozenman, MM; Sakurai, K; Snyder, TM; Liu, DR			Reaction discovery enabled by DNA-templated synthesis and in vitro selection	NATURE			English	Article							ORGANIC-SYNTHESIS; CATALYSTS; CYCLOADDITION; COMBINATORIAL; FLUORESCENCE; EVOLUTION; ENZYMES	Current approaches to reaction discovery focus on one particular transformation. Typically, researchers choose substrates based on their predicted ability to serve as precursors for the target structure, then evaluate reaction conditions(1-6) for their ability to effect product formation. This approach is ideal for addressing specific reactivity problems, but its focused nature might leave many areas of chemical reactivity unexplored. Here we report a reaction discovery approach that uses DNA-templated organic synthesis(7-10) and in vitro selection to simultaneously evaluate many combinations of different substrates for bond-forming reactions in a single solution. Watson - Crick base pairing controls the effective molarities of substrates tethered to DNA strands; bond-forming substrate combinations are then revealed using in vitro selection for bond formation, PCR amplification and DNA microarray analysis. Using this approach, we discovered an efficient and mild carbon - carbon bond-forming reaction that generates an enone from an alkyne and alkene using an inorganic palladium catalyst. Although this approach is restricted to conditions and catalysts that are at least partially compatible with DNA, we expect that its versatility and efficiency will enable the discovery of additional reactions between a wide range of substrates.	Harvard Univ, Dept Chem & Biol Chem, Cambridge, MA 02138 USA	Harvard University	Liu, DR (corresponding author), Harvard Univ, Dept Chem & Biol Chem, 12 Oxford St, Cambridge, MA 02138 USA.	liu@chemistry.harvard.edu	Liu, David R./HCH-3132-2022; Sakurai, Kaori/AAJ-7405-2021; Sakurai, Kaori/F-6238-2013	Sakurai, Kaori/0000-0002-1348-8530; Snyder, Thomas/0000-0001-7256-7821	NIGMS NIH HHS [R01 GM065865, R01 GM065865-03, R01 GM065865-04, R01 GM065865-02, R01 GM065865-01A2] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065865] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BRESLOW R, 1995, ACCOUNTS CHEM RES, V28, P146, DOI 10.1021/ar00051a008; Burrows CJ, 1998, CHEM REV, V98, P1109, DOI 10.1021/cr960421s; Calderone CT, 2002, ANGEW CHEM INT EDIT, V41, P4104, DOI 10.1002/1521-3773(20021104)41:21<4104::AID-ANIE4104>3.0.CO;2-O; Crabtree R. H., 2001, ORGANOMETALLIC CHEM; Evans CA, 2002, CURR OPIN CHEM BIOL, V6, P333, DOI 10.1016/S1367-5931(02)00324-1; Gartner ZJ, 2002, ANGEW CHEM INT EDIT, V41, P1796, DOI 10.1002/1521-3773(20020517)41:10<1796::AID-ANIE1796>3.0.CO;2-Z; Gartner ZJ, 2001, J AM CHEM SOC, V123, P6961, DOI 10.1021/ja015873n; HECK RF, 1982, ORG REACTIONS, V27, P345; Joyce GF, 2004, ANNU REV BIOCHEM, V73, P791, DOI 10.1146/annurev.biochem.73.011303.073717; Kohli RM, 2002, NATURE, V418, P658, DOI 10.1038/nature00907; KRAMER MF, 2001, CURRENT PROTOCOLS MO, V2; Li C., 1997, ORGANIC REACTIONS AQ; Li XY, 2003, J AM CHEM SOC, V125, P10188, DOI 10.1021/ja035379e; Lober O, 2001, J AM CHEM SOC, V123, P4366, DOI 10.1021/ja005881o; MIYAURA N, 1995, CHEM REV, V95, P2457, DOI 10.1021/cr00039a007; Morgan, 1995, COMPREHENSIVE ORGANI, V5, P257; Reetz MT, 2001, ANGEW CHEM INT EDIT, V40, P284, DOI 10.1002/1521-3773(20010119)40:2<284::AID-ANIE284>3.0.CO;2-N; Rosenbaum DM, 2003, J AM CHEM SOC, V125, P13924, DOI 10.1021/ja038058b; Rostovtsev VV, 2002, ANGEW CHEM INT EDIT, V41, P2596, DOI 10.1002/1521-3773(20020715)41:14<2596::AID-ANIE2596>3.0.CO;2-4; Schultz PG, 2002, NATURE, V418, P485, DOI 10.1038/418485a; SMIDT J, 1962, ANGEW CHEM INT EDIT, V74, P93, DOI 10.1002/ange.19620740302; SMIDT J, 1959, ANGEW CHEM INT EDIT, V71, P176, DOI 10.1002/ange.19590710503; Stambuli JP, 2003, CURR OPIN CHEM BIOL, V7, P420, DOI 10.1016/S1367-5931(03)00056-5; Stambuli JP, 2001, J AM CHEM SOC, V123, P2677, DOI 10.1021/ja0058435; Staunton J, 2001, NAT PROD REP, V18, P380, DOI 10.1039/a909079g; Taylor SJ, 1998, SCIENCE, V280, P267, DOI 10.1126/science.280.5361.267; TSUJI J, 1995, PALALDIUM REAGENTS C; WADSWORTH W, 1961, J AM CHEM SOC, V83, P1733, DOI 10.1021/ja01468a042; Wang Q, 2003, J AM CHEM SOC, V125, P3192, DOI 10.1021/ja021381e; Wilson DS, 1999, ANNU REV BIOCHEM, V68, P611, DOI 10.1146/annurev.biochem.68.1.611	30	212	269	4	96	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 30	2004	431	7008					545	549		10.1038/nature02920	http://dx.doi.org/10.1038/nature02920			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC); Current Chemical Reactions (CCR-EXPANDED)	Science & Technology - Other Topics	857YP	15457254	Green Accepted			2022-12-28	WOS:000224156700040
J	Lopez-Rios, F; Illei, PB; Rusch, V; Ladanyi, M				Lopez-Rios, F; Illei, PB; Rusch, V; Ladanyi, M			Evidence against a role for SV40 infection in human mesotheliomas and high risk of false-positive PCR results owing to presence of SV40 sequences in common laboratory plasmids	LANCET			English	Article							LARGE T-ANTIGEN; HUMAN PLEURAL MESOTHELIOMA; HUMAN BRAIN-TUMORS; HUMAN-MALIGNANT MESOTHELIOMA; NON-HODGKIN-LYMPHOMA; DNA-SEQUENCES; HUMAN CANCERS; CELL-LINES; POLIOVIRUS VACCINES; MAMMALIAN-CELLS	Background PCR-based evidence of infection by simian virus 40 (SV40) has been reported in varying proportions of pleural mesotheliomas and other tumours, but data are conflicting and reproducibility limited. During a study of SV40 in relation to homozygous deletion of CDKN2A in mesotheliomas, we became concerned by inconsistent results and therefore used several independent techniques to investigate SV40 in these tumours. Methods High-quality DNA and RNA were extracted from 71 frozen mesothelioma samples. DNA PCR was done with four sets of primers for the SV40 T-antigen gene. RNA transcripts were examined by RT-PCR. Findings The first two primer sets for DNA PCR gave positive results in proportions similar to those reported in positive studies (56-62%) but there were unusual reproducibility difficulties. These primers were in a region of the T-antigen gene (nucleotides 4100-4713) that is present in many common laboratory plasmids. In assays with PCR primers not included within that region, only four cases (6%) showed products but these were too faint to suggest clonal infection. Further PCR assays confirmed that the SV40 sequences in the tumour samples had a deletion found only in plasmids, not in native functional SV40. Review of previous studies showed a similar pattern of discrepancies between SV40 T-antigen DNA PCR results obtained with primers within and beyond the region 4100-4713. All 71 mesotheliomas were negative for T-antigen transcripts by RT-PCR, and lacked T-antigen-positive tumour cells by immunohistochemistry. Interpretation Our data based on three independent experimental approaches do not support a significant role for SV40 in human mesotheliomas. The risk of false-positive results due to contamination by common laboratory plasmids containing SV40 sequences has been underestimated. Studies of SV40 based on PCR methods require careful primer design to reduce this risk. Relevance to practice This paper presents several lines of evidence against the proposed link between SV40 infection and human mesotheliomas. Studies reporting a high prevalence of SV40 DNA in human tumours have been based on molecular assays prone to false-positive results. Because SV40 appears unlikely to have a major role, if any, in human mesotheliomas, clinicians should continue to consider asbestos exposure as the most likely and most thoroughly established aetiological factor in individuals with this cancer.	Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Dept Surg, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Ladanyi, M (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Pathol, 1275 York Ave, New York, NY 10021 USA.	ladanyim@mskcc.org	Ladanyi, Marc/AAG-8585-2019	Rusch, Valerie/0000-0003-2345-6900				AMBINDER RF, 1986, J CLIN MICROBIOL, V24, P16, DOI 10.1128/JCM.24.1.16-20.1986; BERGSAGEL DJ, 1992, NEW ENGL J MED, V326, P988, DOI 10.1056/NEJM199204093261504; Brown F, 1998, DEV BIOL STAND, V94, P1; Butel JS, 1999, JNCI-J NATL CANCER I, V91, P119, DOI 10.1093/jnci/91.2.119; Cacciotti P, 2001, P NATL ACAD SCI USA, V98, P12032, DOI 10.1073/pnas.211026798; Capello D, 2003, LANCET, V361, P88, DOI 10.1016/S0140-6736(03)12157-5; CARBONE M, 1994, ONCOGENE, V9, P1781; Carbone M, 2003, INT J CANCER, V106, P140, DOI 10.1002/ijc.11189; Carbone M, 1997, ONCOGENE, V15, P1877, DOI 10.1038/sj.onc.1201375; de Sanjose S, 2003, INT J CANCER, V104, P522, DOI 10.1002/ijc.10993; DeLuca A, 1997, NAT MED, V3, P913, DOI 10.1038/nm0897-913; Dhaene K, 1999, VIRCHOWS ARCH, V435, P1, DOI 10.1007/s004280050387; Dobbelstein M, 1998, J GEN VIROL, V79, P3079, DOI 10.1099/0022-1317-79-12-3079; Emri S, 2000, ANTICANCER RES, V20, P891; Engels EA, 2003, JNCI-J NATL CANCER I, V95, P532, DOI 10.1093/jnci/95.7.532; Engels EA, 2002, INT J CANCER, V101, P348, DOI 10.1002/ijc.10621; Galateau-Salle F, 1998, J PATHOL, V184, P252, DOI 10.1002/(SICI)1096-9896(199803)184:3<252::AID-PATH15>3.0.CO;2-R; Gazdar AF, 2002, NAT REV CANCER, V2, P957, DOI 10.1038/nrc947; Gordon GJ, 2002, ONCOL REP, V9, P631; GORMAN CM, 1982, MOL CELL BIOL, V2, P1044, DOI 10.1128/MCB.2.9.1044; Griffiths DJ, 1998, DEV BIOL STAND, V94, P127; Hirvonen A, 1999, MOL CARCINOGEN, V26, P93, DOI 10.1002/(SICI)1098-2744(199910)26:2<93::AID-MC4>3.0.CO;2-Z; HOWELL MD, 1987, ANAL BIOCHEM, V161, P311, DOI 10.1016/0003-2697(87)90456-8; Hubner R, 2002, CANCER CAUSE CONTROL, V13, P121, DOI 10.1023/A:1014321729038; Illei PB, 2003, CLIN CANCER RES, V9, P2108; Jasani B, 2001, SEMIN CANCER BIOL, V11, P49, DOI 10.1006/scbi.2000.0346; Kim JYH, 2002, NEURO-ONCOLOGY, V4, P165, DOI 10.1093/neuonc/4.3.165; Klein G, 2002, ONCOGENE, V21, P1141, DOI 10.1038/sj.onc.1205173; Knowles WA, 2003, J MED VIROL, V71, P115, DOI 10.1002/jmv.10450; LEDNICKY JA, 1995, VIROLOGY, V212, P710, DOI 10.1006/viro.1995.1529; Leithner A, 2002, CANCER BIOL THER, V1, P375; Lin PP, 1999, CANCER RES, V59, P1428; MacKenzie J, 2003, J NATL CANCER I, V95, P1001, DOI 10.1093/jnci/95.13.1001; Martinelli M, 2002, AM J PATHOL, V161, P1127, DOI 10.1016/S0002-9440(10)64389-1; Martini F, 1996, CANCER RES, V56, P4820; Martini F, 2002, CANCER-AM CANCER SOC, V94, P1037, DOI 10.1002/cncr.10272; Mayall F, 2003, J CLIN PATHOL, V56, P728, DOI 10.1136/jcp.56.10.728; Mulatero C, 1999, THORAX, V54, P60, DOI 10.1136/thx.54.1.60; MULLIGAN RC, 1980, SCIENCE, V209, P1422, DOI 10.1126/science.6251549; NERENBERG MI, 1991, BIOTECHNIQUES, V11, P332; Pass HI, 1998, J THORAC CARDIOV SUR, V116, P854, DOI 10.1016/S0022-5223(98)00438-3; Pilatte Y, 2000, AM J RESP CELL MOL, V23, P788, DOI 10.1165/ajrcmb.23.6.4251; Prins JB, 1998, INT J CANCER, V75, P649, DOI 10.1002/(SICI)1097-0215(19980209)75:4<649::AID-IJC25>3.3.CO;2-L; Rollison DEM, 2003, CANCER EPIDEM BIOMAR, V12, P460; Saenz-Robles MT, 2001, ONCOGENE, V20, P7899, DOI 10.1038/sj.onc.1204936; SAGER R, 1981, CELL, V23, P41, DOI 10.1016/0092-8674(81)90268-3; Salewski H, 1999, CANCER RES, V59, P1980; Shah KV, 2000, REV MED VIROL, V10, P31, DOI 10.1002/(SICI)1099-1654(200001/02)10:1<31::AID-RMV260>3.0.CO;2-I; Sherr CJ, 2001, NAT REV MOL CELL BIO, V2, P731, DOI 10.1038/35096061; Simsir A, 2001, DIAGN CYTOPATHOL, V25, P203, DOI 10.1002/dc.2039; Strickler HD, 1996, CANCER EPIDEM BIOMAR, V5, P473; Strickler HD, 2003, JNCI-J NATL CANCER I, V95, P38, DOI 10.1093/jnci/95.1.38; Strickler HD, 2001, CANCER EPIDEM BIOMAR, V10, P523; Strickler HD, 1998, JAMA-J AM MED ASSOC, V279, P292, DOI 10.1001/jama.279.4.292; Testa JR, 1998, CANCER RES, V58, P4505; Testa JR, 2001, SEMIN CANCER BIOL, V11, P31, DOI 10.1006/scbi.2000.0344; Tzeng YJ, 1998, ONCOGENE, V16, P2103, DOI 10.1038/sj.onc.1201733; Vilchez RA, 2002, LANCET, V359, P817, DOI 10.1016/S0140-6736(02)07950-3; Vilchez RA, 2003, J NATL CANCER I, V95, P687, DOI 10.1093/jnci/95.9.687; Vilchez RA, 2003, LANCET ONCOL, V4, P188, DOI 10.1016/S1470-2045(03)01024-6; Vilchez RA, 2002, J ACQ IMMUN DEF SYND, V29, P109, DOI 10.1097/00042560-200202010-00001; Vivaldi A, 2003, J CLIN ENDOCR METAB, V88, P892, DOI 10.1210/jc.2002-020436; Volter C, 1998, DEV BIOL STAND, V94, P137; Waheed I, 1999, CANCER RES, V59, P6068; XIAO S, 1995, ONCOGENE, V11, P511; zur Hansen H, 2003, INT J CANCER, V107, P687, DOI 10.1002/ijc.11517	66	149	153	0	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 25	2004	364	9440					1157	1166		10.1016/S0140-6736(04)17102-X	http://dx.doi.org/10.1016/S0140-6736(04)17102-X			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	857FT	15451223				2022-12-28	WOS:000224102400029
J	Oquendo, MA; Baca-Garcia, E				Oquendo, MA; Baca-Garcia, E			Nurture versus nature: evidence of intrauterine effects on suicidal behaviour	LANCET			English	Editorial Material							RISK		Columbia Univ, Dept Psychiat, New York, NY 10032 USA; Fdn Jimenez Diaz, Dept Psychiat, E-28040 Madrid, Spain	Columbia University	Oquendo, MA (corresponding author), Columbia Univ, Dept Psychiat, New York, NY 10032 USA.	mao4@columbia.edu	Baca-García, Enrique/F-4106-2015; Baca-García, Enrique/ABH-9371-2020; Oquendo, Maria/AAC-6237-2019	Baca-García, Enrique/0000-0002-6963-6555; Baca-García, Enrique/0000-0002-6963-6555; 				Brent DA, 2002, ARCH GEN PSYCHIAT, V59, P801, DOI 10.1001/archpsyc.59.9.801; Caspi A, 2003, SCIENCE, V301, P386, DOI 10.1126/science.1083968; Francis DD, 2003, NAT NEUROSCI, V6, P445, DOI 10.1038/nn1038; Mann JJ, 1999, AM J PSYCHIAT, V156, P181; Qin P, 2002, LANCET, V360, P1126, DOI 10.1016/S0140-6736(02)11197-4	5	10	10	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 25	2004	364	9440					1102	1104		10.1016/S0140-6736(04)17115-8	http://dx.doi.org/10.1016/S0140-6736(04)17115-8			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	857FT	15451203				2022-12-28	WOS:000224102400004
J	Tucker, J; Parry, G; Fowlie, PW; McGuire, W				Tucker, J; Parry, G; Fowlie, PW; McGuire, W			ABC of preterm birth - Organisation and delivery of perinatal services	BRITISH MEDICAL JOURNAL			English	Review									Univ Aberdeen, Dugald Baird Ctr, Dept Obstet & Gynaecol, Aberdeen AB9 1FX, Scotland; Univ Sheffield, Sch Hlth & Related Res, Med Care Res Unit, Sheffield S10 2TN, S Yorkshire, England; Univ Dundee, Ninewells Hosp & Med Sch, Tayside Inst Child Hlth, Dundee DD1 4HN, Scotland; Perth Royal Infirm, Perth, Scotland	University of Aberdeen; University of Sheffield; University of Dundee	Tucker, J (corresponding author), Univ Aberdeen, Dugald Baird Ctr, Dept Obstet & Gynaecol, Aberdeen AB9 1FX, Scotland.		Parry, Gareth/CAF-6975-2022	McGuire, William/0000-0001-8572-3467				*CSAG, 1993, ACCESS AVAILABILITY; Parry G, 2003, LANCET, V361, P1789, DOI 10.1016/S0140-6736(03)13397-1; Tucker J, 2002, LANCET, V359, P99	3	5	7	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	SEP 25	2004	329	7468					730	732		10.1136/bmj.329.7468.730	http://dx.doi.org/10.1136/bmj.329.7468.730			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	858RV	15388617	Green Published			2022-12-28	WOS:000224210300023
J	Willis, CM; Church, SM; Guest, CM; Cook, WA; McCarthy, N; Bransbury, AJ; Church, MRT; Church, JCT				Willis, CM; Church, SM; Guest, CM; Cook, WA; McCarthy, N; Bransbury, AJ; Church, MRT; Church, JCT			Olfactory detection of human bladder cancer by dogs: proof of principle study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							IDENTIFICATION; URINE	Objective To determine whether dogs can be trained to identify people with bladder cancer on the basis of urine odour more successfully than would be expected by chance alone. Design Experimental, "proof of principle" study in which six dogs were trained to discriminate between urine from patients with bladder cancer and urine from diseased and healthy controls and then evaluated in tests requiring the selection of one bladder cancer urine sample from six controls. Participants 36 male and female patients (age range 48-90 years) presenting with new or recurrent transitional cell carcinoma of the bladder (27 samples used for training; 9 used for formal testing); 108 male and female controls (diseased and healthy, age range 18-85 years-54 samples used in training; 54 used for testing). Main outcome measure Mean proportion of successes per dog achieved during evaluation, compared with an expected value of 1 in 7 (14%). Results Taken as a group, the dogs correctly selected urine from patients with bladder cancer on 22 out of 54 occasions. This gave a mean success rate of 41% (95% confidence intervals 23% to 58% under assumptions of normality, 26% to 52% using bootstrap methods), compared with 14% expected by chance alone. Multivariate analysis suggested that the dogs' capacity to recognise a characteristic bladder cancer odour was independent of other chemical aspects of the urine detectable by urinalysis. Conclusions Dogs can be trained to distinguish patients with bladder cancer on the basis of urine odour more successfully than would be expected by chance alone. This suggests that tumour related volatile compounds are present in urine, imparting a characteristic odour signature distinct from those associated with secondary effects of the tumour, such as bleeding, inflammation, and infection.	Amersham Hosp, Dept Dermatol, Amersham HP7 0JD, England; Inst Hlth Sci, Ctr Stat Med, Oxford OX3 7LF, England	University of Oxford	Willis, CM (corresponding author), Amersham Hosp, Dept Dermatol, Amersham HP7 0JD, England.	carolyn.willis@sbucks.nhs.uk	McCarthy, Noel D/K-3314-2012	McCarthy, Noel/0000-0003-1113-1017; Guest BSc (Hons) MSc HonDSc. DHP BCAh FRSA, Claire/0000-0002-1169-9246				Carpenter J, 2000, STAT MED, V19, P1141, DOI 10.1002/(SICI)1097-0258(20000515)19:9<1141::AID-SIM479>3.0.CO;2-F; Church J, 2001, LANCET, V358, P930, DOI 10.1016/S0140-6736(01)06065-2; Di Natale C, 2003, BIOSENS BIOELECTRON, V18, P1209, DOI 10.1016/S0956-5663(03)00086-1; Dobson R, 2003, SUNDAY TIMES    0427, P5; FRASER L, 2002, SUNDAY TELEGRAP 0602; Komar D, 1999, J FORENSIC SCI, V44, P405; Lorenzo N, 2003, ANAL BIOANAL CHEM, V376, P1212, DOI 10.1007/s00216-003-2018-7; MILLS DS, 2002, BSAVA MANUAL CANINE; Pashos CL, 2002, CANCER PRACT, V10, P311, DOI 10.1046/j.1523-5394.2002.106011.x; Phillips M, 1999, LANCET, V353, P1930, DOI 10.1016/S0140-6736(98)07552-7; Phillips Michael, 2003, Breast J, V9, P184, DOI 10.1046/j.1524-4741.2003.09309.x; Schoon GAA, 1998, J FORENSIC SCI, V43, P70; SCHOON GAA, 1994, FORENSIC SCI INT, V69, P111, DOI 10.1016/0379-0738(94)90247-X; Spanel P, 1999, RAPID COMMUN MASS SP, V13, P1354, DOI 10.1002/(SICI)1097-0231(19990730)13:14<1354::AID-RCM641>3.0.CO;2-J; WILLIAMS H, 1989, LANCET, V1, P734; YAMADA K, 1992, ARCH DERMATOL, V128, P491, DOI 10.1001/archderm.128.4.491	16	258	266	7	75	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 25	2004	329	7468					712	714A		10.1136/bmj.329.7468.712	http://dx.doi.org/10.1136/bmj.329.7468.712			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	858RV	15388612	Green Submitted, Green Published, Bronze			2022-12-28	WOS:000224210300016
J	Anavekar, NS; McMurray, JJV; Velazquez, EJ; Solomon, SD; Kober, L; Rouleau, J; White, HD; Nordlander, R; Maggioni, A; Dickstein, K; Zelenkofske, S; Leimberger, JD; Califf, RM; Pfeffer, MA				Anavekar, NS; McMurray, JJV; Velazquez, EJ; Solomon, SD; Kober, L; Rouleau, J; White, HD; Nordlander, R; Maggioni, A; Dickstein, K; Zelenkofske, S; Leimberger, JD; Califf, RM; Pfeffer, MA			Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ACUTE CORONARY SYNDROMES; RISK-FACTOR; CREATININE CLEARANCE; SERUM CREATININE; KIDNEY-FUNCTION; HEART-FAILURE; BETA-BLOCKADE; DISEASE; MORTALITY; INSUFFICIENCY	Background: The presence of coexisting conditions has a substantial effect on the outcome of acute myocardial infarction. Renal failure is associated with one of the highest risks, but the influence of milder degrees of renal impairment is less well defined. Methods: As part of the Valsartan in Acute Myocardial Infarction Trial (VALIANT), we identified 14,527 patients with acute myocardial infarction complicated by clinical or radiologic signs of heart failure, left ventricular dysfunction, or both, and a documented serum creatinine measurement. Patients were randomly assigned to receive captopril, valsartan, or both. The glomerular filtration rate (GFR) was estimated by means of the four-component Modification of Diet in Renal Disease equation, and the patients were grouped according to their estimated GFR. We used a 70-candidate variable model to adjust and compare overall mortality and composite cardiovascular events among four GFR groups. Results: The distribution of estimated GFR was wide and normally shaped, with a mean (+/-SD) value of 70+/-21 ml per minute per 1.73 m(2) of body-surface area. The prevalence of coexisting risk factors, prior cardiovascular disease, and a Killip class of more than I was greatest among patients with a reduced estimated GFR (less than 45.0 ml per minute per 1.73 m(2)), and the use of aspirin, beta-blockers, statins, or coronary-revascularization procedures was lowest in this group. The risk of death or the composite end point of death from cardiovascular causes, reinfarction, congestive heart failure, stroke, or resuscitation after cardiac arrest increased with declining estimated GFRs. Although the rate of renal events increased with declining estimated GFRs, the adverse outcomes were predominantly cardiovascular. Below 81.0 ml per minute per 1.73 m(2), each reduction of the estimated GFR by 10 units was associated with a hazard ratio for death and nonfatal cardiovascular outcomes of 1.10 (95 percent confidence interval, 1.08 to 1.12), which was independent of the treatment assignment. Conclusions: Even mild renal disease, as assessed by the estimated GFR, should be considered a major risk factor for cardiovascular complications after a myocardial infarction.	Brigham & Womens Hosp, Div Cardiovasc, Boston, MA 02115 USA; Univ Glasgow, Western Infirm, Dept Cardiol, Glasgow G11 6NT, Lanark, Scotland; Duke Univ, Med Ctr, Durham, NC USA; Rigshosp, Dept Cardiol, DK-2100 Copenhagen, Denmark; Montreal Heart Inst, Montreal, PQ H1T 1C8, Canada; Auckland City Hosp, Green Lane Cardiovasc Serv, Dept Cardiol, Auckland, New Zealand; Stockholm S Hosp, Dept Cardiol, Stockholm, Sweden; Assoc Nazl Med Cardiol Osped Res Ctr, Florence, Italy; Cent Hosp Rogaland, Dept Cardiol, Stavanger, Norway; Novartis Pharmaceut, E Hanover, NJ USA	Harvard University; Brigham & Women's Hospital; University of Glasgow; Duke University; Rigshospitalet; University of Copenhagen; Universite de Montreal; Auckland City Hospital; Associazione Nazionale Medici Cardiologi Ospedalieri (ANMCO); Novartis	Pfeffer, MA (corresponding author), Brigham & Womens Hosp, Div Cardiovasc, 75 Francis St, Boston, MA 02115 USA.	mpfeffer@rics.bwh.harvard.edu	Solomon, Scott/I-5789-2013; Maggioni, Aldo Pietro/AAL-5334-2020; mcmurray, John/B-2467-2013	Maggioni, Aldo Pietro/0000-0003-2764-6779; mcmurray, John/0000-0002-6317-3975; Kober, Lars/0000-0002-6635-1466				Al Suwaidi J, 2002, CIRCULATION, V106, P974, DOI 10.1161/01.CIR.0000027560.41358.B3; Al-Ahmad A, 2001, J AM COLL CARDIOL, V38, P955, DOI 10.1016/S0735-1097(01)01470-X; Beattie JN, 2001, AM J KIDNEY DIS, V37, P1191, DOI 10.1053/ajkd.2001.24522; BEATTIE JN, 2001, AM J KIDNEY DIS, V38, P701; Berger AK, 2003, J AM COLL CARDIOL, V42, P201, DOI 10.1016/S0735-1097(03)00572-2; Braunwald E, 2004, NEW ENGL J MED, V351, P2058; Brewster UC, 2004, AM J MED, V116, P263, DOI 10.1016/j.amjmed.2003.09.034; Chertow GM, 2000, AM J KIDNEY DIS, V35, P1044, DOI 10.1016/S0272-6386(00)70038-2; Cheung AK, 2000, KIDNEY INT, V58, P353, DOI 10.1046/j.1523-1755.2000.00173.x; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Foley RN, 1998, J AM SOC NEPHROL, V9, P267; Freeman RV, 2003, J AM COLL CARDIOL, V41, P718, DOI 10.1016/S0735-1097(02)02956-X; French WJ, 2003, J AM COLL CARDIOL, V42, P1544, DOI 10.1016/j.jacc.2003.08.001; Gibson CM, 2003, J AM COLL CARDIOL, V42, P1535, DOI 10.1016/j.jacc.2003.06.001; Gottlieb SS, 1998, NEW ENGL J MED, V339, P489, DOI 10.1056/NEJM199808203390801; Henry RMA, 2002, KIDNEY INT, V62, P1402, DOI 10.1046/j.1523-1755.2002.00571.x; Herzog CA, 1998, NEW ENGL J MED, V339, P799, DOI 10.1056/NEJM199809173391203; Holdaas H, 2003, LANCET, V361, P2024, DOI 10.1016/S0140-6736(03)13638-0; Januzzi JL, 2002, AM J CARDIOL, V90, P1246, DOI 10.1016/S0002-9149(02)02844-8; Keeley EC, 2003, AM J CARDIOL, V92, P509, DOI 10.1016/S0002-9149(03)00716-1; LEE KL, 1995, CIRCULATION, V91, P1659, DOI 10.1161/01.CIR.91.6.1659; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Lewis EJ, 2001, NEW ENGL J MED, V345, P851, DOI 10.1056/NEJMoa011303; Luft FC, 2000, BASIC RES CARDIOL, V95, P72; Manjunath G, 2003, J AM COLL CARDIOL, V41, P47, DOI 10.1016/S0735-1097(02)02663-3; McCullough PA, 1997, AM J MED, V103, P368, DOI 10.1016/S0002-9343(97)00150-2; McCullough PA, 2002, AM HEART J, V144, P226, DOI 10.1067/mhj.2002.125513; McCullough Peter A, 2003, Rev Cardiovasc Med, V4 Suppl 1, pS2; McCullough Peter A, 2002, Rev Cardiovasc Med, V3, P71; Pfeffer MA, 2003, NEW ENGL J MED, V349, P1893, DOI 10.1056/NEJMoa032292; Ruggenenti P, 2001, J AM SOC NEPHROL, V12, P2832, DOI 10.1681/ASN.V12122832; Sarnak MJ, 2000, AM J KIDNEY DIS, V35, pS117, DOI 10.1016/S0272-6386(00)70239-3; Sarnak MJ, 2003, HYPERTENSION, V42, P1050, DOI 10.1161/01.HYP.0000102971.85504.7c; Shlipak MG, 2002, ANN INTERN MED, V137, P555, DOI 10.7326/0003-4819-137-7-200210010-00006; Shlipak MG, 2003, ANN INTERN MED, V138, P917, DOI 10.7326/0003-4819-138-11-200306030-00013; Sorensen CR, 2002, EUR HEART J, V23, P948, DOI 10.1053/euhj.2001.2989; TOKMAKOVA M, 2003, EUR SOC CARD C VIENN; Tonelli M, 2003, J AM SOC NEPHROL, V14, P1605, DOI 10.1097/01.ASN.0000068461.45784.2F; US Renal Data System, 1999, USRDS 1999 ANN DAT R; Walsh CR, 2002, AM HEART J, V144, P1003, DOI 10.1067/mhj.2002.125504; Wolf G, 2002, AM J KIDNEY DIS, V39, P1, DOI 10.1053/ajkd.2002.29865; Wolfe RA, 1999, NEW ENGL J MED, V341, P1725, DOI 10.1056/NEJM199912023412303; Wright RS, 2002, ANN INTERN MED, V137, P563, DOI 10.7326/0003-4819-137-7-200210010-00007	43	1519	1584	0	39	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 23	2004	351	13					1285	1295		10.1056/NEJMoa041365	http://dx.doi.org/10.1056/NEJMoa041365			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	855TP	15385655	Bronze			2022-12-28	WOS:000223997700006
J	Blendon, RJ; Altman, DE; Benson, JM; Brodie, M				Blendon, RJ; Altman, DE; Benson, JM; Brodie, M			Election 2004: Health care in the 2004 presidential election.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article								Background: We examined the importance for voters of health care as an issue in the presidential election of 2004, how this ranking compares with the importance of health care in past elections, and which issues voters regard as the most important health care issues in the months before the election. Methods: We studied data from 22 national opinion surveys, 9 of them conducted as telephone surveys during the 2004 presidential campaign, 10 conducted as telephone surveys during the previous three presidential elections, and 3 conducted as national exit polls of voters. Results: Voters ranked health care as the fourth most important issue in deciding their vote for president in 2004. The top health care issues for voters were the costs of health care and prescription drugs, prescription-drug benefits for the elderly, the uninsured, and Medicare. Bioterrorism and abortion were also important issues for voters. The voters most concerned about health care were older persons and those who identified themselves as Democrats. Four issues less salient to voters were racial disparities in health care, aid to developing countries to prevent and treat human immunodeficiency virus infection and the acquired immunodeficiency syndrome, medical malpractice, and the quality of care. Conclusions: Although health care ranks higher in importance among voters than most other domestic issues, it is only fourth in importance in deciding their vote for president. The health care issues of greatest concern are the affordability of health care and health care insurance. Health care issues do not appear likely to play a decisive role in the presidential election in 2004, but they might make a difference in some swing states if the race is close.	Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA; Kaiser Family Fdn, Menlo Pk, CA USA	Harvard University; Harvard T.H. Chan School of Public Health	Benson, JM (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, 677 Huntington Ave,4th Fl, Boston, MA 02115 USA.	jmbenson@hsp.harvard.edu						Blendon RJ, 2003, J HEALTH COMMUN, V8, P83, DOI 10.1080/10810730390224884; BLENDON RJ, 2004, CHALLENGE, V47, P6; BRADY HE, 1992, MEDIA POLLS AM POLIT; *COUNC EXC GOV, 2004, COUNC EXC GOV POLL; Curtin R, 2000, PUBLIC OPIN QUART, V64, P413, DOI 10.1086/318638; DANIEL WW, 1991, BIOSTATISTICS FDN AN, P225; FIORINA MORRIS P., 1981, RETROSPECTIVE VOTING, P89; *HARV SCH PUBL HLT, 2003, KAIS FAM FDN HARV SC; *HARV SCH PUBL HLT, 2004, KAIS FAM FDN HARV SC; JOHNSON H, 1996, SYSTEM AM WAY POLITI; Keeter S, 2000, PUBLIC OPIN QUART, V64, P125, DOI 10.1086/317759; Kohn KT, 2000, ERR IS HUMAN BUILDIN; MARKUS GB, 1993, CLASSICS VOTING BEHA, P140; Mosteller F, 1949, PREELECTION POLLS 19; *NAT AC I MED BOAR, 2003, HIDD COSTS VAL LOST; NIEMI RG, 1993, CLASSICS VOTING BEHA, P93; *PEW RES CTR PEOPL, POLLS FAC GROW RES B; *ROP CTR PUBL OP R, 2000, GALL POLL       0911; *ROP CTR PUBL OP R, 1993, GALL CNN US TOD POLL; *ROP CTR PUBL OP R, 1992, VOT RES SURV NAT EL; TAYLORCLARK K, 2003, AFRICAN AM VIEWS HLT; Traugott MW, 2001, PUBLIC OPIN QUART, V65, P389, DOI 10.1086/322850; US Census Bureau, 2003, INC POV HLTH INS COV; VOSS DS, 1995, PUBLIC OPIN QUART, V59, P98, DOI 10.1086/269461; 2004, HARRIS INTERACT 0216; 2004, HARRIS INTERACT 0528; 2000, LOS ANGELES TIM 1107; 2004, HARRIS INTERACT 0623; 1996, LOS ANGELES TIM 1105; 1991, HARRIS POLL     1113; 1996, HARRIS POLL     1212; 2000, HARRIS INTERACTI MAY; 2004, HARRIS INTERACT 0525; 2004, WASHINGTON POST 0617	34	16	16	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 23	2004	351	13					1314	1322		10.1056/NEJMsa042360	http://dx.doi.org/10.1056/NEJMsa042360			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	855TP	15385658	Bronze			2022-12-28	WOS:000223997700009
J	Little, P				Little, P			Commentary: Watchful waiting is useful for children with recurrent throat infections	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ Southampton, Aldermoor Hlth Ctr, Community Clin Sci Div, Southampton SO16 5ST, Hants, England	University of Southampton	Little, P (corresponding author), Univ Southampton, Aldermoor Hlth Ctr, Community Clin Sci Div, Southampton SO16 5ST, Hants, England.	psl3@soton.ac.uk		Little, Paul/0000-0003-3664-1873				Burton MJ, 2000, COCHRANE DB SYST REV; Paradise JL, 2002, PEDIATRICS, V110; PARADISE JL, 1984, NEW ENGL J MED, V310, P674, DOI 10.1056/NEJM198403153101102; VANSTAAIJ BK, 2004, BMJ	4	2	2	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 18	2004	329	7467					654	654		10.1136/bmj.329.7467.654	http://dx.doi.org/10.1136/bmj.329.7467.654			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	856JU	15374915	Green Published, Bronze, Green Submitted			2022-12-28	WOS:000224042300018
J	Aubret, F; Shine, R; Bonnet, X				Aubret, F; Shine, R; Bonnet, X			Adaptive developmental plasticity in snakes	NATURE			English	Editorial Material									CNRS, CEBC, F-79360 Villiers En Bois, France; Univ Poitiers, Conseil Gen Deux Sevres, F-79360 Villiers En Bois, France; Univ Western Australia, Sch Anim Biol, Perth, WA 6009, Australia; Univ Sydney, Sydney, NSW 2006, Australia	Centre National de la Recherche Scientifique (CNRS); Universite de Poitiers; University of Western Australia; University of Sydney	Aubret, F (corresponding author), CNRS, CEBC, F-79360 Villiers En Bois, France.	rics@bio.usyd.edu.au	Shine, Richard/B-8711-2008	Bonnet, Xavier/0000-0001-6150-8199				AUBRET F, 2003, AMPHIBIA-REPTILIA, V25, P9; BOCK WJ, 1980, AM ZOOL, V20, P217; COGGER HG, 1992, REPTILES AMPHIBIANS; Dudley SA, 1996, AM NAT, V147, P445, DOI 10.1086/285860; Forsman A, 1997, BIOL J LINN SOC, V62, P209, DOI 10.1006/bijl.1997.0148; Pigliucci M., 2001, SYN ECO EVO; SHINE R, 1987, HERPETOLOGICA, V43, P233	7	104	107	0	49	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 16	2004	431	7006					261	262		10.1038/431261a	http://dx.doi.org/10.1038/431261a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	853XJ	15372019				2022-12-28	WOS:000223864000027
J	Sprague, AL; Boynton, WV; Kerry, KE; Janes, DM; Hunten, DM; Kim, KJ; Reedy, RC; Metzger, AE				Sprague, AL; Boynton, WV; Kerry, KE; Janes, DM; Hunten, DM; Kim, KJ; Reedy, RC; Metzger, AE			Mars' south polar Ar enhancement: A tracer for south polar seasonal meridional mixing	SCIENCE			English	Article							GENERAL-CIRCULATION; MARTIAN ATMOSPHERE; SURFACE	The gamma ray spectrometer on the Mars Odyssey spacecraft measured an enhancement of atmospheric argon over southern high latitudes during autumn followed by dissipation during winter and spring. Argon does not freeze at temperatures normal for southern winter (similar to145 kelvin) and is left in the atmosphere, enriched relative to carbon dioxide (CO2), as the southern seasonal cap of CO2 frost accumulates. Calculations of seasonal transport of argon into and out of southern high latitudes point to meridional (north-south) mixing throughout southern winter and spring.	Univ Arizona, Lunar & Planetary Lab, Tucson, AZ 85721 USA; Univ New Mexico, Inst Meteorit, Albuquerque, NM 87131 USA; CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA	University of Arizona; University of New Mexico; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL)	Sprague, AL (corresponding author), Univ Arizona, Lunar & Planetary Lab, 1629 E Univ Blvd, Tucson, AZ 85721 USA.	sprague@lpl.arizona.edu		Reedy, Robert/0000-0002-2189-1303; Kim, Kyeong J/0000-0001-6220-8411				Banfield D, 2003, ICARUS, V161, P319, DOI 10.1016/S0019-1035(02)00044-1; Boynton WV, 2004, SPACE SCI REV, V110, P37, DOI 10.1023/B:SPAC.0000021007.76126.15; CHAMBERLAIN J.W., 1987, THEORY PLANETARY ATM; Colaprete A, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002053; Feldman WC, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002101; HABERLE RM, COMMUNICATION; HESS SL, 1979, J GEOPHYS RES, V84, P2969, DOI 10.1029/JB084iB06p02969; KELLY N, 2003, 6 INT C MARS, V3244; Kieffer H. H., 1977, Journal of Geophysical Research, V82, P4249, DOI 10.1029/JS082i028p04249; KIEFFER HH, 1976, SCIENCE, V193, P780, DOI 10.1126/science.193.4255.780; Litvak ML, 2004, SOLAR SYST RES+, V38, P167, DOI 10.1023/B:SOLS.0000030856.83622.17; MCCONNOCHIE TH, 2003, AAS DIVISION PLANETA, P14; MCCONNOCHIE TH, 2003, 6 INT C MARS, V3249; METZGER AE, 1990, J GEOPHYS RES-SOLID, V95, P14695, DOI 10.1029/JB095iB09p14695; Owen T., 1977, J GEOPHYS RES, V82, P4635, DOI DOI 10.1029/JS082I028P04635; POLLACK JB, 1990, J GEOPHYS RES-SOLID, V95, P1447, DOI 10.1029/JB095iB02p01447; Prettyman TH, 2004, J GEOPHYS RES-PLANET, V109, DOI 10.1029/2003JE002139; PRETTYMAN TH, 2004, 35 LUN PLAN SCI C, V1878; SCHOEBERL MR, 1991, SCIENCE, V251, P46, DOI 10.1126/science.251.4989.46; Wilson RJ, 1997, GEOPHYS RES LETT, V24, P123, DOI 10.1029/96GL03814	20	57	57	1	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 19	2004	306	5700					1364	1367		10.1126/science.1098496	http://dx.doi.org/10.1126/science.1098496			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	873SP	15472041				2022-12-28	WOS:000225301600049
J	Lohrer, AM; Thrush, SF; Gibbs, MM				Lohrer, AM; Thrush, SF; Gibbs, MM			Bioturbators enhance ecosystem function through complex biogeochemical interactions	NATURE			English	Article							BIODIVERSITY; DISTURBANCE; PRODUCTIVITY; DIVERSITY; BIOMASS; IMPACTS; TERM	Predicting the consequences of species loss is critically important, given present threats to biological diversity such as habitat destruction, overharvesting and climate change(1). Several empirical studies have reported decreased ecosystem performance ( for example, primary productivity) coincident with decreased biodiversity(2-4), although the relative influence of biotic effects and confounding abiotic factors has been vigorously debated(5-7). Whereas several investigations focused on single trophic levels ( for example, grassland plants)(8,9), studies of whole systems have revealed multiple layers of feedbacks, hidden drivers and emergent properties(10,11), making the consequences of species loss more difficult to predict(12). Here we report functionally important organisms and considerable biocomplexity in a sedimentary seafloor habitat, one of Earth's most widespread ecosystems. Experimental field measurements demonstrate how the abundance of spatangoid urchins - infaunal ( in seafloor sediment) grazers / deposit feeders - is positively related to primary production, as their activities change nutrient fluxes and improve conditions for production by microphytobenthos (sedimentatry microbes and unicellular algae). Declines of spatangoid urchins after trawling are well documented(13,14), and our research linking these bioturbators to important benthic - pelagic fluxes highlights potential ramifications for productivity in coastal oceans.	Natl Inst Water & Atmospher Res, Hamilton, New Zealand	National Institute of Water & Atmospheric Research (NIWA) - New Zealand	Lohrer, AM (corresponding author), Natl Inst Water & Atmospher Res, POB 11-115, Hamilton, New Zealand.	d.lohrer@niwa.co.nz	Ross, Donald J/F-7607-2012	Ross, Donald J/0000-0002-8659-3833; Thrush, Simon/0000-0002-4005-3882				Bolam SG, 2002, ECOL MONOGR, V72, P599, DOI 10.1890/0012-9615(2002)072[0599:DBAEPI]2.0.CO;2; CLARK KR, 2001, PRIMER VERSION 5; Daan R, 1996, ICES J MAR SCI, V53, P1036, DOI 10.1006/jmsc.1996.0129; FALKOWSKI P, 1985, J PLANKTON RES, V7, P715, DOI 10.1093/plankt/7.5.715; Ghiold J., 1989, BIOL OCEANOGRAPHY, V6, P79, DOI DOI 10.1080/01965581.1988.10749524; Gray JS, 1997, BIODIVERS CONSERV, V6, P153, DOI 10.1023/A:1018335901847; Hansen H., 1983, METHODS SEAWATER ANA, P347; Hector A, 2002, BIODIVERSITY AND ECOSYSTEM FUNCTIONING: SYNTHESIS AND PERSPECTIVES, P36; Hector A, 2002, SCIENCE, V295, P639, DOI 10.1126/science.1064815; Herman PMJ, 1999, ADV ECOL RES, V29, P195; Huston MA, 2002, BIODIVERSITY AND ECOSYSTEM FUNCTIONING: SYNTHESIS AND PERSPECTIVES, P47; Jennings S, 2001, MAR ECOL PROG SER, V213, P127, DOI 10.3354/meps213127; LOHRER AM, UNPUB J EXP MAR BIOL; Long BG, 1995, MAR ECOL PROG SER, V129, P127, DOI 10.3354/meps129127; Michener WK, 2001, BIOSCIENCE, V51, P1018, DOI 10.1641/0006-3568(2001)051[1018:DAUB]2.0.CO;2; Naeem S, 2002, BIODIVERSITY AND ECOSYSTEM FUNCTIONING: SYNTHESIS AND PERSPECTIVES, P3; NAEEM S, 1994, NATURE, V368, P734, DOI 10.1038/368734a0; Polis GA, 1998, NATURE, V395, P744, DOI 10.1038/27323; Raffaelli D, 2002, BIODIVERSITY AND ECOSYSTEM FUNCTIONING: SYNTHESIS AND PERSPECTIVES, P147; Sartory D.P., 1982, SPECTROPHOTOMETRIC A; Snelgrove P, 1997, AMBIO, V26, P578; Thompson Bruce, 1993, Bulletin Southern California Academy of Sciences, V92, P25; THRUSH S, UNPUB ECOLOGY; Thrush SF, 2002, ANNU REV ECOL SYST, V33, P449, DOI 10.1146/annurev.ecolsys.33.010802.150515; Thrush SF, 1998, ECOL APPL, V8, P866, DOI 10.2307/2641273; Tilman D, 2002, BIODIVERSITY AND ECOSYSTEM FUNCTIONING: SYNTHESIS AND PERSPECTIVES, P21; Tilman D, 1999, ECOLOGY, V80, P1455, DOI 10.1890/0012-9658(1999)080[1455:TECOCI]2.0.CO;2; Tilman D, 1996, NATURE, V379, P718, DOI 10.1038/379718a0; Tilman D, 2001, SCIENCE, V294, P843, DOI 10.1126/science.1060391; Valiela I, 1995, MARINE ECOLOGICAL PR	30	413	433	12	203	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 28	2004	431	7012					1092	1095		10.1038/nature03042	http://dx.doi.org/10.1038/nature03042			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	865VB	15470385				2022-12-28	WOS:000224730800039
J	Tso, A; Harris, L; Littlewood, T				Tso, A; Harris, L; Littlewood, T			Acceptability to a general haematology clinic of written responses to referrals: questionnaire study	BMJ-BRITISH MEDICAL JOURNAL			English	Article									John Radcliffe Hosp, Dept Haematol, Oxford OX3 9DU, England	University of Oxford	Littlewood, T (corresponding author), John Radcliffe Hosp, Dept Haematol, Oxford OX3 9DU, England.	tim.littlewood@orh.nhs.uk						Wright D, 1992, Health Trends, V24, P145	1	7	7	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 23	2004	329	7472					946	947		10.1136/bmj.38253.703553.F7	http://dx.doi.org/10.1136/bmj.38253.703553.F7			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	866KU	15465846	Green Published, Bronze, Green Submitted			2022-12-28	WOS:000224773200016
J	Potter, BK				Potter, BK			The prince and the professor - With respect, professor, the Prince of Wales is not so wrong	BMJ-BRITISH MEDICAL JOURNAL			English	Letter									Asda Hulme, Manchester M15, England; Univ Nottingham, Nottingham NG7 2RD, England	University of Nottingham	Potter, BK (corresponding author), Asda Hulme, Manchester M15, England.	ldyxrkp@nottingham.ac.uk						Baum M, 2004, BRIT MED J, V329, P118, DOI 10.1136/bmj.329.7457.118	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 9	2004	329	7470					858	859		10.1136/bmj.329.7470.858-b	http://dx.doi.org/10.1136/bmj.329.7470.858-b			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	862EK	15472281	Green Published			2022-12-28	WOS:000224472800041
J	Singer, M				Singer, M			The evolution of postdocs	SCIENCE			English	Editorial Material									Natl Acad, Comm Sci Engn & Publ Policy, Washington, DC 20418 USA; Carnegie Inst Washington, Washington, DC 20005 USA	National Academies of Sciences, Engineering & Medicine; Carnegie Institution for Science	Singer, M (corresponding author), Natl Acad, Comm Sci Engn & Publ Policy, Washington, DC 20418 USA.	msinger@pst.ciw.edu						BENDERLY BL, 2004, SCI NEXT WAVE   0507; DRESSELHAUS MS, COMMUNICATION; Feist GJ, 1998, REV GEN PSYCHOL, V2, P3, DOI DOI 10.1037/1089-2680.2.1.3; HAAK L, 2002, SCI NEXT WAVE   0816; National Research Council (NRC), 2000, ENH POSTD EXP SCI EN; National Science Foundation, SURV GRAD STUD POSTD; *NRC, 1988, TRENDS EARL CAR LIF; *OFF POSTD SERV, 2003, POSTD OPT PROM; SREENIVASAN A, 2003, SCI NEXT WAVE   0321	9	10	10	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 8	2004	306	5694					232	232		10.1126/science.1104916	http://dx.doi.org/10.1126/science.1104916			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	861MC	15472063				2022-12-28	WOS:000224419700022
J	Remondes, M; Schuman, EM				Remondes, M; Schuman, EM			Role for a cortical input to hippocampal area CA1 in the consolidation of a long-term memory	NATURE			English	Article							SLOW-WAVE SLEEP; PLACE; PLASTICITY; LESIONS; AMNESIA; CELLS	A dialogue between the hippocampus and the neocortex is thought to underlie the formation, consolidation and retrieval of episodic memories(1-4), although the nature of this corticohippocampal communication is poorly understood. Using selective electrolytic lesions in rats, here we examined the role of the direct entorhinal projection (temporoammonic, TA) to the hippocampal area CA1 in short-term (24 hours) and long-term (four weeks) spatial memory in the Morris water maze. When short-term memory was examined, both sham- and TA-lesioned animals showed a significant preference for the target quadrant. When re-tested four weeks later, sham- lesioned animals exhibited long-term memory; in contrast, the TA-lesioned animals no longer showed target quadrant preference. Many long-lasting memories require a process called consolidation, which involves the exchange of information between the cortex and hippocampus(3,5,6). The disruption of long-term memory by the TA lesion could reflect a requirement for TA input during either the acquisition or consolidation of long-term memory. To distinguish between these possibilities, we trained animals, verified their spatial memory 24 hours later, and then subjected trained animals to TA lesions. TA-lesioned animals still exhibited a deficit in long-term memory, indicating a disruption of consolidation. Animals in which the TA lesion was delayed by three weeks, however, showed a significant preference for the target quadrant, indicating that the memory had already been adequately consolidated at the time of the delayed lesion. These results indicate that, after learning, ongoing cortical input conveyed by the TA path is required to consolidate long-term spatial memory.	CALTECH, Howard Hughes Med Inst, Div Biol, Pasadena, CA 91125 USA	California Institute of Technology; Howard Hughes Medical Institute	Schuman, EM (corresponding author), CALTECH, Howard Hughes Med Inst, Div Biol, 114-96, Pasadena, CA 91125 USA.	schumane@its.caltech.edu	Schuman, Erin M/D-6204-2011	Remondes, Miguel/0000-0001-9321-3985				Brun VH, 2002, SCIENCE, V296, P2243, DOI 10.1126/science.1071089; COLBERT CM, 1993, BRAIN RES, V606, P87, DOI 10.1016/0006-8993(93)91573-B; Dvorak-Carbone H, 1999, J NEUROPHYSIOL, V81, P1036, DOI 10.1152/jn.1999.81.3.1036; Dvorak-Carbone H, 1999, J NEUROPHYSIOL, V82, P3213, DOI 10.1152/jn.1999.82.6.3213; Eichenbaum H, 2000, NAT REV NEUROSCI, V1, P41, DOI 10.1038/35036213; EICHENBAUM H, 1990, J NEUROSCI, V10, P3531; El-Ghundi M, 1999, EUR J PHARMACOL, V383, P95, DOI 10.1016/S0014-2999(99)00573-7; Frankland PW, 2001, NATURE, V411, P309, DOI 10.1038/35077089; JARRARD LE, 1983, BEHAV NEUROSCI, V97, P873, DOI 10.1037/0735-7044.97.6.873; Lee AK, 2002, NEURON, V36, P1183, DOI 10.1016/S0896-6273(02)01096-6; Li SM, 2003, NAT NEUROSCI, V6, P526, DOI 10.1038/nn1049; MCGAUGH JL, 1966, SCIENCE, V153, P1351, DOI 10.1126/science.153.3742.1351; MCNAUGHTON BL, 1989, EXP BRAIN RES, V76, P485, DOI 10.1007/BF00248904; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; Nakazawa K, 2002, SCIENCE, V297, P211, DOI 10.1126/science.1071795; Otmakhova NA, 1999, J NEUROSCI, V19, P1437; Remondes M, 2003, LEARN MEMORY, V10, P247, DOI 10.1101/lm.59103; Remondes M, 2002, NATURE, V416, P736, DOI 10.1038/416736a; Riedel G, 1999, NAT NEUROSCI, V2, P898, DOI 10.1038/13202; Scoville WB, 2000, J NEUROPSYCH CLIN N, V12, P103; Siapas AG, 1998, NEURON, V21, P1123, DOI 10.1016/S0896-6273(00)80629-7; Sirota A, 2003, P NATL ACAD SCI USA, V100, P2065, DOI 10.1073/pnas.0437938100; SKELTON RW, 1992, HIPPOCAMPUS, V2, P73, DOI 10.1002/hipo.450020110; SQUIRE LR, 1995, CURR OPIN NEUROBIOL, V5, P169, DOI 10.1016/0959-4388(95)80023-9; Squire LR, 1997, PHILOS T R SOC B, V352, P1663, DOI 10.1098/rstb.1997.0148; SUTHERLAND RJ, 1983, BEHAV BRAIN RES, V7, P133, DOI 10.1016/0166-4328(83)90188-2; WILSON MA, 1994, SCIENCE, V265, P676, DOI 10.1126/science.8036517	27	283	292	0	37	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 7	2004	431	7009					699	703		10.1038/nature02965	http://dx.doi.org/10.1038/nature02965			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	859WS	15470431				2022-12-28	WOS:000224299300043
J	de Kraker, J; Graf, N; van Tinteren, H; Pein, F; Sandstedt, B; Godzinski, J; Tournade, MF				de Kraker, J; Graf, N; van Tinteren, H; Pein, F; Sandstedt, B; Godzinski, J; Tournade, MF		Int Soc Paediat Oncology Nephrobla	Reduction of postoperative chemotherapy in children with stage I intermediate-risk and anaplastic Wilms' tumour (SIOP 93-01 trial): a randomised controlled trial	LANCET			English	Article							PAEDIATRIC-ONCOLOGY SIOP; INTERNATIONAL-SOCIETY; PEDIATRIC-ONCOLOGY; CLINICAL-TRIAL; CANCER; EQUIVALENCE; CHILDHOOD; DURATION; SINGLE; COSTS	Background Present treatment for Wilms' tumour is very successful. Now, efforts are aimed at reducing toxicity and burden of treatment by shortening schedules without loss of effectiveness. The objective of this randomised trial was to assess whether postoperative chemotherapy for patients with stage I intermediate-risk and anaplastic Wilms' tumour could be shortened to only 4 weeks from the standard 18 weeks, while maintaining equivalent event-free survival. Methods Between June, 1993, and June, 2000, 410 patients were randomly assigned after four doses of vincristine plus one course of dactinomycin postoperatively either to stop further adjuvant chemotherapy (no further chemotherapy group, n=200), or to receive a further two courses of the same chemotherapy (standard group, n=210). Previous treatment consisted of chemotherapy before nephrectomy of four doses of vincristine and two courses of dactinomycin followed by surgical resection of the tumour. Eligible patients were at least 6 months old and had stage I tumours with either intermediate-risk histology or anaplasia. The primary endpoint of this equivalence trial was 2-year event-free survival. Both per-protocol and intention-to-treat analyses were done. Findings By 2 years, 18 recurrences were reported in the standard group, and 22 in the no further chemotherapy group. Event-free survival was 91.4% (95% CI 87.5-95.2) for the no further chemotherapy group and 88.8% (84.3-93.2) for the standard group (difference=2.6%, upper 97.5% confidence limit 8.4%). The null hypothesis, that experimental treatment is less effective than standard treatment, could be rejected (p=0.008). Conclusions Shortening duration of chemotherapy could reduce acute and late side-effects and inconvenience for patient and parents while maintaining effectiveness, and could be beneficial in terms of health costs.	Univ Amsterdam, Acad Med Ctr, Emma Kinderziekenhuis, Dept Paediat Oncol, NL-1100 DE Amsterdam, Netherlands; Univ Klin Kinder & Jugendmed, Dept Paediat Haematol Oncol, Homburg, Germany; Ctr Comprehens Canc, Amsterdam, Netherlands; Inst Gustave Roussy, Dept Paediat Oncol, Paris, France; Karolinska Inst, Astrid Lindgren Childrens Hosp, Childhood Canc Res Unit, Stockholm, Sweden; Marciniak Hosp, Dept Paediat Surg, Wroclaw, Poland	Emma Children's Hospital; University of Amsterdam; Academic Medical Center Amsterdam; Universitatsklinikum des Saarlandes; UNICANCER; Gustave Roussy; Karolinska Institutet	de Kraker, J (corresponding author), Univ Amsterdam, Acad Med Ctr, Emma Kinderziekenhuis, Dept Paediat Oncol, POB 22700, NL-1100 DE Amsterdam, Netherlands.	j.dekraker@amc.uva.nl	Graf, Norbert/H-1328-2011	Graf, Norbert/0000-0002-2248-323X; van Tinteren, Harm/0000-0002-4626-8702				Barr RD, 1996, INT J ONCOL, V8, P933; BLOOM BS, 1985, JAMA-J AM MED ASSOC, V253, P2393, DOI 10.1001/jama.253.16.2393; Chan ISF, 2003, STAT METHODS MED RES, V12, P37, DOI 10.1191/0962280203sm314ra; DANGIO GJ, 1989, CANCER-AM CANCER SOC, V64, P349, DOI 10.1002/1097-0142(19890715)64:2<349::AID-CNCR2820640202>3.0.CO;2-Q; Delemarre JFM, 1996, MED PEDIATR ONCOL, V26, P145, DOI 10.1002/(SICI)1096-911X(199602)26:2<145::AID-MPO15>3.0.CO;2-H; Godzinski J, 1998, EUR J PEDIATR SURG, V8, P83, DOI 10.1055/s-2008-1071127; Green DM, 1998, J CLIN ONCOL, V16, P3744, DOI 10.1200/JCO.1998.16.12.3744; Green DM, 1998, J CLIN ONCOL, V16, P237, DOI 10.1200/JCO.1998.16.1.237; LEMERLE J, 1976, CANCER, V38, P647, DOI 10.1002/1097-0142(197608)38:2<647::AID-CNCR2820380204>3.0.CO;2-C; LEMERLE J, 1983, J CLIN ONCOL, V1, P604, DOI 10.1200/JCO.1983.1.10.604; MCDONALD GB, 1993, MARROW TRANSPL REV, V3, P49; Mitchell C, 2000, BRIT J CANCER, V83, P602, DOI 10.1054/bjoc.2000.1338; RODARY C, 1989, STAT MED, V8, P593, DOI 10.1002/sim.4780080508; TOURNADE MF, 1993, J CLIN ONCOL, V11, P1014, DOI 10.1200/JCO.1993.11.6.1014; Tournade MF, 2001, J CLIN ONCOL, V19, P488, DOI 10.1200/JCO.2001.19.2.488	15	140	141	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	OCT 2	2004	364	9441					1229	1235		10.1016/S0140-6736(04)17139-0	http://dx.doi.org/10.1016/S0140-6736(04)17139-0			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	859HO	15464183				2022-12-28	WOS:000224254200029
J	Bateman, JM; McNeill, H				Bateman, JM; McNeill, H			Temporal control of differentiation by the insulin receptor/Tor pathway in Drosophila	CELL			English	Article							CONTROLS PLANAR POLARITY; TOP MESSENGER-RNAS; CELL-GROWTH; TUMOR-SUPPRESSOR; EYE DEVELOPMENT; DIRECT TARGET; TRANSCRIPTION FACTORS; RHEB; KINASE; TSC1	Multicellular organisms must integrate growth and differentiation precisely to pattern complex tissues. Despite great progress in understanding how different cell fates are induced, it is poorly understood how differentiation decisions are temporally regulated. In a screen for patterning mutants, we isolated alleles of tsc1, a component of the insulin receptor (InR) growth control pathway. We find that loss of tsc1 disrupts patterning due to a loss of temporal control of differentiation. tsc1 controls the timing of differentiation downstream or in parallel to the RAS/MAPK pathway. Examination of InR, PI3K, PTEN, Tor, Rheb, and S6 kinase mutants demonstrates that increased InR signaling leads to precocious differentiation while decreased signaling leads to delays in differentiation. Importantly, cell fates are unchanged, but tissue organization is lost upon loss of developmental timing controls. These data suggest that intricate developmental decisions are coordinated with nutritional status and tissue growth by the InR signaling pathway.	Canc Res UK, London WC2A 3PX, England	Cancer Research UK	McNeill, H (corresponding author), Canc Res UK, 44 Lincolns Inn Fields, London WC2A 3PX, England.	helen.mcneill@cancer.org.uk	Bateman, Joseph M/F-3625-2011; McNeill, Helen/E-4579-2013	McNeill, Helen/0000-0003-1126-5154; Bateman, Joseph/0000-0003-0754-1785				Behan KJ, 2002, DEV GENES EVOL, V212, P267, DOI 10.1007/s00427-002-0241-4; BOHMANN D, 1994, CELL, V78, P973, DOI 10.1016/0092-8674(94)90273-9; Britton JS, 1998, DEVELOPMENT, V125, P2149; Britton JS, 2002, DEV CELL, V2, P239, DOI 10.1016/S1534-5807(02)00117-X; CAGAN RL, 1992, CELL, V69, P393, DOI 10.1016/0092-8674(92)90442-F; Campos-Ortega J, 1997, EMBRYONIC DEV DROSOP; Daga A, 1996, GENE DEV, V10, P1194, DOI 10.1101/gad.10.10.1194; Datar SA, 2000, EMBO J, V19, P4543, DOI 10.1093/emboj/19.17.4543; DENOOIJ JC, 1995, SCIENCE, V270, P983, DOI 10.1126/science.270.5238.983; Fanto M, 2003, DEVELOPMENT, V130, P763, DOI 10.1242/dev.00304; Gao XS, 2001, GENE DEV, V15, P1383, DOI 10.1101/gad.901101; Garami A, 2003, MOL CELL, V11, P1457, DOI 10.1016/S1097-2765(03)00220-X; GOMEZ MR, 1999, TUBEROUS SCLEROSIS; HIGASHIJIMA SI, 1992, GENE DEV, V6, P50, DOI 10.1101/gad.6.1.50; Inoki K, 2003, GENE DEV, V17, P1829, DOI 10.1101/gad.1110003; Isshiki T, 2001, CELL, V106, P511, DOI 10.1016/S0092-8674(01)00465-2; JAN YN, 1985, J NEUROSCI, V5, P2453; Johnston LA, 1999, CELL, V98, P779, DOI 10.1016/S0092-8674(00)81512-3; Kockel L, 1997, GENE DEV, V11, P1748, DOI 10.1101/gad.11.13.1748; LAI ZC, 1992, CELL, V70, P609, DOI 10.1016/0092-8674(92)90430-K; Lamb RF, 2000, NAT CELL BIOL, V2, P281, DOI 10.1038/35010550; Leevers Sally J., 2004, VVolume 42, P167; Leevers SJ, 1996, EMBO J, V15, P6584, DOI 10.1002/j.1460-2075.1996.tb01049.x; Lewis J, 2003, CURR BIOL, V13, P1398, DOI 10.1016/S0960-9822(03)00534-7; McConnell S K, 1992, Curr Opin Neurobiol, V2, P23, DOI 10.1016/0959-4388(92)90156-F; McNeill H, 2000, NAT REV GENET, V1, P100, DOI 10.1038/35038540; Meyuhas O, 2000, COLD SPRING HARBOR M, V39, P671; MORATA G, 1975, NATURE, V255, P614, DOI 10.1038/255614a0; Neufeld TP, 1998, CELL, V93, P1183, DOI 10.1016/S0092-8674(00)81462-2; Newsome TP, 2000, DEVELOPMENT, V127, P851; Nolo R, 2000, CELL, V102, P349, DOI 10.1016/S0092-8674(00)00040-4; ONEILL EM, 1994, CELL, V78, P137, DOI 10.1016/0092-8674(94)90580-0; Pasquinelli AE, 2002, ANNU REV CELL DEV BI, V18, P495, DOI 10.1146/annurev.cellbio.18.012502.105832; Pende M, 2004, MOL CELL BIOL, V24, P3112, DOI 10.1128/MCB.24.8.3112-3124.2004; Poethig RS, 2003, SCIENCE, V301, P334, DOI 10.1126/science.1085328; Potter CJ, 2001, CELL, V105, P357, DOI 10.1016/S0092-8674(01)00333-6; Prober DA, 2002, GENE DEV, V16, P2286, DOI 10.1101/gad.991102; REBAY I, 1995, CELL, V81, P857, DOI 10.1016/0092-8674(95)90006-3; RODRIGUEZVICIANA P, 1994, NATURE, V370, P527, DOI 10.1038/370527a0; Song JB, 2003, SCIENCE, V300, P502, DOI 10.1126/science.1081203; Sparagana Steven P., 2000, Current Opinion in Neurology, V13, P115, DOI 10.1097/00019052-200004000-00001; Stocker H, 2003, NAT CELL BIOL, V5, P559, DOI 10.1038/ncb995; Stolovich M, 2002, MOL CELL BIOL, V22, P8101, DOI 10.1128/MCB.22.23.8101-8113.2002; Tang AH, 1997, CELL, V90, P459, DOI 10.1016/S0092-8674(00)80506-1; Tapon N, 2001, CELL, V105, P345, DOI 10.1016/S0092-8674(01)00332-4; Tee AR, 2003, CURR BIOL, V13, P1259, DOI 10.1016/S0960-9822(03)00506-2; Thummel CS, 2001, DEV CELL, V1, P453, DOI 10.1016/S1534-5807(01)00060-0; Voas MG, 2004, DEV DYNAM, V229, P162, DOI 10.1002/dvdy.10449; WASSARMAN DA, 1994, GENE, V144, P309, DOI 10.1016/0378-1119(94)90396-4; Wolff Tanya, 1993, P1277; Xu CY, 2000, CELL, V103, P87, DOI 10.1016/S0092-8674(00)00107-0; XU T, 1993, DEVELOPMENT, V117, P1223; Yang CH, 1999, DEVELOPMENT, V126, P5857; Zhang Y, 2003, NAT CELL BIOL, V5, P578, DOI 10.1038/ncb999	54	86	90	1	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 1	2004	119	1					87	96		10.1016/j.cell.2004.08.028	http://dx.doi.org/10.1016/j.cell.2004.08.028			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	859UE	15454083	Bronze			2022-12-28	WOS:000224292600011
J	Eichman, BF; Fanning, E				Eichman, BF; Fanning, E			The power of pumping together: Deconstructing the engine of a DNA replication machine	CELL			English	Editorial Material							SIMIAN-VIRUS-40 T-ANTIGEN; VIRAL ORIGIN; INITIATION; PROTEINS; BINDING	The replicative DNA helicase lies at the heart of the eukaryotic replication machine, yet how it works remains puzzling. New structures of the viral replicative helicase SV40 T antigen (Gai et al., 2004 (this issue of Cell]) suggest that a novel concerted mode of nucleotide binding and hydrolysis powers conformation changes and DNA unwinding.	Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37232 USA; Vanderbilt Univ, Ctr Struct Biol, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University	Eichman, BF (corresponding author), Vanderbilt Univ, Dept Biol Sci, 465 21st Ave S, Nashville, TN 37232 USA.			Eichman, Brandt/0000-0002-0965-2297				Forsburg SL, 2004, MICROBIOL MOL BIOL R, V68, P109, DOI 10.1128/MMBR.68.1.109-131.2004; Gai' DH, 2004, CELL, V119, P47, DOI 10.1016/j.cell.2004.09.017; Huang SG, 1998, BIOCHEMISTRY-US, V37, P15336, DOI 10.1021/bi981094g; Kaplan DL, 2004, MOL CELL, V15, P453, DOI 10.1016/j.molcel.2004.06.039; Reese DK, 2004, J VIROL, V78, P2921, DOI 10.1128/JVI.78.6.2921-2934.2004; Sclafani RA, 2004, GENE DEV, V18, P2039, DOI 10.1101/gad.1240604; Simmons DT, 2000, ADV VIRUS RES, V55, P75, DOI 10.1016/S0065-3527(00)55002-7; Singleton MR, 2000, CELL, V101, P589, DOI 10.1016/S0092-8674(00)80871-5; Stenlund A, 2003, NAT REV MOL CELL BIO, V4, P777, DOI 10.1038/nrm1226; Weisshart K, 1999, J VIROL, V73, P2201, DOI 10.1128/JVI.73.3.2201-2211.1999	10	8	8	0	4	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	OCT 1	2004	119	1					3	4		10.1016/j.cell.2004.09.023	http://dx.doi.org/10.1016/j.cell.2004.09.023			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	859UE	15454074	Bronze			2022-12-28	WOS:000224292600002
J	Collins, S; Bell, G				Collins, S; Bell, G			Phenotypic consequences of 1,000 generations of selection at elevated CO2 in a green alga	NATURE			English	Article							CHLAMYDOMONAS-REINHARDTII; ESCHERICHIA-COLI; DIVERSITY; RESPONSES; ENVIRONMENTS; MECHANISMS; RADIATION	Estimates of the effect of increasing atmospheric CO2 concentrations on future global plant production rely on the physiological response of individual plants or plant communities when exposed to high CO2 (refs 1 - 6). Plant populations may adapt to the changing atmosphere, however, such that the evolved plant communities of the next century are likely to be genetically different from contemporary communities(7-12). The properties of these future communities are unknown, introducing a bias of unknown sign and magnitude into projections of global carbon pool dynamics. Here we report a long-term selection experiment to investigate the phenotypic consequences of selection for growth at elevated CO2 concentrations. After about 1,000 generations, selection lines of the unicellular green alga Chlamydomonas failed to evolve specific adaptation to a CO2 concentration of 1,050 parts per million. Some lines, however, evolved a syndrome involving high rates of photosynthesis and respiration, combined with higher chlorophyll content and reduced cell size. These lines also grew poorly at ambient concentrations of CO2. We tentatively attribute this outcome to the accumulation of conditionally neutral mutations in genes affecting the carbon concentration mechanism.	McGill Univ, Dept Biol, Montreal, PQ H3A 1B1, Canada	McGill University	Bell, G (corresponding author), McGill Univ, Dept Biol, 1205 Doctor Penfield Ave, Montreal, PQ H3A 1B1, Canada.	graham.bell@mcgill.ca	Collins, Sinead/F-3788-2010	Collins, Sinead/0000-0003-3856-4285				Andalo C, 2001, ECOLOGY, V82, P157, DOI 10.1890/0012-9658(2001)082[0157:IAICUE]2.0.CO;2; Badger MR, 1998, CAN J BOT, V76, P1052, DOI 10.1139/b98-074; Badger Murray R., 2000, Advances in Photosynthesis, V9, P369; BAZZAZ FA, 1995, P NATL ACAD SCI USA, V92, P8161, DOI 10.1073/pnas.92.18.8161; Colman B, 2002, FUNCT PLANT BIOL, V29, P261, DOI 10.1071/PP01184; FALCONER DS, 1990, GENET RES, V56, P57, DOI 10.1017/S0016672300028883; Fuhrer J, 2003, AGR ECOSYST ENVIRON, V97, P1, DOI 10.1016/S0167-8809(03)00125-7; Griffin KL, 2001, P NATL ACAD SCI USA, V98, P2473, DOI 10.1073/pnas.041620898; Harris E. H., 1989, CHLAMYDOMONAS SOURCE; Hillebrand H, 1999, J PHYCOL, V35, P403, DOI 10.1046/j.1529-8817.1999.3520403.x; Lee TD, 2001, NEW PHYTOL, V150, P405, DOI 10.1046/j.1469-8137.2001.00095.x; Luscher A, 1998, OECOLOGIA, V113, P37, DOI 10.1007/s004420050351; MacLean RC, 2002, AM NAT, V160, P569, DOI 10.1086/342816; Notley-McRobb L, 1999, ENVIRON MICROBIOL, V1, P33, DOI 10.1046/j.1462-2920.1999.00002.x; Potvin C, 1996, OECOLOGIA, V108, P683, DOI 10.1007/BF00329043; Raven JA, 2001, J PHYCOL, V37, P943, DOI 10.1046/j.1529-8817.2001.01079.x; RUBAN O, 2003, PHOTOSYNTHETICA, V41, P9; Saxe H, 1998, NEW PHYTOL, V139, P395, DOI 10.1046/j.1469-8137.1998.00221.x; Spalding MH, 2002, FUNCT PLANT BIOL, V29, P221, DOI 10.1071/PP01182; Sultemeyer D, 1998, CAN J BOT, V76, P962; SUZUKI K, 1989, PLANT PHYSIOL, V90, P1195, DOI 10.1104/pp.90.3.1195; Thyssen C, 2003, PLANTA, V217, P102, DOI 10.1007/s00425-002-0961-8; Tilman D, 2001, P NATL ACAD SCI USA, V98, P5433, DOI 10.1073/pnas.091093198; Travisano M, 1996, GENETICS, V143, P15; Turner PE, 2000, GENETICS, V156, P1465; Ward JK, 2000, OECOLOGIA, V123, P330, DOI 10.1007/s004420051019; Watson R, 2001, CLIMATE CHANGE 2001: THE SCIENTIFIC BASIS, pIX; Xue XP, 1996, PLANT PHYSIOL, V112, P1005, DOI 10.1104/pp.112.3.1005; Yedid G, 2002, NATURE, V420, P810, DOI 10.1038/nature01151	29	246	255	4	133	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 30	2004	431	7008					566	569		10.1038/nature02945	http://dx.doi.org/10.1038/nature02945			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	857YP	15457260				2022-12-28	WOS:000224156700046
J	Jiang, N; Bao, ZR; Zhang, XY; Eddy, SR; Wessler, SR				Jiang, N; Bao, ZR; Zhang, XY; Eddy, SR; Wessler, SR			Pack-MULE transposable elements mediate gene evolution in plants	NATURE			English	Article							DRAFT SEQUENCE; RICE; GENOME; IDENTIFICATION; DIVERSITY	Mutator-like transposable elements (MULEs) are found in many eukaryotic genomes and are especially prevalent in higher plants(1-3). In maize, rice and Arabidopsis a few MULEs were shown to carry fragments of cellular genes(4-6). These chimaeric elements are called Pack-MULEs in this study. The abundance of MULEs in rice and the availability of most of the genome sequence permitted a systematic analysis of the prevalence and nature of Pack-MULEs in an entire genome. Here we report that there are over 3,000 Pack-MULEs in rice containing fragments derived from more than 1,000 cellular genes. Pack-MULEs frequently contain fragments from multiple chromosomal loci that are fused to form new open reading frames, some of which are expressed as chimaeric transcripts. About 5% of the Pack-MULEs are represented in collections of complementary DNA. Functional analysis of amino acid sequences and proteomic data indicate that some captured gene fragments might be functional. Comparison of the cellular genes and Pack-MULE counterparts indicates that fragments of genomic DNA have been captured, rearranged and amplified over millions of years. Given the abundance of Pack-MULEs in rice and the widespread occurrence of MULEs in all characterized plant genomes, gene fragment acquisition by Pack-MULEs might represent an important new mechanism for the evolution of genes in higher plants.	Univ Georgia, Dept Plant Biol, Athens, GA 30602 USA; Washington Univ, Howard Hughes Med Inst, St Louis, MO 63108 USA; Washington Univ, Dept Genet, St Louis, MO 63108 USA	University System of Georgia; University of Georgia; Howard Hughes Medical Institute; Washington University (WUSTL); Washington University (WUSTL)	Wessler, SR (corresponding author), Univ Georgia, Dept Plant Biol, Athens, GA 30602 USA.	suew@plantbio.uga.edu	Jiang, Ning/G-6546-2012	Eddy, Sean/0000-0001-6676-4706				Bao ZR, 2002, GENOME RES, V12, P1269, DOI 10.1101/gr.88502; BENNETZEN JL, 1994, THEOR APPL GENET, V87, P657, DOI 10.1007/BF00222890; Chalvet F, 2003, MOL BIOL EVOL, V20, P1362, DOI 10.1093/molbev/msg155; CRESSE AD, 1995, GENETICS, V140, P315; Emerson JJ, 2004, SCIENCE, V303, P537, DOI 10.1126/science.1090042; Goff SA, 2002, SCIENCE, V296, P92, DOI 10.1126/science.1068275; Hanley S, 2000, PLANT J, V23, P557, DOI 10.1046/j.1365-313x.2000.00830.x; Jiang N, 2003, NATURE, V421, P163, DOI 10.1038/nature01214; Kikuchi S, 2003, SCIENCE, V301, P376, DOI 10.1126/science.1081288; Koller A, 2002, P NATL ACAD SCI USA, V99, P11969, DOI 10.1073/pnas.172183199; KUMAR S, 2001, MEGA2 MOL EVOLUTIONA; Le QH, 2000, P NATL ACAD SCI USA, V97, P7376, DOI 10.1073/pnas.97.13.7376; LEVY AA, 1991, MOL GEN GENET, V229, P147, DOI 10.1007/BF00264223; Lisch D, 2002, TRENDS PLANT SCI, V7, P498, DOI 10.1016/S1360-1385(02)02347-6; Moran JV, 1999, SCIENCE, V283, P1530, DOI 10.1126/science.283.5407.1530; Normile D, 2002, SCIENCE, V296, P32, DOI 10.1126/science.296.5565.32; Sasaki T, 2002, NATURE, V420, P312, DOI 10.1038/nature01184; TALBERT LE, 1988, MOL BIOL EVOL, V5, P519; TAYLOR LP, 1985, EMBO J, V4, P869, DOI 10.1002/j.1460-2075.1985.tb03712.x; Turcotte K, 2001, PLANT J, V25, P169, DOI 10.1046/j.1365-313x.2001.00945.x; Walbot Virginia, 2002, P533; Yu J, 2002, SCIENCE, V296, P79, DOI 10.1126/science.1068037; Yu YS, 2003, SCIENCE, V300, P1566, DOI 10.1126/science.1083523; Yu ZH, 2000, GENETICS, V156, P2019	24	381	412	1	55	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 30	2004	431	7008					569	573		10.1038/nature02953	http://dx.doi.org/10.1038/nature02953			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	857YP	15457261				2022-12-28	WOS:000224156700047
J	Rohde, DLT; Olson, S; Chang, JT				Rohde, DLT; Olson, S; Chang, JT			Modelling the recent common ancestry of all living humans	NATURE			English	Article							POPULATION; GENEALOGY	If a common ancestor of all living humans is defined as an individual who is a genealogical ancestor of all present-day people, the most recent common ancestor (MRCA) for a randomly mating population would have lived in the very recent past(1-3). However, the random mating model ignores essential aspects of population substructure, such as the tendency of individuals to choose mates from the same social group, and the relative isolation of geographically separated groups. Here we show that recent common ancestors also emerge from two models incorporating substantial population substructure. One model, designed for simplicity and theoretical insight, yields explicit mathematical results through a probabilistic analysis. A more elaborate second model, designed to capture historical population dynamics in a more realistic way, is analysed computationally through Monte Carlo simulations. These analyses suggest that the genealogies of all living humans overlap in remarkable ways in the recent past. In particular, the MRCA of all present-day humans lived just a few thousand years ago in these models. Moreover, among all individuals living more than just a few thousand years earlier than the MRCA, each present-day human has exactly the same set of genealogical ancestors.	MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; Yale Univ, Dept Stat, New Haven, CT 06520 USA	Massachusetts Institute of Technology (MIT); Yale University	Rohde, DLT (corresponding author), MIT, Dept Brain & Cognit Sci, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	dr@tedlab.mit.edu						Bonne-Tamir B, 2003, ANN HUM GENET, V67, P153, DOI 10.1046/j.1469-1809.2003.00024.x; Chang JT, 1999, ADV APPL PROBAB, V31, P1002, DOI 10.1239/aap/1029955256; Derrida B, 2000, PHYSICA A, V281, P1, DOI 10.1016/S0378-4371(00)00031-5; Derrida B, 2000, J THEOR BIOL, V203, P303, DOI 10.1006/jtbi.2000.1095; Fitzhugh W., 1988, CROSSROADS CONTINENT; Hey J, 2003, NAT REV GENET, V4, P535, DOI 10.1038/nrg1112; Hoerder D., 2002, CULTURES CONTACT WOR; Hudson R.R., 1990, Oxford Surveys in Evolutionary Biology, V7, P1; Ingman M, 2000, NATURE, V408, P708, DOI 10.1038/35047064; JONES R, 1995, ANNU REV ANTHROPOL, V24, P423; Jorde L., 1980, CURRENT DEV ANTHR GE, V1, P135, DOI DOI 10.1007/978-1-4613-3084-4_7; MORTON NE, 1971, AM J HUM GENET, V23, P339; NOTOHARA M, 1990, J MATH BIOL, V29, P59, DOI 10.1007/BF00173909; Ohno S, 1996, P NATL ACAD SCI USA, V93, P15276, DOI 10.1073/pnas.93.26.15276; Pletcher SD, 1999, J EVOLUTION BIOL, V12, P430, DOI 10.1046/j.1420-9101.1999.00058.x; Stannard David E., 1992, AM HOLOCAUST COLUMBU; Thomson R, 2000, P NATL ACAD SCI USA, V97, P7360, DOI 10.1073/pnas.97.13.7360; *US NAT OFF VIT ST, 1956, VIT STAT SPEC REP, V43; Wachter K. W., 1980, GENEALOGICAL DEMOGRA, P85; WARD RH, 1970, AM J HUM GENET, V22, P538; WEISS KM, 1976, AM J PHYS ANTHROPOL, V44, P31, DOI 10.1002/ajpa.1330440106; Wilkinson-Herbots HM, 1998, J MATH BIOL, V37, P535, DOI 10.1007/s002850050140; Wiuf C, 1997, GENETICS, V147, P1459; Zerjal T, 2003, AM J HUM GENET, V72, P717, DOI 10.1086/367774	24	74	76	0	50	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 30	2004	431	7008					562	566		10.1038/nature02842	http://dx.doi.org/10.1038/nature02842			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	857YP	15457259	Green Submitted			2022-12-28	WOS:000224156700045
J	Schroeder, SA				Schroeder, SA			The tobacco buyout and the FDA	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Calif San Francisco, Smoking Cessat Leadership Ctr, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Schroeder, SA (corresponding author), Univ Calif San Francisco, Smoking Cessat Leadership Ctr, San Francisco, CA 94143 USA.								0	4	4	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 30	2004	351	14					1377	1380		10.1056/NEJMp048218	http://dx.doi.org/10.1056/NEJMp048218			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	857XT	15459295				2022-12-28	WOS:000224153900002
J	Ghosh, AK; Ghosh, K				Ghosh, AK; Ghosh, K			Misinterpretation of numbers: a potential source of physician's error	LANCET			English	Editorial Material							MEDICINE; TREAT		Mayo Clin Coll Med, Div Gen Internal Med, Rochester, MN 55905 USA	Mayo Clinic	Ghosh, AK (corresponding author), Mayo Clin Coll Med, Div Gen Internal Med, W 17-B, Rochester, MN 55905 USA.	ghosh.amit@mayo.edu						Brennan TA, 2000, NEW ENGL J MED, V342, P1123, DOI 10.1056/NEJM200004133421510; Ghosh AK, 2004, J GEN INTERN MED, V19, P184; Ghosh AK, 2004, J LAB CLIN MED, V144, P60, DOI 10.1016/j.lab.2004.05.013; Ghosh AK, 2004, QJM-INT J MED, V97, P53, DOI 10.1093/qjmed/hch010; GHOSH AK, 2002, J INVEST MED, V50, P243; Hoffrage U, 2000, SCIENCE, V290, P2261, DOI 10.1126/science.290.5500.2261; Kohn KT, 2000, ERR IS HUMAN BUILDIN; Kristiansen IS, 2002, J CLIN EPIDEMIOL, V55, P888, DOI 10.1016/S0895-4356(02)00432-8; Noguchi Y, 2002, J GEN INTERN MED, V17, P848, DOI 10.1046/j.1525-1497.2002.20139.x; Wheeler DW, 2004, J ROY SOC MED, V97, P380, DOI 10.1258/jrsm.97.8.380	10	8	8	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 25	2004	364	9440					1108	1110		10.1016/S0140-6736(04)17119-5	http://dx.doi.org/10.1016/S0140-6736(04)17119-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	857FT	15451207				2022-12-28	WOS:000224102400008
J	Simsek, S; ter Wee, PM				Simsek, S; ter Wee, PM			Klebsiella pneumoniae and pneumoperitoneum	LANCET			English	Editorial Material									VU Univ Med Ctr, Dept Endocrinol, Amsterdam, Netherlands; VU Univ Med Ctr, Dept Nephrol, Amsterdam, Netherlands	Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	Simsek, S (corresponding author), VU Univ Med Ctr, Dept Endocrinol, Boelelaan 1117, Amsterdam, Netherlands.	Simsek@vumc.nl	Simsek, Suat/AAH-6382-2021						0	2	2	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 25	2004	364	9440					1172	1172		10.1016/S0140-6736(04)17105-5	http://dx.doi.org/10.1016/S0140-6736(04)17105-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	857FT	15451226	Bronze			2022-12-28	WOS:000224102400032
J	He, YK; Tang, RH; Hao, Y; Stevens, RD; Cook, CW; Am, SM; Jing, LF; Yang, ZG; Chen, LG; Guo, FQ; Fiorani, F; Jackson, RB; Crawford, NM; Pei, ZM				He, YK; Tang, RH; Hao, Y; Stevens, RD; Cook, CW; Am, SM; Jing, LF; Yang, ZG; Chen, LG; Guo, FQ; Fiorani, F; Jackson, RB; Crawford, NM; Pei, ZM			Nitric oxide represses the Arabidopsis floral transition	SCIENCE			English	Article							FLOWERING-TIME; CIRCADIAN CLOCK; GENE-EXPRESSION; PLANTS; PROTEIN; REGULATOR; ENCODES	The correct timing of flowering is essential for plants to maximize reproductive success and is controlled by environmental and endogenous signals. We report that nitric oxide (NO) repressed the floral transition in Arabidopsis thaliana. Plants treated with NO, as well as a mutant overproducing NO (nox1), flowered late, whereas a mutant producing less NO (nos1) flowered early. NO suppressed CONSTANS and GIGANTEA gene expression and enhanced FLOWERING LOCUS C expression, which indicated that NO regulates the photoperiod and autonomous pathways. Because NO is induced by environmental stimuli and constitutively produced, it may integrate both external and internal cues into the floral decision.	Duke Univ, Dept Biol, Durham, NC 27708 USA; Capital Normal Univ, Dept Biol, Beijing 100037, Peoples R China; Duke Univ, Med Ctr, Mass Spectrometry Lab, Res Triangle Pk, NC 27709 USA; Duke Univ, Med Ctr, Orthopaed Res Lab, Durham, NC 27710 USA; Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA	Duke University; Capital Normal University; Duke University; Duke University; University of California System; University of California San Diego	Pei, ZM (corresponding author), Duke Univ, Dept Biol, Durham, NC 27708 USA.	zpei@duke.edu	Fiorani, Fabio/F-4171-2011	Fiorani, Fabio/0000-0001-8775-1541; Jackson, Robert/0000-0001-8846-7147; Guo, Fang-Qing/0000-0001-6889-394X; Tang, Ruhang/0000-0003-4918-3525; Pei, Zhen-Ming/0000-0003-1473-696X				Beligni MV, 2000, PLANTA, V210, P215, DOI 10.1007/PL00008128; Blazquez MA, 1997, DEVELOPMENT, V124, P3835; Chandok MR, 2003, CELL, V113, P469, DOI 10.1016/S0092-8674(03)00350-7; Fowler S, 1999, EMBO J, V18, P4679, DOI 10.1093/emboj/18.17.4679; Guo FQ, 2003, SCIENCE, V302, P100, DOI 10.1126/science.1086770; HE Y, UNPUB; Hicks KA, 1996, SCIENCE, V274, P790, DOI 10.1126/science.274.5288.790; KOORNNEEF M, 1991, MOL GEN GENET, V229, P57, DOI 10.1007/BF00264213; Lamattina L, 2003, ANNU REV PLANT BIOL, V54, P109, DOI 10.1146/annurev.arplant.54.031902.134752; Leshem YY, 1996, J PLANT PHYSIOL, V148, P258, DOI 10.1016/S0176-1617(96)80251-3; LI HM, 1995, PLANT CELL, V7, P1599, DOI 10.1105/tpc.7.10.1599; Michaels SD, 1999, PLANT CELL, V11, P949, DOI 10.1105/tpc.11.5.949; Morot-Gaudry-Talarmain Y, 2002, PLANTA, V215, P708, DOI 10.1007/s00425-002-0816-3; Mouradov A, 2002, PLANT CELL, V14, pS111, DOI 10.1105/tpc.001362; Onouchi H, 2000, PLANT CELL, V12, P885, DOI 10.1105/tpc.12.6.885; SCHMIDT HHHW, 1994, CELL, V78, P919, DOI 10.1016/0092-8674(94)90267-4; Simpson GG, 2002, SCIENCE, V296, P285, DOI 10.1126/science.296.5566.285; Strayer C, 2000, SCIENCE, V289, P768, DOI 10.1126/science.289.5480.768; Streatfield SJ, 1999, PLANT CELL, V11, P1609, DOI 10.1105/tpc.11.9.1609; Suarez-Lopez P, 2001, NATURE, V410, P1116, DOI 10.1038/35074138; Sun TP, 2004, ANNU REV PLANT BIOL, V55, P197, DOI 10.1146/annurev.arplant.55.031903.141753; Wang ZY, 1998, CELL, V93, P1207, DOI 10.1016/S0092-8674(00)81464-6; Yanovsky MJ, 2002, NATURE, V419, P308, DOI 10.1038/nature00996	23	416	470	7	88	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 24	2004	305	5692					1968	1971		10.1126/science.1098837	http://dx.doi.org/10.1126/science.1098837			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	857RM	15448272				2022-12-28	WOS:000224136000051
J	delBarco-Trillo, J; Ferkin, MH				delBarco-Trillo, J; Ferkin, MH			Male mammals respond to a risk of sperm competition conveyed by odours of conspecific males	NATURE			English	Article							COPULATORY-BEHAVIOR; MEADOW VOLES; EJACULATE; SCENT; GAMES	Sperm competition occurs when a female copulates with two or more males and the sperm of those males compete within the female's reproductive tract to fertilize her eggs(1,2). The frequent occurrence of sperm competition has forced males of many species to develop different strategies to overcome the sperm of competing males(1,3). A prevalent strategy is for males to increase their sperm investment ( total number of sperm allocated by a male to a particular female) after detecting a risk of sperm competition(1,3,4). It has been shown that the proportion of sperm that one male contributes to the sperm pool of a female is correlated with the proportion of offspring sired by that male(5,6). Therefore, by increasing his sperm investment a male may bias a potential spermcompetition in his favour(5,7,8). Here we show that male meadow voles, Microtus pennsylvanicus, increase their sperm investment when they mate in the presence of another male's odours. Such an increase in sperm investment does not occur by augmenting the frequency of ejaculations, but by increasing the amount of sperm in a similar number of ejaculations.	Univ Memphis, Dept Biol, Memphis, TN 38152 USA	University of Memphis	delBarco-Trillo, J (corresponding author), Univ Memphis, Dept Biol, Ellington Hall, Memphis, TN 38152 USA.	jtrillo@memphis.edu	Ferkin, Michael H/A-3968-2009; delBarco-Trillo, Javier/F-6728-2010	delBarco-Trillo, Javier/0000-0002-9948-6674				[Anonymous], [No title captured]; BAKER RR, 1995, HUMAN SPERM COMPETIT, P203; BELLIS MA, 1990, J MAMMAL, V71, P479, DOI 10.2307/1381968; Birkhead TR, 1992, SPERM COMPETITION BI; Birkhead TR, 1998, SPERM COMPETITION SE; BOONSTRA R, 1993, BEHAV ECOL, V4, P83, DOI 10.1093/beheco/4.1.83; Brown R. E., 1985, SOCIAL ODOURS MAMMAL, V1; Dewsbury D.A., 1984, P547; DEWSBURY DA, 1975, SCIENCE, V190, P947, DOI 10.1126/science.1188377; DEWSBURY DA, 1981, BEHAV ECOL SOCIOBIOL, V9, P121, DOI 10.1007/BF00293583; DEWSBURY DA, 1972, Q REV BIOL, V47, P1, DOI 10.1086/407097; DEWSBURY DA, 1982, AM NAT, V119, P601, DOI 10.1086/283938; Dziuk PJ, 1996, ANIM REPROD SCI, V43, P65, DOI 10.1016/0378-4320(95)01463-2; Ferkin MH, 2004, ETHOLOGY, V110, P257, DOI 10.1111/j.1439-0310.2004.00961.x; FERKIN MH, 1995, ANIM BEHAV, V49, P37, DOI 10.1016/0003-3472(95)80151-0; GAGE MJG, 1991, ANIM BEHAV, V42, P1036, DOI 10.1016/S0003-3472(05)80162-9; GINSBERG JR, 1989, TRENDS ECOL EVOL, V4, P74, DOI 10.1016/0169-5347(89)90152-3; GRAY GD, 1975, ANIM BEHAV, V23, P261, DOI 10.1016/0003-3472(75)90074-3; Johnston R.E., 1983, P3; Lezama V, 2001, APPL ANIM BEHAV SCI, V75, P55, DOI 10.1016/S0168-1591(01)00187-3; PARKER GA, 1990, P ROY SOC B-BIOL SCI, V242, P120, DOI 10.1098/rspb.1990.0114; Parker GA, 1997, P ROY SOC B-BIOL SCI, V264, P1793, DOI 10.1098/rspb.1997.0249; Pilastro A, 2002, P NATL ACAD SCI USA, V99, P9913, DOI 10.1073/pnas.152133499; Pizzari T, 2003, NATURE, V426, P70, DOI 10.1038/nature02004; Pound N, 1999, P ROY SOC B-BIOL SCI, V266, P1755, DOI 10.1098/rspb.1999.0842; ROBB GW, 1978, J REPROD FERTIL, V54, P103, DOI 10.1530/jrf.0.0540103; SCHWAGMEYER PL, 1990, ANIM BEHAV, V39, P156, DOI 10.1016/S0003-3472(05)80735-3; Simmons L. W., 2001, MG BEH ECOL; Wedell N, 1999, P ROY SOC B-BIOL SCI, V266, P1033, DOI 10.1098/rspb.1999.0740; Wedell N, 2002, TRENDS ECOL EVOL, V17, P313, DOI 10.1016/S0169-5347(02)02533-8	30	135	139	0	37	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 23	2004	431	7007					446	449		10.1038/nature02845	http://dx.doi.org/10.1038/nature02845			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855UN	15386011				2022-12-28	WOS:000224000500039
J	Inoue, T; Oz, HS; Wiland, D; Gharib, S; Deshpande, R; Hill, RJ; Katz, WS; Sternberg, PW				Inoue, T; Oz, HS; Wiland, D; Gharib, S; Deshpande, R; Hill, RJ; Katz, WS; Sternberg, PW			C-elegans LIN-18 is a Ryk ortholog in parallel to LIN-17/frizzled in Wnt and functions signaling	CELL			English	Article							ASYMMETRIC CELL DIVISIONS; CAENORHABDITIS-ELEGANS; VULVAR DEVELOPMENT; GENE-EXPRESSION; RECEPTOR; PROTEIN; ENCODES; MUTATIONS; LINEAGES; HOMOLOG	Wnt proteins are intercellular signals that regulate various aspects of animal development. In Caenorhabditis elegans, mutations in lin-17, a Frizzled-class Wnt receptor, and in lin-18 affect cell fate patterning in the P7.p vulval lineage. We found that lin-18 encodes a member of the Ryk/Derailed family of tyrosine kinase-related receptors, recently found to function as Wnt receptors. Members of this family have nonactive kinase domains. The LIN-18 kinase domain is dispensable for LIN-18 function, while the Wnt binding WIF domain is required. We also found that Wnt proteins LIN-44, MOM-2, and CWN-2 redundantly regulate P7.p patterning. Genetic interactions indicate that LIN-17 and LIN-18 function independently of each other in parallel pathways, and different ligands display different receptor specificities. Thus, two independent Wnt signaling pathways, one employing a Ryk receptor and the other a Frizzled receptor, function in parallel to regulate cell fate patterning in the C. elegans vulva.	CALTECH, Div Biol, Pasadena, CA 91125 USA; CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA; Univ Kentucky, Coll Med, Dept Biochem, Lexington, KY 40536 USA; Ohio State Univ, Dept Mol Genet, Columbus, OH 43210 USA; Rush Univ, Dept Med, Ctr Med, Chicago, IL 60612 USA	California Institute of Technology; California Institute of Technology; Howard Hughes Medical Institute; University of Kentucky; University System of Ohio; Ohio State University; Rush University	Sternberg, PW (corresponding author), CALTECH, Div Biol, Pasadena, CA 91125 USA.	pws@caltech.edu		Katz, Wendy/0000-0003-3038-6314				Burdine RD, 1998, DEVELOPMENT, V125, P1083; Cadigan KM, 1997, GENE DEV, V11, P3286, DOI 10.1101/gad.11.24.3286; CALLAHAN CA, 1995, NATURE, V376, P171, DOI 10.1038/376171a0; CHAMBERLIN HM, 1995, DEV BIOL, V170, P679, DOI 10.1006/dbio.1995.1246; Eisenmann DM, 1998, DEVELOPMENT, V125, P3667; FERGUSON EL, 1987, NATURE, V326, P259, DOI 10.1038/326259a0; FERGUSON EL, 1985, GENETICS, V110, P17; George SE, 1998, CELL, V92, P633, DOI 10.1016/S0092-8674(00)81131-9; GEORGI LL, 1990, CELL, V61, P635, DOI 10.1016/0092-8674(90)90475-T; Gleason JE, 2002, GENE DEV, V16, P1281, DOI 10.1101/gad.981602; GREENSTEIN D, 1994, GENE DEV, V8, P1935, DOI 10.1101/gad.8.16.1935; GREENWALD IS, 1983, CELL, V34, P435, DOI 10.1016/0092-8674(83)90377-X; Halford MM, 2001, BIOESSAYS, V23, P34, DOI 10.1002/1521-1878(200101)23:1<34::AID-BIES1005>3.3.CO;2-4; Halford MM, 1999, J BIOL CHEM, V274, P7379, DOI 10.1074/jbc.274.11.7379; Halford MM, 2000, NAT GENET, V25, P414, DOI 10.1038/78099; HERMAN MA, 1994, DEVELOPMENT, V120, P1035; HERMAN MA, 1995, CELL, V83, P101, DOI 10.1016/0092-8674(95)90238-4; HILL RJ, 1992, NATURE, V358, P470, DOI 10.1038/358470a0; HOVENS CM, 1992, P NATL ACAD SCI USA, V89, P11818, DOI 10.1073/pnas.89.24.11818; Hsieh JC, 1999, NATURE, V398, P431, DOI 10.1038/18899; Inoue T, 2002, MECH DEVELOP, V119, pS203, DOI 10.1016/S0925-4773(03)00117-5; Jiang LI, 1998, DEVELOPMENT, V125, P2337; Kamath RS, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2000-2-1-research0002; Katso RM, 1999, MOL CELL BIOL, V19, P6427; KIMBLE J, 1981, DEV BIOL, V87, P286, DOI 10.1016/0012-1606(81)90152-4; Korswagen HC, 2002, BIOESSAYS, V24, P801, DOI 10.1002/bies.10145; Kroiher M, 2001, BIOESSAYS, V23, P69, DOI 10.1002/1521-1878(200101)23:1<69::AID-BIES1009>3.3.CO;2-B; MADURO M, 1995, GENETICS, V141, P977; Maloof JN, 1999, DEVELOPMENT, V126, P37; McEwen DG, 2000, CURR BIOL, V10, pR562, DOI 10.1016/S0960-9822(00)00611-4; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Natarajan L, 2001, GENETICS, V159, P159; Oates AC, 1998, MECH DEVELOP, V78, P165, DOI 10.1016/S0925-4773(98)00167-1; Palmer RE, 2002, DEV BIOL, V252, P202, DOI 10.1006/dbio.2002.0850; Patthy L, 2000, TRENDS BIOCHEM SCI, V25, P12, DOI 10.1016/S0968-0004(99)01504-2; PinkasKramarski R, 1996, EMBO J, V15, P2452, DOI 10.1002/j.1460-2075.1996.tb00603.x; Pinson KI, 2000, NATURE, V407, P535, DOI 10.1038/35035124; Prud'homme B, 2002, CURR BIOL, V12, P1395, DOI 10.1016/S0960-9822(02)01068-0; Rocheleau CE, 1997, CELL, V90, P707, DOI 10.1016/S0092-8674(00)80531-0; Savant-Bhonsale S, 1999, GENE, V231, P155, DOI 10.1016/S0378-1119(99)00061-X; Sawa H, 1996, GENE DEV, V10, P2189, DOI 10.1101/gad.10.17.2189; SHACKLEFORD GM, 1993, ONCOGENE, V8, P1857; Sharma-Kishore R, 1999, DEVELOPMENT, V126, P691; Siegfried KR, 2002, DEVELOPMENT, V129, P443; Stein LD, 2003, PLOS BIOL, V1, P166, DOI 10.1371/journal.pbio.0000045; STERNBERG PW, 1986, CELL, V44, P761, DOI 10.1016/0092-8674(86)90842-1; STERNBERG PW, 1988, DEV BIOL, V130, P67, DOI 10.1016/0012-1606(88)90414-9; STERNBERG PW, 1988, NATURE, V335, P551, DOI 10.1038/335551a0; SULSTON JE, 1977, DEV BIOL, V56, P110, DOI 10.1016/0012-1606(77)90158-0; Tamai K, 2000, NATURE, V407, P530, DOI 10.1038/35035117; Thorpe CJ, 1997, CELL, V90, P695, DOI 10.1016/S0092-8674(00)80530-9; Wehrli M, 2000, NATURE, V407, P527, DOI 10.1038/35035110; Wodarz A, 1998, ANNU REV CELL DEV BI, V14, P59, DOI 10.1146/annurev.cellbio.14.1.59; YOCHEM J, 1988, NATURE, V335, P547, DOI 10.1038/335547a0; Yoshikawa S, 2003, NATURE, V422, P583, DOI 10.1038/nature01522; Yoshikawa S, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-01-j0002.2001; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539	57	141	153	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 17	2004	118	6					795	806		10.1016/j.cell.2004.09.001	http://dx.doi.org/10.1016/j.cell.2004.09.001			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	855RW	15369677	Bronze			2022-12-28	WOS:000223992400014
J	Lukas, J; Bartek, J				Lukas, J; Bartek, J			Watching the DNA repair esemble dance	CELL			English	Editorial Material							DOUBLE-STRAND BREAKS; RECOGNITION; DYNAMICS; DAMAGE	Repair of damaged DNA is a dynamic process that requires careful orchestration of a multitude of enzymes, adaptor proteins, and chromatin constituents. In this issue of Cell, Lisby et al. (2004) provide a visual glimpse into how the diverse signaling and repair machines are organized in space and time around the deadliest genetic lesions-the DNA double-strand breaks.	Inst Canc Biol, Danish Canc Soc, DK-2100 Copenhagen, Denmark	Danish Cancer Society	Lukas, J (corresponding author), Inst Canc Biol, Danish Canc Soc, Strandblvd 49, DK-2100 Copenhagen, Denmark.		Bartek, Jiri/G-5870-2014	Lukas, Jiri/0000-0001-9087-506X				Bakkenist CJ, 2004, CELL, V118, P9, DOI 10.1016/j.cell.2004.06.023; Celeste A, 2003, NAT CELL BIOL, V5, P675, DOI 10.1038/ncb1004; Essers J, 2002, EMBO J, V21, P2030, DOI 10.1093/emboj/21.8.2030; KEENEY S, 1995, P NATL ACAD SCI USA, V92, P11274, DOI 10.1073/pnas.92.24.11274; Lisby M, 2004, CELL, V118, P699, DOI 10.1016/j.cell.2004.08.015; Lisby M, 2003, NAT CELL BIOL, V5, P572, DOI 10.1038/ncb997; Lukas C, 2003, NAT CELL BIOL, V5, P255, DOI 10.1038/ncb945; Lukas C, 2004, EMBO J, V23, P2674, DOI 10.1038/sj.emboj.7600269; MELO JA, 2001, NAT REV CANCER, V3, P155; Petrini JHJ, 2003, TRENDS CELL BIOL, V13, P458, DOI 10.1016/S0962-8924(03)00170-3; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011	11	24	25	0	3	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	SEP 17	2004	118	6					666	668		10.1016/j.cell.2004.09.006	http://dx.doi.org/10.1016/j.cell.2004.09.006			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	855RW	15369665	Bronze			2022-12-28	WOS:000223992400002
J	Mancini, EJ; Kainov, DE; Grimes, JM; Tuma, R; Bamford, DH; Stuart, DI				Mancini, EJ; Kainov, DE; Grimes, JM; Tuma, R; Bamford, DH; Stuart, DI			Atomic snapshots of an RNA packaging motor reveal conformational changes linking ATP hydrolysis to RNA translocation	CELL			English	Article							NUCLEOSIDE TRIPHOSPHATASE P4; BLUETONGUE VIRUS CORE; T7 DNA HELICASE; BACTERIOPHAGE PHI-6; CRYSTAL-STRUCTURE; REPLICATIVE HELICASE; POLYMERASE COMPLEX; CATALYTIC SITES; PROTEIN; MECHANISM	Many viruses package their genome into preformed capsids using packaging motors powered by the hydrolysis of ATP. The hexameric ATPase P4 of dsRNA bacteriophage phi12, located at the vertices of the ico-sahedral capsid, is such a packaging motor. We have captured crystallographic structures of P4 for all the key points along the catalytic pathway, including apo, substrate analog bound, and product bound. Substrate and product binding have been observed as both binary complexes and ternary complexes with divalent cations. These structures reveal large movements of the putative RNA binding loop, which are coupled with nucleotide binding and hydrolysis, indicating how ATP hydrolysis drives RNA translocation through cooperative conformational changes. Two distinct conformations of bound nucleotide triphosphate suggest how hydrolysis is activated by RNA binding. This provides a model for chemomechanical coupling for a prototype of the large family of hexameric helicases and oligonucleotide translocating enzymes.	Univ Oxford, Div Struct Biol, Henry Wellcome Bldg Genom Med,Roosevelt Dr, Oxford OX3 7BN, England; Univ Helsinki, Inst Biotechnol, Helsinki 00014, Finland; Univ Helsinki, Fac Biosci, Viikki Bioctr, Helsinki 00014, Finland	University of Oxford; University of Helsinki; University of Helsinki	Stuart, DI (corresponding author), Univ Oxford, Div Struct Biol, Henry Wellcome Bldg Genom Med,Roosevelt Dr, Oxford OX3 7BN, England.	dave@strubi.ox.ac.uk	kainov, denis/I-5526-2019; Tuma, Roman/AAL-4436-2020; Mancini, Erika J/J-9880-2013	kainov, denis/0000-0001-7716-6955; Tuma, Roman/0000-0003-0047-0013; Mancini, Erika J/0000-0001-9591-7898; Bamford, Dennis/0000-0002-6438-8118; Stuart, David/0000-0002-3426-4210; Grimes, Jonathan Mark/0000-0001-9698-0389				Bamford DH, 2002, THEOR POPUL BIOL, V61, P461, DOI 10.1006/tpbi.2002.1591; BLACK LW, 1989, ANNU REV MICROBIOL, V43, P267, DOI 10.1146/annurev.micro.43.1.267; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Butcher SJ, 2001, NATURE, V410, P235, DOI 10.1038/35065653; Cassetti MC, 1998, J VIROL, V72, P5769, DOI 10.1128/JVI.72.7.5769-5780.1998; Catalano CE, 2000, CELL MOL LIFE SCI, V57, P128, DOI 10.1007/s000180050503; de Haas F, 1999, J MOL BIOL, V294, P357, DOI 10.1006/jmbi.1999.3260; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; Diprose JM, 2001, EMBO J, V20, P7229, DOI 10.1093/emboj/20.24.7229; Esnouf RM, 1997, J MOL GRAPH MODEL, V15, P132, DOI 10.1016/S1093-3263(97)00021-1; Fletcher RJ, 2003, NAT STRUCT BIOL, V10, P160, DOI 10.1038/nsb893; Gomis-Ruth FX, 2001, NATURE, V409, P637, DOI 10.1038/35054586; GOTTLIEB P, 1991, VIROLOGY, V181, P589, DOI 10.1016/0042-6822(91)90892-F; GOTTLIEB P, 1994, VIROLOGY, V200, P42, DOI 10.1006/viro.1994.1160; Gouet P, 1999, CELL, V97, P481, DOI 10.1016/S0092-8674(00)80758-8; Grimes JM, 1998, NATURE, V395, P470, DOI 10.1038/26694; GUO PX, 1987, J MOL BIOL, V197, P229, DOI 10.1016/0022-2836(87)90121-5; Hingorani MM, 1997, P NATL ACAD SCI USA, V94, P5012, DOI 10.1073/pnas.94.10.5012; JONES TA, 1990, CRYSTALLOGRAPHIC MOD, P189; Juuti JT, 1998, J MOL BIOL, V279, P347, DOI 10.1006/jmbi.1998.1772; Kainov DE, 2004, NUCLEIC ACIDS RES, V32, P3515, DOI 10.1093/nar/gkh680; Kainov DE, 2003, J BIOL CHEM, V278, P48084, DOI 10.1074/jbc.M306928200; Kim DE, 2002, J MOL BIOL, V321, P807, DOI 10.1016/S0022-2836(02)00733-7; LASKOWSKI RA, 1993, J MOL BIOL, V231, P1049, DOI 10.1006/jmbi.1993.1351; Li DW, 2003, NATURE, V423, P512, DOI 10.1038/nature01691; Lisal J, 2004, J BIOL CHEM, V279, P1343, DOI 10.1074/jbc.M309587200; Mancini EJ, 2004, ACTA CRYSTALLOGR D, V60, P588, DOI 10.1107/S0907444904001052; Menz RI, 2001, CELL, V106, P331, DOI 10.1016/S0092-8674(01)00452-4; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; Mindich L, 1999, MICROBIOL MOL BIOL R, V63, P149, DOI 10.1128/MMBR.63.1.149-160.1999; Mitchell MS, 2002, NUCLEIC ACIDS RES, V30, P4009, DOI 10.1093/nar/gkf524; MORITA M, 1993, VIROLOGY, V193, P748, DOI 10.1006/viro.1993.1183; Nadanaciva S, 1999, BIOCHEMISTRY-US, V38, P15493, DOI 10.1021/bi9917683; Navaza J, 2001, ACTA CRYSTALLOGR D, V57, P1367, DOI 10.1107/S0907444901012422; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Niedenzu T, 2001, J MOL BIOL, V306, P479, DOI 10.1006/jmbi.2000.4398; Ogura T, 2001, GENES CELLS, V6, P575, DOI 10.1046/j.1365-2443.2001.00447.x; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Paatero AO, 1998, J VIROL, V72, P10058, DOI 10.1128/JVI.72.12.10058-10065.1998; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Pirttimaa MJ, 2002, J VIROL, V76, P10122, DOI 10.1128/JVI.76.20.10122-10127.2002; Qiao J, 2003, J BACTERIOL, V185, P4572, DOI 10.1128/JB.185.15.4572-4577.2003; Qiao XY, 2003, J BACTERIOL, V185, P6409, DOI 10.1128/JB.185.21.6409-6414.2003; Reinisch KM, 2000, NATURE, V404, P960, DOI 10.1038/35010041; Roizman B, 1996, FIELDS VIROLOGY, P2231; Sawaya MR, 1999, CELL, V99, P167, DOI 10.1016/S0092-8674(00)81648-7; Simpson AA, 2000, NATURE, V408, P745, DOI 10.1038/35047129; Singleton MR, 2000, CELL, V101, P589, DOI 10.1016/S0092-8674(00)80871-5; Skordalakes E, 2003, CELL, V114, P135, DOI 10.1016/S0092-8674(03)00512-9; Smith DE, 2001, NATURE, V413, P748, DOI 10.1038/35099581; Sprang SR, 1997, CURR OPIN STRUC BIOL, V7, P849, DOI 10.1016/S0959-440X(97)80157-1; STORY RM, 1992, NATURE, V355, P374, DOI 10.1038/355374a0; STUART DI, 1979, J MOL BIOL, V134, P109, DOI 10.1016/0022-2836(79)90416-9; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; WEBER J, 1993, J BIOL CHEM, V268, P20126	55	141	144	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 17	2004	118	6					743	755		10.1016/j.cell.2004.09.007	http://dx.doi.org/10.1016/j.cell.2004.09.007			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	855RW	15369673	Bronze			2022-12-28	WOS:000223992400010
J	Yin, QZ				Yin, QZ			Predicting the Sun's oxygen isotope composition	SCIENCE			English	Editorial Material							SOLAR; FE-60		Univ Calif Davis, Dept Geol, Davis, CA 95616 USA	University of California System; University of California Davis	Yin, QZ (corresponding author), Univ Calif Davis, Dept Geol, Davis, CA 95616 USA.	qyin@ucdavis.edu	Yin, Qing-Zhu/B-8198-2009	Yin, Qing-Zhu/0000-0002-4445-5096				CLAYTON RN, 1993, ANNU REV EARTH PL SC, V21, P115, DOI 10.1146/annurev.earth.21.1.115; Clayton RN, 2002, NATURE, V415, P860, DOI 10.1038/415860b; Clayton RN, 2002, METEORIT PLANET SCI, V37, pA35; IRELAND TR, 2004, LUNAR PLANET SCI, V35, P1448; Kobayashi S, 2003, GEOCHEM J, V37, P663, DOI 10.2343/geochemj.37.663; LYONS JR, 2004, LUNAR PLANET SCI, V35, P1970; Mostefaoui S, 2004, NEW ASTRON REV, V48, P155, DOI 10.1016/j.newar.2003.11.022; Nittler LR, 1998, NATURE, V393, P222, DOI 10.1038/30377; Tachibana S, 2003, ASTROPHYS J, V588, pL41, DOI 10.1086/375362; Thiemens MH, 1999, SCIENCE, V283, P341, DOI 10.1126/science.283.5400.341; Young ED, 1998, SCIENCE, V282, P452, DOI 10.1126/science.282.5388.452; Yurimoto H, 2004, SCIENCE, V305, P1763, DOI 10.1126/science.1100989	13	8	8	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 17	2004	305	5691					1729	1730		10.1126/science.1102893	http://dx.doi.org/10.1126/science.1102893			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	856IS	15375257				2022-12-28	WOS:000224039500028
J	Daniels, MJ; Wang, YM; Lee, MY; Venkitaraman, AR				Daniels, MJ; Wang, YM; Lee, MY; Venkitaraman, AR			Abnormal cytokinesis in cells deficient in the breast cancer susceptibility protein BRCA2	SCIENCE			English	Article							CHROMOSOME SEGREGATION; PHOSPHORYLATION; COMPLEX; INCENP; INSTABILITY; PROGRESSION; METAPHASE; MUTATIONS; SPINDLE; REPAIR	Germ-line mutations inactivating BRCA2 predispose to cancer. BRCA2-deficient cells exhibit alterations in chromosome number (aneuploidy), as well as structurally aberrant chromosomes. Here, we show that BRCA2 deficiency impairs the completion of cell division by cytokinesis. BRCA2 inactivation in murine embryo fibroblasts (MEFs) and HeLa cells by targeted gene disruption or RNA interference delays and prevents cell cleavage. impeded cell separation is accompanied by abnormalities in myosin II organization during the late stages in cytokinesis. BRCA2 may have a role in regulating these events, as it localizes to the cytokinetic midbody. Our findings thus link cytokinetic abnormalities to a hereditary cancer syndrome characterized by chromosomal instability and may help to explain why BRCA2-deficient tumors are frequently aneuploid.	Univ Cambridge, Canc Res UK, Dept Oncol, Cambridge CB2 2XZ, England; Hutchison MRC Res Ctr, MRC, Canc Cell Unit, Cambridge CB2 2XZ, England	Cancer Research UK; CRUK Cambridge Institute; University of Cambridge	Venkitaraman, AR (corresponding author), Univ Cambridge, Canc Res UK, Dept Oncol, Hills Rd, Cambridge CB2 2XZ, England.	arv22@cam.ac.uk	Lee, MiYoung/G-3748-2014	Daniels, Matthew/0000-0002-9250-6214				Adams RR, 2001, J CELL BIOL, V153, P865, DOI 10.1083/jcb.153.4.865; Friedman LS, 1998, CANCER RES, V58, P1338; Glotzer M, 2001, ANNU REV CELL DEV BI, V17, P351, DOI 10.1146/annurev.cellbio.17.1.351; Goggins M, 1996, CANCER RES, V56, P5360; Gretarsdottir S, 1998, CANCER RES, V58, P859; Kaitna S, 2000, CURR BIOL, V10, P1172, DOI 10.1016/S0960-9822(00)00721-1; Lee M, 2004, ONCOGENE, V23, P865, DOI 10.1038/sj.onc.1207223; Lin HR, 2003, J BIOL CHEM, V278, P35979, DOI 10.1074/jbc.M210659200; Marmorstein LY, 2001, CELL, V104, P247, DOI 10.1016/S0092-8674(01)00209-4; Moynahan ME, 2001, MOL CELL, V7, P263, DOI 10.1016/S1097-2765(01)00174-5; Nathanson KN, 2001, NAT MED, V7, P552, DOI 10.1038/87876; Patel KJ, 1998, MOL CELL, V1, P347, DOI 10.1016/S1097-2765(00)80035-0; Scholey JM, 2003, NATURE, V422, P746, DOI 10.1038/nature01599; Severson AF, 2000, CURR BIOL, V10, P1162, DOI 10.1016/S0960-9822(00)00715-6; Tutt A, 1999, CURR BIOL, V9, P1107, DOI 10.1016/S0960-9822(99)80479-5; Venkitaraman AR, 2002, CELL, V108, P171, DOI 10.1016/S0092-8674(02)00615-3; WANG Y, UNPUB; Wheatley SP, 2001, CURR BIOL, V11, P886, DOI 10.1016/S0960-9822(01)00238-X; Yu VPCC, 2000, GENE DEV, V14, P1400	19	237	243	0	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 29	2004	306	5697					876	879		10.1126/science.1102574	http://dx.doi.org/10.1126/science.1102574			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	869FS	15375219				2022-12-28	WOS:000224969400048
J	Krusin-Elbaum, L; Newns, DM; Zeng, H; Derycke, V; Sun, JZ; Sandstrom, R				Krusin-Elbaum, L; Newns, DM; Zeng, H; Derycke, V; Sun, JZ; Sandstrom, R			Room-temperature ferromagnetic nanotubes controlled by electron or hole doping	NATURE			English	Article							VANADIUM-OXIDE; MAGNETIC-PROPERTIES; SPIN	Nanotubes and nanowires with both elemental(,)(1)(2) (carbon or silicon) and multi-element(3-5) compositions (such as compound semiconductors or oxides), and exhibiting electronic properties ranging from metallic to semiconducting, are being extensively investigated for use in device structures designed to control electron charge(6-8). However, another important degree of freedom-electron spin, the control of which underlies the operation of 'spintronic' devices(9)-has been much less explored. This is probably due to the relative paucity of nanometre-scale ferromagnetic building blocks(10) (in which electron spins are naturally aligned) from which spin-polarized electrons can be injected. Here we describe nanotubes of vanadium oxide (VOx), formed by controllable self-assembly(11), that are ferromagnetic at room temperature. The as-formed nanotubes are transformed from spin-frustrated semiconductors to ferromagnets by doping with either electrons or holes, potentially offering a route to spin control(12) in nanotube-based heterostructures(13).	IBM Corp, Div Res, Thomas J Watson Res Ctr, Yorktown Hts, NY 10598 USA	International Business Machines (IBM)	Krusin-Elbaum, L (corresponding author), IBM Corp, Div Res, Thomas J Watson Res Ctr, Yorktown Hts, NY 10598 USA.	krusin@us.ibm.com	Zeng, Hao/E-1994-2012; Zeng, Hao/AAD-8060-2021	Derycke, Vincent/0000-0002-3272-9694				Bergstrom O, 1997, ACTA CRYSTALLOGR C, V53, P528, DOI 10.1107/S0108270196015235; Bertotti G., 1998, HYSTERESIS MAGNETISM; Cao J, 2004, CHEM MATER, V16, P731, DOI 10.1021/cm035119w; Cui Y, 2001, SCIENCE, V291, P851, DOI 10.1126/science.291.5505.851; Dekker C, 1999, PHYS TODAY, V52, P22, DOI 10.1063/1.882658; Derycke V, 2001, NANO LETT, V1, P453, DOI 10.1021/nl015606f; Dobley A, 2001, CHEM MATER, V13, P4382, DOI 10.1021/cm010518h; Fuhrer MS, 2000, SCIENCE, V288, P494, DOI 10.1126/science.288.5465.494; Hacohen YR, 1998, NATURE, V395, P336, DOI 10.1038/26380; Hueso L, 2004, NATURE, V427, P301, DOI 10.1038/427301a; IIJIMA S, 1991, NATURE, V354, P56, DOI 10.1038/354056a0; Imada M, 1998, REV MOD PHYS, V70, P1039, DOI 10.1103/RevModPhys.70.1039; Kanada M, 1998, J PHYS SOC JPN, V67, P2904, DOI 10.1143/JPSJ.67.2904; Korotin MA, 1999, PHYS REV LETT, V83, P1387, DOI 10.1103/PhysRevLett.83.1387; Krumeich F, 1999, J AM CHEM SOC, V121, P8324, DOI 10.1021/ja991085a; Lee KW, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.237003; Levy P, 2003, APPL PHYS LETT, V83, P5247, DOI 10.1063/1.1635663; Limelette P, 2003, SCIENCE, V302, P89, DOI 10.1126/science.1088386; Lumsden MD, 2001, PHYS REV LETT, V86, P159, DOI 10.1103/PhysRevLett.86.159; Mott N.F, 1974, METAL INSULATOR TRAN; Onoda M, 1996, J SOLID STATE CHEM, V127, P359, DOI 10.1006/jssc.1996.0395; Remskar M, 2001, SCIENCE, V292, P479, DOI 10.1126/science.1059011; TENNE R, 1992, NATURE, V360, P444, DOI 10.1038/360444a0; Tokura Y, 2000, SCIENCE, V288, P462, DOI 10.1126/science.288.5465.462; Tsukagoshi K, 1999, NATURE, V401, P572, DOI 10.1038/44108; Wang XQ, 1998, CHEM COMMUN, P1009, DOI 10.1039/a802059k; Wolf SA, 2001, SCIENCE, V294, P1488, DOI 10.1126/science.1065389; Yamauchi T, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.057002; Yao Z, 1999, NATURE, V402, P273, DOI 10.1038/46241; Zavalij PY, 1999, ACTA CRYSTALLOGR B, V55, P627, DOI 10.1107/S0108768199004000	30	197	201	0	59	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 7	2004	431	7009					672	676		10.1038/nature02970	http://dx.doi.org/10.1038/nature02970			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	859WS	15470424				2022-12-28	WOS:000224299300036
J	Strzepek, RF; Harrison, PJ				Strzepek, RF; Harrison, PJ			Photosynthetic architecture differs in coastal and oceanic diatoms	NATURE			English	Article							GROWTH IRRADIANCE; IRON REQUIREMENT; PHOTOSYSTEM-II; LIGHT; LIMITATION; RATES; PHOTOPROTECTION; ENERGY; SIZE	Diatoms are a key taxon of eukaryotic phytoplankton and a major contributor to global carbon fixation(1). They are ubiquitous in the marine ecosystem despite marked gradients in environmental properties, such as dissolved iron concentrations, between coastal and oceanic waters. Previous studies have shown that offshore species of diatoms and other eukaryotic algae have evolved lower iron requirements to subsist in iron-poor oceanic waters, but the biochemical mechanisms responsible for their decreased iron demand are unknown(2,3). Here we show, using laboratory-cultured model species, a fundamental difference between a coastal and an oceanic diatom in their photosynthetic architecture. Specifically, the oceanic diatom had up to fivefold lower photosystem I and up to sevenfold lower cytochrome b(6)f complex concentrations than a coastal diatom. These changes to the photosynthetic apparatus markedly decrease the cellular iron requirements of the oceanic diatom but not its photosynthetic rates. However, oceanic diatoms might have also sacrificed their ability to acclimate to rapid fluctuations in light intensity-a characteristic of dynamic and turbid coastal waters. We suggest that diatoms, and probably other eukaryotic algal taxa, exploited this difference in the underwater light climate between oceanic and coastal waters, enabling them to decrease their iron requirements without compromising photosynthetic capacity. This adaptation probably facilitated the colonization of the open ocean by diatoms, and contributes to their persistence in this iron-impoverished environment.	Univ British Columbia, Dept Bot, Vancouver, BC V6T 1Z4, Canada; Univ British Columbia, Dept Earth & Ocean Sci, Vancouver, BC V6T 1Z4, Canada	University of British Columbia; University of British Columbia	Strzepek, RF (corresponding author), Univ Otago, Dept Chem, NIWA Ctr Chem & Phys Oceanog, POB 56, Dunedin, New Zealand.	roberts@alkali.otago.ac.nz	Strzepek, Robert/GQH-8703-2022; Strzepek, Robert Francis/A-1216-2011	Strzepek, Robert Francis/0000-0002-6442-7121				Anbar AD, 2002, SCIENCE, V297, P1137, DOI 10.1126/science.1069651; Behrenfeld MJ, 1998, PHOTOSYNTH RES, V58, P259, DOI 10.1023/A:1006138630573; Bendall DS, 1971, METHOD ENZYMOL, V23A, P327, DOI DOI 10.1016/S0076-6879(71)23109-8; BILGER W, 1990, PHOTOSYNTH RES, V25, P173, DOI 10.1007/BF00033159; BRAND LE, 1983, LIMNOL OCEANOGR, V28, P1182, DOI 10.4319/lo.1983.28.6.1182; Dugdale RC, 1998, NATURE, V391, P270, DOI 10.1038/34630; FALKOWSKI PG, 1981, PLANT PHYSIOL, V68, P969, DOI 10.1104/pp.68.4.969; GLOVER H, 1977, J PHYCOL, V13, P208; GREENE RM, 1991, LIMNOL OCEANOGR, V36, P1772, DOI 10.4319/lo.1991.36.8.1772; Horton P, 1996, ANNU REV PLANT PHYS, V47, P655, DOI 10.1146/annurev.arplant.47.1.655; HUDSON RJM, 1992, MAR CHEM, V38, P209, DOI 10.1016/0304-4203(92)90035-9; JASSBY AD, 1976, LIMNOL OCEANOGR, V21, P540, DOI 10.4319/lo.1976.21.4.0540; KOLBER Z, 1988, PLANT PHYSIOL, V88, P923, DOI 10.1104/pp.88.3.923; Kulheim C, 2002, SCIENCE, V297, P91, DOI 10.1126/science.1072359; Kurisu G, 2003, SCIENCE, V302, P1009, DOI 10.1126/science.1090165; Lavaud J, 2002, PLANT PHYSIOL, V129, P1398, DOI 10.1104/pp.002014; LEY AC, 1982, BIOCHIM BIOPHYS ACTA, V680, P95, DOI 10.1016/0005-2728(82)90320-6; MacIntyre HL, 2000, TRENDS PLANT SCI, V5, P12, DOI 10.1016/S1360-1385(99)01504-6; Maldonado MT, 1996, MAR ECOL PROG SER, V141, P161, DOI 10.3354/meps141161; Munekage Y, 2001, PLANT J, V28, P351, DOI 10.1046/j.1365-313X.2001.01178.x; PRICE GD, 1995, AUST J PLANT PHYSIOL, V22, P285, DOI 10.1071/PP9950285; Quigg A, 2003, NATURE, V425, P291, DOI 10.1038/nature01953; Raven JA, 1999, PHOTOSYNTH RES, V60, P111, DOI 10.1023/A:1006282714942; RAVEN JA, 1990, NEW PHYTOL, V116, P1, DOI 10.1111/j.1469-8137.1990.tb00505.x; RYTHER JH, 1961, ECOLOGY, V42, P444, DOI 10.2307/1932105; SCHREIBER U, 1986, PHOTOSYNTH RES, V9, P261, DOI 10.1007/BF00029749; SUNDA WG, 1995, MAR CHEM, V50, P189, DOI 10.1016/0304-4203(95)00035-P; SUNDA WG, 1991, NATURE, V351, P55, DOI 10.1038/351055a0; Sunda WG, 1997, NATURE, V390, P389, DOI 10.1038/37093; WOOD PM, 1978, EUR J BIOCHEM, V87, P9, DOI 10.1111/j.1432-1033.1978.tb12346.x	30	328	349	0	100	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	OCT 7	2004	431	7009					689	692		10.1038/nature02954	http://dx.doi.org/10.1038/nature02954			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	859WS	15470428				2022-12-28	WOS:000224299300040
J	Cottam, R				Cottam, R			Obesity and culture	LANCET			English	Editorial Material									Croydon Primary Care Trust, Surrey CR0 6SR, England		Cottam, R (corresponding author), Croydon Primary Care Trust, Surrey CR0 6SR, England.	rachelcottam@pink2.demon.co.uk						ATKINS R, 2003, ATKINS LIFE; *CAB OFF, 2004, ALC HARM RED STRAT E; Critser G., 2003, FAT LAND AM BECAME F; Furedi F., 2004, THERAPY CULTURE CULT; GROSSMAN M, 2004, EC OBESITY PUBLIC IN; MEEK J, 2002, GUARDIAN        1008; *NAT I CLIN EX, 2002, SELF HARM SHORT TERM; *NAT I CLIN EX, 2004, SCOP CONS DRAFT GUID; *NAT I CLIN EXC, FULL LIST STAK; National Institutes of Health, 2004, STRAT PLAN NIH OB RE; Packard V., 1957, HIDDEN PERSUADERS; SHAPIN S, 2004, LONDON REV BOOK 0805, P16; *UK PARL, 2004, 3 UK PARL SEL COMM H; 2004, GUARDIAN        0729	14	7	7	1	5	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	OCT 2	2004	364	9441					1202	1203		10.1016/S0140-6736(04)17159-6	http://dx.doi.org/10.1016/S0140-6736(04)17159-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	859HO	15464169				2022-12-28	WOS:000224254200009
J	Tercier, J				Tercier, J			Resuscitation	LANCET			English	Editorial Material									Univ Calif San Francisco, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Tercier, J (corresponding author), Univ Calif San Francisco, San Francisco, CA 94143 USA.	jtercier@itsa.ucsf.edu							0	0	0	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	OCT 2	2004	364	9441					1211	1211		10.1016/S0140-6736(04)17166-3	http://dx.doi.org/10.1016/S0140-6736(04)17166-3			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	859HO	15464171	Bronze			2022-12-28	WOS:000224254200013
J	Screaton, RA; Conkright, MD; Katoh, Y; Best, JL; Canettieri, G; Jeffries, S; Guzman, E; Niessen, S; Yates, JR; Takemori, H; Okamoto, M; Montminy, M				Screaton, RA; Conkright, MD; Katoh, Y; Best, JL; Canettieri, G; Jeffries, S; Guzman, E; Niessen, S; Yates, JR; Takemori, H; Okamoto, M; Montminy, M			The CREB coactivator TORC2 functions as a calcium- and cAMP-sensitive coincidence detector	CELL			English	Article							RENAL-TRANSPLANT RECIPIENTS; DEPENDENT PROTEIN-KINASE; SALT-INDUCIBLE KINASE; PANCREATIC BETA-CELL; TRANSCRIPTIONAL REGULATION; PHOSPHORYLATION; BINDING; IDENTIFICATION; ACTIVATION; LKB1	Elevations in circulating glucose and gut hormones during feeding promote pancreatic islet cell viability in part via the calcium- and cAMP-dependent activation of the transcription factor CREB. Here, we describe a signaling module that mediates the synergistic effects of these pathways on cellular gene expression by stimulating the dephosphorylation and nuclear entry of TORC2, a CREB coactivator. This module consists of the calcium-regulated phosphatase calcineurin and the Ser/Thr kinase SIK2, both of which associate with TORC2. Under resting conditions, TORC2 is sequestered in the cytoplasm via a phosphorylation-dependent interaction with 14-3-3 proteins. Triggering of the calcium and cAMP second messenger pathways by glucose and gut hormones disrupts TORC2:14-3-3 complexes via complementary effects on TORC2 dephosphorylation; calcium influx increases calcineurin activity, whereas cAMP inhibits SIK2 kinase activity. Our results illustrate how a phosphatase/kinase module connects two signaling pathways in response to nutrient and hormonal cues.	Osaka Univ, Grad Sch Med, Dept Biochem & Mol Biol, Suita, Osaka 5650871, Japan; Salk Inst Biol Studies, Clayton Fdn Labs Peptide Biol, La Jolla, CA 92037 USA; Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA	Osaka University; Salk Institute; Scripps Research Institute	Takemori, H (corresponding author), Osaka Univ, Grad Sch Med, Dept Biochem & Mol Biol, H-1,2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	mr-mb002@pop.med.osaka-u.ac.jp; montminy@salk.edu		CANETTIERI, Gianluca/0000-0001-6694-2613; Screaton, Robert/0000-0002-4917-9473				Al-Uzri A, 2001, TRANSPLANTATION, V72, P1020, DOI 10.1097/00007890-200109270-00007; Asahara H, 2001, MOL CELL BIOL, V21, P7892, DOI 10.1128/MCB.21.23.7892-7900.2001; BONNI A, 1995, MOL CELL NEUROSCI, V6, P168, DOI 10.1006/mcne.1995.1015; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Carling D, 2004, TRENDS BIOCHEM SCI, V29, P18, DOI 10.1016/j.tibs.2003.11.005; Chen MS, 2003, MOL CELL BIOL, V23, P7488, DOI 10.1128/MCB.23.21.7488-7497.2003; Chow CW, 2000, MOL CELL BIOL, V20, P702, DOI 10.1128/MCB.20.2.702-712.2000; Conkright MD, 2003, MOL CELL, V11, P1101, DOI 10.1016/S1097-2765(03)00134-5; Conkright MD, 2003, MOL CELL, V12, P413, DOI 10.1016/j.molcel.2003.08.013; Doi J, 2002, J BIOL CHEM, V277, P15629, DOI 10.1074/jbc.M109365200; Durocher D, 2000, MOL CELL, V6, P1169, DOI 10.1016/S1097-2765(00)00114-3; Filler G, 2000, NEPHROL DIAL TRANSPL, V15, P867, DOI 10.1093/ndt/15.6.867; HAGIWARA M, 1992, CELL, V70, P105, DOI 10.1016/0092-8674(92)90537-M; Hinke SA, 2004, J PHYSIOL-LONDON, V558, P369, DOI 10.1113/jphysiol.2004.064881; Hogan PG, 2003, GENE DEV, V17, P2205, DOI 10.1101/gad.1102703; Hui HX, 2003, ENDOCRINOLOGY, V144, P1444, DOI 10.1210/en.2002-220897; Impey S, 2002, NEURON, V34, P235, DOI 10.1016/S0896-6273(02)00654-2; Inada A, 2004, MOL CELL BIOL, V24, P2831, DOI 10.1128/MCB.24.7.2831-2841.2004; Iourgenko V, 2003, P NATL ACAD SCI USA, V100, P12147, DOI 10.1073/pnas.1932773100; Jhala US, 2003, GENE DEV, V17, P1575, DOI 10.1101/gad.1097103; Kornhauser JM, 2002, NEURON, V34, P221, DOI 10.1016/S0896-6273(02)00655-4; Link AJ, 1999, NAT BIOTECHNOL, V17, P676, DOI 10.1038/10890; Lizcano JM, 2004, EMBO J, V23, P833, DOI 10.1038/sj.emboj.7600110; MacCoss MJ, 2002, P NATL ACAD SCI USA, V99, P7900, DOI 10.1073/pnas.122231399; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; Montclare JK, 2001, NUCLEIC ACIDS RES, V29, P3311, DOI 10.1093/nar/29.16.3311; Newman JRS, 2003, SCIENCE, V300, P2097, DOI 10.1126/science.1084648; Okamoto M, 2004, TRENDS ENDOCRIN MET, V15, P21, DOI 10.1016/j.tem.2003.11.002; RADHAKRISHNAN I, 1997, CELL, V91, P7411; SCHWANINGER M, 1995, J BIOL CHEM, V270, P8860, DOI 10.1074/jbc.270.15.8860; Shaw RJ, 2004, P NATL ACAD SCI USA, V101, P3329, DOI 10.1073/pnas.0308061100; SHENG M, 1991, SCIENCE, V252, P1427, DOI 10.1126/science.1646483; Tabb DL, 2002, J PROTEOME RES, V1, P21, DOI 10.1021/pr015504q; Woods A, 2003, CURR BIOL, V13, P2004, DOI 10.1016/j.cub.2003.10.031; Yaffe MB, 2002, FEBS LETT, V513, P53, DOI 10.1016/S0014-5793(01)03288-4	35	489	520	0	33	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 1	2004	119	1					61	74		10.1016/j.cell.2004.09.015	http://dx.doi.org/10.1016/j.cell.2004.09.015			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	859UE	15454081	Bronze			2022-12-28	WOS:000224292600009
J	Norrby, SR				Norrby, SR			Alert to a European epidemic	NATURE			English	Editorial Material									Swedish Inst Infect Dis Control, SE-17182 Solna, Sweden	Swedish Institute for Infectious Disease Control	Norrby, SR (corresponding author), Swedish Inst Infect Dis Control, SE-17182 Solna, Sweden.							Cars O, 2001, LANCET, V357, P1851, DOI 10.1016/S0140-6736(00)04972-2; COX P, 2004, OFFICIAL J EUROPEA L, V142, P1; Shlaes DM, 2004, ASM NEWS, V70, P275	3	4	4	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 30	2004	431	7008					507	508		10.1038/431507a	http://dx.doi.org/10.1038/431507a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	857YP	15457233	Green Published, Bronze			2022-12-28	WOS:000224156700016
J	Steinbrook, R				Steinbrook, R			Medical marijuana, physician-assisted suicide, and the controlled substance act	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																		Joy JE, 1999, MARIJUANA MED ASSESS; Kassirer JP, 1997, NEW ENGL J MED, V336, P366, DOI 10.1056/NEJM199701303360509; Steinbrook R, 2002, NEW ENGL J MED, V346, P460, DOI 10.1056/NEJM200202073460624	3	2	2	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 30	2004	351	14					1380	1383		10.1056/NEJMp048222	http://dx.doi.org/10.1056/NEJMp048222			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	857XT	15459296				2022-12-28	WOS:000224153900003
J	Ibanez, P; Bonnet, AM; Debarges, B; Lohmann, E; Tison, F; Pollak, P; Agid, Y; Durr, A; Brice, A				Ibanez, P; Bonnet, AM; Debarges, B; Lohmann, E; Tison, F; Pollak, P; Agid, Y; Durr, A; Brice, A		French Parkinson's Disease Genetic	Causal relation between alpha-synuclein gene duplication and familial Parkinson's disease	LANCET			English	Article								The alpha-synuclein gene (SNCA) has been implicated in autosomal dominant forms,of Parkinson's disease. We screened 119 individuals from families with this rare form of the disease for SNCA duplications by 94 semiquantitative multiplex PCR. Two patients had duplications, which were confirmed by analysis of intragenic and flanking microsatellite markers. The phenotype in both patients was indistinguishable from idiopathic Parkinson's disease and no atypical features were present, by contrast with reports of families with triplication of the same gene. These results indicate that SNCA is more frequently associated with familial Parkinson's disease than previously thought, and that there is a clear dosage effect according to the number of supernumerary copies of this gene.	AP HP, Hop La Pitie Salpetriere, INSERM, U289, F-75651 Paris 13, France; AP HP, Hop La Pitie Salpetriere, Dept Genet Cytogenet & Embryol, F-75651 Paris 13, France; AP HP, CHU Pitie Salpetriere, Federat Neurol, F-75013 Paris, France; CHU Bordeaux, Hop Haut Leveque, Serv Neurol, Pessac, France; CHU Grenoble, Dept Neurol, F-38043 Grenoble, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; CHU Bordeaux; CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA)	Brice, A (corresponding author), AP HP, Hop La Pitie Salpetriere, INSERM, U289, 47 Blvd Hop, F-75651 Paris 13, France.	brice@ccr.jussieu.fr	Brice, Alexis/A-2170-2009; brice, alexis/AAE-8275-2019	brice, alexis/0000-0002-0941-3990				Farrer M, 2004, ANN NEUROL, V55, P174, DOI 10.1002/ana.10846; Lansbury PT, 2002, CURR OPIN GENET DEV, V12, P299, DOI 10.1016/S0959-437X(02)00302-7; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Vaughan JR, 1998, HUM MOL GENET, V7, P751, DOI 10.1093/hmg/7.4.751	5	786	807	2	34	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 25	2004	364	9440					1169	1171		10.1016/S0140-6736(04)17104-3	http://dx.doi.org/10.1016/S0140-6736(04)17104-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	857FT	15451225				2022-12-28	WOS:000224102400031
J	Gascon, C; Smith, ML				Gascon, C; Smith, ML			Ecology - Where rivers meet	SCIENCE			English	Editorial Material							DIVERSITY		Conservat Int, Washington, DC 20036 USA	Conservation International	Gascon, C (corresponding author), Conservat Int, Washington, DC 20036 USA.	c.gascon@conservation.org; m.smith@conservation.org						AYRES JM, 1992, AM NAT, V140, P531, DOI 10.1086/285427; DUELLMAN WE, 1988, ANN MO BOT GARD, V75, P79, DOI 10.2307/2399467; Fernandes CC, 2004, SCIENCE, V305, P1960, DOI 10.1126/science.1101240; Gascon C, 2000, P NATL ACAD SCI USA, V97, P13672, DOI 10.1073/pnas.230136397; Matthews W. J., 1998, PATTERNS FRESHWATER; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Silva Jose Maria Cardoso Da, 1995, Bulletin of the British Ornithologists' Club, V115, P200	7	2	2	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 24	2004	305	5692					1922	1923		10.1126/science.1104418	http://dx.doi.org/10.1126/science.1104418			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	857RM	15448259				2022-12-28	WOS:000224136000035
J	Conway, SL; Shinbrot, T; Glasser, BJ				Conway, SL; Shinbrot, T; Glasser, BJ			A Taylor vortex analogy in granular flows	NATURE			English	Article							DYNAMICS; SEGREGATION; SEPARATION; MOTION; ONSET	Fluids sheared between concentric rotating cylinders undergo a series of three-dimensional instabilities. Since Taylor's archetypal 1923 study(1), these have proved pivotal to understanding how fluid flows become unstable and eventually undergo transitions to chaotic or turbulent states(2-5). In contrast, predicting the dynamics of granular systems - from nano-sized particles to debris flows - is far less reliable. Under shear these materials resemble fluids, but solid-like responses, non-equilibrium structures and segregation patterns develop unexpectedly(6-9). As a result, the analysis of geophysical events(10) and the performance of largely empirical particle technologies might suffer(11,12). Here, using gas fluidization to overcome jamming(6,13), we show experimentally that granular materials develop vortices consistent with the primary Taylor instability in fluids. However, the vortices observed in our fluidized granular bed are unlike those in fluids in that they are accompanied by novel mixing segregation transitions. The vortices seem to alleviate increased strain by spawning new vortices, directly modifying the scale of kinetic interactions. Our observations provide insights into the mechanisms of shear transmission by particles and their consequent convective mixing.	Rutgers State Univ, Dept Chem & Biochem Engn, Piscataway, NJ 08854 USA; Rutgers State Univ, Dept Biomed Engn, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick	Glasser, BJ (corresponding author), Rutgers State Univ, Dept Chem & Biochem Engn, Piscataway, NJ 08854 USA.	bglasser@rutgers.edu						Abshagen J, 2003, J FLUID MECH, V476, P335, DOI 10.1017/S002211200200321X; ANDERECK CD, 1986, J FLUID MECH, V164, P155, DOI 10.1017/S0022112086002513; Apicella E, 1997, AICHE J, V43, P1362, DOI 10.1002/aic.690430526; Bridgwater J, 2003, GRANUL MATTER, V4, P175, DOI 10.1007/s10035-002-0120-8; BRIDGWATER J, 1976, POWDER TECHNOL, V15, P215, DOI 10.1016/0032-5910(76)80051-4; Burtally N, 2002, SCIENCE, V295, P1877, DOI 10.1126/science.1066850; Conway SL, 2004, PHYS FLUIDS, V16, P509, DOI 10.1063/1.1637348; Djeridi H, 1999, EXP FLUIDS, V26, P233, DOI 10.1007/s003480050284; Forterre Y, 2001, PHYS REV LETT, V86, P5886, DOI 10.1103/PhysRevLett86.5886; Hirshfeld D, 1998, PHYS REV LETT, V80, P5337, DOI 10.1103/PhysRevLett.80.5337; Joseph DD, 2003, J FLUID MECH, V496, P139, DOI 10.1017/S0022112003006451; Khosropour R, 1997, PHYS REV E, V56, P4467, DOI 10.1103/PhysRevE.56.4467; Losert W, 2000, PHYS REV LETT, V85, P1428, DOI 10.1103/PhysRevLett.85.1428; Matson WR, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.050301; MEDLIN J, 1974, IND ENG CHEM FUND, V13, P247, DOI 10.1021/i160051a017; Michaels JN, 2003, POWDER TECHNOL, V138, P1, DOI 10.1016/j.powtec.2003.08.035; Mobius ME, 2001, NATURE, V414, P270, DOI 10.1038/35104697; Mueth DM, 2000, NATURE, V406, P385, DOI 10.1038/35019032; MULLIN T, 1980, NATURE, V288, P567, DOI 10.1038/288567a0; MULLIN T, 1982, J FLUID MECH, V121, P207, DOI 10.1017/S0022112082001864; Ottino JM, 2000, ANNU REV FLUID MECH, V32, P55, DOI 10.1146/annurev.fluid.32.1.55; SAVAGE SB, 1984, J FLUID MECH, V142, P391, DOI 10.1017/S0022112084001166; Scott DR, 1996, NATURE, V381, P592, DOI 10.1038/381592a0; Shinbrot T, 2000, PHYS TODAY, V53, P25, DOI 10.1063/1.883018; SILVA SRD, 1999, IUTAM S SEGREGATION, P11; Taylor GI, 1923, PHILOS T R SOC LOND, V223, P289, DOI 10.1098/rsta.1923.0008; Wereley ST, 1998, J FLUID MECH, V364, P59, DOI 10.1017/S0022112098008969; Wightman C, 1996, POWDER TECHNOL, V89, P165, DOI 10.1016/S0032-5910(96)03178-6; Wilkes J. O., 1999, PR H PHYS C	29	49	50	1	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 23	2004	431	7007					433	437		10.1038/nature02901	http://dx.doi.org/10.1038/nature02901			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855UN	15386007				2022-12-28	WOS:000224000500035
J	Millgate, AG; Pogson, BJ; Wilson, IW; Kutchan, TM; Zenk, MH; Gerlachll, WL; Fist, AJ; Larkin, PJ				Millgate, AG; Pogson, BJ; Wilson, IW; Kutchan, TM; Zenk, MH; Gerlachll, WL; Fist, AJ; Larkin, PJ			Analgesia - Morphine-pathway block in top1 poppies	NATURE			English	Editorial Material							ALKALOID BIOSYNTHESIS; CELL		CSIRO Plant Ind, Canberra, ACT 2601, Australia; Australian Natl Univ, Sch Biochem & Mol Biol, Canberra, ACT 0200, Australia; Leibniz Inst Plant Biochem, Dept Nat Prod Biotechnol, D-06120 Halle Saale, Germany; Univ Halle Wittenberg, Biozentrum, D-06120 Halle Saale, Germany; Johnson & Johnson, Strawberry Hills, NSW 2012, Australia; Tasmanian Alkaloids, Westbury, Tas 7303, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO); Australian National University; Leibniz Institut fur Pflanzenbiochemie; Martin Luther University Halle Wittenberg; Johnson & Johnson	Millgate, AG (corresponding author), CSIRO Plant Ind, Black Mt, Canberra, ACT 2601, Australia.	philip.larkin@csiro.au	Wilson, Iain/D-4839-2009; Pogson, Barry J/C-9953-2009; Kutchan, Toni/L-4625-2013; Larkin, Philip/AAU-3195-2021; Larkin, Philip J/A-9468-2008	Wilson, Iain/0000-0002-4626-8059; Pogson, Barry J/0000-0003-1869-2423; Larkin, Philip/0000-0002-2608-1924; Larkin, Philip J/0000-0002-2608-1924				Bird DA, 2003, PLANT CELL, V15, P2626, DOI 10.1105/tpc.015396; Bock A, 2002, PLANTA, V216, P57, DOI 10.1007/s00425-002-0867-5; BROCHMANNHANSSEN E, 1984, PLANTA MED, V50, P343, DOI 10.1055/s-2007-969727; De Luca V, 2000, TRENDS PLANT SCI, V5, P168, DOI 10.1016/S1360-1385(00)01575-2; Kutchan TM, 1996, GENE, V179, P73, DOI 10.1016/S0378-1119(96)00426-X; KUTCHAN TM, IN PRESS ADV PLANT B; PARKER HI, 1972, J AM CHEM SOC, V94, P1276, DOI 10.1021/ja00759a039; Zenk M.H., 1995, ORGANIC REACTIVITY P, P89	8	76	87	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 23	2004	431	7007					413	414		10.1038/431413a	http://dx.doi.org/10.1038/431413a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855UN	15386001				2022-12-28	WOS:000224000500029
J	Kelly, D; Jara, P; Rodeck, B; Lykavieris, P; Burdelski, M; Becker, M; Gridelli, B; Boillot, O; Manzanares, J; Reding, R				Kelly, D; Jara, P; Rodeck, B; Lykavieris, P; Burdelski, M; Becker, M; Gridelli, B; Boillot, O; Manzanares, J; Reding, R			Tacrolimus and steroids versus ciclosporin microemulsion, steroids, and azathioprine in children undergoing liver transplantation: randomised European multicentre trial	LANCET			English	Article							LIPID-METABOLISM; FK506; IMMUNOSUPPRESSION; RECIPIENTS; FK-506; REJECTION; MORTALITY; GLUCOSE	Background Results of studies in adult recipients of liver allograft suggest that tacrolimus is more efficacious than ciclosporin microemulsion in the prevention of acute rejection. We aimed to compare these drugs in children undergoing liver transplantation. Methods This 12-month multicentre, open-label, parallel-group, randomised study compared a dual tacrolimus regimen (tacrolimus/corticosteroids, n=93) with a triple ciclosporin microemulsion regimen (ciclosporin microemulsion/corticosteroids/azathioprine, n=92) in children who had had liver transplants (age less than or equal to16 years, bodyweight less than or equal to40 kg). Initial oral daily doses were 0.30 mg/kg for tacrolimus and 10 mg/kg for ciclosporin microemulsion. Primary endpoint was the incidence of and time to first histologically proven acute rejection. We excluded patients from analysis if they did not receive the study drug, or were given incorrect medication. Otherwise patients were analysed in accordance with their random treatment allocation, irrespective of whether they switched medication during the trial. Findings Median age was 22 months (IQR 9-56) in the tacrolimus group and 17 months (9-54) in the ciclosporin microemulsion group. We noted no difference between treatment groups with respect to patient survival (93.4% vs 92.2%; p=0.77) or graft survival (92.3% vs 85.4%; p=0.16) at month 12 after transplant. The acute rejection free rate at study end (Kaplan-Meier method) was 55.5% for patients on tacrolimus and 40.2% for patients on ciclosporin microemulsion (p=0.0288). The Kaplan-Meier estimate of patients free from corticosteroid-resistant acute rejection at study end was 94.0% for tacrolimus-treated patients and 70.4% for ciclosporin-microemulsion-treated patients (p<0.0001). Overall, incidence of adverse events did not differ between groups. Interpretation Tacrolimus is a safe and effective treatment for the prevention of rejection after liver transplantation in children.	Birmingham Childrens Hosp NHS Trust, Liver Unit, Birmingham B4 6NH, W Midlands, England; Hosp Infantil La Paz, Dept Paediat Hepatol, Madrid, Spain; Hannover Med Sch, Kinderklin, Hannover, Germany; Hop Kremlin Bicetre, Serv Hepatol Pediat, Paris, France; Univ Hamburg, Krankenhaus Eppendorf, Kinderklin Padiat Gastroenterol, D-2000 Hamburg, Germany; Univ Klin Charite, Berlin, Germany; Osped Riuniti Bergamo, Ctr Trapiantodi Fegato Pediat, I-24100 Bergamo, Italy; Hop Edouard Herriot, Serv Transplantat Hepat, Lyon, France; Hosp Materno Infantil Doce Octubre, Serv Gastroenterol, Madrid, Spain; Univ Catholique Louvain, Clin Univ St Luc, Dept Chirurg, Paediat Liver Transplantat Program, B-1200 Brussels, Belgium	Hospital Universitario La Paz; Hannover Medical School; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; University of Hamburg; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Ospedali Riuniti di Bergamo; CHU Lyon; Hospital Universitario 12 de Octubre; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc	Kelly, D (corresponding author), Birmingham Childrens Hosp NHS Trust, Liver Unit, Steelhouse Lane, Birmingham B4 6NH, W Midlands, England.	Deirdre.Kelly@bch.nhs.uk		Jara Vega, Paloma/0000-0002-4669-7929				ATKISON P, 1995, LANCET, V345, P894, DOI 10.1016/S0140-6736(95)90011-X; BUSUTTIL RW, 1994, NEW ENGL J MED, V331, P1110; Cao S, 1999, Pediatr Transplant, V3, P22, DOI 10.1034/j.1399-3046.1999.00002.x; COX KL, 1995, TRANSPLANTATION, V59, P524; Cox KL, 1996, CLIN INVEST MED, V19, P389; Fridell JA, 2002, TRANSPLANTATION, V74, P1721, DOI 10.1097/01.TP.0000039334.85487.AB; Jain A, 2003, TRANSPLANTATION, V75, P1020, DOI 10.1097/01.TP.0000056168.79903.20; Jain A, 2000, TRANSPLANTATION, V70, P617, DOI 10.1097/00007890-200008270-00015; Johnston SD, 2002, TRANSPLANTATION, V73, P901, DOI 10.1097/00007890-200203270-00012; Kogan-Liberman D, 2001, J PEDIATR GASTR NUTR, V33, P445, DOI 10.1097/00005176-200110000-00005; Krieger NR, 2000, LIVER TRANSPLANT, V6, P62, DOI 10.1016/S1527-6465(00)80034-9; LOSS M, 1995, TRANSPLANT P, V27, P1136; Loss M, 1996, TRANSPLANT P, V28, P1006; MCDIARMID SV, 1993, TRANSPLANTATION, V55, P1328, DOI 10.1097/00007890-199306000-00022; MCDIARMID SV, 1995, TRANSPLANTATION, V59, P530; Moore R, 2001, DRUG SAFETY, V24, P755, DOI 10.2165/00002018-200124100-00004; Muhlbacher F, 2001, TRANSPLANT P, V33, P1339, DOI 10.1016/S0041-1345(00)02500-8; Nakata Y, 2000, TRANSPLANTATION, V69, P1960, DOI 10.1097/00007890-200005150-00039; NEUHAUS P, 1994, LANCET, V344, P423; O'Grady JG, 2002, LANCET, V360, P1119, DOI 10.1016/S0140-6736(02)11196-2; Reding R, 2002, PEDIATR TRANSPLANT, V6, P447, DOI 10.1034/j.1399-3046.2002.t01-3-00002.x; Rowe D T, 2001, Transpl Infect Dis, V3, P79, DOI 10.1034/j.1399-3062.2001.003002079.x; Smets F, 2002, PEDIATR TRANSPLANT, V6, P280, DOI 10.1034/j.1399-3046.2002.02029.x; SPADA M, 2000, TRANSPLANT INT S1, V13; Wallemacq PE, 1998, EUR J DRUG METAB PH, V23, P367, DOI 10.1007/BF03192295	25	92	96	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 18	2004	364	9439					1054	1061		10.1016/S0140-6736(04)17060-8	http://dx.doi.org/10.1016/S0140-6736(04)17060-8			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	855FT	15380964				2022-12-28	WOS:000223959300024
J	[Anonymous]				[Anonymous]			Prescribing of lipid regulating drugs and admissions for myocardial infarction in England	BMJ-BRITISH MEDICAL JOURNAL			English	Article													Aylin, Paul/A-1073-2014	Bottle, Alex/0000-0001-9978-2011; Aylin, Paul/0000-0003-4589-1743; Majeed, Azeem/0000-0002-2357-9858					0	3	4	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 18	2004	329	7467					645	+		10.1136/bmj.329.7467.645	http://dx.doi.org/10.1136/bmj.329.7467.645			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	856JU	15374914	Green Published			2022-12-28	WOS:000224042300015
J	Gluckman, PD; Hanson, MA				Gluckman, PD; Hanson, MA			Living with the past: Evolution, development, and patterns of disease	SCIENCE			English	Review							LOW-BIRTH-WEIGHT; CORONARY-HEART-DISEASE; INSULIN-RESISTANCE; FETAL ORIGINS; EARLY GROWTH; LATER LIFE; DIABETES-MELLITUS; PRENATAL EXPOSURE; ADULT DISEASE; BODY-MASS		Univ Auckland, Liggins Inst, Auckland, New Zealand; Natl Res Ctr Growth & Dev, Auckland, New Zealand; Univ Southampton, Ctr Dev Origins Hlth & Dis, Princess Anne Hosp, Southampton SO16 5YA, Hants, England	University of Auckland; University of Auckland; University of Southampton	Gluckman, PD (corresponding author), Univ Auckland, Liggins Inst, 2-6 Pk Ave,Private Bag 92019, Auckland, New Zealand.	pd.gluckman@auckland.ac.nz	Hanson, Mark/AAE-8236-2019	Hanson, Mark/0000-0002-6907-613X				Agrawal AA, 1999, NATURE, V401, P60, DOI 10.1038/43425; Applebaum SW, 1999, ANNU REV ENTOMOL, V44, P317, DOI 10.1146/annurev.ento.44.1.317; Barker DJP, 2002, INT J EPIDEMIOL, V31, P1235, DOI 10.1093/ije/31.6.1235; BARKER DJP, 2001, FETAL ORIGINS CARDIO; Bertram CE, 2002, REPRODUCTION, V124, P459, DOI 10.1530/rep.0.1240459; Bertram CE, 2001, BRIT MED BULL, V60, P103, DOI 10.1093/bmb/60.1.103; Brawley L, 2004, J PHYSIOL-LONDON, V554, P497, DOI 10.1113/jphysiol.2003.052068; Cooney CA, 2002, J NUTR, V132, p2393S; Curhan GC, 1996, CIRCULATION, V94, P3246, DOI 10.1161/01.CIR.94.12.3246; Dennison EM, 2001, PAEDIATR PERINAT EP, V15, P211, DOI 10.1046/j.1365-3016.2001.00350.x; DESAI M, 1995, BIOCHEM SOC T, V23, P331, DOI 10.1042/bst0230331; Doblhammer G, 2001, P NATL ACAD SCI USA, V98, P2934, DOI 10.1073/pnas.041431898; Dodic M, 1998, CLIN SCI, V94, P149, DOI 10.1042/cs0940149; Drake AJ, 2004, J ENDOCRINOL, V180, P1, DOI 10.1677/joe.0.1800001; Eriksson JG, 2001, BRIT MED J, V322, P949, DOI 10.1136/bmj.322.7292.949; Eriksson JG, 2002, DIABETES, V51, P2321, DOI 10.2337/diabetes.51.7.2321; Fall Caroline H D, 2003, Indian Pediatr, V40, P480; Fowden AL, 2001, BRIT MED BULL, V60, P123, DOI 10.1093/bmb/60.1.123; Gluckman PD, 2004, TRENDS ENDOCRIN MET, V15, P183, DOI 10.1016/j.tem.2004.03.002; GLUCKMAN PD, IN PRESS SEMIN NEONA; GLUCKMAN PD, IN PRESS FETAL MATRI; Godfrey K, 1996, BRIT MED J, V312, P410, DOI 10.1136/bmj.312.7028.410; Hales CN, 2001, BRIT MED BULL, V60, P5, DOI 10.1093/bmb/60.1.5; Hattersley AT, 1998, NAT GENET, V19, P268, DOI 10.1038/953; Hattersley AT, 1999, LANCET, V353, P1789, DOI 10.1016/S0140-6736(98)07546-1; Hofman PL, 1997, J CLIN ENDOCR METAB, V82, P402, DOI 10.1210/jc.82.2.402; Huxley R, 2002, LANCET, V360, P659, DOI 10.1016/S0140-6736(02)09834-3; Ibanez L, 2000, PEDIATR RES, V47, P575, DOI 10.1203/00006450-200005000-00003; Ibanez L, 2001, CLIN ENDOCRINOL, V55, P667, DOI 10.1046/j.1365-2265.2001.01399.x; Jablonka E, 1995, PHILOS T R SOC B, V350, P133, DOI 10.1098/rstb.1995.0147; Kannisto V, 1997, AM J EPIDEMIOL, V145, P987, DOI 10.1093/oxfordjournals.aje.a009067; Khan LY, 2003, HYPERTENSION, V41, P168, DOI 10.1161/01.HYP.0000047511.97879.FC; Kind KL, 2003, AM J PHYSIOL-REG I, V284, pR140, DOI 10.1152/ajpregu.00587.2001; Kwong WY, 2000, DEVELOPMENT, V127, P4195; LANGLEY SC, 1994, CLIN SCI, V86, P217, DOI 10.1042/cs0860217; Langley-Evans SC, 1999, LIFE SCI, V64, P965, DOI 10.1016/S0024-3205(99)00022-3; Lawlor DA, 2004, HEART, V90, P381, DOI 10.1136/hrt.2002.009548; LEE TM, 1988, AM J PHYSIOL, V255, pR831, DOI 10.1152/ajpregu.1988.255.5.R831; Leeson CPM, 1997, CIRCULATION, V96, P2233; Lev-Ran A, 2001, DIABETES-METAB RES, V17, P347, DOI 10.1002/dmrr.230; Lucas A, 1998, BRIT MED J, V317, P1481, DOI 10.1136/bmj.317.7171.1481; Lumey L H, 1992, Paediatr Perinat Epidemiol, V6, P240, DOI 10.1111/j.1365-3016.1992.tb00764.x; NEEL JV, 1962, AM J HUM GENET, V14, P353; Norman JF, 2001, ATHEROSCLEROSIS, V157, P41, DOI 10.1016/S0021-9150(00)00668-7; Ong KKL, 2002, PEDIATR RES, V52, P863, DOI 10.1203/00006450-200212000-00009; Ozanne SE, 2004, NATURE, V427, P411, DOI 10.1038/427411b; Ozanne SE, 2003, J ENDOCRINOL, V177, P235, DOI 10.1677/joe.0.1770235; Phillips DIW, 1997, DIABETIC MED, V14, P673, DOI 10.1002/(SICI)1096-9136(199708)14:8<673::AID-DIA458>3.0.CO;2-9; Plagemann A, 1999, BRAIN RES, V836, P146, DOI 10.1016/S0006-8993(99)01662-5; Poore KR, 2004, DIABETOLOGIA, V47, P340, DOI 10.1007/s00125-003-1305-3; Power C, 2002, INT J EPIDEMIOL, V31, P413, DOI 10.1093/ije/31.2.413; Roseboom TJ, 2001, MOL CELL ENDOCRINOL, V185, P93, DOI 10.1016/S0303-7207(01)00721-3; Seckl JR, 1997, STEROIDS, V62, P89, DOI 10.1016/S0039-128X(96)00165-1; Singhal A, 2003, LANCET, V361, P1089, DOI 10.1016/S0140-6736(03)12895-4; Singhal A, 2003, AM J CLIN NUTR, V77, P726, DOI 10.1093/ajcn/77.3.726; Thompson C, 2001, BRIT J PSYCHIAT, V179, P450, DOI 10.1192/bjp.179.5.450; Vaupel JW, 1998, SCIENCE, V280, P855, DOI 10.1126/science.280.5365.855; Vickers MH, 2000, AM J PHYSIOL-ENDOC M, V279, pE83; Vickers MH, 2003, AM J PHYSIOL-REG I, V285, pR271, DOI 10.1152/ajpregu.00051.2003; Waddington C H, 1957, STRATEGY GENES DISCU; Wahlbeck K, 2001, ARCH GEN PSYCHIAT, V58, P48, DOI 10.1001/archpsyc.58.1.48; Weaver ICG, 2004, NAT NEUROSCI, V7, P847, DOI 10.1038/nn1276; West-Eberhard Mary Jane, 2003, pi; Young LE, 2001, NAT GENET, V27, P153, DOI 10.1038/84769	64	1281	1316	4	179	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 17	2004	305	5691					1733	1736		10.1126/science.1095292	http://dx.doi.org/10.1126/science.1095292			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	856IS	15375258				2022-12-28	WOS:000224039500029
J	Lisby, M; Barlow, JH; Burgess, RC; Rothstein, R				Lisby, M; Barlow, JH; Burgess, RC; Rothstein, R			Choreography of the DNA damage response: Spatiotemporal relationships among checkpoint and repair proteins	CELL			English	Article							DOUBLE-STRAND BREAKS; STALLED REPLICATION FORKS; SACCHAROMYCES-CEREVISIAE; S-PHASE; RAD52 PROTEIN; MRE11 COMPLEX; NUCLEAR FOCI; HOMOLOGOUS RECOMBINATION; TELOMERE MAINTENANCE; SENSITIVE MUTANTS	DNA repair is an essential process for preserving genome integrity in all organisms. In eukaryotes, recombinational repair is choreographed by multiprotein complexes that are organized into centers (foci). Here, we analyze the cellular response to DNA double-strand breaks (DSBs) and replication stress in Saccharomyces cerevisiae. The Mre11 nuclease and the ATM-related Tell kinase are the first proteins detected at DSBs. Next, the Rfa1 single-strand DNA binding protein relocalizes to the break and recruits other key checkpoint proteins. Later and only in S and G2 phase, the homologous recombination machinery assembles at the site. Unlike the response to DSBs, Mre11 and recombination proteins are not recruited to hydroxyurea-stalled replication forks unless the forks collapse. The cellular response to DSBs and DNA replication stress is likely directed by the Mre11 complex detecting and processing DNA ends in conjunction with Sae2 and by RP-A recognizing single-stranded DNA and recruiting additional checkpoint and repair proteins.	Columbia Univ Coll Phys & Surg, Dept Genet & Dev, New York, NY 10032 USA; Columbia Univ, Dept Biol Sci, New York, NY 10027 USA	Columbia University; Columbia University	Rothstein, R (corresponding author), Columbia Univ Coll Phys & Surg, Dept Genet & Dev, 701 W 168th St, New York, NY 10032 USA.	rothstein@cancercenter.columbia.edu	Lisby, Michael/K-9814-2014	Lisby, Michael/0000-0002-4830-5247; Rothstein, Rodney/0000-0002-4107-9654				ALANI E, 1992, J MOL BIOL, V227, P54, DOI 10.1016/0022-2836(92)90681-9; Alexeev A, 2003, NAT STRUCT BIOL, V10, P182, DOI 10.1038/nsb901; ALLEN JB, 1994, GENE DEV, V8, P2401, DOI 10.1101/gad.8.20.2401; ANDERSEN AH, 1991, J BIOL CHEM, V266, P9203; Aten JA, 2004, SCIENCE, V303, P92, DOI 10.1126/science.1088845; Benson FE, 1998, NATURE, V391, P401, DOI 10.1038/34937; Borde V, 2004, MOL CELL, V13, P389, DOI 10.1016/S1097-2765(04)00034-6; Boulton SJ, 1998, EMBO J, V17, P1819, DOI 10.1093/emboj/17.6.1819; Carson CT, 2003, EMBO J, V22, P6610, DOI 10.1093/emboj/cdg630; Chan SWL, 2003, MOL CELL, V11, P1379, DOI 10.1016/S1097-2765(03)00174-6; Chang M, 2002, P NATL ACAD SCI USA, V99, P16934, DOI 10.1073/pnas.262669299; Clever B, 1997, EMBO J, V16, P2535, DOI 10.1093/emboj/16.9.2535; Costanzo V, 2003, MOL CELL, V11, P203, DOI 10.1016/S1097-2765(02)00799-2; D'Amours D, 2001, GENE DEV, V15, P2238, DOI 10.1101/gad.208701; Davis AP, 2001, GENETICS, V159, P515; de Jager M, 2001, MOL CELL, V8, P1129, DOI 10.1016/S1097-2765(01)00381-1; de la Torre-Ruiz MA, 1998, EMBO J, V17, P2687, DOI 10.1093/emboj/17.9.2687; Desany BA, 1998, GENE DEV, V12, P2956, DOI 10.1101/gad.12.18.2956; Frank-Vaillant M, 2002, MOL CELL, V10, P1189, DOI 10.1016/S1097-2765(02)00705-0; Frei C, 2000, GENE DEV, V14, P81; Friedl AA, 1998, GENETICS, V148, P975; Fujimori A, 2001, EMBO J, V20, P5513, DOI 10.1093/emboj/20.19.5513; GAME JC, 1974, MUTAT RES, V24, P281, DOI 10.1016/0027-5107(74)90176-6; Gasior SL, 2001, P NATL ACAD SCI USA, V98, P8411, DOI 10.1073/pnas.121046198; Gasior SL, 1998, GENE DEV, V12, P2208, DOI 10.1101/gad.12.14.2208; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Gilbert CS, 2001, MOL CELL, V8, P129, DOI 10.1016/S1097-2765(01)00267-2; Grenon M, 2001, NAT CELL BIOL, V3, P844, DOI 10.1038/ncb0901-844; HAAF T, 1995, P NATL ACAD SCI USA, V92, P2298, DOI 10.1073/pnas.92.6.2298; Haaf T, 1999, J CELL BIOL, V144, P11, DOI 10.1083/jcb.144.1.11; HAYS SL, 1995, P NATL ACAD SCI USA, V92, P6925, DOI 10.1073/pnas.92.15.6925; Hays SL, 1998, MOL CELL BIOL, V18, P4400, DOI 10.1128/MCB.18.7.4400; Jiang H, 1996, J BIOL CHEM, V271, P33181, DOI 10.1074/jbc.271.52.33181; Katou Y, 2003, NATURE, V424, P1078, DOI 10.1038/nature01900; KEENEY S, 1995, P NATL ACAD SCI USA, V92, P11274, DOI 10.1073/pnas.92.24.11274; Kim HS, 2003, DNA REPAIR, V2, P1321, DOI 10.1016/j.dnarep.2003.07.004; Kim HS, 2001, MOL CELL BIOL, V21, P3725, DOI 10.1128/MCB.21.11.3725-3737.2001; Klein HL, 1997, GENETICS, V147, P1533; Krejci L, 2001, MOL CELL BIOL, V21, P966, DOI 10.1128/MCB.21.3.966-976.2001; Lee JH, 2004, SCIENCE, V304, P93, DOI 10.1126/science.1091496; Lee SE, 2001, CURR BIOL, V11, P1053, DOI 10.1016/S0960-9822(01)00296-2; Lee SE, 1998, CELL, V94, P399, DOI 10.1016/S0092-8674(00)81482-8; Lisby M, 2003, NAT CELL BIOL, V5, P572, DOI 10.1038/ncb997; Lisby M, 2001, P NATL ACAD SCI USA, V98, P8276, DOI 10.1073/pnas.121006298; Lisby M, 2003, CELL CYCLE, V2, P479, DOI 10.4161/cc.2.5.483; Lobachev KS, 2002, CELL, V108, P183, DOI 10.1016/S0092-8674(02)00614-1; Lopes M, 2001, NATURE, V412, P557, DOI 10.1038/35087613; Lucca C, 2004, ONCOGENE, V23, P1206, DOI 10.1038/sj.onc.1207199; Lukas C, 2003, NAT CELL BIOL, V5, P255, DOI 10.1038/ncb945; Majka J, 2003, P NATL ACAD SCI USA, V100, P2249, DOI 10.1073/pnas.0437148100; Manke IA, 2003, SCIENCE, V302, P636, DOI 10.1126/science.1088877; Martin SG, 1999, CELL, V97, P621, DOI 10.1016/S0092-8674(00)80773-4; Maser RS, 1997, MOL CELL BIOL, V17, P6087, DOI 10.1128/MCB.17.10.6087; Melo J, 2002, CURR OPIN CELL BIOL, V14, P237, DOI 10.1016/S0955-0674(02)00312-5; Melo JA, 2001, GENE DEV, V15, P2809; Moreau S, 1999, MOL CELL BIOL, V19, P556; Moreau S, 2001, GENETICS, V159, P1423; Nakada D, 2003, GENE DEV, V17, P1957, DOI 10.1101/gad.1099003; Nelms BE, 1998, SCIENCE, V280, P590, DOI 10.1126/science.280.5363.590; New JH, 1998, NATURE, V391, P407, DOI 10.1038/34950; Nugent CI, 1998, CURR BIOL, V8, P657, DOI 10.1016/S0960-9822(98)70253-2; PADMORE R, 1991, CELL, V66, P1239, DOI 10.1016/0092-8674(91)90046-2; Paulovich AG, 1997, GENETICS, V145, P45; Petukhova G, 2000, GENE DEV, V14, P2206, DOI 10.1101/gad.826100; Raderschall E, 1999, P NATL ACAD SCI USA, V96, P1921, DOI 10.1073/pnas.96.5.1921; REICHARD P, 1988, ANNU REV BIOCHEM, V57, P349, DOI 10.1146/annurev.bi.57.070188.002025; Rijkers T, 1998, MOL CELL BIOL, V18, P6423, DOI 10.1128/MCB.18.11.6423; SHINOHARA A, 1992, CELL, V69, P457, DOI 10.1016/0092-8674(92)90447-K; Shinohara M, 1997, GENETICS, V147, P1545; Sogo JM, 2002, SCIENCE, V297, P599, DOI 10.1126/science.1074023; Sugawara N, 2003, MOL CELL, V12, P209, DOI 10.1016/S1097-2765(03)00269-7; Sung P, 1997, GENE DEV, V11, P1111, DOI 10.1101/gad.11.9.1111; Sung P, 1997, J BIOL CHEM, V272, P28194, DOI 10.1074/jbc.272.45.28194; Symington LS, 2002, MICROBIOL MOL BIOL R, V66, P630, DOI 10.1128/MMBR.66.4.630-670.2002; Takata H, 2004, MOL CELL, V14, P515, DOI 10.1016/S1097-2765(04)00262-X; Tercero JA, 2001, NATURE, V412, P553, DOI 10.1038/35087607; Trujillo KM, 2001, J BIOL CHEM, V276, P35458, DOI 10.1074/jbc.M105482200; TRUJILLO KM, 2003, J BIOL CHEM, V49, P48967; Usui T, 2001, MOL CELL, V7, P1255, DOI 10.1016/S1097-2765(01)00270-2; Uziel T, 2003, EMBO J, V22, P5612, DOI 10.1093/emboj/cdg541; Van Dyck E, 1999, NATURE, V398, P728, DOI 10.1038/43942; Yu XC, 2003, SCIENCE, V302, P639, DOI 10.1126/science.1088753; Zou L, 2002, GENE DEV, V16, P198, DOI 10.1101/gad.950302; Zou L, 2003, P NATL ACAD SCI USA, V100, P13827, DOI 10.1073/pnas.2336100100; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	85	707	723	2	31	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 17	2004	118	6					699	713		10.1016/j.cell.2004.08.015	http://dx.doi.org/10.1016/j.cell.2004.08.015			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	855RW	15369670	Bronze			2022-12-28	WOS:000223992400007
J	Senghas, A; Kita, S; Ozyurek, A				Senghas, A; Kita, S; Ozyurek, A			Children creating core properties of language: Evidence from an emerging sign language in Nicaragua	SCIENCE			English	Article							GESTURE	A new sign language has been created by deaf Nicaraguans over the past 25 years, providing an opportunity to observe the inception of universal hallmarks of language. We found that in their initial creation of the language, children analyzed complex events into basic elements and sequenced these elements into hierarchically structured expressions according to principles not observed in gestures accompanying speech in the surrounding language. Successive cohorts of learners extended this procedure, transforming Nicaraguan signing from its early gestural form into a linguistic system. We propose that this early segmentation and recombination reflect mechanisms with which children learn, and thereby perpetuate, language. Thus, children naturally possess learning abilities capable of giving language its fundamental structure.	Columbia Univ Barnard Coll, Dept Psychol, New York, NY 10027 USA; Univ Bristol, Dept Expt Psychol, Bristol BS8 1TN, Avon, England; Univ Nijmegen, FC Donders Ctr Cognit Neuroimaging, NL-6525 EK Nijmegen, Netherlands; Max Planck Inst Psycholinguist, NL-6525 XD Nijmegen, Netherlands; Koc Univ, Dept Psychol, TR-34450 Istanbul, Turkey	Columbia University; University of Bristol; Radboud University Nijmegen; Max Planck Society; Koc University	Senghas, A (corresponding author), Columbia Univ Barnard Coll, Dept Psychol, 3009 Broadway, New York, NY 10027 USA.	annie@alum.mit.edu	Kita, Sotaro/B-2860-2008; ozyurek, asli/M-5366-2013; Galantucci, Bruno/E-5770-2010	Kita, Sotaro/0000-0002-0088-3654; 	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC000491, R01DC005407] Funding Source: NIH RePORTER; NIDCD NIH HHS [R01 DC005407, R01 DC00491, R01 DC05407] Funding Source: Medline	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		ANDERSEN RW, 1983, PIDGINISATION CREOLI, P1; BICKERTON D, 1984, BEHAV BRAIN SCI, V7, P173, DOI 10.1017/S0140525X00044149; Christiansen MH, 2003, TRENDS COGN SCI, V7, P300, DOI 10.1016/S1364-6613(03)00136-0; Coppola M., 2002, THESIS U ROCHESTER; DeGraff M., 1999, LANGUAGE CREATION LA; Goldin-Meadow S., 1982, LANG ACQUIS, P51; Hauser MD, 2002, SCIENCE, V298, P1569, DOI 10.1126/science.298.5598.1569; Hockett C. F., 1987, REFURBISHING OUR FDN; HOLM J, 1988, PIDGINS CREOLES, V1; Jackendoff R., 2002, FDN LANGUAGE BRAIN, DOI 10.1093/acprof:oso/9780198270126.001.0001; Kegl J, 1999, LEARN DEV CONCEP CH, P179; Kirby S., 1999, FUNCTION SELECTION I; Kita S, 2003, J MEM LANG, V48, P16, DOI 10.1016/S0749-596X(02)00505-3; Lenneberg, 1967, BIOL FDN LANGUAGE, DOI 10.1080/21548331.1967.11707799; McNeill D, 1992, HAND MIND WHAT GESTU; MEIER RP, 1987, J MEM LANG, V26, P362, DOI 10.1016/0749-596X(87)90119-7; Morford JP, 1996, LANG COMMUN, V16, P165, DOI 10.1016/0271-5309(96)00008-0; NEWPORT EL, 1990, COGNITIVE SCI, V14, P11, DOI 10.1207/s15516709cog1401_2; PINKER S, 1990, BEHAV BRAIN SCI, V13, P707, DOI 10.1017/S0140525X00081061; POLICH L, IN PRESS BUT SIGN LA; Sankoff Gillian, 1973, KIVUNG, V6, P32; Senghas A, 2003, COGNITIVE DEV, V18, P511, DOI 10.1016/j.cogdev.2003.09.006; Senghas A, 2001, PSYCHOL SCI, V12, P323, DOI 10.1111/1467-9280.00359; Senghas A., 1995, THESIS MIT; SENGHAS RJ, 1997, THESIS U ROCHESTER; Talmy L, 1985, LANGUAGE TYPOLOGY SY, V3, P57, DOI DOI 10.1017/CB09780511618437; TOMASELLO M, 2003, LANGUAGE EVOLUTION, P94, DOI DOI 10.1093/ACPROF:OSO/9780199244843.003.0006; [No title captured]	28	300	304	1	82	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 17	2004	305	5691					1779	1782		10.1126/science.1100199	http://dx.doi.org/10.1126/science.1100199			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	856IS	15375269	Green Submitted			2022-12-28	WOS:000224039500043
J	Baulcombe, D				Baulcombe, D			RNA silencing in plants	NATURE			English	Article							DOUBLE-STRANDED-RNA; TRANSMEMBRANE PROTEIN SID-1; SMALL INTERFERING RNA; TO-CELL MOVEMENT; VIRAL SUPPRESSOR; VIRUS-RESISTANCE; GENE-REGULATION; LEAF POLARITY; HISTONE H3; C-ELEGANS		John Innes Ctr Plant Sci Res, Sainsbury Lab, Norwich NR4 7UH, Norfolk, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center	Baulcombe, D (corresponding author), John Innes Ctr Plant Sci Res, Sainsbury Lab, Colney Lane, Norwich NR4 7UH, Norfolk, England.	david.baulcombe@sainsbury-laboratory.ac.uk		Baulcombe, David/0000-0003-0780-6878				ACHARD P, IN PRESS GENES DEV; Aukerman MJ, 2003, PLANT CELL, V15, P2730, DOI 10.1105/tpc.016238; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Boutet S, 2003, CURR BIOL, V13, P843, DOI 10.1016/S0960-9822(03)00293-8; Chapman EJ, 2004, GENE DEV, V18, P1179, DOI 10.1101/gad.1201204; Chen XM, 2004, SCIENCE, V303, P2022, DOI 10.1126/science.1088060; Cogoni C, 1999, NATURE, V399, P166, DOI 10.1038/20215; Covey SN, 1997, NATURE, V385, P781, DOI 10.1038/385781a0; Dalmay T, 2000, CELL, V101, P543, DOI 10.1016/S0092-8674(00)80864-8; Dalmay T, 2001, EMBO J, V20, P2069, DOI 10.1093/emboj/20.8.2069; Ding B, 1997, PLANT J, V12, P931, DOI 10.1046/j.1365-313X.1997.12040931.x; Dunoyer P, 2004, PLANT CELL, V16, P1235, DOI 10.1105/tpc.020719; Emery JF, 2003, CURR BIOL, V13, P1768, DOI 10.1016/j.cub.2003.09.035; Fagard M, 2000, P NATL ACAD SCI USA, V97, P11650, DOI 10.1073/pnas.200217597; Feinberg EH, 2003, SCIENCE, V301, P1545, DOI 10.1126/science.1087117; Finnegan EJ, 2003, CURR BIOL, V13, P236, DOI 10.1016/S0960-9822(03)00010-1; Floyd SK, 2004, NATURE, V428, P485, DOI 10.1038/428485a; Hamilton A, 2002, EMBO J, V21, P4671, DOI 10.1093/emboj/cdf464; Hamilton AJ, 1999, SCIENCE, V286, P950, DOI 10.1126/science.286.5441.950; Hammond SM, 2001, SCIENCE, V293, P1146, DOI 10.1126/science.1064023; Han MH, 2004, P NATL ACAD SCI USA, V101, P1093, DOI 10.1073/pnas.0307969100; Haywood V, 2002, PLANT CELL, V14, pS303, DOI 10.1105/tpc.000778; Himber C, 2003, EMBO J, V22, P4523, DOI 10.1093/emboj/cdg431; Hunter C, 2003, CURR BIOL, V13, P1734, DOI 10.1016/j.cub.2003.09.004; Iyer LM, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-5; Jones L, 2001, CURR BIOL, V11, P747, DOI 10.1016/S0960-9822(01)00226-3; Jones-Rhoades MW, 2004, MOL CELL, V14, P787, DOI 10.1016/j.molcel.2004.05.027; Juarez MT, 2004, NATURE, V428, P84, DOI 10.1038/nature02363; Kasschau KD, 2003, DEV CELL, V4, P205, DOI 10.1016/S1534-5807(03)00025-X; Kidner CA, 2004, NATURE, V428, P81, DOI 10.1038/nature02366; Kim M, 2001, SCIENCE, V293, P287, DOI 10.1126/science.1059805; Lakatos L, 2004, EMBO J, V23, P876, DOI 10.1038/sj.emboj.7600096; Li HW, 2002, SCIENCE, V296, P1319, DOI 10.1126/science.1070948; Li WX, 2004, P NATL ACAD SCI USA, V101, P1350, DOI 10.1073/pnas.0308308100; Lichner Z, 2003, J GEN VIROL, V84, P975, DOI 10.1099/vir.0.18987-0; Lingel A, 2003, NATURE, V426, P465, DOI 10.1038/nature02123; LIU J, 2004, SCIENCE         0729, DOI DOI 10.11261/SCIENCE.1102513; Llave C, 2002, PLANT CELL, V14, P1605, DOI 10.1105/tpc.003210; Llave C, 2002, SCIENCE, V297, P2053, DOI 10.1126/science.1076311; Makeyev EV, 2002, MOL CELL, V10, P1417, DOI 10.1016/S1097-2765(02)00780-3; Mallory AC, 2004, CURR BIOL, V14, P1035, DOI 10.1016/j.cub.2004.06.022; Mallory AC, 2002, P NATL ACAD SCI USA, V99, P15228, DOI 10.1073/pnas.232434999; Mallory AC, 2001, PLANT CELL, V13, P571, DOI 10.1105/tpc.13.3.571; Martinez-Espinoza AD, 2002, FUNGAL GENET BIOL, V35, P1, DOI 10.1006/fgbi.2001.1301; Mette MF, 2000, EMBO J, V19, P5194, DOI 10.1093/emboj/19.19.5194; Mochizuki K, 2002, CELL, V110, P689, DOI 10.1016/S0092-8674(02)00909-1; Moissiard G, 2004, MOL PLANT PATHOL, V5, P71, DOI 10.1111/j.1364-3703.2004.00207.x; Mourrain P, 2000, CELL, V101, P533, DOI 10.1016/S0092-8674(00)80863-6; Palatnik JF, 2003, NATURE, V425, P257, DOI 10.1038/nature01958; Palauqui JC, 1997, EMBO J, V16, P4738, DOI 10.1093/emboj/16.15.4738; Papp I, 2003, PLANT PHYSIOL, V132, P1382, DOI 10.1104/pp.103.021980; Park W, 2002, CURR BIOL, V12, P1484, DOI 10.1016/S0960-9822(02)01017-5; Pfeffer S, 2004, SCIENCE, V304, P734, DOI 10.1126/science.1096781; Pruss GJ, 2004, VIROLOGY, V320, P107, DOI 10.1016/j.virol.2003.11.027; Ratcliff F, 1997, SCIENCE, V276, P1558, DOI 10.1126/science.276.5318.1558; Rhoades MW, 2002, CELL, V110, P513, DOI 10.1016/S0092-8674(02)00863-2; SCHANK RC, 1991, J LEARN SCI, V1, P7; SCHIEBEL W, 1993, J BIOL CHEM, V268, P11858; Schwarz DS, 2003, CELL, V115, P199, DOI 10.1016/S0092-8674(03)00759-1; Sijen T, 2001, CELL, V107, P465, DOI 10.1016/S0092-8674(01)00576-1; Smardon A, 2000, CURR BIOL, V10, P169, DOI 10.1016/S0960-9822(00)00323-7; SUNKAR R, IN PRESS PLANT CELL; Szittya G, 2002, PLANT CELL, V14, P359, DOI 10.1105/tpc.010366; Tang GL, 2003, GENE DEV, V17, P49, DOI 10.1101/gad.1048103; Taverna SD, 2002, CELL, V110, P701, DOI 10.1016/S0092-8674(02)00941-8; Timmons L, 1998, NATURE, V395, P854, DOI 10.1038/27579; Vaistij FE, 2002, PLANT CELL, V14, P857, DOI 10.1105/tpc.010480; VanHoudt H, 1997, PLANT J, V12, P379, DOI 10.1046/j.1365-313X.1997.12020379.x; Vargason JM, 2003, CELL, V115, P799, DOI 10.1016/S0092-8674(03)00984-X; Vaucheret H, 2004, GENE DEV, V18, P1187, DOI 10.1101/gad.1201404; Vazquez F, 2004, CURR BIOL, V14, P346, DOI 10.1016/j.cub.2004.01.035; Verdel A, 2004, SCIENCE, V303, P672, DOI 10.1126/science.1093686; Voinnet O, 1997, NATURE, V389, P553, DOI 10.1038/39215; Voinnet O, 1998, CELL, V95, P177, DOI 10.1016/S0092-8674(00)81749-3; Voinnet O, 2000, CELL, V103, P157, DOI 10.1016/S0092-8674(00)00095-7; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973; Wang MB, 2004, P NATL ACAD SCI USA, V101, P3275, DOI 10.1073/pnas.0400104101; WASSENEGGER M, 1994, CELL, V76, P567, DOI 10.1016/0092-8674(94)90119-8; Wingard SA, 1928, J AGRIC RES, V37, P0127; Winston WM, 2002, SCIENCE, V295, P2456, DOI 10.1126/science.1068836; Xie ZX, 2004, PLOS BIOL, V2, P642, DOI 10.1371/journal.pbio.0020104; Xie ZX, 2003, CURR BIOL, V13, P784, DOI 10.1016/S0960-9822(03)00281-1; Xie ZX, 2001, P NATL ACAD SCI USA, V98, P6516, DOI 10.1073/pnas.111440998; Yamada K, 2003, SCIENCE, V302, P842, DOI 10.1126/science.1088305; Ye KQ, 2003, NATURE, V426, P874, DOI 10.1038/nature02213; Yoo BC, 2004, PLANT CELL, V16, P1979, DOI 10.1105/tpc.104.023614; Zilberman D, 2003, SCIENCE, V299, P716, DOI 10.1126/science.1079695	87	1747	1923	14	372	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 16	2004	431	7006					356	363		10.1038/nature02874	http://dx.doi.org/10.1038/nature02874			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	853XJ	15372043				2022-12-28	WOS:000223864000052
J	Buckley, SA; Clark, KA; Evershed, RP				Buckley, SA; Clark, KA; Evershed, RP			Complex organic chemical balms of Pharaonic animal mummies	NATURE			English	Article							EGYPTIAN MUMMIES; BITUMEN; BEESWAX	Millions of votive mummies of mammals, birds and reptiles were produced throughout ancient Egypt, with their popularity increasing during the reign of Amenhotep III (1400 BC) and thereafter. The scale of production has been taken to indicate that relatively little care and expense was involved in their preparation compared with human mummies(1-3). The accepted view is that animals were merely wrapped in coarse linen bandages and/or dipped in 'resin' before death(2-4). However, as with human mummification there was a range of qualities of treatments, and visual inspection of animal mummies suggests that the procedures used were often as complex as those used in humans (for example, evisceration and elaborate bandaging). Moreover, the ancient Egyptians treated animals with great respect, regarding them both as domestic pets and representatives of the gods; for example, the cat symbolized the goddess Bastet; the hawk, Horus; the ibis, Thoth, and so on. We report here the results of chemical investigations of tissues and wrappings from Pharaonic cat, hawk and ibis mummies using gas chromatography, gas chromatography-mass spectrometry, thermal desorption-gas chromatography-mass spectrometry and pyrolysis-gas chromatography-mass spectrometry(5,6). The analyses reveal the presence of highly complex mixtures of n-alkyl and cyclic biomarker components characteristic of fats, oils, beeswax, sugar gum, petroleum bitumen, and coniferous, Pistacia and possibly cedar resins. The mixture of balms is of comparable complexity to those used to mummify humans from the same period(6-8).	Sch Chem, Bristol Biogeochem Res Ctr, Organ Geochem Unit, Bristol BS8 1TS, Avon, England	University of Bristol	Evershed, RP (corresponding author), Univ York, Dept Archaeol, Kings Manor, York YO1 7EP, N Yorkshire, England.	r.p.evershed@bristol.ac.uk						Brier B., 1996, EGYPTIAN MUMMIES; Buckley SA, 1999, ANALYST, V124, P443, DOI 10.1039/a809022j; Buckley SA, 2001, NATURE, V413, P837, DOI 10.1038/35101588; Colombini MP, 2000, STUD CONSERV, V45, P19, DOI 10.2307/1506680; Connan J, 1999, PHILOS T ROY SOC B, V354, P33, DOI 10.1098/rstb.1999.0358; CONNAN J, 1991, CR ACAD SCI II, V312, P1445; DIODORUS, 1935, LIB HIST; Evershed RP, 2003, J ARCHAEOL SCI, V30, P1, DOI 10.1006/jasc.2001.0827; Evershed RP, 1997, ANTIQUITY, V71, P979, DOI 10.1017/S0003598X00085860; Gunstone F., 1986, LIPID HDB; Harrell JA, 2002, ARCHAEOMETRY, V44, P285, DOI 10.1111/1475-4754.t01-1-00060; Ikram S, 1998, MUMMY ANCIENT EGYPT; Koller J, 2003, NATURE, V425, P784, DOI 10.1038/425784a; Koller J, 1998, NATURE, V391, P343, DOI 10.1038/34809; Lucas A., 1931, J EGYPT ARCHAEOL, V17, P13; Lucas A., 1989, ANCIENT EGYPTIAN MAT, V4th; Malek J, 1997, CAT ANCIENT EGYPT; Marincola John M., 1996, HISTORIES; Maurer J, 2002, J ARCHAEOL SCI, V29, P751, DOI 10.1006/jasc.2001.0773; MILLS JS, 1989, ARCHAEOMETRY, V31, P37, DOI 10.1111/j.1475-4754.1989.tb01054.x; Regert M, 2001, ARCHAEOMETRY, V43, P549, DOI 10.1111/1475-4754.00036; RULLKOTTER J, 1988, NATURWISSENSCHAFTEN, V75, P618, DOI 10.1007/BF00366476; SERPICO M, 1998, CHEM ANAL CONIFEROUS, P1037; Serpico M., 2000, ANCIENT EGYPTIAN MAT, P430	24	70	75	5	53	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 16	2004	431	7006					294	299		10.1038/nature02849	http://dx.doi.org/10.1038/nature02849			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	853XJ	15372029				2022-12-28	WOS:000223864000037
J	Gliki, G; Ebnet, K; Aurrand-Lions, M; Imhof, BA; Adams, RH				Gliki, G; Ebnet, K; Aurrand-Lions, M; Imhof, BA; Adams, RH			Spermatid differentiation requires the assembly of a cell polarity complex downstream of junctional adhesion molecule-C	NATURE			English	Article							EPITHELIAL TIGHT JUNCTION; JAM FAMILY; ROLES; APKC; ESTABLISHMENT; DYNAMICS; NECTIN-2; ACROSOME; CDC42; PAR-6	During spermatogenesis in the mammalian testis, stem cells (spermatogonia) differentiate into spermatocytes, which subsequently undergo two consecutive meiotic divisions to give rise to haploid spermatids. These cells are initially round but progressively elongate, condense their nuclei, acquire flagellar and acrosomal structures, and shed a significant amount of their cytoplasm to form spermatozoa (the sperm cells) in a developmental cascade termed spermiogenesis(1,2). Defects in these processes will lead to a lack of mature sperm cells ( azoospermia), which is a major cause of male infertility in the human population(3). Here we report that a cell-surface protein of the immunoglobulin superfamily, junctional adhesion molecule-C (JAM-C), is critically required for the differentiation of round spermatids into spermatozoa in mice. We found that Jam-C is essential for the polarization of round spermatids, a function that we attribute to its role in the assembly of a cell polarity complex.	Canc Res UK London Res Inst, Vasc Dev Lab, London WC2A 3PX, England; Univ Hosp Munster, Inst Cell Biol, ZMBE, D-48149 Munster, Germany; Univ Geneva, CMU, Dept Pathol, CH-1211 Geneva, Switzerland	Cancer Research UK; University of Geneva	Adams, RH (corresponding author), Canc Res UK London Res Inst, Vasc Dev Lab, London WC2A 3PX, England.	ralf.adams@cancer.org.uk	Ebnet, Klaus T/C-8314-2009; Adams, Ralf H/AAE-9274-2019; Aurrand-Lions, Michel/O-9953-2016	Ebnet, Klaus T/0000-0002-0417-7888; Aurrand-Lions, Michel/0000-0002-8361-3034				Arrate MP, 2001, J BIOL CHEM, V276, P45826, DOI 10.1074/jbc.M105972200; Aurrand-Lions M, 2002, VASC PHARMACOL, V39, P239, DOI 10.1016/S1537-1891(03)00012-0; Bazzoni G, 2003, CURR OPIN CELL BIOL, V15, P525, DOI 10.1016/S0955-0674(03)00104-2; Bouchard MJ, 2000, MOL CELL BIOL, V20, P2865, DOI 10.1128/MCB.20.8.2865-2873.2000; Chavakis T, 2003, THROMB HAEMOSTASIS, V89, P13; Cheng CY, 2002, PHYSIOL REV, V82, P825, DOI 10.1152/physrev.00009.2002; Compagni A, 2003, DEV CELL, V5, P217, DOI 10.1016/S1534-5807(03)00198-9; Ebnet K, 2001, EMBO J, V20, P3738, DOI 10.1093/emboj/20.14.3738; Ebnet K, 2003, J CELL SCI, V116, P3879, DOI 10.1242/jcs.00704; Ebnet K, 2004, J CELL SCI, V117, P19, DOI 10.1242/jcs.00930; Erickson JW, 2001, CURR OPIN CELL BIOL, V13, P153, DOI 10.1016/S0955-0674(00)00192-7; Etienne-Manneville S, 2003, CURR OPIN CELL BIOL, V15, P67, DOI 10.1016/S0955-0674(02)00005-4; Ezeh UIO, 2000, HUM REPROD, V15, P2356, DOI 10.1093/humrep/15.11.2356; GRISWOLD MD, 1995, BIOL REPROD, V52, P211, DOI 10.1095/biolreprod52.2.211; Hurd TW, 2003, NAT CELL BIOL, V5, P137, DOI 10.1038/ncb923; Hutterer A, 2004, DEV CELL, V6, P845, DOI 10.1016/j.devcel.2004.05.003; Izumi Y, 1998, J CELL BIOL, V143, P95, DOI 10.1083/jcb.143.1.95; Kang-Decker N, 2001, SCIENCE, V294, P1531, DOI 10.1126/science.1063665; Kierszenbaum AL, 2003, MOL BIOL CELL, V14, P4628, DOI 10.1091/mbc.E03-04-0226; Lallemand Y, 1998, TRANSGENIC RES, V7, P105, DOI 10.1023/A:1008868325009; Liang TW, 2002, J IMMUNOL, V168, P1618, DOI 10.4049/jimmunol.168.4.1618; Lui WY, 2003, BIOL REPROD, V68, P1087, DOI 10.1095/biolreprod.102.010371; Mueller S, 2003, BIOL REPROD, V69, P1330, DOI 10.1095/biolreprod.102.014670; Muller WA, 2003, TRENDS IMMUNOL, V24, P327, DOI 10.1016/S1471-4906(03)00117-0; Nam SC, 2003, DEVELOPMENT, V130, P4363, DOI 10.1242/dev.00648; Ohno S, 2001, CURR OPIN CELL BIOL, V13, P641, DOI 10.1016/S0955-0674(00)00264-7; Ozaki-Kuroda K, 2002, CURR BIOL, V12, P1145, DOI 10.1016/S0960-9822(02)00922-3; Roh MH, 2003, J CELL SCI, V116, P2895, DOI 10.1242/jcs.00500; Straight SW, 2004, MOL BIOL CELL, V15, P1981, DOI 10.1091/mbc.E03-08-0620; Wodarz A, 2002, NAT CELL BIOL, V4, pE39, DOI 10.1038/ncb0202-e39	30	199	212	1	11	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 16	2004	431	7006					320	324		10.1038/nature02877	http://dx.doi.org/10.1038/nature02877			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	853XJ	15372036				2022-12-28	WOS:000223864000044
J	Hoagland, M				Hoagland, M			Enter transfer RNA	NATURE			English	Editorial Material									Worcester Fdn Biomed Res, Worcester, MA 01605 USA	Worcester Foundation for Biomedical Research	Hoagland, M (corresponding author), Worcester Fdn Biomed Res, Worcester, MA 01605 USA.								0	9	12	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 16	2004	431	7006					249	249		10.1038/431249a	http://dx.doi.org/10.1038/431249a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	853XJ	15372010				2022-12-28	WOS:000223864000020
J	Lee, WA				Lee, WA			Endovascular repair of a ruptured abdominal aortic aneurysm	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Florida, Coll Med, Gainesville, FL 32610 USA	State University System of Florida; University of Florida	Lee, WA (corresponding author), Univ Florida, Coll Med, Gainesville, FL 32610 USA.								0	1	1	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 16	2004	351	12					E11	E11		10.1056/NEJMicm030750	http://dx.doi.org/10.1056/NEJMicm030750			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	853WS	15371591				2022-12-28	WOS:000223861300013
J	Wen, B; Li, H; Lu, DR; Song, XF; Zhang, F; He, YG; Li, F; Gao, Y; Mao, XY; Zhang, L; Qian, J; Tan, JZ; Jin, JZ; Huang, W; Deka, R; Su, B; Chakraborty, R; Jin, L				Wen, B; Li, H; Lu, DR; Song, XF; Zhang, F; He, YG; Li, F; Gao, Y; Mao, XY; Zhang, L; Qian, J; Tan, JZ; Jin, JZ; Huang, W; Deka, R; Su, B; Chakraborty, R; Jin, L			Genetic evidence supports demic diffusion of Han culture	NATURE			English	Article							INFERRING ADMIXTURE PROPORTIONS; Y-CHROMOSOME; CHINESE POPULATIONS; MITOCHONDRIAL-DNA; PARENTAL POPULATIONS; HUMAN-EVOLUTION; MOLECULAR-DATA; FREQUENCIES; HAPLOTYPES; DISTANCES	The spread of culture and language in human populations is explained by two alternative models: the demic diffusion model, which involves mass movement of people; and the cultural diffusion model, which refers to cultural impact between populations and involves limited genetic exchange between them(1). The mechanism of the peopling of Europe has long been debated, a key issue being whether the diffusion of agriculture and language from the Near East was concomitant with a large movement of farmers(1-3). Here we show, by systematically analysing Y-chromosome and mitochondrial DNA variation in Han populations, that the pattern of the southward expansion of Han culture is consistent with the demic diffusion model, and that males played a larger role than females in this expansion. The Han people, who all share the same culture and language, exceed 1.16 billion (2000 census), and are by far the largest ethnic group in the world. The expansion process of Han culture is thus of great interest to researchers in many fields.	Fudan Univ, State Key Lab Genet Engn, Shanghai 200433, Peoples R China; Fudan Univ, Sch Life Sci, Ctr Anthropol Studies, Shanghai 200433, Peoples R China; Fudan Univ, Moragn Tan Inst Ctr Life Sci, Shanghai 200433, Peoples R China; Chinese Natl Human Genome Ctr, Shanghai 201203, Peoples R China; Univ Cincinnati, Dept Environm Hlth, Ctr Genome Informat, Cincinnati, OH 45267 USA; Chinese Acad Sci, Kunming Inst Zool, Key Lab Cellular & Mol Evolut, Kunming 650223, Peoples R China	Fudan University; Fudan University; Fudan University; University System of Ohio; University of Cincinnati; Chinese Academy of Sciences; Kunming Institute of Zoology	Jin, L (corresponding author), Fudan Univ, State Key Lab Genet Engn, Shanghai 200433, Peoples R China.	lijin@fudan.edu.cn	Zhang, Liang/F-8064-2013; mao, xianyun/B-4664-2014; Jin, Li/M-5063-2019; Li, Hui/A-2014-2010; Wen, Bo/P-5332-2019; Zhang, Feng/C-7735-2009; Jin, Li/C-1468-2009	Zhang, Liang/0000-0002-7672-1168; mao, xianyun/0000-0002-1236-4800; Wen, Bo/0000-0003-0394-7366; Zhang, Feng/0000-0003-4556-8276; Jin, Li/0000-0002-4546-2415; He, Yungang/0000-0002-2931-2871				Bertorelle G, 1998, MOL BIOL EVOL, V15, P1298, DOI 10.1093/oxfordjournals.molbev.a025858; Cavalli-Sforza L. L., 1994, HIST GEOGRAPHY HUMAN; Cavalli-Sforza LL, 2003, NAT GENET, V33, P266, DOI 10.1038/ng1113; CHAKRABORTY R, 1986, YEARB PHYS ANTHROPOL, V29, P1; Chikhi L, 2002, P NATL ACAD SCI USA, V99, P11008, DOI 10.1073/pnas.162158799; Chu JY, 1998, P NATL ACAD SCI USA, V95, P11763, DOI 10.1073/pnas.95.20.11763; Du RF, 1997, SCI CHINA SER C, V40, P613, DOI 10.1007/BF02882691; Dupanloup I, 2001, MOL BIOL EVOL, V18, P672, DOI 10.1093/oxfordjournals.molbev.a003847; Ellis N, 2002, GENOME RES, V12, P339; EXCOFFIER L, 1992, GENETICS, V131, P479; FEI XT, 1999, PATTERN DIVERSITY UN; Jin L, 2000, NAT REV GENET, V1, P126, DOI 10.1038/35038565; Jobling MA, 2003, NAT REV GENET, V4, P598, DOI 10.1038/nrg1124; Kivisild T, 2002, MOL BIOL EVOL, V19, P1737, DOI 10.1093/oxfordjournals.molbev.a003996; ROBERTS DF, 1965, HUM BIOL, V37, P38; Sans M, 2002, AM J PHYS ANTHROPOL, V118, P33, DOI 10.1002/ajpa.10071; Schneider S., 2000, ARLEQUIN VER 2 000 S; SOKAL RR, 1991, NATURE, V351, P143, DOI 10.1038/351143a0; Su B, 1999, AM J HUM GENET, V65, P1718, DOI 10.1086/302680; Su B, 2000, HUM GENET, V107, P582, DOI 10.1007/s004390000406; Underhill PA, 2000, NAT GENET, V26, P358, DOI 10.1038/81685; Wallace DC, 1999, GENE, V238, P211, DOI 10.1016/S0378-1119(99)00295-4; Wang JL, 2003, GENETICS, V164, P747; Wen B, 2004, AM J HUM GENET, V74, P856, DOI 10.1086/386292; Wu S. D., 1997, ZHONGGUO YIMIN SHI; Xiao CJ, 2000, SCI CHINA SER C, V43, P472; XU YT, 2003, J CENTR U NATL, V30, P59; Yao YG, 2002, AM J HUM GENET, V70, P635, DOI 10.1086/338999; ZHAO T, 1989, HUM GENET, V83, P101, DOI 10.1007/BF00286699	29	297	334	3	108	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 16	2004	431	7006					302	305		10.1038/nature02878	http://dx.doi.org/10.1038/nature02878			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	853XJ	15372031				2022-12-28	WOS:000223864000039
J	Nitzan, U; Lichtenberg, P				Nitzan, U; Lichtenberg, P			Questionnaire survey on use of placebo	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CLINICAL-PRACTICE; TRIALS	Objectives To gauge the frequency and circumstances of use of placebo in clinical practice and the attitudes towards its use among those who administer it. Design Retrospective questionnaire. Setting Two large hospitals and various community clinics in the Jerusalem area. Participants 31. physicians working in hospital inpatient and outpatient departments, 31 head nurses working in hospital inpatient departments, and 27 family physicians working in community clinics. Main outcome measures Self report of frequency and circumstances of; and attitudes towards, use of placebo. Results Among the 89 respondents, 53 (60%) used placebos (95% confidence interval 49% to 70%). Among users, 33 (62%) prescribed a placebo as often as once a month or more; 36 (68%) told patients they were receiving actual medication; 15 (28%) considered that placebos were a diagnostic tool; and 48/51 (94%) reported that they found placebos generally or occasionally effective. Conclusion Most practitioners questioned in this study continue to use placebos. Used wisely, placebos might have a legitimate place in therapeutics. Wider recognition of the practice and debate about its implications are imperative.	Herzog Hosp, IL-91351 Jerusalem, Israel; Hadassah Med Sch, Dept Psychiat, IL-91351 Jerusalem, Israel	Hebrew University of Jerusalem; Herzog Medical Center; Hebrew University of Jerusalem	Lichtenberg, P (corresponding author), Herzog Hosp, POB 35300, IL-91351 Jerusalem, Israel.	licht@cc.huji.ac.il						BROWN WA, 1994, NEUROPSYCHOPHARMACOL, V10, P265, DOI 10.1038/npp.1994.53; DeDeyn PP, 1996, J MED ETHICS, V22, P140, DOI 10.1136/jme.22.3.140; GOODWIN JS, 1979, ANN INTERN MED, V91, P106, DOI 10.7326/0003-4819-91-1-106; Hill Joal, 2003, Lancet, V362, P254, DOI 10.1016/S0140-6736(03)13940-2; Hrobjartsson A, 2001, NEW ENGL J MED, V344, P1594, DOI 10.1056/NEJM200105243442106; Hyland ME, 2003, CLIN MED, V3, P347, DOI 10.7861/clinmedicine.3-4-347; LICHTENBERG P, IN PRESS J MED ETHIC; Lione A, 2003, LANCET, V362, P999, DOI 10.1016/S0140-6736(03)14382-6; Vase L, 2002, PAIN, V99, P443, DOI 10.1016/S0304-3959(02)00205-1	9	91	91	1	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 23	2004	329	7472					944	946		10.1136/bmj.38236.646678.55	http://dx.doi.org/10.1136/bmj.38236.646678.55			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	866KU	15377572	Green Published, Bronze			2022-12-28	WOS:000224773200015
J	Hu, W; Kemp, A; Kerridge, I				Hu, W; Kemp, A; Kerridge, I			Ethics in practice - Making clinical decisions when the stakes are high and the evidence unclear	BMJ-BRITISH MEDICAL JOURNAL			English	Article							FOOD ALLERGY; ANAPHYLACTIC REACTIONS; PEANUT ALLERGY; CHILDREN; CHILDHOOD; MANAGEMENT; EPINEPHRINE; EPIPEN; RISK; UK		Childrens Hosp Westmead, Dept Allergy Immunol & Infect Dis, Westmead, NSW 2145, Australia; Univ New S Wales, Sch Publ Hlth & Community Med, Sydney, NSW 2052, Australia; Univ Sydney, Ctr Values Eth & Law Med, Sydney, NSW 2006, Australia	University of Sydney; University of New South Wales Sydney; University of Sydney	Hu, W (corresponding author), Childrens Hosp Westmead, Dept Allergy Immunol & Infect Dis, Locked Bag 4001, Westmead, NSW 2145, Australia.	wendy.hu@unswedu.au	Kerridge, Ian H/A-8355-2011; Hu, Wendy CY/A-9425-2012	Hu, Wendy CY/0000-0002-1711-3808; Kerridge, Ian/0000-0001-7445-4660				Avery NJ, 2003, PEDIAT ALLERG IMM-UK, V14, P378, DOI 10.1034/j.1399-3038.2003.00072.x; Bellaby P, 2003, BRIT MED J, V327, P725, DOI 10.1136/bmj.327.7417.725; Bennett P., 1999, RISK COMMUNICATION P; Bock SA, 2001, J ALLERGY CLIN IMMUN, V107, P191, DOI 10.1067/mai.2001.112031; Clark AT, 2003, ARCH DIS CHILD, V88, P79, DOI 10.1136/adc.88.1.79; du Toit G, 2003, CLIN EXP ALLERGY, V33, P1019, DOI 10.1046/j.1365-2222.2003.01758.x; EDDY D, 1996, CLIN DECISION MAKING, P308; Gold MS, 2000, J ALLERGY CLIN IMMUN, V106, P171, DOI 10.1067/mai.2000.106041; GRAY JAM, 1997, EVIDENCE BASED HLTH; Grundy J, 2002, J ALLERGY CLIN IMMUN, V110, P784, DOI 10.1067/mai.2002.128802; Guadagnoli E, 1998, SOC SCI MED, V47, P329, DOI 10.1016/S0277-9536(98)00059-8; Hourihane JO, 2001, ALLERGY, V56, P1023; Jonsen AR, 2002, CLIN ETHICS PRACTICA; Kasperson J.X., 2003, SOC CONTOURS RISK, p217.; Kemp AS, 2003, J PAEDIATR CHILD H, V39, P372, DOI 10.1046/j.1440-1754.2003.00157.x; Macdougall CF, 2002, ARCH DIS CHILD, V86, P236, DOI 10.1136/adc.86.4.236; Munoz-Furlong A, 2003, PEDIATRICS, V111, P1654; Pumphrey RSH, 2000, CLIN EXP ALLERGY, V30, P1144, DOI 10.1046/j.1365-2222.2000.00864.x; Sampson HA, 2002, NEW ENGL J MED, V346, P1294, DOI 10.1056/NEJMcp012667; SAMPSON HA, 1992, NEW ENGL J MED, V327, P380, DOI 10.1056/NEJM199208063270603; Scott S, 1998, SOCIOLOGY, V32, P689, DOI 10.1017/S0038038598000182; Sicherer SH, 2000, PEDIATRICS, V105, P359, DOI 10.1542/peds.105.2.359; Slovic P, 2000, PERCEPTION RISK; Taylor SL, 2002, J ALLERGY CLIN IMMUN, V109, P24, DOI 10.1067/mai.2002.120564; Unsworth DJ, 2001, ARCH DIS CHILD, V84, P410, DOI 10.1136/adc.84.5.410; Warner JO, 2002, PEDIATR ALLERGY IMMU, V13, P149, DOI 10.1034/j.1399-3038.2002.00059.x	26	13	13	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 9	2004	329	7470					852	854A		10.1136/bmj.329.7470.852	http://dx.doi.org/10.1136/bmj.329.7470.852			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	862EK	15472271	Green Submitted, Green Published			2022-12-28	WOS:000224472800027
J	Babaev, E; Sudbo, A; Ashcroft, NW				Babaev, E; Sudbo, A; Ashcroft, NW			A superconductor to superfluid phase transition in liquid metallic hydrogen	NATURE			English	Article							HELIUM	Although hydrogen is the simplest of atoms, it does not form the simplest of solids or liquids. Quantum effects in these phases are considerable (a consequence of the light proton mass) and they have a demonstrable and often puzzling influence on many physical properties(1), including spatial order. To date, the structure of dense hydrogen remains experimentally elusive(2). Recent studies of the melting curve of hydrogen(3,4) indicate that at high (but experimentally accessible) pressures, compressed hydrogen will adopt a liquid state, even at low temperatures. In reaching this phase, hydrogen is also projected to pass through an insulator-to-metal transition. This raises the possibility of new state of matter: a near ground-state liquid metal, and its ordered states in the quantum domain. Ordered quantum fluids are traditionally categorized as superconductors or superfluids; these respective systems feature dissipationless electrical currents or mass flow. Here we report a topological analysis of the projected phase of liquid metallic hydrogen, finding that it may represent a new type of ordered quantum fluid. Specifically, we show that liquid metallic hydrogen cannot be categorized exclusively as a superconductor or superfluid. We predict that, in the presence of a magnetic field, liquid metallic hydrogen will exhibit several phase transitions to ordered states, ranging from superconductors to superfluids.	Cornell Univ, Atom & Solid State Phys Lab, Ithaca, NY 14853 USA; Norwegian Univ Sci & Technol, Dept Phys, N-7491 Trondheim, Norway	Cornell University; Norwegian University of Science & Technology (NTNU)	Babaev, E (corresponding author), Cornell Univ, Atom & Solid State Phys Lab, Ithaca, NY 14853 USA.	eb235@cornell.edu	Babaev, Egor/L-4458-2016	Babaev, Egor/0000-0001-7593-4543				Ashcroft NW, 2000, J PHYS-CONDENS MAT, V12, pA129, DOI 10.1088/0953-8984/12/8A/314; Ashcroft NW, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.187002; Babaev E, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.067001; Babaev E, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.100512; BONEV SA, UNPUB NATURE; Datchi F, 2000, PHYS REV B, V61, P6535, DOI 10.1103/PhysRevB.61.6535; FOSSHEIM K, 2004, SUPERCONDUCTIVITY PH, pCH8; Guillot T, 2004, PHYS TODAY, V57, P63, DOI 10.1063/1.1752424; Hemley RJ, 1996, J NON-CRYST SOLIDS, V205, P282, DOI 10.1016/S0022-3093(96)00238-4; JAFFE J, 1983, PHYS REV B, V27, P5852, DOI 10.1103/PhysRevB.27.5852; JAFFE JE, 1981, PHYS REV B, V23, P6176, DOI 10.1103/PhysRevB.23.6176; MOULOPOULOS K, 1991, PHYS REV LETT, V66, P2915, DOI 10.1103/PhysRevLett.66.2915; PENROSE O, 1956, PHYS REV, V104, P576, DOI 10.1103/PhysRev.104.576; Smiseth J, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.077002; STEVENSON DJ, 1974, PHYS REV A, V9, P782, DOI 10.1103/PhysRevA.9.782	15	255	260	1	85	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 7	2004	431	7009					666	668		10.1038/nature02910	http://dx.doi.org/10.1038/nature02910			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	859WS	15470422	Green Submitted			2022-12-28	WOS:000224299300034
J	Enriquez-Sarano, M; Tajik, AJ				Enriquez-Sarano, M; Tajik, AJ			Aortic regurgitation	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							VALVE-REPLACEMENT; ASYMPTOMATIC PATIENTS; ORIFICE AREA; PREDICTION; MORTALITY; SEVERITY; DETERMINANTS; DILATATION; PREVALENCE; NIFEDIPINE	A 48-year-old woman who reports mild fatigue but no dyspnea, chest pain, or palpitation is found to have a diastolic cardiac murmur. The blood pressure is 140/50 mm Hg, and the pulses are bounding. Cardiac examination reveals decreased S1 and increased S2 intensity, with a grade 1/6 systolic murmur and a grade 3/6 diastolic murmur along the left sternal border. Doppler color-flow echocardiography shows a bicuspid aortic valve with an eccentric jet of aortic regurgitation. The left ventricle is moderately enlarged, with an end-diastolic diameter of 66 mm ( or 39 mm per square meter of body-surface area) and an end-systolic diameter of 46 mm ( or 27 mm per square meter); the ejection fraction is 51 percent, and the ascending aorta is enlarged, at 48 mm. How should this patient be treated?	Mayo Clin & Mayo Fdn, Div Cardiovasc Dis & Internal Med, Rochester, MN 55905 USA	Mayo Clinic	Enriquez-Sarano, M (corresponding author), Mayo Clin & Mayo Fdn, Div Cardiovasc Dis & Internal Med, 200 1st St SW, Rochester, MN 55905 USA.	sarano.maurice@mayo.edu						ACAR J, 1981, J THORAC CARDIOV SUR, V82, P114; Acar J, 1996, CIRCULATION, V94, P2107, DOI 10.1161/01.CIR.94.9.2107; *AM HEART ASS, WALL CARD PAG; Birkmeyer JD, 2002, NEW ENGL J MED, V346, P1128, DOI 10.1056/NEJMsa012337; BONOW RO, 1988, CIRCULATION, V78, P1108, DOI 10.1161/01.CIR.78.5.1108; Bonow RO, 1998, CIRCULATION, V98, P1949, DOI 10.1161/01.CIR.98.18.1949; BONOW RO, 1991, CIRCULATION, V84, P1625, DOI 10.1161/01.CIR.84.4.1625; BONOW RO, 1985, CIRCULATION, V72, P1244, DOI 10.1161/01.CIR.72.6.1244; Borer JS, 1998, CIRCULATION, V97, P525; BOUCHER CA, 1983, CIRCULATION, V67, P1091, DOI 10.1161/01.CIR.67.5.1091; Braunwald E., 1997, HEART DIS TXB CARDIO, V5th; Coady MA, 1997, J THORAC CARDIOV SUR, V113, P476, DOI 10.1016/S0022-5223(97)70360-X; Davies RR, 2002, ANN THORAC SURG, V73, P17, DOI 10.1016/S0003-4975(01)03236-2; Desjardins VA, 1996, AM J MED, V100, P149, DOI 10.1016/S0002-9343(97)89452-1; Dujardin KS, 1999, CIRCULATION, V99, P1851, DOI 10.1161/01.CIR.99.14.1851; Edwards FH, 2001, J AM COLL CARDIOL, V37, P885, DOI 10.1016/S0735-1097(00)01202-X; ENRIQUEZSARANO M, 1994, J AM COLL CARDIOL, V23, P443, DOI 10.1016/0735-1097(94)90432-4; Gillinov AM, 2001, ANN THORAC SURG, V72, P20, DOI 10.1016/S0003-4975(01)02677-7; Gott VL, 2002, ANN THORAC SURG, V73, P438, DOI 10.1016/S0003-4975(01)03336-7; Grunkemeier GL, 2000, CURR PROB CARDIOLOGY, V25, P78, DOI 10.1053/cd.2000.v25.a103682; IUNG B, 2002, CIRCULATION, V106, P2687; Klodas E, 1997, J AM COLL CARDIOL, V30, P746, DOI 10.1016/S0735-1097(97)00205-2; Klodas E, 1996, J AM COLL CARDIOL, V27, P670, DOI 10.1016/0735-1097(95)00525-0; Klodas E, 1996, CIRCULATION, V94, P2472, DOI 10.1161/01.CIR.94.10.2472; Kouchoukos NT, 1999, ANN THORAC SURG, V67, P1846, DOI 10.1016/S0003-4975(99)00443-9; Lebowitz NE, 2000, J AM COLL CARDIOL, V36, P461, DOI 10.1016/S0735-1097(00)00744-0; Levine HJ, 1996, J AM COLL CARDIOL, V28, P1083, DOI 10.1016/S0735-1097(96)00288-4; LIN M, 1994, J AM COLL CARDIOL, V24, P1046, DOI 10.1016/0735-1097(94)90868-0; Reimold SC, 1998, J AM SOC ECHOCARDIOG, V11, P259, DOI 10.1016/S0894-7317(98)70087-2; REIMOLD SC, 1991, J AM COLL CARDIOL, V18, P761, DOI 10.1016/0735-1097(91)90800-O; SCOGNAMIGLIO R, 1990, J AM COLL CARDIOL, V16, P424, DOI 10.1016/0735-1097(90)90596-H; SCOGNAMIGLIO R, 1994, NEW ENGL J MED, V331, P689, DOI 10.1056/NEJM199409153311101; SHORES J, 1994, NEW ENGL J MED, V330, P1335, DOI 10.1056/NEJM199405123301902; Singh JP, 1999, AM J CARDIOL, V83, P897, DOI 10.1016/S0002-9149(98)01064-9; Singh JP, 1999, AM J CARDIOL, V84, P1143; Tarasoutchi F, 2003, J AM COLL CARDIOL, V41, P1316, DOI 10.1016/S0735-1097(03)00129-3; TORNOS MP, 1990, AM HEART J, V120, P649, DOI 10.1016/0002-8703(90)90023-Q; Tribouilloy CM, 2000, CIRCULATION, V102, P558; Tribouilloy CM, 1998, J AM COLL CARDIOL, V32, P1032, DOI 10.1016/S0735-1097(98)00356-8; Tribouilloy CM, 2001, AM J MED, V111, P96, DOI 10.1016/S0002-9343(01)00769-0; WISENBAUGH T, 1984, J AM COLL CARDIOL, V3, P916, DOI 10.1016/S0735-1097(84)80349-6; Zoghbi WA, 2003, J AM SOC ECHOCARDIOG, V16, P777, DOI 10.1016/S0894-7317(03)00335-3	42	84	88	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 7	2004	351	15					1539	1546		10.1056/NEJMcp030912	http://dx.doi.org/10.1056/NEJMcp030912			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	859UP	15470217				2022-12-28	WOS:000224293700012
J	Bodenheimer, T				Bodenheimer, T			Insuring the uninsured: Will the 2004 election provide an answer?	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							MEDICAL SAVINGS ACCOUNTS; HEALTH-INSURANCE; TAX-REFORM; PROPOSAL; SINGAPORE; CHOICE		Univ Calif San Francisco, San Francisco Gen Hosp, Dept Family & Community Med, San Francisco, CA 94110 USA	San Francisco General Hospital Medical Center; University of California System; University of California San Francisco	Bodenheimer, T (corresponding author), Univ Calif San Francisco, San Francisco Gen Hosp, Dept Family & Community Med, Bldg 80-83,1001 Potrero Ave, San Francisco, CA 94110 USA.	tbodenheimer@medsch.uscf.edu						ABBE B, 2002, HLTH AFF WEB EX 1023; *AM AC FAM PHYS, 2001, ASS HLTH CAR COV ALL; *AM COLL PHYS AM S, 2002, ACH AFF HLTH INS COV; *AM MED ASS, 2003, 1 AM MED ASS COUNC M; *AM MED ASS, HLTH INS REF; BLENDON RJ, 2003, HLTH AFF WEB EX 0827; BODENHEIMER T, 2002, UNDERSTANDING HLTH P, P76; BUNTIN MB, 2003, HLTH AFF WEB EX 0924; Butler S, 1999, HEALTH AFFAIR, V18, P45, DOI 10.1377/hlthaff.18.6.45; BUTLER SM, 1991, JAMA-J AM MED ASSOC, V265, P2541, DOI 10.1001/jama.265.19.2541; CHOLLET D, 1995, HEALTH AFFAIR, V14, P273, DOI 10.1377/hlthaff.14.2.273; CHOLLET D, 1995, HLTH AFF MILLWOOD, V14, P277; CONNOLLY C, 2004, WASHINGTON POST 0506, pA8; CUNNINGHAM R, 2002, HLTH AFF WEB EX 0918; DAVIS K, 2003, HLTH AFF WEB EX 0423; *FAM US FDN, 2004, ONE 3 NON AM WITH HL; GABEL J, 2002, HLTH AFF WEB EX 0417; Gruber J, 2000, HEALTH AFFAIR, V19, P72, DOI 10.1377/hlthaff.19.1.72; HEFFLER S, 2003, HLTH AFF WEB EX 0207; HSIAO WC, 1995, HEALTH AFFAIR, V14, P260, DOI 10.1377/hlthaff.14.2.260; *KAIS FAM FDN, 2004, COV COST IMP PRES HL; MASSARO TA, 1995, HEALTH AFFAIR, V14, P267, DOI 10.1377/hlthaff.14.2.267; Mills RJ, 2003, HLTH INSURANCE COVER; NEUSCHLER E, 2003, HLTH AFF WEB EX 0521; OBERLANDER J, 2003, HLTH AFF WEB EX 0827; Palmisano DJ, 2004, JAMA-J AM MED ASSOC, V291, P2237, DOI 10.1001/jama.291.18.2237; PAULY MV, 1995, HEALTH AFFAIR, V14, P277, DOI 10.1377/hlthaff.14.2.277; POLLITZ K, 2002, HLTH AFF WEB EX 1023; RESCHOVSKY JD, 2004, HLTH AFF WEB EX 0225; ROLLINS G, 2004, ACP OBSERVER, V24, P1; ROLLINS G, 2004, ACP OBSERVER, V24, P18; THORPE KE, 2004, FEDERAL COSTS NEWLY; THORPE KE, 2004, FEDERAL COSTS SAVING; *US DEP HHS AG HEA, 2004, HLTH CAR EXP US 2000; Woolhandler S, 2003, JAMA-J AM MED ASSOC, V290, P798; 2004, NY TIMES        0122, pA24	36	4	4	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 5	2004	141	7					556	561		10.7326/0003-4819-141-7-200410050-00013	http://dx.doi.org/10.7326/0003-4819-141-7-200410050-00013			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	862CR	15466773				2022-12-28	WOS:000224467800008
J	Jindani, A; Nunn, AJ; Enarson, DA				Jindani, A; Nunn, AJ; Enarson, DA			Two 8-month regimens of chemotherapy for treatment of newly diagnosed pulmonary tuberculosis: international multicentre randomised trial	LANCET			English	Article							DRUGS	Background A WHO-recommended 8-month regimen based on ethambutol and isoniazid was evaluated in a randomised clinical trial against a 6-month standard regimen. Methods 1355 patients with newly diagnosed smear-positive pulmonary tuberculosis were randomly assigned one of three regimens: daily ethambutol, isoniazid, rifampicin, and pyrazinamide for 2 months, followed by ethambutol and isoniazid for 6 months (2EHRZ/6HE); the same drugs but given three times weekly in the initial intensive phase (2[EHRZ](3)/6HE); or the same initial intensive phase as the first regimen, followed by 4 months of daily rifampicin and isoniazid (2EHRZ/4HR). Follow-up was to 30 months after the start of chemotherapy. Sputum was regularly examined by microscopy and culture. Unfavourable outcome was defined as failure during treatment or relapse afterwards. Analyses were by intention to treat. Findings At 2 months, a significantly higher proportion of patients assigned the daily intensive phase than of those assigned the three-times-weekly regimen were culture negative (700/828 [85%] vs 333/433 [77%], p=0.001). 12 months after the end of chemotherapy, the proportions of unfavourable outcomes were 36 of 346 (10%) with 2EHRZ/6HE, 48 of 351 (14%) with 2(EHRZ)(3)/6HE, and 17 of 347 (5%) with 2EHRZ/4HR. Both 8-month regimens were significantly inferior to the control 6-month standard regimen (difference between control and 2EHRZ/6HE 5.5% [95% CI 1.6 to 9.4]; between control and 2(EHRZ)(3)/6HE 8.8% [4.5 to 13.01]). Adverse effects leading to interruption of treatment for 7 days or longer occurred in 28 patients (12 2EHRZ/6HE, five 2[EHRZ](3)/6HE, 11 2EHRZ/4HR). Interpretation The results of this study must be taken into account in recommendations on management of new cases of smear-positive tuberculosis.	Int Union Against TB & Lung Dis, F-75006 Paris, France; MRC, Clin Trials Unit, London, England	Medical Research Council Clinical Trials Unit	Enarson, DA (corresponding author), Int Union Against TB & Lung Dis, 68 Blvd St Michel, F-75006 Paris, France.	denarson@iuatld.org		Jindani, Amina/0000-0002-7110-5286; Nunn, Andrew/0000-0002-9158-4595				ANGEL JH, 1984, BRIT J DIS CHEST, V78, P330; [Anonymous], 1982, Tubercle, V63, P89; *BRIT MED RES COUN, 1999, INT J TUBERC LUND S2, V3, pS231; DICKINSON JM, 1977, AM REV RESPIR DIS, V116, P627, DOI 10.1164/arrd.1977.116.4.627; East and Central African, 1986, Tubercle, V67, P5; Enarson D.A., 2000, MANAGEMENT TUBERCULO; Harries AD, 2001, INT J TUBERC LUNG D, V5, P483; *HONG KONG CHEST S, 1987, AM REV RESPIR DIS, V136, P1339; Jindani A, 2003, AM J RESP CRIT CARE, V167, P1348, DOI 10.1164/rccm.200210-1125OC; Machin D., 1997, STAT TABLES DESIGN C, V2nd; MITCHISON D A, 1978, Bulletin of the International Union Against Tuberculosis, V53, P254; Mitchison DA, 2000, INT J TUBERC LUNG D, V4, P796; NUNN P, 1991, LANCET, V337, P627; THIRD EAST AFRICAN/BRITISH MEDICAL RESEARCH COUNCIL STUDY, 1980, Tubercle, V61, P59; *WHO, 1995, WHOTB95; *WHO INT AG TUB GL, 1997, WHOTB97229; World Health Organization, 2003, TREATM TUB GUID NAT	17	189	192	0	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 2	2004	364	9441					1244	1251		10.1016/S0140-6736(04)17141-9	http://dx.doi.org/10.1016/S0140-6736(04)17141-9			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	859HO	15464185				2022-12-28	WOS:000224254200031
J	Lempp, H; Seale, C				Lempp, H; Seale, C			The hidden curriculum in undergraduate medical education: qualitative study of medical students' perceptions of teaching	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ETHICS; SCHOOL	Objective To study medical students' views about the quality of the teaching they receive during their undergraduate training, especially in terms of the hidden curriculum. Design Semistructured interviews with individual students. Setting One medical school in the United Kingdom. Participants 36 undergraduate medical students, across all stages of their training, selected by random and quota sampling, stratified by sex and ethnicity, with the whole medical school population as a sampling frame. Main outcome measures Medical students' experiences and perceptions of the quality of teaching received during their undergraduate training. Results Students reported many examples of positive, role models and effective, approachable teachers, with valued characteristics perceived according to traditional gendered stereotypes. They also described a hierarchical and competitive atmosphere in the medical school, in which haphazard instruction and teaching by humiliation occur, especially during the clinical training years. Conclusions Following on from the recent reforms of the manifest curriculum, the hidden curriculum now needs attention to produce the necessary fundamental changes in the culture of undergraduate medical education.	Kings Coll London, Guys Kings & St Thomas Sch Med, London SE5 9RJ, England; Brunel Univ, Dept Human Sci, Uxbridge UB8 3PH, Middx, England; Univ London, Univ London Goldsmiths Coll, Dept Sociol, London WC1E 7HU, England	University of London; King's College London; Brunel University; University of London; Goldsmiths University London	Lempp, H (corresponding author), Kings Coll London, Guys Kings & St Thomas Sch Med, London SE5 9RJ, England.	heidi.k.lempp@kcl.ac.uk	Lempp, Heidi/E-4959-2010; Lempp, Heidi/T-2914-2017	Lempp, Heidi/0000-0003-2509-3656				ANDERSON DJ, 1992, AM J ROENTGENOL, V159, P21, DOI 10.2214/ajr.159.1.1609700; ASSOR A, 1987, J CURRICULUM STUD, V19, P329, DOI 10.1080/0022027870190404; BLOOM BS, 1972, SCHOOL REV, V80, P333, DOI 10.1086/443036; BLOOM SW, 1989, MED EDUC, V23, P228, DOI 10.1111/j.1365-2923.1989.tb01538.x; Coldicott Y, 2003, BRIT MED J, V326, P97, DOI 10.1136/bmj.326.7380.97; Cribb A, 1999, STUD HIGH EDUC, V24, P195, DOI 10.1080/03075079912331379888; DEARING R, 1997, SUMMARY REPORT NATL; DeSchepper E J, 1987, J Dent Educ, V51, P575; *GEN MED COUNC, 2002, TOM DOCT REC UND MED; General Medical Council, 1993, TOM DOCT REC UND MED; HAFFERTY FW, 1994, ACAD MED, V69, P861, DOI 10.1097/00001888-199411000-00001; Hafferty FW, 1998, ACAD MED, V73, P403, DOI 10.1097/00001888-199804000-00013; HAFFERTY FW, 2000, HDB MED SOCIOLOGY, P238; HELMAN C, 1991, BODY MYTHS, P114; Hicks Brendan, 2003, BMJ, V326, pS129, DOI 10.1136/bmj.326.7393.S129; Leinster SJ, 2003, MED EDUC, V37, P397, DOI 10.1046/j.1365-2923.2003.01457.x; LEMPP HK, 2004, THESIS U LONDON GOLD; Marinov K, 2001, NATO SCI SER II MATH, V31, P293; Mayson J, 1997, Nurs Prax N Z, V12, P16; SAVAGE J, 1995, BRIT MED J, V311, P274; Seabrook MA, 2003, MED EDUC, V37, P213, DOI 10.1046/j.1365-2923.2003.01437.x; SINCLAIR S., 1997, MAKING DOCTORS I APP; Wright SM, 1998, NEW ENGL J MED, V339, P1986, DOI 10.1056/NEJM199812313392706; [No title captured]	24	420	437	5	64	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 2	2004	329	7469					770	773		10.1136/bmj.329.7469.770	http://dx.doi.org/10.1136/bmj.329.7469.770			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	859TW	15459051	Green Submitted, Green Published, Bronze			2022-12-28	WOS:000224291800017
J	Reichenbach, L; Brown, H				Reichenbach, L; Brown, H			Gender and academic medicine: impacts on the health workforce	BMJ-BRITISH MEDICAL JOURNAL			English	Article							WOMEN	Recent discussions about the "feminisation of medicine" raise critical questions for how academic medicine deals with gender issues. Addressing the gender dimensions of enrolment, curriculum, and promotion practices in academic medicine may be a good starting point.	Harvard Ctr Populat & Dev Studies, Cambridge, MA 02138 USA; Rockefeller Fdn, New York, NY 10018 USA	Harvard University; Harvard T.H. Chan School of Public Health	Reichenbach, L (corresponding author), Harvard Ctr Populat & Dev Studies, Cambridge, MA 02138 USA.	laura@hsph.harvard.edu						[Anonymous], 2004, BBC NEWS; *ANUIES, 2004, ANN EST PROF 1990 20; BICKEL J, 1988, NEW ENGL J MED, V319, P1579, DOI 10.1056/NEJM198812153192405; Brooks F, 1998, SOC SCI MED, V47, P181, DOI 10.1016/S0277-9536(98)00058-6; Heath I, 2004, BRIT MED J, V329, P412, DOI 10.1136/bmj.329.7463.412; JESANI A, 2002, GENDER MED ED REPORT; KRIEGER N, 1984, WOMENS HLTH POLITICS; Lorber Judith, 1984, WOMEN PHYS CAREERS S; Lorber Judith, 1997, GENDER SOCIAL CONSTR; Narasimhan V, 2004, LANCET, V363, P1469, DOI 10.1016/S0140-6736(04)16108-4; Riska E., 2001, MED CAREERS FEMINIST; Riska E., 1993, GENDER WORK MED WOME; TESCH BJ, 1995, JAMA-J AM MED ASSOC, V273, P1022, DOI 10.1001/jama.273.13.1022; *WHO DEP GEND WOM, 2003, ENG MILL DEV GOALS M; Yedidia MJ, 2001, ACAD MED, V76, P453, DOI 10.1097/00001888-200105000-00017	15	57	57	1	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 2	2004	329	7469					792	795		10.1136/bmj.329.7469.792	http://dx.doi.org/10.1136/bmj.329.7469.792			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	859TW	15459056	Green Published			2022-12-28	WOS:000224291800026
J	Singleton, A; Gwinn-Hardy, K				Singleton, A; Gwinn-Hardy, K			Parkinson's disease and dementia with Lewy bodies: a difference in dose?	LANCET			English	Editorial Material							ALPHA-SYNUCLEIN; LOCUS TRIPLICATION; MUTATION; SNCA		NIA, Mol Genet Sect, Neurogenet Lab, NIH, Bethesda, MD 20892 USA; NINDS, Parkinsons Unit, Neurogenet Branch, NIH, Bethesda, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Singleton, A (corresponding author), NIA, Mol Genet Sect, Neurogenet Lab, NIH, Bethesda, MD 20892 USA.	singleta@mail.nih.gov	Gwinn, Katrina A/C-2508-2009; Singleton, Andrew B/C-3010-2009	Gwinn, Katrina/0000-0002-8277-651X	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [Z01NS003006] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Chiba-Falek O, 2001, HUM MOL GENET, V10, P3101, DOI 10.1093/hmg/10.26.3101; Farrer M, 2004, ANN NEUROL, V55, P174, DOI 10.1002/ana.10846; Farrer M, 2001, HUM MOL GENET, V10, P1847, DOI 10.1093/hmg/10.17.1847; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Miller DW, 2004, NEUROLOGY, V62, P1835, DOI 10.1212/01.WNL.0000127517.33208.F4; Muenter MD, 1998, ANN NEUROL, V43, P768, DOI 10.1002/ana.410430612; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Singleton A, 2004, HUM MOL GENET, V13, pR123, DOI 10.1093/hmg/ddh093; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166	10	57	60	0	6	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 25	2004	364	9440					1105	1107		10.1016/S0140-6736(04)17117-1	http://dx.doi.org/10.1016/S0140-6736(04)17117-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	857FT	15451205				2022-12-28	WOS:000224102400006
J	Hirn, A; Laigle, M				Hirn, A; Laigle, M			Geophysics - Silent heralds of megathrust earthquakes?	SCIENCE			English	Editorial Material							SUBDUCTION; SLIP; TREMOR; ZONE		Inst Phys Globe, Dept Sismol, CNRS 7580, Lab Sismol Expt, F-75252 Paris, France	UDICE-French Research Universities; Universite Paris Cite	Hirn, A (corresponding author), Inst Phys Globe, Dept Sismol, CNRS 7580, Lab Sismol Expt, 4 Pl Jussieu, F-75252 Paris, France.	hirn@ipgp.jussieu.fr; laigle@ipgp.jussieu.fr	Laigle, Mireille/AAB-9573-2022					Calvert AJ, 2004, NATURE, V428, P163, DOI 10.1038/nature02372; Dragert H, 2001, SCIENCE, V292, P1525, DOI 10.1126/science.1060152; Hyndman RD, 1997, ISL ARC, V6, P244, DOI 10.1111/j.1440-1738.1997.tb00175.x; Kamiya S, 2000, GEOPHYS RES LETT, V27, P819, DOI 10.1029/1999GL011080; Katsumata A, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2002GL015981; Kodaira S, 2004, SCIENCE, V304, P1295, DOI 10.1126/science.1096535; Laigle M, 2004, TECTONOPHYSICS, V391, P85, DOI 10.1016/j.tecto.2004.07.009; Miller MM, 2002, SCIENCE, V295, P2423, DOI 10.1126/science.1071193; Nedimovic MR, 2003, NATURE, V424, P416, DOI 10.1038/nature01840; Obara K, 2002, SCIENCE, V296, P1679, DOI 10.1126/science.1070378; Ozawa S, 2002, SCIENCE, V298, P1009, DOI 10.1126/science.1076780; Preston LA, 2003, SCIENCE, V302, P1197, DOI 10.1126/science.1090751; Rogers G, 2003, SCIENCE, V300, P1942, DOI 10.1126/science.1084783; Scholz CH, 1998, NATURE, V391, P37, DOI 10.1038/34097	14	7	9	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 24	2004	305	5692					1917	1918		10.1126/science.1101152	http://dx.doi.org/10.1126/science.1101152			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	857RM	15448257				2022-12-28	WOS:000224136000032
J	Mack, MC; Schuur, EAG; Bret-Harte, MS; Shaver, GR; Chapin, FS				Mack, MC; Schuur, EAG; Bret-Harte, MS; Shaver, GR; Chapin, FS			Ecosystem carbon storage in arctic tundra reduced by long-term nutrient fertilization	NATURE			English	Article							LITTER DECOMPOSITION; SOILS; TEMPERATURE; RESPONSES; NITROGEN; CLIMATE; MINERALIZATION; TURNOVER; BALANCE; BIOMASS	Global warming is predicted to be most pronounced at high latitudes, and observational evidence over the past 25 years suggests that this warming is already under way(1). One-third of the global soil carbon pool is stored in northern latitudes(2), so there is considerable interest in understanding how the carbon balance of northern ecosystems will respond to climate warming(3,4). Observations of controls over plant productivity in tundra and boreal ecosystems(5,6) have been used to build a conceptual model of response to warming, where warmer soils and increased decomposition of plant litter increase nutrient availability, which, in turn, stimulates plant production and increases ecosystem carbon storage(6,7). Here we present the results of a long-term fertilization experiment in Alaskan tundra, in which increased nutrient availability caused a net ecosystem loss of almost 2,000 grams of carbon per square meter over 20 years. We found that annual aboveground plant production doubled during the experiment. Losses of carbon and nitrogen from deep soil layers, however, were substantial and more than offset the increased carbon and nitrogen storage in plant biomass and litter. Our study suggests that projected release of soil nutrients associated with high-latitude warming may further amplify carbon release from soils, causing a net loss of ecosystem carbon and a positive feedback to climate warming.	Univ Florida, Dept Bot, Gainesville, FL 32611 USA; Univ Alaska Fairbanks, Inst Arctic Biol, Fairbanks, AK 99775 USA; Marine Biol Lab, Ctr Ecosyst, Woods Hole, MA 02543 USA	State University System of Florida; University of Florida; University of Alaska System; University of Alaska Fairbanks; Marine Biological Laboratory - Woods Hole	Mack, MC (corresponding author), Univ Florida, Dept Bot, Gainesville, FL 32611 USA.	mcmack@ufl.edu	Chapin, F Stuart/AAZ-3931-2020	Chapin, F Stuart/0000-0002-2558-9910				Berg Bjorn, 1997, Environmental Reviews, V5, P1, DOI 10.1139/er-5-1-1; Bliss LC, 1992, ARCTIC ECOSYSTEMS CH; Bret-Harte MS, 2002, J ECOL, V90, P251, DOI 10.1046/j.1365-2745.2001.00657.x; CHAPIN FS, 1995, ECOLOGY, V76, P694, DOI 10.2307/1939337; DIXON RK, 1994, SCIENCE, V263, P185, DOI 10.1126/science.263.5144.185; GIBLIN AE, 1991, ECOL MONOGR, V61, P415, DOI 10.2307/2937049; GORHAM E, 1991, ECOL APPL, V1, P182, DOI 10.2307/1941811; Goulden ML, 1998, SCIENCE, V279, P214, DOI 10.1126/science.279.5348.214; Hobbie SE, 1998, ECOLOGY, V79, P1526; Hobbie SE, 2004, OECOLOGIA, V140, P113, DOI 10.1007/s00442-004-1556-9; Hobbie SE, 2002, PLANT SOIL, V242, P163, DOI 10.1023/A:1019670731128; Hobbie SE, 1996, ECOL MONOGR, V66, P503, DOI 10.2307/2963492; Hobbie SE, 2000, GLOBAL CHANGE BIOL, V6, P196, DOI 10.1046/j.1365-2486.2000.06021.x; Jonasson S, 1999, ECOLOGY, V80, P1828, DOI 10.1890/0012-9658(1999)080[1828:RIMAPT]2.0.CO;2; Kirschbaum MUF, 2000, BIOGEOCHEMISTRY, V48, P21, DOI 10.1023/A:1006238902976; McKane RB, 1997, ECOLOGY, V78, P1170, DOI 10.1890/0012-9658(1997)078[1170:CEOTCS]2.0.CO;2; Michaelson GJ, 1996, ARCTIC ALPINE RES, V28, P414, DOI 10.2307/1551852; Moore JC, 2003, ECOLOGY, V84, P846, DOI 10.1890/0012-9658(2003)084[0846:TIBDPI]2.0.CO;2; Nadelhoffer KJ, 2002, PLANT SOIL, V242, P107, DOI 10.1023/A:1019646124768; NADELHOFFER KJ, 1991, ECOLOGY, V72, P242, DOI 10.2307/1938918; Neff JC, 2002, NATURE, V419, P915, DOI 10.1038/nature01136; Oechel WC, 2000, NATURE, V406, P978, DOI 10.1038/35023137; Serreze MC, 2000, CLIMATIC CHANGE, V46, P159, DOI 10.1023/A:1005504031923; Shaver GR, 2001, ECOLOGY, V82, P3163, DOI 10.1890/0012-9658(2001)082[3163:SCIWFT]2.0.CO;2; SHAVER GR, 1991, ECOL MONOGR, V61, P1, DOI 10.2307/1942997; SHAVER GR, 1992, BIOSCIENCE, V42, P433, DOI 10.2307/1311862; Sturm M, 2001, NATURE, V411, P546, DOI 10.1038/35079180; *SYSTAT INC, 1997, SYST WIND STAT VERS; VITOUSEK P, 1982, AM NAT, V119, P553, DOI 10.1086/283931; Weintraub MN, 2003, ECOSYSTEMS, V6, P129, DOI 10.1007/s10021-002-0124-6	30	746	803	28	522	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 23	2004	431	7007					440	443		10.1038/nature02887	http://dx.doi.org/10.1038/nature02887			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855UN	15386009				2022-12-28	WOS:000224000500037
J	Schubert, H; Haage, P				Schubert, H; Haage, P			Morgagni's hernia	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Hosp Aachen, D-52057 Aachen, Germany	RWTH Aachen University; RWTH Aachen University Hospital	Schubert, H (corresponding author), Univ Hosp Aachen, D-52057 Aachen, Germany.								0	1	1	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 23	2004	351	13					E12	E12		10.1056/ENEJMicm030667	http://dx.doi.org/10.1056/ENEJMicm030667			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	855TP	15385673				2022-12-28	WOS:000223997700012
J	Naser, SA; Ghobrial, G; Romero, C; Valentine, JF				Naser, SA; Ghobrial, G; Romero, C; Valentine, JF			Culture of Mycobacterium avium subspecies paratuberculosis from the blood of patients with Crohn's disease	LANCET			English	Article							POLYMERASE-CHAIN-REACTION; LYMPH-NODES; TISSUE; IDENTIFICATION; MILK; SUSCEPTIBILITY; ASSOCIATION; MUTATION; BACILLI; COWS	Background Crohn's disease, a form of inflammatory bowel disease, resembles some aspects of tuberculosis, leprosy, and paratuberculosis. The role of Mycobacterium avium subspecies paratuberculosis (MAP) in Crohn's disease is controversial. Methods We tested for MAP by PCR and culture in buffy coat preparations from 28 individuals with Crohn's disease, nine with ulcerative colitis, and 15 without inflammatory bowel disease. Findings MAP DNA in uncultured buffy coats was identified by PCR in 13 (46%) individuals with Crohn's disease, four (45%) with ulcerative colitis, and three (20%) without inflammatory bowel disease. Viable MAP was cultured from the blood of 14 (50%) patients with Crohn's disease, two (22%) with ulcerative colitis, and none of the individuals without inflammatory bowel disease. Current use of immunosuppressive medication did not correlate with a positive MAP culture. Sequencing of PCR products from MAP cultures confirmed the presence of the MAP-specific IS900 fragment. Among 11 MAP isolates assessed, we identified nine strains that were not identical. Interpretation We detected viable MAP in peripheral blood in a higher proportion of individuals with Crohn's disease than in controls. These data contribute to the evidence that MAP might be a cause of Crohn's disease.	Univ Cent Florida, Dept Mol Biol & Microbiol, Orlando, FL 32816 USA; Univ Cent Florida, Burnett Coll Biomed Sci, Biomol Sci Ctr, Orlando, FL 32816 USA; Univ Florida, Dept Med, Gainesville, FL USA; Gainesville VAMC, Gainesville, FL USA	State University System of Florida; University of Central Florida; State University System of Florida; University of Central Florida; State University System of Florida; University of Florida	Naser, SA (corresponding author), Univ Cent Florida, Dept Mol Biol & Microbiol, Orlando, FL 32816 USA.	nasers@mail.ucf.edu	Valentine, John/L-6631-2019	Valentine, John/0000-0002-1894-9930	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI051251] Funding Source: NIH RePORTER; NIAID NIH HHS [R01-AI51251-01] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bouma G, 2003, NAT REV IMMUNOL, V3, P521, DOI 10.1038/nri1132; Bull TJ, 2003, J CLIN MICROBIOL, V41, P2915, DOI 10.1128/JCM.41.7.2915-2923.2003; Chen GI, 2002, CAN J GASTROENTEROL, V16, P29, DOI 10.1155/2002/219187; CHIODINI RJ, 1986, J CLIN MICROBIOL, V24, P357, DOI 10.1128/JCM.24.3.357-363.1986; CHIODINI RJ, 1989, CLIN MICROBIOL REV, V2, P90, DOI 10.1128/CMR.2.1.90-117.1989; Crohn BB, 1932, J AMER MED ASSOC, V99, P1323, DOI 10.1001/jama.1932.02740680019005; DALZEIL TK, 1913, BRIT MED J, V2, P1068; DeFrancesco MA, 1996, EUR J CLIN MICROBIOL, V15, P551, DOI 10.1007/BF01709362; Grant IR, 2002, APPL ENVIRON MICROB, V68, P2428, DOI 10.1128/AEM.68.5.2428-2435.2002; GREEN EP, 1989, NUCLEIC ACIDS RES, V17, P9063, DOI 10.1093/nar/17.22.9063; Greenstein RJ, 2004, LANCET, V364, P396, DOI 10.1016/S0140-6736(04)16781-0; Gwozdz JM, 2000, AUST VET J, V78, P622, DOI 10.1111/j.1751-0813.2000.tb11938.x; HAAGSMA J, 1989, SCAND J GASTROENTERO, V24, pS158; Hampe J, 2001, LANCET, V357, P1925, DOI 10.1016/S0140-6736(00)05063-7; HARVEY RF, 1980, LANCET, V1, P514; Hermon-Taylor J, 1998, BRIT MED J, V316, P449, DOI 10.1136/bmj.316.7129.449; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; LISBY G, 1994, SCAND J GASTROENTERO, V29, P923, DOI 10.3109/00365529409094864; MARKESICH DC, 1988, J CLIN MICROBIOL, V26, P1600, DOI 10.1128/JCM.26.8.1600-1603.1988; MCFADDEN JJ, 1987, J CLIN MICROBIOL, V25, P796, DOI 10.1128/JCM.25.5.796-801.1987; Mishina D, 1996, P NATL ACAD SCI USA, V93, P9816, DOI 10.1073/pnas.93.18.9816; Naser SA, 2000, AM J GASTROENTEROL, V95, P1094, DOI 10.1111/j.1572-0241.2000.01954.x; Naser SA, 2002, MOL CELL PROBE, V16, P41, DOI 10.1006/mcpr.2001.0395; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; SANDERSON JD, 1992, GUT, V33, P890, DOI 10.1136/gut.33.7.890; Sands BE, 2004, GASTROENTEROLOGY, V126, P1518, DOI 10.1053/j.gastro.2004.02.072; SAXEGAARD F, 1985, J CLIN MICROBIOL, V22, P312, DOI 10.1128/JCM.22.2.312-313.1985; Schwartz D, 2000, CLIN MICROBIOL INFEC, V6, P303, DOI 10.1046/j.1469-0691.2000.00093.x; Shafran I, 2002, DIGEST LIVER DIS, V34, P22, DOI 10.1016/S1590-8658(02)80055-X; SWEENEY RW, 1992, J CLIN MICROBIOL, V30, P166, DOI 10.1128/JCM.30.1.166-171.1992; Zhang Y, 2004, FRONT BIOSCI-LANDMRK, V9, P1136, DOI 10.2741/1291	31	484	494	0	34	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 18	2004	364	9439					1039	1044		10.1016/S0140-6736(04)17058-X	http://dx.doi.org/10.1016/S0140-6736(04)17058-X			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	855FT	15380962				2022-12-28	WOS:000223959300022
J	Selby, WS				Selby, WS			Mycobacterium avium subspecies paratuberculosis, bacteraemia in patients with inflammatory bowel disease	LANCET			English	Editorial Material							CROHNS-DISEASE		Royal Prince Alfred Hosp, AW Morrow Gastroenterol & Liver Ctr, Sydney, NSW 2050, Australia; Univ Sydney, Dept Med, Sydney, NSW 2006, Australia	University of Sydney; University of Sydney	Selby, WS (corresponding author), Royal Prince Alfred Hosp, AW Morrow Gastroenterol & Liver Ctr, Sydney, NSW 2050, Australia.	warwicks@galen.med.usyd.edu.au						Bull TJ, 2003, J CLIN MICROBIOL, V41, P2915, DOI 10.1128/JCM.41.7.2915-2923.2003; Chamberlin W, 2001, ALIMENT PHARM THER, V15, P337, DOI 10.1046/j.1365-2036.2001.00933.x; CHIODINI RJ, 1989, CLIN MICROBIOL REV, V2, P90, DOI 10.1128/CMR.2.1.90-117.1989; Greenstein RJ, 2004, LANCET, V364, P396, DOI 10.1016/S0140-6736(04)16781-0; Greenstein RJ, 2003, LANCET INFECT DIS, V3, P507, DOI 10.1016/S1473-3099(03)00724-2; Hermon-Taylor J, 2002, DIGEST LIVER DIS, V34, P9, DOI 10.1016/S1590-8658(02)80052-4; Hermon-Taylor J, 2001, GUT, V49, P755, DOI 10.1136/gut.49.6.755; Kennedy DJ, 2003, PROCEEDINGS OF THE SEVENTH INTERNATIONAL COLLOQUIUM ON PARATUBERCULOSIS, P429; Macpherson AJ, 2004, SCIENCE, V303, P1662, DOI 10.1126/science.1091334; Naser SA, 2000, AM J GASTROENTEROL, V95, P1094, DOI 10.1111/j.1572-0241.2000.01954.x; Quirke P, 2001, GUT, V49, P757, DOI 10.1136/gut.49.6.757; Richter E, 2002, EMERG INFECT DIS, V8, P729, DOI 10.3201/eid0807.010388	12	18	18	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 18	2004	364	9439					1013	1014		10.1016/S0140-6736(04)17071-2	http://dx.doi.org/10.1016/S0140-6736(04)17071-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	855FT	15380947				2022-12-28	WOS:000223959300003
J	Brugge, WR; Lauwers, GY; Sahani, D; Fernandez-del Castillo, C; Warshaw, AL				Brugge, WR; Lauwers, GY; Sahani, D; Fernandez-del Castillo, C; Warshaw, AL			Cystic neoplasms of the pancreas	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							PAPILLARY MUCINOUS TUMORS; SEROUS CYSTADENOMA; FLUID ANALYSIS; DIFFERENTIAL-DIAGNOSIS; NEEDLE-ASPIRATION; LESIONS; EUS; CT; MANAGEMENT; FEATURES		Massachusetts Gen Hosp, Gastrointestinal Unit, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Surg, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital	Brugge, WR (corresponding author), Massachusetts Gen Hosp, Gastrointestinal Unit, Blake 452C,55 Fruit St, Boston, MA 02114 USA.	wbrugge@partners.org	Castillo, Carlos Fenandez-del/AAO-2602-2020					Adsay NV, 2000, SEMIN DIAGN PATHOL, V17, P1; Ahmad NA, 2001, AM J GASTROENTEROL, V96, P3295; Balci NC, 2001, EUR J RADIOL, V38, P113, DOI 10.1016/S0720-048X(01)00296-0; Balcom JH, 2001, ARCH SURG-CHICAGO, V136, P391, DOI 10.1001/archsurg.136.4.391; Bassi C, 2003, WORLD J SURG, V27, P319, DOI 10.1007/s00268-002-6570-7; BOUNDS BC, 2002, ENDOSC CLIN N AM, V12, P735; Brandwein SL, 2001, GASTROINTEST ENDOSC, V53, P722, DOI 10.1067/mge.2001.114783; Brugge WR, 2004, GASTROENTEROLOGY, V126, P1330, DOI 10.1053/j.gastro.2004.02.013; Brugge WR, 2000, GASTROINTEST ENDOSC, V52, pS18, DOI 10.1067/mge.2000.110720; Buetow PC, 1998, RADIOGRAPHICS, V18, P433, DOI 10.1148/radiographics.18.2.9536488; Centeno BA, 1997, ACTA CYTOL, V41, P972, DOI 10.1159/000332775; Chari ST, 2002, GASTROENTEROLOGY, V123, P1500, DOI 10.1053/gast.2002.36552; Curry CA, 2000, AM J ROENTGENOL, V175, P99, DOI 10.2214/ajr.175.1.1750099; Fernandez-del Castillo C, 2003, ARCH SURG-CHICAGO, V138, P427; Fernandez-del Castillo C, 2000, Adv Surg, V34, P237; Frossard JL, 2003, AM J GASTROENTEROL, V98, P1516, DOI 10.1016/S0002-9270(03)00359-9; Gress F, 2000, AM J GASTROENTEROL, V95, P961; Hamilton SR, 2000, WHO CLASSIFICATION T, V2; Hara T, 2002, GASTROENTEROLOGY, V122, P34, DOI 10.1053/gast.2002.30337; Irie H, 2000, AM J ROENTGENOL, V174, P1403, DOI 10.2214/ajr.174.5.1741403; ITOH S, 1992, RADIOLOGY, V183, P81, DOI 10.1148/radiology.183.1.1312735; KERLIN DL, 1987, SURG GYNECOL OBSTET, V165, P475; Kimura W, 1996, HEPATO-GASTROENTEROL, V43, P692; Klimstra DS, 2000, SEMIN DIAGN PATHOL, V17, P66; Kloppel G, 1998, HEPATO-GASTROENTEROL, V45, P1981; Kloppel G., 1998, HISTOLOGICAL TYPING, V2nd ed.; Koito K, 1997, GASTROINTEST ENDOSC, V45, P268, DOI 10.1016/S0016-5107(97)70269-4; Koito K, 1998, RADIOLOGY, V208, P231, DOI 10.1148/radiology.208.1.9646818; LEWANDROWSKI KB, 1993, ANN SURG, V217, P41, DOI 10.1097/00000658-199301000-00008; McNulty NJ, 2001, RADIOLOGY, V220, P97, DOI 10.1148/radiology.220.1.r01jl1897; MINAMI M, 1989, RADIOLOGY, V171, P53, DOI 10.1148/radiology.171.1.2928546; Mohr VH, 2000, AM J PATHOL, V157, P1615, DOI 10.1016/S0002-9440(10)64799-2; Morgan DE, 1997, RADIOLOGY, V203, P773, DOI 10.1148/radiology.203.3.9169703; Nguyen GK, 1997, DIAGN CYTOPATHOL, V17, P177, DOI 10.1002/(SICI)1097-0339(199709)17:3<177::AID-DC2>3.0.CO;2-C; Paye F, 2000, SURGERY, V127, P536, DOI 10.1067/msy.2000.106126; PINTO MM, 1991, ACTA CYTOL, V35, P456; Procacci C, 1997, J COMPUT ASSIST TOMO, V21, P373, DOI 10.1097/00004728-199705000-00007; Procacci C, 1999, RADIOGRAPHICS, V19, P1447, DOI 10.1148/radiographics.19.6.g99no011447; PYKE CM, 1992, ANN SURG, V215, P132, DOI 10.1097/00000658-199202000-00007; Sand JA, 1996, SURGERY, V119, P275, DOI 10.1016/S0039-6060(96)80113-9; Santos LD, 2002, PATHOLOGY, V34, P148, DOI 10.1080/003130201201117963; Sarr MG, 2003, J GASTROINTEST SURG, V7, P417, DOI 10.1016/S1091-255X(02)00163-4; Sarr MG, 2000, ANN SURG, V231, P205, DOI 10.1097/00000658-200002000-00009; Sedlack R, 2002, GASTROINTEST ENDOSC, V56, P543, DOI 10.1067/mge.2002.128106; Sperti C, 1997, AM J GASTROENTEROL, V92, P672; Sperti C, 1996, CANCER, V78, P237, DOI 10.1002/(SICI)1097-0142(19960715)78:2<237::AID-CNCR8>3.0.CO;2-I; Sperti C, 2001, ANN SURG, V234, P675, DOI 10.1097/00000658-200111000-00014; Terris B, 2000, AM J SURG PATHOL, V24, P1372, DOI 10.1097/00000478-200010000-00006; Vortmeyer AO, 1997, AM J PATHOL, V151, P951; Walsh RM, 2002, SURGERY, V132, P628, DOI 10.1067/msy.2002.127543; Warshaw AL, 1998, ARCH SURG-CHICAGO, V133, P327, DOI 10.1001/archsurg.133.3.327; WARSHAW AL, 1987, ANN SURG, V205, P393, DOI 10.1097/00000658-198704000-00009; WARSHAW AL, 1990, ANN SURG, V212, P432, DOI 10.1097/00000658-199010000-00006; Wilentz RE, 1999, AM J SURG PATHOL, V23, P1320, DOI 10.1097/00000478-199911000-00002; YEO CJ, 1994, CURR PROB SURG, V31, P167; Zamboni G, 1999, AM J SURG PATHOL, V23, P410, DOI 10.1097/00000478-199904000-00005; Zgraggen K, 1997, ANN SURG, V226, P491, DOI 10.1097/00000658-199710000-00010	57	526	571	0	22	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 16	2004	351	12					1218	1226		10.1056/NEJMra031623	http://dx.doi.org/10.1056/NEJMra031623			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	853WS	15371579				2022-12-28	WOS:000223861300010
J	Pellegrini, G				Pellegrini, G			Changing the cell source in cell therapy?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Osped Civile Venezia, Veneto Eye Bank Fdn, Epithelial Stem Cell Res Ctr, Venice, Italy		Pellegrini, G (corresponding author), Osped Civile Venezia, Veneto Eye Bank Fdn, Epithelial Stem Cell Res Ctr, Venice, Italy.		Pellegrini, Graziella/E-1189-2015	Pellegrini, Graziella/0000-0001-9861-0736				Henderson TRM, 2001, BRIT J OPHTHALMOL, V85, P604, DOI 10.1136/bjo.85.5.604; KENYON KR, 1989, OPHTHALMOLOGY, V96, P709; Pellegrini G, 1997, LANCET, V349, P990, DOI 10.1016/S0140-6736(96)11188-0	3	17	18	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 16	2004	351	12					1170	1172		10.1056/NEJMp048199	http://dx.doi.org/10.1056/NEJMp048199			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	853WS	15371573				2022-12-28	WOS:000223861300004
J	Kozer, E; Seto, W; Verjee, Z; Parshuram, C; Khattak, S; Koren, G; Jarvis, DA				Kozer, E; Seto, W; Verjee, Z; Parshuram, C; Khattak, S; Koren, G; Jarvis, DA			Prospective observational study on the incidence of medication errors during simulated resuscitation in a paediatric emergency department	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CHILDREN; EVENTS; CARE	Objectives To characterise the incidence and nature of medication errors during paediatric resuscitations. Design A prospective observational study of simulated emergencies. Setting Emergency department of a tertiary paediatric hospital. Participants Teams that included a clinician who commonly leads "real" resuscitations, at least two assisting physicians, and two or three paediatric nurses. Interventions The teams conducted eight mock resuscitations, including ordering medications. Exercises were videotaped and drugs ordered and administered during the resuscitation were recorded. Syringes and drugs prepared during the resuscitation were collected and analysed for concentrations and actual amounts. Main outcome measures Number and type of drug errors. Results Participants gave 125 orders for medications. In 21 (17%) of the orders the exact dose was not specified. Nine dosing errors occur-red during the ordering phase. Of these errors, five were intercepted before the drug reached the patient. Four 10-fold errors were identified. In nine (16%) out of 58 syringes analysed, measured drug concentrations showed a deviation of at least 20% from the ordered dose. A large deviation (at least 50%) from the expected dose was found in four (7%) cases. Conclusions Medication errors commonly occur during all stages of paediatric resuscitation. Many errors could be detected only by analysing syringe content, suggesting that such errors may be a major source of morbidity and mortality in resuscitated children.	Hosp Sick Children, Div Paediat Emergency Med, Toronto, ON M5G 1X8, Canada; Hosp Sick Children, Dept Pharm, Toronto, ON M5G 1X8, Canada; Hosp Sick Children, Dept Clin Biochem, Toronto, ON M5G 1X8, Canada; Hosp Sick Children, Div Clin Pharmacol & Toxicol, Toronto, ON M5G 1X8, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Kozer, E (corresponding author), Assaf Harofeh Med Ctr, Paediat Emergency Serv, IL-70300 Zerifin, Israel.	erank@asaf.health.gov.il	Parshuram, Christopher/AAI-6669-2020; Koren, Gideon/AAG-7726-2019	Parshuram, Christopher/0000-0002-7744-481X; Koren, Gideon/0000-0002-9234-0875				Dean B, 2002, LANCET, V359, P1373, DOI 10.1016/S0140-6736(02)08350-2; KOREN G, 1994, J CLIN PHARMACOL, V34, P1043, DOI 10.1002/j.1552-4604.1994.tb01978.x; Kozer E, 2002, PEDIATRICS, V110, P737, DOI 10.1542/peds.110.4.737; Kozer E, 2002, NEW ENGL J MED, V346, P1175, DOI 10.1056/NEJM200204113461518; LEAPE LL, 1991, NEW ENGL J MED, V324, P377, DOI 10.1056/NEJM199102073240605; Lesar TS, 1997, JAMA-J AM MED ASSOC, V277, P312, DOI 10.1001/jama.277.4.312; Lesar TS, 1998, ARCH PEDIAT ADOL MED, V152, P340; Parshuram CS, 2003, CRIT CARE MED, V31, P2483, DOI 10.1097/01.CCM.0000089638.83803.B2; Schindler MB, 1996, NEW ENGL J MED, V335, P1473, DOI 10.1056/NEJM199611143352001; Shah AN, 2003, ARCH PEDIAT ADOL MED, V157, P229, DOI 10.1001/archpedi.157.3.229; Tissot E, 1999, INTENS CARE MED, V25, P353, DOI 10.1007/s001340050857	11	86	89	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 4	2004	329	7478					1321	1324		10.1136/bmj.38244.607083.55	http://dx.doi.org/10.1136/bmj.38244.607083.55			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	878PC	15454495	Green Published, Green Submitted, Bronze			2022-12-28	WOS:000225657800020
J	Kyffin, RGE; Goldacre, MJ; Gill, M				Kyffin, RGE; Goldacre, MJ; Gill, M			Mortality rates and self reported health: database analysis by English local authority area	BRITISH MEDICAL JOURNAL			English	Article									Govt Off SE, SE Reg Publ Hlth Grp, Surrey GU1 4GA, England; Univ Oxford, Dept Publ Hlth, Unit Hlth Care Epidemiol, Oxford OX3 7LF, England	University of Oxford	Kyffin, RGE (corresponding author), Govt Off SE, SE Reg Publ Hlth Grp, Bridge House, Surrey GU1 4GA, England.	robert.kyffin@dh.gsi.gov.uk						*DEP HLTH, 2003, COMP CLIN HLTH IND 2; *OFF NAT STAT, 2003, 2001 CENS POP	2	28	28	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 16	2004	329	7471					887	888		10.1136/bmj.38238.508021.F7	http://dx.doi.org/10.1136/bmj.38238.508021.F7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	863MU	15447954	Green Submitted, Bronze, Green Published			2022-12-28	WOS:000224566800016
J	Fancher, TL; White, RH; Kravitz, RL				Fancher, TL; White, RH; Kravitz, RL			Combined use of rapid D-dimer testing and estimation of clinical probability in the diagnosis of deep vein thrombosis: systematic review	BMJ-BRITISH MEDICAL JOURNAL			English	Review							SIMPLIRED D-DIMER; PLASMA D-DIMER; VENOUS THROMBOSIS; WHOLE-BLOOD; COMPRESSION ULTRASONOGRAPHY; PULMONARY-EMBOLISM; IMPEDANCE PLETHYSMOGRAPHY; SYMPTOMATIC OUTPATIENTS; IMMUNOFILTRATION ASSAY; NONINVASIVE DIAGNOSIS	Objective To summarise the evidence supporting the use of rapid D-dimer testing combined with estimation of clinical probability to exclude the diagnosis of deep venous thrombosis among outpatients. Data sources Medline Uune 1993 to December 2003), the Database of Abstracts and Reviews (DARE), and reference lists of studies in English. Selection of studies We selected 12 studies from among 84 reviewed. The selected studies included more than 5000 patients and used a rapid D-dimer assay and explicit criteria to classify cases as having low, intermediate, or high clinical probability of deep vein thrombosis of the lower extremity among consecutive outpatients. Review methods Diagnosis required objective confirmation, and untreated patients had to have at least three months of follow up. The outcome was objectively documented venous thromboembolism. Two authors independently abstracted data by using a data collection form. Results When the less sensitive SimpliRED D-dimer assay was used the three month incidence of venous thromboembolism was 0.5% (95% confidence interval 0.07% to 1.1%) among patients with a low clinical probability of deep vein thrombosis and normal D-dimer concentrations. When a highly sensitive D-dimer assay was used, the three month incidence of venous thromboembolism was 0.4% (0.04% to 1.1%) among outpatients with low or moderate clinical probability of deep vein thrombosis and a normal D-dimer concentration. Conclusions The combination of low clinical probability for deep vein thrombosis and a normal result from the SimpliRED D-dimer test safely excludes a diagnosis of acute venous thrombosis. A normal result from a highly sensitive D-dimer test effectively rules out deep vein thrombosis among patients classified as having either low or moderate clinical probability of deep vein thrombosis.	Univ Calif Davis, Div Gen Med, Sacramento, CA 95817 USA; Ctr Hlth Serv Res Primary Care, Sacramento, CA 95817 USA	University of California System; University of California Davis	Fancher, TL (corresponding author), Univ Calif Davis, Div Gen Med, Patient Support Serv Bldg,Suite 2400, Sacramento, CA 95817 USA.	Tonya.Fancher@ucdmc.ucdavis.edu	Kravitz, Richard/AAF-7425-2021	Kravitz, Richard/0000-0001-5575-529X	PHS HHS [1 D55 HP 00232] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Aguilar C, 2002, BRIT J HAEMATOL, V118, P275, DOI 10.1046/j.1365-2141.2002.03614.x; Anderson DR, 1999, ARCH INTERN MED, V159, P477, DOI 10.1001/archinte.159.5.477; Anderson DR, 2000, J EMERG MED, V19, P225, DOI 10.1016/S0736-4679(00)00225-0; Arcelus JI, 1996, J VASC SURG, V23, P616, DOI 10.1016/S0741-5214(96)80041-3; Aschwanden M, 2001, West J Med, V174, P255, DOI 10.1136/ewjm.174.4.255; Aschwanden M, 1999, J VASC SURG, V30, P929, DOI 10.1016/S0741-5214(99)70019-4; Bates SM, 2003, ANN INTERN MED, V138, P787, DOI 10.7326/0003-4819-138-10-200305200-00006; Bates SM, 2001, ARCH INTERN MED, V161, P447, DOI 10.1001/archinte.161.3.447; Bensousan TA, 1997, INTENS CARE MED, V23, P1287, DOI 10.1007/s001340050503; Bernardi E, 1998, BRIT MED J, V317, P1037; Blattler W, 2000, J VASC SURG, V32, P855, DOI 10.1067/mva.2000.110345; BOUMAN CSC, 1995, THROMB RES, V77, P225, DOI 10.1016/0049-3848(95)91610-W; Bradley M, 2000, CLIN RADIOL, V55, P525, DOI 10.1053/crad.1999.0482; BRADLEY MJ, 1993, CLIN RADIOL, V47, P399, DOI 10.1016/S0009-9260(05)81060-8; BRENNER B, 1995, BLOOD COAGUL FIBRIN, V6, P219, DOI 10.1097/00001721-199505000-00004; Brimble KS, 1997, THROMB RES, V88, P291, DOI 10.1016/S0049-3848(97)00256-9; Bucek RA, 2002, THROMB RES, V105, P43, DOI 10.1016/S0049-3848(01)00411-X; Bucek RA, 2001, THROMB RES, V103, P17, DOI 10.1016/S0049-3848(00)00367-4; *COCHR METH GROUP, 1996, REC METH; Cornuz J, 2002, AM J MED, V112, P198, DOI 10.1016/S0002-9343(01)01110-X; DALE S, 1994, THROMB HAEMOSTASIS, V71, P270; DAngelo A, 1996, THROMB HAEMOSTASIS, V75, P412; de Moerloose P, 2001, THROMB HAEMOSTASIS, V85, P185; Dryjski M, 2001, J VASC SURG, V34, P1010, DOI 10.1067/mva.2001.119889; ELIAS A, 1987, INT ANGIOL, V6, P175; Elias A, 1996, THROMB HAEMOSTASIS, V76, P518; Escoffre-Barbe M, 1998, AM J CLIN PATHOL, V109, P748; Farrell S, 2000, ANN EMERG MED, V35, P121, DOI 10.1016/S0196-0644(00)70130-2; Fleiss J. L., 1981, STAT METHODS RATES P, V2; Freyburger G, 1998, THROMB HAEMOSTASIS, V79, P32; Frost SD, 2003, MAYO CLIN PROC, V78, P1385, DOI 10.4065/78.11.1385; Funfsinn N, 2001, BLOOD COAGUL FIBRIN, V12, P165, DOI 10.1097/00001721-200104000-00001; Ginsberg JS, 1997, ARCH INTERN MED, V157, P1077, DOI 10.1001/archinte.157.10.1077; Gordis L, 1996, EPIDEMIOLOGY; Gosselin RC, 2000, BLOOD COAGUL FIBRIN, V11, P715, DOI 10.1097/00001721-200012000-00004; Gouin-Thibault I, 1999, SEMIN THROMB HEMOST, V25, P167, DOI 10.1055/s-2007-994918; HANSSON PO, 1994, J INTERN MED, V235, P143, DOI 10.1111/j.1365-2796.1994.tb01048.x; Harper P, 2001, NEW ZEAL MED J, V114, P61; HEIJBOER H, 1993, NEW ENGL J MED, V329, P1365, DOI 10.1056/NEJM199311043291901; Heim SW, 1999, J FAM PRACTICE, V48, P13; Hein-Rasmussen R, 2000, THROMB RES, V100, P287, DOI 10.1016/S0049-3848(00)00316-9; Hellgren M, 2003, SEMIN THROMB HEMOST, V29, P125, DOI 10.1055/s-2003-38897; Houbouyan-Reveillard LL, 2000, THROMB HAEMOSTASIS, V84, P770; Hull RD, 2002, AM J MED, V113, P687, DOI 10.1016/S0002-9343(02)01419-5; IRWIG L, 1994, ANN INTERN MED, V120, P667, DOI 10.7326/0003-4819-120-8-199404150-00008; Janes S, 2001, BRIT J HAEMATOL, V112, P1079, DOI 10.1046/j.1365-2141.2001.02607.x; Janssen MCH, 1997, THROMB HAEMOSTASIS, V77, P262; Johanning JM, 2002, J VASC SURG, V36, P877, DOI 10.1067/mva.2002.129247; Jones S, 2001, EMERG MED J, V18, P120, DOI 10.1136/emj.18.2.120; Kearon C, 1998, ANN INTERN MED, V128, P663, DOI 10.7326/0003-4819-128-8-199804150-00011; Kearon C, 2001, ANN INTERN MED, V135, P108, DOI 10.7326/0003-4819-135-2-200107170-00011; Keeling DM, 2004, BRIT J HAEMATOL, V124, P15, DOI 10.1046/j.1365-2141.2003.04723.x; Keeling DM, 1999, CLIN LAB HAEMATOL, V21, P359, DOI 10.1046/j.1365-2257.1999.00248.x; Kelly J, 2003, CHEST, V124, P1116, DOI 10.1378/chest.124.3.1116; Killick SB, 1997, BRIT J HAEMATOL, V96, P846, DOI 10.1046/j.1365-2141.1997.d01-2097.x; Kovacs MJ, 2001, BRIT J HAEMATOL, V115, P140, DOI 10.1046/j.1365-2141.2001.03060.x; Kozman H, 1997, SOUTHERN MED J, V90, P907, DOI 10.1097/00007611-199709000-00009; Kraaijenhagen RA, 2002, ARCH INTERN MED, V162, P907, DOI 10.1001/archinte.162.8.907; KRULP MJ, 2003, ANN INTERN MED, V138, P941; LaCapra S, 2000, BLOOD COAGUL FIBRIN, V11, P371, DOI 10.1097/00001721-200006000-00009; Larsen TB, 2002, J INTERN MED, V252, P36, DOI 10.1046/j.1365-2796.2002.00998.x; Le Blanche AF, 1999, ANGIOLOGY, V50, P873, DOI 10.1177/000331979905001101; Lee AYY, 1999, ANN INTERN MED, V131, P417, DOI 10.7326/0003-4819-131-6-199909210-00004; Legnani C, 1997, BLOOD COAGUL FIBRIN, V8, P296, DOI 10.1097/00001721-199707000-00006; Legnani C, 1999, BLOOD COAGUL FIBRIN, V10, P69, DOI 10.1097/00001721-199903000-00002; Lennox AF, 1999, J VASC SURG, V30, P794, DOI 10.1016/S0741-5214(99)70003-0; Leroyer C, 1997, THROMB HAEMOSTASIS, V77, P637; Line BR, 1997, J NUCL MED, V38, P89; Mauron T, 1998, THROMB HAEMOSTASIS, V79, P1217, DOI 10.1055/s-0037-1615046; Mayer W, 1997, VASA-J VASCULAR DIS, V26, P97; Michiels JJ, 1999, CLIN APPL THROMB-HEM, V5, P219; Michiels JJ, 1998, SEMIN THROMB HEMOST, V24, P401, DOI 10.1055/s-2007-996029; Michiels JJ, 2000, SEMIN THROMB HEMOST, V26, P657, DOI 10.1055/s-2000-13222; Miron MJ, 2000, J INTERN MED, V247, P249, DOI 10.1046/j.1365-2796.2000.00605.x; MITCHELL DC, 1991, BRIT J SURG, V78, P611, DOI 10.1002/bjs.1800780528; Numans ME, 2004, ANN INTERN MED, V140, P518, DOI 10.7326/0003-4819-140-7-200404060-00011; Permpikul Chairat, 2000, Journal of the Medical Association of Thailand, V83, P732; Perrier A, 1999, LANCET, V353, P190, DOI 10.1016/S0140-6736(98)05248-9; Philbrick JT, 2003, CLIN CHEM, V49, P570, DOI 10.1373/49.4.570; Reber G, 2001, BLOOD COAGUL FIBRIN, V12, P217, DOI 10.1097/00001721-200104000-00010; Roy PM, 1998, LANCET, V351, P1588, DOI 10.1016/S0140-6736(05)61158-0; Sadouk M, 2000, CLIN CHEM, V46, P286; Sandrick K, 2000, CAP Today, V14, P40; SANDRICK K, 2000, CAP TODAY, V14, P44; SANDRICK K, 2000, CAP TODAY, V14, P46; Scarano L, 1997, THROMB RES, V86, P93, DOI 10.1016/S0049-3848(97)00053-4; Schutgens REG, 2003, J THROMB HAEMOST, V1, P976, DOI 10.1046/j.1538-7836.2003.00148.x; Schutgens REG, 2003, CIRCULATION, V107, P593, DOI 10.1161/01.CIR.0000045670.12988.1E; Schutgens REG, 2002, AM J MED, V112, P617, DOI 10.1016/S0002-9343(02)01115-4; Shields GP, 2002, ACAD EMERG MED, V9, P561, DOI 10.1111/j.1553-2712.2002.tb02292.x; Shitrit D, 2001, THROMB RES, V102, P125, DOI 10.1016/S0049-3848(01)00221-3; Siragusa S, 2001, HAEMATOLOGICA, V86, P856; Spiegelhalter DJ, 1999, WINBUGS VERSION 1 2; Stern SD, 2004, NEW ENGL J MED, V350, P192; Sutton AJAK, 2000, METHODS METAANALYSIS; TENGBORN L, 1994, HAEMOSTASIS, V24, P344; Tick LW, 2002, AM J MED, V113, P630, DOI 10.1016/S0002-9343(02)01347-5; Turkstra F, 1996, THROMB HAEMOSTASIS, V76, P9; van der Graaf F, 2000, THROMB HAEMOSTASIS, V83, P191; Villa P, 2000, HAEMATOLOGICA, V85, P520; Wahlander K, 1999, BLOOD COAGUL FIBRIN, V10, P121; Walsh K, 2002, POSTGRAD MED J, V78, P742, DOI 10.1136/pmj.78.926.742; Wells P S, 2000, Curr Opin Pulm Med, V6, P309, DOI 10.1097/00063198-200007000-00010; Wells PS, 2003, NEW ENGL J MED, V349, P1227, DOI 10.1056/NEJMoa023153; Wells PS, 1995, THROMB HAEMOSTASIS, V74, P1423; WELLS PS, 1995, LANCET, V345, P1326, DOI 10.1016/S0140-6736(95)92535-X; WELLS PS, 1995, CIRCULATION, V91, P2184, DOI 10.1161/01.CIR.91.8.2184; Wells PS, 1997, LANCET, V350, P1795, DOI 10.1016/S0140-6736(97)08140-3; Wells PS, 1998, LANCET, V351, P1405, DOI 10.1016/S0140-6736(05)79444-7; WHITE RH, 1989, ANN INTERN MED, V111, P297, DOI 10.7326/0003-4819-111-4-297; Wijns W, 1998, ACTA CLIN BELG, V53, P270; Wildberger JE, 1998, INVEST RADIOL, V33, P232, DOI 10.1097/00004424-199804000-00006; Wilkes MM, 2001, ANN INTERN MED, V135, P149, DOI 10.7326/0003-4819-135-3-200108070-00007; Wilson DB, 2003, AM J CLIN PATHOL, V120, P930, DOI 10.1309/U3XCMGP4PMM1AB18	114	89	95	1	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 9	2004	329	7470					821	824C		10.1136/bmj.38226.719803.EB	http://dx.doi.org/10.1136/bmj.38226.719803.EB			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	862EK	15383452	Green Published, Green Submitted, Bronze			2022-12-28	WOS:000224472800016
J	Hu, D; Hook, EW; Goldie, SJ				Hu, D; Hook, EW; Goldie, SJ			Screening for Chlamydia trachomatis in women 15 to 29 years of age: A cost-effectiveness analysis	ANNALS OF INTERNAL MEDICINE			English	Article							PELVIC-INFLAMMATORY-DISEASE; SEXUALLY-TRANSMITTED-DISEASES; DIRECT MEDICAL COST; UNITED-STATES; ASYMPTOMATIC WOMEN; YOUNG-WOMEN; FOLLOW-UP; INFECTION; PREVALENCE; TESTS	Background: Clinical guidelines have traditionally advised annual Chlamydia trachomatis screening for women younger than 25 years of age. Objective: To assess the cost-effectiveness of recently proposed strategies for chlamyclia screening. Design: State transition simulation model; cost-effectiveness analysis. Data Sources: Published literature. Target Population: Sexually active U.S. women 15 to 29 years of age. Time Horizon: Lifetime. Perspective: Modified societal. Interventions: Four strategies targeted to 3 specific age groups (15 to 19 years, 15 to 24 years, and 15 to 29 years): 1) no screening, 2) annual screening for all women, 3) annual screening followed by 1 repeated test within 3 to 6 months after a positive test result, and 4) annual screening followed by selective semiannual screening for women with a history of infection. Outcome Measures: Clinical events (for example, pelvic inflammatory disease, chronic pelvic pain, ectopic pregnancy, and infertility), lifetime costs, quality-adjusted life expectancy, and incremental cost-effectiveness ratios. Results of Base-Case Analysis: Annual screening in women 15 to 29 years of age followed by semiannual screening for those with a history of infection was the most effective and cost-effective strategy. It consistently had an incremental cost-effectiveness ratio less than $25 000 per quality-adjusted life-year (QALY) compared with the next most effective strategy. When the indirect transmission effects of a 10-year screening program on the probability of infection in uninfected women (that is, per-susceptible rate of infection) were considered, all strategies became more cost-effective. Results of Sensitivity Analysis: Results were sensitive to the annual incidence of chlamyclia, probability of persistent infection, screening test costs, and costs of treating long-term complications. Each variable was associated with threshold values beyond which screening became cost-saving. In probabilistic analysis, annual screening in women 15 to 29 years of age followed by semiannual screening for those with a history of infection had an incremental cost-effectiveness ratio less than $50 000 per QALY in 99% of simulations. Limitations: Uncertainty about the natural history of chlamydial infection and consideration of only the indirect transmission effects of C. trachomatis screening. Conclusions: Annual C. trachomatis screening for all women 15 to 29 years of age and selective targeting of those with a history of infection for semiannual screening is very cost-effective compared with other well-accepted clinical interventions.	Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA; Univ Alabama Birmingham, Birmingham, AL USA	Harvard University; Harvard T.H. Chan School of Public Health; University of Alabama System; University of Alabama Birmingham	Goldie, SJ (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, 718 Huntington Ave,2nd Floor, Boston, MA 02115 USA.							Abma J C, 1997, Vital Health Stat 23, P1; Anderson R.M., 1999, SEX TRANSM DIS, V3rd, P25; [Anonymous], 1998, MMWR Recomm Rep, V47, P1; ARAL SO, 1991, JAMA-J AM MED ASSOC, V266, P2570, DOI 10.1001/jama.266.18.2570; Bachmann LH, 2003, SEX TRANSM DIS, V30, P20, DOI 10.1097/00007435-200301000-00005; Berg AO, 2001, AM J PREV MED, V20, P90, DOI 10.1016/S0749-3797(01)00254-9; Black CM, 2002, J CLIN MICROBIOL, V40, P3757, DOI 10.1128/JCM.40.10.3757-3763.2002; BRIHMER C, 1989, EUR J OBSTET GYN R B, V30, P263, DOI 10.1016/0028-2243(89)90011-7; Britton T F, 1992, Am J Gynecol Health, V6, P80; BUHAUG H, 1990, BRIT J GEN PRACT, V40, P142; BUHAUG H, 1989, MED CARE, V27, P833, DOI 10.1097/00005650-198908000-00007; Burstein GR, 2001, SEX TRANSM INFECT, V77, P26, DOI 10.1136/sti.77.1.26; Burstein GR, 1998, JAMA-J AM MED ASSOC, V280, P521, DOI 10.1001/jama.280.6.521; *CDCP, 2001, CHL PREV MON PROJ S; *CDCP, 2001, TRACK HIDD EP TRENDS; *CDCP, 1996, SEX TRANSM DIS SURV; Centers for Disease Control and Prevention (CDC), 2016, DEV WAT MAN PROGR RE; Chesson HW, 2004, PERSPECT SEX REPRO H, V36, P11, DOI 10.1363/3601104; Dean D, 1998, J CLIN MICROBIOL, V36, P94, DOI 10.1128/JCM.36.1.94-99.1998; Edmunds WJ, 1999, STAT MED, V18, P3263, DOI 10.1002/(SICI)1097-0258(19991215)18:23&lt;3263::AID-SIM315&gt;3.0.CO;2-3; FRYBACK DG, 1993, MED DECIS MAKING, V13, P89, DOI 10.1177/0272989X9301300202; Gift TL, 2002, SEX TRANSM DIS, V29, P542, DOI 10.1097/00007435-200209000-00009; Goeree R, 2001, SEX TRANSM DIS, V28, P701, DOI 10.1097/00007435-200112000-00007; Gold MR, 1996, COST EFFECTIVENESS H; Golden MR, 2000, SEX TRANSM DIS, V27, P329, DOI 10.1097/00007435-200007000-00006; GOLDSMITH MF, 1986, JAMA-J AM MED ASSOC, V255, P1665, DOI 10.1001/jama.255.13.1665; Graham JD, 1998, ANNU REV PUBL HEALTH, V19, P125, DOI 10.1146/annurev.publhealth.19.1.125; Groseclose SL, 1999, SEX TRANSM DIS, V26, P339, DOI 10.1097/00007435-199907000-00006; HALVORSEN L E, 1988, Tidsskrift for den Norske Laegeforening, V108, P2706; HAMMERSCHLAG MR, 1999, SEXUALLY TRANSMITTED, P1155; HILLIS SD, 1995, FAM PLANN PERSPECT, V27, P108, DOI 10.2307/2136107; HILLIS SD, 1994, AM J OBSTET GYNECOL, V170, P801, DOI 10.1016/S0002-9378(94)70286-1; HILLIS SD, 1995, 11 M INT SOC STD RES, V267, P156; *HLTH CAR FIN ADM, 2000, MED B; Howell MR, 1999, SEX TRANSM DIS, V26, P519, DOI 10.1097/00007435-199910000-00007; Howell MR, 1998, ANN INTERN MED, V128, P277, DOI 10.7326/0003-4819-128-4-199802150-00005; KATZ BP, 1988, SEX TRANSM DIS, V15, P11, DOI 10.1097/00007435-198801000-00003; Kretzschmar M, 1996, AM J EPIDEMIOL, V144, P306; Kretzschmar M, 2001, AM J EPIDEMIOL, V153, P90, DOI 10.1093/aje/153.1.90; Lau CY, 2002, SEX TRANSM DIS, V29, P497, DOI 10.1097/00007435-200209000-00001; Lawrence RS., 2000, VACCINES 21 CENTURY, P149; Low W., 1999, SEX TRANSM DIS, P407; Magid D, 1996, ANN INTERN MED, V124, P389, DOI 10.7326/0003-4819-124-4-199602150-00002; MARDH PA, 1977, NEW ENGL J MED, V296, P1377, DOI 10.1056/NEJM197706162962403; Martin Joyce A, 2002, Natl Vital Stat Rep, V50, P1; MCCORMACK WM, 1979, NEW ENGL J MED, V300, P123, DOI 10.1056/NEJM197901183000305; *MED EC, 2000, DRUG TOP RED BOOK; Mertz KJ, 2002, SEX TRANSM DIS, V29, P271, DOI 10.1097/00007435-200205000-00004; Mertz KJ, 2001, AM J PUBLIC HEALTH, V91, P1287, DOI 10.2105/AJPH.91.8.1287; Miller WC, 2004, JAMA-J AM MED ASSOC, V291, P2229, DOI 10.1001/jama.291.18.2229; Ness RB, 2002, AM J OBSTET GYNECOL, V186, P929, DOI 10.1067/mob.2002.121625; Nsuami M, 2000, SEX TRANSM DIS, V27, P473, DOI 10.1097/00007435-200009000-00010; Oh MK, 1996, J ADOLESCENT HEALTH, V18, P270, DOI 10.1016/1054-139X(95)00232-H; Ostergaard L, 1998, BRIT MED J, V317, P26, DOI 10.1136/bmj.317.7150.26; PAAVONEN J, 1985, AM J OBSTET GYNECOL, V152, P280, DOI 10.1016/S0002-9378(85)80210-6; Parks KS, 1997, SEX TRANSM DIS, V24, P229, DOI 10.1097/00007435-199704000-00008; Quinn TC, 1996, JAMA-J AM MED ASSOC, V276, P1737, DOI 10.1001/jama.276.21.1737; Rein DB, 2000, OBSTET GYNECOL, V95, P397, DOI 10.1016/S0029-7844(99)00551-7; Richey CM, 1999, SEX TRANSM DIS, V26, P4, DOI 10.1097/00007435-199901000-00002; Rietmeijer CA, 2002, SEX TRANSM DIS, V29, P65, DOI 10.1097/00007435-200202000-00001; Scholes D, 1996, NEW ENGL J MED, V334, P1362, DOI 10.1056/NEJM199605233342103; Schwebke JR, 1997, SEX TRANSM DIS, V24, P181, DOI 10.1097/00007435-199704000-00001; Shafer MAB, 1999, ARCH PEDIAT ADOL MED, V153, P119; *SIG HLTH CAR INF, 1994, MED REG GEP GEG 1993; SMITH TW, 1991, FAM PLANN PERSPECT, V23, P102, DOI 10.2307/2135820; STAMM WE, 1984, NEW ENGL J MED, V310, P545, DOI 10.1056/NEJM198403013100901; STEECE R, 1997, NATL PRICING CHLAMYD; Stephen EH, 2000, FAM PLANN PERSPECT, V32, P132, DOI 10.2307/2648162; Tao G, 2002, SEX TRANSM DIS, V29, P703, DOI 10.1097/00007435-200211000-00014; TEISALA K, 1987, OBSTET GYNECOL, V69, P343; *US CENS BUR, 2000, STAT ABSTR US  2000; *US DEP LAB BUR LA, 2003, 952 US DEP LAB BUR L; VISCIDI RP, 1993, J INFECT DIS, V168, P488, DOI 10.1093/infdis/168.2.488; WASHINGTON AE, 1991, JAMA-J AM MED ASSOC, V266, P2565, DOI 10.1001/jama.266.18.2565; WASHINGTON AE, 1984, JAMA-J AM MED ASSOC, V251, P2529, DOI 10.1001/jama.251.19.2529; WASHINGTON AE, 1986, JAMA-J AM MED ASSOC, V255, P1735, DOI 10.1001/jama.255.13.1735; Watson EJ, 2002, J MED MICROBIOL, V51, P1021, DOI 10.1099/0022-1317-51-12-1021; Welte R, 2000, SEX TRANSM DIS, V27, P518, DOI 10.1097/00007435-200010000-00005; WESTROM L, 1980, AM J OBSTET GYNECOL, V138, P880, DOI 10.1016/0002-9378(80)91077-7; WESTROM L, 1992, SEX TRANSM DIS, V19, P185, DOI 10.1097/00007435-199207000-00001; WESTROM LV, 1994, SEX TRANSM DIS, V21, pS32; Whittington WLH, 2001, SEX TRANSM DIS, V28, P117, DOI 10.1097/00007435-200102000-00011; Wiesenfeld HC, 2001, SEX TRANSM DIS, V28, P321, DOI 10.1097/00007435-200106000-00003; WOLNERHANSSEN P, 1983, OBSTET GYNECOL, V61, P702; Yeh JM, 2003, SEX TRANSM DIS, V30, P369, DOI 10.1097/00007435-200305000-00001; 1997, MMWR MORB MORTAL WKL, V46, P193	86	103	104	0	10	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 5	2004	141	7					501	513		10.7326/0003-4819-141-7-200410050-00006	http://dx.doi.org/10.7326/0003-4819-141-7-200410050-00006			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	862CR	15466767				2022-12-28	WOS:000224467800002
J	Richards, DA; Godfrey, L; Tawfik, J; Ryan, M; Meakins, J; Dutton, E; Miles, J				Richards, DA; Godfrey, L; Tawfik, J; Ryan, M; Meakins, J; Dutton, E; Miles, J			NHS Direct versus general practice based triage for same day appointments in primary care: cluster randomised controlled trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							NURSE TELEPHONE CONSULTATION; REQUESTS; WORKLOAD	Objective To assess the relative effects on consultation workload and costs of off-site triage by NHS Direct for patients requesting same day appointments compared with usual on-site nurse telephone triage in general practice. Design Cluster randomised controlled trial. Setting Three primary care sites in York, England. Participants 4703 patients: 2452 with practice based triage, 2251 with NHS Direct triage. All consecutive patients making requests for same day appointments during study weeks were eligible for the trial. Main outcome measures Type of consultation after request for same day appointment (telephone, appointment, or visit); time taken for consultation; service use during the month after same day contact; costs of same day, follow up, and emergency care. Results Patients in the NHS Direct group were less likely to have their call resolved by a nurse and were more likely to have an appointment with a general practitioner. Mean total time per patient in the NHS Direct group was 7.62 minutes longer than in the practice based group. Costs were greater in the NHS Direct group-pound2.88 (95% confidence interval pound0.88 to pound4.87) per patient triaged-as a result of the difference between the groups in proportions of patients at each final point of contact after triage. Conclusions External management of requests for same day appointments by nurse telephone triage through NHS Direct is possible but comes at a higher cost than practice nurse delivered triage in primary care. If NHS Direct could achieve the same proportions of consultation types as practice based triage, costs would be comparable.	Univ York, Dept Hlth Sci, York YO10 5DD, N Yorkshire, England; Priory Med Ctr, York YO24 3WX, N Yorkshire, England; TENYAS NHS Direct, Tees E&N Yorkshire Ambulance Serv, Kingston Upon Hull HU10 6HD, N Humberside, England	University of York - UK	Richards, DA (corresponding author), Univ York, Dept Hlth Sci, York YO10 5DD, N Yorkshire, England.	dr17@york.ac.uk	Richards, David/B-4807-2009	Richards, David/0000-0002-8821-5027				BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Gallagher M, 1998, BRIT J GEN PRACT, V48, P1141; Jones K, 1998, BRIT J GEN PRACT, V48, P1303; Lattimer V, 1998, BMJ-BRIT MED J, V317, P1054; Luthra M, 2001, BRIT J GEN PRACT, V51, P39; Munro J, 2000, BRIT MED J, V321, P150, DOI 10.1136/bmj.321.7254.150; Richards DA, 2002, BRIT MED J, V325, P1214, DOI 10.1136/bmj.325.7374.1214; RICHARDS DA, 2001, IN PRESS J ADV NURS; Thompson F, 1999, BMJ-BRIT MED J, V319, P1408, DOI 10.1136/bmj.319.7222.1408	9	22	22	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 2	2004	329	7469					774	777		10.1136/bmj.38226.605995.55	http://dx.doi.org/10.1136/bmj.38226.605995.55			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	859TW	15377574	Green Published, Bronze, Green Submitted			2022-12-28	WOS:000224291800021
J	Aida, M; Beis, D; Heidstra, R; Willemsen, V; Blilou, I; Galinha, C; Nussaume, L; Noh, YS; Amasino, R; Scheres, B				Aida, M; Beis, D; Heidstra, R; Willemsen, V; Blilou, I; Galinha, C; Nussaume, L; Noh, YS; Amasino, R; Scheres, B			The PLETHORA genes mediate patterning of the Arabidopsis root stem cell niche	CELL			English	Article							DEPENDENT AUXIN GRADIENTS; RADIAL ORGANIZATION; RESPONSE FACTORS; EMBRYO; MONOPTEROS; MERISTEM; TRANSCRIPTION; SCARECROW; MUTATION; THALIANA	A small organizing center, the quiescent center (QC), maintains stem cells in the Arabidopsis root and defines the stem cell niche. The phytohormone auxin influences the position of this niche by an unknown mechanism. Here, we identify the PLETHORA1 (PLT1) and PLT2 genes encoding AP2 class putative transcription factors, which are essential for QC specification and stem cell activity. The PLT genes are transcribed in response to auxin accumulation and are dependent on auxin response transcription factors. Distal PLT transcript accumulation creates an overlap with the radial expression domains of SHORT-ROOT and SCARECROW, providing positional information for the stem cell niche. Furthermore, the PLT genes are activated in the basal embryo region that gives rise to hypocotyl, root, and root stem cells and, when ectopically expressed, transform apical regions to these identities. Thus, the PLT genes are key effectors for establishment of the stem cell niche during embryonic pattern formation.	Univ Utrecht, Dept Mol Cell Biol, NL-3514 CH Utrecht, Netherlands; Univ Mediterranee, UMR 163 CNRS, CEA,DSVDEVM, LBDP, F-13108 St Paul Les Durance, France; Univ Wisconsin, Coll Agr & Life Sci, Dept Biochem, Madison, WI 53706 USA	Utrecht University; CEA; UDICE-French Research Universities; Aix-Marseille Universite; University of Wisconsin System; University of Wisconsin Madison	Scheres, B (corresponding author), Univ Utrecht, Dept Mol Cell Biol, Padualaan 8, NL-3514 CH Utrecht, Netherlands.	b.scheres@bio.uu.nl	NUSSAUME, Laurent/AAB-8312-2020; NUSSAUME, Laurent/AAA-5980-2022; Aida, Mitsuhiro/AAW-7703-2020	NUSSAUME, Laurent/0000-0002-9445-2563; Aida, Mitsuhiro/0000-0001-9000-7502; Blilou, Ikram/0000-0001-8003-3782; Beis, Dimitris/0000-0003-2579-7848; Scheres, Ben/0000-0001-5400-9578				Aida M, 2002, DEVELOPMENT, V129, P3965; Aida M, 1997, PLANT CELL, V9, P841, DOI 10.1105/tpc.9.6.841; BECHTOLD N, 1993, CR ACAD SCI III-VIE, V316, P1194; BENFEY PN, 1993, DEVELOPMENT, V119, P57; Benkova E, 2003, CELL, V115, P591, DOI 10.1016/S0092-8674(03)00924-3; BERLETH T, 1993, DEVELOPMENT, V118, P575; BRAND AH, 1993, DEVELOPMENT, V118, P401; Colon-Carmona A, 1999, PLANT J, V20, P503, DOI 10.1046/j.1365-313x.1999.00620.x; DiLaurenzio L, 1996, CELL, V86, P423, DOI 10.1016/S0092-8674(00)80115-4; Friml J, 2003, PLANT J, V34, P115, DOI 10.1046/j.1365-313X.2003.01705.x; Friml J, 2002, CELL, V108, P661, DOI 10.1016/S0092-8674(02)00656-6; Friml J, 2003, NATURE, V426, P147, DOI 10.1038/nature02085; Fukaki H, 1998, PLANT J, V14, P425, DOI 10.1046/j.1365-313X.1998.00137.x; Fukaki H, 2002, PLANT J, V29, P153, DOI 10.1046/j.0960-7412.2001.01201.x; Hamann T, 1999, DEVELOPMENT, V126, P1387; Hamann T, 2002, GENE DEV, V16, P1610, DOI 10.1101/gad.229402; Hardtke CS, 2004, DEVELOPMENT, V131, P1089, DOI 10.1242/dev.00925; Hardtke CS, 1998, EMBO J, V17, P1405, DOI 10.1093/emboj/17.5.1405; Helariutta Y, 2000, CELL, V101, P555, DOI 10.1016/S0092-8674(00)80865-X; Hellens RP, 2000, PLANT MOL BIOL, V42, P819, DOI 10.1023/A:1006496308160; Hellmann H, 2003, EMBO J, V22, P3314, DOI 10.1093/emboj/cdg335; Hobbie L, 2000, DEVELOPMENT, V127, P23; Laux T, 2003, CELL, V113, P281, DOI 10.1016/S0092-8674(03)00312-X; Mayer KFX, 1998, CELL, V95, P805, DOI 10.1016/S0092-8674(00)81703-1; MORRISON JFJ, 1995, PCR 2 PRACTICAL APPR, P165; Nakajima K, 2001, NATURE, V413, P307, DOI 10.1038/35095061; Parinov S, 1999, PLANT CELL, V11, P2263, DOI 10.1105/tpc.11.12.2263; Reinhardt D, 2003, NATURE, V426, P255, DOI 10.1038/nature02081; Riechmann JL, 1998, BIOL CHEM, V379, P633; Sabatini S, 1999, CELL, V99, P463, DOI 10.1016/S0092-8674(00)81535-4; Sabatini S, 2003, GENE DEV, V17, P354, DOI 10.1101/gad.252503; SCHERES B, 1995, DEVELOPMENT, V121, P53; SCHERES B, 1994, DEVELOPMENT, V120, P2475; Schomburg FM, 2003, PLANT CELL, V15, P151, DOI 10.1105/tpc.005975; Spradling A, 2001, NATURE, V414, P98, DOI 10.1038/35102160; Swarup R, 2001, GENE DEV, V15, P2648, DOI 10.1101/gad.210501; Ulmasov T, 1999, P NATL ACAD SCI USA, V96, P5844, DOI 10.1073/pnas.96.10.5844; Ulmasov T, 1997, PLANT CELL, V9, P1963, DOI 10.1105/tpc.9.11.1963; vandenBerg C, 1997, NATURE, V390, P287, DOI 10.1038/36856; Wada T, 1997, SCIENCE, V277, P1113, DOI 10.1126/science.277.5329.1113; Weigel D, 2002, NATURE, V415, P751, DOI 10.1038/415751a; Weijers D, 2001, DEVELOPMENT, V128, P4289; Willemsen V, 1998, DEVELOPMENT, V125, P521; Wysocka-Diller JW, 2000, DEVELOPMENT, V127, P595	45	777	842	7	173	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 1	2004	119	1					109	+		10.1016/j.cell.2004.09.018	http://dx.doi.org/10.1016/j.cell.2004.09.018			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	859UE	15454085	Green Published, Bronze			2022-12-28	WOS:000224292600013
J	Fujita, N; Jaye, DL; Geigerman, C; Akyildiz, A; Mooney, MR; Boss, JM; Wade, PA				Fujita, N; Jaye, DL; Geigerman, C; Akyildiz, A; Mooney, MR; Boss, JM; Wade, PA			MTA3 and the Mi-2/NuRD complex regulate cell fate during B lymphocyte differentiation	CELL			English	Article							CLASS-II TRANSACTIVATOR; N-COR; HISTONE DEACETYLASE; PLASMA-CELLS; TRANSCRIPTIONAL REPRESSION; COREPRESSOR COMPLEX; GENE-EXPRESSION; POZ DOMAIN; BCL-6; SMRT	The transcriptional repressor BCL-6 regulates B lymphocyte cell fate during the germinal center reaction by preventing terminal differentiation of B lymphocytes into plasma cells until appropriate signals are received. Here, we report a cofactor, MTA3, a cell type-specific subunit of the corepressor complex Mi-2/ NuRD, for BCL-6-dependent cell fate determination. MTA3 is expressed in the same pattern in germinal centers as BCL-6. BCL-6 physically interacts with Mi-2/NuRD and this interaction is sensitive to BCL-6 acetylation status. Depletion of MTA3 by RNAi impairs BCL-6-dependent repression and alters the cell-specific transcriptional pattern characteristic of the B lymphocyte. Remarkably, exogenous expression of BCL-6 in a plasma cell line leads, in an MTA3-dependent manner, to repression of plasma cell-specific transcripts, reactivation of the B cell transcriptional program, expression of B lymphocyte cell surface markers, and reprogramming of cell fate.	Emory Univ, Sch Med, Dept Pathol & Lab Med, Atlanta, GA 30322 USA; Emory Univ, Sch Med, Div Hematopathol, Atlanta, GA 30322 USA; Emory Univ, Sch Med, Winship Canc Inst, Atlanta, GA 30322 USA; Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA	Emory University; Emory University; Emory University; Emory University	Wade, PA (corresponding author), Emory Univ, Sch Med, Dept Pathol & Lab Med, Atlanta, GA 30322 USA.	pwade@emory.edu	Wade, Paul A/D-2374-2019	Wade, Paul A/0000-0002-6042-357X; jaye, david/0000-0001-7977-6909	NIAID NIH HHS [AI34000] Funding Source: Medline; NIDDK NIH HHS [DK065961, DK60647] Funding Source: Medline; NIGMS NIH HHS [GM47310, GM20675] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI034000, R01AI034000, R56AI034000] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK060647, R01DK065961] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES101965] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047310] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ABTS H, 1989, J IMMUNOL METHODS, V125, P19, DOI 10.1016/0022-1759(89)90073-2; ACCOLLA RS, 1983, J EXP MED, V157, P1053, DOI 10.1084/jem.157.3.1053; Ahmad KF, 2003, MOL CELL, V12, P1551, DOI 10.1016/S1097-2765(03)00454-4; Bereshchenko OR, 2002, NAT GENET, V32, P606, DOI 10.1038/ng1018; Bishop GA, 2003, CRIT REV IMMUNOL, V23, P149, DOI 10.1615/CritRevImmunol.v23.i3.10; Boss JM, 2003, CURR OPIN IMMUNOL, V15, P105, DOI 10.1016/S0952-7915(02)00015-8; Bowen NJ, 2004, BBA-GENE STRUCT EXPR, V1677, P52, DOI 10.1016/j.bbaexp.2003.10.010; Calame KL, 2003, ANNU REV IMMUNOL, V21, P205, DOI 10.1146/annurev.immunol.21.120601.141138; Coffee B, 1999, NAT GENET, V22, P98, DOI 10.1038/8807; Dhordain P, 1997, P NATL ACAD SCI USA, V94, P10762, DOI 10.1073/pnas.94.20.10762; Dhordain P, 1998, NUCLEIC ACIDS RES, V26, P4645, DOI 10.1093/nar/26.20.4645; EPSTEIN MA, 1966, J NATL CANCER I, V37, P547; Fujita N, 2003, CELL, V113, P207, DOI 10.1016/S0092-8674(03)00234-4; GAZDAR AF, 1986, BLOOD, V67, P1542; Gyory I, 2004, NAT IMMUNOL, V5, P299, DOI 10.1038/ni1046; HARRIS NS, 1974, NATURE, V250, P507, DOI 10.1038/250507a0; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Huynh KD, 1998, ONCOGENE, V17, P2473, DOI 10.1038/sj.onc.1202197; Huynh KD, 2000, GENE DEV, V14, P1810; Ivanov AI, 2004, MOL BIOL CELL, V15, P176, DOI 10.1091/mbc.E03-05-0319; Jaskelioff M, 2003, NAT CELL BIOL, V5, P395, DOI 10.1038/ncb0503-395; Jaye DL, 2003, AM J PATHOL, V162, P1419, DOI 10.1016/S0002-9440(10)64275-7; Jaye DL, 2001, J IMMUNOL, V166, P7250, DOI 10.4049/jimmunol.166.12.7250; KLEIN G, 1975, INTERVIROLOGY, V5, P319, DOI 10.1159/000149930; Landry J, 2000, BIOCHEM BIOPH RES CO, V278, P685, DOI 10.1006/bbrc.2000.3854; Leon RP, 1998, P NATL ACAD SCI USA, V95, P13159, DOI 10.1073/pnas.95.22.13159; Li JW, 2000, EMBO J, V19, P4342, DOI 10.1093/emboj/19.16.4342; Lin KI, 2003, IMMUNOL REV, V194, P19, DOI 10.1034/j.1600-065X.2003.00040.x; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; McHeyzer-Williams LJ, 2001, CURR OPIN HEMATOL, V8, P52, DOI 10.1097/00062752-200101000-00010; MONOD J, 1961, COLD SPRING HARB SYM, V26, P389, DOI 10.1101/SQB.1961.026.01.048; MuhlethalerMOttet A, 1997, EMBO J, V16, P2851, DOI 10.1093/emboj/16.10.2851; Nagarajan UM, 2002, J IMMUNOL, V169, P5078, DOI 10.4049/jimmunol.169.9.5078; NILSSON K, 1970, CLIN EXP IMMUNOL, V7, P477; Niu HF, 2002, HEMATOL ONCOL, V20, P155, DOI 10.1002/hon.689; Piskurich JF, 2000, NAT IMMUNOL, V1, P526, DOI 10.1038/82788; Shaffer AL, 2002, NAT REV IMMUNOL, V2, P920, DOI 10.1038/nri953; Shaffer AL, 2000, IMMUNITY, V13, P199, DOI 10.1016/S1074-7613(00)00020-0; Shaffer AL, 2002, IMMUNITY, V17, P51, DOI 10.1016/S1074-7613(02)00335-7; Shapiro-Shelef M, 2003, IMMUNITY, V19, P607, DOI 10.1016/S1074-7613(03)00267-X; SLAVIN S, 1978, NATURE, V272, P624, DOI 10.1038/272624a0; Tachibana M, 2001, J BIOL CHEM, V276, P25309, DOI 10.1074/jbc.M101914200; Ting JPY, 2002, CELL, V109, pS21, DOI 10.1016/S0092-8674(02)00696-7; Underhill C, 2000, J BIOL CHEM, V275, P40463, DOI 10.1074/jbc.M007864200; UNKELESS JC, 1979, J EXP MED, V150, P580, DOI 10.1084/jem.150.3.580; Urnov FD, 2000, EMBO J, V19, P4074, DOI 10.1093/emboj/19.15.4074; Wang LL, 2001, ONCOGENE, V20, P3716, DOI 10.1038/sj.onc.1204479; WEINTRAUB H, 1991, SCIENCE, V251, P761, DOI 10.1126/science.1846704; Wen YD, 2000, P NATL ACAD SCI USA, V97, P7202, DOI 10.1073/pnas.97.13.7202; Wong CW, 1998, J BIOL CHEM, V273, P27695, DOI 10.1074/jbc.273.42.27695; YE BHH, 1993, CANCER RES, V53, P2732; YOSHIDA M, 1990, J BIOL CHEM, V265, P17174; ZECH L, 1976, INT J CANCER, V17, P47, DOI 10.1002/ijc.2910170108; Zhang H, 2001, BBA-MOL CELL RES, V1540, P188, DOI 10.1016/S0167-4889(01)00128-8	54	260	277	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 1	2004	119	1					75	86		10.1016/j.cell.2004.09.014	http://dx.doi.org/10.1016/j.cell.2004.09.014			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	859UE	15454082	Bronze			2022-12-28	WOS:000224292600010
J	Lee, CTA				Lee, CTA			Are Earth's core and mantle on speaking terms?	SCIENCE			English	Editorial Material									Rice Univ, Dept Earth Sci, Houston, TX 77005 USA	Rice University	Lee, CTA (corresponding author), Rice Univ, Dept Earth Sci, Houston, TX 77005 USA.	ctlee@rice.edu	Lee, Cin-Ty/A-5469-2008; Lee, Cin-Ty/AAV-8155-2021	Lee, Cin-Ty/0000-0002-3586-0110				Brandon AD, 1998, SCIENCE, V280, P1570, DOI 10.1126/science.280.5369.1570; Garnero EJ, 2004, SCIENCE, V304, P834, DOI 10.1126/science.1097849; Humayun M, 2004, SCIENCE, V306, P91, DOI 10.1126/science.1101050; MCDONOUGH WF, 1995, CHEM GEOL, V120, P223, DOI 10.1016/0009-2541(94)00140-4; Ravizza G, 2001, EARTH PLANET SC LETT, V188, P369, DOI 10.1016/S0012-821X(01)00337-5; Schersten A, 2004, NATURE, V427, P234, DOI 10.1038/nature02221	6	40	42	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 1	2004	306	5693					64	65		10.1126/science.1102976	http://dx.doi.org/10.1126/science.1102976			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	859YJ	15459375				2022-12-28	WOS:000224304000032
J	Addo-Yobo, E; Chisaka, N; Hassan, M; Hibberd, P; Lozano, JM; Jeena, P; MacLeod, WB; Maulen, I; Patel, A; Qazi, S; Thea, DM; Nguyen, NTV				Addo-Yobo, E; Chisaka, N; Hassan, M; Hibberd, P; Lozano, JM; Jeena, P; MacLeod, WB; Maulen, I; Patel, A; Qazi, S; Thea, DM; Nguyen, NTV		APPIS grp	Oral amoxicillin versus injectable penicillin for severe pneumonia in children aged 3 to 59 months: a randomised multicentre equivalency study	LANCET			English	Article; Proceedings Paper	2nd International Conference on Improving Use of Medicines	MAR 30-APR 02, 2004	Chiang Mai, THAILAND				ACUTE RESPIRATORY-INFECTIONS; ACUTE OTITIS-MEDIA; COMMUNITY-ACQUIRED PNEUMONIA; SYNCYTIAL VIRUS-INFECTION; DEVELOPING-COUNTRIES; CHILDHOOD PNEUMONIA; CLINICAL EFFICACY; TRACT INFECTION; CASE-MANAGEMENT; ETIOLOGY	Background Injectable penicillin is the recommended treatment for WHO-defined severe pneumonia (lower chest indrawing). If oral amoxicillin proves equally effective, it could reduce referral, admission, and treatment costs. We aimed to determine whether oral amoxicillin and parenteral penicillin were equivalent in the treatment of severe pneumonia in children aged 3-59 months. Methods This multicentre, randomised, open-label equivalency study was undertaken at tertiary-care centres in eight developing countries in Africa, Asia, and South America. Children aged 3-59 months with severe pneumonia were admitted for 48 h and, if symptoms improved, were discharged with a 5-day course of oral amoxicillin. 1702 children were randomly allocated to receive either oral amoxicillin (n = 857) or parenteral penicillin (n = 845) for 48 h. Follow-up assessments were done at 5 and 14 days after enrolment. Primary outcome was treatment failure (persistence of lower chest indrawing or new danger signs) at 48 h. Analyses were by intention-to-treat and per protocol. Findings Treatment failure was 19% in each group (161 patients, pencillin; 167 amoxillin; risk difference -0.4%; 95% CI-4.2 to 3.3) at 48 h. Infancy (age 3-11 months; odds ratio 2.72, 95% CI 1.95 to 3.79), very fast breathing (1.94, 1.42 to 2.65), and hypoxia (1.95, 1.34 to 2.82) at baseline predicted treatment failure by multivariate analysis. Interpretation Injectable penicillin and oral amoxicillin are equivalent for severe pneumonia treatment in controlled settings. Potential benefits of oral treatment include decreases in (1) risk of needle-borne infections; (2) need for referral or admission; (3) administration costs; and (4) costs to the family.	WHO, Dept Child & Adolescent Hlth & Dev, CH-1211 Geneva 27, Switzerland; Boston Univ, ARCH Project, Boston, MA 02215 USA	University of Geneva; World Health Organization; Boston University	Qazi, S (corresponding author), WHO, Dept Child & Adolescent Hlth & Dev, CH-1211 Geneva 27, Switzerland.	qazis@who.int		Hibberd, Patricia/0000-0002-7455-8117; Thea, Donald/0000-0002-6933-1030; MacLeod, William/0000-0001-8003-8874				[Anonymous], 1994, MMWR Recomm Rep, V43, P1; Chan PWK, 2002, PEDIATR PULM, V34, P47, DOI 10.1002/ppul.10095; Chintu C, 2002, LANCET, V360, P985, DOI 10.1016/S0140-6736(02)11082-8; Chow SC, 2002, CONTROL CLIN TRIALS, V23, P515, DOI 10.1016/S0197-2456(02)00222-2; Dagan R, 2002, PEDIATR INFECT DIS J, V21, P894, DOI 10.1097/00006454-200210000-00003; Delport SD, 2002, SAMJ S AFR MED J, V92, P907; FORGIE IM, 1992, PEDIATR INFECT DIS J, V11, P466, DOI 10.1097/00006454-199206000-00009; FORREST KV, 2003, MANUAL CLIN MICROBIO; GHAFOOR A, 1990, REV INFECT DIS S14, V12; Hazir T, 2002, LANCET, V360, P835; HIETALA J, 1989, PEDIATR INFECT DIS J, V8, P683, DOI 10.1097/00006454-198910000-00004; Hussey GD, 2000, S AFR MED J, V90, P509; Juven T, 2000, PEDIATR INFECT DIS J, V19, P293, DOI 10.1097/00006454-200004000-00006; KORPPI M, 1989, PEDIATR INFECT DIS J, V8, P687, DOI 10.1097/00006454-198910000-00005; Marchant CD, 2002, PEDIATR INFECT DIS J, V21, P891, DOI 10.1097/00006454-200210000-00002; MARCHANT CD, 1992, J PEDIATR-US, V120, P72, DOI 10.1016/S0022-3476(05)80601-8; MATHERS CD, 2001, GLOBAL BURDEN DIS 20; Mulholland K, 1999, LANCET, V354, P590, DOI 10.1016/S0140-6736(98)10238-6; Nascimento-Carvalho Cristiana M C, 2002, Indian Pediatr, V39, P205; OBRIEN PC, 1984, BIOMETRICS, V40, P1079, DOI 10.2307/2531158; OBRIEN PC, 1979, BIOMETRICS, V35, P549, DOI 10.2307/2530245; Pepin J, 2001, T ROY SOC TROP MED H, V95, P410, DOI 10.1016/S0035-9203(01)90199-3; Qazi SA, 2002, ARCH DIS CHILD, V86, P113, DOI 10.1136/adc.86.2.113; Qazi SA, 1996, B WORLD HEALTH ORGAN, V74, P501; QAZI SA, 1995, REDUCTION ACUTE RESP; Sazawal S, 2003, LANCET INFECT DIS, V3, P547, DOI 10.1016/S1473-3099(03)00737-0; Sehgal V, 1997, Indian Pediatr, V34, P213; SHANN F, 1989, PEDIATR INFECT DIS J, V8, P852, DOI 10.1097/00006454-198912000-00005; SHANN F, 1986, PEDIATR INFECT DIS J, V5, P247, DOI 10.1097/00006454-198603000-00017; Stensballe LG, 2003, PEDIATR INFECT DIS J, V22, pS21, DOI 10.1097/00006454-200302001-00004; Straus WL, 1998, LANCET, V352, P270, DOI 10.1016/S0140-6736(97)10294-X; TUPASI TE, 1990, REV INFECT DIS, V12, pS929; TUPASI TE, 1988, J INFECT DIS, V157, P615, DOI 10.1093/infdis/157.4.615; USHA N, 1990, TROP DOCT, V20, P158, DOI 10.1177/004947559002000405; Weber MW, 1998, TROP MED INT HEALTH, V3, P268, DOI 10.1046/j.1365-3156.1998.00213.x; *WHO, 2003, WHOFCHCAH042; *WHO, BRONCH OTH MED TREAT; Williams BG, 2002, LANCET INFECT DIS, V2, P25, DOI 10.1016/S1473-3099(01)00170-0; World Health Organization, 1990, 5 WHO; Zar H J, 2001, SADJ, V56, P617	40	135	136	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 25	2004	364	9440					1141	1148		10.1016/S0140-6736(04)17100-6	http://dx.doi.org/10.1016/S0140-6736(04)17100-6			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	857FT	15451221				2022-12-28	WOS:000224102400027
J	Lundin, R; Barabash, S; Andersson, H; Holmstrom, M; Grigoriev, A; Yamauchi, M; Sauvaud, JA; Fedorov, A; Budnik, E; Thocaven, JJ; Winningham, D; Frahm, R; Scherrer, J; Sharber, J; Asamura, K; Hayakawa, H; Coates, A; Linder, DR; Curtis, C; Hsieh, KC; Sandel, BR; Grande, M; Carter, M; Reading, DH; Koskinen, H; Kallio, E; Riihela, P; Schmidt, W; Sales, T; Kozyra, J; Krupp, N; Woch, J; Luhmann, J; McKenna-Lawler, S; Ceruw-Irelli, R; Orsini, S; Maggi, M; Mura, A; Milillo, A; Roelof, E; Williams, D; Livi, S; Brandt, P; Wurz, P; Bochslers, P				Lundin, R; Barabash, S; Andersson, H; Holmstrom, M; Grigoriev, A; Yamauchi, M; Sauvaud, JA; Fedorov, A; Budnik, E; Thocaven, JJ; Winningham, D; Frahm, R; Scherrer, J; Sharber, J; Asamura, K; Hayakawa, H; Coates, A; Linder, DR; Curtis, C; Hsieh, KC; Sandel, BR; Grande, M; Carter, M; Reading, DH; Koskinen, H; Kallio, E; Riihela, P; Schmidt, W; Sales, T; Kozyra, J; Krupp, N; Woch, J; Luhmann, J; McKenna-Lawler, S; Ceruw-Irelli, R; Orsini, S; Maggi, M; Mura, A; Milillo, A; Roelof, E; Williams, D; Livi, S; Brandt, P; Wurz, P; Bochslers, P			Solar wind-induced atmospheric erosion at Mars: First results from ASPERA-3 on Mars Express	SCIENCE			English	Article							MAG/ER EXPERIMENT; GLOBAL SURVEYOR; IONOSPHERE; ESCAPE; VENUS	The Analyzer of Space Plasma and Energetic Atoms (ASPERA) on board the Mars Express spacecraft found that solar wind plasma and accelerated ionospheric ions may be observed all the way down to the Mars Express pericenter of 270 kilometers above the dayside planetary surface. This is very deep in the ionosphere, implying direct exposure of the martian topside atmosphere to solar wind plasma forcing. The low-altitude penetration of solar wind plasma and the energization of ionospheric plasma may be due to solar wind irregularities or perturbations, to magnetic anomalies at Mars, or both.	Swedish Inst Space Phys, S-98128 Kiruna, Sweden; Ctr Etud Spatiale Rayonnements, F-31028 Toulouse, France; SW Res Inst, San Antonio, TX 78228 USA; Inst Space & Astronaut Sci, Sagamihara, Japan; UCL, Mullard Space Sci Lab, Dorking RH5 6NT, Surrey, England; Univ Arizona, Tucson, AZ 85721 USA; Rutherford Appleton Lab, Didcot OX11 0QX, Oxon, England; Finnish Meteorol Inst, FIN-00101 Helsinki, Finland; Univ Michigan, Space Phys Res Lab, Ann Arbor, MI 48109 USA; Max Planck Inst Sonnensyst Forsch, D-37191 Katlenburg Lindau, Germany; Univ Calif Berkeley, Space Sci Lab, Berkeley, CA 94720 USA; Natl Univ Ireland, Space Technol Ltd, Maynooth, Kildare, Ireland; Inst Fis Spazio Interplanetari, I-00133 Rome, Italy; Johns Hopkins Univ, Appl Phys Lab, Laurel, MD 20723 USA; Univ Bern, Inst Phys, CH-3012 Bern, Switzerland	Southwest Research Institute; Japan Aerospace Exploration Agency (JAXA); Institute of Space & Astronautical Science (ISAS); University of London; University College London; University of Arizona; UK Research & Innovation (UKRI); Science & Technology Facilities Council (STFC); STFC Rutherford Appleton Laboratory; Finnish Meteorological Institute; University of Michigan System; University of Michigan; Max Planck Society; University of California System; University of California Berkeley; Maynooth University; Johns Hopkins University; Johns Hopkins University Applied Physics Laboratory; University of Bern	Lundin, R (corresponding author), Swedish Inst Space Phys, Box 812, S-98128 Kiruna, Sweden.	rickard.lundin@irf.se	Wurz, Peter/R-2273-2017; Coates, Andrew/C-2396-2008; Kallio, Esa/F-9410-2014; kallio, esa/M-9541-2019; Roelof, Edmond/G-6654-2019; Brandt, Pontus C/N-1218-2016; Koskinen, Hannu E. J./B-4971-2017; Grande, Manuel/C-2242-2013; Mura, Alessandro/AAG-1885-2020	Wurz, Peter/0000-0002-2603-1169; Coates, Andrew/0000-0002-6185-3125; Kallio, Esa/0000-0002-9791-804X; kallio, esa/0000-0002-9791-804X; Roelof, Edmond/0000-0002-2270-0652; Brandt, Pontus C/0000-0002-4644-0306; Koskinen, Hannu E. J./0000-0003-3839-6461; Grande, Manuel/0000-0002-2233-2618; Mura, Alessandro/0000-0002-4552-4292; Milillo, Anna/0000-0002-0266-2556; asamura, kazushi/0000-0002-6076-3814				Acuna MH, 1999, SCIENCE, V284, P790, DOI 10.1126/science.284.5415.790; Amerstorfer U. V., 2003, INT J ASTROBIOL, V2, P195, DOI [10.1017/S1473550403001605, DOI 10.1017/S1473550403001605]; BARABASH SR, 2004, ESA SPECIAL PUBLICAT; Chassefiere E, 1996, ICARUS, V124, P537, DOI 10.1006/icar.1996.0229; Hanson W. B., 1977, Journal of Geophysical Research, V82, P4351, DOI 10.1029/JS082i028p04351; HOLMSTROM M, 2002, J GEOPHYS RES, V107, P1029; Kerr RA, 2000, SCIENCE, V289, P714, DOI 10.1126/science.289.5480.714; LUHMANN JG, 1987, J GEOPHYS RES, V92, P8545, DOI 10.1029/JA092iA08p08545; LUHMANN JG, 1992, GEOPHYS MONOGR SER, V66, P417, DOI DOI 10.1029/GM066P0417; LUNDIN R, 1989, NATURE, V341, P609, DOI 10.1038/341609a0; LUNDIN R, 1990, GEOPHYS RES LETT, V17, P873, DOI 10.1029/GL017i006p00873; Lundin R, 2001, SCIENCE, V291, P1909, DOI 10.1126/science.1059763; McElroy M. B., 1977, Journal of Geophysical Research, V82, P4379, DOI 10.1029/JS082i028p04379; MELOSH HJ, 1989, NATURE, V338, P487, DOI 10.1038/338487a0; Mitchell DL, 2001, J GEOPHYS RES-PLANET, V106, P23419, DOI 10.1029/2000JE001435; Nagy AF, 2001, J GEOPHYS RES-SPACE, V106, P21565, DOI 10.1029/2001JA000007; NORBERG O, 1992, P COSPAR C, V4, P299; Perez-de-Tejada H, 1998, J GEOPHYS RES-PLANET, V103, P31499, DOI 10.1029/1998JE900001; PEREZDETEJADA H, 1987, J GEOPHYS RES, V92, P4713, DOI 10.1029/JA092iA05p04713; Vignes D, 2000, GEOPHYS RES LETT, V27, P49, DOI 10.1029/1999GL010703	20	172	178	1	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 24	2004	305	5692					1933	1936		10.1126/science.1101860	http://dx.doi.org/10.1126/science.1101860			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	857RM	15448263				2022-12-28	WOS:000224136000039
J	Mortuza, GB; Haire, LF; Stevens, A; Smerdon, SJ; Stoye, JP; Taylor, IA				Mortuza, GB; Haire, LF; Stevens, A; Smerdon, SJ; Stoye, JP; Taylor, IA			High-resolution structure of a retroviral capsid hexameric amino-terminal domain	NATURE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; REVERSE TRANSCRIPTION COMPLEXES; MURINE LEUKEMIA-VIRUS; CA PROTEIN; HIV-1; CORE; REPLICATION; INFECTION; FRAGMENT; EXCHANGE	Retroviruses are the aetiological agents of a range of human diseases including AIDS and T-cell leukaemias. They follow complex life cycles, which are still only partly understood at the molecular level. Maturation of newly formed retroviral particles is an essential step in production of infectious virions, and requires proteolytic cleavage of Gag polyproteins in the immature particle to form the matrix, capsid and nucleocapsid proteins present in the mature virion(1). Capsid proteins associate to form a dense viral core(2) that may be spherical, cylindrical or conical depending on the genus of the virus(3). Nonetheless, these assemblies all appear to be composed of a lattice formed from hexagonal rings, each containing six capsid monomers(2,4,5). Here, we describe the X-ray structure of an individual hexagonal assembly from N-tropic murine leukaemia virus (N-MLV). The interface between capsid monomers is generally polar, consistent with weak interactions within the hexamer. Similar architectures are probably crucial for the regulation of capsid assembly and disassembly in all retroviruses. Together, these observations provide new insights into retroviral uncoating and how cellular restriction factors may interfere with viral replication.	Natl Inst Med Res, Div Prot Struct, London NW7 1AA, England; Natl Inst Med Res, Div Virol, London NW7 1AA, England	MRC National Institute for Medical Research; MRC National Institute for Medical Research	Taylor, IA (corresponding author), Natl Inst Med Res, Div Prot Struct, Mill Hill, London NW7 1AA, England.	itaylor@nimr.mrc.ac.uk		Stoye, Jonathan/0000-0003-3377-323X; Smerdon, Stephen/0000-0001-5688-8465				Best S, 1996, NATURE, V382, P826, DOI 10.1038/382826a0; BOONE LR, 1983, J VIROL, V48, P110, DOI 10.1128/JVI.48.1.110-119.1983; Briggs JAG, 2004, NAT STRUCT MOL BIOL, V11, P672, DOI 10.1038/nsmb785; Briggs JAG, 2003, EMBO J, V22, P1707, DOI 10.1093/emboj/cdg143; Cornilescu CC, 2001, J MOL BIOL, V306, P783, DOI 10.1006/jmbi.2000.4395; Cowtan K., 1994, JOINT CCP4 ESF EACBM, V31, P34; Fassati A, 2001, J VIROL, V75, P3626, DOI 10.1128/JVI.75.8.3626-3635.2001; Fassati A, 1999, J VIROL, V73, P8919, DOI 10.1128/JVI.73.11.8919-8925.1999; Forshey BM, 2002, J VIROL, V76, P5667, DOI 10.1128/JVI.76.11.5667-5677.2002; Gamble TR, 1996, CELL, V87, P1285, DOI 10.1016/S0092-8674(00)81823-1; Ganser BK, 2003, EMBO J, V22, P2886, DOI 10.1093/emboj/cdg276; Ganser-Pornillos BK, 2004, J VIROL, V78, P2545, DOI 10.1128/JVI.78.5.2545-2552.2004; Gitti RK, 1996, SCIENCE, V273, P231, DOI 10.1126/science.273.5272.231; Gross I, 1998, J VIROL, V72, P4798, DOI 10.1128/JVI.72.6.4798-4810.1998; Jin ZM, 1999, J MOL BIOL, V286, P83, DOI 10.1006/jmbi.1998.2443; KARAGEORGOS L, 1993, AIDS RES HUM RETROV, V9, P817, DOI 10.1089/aid.1993.9.817; Khorasanizadeh S, 1999, J MOL BIOL, V291, P491, DOI 10.1006/jmbi.1999.2986; Kingston RL, 2000, STRUCTURE, V8, P617, DOI 10.1016/S0969-2126(00)00148-9; Lanman J, 2004, NAT STRUCT MOL BIOL, V11, P676, DOI 10.1038/nsmb790; Lanman J, 2003, J MOL BIOL, V325, P759, DOI 10.1016/S0022-2836(02)01245-7; Li S, 2000, NATURE, V407, P409, DOI 10.1038/35030177; Morris RJ, 2003, METHOD ENZYMOL, V374, P229, DOI 10.1016/S0076-6879(03)74011-7; Nandhagopal N, 2004, J MOL BIOL, V335, P275, DOI 10.1016/j.jmb.2003.10.034; Nermut MV, 1996, CURR TOP MICROBIOL, V214, P1; Stremlau M, 2004, NATURE, V427, P848, DOI 10.1038/nature02343; Swanstrom R, 1997, RETROVIRUSES; Tang C, 2002, NAT STRUCT BIOL, V9, P537, DOI 10.1038/nsb806; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; von Schwedler UK, 2000, EMBO J, V19, P2391, DOI 10.1038/sj.emboj.7593063; von Schwedler UK, 2003, J VIROL, V77, P5439, DOI 10.1128/JVI.77.9.5439-5450.2003; von Schwedler UK, 1998, EMBO J, V17, P1555, DOI 10.1093/emboj/17.6.1555	31	161	162	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 23	2004	431	7007					481	485		10.1038/nature02915	http://dx.doi.org/10.1038/nature02915			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855UN	15386017				2022-12-28	WOS:000224000500047
J	Aktas, MK; Ozduran, V; Pothier, CE; Lang, R; Lauer, MS				Aktas, MK; Ozduran, V; Pothier, CE; Lang, R; Lauer, MS			Global risk scores and exercise testing for predicting all-cause mortality in a preventive medicine program	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CORONARY-HEART-DISEASE; HEALTH-CARE PROFESSIONALS; TREADMILL EXERCISE; RATE RECOVERY; PROGNOSTIC IMPLICATIONS; EUROPEAN POPULATIONS; AMERICAN-COLLEGE; DEATH; ASSOCIATION; STATEMENT	Context The usefulness of exercise stress test results and global cardiovascular risk systems for predicting all-cause mortality in asymptomatic individuals seen in clinical settings is unclear. Objectives To determine the validity for prediction of all-cause mortality of the Framingham Risk Score and of a recently described European global scoring system Systematic Coronary Risk Evaluation (SCORE) for cardiovascular mortality among asymptomatic individuals evaluated in a clinical setting and to determine the potential prognostic value of exercise stress testing once these baseline risks are known. Design, Setting, and Participants Prospective cohort study of 3554 asymptomatic adults between the ages of 50 and 75 years who underwent exercise stress testing as part of an executive health program between October 1990 and December 2002; participants were followed up for a mean of 8 years. Main Outcome Measures Global risk based on the Framingham Risk Score and the European SCORE. Prospectively recorded exercise stress test result abnormalities included impaired physical fitness, abnormal heart rate recovery, ventricular ectopy, and ST-segment abnormalities. The primary end point was all-cause mortality. Results There were 114 deaths. The c-index, which corresponds to receiver operating characteristic curve values, and the Akaike Information Criteria found that the European SCORE was superior to the Framingham Risk Score in estimating global mortality risk. In a multivariable model, independent predictors of death were a higher SCORE (for 1% predicted increase in absolute risk, relative risk [RR], 1.07; 95% confidence interval [CI], 1.04-1.09; P<.001), impaired functional capacity (RR, 2.95; 95% Cl, 1.98-4.39; P<.001), and an abnormal heart rate recovery (RR, 1.59; 95%, 1.04-2.41; P=.03). ST-segment depression did not predict mortality. Among patients in the highest tertile from the SCORE, an abnormal exercise stress test result, defined as either impaired functional capacity or an abnormal heart rate recovery, identified a mortality risk of more than 1% per year. Conclusion Exercise stress testing when combined with the European global risk SCORE may be useful for stratifying risk in asymptomtic individuals in a comprehensive executive health screening program.	Cleveland Clin Fdn, Dept Cardiovasc Med, Cleveland, OH 44195 USA; Cleveland Clin Fdn, Dept Med, Cleveland, OH 44195 USA; Cleveland Clin Fdn, Dept Gen Internal Med, Cleveland, OH 44195 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation	Lauer, MS (corresponding author), Cleveland Clin Fdn, Dept Cardiovasc Med, Desk F25,9500 Euclid Ave, Cleveland, OH 44195 USA.	Lauerm@ccf.org	Aktas, Mehmet Kemal/AAF-2164-2019; Lauer, Michael S/L-9656-2013	Aktas, Mehmet Kemal/0000-0002-9003-9384; Lauer, Michael S/0000-0002-9217-8177	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL066004] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL-66004] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		AKAIKE H, 1978, ANN I STAT MATH, V30, P9, DOI 10.1007/BF02480194; BOYLE CA, 1990, AM J EPIDEMIOL, V131, P160, DOI 10.1093/oxfordjournals.aje.a115470; Burnham KP., 2004, MODEL SELECTION MULT, V2, DOI 10.1007/b97636; Cole CR, 1999, NEW ENGL J MED, V341, P1351, DOI 10.1056/NEJM199910283411804; Conroy RM, 2003, EUR HEART J, V24, P987, DOI 10.1016/S0195-668X(03)00114-3; D'Agostino RB, 2001, JAMA-J AM MED ASSOC, V286, P180, DOI 10.1001/jama.286.2.180; FLETCHER GF, 1995, CIRCULATION, V91, P580, DOI 10.1161/01.CIR.91.2.580; Fowler-Brown Angela, 2004, Ann Intern Med, V140, pW9; Froelicher VF, 1998, ANN INTERN MED, V128, P965, DOI 10.7326/0003-4819-128-12_Part_1-199806150-00001; Frolkis JP, 2003, NEW ENGL J MED, V348, P781, DOI 10.1056/NEJMoa022353; Gibbons RJ, 2002, CIRCULATION, V106, P1883, DOI 10.1161/01.CIR.0000034670.06526.15; Goraya TY, 2000, ANN INTERN MED, V132, P862, DOI 10.7326/0003-4819-132-11-200006060-00003; Gottlieb SS, 1997, LANCET, V349, P662, DOI 10.1016/S0140-6736(97)22010-6; Greenland P, 2001, CIRCULATION, V104, P1863, DOI 10.1161/hc4201.097189; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Grundy SM, 1999, CIRCULATION, V100, P1481, DOI 10.1161/01.CIR.100.13.1481; Gulati M, 2003, CIRCULATION, V108, P1554, DOI 10.1161/01.CIR.0000091080.57509.E9; Haq IU, 1999, HEART, V81, P40, DOI 10.1136/hrt.81.1.40; HARRELL FE, 1984, STAT MED, V3, P143, DOI 10.1002/sim.4780030207; HARRELL FE, 1982, JAMA-J AM MED ASSOC, V247, P2543, DOI 10.1001/jama.247.18.2543; HARRELL FE, 2001, REGRESSION MODELING, P493; Hawthorne V, 2002, HEART, V88, P222; ISHWARAN H, IN PRESS J AM STAT A; Lauer MS, 1999, J AM COLL CARDIOL, V34, P618, DOI 10.1016/S0735-1097(99)00250-8; Lauer MS, 1996, CIRCULATION, V93, P1520, DOI 10.1161/01.CIR.93.8.1520; LAUER MS, 1995, J AM COLL CARDIOL, V26, P1630, DOI 10.1016/0735-1097(95)00388-6; Lauer MS, 2002, NEW ENGL J MED, V346, P1468, DOI 10.1056/NEJMcp012672; Lloyd-Jones DM, 1998, ANN INTERN MED, V129, P1020, DOI 10.7326/0003-4819-129-12-199812150-00005; Marwick TH, 1997, J AM COLL CARDIOL, V30, P83, DOI 10.1016/S0735-1097(97)00148-4; Menotti A, 2000, HEART, V84, P238, DOI 10.1136/heart.84.3.238; Mora S, 2003, JAMA-J AM MED ASSOC, V290, P1600, DOI 10.1001/jama.290.12.1600; Newman TB, 1997, J AM MED INFORM ASSN, V4, P233, DOI 10.1136/jamia.1997.0040233; Nishime EO, 2000, JAMA-J AM MED ASSOC, V284, P1392, DOI 10.1001/jama.284.11.1392; Snader CE, 1997, J AM COLL CARDIOL, V30, P641, DOI 10.1016/S0735-1097(97)00217-9; Topol EJ, 2003, LANCET, V362, P1776, DOI 10.1016/S0140-6736(03)14941-0; Watanabe J, 2001, CIRCULATION, V104, P1911, DOI 10.1161/circ.104.16.1911; Wei M, 1999, JAMA-J AM MED ASSOC, V282, P1547, DOI 10.1001/jama.282.16.1547; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837	38	139	148	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 22	2004	292	12					1462	1468		10.1001/jama.292.12.1462	http://dx.doi.org/10.1001/jama.292.12.1462			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	856FT	15383517	Bronze			2022-12-28	WOS:000224031800028
J	Bergman, GJD; Winters, JC; Groenier, KH; Pool, JJM; Meyboom-de Jong, B; Postema, K; van der Heijden, GJMG				Bergman, GJD; Winters, JC; Groenier, KH; Pool, JJM; Meyboom-de Jong, B; Postema, K; van der Heijden, GJMG			Manipulative therapy in addition to usual medical care for patients with shoulder dysfunction and pain - A randomized, controlled trial	ANNALS OF INTERNAL MEDICINE			English	Article							CERVICOTHORACIC MOTION SEGMENT; GENERAL-PRACTICE; FUNCTIONAL STATUS; COMPLAINTS; DISORDERS; QUESTIONNAIRE; PHYSIOTHERAPY; MOBILITY; DESIGN	Background: Dysfunction of the cervicothoracic spine and the adjacent ribs (also called the shoulder girdle) is considered to predict occurrence and poor outcome of shoulder symptoms. it can be treated with manipulative therapy, but scientific evidence for the effectiveness of such therapy is lacking. Objective: To study the effectiveness of manipulative therapy for the shoulder girdle in addition to usual medical care for relief of shoulder pain and dysfunction. Design: Randomized, controlled trial. Setting: General practices in Groningen, the Netherlands. Patients: 150 patients with shoulder symptoms and dysfunction of the shoulder girdle. Interventions: All patients received usual medical care from their general practitioners. Only the intervention group received additional manipulative therapy, up to 6 treatment sessions in a 12-week period. Measurements: Patient-perceived recovery, severity of the main complaint, shoulder pain, shoulder disability, and general health. Data were collected during and at the end of the treatment period (at 6 and 12 weeks) and during the follow-up period (at 26 and 52 weeks). Results: During treatment (6 weeks), no significant differences were found between study groups. After completion of treatment (12 weeks), 43% of the intervention group and 21% of the control group reported full recovery. After 52 weeks, approximately the same difference in recovery rate (17 percentage points) was seen between groups. During the intervention and follow-up periods, a consistent between-group difference in severity of the main complaint, shoulder pain and disability, and general health favored additional manipulative therapy. Limitations: The sample size was small, and assessment of end points was subjective. Conclusion: manipulative therapy for the shoulder girdle in addition to usual medical care accelerates recovery of shoulder symptoms.	Univ Groningen, Dept Gen Practice, NL-9700 AD Groningen, Netherlands; Univ Groningen Hosp, Groningen, Netherlands; Maastricht Univ, Maastricht, Netherlands; Vrije Univ Amsterdam, Ctr Med, NL-1081 HV Amsterdam, Netherlands; Univ Utrecht, Ctr Med, Utrecht, Netherlands	University of Groningen; University of Groningen; Maastricht University; Vrije Universiteit Amsterdam; Utrecht University	Bergman, GJD (corresponding author), Univ Groningen, Dept Gen Practice, POB 196, NL-9700 AD Groningen, Netherlands.	g.j.d.bergman@med.rug.nl	van der Heijden, Geert/M-3733-2013	van der Heijden, Geert/0000-0003-4979-2099				Bergman GJD, 2002, J MANIP PHYSIOL THER, V25, P543, DOI 10.1067/mmt.2002.128373; Beurskens AJ, 1999, J MANIP PHYSIOL THER, V22, P144, DOI 10.1016/S0161-4754(99)70127-2; Cyriax JH, 1982, TXB ORTHOPAEDIC MED; Dolan P, 1997, MED CARE, V35, P1095, DOI 10.1097/00005650-199711000-00002; Goossens MEJB, 2000, J CLIN EPIDEMIOL, V53, P688, DOI 10.1016/S0895-4356(99)00177-8; Greenman P., 1996, PRINCIPLES MANUAL ME; Lewit K, 1999, MANIPULATIVE THERAPY; Moher D, 2001, LANCET, V357, P1191, DOI 10.1016/S0140-6736(00)04337-3; Norlander S, 1997, SCAND J REHABIL MED, V29, P167; Norlander S, 1996, SCAND J REHABIL MED, V28, P183; PICAVET HS, 2000, 266807002 RIVM NAT I; Picavet HSJ, 2003, PAIN, V102, P167, DOI 10.1016/S0304-3959(02)00372-X; Sobel J S, 1996, J Manipulative Physiol Ther, V19, P469; SOBEL JS, 1995, HUISARTS WET, V38, P342; van der Heijden GJMG, 1999, BEST PRACT RES CL RH, V13, P287, DOI 10.1053/berh.1999.0021; van der Heijden GJMG, 2000, J CLIN EPIDEMIOL, V53, P29, DOI 10.1016/S0895-4356(99)00078-5; Van der Windt DAWM, 2000, BRIT J GEN PRACT, V50, P371; vanderWindt DAWM, 1996, BRIT J GEN PRACT, V46, P519; VANDERWINDT DAWM, 1995, ANN RHEUM DIS, V54, P959, DOI 10.1136/ard.54.12.959; Winters JC, 1996, SCAND J REHABIL MED, V28, P163; Winters JC, 1997, BRIT MED J, V314, P1320, DOI 10.1136/bmj.314.7090.1320; Winters JC, 1999, RHEUMATOLOGY, V38, P160, DOI 10.1093/rheumatology/38.2.160; Winters JC, 1999, BRIT MED J, V318, P1395, DOI 10.1136/bmj.318.7195.1395; WINTERS JC, 1999, HUISARTS WET, V42, P222; Wright CC, 2003, J CLIN EPIDEMIOL, V56, P833, DOI 10.1016/S0895-4356(03)00155-0	25	107	107	1	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 21	2004	141	6					432	439		10.7326/0003-4819-141-6-200409210-00008	http://dx.doi.org/10.7326/0003-4819-141-6-200409210-00008			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	856TM	15381516				2022-12-28	WOS:000224067900003
J	Verheugt, FWA				Verheugt, FWA			Lyse now, stent later: the grace of GRACIA	LANCET			English	Editorial Material							ACUTE MYOCARDIAL-INFARCTION; PRIMARY ANGIOPLASTY; THROMBOLYTIC THERAPY; REOCCLUSION		Univ Med Ctr, Dept Cardiol 540, Ctr Heart, NL-6500 HB Nijmegen, Netherlands	Radboud University Nijmegen	Verheugt, FWA (corresponding author), Univ Med Ctr, Dept Cardiol 540, Ctr Heart, NL-6500 HB Nijmegen, Netherlands.	f.verheugt@cardio.umcn.nl	Verheugt, F.W.A./H-8105-2014					Antman EM, 1999, CIRCULATION, V99, P2720, DOI 10.1161/01.CIR.99.21.2720; Ellis SG, 2000, AM HEART J, V139, P1046, DOI 10.1067/mhj.2000.106624; Keeley EC, 2003, LANCET, V361, P13, DOI 10.1016/S0140-6736(03)12113-7; KIM CB, 1993, CIRCULATION, V88, P2426, DOI 10.1161/01.CIR.88.5.2426; Liem A, 2000, J AM COLL CARDIOL, V35, P600, DOI 10.1016/S0735-1097(99)00597-5; MICHELS KB, 1995, CIRCULATION, V91, P476, DOI 10.1161/01.CIR.91.2.476; Ross AM, 1999, J AM COLL CARDIOL, V34, P1954, DOI 10.1016/S0735-1097(99)00444-1; Verheugt FWA, 2003, EUR HEART J, V24, P1801, DOI 10.1016/j.ehj.2003.08.007; Verheugt FWA, 2001, LANCET, V357, P1898, DOI 10.1016/S0140-6736(00)05087-X; Verheugt FWA, 1996, J AM COLL CARDIOL, V27, P766, DOI 10.1016/0735-1097(95)00492-0; Wilson SH, 2001, AM HEART J, V141, P704, DOI 10.1067/mhj.2001.114971; Zeymer U, 2003, CIRCULATION, V108, P1324, DOI 10.1161/01.CIR.0000087605.09362.0E	12	18	20	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 18	2004	364	9439					1014	1015		10.1016/S0140-6736(04)17072-4	http://dx.doi.org/10.1016/S0140-6736(04)17072-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	855FT	15380948				2022-12-28	WOS:000223959300004
J	Finch, CE; Crimmins, EM				Finch, CE; Crimmins, EM			Inflammatory exposure and historical changes in human life-spans	SCIENCE			English	Review							CORONARY-ARTERY-DISEASE; C-REACTIVE PROTEIN; ALZHEIMERS-DISEASE; PATHOGEN BURDEN; HEART-DISEASE; MORTALITY; DIARRHEA; SWEDEN; RISK; CHILDHOOD	Most explanations of the increase in life expectancy at older ages over history emphasize the importance of medical and public health factors of a particular historical period. We propose that the reduction in lifetime exposure to infectious diseases and other sources of inflammation-a cohort mechanism-has also made an important contribution to the historical decline in old-age mortality. Analysis of birth cohorts across the life-span since 1751 in Sweden reveals strong associations between early-age mortality and subsequent mortality in the same cohorts. We propose that a "cohort morbidity phenotype" represents inflammatory processes that persist from early age into adult life.	Univ So Calif, Ethel Percy Andrus Gerontol Ctr, Los Angeles, CA 90089 USA; Univ So Calif, Dept Biol Sci, Los Angeles, CA 90089 USA; Univ So Calif, Dept Sociol, Los Angeles, CA 90089 USA	University of Southern California; University of Southern California; University of Southern California	Finch, CE (corresponding author), Univ So Calif, Ethel Percy Andrus Gerontol Ctr, Los Angeles, CA 90089 USA.	cefinch@usc.edu	Finch, Caleb/AAA-7250-2022		NATIONAL INSTITUTE ON AGING [P01AG014751, R01AG013499, P30AG017265] Funding Source: NIH RePORTER; NIA NIH HHS [AG14751, AG17265, AG13499, AG05142] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Barker DJP, 2002, TRENDS ENDOCRIN MET, V13, P364, DOI 10.1016/S1043-2760(02)00689-6; Bengtsson T, 2003, INT J EPIDEMIOL, V32, P286, DOI 10.1093/ije/dyg061; Blackwell DL, 2001, SOC SCI MED, V52, P1269, DOI 10.1016/S0277-9536(00)00230-6; Breitner JCS, 2003, LANCET NEUROL, V2, P527, DOI 10.1016/S1474-4422(03)00498-8; BUCK C, 1982, J EPIDEMIOL COMMUN H, V36, P27, DOI 10.1136/jech.36.1.27; Cadwgan AM, 2000, J INFECTION, V41, P159, DOI 10.1053/jinf.2000.0717; Costa DL, 2000, DEMOGRAPHY, V37, P53, DOI 10.2307/2648096; Doblhammer G, 2001, P NATL ACAD SCI USA, V98, P2934, DOI 10.1073/pnas.041431898; ELO IT, 1992, POPUL INDEX, V58, P186, DOI 10.2307/3644718; FINCH CE, 1990, SCIENCE, V249, P902, DOI 10.1126/science.2392680; Floud R, 1990, HEIGHT HLTH HIST; Georges JL, 2003, AM J CARDIOL, V92, P515, DOI 10.1016/S0002-9149(03)00717-3; Harvey RF, 2002, QJM-INT J MED, V95, P519, DOI 10.1093/qjmed/95.8.519; Hunter RJ, 2001, J NUTR, V131, P1513, DOI 10.1093/jn/131.5.1513; JONES H B, 1956, Adv Biol Med Phys, V4, P281; Kannisto V, 1997, AM J EPIDEMIOL, V145, P987, DOI 10.1093/oxfordjournals.aje.a009067; Kermack WO, 1934, LANCET, V1, P698; Lawn SD, 2000, INT J TUBERC LUNG D, V4, P340; Li XJ, 2000, CLIN MICROBIOL REV, V13, P547, DOI 10.1128/CMR.13.4.547-558.2000; Oeppen J, 2002, SCIENCE, V296, P1029, DOI 10.1126/science.1069675; Palinski W, 2002, FASEB J, V16, P1348, DOI 10.1096/fj.02-0226rev; Riley J, 2001, RISING LIFE EXPECTAN; SHAHEEN SO, 1994, AM J RESP CRIT CARE, V149, P616, DOI 10.1164/ajrccm.149.3.8118627; SYTKOWSKI PA, 1990, NEW ENGL J MED, V322, P1635, DOI 10.1056/NEJM199006073222304; Vagnucci AH, 2003, LANCET, V361, P605, DOI 10.1016/S0140-6736(03)12521-4; Willerson JT, 2004, CIRCULATION, V109, P2, DOI 10.1161/01.CIR.0000129535.04194.38; Wilmoth JR, 2000, SCIENCE, V289, P2366, DOI 10.1126/science.289.5488.2366; Zhu JH, 2000, AM J CARDIOL, V85, P140, DOI 10.1016/S0002-9149(99)00653-0	28	466	479	0	57	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 17	2004	305	5691					1736	1739		10.1126/science.1092556	http://dx.doi.org/10.1126/science.1092556			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	856IS	15375259				2022-12-28	WOS:000224039500030
J	Schumacher, MA; Allen, GS; Diel, M; Seidel, G; Hillen, W; Brennan, RG				Schumacher, MA; Allen, GS; Diel, M; Seidel, G; Hillen, W; Brennan, RG			Structural basis for allosteric control of the transcription regulator CcpA by the phosphoprotein HPr-Ser46-P	CELL			English	Article							CARBON CATABOLITE REPRESSION; GRAM-POSITIVE BACTERIA; CONTROL PROTEIN CCPA; BACILLUS-SUBTILIS; DNA-BINDING; HPR KINASE/PHOSPHORYLASE; PHOSPHOCARRIER PROTEIN; RESPONSIVE ELEMENTS; CRYSTAL-STRUCTURE; SENSOR ENZYME	Carbon catabolite repression (CCR) is one of the most fundamental environmental-sensing mechanisms in bacteria and imparts competitive advantage by establishing priorities in carbon metabolism. In gram-positive bacteria, the master transcription regulator of CCR is CcpA. CcpA is a Lacl-GaIR family member that employs, as an allosteric corepressor, the phosphoprotein HPr-Ser46-P, which is formed in glucose-replete conditions. Here we report structures of the Bacillus megaterium apoCcpA and a CcpA-(HPr-Ser46-P)-DNA complex. These structures reveal that HPr-Ser46-P mediates a novel two-component allosteric DNA binding activation mechanism that involves both rotation of the CcpA subdomains and relocation of pivot-point residue Thr61, which leads to juxtaposition of the DNA binding regions permitting "hinge" helix formation in the presence of cognate DNA. The structure of the CcpA-(HPr-Ser46-P)-cre complex also reveals the elegant mechanism by which CcpA family-specific interactions with HPr-Ser46-P residues Ser46-P and His15 partition the high-energy CCR and low-energy PTS pathways, the latter requiring HPr-His15-P.	Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97239 USA; Univ Erlangen Nurnberg, Lehrstuhl Mikrobiol, Inst Mikrobiol Biochem & Genet, D-91058 Erlangen, Germany	Oregon Health & Science University; University of Erlangen Nuremberg	Brennan, RG (corresponding author), Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97239 USA.	brennanr@ohsu.edu		Brennan, Richard/0000-0001-7647-485X	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI048593, T32AI007472] Funding Source: NIH RePORTER; NIAID NIH HHS [AI07472, AI48593] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Audette GF, 2000, J MOL BIOL, V303, P545, DOI 10.1006/jmbi.2000.4166; Aung-Hilbrich LM, 2002, J MOL BIOL, V319, P77, DOI 10.1016/S0022-2836(02)00245-0; Bell CE, 2000, NAT STRUCT BIOL, V7, P209; Bell CE, 2001, J MOL BIOL, V312, P921, DOI 10.1006/jmbi.2001.5024; Bruckner R, 2002, FEMS MICROBIOL LETT, V209, P141; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chauvaux S, 1998, J BACTERIOL, V180, P491, DOI 10.1128/JB.180.3.491-497.1998; DEUTSCHER J, 1983, P NATL ACAD SCI-BIOL, V80, P6790, DOI 10.1073/pnas.80.22.6790; Galinier A, 1999, J MOL BIOL, V286, P307, DOI 10.1006/jmbi.1998.2492; GALINIER A, 1997, P NATL ACAD SCI USA, V94, P8739; Gosseringer R, 1997, J MOL BIOL, V266, P665, DOI 10.1006/jmbi.1996.0820; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Henkin TM, 1996, FEMS MICROBIOL LETT, V135, P9; Jones BE, 1997, PROTEIN SCI, V6, P2107; Jones BE, 1997, J BIOL CHEM, V272, P26530, DOI 10.1074/jbc.272.42.26530; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kalodimos CG, 2002, EMBO J, V21, P2866, DOI 10.1093/emboj/cdf318; Kim JH, 1998, P NATL ACAD SCI USA, V95, P9590, DOI 10.1073/pnas.95.16.9590; Kissinger CR, 1999, ACTA CRYSTALLOGR D, V55, P484, DOI 10.1107/S0907444998012517; Kraus A, 1998, MOL MICROBIOL, V30, P955, DOI 10.1046/j.1365-2958.1998.01123.x; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lewis M, 1996, SCIENCE, V271, P1247, DOI 10.1126/science.271.5253.1247; Magasanik B, 1970, LACTOSE OPERON, P189; Miwa Y, 2001, J BACTERIOL, V183, P5877, DOI 10.1128/JB.183.20.5877-5884.2001; Miwa Y, 2000, NUCLEIC ACIDS RES, V28, P1206, DOI 10.1093/nar/28.5.1206; Moreno MS, 2001, MOL MICROBIOL, V39, P1366, DOI 10.1046/j.1365-2958.2001.02328.x; Nessler S, 2003, J BACTERIOL, V185, P4003, DOI 10.1128/JB.185.14.4003-4010.2003; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Poncet S, 2004, BBA-PROTEINS PROTEOM, V1697, P123, DOI 10.1016/j.bbapap.2003.11.018; POSTMA PW, 1993, MICROBIOL REV, V57, P543, DOI 10.1128/MMBR.57.3.543-594.1993; Quiocho FA, 1996, MOL MICROBIOL, V20, P17, DOI 10.1111/j.1365-2958.1996.tb02484.x; Reizer J, 1996, J BACTERIOL, V178, P5480, DOI 10.1128/jb.178.18.5480-5486.1996; SAIER MH, 1995, TRENDS BIOCHEM SCI, V20, P267, DOI 10.1016/S0968-0004(00)89041-6; SCHUMACHER MA, 1995, CELL, V83, P147, DOI 10.1016/0092-8674(95)90243-0; SCHUMACHER MA, 1994, SCIENCE, V266, P763, DOI 10.1126/science.7973627; Steinhauer K, 2002, ACTA CRYSTALLOGR D, V58, P515, DOI 10.1107/S090744490102145X; Stulke J, 2000, ANNU REV MICROBIOL, V54, P849, DOI 10.1146/annurev.micro.54.1.849; Stulke J, 1998, NATURWISSENSCHAFTEN, V85, P583, DOI 10.1007/s001140050555; Turinsky AJ, 1998, J BACTERIOL, V180, P5961, DOI 10.1128/JB.180.22.5961-5967.1998; ULLMANN A, 1983, ADV CYCL NUCL RES<D>, V15, P1; Warner JB, 2003, MICROBIOL MOL BIOL R, V67, P475, DOI 10.1128/MMBR.67.4.475-490.2003; WEICKERT MJ, 1990, P NATL ACAD SCI USA, V87, P6238, DOI 10.1073/pnas.87.16.6238; WEICKERT MJ, 1992, J BIOL CHEM, V267, P15869; Yuan YP, 1998, BIOINFORMATICS, V14, P285, DOI 10.1093/bioinformatics/14.3.285; Zalieckas JM, 1998, MOL MICROBIOL, V27, P1031, DOI 10.1046/j.1365-2958.1998.00751.x; Zalieckas JM, 1999, J BACTERIOL, V181, P2883, DOI 10.1128/JB.181.9.2883-2888.1999	47	134	140	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 17	2004	118	6					731	741		10.1016/j.cell.2004.08.027	http://dx.doi.org/10.1016/j.cell.2004.08.027			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	855RW	15369672	Bronze			2022-12-28	WOS:000223992400009
J	Cook, ER; Woodhouse, CA; Eakin, CM; Meko, DM; Stahle, DW				Cook, ER; Woodhouse, CA; Eakin, CM; Meko, DM; Stahle, DW			Long-term aridity changes in the western United States	SCIENCE			English	Article							MOISTURE REGIMES; FIRE HISTORY; DROUGHT; CLIMATE; CALIFORNIA; FREQUENCY; RECONSTRUCTION; VEGETATION; PACIFIC; ENSO	The western United States is experiencing a severe multiyear drought that is unprecedented in some hydroclimatic records. Using gridded drought reconstructions that cover most of the western United States over the past 1200 years, we show that this drought pales in comparison to an earlier period of elevated aridity and epic drought in AD 900 to 1300, an interval broadly consistent with the Medieval Warm Period. If elevated aridity in the western United States is a natural response to climate warming, then any trend toward warmer temperatures in the future could lead to a serious long-term increase in aridity over western North America.	Lamont Doherty Earth Observ, Palisades, NY 10964 USA; NOAA, Natl Climat Data Ctr, Boulder, CO 80305 USA; Univ Arizona, Tree Ring Res Lab, Tucson, AZ 85721 USA; Univ Arkansas, Dept Geosci, Fayetteville, AR 72701 USA	Columbia University; National Center Atmospheric Research (NCAR) - USA; National Oceanic Atmospheric Admin (NOAA) - USA; University of Arizona; University of Arkansas System; University of Arkansas Fayetteville	Cook, ER (corresponding author), Lamont Doherty Earth Observ, Palisades, NY 10964 USA.	drdendro@ldeo.columbia.edu	Eakin, C. Mark/F-5585-2010	Eakin, C. Mark/0000-0002-5987-0858				[Anonymous], CLIMATE 2002 ANN REV; Barlow M, 2001, J CLIMATE, V14, P2105, DOI 10.1175/1520-0442(2001)014<2105:EPDVAU>2.0.CO;2; Benson L, 2002, QUATERNARY SCI REV, V21, P659, DOI 10.1016/S0277-3791(01)00048-8; Brunelle A, 2003, QUATERNARY RES, V60, P307, DOI 10.1016/j.yqres.2003.07.009; Cane MA, 1997, SCIENCE, V275, P957, DOI 10.1126/science.275.5302.957; Cole JE, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL013561; Cook ER, 1999, J CLIMATE, V12, P1145, DOI 10.1175/1520-0442(1999)012<1145:DRFTCU>2.0.CO;2; Dai A, 1998, GEOPHYS RES LETT, V25, P3367, DOI 10.1029/98GL52511; DAI A, IN PRESS J HYDROMETE; Fye FK, 2003, B AM METEOROL SOC, V84, P901, DOI 10.1175/BAMS-84-7-901; Gershunov A, 1998, B AM METEOROL SOC, V79, P2715, DOI 10.1175/1520-0477(1998)079<2715:IMOET>2.0.CO;2; Heim RR, 2002, B AM METEOROL SOC, V83, P1149, DOI 10.1175/1520-0477-83.8.1149; Hoerling M, 2003, SCIENCE, V299, P691, DOI 10.1126/science.1079053; Laird KR, 1996, NATURE, V384, P552, DOI 10.1038/384552a0; Laird KR, 2003, P NATL ACAD SCI USA, V100, P2483, DOI 10.1073/pnas.0530193100; LAMARCHE VC, 1974, SCIENCE, V183, P1043, DOI 10.1126/science.183.4129.1043; MANN ME, IN PRESS J CLIM; Mason JA, 2004, HOLOCENE, V14, P209, DOI 10.1191/0959683604hl677rp; McCabe GJ, 2004, P NATL ACAD SCI USA, V101, P4136, DOI 10.1073/pnas.0306738101; Millspaugh SH, 2000, GEOLOGY, V28, P211, DOI 10.1130/0091-7613(2000)28<211:VIFFAC>2.0.CO;2; MISKUS D, 2004, US DROUGHT MONITOR; Mohr JA, 2000, HOLOCENE, V10, P587, DOI 10.1191/095968300675837671; Palmer W. C., 1965, 45 US DEP COMM WEATH; Rein B, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020161; Russ J, 2000, QUATERN INT, V67, P29, DOI 10.1016/S1040-6182(00)00006-9; STINE S, 1994, NATURE, V369, P546, DOI 10.1038/369546a0; SWETNAM TW, 1993, SCIENCE, V262, P885, DOI 10.1126/science.262.5135.885; Wetherald RT, 1999, CLIMATIC CHANGE, V43, P495, DOI 10.1023/A:1005499220385; Zhang ZH, 2004, HOLOCENE, V14, P502, DOI 10.1191/0959683604hl727rp	29	1153	1210	9	349	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 5	2004	306	5698					1015	1018		10.1126/science.1102586	http://dx.doi.org/10.1126/science.1102586			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	869RG	15472040				2022-12-28	WOS:000225001100038
J	Terasawa, T; Blackmore, CC; Bent, S; Kohlwes, RJ				Terasawa, T; Blackmore, CC; Bent, S; Kohlwes, RJ			Systematic review: Computed tomography and ultrasonography to detect acute appendicitis in adults and adolescents	ANNALS OF INTERNAL MEDICINE			English	Review							SUSPECTED ACUTE APPENDICITIS; ABDOMINAL SONOGRAPHY; DIAGNOSTIC-TESTS; HELICAL CT; US; METAANALYSIS; ACCURACY; ULTRASOUND; DECISION; PATIENT	Background: Although clinicians commonly use computed tomography or ultrasonography to diagnose acute appendicitis, the accuracy of these imaging tests remains unclear. Purpose: To review the diagnostic accuracy of computed tomography and ultrasonography in adults and adolescents with suspected acute appendicitis. Data Sources: The authors used MEDLINE, EMBASE, bibliographies, review articles, textbooks, and expert opinion to retrieve English- and non-English-language articles published from 1966 to December 2003. Study Selection: The authors included prospective studies evaluating computed tomography or ultrasonography followed by surgical confirmation or clinical follow-up in patients at least 14 years of age with suspected appendicitis. Data Extraction: One assessor (for non-English-language studies) or 2 assessors (for English-language studies) independently reviewed each article to abstract relevant study characteristics and results. Data Synthesis: Twelve computed tomography studies and 14 ultrasonography studies met inclusion criteria. Computed tomography had an overall sensitivity of 0.94 (95% Cl, 0.91 to 0.95), a specificity of 0.95 (Cl, 0.93 to 0.96), a positive likelihood ratio of 13.3 (Cl, 9.9 to 17.9), and a negative likelihood ratio of 0.09 (Cl, 0.07 to 0.12). Ultrasonography had an overall sensitivity of 0.86 (Cl, 0.83 to 0.88), a specificity of 0.81 (Cl, 0.78 to 0.84), a positive likelihood ratio of 5.8 (Cl, 3.5 to 9.5), and a negative likelihood ratio of 0.19 (Cl, 0.13 to 0.27). Verification bias and inappropriate blinding of reference standards were noted in all of the included studies. Limitations: The summary assessment of the diagnostic accuracy for both tests was limited by the small number of studies, heterogeneity among study samples, and poor methodologic quality in the original studies. Conclusions: Computed tomography is probably more accurate than ultrasonography for diagnosing appendicitis in adults and adolescents. Prospective studies that apply gold standard diagnostic testing to all study participants would more reliably estimate the true diagnostic accuracy of these tests.	San Francisco VA Med Ctr, San Francisco, CA USA; Univ Calif San Francisco, San Francisco, CA 94143 USA; Univ Washington, Harborview Med Ctr, Seattle, WA 98195 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center; University of California System; University of California San Francisco; Harborview Medical Center; University of Washington; University of Washington Seattle	Terasawa, T (corresponding author), Nagoya Natl Hosp, Dept Clin Res & Hematol, Naka Ku, 4-1-1 Sannomaru, Nagoya, Aichi 4600001, Japan.	terasawa@nnh.hosp.go.jp			AHRQ HHS [K08-HS11291] Funding Source: Medline; NCCIH NIH HHS [1 K08-AT001338-01] Funding Source: Medline; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [K08HS011291] Funding Source: NIH RePORTER; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [K08AT001338] Funding Source: NIH RePORTER	AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NCCIH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine)		ADAMS DH, 1988, AM J SURG, V155, P93, DOI 10.1016/S0002-9610(88)80264-2; ADDISS DG, 1990, AM J EPIDEMIOL, V132, P910, DOI 10.1093/oxfordjournals.aje.a115734; AMGWERD M, 1994, LANGENBECK ARCH CHIR, V379, P335; BALTHAZAR EJ, 1994, RADIOLOGY, V190, P31, DOI 10.1148/radiology.190.1.8259423; BILBEY JH, 1989, J CAN ASSOC RADIOL, V40, P22; Birnbaum BA, 2000, RADIOLOGY, V215, P337, DOI 10.1148/radiology.215.2.r00ma24337; BLACKMORE CC, 2000, EMERG RADIOL, V7, P142; Bouillot J, 2001, ANN CHIR, V126, P427, DOI 10.1016/S0003-3944(01)00540-5; Cakirer Sinan, 2002, Emerg Radiol, V9, P155; Chen SC, 1998, WORLD J SURG, V22, P449, DOI 10.1007/s002689900414; Cobben LPJ, 2000, RADIOLOGY, V215, P349, DOI 10.1148/radiology.215.2.r00ma08349; *COCHR METH GROUP, REC METH; Crombe A, 2000, ANN CHIR, V125, P57, DOI 10.1016/S0003-3944(00)00291-1; Deeks JJ., 2001, SYSTEMATIC REV HLTH, P248, DOI DOI 10.1002/9780470693926.CH14; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Flum DR, 2001, JAMA-J AM MED ASSOC, V286, P1748, DOI 10.1001/jama.286.14.1748; Hallan S, 1997, SCAND J CLIN LAB INV, V57, P373, DOI 10.3109/00365519709084584; Hershko DD, 2002, AM SURGEON, V68, P1003; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hong John J, 2003, Surg Infect (Larchmt), V4, P231, DOI 10.1089/109629603322419562; Horton MD, 2000, AM J SURG, V179, P379, DOI 10.1016/S0002-9610(00)00372-X; Incesu L, 1997, AM J ROENTGENOL, V168, P669, DOI 10.2214/ajr.168.3.9057512; Kan JH, 2001, ACAD RADIOL, V8, P1208, DOI 10.1016/S1076-6332(03)80703-1; KANG WM, 1989, SURGERY, V105, P154; Lane MJ, 1997, AM J ROENTGENOL, V168, P405, DOI 10.2214/ajr.168.2.9016216; Lijmer JG, 1999, JAMA-J AM MED ASSOC, V282, P1061, DOI 10.1001/jama.282.11.1061; Lim HK, 1996, RADIOLOGY, V201, P221, DOI 10.1148/radiology.201.1.8816547; MALONE AJ, 1993, AM J ROENTGENOL, V160, P763, DOI 10.2214/ajr.160.4.8456661; Maluccio M A, 2001, Surg Infect (Larchmt), V2, P205, DOI 10.1089/109629601317202687; ORR RK, 1995, ACAD EMERG MED, V2, P644, DOI 10.1111/j.1553-2712.1995.tb03606.x; PUYLAERT JBCM, 1987, NEW ENGL J MED, V317, P666, DOI 10.1056/NEJM198709103171103; PUYLAERT JBCM, 1986, RADIOLOGY, V158, P355, DOI 10.1148/radiology.158.2.2934762; Puylaert JBCM, 1997, AM J ROENTGENOL, V168, P179, DOI 10.2214/ajr.168.1.8976943; Ralls P W, 2000, Radiology, V215 Suppl, P159; RANSOHOFF DF, 1978, NEW ENGL J MED, V299, P926, DOI 10.1056/NEJM197810262991705; Rao PM, 1998, NEW ENGL J MED, V338, P141, DOI 10.1056/NEJM199801153380301; ROBINS J, 1986, BIOMETRICS, V42, P311, DOI 10.2307/2531052; Smith-Bindman R, 1998, JAMA-J AM MED ASSOC, V280, P1510, DOI 10.1001/jama.280.17.1510; SOUPARIS AC, 2000, ARCH GASTROENTEROHEP, V19, P28; Sun SS, 2002, ABDOM IMAGING, V27, P734, DOI 10.1007/s00261-002-0015-5; Vermeulen B, 1999, RADIOLOGY, V210, P639, DOI 10.1148/radiology.210.3.r99fe54639; Wagner JM, 1996, JAMA-J AM MED ASSOC, V276, P1589, DOI 10.1001/jama.276.19.1589; Walker S, 2000, AM J SURG, V180, P450, DOI 10.1016/S0002-9610(00)00540-7; Wijetunga R, 2001, RADIOLOGY, V221, P747, DOI 10.1148/radiol.2213001581; Wise SW, 2001, AM J ROENTGENOL, V176, P933, DOI 10.2214/ajr.176.4.1760933	45	237	243	0	7	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 5	2004	141	7					537	546		10.7326/0003-4819-141-7-200410050-00011	http://dx.doi.org/10.7326/0003-4819-141-7-200410050-00011			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	862CR	15466771				2022-12-28	WOS:000224467800006
J	Ogilvie, D; Egan, M; Hamilton, V; Petticrew, M				Ogilvie, D; Egan, M; Hamilton, V; Petticrew, M			Promoting walking and cycling as an alternative to using cars: systematic review	BMJ-BRITISH MEDICAL JOURNAL			English	Article							HEALTH; SAFER	Objectives To assess what interventions are effective in promoting a population shift from using cars towards walking and cycling and to assess the health effects of such interventions. Data sources Published and unpublished reports in any language identified from electronic databases, bibliographies, websites, and reference lists. Review methods Systematic search and appraisal to identify experimental or observational studies with a prospective or controlled retrospective design that evaluated any intervention applied to an urban population or area by measuring outcomes in members of the local population. Results 22 studies met the inclusion criteria. We found some evidence that targeted behaviour change programmes can change the behaviour of motivated subgroups, resulting (in the largest study) in a shift of around 5% of all trips at a population level. Single studies of commuter subsidies and a new railway station also showed positive effects. The balance of best available evidence about publicity campaigns, engineering measures, and other interventions suggests that they have not been effective. Participants in trials of active commuting experienced short term improvements in certain measures of health and fitness, but we found no good evidence on effects on health of any effective intervention at population level. Conclusions The best available evidence of effectiveness in promoting a modal shift is for targeted behaviour change programmes, but the social distribution of their effects is unclear and some other types of intervention have yet to be rigorously evaluated.	Univ Glasgow, MRC, Social & Publ Hlth Sci Unit, Glasgow G12 8RZ, Lanark, Scotland; Univ Strathclyde, Ctr Digital Lib Res, Glasgow G1 1XH, Lanark, Scotland	MRC/CSO SOCIAL AND PUBLIC HEALTH SCIENCES UNIT; University of Glasgow; University of Strathclyde	Ogilvie, D (corresponding author), Univ Glasgow, MRC, Social & Publ Hlth Sci Unit, Glasgow G12 8RZ, Lanark, Scotland.	d.ogilvic@msoc.mrc.gla.ac.uk	Ogilvie, David/B-2444-2012; Petticrew, Mark/AAY-6274-2021	Ogilvie, David/0000-0002-0270-4672				Alderson P, 2004, BMJ-BRIT MED J, V328, P476, DOI 10.1136/bmj.328.7438.476; [Anonymous], 1998, NEW DEAL TRANSP BETT; Carnall D, 2000, BRIT MED J, V320, P888, DOI 10.1136/bmj.320.7239.888; Clarke GM, 2000, CONSERV BIOL SER, V4, P1; CLARKE M, 2002, COCHRANE REV HDB 4 1; *COMM INT TRANSP, 2001, EUR BEST PRACT DEL I; *DAN MIN TRANSP, 1998, ADONIS PROJ BEST PRA; Dora C, 1999, BRIT MED J, V318, P1686, DOI 10.1136/bmj.318.7199.1686; Egan M, 2003, AM J PUBLIC HEALTH, V93, P1463, DOI 10.2105/AJPH.93.9.1463; *HOUS COMM HLTH CO, 2004, OB 3 REP SESS 2003 0; Jacobsen PL, 2003, INJURY PREV, V9, P205, DOI 10.1136/ip.9.3.205rep; McCarthy M., 1999, SOCIAL DETERMINANTS; MORRIS JN, 1994, MED SCI SPORT EXER, V26, P807; Morrison DS, 2003, J EPIDEMIOL COMMUN H, V57, P327, DOI 10.1136/jech.57.5.327; NHS Centre for Reviews and Dissemination, 2001, 4 CRD NHS CTR REV DI; Petticrew M, 2003, AM J PREV MED, V24, P2, DOI 10.1016/S0749-3797(02)00650-5; Roberts I, 2003, BMJ-BRIT MED J, V326, P345, DOI 10.1136/bmj.326.7385.345; Rychetnik L, 2002, J EPIDEMIOL COMMUN H, V56, P119, DOI 10.1136/jech.56.2.119; *SCOTT EX, 2001, TRANSP SCOTL SOM SCO; *SCOTT EX, 2001, TRANSP SCOTL SOME SC; *SECR STAT SCOTL, 1998, TRAV CHOIC SCOTL SCO; *SUSTR, 2004, NAT CYCL NETW ROUT U; *TRANSP LOND, 2004, CONG CHARG CENTR LON; Wanless D., 2004, SECURING GOOD HLTH W	24	258	259	1	67	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 2	2004	329	7469					763	766B		10.1136/bmj.38216.714560.55	http://dx.doi.org/10.1136/bmj.38216.714560.55			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	859TW	15385407	Green Submitted, Green Published, Green Accepted, Bronze			2022-12-28	WOS:000224291800015
J	Holliday, R				Holliday, R			Francis Crick (1916-2004)	CELL			English	Biographical-Item											Holliday, R (corresponding author), 12 Roma Court,W Pennant Hills, Sydney, NSW 2125, Australia.	randl.holliday@bigpond.com						CRICK FH, PUBLICATION LIST	1	1	2	0	2	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	OCT 1	2004	119	1					1	2		10.1016/j.cell.2004.09.022	http://dx.doi.org/10.1016/j.cell.2004.09.022			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	859UE	15454073	Bronze			2022-12-28	WOS:000224292600001
J	Pochan, DJ; Chen, ZY; Cui, HG; Hales, K; Qi, K; Wooley, KL				Pochan, DJ; Chen, ZY; Cui, HG; Hales, K; Qi, K; Wooley, KL			Toroidal triblock copolymer assemblies	SCIENCE			English	Article							DIBLOCK COPOLYMERS; BLOCK-COPOLYMERS; MULTIPLE MORPHOLOGIES; SHAPED MORPHOLOGY; DILUTE-SOLUTION; DNA COMPLEXES; F-ACTIN; MICELLES; VESICLES; SURFACTANT	A stable phase of toroidal, or ringlike, supramolecular assemblies was formed by combining dilute solution characteristics critical for both bundling of like-charged biopolymers and block copolymer micelle formation. The key to toroid versus classic cylinder micelle formation is the interaction of the negatively charged hydrophilic block of an amphiphilic triblock copolymer with a positively charged divalent organic counterion. This produces a self-attraction of cylindrical micelles that leads to toroid formation, a mechanism akin to the toroidal bundling of semiflexible charged biopolymers such as DNA. The toroids can be kinetically trapped or chemically cross-linked. insight into the mechanism of toroid formation can be gained by observation of intermediate structures kinetically trapped during film casting.	Univ Delaware, Delaware Biotechnol Inst, Newark, DE 19716 USA; Washington Univ, Ctr Mat Innovat, St Louis, MO 63130 USA; Washington Univ, Dept Chem, St Louis, MO 63130 USA	University of Delaware; Washington University (WUSTL); Washington University (WUSTL)	Pochan, DJ (corresponding author), Univ Delaware, Delaware Biotechnol Inst, Newark, DE 19716 USA.		Cui, Honggang/E-8012-2010; Wooley, Karen L/D-4399-2015; Qi, Kai/C-2558-2018; Cui, Honggang/C-6550-2008; Wooley, Karen/AAX-2259-2020	Wooley, Karen L/0000-0003-4086-384X; Qi, Kai/0000-0002-4166-7421; Wooley, Karen/0000-0003-4086-384X				Bermudez H, 2002, MACROMOLECULES, V35, P8203, DOI 10.1021/ma020669l; Bernheim-Groswasser A, 2000, J PHYS CHEM B, V104, P4005, DOI 10.1021/jp994301a; Bloomfield VA, 1997, BIOPOLYMERS, V44, P269, DOI 10.1002/(SICI)1097-0282(1997)44:3<269::AID-BIP6>3.0.CO;2-T; Bottcher C, 1998, J AM CHEM SOC, V120, P12, DOI 10.1021/ja971047w; Cornelissen JJLM, 1998, SCIENCE, V280, P1427, DOI 10.1126/science.280.5368.1427; Dalhaimer P, 2004, J POLYM SCI POL PHYS, V42, P168, DOI 10.1002/polb.10709; Discher BM, 1999, SCIENCE, V284, P1143, DOI 10.1126/science.284.5417.1143; Ewert K, 2004, CURR MED CHEM, V11, P133, DOI 10.2174/0929867043456160; Hartgerink JD, 2001, SCIENCE, V294, P1684, DOI 10.1126/science.1063187; In M, 1999, J PHYS CHEM B, V103, P7747, DOI 10.1021/jp9919922; Jain S, 2004, MACROMOLECULES, V37, P1511, DOI 10.1021/ma035467j; Jain S, 2003, SCIENCE, V300, P460, DOI 10.1126/science.1082193; Koltover I, 1998, SCIENCE, V281, P78, DOI 10.1126/science.281.5373.78; Prochazka K, 1996, MACROMOLECULES, V29, P6518, DOI 10.1021/ma960630e; Raez J, 2002, J AM CHEM SOC, V124, P10381, DOI 10.1021/ja020349h; Riegel IC, 2002, LANGMUIR, V18, P3358, DOI 10.1021/la015592t; Silva GA, 2004, SCIENCE, V303, P1352, DOI 10.1126/science.1093783; Tang JX, 1996, J BIOL CHEM, V271, P8556, DOI 10.1074/jbc.271.15.8556; Tang JX, 2001, EUR BIOPHYS J BIOPHY, V30, P477, DOI 10.1007/s002490100178; van der Schoot P, 1999, MACROMOL THEOR SIMUL, V8, P428; Vriezema DM, 2004, MACROMOLECULES, V37, P4736, DOI 10.1021/ma035789n; Vriezema DM, 2003, ANGEW CHEM INT EDIT, V42, P772, DOI 10.1002/anie.200390204; Won YY, 1999, SCIENCE, V283, P960, DOI 10.1126/science.283.5404.960; Wong GCL, 2000, SCIENCE, V288, P2035, DOI 10.1126/science.288.5473.2035; Yu K, 1996, LANGMUIR, V12, P5980, DOI 10.1021/la960894u; ZHANG LF, 1995, SCIENCE, V268, P1728, DOI 10.1126/science.268.5218.1728; Zhang LF, 1997, PHYS REV LETT, V79, P5034, DOI 10.1103/PhysRevLett.79.5034; Zhang LF, 1996, J AM CHEM SOC, V118, P3168, DOI 10.1021/ja953709s; Zhu JT, 2004, LANGMUIR, V20, P3809, DOI 10.1021/la0361565	29	678	686	6	372	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 1	2004	306	5693					94	97		10.1126/science.1102866	http://dx.doi.org/10.1126/science.1102866			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	859YJ	15459386				2022-12-28	WOS:000224304000043
J	Splawski, I; Timothy, KW; Sharpe, LM; Decher, N; Kumar, P; Bloise, R; Napolitano, C; Schwartz, PJ; Joseph, RM; Condouris, K; Tager-Flusberg, H; Priori, SG; Sanguinetti, MC; Keating, MT				Splawski, I; Timothy, KW; Sharpe, LM; Decher, N; Kumar, P; Bloise, R; Napolitano, C; Schwartz, PJ; Joseph, RM; Condouris, K; Tager-Flusberg, H; Priori, SG; Sanguinetti, MC; Keating, MT			Ca(v)1.2 calcium channel dysfunction causes a multisystem disorder including arrhythmia and autism	CELL			English	Article							LONG-QT SYNDROME; PERVASIVE DEVELOPMENTAL DISORDERS; STATIONARY NIGHT BLINDNESS; LANGE-NIELSEN-SYNDROME; HUMAN GENETIC-DISEASE; SUDDEN CARDIAC DEATH; CA2+ CHANNEL; MOLECULAR DETERMINANTS; FUNCTIONAL EXPRESSION; POTASSIUM CHANNEL	Ca(v)1.2, the cardiac L-type calcium channel, is important for excitation and contraction of the heart. Its role in other tissues is unclear. Here we present Timothy syndrome, a novel disorder characterized by multiorgan dysfunction including lethal arrhythmias, webbing of fingers and toes, congenital heart disease, immune deficiency, intermittent hypoglycemia, cognitive abnormalities, and autism. In every case, Timothy syndrome results from the identical, de novo Ca(v)1.2 missense mutation G406R. Ca(v)1.2 is expressed in all affected tissues. Functional expression reveals that G406R produces maintained inward Ca2+ currents by causing nearly complete loss of voltage-dependent channel inactivation. This likely induces intracellular Ca2+ overload in multiple cell types. In the heart, prolonged Ca2+ current delays cardiomyocyte repolarization and increases risk of arrhythmia, the ultimate cause of death in this disorder. These discoveries establish the importance of Ca(v)1.2 in human physiology and development and implicate Ca2+ signaling in autism.	Harvard Univ, Sch Med, Childrens Hosp,Dept Cardiol, Dept Pediat, Boston, MA 02115 USA; Harvard Univ, Sch Med, Childrens Hosp,Dept Cardiol, Dept Cell Biol, Boston, MA 02115 USA; Univ Utah, Dept Human Genet, Salt Lake City, UT 84112 USA; Univ Utah, Dept Physiol, Salt Lake City, UT 84112 USA; Univ Utah, Nora Eccles Harrison Cardiovasc Res & Training In, Salt Lake City, UT 84112 USA; IRCCS, Fdn Salvatore Maugeri, Dept Mol Cardiol, I-27100 Pavia, Italy; Univ Pavia, Dept Cardiol, I-27100 Pavia, Italy; IRCCS, Policlin San Matteo, I-27100 Pavia, Italy; Boston Univ, Sch Med, Dept Anat & Neurobiol, Boston, MA 02118 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Istituti Clinici Scientifici Maugeri IRCCS; University of Pavia; University of Pavia; IRCCS Fondazione San Matteo; University of Pavia; Boston University	Splawski, I (corresponding author), Harvard Univ, Sch Med, Childrens Hosp,Dept Cardiol, Dept Pediat, Boston, MA 02115 USA.	igor@enders.tch.harvard.edu	Decher, Niels/AAF-5002-2020; Schwartz, Peter J/J-4267-2016; Napolitano, Carlo/K-4760-2016; Priori, Silvia G G/A-6116-2014; Tager-Flusberg, Helen B/D-5265-2009; napolitano, carlo/ABI-4608-2020; Priori, Silvia G/ABH-6894-2020; Tuluc, Petronel/C-2527-2011; bloise, raffaella/AAC-2922-2020; Sanguinetti, Michael/AAN-2615-2020	Schwartz, Peter J/0000-0003-0367-1048; Napolitano, Carlo/0000-0002-7643-4628; Priori, Silvia G G/0000-0001-6877-0288; napolitano, carlo/0000-0002-7643-4628; Priori, Silvia G/0000-0001-6877-0288; bloise, raffaella/0000-0003-3485-9596; Decher, Niels/0000-0002-9433-687X; Joseph, Robert/0000-0001-6879-0254; Tager-Flusberg, Helen/0000-0002-8768-5414	NHLBI NIH HHS [HL46401, T32 HL007572, HL52338] Funding Source: Medline; NIDCD NIH HHS [DC03610] Funding Source: Medline; NIMH NIH HHS [MH66398] Funding Source: Medline; Telethon [GP0227Y01] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL052338, R01HL046401, R29HL046401] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U54MH066398] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Telethon(Fondazione Telethon); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Abernethy DR, 2002, J PHARMACOL EXP THER, V300, P724, DOI 10.1124/jpet.300.3.724; Allen G, 2003, AM J PSYCHIAT, V160, P262, DOI 10.1176/appi.ajp.160.2.262; Antzelevitch C, 2003, J CARDIOVASC ELECTR, V14, P1259, DOI 10.1046/j.1540-8167.2003.03316.x; APA, 2000, DIAGN STAT MAN MENT; Arikkath J, 2003, CURR OPIN NEUROBIOL, V13, P298, DOI 10.1016/S0959-4388(03)00066-7; BEAN BP, 1984, P NATL ACAD SCI-BIOL, V81, P6388, DOI 10.1073/pnas.81.20.6388; Bech-Hansen NT, 1998, NAT GENET, V19, P264, DOI 10.1038/947; Berger UV, 2001, J COMP NEUROL, V433, P101, DOI 10.1002/cne.1128; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; BERS DM, 1994, METHOD CELL BIOL, V40, P3; Bertrand J, 2001, PEDIATRICS, V108, P1155, DOI 10.1542/peds.108.5.1155; Berument SK, 1999, BRIT J PSYCHIAT, V175, P444, DOI 10.1192/bjp.175.5.444; Brambilla P, 2003, BRAIN RES BULL, V61, P557, DOI 10.1016/j.brainresbull.2003.06.001; Brini M, 2000, CELL MOL LIFE SCI, V57, P354, DOI 10.1007/PL00000698; Bryson SE, 2003, CAN J PSYCHIAT, V48, P506, DOI 10.1177/070674370304800802; Catterall WA, 2000, ANNU REV CELL DEV BI, V16, P521, DOI 10.1146/annurev.cellbio.16.1.521; Colecraft HM, 2002, J PHYSIOL-LONDON, V541, P435, DOI 10.1113/jphysiol.2002.018515; COOPER DN, 1988, HUM GENET, V78, P151, DOI 10.1007/BF00278187; Ertel EA, 2000, NEURON, V25, P533, DOI 10.1016/S0896-6273(00)81057-0; Faber GM, 2000, BIOPHYS J, V78, P2392, DOI 10.1016/S0006-3495(00)76783-X; Fombonne E, 2003, J AUTISM DEV DISORD, V33, P365, DOI 10.1023/A:1025054610557; GOLDIN AL, 1991, METHOD CELL BIOL, V36, P487; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Herlitze S, 1997, P NATL ACAD SCI USA, V94, P1512, DOI 10.1073/pnas.94.4.1512; HURLE JM, 1986, J EMBRYOL EXP MORPH, V94, P231; Imamura S, 2000, J HISTOCHEM CYTOCHEM, V48, P35, DOI 10.1177/002215540004800104; Keating MT, 2001, CELL, V104, P569, DOI 10.1016/S0092-8674(01)00243-4; Korkman M., 2007, NEPSY 2, V2nd; LEE KS, 1985, J PHYSIOL-LONDON, V364, P395, DOI 10.1113/jphysiol.1985.sp015752; Lord C, 2000, J AUTISM DEV DISORD, V30, P205, DOI 10.1023/A:1005592401947; LORD C, 1994, J AUTISM DEV DISORD, V24, P659, DOI 10.1007/BF02172145; MARKS ML, 1995, J AM COLL CARDIOL, V25, P59, DOI 10.1016/0735-1097(94)00318-K; MIKAMI A, 1989, NATURE, V340, P230, DOI 10.1038/340230a0; Monnier N, 1997, AM J HUM GENET, V60, P1316, DOI 10.1086/515454; Neyroud N, 1997, NAT GENET, V15, P186, DOI 10.1038/ng0297-186; Ophoff RA, 1996, CELL, V87, P543, DOI 10.1016/S0092-8674(00)81373-2; Orrenius S, 2003, NAT REV MOL CELL BIO, V4, P552, DOI 10.1038/nrm1150; Priori SG, 2002, EUROPACE, V4, P3, DOI 10.1053/eupc.2001.0214; PTACEK LJ, 1994, CELL, V77, P863; Reichenbach H, 1992, Kinderarztl Prax, V60, P54; Ren DJ, 2001, NATURE, V413, P603, DOI 10.1038/35098027; SANGUINETTI MC, 1984, CIRC RES, V55, P336, DOI 10.1161/01.RES.55.3.336; SCHULTZ D, 1993, P NATL ACAD SCI USA, V90, P6228, DOI 10.1073/pnas.90.13.6228; SchulzeBahr E, 1997, NAT GENET, V17, P267, DOI 10.1038/ng1197-267; Shi CZ, 2002, J BIOL CHEM, V277, P6813, DOI 10.1074/jbc.M110524200; Splawski I, 1997, NAT GENET, V17, P338, DOI 10.1038/ng1197-338; Splawski I, 1997, NEW ENGL J MED, V336, P1562, DOI 10.1056/NEJM199705293362204; Strom TM, 1998, NAT GENET, V19, P260, DOI 10.1038/940; STUHMER W, 1992, METHOD ENZYMOL, V207, P319; Tananari Y, 2000, JPN CIRC J, V64, P684, DOI 10.1253/jcj.64.684; Tyson J, 1997, HUM MOL GENET, V6, P2179, DOI 10.1093/hmg/6.12.2179; Vitkup D, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-11-r72; Volkmar FR, 2003, LANCET, V362, P1133, DOI 10.1016/S0140-6736(03)14471-6; WHITE MM, 1990, MOL PHARMACOL, V37, P720; ZHANG JF, 1994, NATURE, V372, P97, DOI 10.1038/372097a0; Zhang L, 2000, CIRCULATION, V102, P2849; Zheng ZJ, 2001, CIRCULATION, V104, P2158, DOI 10.1161/hc4301.098254; Zoghbi HY, 2003, SCIENCE, V302, P826, DOI 10.1126/science.1089071	58	1065	1116	1	79	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 1	2004	119	1					19	31		10.1016/j.cell.2004.09.011	http://dx.doi.org/10.1016/j.cell.2004.09.011			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	859UE	15454078	Bronze			2022-12-28	WOS:000224292600006
J	Rhie, J; Romanowicz, B				Rhie, J; Romanowicz, B			Excitation of Earth's continuous free oscillations by atmosphere-ocean-seafloor coupling	NATURE			English	Article							BACKGROUND FREE OSCILLATIONS; EARTHQUAKES; WAVES	The Earth undergoes continuous oscillations, and free oscillation peaks have been consistently identified in seismic records in the frequency range 2 - 7 mHz (refs 1, 2), on days without significant earthquakes. The level of daily excitation of this 'hum' is equivalent to that of magnitude 5.75 to 6.0 earthquakes(3,4), which cannot be explained by summing the contributions of small earthquakes(1,3.) As slow or silent earthquakes have been ruled out as a source for the hum(4) ( except in a few isolated cases(5)), turbulent motions in the atmosphere or processes in the oceans have been invoked(3,6-8) as the excitation mechanism. We have developed an array-based method to detect and locate sources of the excitation of the hum. Our results demonstrate that the Earth's hum originates mainly in the northern Pacific Ocean during Northern Hemisphere winter, and in the Southern oceans during Southern Hemisphere winter. We conclude that the Earth's hum is generated by the interaction between atmosphere, ocean and sea floor, probably through the conversion of storm energy to oceanic infragravity waves that interact with seafloor topography.	Univ Calif Berkeley, Berkeley Seismol Lab, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Earth & Planetary Sci, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley	Romanowicz, B (corresponding author), Univ Calif Berkeley, Berkeley Seismol Lab, Berkeley, CA 94720 USA.	barbara@seismo.berkeley.edu	Romanowicz, barbara A/H-6726-2017; Rhie, Junkee/A-8901-2008	Romanowicz, barbara A/0000-0002-6208-6044; Rhie, Junkee/0000-0002-7836-3317				BEROZA GC, 1990, J GEOPHYS RES-SOLID, V95, P2485, DOI 10.1029/JB095iB03p02485; *COMM IMPL SEAFL O, 2003, EN OC RES 21 CENT IM; DZIEWONSKI AM, 1981, PHYS EARTH PLANET IN, V25, P297, DOI 10.1016/0031-9201(81)90046-7; Ekstrom G, 2003, SCIENCE, V302, P622, DOI 10.1126/science.1088057; Ekstrom G, 1997, J GEOPHYS RES-SOL EA, V102, P8137, DOI 10.1029/96JB03729; Ekstrom G, 2001, J GEOPHYS RES-SOL EA, V106, P26483, DOI 10.1029/2000JB000086; Friedrich A, 1998, J SEISMOL, V2, P47, DOI 10.1023/A:1009788904007; Fukao Y, 2002, J GEOPHYS RES-SOL EA, V107, DOI 10.1029/2001JB000153; Kobayashi N, 1998, NATURE, V395, P357, DOI 10.1038/26427; MUNK W, 1964, J FLUID MECH, V20, P529, DOI 10.1017/S0022112064001392; Nishida K, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL013862; Nishida K, 1999, J GEOPHYS RES-SOL EA, V104, P28741, DOI 10.1029/1999JB900286; RHIE J, 2002, EOS S, V83; Rost S, 2002, REV GEOPHYS, V40, DOI 10.1029/2000RG000100; ROULAND D, 1992, B SEISMOL SOC AM, V82, P2448; Roult G, 2000, PHYS EARTH PLANET IN, V121, P325, DOI 10.1016/S0031-9201(00)00172-2; Schimmel M, 1997, GEOPHYS J INT, V130, P497, DOI 10.1111/j.1365-246X.1997.tb05664.x; Schulte-Pelkum V, 2004, GEOCHEM GEOPHY GEOSY, V5, DOI 10.1029/2003GC000520; SEGGERN DV, 1972, GEOPHYS J ROY ASTR S, V26, P499, DOI 10.1111/j.1365-246X.1972.tb05765.x; Suda N, 1998, SCIENCE, V279, P2089, DOI 10.1126/science.279.5359.2089; Tanimoto T, 1999, J GEOPHYS RES-SOL EA, V104, P28723, DOI 10.1029/1999JB900252; Tanimoto T, 1998, GEOPHYS RES LETT, V25, P1553, DOI 10.1029/98GL01223; TANIMOTO T, 2003, EOS S, V84; WATADA S, 2001, EOS, V82, pF871; WEBB S, 1995, REV GEOPHYS, V36, P105; Webb SC, 1999, B SEISMOL SOC AM, V89, P1535; WEBB SC, 1991, J GEOPHYS RES-OCEANS, V96, P2723, DOI 10.1029/90JC02212; WIELANDT E, 1982, B SEISMOL SOC AM, V72, P2349	28	219	235	1	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 30	2004	431	7008					552	556		10.1038/nature02942	http://dx.doi.org/10.1038/nature02942			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	857YP	15457256				2022-12-28	WOS:000224156700042
J	Kitamura, Y; Hayashi, K				Kitamura, Y; Hayashi, K			Pushing the imatinib envelope	LANCET			English	Editorial Material							GASTROINTESTINAL STROMAL TUMORS; KINASE INHIBITOR STI571; BONE-SARCOMA-GROUP; EORTC-SOFT-TISSUE; PHASE-II; C-KIT; MESYLATE; EFFICACY; SAFETY		Tokyo Womens Med Univ, Inst Gastroenterol, Dept Surg, Shinjuku Ku, Tokyo 1628666, Japan	Tokyo Women's Medical University	Kitamura, Y (corresponding author), Tokyo Womens Med Univ, Inst Gastroenterol, Dept Surg, Shinjuku Ku, Tokyo 1628666, Japan.	kitamura@ige.twmu.ac.jp						BLAY JY, 2004, P ASCO, V22, pS819; Buchdunger E, 2000, J PHARMACOL EXP THER, V295, P139; Debiec-Rychter M, 2004, EUR J CANCER, V40, P689, DOI 10.1016/j.ejca.2003.11.025; DeMatteo RP, 2000, ANN SURG, V231, P51, DOI 10.1097/00000658-200001000-00008; Demetri GD, 2002, NEW ENGL J MED, V347, P472, DOI 10.1056/NEJMoa020461; DEMETRI GD, 2004, P ASCO, V22, pS195; Hirota S, 1998, SCIENCE, V279, P577, DOI 10.1126/science.279.5350.577; Joensuu H, 2001, NEW ENGL J MED, V344, P1052, DOI 10.1056/NEJM200104053441404; Miettinen M, 1999, HUM PATHOL, V30, P1213, DOI 10.1016/S0046-8177(99)90040-0; RANKIN C, 2004, P ASCO, V22, pS819; van Oosterom AT, 2001, LANCET, V358, P1421, DOI 10.1016/S0140-6736(01)06535-7; Verweij J, 2003, EUR J CANCER, V39, P2006, DOI 10.1016/S0959-8049(02)00836-5; ZALCBERG JR, 2004, P ASCO, V22, pS819	13	1	1	0	3	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 25	2004	364	9440					1101	1102		10.1016/S0140-6736(04)17114-6	http://dx.doi.org/10.1016/S0140-6736(04)17114-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	857FT	15451202				2022-12-28	WOS:000224102400003
J	Bockrath, C; Ballhaus, C; Holzheid, A				Bockrath, C; Ballhaus, C; Holzheid, A			Fractionation of the platinum-group elements during mantle melting	SCIENCE			English	Article							HIGHLY SIDEROPHILE ELEMENTS; SILICATE MELTS; CORE FORMATION; SULFIDE; PERIDOTITE; MAGMAS; DISEQUILIBRIUM; TEMPERATURE; SATURATION; XENOLITHS	Experiments in sulfide-silicate systems demonstrate that two sulfide phases are stable in the asthenospheric upper mantle: a crystalline osmium-iridium-ruthenium-enriched monosulfide and a rhodium-platinum-palladium-enriched sulfide melt. During silicate melt segregation, monosulfide stays in the solid residue, dominating the noble metal spectrum of residual mantle. The sulfide melt is entrained as immiscible droplets in the segregating silicate melt, defining the noble metal inventory of the basaltic component.	Univ Munster, Inst Mineral, D-48149 Munster, Germany	University of Munster	Bockrath, C (corresponding author), Univ Munster, Inst Mineral, Corrensstr 24, D-48149 Munster, Germany.	bockrat@nwz.uni-muenster.de	Holzheid, Astrid/S-5513-2018	Holzheid, Astrid/0000-0001-5154-9886				Alard O, 2000, NATURE, V407, P891, DOI 10.1038/35038049; Ballhaus C, 2001, J PETROL, V42, P1911, DOI 10.1093/petrology/42.10.1911; BALLHAUS C, 1995, EARTH PLANET SC LETT, V132, P75, DOI 10.1016/0012-821X(95)00047-G; BARNES SJ, 1985, CHEM GEOL, V53, P303, DOI 10.1016/0009-2541(85)90076-2; Borisov A, 2000, AM MINERAL, V85, P1665; Burton KW, 1999, EARTH PLANET SC LETT, V172, P311, DOI 10.1016/S0012-821X(99)00207-1; d'Ars JD, 2001, EARTH PLANET SC LETT, V186, P371; DOYLE CD, 1987, ECON GEOL, V82, P208, DOI 10.2113/gsecongeo.82.1.208; FALLOON TJ, 1988, J PETROL, V29, P1257, DOI 10.1093/petrology/29.6.1257; FALLOON TJ, 1990, GEOLOGY, V18, P195, DOI 10.1130/0091-7613(1990)018<0195:SOCFPU>2.3.CO;2; Fleet ME, 1996, GEOCHIM COSMOCHIM AC, V60, P2397, DOI 10.1016/0016-7037(96)00100-7; Holzheid A, 2002, AM MINERAL, V87, P227; KINZLER RJ, 1992, J GEOPHYS RES-SOL EA, V97, P6885, DOI 10.1029/91JB02840; Lorand JP, 2001, GEOCHIM COSMOCHIM AC, V65, P2789, DOI 10.1016/S0016-7037(01)00627-5; Luguet A, 2003, GEOCHIM COSMOCHIM AC, V67, P1553, DOI 10.1016/S0016-7037(02)01133-X; Mavrogenes JA, 1999, GEOCHIM COSMOCHIM AC, V63, P1173, DOI 10.1016/S0016-7037(98)00289-0; Morgan JW, 2001, METEORIT PLANET SCI, V36, P1257, DOI 10.1111/j.1945-5100.2001.tb01959.x; O'Neill HSC, 2002, J PETROL, V43, P1049, DOI 10.1093/petrology/43.6.1049; ONEILL HSC, 1995, CHEM GEOL, V120, P255, DOI 10.1016/0009-2541(94)00141-T; Palme H., 2003, TREATISE GEOCHEMISTR, V2, P1, DOI DOI 10.1016/B978-0-08-095975-7.00201-1; Pearson D.G., 2004, TREATISE GEOCHEMISTR, P171, DOI DOI 10.1016/B0-08-043751-6/02005-3; Pearson DG, 2004, CHEM GEOL, V208, P29, DOI 10.1016/j.chemgeo.2004.04.005; PRESS S, 1986, GEOCHIM COSMOCHIM AC, V50, P2587, DOI 10.1016/0016-7037(86)90212-7; Puchtel I, 2000, GEOCHIM COSMOCHIM AC, V64, P4227, DOI 10.1016/S0016-7037(00)00492-0; Rehkamper M, 1999, EARTH PLANET SC LETT, V172, P65, DOI 10.1016/S0012-821X(99)00193-4; RYSHENKO B, 1973, AM J SCI, V273, P803; Schubert G, 2001, MANTLE CONVECTION EA; SPIEGELMAN M, 1993, EARTH PLANET SC LETT, V118, P1, DOI 10.1016/0012-821X(93)90155-3	28	229	244	1	57	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 24	2004	305	5692					1951	1953		10.1126/science.1100160	http://dx.doi.org/10.1126/science.1100160			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	857RM	15448267				2022-12-28	WOS:000224136000044
J	Siegert, MJ; Welch, B; Morse, D; Vieli, A; Blankenship, DD; Joughin, I; King, EC; Vieli, GJMCL; Payne, AJ; Jacobel, R				Siegert, MJ; Welch, B; Morse, D; Vieli, A; Blankenship, DD; Joughin, I; King, EC; Vieli, GJMCL; Payne, AJ; Jacobel, R			Ice flow direction change in interior West Antarctica	SCIENCE			English	Article							PENETRATING RADAR; STREAM; SHEET; ZONE; AGE	Upstream of Byrd Station (West Antarctica), ice-penetrating radar data reveal a distinctive fold structure within the ice, in which isochronous layers are unusually deep. The fold has an axis more than 50 kilometers long, which is aligned up to 45degrees to the ice flow direction. Although explanations for the fold's formation under the present flow are problematic, it can be explained if flow was parallel to the fold axis similar to 1500 years ago. This flow change may be associated with ice stream alterations nearer the margin. If this is true, central West Antarctica may respond to future alterations more than previously thought.	Univ Bristol, Sch Geog Sci, Bristol Glaciol Ctr, Ctr Polar Observat & Modelling, Bristol BS8 1SS, Avon, England; St Olaf Coll, Dept Phys, Northfield, MN 55057 USA; Univ Texas, John A & Katherine G Jackson Sch Geosci, Inst Geophys, Austin, TX 78759 USA; CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; British Antarctic Survey, Div Phys Sci, Cambridge CB3 0ET, England	University of Bristol; Saint Olaf College; University of Texas System; University of Texas Austin; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey	Siegert, MJ (corresponding author), Univ Bristol, Sch Geog Sci, Bristol Glaciol Ctr, Ctr Polar Observat & Modelling, Bristol BS8 1SS, Avon, England.	m.j.siegert@bristot.ac.uk	Joughin, Ian R/A-2998-2008; Joughin, Ian/AAR-7778-2021; Blankenship, Donald/G-5935-2010; payne, antony/A-8916-2008; Siegert, Martin/M-9939-2019; Siegert, Martin J/A-3826-2008; Vieli, Andreas/A-6767-2011	Joughin, Ian R/0000-0001-6229-679X; Joughin, Ian/0000-0001-6229-679X; payne, antony/0000-0001-8825-8425; Siegert, Martin/0000-0002-0090-4806; Siegert, Martin J/0000-0002-0090-4806; Leysinger Vieli, Gwendolyn/0000-0003-1817-0641				Ackert RP, 1999, SCIENCE, V286, P276, DOI 10.1126/science.286.5438.276; BLUNIER T, 2001, DATA CONTRIBUTION SE; Conway H, 1999, SCIENCE, V286, P280, DOI 10.1126/science.286.5438.280; Fahnestock M, 2001, SCIENCE, V294, P2338, DOI 10.1126/science.1065370; Fahnestock MA, 2000, J GLACIOL, V46, P652, DOI 10.3189/172756500781832693; Huybrechts P, 2002, QUATERNARY SCI REV, V21, P203, DOI 10.1016/S0277-3791(01)00082-8; JACOBEL RW, 1993, J GLACIOL, V39, P528; Jacobel RW, 2000, J GLACIOL, V46, P102, DOI 10.3189/172756500781833485; Jacobel RW, 1996, J GEOPHYS RES-SOL EA, V101, P5499, DOI 10.1029/95JB03735; Joughin I, 1999, SCIENCE, V286, P283, DOI 10.1126/science.286.5438.283; Joughin I, 2002, J GEOPHYS RES-SOL EA, V107, DOI 10.1029/2001JB001029; JOUGHIN I, IN PRESS J GLACIOL; Lythe MB, 2001, J GEOPHYS RES-SOL EA, V106, P11335, DOI 10.1029/2000JB900449; Morse DL, 2002, ANN GLACIOL-SER, V35, P36, DOI 10.3189/172756402781816636; Ng F, 2004, GEOLOGY, V32, P481, DOI 10.1130/g20317.1; Pettit EC, 2003, ANN GLACIOL, V37, P370, DOI 10.3189/172756403781815997; RAYMOND CF, 1983, J GLACIOL, V29, P357, DOI 10.3189/S0022143000030288; Siegert MJ, 2003, QUATERNARY RES, V59, P114, DOI 10.1016/S0033-5894(02)00014-5; Siegert MJ, 1996, ANTARCT SCI, V8, P281, DOI 10.1017/S0954102096000405; Vaughan DG, 1999, NATURE, V398, P323, DOI 10.1038/18653; WEERTMAN J, 1976, QUATERNARY RES, V6, P203, DOI 10.1016/0033-5894(76)90050-8; Welch BC, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017210	22	45	48	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 24	2004	305	5692					1948	1951		10.1126/science.1101072	http://dx.doi.org/10.1126/science.1101072			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	857RM	15448266				2022-12-28	WOS:000224136000043
J	Zeitoun, P; Faivre, G; Sebban, S; Mocek, T; Hallou, A; Fajardo, M; Aubert, D; Balcou, P; Burgy, F; Douillet, D; Kazamias, S; de Lacheze-Murel, G; Lefrou, T; le Pape, S; Mercere, P; Merdji, H; Morlens, AS; Rousseau, JP; Valentin, C				Zeitoun, P; Faivre, G; Sebban, S; Mocek, T; Hallou, A; Fajardo, M; Aubert, D; Balcou, P; Burgy, F; Douillet, D; Kazamias, S; de Lacheze-Murel, G; Lefrou, T; le Pape, S; Mercere, P; Merdji, H; Morlens, AS; Rousseau, JP; Valentin, C			A high-intensity highly coherent soft X-ray femtosecond laser seeded by a high harmonic beam	NATURE			English	Article							AMPLIFICATION; GENERATION; RADIATION	Synchrotrons have for decades provided invaluable sources of soft X-rays, the application of which has led to significant progress in many areas of science and technology. But future applications of soft X-rays - in structural biology, for example anticipate the need for pulses with much shorter duration (femtoseconds) and much higher energy (millijoules) than those delivered by synchrotrons. Soft X-ray free-electron lasers(1) should fulfil these requirements but will be limited in number; the pressure on beamtime is therefore likely to be considerable. Laser-driven soft X-ray sources offer a comparatively inexpensive and widely available alternative, but have encountered practical bottlenecks in the quest for high intensities. Here we establish and characterize a soft X-ray laser chain that shows how these bottlenecks can in principle be overcome. By combining the high optical quality available from high-harmonic laser sources ( as a seed beam) with a highly energetic soft X-ray laser plasma amplifier, we produce a tabletop soft X-ray femtosecond laser operating at 10 Hz and exhibiting full saturation, high energy, high coherence and full polarization. This technique should be readily applicable on all existing laser-driven soft X-ray facilities.	Lab Opt Appl, F-91761 Palaiseau, France; Inst Super Tecn, Ctr Fis Plasmas, P-1049001 Lisbon, Portugal; CEA, DIF, F-91680 Bruyeres Le Chatel, France; Univ Paris 11, Lab Interact Rayonnement X Avex Mat, F-91405 Orsay, France; Ecole Polytech, Lab Utilisat Lasers Intenses, F-91128 Palaiseau, France; CEA, SPAM, F-91191 Gif Sur Yvette, France	Universidade de Lisboa; Instituto Superior Tecnico; CEA; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Sorbonne Universite; CEA; Centre National de la Recherche Scientifique (CNRS); Institut Polytechnique de Paris; CEA; UDICE-French Research Universities; Universite Paris Saclay	Zeitoun, P (corresponding author), Lab Opt Appl, Chemin Huniere, F-91761 Palaiseau, France.	philippe.zeitoun@ensta.fr	Valentin, Constance/A-6899-2018; Mocek, Tomas/G-5344-2014; Balcou, Philippe/I-4624-2017; Fajardo, Marta/AAO-9798-2020; Fajardo, Marta/A-4608-2012	Valentin, Constance/0000-0001-7519-3829; Mocek, Tomas/0000-0002-9567-2875; Balcou, Philippe/0000-0002-5546-6436; Fajardo, Marta/0000-0003-2133-2365; Merdji, Hamed/0000-0003-3512-3855				Ayvazyan V, 2002, EUR PHYS J D, V20, P149, DOI 10.1140/epjd/e2002-00121-4; CASPERSON LW, 1972, IEEE J QUANTUM ELECT, VQE 8, P80, DOI 10.1109/JQE.1972.1076944; Daido H, 2002, REP PROG PHYS, V65, P1513, DOI 10.1088/0034-4885/65/10/204; DITMIRE T, 1995, PHYS REV A, V51, pR4337, DOI 10.1103/PhysRevA.51.R4337; Gibson EA, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.033001; Kazamias S, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.193901; Lee DG, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.243902; LEMOFF BE, 1994, OPT LETT, V19, P569, DOI 10.1364/OL.19.000569; MCGOWAN BJ, 1990, PHYS REV LETT, V65, P420; Mocek T, 2004, APPL PHYS B-LASERS O, V78, P939, DOI 10.1007/s00340-004-1436-3; MOCEK T, IN PRESS P 9 INT C X; PLOWES JA, 1995, OPT COMMUN, V116, P260, DOI 10.1016/0030-4018(95)00080-R; Reitze DH, 2004, OPT LETT, V29, P86, DOI 10.1364/OL.29.000086; Rocca JJ, 1999, REV SCI INSTRUM, V70, P3799, DOI 10.1063/1.1150041; RUS B, 1995, PHYS REV A, V51, P2316, DOI 10.1103/PhysRevA.51.2316; Sebban S, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.253901; Sebban S, 2003, J OPT SOC AM B, V20, P195, DOI 10.1364/JOSAB.20.000195; Sebban S, 2001, PHYS REV LETT, V86, P3004, DOI 10.1103/PhysRevLett.86.3004; Siegman A. E., 1986, LASER; Smith RF, 2003, OPT LETT, V28, P2261, DOI 10.1364/OL.28.002261; Takahashi E, 2003, J OPT SOC AM B, V20, P158, DOI 10.1364/JOSAB.20.000158	21	291	296	3	64	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 23	2004	431	7007					426	429		10.1038/nature02883	http://dx.doi.org/10.1038/nature02883			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855UN	15386005				2022-12-28	WOS:000224000500033
J	Tucker, J; McGuire, W				Tucker, J; McGuire, W			ABC of preterm birth - Epidemiology of preterm birth	BRITISH MEDICAL JOURNAL			English	Review									Univ Aberdeen, Dept Obstet & Gynaecol, Dugald Baird Ctr, Aberdeen AB9 1FX, Scotland; Univ Dundee, Ninewells Hosp & Med Sch, Tayside Inst Child Hlth, Dundee DD1 4HN, Scotland	University of Aberdeen; University of Dundee	Tucker, J (corresponding author), Univ Aberdeen, Dept Obstet & Gynaecol, Dugald Baird Ctr, Aberdeen AB9 1FX, Scotland.			McGuire, William/0000-0001-8572-3467				Draper ES, 1999, BRIT MED J, V319, P1093, DOI 10.1136/bmj.319.7217.1093; Kramer MS, 2000, PAEDIATR PERINAT EP, V14, P194, DOI 10.1046/j.1365-3016.2000.00266.x; Lumley J., 2000, COCHRANE DB SYST REV, V2; Slattery MM, 2002, LANCET, V360, P1489, DOI 10.1016/S0140-6736(02)11476-0; Wood NS, 2000, NEW ENGL J MED, V343, P378, DOI 10.1056/NEJM200008103430601	5	286	300	1	33	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	SEP 18	2004	329	7467					675	678		10.1136/bmj.329.7467.675	http://dx.doi.org/10.1136/bmj.329.7467.675			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	856JU	15374920	Green Published			2022-12-28	WOS:000224042300027
J	Huang, YZ; McNamara, JO				Huang, YZ; McNamara, JO			Ischemic stroke: "Acidotoxicity" is a perpetrator	CELL			English	Editorial Material							ACIDOSIS; CONTRIBUTES	Ischemic stroke is a devastating neurological disease. The responsible mechanisms are not completely understood. In this issue of Cell, Xiong et al. (2004) elucidate a molecular mechanism by which acidosis damages the brain during ischemia.	Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Med Neurol, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Pharmacol & Mol Canc Biol, Durham, NC 27710 USA	Duke University; Duke University; Duke University	Huang, YZ (corresponding author), Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS056217] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS056217] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		[Anonymous], 1996, ADV NEUROL; CHOI DW, 1988, NEURON, V1, P623, DOI 10.1016/0896-6273(88)90162-6; REHNCRONA S, 1985, ANN EMERG MED, V14, P770, DOI 10.1016/S0196-0644(85)80055-X; Siesjo BK, 1996, ADV NEUROL, V71, P209; TOMBAUGH GC, 1993, J NEUROCHEM, V61, P793, DOI 10.1111/j.1471-4159.1993.tb03589.x; Wemmie JA, 2002, NEURON, V34, P463, DOI 10.1016/S0896-6273(02)00661-X; Wemmie JA, 2003, J NEUROSCI, V23, P5496	7	73	79	2	7	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	SEP 17	2004	118	6					665	666		10.1016/j.cell.2004.09.004	http://dx.doi.org/10.1016/j.cell.2004.09.004			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	855RW	15369664	Bronze			2022-12-28	WOS:000223992400001
J	West, R				West, R			Japan bats a triple	SCIENCE			English	Editorial Material							MOLECULES; ELEMENTS; SILICON; BONDS		Univ Wisconsin, Dept Chem, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	West, R (corresponding author), Univ Wisconsin, Dept Chem, 1101 Univ Ave, Madison, WI 53706 USA.	rwest@wiscmail.wisc.edu						BROOK AG, 1981, CHEM COMMUN, P317; COWLEY AH, 1984, POLYHEDRON, V3, P389, DOI 10.1016/S0277-5387(00)84513-1; MAERKL G, 1986, ANGEW CHEM INT EDIT, V25, P264; MULLIKEN RS, 1955, J AM CHEM SOC, V77, P884, DOI 10.1021/ja01609a020; Nagase S, 2000, J ORGANOMET CHEM, V611, P264, DOI 10.1016/S0022-328X(00)00489-7; PITZER KS, 1948, J AM CHEM SOC, V70, P2140, DOI 10.1021/ja01186a043; Power PP, 2003, CHEM COMMUN, P2091, DOI 10.1039/b212224c; REGITZ M, 1990, CHEM REV, V90, P191, DOI 10.1021/cr00099a007; Sekiguchi A, 2004, SCIENCE, V305, P1755, DOI 10.1126/science.1102209; WEST R, 1981, SCIENCE, V214, P1343, DOI 10.1126/science.214.4527.1343	10	9	9	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 17	2004	305	5691					1724	1725		10.1126/science.1103582	http://dx.doi.org/10.1126/science.1103582			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	856IS	15375254				2022-12-28	WOS:000224039500025
J	Ambros, V				Ambros, V			The functions of animal microRNAs	NATURE			English	Article							C-ELEGANS; CAENORHABDITIS-ELEGANS; REGULATORY RNA; IDENTIFICATION; EXPRESSION; LIN-28; PREDICTION; ASYMMETRY; ANTISENSE; INHIBIT		Dartmouth Coll Sch Med, Dept Genet, Hanover, NH 03755 USA	Dartmouth College	Ambros, V (corresponding author), Dartmouth Coll Sch Med, Dept Genet, Hanover, NH 03755 USA.	vra@dartmouth.edu	yang, xiao-jun/B-1927-2009					Abrahante JE, 2003, DEV CELL, V4, P625, DOI 10.1016/S1534-5807(03)00127-8; Ambros V, 2003, RNA, V9, P277, DOI 10.1261/rna.2183803; Ambros V, 2003, CURR BIOL, V13, P807, DOI 10.1016/S0960-9822(03)00287-2; Bartel DP, 2004, NAT REV GENET, V5, P396, DOI 10.1038/nrg1328; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bashirullah A, 2003, DEV BIOL, V259, P1, DOI 10.1016/S0012-1606(03)00063-0; Brennecke J, 2003, CELL, V113, P25, DOI 10.1016/S0092-8674(03)00231-9; Chang S, 2004, NATURE, V430, P785, DOI 10.1038/nature02752; Chang S, 2003, GENE DEV, V17, P2123, DOI 10.1101/gad.1117903; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Doench JG, 2004, GENE DEV, V18, P504, DOI 10.1101/gad.1184404; Doench JG, 2003, GENE DEV, V17, P438, DOI 10.1101/gad.1064703; Enright AJ, 2004, GENOME BIOL, V5; Feinbaum R, 1999, DEV BIOL, V210, P87, DOI 10.1006/dbio.1999.9272; Grad Y, 2003, MOL CELL, V11, P1253, DOI 10.1016/S1097-2765(03)00153-9; Hipfner DR, 2002, GENETICS, V161, P1527; Houbaviy HB, 2003, DEV CELL, V5, P351, DOI 10.1016/S1534-5807(03)00227-2; Hutvagner G, 2004, PLOS BIOL, V2, P465, DOI 10.1371/journal.pbio.0020098; Hutvagner G, 2002, SCIENCE, V297, P2056, DOI 10.1126/science.1073827; Johnston RJ, 2003, NATURE, V426, P845, DOI 10.1038/nature02255; Kiriakidou M, 2004, GENE DEV, V18, P1165, DOI 10.1101/gad.1184704; Lagos-Quintana M, 2003, RNA, V9, P175, DOI 10.1261/rna.2146903; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Lai EC, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-7-r42; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Lee RC, 2001, SCIENCE, V294, P862, DOI 10.1126/science.1065329; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lim LP, 2003, SCIENCE, V299, P1540, DOI 10.1126/science.1080372; Lim LP, 2003, GENE DEV, V17, P991, DOI 10.1101/gad.1074403; Lin SY, 2003, DEV CELL, V4, P639, DOI 10.1016/S1534-5807(03)00124-2; Meister G, 2004, RNA, V10, P544, DOI 10.1261/rna.5235104; Moss EG, 2003, DEV BIOL, V258, P432, DOI 10.1016/S0012-1606(03)00126-X; Moss EG, 1997, CELL, V88, P637, DOI 10.1016/S0092-8674(00)81906-6; Olsen PH, 1999, DEV BIOL, V216, P671, DOI 10.1006/dbio.1999.9523; Rajewsky N, 2004, DEV BIOL, V267, P529, DOI 10.1016/j.ydbio.2003.12.003; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Rhoades MW, 2002, CELL, V110, P513, DOI 10.1016/S0092-8674(02)00863-2; Seggerson K, 2002, DEV BIOL, V243, P215, DOI 10.1006/dbio.2001.0563; Seitz H, 2003, NAT GENET, V34, P261, DOI 10.1038/ng1171; Sernpere LF, 2003, DEV BIOL, V259, P9, DOI 10.1016/S0012-1606(03)00208-2; Slack FJ, 2000, MOL CELL, V5, P659, DOI 10.1016/S1097-2765(00)80245-2; Stark A, 2003, PLOS BIOL, V1, P397, DOI 10.1371/journal.pbio.0000060; Tang GL, 2003, GENE DEV, V17, P49, DOI 10.1101/gad.1048103; Vella MC, 2004, GENE DEV, V18, P132, DOI 10.1101/gad.1165404; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; Xu PZ, 2003, CURR BIOL, V13, P790, DOI 10.1016/S0960-9822(03)00250-1; Yekta S, 2004, SCIENCE, V304, P594, DOI 10.1126/science.1097434; Zeng Y, 2003, P NATL ACAD SCI USA, V100, P9779, DOI 10.1073/pnas.1630797100; Zeng Y, 2002, MOL CELL, V9, P1327, DOI 10.1016/S1097-2765(02)00541-5	51	8640	9305	26	941	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 16	2004	431	7006					350	355		10.1038/nature02871	http://dx.doi.org/10.1038/nature02871			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	853XJ	15372042				2022-12-28	WOS:000223864000051
J	Bizzarro, M; Baker, JA; Haack, H				Bizzarro, M; Baker, JA; Haack, H			Mg isotope evidence for contemporaneous formation of chondrules and refractory inclusions	NATURE			English	Article							SHORT-LIVED NUCLIDES; ALUMINUM-RICH INCLUSIONS; SOLAR-SYSTEM; FERROMAGNESIAN CHONDRULES; NEBULA; ORIGIN; AL-26; CONSTRAINTS; AGES	Primitive or undifferentiated meteorites (chondrites) date back to the origin of the Solar System(1), and thus preserve a record of the physical and chemical processes that occurred during the earliest evolution of the accretion disk surrounding the young Sun. The oldest Solar System materials present within these meteorites are millimetre- to centimetre-sized calcium-aluminium-rich inclusions (CAIs) and ferromagnesian silicate spherules (chondrules), which probably originated by thermal processing of pre-existing nebula solids(2-4). Chondrules are currently believed to have formed similar to2-3 million years (Myr) after CAIs (refs 5-10)-a timescale inconsistent with the dynamical lifespan of small particles in the early Solar System(11). Here, we report the presence of excess Mg-26 resulting from in situ decay of the short-lived Al-26 nuclide in CAIs and chondrules from the Allende meteorite. Six CAIs define an isochron corresponding to an initial Al-26/Al-27 ratio of (5.25 +/- 0.10) x 10(-5), and individual model ages with uncertainties as low as +/-30,000 years, suggesting that these objects possibly formed over a period as short as 50,000 years. In contrast, the chondrules record a range of initial Al-26/Al-27 ratios from (5.66 +/- 0.80) to (1.36 +/- 0.52) x 10(-5), indicating that Allende chondrule formation began contemporaneously with the formation of CAIs, and continued for at least 1.4 Myr. Chondrule formation processes recorded by Allende and other chondrites may have persisted for at least 2-3 Myr in the young Solar System.	Danish Lithosphere Ctr, DK-1350 Copenhagen, Denmark; Geol Museum, DK-1350 Copenhagen, Denmark; Victoria Univ Wellington, Sch Earth Sci, Wellington, New Zealand	Victoria University Wellington	Bizzarro, M (corresponding author), Danish Lithosphere Ctr, OSter Voldgade 10, DK-1350 Copenhagen, Denmark.	mbi@dlc.ku.dk	Haack, Henning/A-4807-2013; Bizzarro, Martin/I-8701-2012; Baker, Joel/A-3477-2008; Bizzarro, Martin/M-7474-2019	Haack, Henning/0000-0002-4618-3178; Bizzarro, Martin/0000-0001-9966-2124; Bizzarro, Martin/0000-0001-9966-2124; Baker, Joel/0000-0001-6371-5060				ADACHI I, 1976, PROG THEOR PHYS, V56, P1756, DOI 10.1143/PTP.56.1756; Alexander CMO, 2001, SCIENCE, V293, P64; Amelin Y, 2002, SCIENCE, V297, P1678, DOI 10.1126/science.1073950; AMELIN Y, 2004, GEOCHIM COSMOCHIM AC, V68; BISCHOFF A, 1984, GEOCHIM COSMOCHIM AC, V48, P693, DOI 10.1016/0016-7037(84)90096-6; Busso M, 1999, ANNU REV ASTRON ASTR, V37, P239, DOI 10.1146/annurev.astro.37.1.239; Desch SJ, 2002, METEORIT PLANET SCI, V37, P183, DOI 10.1111/j.1945-5100.2002.tb01104.x; Galy A, 2003, J ANAL ATOM SPECTROM, V18, P1352, DOI 10.1039/b309273a; Galy A, 2000, SCIENCE, V290, P1751, DOI 10.1126/science.290.5497.1751; Goswami JN, 2004, NEW ASTRON REV, V48, P125, DOI 10.1016/j.newar.2003.11.018; Hsu WB, 2003, METEORIT PLANET SCI, V38, P35, DOI 10.1111/j.1945-5100.2003.tb01044.x; Huss GR, 2001, METEORIT PLANET SCI, V36, P975, DOI 10.1111/j.1945-5100.2001.tb01934.x; Itoh S, 2003, NATURE, V423, P728, DOI 10.1038/nature01699; Kita NT, 2000, GEOCHIM COSMOCHIM AC, V64, P3913, DOI 10.1016/S0016-7037(00)00488-9; MacPherson GJ, 2005, TREATISE GEOCHEM, V1, P201; Marhas KK, 2002, SCIENCE, V298, P2182, DOI 10.1126/science.1078322; MCDONOUGH WF, 1995, CHEM GEOL, V120, P223, DOI 10.1016/0009-2541(94)00140-4; Mostefaoui S, 2002, METEORIT PLANET SCI, V37, P421, DOI 10.1111/j.1945-5100.2002.tb00825.x; PODOSEK FA, 1994, METEORITICS, V29, P6, DOI 10.1111/j.1945-5100.1994.tb00649.x; Richter FM, 2002, GEOCHIM COSMOCHIM AC, V66, P521, DOI 10.1016/S0016-7037(01)00782-7; Rubin AE, 2000, EARTH-SCI REV, V50, P3, DOI 10.1016/S0012-8252(99)00067-7; Russell SS, 1996, SCIENCE, V273, P757, DOI 10.1126/science.273.5276.757; Sahijpal S, 1998, NATURE, V391, P559, DOI 10.1038/35325; SANERS IA, 1996, CHONDRULES PROTOPLAN, P327; Shu FH, 2001, ASTROPHYS J, V548, P1029, DOI 10.1086/319018; Srinivasan G, 1999, SCIENCE, V284, P1348, DOI 10.1126/science.284.5418.1348; UREY HC, 1955, P NATL ACAD SCI USA, V41, P127, DOI 10.1073/pnas.41.3.127; WASSERBURG GJ, 1995, ASTROPHYS J, V440, pL101, DOI 10.1086/187771; Weidenschilling SJ, 1998, SCIENCE, V279, P681, DOI 10.1126/science.279.5351.681	30	211	217	2	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 16	2004	431	7006					275	278		10.1038/nature02882	http://dx.doi.org/10.1038/nature02882			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	853XJ	15372023				2022-12-28	WOS:000223864000031
J	Nioche, P; Berka, V; Vipond, J; Minton, N; Tsai, AL; Raman, CS				Nioche, P; Berka, V; Vipond, J; Minton, N; Tsai, AL; Raman, CS			Femtomolar sensitivity of a NO sensor from Clostridium botulinum	SCIENCE			English	Article							SOLUBLE GUANYLATE-CYCLASE; NITRIC-OXIDE; OXYGEN-BINDING; BOVINE LUNG; HEME; RESONANCE; PROTEINS; FNR	Nitric oxide (NO) is extremely toxic to Clostridium botulinum, but its molecular targets are unknown. Here, we identify a heme protein sensor (SONO) that displays femtomolar affinity for NO. The crystal structure of the SONO heme domain reveals a previously undescribed fold and a strategically placed tyrosine residue that modulates heme-nitrosyl coordination. Furthermore, the domain architecture of a SONO ortholog cloned from Chlamydomonas reinhardtii indicates that NO signaling through cyclic guanosine monophosphate arose before the origin of multicellular eukaryotes. Our findings have broad implications for understanding bacterial responses to NO, as well as for the activation of mammalian NO-sensitive guanylyl cyclase.	Univ Texas, Sch Med, Struct Biol Res Ctr, Houston, TX 77030 USA; Univ Texas, Sch Med, Dept Biochem & Mol Biol, Houston, TX 77030 USA; Univ Texas, Sch Med, Div Hematol, Houston, TX 77030 USA; Hlth Protect Agcy, Salisbury SP4 0JG, Wilts, England; Univ Nottingham, Ctr Biomol Sci, Nottingham NG7 2RD, England; Univ Nottingham, Inst Infect Immun & Inflammat, Nottingham NG7 2RD, England	University of Texas System; University of Texas System; University of Texas System; Health Protection Agency; University of Nottingham; University of Nottingham	Raman, CS (corresponding author), Univ Texas, Sch Med, Struct Biol Res Ctr, Houston, TX 77030 USA.	c.s.raman@uth.tmc.edu		Minton, Nigel/0000-0002-9277-1261; Raman, C. S./0000-0002-1036-3193	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI054444] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI054444, R01 AI054444-05] Funding Source: Medline; PHS HHS [AY343540] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		CAMILLI A, COMMUNICATION; Cammack R, 1999, BBA-BIOENERGETICS, V1411, P475, DOI 10.1016/S0005-2728(99)00033-X; Corker H, 2003, J BIOL CHEM, V278, P31584, DOI 10.1074/jbc.M303282200; Davidson M., 2001, FOOD MICROBIOLOGY FU, P593; FERGUSON SJ, 1991, BIOCHIM BIOPHYS ACTA, V1058, P17, DOI 10.1016/S0005-2728(05)80259-2; Ford PC, 2002, CHEM REV, V102, P993, DOI 10.1021/cr0000271; GERZER R, 1981, FEBS LETT, V132, P71, DOI 10.1016/0014-5793(81)80429-2; Hou SB, 2000, NATURE, V403, P540, DOI 10.1038/35000570; Ignarro LJ, 2000, NITRIC OXIDE BIOL PA, P3; Karow DS, 2004, BIOCHEMISTRY-US, V43, P10203, DOI 10.1021/bi049374l; Kharitonov VG, 1997, BIOCHEMISTRY-US, V36, P6814, DOI 10.1021/bi970201o; Knoll AH, 1999, SCIENCE, V285, P1025, DOI 10.1126/science.285.5430.1025; Koesling D, 2004, NEUROCHEM INT, V45, P813, DOI 10.1016/j.neuint.2004.03.011; Martin W, 1998, NATURE, V393, P162, DOI 10.1038/30234; Merrell DS, 2002, NATURE, V417, P642, DOI 10.1038/nature00778; Murad F, 1999, ANGEW CHEM INT EDIT, V38, P1857, DOI 10.1002/(SICI)1521-3773(19990712)38:13/14<1856::AID-ANIE1856>3.0.CO;2-D; OLSON JS, COMMUNICATION; Outten CE, 2001, SCIENCE, V292, P2488, DOI 10.1126/science.1060331; Pellicena P, 2004, P NATL ACAD SCI USA, V101, P12854, DOI 10.1073/pnas.0405188101; Pesce A, 2004, J BIOL CHEM, V279, P33662, DOI 10.1074/jbc.M403597200; Phillips GN, 1999, J PHYS CHEM B, V103, P8817, DOI 10.1021/jp9918205; Polleux F, 2000, NATURE, V404, P567, DOI 10.1038/35007001; REDDY D, 1983, SCIENCE, V221, P769, DOI 10.1126/science.6308761; STONE JR, 1994, BIOCHEMISTRY-US, V33, P5636, DOI 10.1021/bi00184a036; Thomas MR, 2001, BIOCHEMISTRY-US, V40, P15047, DOI 10.1021/bi011440l; TIMKOVICH R, COMMUNICATION; TRAYLOR TG, 1992, BIOCHEMISTRY-US, V31, P2847, DOI 10.1021/bi00126a001; WEDEL B, 1994, P NATL ACAD SCI USA, V91, P2592, DOI 10.1073/pnas.91.7.2592; WILLIAMS RJP, 1991, BIOCHIM BIOPHYS ACTA, V1058, P71, DOI 10.1016/S0005-2728(05)80272-5; Wyllie GRA, 2002, CHEM REV, V102, P1067, DOI 10.1021/cr000080p; Xue YF, 2001, INT J SYST EVOL MICR, V51, P1335, DOI 10.1099/00207713-51-4-1335; Yonetani T, 1998, J BIOL CHEM, V273, P20323, DOI 10.1074/jbc.273.32.20323; Zumft WG, 2002, J MOL MICROB BIOTECH, V4, P277	33	169	177	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 26	2004	306	5701					1550	1553		10.1126/science.1103596	http://dx.doi.org/10.1126/science.1103596			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	875ST	15472039				2022-12-28	WOS:000225442700057
J	Sedrakyan, A; van der Meulen, J; Lewsey, J; Treasure, T				Sedrakyan, A; van der Meulen, J; Lewsey, J; Treasure, T			Video assisted thoracic surgery for treatment of pneumothorax and lung resections: systematic review of randomised clinical trials	BMJ-BRITISH MEDICAL JOURNAL			English	Article							SOLITARY PULMONARY NODULE; THORACOSCOPIC SURGERY; THORACOTOMY; LOBECTOMY; DIAGNOSIS; DISEASE; BIOPSY; CANCER	Objectives To determine if video assisted thoracic surgery is associated with better clinical outcomes than thoracotomy for three common procedures: surgery for pneumothorax, minor resections, and lobectomy. Design Systematic review of randomised clinical trials. Data sources Medline, Embase, Cochrane database of systematic reviews, Cochrane controlled trials register. Reference lists of relevant articles and reviews. Methods Criteria for inclusion were random allocation of patients and no concurrent use of another experimental medication or device. At least two authors performed and confirmed data abstraction and analyses. Information on quality of trials, demographics, frequency of the events, and numbers randomised were collected. Results 12 trials randomised 670 patients. Video assisted thoracic surgery was associated with shorter length of stay (reduction ranged from 1.0 to 4.2 days) and less pain or use of pain medication than thoracotomy in the five out of seven trials in which the technique was used for pneumothorax or minor lung resection. In the treatment of pneumothorax, video assisted thoracic surgery was associated with substantially fewer recurrences than pleural drainage in two trials (from 20 to 53 events prevented per 100 treated patients). No substantial advantages were observed for video assisted thoracic surgery in lobectomies. Conclusions Video assisted thoracic surgery is associated with better outcomes and seems to have a complication profile comparable with that of thoracotomy for the treatment of pneumothorax and minor resections. As for lobectomy, further studies are needed to determine how it compares with thoracotomy.	Guys Hosp, Cardiothorac Unit, London SE1 9RT, England; Univ London London Sch Hyg & Trop Med, Dept Publ Hlth & Policy, Hlth Serv Res Unit, London WC1E 7HT, England	Guy's & St Thomas' NHS Foundation Trust; University of London; London School of Hygiene & Tropical Medicine	Treasure, T (corresponding author), Guys Hosp, Cardiothorac Unit, London SE1 9RT, England.	Tom.Treasure@ukgateway.net	Lewsey, James/F-7546-2010	van der Meulen, Jan/0000-0002-9451-2335				Abdala OA, 2001, MEDICINA-BUENOS AIRE, V61, P157; Ayed AK, 2000, MED PRIN PRACT, V9, P113, DOI 10.1159/000026127; Ayed AK, 2000, J ROY COLL SURG EDIN, V45, P159; Cardillo G, 2003, ANN THORAC SURG, V75, P1607, DOI 10.1016/S0003-4975(02)04827-0; Craig SR, 2001, EUR J CARDIO-THORAC, V20, P455, DOI 10.1016/S1010-7940(01)00841-7; de Andres JJR, 2002, ARCH BRONCONEUMOL, V38, P60; Gebhard FT, 1996, ARCH SURG-CHICAGO, V131, P1079; Gharagozloo F, 2003, ANN THORAC SURG, V76, P1009, DOI 10.1016/S0003-4975(03)00267-4; Hatz RA, 2000, ANN THORAC SURG, V70, P253, DOI 10.1016/S0003-4975(00)01411-9; HAZELRIGG SR, 1993, ANN THORAC SURG, V56, P633, DOI 10.1016/0003-4975(93)90934-A; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Jimenez MF, 2001, EUR J CARDIO-THORAC, V19, P562, DOI 10.1016/S1010-7940(01)00650-9; KIRBY TJ, 1995, J THORAC CARDIOV SUR, V109, P997, DOI 10.1016/S0022-5223(95)70326-8; Margolis M, 2003, ANN THORAC SURG, V76, P1661, DOI 10.1016/S0003-4975(02)04816-6; Miller JD, 2000, ANN THORAC SURG, V70, P1647, DOI 10.1016/S0003-4975(00)01913-5; SANTAMBROGIO L, 1995, ANN THORAC SURG, V59, P868, DOI 10.1016/0003-4975(94)00952-4; Sekine Y, 1999, EUR J CARDIO-THORAC, V16, P48, DOI 10.1016/S1010-7940(99)00142-6; Sugi K, 2000, WORLD J SURG, V24, P27, DOI 10.1007/s002689910006; Tschopp JM, 2002, EUR RESPIR J, V20, P1003, DOI 10.1183/09031936.02.00278202; WAKABAYASHI A, 1991, J THORAC CARDIOV SUR, V102, P721; Walker WS, 2003, EUR J CARDIO-THORAC, V23, P397, DOI 10.1016/S1010-7940(02)00814-X; WALLER DA, 1994, ANN THORAC SURG, V58, P372, DOI 10.1016/0003-4975(94)92210-1	22	79	83	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 30	2004	329	7473					1008	1010A		10.1136/bmj.38243.440486.55	http://dx.doi.org/10.1136/bmj.38243.440486.55			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	867OR	15385408	Bronze, Green Published, Green Submitted, Green Accepted			2022-12-28	WOS:000224852400018
J	Hammer, NI; Shin, JW; Headrick, JM; Diken, EG; Roscioli, JR; Weddle, GH; Johnson, MA				Hammer, NI; Shin, JW; Headrick, JM; Diken, EG; Roscioli, JR; Weddle, GH; Johnson, MA			How do small water clusters bind an excess electron?	SCIENCE			English	Article							SIZE-DEPENDENT COMPETITION; HYDRATED-ELECTRON; SOLVATED ELECTRON; PREDISSOCIATION SPECTROSCOPY; PHOTOELECTRON-SPECTROSCOPY; INFRARED-SPECTROSCOPY; DYNAMICS; SPECTRA; ABSORPTION; ANIONS	The arrangement of water molecules around a hydrated electron has eluded explanation for more than 40 years. Here we report sharp vibrational bands for small gas-phase water cluster anions, (H2O)(4-6)(-) and (D2O)(4-6)(-). Analysis of these bands reveals a detailed picture of the diffuse electron-binding site. The electron is closely associated with a single water molecule attached to the supporting network through a double H-bond acceptor motif. The local OH stretching bands of this molecule are dramatically distorted in the pentamer and smaller clusters because the excited vibrational levels are strongly coupled to the electron continuum. The vibration-to-electronic energy transfer rates, as revealed by tine shape analysis, are mode-specific and remarkably fast, with the symmetric stretching mode surviving for less than 10 vibrational periods [50 fs in (H2O)(4)(-)].	Yale Univ, Sterling Chem Lab, New Haven, CT 06520 USA	Yale University	Johnson, MA (corresponding author), Yale Univ, Sterling Chem Lab, POB 208107, New Haven, CT 06520 USA.	mark.johnson@yale.edu	Shin, Joong-Won/D-5213-2009	Hammer, Nathan/0000-0002-6221-2709				Arnold ST, 1996, J PHYS CHEM-US, V100, P2900, DOI 10.1021/jp952584a; Ayotte P, 1998, J CHEM PHYS, V108, P444, DOI 10.1063/1.475406; Ayotte P, 1999, J CHEM PHYS, V110, P6268, DOI 10.1063/1.478531; AYOTTE P, 1999, THESIS YALE U; Bailey CG, 1996, J PHYS CHEM-US, V100, P16782, DOI 10.1021/jp962268b; Baltuska A, 1999, J PHYS CHEM A, V103, P10065, DOI 10.1021/jp992482a; BARNETT RN, 1988, J CHEM PHYS, V88, P4421, DOI 10.1063/1.454726; Beyer MK, 2001, J CHEM PHYS, V115, P9288, DOI 10.1063/1.1413982; CAMPAGNOLA PJ, 1991, J CHEM PHYS, V94, P5240, DOI 10.1063/1.460530; COE JV, 1990, J CHEM PHYS, V92, P3980, DOI 10.1063/1.457805; Corcelli SA, 2002, J PHYS CHEM A, V106, P4872, DOI 10.1021/jp013956k; FANO U, 1961, PHYS REV, V124, P1866, DOI 10.1103/PhysRev.124.1866; GOLDEN S, 1979, J CHEM SOC FARAD T 2, V75, P474, DOI 10.1039/f29797500474; HABERLAND H, 1984, BER BUNSEN PHYS CHEM, V88, P270, DOI 10.1002/bbpc.19840880322; HABERLAND H, 1984, J CHEM PHYS, V81, P3742, DOI 10.1063/1.448127; HABERLAND H, 1984, J PHYS CHEM-US, V88, P3903, DOI 10.1021/j150661a042; HART EJ, 1962, J AM CHEM SOC, V84, P4090, DOI 10.1021/ja00880a025; Jordan KD, 2003, ANNU REV PHYS CHEM, V54, P367, DOI 10.1146/annurev.physchem.54.011002.103851; Kambhampati P, 2002, J PHYS CHEM A, V106, P2374, DOI 10.1021/jp014291p; Kim J, 1998, CHEM PHYS LETT, V297, P90, DOI 10.1016/S0009-2614(98)01109-9; Kraus CA, 1908, J AM CHEM SOC, V30, P1323, DOI 10.1021/ja01951a001; Lee HM, 2003, J CHEM PHYS, V119, P187, DOI 10.1063/1.1576757; OGG RA, 1946, J CHEM PHYS, V14, P114, DOI 10.1063/1.1724103; Paul JB, 1999, J PHYS CHEM A, V103, P2972, DOI 10.1021/jp984618v; POSEY LA, 1988, J CHEM PHYS, V89, P4807, DOI 10.1063/1.455674; Price EA, 2004, J PHYS CHEM A, V108, P3910, DOI 10.1021/jp031239f; Pshenichnikov MS, 2004, CHEM PHYS LETT, V389, P171, DOI 10.1016/j.cplett.2004.03.107; Rau ARP, 2004, PHYS SCRIPTA, V69, pC10, DOI 10.1238/Physica.Regular.069a00C10; Robertson WH, 2000, REV SCI INSTRUM, V71, P4431, DOI 10.1063/1.1326931; Robertson WH, 2002, J CHEM PHYS, V116, P4853, DOI 10.1063/1.1451249; Robertson WH, 2003, ANNU REV PHYS CHEM, V54, P173, DOI 10.1146/annurev.physchem.54.011002.103801; SCHWARTZ BJ, 1994, J CHEM PHYS, V101, P6917, DOI 10.1063/1.468320; SHIN JW, IN PRESS CHEM PHYS L; Silva C, 1998, PHYS REV LETT, V80, P1086, DOI 10.1103/PhysRevLett.80.1086; Sobolewski AL, 2002, PHYS CHEM CHEM PHYS, V4, P4, DOI 10.1039/b107373g; Tauber MJ, 2003, J AM CHEM SOC, V125, P1394, DOI 10.1021/ja021134a; TSAI CJ, 1993, CHEM PHYS LETT, V213, P181, DOI 10.1016/0009-2614(93)85438-T; Tsurusawa T, 1999, CHEM PHYS LETT, V315, P433, DOI 10.1016/S0009-2614(99)01279-8; Weyl W., 1864, ANN PHYS CHEM, V197, P601	40	263	286	3	98	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 22	2004	306	5696					675	679		10.1126/science.1102792	http://dx.doi.org/10.1126/science.1102792			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866EN	15375220				2022-12-28	WOS:000224756700048
J	Paik, DH; Lee, IR; Yang, DS; Baskin, JS; Zewail, AH				Paik, DH; Lee, IR; Yang, DS; Baskin, JS; Zewail, AH			Electrons in finite-sized water cavities: Hydration dynamics observed in real time	SCIENCE			English	Article							PHOTOELECTRON-SPECTROSCOPY; SOLVATION DYNAMICS; LIQUID WATER; FEMTOSECOND DYNAMICS; PRESOLVATED ELECTRON; CLUSTER ANIONS; AB-INITIO; ENERGY; STATES; (H2O)(N)(-)	We directly observed the hydration dynamics of an excess electron in the finite-sized water clusters of (H2O)(n)(-) with n=15, 20, 25, 30, and 35. We initiated the solvent motion by exciting the hydrated electron in the cluster. By resolving the binding energy of the excess electron in real time with femtosecond resolution, we captured the ultrafast dynamics of the electron in the presolvated ("wet") and hydrated states and obtained, as a function of cluster size, the subsequent relaxation times. The solvation time (300 femtoseconds) after the internal conversion [140 femtoseconds for (H2O)(35)(-)] was similar to that of bulk water, indicating the dominant role of the local water structure in the dynamics of hydration. In contrast, the relaxation in other nuclear coordinates was on a much longer time scale (2 to 10 pico-seconds) and depended critically on cluster size.	CALTECH, Arthur Amos Noyes Lab Chem Phys, Lab Mol Sci, Pasadena, CA 91125 USA	California Institute of Technology	Zewail, AH (corresponding author), CALTECH, Arthur Amos Noyes Lab Chem Phys, Lab Mol Sci, Pasadena, CA 91125 USA.	zewail@caltech.edu	Yang, Ding-Shyue/A-8648-2010	Yang, Ding-Shyue/0000-0003-2713-9128; Lee, I-Ren/0000-0001-5655-6049; gaber, sarah/0000-0002-5995-7291				ALFANO JC, 1993, J CHEM PHYS, V98, P5996, DOI 10.1063/1.464839; Anderson NA, 2000, CHEM PHYS LETT, V329, P386, DOI 10.1016/S0009-2614(00)01046-0; ARMBRUSTER M, 1981, PHYS REV LETT, V47, P323, DOI 10.1103/PhysRevLett.47.323; Arnold ST, 1996, J PHYS CHEM-US, V100, P2900, DOI 10.1021/jp952584a; Assel M, 2000, CHEM PHYS LETT, V317, P13, DOI 10.1016/S0009-2614(99)01369-X; Ayotte P, 1997, J CHEM PHYS, V106, P811, DOI 10.1063/1.473167; Ayotte P, 1999, J CHEM PHYS, V110, P6268, DOI 10.1063/1.478531; Baltuska A, 1999, J PHYS CHEM A, V103, P10065, DOI 10.1021/jp992482a; BARNETT RN, 1988, J CHEM PHYS, V88, P4429, DOI 10.1063/1.453801; CAMPAGNOLA PJ, 1991, J CHEM PHYS, V95, P7998, DOI 10.1063/1.461330; Castleman AW, 1996, J PHYS CHEM-US, V100, P12911, DOI 10.1021/jp961030k; COE JV, 1990, J CHEM PHYS, V92, P3980, DOI 10.1063/1.457805; Coe JV, 1997, J CHEM PHYS, V107, P6023, DOI 10.1063/1.474271; Diau EWG, 1998, SCIENCE, V279, P847, DOI 10.1126/science.279.5352.847; Goldman N, 2004, J CHEM PHYS, V120, P4777, DOI 10.1063/1.1645777; Hertwig A, 2002, PHYS CHEM CHEM PHYS, V4, P4412, DOI 10.1039/b204530n; JOHNSON MA, 1988, TECHNIQUES CHEM, V20, P591; KAHN A, 2004, J CHEM PHYS, V121, P280; Kim J, 1999, J CHEM PHYS, V111, P10077, DOI 10.1063/1.480326; Kim J, 1997, J CHEM PHYS, V106, P10207, DOI 10.1063/1.474106; Kummrow A, 1998, J PHYS CHEM A, V102, P4172, DOI 10.1021/jp980254v; Lehr L, 1999, SCIENCE, V284, P635, DOI 10.1126/science.284.5414.635; LONG FH, 1990, PHYS REV LETT, V64, P1469, DOI 10.1103/PhysRevLett.64.1469; MIGUS A, 1987, PHYS REV LETT, V58, P1559, DOI 10.1103/PhysRevLett.58.1559; NERIA E, 1991, PHYS REV LETT, V67, P1011, DOI 10.1103/PhysRevLett.67.1011; Nicolas C, 2003, J CHEM PHYS, V118, P9689, DOI 10.1063/1.1570407; Paik DH, 2003, J CHEM PHYS, V118, P6923, DOI 10.1063/1.1561433; Pal SK, 2004, CHEM REV, V104, P2099, DOI 10.1021/cr020689l; Pshenichnikov MS, 2004, CHEM PHYS LETT, V389, P171, DOI 10.1016/j.cplett.2004.03.107; Smith DMA, 1997, J CHEM PHYS, V107, P5788, DOI 10.1063/1.474338; Sobolewski AL, 2003, PHYS CHEM CHEM PHYS, V5, P1130, DOI 10.1039/b211893a; Stolow A, 2004, CHEM REV, V104, P1719, DOI 10.1021/cr020683w; Weber JM, 2001, CHEM PHYS LETT, V339, P337, DOI 10.1016/S0009-2614(01)00295-0; Yang CY, 2001, J CHEM PHYS, V114, P3598, DOI 10.1063/1.1343871; Yokoyama K, 1998, J PHYS CHEM A, V102, P6957, DOI 10.1021/jp981809p; Zhong DP, 1998, J PHYS CHEM A, V102, P4031, DOI 10.1021/jp9805196	36	195	217	4	61	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 22	2004	306	5696					672	675		10.1126/science.1102827	http://dx.doi.org/10.1126/science.1102827			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866EN	15375221				2022-12-28	WOS:000224756700047
J	Fowlie, PW; McGuire, W				Fowlie, PW; McGuire, W			ABC of preterm birth - Immediate care of the preterm infant	BRITISH MEDICAL JOURNAL			English	Review									Perth Royal Infirm, Perth, Scotland; Univ Dundee, Tayside Inst Child Hlth, Ninewells Hosp & Med Sch, Dundee DD1 4HN, Scotland	University of Dundee	Fowlie, PW (corresponding author), Perth Royal Infirm, Perth, Scotland.			McGuire, William/0000-0001-8572-3467				Gee H, 2000, PRENAT NEONAT MED, V5, P209; *JOINT WORK PART R, 1997, RES BAB BIRTH; *RES COUNC, 2002, RES BIRTH NEWB LIF S; SOLL RF, 2003, COCHRANE DATABASE SY, DOI UNSP CD000510; Wood NS, 2000, NEW ENGL J MED, V343, P378, DOI 10.1056/NEJM200008103430601	5	6	7	0	4	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 9	2004	329	7470					845	848		10.1136/bmj.329.7470.845	http://dx.doi.org/10.1136/bmj.329.7470.845			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	862EK	15472269	Green Published			2022-12-28	WOS:000224472800025
J	Bradley, EH; Herrin, J; Wang, YF; McNamara, RL; Webster, TR; Magid, DJ; Blaney, M; Peterson, ED; Canto, JG; Pollack, CV; Krumholz, HM				Bradley, EH; Herrin, J; Wang, YF; McNamara, RL; Webster, TR; Magid, DJ; Blaney, M; Peterson, ED; Canto, JG; Pollack, CV; Krumholz, HM			Racial and ethnic differences in time to acute reperfusion therapy for patients hospitalized with myocardial infarction	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							NATIONAL REGISTRY; REVASCULARIZATION PROCEDURES; MORTALITY; DELAY; CLASSIFICATIONS; ANGIOPLASTY; OUTCOMES; RACE	Context Nonwhite patients experience significantly longer times to fibrinolytic therapy (door-to-drug times) and percutaneous coronary intervention (door-to-balloon times) than white patients, raising concerns of health care disparities, but the reasons for these patterns are poorly understood. Objectives To estimate race/ethnicity differences in door-to-drug and door-to-balloon times for patients receiving primary reperfusion for ST-segment elevation myocardial infarction; to examine how sociodemographic factors, insurance status, clinical characteristics, and hospital features mediate racial/ethnic differences. Design, Setting, and Patients Retrospective, observational study using admission and treatment data from the National Registry of Myocardial infarction (NRMI) for a US cohort of patients with ST-segment elevation myocardial infarction or left bundle-branch block and receiving reperfusion therapy. Patients (73032 receiving fibrinolytic therapy; 37143 receiving primary percutaneous coronary intervention) were admitted from January 1, 1999, through December 31, 2002, to hospitals participating in NRMI 3 and 4. Main Outcome Measure Minutes between hospital arrival and acute reperfusion therapy. Results Door-to-drug times were significantly longer for patients identified as African American/black (41.1 minutes), Hispanic (36.1 minutes), and Asian/Pacific Islander (37.4 minutes), compared with patients identified as white (33.8 minutes) (P<.01 for all). Door-to-balloon times for patients identified as African American/black (122.3 minutes) or Hispanic (114.8 minutes) were significantly longer than for patients identified as white (103.4 minutes) (P<.001 for both). Racial/ethnic differences were still significant but were substantially reduced after accounting for differences in mean times to treatment for the hospitals in which patients were treated; significant racial/ethnic differences persisted after further adjustment for sociodemographic characteristics, insurance status, and clinical and hospital characteristics (P<.01 for all). Conclusion A substantial portion of the racial/ethnic disparity in time to treatment was accounted for by the specific hospital to which patients were admitted, in contrast to differential treatment by race/ethnicity inside the hospital.	Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, Sect Hlth Policy & Adm, New Haven, CT 06520 USA; Yale Univ, Sch Med, Dept Med, Sect Cardiovasc Med, New Haven, CT 06520 USA; Yale Univ, Sch Med, Dept Med, Robert Wood Johnson Clin Scholars Program, New Haven, CT 06520 USA; Yale New Haven Med Ctr, Ctr Outcomes Res & Evaluat, New Haven, CT 06504 USA; Flying Buttress Associates, Charlottesville, VA USA; Kaiser Permanente Clin Res Unit, Denver, CO USA; Univ Colorado, Hlth Sci Ctr, Dept Prevent Med & Biometr, Denver, CO 80262 USA; Univ Colorado, Hlth Sci Ctr, Div Emergency Med, Denver, CO USA; Genentech Inc, San Francisco, CA 94080 USA; Duke Univ, Dept Med, Div Cardiol, Durham, NC USA; Watson Clin, Ctr Cardiovasc Prevent Res & Educ, Lakeland, FL USA; Penn Hosp, Dept Emergency Med, Philadelphia, PA 19107 USA	Yale University; Yale University; Yale University; Yale University; Kaiser Permanente; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Roche Holding; Genentech; Duke University; University of Pennsylvania; Pennsylvania Medicine	Krumholz, HM (corresponding author), Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, Sect Hlth Policy & Adm, 333 Cedar St,POB 208088, New Haven, CT 06520 USA.	harlan.krumholz@yale.edu	, Harlan/AAI-2875-2020; Peterson, Eric David/ABF-5033-2021		AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R01HS010407] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG021342] Funding Source: NIH RePORTER; AHRQ HHS [R01HS10407-01] Funding Source: Medline; NIA NIH HHS [P30AG21342] Funding Source: Medline	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		*AG HEALTHC RES QU, NAT HEALTHC DISP REP; *AM HOSP ASS, 1998, ANN SURV HOSP DAT DO; Angeja BG, 2002, AM J CARDIOL, V89, P1156, DOI 10.1016/S0002-9149(02)02296-8; APPLEBY P, 1994, LANCET, V343, P311, DOI 10.1016/S0140-6736(94)91161-4; AYANIAN JZ, 1993, JAMA-J AM MED ASSOC, V269, P2642, DOI 10.1001/jama.269.20.2642; Bland JM, 1996, BRIT MED J, V312, P1079; Bland JM, 1996, BMJ-BRIT MED J, V312, P1153; BLUSTEIN J, 1994, AM J PUBLIC HEALTH, V84, P1018, DOI 10.2105/AJPH.84.6.1018; Boehmer U, 2002, AM J PUBLIC HEALTH, V92, P1471, DOI 10.2105/AJPH.92.9.1471; Bryk A. S., 1992, HIERARCHICAL LINEAR; Cannon CP, 2000, JAMA-J AM MED ASSOC, V283, P2941, DOI 10.1001/jama.283.22.2941; Canto JG, 1998, AM J CARDIOL, V82, P1013, DOI 10.1016/S0002-9149(98)00590-6; Canto JG, 2000, ARCH INTERN MED, V160, P817, DOI 10.1001/archinte.160.6.817; *CDCP, 2003, HLTH PEOPL 2010; Chen J, 2001, NEW ENGL J MED, V344, P1443, DOI 10.1056/NEJM200105103441906; Collins T. C., 2002, MED CARE S, V40, P127, DOI DOI 10.1097/00005650-200201001-00004; Conigliaro J, 2000, ARCH INTERN MED, V160, P1329, DOI 10.1001/archinte.160.9.1329; De Luca G, 2004, CIRCULATION, V109, P1223, DOI 10.1161/01.CIR.0000121424.76486.20; DONNER A, 1993, J CLIN EPIDEMIOL, V46, P123, DOI 10.1016/0895-4356(93)90050-B; Every NR, 1999, J AM COLL CARDIOL, V33, P1886, DOI 10.1016/S0735-1097(99)00113-8; French WJ, 2000, AM J CARDIOL, V85, p5B; Goldberg RJ, 1998, AM J CARDIOL, V82, P259, DOI 10.1016/S0002-9149(98)00342-7; *I MED, 2003, UNEQ TREATM CONFR RA; Kaplan JB, 2003, JAMA-J AM MED ASSOC, V289, P2709, DOI 10.1001/jama.289.20.2709; King G, 2000, AM J POLIT SCI, V44, P347, DOI 10.2307/2669316; King Gary, 1996, Ethnicity and Disease, V6, P30; Kressin NR, 2001, ANN INTERN MED, V135, P352, DOI 10.7326/0003-4819-135-5-200109040-00012; Kressin NR, 2003, AM J PUBLIC HEALTH, V93, P1734, DOI 10.2105/AJPH.93.10.1734; Leyland AH, 2001, MULTILEVEL MODELLING; Moscou S, 2003, AM J PUBLIC HEALTH, V93, P1084, DOI 10.2105/AJPH.93.7.1084; Ofili Elizabeth, 2001, Ethnicity and Disease, V11, P838; Pan CX, 1999, J AM GERIATR SOC, V47, P730, DOI 10.1111/j.1532-5415.1999.tb01599.x; Petersen LA, 2002, MED CARE, V40, P86; ROGERS WJ, 1994, CIRCULATION, V90, P2103, DOI 10.1161/01.CIR.90.4.2103; Schneider EC, 2001, ANN INTERN MED, V135, P328, DOI 10.7326/0003-4819-135-5-200109040-00009; *SMG MARK GROUP, MARK OV; Syed M, 2000, AM HEART J, V140, P643, DOI 10.1067/mhj.2000.109644; Taylor HA, 1998, AM J CARDIOL, V82, P1019, DOI 10.1016/S0002-9149(98)00547-5; TOPOL E, 1993, NEW ENGL J MED, V329, P673, DOI 10.1056/nejm199309023291001	39	205	206	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 6	2004	292	13					1563	1572		10.1001/jama.292.13.1563	http://dx.doi.org/10.1001/jama.292.13.1563			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	859HS	15467058	Bronze			2022-12-28	WOS:000224254600023
J	Bucca, C				Bucca, C			Take the side-effects of drugs into account	LANCET			English	Editorial Material									Univ Turin, Dept Biomed Sci & Human Oncol, I-10126 Turin, Italy	University of Turin	Bucca, C (corresponding author), Univ Turin, Dept Biomed Sci & Human Oncol, I-10126 Turin, Italy.	Caterina.Bucca@unito.it	Bucca, Caterina/C-9886-2009	Bucca, Caterina/0000-0002-9941-9236					0	7	7	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	OCT 2	2004	364	9441					1285	1285		10.1016/S0140-6736(04)17149-3	http://dx.doi.org/10.1016/S0140-6736(04)17149-3			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	859HO	15464190				2022-12-28	WOS:000224254200039
J	Debiec, H; Nauta, J; Coulet, F; van der Burg, M; Guigonis, V; Schurmans, T; de Heer, E; Soubrier, F; Janssen, F; Ronco, P				Debiec, H; Nauta, J; Coulet, F; van der Burg, M; Guigonis, V; Schurmans, T; de Heer, E; Soubrier, F; Janssen, F; Ronco, P			Role of truncating mutations in MME gene in fetomaternal alloimmunisation and antenatal glomerulopathies	LANCET			English	Article							LYMPHOBLASTIC-LEUKEMIA ANTIGEN; NEUTRAL ENDOPEPTIDASE; MEMBRANOUS NEPHROPATHY; NEPHROTIC SYNDROME; GLOMERULAR PROTEIN; GLOMERULONEPHRITIS; ANTIBODIES; ENKEPHALINASE; ONTOGENESIS; NEPRILYSIN	Background Membranous glomerulonephritis is an immune-mediated disease. In a recent case of antenatal membranous glomerulonephritis, we identified neutral endopeptidase (NEP) as the podocyte target antigen of circulating antibodies produced by the mother who failed to express NEP on granulocytes. We aimed to investigate whether the disease could affect other families, to search for mutations in the metallomembrane endopeptidase (MME) gene for NEP, and to analyse the outcome of the antenatal renal insult. Methods From three families with a case of neonatal membranous glomerulopathy, we detected mutations by direct sequencing of genomic PCR products. Single nucleotide polymorphism (SNP) analysis was undertaken with five SNPs located in the MME gene. IgG subclasses with anti-NEP activity were determined by western blotting. Findings In five mothers, we identified two compound heterozygous or homozygous mutations in the MME gene. The first, a 1342C-->T nonsense mutation, was detected in one family. The second, 446delC, was detected in all three families; all chromosomes bearing this mutation had the same alleles for the five SNPs. Severity of neonatal renal disease was determined by the mothers' IgG response to fetal NEP antigens expressed on glomerular podocytes. The oldest affected individual, now aged 20 years, has developed severe chronic renal failure. Interpretation Truncating mutations in the MME gene are the cause of alloimmunisation during pregnancy. idiopathic renal failure in early adulthood might be caused by immune-mediated fetal nephron loss. We show that disease caused by fetomaternal alloimmunisation secondary to a genetic defect is not restricted to blood cells. Relevance to clinical practice During pregnancy, the absence of the NEP protein induces an alloimmunisation process against NEP presented by fetal cells, including syncytiotrophoblasts. The fetal podocyte insult and ensuing nephron loss could lead to chronic renal failure in early adulthood. Alloimmunisation against NEP should be considered as a leading cause of membranous glomerulopathy early in life. Concentrations of circulating anti-NEP antibodies should be carefully monitored during subsequent pregnancies, and specific therapeutic approaches developed. This new disease might also account for idiopathic chronic renal failure detected during adolescence, in individuals who can be identified by searching for anti-NEP antibodies in their mother and by MME gene mutation analysis. NEP deficiency should also be considered in patients developing de-novo membranous glomerulopathy after renal transplantation.	Tenon Hosp, APHP, INSERM, U489, F-75020 Paris, France; Tenon Hosp, APHP, Dept Human Genet, Paris, France; Univ Paris 06, Paris, France; Armand Trousseau Hosp, APHP, Dept Pediat Nephrol, Paris, France; Erasmus MC, Sophia Childrens Hosp, Rotterdam, Netherlands; Erasmus MC, Sophia Childrens Hosp, Dept Immunol, Rotterdam, Netherlands; Free Univ Brussels, Dept Pediat Nephrol, Brussels, Belgium; Leiden Univ, Med Ctr, Dept Pathol, Leiden, Netherlands	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Tenon - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Tenon - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Armand-Trousseau - APHP; UDICE-French Research Universities; Sorbonne Universite; Erasmus University Rotterdam; Erasmus MC; Erasmus MC - Sophia Children's Hospital; Erasmus University Rotterdam; Erasmus MC; Erasmus MC - Sophia Children's Hospital; Universite Libre de Bruxelles; Vrije Universiteit Brussel; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Debiec, H (corresponding author), Tenon Hosp, APHP, INSERM, U489, F-75020 Paris, France.	hanna.debiec@tnn.ap-hop-paris.fr	De Heer, Emile/C-1110-2009; Ronco, Pierre/AAC-8390-2022; Debiec, Hanna/AAL-8144-2021; Guigonis, Vincent/O-8863-2016	Debiec, Hanna/0000-0002-8946-8245; Guigonis, Vincent/0000-0002-2529-0919				APPAY MD, 1985, CLIN IMMUNOL IMMUNOP, V37, P103, DOI 10.1016/0090-1229(85)90141-2; ARDAILLOU N, 1992, J CELL PHYSIOL, V152, P599, DOI 10.1002/jcp.1041520320; Bonvouloir N, 2001, DNA CELL BIOL, V20, P493, DOI 10.1089/104454901316976127; Boute N, 2000, NAT GENET, V24, P349, DOI 10.1038/74166; Bowman John M., 1994, P553; Clark MR, 1997, CHEM IMMUNOL, V65, P88; CYBULSKY AV, 2000, KIDNEY PHYSL PATHOPH, P2645; DADAMIO L, 1989, P NATL ACAD SCI USA, V86, P7103, DOI 10.1073/pnas.86.18.7103; Debiec H, 2002, NEW ENGL J MED, V346, P2053, DOI 10.1056/NEJMoa012895; FARQUHAR MG, 1995, J AM SOC NEPHROL, V6, P35; Fernandez D, 2002, PEPTIDES, V23, P461, DOI 10.1016/S0196-9781(01)00622-2; Glassock RJ, 2003, SEMIN NEPHROL, V23, P324, DOI 10.1016/S0270-9295(03)00049-4; HEYMANN W, 1959, P SOC EXP BIOL MED, V100, P660; Horl WH, 2000, J NEPHROL, V13, P291; Ikeda K, 1999, J BIOL CHEM, V274, P32469, DOI 10.1074/jbc.274.45.32469; Imai H, 1997, KIDNEY INT, V51, P270, DOI 10.1038/ki.1997.32; Iwata N, 2001, SCIENCE, V292, P1550, DOI 10.1126/science.1059946; JOHNSON AR, 1984, PEPTIDES, V5, P789, DOI 10.1016/0196-9781(84)90023-8; Kaplan JM, 2000, NAT GENET, V24, P251, DOI 10.1038/73456; Kerjaschki D, 2000, J NEPHROL, V13, pS96; Kestila M, 1998, MOL CELL, V1, P575, DOI 10.1016/S1097-2765(00)80057-X; Lu B, 1997, NAT MED, V3, P904, DOI 10.1038/nm0897-904; METZGAR RS, 1981, J EXP MED, V154, P1249, DOI 10.1084/jem.154.4.1249; NAUTA J, 1990, PEDIATR NEPHROL, V4, P111, DOI 10.1007/BF00858820; PLATT JL, 1983, J EXP MED, V157, P155, DOI 10.1084/jem.157.1.155; Poduslo SE, 1999, HUM GENET, V105, P32, DOI 10.1007/s004390051060; RONCO P, 1988, LAB INVEST, V58, P210; Simister NE, 1997, J REPROD IMMUNOL, V37, P1, DOI 10.1016/S0165-0378(97)00068-5; Simister NE, 2003, VACCINE, V21, P3365, DOI 10.1016/S0264-410X(03)00334-7; Squarer A, 1998, J AM SOC NEPHROL, V9, P1389; Turner AJ, 2001, BIOESSAYS, V23, P261, DOI 10.1002/1521-1878(200103)23:3<261::AID-BIES1036>3.0.CO;2-K; Usmani BA, 2000, CLIN CANCER RES, V6, P1664; VALIM YML, 1991, CLIN EXP IMMUNOL, V84, P1, DOI 10.1111/j.1365-2249.1991.tb08115.x; Wasserstein AG, 1997, J AM SOC NEPHROL, V8, P664	34	142	156	0	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 2	2004	364	9441					1252	1259		10.1016/S0140-6736(04)17142-0	http://dx.doi.org/10.1016/S0140-6736(04)17142-0			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	859HO	15464186				2022-12-28	WOS:000224254200032
J	Lu, WG; Yamamoto, V; Ortega, B; Baltimore, D				Lu, WG; Yamamoto, V; Ortega, B; Baltimore, D			Mammalian Ryk is a Wnt coreceptor required for stimulation of neurite outgrowth	CELL			English	Article							DROSOPHILA DERAILED RECEPTOR; NEURONAL PATHWAY SELECTION; TRANSCRIPTION FACTOR LEF-1; NEURAL CREST DEVELOPMENT; BETA-CATENIN; INT-1 PROTOONCOGENE; WNT/BETA-CATENIN; XENOPUS EMBRYOS; GENE LINOTTE; PROTEIN	The Ryk receptor belongs to the atypical receptor tyrosine kinase family. It is a new member of the family of Wnt receptor proteins. However, the molecular mechanisms by which the Ryk receptor functions remain unknown. Here, we report that mammalian Ryk, unlike the Drosophila Ryk homolog Derailed, functions as a coreceptor along with Frizzled for Wnt ligands. Ryk also binds to Dishevelled, through which it activates the canonical Writ pathway, providing a link between Wnt and Dishevelled. Transgenic mice expressing Ryk siRNA exhibit defects in axon guidance, and Ryk is required for neurite outgrowth induced by Wnt-3a and in the activation of T cell factor (TCF) induced by Wnt-1. Thus, Ryk appears to play a crucial role in Wnt-mediated signaling.	CALTECH, Div Biol, Pasadena, CA 91125 USA	California Institute of Technology	Baltimore, D (corresponding author), CALTECH, Div Biol, Pasadena, CA 91125 USA.	baltimo@caltech.edu			NCI NIH HHS [2R01 CA51462-13] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA051462] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Aberle H, 1997, EMBO J, V16, P3797, DOI 10.1093/emboj/16.13.3797; Behrens J, 1996, NATURE, V382, P638, DOI 10.1038/382638a0; Bhanot P, 1996, NATURE, V382, P225, DOI 10.1038/382225a0; Bonkowsky JL, 1999, NATURE, V402, P540, DOI 10.1038/990122; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Cadigan KM, 1997, GENE DEV, V11, P3286, DOI 10.1101/gad.11.24.3286; CALLAHAN CA, 1995, NATURE, V376, P171, DOI 10.1038/376171a0; Castelo-Branco GA, 2003, P NATL ACAD SCI USA, V100, P12747, DOI 10.1073/pnas.1534900100; Chenn A, 2003, CEREB CORTEX, V13, P599, DOI 10.1093/cercor/13.6.599; DURA JM, 1995, FEBS LETT, V370, P250, DOI 10.1016/0014-5793(95)00847-3; DURA JM, 1993, J NEUROGENET, V9, P1, DOI 10.3109/01677069309167272; Garcia-Castro MI, 2002, SCIENCE, V297, P848, DOI 10.1126/science.1070824; Halford MM, 2001, BIOESSAYS, V23, P34, DOI 10.1002/1521-1878(200101)23:1<34::AID-BIES1005>3.3.CO;2-4; Halford MM, 2000, NAT GENET, V25, P414, DOI 10.1038/78099; Hall AC, 2000, CELL, V100, P525, DOI 10.1016/S0092-8674(00)80689-3; Hari L, 2002, J CELL BIOL, V159, P867, DOI 10.1083/jcb.200209039; HOVENS CM, 1992, P NATL ACAD SCI USA, V89, P11818, DOI 10.1073/pnas.89.24.11818; Hsieh JC, 1999, NATURE, V398, P431, DOI 10.1038/18899; Huber O, 1996, MECH DEVELOP, V59, P3, DOI 10.1016/0925-4773(96)00597-7; Ikeya M, 1997, NATURE, V389, P966, DOI 10.1038/40146; Ishitani T, 2003, MOL CELL BIOL, V23, P1379, DOI 10.1128/MCB.23.4.1379-1389.2003; Ishitani T, 1999, NATURE, V399, P798, DOI 10.1038/21674; Kamitori K, 1999, DEV BRAIN RES, V114, P149, DOI 10.1016/S0165-3806(99)00033-4; Krylova O, 2002, NEURON, V35, P1043, DOI 10.1016/S0896-6273(02)00860-7; Lee HY, 2004, SCIENCE, V303, P1020, DOI 10.1126/science.1091611; Lewis JL, 2004, DEVELOPMENT, V131, P1299, DOI 10.1242/dev.01007; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; Lucas FR, 1997, DEV BIOL, V192, P31, DOI 10.1006/dbio.1997.8734; Lyuksyutova AI, 2003, SCIENCE, V302, P1984, DOI 10.1126/science.1089610; MCMAHON AP, 1992, CELL, V69, P581, DOI 10.1016/0092-8674(92)90222-X; MCMAHON AP, 1990, CELL, V62, P1073, DOI 10.1016/0092-8674(90)90385-R; Molenaar M, 1996, CELL, V86, P391, DOI 10.1016/S0092-8674(00)80112-9; Moon RT, 2002, SCIENCE, V296, P1644, DOI 10.1126/science.1071549; Moreau-Fauvarque C, 1998, MECH DEVELOP, V78, P47, DOI 10.1016/S0925-4773(98)00147-6; Oates AC, 1998, MECH DEVELOP, V78, P165, DOI 10.1016/S0925-4773(98)00167-1; Orford K, 1997, J BIOL CHEM, V272, P24735, DOI 10.1074/jbc.272.40.24735; Orioli D, 1996, EMBO J, V15, P6035, DOI 10.1002/j.1460-2075.1996.tb00992.x; Packard M, 2002, CELL, V111, P319, DOI 10.1016/S0092-8674(02)01047-4; Patthy L, 2000, TRENDS BIOCHEM SCI, V25, P12, DOI 10.1016/S0968-0004(99)01504-2; Peifer M, 2000, SCIENCE, V287, P1606, DOI 10.1126/science.287.5458.1606; PEIFER M, 1994, DEV BIOL, V166, P543, DOI 10.1006/dbio.1994.1336; Salic A, 2000, MOL CELL, V5, P523, DOI 10.1016/S1097-2765(00)80446-3; Simon AF, 1998, MECH DEVELOP, V76, P45, DOI 10.1016/S0925-4773(98)00104-X; Smit L, 2004, J BIOL CHEM, V279, P17232, DOI 10.1074/jbc.M307801200; STERNBERG PW, 1988, DEV BIOL, V130, P67, DOI 10.1016/0012-1606(88)90414-9; Tamai K, 2000, NATURE, V407, P530, DOI 10.1038/35035117; Tanaka M, 1997, P NATL ACAD SCI USA, V94, P4493, DOI 10.1073/pnas.94.9.4493; THOMAS KR, 1990, NATURE, V346, P847, DOI 10.1038/346847a0; van Es JH, 2003, CURR OPIN GENET DEV, V13, P28, DOI 10.1016/S0959-437X(02)00012-6; Veeman MT, 2003, DEV CELL, V5, P367, DOI 10.1016/S1534-5807(03)00266-1; Wehrli M, 2000, NATURE, V407, P527, DOI 10.1038/35035110; Willert K, 1998, CURR OPIN GENET DEV, V8, P95, DOI 10.1016/S0959-437X(98)80068-3; Wodarz A, 1998, ANNU REV CELL DEV BI, V14, P59, DOI 10.1146/annurev.cellbio.14.1.59; Wong HC, 2003, MOL CELL, V12, P1251, DOI 10.1016/S1097-2765(03)00427-1; YEE K, 1993, BLOOD, V82, P1335; Yoshikawa S, 2003, NATURE, V422, P583, DOI 10.1038/nature01522; Yost C, 1996, GENE DEV, V10, P1443, DOI 10.1101/gad.10.12.1443	57	343	368	2	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 1	2004	119	1					97	108		10.1016/j.cell.2004.09.019	http://dx.doi.org/10.1016/j.cell.2004.09.019			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	859UE	15454084	Bronze			2022-12-28	WOS:000224292600012
J	Beachy, PA; Karhadkar, SS; Berman, DM				Beachy, PA; Karhadkar, SS; Berman, DM			Mending and malignancy	NATURE			English	Editorial Material							HEDGEHOG		Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Urol, Baltimore, MD 21205 USA	Johns Hopkins University; Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Beachy, PA (corresponding author), Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA.		Karhadkar, Sunil/Y-9235-2019; berman, david/HIR-4177-2022	Karhadkar, Sunil/0000-0001-7943-0203; berman, david/0000-0001-5985-3698				Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; KARHADKAR SS, 2004, NATURE          0912, DOI DOI 10.1038/NATURE02962; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Taipale J, 2001, NATURE, V411, P349, DOI 10.1038/35077219; Watkins DN, 2003, NATURE, V422, P313, DOI 10.1038/nature01493	6	48	58	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 23	2004	431	7007					402	402		10.1038/431402a	http://dx.doi.org/10.1038/431402a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855UN	15385990	Bronze			2022-12-28	WOS:000224000500020
J	Nuland, SB				Nuland, SB			Mistakes in the operating room - Error and responsibility	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Yale Univ, Sch Med, Dept Surg, New Haven, CT 06510 USA	Yale University	Nuland, SB (corresponding author), Yale Univ, Sch Med, Dept Surg, New Haven, CT 06510 USA.								0	13	13	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 23	2004	351	13					1281	1283		10.1056/NEJMp048175	http://dx.doi.org/10.1056/NEJMp048175			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	855TP	15385653				2022-12-28	WOS:000223997700004
J	Luscombe, NM; Babu, MM; Yu, HY; Snyder, M; Teichmann, SA; Gerstein, M				Luscombe, NM; Babu, MM; Yu, HY; Snyder, M; Teichmann, SA; Gerstein, M			Genomic analysis of regulatory network dynamics reveals large topological changes	NATURE			English	Article							GENE-EXPRESSION; TRANSCRIPTION FACTORS; SMALL-WORLD; PROGRAM; MOTIFS; CELLS	Network analysis has been applied widely, providing a unifying language to describe disparate systems ranging from social interactions to power grids. It has recently been used in molecular biology, but so far the resulting networks have only been analysed statically(1-8). Here we present the dynamics of a biological network on a genomic scale, by integrating transcriptional regulatory information(9-11) and gene-expression data(12-16) for multiple conditions in Saccharomyces cerevisiae. We develop an approach for the statistical analysis of network dynamics, called SANDY, combining well-known global topological measures, local motifs and newly derived statistics. We uncover large changes in underlying network architecture that are unexpected given current viewpoints and random simulations. In response to diverse stimuli, transcription factors alter their interactions to varying degrees, thereby rewiring the network. A few transcription factors serve as permanent hubs, but most act transiently only during certain conditions. By studying sub-network structures, we show that environmental responses facilitate fast signal propagation (for example, with short regulatory cascades), whereas the cell cycle and sporulation direct temporal progression through multiple stages (for example, with highly inter-connected transcription factors). Indeed, to drive the latter processes forward, phase-specific transcription factors interregulate serially, and ubiquitously active transcription factors layer above them in a two-tiered hierarchy. We anticipate that many of the concepts presented here-particularly the large-scale topological changes and hub transience-will apply to other biological networks, including complex sub-systems in higher eukaryotes.	Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; Yale Univ, Dept Comp Sci, New Haven, CT 06520 USA; MRC, Mol Biol Lab, Div Struct Studies, Cambridge CB2 2QH, England	Yale University; Yale University; Yale University; MRC Laboratory Molecular Biology	Luscombe, NM (corresponding author), Yale Univ, Dept Mol Biophys & Biochem, POB 208114, New Haven, CT 06520 USA.	sandy@bioinfo.mbb.yale.edu	Califano, Andrea/F-7239-2012; 白, 纯歌/V-1853-2017; Mohan, Babu P./I-7362-2019	Teichmann, Sarah/0000-0002-6294-6366; Snyder, Michael/0000-0003-0784-7987				Babu MM, 2003, NUCLEIC ACIDS RES, V31, P1234, DOI 10.1093/nar/gkg210; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Cho RJ, 1998, MOL CELL, V2, P65, DOI 10.1016/S1097-2765(00)80114-8; Christie KR, 2004, NUCLEIC ACIDS RES, V32, pD311, DOI 10.1093/nar/gkh033; Chu S, 1998, SCIENCE, V282, P699, DOI 10.1126/science.282.5389.699; DeRisi JL, 1997, SCIENCE, V278, P680, DOI 10.1126/science.278.5338.680; Gasch AP, 2001, MOL BIOL CELL, V12, P2987, DOI 10.1091/mbc.12.10.2987; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Guelzim N, 2002, NAT GENET, V31, P60, DOI 10.1038/ng873; Horak CE, 2002, GENE DEV, V16, P3017, DOI 10.1101/gad.1039602; Jeong H, 2000, NATURE, V407, P651, DOI 10.1038/35036627; Lee TI, 2002, SCIENCE, V298, P799, DOI 10.1126/science.1075090; Martinez-Antonio A, 2003, CURR OPIN MICROBIOL, V6, P482, DOI 10.1016/j.mib.2003.09.002; Milo R, 2004, SCIENCE, V303, P1538, DOI 10.1126/science.1089167; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Odom DT, 2004, SCIENCE, V303, P1378, DOI 10.1126/science.1089769; Oltvai ZN, 2002, SCIENCE, V298, P763, DOI 10.1126/science.1078563; Pilpel Y, 2001, NAT GENET, V29, P153, DOI 10.1038/ng724; Shen-Orr SS, 2002, NAT GENET, V31, P64, DOI 10.1038/ng881; Simon I, 2001, CELL, V106, P697, DOI 10.1016/S0092-8674(01)00494-9; Svetlov VV, 1995, YEAST, V11, P1439, DOI 10.1002/yea.320111502; Teichmann SA, 2004, NAT GENET, V36, P492, DOI 10.1038/ng1340; Ueda HR, 2002, NATURE, V418, P534, DOI 10.1038/nature00906; Wagner A, 2001, P ROY SOC B-BIOL SCI, V268, P1803, DOI 10.1098/rspb.2001.1711; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Yu HY, 2004, NUCLEIC ACIDS RES, V32, P328, DOI 10.1093/nar/gkh164; Yu HY, 2004, TRENDS GENET, V20, P227, DOI 10.1016/j.tig.2004.04.008; Zeitlinger J, 2003, CELL, V113, P395, DOI 10.1016/S0092-8674(03)00301-5	28	686	710	2	87	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 16	2004	431	7006					308	312		10.1038/nature02782	http://dx.doi.org/10.1038/nature02782			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	853XJ	15372033				2022-12-28	WOS:000223864000041
J	Sazonova, V; Yaish, Y; Ustunel, H; Roundy, D; Arias, TA; McEuen, PL				Sazonova, V; Yaish, Y; Ustunel, H; Roundy, D; Arias, TA; McEuen, PL			A tunable carbon nanotube electromechanical oscillator	NATURE			English	Article							ATTONEWTON FORCE DETECTION; CANTILEVERS; TRANSISTOR; RESONATOR; QUANTUM; PHYSICS; ROOM	Nanoelectromechanical systems (NEMS) hold promise for a number of scientific and technological applications. In particular, NEMS oscillators have been proposed for use in ultrasensitive mass detection(1,2), radio-frequency signal processing(3,4), and as a model system for exploring quantum phenomena in macroscopic systems(5,6). Perhaps the ultimate material for these applications is a carbon nanotube. They are the stiffest material known, have low density, ultrasmall cross-sections and can be defect-free. Equally important, a nanotube can act as a transistor(7) and thus may be able to sense its own motion. In spite of this great promise, a room-temperature, self-detecting nanotube oscillator has not been realized, although some progress has been made(8-12). Here we report the electrical actuation and detection of the guitar-string-like oscillation modes of doubly clamped nanotube oscillators. We show that the resonance frequency can be widely tuned and that the devices can be used to transduce very small forces.	Cornell Univ, Atom & Solid State Phys Lab, Ithaca, NY 14853 USA	Cornell University	McEuen, PL (corresponding author), Cornell Univ, Atom & Solid State Phys Lab, Ithaca, NY 14853 USA.	mceuen@ccmr.cornell.edu	Toffoli, Hande/A-3579-2016; Roundy, David/AAG-2356-2019	Toffoli, Hande/0000-0003-0307-9036; Roundy, David/0000-0001-5287-5472				Babic B, 2003, NANO LETT, V3, P1577, DOI 10.1021/nl0344716; Bhiladvala RB, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.036307; BRENNER DW, 1990, PHYS REV B, V42, P9458, DOI 10.1103/PhysRevB.42.9458; Cho A, 2003, SCIENCE, V299, P36, DOI 10.1126/science.299.5603.36; Dresselhaus MS, 2001, CARBON NANOTUBES; Gao RP, 2000, PHYS REV LETT, V85, P622, DOI 10.1103/PhysRevLett.85.622; Hertel T, 1998, PHYS REV B, V58, P13870, DOI 10.1103/PhysRevB.58.13870; Jenkins NE, 2004, J VAC SCI TECHNOL B, V22, P909, DOI 10.1116/1.1695336; Knobel RG, 2003, NATURE, V424, P291, DOI 10.1038/nature01773; Kong J, 1998, NATURE, V395, P878, DOI 10.1038/27632; LaHaye MD, 2004, SCIENCE, V304, P74, DOI 10.1126/science.1094419; Mamin HJ, 2001, APPL PHYS LETT, V79, P3358, DOI 10.1063/1.1418256; Minot ED, 2004, NATURE, V428, P536, DOI 10.1038/nature02425; Minot ED, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.156401; Mohanty P, 2000, PHYSICA B, V284, P2143, DOI 10.1016/S0921-4526(99)02997-X; Nguyen CTC, 1999, IEEE T MICROW THEORY, V47, P1486, DOI 10.1109/22.780400; NGUYEN CTC, 1999, SOL STAT CIRC C 78 7; Poncharal P, 1999, SCIENCE, V283, P1513, DOI 10.1126/science.283.5407.1513; Purcell ST, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.276103; Reulet B, 2000, PHYS REV LETT, V85, P2829, DOI 10.1103/PhysRevLett.85.2829; Roukes M, 2001, SCI AM, V285, P48, DOI 10.1038/scientificamerican0901-48; Sapmaz S, 2003, PHYS REV B, V67, DOI 10.1103/PhysRevB.67.235414; SIDLES JA, 1995, REV MOD PHYS, V67, P249, DOI 10.1103/RevModPhys.67.249; Stipe BC, 2001, PHYS REV LETT, V86, P2874, DOI 10.1103/PhysRevLett.86.2874; Stowe TD, 1997, APPL PHYS LETT, V71, P288, DOI 10.1063/1.119522; Tans SJ, 1998, NATURE, V393, P49, DOI 10.1038/29954; YURKE B, 1995, PHYS REV A, V51, P4211, DOI 10.1103/PhysRevA.51.4211; Zhou CW, 2000, PHYS REV LETT, V84, P5604, DOI 10.1103/PhysRevLett.84.5604	28	1101	1134	12	277	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 16	2004	431	7006					284	287		10.1038/nature02905	http://dx.doi.org/10.1038/nature02905			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	853XJ	15372026	Green Submitted			2022-12-28	WOS:000223864000034
J	Viner, R; Hotopf, M				Viner, R; Hotopf, M			Childhood predictors of self reported chronic fatigue syndrome/myalgic encephalomyelitis in adults: national birth cohort study	BRITISH MEDICAL JOURNAL			English	Article							ADOLESCENTS; HISTORY; ILLNESS; CARE	Objective To study childhood risk factors for chronic fatigue syndrome in adult life. Design Examination of data from the 1970 British birth cohort Participants 16 567 babies born 5-11 April 1970, followed up at 5, 10, 16, and 29-30 years. Main outcome measures Chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) identified by self report at age 30 years. Data from childhood from questionnaires given to parents and teachers. Maternal mental health assessed with the malaise inventory. Results 93 (0.8%. 95% confidence interval 0.7 to 1.0) of 11261 participants reported ever having CFS/ME, and 48 (0.4%, 0.3 to 0.6) had the condition currently. Higher risk of CFS/ME was associated with having a limiting longstanding condition in childhood (odds ratio 2.3, 1.4 to 3.9), female sex (2.3, 1.4 to 2.6), and high social class in childhood (2.2, 1.4 to 3.5). Higher levels of exercise in childhood were associated with lower risk (0.5, 0.2 to 0.9). Maternal psychological disorder, psychological problems in childhood, birth weight, birth order, atopy, obesity, school absence, academic ability. and parental illness were not associated with risk of CFS/ME. Conclusions We identified no association between maternal or child psychological distress, academic ability, parental illness, atopy, or birth order and increasing risk of lifetime CFS/ME. Sedentary behaviour increased the risk.	Middlesex Hosp, Royal Free & Univ Coll Med Sch, Dept Paediat, London W1T 3AA, England; Inst Psychiat, Dept Psychol Med, London SE5 8AF, England	University of London; University College London; University of London; King's College London	Viner, R (corresponding author), Middlesex Hosp, Royal Free & Univ Coll Med Sch, Dept Paediat, London W1T 3AA, England.	R.Viner@ich.ucl.ac.uk	Hotopf, Matthew/E-4971-2010; Viner, Russell M/A-1441-2009	Viner, Russell M/0000-0003-3047-2247; Hotopf, Matthew/0000-0002-3980-4466				Brimacombe M, 2002, HUM BIOL, V74, P615, DOI 10.1353/hub.2002.0038; BYNNER J, 2002, 1 CLS I ED; Chalder T, 2003, BRIT MED J, V327, P654, DOI 10.1136/bmj.327.7416.654; COLE TJ, 1995, ARCH DIS CHILD, V73, P25, DOI 10.1136/adc.73.1.25; Elliot C. D., 1983, BRIT ABILITY SCALES; Endicott NA, 1998, PSYCHOSOM MED, V60, P744, DOI 10.1097/00006842-199811000-00017; Euba R, 1996, BRIT J PSYCHIAT, V168, P121, DOI 10.1192/bjp.168.1.121; Fisher L, 2003, J PSYCHOSOM RES, V54, P439, DOI 10.1016/S0022-3999(02)00458-0; FUKUDA K, 1994, ANN INTERN MED, V121, P953, DOI 10.7326/0003-4819-121-12-199412150-00009; Garralda E, 1999, J AM ACAD CHILD PSY, V38, P1515, DOI 10.1097/00004583-199912000-00012; Goldberg D.P., 1988, USERS GUIDE GEN HLTH; Hall GJ, 1998, J ROY COLL PHYS LOND, V32, P44; HART JG, 1982, BR J ED PSYCHOL, V22, P167; Hotopf M, 1996, J NEUROL NEUROSUR PS, V60, P504, DOI 10.1136/jnnp.60.5.504; Irving B, 2002, PREDICTING ADOLESCEN; Krilov LR, 1998, PEDIATRICS, V102, P360, DOI 10.1542/peds.102.2.360; Levine PH, 1997, J PSYCHIATR RES, V31, P7, DOI 10.1016/S0022-3956(96)00058-1; MacDonald KL, 1996, AM J MED, V100, P548, DOI 10.1016/S0002-9343(96)00017-4; Rodgers B, 1999, SOC PSYCH PSYCH EPID, V34, P333, DOI 10.1007/s001270050153; Salit IE, 1997, J PSYCHIATR RES, V31, P59, DOI 10.1016/S0022-3956(96)00050-7; Sullivan PF, 2003, PSYCHOL MED, V33, P263, DOI 10.1017/S0033291702007031; WESSELY S, 1995, LANCET, V345, P1333, DOI 10.1016/S0140-6736(95)92537-6; White PD, 2001, LANCET, V358, P1946, DOI 10.1016/S0140-6736(01)06961-6	23	70	72	0	8	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 23	2004	329	7472					941	943		10.1136/bmj.38258.507928.55	http://dx.doi.org/10.1136/bmj.38258.507928.55			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	866KU	15469945	Bronze, Green Published, Green Submitted			2022-12-28	WOS:000224773200014
J	Bragg, AE; Verlet, JRR; Kammrath, A; Cheshnovsky, O; Neumark, DM				Bragg, AE; Verlet, JRR; Kammrath, A; Cheshnovsky, O; Neumark, DM			Hydrated electron dynamics: From clusters to bulk	SCIENCE			English	Article							CHARGED WATER CLUSTERS; PHOTOELECTRON-SPECTROSCOPY; SOLVATED ELECTRON; COMPUTER-SIMULATION; ABSORPTION; SPECTRA; SURFACE; ANIONS; STATE	The electronic relaxation dynamics of size-selected (H2O)(n)(-)/(D2O)(n)(-)[25less than or equal tonless than or equal to50] clusters have been studied with time-resolved photoelectron imaging. The excess electron (e(c)(-)) was excited through the e(c)(-)(p)<--e(c)(-)(s) transition with an ultrafast laser pulse, with subsequent evolution of the excited state monitored with photodetachment and photoelectron imaging. All clusters exhibited p-state population decay with concomitant s-state repopulation (internal conversion) on time scales ranging from 180 to 130 femtoseconds for (H2O)n- and 400 to 225 femtoseconds for (D2O)(n)(-); the lifetimes decrease with increasing cluster sizes. Our results support the "nonadiabatic relaxation" mechanism for the bulk hydrated electron (e(aq)(-)), which invokes a 50-femtosecond e(aq)(-) (p)-->e(aq)(-) (s(dagger)) internal conversion lifetime.	Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; Tel Aviv Univ, Sackler Fac Exact Sci, Sch Chem, IL-69978 Tel Aviv, Israel; Univ Calif Berkeley, Lawrence Berkeley Lab, Div Chem Sci, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; Tel Aviv University; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Neumark, DM (corresponding author), Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.	dan@radon.cchem.berketey.edu	Neumark, Daniel M/B-9551-2009; Verlet, Jan RR/G-5940-2012	Neumark, Daniel M/0000-0002-3762-9473; Verlet, Jan RR/0000-0002-9480-432X				ARMBRUSTER M, 1981, PHYS REV LETT, V47, P323, DOI 10.1103/PhysRevLett.47.323; Assel M, 2000, CHEM PHYS LETT, V317, P13, DOI 10.1016/S0009-2614(99)01369-X; Ayotte P, 1997, J CHEM PHYS, V106, P811, DOI 10.1063/1.473167; Ayotte P, 1999, J CHEM PHYS, V110, P6268, DOI 10.1063/1.478531; BARNETT RN, 1988, J CHEM PHYS, V88, P4429, DOI 10.1063/1.453801; Boero M, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.226403; Bragg AE, 2003, CHEM PHYS LETT, V376, P767, DOI 10.1016/S0009-2614(03)01060-1; Bratos S, 1997, PHYS REV E, V55, P7217, DOI 10.1103/PhysRevE.55.7217; COE JV, 1990, J CHEM PHYS, V92, P3980, DOI 10.1063/1.457805; Coe JV, 2001, INT REV PHYS CHEM, V20, P33, DOI 10.1080/01442350010008589; Eppink ATJB, 1997, REV SCI INSTRUM, V68, P3477, DOI 10.1063/1.1148310; Even U, 2000, J CHEM PHYS, V112, P8068, DOI 10.1063/1.481405; HART EJ, 1962, J AM CHEM SOC, V84, P4090, DOI 10.1021/ja00880a025; Hertwig A, 1998, BER BUNSEN PHYS CHEM, V102, P805, DOI 10.1002/bbpc.19981020603; KEVAN L, 1981, ACCOUNTS CHEM RES, V14, P138, DOI 10.1021/ar00065a002; Khan A, 2003, J CHEM PHYS, V118, P1684, DOI 10.1063/1.1531100; Kim J, 1998, CHEM PHYS LETT, V297, P90, DOI 10.1016/S0009-2614(98)01109-9; KIMURA Y, 1994, J PHYS CHEM-US, V98, P3450, DOI 10.1021/j100064a029; MIGUS A, 1987, PHYS REV LETT, V58, P1559, DOI 10.1103/PhysRevLett.58.1559; Pshenichnikov MS, 2004, CHEM PHYS LETT, V389, P171, DOI 10.1016/j.cplett.2004.03.107; ROSSKY PJ, 1988, J PHYS CHEM-US, V92, P4277, DOI 10.1021/j100326a009; SCHWARTZ BJ, 1994, J CHEM PHYS, V101, P6902, DOI 10.1063/1.468319; Stolow A, 2004, CHEM REV, V104, P1719, DOI 10.1021/cr020683w; Tauber MJ, 2003, J AM CHEM SOC, V125, P1394, DOI 10.1021/ja021134a; VERLET JRR, UNPUB; Weber JM, 2001, CHEM PHYS LETT, V339, P337, DOI 10.1016/S0009-2614(01)00295-0; WEYL W, 1863, ANN PHYS, V197, P601; Yokoyama K, 1998, J PHYS CHEM A, V102, P6957, DOI 10.1021/jp981809p	29	233	257	3	129	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 22	2004	306	5696					669	671		10.1126/science.1103527	http://dx.doi.org/10.1126/science.1103527			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866EN	15375222				2022-12-28	WOS:000224756700046
J	Deak, JC; Pang, YS; Sechler, TD; Wang, ZH; Dlott, DD				Deak, JC; Pang, YS; Sechler, TD; Wang, ZH; Dlott, DD			Vibrational energy transfer across a reverse micelle surfactant layer	SCIENCE			English	Article							IR-RAMAN SPECTROSCOPY; CARBON-TETRACHLORIDE; POLYATOMIC LIQUIDS; AEROSOL OT; WATER; RELAXATION; REDISTRIBUTION; DYNAMICS; METHANOL; MOLECULE	In a suspension of reverse micelles, in which the surfactant sodium dioctyl sulfosuccinate (AOT) separates a water nanodroplet from a bulk nonpolar CCl4 phase, ultrafast vibrational spectroscopy was used to study vibrational energy transfer from the nanodroplet through the AOT interfacial monolayer to the surrounding CCl4. Most of the vibrational energy from the nanodroplet was transferred to the polar AOT head group within 1.8 picoseconds and then out to the CCl4 within 10 picoseconds. Vibrational energy pumped directly into the AOT tail resulted in a slower 20- to 40-picosecond transfer of energy to the CCl4.	Univ Illinois, Sch Chem Sci, Chem & Life Sci Lab, Urbana, IL 61801 USA; Univ Scranton, Dept Chem, Scranton, PA 18510 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Scranton	Dlott, DD (corresponding author), Univ Illinois, Sch Chem Sci, Chem & Life Sci Lab, Box 01-6,600 S Mathews Ave, Urbana, IL 61801 USA.	dlott@scs.uiuc.edu	Pang, Yoonsoo/G-9879-2012	Pang, Yoonsoo/0000-0002-7291-232X; Dlott, Dana/0000-0001-8719-7093				Boyd JE, 2002, J PHYS CHEM B, V106, P6346, DOI 10.1021/jp0255740; BROWN D, 1988, J PHYS CHEM-US, V92, P2881, DOI 10.1021/j100321a036; DE TK, 1995, ADV COLLOID INTERFAC, V59, P95, DOI 10.1016/0001-8686(95)80005-N; Deak JC, 2000, J RAMAN SPECTROSC, V31, P263, DOI 10.1002/(SICI)1097-4555(200004)31:4<263::AID-JRS538>3.0.CO;2-Q; Deak JC, 2000, J PHYS CHEM A, V104, P4866, DOI 10.1021/jp99442h; Deak JC, 1999, J PHYS CHEM A, V103, P971, DOI 10.1021/jp9839899; Deak JC, 1998, J PHYS CHEM A, V102, P8193, DOI 10.1021/jp9822743; Derecskei B, 1999, LANGMUIR, V15, P1981, DOI 10.1021/la980419r; Faeder J, 2000, J PHYS CHEM B, V104, P1033, DOI 10.1021/jp993076u; Graham PB, 2004, J CHEM PHYS, V121, P5348, DOI 10.1063/1.1784441; Iwaki L. K., 2000, ULTRAFAST INFRARED R, P541; Iwaki LK, 2000, J PHYS CHEM A, V104, P9101, DOI 10.1021/jp002246w; Kropman MF, 2003, CHEM PHYS LETT, V370, P741, DOI 10.1016/S0009-2614(03)00123-4; LAUBEREAU A, 1978, REV MOD PHYS, V50, P607, DOI 10.1103/RevModPhys.50.607; Levinger NE, 2002, SCIENCE, V298, P1722, DOI 10.1126/science.1079322; MORAN PD, 1995, J MATER CHEM, V5, P295, DOI 10.1039/jm9950500295; MORAN PD, 1995, LANGMUIR, V11, P738, DOI 10.1021/la00003a012; NITZAN A, 1973, MOL PHYS, V25, P713, DOI 10.1080/00268977300100651; ONORI G, 1993, J PHYS CHEM-US, V97, P5430, DOI 10.1021/j100122a040; Pakoulev A, 2003, CHEM PHYS LETT, V380, P404, DOI 10.1016/j.cplett.2003.09.002; Patzlaff T, 2000, CHEM PHYS, V261, P381, DOI 10.1016/S0301-0104(00)00287-1; Seifert G, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.147402; SEIN E, 1979, J COLLOID INTERF SCI, V72, P363, DOI 10.1016/0021-9797(79)90122-X; TAN HS, UNPUB; Venables DS, 2001, J PHYS CHEM B, V105, P9132, DOI 10.1021/jp0112065; Wang ZH, 2003, CHEM PHYS LETT, V378, P281, DOI 10.1016/S0009-2614(03)01267-3; Wang ZH, 2002, SCIENCE, V296, P2201, DOI 10.1126/science.1071293	27	107	107	0	53	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 15	2004	306	5695					473	476		10.1126/science.1102074	http://dx.doi.org/10.1126/science.1102074			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	864IF	15388896				2022-12-28	WOS:000224626500049
J	Briffa, JP				Briffa, JP			The prince and the professor - Which emperor is naked?	BRITISH MEDICAL JOURNAL			English	Letter												drjbriffa@aol.com						Baum M, 2004, BRIT MED J, V329, P118, DOI 10.1136/bmj.329.7457.118; VARMAN S, 2004, BRAVO ELECT RESPONSE	2	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 9	2004	329	7470					858	858		10.1136/bmj.329.7470.858	http://dx.doi.org/10.1136/bmj.329.7470.858			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	862EK	15472283	Green Published			2022-12-28	WOS:000224472800039
J	Espagne, E; Dupuy, C; Huguet, E; Cattolico, L; Provost, B; Martins, N; Poirie, M; Periquet, G; Drezen, JM				Espagne, E; Dupuy, C; Huguet, E; Cattolico, L; Provost, B; Martins, N; Poirie, M; Periquet, G; Drezen, JM			Genome sequence of a polydnavirus: Insights into symbiotic virus evolution	SCIENCE			English	Article							KAPPA-B; GENE; WASP; PARASITOIDS; INHIBITION; RESISTANCE; PROTEINS; FAMILIES; ORIGINS	Little is known of the fate of viruses involved in long-term obligatory associations with eukaryotes. For example, many species of parasitoid wasps have symbiotic viruses to manipulate host defenses and to allow development of parasitoid larvae. The complete nucleotide sequence of the DNA enclosed in the virus particles injected by a parasitoid wasp revealed a complex organization, resembling a eukaryote genomic region more than a viral genome. Although endocellular symbiont genomes have undergone a dramatic loss of genes, the evolution of symbiotic viruses appears to be characterized by extensive duplication of virulence genes coding for truncated versions of cellular proteins.	UFR Sci & Tech, Inst Rech Biol Insecte, CNRS, UMR 6035,UFR Sci & Tech, F-37200 Tours, France; Natl Ctr Sequencage, Genoscope, F-91057 Evry, France	Centre National de la Recherche Scientifique (CNRS)	Dupuy, C (corresponding author), UFR Sci & Tech, Inst Rech Biol Insecte, CNRS, UMR 6035,UFR Sci & Tech, Parc Grandrnont, F-37200 Tours, France.	catherine.dupuy@univ-tours.fr	POIRIE, MARYLENE/A-2909-2009; Dupuy, Catherine/AFK-5583-2022; Espagne, Eric/AAF-9794-2019; Espagne, Eric/GMX-2417-2022; martins, natalia florencio/AAE-7875-2019; Huguet, Elisabeth/D-3321-2009	Dupuy, Catherine/0000-0002-3947-3580; Huguet, Elisabeth/0000-0002-0096-0330; Espagne, Eric/0000-0002-5813-498X; Drezen, Jean-Michel/0000-0001-7578-635X				Abrahamson M, 2003, BIOCHEM SOC SYMP, V70, P179, DOI 10.1042/bss0700179; Andersen JN, 2001, MOL CELL BIOL, V21, P7117, DOI 10.1128/MCB.21.21.7117-7136.2001; BECKAGE NE, 1993, INSECT BIOCHEM MOLEC, V23, P643, DOI 10.1016/0965-1748(93)90038-T; Beckage NE, 2004, ANNU REV ENTOMOL, V49, P299, DOI 10.1146/annurev.ento.49.061802.123324; Beckage NE, 1998, PARASITOLOGY, V116, pS57, DOI 10.1017/S0031182000084948; Belle E, 2002, J VIROL, V76, P5793, DOI 10.1128/JVI.76.11.5793-5796.2002; CLEM RJ, 1994, J VIROL, V68, P6759, DOI 10.1128/JVI.68.10.6759-6762.1994; Dahlman DL, 2003, INSECT MOL BIOL, V12, P527, DOI 10.1046/j.1365-2583.2003.00439.x; Deleuil F, 2003, CELL MICROBIOL, V5, P53, DOI 10.1046/j.1462-5822.2003.00236.x; Deng LQ, 2000, VIROLOGY, V269, P440, DOI 10.1006/viro.2000.0248; Drezen JM, 2003, J INSECT PHYSIOL, V49, P407, DOI 10.1016/S0022-1910(03)00058-1; Dushay MS, 1996, P NATL ACAD SCI USA, V93, P10343, DOI 10.1073/pnas.93.19.10343; Dyall SD, 2004, SCIENCE, V304, P253, DOI 10.1126/science.1094884; Einerwold J, 2001, BIOCHEMISTRY-US, V40, P14404, DOI 10.1021/bi011499s; ESPAGNE E, UNPUB; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; HARWOOD SH, 1994, VIROLOGY, V205, P381, DOI 10.1006/viro.1994.1659; Iyer LM, 2001, J VIROL, V75, P11720, DOI 10.1128/JVI.75.23.11720-11734.2001; Kroemer JA, 2004, ANNU REV ENTOMOL, V49, P431, DOI 10.1146/annurev.ento.49.072103.120132; Maiti IB, 2003, PLANT BIOTECHNOL J, V1, P209, DOI 10.1046/j.1467-7652.2003.00019.x; PROVOST B, IN PRESS J VIROL; Revilla Y, 1998, J BIOL CHEM, V273, P5405, DOI 10.1074/jbc.273.9.5405; Schierack P, 2003, INFECT IMMUN, V71, P2422, DOI 10.1128/IAI.71.5.2422-2429.2003; Stasiak K, 2000, J GEN VIROL, V81, P3059, DOI 10.1099/0022-1317-81-12-3059; STOLTZ DB, 1984, INTERVIROLOGY, V21, P1, DOI 10.1159/000149497; STOLTZ DB, 1990, J GEN VIROL, V71, P1051, DOI 10.1099/0022-1317-71-5-1051; Teramato T, 2003, J INSECT PHYSIOL, V49, P463, DOI 10.1016/S0022-1910(03)00063-5; Turnbull M, 2002, ADV VIRUS RES, V58, P203, DOI 10.1016/S0065-3527(02)58006-4; Urwin PE, 1998, PLANTA, V204, P472, DOI 10.1007/s004250050281; WEBB BA, 2002, VIRUS TAXONOMY, P253; Whitfield JB, 1997, NATURWISSENSCHAFTEN, V84, P502, DOI 10.1007/s001140050434; Whitfield JB, 2002, P NATL ACAD SCI USA, V99, P7508, DOI 10.1073/pnas.112067199; WHITFIELD JB, 1990, PARASITOL TODAY, V6, P381, DOI 10.1016/0169-4758(90)90146-U	33	200	215	1	41	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 8	2004	306	5694					286	289		10.1126/science.1103066	http://dx.doi.org/10.1126/science.1103066			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	861MC	15472078				2022-12-28	WOS:000224419700043
J	Debes, JD; Tindall, DJ				Debes, JD; Tindall, DJ			Mechanisms of androgen-refractory prostate cancer.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Mayo Clin, Coll Med, Dept Urol, Rochester, MN 55905 USA; Mayo Clin, Coll Med, Dept Biochem, Rochester, MN USA; Mayo Clin, Coll Med, Dept Mol Biol, Rochester, MN USA	Mayo Clinic; Mayo Clinic; Mayo Clinic	Debes, JD (corresponding author), Mayo Clin, Coll Med, Dept Urol, Rochester, MN 55905 USA.							Chen CD, 2004, NAT MED, V10, P33, DOI 10.1038/nm972; Feldman BJ, 2001, NAT REV CANCER, V1, P34, DOI 10.1038/35094009; Grossmann ME, 2001, JNCI-J NATL CANCER I, V93, P1687, DOI 10.1093/jnci/93.22.1687	3	420	436	0	18	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 7	2004	351	15					1488	1490		10.1056/NEJMp048178	http://dx.doi.org/10.1056/NEJMp048178			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	859UP	15470210				2022-12-28	WOS:000224293700005
J	Smith, NL; Heckbert, SR; Lemaitre, RN; Reiner, AP; Lumley, T; Weiss, NS; Larson, EB; Rosendaal, FR; Psaty, BM				Smith, NL; Heckbert, SR; Lemaitre, RN; Reiner, AP; Lumley, T; Weiss, NS; Larson, EB; Rosendaal, FR; Psaty, BM			Esterified estrogens and conjugated equine estrogens and the risk of venous thrombosis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HORMONE REPLACEMENT THERAPY; POSTMENOPAUSAL WOMEN; MYOCARDIAL-INFARCTION; ORAL-CONTRACEPTIVES; COAGULATION; FIBRINOLYSIS; PHARMACOKINETICS; ESTRADIOL; PROTEIN	Context Clinical trial evidence indicates that estrogen therapy with or without progestins increases venous thrombotic risk. The findings from these trials, which used oral conjugated equine estrogens, may not be generalizable to other estrogen compounds. Objective To compare risk of venous thrombosis among esterified estrogen users, conjugated equine estrogen users, and nonusers. Design, Setting, and Participants This population-based, case-control study was conducted at a large health maintenance organization in Washington State. Cases were perimenopausal and postmenopausal women aged 30 to 89 years who sustained a first venous thrombosis between January 1995 and December 2001 and controls were matched on age, hypertension status, and calendar year. Main Outcome Measure Risk of first venous thrombosis in relation to current use of esterified or conjugated equine estrogens, with or without concomitant progestin. Current use was defined as use at thrombotic event for cases and a comparable reference date for controls. Results Five hundred eighty-six incident venous thrombosis cases and 2268 controls were identified. Compared with women not currently using hormones, current users of esterified estrogen had no increase in venous thrombotic risk (odds ratio [OR], 0.92; 95% confidence interval [CI], 0.69-1.22). In contrast, women currently taking conjugated equine estrogen had an elevated risk (OR, 1.65; 95% CI, 1.24-2.19). When analyses were restricted to estrogen users, current users of conjugated equine estrogen had a higher risk than current users of esterified estrogen (OR, 1.78; 95% CI, 1.11-2.84). Among conjugated equine estrogen users, increasing daily dose was associated with increased risk (trend P value=.02). Among all estrogen users, concomitant progestin use was associated with increased risk compared with use of estrogen alone (OR, 1.60; 95% CI, 1.13-2.26). Conclusion Our finding that conjugated equine estrogen but not esterified estrogen was associated with venous thrombotic risk needs to be replicated and may have implications for the choice of hormones in perimenopausal and postmenopausal women.	Univ Washington, Dept Epidemiol, Cardiovasc Hlth Res Unit, Seattle, WA 98101 USA; Univ Washington, Dept Med, Seattle, WA USA; Univ Washington, Dept Biostat, Seattle, WA 98195 USA; Univ Washington, Dept Hlth Serv, Seattle, WA 98195 USA; Grp Hlth Cooperat Puget Sound, Ctr Hlth Studies, Seattle, WA 98101 USA; Leiden Univ, Med Ctr, Leiden, Netherlands	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Group Health Cooperative; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Smith, NL (corresponding author), Univ Washington, Dept Epidemiol, Cardiovasc Hlth Res Unit, 1730 Minor Ave,Suite 1360, Seattle, WA 98101 USA.	nlsmith@u.washington.edu	Rosendaal, Frits/Q-3842-2017	Rosendaal, Frits/0000-0003-2558-7496	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL068986, R01HL074745, R01HL068639, R01HL043201, R01HL073410, R01HL060739] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG009556] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL68639, HL60739, HL73410, HL68986, HL74745, HL43201] Funding Source: Medline; NIA NIH HHS [AG09556] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Anderson GL, 2004, JAMA-J AM MED ASSOC, V291, P1701, DOI 10.1001/jama.291.14.1701; Andrade SE, 2000, MED CARE, V38, P970, DOI 10.1097/00005650-200009000-00010; Ansbacher R, 2001, AM J OBSTET GYNECOL, V184, P255, DOI 10.1067/mob.2001.109656; Bhavnani BR, 1998, P SOC EXP BIOL MED, V217, P6; Bitondo RD, 2002, HUM MOL GENET, V11, P723, DOI 10.1093/hmg/11.7.723; Cushman M, 2001, BRIT J HAEMATOL, V114, P162, DOI 10.1046/j.1365-2141.2001.02911.x; Friebely JS, 2001, J WOMEN HEALTH GEN-B, V10, P181, DOI 10.1089/152460901300039548; Gardner J, 1998, J WOMENS HEALTH, V7, P1027, DOI 10.1089/jwh.1998.7.1027; Genant HK, 1997, ARCH INTERN MED, V157, P2609, DOI 10.1001/archinte.157.22.2609; Good W R, 1999, Climacteric, V2, P29, DOI 10.3109/13697139909025560; Gottsater A, 2001, J INTERN MED, V249, P237, DOI 10.1046/j.1365-2796.2001.00797.x; Grady D, 2000, ANN INTERN MED, V132, P689, DOI 10.7326/0003-4819-132-9-200005020-00002; Heckbert SR, 1997, ARCH INTERN MED, V157, P1330, DOI 10.1001/archinte.157.12.1330; JURGENS RW, 1992, AM J OBSTET GYNECOL, V167, P459, DOI 10.1016/S0002-9378(11)91429-X; Kaplan RC, 1998, AM J HYPERTENS, V11, P471, DOI 10.1016/S0895-7061(97)00494-9; Koh KK, 1999, THROMB HAEMOSTASIS, V82, P626, DOI 10.1055/s-0037-1615889; LOBO RA, 1991, J CLIN ENDOCR METAB, V73, P925, DOI 10.1210/jcem-73-5-925; Lowe GDO, 2001, THROMB HAEMOSTASIS, V86, P550; Meijers JCM, 2000, THROMB HAEMOSTASIS, V84, P9; Meyer WR, 2001, FERTIL STERIL, V75, P394, DOI 10.1016/S0015-0282(00)01712-X; Middeldorp S, 2000, THROMB HAEMOSTASIS, V84, P4; Nelson HD, 2004, JAMA-J AM MED ASSOC, V291, P1610, DOI 10.1001/jama.291.13.1610; Nozaki M, 1999, Climacteric, V2, P124, DOI 10.3109/13697139909025576; OCONNELL MB, 1995, J CLIN PHARMACOL, V35, pS18, DOI 10.1002/j.1552-4604.1995.tb04143.x; PSATY BM, 1994, ARCH INTERN MED, V154, P1333, DOI 10.1001/archinte.154.12.1333; PSATY BM, 1995, JAMA-J AM MED ASSOC, V274, P620, DOI 10.1001/jama.274.8.620; RAGHUNATHAN TE, 1998, IVEWARE IMPUTATION V; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Teede HJ, 2000, ARTERIOSCL THROM VAS, V20, P1404, DOI 10.1161/01.ATV.20.5.1404; van Baal WM, 1999, EUR J CLIN INVEST, V29, P913; van Tilburg NH, 2000, BLOOD, V95, P2855, DOI 10.1182/blood.V95.9.2855.009k02_2855_2859; von Holst T, 2002, MATURITAS, V43, P265, DOI 10.1016/S0378-5122(02)00203-7	32	119	121	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 6	2004	292	13					1581	1587		10.1001/jama.292.13.1581	http://dx.doi.org/10.1001/jama.292.13.1581			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	859HS	15467060	Bronze, Green Published			2022-12-28	WOS:000224254600025
J	Coleman, EA; Berenson, RA				Coleman, EA; Berenson, RA			Lost in transition: Challenges and opportunities for improving the quality of transitional care	ANNALS OF INTERNAL MEDICINE			English	Article							CONGESTIVE-HEART-FAILURE; OLDER PATIENTS; HOSPITAL-CARE; FOLLOW-UP; DISCHARGE; INTERVENTION; NEEDS	Transitional care has been defined as a set of actions designed to ensure the coordination and continuity of health care as patients transfer between different locations or different levels of care in the same location. Transitional care, which primarily concerns the relatively brief time interval that begins with preparing a patient to leave one setting and concludes when the patient is received in the next setting, poses challenges that distinguish it from other types of care. Many transitions are unplanned, result from unanticipated medical problems, occur in "real time" during nights and on weekends, involve clinicians who may not have an ongoing relationship with the patient, and happen so quickly that formal and informal support mechanisms cannot respond in a timely manner. This article describes the challenges involved in and potential solutions for improving the quality of transitional care.	Univ Colorado, Div Hlth Care Policy & Res, Hlth Sci Ctr, Aurora, CO 80011 USA; Urban Inst, Ctr Hlth Policy, Washington, DC 20037 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; Urban Institute	Coleman, EA (corresponding author), Univ Colorado, Div Hlth Care Policy & Res, Hlth Sci Ctr, 13611 E Colfax,Suite 100, Aurora, CO 80011 USA.	Eric.Coleman@uchsc.edu						*AG HEALTHC RES QU, 2000, MED ERR SCOP PROBL; *ASTM INT MASS MED, CONT CAR REC CCR CON; Bazzoli GJ, 2003, HEALTH AFFAIR, V22, P40, DOI 10.1377/hlthaff.22.6.40; BEERS MH, 1992, HOSP FORMUL, V27, P720; BREWSTER L, EMERGENCY ROOM DIVER; Burns LR, 2002, HEALTH AFFAIR, V21, P128, DOI 10.1377/hlthaff.21.4.128; *CAL HLTH CAR FDN, RES PAT EV PERF PEP; Centers for Medicare and Medicaid Services, HEALTHC COMM PROC CO; Coleman EA, 2003, J AM GERIATR SOC, V51, P556, DOI 10.1046/j.1532-5415.2003.51186.x; Coleman EA, 2004, J AM GERIATR SOC, V52, pS1; Coleman EA, 2003, J AM GERIATR SOC, V51, P549, DOI 10.1046/j.1532-5415.2003.51185.x; COLEMAN EA, 2004, IN PRESS HLTH SERV R; COLEMAN EA, 2004, IN PRESS MED CARE; COLEMAN EA, 2002, ASP TRANS CAR C P; COLEMAN EA, 2002, DEV TESTING MEASURE; Dudas V, 2001, AM J MED, V111, P26, DOI 10.1016/S0002-9343(01)00966-4; Einstadter D, 1996, J GEN INTERN MED, V11, P684, DOI 10.1007/BF02600160; Forster AJ, 2003, ANN INTERN MED, V138, P161, DOI 10.7326/0003-4819-138-3-200302040-00007; Harrison A, 2002, HEALTH SERV RES, V37, P1031, DOI 10.1034/j.1600-0560.2002.64_2.x; *HMO CAR MAN WORKG, ON PAT MAN PLAC MAN; *I MED COMM DAT ST, 2001, KEY CAP EL HLTH REC; Institute of Medicine, 2001, CROSSING QUALITY CHA; Institute of Medicine, 2000, ERR IS HUM BUILD SAF; *JOINT COMM ACCR H, 2001, STAND INT STAT 1, P69; Katz T.F., 2000, ANN LONG TERM CARE, V8, P51; KRAMER A, 2003, SUMMARY STATUS ELECT, P1; LEVINE C, 1998, CROSSINGS FAMILY CAR; *MED PAYM ADV COMM, 2003, US MARK COMP FEE FOR, P131; *MED PAYM ADV COMM, US INC IMPR QUAL CAR; Moore C, 2003, J GEN INTERN MED, V18, P646, DOI 10.1046/j.1525-1497.2003.20722.x; Naylor MD, 1999, JAMA-J AM MED ASSOC, V281, P613, DOI 10.1001/jama.281.7.613; Partnership for Solutions, 2002, CHRON COND MAK CAS O; Phillips CO, 2004, JAMA-J AM MED ASSOC, V291, P1358, DOI 10.1001/jama.291.11.1358; RICH MW, 1995, NEW ENGL J MED, V333, P1190, DOI 10.1056/NEJM199511023331806; Stewart S, 1998, ARCH INTERN MED, V158, P1067, DOI 10.1001/archinte.158.10.1067; *US DEP HHS OFF IN, 1997, US DEP HLTH HUM SERV; vom Eigen KA, 1999, MED CARE, V37, P33, DOI 10.1097/00005650-199901000-00006; Wachter RM, 2002, JAMA-J AM MED ASSOC, V287, P487, DOI 10.1001/jama.287.4.487; Weaver F M, 1998, Home Health Care Serv Q, V17, P27; Wenger NS, 2003, ANN INTERN MED, V139, P740, DOI 10.7326/0003-4819-139-9-200311040-00008	40	454	458	0	33	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 5	2004	141	7					533	535		10.7326/0003-4819-141-7-200410050-00009	http://dx.doi.org/10.7326/0003-4819-141-7-200410050-00009			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	862CR	15466770				2022-12-28	WOS:000224467800005
J	Bobak, M; Kristenson, M; Pikhart, H; Marmot, M				Bobak, M; Kristenson, M; Pikhart, H; Marmot, M			Life span and disability: a cross sectional comparison of Russian and Swedish community based data	BRITISH MEDICAL JOURNAL			English	Article							HEALTH SURVEY SF-36; MONICA PROJECT; EVENT RATES; MORBIDITY; MORTALITY; POPULATIONS; COMPRESSION; EXPECTANCY; COUNTRIES	Objectives To compare levels of disability (in terms of physical function and self rated health) among middle aged and elderly people in Russia and Sweden, a country with high life expectancy. Design Cross sectional study. Setting General population of the Russian Federation and of two counties in southern Sweden. Participants Randomly selected men and women in Sweden (n = 9489) and Russia (n = 1599). Main outcome measures Official life table data; self rated health and physical functioning (subscale of the SF-36). Results The official life table data showed large differences in mortality-for example, 36% of Russian men aged 45-49 years would survive the next 25 years compared with 75% of Swedish men. The survey data showed, for both sexes, similar levels of self rated health and physical functioning in the two countries up to the age of about 45 years, but after that, the age related decline in both outcomes was much faster in Russia than in Sweden. By combining the national life tables with survey data on physical functioning we estimated that in the age group 45-49 years, 99% of Russian and 97% of Swedish men would be free of disability; of these, if these data were for a cohort, only 17% of Russians would be alive and free of disability 25 years later compared with 65% of Swedes. The difference in survival was similar in women. Conclusions Large differences exist in survival without disability between elderly Russians and Swedes. The short life span in Russia reflects high levels of ill health and disability and is associated with a rapid age related decline in physical functioning.	UCL, Int Ctr Hlth & Soc, London WC1E 6BT, England; Linkoping Univ, Fac Hlth Sci, Dept Hlth & Soc, S-58183 Linkoping, Sweden	University of London; University College London; Linkoping University	Bobak, M (corresponding author), UCL, Int Ctr Hlth & Soc, Mortimer St, London WC1E 6BT, England.	m.bobak@ucl.ac.uk	Marmot, M G/Y-3920-2019; Pikhart, Hynek/E-3074-2010	Marmot, M G/0000-0002-2431-6419; Pikhart, Hynek/0000-0001-5277-4049; Bobak, Martin/0000-0002-2633-6851	Medical Research Council [G8802774, G19/35, G0100222] Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Bobak M, 1998, SOC SCI MED, V47, P269, DOI 10.1016/S0277-9536(98)00095-1; Fries JF, 2003, ANN INTERN MED, V139, P455, DOI 10.7326/0003-4819-139-5_Part_2-200309021-00015; FRIES JF, 1980, NEW ENGL J MED, V303, P130, DOI 10.1056/NEJM198007173030304; Kalache A, 2002, B WORLD HEALTH ORGAN, V80, P243; Kristenson M, 1998, PSYCHOSOM MED, V60, P277, DOI 10.1097/00006842-199805000-00011; Kuh D, 1997, LIFE COURSE APPROACH; Leon DA, 1997, LANCET, V350, P383, DOI 10.1016/S0140-6736(97)03360-6; Mathers CD, 2001, LANCET, V357, P1685, DOI 10.1016/S0140-6736(00)04824-8; MCHORNEY CA, 1993, MED CARE, V31, P247, DOI 10.1097/00005650-199303000-00006; Notzon FC, 1998, JAMA-J AM MED ASSOC, V279, P793, DOI 10.1001/jama.279.10.793; Pudaric S, 2003, SOC SCI MED, V56, P2493, DOI 10.1016/S0277-9536(02)00284-8; SEN A, 2002, BRIT MED J, V324, P800; Tunstall-Pedoe H, 1999, LANCET, V353, P1547, DOI 10.1016/S0140-6736(99)04021-0; TUNSTALLPEDOE H, 1994, CIRCULATION, V90, P583, DOI 10.1161/01.CIR.90.1.583; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; WHO, HLTH LIF EXP; *WHO, WHOSIS EV INF HLTH P; *WHOSIS, EV INF HLTH POL	18	28	29	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 2	2004	329	7469					767	770		10.1136/bmj.38202.667130.55	http://dx.doi.org/10.1136/bmj.38202.667130.55			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	859TW	15377571	Bronze, Green Submitted, Green Published			2022-12-28	WOS:000224291800016
J	Haines, A; Victora, C				Haines, A; Victora, C			Evidence-based action needed on health systems	LANCET			English	Editorial Material							MILLENNIUM DEVELOPMENT GOALS		Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England; Univ Fed Pelotas, Pelotas, Brazil	University of London; London School of Hygiene & Tropical Medicine; Universidade Federal de Pelotas	Haines, A (corresponding author), Univ London London Sch Hyg & Trop Med, Keppel St, London WC1E 7HT, England.	Andy.Haines@lshtm.ac.uk	Victora, Cesar G/D-4476-2013; Victora, Cesar Gomes/Y-2455-2019	Victora, Cesar G/0000-0002-2465-2180; Victora, Cesar Gomes/0000-0002-2465-2180; Haines, Andy/0000-0002-8053-4605				Becerra-Posada F, 2004, LANCET, V364, P997, DOI 10.1016/S0140-6736(04)17026-8; Haines A, 2004, LANCET, V363, P261, DOI 10.1016/S0140-6736(03)15419-0; Travis P, 2004, LANCET, V364, P900, DOI 10.1016/S0140-6736(04)16987-0	3	8	8	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	OCT 2	2004	364	9441					1204	1204		10.1016/S0140-6736(04)17160-2	http://dx.doi.org/10.1016/S0140-6736(04)17160-2			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	859HO	15464170				2022-12-28	WOS:000224254200010
J	Lachs, MS; Pillemer, K				Lachs, MS; Pillemer, K			Elder abuse	LANCET			English	Review							FAMILY VIOLENCE; RISK-FACTORS; OLDER VICTIMS; NEGLECT; PREVALENCE; DEMENTIA; PEOPLE; MISTREATMENT; CARERS	Elder abuse has received increasing attention over the past decade as a common problem with serious consequences for the health and wellbeing of old people. Our aim is to assist clinicians by summarising recent international research and clinical findings about elder abuse, and to assess their quality, relevance, and feasibility for health-care providers in clinical practice. This seminar includes issues of definition and frequency of elder abuse and a summary of major known risk factors. The advantages and disadvantages of screening for elder abuse are discussed. We review clinical manifestations and diagnosis of elder abuse, and propose a protocol for medical assessment of a patient with confirmed or suspected abuse. Suggestions for treatment are offered on the basis that elder abuse is multifactorial and needs individual medical and social intervention strategies, preferably in the context of a multidisciplinary team.	Cornell Univ, Weill Med Coll, Div Geriatr Med & Gerontol, New York, NY 10021 USA; Cornell Univ, Cornell Gerontol Res Inst, New York, NY USA; Cornell Univ, Dept Human Dev, New York, NY USA	Cornell University; Cornell University; Cornell University	Lachs, MS (corresponding author), Cornell Univ, Weill Med Coll, Div Geriatr Med & Gerontol, 1300 York Ave,Box 39, New York, NY 10021 USA.	mslachs@mail.med.cornell.edu		Pillemer, Karl/0000-0002-7700-3563	NIA NIH HHS [K24AG022399, P30AG022845-01] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [K24AG022399, P30AG022845] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Akaza Kayoko, 2003, Leg Med (Tokyo), V5, P7, DOI 10.1016/S1344-6223(02)00057-3; *AM MED ASS DIAGN, 1992, GUID ELD AB NEGL; Anetzberger GJ, 2000, GERONTOLOGIST, V40, P492, DOI 10.1093/geront/40.4.492; ANETZBERGER GJ, 1994, J INTERPERS VIOLENCE, V9, P184, DOI 10.1177/088626094009002003; Bonnie R., 2002, ELDER ABUSE ABUSE NE; BRISTOWE E, 1989, J ELDER ABUSE NEGL, V1, P45; Cham G. W., 2000, SINGAPORE MED, V41, P567; Choi NG, 1999, J ELDER ABUSE NEGL, V10, P39, DOI 10.1300/J084v10n03_03; Cohn F., 2002, CONFRONTING CHRONIC; Comijs HC, 1999, J GERONTOL B-PSYCHOL, V54, pP240, DOI 10.1093/geronb/54B.4.P240; Compton SA, 1997, INT J GERIATR PSYCH, V12, P632, DOI 10.1002/(SICI)1099-1166(199706)12:6<632::AID-GPS570>3.3.CO;2-0; Cooney C, 1995, INT J SOC PSYCHIATR, V41, P276, DOI 10.1177/002076409504100405; DYER C, 2002, ELDER ABUSE ABUSE NE; Dyer CB, 2000, J AM GERIATR SOC, V48, P205, DOI 10.1111/j.1532-5415.2000.tb03913.x; Eriksson C, 2002, SCAND J CARING SCI, V16, P79, DOI 10.1046/j.1471-6712.2002.00061.x; Fulmer T, 2004, J AM GERIATR SOC, V52, P297, DOI 10.1111/j.1532-5415.2004.52074.x; GRAFSTROM M, 1993, SCAND J SOC MED, V21, P247, DOI 10.1177/140349489302100404; Greenberg Jan R., 1990, J ELDER ABUSE NEGL, V2, P73, DOI DOI 10.1300/J084V02N01_05; Harrell R, 2002, AM J MED SCI, V323, P34, DOI 10.1097/00000441-200201000-00006; Heath JM, 2002, ACAD MED, V77, P1101, DOI 10.1097/00001888-200211000-00007; HOMER AC, 1990, BRIT MED J, V301, P1359, DOI 10.1136/bmj.301.6765.1359; JONES J, 1988, ANN EMERG MED, V17, P1006, DOI 10.1016/S0196-0644(88)80436-0; Lachs MS, 1997, GERONTOLOGIST, V37, P469, DOI 10.1093/geront/37.4.469; Lachs MS, 1998, JAMA-J AM MED ASSOC, V280, P428, DOI 10.1001/jama.280.5.428; Lachs MS, 2004, ANN INTERN MED, V140, P399, DOI 10.7326/0003-4819-140-5-200403020-00017; LACHS MS, 1994, J AM GERIATR SOC, V42, P169, DOI 10.1111/j.1532-5415.1994.tb04947.x; Lachs MS, 2002, GERONTOLOGIST, V42, P734, DOI 10.1093/geront/42.6.734; LACHS MS, 1995, NEW ENGL J MED, V332, P437, DOI 10.1056/NEJM199502163320706; Lachs MS, 1995, J ELDER ABUSE NEGL, V7, P1; Lachs MS, 1997, ANN EMERG MED, V30, P448, DOI 10.1016/S0196-0644(97)70003-9; McCreadie C, 2000, J ROY SOC MED, V93, P67, DOI 10.1177/014107680009300205; MOON A, 1993, GERONTOLOGIST, V33, P386, DOI 10.1093/geront/33.3.386; *MOUNT SIN VICT SE, 1988, ELD MISTR GUID HLTH; Patterson C., 1993, CANADIAN TASK FORCE, P922; PAVEZA GJ, 1992, GERONTOLOGIST, V32, P493, DOI 10.1093/geront/32.4.493; PILLEMER K, 1992, J GERONTOL, V47, pS165, DOI 10.1093/geronj/47.4.S165; PILLEMER K, 1988, GERONTOLOGIST, V28, P51, DOI 10.1093/geront/28.1.51; PILLEMER K, 1989, AM J ORTHOPSYCHIAT, V59, P179, DOI 10.1111/j.1939-0025.1989.tb01649.x; PILLEMER K, 2004, CURRENT CONTROVERSIE; Podnieks E., 1992, J ELDER ABUSE NEGL, V4, P5, DOI [DOI 10.1300/J084V04N01_02, 10.1300/j084v04n01_02]; Reay AMC, 2001, AGING MENT HEALTH, V5, P56, DOI 10.1080/13607860020020654; Reis M, 1998, GERONTOLOGIST, V38, P471, DOI 10.1093/geront/38.4.471; Schofield MJ, 2003, GERONTOLOGIST, V43, P110, DOI 10.1093/geront/43.1.110; Shugarman LR, 2003, J AM GERIATR SOC, V51, P24, DOI 10.1034/j.1601-5215.2002.51005.x; Thomsson KA, 2002, GLYCOBIOLOGY, V12, P1, DOI 10.1093/glycob/12.1.1; Tornstam L., 1989, J ELDER ABUSE NEGL, V1, P35; US Preventive Services Task Force, 1996, GUID CLIN PREV SERV, P18; Williamson GM, 2001, PSYCHOL AGING, V16, P217, DOI 10.1037//0882-7974.16.2.217; Wolf RS, 2001, J WOMEN AGING, V13, P71, DOI 10.1300/J074v13n04_06; WOLF RS, 1989, HELPING ELDERLY VICT; World Health Organization, 2002, MISS VOIC VIEWS OLD; World Health Organization, 2002, WORLD REPORT VIOLENC; World Health Organization (WHO), 2002, TOR DECL GLOB PREV	53	325	334	1	28	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 2	2004	364	9441					1263	1272		10.1016/S0140-6736(04)17144-4	http://dx.doi.org/10.1016/S0140-6736(04)17144-4			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	859HO	15464188				2022-12-28	WOS:000224254200034
J	Foukal, P; North, G; Wigley, T				Foukal, P; North, G; Wigley, T			A stellar view on solar variations and climate	SCIENCE			English	Editorial Material							BRIGHTNESS CHANGES; MAGNETIC-FLUX; IRRADIANCE; 20TH-CENTURY; CYCLES; STARS		Heliophys Inc, Nahant, MA 01908 USA; Texas A&M Univ, Dept Atmospher Sci, College Stn, TX 77843 USA; Natl Ctr Atmospher Res, Boulder, CO 80307 USA	Texas A&M University System; Texas A&M University College Station; National Center Atmospheric Research (NCAR) - USA	Foukal, P (corresponding author), Heliophys Inc, Nahant, MA 01908 USA.	pfoukal@world.std.com	North, Gerald R/G-1019-2011					BALIUNAS S, 1990, NATURE, V348, P520, DOI 10.1038/348520a0; Crowley TJ, 2000, SCIENCE, V289, P270, DOI 10.1126/science.289.5477.270; deMello GFP, 1997, ASTROPHYS J, V482, pL89, DOI 10.1086/310693; Foukal P, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL015474; Foukal P, 2001, GEOPHYS RES LETT, V28, P883, DOI 10.1029/2000GL012072; Foukal P., 2003, EOS T AM GEOPHYS UN, V84, P205; Frohlich C, 1998, GEOPHYS RES LETT, V25, P4377, DOI 10.1029/1998GL900157; GIAMPAPA M, UNPUB; HALL J, IN PRESS ASTROPHYS J; HENRY G, UNPUB; Houghton J. T., 2001, CLIMATE CHANGE 2001; HOYT DV, 1993, J GEOPHYS RES-SPACE, V98, P18895, DOI 10.1029/93JA01944; LEAN J, 1995, GEOPHYS RES LETT, V22, P3195, DOI 10.1029/95GL03093; Lean JL, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL015880; LOCKWOOD GW, 1992, NATURE, V360, P653, DOI 10.1038/360653a0; Lockwood M, 1999, GEOPHYS RES LETT, V26, P2461, DOI 10.1029/1999GL900485; Lockwood M, 1999, NATURE, V399, P437, DOI 10.1038/20867; Stott PA, 2001, CLIM DYNAM, V17, P1, DOI 10.1007/PL00007924; Wigley TML, 2001, SCIENCE, V293, P451, DOI 10.1126/science.1061604	19	73	76	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 1	2004	306	5693					68	69		10.1126/science.1101694	http://dx.doi.org/10.1126/science.1101694			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	859YJ	15459378				2022-12-28	WOS:000224304000035
J	Lin, JD; Wu, PH; Tarr, PT; Lindenberg, KS; St-Pierre, J; Zhang, CY; Mootha, VK; Jager, S; Vianna, CR; Reznick, RM; Cui, LB; Manieri, M; Donovan, MX; Wu, ZD; Cooper, MP; Fan, MC; Rohas, LM; Zavacki, AM; Cinti, S; Shulman, GI; Lowell, BB; Krainc, D; Spiegelman, BM				Lin, JD; Wu, PH; Tarr, PT; Lindenberg, KS; St-Pierre, J; Zhang, CY; Mootha, VK; Jager, S; Vianna, CR; Reznick, RM; Cui, LB; Manieri, M; Donovan, MX; Wu, ZD; Cooper, MP; Fan, MC; Rohas, LM; Zavacki, AM; Cinti, S; Shulman, GI; Lowell, BB; Krainc, D; Spiegelman, BM			Defects in adaptive energy metabolism with CNS-Linked hyperactivity in PGC-1 alpha null mice	CELL			English	Article							PHOSPHOENOLPYRUVATE CARBOXYKINASE GTP; CONTROLLING MITOCHONDRIAL BIOGENESIS; TRANSCRIPTIONAL COACTIVATOR PGC-1; INSULIN-RESISTANCE; HEPATIC GLUCONEOGENESIS; UNCOUPLING PROTEIN; GLUCOSE-PRODUCTION; BINDING-PROTEIN; TRANSGENIC MICE; CDNA CLONING	PGC-1alpha is a coactivator of nuclear receptors and other transcription factors that regulates several metabolic processes, including mitochondrial biogenesis and respiration, hepatic gluconeogenesis, and muscle fiber-type switching. We show here that, while hepatocytes lacking PGC-1alpha are defective in the program of hormone-stimulated gluconeogenesis, the mice have constitutively activated gluconeogenic gene expression that is completely insensitive to normal feeding controls. C/EBPbeta is elevated in the livers of these mice and activates the gluconeogenic genes in a PGC-1alpha-independent manner. Despite having reduced mitochondrial function, PGC-1alpha null mice are paradoxically lean and resistant to diet-induced obesity. This is largely due to a profound hyperactivity displayed by the null animals and is associated with lesions in the striatal region of the brain that controls movement. These data illustrate a central role for PGC-1alpha in the control of energy metabolism but also reveal novel systemic compensatory mechanisms and pathogenic effects of impaired energy homeostasis.	Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; Harvard Univ, Massachusetts Gen Hosp, Sch Med,Mass Gen Inst Neurodegenerat, Dept Neurol, Charlestown, MA 02129 USA; Beth Israel Deaconess Med Ctr, Dept Med, Div Endocrinol, Boston, MA 02215 USA; Harvard Univ, Sch Med, Boston, MA 02215 USA; MIT, Ctr Genome Res, Whitehead Inst, Cambridge, MA 02139 USA; Yale Univ, Sch Med, Howard Hughes Med Inst, Dept Internal Med, New Haven, CT 06520 USA; Univ Ancona, Fac Med, Inst Normal Human Morphol, I-60020 Ancona, Italy; Brigham & Womens Hosp, Div Rheumatol Immunol & Allergy, Dept Med, Boston, MA 02115 USA; Brigham & Womens Hosp, Div Endocrinol Diabet & Hypertens, Thyroid Sect, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT); Whitehead Institute; Howard Hughes Medical Institute; Yale University; Marche Polytechnic University; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital	Spiegelman, BM (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA.	bruce_spiegelman@dfci.harvard.edu	Shulman, Gerald I./P-7176-2019; St-Pierre, Julie/AGB-3651-2022; vianna, claudia/I-4991-2012; Wu, Pei-Hsuan/AAL-1704-2020	Shulman, Gerald I./0000-0003-1529-5668; St-Pierre, Julie/0000-0002-2815-7099; Wu, Pei-Hsuan/0000-0002-6690-0744; CINTI, Saverio/0000-0003-0362-5017; Wu, Zhidan/0000-0001-7289-9420; Jager, Sibylle/0000-0001-8102-7149; Fan, Melina/0000-0002-6196-8408	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK054477, R01DK061562, K01DK065584, R01DK040936, R01DK054477] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS045242] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK54477, DK61562, R01 DK040936, DK065584, DK40936] Funding Source: Medline; NINDS NIH HHS [NS002174, NS045242] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Aoki T T, 1981, Prog Clin Biol Res, V67, P161; Baar K, 2002, FASEB J, V16, P1879, DOI 10.1096/fj.02-0367com; BOUILLAUD F, 1985, P NATL ACAD SCI USA, V82, P445, DOI 10.1073/pnas.82.2.445; Carling D, 2004, TRENDS BIOCHEM SCI, V29, P18, DOI 10.1016/j.tibs.2003.11.005; Croniger C, 1998, J BIOL CHEM, V273, P31629, DOI 10.1074/jbc.273.48.31629; Fan M, 2004, GENE DEV, V18, P278, DOI 10.1101/gad.1152204; Ginsberg HN, 2000, J CLIN INVEST, V106, P453, DOI 10.1172/JCI10762; Goto M, 2000, BIOCHEM BIOPH RES CO, V274, P350, DOI 10.1006/bbrc.2000.3134; GRONINGER C, 1997, J BIOL CHEM, V272, P26306; Hanson RW, 1997, ANNU REV BIOCHEM, V66, P581, DOI 10.1146/annurev.biochem.66.1.581; Herzig S, 2001, NATURE, V413, P179, DOI 10.1038/35093131; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; JACOBSSON A, 1985, J BIOL CHEM, V260, P6250; Kelly DP, 2004, GENE DEV, V18, P357, DOI 10.1101/gad.1177604; Kirpichnikov D, 2002, ANN INTERN MED, V137, P25, DOI 10.7326/0003-4819-137-1-200207020-00009; Koo SH, 2004, NAT MED, V10, P530, DOI 10.1038/nm1044; Lehman JJ, 2000, J CLIN INVEST, V106, P847, DOI 10.1172/JCI10268; Lewandoski M, 1997, CURR BIOL, V7, P148, DOI 10.1016/S0960-9822(06)00059-5; Lieberman LS, 2003, ANNU REV NUTR, V23, P345, DOI 10.1146/annurev.nutr.23.011702.073212; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Lin JD, 2003, J BIOL CHEM, V278, P30843, DOI 10.1074/jbc.M303643200; Lin JD, 2002, J BIOL CHEM, V277, P1645, DOI 10.1074/jbc.C100631200; Liu S, 1999, J CLIN INVEST, V103, P207, DOI 10.1172/JCI4243; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Miyake K, 2002, J CLIN INVEST, V110, P1483, DOI 10.1172/JCI200215880; Moller DE, 2001, NATURE, V414, P821, DOI 10.1038/414821a; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Nordlie RC, 1999, ANNU REV NUTR, V19, P379, DOI 10.1146/annurev.nutr.19.1.379; PARK EA, 1993, J BIOL CHEM, V268, P613; Patti ME, 2003, P NATL ACAD SCI USA, V100, P8466, DOI 10.1073/pnas.1032913100; Petersen KF, 2004, NEW ENGL J MED, V350, P664, DOI 10.1056/NEJMoa031314; Petersen KF, 2003, SCIENCE, V300, P1140, DOI 10.1126/science.1082889; PILKIS SJ, 1992, ANNU REV PHYSIOL, V54, P885, DOI 10.1146/annurev.ph.54.030192.004321; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Puigserver P, 2003, ENDOCR REV, V24, P78, DOI 10.1210/er.2002-0012; Rhee J, 2003, P NATL ACAD SCI USA, V100, P4012, DOI 10.1073/pnas.0730870100; Roesler WJ, 2001, ANNU REV NUTR, V21, P141, DOI 10.1146/annurev.nutr.21.1.141; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Schilling G, 1999, HUM MOL GENET, V8, P397, DOI 10.1093/hmg/8.3.397; Schon EA, 2003, J CLIN INVEST, V111, P303, DOI 10.1172/JCI200317741; Shin DJ, 2003, J BIOL CHEM, V278, P50047, DOI 10.1074/jbc.M309736200; St-Pierre J, 2003, J BIOL CHEM, V278, P26597, DOI 10.1074/jbc.M301850200; Tritos NA, 2003, BRAIN RES, V961, P255, DOI 10.1016/S0006-8993(02)03961-6; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050; Zimmet P, 2001, NATURE, V414, P782, DOI 10.1038/414782a	46	940	979	3	65	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 1	2004	119	1					121	+		10.1016/j.cell.2004.09.013	http://dx.doi.org/10.1016/j.cell.2004.09.013			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	859UE	15454086	Bronze, Green Published			2022-12-28	WOS:000224292600014
J	Verma, R; Peters, NR; D'Onofrio, M; Tochtrop, GP; Sakamoto, KM; Varadan, R; Zhang, MS; Coffino, P; Fushman, D; Deshaies, RJ; King, RW				Verma, R; Peters, NR; D'Onofrio, M; Tochtrop, GP; Sakamoto, KM; Varadan, R; Zhang, MS; Coffino, P; Fushman, D; Deshaies, RJ; King, RW			Ubistatins inhibit proteasome-dependent degradation by binding the ubiquitin chain	SCIENCE			English	Article							XENOPUS EGG EXTRACTS; 26S PROTEASOME; DEUBIQUITINATION; RECONSTITUTION; RECOGNITION; PROTEOMICS; SUBSTRATE; PROTEINS; MITOSIS; SYSTEM	To identify previously unknown small molecules that inhibit cell cycle machinery, we performed a chemical genetic screen in Xenopus extracts. One class of inhibitors, termed ubistatins, blocked cell cycle progression by inhibiting cyclin B proteolysis and inhibited degradation of ubiquitinated Sic1 by purified proteasomes. Ubistatins blocked the binding of ubiquitinated substrates to the proteasome by targeting the ubiquitin-ubiquitin interface of Lys(48)-linked chains. The same interface is recognized by ubiquitin-chain receptors of the proteasome, indicating that ubistatins act by disrupting a critical protein-protein interaction in the ubiquitin-proteasome system.	Harvard Univ, Sch Med, Inst Chem & Cell Biol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; CALTECH, Howard Hughes Med Inst, Dept Biol, Pasadena, CA 91125 USA; Univ Maryland, Dept Chem & Biochem, Ctr Biomol Struct & Org, College Pk, MD 20742 USA; Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Mattel Childrens Hosp, Div Hematol Oncol,David Geffen Sch Med, Los Angeles, CA 90095 USA; Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; California Institute of Technology; Howard Hughes Medical Institute; University System of Maryland; University of Maryland College Park; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California San Francisco	King, RW (corresponding author), Harvard Univ, Sch Med, Inst Chem & Cell Biol, 240 Longwood Ave, Boston, MA 02115 USA.	randy_king@hms.harvard.edu	Deshaies, Raymond/B-8354-2014	Deshaies, Raymond/0000-0002-3671-9354; D'ONOFRIO, Mariapina/0000-0002-8699-0847; Sakamoto, Kathleen/0000-0003-0494-8838	NCI NIH HHS [CA78048, R21CA108545, P50 CA92131] Funding Source: Medline; NIGMS NIH HHS [GM068276, GM65334, GM66492, R01 GM-45335] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA078048, R21CA108545, P50CA092131] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM068276, R56GM066492, R01GM045335, R01GM065334, R01GM066492] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adams J, 2004, NAT REV CANCER, V4, P349, DOI 10.1038/nrc1361; COOK WJ, 1992, J BIOL CHEM, V267, P16467; DASSO M, 1990, CELL, V61, P811, DOI 10.1016/0092-8674(90)90191-G; FUSHMAN D, UNPUB; Hartmann-Petersen R, 2003, TRENDS BIOCHEM SCI, V28, P26, DOI 10.1016/S0968-0004(02)00002-6; Mayer TU, 2003, TRENDS CELL BIOL, V13, P270, DOI 10.1016/S0962-8924(03)00077-1; Meng LH, 1999, P NATL ACAD SCI USA, V96, P10403, DOI 10.1073/pnas.96.18.10403; MINSHULL J, 1994, CELL, V79, P475, DOI 10.1016/0092-8674(94)90256-9; Peng JM, 2003, NAT BIOTECHNOL, V21, P921, DOI 10.1038/nbt849; Peters JM, 2002, MOL CELL, V9, P931, DOI 10.1016/S1097-2765(02)00540-3; PETERS N, UNPUB; Pfleger CM, 2000, GENE DEV, V14, P655; Pickart CM, 2004, CELL, V116, P181, DOI 10.1016/S0092-8674(03)01074-2; Sakamoto KM, 2003, MOL CELL PROTEOMICS, V2, P1350, DOI 10.1074/mcp.T300009-MCP200; Salic A, 2000, MOL CELL, V5, P523, DOI 10.1016/S1097-2765(00)80446-3; Seol JH, 1999, GENE DEV, V13, P1614, DOI 10.1101/gad.13.12.1614; Skowyra D, 1999, SCIENCE, V284, P662, DOI 10.1126/science.284.5414.662; Varadan R, 2004, J BIOL CHEM, V279, P7055, DOI 10.1074/jbc.M309184200; Varadan R, 2002, J MOL BIOL, V324, P637, DOI 10.1016/S0022-2836(02)01198-1; Verma R, 2002, SCIENCE, V298, P611, DOI 10.1126/science.1075898; Verma R, 2004, CELL, V118, P99, DOI 10.1016/j.cell.2004.06.014; Verma R, 2000, MOL BIOL CELL, V11, P3425, DOI 10.1091/mbc.11.10.3425; Verma R, 2001, MOL CELL, V8, P439, DOI 10.1016/S1097-2765(01)00308-2; Walling LA, 2001, J CELL BIOCHEM, V84, P7, DOI 10.1002/jcb.10075; Yao TT, 2002, NATURE, V419, P403, DOI 10.1038/nature01071; Zhang MS, 2003, EMBO J, V22, P1488, DOI 10.1093/emboj/cdg158	26	153	158	0	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 1	2004	306	5693					117	120		10.1126/science.1100946	http://dx.doi.org/10.1126/science.1100946			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	859YJ	15459393	Green Accepted			2022-12-28	WOS:000224304000050
J	Maiolino, R; Schneider, R; Oliva, E; Bianchi, S; Ferrara, A; Mannucci, F; Pedani, M; Sogorb, MR				Maiolino, R; Schneider, R; Oliva, E; Bianchi, S; Ferrara, A; Mannucci, F; Pedani, M; Sogorb, MR			A supernova origin for dust in a high-redshift quasar	NATURE			English	Article							EARLY STAR-FORMATION; DISTANT QUASARS; II SUPERNOVAE; EVOLUTION; EMISSION; GRAINS	Interstellar dust plays a crucial role in the evolution of the Universe by assisting the formation of molecules(1), by triggering the formation of the first low-mass stars(2), and by absorbing stellar ultraviolet - optical light and subsequently re-emitting it at infrared/millimetre wavelengths. Dust is thought to be produced predominantly in the envelopes of evolved ( age > 1 Gyr), low-mass stars(3). This picture has, however, recently been brought into question by the discovery of large masses of dust in the host galaxies of quasars(4,5) at redshift z > 6, when the age of the Universe was less than 1 Gyr. Theoretical studies(6-8), corroborated by observations of nearby supernova remnants(9-11), have suggested that supernovae provide a fast and efficient dust formation environment in the early Universe. Here we report infrared observations of a quasar at redshift 6.2, which are used to obtain directly its dust extinction curve. We then show that such a curve is in excellent agreement with supernova dust models. This result demonstrates a supernova origin for dust in this high-redshift quasar, from which we infer that most of the dust at high redshifts probably has the same origin.	Osserv Astrofis Arcetri, INAF, I-50125 Florence, Italy; CNR, IRA, Sez Firenze, I-50125 Florence, Italy; Enrico Fermi Ctr, I-00184 Rome, Italy; Telescopio Nazl Galileo, Santa Cruz De La Palma 38700, Spain; Scuola Int Super Studi Avanzati, Int Sch Adv Studies, I-34100 Trieste, Italy; Univ La Laguna, Astrofis Fco Sanchez, E-38206 Tenerife, Spain	Istituto Nazionale Astrofisica (INAF); Consiglio Nazionale delle Ricerche (CNR); International School for Advanced Studies (SISSA); Universidad de la Laguna	Maiolino, R (corresponding author), Osserv Astrofis Arcetri, INAF, Largo Enrico Fermi 5, I-50125 Florence, Italy.	maiolino@arcetri.astro.it	Schneider, Raffaella/E-4216-2017	Schneider, Raffaella/0000-0001-9317-2888; Maiolino, Roberto/0000-0002-4985-3819; Bianchi, Simone/0000-0002-9384-846X; mannucci, filippo/0000-0002-4803-2381; Oliva, Ernesto/0000-0002-9123-0412				[Anonymous], 1989, EVOLUTION INTERSTELL; Baffa C, 2001, ASTRON ASTROPHYS, V378, P722, DOI 10.1051/0004-6361:20011194; Bertoldi F, 2003, ASTRON ASTROPHYS, V406, pL55, DOI 10.1051/0004-6361:20030710; Dunne L, 2003, NATURE, V424, P285, DOI 10.1038/nature01792; GASKELL CM, 2003, UNPUB ASTROPHYS J; Hirashita H, 2002, MON NOT R ASTRON SOC, V337, P921, DOI 10.1046/j.1365-8711.2002.05968.x; Hirashita H, 2002, MON NOT R ASTRON SOC, V330, pL19, DOI 10.1046/j.1365-8711.2002.05283.x; HOPKINS P, 2004, IN PRESS ASTROPHYS J; Larson RB, 1998, MON NOT R ASTRON SOC, V301, P569, DOI 10.1046/j.1365-8711.1998.02045.x; Maiolino R, 2004, ASTRON ASTROPHYS, V420, P889, DOI 10.1051/0004-6361:20035704; Maiolino R, 2003, ASTROPHYS J, V596, pL155, DOI 10.1086/379600; Maiolino R, 2001, ASTRON ASTROPHYS, V365, P28, DOI 10.1051/0004-6361:20000177; Morgan HL, 2003, ASTROPHYS J, V597, pL33, DOI 10.1086/379639; MOSELEY SH, 1989, NATURE, V340, P697, DOI 10.1038/340697a0; Nozawa T, 2003, ASTROPHYS J, V598, P785, DOI 10.1086/379011; Priddey RS, 2003, MON NOT R ASTRON SOC, V344, pL74, DOI 10.1046/j.1365-8711.2003.07076.x; Reichard TA, 2003, ASTRON J, V126, P2594, DOI 10.1086/379293; Richards GT, 2003, ASTRON J, V126, P1131, DOI 10.1086/377014; Scott A, 1996, ASTROPHYS J SUPPL S, V105, P401, DOI 10.1086/192321; Todini P, 2001, MON NOT R ASTRON SOC, V325, P726, DOI 10.1046/j.1365-8711.2001.04486.x; Whittet D. C. B., 2003, SERIES ASTRONOMY AST; WOOSLEY SE, 1995, ASTROPHYS J SUPPL S, V101, P181, DOI 10.1086/192237; Zubko VG, 1996, MON NOT R ASTRON SOC, V282, P1321, DOI 10.1093/mnras/282.4.1321	25	241	242	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 30	2004	431	7008					533	535		10.1038/nature02930	http://dx.doi.org/10.1038/nature02930			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	857YP	15457250				2022-12-28	WOS:000224156700036
J	Park, M; Penick, EC; Edwards, JG; Kauer, JA; Ehlers, MD				Park, M; Penick, EC; Edwards, JG; Kauer, JA; Ehlers, MD			Recycling endosomes supply AMPA receptors for LTP	SCIENCE			English	Article							CULTURED HIPPOCAMPAL-NEURONS; LONG-TERM POTENTIATION; SYNAPTIC PLASTICITY; PLASMA-MEMBRANE; SILENT SYNAPSES; ACTIVATION; INSERTION; CELLS; RAB6; TRANSMISSION	Long-term potentiation (LTP) of synaptic strength, the most established cellular model of information storage in the brain, is expressed by an increase in the number of postsynaptic AMPA receptors. However, the source of AMPA receptors mobilized during LTP is unknown. We report that AMPA receptors are transported from recycling endosomes to the plasma membrane for LTP. Stimuli that triggered LTP promoted not only AMPA receptor insertion but also generalized recycling of cargo and membrane from endocytic compartments. Thus, recycling endosomes supply AMPA receptors for LTP and provide a mechanistic link between synaptic potentiation and membrane remodeling during synapse modification.	Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA; Duke Univ, Med Ctr, Neuroproteom Lab, Durham, NC 27710 USA; Brown Univ, Dept Mol Pharmacol Physiol & Biotechnol, Providence, RI 02912 USA	Duke University; Duke University; Duke University; Duke University; Duke University; Brown University	Ehlers, MD (corresponding author), Duke Univ, Med Ctr, Dept Neurobiol, Box 3209, Durham, NC 27710 USA.	ehlers@neuro.duke.edu		Kauer, Julie/0000-0002-3362-1642	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH064748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS039402] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA011289] Funding Source: NIH RePORTER; NIDA NIH HHS [DA11289] Funding Source: Medline; NIMH NIH HHS [MH64748] Funding Source: Medline; NINDS NIH HHS [NS39402] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P331, DOI 10.1113/jphysiol.1973.sp010273; Bredt DS, 2003, NEURON, V40, P361, DOI 10.1016/S0896-6273(03)00640-8; Ehlers MD, 2000, NEURON, V28, P511, DOI 10.1016/S0896-6273(00)00129-X; ISAAC JTR, 1995, NEURON, V15, P427, DOI 10.1016/0896-6273(95)90046-2; Karcher RL, 2001, SCIENCE, V293, P1317, DOI 10.1126/science.1061086; KAUER JA, 1988, NEURON, V1, P911, DOI 10.1016/0896-6273(88)90148-1; Khvotchev MV, 2003, J NEUROSCI, V23, P10531; Knight DE, 2002, TRAFFIC, V3, P298, DOI 10.1034/j.1600-0854.2002.030407.x; Lee SH, 2004, NEURON, V43, P221, DOI 10.1016/j.neuron.2004.06.015; LIAO DZ, 1995, NATURE, V375, P400, DOI 10.1038/375400a0; Lin SX, 2001, NAT CELL BIOL, V3, P567, DOI 10.1038/35078543; Lu WY, 2001, NEURON, V29, P243, DOI 10.1016/S0896-6273(01)00194-5; Luscher C, 2000, NAT NEUROSCI, V3, P545, DOI 10.1038/75714; Luscher C, 1999, NEURON, V24, P649, DOI 10.1016/S0896-6273(00)81119-8; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Man HY, 2003, NEURON, V38, P611, DOI 10.1016/S0896-6273(03)00228-9; Nizak C, 2003, SCIENCE, V300, P984, DOI 10.1126/science.1083911; Passafaro M, 1999, NAT NEUROSCI, V2, P1063, DOI 10.1038/15990; Passafaro M, 2001, NAT NEUROSCI, V4, P917, DOI 10.1038/nn0901-917; Pickard L, 2001, NEUROPHARMACOLOGY, V41, P700, DOI 10.1016/S0028-3908(01)00127-7; Prekeris R, 1998, J CELL BIOL, V143, P957, DOI 10.1083/jcb.143.4.957; Rosenberg M, 2001, J NEUROSCI, V21, P5036, DOI 10.1523/JNEUROSCI.21-14-05036.2001; Shi SH, 1999, SCIENCE, V284, P1811, DOI 10.1126/science.284.5421.1811; Short B, 2002, CURR BIOL, V12, P1792, DOI 10.1016/S0960-9822(02)01221-6; Steiner P, 2002, J CELL BIOL, V157, P1197, DOI 10.1083/jcb.200202022; Sun W, 2003, J CELL BIOL, V162, P125, DOI 10.1083/jcb.200302083; White J, 1999, J CELL BIOL, V147, P743, DOI 10.1083/jcb.147.4.743; Yuste R, 2001, ANNU REV NEUROSCI, V24, P1071, DOI 10.1146/annurev.neuro.24.1.1071; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055	30	545	558	0	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 24	2004	305	5692					1972	1975		10.1126/science.1102026	http://dx.doi.org/10.1126/science.1102026			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	857RM	15448273				2022-12-28	WOS:000224136000052
J	Fairen, AG; Fernandez-Remolar, D; Dohm, JM; Baker, VR; Amils, R				Fairen, AG; Fernandez-Remolar, D; Dohm, JM; Baker, VR; Amils, R			Inhibition of carbonate synthesis in acidic oceans on early Mars	NATURE			English	Article							IMPACT EROSION; IRON; MINERALS	Several lines of evidence have recently reinforced the hypothesis that an ocean existed on early Mars(1-7). Carbonates are accordingly expected to have formed from oceanic sedimentation of carbon dioxide from the ancient martian atmosphere(7,8). But spectral imaging of the martian surface has revealed the presence of only a small amount of carbonate, widely distributed in the martian dust(9). Here we examine the feasibility of carbonate synthesis in ancient martian oceans using aqueous equilibrium calculations. We show that partial pressures of atmospheric carbon dioxide in the range 0.8-4 bar, in the presence of up to 13.5 mM sulphate and 0.8 mM iron in sea water(8), result in an acidic oceanic environment with a pH of less than 6.2. This precludes the formation of siderite, usually expected to be the first major carbonate mineral to precipitate(8). We conclude that extensive interaction between an atmosphere dominated by carbon dioxide and a lasting sulphate- and iron-enriched acidic ocean on early Mars is a plausible explanation for the observed absence of carbonates.	Univ Autonoma Madrid, Ctr Biol Mol, CSIC, E-28049 Madrid, Spain; CSIC, INTA, Ctr Astrobiol, Madrid 28850, Spain; Univ Arizona, Dept Hydrol & Water Resources, Tucson, AZ 85721 USA; Univ Arizona, Lunar & Planetary Lab, Tucson, AZ 85721 USA	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Astrobiologia (INTA); University of Arizona; University of Arizona	Fairen, AG (corresponding author), Univ Autonoma Madrid, Ctr Biol Mol, CSIC, E-28049 Madrid, Spain.	agfairen@cbm.uam.es	FernÃndez-Remolar, David/AAG-8643-2020; Dohm, James/A-3831-2014; Amils, Ricardo/X-2706-2019	FernÃndez-Remolar, David/0000-0003-2409-7444; 				Baker VR, 2001, NATURE, V412, P228, DOI 10.1038/35084172; Bandfield JL, 2003, SCIENCE, V301, P1084, DOI 10.1126/science.1088054; Barley ME, 1997, NATURE, V385, P55, DOI 10.1038/385055a0; BHATTACHARYYA A, 1983, MODERN CARBONATE ENV; Brain DA, 1998, J GEOPHYS RES-PLANET, V103, P22689, DOI 10.1029/98JE02074; Bruland K. W., 1983, CHEM OCEANOGR, V8, P157, DOI 10.1016/b978-0-12-588608-6.50009-2.; BURNS RG, 1987, J GEOPHYS RES-SOLID, V92, pE570, DOI 10.1029/JB092iB04p0E570; CARR MH, 2003, J GEOPHYS RES-PLANET, V108, DOI [DOI 10.1029/2002JE001963, 10.1029/2002je001963]; Catling DC, 1999, J GEOPHYS RES-PLANET, V104, P16453, DOI 10.1029/1998JE001020; CLARK BC, 1999, 5 MARS C LUN PLAN I; Clifford SM, 2001, ICARUS, V154, P40, DOI 10.1006/icar.2001.6671; Craddock RA, 2002, J GEOPHYS RES-PLANET, V107, DOI 10.1029/2001JE001505; Dohm JM, 2001, J GEOPHYS RES-PLANET, V106, P32943, DOI 10.1029/2000JE001468; Fairen AG, 2003, ICARUS, V165, P53, DOI 10.1016/S0019-1035(03)00144-1; Fernandez-Remolar D, 2004, PLANET SPACE SCI, V52, P239, DOI 10.1016/j.pss.2003.08.027; Forget F, 1997, SCIENCE, V278, P1273, DOI 10.1126/science.278.5341.1273; Head JW, 2002, J GEOPHYS RES-PLANET, V107, DOI 10.1029/2000JE001445; HOLLAND HD, 1973, ECON GEOL, V68, P1169, DOI 10.2113/gsecongeo.68.7.1169; HUGUENIN RL, 1974, J GEOPHYS RES, V79, P3895, DOI 10.1029/JB079i026p03895; JOHNSON JW, 1991, SUPCRT92 SOFTWARE PA; Kirkland LE, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002105; Malin MC, 2003, SCIENCE, V302, P1931, DOI 10.1126/science.1090544; MELOSH HJ, 1989, NATURE, V338, P487, DOI 10.1038/338487a0; Moore JM, 2004, NATURE, V428, P711, DOI 10.1038/428711a; Mukhin LM, 1996, NATURE, V379, P141, DOI 10.1038/379141a0; Phillips RJ, 2001, SCIENCE, V291, P2587, DOI 10.1126/science.1058701; Russell MJ, 1997, J GEOL SOC LONDON, V154, P377, DOI 10.1144/gsjgs.154.3.0377; SCHAEFER MW, 1993, GEOCHIM COSMOCHIM AC, V57, P4619, DOI 10.1016/0016-7037(93)90187-2; SQUYRES SW, 1994, SCIENCE, V265, P744, DOI 10.1126/science.265.5173.744; Zuber MT, 2001, NATURE, V412, P220, DOI 10.1038/35084163	30	137	145	0	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 23	2004	431	7007					423	426		10.1038/nature02911	http://dx.doi.org/10.1038/nature02911			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855UN	15386004				2022-12-28	WOS:000224000500032
J	Lane, M				Lane, M			Bioethics, health, and inequality	LANCET			English	Editorial Material									Univ Cambridge, Univ London Kings Coll, Ctr Hist & Econ, Cambridge CB2 1ST, England	University of Cambridge; University of London; King's College London	Lane, M (corresponding author), Univ Cambridge, Univ London Kings Coll, Ctr Hist & Econ, Cambridge CB2 1ST, England.	melissa.lane@kings.cam.ac.uk						[Anonymous], 1999, DEV FREEDOM; MCCONNELL T, 2000, INALIENABLE RIGHTS L, P122; MILL JS, 1978, LIBERTY 1859; Nussbaum M., 2001, WOMEN HUMAN DEV CAPA, V3; RADIN MARGARET JANE, 1996, CONTESTED COMMODITIE, P14	5	2	3	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 18	2004	364	9439					1017	1019		10.1016/S0140-6736(04)17074-8	http://dx.doi.org/10.1016/S0140-6736(04)17074-8			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	855FT	15380950				2022-12-28	WOS:000223959300006
J	Naito, AT; Minamino, T; Tateno, K; Nagai, T; Komuro, I				Naito, AT; Minamino, T; Tateno, K; Nagai, T; Komuro, I			Steroid-responsive thromboangiitis obliterans	LANCET			English	Editorial Material							BUERGERS-DISEASE; EOSINOPHILIA		Chiba Univ, Grad Sch Med, Dept Cardiovasc Sci & Med, Chuo Ku, Chiba 2608670, Japan	Chiba University	Komuro, I (corresponding author), Chiba Univ, Grad Sch Med, Dept Cardiovasc Sci & Med, Chuo Ku, 1-8-1 Inohana, Chiba 2608670, Japan.	komuro-tky@umin.ac.jp	Minamino, Tohru/P-8145-2018	Minamino, Tohru/0000-0003-1627-6151				FERGUSON GT, 1985, ARCH INTERN MED, V145, P1726, DOI 10.1001/archinte.145.9.1726; Fujimoto M, 1996, DERMATOLOGY, V192, P32, DOI 10.1159/000246310; LIE JT, 1988, HUM PATHOL, V19, P598, DOI 10.1016/S0046-8177(88)80212-0; Olin JW, 2000, NEW ENGL J MED, V343, P864, DOI 10.1056/NEJM200009213431207; Sasaki S, 2000, INT J CARDIOL, V75, pS175, DOI 10.1016/S0167-5273(00)00190-X	5	10	12	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 18	2004	364	9439					1098	1098		10.1016/S0140-6736(04)17068-2	http://dx.doi.org/10.1016/S0140-6736(04)17068-2			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	855FT	15380972				2022-12-28	WOS:000223959300032
J	Rando, TA				Rando, TA			Artificial sweeteners - Enhancing glycosylation to treat muscular dystrophies	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Stanford Univ, Dept Neurol & Neurol Sci, Palo Alto, CA 94304 USA; Vet Affairs Palo Alto Hlth Care Syst, Neurol Serv, Palo Alto, CA USA	Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System	Rando, TA (corresponding author), Stanford Univ, Dept Neurol & Neurol Sci, Palo Alto, CA 94304 USA.							BARRESI R, 2004, NAT MED, V117, P953; Engvall E, 2003, FASEB J, V17, P1579, DOI 10.1096/fj.02-1215rev; Muntoni F, 2004, CURR OPIN NEUROL, V17, P205, DOI 10.1097/00019052-200404000-00020; Nguyen HH, 2002, P NATL ACAD SCI USA, V99, P5616, DOI 10.1073/pnas.082613599; Rando TA, 2001, MUSCLE NERVE, V24, P1575, DOI 10.1002/mus.1192	5	4	5	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 16	2004	351	12					1254	1256		10.1056/NEJMcibr042066	http://dx.doi.org/10.1056/NEJMcibr042066			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	853WS	15371584				2022-12-28	WOS:000223861300017
J	Schmutz, J; Martin, J; Terry, A; Couronne, O; Grimwood, J; Lowry, S; Gordon, LA; Scott, D; Xie, G; Huang, W; Hellsten, U; Tran-Gyamfi, M; She, XW; Prabhakar, S; Aerts, A; Altherr, M; Bajorek, E; Black, S; Branscomb, E; Caoile, C; Challacombe, JF; Chan, YM; Denys, M; Detter, JC; Escobar, J; Flowers, D; Fotopulos, D; Glavina, T; Gomez, M; Gonzales, E; Goodstein, D; Grigoriev, I; Groza, M; Hammon, N; Hawkins, T; Haydu, L; Israni, S; Jett, J; Kadner, K; Kimball, H; Kobayashi, A; Lopez, F; Lou, YN; Martinez, D; Medina, C; Morgan, J; Nandkeshwar, R; Noonan, JP; Pitluck, S; Pollard, M; Predki, P; Priest, J; Ramirez, L; Retterer, J; Rodriguez, A; Rogers, S; Salamov, A; Salazar, A; Thayer, N; Tice, H; Tsai, M; Ustaszewska, A; Vo, N; Wheeler, J; Wu, K; Yang, J; Dickson, M; Cheng, JF; Eichler, EE; Olsen, A; Pennacchio, LA; Rokhsar, DS; Richardson, P; Lucas, SM; Myers, RM; Rubin, EM				Schmutz, J; Martin, J; Terry, A; Couronne, O; Grimwood, J; Lowry, S; Gordon, LA; Scott, D; Xie, G; Huang, W; Hellsten, U; Tran-Gyamfi, M; She, XW; Prabhakar, S; Aerts, A; Altherr, M; Bajorek, E; Black, S; Branscomb, E; Caoile, C; Challacombe, JF; Chan, YM; Denys, M; Detter, JC; Escobar, J; Flowers, D; Fotopulos, D; Glavina, T; Gomez, M; Gonzales, E; Goodstein, D; Grigoriev, I; Groza, M; Hammon, N; Hawkins, T; Haydu, L; Israni, S; Jett, J; Kadner, K; Kimball, H; Kobayashi, A; Lopez, F; Lou, YN; Martinez, D; Medina, C; Morgan, J; Nandkeshwar, R; Noonan, JP; Pitluck, S; Pollard, M; Predki, P; Priest, J; Ramirez, L; Retterer, J; Rodriguez, A; Rogers, S; Salamov, A; Salazar, A; Thayer, N; Tice, H; Tsai, M; Ustaszewska, A; Vo, N; Wheeler, J; Wu, K; Yang, J; Dickson, M; Cheng, JF; Eichler, EE; Olsen, A; Pennacchio, LA; Rokhsar, DS; Richardson, P; Lucas, SM; Myers, RM; Rubin, EM			The DNA sequence and comparative analysis of human chromosome 5	NATURE			English	Article							HUMAN-GENOME; GENE; REGION; MOUSE; MAP; RECOMBINATION; EVOLUTION; ELEMENTS; CLUSTER; DOMAIN	Chromosome 5 is one of the largest human chromosomes and contains numerous intrachromosomal duplications, yet it has one of the lowest gene densities. This is partially explained by numerous gene-poor regions that display a remarkable degree of noncoding conservation with non-mammalian vertebrates, suggesting that they are functionally constrained. In total, we compiled 177.7 million base pairs of highly accurate finished sequence containing 923 manually curated protein-coding genes including the protocadherin and interleukin gene families. We also completely sequenced versions of the large chromosome-5-specific internal duplications. These duplications are very recent evolutionary events and probably have a mechanistic role in human physiological variation, as deletions in these regions are the cause of debilitating disorders including spinal muscular atrophy.	Stanford Univ, Sch Med, Stanford Human Genome Ctr, Dept Genet, Palo Alto, CA 94304 USA; DOEs Joint Genome Inst, Walnut Creek, CA 94598 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Berkeley, CA 94720 USA; Lawrence Livermore Natl Lab, Livermore, CA 94550 USA; Los Alamos Natl Lab, Los Alamos, NM 87545 USA; Case Western Reserve Univ, Sch Med, Ctr Computat Genom, Dept Genet, Cleveland, OH 44106 USA; Case Western Reserve Univ, Sch Med, Ctr Human Genet, Cleveland, OH 44106 USA; Univ Hosp Cleveland, Cleveland, OH 44106 USA; Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA	Stanford University; United States Department of Energy (DOE); Joint Genome Institute - JGI; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; United States Department of Energy (DOE); Los Alamos National Laboratory; Case Western Reserve University; Case Western Reserve University; University Hospitals of Cleveland; Stanford University	Schmutz, J (corresponding author), Stanford Univ, Sch Med, Stanford Human Genome Ctr, Dept Genet, 975 Calif Ave, Palo Alto, CA 94304 USA.	jeremy@shgc.stanford.edu; EMRubin@lbl.gov	Couronne, Olivier Couronne/G-1244-2012; Schmutz, Jeremy/N-3173-2013; Noonan, James/ABF-1320-2021; Terry, Astrid Y/A-2538-2011; Grimwood, Jane/ABD-5737-2021	Schmutz, Jeremy/0000-0001-8062-9172; Terry, Astrid Y/0000-0002-5234-1224; Martin, Joel/0000-0001-9511-6441; Goodstein, David/0000-0001-6287-2697; Grigoriev, Igor/0000-0002-3136-8903; Cheng, Jan-Fang/0000-0001-7315-7613; Rokhsar, Daniel/0000-0002-8704-2224; Pennacchio, Len/0000-0002-8748-3732				Bailey JA, 2001, GENOME RES, V11, P1005, DOI 10.1101/gr.GR-1871R; BARTON DE, 1989, CYTOGENET CELL GENET, V50, P137, DOI 10.1159/000132743; Brudno M, 2003, GENOME RES, V13, P721, DOI 10.1101/gr.926603; Chen QF, 1998, GENOMICS, V48, P121, DOI 10.1006/geno.1997.5141; Church DM, 1997, GENOME RES, V7, P787, DOI 10.1101/gr.7.8.787; Clark AG, 2003, SCIENCE, V302, P1960, DOI 10.1126/science.1088821; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Flint J, 2001, HUM MOL GENET, V10, P371, DOI 10.1093/hmg/10.4.371; Frazer KA, 1997, GENOME RES, V7, P495, DOI 10.1101/gr.7.5.495; Ghanem N, 2003, GENOME RES, V13, P533, DOI 10.1101/gr.716103; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Grimwood J, 2004, NATURE, V428, P529, DOI 10.1038/nature02399; Groenen MAM, 2000, GENOME RES, V10, P137; HASTBACKA J, 1994, CELL, V78, P1073, DOI 10.1016/0092-8674(94)90281-X; Heilig R, 2003, NATURE, V421, P601, DOI 10.1038/nature01348; Hillier LW, 2003, NATURE, V424, P157, DOI 10.1038/nature01782; Hocking LJ, 2002, HUM MOL GENET, V11, P2735, DOI 10.1093/hmg/11.22.2735; Jurka J, 2000, TRENDS GENET, V16, P418, DOI 10.1016/S0168-9525(00)02093-X; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; KURDOAKAWAGUCHI T, 2001, NAT GENET, V29, P279; KURODA SY, 1965, FOUND LANG, V1, P30; Kurotaki N, 2003, HUM MUTAT, V22, P378, DOI 10.1002/humu.10270; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Locke DP, 2003, GENOME RES, V13, P347, DOI 10.1101/gr.1003303; Loots GG, 2000, SCIENCE, V288, P136, DOI 10.1126/science.288.5463.136; McMurray AA, 1998, GENOME RES, V8, P562, DOI 10.1101/gr.8.5.562; MELKI J, 1994, SCIENCE, V264, P1474, DOI 10.1126/science.7910982; Monani UR, 1999, HUM MOL GENET, V8, P1177, DOI 10.1093/hmg/8.7.1177; Nanda I, 1999, NAT GENET, V21, P258, DOI 10.1038/6769; Nobrega MA, 2003, SCIENCE, V302, P413, DOI 10.1126/science.1088328; Noor MAF, 2001, P NATL ACAD SCI USA, V98, P12084, DOI 10.1073/pnas.221274498; Olivier M, 2001, SCIENCE, V291, P1298, DOI 10.1126/science.1057437; Parsons JD, 1995, COMPUT APPL BIOSCI, V11, P615; Pennacchio LA, 2001, NAT REV GENET, V2, P100, DOI 10.1038/35052548; Puechberty J, 1999, GENOMICS, V56, P274, DOI 10.1006/geno.1999.5742; Riethman HC, 2001, NATURE, V409, P948, DOI 10.1038/35057180; Schmutz J, 2004, NATURE, V429, P365, DOI 10.1038/nature02390; Schuler GD, 1997, GENOME RES, V7, P541, DOI 10.1101/gr.7.5.541; Schwartz S, 2003, GENOME RES, V13, P103, DOI 10.1101/gr.809403; Symula DJ, 1999, NAT GENET, V23, P241, DOI 10.1038/13880; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; YUNIS JJ, 1982, SCIENCE, V215, P1525, DOI 10.1126/science.7063861; Zhang ZL, 2003, GENOME RES, V13, P2541, DOI 10.1101/gr.1429003	44	76	569	1	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 16	2004	431	7006					268	274		10.1038/nature02919	http://dx.doi.org/10.1038/nature02919			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	853XJ	15372022	Green Submitted, Bronze			2022-12-28	WOS:000223864000030
J	Moss, PJ; Lambert, TW; Goldacre, MJ; Lee, P				Moss, PJ; Lambert, TW; Goldacre, MJ; Lee, P			Reasons for considering leaving UK medicine: questionnaire study of junior doctors' comments	BMJ-BRITISH MEDICAL JOURNAL			English	Article							UNITED-KINGDOM	Objectives To study the reasons given by junior doctors trained in the United Kingdom for considering leaving UK medicine. Design Analysis of replies to postal questionnaire surveys. Setting United Kingdom. Participants 1326 doctors who qualified in 1999. Main outcome measure Reasons for considering leaving. Results Of 1047 doctors who indicated that they would stay in medicine but not necessarily in the United Kingdom, 650/o (682) gave reasons for leaving that concerned lifestyle, such as a preference for living outside the United Kingdom; 41% (433) gave reasons concerning working conditions in UK medicine; and 18% (184) gave positive work related reasons, such as wanting to work in developing countries. Of 279 doctors considering leaving medicine, 75% (210) cited working conditions, 23% (63) cited lifestyle reasons, and 9% (24) cited positive interests in a different career. Of the 169 doctors who said that they would probably or definitely leave the United Kingdom but remain in medicine, 78% (132) specified lifestyle reasons. Of the 42 who said that they would probably or definitely leave medicine, 67% (28) cited working conditions. Conclusions The wish to work abroad, but to stay in medicine, was more common than the wish to leave medicine. The preference for a different lifestyle, particularly to live outside the United Kingdom, is not readily amenable to policy changes to the medical working environment. The smaller numbers of doctors who gave work experience as a reason for considering leaving medicine might be influenced to stay by improvements in working lives.	Univ Oxford, Dept Publ Hlth, Unit Hlth Care Epidemiol, UK Med Careers Res Grp, Oxford OX3 7LF, England	University of Oxford	Goldacre, MJ (corresponding author), Univ Oxford, Dept Publ Hlth, Unit Hlth Care Epidemiol, UK Med Careers Res Grp, Oxford OX3 7LF, England.	michael.goldacre@dphpc.ox.ac.uk		Lambert, Trevor/0000-0001-9688-3036				Davidson JM, 1998, BRIT MED J, V317, P1425, DOI 10.1136/bmj.317.7170.1425; *DEP HLTH, 2000, JUN DOCT CONTR COMPL; *DEP HLTH, 2001, INV REF NHS STAFF TA; *DEP HLTH, 2002, GUID WORK PATT JUN D; *DEP HLTH, 2003, JUN DOCT CONTR COMPL; Department of Health, 2000, NHS PLAN PLAN INV PL; Department of Health, 2002, DEL NHS PLAN NEXT ST; Goldacre MJ, 2001, MED EDUC, V35, P337, DOI 10.1046/j.1365-2923.2001.00939.x; Lambert SJ, 2002, CLIM DYNAM, V19, P1, DOI 10.1007/s00382-001-0206-8; Lambert TW, 1998, BRIT MED J, V317, P1429, DOI 10.1136/bmj.317.7170.1429; Lambert TW, 1997, BRIT MED J, V314, P1591, DOI 10.1136/bmj.314.7094.1591; Lambert TW, 1996, BRIT MED J, V313, P19, DOI 10.1136/bmj.313.7048.19; *NHS MAN EX, 1991, JUN DOCT NEW DEAL; Parker EN, 2001, CHINESE J ASTRON AST, V1, P99, DOI 10.1088/1009-9271/1/2/99; *ROYAL COLL PHYS, 2003, IMPL EUR WORK TIM DI	15	29	29	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 27	2004	329	7477					1263	1265		10.1136/bmj.38247.594769.AE	http://dx.doi.org/10.1136/bmj.38247.594769.AE			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	876FC	15469947	Green Published, Bronze, Green Submitted			2022-12-28	WOS:000225480900014
J	Osborn, TJ; Briffa, KR				Osborn, TJ; Briffa, KR			The real color of climate change?	SCIENCE			English	Editorial Material									Univ E Anglia, Climat Res Unit, Norwich NR4 7TJ, Norfolk, England	University of East Anglia	Osborn, TJ (corresponding author), Univ E Anglia, Climat Res Unit, Norwich NR4 7TJ, Norfolk, England.	t.osborn@uea.ac.uk; k.briffa@uea.ac.uk	Osborn, Timothy/AAK-9279-2020; Osborn, Timothy/E-9740-2011; Briffa, Keith/C-8834-2009	Osborn, Timothy/0000-0001-8425-6799; Osborn, Timothy/0000-0001-8425-6799; Briffa, Keith/0000-0003-3323-3639	Natural Environment Research Council [NER/T/S/2002/00440] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Briffa KR, 2001, J GEOPHYS RES-ATMOS, V106, P2929, DOI 10.1029/2000JD900617; Houghton J. T., 2001, CLIMATE CHANGE 2001; Jones PD, 2004, REV GEOPHYS, V42, DOI 10.1029/2003RG000143; Mann ME, 1998, NATURE, V392, P779, DOI 10.1038/33859; von Storch H, 2004, SCIENCE, V306, P679, DOI 10.1126/science.1096109	5	29	29	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 22	2004	306	5696					621	622		10.1126/science.1104416	http://dx.doi.org/10.1126/science.1104416			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866EN	15459347				2022-12-28	WOS:000224756700031
J	Aylin, P; Bottle, A; Jarman, B; Elliott, P				Aylin, P; Bottle, A; Jarman, B; Elliott, P			Paediatric cardiac surgical mortality in England after Bristol: descriptive analysis of hospital episode statistics 1991-2002	BRITISH MEDICAL JOURNAL			English	Article							CHILDREN; RATES	Objective To describe trends in mortality of open cardiac surgery in children in Bristol and England since 1991. Design Retrospective analysis of hospital episode statistics data. Setting All open cardiac surgery of children in England. Population Patients younger than 16 undergoing open cardiac surgical procedures in England between April 1991 and March 2002. Three time periods were defined: epoch 3 (April 1991 to March 1995), epoch 5 (April 1996 to March 1999), epoch 6 (April 1999 to March 2002). Main outcome measure Mortality in hospital within 30 days of a cardiac procedure. Results We identified 5221 open operations between April 1996 and March 2002 in children under I year and 6385 in children aged 1-15 years. Mortality for all centres combined fell from 12% in epoch 3 to 4% in epoch 6. Mortality in children under 1 year at Bristol fell from 29% (95% confidence interval 21% to 37%) in epoch 3 to 3% (11% to 6%) in epoch 6, below the national average. The reduction in mortality did not seem to be due to fewer high risk procedures or an increase in the numbers of low risk cases. Oxford had a significantly higher mortality than the national average in all three epochs (11% (5% to 18%) in epoch 6), which was not affected by adjusting for procedure or the inclusion of cases with missing outcomes. Conclusions At Bristol, mortality for open operations in children aged under 1 year has fallen markedly, to below the national average. Nationwide mortality has also fallen. Improved quality of care may account for the drop in mortality, through new technologies or improved perioperative and postoperative care, or both.	Univ London Imperial Coll Sci Technol & Med, Dept Epidemiol & Publ Hlth, Sch Med, London W2 1PG, England	Imperial College London	Aylin, P (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Epidemiol & Publ Hlth, Sch Med, London W2 1PG, England.	p.aylin@imperial.ac.uk	Aylin, Paul/A-1073-2014	Aylin, Paul/0000-0003-4589-1743; Bottle, Alex/0000-0001-9978-2011				Aylin P, 2001, LANCET, V358, P181, DOI 10.1016/S0140-6736(01)05404-6; AYLIN P, 1999, ANAL HOSP EPISODE ST; BRIDGE S, 2000, REPORT EXTERNAL REV; *BRIST ROYAL INF I, 2001, CMND5207; *DEP HLTH, 2003, REP PAED CONG CARD S; Gentili P, 2000, DIABETES NUTR METAB, V13, P1; Gibbs JL, 2004, BRIT MED J, V328, P611, DOI 10.1136/bmj.38027.613403.F6; Goldman AP, 1996, ANN THORAC SURG, V62, P750, DOI 10.1016/S0003-4975(96)00375-X; Marshall EG, 1998, BRIT MED J, V316, P1701, DOI 10.1136/bmj.316.7146.1701; *NAT DOWN SYNDR CY, 2003, NAT DAWN SYNDR CYT R; Poloniecki J, 2004, BRIT MED J, V328, P375, DOI 10.1136/bmj.37956.520567.44; ROSS DN, 1967, LANCET, V2, P956; *SOC CARD SURG GRE, 2001, TRENDS SURG CONG HEA; SPIEGELHALTER DJ, 2000, OVERVIEW STAT EVIDEN	14	41	42	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 9	2004	329	7470					825	827		10.1136/bmj.329.7470.825	http://dx.doi.org/10.1136/bmj.329.7470.825			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	862EK	15472264	Green Submitted, Bronze, Green Published			2022-12-28	WOS:000224472800017
J	Bonev, SA; Schwegler, E; Ogitsu, T; Galli, G				Bonev, SA; Schwegler, E; Ogitsu, T; Galli, G			A quantum fluid of metallic hydrogen suggested by first-principles calculations	NATURE			English	Article							MOLECULAR-DYNAMICS; SOLID HYDROGEN; MELTING CURVES; TRANSITIONS; DEUTERIUM	It is generally assumed(1-3) that solid hydrogen will transform into a metallic alkali-like crystal at sufficiently high pressure. However, some theoretical models(4,5) have also suggested that compressed hydrogen may form an unusual two-component (protons and electrons) metallic fluid at low temperature, or possibly even a zero-temperature liquid ground state. The existence of these new states of matter is conditional on the presence of a maximum in the melting temperature versus pressure curve (the 'melt line'). Previous measurements(6-8) of the hydrogen melt line up to pressures of 44 GPa have led to controversial conclusions regarding the existence of this maximum. Here we report ab initio calculations that establish the melt line up to 200 GPa. We predict that subtle changes in the intermolecular interactions lead to a decline of the melt line above 90 GPa. The implication is that as solid molecular hydrogen is compressed, it transforms into a low-temperature quantum fluid before becoming a monatomic crystal. The emerging low-temperature phase diagram of hydrogen and its isotopes bears analogies with the familiar phases of He-3 and He-4 (the only known zero-temperature liquids), but the long-range Coulomb interactions and the large component mass ratio present in hydrogen would result in dramatically different properties(9).	Lawrence Livermore Natl Lab, Livermore, CA 94550 USA	United States Department of Energy (DOE); Lawrence Livermore National Laboratory	Bonev, SA (corresponding author), Lawrence Livermore Natl Lab, Livermore, CA 94550 USA.	bonev1@llnl.gov	Schwegler, Eric/A-2436-2016; Schwegler, Eric/F-7294-2010	Schwegler, Eric/0000-0003-3635-7418; 				Alfe D, 2003, PHYS REV B, V68, DOI 10.1103/PhysRevB.68.064423; Ashcroft NW, 2003, J PHYS A-MATH GEN, V36, P6137, DOI 10.1088/0305-4470/36/22/341; Ashcroft NW, 2000, J PHYS-CONDENS MAT, V12, pA129, DOI 10.1088/0953-8984/12/8A/314; ASHCROFT NW, 1968, PHYS REV LETT, V21, P1748, DOI 10.1103/PhysRevLett.21.1748; Bonev SA, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.014101; Brovman E. G., 1972, Soviet Physics - JETP, V35, P783; CHACHAM H, 1992, PHYS REV B, V46, P6688, DOI 10.1103/PhysRevB.46.6688; Datchi F, 2000, PHYS REV B, V61, P6535, DOI 10.1103/PhysRevB.61.6535; DIATSCHENKO V, 1985, PHYS REV B, V32, P381, DOI 10.1103/PhysRevB.32.381; Gregoryanz E, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.175701; HEMLEY RJ, 1990, PHYS REV B, V42, P6458, DOI 10.1103/PhysRevB.42.6458; HEMLEY RJ, 1994, NATURE, V369, P384, DOI 10.1038/369384a0; Izvekov S, 2004, J CHEM PHYS, V120, P10896, DOI 10.1063/1.1739396; JAYARAMAN A, 1967, PHYS REV, V159, P527, DOI 10.1103/PhysRev.159.527; Kechin VV, 2004, JETP LETT+, V79, P40, DOI 10.1134/1.1675919; Kechin VV, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.052102; Loubeyre P, 2002, NATURE, V416, P613, DOI 10.1038/416613a; MAO HK, 1994, REV MOD PHYS, V66, P671, DOI 10.1103/RevModPhys.66.671; Marzari N, 1997, PHYS REV B, V56, P12847, DOI 10.1103/PhysRevB.56.12847; MORRIS JR, 1994, PHYS REV B, V49, P3109, DOI 10.1103/PhysRevB.49.3109; MOSHARY F, 1993, PHYS REV B, V48, P12613, DOI 10.1103/PhysRevB.48.12613; Nagao K, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.035501; Ogitsu T, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.175502; Perdew JP, 1996, PHYS REV LETT, V77, P3865, DOI 10.1103/PhysRevLett.77.3865; Scandolo S, 2003, P NATL ACAD SCI USA, V100, P3051, DOI 10.1073/pnas.0038012100; Souza I, 2000, PHYS REV B, V62, P15505, DOI 10.1103/PhysRevB.62.15505; STEINHARDT PJ, 1983, PHYS REV B, V28, P784, DOI 10.1103/PhysRevB.28.784; Wigner E, 1935, J CHEM PHYS, V3, P764, DOI 10.1063/1.1749590; YOSHIDA T, 1974, PROG THEOR PHYS, V52, P822, DOI 10.1143/PTP.52.822	30	247	256	1	67	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 7	2004	431	7009					669	672		10.1038/nature02968	http://dx.doi.org/10.1038/nature02968			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	859WS	15470423	Green Submitted			2022-12-28	WOS:000224299300035
J	Lepow, ML				Lepow, ML			Conquering polio - Advances in virology - Weller and Robbins	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Albany Med Coll, Dept Pediat, Albany, NY 12208 USA	Albany Medical College	Lepow, ML (corresponding author), Albany Med Coll, Dept Pediat, Albany, NY 12208 USA.							Weller Thomas H., 2004, GROWING PATHOGENS TI	1	3	3	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 7	2004	351	15					1483	1485		10.1056/NEJMp048220	http://dx.doi.org/10.1056/NEJMp048220			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	859UP	15470208				2022-12-28	WOS:000224293700003
J	Vaniman, DT; Bish, DL; Chipera, SJ; Fialips, CI; Carey, JW; Feldman, WC				Vaniman, DT; Bish, DL; Chipera, SJ; Fialips, CI; Carey, JW; Feldman, WC			Magnesium sulphate salts and the history of water on Mars	NATURE			English	Article							MINERALS; ROCKS	Recent reports of similar to30 wt% of sulphate within saline sediments onMars(1,2)-probably occurring in hydrated form(3)-suggest a role for sulphates in accounting for equatorial H2O observed in a global survey by the Odyssey spacecraft(4). Among salt hydrates likely to be present(3), those of the MgSO4.nH(2)O series have many hydration states. Here we report the exposure of several of these phases to varied temperature, pressure and humidity to constrain their possible H2O contents under martian surface conditions. We found that crystalline structure and H2O content are dependent on temperature-pressure history, that an amorphous hydrated phase with slow dehydration kinetics forms at <1% relative humidity, and that equilibrium calculations may not reflect the true H2O-bearing potential of martian soils. Mg sulphate salts can retain sufficient H2O to explain a portion of the Odyssey observations(5). Because phases in the MgSO4 center dot nH(2)O system are sensitive to temperature and humidity, they can reveal much about the history of water on Mars. However, their ease of transformation implies that salt hydrates collected on Mars will not be returned to Earth unmodified, and that accurate in situ analysis is imperative.	Los Alamos Natl Lab, Los Alamos, NM 87545 USA; Indiana Univ, Bloomington, IN 47405 USA	United States Department of Energy (DOE); Los Alamos National Laboratory; Indiana University System; Indiana University Bloomington	Vaniman, DT (corresponding author), Los Alamos Natl Lab, MS D462, Los Alamos, NM 87545 USA.	vaniman@lanl.gov	Bish, David/AAY-7618-2020; Carey, James/B-4421-2011					Banin A, 1997, J GEOPHYS RES-PLANET, V102, P13341, DOI 10.1029/97JE01160; Bish D. L., 2003, 6 INT C MARS; Bish DL, 2003, ICARUS, V164, P96, DOI 10.1016/S0019-1035(03)00140-4; BRUECKNER J, 2004, EOS S, V85; Chipera S.J., 1997, ADV X-RAY ANAL, V39, P713, DOI [10.1154/S0376030800023168, DOI 10.1154/S0376030800023168]; Chou IM, 2003, ASTROBIOLOGY, V3, P619, DOI 10.1089/153110703322610708; CHRISTENSEN PR, 1982, J GEOPHYS RES, V87, P9985, DOI 10.1029/JB087iB12p09985; CLARK BC, 1981, ICARUS, V45, P370, DOI 10.1016/0019-1035(81)90041-5; CLARK BC, 1978, ICARUS, V34, P645, DOI 10.1016/0019-1035(78)90052-0; CLARK BC, 1976, SCIENCE, V194, P1283, DOI 10.1126/science.194.4271.1283; CLARK BC, 1979, J GEOPHYS RES, V84, P8395, DOI 10.1029/JB084iB14p08395; Feldman WC, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020181; FELDMAN WC, 2004, J GEOPHYS RES-PLANET, V109, DOI DOI 10.1029/2003JE002160; FOLEY CN, 2003, J GEOPHYS RES, V108, DOI DOI 10.1019/2002JE002019; Gounelle M, 2001, METEORIT PLANET SCI, V36, P1321, DOI 10.1111/j.1945-5100.2001.tb01827.x; Hawthorne FC, 2000, REV MINERAL GEOCHEM, V40, P1, DOI 10.2138/rmg.2000.40.1; McSween HY, 2004, SCIENCE, V305, P842, DOI 10.1126/science.3050842; MELLON MT, 1995, J GEOPHYS RES-PLANET, V100, P11781, DOI 10.1029/95JE01027; SAVIJARVI H, 1995, ICARUS, V117, P120, DOI 10.1006/icar.1995.1146; TAYLOR LA, 1973, P LUNAR PLANET SCI C, P829; Toulmin P.  III, 1977, Journal of Geophysical Research, V82, P4625, DOI 10.1029/JS082i028p04625; Wanke H, 2001, SPACE SCI REV, V96, P317, DOI 10.1023/A:1011961725645; [No title captured]	23	241	245	2	66	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 7	2004	431	7009					663	665		10.1038/nature02973	http://dx.doi.org/10.1038/nature02973			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	859WS	15470421				2022-12-28	WOS:000224299300033
J	Gwatkin, DR; Bhuiya, A; Victora, CG				Gwatkin, DR; Bhuiya, A; Victora, CG			Making health systems more equitable	LANCET			English	Review								Health systems are consistently inequitable, providing more and higher quality services to the well-off, who need them less, than to the poor, who are unable to obtain them. In the absence of a concerted effort to ensure that health systems reach disadvantaged groups more effectively, such inequities are likely to continue. Yet this situation need not be accepted as inevitable, for there are many promising measures that might be pursued: establishment of goals for improved coverage in the poor, rather than in entire populations, and use of those goals to direct planning toward the needs of the disadvantaged; use of one or more of the several techniques that seem to have been effective in at least some of the settings where they have been tried; and empowerment of poor clients to have a more central role in health system design and operation.	Ctr Hlth & Populat Res, Dhaka, Bangladesh; Univ Fed Pelotas, Pelotas, Brazil	Universidade Federal de Pelotas	Gwatkin, DR (corresponding author), 6483 Wishbone Terrace, Cabin John, MD 20818 USA.	dgwatkin@comcast.net	Victora, Cesar Gomes/Y-2455-2019; Victora, Cesar G/D-4476-2013	Victora, Cesar Gomes/0000-0002-2465-2180; Victora, Cesar G/0000-0002-2465-2180				ALBERTS M, 2003, SOCIOECONOMIC STATUS; DIOP F, 1998, 20 PARTN HLTH REF; *EC REL DIV MIN FI, 2003, GOV BANGL BANGL NAT, P25; FILMER D, INCIDENCE PUBLIC EXP; *GOV BOL, 2001, ESTR BOL RED POBR, P175; *GOV TANZ, 2000, POV RED STRAT PAP, P41; Gwatkin DR, SOCIOECONOMIC DIFFER; HART JT, 1971, LANCET, V1, P405, DOI 10.1016/S0140-6736(71)92410-X; MUNISHI G, 1997, PRIVATE HLTH CARE TA; People's Health Movement, 2012, PEOPL CHART HLTH; *STAT OFF, 1998, IND INQ IN HLTH REP; *US BUR CENS, 2003, STAT ABSTR US; Victora CG, 2000, LANCET, V356, P1093, DOI 10.1016/S0140-6736(00)02741-0; VICTORA CG, WHAT WORKS NEXT EXTE; VICTORA CG, 2004, CASE STUDY BRAZIL IN; *WORLD BANK, 2003, 2003 WORLD DEV IND, P58; World Bank, 2004, WORLD DEV REP 2004 M, DOI [10.1596/0-8213-5468-x, DOI 10.1596/0-8213-5468-X]; *WORLD BANK, 2003, 2003 WORLD DEV IND, P20; World Bank, 2001, WORLD DEV REP 2000 2; *WORLD BANK, 2003, 2003 WORLD DEV IND, P40	20	249	252	0	10	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 2	2004	364	9441					1273	1280		10.1016/S0140-6736(04)17145-6	http://dx.doi.org/10.1016/S0140-6736(04)17145-6			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	859HO	15464189				2022-12-28	WOS:000224254200035
J	Murphy, DJ; Fowlie, PW; McGuire, W				Murphy, DJ; Fowlie, PW; McGuire, W			ABC of preterm birth - Obstetric issues in preterm birth	BRITISH MEDICAL JOURNAL			English	Review								Predicting and preventing preterm labour and choosing the safest method of delivery are important challenges in reducing the number of preterm births and improving outcomes for mother and baby. This article covers the predictive tests, methods of prevention, maternal and fetal indications for preterm birth, and various approaches. to delivery.	Univ Dundee, Ninewells Hosp & Med Sch, Tayside Inst Child Hlth, Dundee DD1 9SY, Scotland; Perth Royal Infirm, Perth, Scotland	University of Dundee	Murphy, DJ (corresponding author), Univ Dundee, Ninewells Hosp & Med Sch, Tayside Inst Child Hlth, Dundee DD1 9SY, Scotland.			McGuire, William/0000-0001-8572-3467; Murphy, Deirdre/0000-0001-6074-6718				CROWLEY P, 2003, COCHRANE DATABASE SY, DOI UNSP CD000065; HOFMEYR GJ, 2003, COCHRANE DATABASE SY, DOI UNSP CD001059; Honest H, 2002, BMJ-BRIT MED J, V325, P301, DOI 10.1136/bmj.325.7359.301; Kenyon S, 2013, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD001058; KING J, 2003, COCHRANE DATABASE SY, DOI UNSP CD000246; KNIGHT M, 2003, COCHRANE DATABASE SY, DOI UNSP CD000492; NEILSON JP, 2003, COCHRANE DATABASE SY, DOI UNSP CD000073	7	7	9	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 2	2004	329	7469					783	786		10.1136/bmj.329.7469.783	http://dx.doi.org/10.1136/bmj.329.7469.783			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	859TW	15459053	Green Published			2022-12-28	WOS:000224291800023
J	Frost, H; Lamb, SE; Doll, HA; Carver, PT; Stewart-Brown, S				Frost, H; Lamb, SE; Doll, HA; Carver, PT; Stewart-Brown, S			Randomised controlled trial of physiotherapy compared with advice for low back pain	BRITISH MEDICAL JOURNAL			English	Article							PRIMARY-CARE; INFORMATION; MANAGEMENT; QUESTIONNAIRE; DISABILITY; EXERCISE; THERAPY; BOOKLET; UK	Objective To measure the effectiveness of routine physiotherapy compared with an assessment session and advice from a physiotherapist for patients with low back pain. Design Pragmatic, multicentre, randomised controlled trial. Setting Seven NHS physiotherapy departments. Participants 286 patients with low back pain of more than six weeks' duration. Intervention Routine physiotherapy or advice on remaining active from a physiotherapist. Main outcome measures Primary outcome was scores on the Oswestry disability index at 12 months. Secondary outcomes were scores on the Oswestry disability index (2 and 6 months), scores on the Roland and Morris disability questionnaire and SF-36 (2, 6 and 12 months), and patient perceived benefit from treatment (2, 6, and 12 months). Results 200 of 286 patients (70%) provided follow up information at 12 months. Patients in the therapy group reported enhanced perceptions of benefit, but there was no evidence of a long term effect of physiotherapy in either disease specific or generic outcome measures (mean difference in change in Oswestry disability index scores at 12 months -1.0%, 95% confidence interval -3.7% to 1.6%). The most common treatments were low velocity spinal joint mobilisation techniques (72%, 104 of 144 patients) and lumbar spine mobility and abdominal strengthening exercises (94%, 136 patients). Conclusion Routine physiotherapy seemed to be no more effective than one session of assessment and advice from a physiotherapist.	Univ Warwick, Warwick Med Sch, Div Hlth Community, Coventry CV4 7AL, W Midlands, England; Univ Oxford, Dept Publ Hlth, Hlth Serv Res Unit, Oxford OX3 7LF, England; Nuffield Orthopaed Ctr NHS Trust, Oxford OX3 7LD, England	University of Warwick; University of Oxford; Nuffield Orthopaedic Centre	Frost, H (corresponding author), Univ Warwick, Warwick Med Sch, Div Hlth Community, Coventry CV4 7AL, W Midlands, England.	h.frost.l@warwick.ac.uk		Frost, Helen/0000-0001-9241-8970; Lamb, Sarah/0000-0003-4349-7195				Bekkering G., 2003, PHYSIOTHERAPY, V89, P82, DOI DOI 10.1016/S0031-9406(05)60579-2; BRAZIER JE, 1992, BMJ-BRIT MED J, V305, P160, DOI 10.1136/bmj.305.6846.160; Burton AK, 1999, SPINE, V24, P2484, DOI 10.1097/00007632-199912010-00010; Clinical Standards Advisory Group, 1994, EP REV EP COST BACK; Clinical Standards Advisory Group on Back Pain, 1994, BACK PAIN; Fairbank JCT, 2000, SPINE, V25, P2940, DOI 10.1097/00007632-200011150-00017; Foster NE, 1999, SPINE, V24, P1332, DOI 10.1097/00007632-199907010-00011; KIRKWOOD B, 1990, ESSENTIALS MED STAT; Knight M, 2001, J PUBLIC HEALTH MED, V23, P179, DOI 10.1093/pubmed/23.3.179; Koes BW, 2001, SPINE, V26, P2504, DOI 10.1097/00007632-200111150-00022; Little P, 2001, SPINE, V26, P2065, DOI 10.1097/00007632-200110010-00003; Maniadakis N, 2000, PAIN, V84, P95, DOI 10.1016/S0304-3959(99)00187-6; MCKENZIE RA, 1981, LUMBAR SPINE MECH DI; MOFFETT JK, 1999, BRIT MED J, V319, P270; MOFFETT JK, 1995, 129 NHS U YORK CTR H; Ong CK, 2004, HEALTH SOC CARE COMM, V12, P265, DOI 10.1111/j.1365-2524.2004.00497.x; Petersen T, 2002, SPINE, V27, P1702, DOI 10.1097/00007632-200208150-00004; Pocock SJ., 2013, CLIN TRIALS PRACTICA; PRESCOTT RJ, 1999, HEALTH TECHNOL ASSES, V3, P71; ROLAND M, 1983, SPINE, V8, P141, DOI 10.1097/00007632-198303000-00004; ROLAND M, 1993, SPINE, V8, P11; van Tulder M, 2000, SPINE, V25, P2784, DOI 10.1097/00007632-200011010-00011; 1997, BACK BOOK	23	132	136	1	10	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	SEP 25	2004	329	7468					708	711		10.1136/bmj.38216.868808.7C	http://dx.doi.org/10.1136/bmj.38216.868808.7C			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	858RV	15377573	Green Published, Green Submitted, Bronze			2022-12-28	WOS:000224210300015
J	Huq, E; Al-Sady, B; Hudson, M; Kim, CH; Apel, M; Quail, PH				Huq, E; Al-Sady, B; Hudson, M; Kim, CH; Apel, M; Quail, PH			PHYTOCHROME-INTERACTING FACTOR 1 is a critical bHLH regulator of chlorophyll biosynthesis	SCIENCE			English	Article							SIGNAL-TRANSDUCTION; TRANSCRIPTION FACTOR; NEGATIVE REGULATOR; LIGHT; ARABIDOPSIS; PIF3; PROTEIN; PROMOTER; PLANTS	Photosynthetic organisms must achieve a delicate balance between the light energy absorbed by chlorophyll and their capacity to channel that energy into productive photochemical reactions. Release of excess absorbed energy in the cell can cause lethal photooxidative damage. We identified a basic helix-toop-helix (bHLH) transcription factor, designated PHYTOCHROME-INTERACTING FACTOR 1 (PIF1), that negatively regulates chlorophyll biosynthesis. pif1 mutant seedlings accumulate excess free protochlorophyllide when grown in the dark, with consequent lethal bleaching upon exposure to light. PIF1 interacts specifically with the photoactivated conformer of phytochromes A and B, suggesting a signaling pathway by which chlorophyll biosynthetic rates are tightly controlled during the critical initial emergence of seedlings from subterranean darkness into sunlight.	Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA; Univ Texas, Sect Mol Cell & Dev Biol, Austin, TX 78712 USA; Univ Texas, Inst Mol Biol, Austin, TX 78712 USA; ARS, USDA, Ctr Plant Gene Express, Albany, CA 94710 USA; ETH, Inst Plant Sci, CH-8092 Zurich, Switzerland	University of California System; University of California Berkeley; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; United States Department of Agriculture (USDA); Swiss Federal Institutes of Technology Domain; ETH Zurich	Quail, PH (corresponding author), Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA.	quait@nature.berkeley.edu	Kim, Chanhong/AAL-4930-2021; Hudson, Matthew E/A-4438-2008; Kim, Chanhong/G-5506-2012	Kim, Chanhong/0000-0003-4133-9070; Hudson, Matthew E/0000-0002-4737-0936; Al-Sady, Bassem/0000-0002-8996-7941; Huq, Enamul/0000-0001-7692-5139	NIGMS NIH HHS [GM47475] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047475] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bauer D, 2004, PLANT CELL, V16, P1433, DOI 10.1105/tpc.021568; Fairchild CD, 2000, GENE DEV, V14, P2377; Halliday KJ, 1999, P NATL ACAD SCI USA, V96, P5832, DOI 10.1073/pnas.96.10.5832; Huq E, 2002, EMBO J, V21, P2441, DOI 10.1093/emboj/21.10.2441; HUQ E, UNPUB; INSKEEP WP, 1985, PLANT PHYSIOL, V77, P483, DOI 10.1104/pp.77.2.483; Kim JY, 2003, PLANT CELL, V15, P2399, DOI 10.1105/tpc.014498; Kircher S, 2002, PLANT CELL, V14, P1541, DOI 10.1105/tpc.001156; Martinez-Garcia JF, 2000, SCIENCE, V288, P859, DOI 10.1126/science.288.5467.859; Meskauskiene R, 2001, P NATL ACAD SCI USA, V98, P12826, DOI 10.1073/pnas.221252798; MONTE E, UNPUB; Nagy F, 2002, ANNU REV PLANT BIOL, V53, P329, DOI 10.1146/annurev.arplant.53.100301.135302; Neff MM, 2000, GENE DEV, V14, P257; Ni M, 1998, CELL, V95, P657, DOI 10.1016/S0092-8674(00)81636-0; Ni M, 1999, NATURE, V400, P781, DOI 10.1038/23500; op den Camp RGL, 2003, PLANT CELL, V15, P2320, DOI 10.1105/tpc.014662; Quail PH, 2002, NAT REV MOL CELL BIO, V3, P85, DOI 10.1038/nrm728; Quail PH, 2000, SEMIN CELL DEV BIOL, V11, P457, DOI 10.1006/scdb.2000.0199; Reinbothe S, 1996, CELL, V86, P703, DOI 10.1016/S0092-8674(00)80144-0; Salter MG, 2003, NATURE, V426, P680, DOI 10.1038/nature02174; WANG H, 2004, ARABIDOPSIS BOOK; Zhu YX, 2000, P NATL ACAD SCI USA, V97, P13419, DOI 10.1073/pnas.230433797	22	353	397	4	118	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 24	2004	305	5692					1937	1941		10.1126/science.1099728	http://dx.doi.org/10.1126/science.1099728			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	857RM	15448264				2022-12-28	WOS:000224136000040
J	Mariner, WK				Mariner, WK			Legal issues in medicine: The Supreme Court's limitation of managed-care liability	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							INCENTIVES; QUALITY		Boston Univ, Sch Publ Hlth, Dept Hlth Law Bioeth & Human Rights, Boston, MA 02215 USA	Boston University	Mariner, WK (corresponding author), Boston Univ, Sch Publ Hlth, Dept Hlth Law Bioeth & Human Rights, Boston, MA 02215 USA.			Mariner, Wendy/0000-0001-5176-5917				AGRAWAL GB, 2003, ST LOUIS U LJ, V47, P235; ANDERSON ER, 2000, INSURANCE COVERAGE L; Annas GJ, 2004, RIGHTS PATIENTS; BARKER WT, 2000, CONN INSUR LAW J, V6, P81; Bloche MG, 2004, HEALTH AFFAIR, V23, P29, DOI 10.1377/hlthaff.23.2.29; Bloche MG, 2002, STANFORD LAW REV, V55, P919, DOI 10.2307/1229676; Dudley RA, 2001, NEW ENGL J MED, V344, P1087, DOI 10.1056/NEJM200104053441410; Dudley RA, 1998, MILBANK Q, V76, P649, DOI 10.1111/1468-0009.00109; Havighurst CC, 2000, AM J LAW MED, V26, P7; HEFFLER S, 2003, HLTH AFFAIRS    0207; HENDERSON RC, 1995, ARIZ L REV, V37, P1153; JACOBSON PD, 1998, HOUSTON LAW REV, V35, P985; JAPSEN B, 2004, CHICAGO TRIBUNE 0622, P1; Keeton W., 1984, PROSSER KEETON LAW T; LANE C, 2004, WASHINGTON POST 0305, pA1; Langbein JH, 2003, COLUMBIA LAW REV, V103, P1317, DOI 10.2307/3593389; Levit K, 2004, HEALTH AFFAIR, V23, P147, DOI 10.1377/hlthaff.23.1.147; Mariner WK, 2002, NEW ENGL J MED, V347, P2178, DOI 10.1056/NEJMlim021769; Mariner WK, 2001, J LAW MED ETHICS, V29, P253, DOI 10.1111/j.1748-720X.2001.tb00347.x; Mariner WK, 1996, NEW ENGL J MED, V335, P1986, DOI 10.1056/NEJM199612263352610; MARINER WK, 2004, BROOK L REV, V69, P485; Reinhardt Uwe E., 1999, REGULATING MANAGED C, P91; Robinson JC, 2004, JAMA-J AM MED ASSOC, V291, P1880, DOI 10.1001/jama.291.15.1880; Robinson JC, 2001, MILBANK Q, V79, P149, DOI 10.1111/1468-0009.00202; Rodwin MA, 1999, J HEALTH POLIT POLIC, V24, P1115; Rosoff AJ, 2001, J LEGAL MED, V22, P55, DOI 10.1080/019476401750171133; Stempel J W, 2001, Tort Insur Law J, V36, P687; STEMPEL JW, 2002, LAW INSURANCE CONTRA; STRUNK BC, 2003, HLTH AFFAIRS    0609; 2000, FED REG, V65, P70245	30	4	4	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 23	2004	351	13					1347	1352		10.1056/NEJMlim042143	http://dx.doi.org/10.1056/NEJMlim042143			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	855TP	15385665	Green Published			2022-12-28	WOS:000223997700017
J	Stern, AM; Markel, H				Stern, AM; Markel, H			International efforts to control infectious diseases, 1851 to the present	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							1ST 100 YEARS; SANITARY-CONFERENCES; HEALTH-ORGANIZATION; PUBLIC-HEALTH; HUMAN-RIGHTS; REFLECTIONS	Many 21st-century observers explain international efforts to control infectious diseases as a function of globalization and recent transformations in international commerce, transportation, and human migration. However, these contemporary global health initiatives can be more fully understood by also exploring the origins of international health organizations and regulations, which were initially dedicated exclusively to stemming the tide of infectious epidemics. This article reviews 3 eras of international approaches to controlling infectious diseases (1851-1881, 1881-1945, and 1945 to the present) and concludes by assessing how nations have a strong fiscal and humanitarian incentive to invest in infectious disease control programs and infrastructures in and beyond their own borders.	Univ Michigan, Dept Obstet & Gynecol, Ctr Hist Med, Simpson Mem Inst 100, Ann Arbor, MI 48109 USA; Univ Michigan, Program Amer Culture, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Pediat & Communicable Dis, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Hist, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Markel, H (corresponding author), Univ Michigan, Dept Obstet & Gynecol, Ctr Hist Med, Simpson Mem Inst 100, 102 Observ,0725, Ann Arbor, MI 48109 USA.	howard@umich.edu						ACKERKNECHT ERWIN H., 1948, BULL HISTORY MED, V22, P562; ACUNA HR, 1977, PUBLIC HEALTH REP, V92, P537; Alleyne GAO, 2002, AM J PUBLIC HEALTH, V92, P1890, DOI 10.2105/AJPH.92.12.1890; Annas GJ, 1998, NEW ENGL J MED, V339, P1778, DOI 10.1056/NEJM199812103392411; [Anonymous], 1993, HIST PUBLIC HLTH; [Anonymous], MILLENNIUM DEV GOALS; BARNETT T, 2004, 21 CENTURY DIS GLOBA; BIGGS H, 1911, MONTHLY B DEP HLTH C, V1, P225; Birn AE, 1999, AM J PUBLIC HEALTH, V89, P399, DOI 10.2105/AJPH.89.3.399; Birn Anne-Emanuelle, 2002, Can Bull Med Hist, V19, P17; Bloom BR, 1999, SCIENCE, V284, P911, DOI 10.1126/science.284.5416.911; Bloom Khaled J., 1993, MISSISSIPPI VALLEYS; BRAND JL, 1989, B HIST MED, V63, P579; BUSTAMANTE ME, 1955, PANAMERICA SANITARY; BYNUM WF, 1993, HIST PHIL LIFE SCI, V15, P421; CHARLES J, 1968, BRIT MED J, V4, P293; Crosby A., 1972, COLUMBIAN EXCHANGE B; Cueto M, 2001, RETURN EPIDEMICS HLT; Cueto Marcos, 1994, MISSIONARIES SCI ROC; CURTIN PD, 1998, DIS EMPIRE HLTH EUR; de Kruif P, 1926, MICROBE HUNTERS; Farley J, 2003, BILHARZIA HIST IMPER; Farmer P., 1999, INFECT INEQUALITIES; Fee E, 2002, AM J PUBLIC HEALTH, V92, P1888, DOI 10.2105/AJPH.92.12.1888; FEE Elizabeth, 1993, HIST PUBLIC HLTH, pIX; Fidler DP, 2001, B WORLD HEALTH ORGAN, V79, P842; Fox DM, 2001, AM J PUBLIC HEALTH, V91, P1554, DOI 10.2105/AJPH.91.10.1554; Fox RC, 1995, SOC SCI MED, V41, P1607, DOI 10.1016/0277-9536(95)00144-V; Garrett L., 2000, BETRAYAL TRUST COLLA; Gorgas William Crawford, 1915, SANITATION PANAMA; GOSTIN LO, 2004, JAMA-J AM MED ASSOC, V2691, P2623; HOWARDJONES N, 1981, PERSPECT BIOL MED, V24, P467; HOWARDJONES N, 1974, WHO CHRON, V28, P369; HOWARDJONES N, 1974, WHO CHRON, V28, P414; HOWARDJONES N, 1974, WHO CHRON, V28, P455; HOWARDJONES N, 1974, WHO CHRON, V28, P495; HOWARDJONES N, 1974, WHO CHRON, V28, P159; HOWARDJONES N, 1974, WHO CHRON, V28, P229; HUMPHREYS Margaret, 1992, YELLOW FEVER S; KELLY L, 2004, GLOBALIZATION HLTH I; KOOP CE, 2002, CRITICAL ISSUES GLOB; Le Prince JA, 1916, MOSQUITO CONTROL PAN; MACLEOD R, 1988, MED EMPIRE PERSPECTI; MAHLER H, 1977, WHO CHRON, V31, P491; MARCUS AI, 1979, B HIST MED, V53, P184; Markel H, 2002, MILBANK Q, V80, P757, DOI 10.1111/1468-0009.00030; Markel Howard., 1997, QUARANTINE E EUROPEA; Markel Howard, 2004, GERMS TRAVEL 6 MAJOR; McCullough David, 1977, PATH SEAS CREATION P, P12; MCNEILL W, 1967, PLAGUES PEOPLES; POOLE GA, 2004, NY TIMES        0604, pA1; Roemer M I, 1994, Clio Med, V26, P403; Rosenberg Charles E, 1987, CHOLERA YEARS US 183; SACHS J, 1999, ECONOMIST, V352, P17; Sachs JD, 2001, SCI AM, V284, P70, DOI 10.1038/scientificamerican0301-70; SACHS JD, INVESTING HLTH EC DE; TRUBY AE, 1943, MEMOIR W REED YELLOW; VONPETTENKOFER M, 1975, CHOLERA PREVENT RESI; *WHO, 6 DIS CAUS 90 INF DI; *WHO, 2000, B WORLD HEALTH ORGAN, V80, P983; Williams G, 1988, World Health Forum, V9, P7; WILLIAMS G, 1988, World Health Forum, V9, P185; Williams Ralph C., 1951, US PUBLIC HLTH SERVI; Winslow C., 1944, CONQUEST EPIDEMIC DI; 1995, WORLD HLTH FORUM, V16, P388	65	34	38	3	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 22	2004	292	12					1474	1479		10.1001/jama.292.12.1474	http://dx.doi.org/10.1001/jama.292.12.1474			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	856FT	15383519				2022-12-28	WOS:000224031800030
J	Wilson, JF				Wilson, JF			Frailty - and its dangerous effects - Might be preventable	ANNALS OF INTERNAL MEDICINE			English	Article							SERUM INTERLEUKIN-6; FUNCTIONAL DECLINE; GERIATRIC SYNDROME; PROGRAM					jenwilson@acponline.org	Wilson, Jennifer/Q-3623-2019	Wilson, Jennifer/0000-0003-4025-3136				Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146; Gill TM, 2002, NEW ENGL J MED, V347, P1068, DOI 10.1056/NEJMoa020423; Gill TM, 2004, ARCH PHYS MED REHAB, V85, P1043, DOI 10.1016/j.apmr.2003.10.021; Keysor JJ, 2001, J GERONTOL A-BIOL, V56, pM412, DOI 10.1093/gerona/56.7.M412; Leng S, 2002, J AM GERIATR SOC, V50, P1268, DOI 10.1046/j.1532-5415.2002.50315.x; Leng SX, 2004, AGING CLIN EXP RES, V16, P153; LIPSITZ LA, 2004, SCI AGING KNWOLEDGE, DOI DOI 10.1126/SAGEKE.2004.16PE16; Morley JE, 2002, J GERONTOL A-BIOL, V57, pM698, DOI 10.1093/gerona/57.11.M698; Studenski S, 2003, J AM GERIATR SOC, V51, P314, DOI 10.1046/j.1532-5415.2003.51104.x; Walston J, 2002, ARCH INTERN MED, V162, P2333, DOI 10.1001/archinte.162.20.2333; WALSTON J, SCI AGING KNOWLEDGE, DOI DOI 10.1126/SAGEKE.4.PE4	11	37	40	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 21	2004	141	6					489	492		10.7326/0003-4819-141-6-200409210-00035	http://dx.doi.org/10.7326/0003-4819-141-6-200409210-00035			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	856TM	15381535				2022-12-28	WOS:000224067900026
J	Degeling, PJ; Maxwell, S; Iedema, R; Hunter, DJ				Degeling, PJ; Maxwell, S; Iedema, R; Hunter, DJ			Making clinical governance work	BMJ-BRITISH MEDICAL JOURNAL			English	Article									Univ Durham, Sch Hlth, Durham DH1 3HP, England; Univ Durham, Ctr Clin Management Dev, Stockton On Tees TS17 6BH, England; Univ New S Wales, Ctr Clin Governance, Sydney, NSW, Australia	Durham University; Durham University; University of New South Wales Sydney	Hunter, DJ (corresponding author), Univ Durham, Sch Hlth, Durham DH1 3HP, England.	d.j.hunter@durham.ac.uk		Iedema, Roderick/0000-0001-6792-1048				Degeling P, 2001, Health Serv Manage Res, V14, P36, DOI 10.1258/0951484011912519; Degeling P, 2000, INT J HEALTH PLAN M, V15, P3; DEGELING P, 2004, GOVERNING MED THEORY, P60; DEGELING P, IN PRESS PUBLIC MANA; DEGELING P, 2003, QUAL PRIM CARE, V11, P147; DEGELING P, 2002, PROFESSIONAL SUBCULT; Edwards N, 2003, BRIT MED J, V326, P116, DOI 10.1136/bmj.326.7381.116; FLYNN AM, 1993, J NURS CARE QUAL, V1, P58; Giuliano K K, 1991, Nurs Manage, V22, P52; GRAY A, 2004, GOVT MED THEORY PRAC, pCH2; Gregor C, 1996, JOINT COMM J QUAL IM, V22, P617, DOI 10.1016/S1070-3241(16)30269-3; Johnson SL, 1997, J CONSULT CLIN PSYCH, V65, P15, DOI 10.1037/0022-006X.65.1.15; Leatherman S.T., 2003, QUEST QUALITY NHS MI; MARNOCH G, 1996, DOCTORS MANAGEMENT; POOLE DL, 1994, PHYSIOTHERAPY, V80, P256; Rose Nikolas, 1996, QUESTIONS CULTURAL I, P128; Scally G, 1998, BRIT MED J, V317, P61, DOI 10.1136/bmj.317.7150.61; Secretary of State for Health, 1998, 1 CLASS SERV QUAL NE	18	59	60	0	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 18	2004	329	7467					679	681		10.1136/bmj.329.7467.679	http://dx.doi.org/10.1136/bmj.329.7467.679			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	856JU	15374921	Green Published, Green Accepted, Green Submitted			2022-12-28	WOS:000224042300028
J	Phillips, MR; Yang, GH; Li, SR; Li, Y				Phillips, MR; Yang, GH; Li, SR; Li, Y			Suicide and the unique prevalence pattern of schizophrenia in mainland China: a retrospective observational study	LANCET			English	Article							PSYCHOLOGICAL AUTOPSY; RISK-FACTORS; SEX; HEALTH	Background Unlike almost every other country in the world, the prevalence of both schizophrenia and suicide in China is higher in women than in men. Schizophrenia and suicide are important public-health problems for China that might be related to each other. We present prevalence data for schizophrenia and estimate relative and attributable risk of suicide in people with schizophrenia in mainland China. Methods We used data from the national psychiatric epidemiology study, the Ministry of Health's mortality registry, the census, and the national psychological autopsy study to estimate frequencies and rates of schizophrenia, suicide, and suicide in people with schizophrenia aged 15 years and older in mainland China during 1995-99. Findings We estimated 4.25 million people with schizophrenia in China, and 284 614 suicides and 28 737 suicides in people with schizophrenia yearly. Prevalence of schizophrenia was higher in women than men (relative risk 1.77 [95% CI 1.15-2.72]), and greater in urban than rural areas (1.62 [1.10-2.40]). Risk of suicide was greater in women than men (1.22 [1.20-1.23]) and in rural than urban areas (3.61 [3.56-3.66]). Relative risk of suicide in individuals with schizophrenia compared with those without was 23.8 (18.8-30.2); the proportion of all suicides attributable to schizophrenia was 9.7% (7.7-12.1). Relative risk of suicide in rural residents with schizophrenia versus those without was higher in men than in women (ratio of two relative risks 2.02 [1.13-3.63]), but in urban residents with schizophrenia the ratio was lower in men than women (0.56 [0.21-1.49]). Interpretation Risk factors for suicide vary in people with different mental disorders, so identification of illness-specific risk profiles would improve prediction of suicide and help tailor prevention efforts. The difference in suicide rates by sex and residential location in individuals with schizophrenia might be one of several contributing factors to the unique epidemiological pattern of schizophrenia in China.	Beijing Hui Long Guan Hosp, Beijing Suicide Res & Prevent Ctr, Beijing 100096, Peoples R China; Chinese Acad Med Sci, Peking Union Med Coll, Inst Basic Med Sci, Beijing, Peoples R China; Beijing Univ, Inst Mental Hlth, Beijing 100871, Peoples R China; Univ Rochester, Med Ctr, Dept Community & Prevent Med, Rochester, NY 14642 USA	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Peking University; University of Rochester	Phillips, MR (corresponding author), Beijing Hui Long Guan Hosp, Beijing Suicide Res & Prevent Ctr, Beijing 100096, Peoples R China.	phillips@public3.bta.net.cn	Phillips, Michael Robert/AAE-7585-2021	Phillips, Michael Robert/0000-0002-5973-2439				Aleman A, 2003, ARCH GEN PSYCHIAT, V60, P565, DOI 10.1001/archpsyc.60.6.565; *AM PSYC ASS, 1997, PRACT GUID TREATM PA; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th ed., DOI DOI 10.1001/JAMA.1994.03520100096; ANDREASSON S, 1987, LANCET, V2, P1483, DOI 10.1016/s0140-6736(87)92620-1; *CDER, CDER NEW GEN DRUG AP; *CHIN BUR STAT, 1996, CHIN POP STAT YB; CLAYTON D, 1993, STAT MODELS EPIDEMIO, P123; Cooper JE, 1996, MENTAL DISORDERS CHI; DELEO D, 2003, SUICIDE PREVENTION M, P11; FIRST MB, 1996, STRUCT CLIN INTERVIE; FREEMAN H, 1994, BRIT J PSYCHIAT, V164, P39, DOI 10.1192/S0007125000292726; GOLDNEY RD, 2000, INT HDB SUICIDE ATTE, P121; Hawton K, 1998, J AFFECT DISORDERS, V50, P269; Heila H, 1997, AM J PSYCHIAT, V154, P1235; LIU JC, 2000, J CLIN PSYCHOL MED, V10, P185; Meltzer HY, 2003, ARCH GEN PSYCHIAT, V60, P82, DOI 10.1001/archpsyc.60.1.82; Murphy GE., 2000, INT HDB SUICIDE ATTE, P135; Murray CJL., 1996, GLOBAL HLTH STAT COM, V1996; PEARSON V, 1995, SOC SCI MED, V41, P1159, DOI 10.1016/0277-9536(94)00424-R; Phillips M R, 2001, Dialogues Clin Neurosci, V3, P109; Phillips MR, 1999, CULT MED PSYCHIAT, V23, P25, DOI 10.1023/A:1005462530658; Phillips MR, 2002, LANCET, V360, P1728, DOI 10.1016/S0140-6736(02)11681-3; Phillips MR, 2002, LANCET, V359, P835, DOI 10.1016/S0140-6736(02)07954-0; RAN MS, 1998, CHINESE J PSYCHIAT, V31, P123; Rossau CD, 1997, BRIT J PSYCHIAT, V171, P355, DOI 10.1192/bjp.171.4.355; Sartorius N, 1996, SOC PSYCH PSYCH EPID, V31, P249; SUSSER E, 1994, ARCH GEN PSYCHIAT, V51, P294; United Nations, 1996, PREV SUIC GUID FORM; Wing J. K. C., 1974, MEASUREMENT CLASSIFI; Zhang QJ, 1997, INT J MICROWAVE MILL, V7, P83, DOI 10.1002/(SICI)1522-6301(199701)7:1<83::AID-MMCE6>3.0.CO;2-K; Zhang W.X., 1998, CHINESE J PSYCHIAT, V31, P69; [No title captured]	32	94	99	1	34	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 18	2004	364	9439					1062	1068		10.1016/S0140-6736(04)17061-X	http://dx.doi.org/10.1016/S0140-6736(04)17061-X			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	855FT	15380965				2022-12-28	WOS:000223959300025
J	Watts, J				Watts, J			Profile - Masood Hyder, UN humanitarian coordinator in North Korea	LANCET			English	Biographical-Item												llamaman@mub.biglobe.ne.jp							0	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 18	2004	364	9439					1031	1031		10.1016/S0140-6736(04)17048-7	http://dx.doi.org/10.1016/S0140-6736(04)17048-7			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	855FT	15455485	Bronze			2022-12-28	WOS:000223959300012
J	Clevers, H				Clevers, H			At the crossroads of inflammation and cancer	CELL			English	Editorial Material							COLORECTAL-CANCER; INTESTINAL POLYPOSIS; ANIMAL-MODELS; INHIBITION; CYCLOOXYGENASE-2; TUMORIGENESIS; PREVENTION; ACTIVATION; BETA; IKK	Chronic inflammation and cancer are closely associated in the intestine. Anti-inflammatory medication reduces intestinal neoplasia, while colorectal cancer incidence is increased in ulcerative colitis. Cyclooxy-genases are key to both diseases, yet the molecular basis of the association remains incompletely understood. Two recent Cell (Greten et al., 2004; Rakoff-Nahoum et al., 2004) papers illuminate roles of Toll-like receptors and the NF-kappaB pathway in the control of epithelial homeostasis in health and disease.	Ctr Biomed Genet, Hubrecht Lab, NL-3584 CT Utrecht, Netherlands	Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW)	Clevers, H (corresponding author), Ctr Biomed Genet, Hubrecht Lab, Uppsalalaan 8, NL-3584 CT Utrecht, Netherlands.							Amit S, 2003, SEMIN CANCER BIOL, V13, P15, DOI 10.1016/S1044-579X(02)00096-2; Beutler B, 2004, NATURE, V430, P257, DOI 10.1038/nature02761; Chen LW, 2003, NAT MED, V9, P575, DOI 10.1038/nm849; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Greten FR, 2004, CELL, V118, P285, DOI 10.1016/j.cell.2004.07.013; Gupta RA, 2001, NAT REV CANCER, V1, P11, DOI 10.1038/35094017; Hooper LV, 2001, SCIENCE, V292, P1115, DOI 10.1126/science.1058709; Itzkowitz SH, 2004, AM J PHYSIOL-GASTR L, V287, pG7, DOI 10.1152/ajpgi.00079.2004; Koehne CH, 2004, SEMIN ONCOL, V31, P12, DOI 10.1053/j.seminoncol.2004.03.041; KRAOFFNAHOUM S, 2004, CELL, V118, P229; Oshima M, 2002, CURR PHARM DESIGN, V8, P1021, DOI 10.2174/1381612023394953; Rogers AB, 2004, AM J PHYSIOL-GASTR L, V286, pG361, DOI 10.1152/ajpgi.00499.2003; Schuppler M, 2004, INFECT IMMUN, V72, P1983, DOI 10.1128/IAI.72.4.1983-1990.2004; Seril DN, 2003, CARCINOGENESIS, V24, P353, DOI 10.1093/carcin/24.3.353; Sonoshita M, 2001, NAT MED, V7, P1048, DOI 10.1038/nm0901-1048; Takeda H, 2003, CANCER RES, V63, P4872; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Yamamoto Y, 1999, J BIOL CHEM, V274, P27307, DOI 10.1074/jbc.274.38.27307; Yin MJ, 1998, NATURE, V396, P77, DOI 10.1038/23948	19	415	440	0	25	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	SEP 17	2004	118	6					671	674		10.1016/j.cell.2004.09.005	http://dx.doi.org/10.1016/j.cell.2004.09.005			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	855RW	15369667	Bronze			2022-12-28	WOS:000223992400004
J	Aitken, CM; Jones, DM; Larter, SR				Aitken, CM; Jones, DM; Larter, SR			Anaerobic hydrocarbon biodegradation in deep subsurface oil reservoirs	NATURE			English	Article							PETROLEUM RESERVOIRS; AROMATIC-HYDROCARBONS; CRUDE-OIL; IN-SITU; DEGRADATION; NAPHTHALENE; MICROBIOLOGY; METABOLITES; OXIDATION; BACTERIA	Biodegradation of crude oil in subsurface petroleum reservoirs is an important alteration process with major economic consequences(1). Aerobic degradation of petroleum hydrocarbons at the surface is well documented(2) and it has long been thought that the flow of oxygen- and nutrient-bearing meteoric waters into reservoirs was necessary for in-reservoir petroleum biodegradation(3). The occurrence of biodegraded oils in reservoirs where aerobic conditions are unlikely(4), together with the identification of several anaerobic microorganisms in oil fields(5) and the discovery of anaerobic hydrocarbon biodegradation mechanisms(6,7), suggests that anaerobic degradation processes could also be responsible. The extent of anaerobic hydrocarbon degradation processes in the world's deep petroleum reservoirs, however, remains strongly contested. Moreover, no organism has yet been isolated that has been shown to degrade hydrocarbons under the conditions found in deep petroleum reservoirs(8). Here we report the isolation of metabolites indicative of anaerobic hydrocarbon degradation from a large fraction of 77 degraded oil samples from both marine and lacustrine sources from around the world, including the volumetrically important Canadian tar sands. Our results therefore suggest that anaerobic hydrocarbon degradation is a common process in biodegraded subsurface oil reservoirs.	Univ Newcastle Upon Tyne, Sch Civil Engn & Geosci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; Univ Calgary, Dept Geol & Geophys, Calgary, AB T2N 1N4, Canada	Newcastle University - UK; University of Calgary	Jones, DM (corresponding author), Univ Newcastle Upon Tyne, Sch Civil Engn & Geosci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	martin.jones@ncl.ac.uk		Larter, Stephen/0000-0001-7195-1477				Aitken C.M., 2004, THESIS U NEWCASTLE U; Annweiler E, 2002, APPL ENVIRON MICROB, V68, P852, DOI 10.1128/AEM.68.2.852-858.2002; ATLAS RM, 1992, ADV MICROB ECOL, V12, P287; Bastin ES, 1926, SCIENCE, V63, P21, DOI 10.1126/science.63.1618.21; BENNETT PC, 1993, APPL GEOCHEM, V8, P529, DOI 10.1016/0883-2927(93)90012-6; Boll M, 2002, CURR OPIN CHEM BIOL, V6, P604, DOI 10.1016/S1367-5931(02)00375-7; Connan J., 1986, ADV PETROLEUM GEOCHE, V1, P299, DOI DOI 10.1016/B978-0-12-032001-1.50011-0; Elshahed MS, 2001, ENVIRON SCI TECHNOL, V35, P682, DOI 10.1021/es001571u; EVANS CR, 1971, CHEM GEOL, V8, P147, DOI 10.1016/0009-2541(71)90002-7; Gieg LM, 2002, ENVIRON SCI TECHNOL, V36, P3755, DOI 10.1021/es0205333; Head IM, 2003, NATURE, V426, P344, DOI 10.1038/nature02134; HORSTAD I, 1992, ORG GEOCHEM, V19, P107, DOI 10.1016/0146-6380(92)90030-2; Jones DM, 2001, ANAL CHEM, V73, P703, DOI 10.1021/ac000621a; Kartsev A.A., 1959, GEOCHEMICAL METHODS, P287, DOI [10.1525/9780520346079, DOI 10.1525/9780520346079]; Larter S, 2003, ORG GEOCHEM, V34, P601, DOI 10.1016/S0146-6380(02)00240-1; LHARIDON S, 1995, NATURE, V377, P223, DOI 10.1038/377223a0; MAGOT M, 1994, RECHERCHE, V25, P936; Magot M, 2000, ANTON LEEUW INT J G, V77, P103, DOI 10.1023/A:1002434330514; Palmer S.E., 1993, ORG GEOCHEM, P511, DOI 10.1007/978-1-4615-2890-6_23; Peters K.E., 1993, BIOMARKER GUIDE; Phelps CD, 2002, ENVIRON MICROBIOL, V4, P532, DOI 10.1046/j.1462-2920.2002.00330.x; Rios-Hernandez LA, 2003, APPL ENVIRON MICROB, V69, P434, DOI 10.1128/AEM.69.1.434-443.2003; Roling WFM, 2003, RES MICROBIOL, V154, P321, DOI 10.1016/S0923-2508(03)00086-X; RUETER P, 1994, NATURE, V372, P455, DOI 10.1038/372455a0; Seewald JS, 2003, NATURE, V426, P327, DOI 10.1038/nature02132; Van Der LINDEN A. C, 1965, ADVANCE ENZYMOLADVANCES IN ENZYMOLOGY AND RELATED SUBJECTS OF BIOCHEMISTRY, V27, P469; WATSON JS, 1999, THESIS U NEWCASTLE U; Widdel F, 2001, CURR OPIN BIOTECH, V12, P259, DOI 10.1016/S0958-1669(00)00209-3; Zengler K, 1999, NATURE, V401, P266, DOI 10.1038/45777; Zhang XM, 2000, BIODEGRADATION, V11, P117, DOI 10.1023/A:1011128109670	30	274	297	7	135	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 16	2004	431	7006					291	294		10.1038/nature02922	http://dx.doi.org/10.1038/nature02922			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	853XJ	15372028				2022-12-28	WOS:000223864000036
J	Bacci, A; Huguenard, JR; Prince, DA				Bacci, A; Huguenard, JR; Prince, DA			Long-lasting self-inhibition of neocortical interneurons mediated by endocannabinoids	NATURE			English	Article							ENDOGENOUS CANNABINOIDS; VISUAL-CORTEX; PYRAMIDAL NEURONS; CELLS; SYNAPSES; SUPPRESSION; ANANDAMIDE; RECORDINGS; CHANNELS; NETWORKS	Neocortical GABA-containing interneurons form complex functional networks responsible for feedforward and feedback inhibition and for the generation of cortical oscillations associated with several behavioural functions(1,2). We previously reported that fast-spiking (FS), but not low-threshold-spiking (LTS), neocortical interneurons from rats generate a fast and precise self-inhibition mediated by inhibitory autaptic transmission(3). Here we show that LTS cells possess a different form of self-inhibition. LTS, but not FS, interneurons undergo a prominent hyperpolarization mediated by an increased K+-channel conductance. This self-induced inhibition lasts for many minutes, is dependent on an increase in intracellular [Ca2+] and is blocked by the cannabinoid receptor antagonist AM251, indicating that it is mediated by the autocrine release of endogenous cannabinoids. Endocannabinoid-mediated slow self-inhibition represents a powerful and long-lasting mechanism that alters the intrinsic excitability of LTS neurons, which selectively target the major site of excitatory connections onto pyramidal neurons; that is, their dendrites(4-7). Thus, modulation of LTS networks after their sustained firing will lead to long-lasting changes of glutamate-mediated synaptic strength in pyramidal neurons, with consequences during normal and pathophysiological cortical network activities.	Stanford Univ, Sch Med, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA	Stanford University	Prince, DA (corresponding author), Stanford Univ, Sch Med, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA.	daprince@stanford.edu	Huguenard, John/K-6429-2019; Huguenard, John/I-5016-2012	Huguenard, John/0000-0002-6950-1191; Huguenard, John/0000-0002-6950-1191; Bacci, Alberto/0000-0002-3355-5892				Bacci A, 2003, J NEUROSCI, V23, P9664; Bacci A, 2003, J NEUROSCI, V23, P859; Beierlein M, 2000, NAT NEUROSCI, V3, P904, DOI 10.1038/78809; Chevaleyre V, 2003, NEURON, V38, P461, DOI 10.1016/S0896-6273(03)00235-6; Cravatt BF, 2001, P NATL ACAD SCI USA, V98, P9371, DOI 10.1073/pnas.161191698; Diana MA, 2003, J NEUROSCI, V23, P5906; DIMARZO V, 1994, NATURE, V372, P686, DOI 10.1038/372686a0; Freund TF, 2003, TRENDS NEUROSCI, V26, P489, DOI 10.1016/S0166-2236(03)00227-3; Freund TF, 2003, PHYSIOL REV, V83, P1017, DOI 10.1152/physrev.00004.2003; Galarreta M, 1999, NATURE, V402, P72, DOI 10.1038/47029; Gibson JR, 1999, NATURE, V402, P75, DOI 10.1038/47035; Grenier F, 2003, J NEUROPHYSIOL, V89, P841, DOI 10.1152/jn.00420.2002; Kreitzer AC, 2001, NEURON, V29, P717, DOI 10.1016/S0896-6273(01)00246-X; Kreitzer AC, 2002, NEURON, V34, P787, DOI 10.1016/S0896-6273(02)00695-5; Losonczy A, 2004, P NATL ACAD SCI USA, V101, P1362, DOI 10.1073/pnas.0304752101; MACKIE K, 1995, J NEUROSCI, V15, P6552; McBain CJ, 2001, NAT REV NEUROSCI, V2, P11, DOI 10.1038/35049047; Ohno-Shosaku T, 2001, NEURON, V29, P729, DOI 10.1016/S0896-6273(01)00247-1; Piomelli D, 2003, NAT REV NEUROSCI, V4, P873, DOI 10.1038/nrn1247; Pouzat C, 1999, J NEUROSCI, V19, P1675; Stella N, 1997, NATURE, V388, P773, DOI 10.1038/42015; Tamas G, 1997, J PHYSIOL-LONDON, V500, P715, DOI 10.1113/jphysiol.1997.sp022054; Tamas G, 1998, J NEUROSCI, V18, P4255; Thomson AM, 1997, CEREB CORTEX, V7, P510, DOI 10.1093/cercor/7.6.510; Trettel J, 2004, J PHYSIOL-LONDON, V556, P95, DOI 10.1113/jphysiol.2003.058198; Williams SR, 2002, SCIENCE, V295, P1907, DOI 10.1126/science.1067903; Wilson RI, 2001, NATURE, V410, P588, DOI 10.1038/35069076; Wischmeyer E, 1998, J BIOL CHEM, V273, P34063, DOI 10.1074/jbc.273.51.34063; Xiang ZX, 2002, J NEUROPHYSIOL, V88, P740, DOI 10.1152/jn.2002.88.2.740; Yamada M, 1998, PHARMACOL REV, V50, P723	30	214	219	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 16	2004	431	7006					312	316		10.1038/nature02913	http://dx.doi.org/10.1038/nature02913			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	853XJ	15372034				2022-12-28	WOS:000223864000042
J	Vetsch, M; Puorger, C; Spirig, T; Grauschopf, U; Weber-Ban, EU; Glockshuber, R				Vetsch, M; Puorger, C; Spirig, T; Grauschopf, U; Weber-Ban, EU; Glockshuber, R			Pilus chaperones represent a new type of protein-folding catalyst	NATURE			English	Article							DRIVES FIBER FORMATION; ESCHERICHIA-COLI; OUTER-MEMBRANE; BIOGENESIS; FIMC; PAPD; MECHANISM; SUBUNITS; BACTERIA; PATHWAY	Adhesive type 1 pili from uropathogenic Escherichia coli strains have a crucial role during infection by mediating the attachment to and potentially the invasion of host tissue. These filamentous, highly oligomeric protein complexes are assembled by the 'chaperone-usher' pathway(1), in which the individual pilus subunits fold in the bacterial periplasm and form stoichiometric complexes with a periplasmic chaperone molecule that is essential for pilus assembly(2-4). The chaperone subsequently delivers the subunits to an assembly platform (usher) in the outer membrane, which mediates subunit assembly and translocation to the cell surface(5-8). Here we show that the periplasmic type 1 pilus chaperone FimC binds non-native pilus subunits and accelerates folding of the subunit FimG by 100-fold. Moreover, we find that the FimC FimG complex is formed quantitatively and very rapidly when folding of FimG is initiated in the presence of both FimC and the assembly-competent subunit FimF, even though the FimC-FimG complex is thermodynamically less stable than the FimF-FimG complex. FimC thus represents a previously unknown type of protein-folding catalyst, and simultaneously acts as a kinetic trap preventing spontaneous subunit assembly in the periplasm.	ETH Honggerberg, Inst Mol Biol & Biophys, CH-8093 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Glockshuber, R (corresponding author), ETH Honggerberg, Inst Mol Biol & Biophys, CH-8093 Zurich, Switzerland.	rudi@mol.biol.ethz.ch		Weber-Ban, Eilika/0000-0002-5773-9274; Spirig, Thomas/0000-0001-8936-238X				BAKER D, 1992, NATURE, V356, P263, DOI 10.1038/356263a0; BALBACH J, 2000, FRONTIERS MOL BIOL; Brinker A, 2001, CELL, V107, P223, DOI 10.1016/S0092-8674(01)00517-7; Choudhury D, 1999, SCIENCE, V285, P1061, DOI 10.1126/science.285.5430.1061; DODSON KW, 1993, P NATL ACAD SCI USA, V90, P3670, DOI 10.1073/pnas.90.8.3670; EDER J, 1995, MOL MICROBIOL, V16, P609, DOI 10.1111/j.1365-2958.1995.tb02423.x; Frand AR, 2000, TRENDS CELL BIOL, V10, P203, DOI 10.1016/S0962-8924(00)01745-1; Hahn E, 2002, J MOL BIOL, V323, P845, DOI 10.1016/S0022-2836(02)01005-7; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; Hermanns U, 2000, BIOCHEMISTRY-US, V39, P11564, DOI 10.1021/bi000549a; JACOBDUBUISSON F, 1994, J BIOL CHEM, V269, P12447; Jones CH, 1997, EMBO J, V16, P6394, DOI 10.1093/emboj/16.21.6394; JONES CH, 1993, P NATL ACAD SCI USA, V90, P8397, DOI 10.1073/pnas.90.18.8397; KLEMM P, 1990, MOL GEN GENET, V220, P334; KUEHN MJ, 1991, P NATL ACAD SCI USA, V88, P10586, DOI 10.1073/pnas.88.23.10586; LINDBERG F, 1989, J BACTERIOL, V171, P6052, DOI 10.1128/jb.171.11.6052-6058.1989; Nishlyama M, 2003, J MOL BIOL, V330, P513, DOI 10.1016/S0022-2836(03)00591-6; PUGSLEY AP, 1993, MICROBIOL REV, V57, P50, DOI 10.1128/MMBR.57.1.50-108.1993; Sauer FG, 2000, CURR OPIN STRUC BIOL, V10, P548, DOI 10.1016/S0959-440X(00)00129-9; Sauer FG, 2002, CELL, V111, P543, DOI 10.1016/S0092-8674(02)01050-4; Sauer FG, 1999, SCIENCE, V285, P1058, DOI 10.1126/science.285.5430.1058; Saulino ET, 2000, P NATL ACAD SCI USA, V97, P9240, DOI 10.1073/pnas.160070497; Schiene-Fischer C, 2002, NAT STRUCT BIOL, V9, P419, DOI 10.1038/nsb804; SCHMID FX, 1983, BIOCHEMISTRY-US, V22, P4690, DOI 10.1021/bi00289a013; Thanassi DG, 1998, P NATL ACAD SCI USA, V95, P3146, DOI 10.1073/pnas.95.6.3146; Vetsch M, 2002, J MOL BIOL, V322, P827, DOI 10.1016/S0022-2836(02)00845-8; Zavialov AV, 2003, CELL, V113, P587, DOI 10.1016/S0092-8674(03)00351-9; Zavialov AV, 2002, MOL MICROBIOL, V45, P983, DOI 10.1046/j.1365-2958.2002.03066.x	28	90	95	1	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 16	2004	431	7006					329	332		10.1038/nature02891	http://dx.doi.org/10.1038/nature02891			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	853XJ	15372038				2022-12-28	WOS:000223864000046
